PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lenselink, AM; Rotaru, DC; Li, KW; van Nierop, P; Rao-Ruiz, P; Loos, M; van der Schors, R; Gouwenberg, Y; Wortel, J; Mansvelder, HD; Smit, AB; Spijker, S				Lenselink, A. Mariette; Rotaru, Diana C.; Li, Ka Wan; van Nierop, Pim; Rao-Ruiz, Priyanka; Loos, Maarten; van der Schors, Roel; Gouwenberg, Yvonne; Wortel, Joke; Mansvelder, Huibert D.; Smit, August B.; Spijker, Sabine			Strain Differences in Presynaptic Function: PROTEOMICS, ULTRASTRUCTURE, AND PHYSIOLOGY OF HIPPOCAMPAL SYNAPSES IN DBA/2J AND C57Bl/6J MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; exocytosis; neuroscience; neurotransmitter release; proteomics; synaptic plasticity; RASAL1; iTRAQ; presynaptic	PROTEIN-KINASE-C; GTPASE-ACTIVATING PROTEINS; INBRED MOUSE STRAINS; DEPENDENT DIFFERENCES; SYNAPTIC PLASTICITY; CA2+ OSCILLATIONS; GAP1 FAMILY; WATER MAZE; MEMORY; RAS	Background: The inbred mouse strain DBA/2J shows impaired hippocampal memory formation, which has been attributed to postsynaptic changes. Results: DBA/2J shows reduced expression of exocytosis proteins, paired-pulse facilitation, and number of synaptic vesicles. Conclusion: Proteomic, ultrastructural, and physiological investigations suggest a deficit in presynaptic function in DBA/2J. Significance: This is the first study describing the DBA/2J hippocampal proteome and ultrastructure. The inbred strains C57BL/6J and DBA/2J (DBA) display striking differences in a number of behavioral tasks depending on hippocampal function, such as contextual memory. Historically, this has been explained through differences in postsynaptic protein expression underlying synaptic transmission and plasticity. We measured the synaptic hippocampal protein content (iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) and mass spectrometry), CA1 synapse ultrastructural morphology, and synaptic functioning in adult C57BL/6J and DBA mice. DBA mice showed a prominent decrease in the Ras-GAP calcium-sensing protein RASAL1. Furthermore, expression of several presynaptic markers involved in exocytosis, such as syntaxin (Stx1b), Ras-related proteins (Rab3a/c), and rabphilin (Rph3a), was reduced. Ultrastructural analysis of CA1 hippocampal synapses showed a significantly lower number of synaptic vesicles and presynaptic cluster size in DBA mice, without changes in postsynaptic density or active zone. In line with this compromised presynaptic morphological and molecular phenotype in DBA mice, we found significantly lower paired-pulse facilitation and enhanced short term depression of glutamatergic synapses, indicating a difference in transmitter release and/or refilling mechanisms. Taken together, our data suggest that in addition to strain-specific postsynaptic differences, the change in dynamic properties of presynaptic transmitter release may underlie compromised synaptic processing related to cognitive functioning in DBA mice.	[Lenselink, A. Mariette; Rotaru, Diana C.; Li, Ka Wan; van Nierop, Pim; Rao-Ruiz, Priyanka; Loos, Maarten; van der Schors, Roel; Gouwenberg, Yvonne; Smit, August B.; Spijker, Sabine] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Rotaru, Diana C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands; [Wortel, Joke] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), CNCR, Dept Mol & Cellular Neurobiol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.spijker@vu.nl	Mansvelder, Huibert/N-6138-2018; Rotaru, Diana/AAZ-9058-2020	Mansvelder, Huibert/0000-0003-1365-5340; li, ka wan/0000-0001-6983-5055; Rao-Ruiz, Priyanka/0000-0001-9504-1427; Spijker, Sabine/0000-0002-6814-2019	NeuroBsik grant; Center for Medical Systems Biology; Netherlands Consortium for Systems Biology [050-060-409]; Dutch Medical Research Council [ZonMW 912-04-022, HEALTH-2009-2.1.2-1 EU-FP7 "SynSys", 242167]	NeuroBsik grant; Center for Medical Systems Biology; Netherlands Consortium for Systems Biology; Dutch Medical Research Council(Danish Medical Research Council)	This work was supported by a NeuroBsik grant to the Dutch Mouse Phenomics consortium (to A. B. S., K. W. L., and S. S.), the Center for Medical Systems Biology (to A. B. S., K. W. L., and S. S.), Netherlands Consortium for Systems Biology Grant 050-060-409 (to M. L. and S. S.), Dutch Medical Research Council Grant ZonMW 912-04-022, and HEALTH-2009-2.1.2-1 EU-FP7 "SynSys" Grant 242167 (to A. B. S., K. W. L., and S. S.).	Andre JM, 2012, BEHAV NEUROSCI, V126, P249, DOI 10.1037/a0027048; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; BOWERS BJ, 1995, J NEUROCHEM, V64, P2737; Cijsouw T, 2014, J CELL BIOL, V204, P759, DOI 10.1083/jcb.201308026; Counotte DS, 2010, EUR J NEUROSCI, V32, P1452, DOI 10.1111/j.1460-9568.2010.07404.x; Craske H, 1999, P NATL ACAD SCI USA, V96, P4426, DOI 10.1073/pnas.96.8.4426; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; FORDYCE DE, 1995, BRAIN RES, V672, P170, DOI 10.1016/0006-8993(94)01389-Y; Giese KP, 2013, LEARN MEMORY, V20, P540, DOI 10.1101/lm.028449.112; Goudriaan A, 2014, SCHIZOPHRENIA BULL, V40, P925, DOI 10.1093/schbul/sbt109; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Izquierdo I, 2000, BEHAV PHARMACOL, V11, P517, DOI 10.1097/00008877-200011000-00001; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jones MW, 2001, HIPPOCAMPUS, V11, P391, DOI 10.1002/hipo.1053.abs; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Klemmer P, 2011, J BIOL CHEM, V286, P25495, DOI 10.1074/jbc.M110.210260; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; Menard C, 2004, BRAIN RES, V1010, P134, DOI 10.1016/j.brainres.2004.03.012; Meyer-Arendt K, 2011, J PROTEOME RES, V10, P3060, DOI 10.1021/pr200039p; Nguyen PV, 2000, J NEUROPHYSIOL, V84, P2484, DOI 10.1152/jn.2000.84.5.2484; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Paylor R, 1996, BEHAV NEUROSCI, V110, P1415, DOI 10.1037/0735-7044.110.6.1415; Rao-Ruiz P, 2015, HIPPOCAMPUS, V25, P1250, DOI 10.1002/hipo.22432; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; Schimanski LA, 2005, BEHAV NEUROSCI, V119, P38, DOI 10.1037/0735-7044.119.1.38; Schimanski LA, 2004, NEUROSCI BIOBEHAV R, V28, P463, DOI 10.1016/j.neubiorev.2004.04.002; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Sot B, 2013, P NATL ACAD SCI USA, V110, P111, DOI 10.1073/pnas.1201658110; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; Verbich D, 2012, GLIA, V60, P1067, DOI 10.1002/glia.22335; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197; WEHNER JM, 1990, BRAIN RES, V523, P181, DOI 10.1016/0006-8993(90)91485-Y; Wollert T, 2011, J BIOL CHEM, V286, P14352, DOI 10.1074/jbc.M110.187286; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034; Zilles K, 2000, HIPPOCAMPUS, V10, P213, DOI 10.1002/1098-1063(2000)10:3<213::AID-HIPO2>3.0.CO;2-Q	51	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15635	15645		10.1074/jbc.M114.628776	http://dx.doi.org/10.1074/jbc.M114.628776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25911096	Green Published, hybrid			2022-12-26	WOS:000356527400027
J	Yang, J; Tan, GQ; Zhang, T; White, RH; Lu, JX; Ding, HG				Yang, Jing; Tan, Guoqiang; Zhang, Ting; White, Robert H.; Lu, Jianxin; Ding, Huangen			Deletion of the Proposed Iron Chaperones IscA/SufA Results in Accumulation of a Red Intermediate Cysteine Desulfurase IscS in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; SCAFFOLD PROTEIN ISCU; BACTERIAL FRATAXIN; BINDING ACTIVITY; FUNCTIONAL-CHARACTERIZATION; MONOTHIOL GLUTAREDOXINS; 2FE-2S CLUSTERS; BOUND FORMS; BIOGENESIS; CYAY	In Escherichia coli, sulfur in iron-sulfur clusters is primarily derived from L-cysteine via the cysteine desulfurase IscS. However, the iron donor for iron-sulfur cluster assembly remains elusive. Previous studies have shown that, among the iron-sulfur cluster assembly proteins in E. coli, IscA has a unique and strong iron-binding activity and that the iron-bound IscA can efficiently provide iron for iron-sulfur cluster assembly in proteins in vitro, indicating that IscA may act as an iron chaperone for iron-sulfur cluster biogenesis. Here we report that deletion of IscA and its paralog SufA in E. coli cells results in the accumulation of a red-colored cysteine desulfurase IscS under aerobic growth conditions. Depletion of intracellular iron using a membrane-permeable iron chelator, 2,2'-dipyridyl, also leads to the accumulation of red IscS in wild-type E. coli cells, suggesting that the deletion of IscA/SufA may be emulated by depletion of intracellular iron. Purified red IscS has an absorption peak at 528 nm in addition to the peak at 395 nm of pyridoxal 5'-phosphate. When red IscS is oxidized by hydrogen peroxide, the peak at 528 nm is shifted to 510 nm, which is similar to that of alanine-quinonoid intermediate in cysteine desulfurases. Indeed, red IscS can also be produced in vitro by incubating wild-type IscS with excess L-alanine and sulfide. The results led us to propose that deletion of IscA/SufA may disrupt the iron delivery for iron-sulfur cluster biogenesis, therefore impeding sulfur delivery by IscS, and result in the accumulation of red IscS in E. coli cells.	[Yang, Jing; Tan, Guoqiang; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [White, Robert H.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Tan, Guoqiang; Zhang, Ting; Lu, Jianxin] Wenzhou Med Univ, Lab Mol Med, Wenzhou 325035, Zhejiang, Peoples R China	Louisiana State University System; Louisiana State University; Virginia Polytechnic Institute & State University; Wenzhou Medical University	Lu, JX (corresponding author), Wenzhou Med Univ, Lab Mol Med, Wenzhou 325035, Zhejiang, Peoples R China.	jxlu313@163.com; hding@lsu.edu	Regan, Clinton/E-6250-2012; Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336	National Institutes of Health [GM109399]; American Heart Association [13GRNT16890014]; Chinese National Natural Science Foundation [31228006, 31200587]; Natural Science Foundation of Zhejiang Province [LY12C05003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM109399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Award GM109399. This work was also supported by American Heart Association Grant 13GRNT16890014, Chinese National Natural Science Foundation Grants 31228006 and 31200587, and Natural Science Foundation of Zhejiang Province Grant LY12C05003.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; An XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051265; Banci L, 2014, P NATL ACAD SCI USA, V111, P6203, DOI 10.1073/pnas.1400102111; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Bitoun JP, 2008, BIOMETALS, V21, P693, DOI 10.1007/s10534-008-9154-7; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Ding BJ, 2005, BIOCHEM J, V389, P797, DOI 10.1042/BJ20050405; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702; Ding HG, 2007, J BIOL CHEM, V282, P7997, DOI 10.1074/jbc.M609665200; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; Karsten WE, 2009, BBA-GEN SUBJECTS, V1790, P575, DOI 10.1016/j.bbagen.2009.02.012; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Kim JH, 2014, J AM CHEM SOC, V136, P11586, DOI 10.1021/ja5055252; Kim JH, 2014, J AM CHEM SOC, V136, P7933, DOI 10.1021/ja501260h; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Kurihara T, 2003, BBA-PROTEINS PROTEOM, V1647, P303, DOI 10.1016/S1570-9639(03)00078-5; Landry AP, 2013, DALTON T, V42, P3100, DOI 10.1039/c2dt32000b; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Li DS, 1999, FEBS LETT, V456, P13, DOI 10.1016/S0014-5793(99)00896-0; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; Lu JX, 2010, BIOCHEM J, V428, P125, DOI 10.1042/BJ20100122; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8056, DOI 10.1021/bi300664j; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Mettert EL, 2008, J MOL BIOL, V384, P798, DOI 10.1016/j.jmb.2008.09.080; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Nuth M, 2009, J BIOL INORG CHEM, V14, P829, DOI 10.1007/s00775-009-0495-7; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pastore C, 2006, STRUCTURE, V14, P857, DOI 10.1016/j.str.2006.02.010; Roche B, 2015, MOL MICROBIOL, V95, P605, DOI 10.1111/mmi.12888; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Shakamuri P, 2012, J AM CHEM SOC, V134, P15213, DOI 10.1021/ja306061x; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Tan GQ, 2014, MOL MICROBIOL, V93, P629, DOI 10.1111/mmi.12676; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Vivas E, 2006, J BACTERIOL, V188, P1175, DOI 10.1128/JB.188.3.1175-1179.2006; Wang W, 2010, BIOCHEM J, V432, P429, DOI 10.1042/BJ20101507; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Yan R, 2014, CHEMBIOCHEM, V15, P1681, DOI 10.1002/cbic.201402211; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	70	5	7	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14226	14234		10.1074/jbc.M115.654269	http://dx.doi.org/10.1074/jbc.M115.654269			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25907559	Green Published, hybrid			2022-12-26	WOS:000355313000049
J	Hanggi, J; Langer, N; Lutz, K; Birrer, K; Merillat, S; Jancke, L				Haenggi, Juergen; Langer, Nicolas; Lutz, Kai; Birrer, Karin; Merillat, Susan; Jaencke, Lutz			Structural Brain Correlates Associated with Professional Handball Playing	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; WHITE-MATTER; CORTICAL THICKNESS; MOTOR CORTEX; FIBER TRACTS; PLASTICITY; ABNORMALITIES; ASYMMETRY; VOLUME; AREAS	Background There is no doubt that good bimanual performance is very important for skilled handball playing. The control of the non-dominant hand is especially demanding since efficient catching and throwing needs both hands. Methodology/Hypotheses We investigated training-induced structural neuroplasticity in professional handball players using several structural neuroimaging techniques and analytic approaches and also provide a review of the literature about sport-induced structural neuroplastic alterations. Structural brain adaptations were expected in regions relevant for motor and somatosensory processing such as the grey matter (GM) of the primary/secondary motor (MI/supplementary motor area, SMA) and somatosensory cortex (SI/SII), basal ganglia, thalamus, and cerebellum and in the white matter (WM) of the corticospinal tract (CST) and corpus callosum, stronger in brain regions controlling the non-dominant left hand. Results Increased GM volume in handball players compared with control subjects were found in the right MI/SI, bilateral SMA/cingulate motor area, and left intraparietal sulcus. Fractional anisotropy (FA) and axial diffusivity were increased within the right CST in handball players compared with control women. Age of handball training commencement correlated inversely with GM volume in the right and left MI/SI and years of handball training experience correlated inversely with radial diffusivity in the right CST. Subcortical structures tended to be larger in handball players. The anatomical measures of the brain regions associated with handball playing were positively correlated in handball players, but not interrelated in control women. Discussion/Conclusion Training-induced structural alterations were found in the somatosensory-motor network of handball players, more pronounced in the right hemisphere controlling the non-dominant left hand. Correlations between handball training-related measures and anatomical differences suggest neuroplastic adaptations rather than a genetic predisposition for a ball playing affinity. Investigations of neuroplasticity specifically in sportsmen might help to understand the neural mechanisms of expertise in general.	[Haenggi, Juergen; Langer, Nicolas; Lutz, Kai; Birrer, Karin; Merillat, Susan; Jaencke, Lutz] Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland; [Langer, Nicolas] CUNY, Neural Syst Lab, New York, NY 10021 USA; [Langer, Nicolas] Child Mind Inst, New York, NY USA; [Lutz, Kai] Cereneo AG, Ctr Neurol & Rehabil, Vitznau, Switzerland; [Lutz, Kai] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Birrer, Karin] Univ Childrens Hosp Zurich, Rehabil Ctr Affoltern Am Albis, Affoltern Am Albis, Switzerland; [Merillat, Susan; Jaencke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Dynam Hlth Aging, Univ Res Prior Program, Zurich, Switzerland; [Jaencke, Lutz] King Abdulaziz Univ, Dept Special Educ, Jeddah 21413, Saudi Arabia	University of Zurich; City University of New York (CUNY) System; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; King Abdulaziz University	Hanggi, J (corresponding author), Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland.	j.haenggi@psychologie.uzh.ch	Lutz, Kai/C-1433-2011	Hanggi, Jurgen/0000-0001-8124-6018; Merillat, Susan/0000-0002-0566-088X	National Centre of Competence in Research (NCCR) on Neural Plasticity and Repair; Swiss National Science Foundation (SNF) [31003A-100109]	National Centre of Competence in Research (NCCR) on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	The authors thank all volunteers for their participation in the study. The present work was supported by the National Centre of Competence in Research (NCCR) on Neural Plasticity and Repair and by the grant number 31003A-100109 awarded to L.J. from the Swiss National Science Foundation (SNF).	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Andersson JLR, 2007, TECHNICAL REPORTS; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bailey JA, 2014, J COGNITIVE NEUROSCI, V26, P755, DOI 10.1162/jocn_a_00527; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Burciu RG, 2013, J NEUROSCI, V33, P4594, DOI 10.1523/JNEUROSCI.3381-12.2013; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Causby R, 2014, PERCEPT MOTOR SKILL, V118, P765, DOI 10.2466/25.27.PMS.118k27w2; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Paola M, 2013, HUM BRAIN MAPP, V34, P2707, DOI 10.1002/hbm.22095; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Ericsson KA, 2009, ANN NY ACAD SCI, V1172, P199, DOI 10.1196/annals.1393.001; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Gaser C, 2003, J NEUROSCI, V23, P9240; Geyer S, 2004, Adv Anat Embryol Cell Biol, V174, pI; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, REV NEUROL-FRANCE, V157, P797; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huang R, 2013, BRAIN STRUCT FUNCT; Hufner K, 2011, HIPPOCAMPUS, V21, P855, DOI 10.1002/hipo.20801; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jacini Wantuir F S, 2009, J Sci Med Sport, V12, P688, DOI 10.1016/j.jsams.2008.11.004; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jancke L, 1996, PERCEPT MOTOR SKILL, V82, P735; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Johansson RS, 2006, PLOS BIOL, V4, P1025, DOI 10.1371/journal.pbio.0040158; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Langer N, 2012, NEUROLOGY, V78, P182, DOI 10.1212/WNL.0b013e31823fcd9c; Lepage JF, 2014, GENES BRAIN BEHAV, V13, P127, DOI 10.1111/gbb.12107; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Makin TR, 2013, ELIFE, V2, DOI 10.7554/eLife.01273; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Meyer M, 2014, CEREB CORTEX, V24, P2541, DOI 10.1093/cercor/bht094; Mietchen Daniel, 2009, Front Neuroinform, V3, P25, DOI 10.3389/neuro.11.025.2009; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Park IS, 2012, CEREBELLUM, V11, P925, DOI 10.1007/s12311-012-0366-6; Park IS, 2011, HUM MOVEMENT SCI, V30, P56, DOI 10.1016/j.humov.2010.09.001; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Park IS, 2006, J KOREAN MED SCI, V21, P342, DOI 10.3346/jkms.2006.21.2.342; Raznahan A, 2010, NEUROIMAGE, V49, P2915, DOI 10.1016/j.neuroimage.2009.11.057; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Schlaffke L, 2014, NEUROSCIENCE, V259, P35, DOI 10.1016/j.neuroscience.2013.11.046; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smolker HR, 2014, BRAIN STRUCT FUNCT; Steingruber HJ, 1971, ZEITSCHRIFT FUR EXPE, V18, P337, DOI [10.1107/S0108767309007235, DOI 10.1107/S0108767309007235]; Takao H, 2013, NEUROSCIENCE, V231, P1, DOI 10.1016/j.neuroscience.2012.11.038; Taubert M, 2013, POSTER PRESENTED AT; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Valko PO, 2010, EUR J NEUROL, V17, P612, DOI 10.1111/j.1468-1331.2009.02872.x; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wei GX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; Wei GX, 2009, PROG NAT SCI-MATER, V19, P1397, DOI 10.1016/j.pnsc.2008.12.009; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang HY, 2012, HIGH ALT MED BIOL, V13, P118, DOI 10.1089/ham.2011.1073; Zhang YC, 2013, MED SCI SPORT EXER, V45, P1077, DOI 10.1249/MSS.0b013e31827f4370	84	30	30	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124222	10.1371/journal.pone.0124222	http://dx.doi.org/10.1371/journal.pone.0124222			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915906	Green Accepted, Green Published, gold			2022-12-26	WOS:000353659100040
J	Yamaguchi, H; Tada, S; Nakanishi, Y; Kawaminami, S; Shin, T; Tabata, R; Yuasa, S; Shimizu, N; Kohno, M; Tsuchiya, A; Tani, K				Yamaguchi, Harutaka; Tada, Saaya; Nakanishi, Yoshinori; Kawaminami, Shingo; Shin, Teruki; Tabata, Ryo; Yuasa, Shino; Shimizu, Nobuhiko; Kohno, Mitsuhiro; Tsuchiya, Atsushi; Tani, Kenji			Association between Mouth Breathing and Atopic Dermatitis in Japanese Children 2-6 years Old: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							ADENOTONSILLAR HYPERTROPHY; SCHOOL-CHILDREN; PREVALENCE; SYMPTOMS; ASTHMA; FILAGGRIN; ECZEMA; SLEEP; NASAL; SKIN	As mouth breathing is associated with asthma and otitis media, it may be associated with other diseases. Therefore, this population-based cross-sectional study evaluated the association of mouth breathing with the prevalences of various diseases in children. Preschool children older than 2 years were included. A questionnaire was given to parents/guardians at 13 nurseries in Tokushima City. There were 468 valid responses (45.2%). We defined a subject as a mouth breather in daytime (MBD) if they had 2 or more positive items among the 3 following items: "breathes with mouth ordinarily," "mouth is open ordinarily," and "mouth is open when chewing." We defined subjects as mouth breathers during sleep (MBS) if they had 2 or more positive items among the following 3 items: "snoring," "mouth is open during sleeping," and "mouth is dry when your child gets up." The prevalences of MBD and MBS were 35.5% and 45.9%, respectively. There were significant associations between MBD and atopic dermatitis (odds ratio [OR]: 2.4, 95% confidence interval [CI]: 1.4-4.2), MBS and atopic dermatitis (OR: 2.4, 95% CI: 1.3-4.2), and MBD and asthma (OR: 2.2, 95% CI: 1.2-4.0). After adjusting for history of asthma and allergic rhinitis; family history of atopic dermatitis, asthma, and allergic rhinitis; and nasal congestion; both MBD (OR: 2.6, 95% CI: 1.3-5.4) and MBS (OR: 4.1, 95% CI: 1.8-9.2) were significantly associated with atopic dermatitis. In preschool children older than 2 years, both MBD and MBS may be associated with the onset or development of atopic dermatitis.	[Yamaguchi, Harutaka; Tada, Saaya; Shin, Teruki; Tabata, Ryo; Shimizu, Nobuhiko; Kohno, Mitsuhiro; Tani, Kenji] Univ Tokushima, Dept Gen Med, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Nakanishi, Yoshinori] Tokushima Prefecture Naruto Hosp, Naruto, Japan; [Kawaminami, Shingo] Outpatient Facil Kameda Clin, Tateyama, Toyama, Japan; [Tsuchiya, Atsushi] Univ Tokushima, Dept Civil & Environm Studies, Fac Integrated Arts & Sci, Grad Sch, Tokushima, Japan	Tokushima University; Tokushima University	Tani, K (corresponding author), Univ Tokushima, Dept Gen Med, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	taniken@tokusima-u.ac.jp						Abreu RR, 2008, J PEDIAT-BRAZIL, V84, P467, DOI 10.2223/JPED.1806; Barros Juliana R. C., 2006, J. Pediatr. (Rio J.), V82, P458; Bonuck KA, 2011, SLEEP, V34, P875, DOI 10.5665/SLEEP.1118; Camfferman D, 2010, SLEEP MED REV, V14, P359, DOI 10.1016/j.smrv.2010.01.004; Chamlin SL, 2005, ARCH PEDIAT ADOL MED, V159, P745, DOI 10.1001/archpedi.159.8.745; CHEN WY, 1982, CHEST, V81, P675, DOI 10.1378/chest.81.6.675; Costa EC, 2013, BRAZ J OTORHINOLAR, V79, P663, DOI 10.5935/1808-8694.20130123; Menezes Valdenice Aparecida De, 2006, Rev. Bras. Otorrinolaringol., V72, P394, DOI 10.1590/S0034-72992006000300017; Demir UL, 2013, AM J OTOLARYNG, V34, P501, DOI 10.1016/j.amjoto.2013.04.013; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eichenfield LF, 2003, PEDIATRICS, V111, P608, DOI 10.1542/peds.111.3.608; Elad D, 2008, RESP PHYSIOL NEUROBI, V163, P121, DOI 10.1016/j.resp.2008.05.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felcar JM, 2010, CIENC SAUDE COLETIVA, V15, P437, DOI 10.1590/S1413-81232010000200020; Garde J B, 2014, J Int Oral Health, V6, P39; Gill AI, 2012, SLEEP MED, V13, P1191, DOI 10.1016/j.sleep.2012.05.007; GRIFFIN MP, 1982, J ALLERGY CLIN IMMUN, V69, P354, DOI 10.1016/0091-6749(82)90145-2; Gudjonsson JE, 2003, BRIT J DERMATOL, V149, P530, DOI 10.1046/j.1365-2133.2003.05552.x; Hansen TE, 2013, ACTA PAEDIATR, V102, P47, DOI 10.1111/apa.12030; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Japan Health Promotion and Fitness Foundation, 2012, AD SMOK RAT NAT HLTH; Kharbanda O P, 2003, J Indian Soc Pedod Prev Dent, V21, P120; Limeira AB, 2013, EUR J PEDIATR, V172, P519, DOI 10.1007/s00431-012-1919-x; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Okabe Y, 2012, PEDIAT ALLERG IMM-UK, V23, P550, DOI 10.1111/j.1399-3038.2011.01261.x; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Satoh T, 2003, ACTA DERM-VENEREOL, V83, P376, DOI 10.1080/00015550310003728; Satoh T, 2002, J AM ACAD DERMATOL, V46, P942, DOI 10.1067/mjd.2002.120605; Shetty S R, 1998, J Indian Soc Pedod Prev Dent, V16, P61; Sigurdardottir SL, 2013, BRIT J DERMATOL, V168, P237, DOI 10.1111/j.1365-2133.2012.11215.x; Sogut A, 2009, INT J PEDIATR OTORHI, V73, P1769, DOI 10.1016/j.ijporl.2009.09.026; Sonoda T, 2001, BRIT J DERMATOL, V145, P516, DOI 10.1046/j.1365-2133.2001.04395.x; Steinsvag SK, 2007, INT J PEDIATR OTORHI, V71, P615, DOI 10.1016/j.ijporl.2006.12.012; Stensson M, 2008, INT J PAEDIATR DENT, V18, P243, DOI 10.1111/j.1365-263X.2008.00921.x; Sue-Chu M, 2012, BRIT J SPORT MED, V46, P397, DOI 10.1136/bjsports-2011-090822; Takeuchi S, 2014, J DERMATOL, V41, P200, DOI 10.1111/1346-8138.12331; The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee, 1988, LANCET, V351, P1225; Thorleifsdottir RH, 2012, J IMMUNOL, V188, P5160, DOI 10.4049/jimmunol.1102834; Trabalon M, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/207605; Valera FCP, 2003, INT J PEDIATR OTORHI, V67, P761, DOI 10.1016/S0165-5876(03)00095-8; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; VANBON MJH, 1989, INT J PEDIATR OTORHI, V17, P119, DOI 10.1016/0165-5876(89)90087-6; Verma M, 2006, J PHYSIOL-LONDON, V574, P859, DOI 10.1113/jphysiol.2005.102129; WAGAIYU EG, 1991, J CLIN PERIODONTOL, V18, P698, DOI 10.1111/j.1600-051X.1991.tb00112.x; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Yura A, 2011, PEDIAT ALLERG IMM-UK, V22, P631, DOI 10.1111/j.1399-3038.2011.01159.x	47	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125916	10.1371/journal.pone.0125916	http://dx.doi.org/10.1371/journal.pone.0125916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915864	gold, Green Published			2022-12-26	WOS:000353659100152
J	Li, LJ; Aris, I; Su, LL; Tint, MT; Cheung, CYL; Ikram, MK; Gluckman, P; Godfrey, KM; Tan, KH; Yeo, G; Yap, F; Kwek, K; Saw, SM; Chong, YS; Wong, TY; Lee, YS				Li, Ling-Jun; Aris, Izzuddin; Su, Lin Lin; Tint, Mya Thway; Cheung, Carol Yim-Lui; Ikram, M. Kamran; Gluckman, Peter; Godfrey, Keith M.; Tan, Kok Hian; Yeo, George; Yap, Fabian; Kwek, Kenneth; Saw, Seang-Mei; Chong, Yap-Seng; Wong, Tien-Yin; Lee, Yung Seng			Associations of Maternal Retinal Vasculature with Subsequent Fetal Growth and Birth Size	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; VELOCITY WAVE-FORMS; BLOOD-FLOW; RISK-FACTORS; MICROVASCULAR CHARACTERISTICS; HEMODYNAMIC-CHANGES; PREGNANCY; PREECLAMPSIA; WEIGHT; ULTRASOUND	Objective We aimed to study the maternal retinal microvasculature at mid-trimester and its relationship with subsequent fetal growth and birth size. Methods We recruited 732 pregnant women aged 18-46 years in the first trimester with singleton pregnancies. All had retinal photography and fetal scan performed at 26-28 weeks gestation, and subsequent fetal scan at 32-34 weeks gestation. Infant anthropometric measurements were done at birth. Retinal microvasculature was measured using computer software from the retinal photographs. Results In multiple linear regression models, each 10 mu m narrowing in maternal retinal arteriolar caliber was associated with decreases of 1.36 mm in fetal head circumference at 32-34 weeks gestation, as well as decreases of 1.50 mm and 2.30 mm in infant head circumference and birth length at delivery, respectively. Each standard deviation decrease in maternal retinal arteriolar fractal dimension was associated with decreases of 1.55 mm in fetal head circumference at 32-34 weeks gestation, as well as decreases of 1.08 mm and 46.42 g in infant head circumference and birth weight at delivery, respectively. Conclusions Narrower retinal arteriolar caliber and a sparser retinal vascular network in mothers, reflecting a suboptimal uteroplacental microvasculature during mid-pregnancy, were associated with poorer fetal growth and birth size.	[Li, Ling-Jun; Cheung, Carol Yim-Lui; Ikram, M. Kamran; Saw, Seang-Mei; Wong, Tien-Yin] Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore; [Aris, Izzuddin; Lee, Yung Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117548, Singapore; [Su, Lin Lin; Tint, Mya Thway; Chong, Yap-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore 117548, Singapore; [Cheung, Carol Yim-Lui] DUKE NUS Grad Med Sch, Singapore, Singapore; [Ikram, M. Kamran] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Kamran] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Ikram, M. Kamran] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore; [Gluckman, Peter; Lee, Yung Seng] Singapore Inst Clin Sci, Agcy Sci Technol & Res, Singapore, Singapore; [Godfrey, Keith M.] Univ Southampton, Biomed Res Ctr, Med Res Council Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, Biomed Res Ctr, NIHR Southampton, Southampton, Hants, England; [Tan, Kok Hian; Yeo, George; Yap, Fabian; Kwek, Kenneth] KK Womens & Childrens Hosp, Singapore, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wong, Tien-Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117548, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Southampton; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore	Wong, TY (corresponding author), Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore.	wong.tien.yin@snec.com.sg; yung_seng_lee@nuhs.edu.sg	Tint, Mya-Thway/HGU-1202-2022; Aris, Izzuddin/C-1855-2017; Lee, Yung Seng/F-2169-2014; Wong, Tien Yin/AAC-9724-2020; Cheung, Carol Y./G-7895-2016; Cheung, Carol/AAF-1101-2020; Tan, Kok Hian/AFS-6514-2022	Aris, Izzuddin/0000-0002-9239-7476; Lee, Yung Seng/0000-0002-1253-0557; Wong, Tien Yin/0000-0002-8448-1264; Cheung, Carol/0000-0002-9672-1819; Godfrey, Keith/0000-0002-4643-0618; Ikram, Mohammad Kamran/0000-0003-0173-9571; Yap, Fabian/0000-0003-1083-7958; Tan, Kok Hian/0000-0003-1945-0266; Cheung, Carol/0000-0003-0869-859X; TINT, Mya Thway/0000-0002-9548-7186; Chong, Yap Seng/0000-0002-7232-8473	National Research Foundation (NRF) [NMRC/TCR/004-NUS/2008]; MRC [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: researchfish	National Research Foundation (NRF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is under the Translational Clinical Research (TCR) Flagship Program on Developmental Pathways to Metabolic Disease, NMRC/TCR/004-NUS/2008 funded by the National Research Foundation (NRF) and administered by the National Medical Research Council (NMRC), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaiges G, 2003, ULTRASOUND OBST GYN, V21, P170, DOI 10.1002/uog.30; Amit A, 1998, ULTRASOUND OBST GYN, V11, P94, DOI 10.1046/j.1469-0705.1998.11020094.x; Aris IM, 2014, J CLIN ENDOCR METAB, V99, P240, DOI 10.1210/jc.2013-2738; Baykal Cem, 2004, Archives of Gynecology and Obstetrics, V270, P99; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; BOWER S, 1993, BRIT J OBSTET GYNAEC, V100, P989, DOI 10.1111/j.1471-0528.1993.tb15139.x; CHANDLER KD, 1985, BRIT J NUTR, V53, P625, DOI 10.1079/BJN19850072; CHANG TC, 1993, J CLIN ULTRASOUND, V21, P515, DOI 10.1002/jcu.1870210808; Chapman AB, 1997, AM J PHYSIOL-RENAL, V273, pF777, DOI 10.1152/ajprenal.1997.273.5.F777; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CY, 2011, J HYPERTENS, V29, P1380, DOI 10.1097/HJH.0b013e328347266c; Daien V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071089; Daien V, 2013, ACTA OPHTHALMOL, V91, pE283, DOI 10.1111/aos.12094; Deloison B, 2012, BJOG-INT J OBSTET GY, V119, P626, DOI 10.1111/j.1471-0528.2011.03251.x; Dudley NJ, 2005, ULTRASOUND OBST GYN, V25, P80, DOI 10.1002/uog.1751; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; El Assaad MA, 2002, BLOOD PRESS MONIT, V7, P237, DOI 10.1097/00126097-200208000-00006; Filly RA, 2000, ULTRASONOGRAPHY OBST, P146; Grab D, 2000, ULTRASOUND OBST GYN, V15, P19, DOI 10.1046/j.1469-0705.2000.00009.x; Greiss FC, 2008, UTERINE PLACENTAL BL, P1756; Gull I, 2002, ULTRASOUND OBST GYN, V20, P57, DOI 10.1046/j.1469-0705.2002.00742.x; HADLOCK FP, 1982, AM J ROENTGENOL, V138, P649, DOI 10.2214/ajr.138.4.649; HENDRICKS SK, 1989, AM J OBSTET GYNECOL, V161, P761, DOI 10.1016/0002-9378(89)90397-9; Heringa SM, 2013, J CEREBR BLOOD F MET, V33, P983, DOI 10.1038/jcbfm.2013.58; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Irion O, 1998, BRIT J OBSTET GYNAEC, V105, P422, DOI 10.1111/j.1471-0528.1998.tb10128.x; JACKSON MR, 1995, AM J OBSTET GYNECOL, V172, P518, DOI 10.1016/0002-9378(95)90566-9; Khan F, 2005, HYPERTENSION, V46, P1123, DOI 10.1161/01.HYP.0000186328.90667.95; Khan F, 2010, MICROCIRCULATION, V17, P608, DOI 10.1111/j.1549-8719.2010.00055.x; Kliman HJ, 2000, AM J PATHOL, V157, P1759, DOI 10.1016/S0002-9440(10)64813-4; Li LJ, 2012, OBSTET GYNECOL, V120, P627, DOI 10.1097/AOG.0b013e3182639577; Li LJ, 2012, HYPERTENSION, V60, P223, DOI 10.1161/HYPERTENSIONAHA.112.195404; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Lupton SJ, 2013, HYPERTENSION, V62, P899, DOI 10.1161/HYPERTENSIONAHA.113.01890; Luther Justin S, 2005, Hum Fertil (Camb), V8, P179, DOI 10.1080/14647270500320121; MAINSTER MA, 1990, EYE, V4, P235, DOI 10.1038/eye.1990.33; Melchiorre K, 2009, ULTRASOUND OBST GYN, V33, P524, DOI 10.1002/uog.6368; METCALFE J, 1974, Progress in Cardiovascular Diseases, V16, P363, DOI 10.1016/0033-0620(74)90028-0; Neri I, 1996, ACTA OBSTET GYN SCAN, V75, P208, DOI 10.3109/00016349609047088; NORTH RA, 1994, OBSTET GYNECOL, V83, P378; NOVY MJ, 1975, AM J OBSTET GYNECOL, V122, P419, DOI 10.1016/S0002-9378(16)33533-5; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Pardi G, 2006, AM J OBSTET GYNECOL, V194, P1088, DOI 10.1016/j.ajog.2005.12.056; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; PHIPPARD AF, 1986, J HYPERTENS, V4, P773, DOI 10.1097/00004872-198612000-00013; Predanic M, 2002, J ULTRAS MED, V21, P495, DOI 10.7863/jum.2002.21.5.495; Regnault TRH, 2002, PLACENTA, V23, pS119, DOI 10.1053/plac.2002.0792; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Shalev I, 2013, PSYCHOL SCI, V24, P1198, DOI 10.1177/0956797612470959; SHEPARD MJ, 1982, AM J OBSTET GYNECOL, V142, P47; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Soh SE, 2013, INT J EPIDEMIOL; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Thornburg KL, 2000, SEMIN PERINATOL, V24, P11, DOI 10.1016/S0146-0005(00)80047-6; UELAND K, 1976, AM J OBSTET GYNECOL, V126, P671, DOI 10.1016/0002-9378(76)90517-2; VINTZILEOS AM, 1984, OBSTET GYNECOL, V64, P779; Wallace JM, 2002, AM J PHYSIOL-REG I, V282, pR1027, DOI 10.1152/ajpregu.00465.2001; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; ZAMIR M, 1976, J THEOR BIOL, V62, P227, DOI 10.1016/0022-5193(76)90058-8	61	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0118250	10.1371/journal.pone.0118250	http://dx.doi.org/10.1371/journal.pone.0118250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909909	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353376800003
J	Takagishi, T; Oda, M; Kabura, M; Kurosawa, M; Tominaga, K; Urano, S; Ueda, Y; Kobayashi, K; Kobayashi, T; Sakurai, J; Terao, Y; Nagahama, M				Takagishi, Teruhisa; Oda, Masataka; Kabura, Michiko; Kurosawa, Mie; Tominaga, Kaori; Urano, Shiori; Ueda, Yoshibumi; Kobayashi, Keiko; Kobayashi, Toshihide; Sakurai, Jun; Terao, Yutaka; Nagahama, Masahiro			Clostridium perfringens Alpha-Toxin Induces Gm1a Clustering and Trka Phosphorylation in the Host Cell Membrane	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHOLIPASE-C; TRANSBILAYER MOVEMENT; LEUKOCYTE ADHERENCE; DIACYLGLYCEROL; METABOLISM; PATHOGENESIS; ACTIVATION; HEMOLYSIS; CERAMIDE	Clostridium perfringens alpha-toxin elicits various immune responses such as the release of cytokines, chemokines, and superoxide via the GM1a/TrkA complex. Alpha-toxin possesses phospholipase C (PLC) hydrolytic activity that contributes to signal transduction in the pathogenesis of gas gangrene. Little is known about the relationship between lipid metabolism and TrkA activation by alpha-toxin. Using live-cell fluorescence microscopy, we monitored transbilayer movement of diacylglycerol (DAG) with the yellow fluorescent protein-tagged C1AB domain of protein kinase C-gamma (EYFP-C1AB). DAG accumulated at the marginal region of the plasma membrane in alpha toxin-treated A549 cells, which also exhibited GM1a clustering and TrkA phosphorylation. Annexin V binding assays showed that alpha-toxin induced the exposure of phosphatidylserine on the outer leaflet of the plasma membrane. However, H148G, a variant toxin which binds cell membrane and has no enzymatic activity, did not induce DAG translocation, GM1a clustering, or TrkA phosphorylation. Alpha-toxin also specifically activated endogenous phospholipase C gamma-1 (PLC gamma-1), a TrkA adaptor protein, via phosphorylation. U73122, an endogenous PLC inhibitor, and siRNA for PLC gamma-1 inhibited the formation of DAG and release of IL-8. GM1a accumulation and TrkA phosphorylation in A549 cells treated with alpha-toxin were also inhibited by U73122. These results suggest that the flip-flop motion of hydrophobic lipids such as DAG leads to the accumulation of GM1a and TrkA. We conclude that the formation of DAG by alpha-toxin itself (first step) and activation of endogenous PLC gamma-1 (second step) leads to alterations in membrane dynamics, followed by strong phosphorylation of TrkA.	[Takagishi, Teruhisa; Oda, Masataka; Kabura, Michiko; Tominaga, Kaori; Urano, Shiori; Kobayashi, Keiko; Sakurai, Jun; Nagahama, Masahiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Tokushima 7708514, Japan; [Oda, Masataka; Kurosawa, Mie; Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, Niigata 25274, Japan; [Ueda, Yoshibumi] Kanazawa Med Univ, Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan; [Kobayashi, Toshihide] RIKEN, Rikagaku Kenkyujo, Lipid Biol Lab, Wako, Saitama 3510198, Japan	Tokushima Bunri University; Niigata University; Kanazawa Medical University; RIKEN	Oda, M (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro Cho 180, Tokushima 7708514, Japan.	masataka@dent.niigata-u.ac.jp	Oda, Masataka/ABG-6047-2020; KOBAYASHI, TOSHIHIDE/S-8313-2019; Ueda, Yoshibumi/AHA-4956-2022	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Ueda, Yoshibumi/0000-0003-1500-3469; Terao, Yutaka/0000-0002-4450-5583	JSPS KAKENHI Grant [24590542]; Takeda Science Foundation	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was supported by JSPS KAKENHI Grant Number 24590542 and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN D, 1978, NATURE, V276, P289, DOI 10.1038/276289a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bryant AE, 1996, INFECT IMMUN, V64, P358, DOI 10.1128/IAI.64.1.358-362.1996; Bryant AE, 2012, EXPERT REV ANTI-INFE, V10, P1, DOI [10.1586/ERI.11.147, 10.1586/eri.11.147]; Bunting M, 1997, J CLIN INVEST, V100, P565, DOI 10.1172/JCI119566; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; CARVETH HJ, 1989, BIOCHEM BIOPH RES CO, V162, P387, DOI 10.1016/0006-291X(89)92009-3; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Contreras F. -Xabier, 2009, V462, P155, DOI 10.1007/978-1-60327-115-8_10; Flores-Diaz M, 2003, TOXICON, V42, P979, DOI 10.1016/j.toxicon.2003.11.013; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HAMILTON JA, 1991, J BIOL CHEM, V266, P1177; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Lattanzio Rossano, 2013, Advances in Biological Regulation, V53, P309, DOI 10.1016/j.jbior.2013.07.006; Monturiol-Gross L, 2014, CELL MICROBIOL, V16, P535, DOI 10.1111/cmi.12237; Monturiol-Gross L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086475; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; NAGAHAMA M, 1995, J BACTERIOL, V177, P1179, DOI 10.1128/jb.177.5.1179-1185.1995; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Ochi S, 2002, MICROBIOL-SGM, V148, P237, DOI 10.1099/00221287-148-1-237; Ochi S, 1996, INFECT IMMUN, V64, P3930, DOI 10.1128/IAI.64.9.3930-3933.1996; Oda M, 2006, INFECT IMMUN, V74, P2876, DOI 10.1128/IAI.74.5.2876-2886.2006; Oda M, 2008, J PHARMACOL EXP THER, V327, P934, DOI 10.1124/jpet.108.143677; Oda M, 2008, J LIPID RES, V49, P1039, DOI 10.1194/jlr.M700587-JLR200; Oda M, 2012, J BIOL CHEM, V287, P33070, DOI 10.1074/jbc.M112.393801; Oda M, 2012, BBA-MOL BASIS DIS, V1822, P1581, DOI 10.1016/j.bbadis.2012.06.007; Oda M, 2011, BIOCHEM BIOPH RES CO, V411, P241, DOI 10.1016/j.bbrc.2011.06.103; Ogushi F, 2012, CHEM PHYS LETT, V522, P96, DOI 10.1016/j.cplett.2011.11.057; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; SAKURAI J, 1994, INFECT IMMUN, V62, P717, DOI 10.1128/IAI.62.2.717-721.1994; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Stevens DL, 2012, ANAEROBE, V18, P254, DOI 10.1016/j.anaerobe.2011.11.001; Stevens DL, 1997, CLIN INFECT DIS, V25, pS160, DOI 10.1086/516249; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; TITBALL RW, 1993, FEMS MICROBIOL LETT, V110, P45, DOI 10.1016/0378-1097(93)90240-3; Titball RW, 1997, TRENDS MICROBIOL, V5, P265, DOI 10.1016/S0966-842X(97)88834-8; Ueda Y, 2013, FASEB J, V27, P3284, DOI 10.1096/fj.12-226548; Urbina P, 2011, BBA-BIOMEMBRANES, V1808, P2618, DOI 10.1016/j.bbamem.2011.06.008; Urbina P, 2011, BBA-BIOMEMBRANES, V1808, P279, DOI 10.1016/j.bbamem.2010.08.011; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	50	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0120497	10.1371/journal.pone.0120497	http://dx.doi.org/10.1371/journal.pone.0120497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910247	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800009
J	Tian, FX; Zang, JL; Wang, T; Xie, YL; Zhang, J; Hu, JJ				Tian, Feng-Xia; Zang, Jian-Lei; Wang, Tan; Xie, Yu-Li; Zhang, Jin; Hu, Jian-Jun			Aldehyde Dehydrogenase Gene Superfamily in Populus: Organization and Expression Divergence between Paralogous Gene Pairs	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ARABIDOPSIS-THALIANA; COMPREHENSIVE ANALYSIS; TOBACCO PLANTS; STRESS; RICE; EVOLUTIONARY; POPLAR; FAMILY; TOLERANCE	Aldehyde dehydrogenases (ALDHs) constitute a superfamily of NAD(P)+-dependent enzymes that catalyze the irreversible oxidation of a wide range of reactive aldehydes to their corresponding nontoxic carboxylic acids. ALDHs have been studied in many organisms from bacteria to mammals; however, no systematic analyses incorporating genome organization, gene structure, expression profiles, and cis-acting elements have been conducted in the model tree species Populus trichocarpa thus far. In this study, a comprehensive analysis of the Populus ALDH gene superfamily was performed. A total of 26 Populus ALDH genes were found to be distributed across 12 chromosomes. Genomic organization analysis indicated that purifying selection may have played a pivotal role in the retention and maintenance of PtALDH gene families. The exon-intron organizations of PtALDHs were highly conserved within the same family, suggesting that the members of the same family also may have conserved functionalities. Microarray data and qRT-PCR analysis indicated that most PtALDHs had distinct tissue-specific expression patterns. The specificity of cis-acting elements in the promoter regions of the PtALDHs and the divergence of expression patterns between nine paralogous PtALDH gene pairs suggested that gene duplications may have freed the duplicate genes from the functional constraints. The expression levels of some ALDHs were up-or down-regulated by various abiotic stresses, implying that the products of these genes may be involved in the adaptation of Populus to abiotic stresses. Overall, the data obtained from our investigation contribute to a better understanding of the complexity of the Populus ALDH gene superfamily and provide insights into the function and evolution of ALDH gene families in vascular plants.	[Tian, Feng-Xia; Zang, Jian-Lei; Wang, Tan; Xie, Yu-Li] Nanyang Normal Univ, Coll Life Sci & Technol, Nanyang 473061, Henan, Peoples R China; [Tian, Feng-Xia; Zang, Jian-Lei; Wang, Tan; Xie, Yu-Li; Zhang, Jin; Hu, Jian-Jun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing 100091, Peoples R China; [Zhang, Jin] Chinese Acad Forestry, Res Inst Wood Ind, Beijing 100091, Peoples R China	Nanyang Normal College; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Wood Industry, CAF	Zhang, J (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing 100091, Peoples R China.	Zhang007jin@163.com; Hujj@caf.ac.cn	Zhang, Jin/J-9618-2019	Zhang, Jin/0000-0002-8397-5078	National Nonprofit Institute Research Grant of CAF [CAFYBB2014ZX001-4, TGB2013009]; China Postdoctoral Science Foundation [2014M550104]	National Nonprofit Institute Research Grant of CAF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Nonprofit Institute Research Grant of CAF [CAFYBB2014ZX001-4] and [TGB2013009] to JJH and the China Postdoctoral Science Foundation [2014M550104] to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; Brunner AM, 2004, TRENDS PLANT SCI, V9, P49, DOI 10.1016/j.tplants.2003.11.006; Chai GH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-253; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; Guillaumie S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-71; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hofberger JA, 2015, GENOME BIOL EVOL; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang WZ, 2008, PLANT MOL BIOL, V68, P451, DOI 10.1007/s11103-008-9382-9; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kotchoni S, 2003, BULG J PLANT PHYSL S, V2003, P37; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li XQ, 2013, PLANT PHYSIOL BIOCH, V71, P268, DOI 10.1016/j.plaphy.2013.07.017; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Liu F, 2002, PLANT PHYSIOL, V130, P1657, DOI 10.1104/pp.012336; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nuruzzaman M, 2012, BIOCHEM BIOPH RES CO, V423, P417, DOI 10.1016/j.bbrc.2012.05.142; Ohno S., 1970, P1; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Skibbe David S., 2002, Plant Molecular Biology, V48, P751, DOI 10.1023/A:1014870429630; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsuji H, 2003, GENE, V305, P195, DOI 10.1016/S0378-1119(03)00383-4; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Walsh B, 2003, GENETICA, V118, P279, DOI 10.1023/A:1024194802441; Weston DJ, 2011, PLANT CELL ENVIRON, V34, P1488, DOI 10.1111/j.1365-3040.2011.02347.x; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang JL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1555-8; Zhou ML, 2012, FUNCT INTEGR GENOMIC, V12, P683, DOI 10.1007/s10142-012-0290-3	63	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124669	10.1371/journal.pone.0124669	http://dx.doi.org/10.1371/journal.pone.0124669			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909656	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800099
J	Austin, PJ; Bembrick, AL; Denyer, GS; Keay, KA				Austin, Paul J.; Bembrick, Alison L.; Denyer, Gareth S.; Keay, Kevin A.			Injury-Dependent and Disability-Specific Lumbar Spinal Gene Regulation following Sciatic Nerve Injury in the Rat	PLOS ONE			English	Article							CHRONIC CONSTRICTION INJURY; CATECHOL-O-METHYLTRANSFERASE; PERIPHERAL BENZODIAZEPINE-RECEPTOR; SUBSTANTIA-GELATINOSA NEURONS; IMAGE NEUROPATHIC PAIN; LONG-TERM CHANGES; DORSAL-HORN; CENTRAL SENSITIZATION; ANIMAL-MODEL; NOCICEPTIVE NEURONS	Allodynia, hyperalgesia and spontaneous pain are cardinal sensory signs of neuropathic pain. Clinically, many neuropathic pain patients experience affective-motivational state changes, including reduced familial and social interactions, decreased motivation, anhedonia and depression which are severely debilitating. In earlier studies we have shown that sciatic nerve chronic constriction injury (CCI) disrupts social interactions, sleep-wake-cycle and endocrine function in one third of rats, a subgroup reliably identified six days after injury. CCI consistently produces allodynia and hyperalgesia, the intensity of which was unrelated either to the altered social interactions, sleep-wake-cycle or endocrine changes. This decoupling of the sensory consequences of nerve injury from the affective-motivational changes is reported in both animal experiments and human clinical data. The sensory changes triggered by CCI are mediated primarily by functional changes in the lumbar dorsal horn, however, whether lumbar spinal changes may drive different affective-motivational states has never been considered. In these studies, we used microarrays to identify the unique transcriptomes of rats with altered social behaviours following sciatic CCI to determine whether specific patterns of lumbar spinal adaptations characterised this subgroup. Rats underwent CCI and on the basis of reductions in dominance behaviour in resident-intruder social interactions were categorised as having Pain & Disability, Pain & Transient Disability or Pain alone. We examined the lumbar spinal transcriptomes two and six days after CCI. Fifty-four 'disability-specific' genes were identified. Sixty-five percent were unique to Pain & Disability rats, two-thirds of which were associated with neurotransmission, inflammation and/or cellular stress. In contrast, 40% of genes differentially regulated in rats without disabilities were involved with more general homeostatic processes (cellular structure, transcription or translation). We suggest that these patterns of gene expression lead to either the expression of disability, or to resilience and recovery, by modifying local spinal circuitry at the origin of ascending supraspinal pathways.	[Austin, Paul J.; Bembrick, Alison L.; Keay, Kevin A.] Univ Sydney, Sch Med Sci Anat & Histol, Sydney, NSW 2006, Australia; [Denyer, Gareth S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Keay, KA (corresponding author), Univ Sydney, Sch Med Sci Anat & Histol, Sydney, NSW 2006, Australia.	keay@anatomy.usyd.edu.au	Denyer, Gareth/M-5417-2016	Denyer, Gareth/0000-0003-1551-3936; Austin, Paul/0000-0001-5253-6876; Keay, Kevin Anthony/0000-0003-3934-4380	National Health and Medical Research Council [457490]; NWG Macintosh Memorial Research Fund	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NWG Macintosh Memorial Research Fund	Support was provided by the National Health and Medical Research Council (# 457490; KAK [https://www.nhmrc.gov.au/] NWG Macintosh Memorial Research Fund (KAK; ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Ahmadi S, 2001, MOL PHARMACOL, V59, P612, DOI 10.1124/mol.59.3.612; Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; Andersen ML, 2003, BRAIN RES, V984, P84, DOI 10.1016/S0006-8993(03)03095-6; Andersen ML, 2009, PROG NEURO-PSYCHOPH, V33, P960, DOI 10.1016/j.pnpbp.2009.04.022; Austin PJ, 2010, NEUROSCIENCE, V171, P329, DOI 10.1016/j.neuroscience.2010.08.040; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Avila-Martin G, 2015, EUR J PAIN, V19, P111, DOI 10.1002/ejp.528; Bai HP, 2014, J NEUROL SCI, V341, P68, DOI 10.1016/j.jns.2014.04.002; Baird AJ, 2013, PHYS THER, V93, P1615, DOI 10.2522/ptj.20120429; Bardin L, 2000, PAIN, V86, P11, DOI 10.1016/S0304-3959(99)00307-3; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bhangoo SK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-48; Bond BC, 2002, MOL BRAIN RES, V106, P101, DOI 10.1016/S0169-328X(02)00417-5; Bravo L, 2012, ANESTHESIOLOGY, V117, P613, DOI 10.1097/ALN.0b013e3182657b3e; Briscini L, 2002, EUR J PHARMACOL, V447, P59, DOI 10.1016/S0014-2999(02)01833-2; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cardoso-Cruz H, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00043; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Caspani O, 2014, PHARMACOL BIOCHEM BE, V124, P290, DOI 10.1016/j.pbb.2014.06.018; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016/S0304-3959(98)00234-6; Chiang CY, 2007, J NEUROSCI, V27, P9068, DOI 10.1523/JNEUROSCI.2260-07.2007; Clemens S, 2004, J NEUROSCI, V24, P11337, DOI 10.1523/JNEUROSCI.3698-04.2004; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Daigo E, 2012, NEUROSCI LETT, V529, P39, DOI 10.1016/j.neulet.2012.09.007; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Fishbain DA, 2014, PAIN PRACT, V14, P515, DOI 10.1111/papr.12090; Fishbain DA, 2012, PAIN MED, V13, P552, DOI 10.1111/j.1526-4637.2012.01358.x; Franek M, 2004, PHYSIOL RES, V53, P351; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Grace PM, 2012, J NEUROCHEM, V122, P976, DOI 10.1111/j.1471-4159.2012.07833.x; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; Gregoire S, 2012, PAIN, V153, P1657, DOI 10.1016/j.pain.2012.04.023; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Guo W, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-35; Hama AT, 2004, NEUROSCI LETT, V358, P21, DOI 10.1016/j.neulet.2003.12.111; Hegyi Z, 2009, EUR J NEUROSCI, V30, P251, DOI 10.1111/j.1460-9568.2009.06816.x; Hu B, 2009, PAIN, V143, P206, DOI 10.1016/j.pain.2009.02.018; Hummel M, 2008, NEUROSCIENCE, V155, P492, DOI 10.1016/j.neuroscience.2008.05.041; Hummel M, 2008, PAIN, V140, P436, DOI 10.1016/j.pain.2008.09.020; Ibuki T, 1997, NEUROSCIENCE, V76, P845, DOI 10.1016/S0306-4522(96)00341-7; Jancalek R, 2011, ANN NEUROSCI, V18, P123, DOI [10.5214/ans.0972.7531.11183010, 10.5214/ans.0972-7531.11183010]; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; JASMIN L, 1994, J NEUROSCI, V14, P7252; Jergova S, 2005, EUR J PAIN, V9, P345, DOI 10.1016/j.ejpain.2004.09.002; Jiang ES, 2012, J NEUROCHEM, V121, P526, DOI 10.1111/j.1471-4159.2012.07694.x; Ju J, 2013, NEUROSCI LETT, V542, P118, DOI 10.1016/j.neulet.2013.03.026; Kambur O, 2010, BRIT J PHARMACOL, V161, P1553, DOI 10.1111/j.1476-5381.2010.00999.x; Kambur O, 2011, EUR J PAIN, V15, P732, DOI 10.1016/j.ejpain.2010.12.001; Karchewski LA, 2004, EUR J NEUROSCI, V20, P671, DOI 10.1111/j.1460-9568.2004.03530.x; Karhunen T, 1996, NEUROSCIENCE, V73, P267, DOI 10.1016/0306-4522(96)00016-4; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Keay KA, 2004, NEUROSCI LETT, V361, P188, DOI 10.1016/j.neulet.2003.12.010; Keeler BE, 2012, EXP NEUROL, V238, P273, DOI 10.1016/j.expneurol.2012.09.002; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kennis JHH, 1997, EXP NEUROL, V147, P18, DOI 10.1006/exnr.1997.6576; Kilburn-Watt E, 2014, BRAIN RES BULL, V107, P110, DOI 10.1016/j.brainresbull.2014.07.004; Kilburn-Watt E, 2010, J NEUROENDOCRINOL, V22, P960, DOI 10.1111/j.1365-2826.2010.02038.x; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Kondo D, 2009, J PHARMACOL SCI, V110, P55, DOI 10.1254/jphs.09028FP; Kontinen VK, 2003, PHYSIOL BEHAV, V78, P241, DOI 10.1016/S0031-9384(02)00966-6; Kontinen VK, 1999, PAIN, V80, P341, DOI 10.1016/S0304-3959(98)00230-9; Kunori S, 2009, NEUROSCIENCE, V163, P362, DOI 10.1016/j.neuroscience.2009.05.069; LaBuda CJ, 2000, EXP NEUROL, V163, P490, DOI 10.1006/exnr.2000.7395; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; LaCroix-Fralish ML, 2007, PAIN, V131, DOI 10.1016/j.pain.2007.04.041; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; LASCELLE.RG, 1966, BRIT J PSYCHIAT, V112, P651, DOI 10.1192/bjp.112.488.651; Lee HL, 2004, NEUROREPORT, V15, P2807; Lee KM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.10.017; Leite-Almeida H, 2012, PAIN, V153, P2218, DOI 10.1016/j.pain.2012.07.007; Leitner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073370; Leys LJ, 2013, PAIN, V154, P1092, DOI 10.1016/j.pain.2013.03.019; Li Q, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/158987; Li SS, 2014, NEUROSCI LETT, V560, P21, DOI 10.1016/j.neulet.2013.12.012; Lim G, 2003, PAIN, V105, P275, DOI 10.1016/S0304-3959(03)00242-2; Lim J, 2006, BRAIN RES, V1123, P80, DOI 10.1016/j.brainres.2006.09.059; Liu C, 2006, J NEUROPHYSIOL, V96, P2984, DOI 10.1152/jn.00498.2006; Matsumura S, 2010, NEUROSCIENCE, V170, P942, DOI 10.1016/j.neuroscience.2010.07.034; McCarson KE, 2005, BIOCHEM PHARMACOL, V71, P196, DOI 10.1016/j.bcp.2005.10.026; Meyer-Rosberg K, 2001, EUR J PAIN, V5, P391, DOI 10.1053/eujp.2001.0260; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; Milligan ED, 2003, J NEUROSCI, V23, P1026; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Monassi CR, 2003, EUR J NEUROSCI, V17, P1907, DOI 10.1046/j.1460-9568.2003.02627.x; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Mor D, 2010, NEUROSCIENCE, V166, P1167, DOI 10.1016/j.neuroscience.2010.01.045; Mor D, 2013, CELL MOL NEUROBIOL, V33, P953, DOI 10.1007/s10571-013-9962-3; Mor D, 2011, J CHEM NEUROANAT, V41, P158, DOI 10.1016/j.jchemneu.2011.01.004; Murakami T, 2013, EXP THER MED, V6, P1194, DOI 10.3892/etm.2013.1296; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Nackley AG, 2007, PAIN, V128, P199, DOI 10.1016/j.pain.2006.09.022; Nie FC, 2013, INT J MOL MED, V31, P1333, DOI 10.3892/ijmm.2013.1344; Nyilas R, 2009, EUR J NEUROSCI, V29, P1964, DOI 10.1111/j.1460-9568.2009.06751.x; Obata H, 2010, BRAIN RES, V1363, P72, DOI 10.1016/j.brainres.2010.09.105; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Parkitna JR, 2006, J PHYSIOL PHARMACOL, V57, P401; Pertovaara A, 2001, EXP NEUROL, V167, P425, DOI 10.1006/exnr.2000.7574; Pettersson LME, 2002, BRAIN RES, V945, P266, DOI 10.1016/S0006-8993(02)02817-2; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PIEHL F, 1995, EUR J NEUROSCI, V7, P2101, DOI 10.1111/j.1460-9568.1995.tb00632.x; Pirildar Sebnem, 2003, Psychopharmacol Bull, V37, P127; Qu CL, 2011, PAIN, V152, P1641, DOI 10.1016/j.pain.2011.03.002; Roeska K, 2008, PAIN, V139, P349, DOI 10.1016/j.pain.2008.05.003; Roeska K, 2009, NEUROSCI LETT, V464, P160, DOI 10.1016/j.neulet.2009.08.031; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; Schoeniger-Skinner DK, 2007, BRAIN BEHAV IMMUN, V21, P660, DOI 10.1016/j.bbi.2006.10.010; Schroder W, 2014, BRIT J PHARMACOL, V171, P3777, DOI 10.1111/bph.12744; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Shiokawa H, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-26; Stamer UM, 2007, CURR OPIN ANESTHESIO, V20, P478, DOI 10.1097/ACO.0b013e3282ef6b2c; Sternbach R A, 1974, Clin Neurosurg, V21, P323; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Sun H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-11; Takahashi T, 2013, J PHARMACOL SCI, V122, P51, DOI 10.1254/jphs.13029SC; Tamae A, 2005, J PHYSIOL-LONDON, V568, P243, DOI 10.1113/jphysiol.2005.091843; Tammimaki A, 2012, PHARMACOGENET GENOM, V22, P673, DOI 10.1097/FPC.0b013e3283560c46; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; TIMMERMANS G, 1974, SCIENCE, V184, P806, DOI 10.1126/science.184.4138.806; Toki H, 1998, J NEUROCHEM, V71, P913; Tokunaga S, 2007, BIOL PHARM BULL, V30, P2088, DOI 10.1248/bpb.30.2088; Tsuboi Y, 2011, EUR J NEUROSCI, V34, P292, DOI 10.1111/j.1460-9568.2011.07747.x; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Villarinho JG, 2013, PROG NEURO-PSYCHOPH, V44, P136, DOI 10.1016/j.pnpbp.2013.02.005; Villarinho JG, 2012, EUR J PHARMACOL, V690, P107, DOI 10.1016/j.ejphar.2012.06.042; Wang S, 2007, PAIN, V131, P96, DOI 10.1016/j.pain.2006.12.019; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wang XL, 2011, NEUROSCI LETT, V490, P112, DOI 10.1016/j.neulet.2010.12.038; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Yang LA, 2004, EUR J NEUROSCI, V19, P871, DOI 10.1111/j.0953-816X.2004.03121.x; Zhang SZ, 2014, PAIN, V155, P1504, DOI 10.1016/j.pain.2014.04.026; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	147	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124755	10.1371/journal.pone.0124755	http://dx.doi.org/10.1371/journal.pone.0124755			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905723	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000087
J	Hamasur, B; Bruchfeld, J; van Helden, P; Kallenius, G; Svenson, S				Hamasur, Beston; Bruchfeld, Judith; van Helden, Paul; Kallenius, Gunilla; Svenson, Stefan			A Sensitive Urinary Lipoarabinomannan Test for Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIAL LIPOARABINOMANNAN; LAM-ELISA; DIAGNOSIS; ASSAY; FEATURES; HIV	We have previously developed a diagnostic test for tuberculosis based on detection of mycobacterial lipoarabinomannan (LAM) in urine. The method depended on a laborious concentration step. We have now developed an easy to perform test based on a magnetic immunoassay platform, utilizing high avidity monoclonal antibodies for the detection of LAM in urine. With this method the analytical sensitivity of the assay was increased 50-100-fold compared to conventional ELISA. In a pilot study of HIV-negative patients with microbiologically verified TB (n=17) and healthy controls (n=22) the sensitivity of the test was 82% and the specificity 100%. This is in stark positive contrast to a range of studies using available commercial tests with polyclonal anti-LAM Abs where the sensitivity of the tests in HIV-negative TB patients was very low.	[Hamasur, Beston; Kallenius, Gunilla; Svenson, Stefan] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Bruchfeld, Judith] Karolinska Inst Solna, Inst Med, Infect Dis Unit, Stockholm, Sweden; [Bruchfeld, Judith] Karolinska Univ Hosp, Stockholm, Sweden; [van Helden, Paul] Univ Stellenbosch, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res, US MRC Ctr TB Res,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; National Research Foundation - South Africa; Stellenbosch University	Hamasur, B (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	beston.hamasur@ki.se	Källenius, Gunilla/AGZ-3956-2022		European Community; Swedish Medical Research Council; King Oscar II Jubilee Foundation; Swedish Heart-Lung Foundation; European Union [221948]; ICONZ (Integrated Control of Neglected Zoonoses); Foundation for Innovative New Diagnostics	European Community(European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); King Oscar II Jubilee Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); European Union(European Commission); ICONZ (Integrated Control of Neglected Zoonoses); Foundation for Innovative New Diagnostics	The study was in the early stage supported by grants from the European Community, the Swedish Medical Research Council, King Oscar II Jubilee Foundation, the Swedish Heart-Lung Foundation and funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated Control of Neglected Zoonoses). The production of mAbs against LAM was partially funded by Foundation for Innovative New Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Conesa-Botella A, 2011, JAIDS-J ACQ IMM DEF, V58, P463, DOI 10.1097/QAI.0b013e31823801de; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kerkhoff AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103285; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Mazurek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042515; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; Pai NP, 2012, DISCOV MED, V13, P35; Reither K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-141; Schmidt R, 2011, J PROTEOME RES, V10, P1316, DOI 10.1021/pr101070j; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Tessema TA, 2002, SCAND J INFECT DIS, V34, P167, DOI 10.1080/00365540110077254; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306	22	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123457	10.1371/journal.pone.0123457	http://dx.doi.org/10.1371/journal.pone.0123457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905641	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000032
J	Pan, T; Wu, SH; Liu, YJ				Pan, Tao; Wu, Shaohong; Liu, Yujie			Relative Contributions of Land Use and Climate Change to Water Supply Variations over Yellow River Source Area in Tibetan Plateau during the Past Three Decades	PLOS ONE			English	Article							MANAGING ECOSYSTEM SERVICES; LOESS PLATEAU; IMPACTS; VARIABILITY; DEGRADATION; CATCHMENT; FUTURE; REGION; COVER	There is increasing evidence of environmental change impacts on ecosystem processes and services, yet poor understanding of the relative contributions of land use and climate change to ecosystem services variations. Based on detailed meteorological, hydrological records and satellite data over the Yellow River Source Area (YRSA) in Tibetan Plateau from 1980s to 2008, together with a water-yield module of Integrated Valuation of Ecosystem Services and Tradeoffs (InVEST) model and also a Residual Trends (RESTREND) method, we assessed the water supply variations in YRSA during the past three decades and disentangled the relative contributions of land use and climate change. Results show that water supply significantly decreased from 1980 to 2005 and then increased from 2005 to 2008. The quantity slightly decreased from 283.01mm in 1980 to 276.95mm in 1995, 270.12mm in 2000 and 267.97mm in 2005, and it then rebounded slightly to 275.26mm in 2008. The water supply variation ranged from 283.01mm to 267.97mm. Climate change contributed dominantly to water supply decrease from 1980 to 1995, which accounts for approximately 64% of the decrease. During 1995 to 2000, land use contributed more and about 58% to the water supply decrease as the intense human activities. From 2000 to 2005, climate change became a positive contribution to the water supply as the increased precipitation, but the land use still contributed negatively. From 2005 to 2008, both climate and land use have positive impacts, but land use contributed about 61% to the water supply increase. The implementation of the Three Rivers Source Area Ecological Protection Project has greatly improved the vegetation coverage conditions and the water retention ability during this period. We recommend that the implementation of ecological projects, grazing policies and artificial improvement of degraded grassland would help to conserve the water retention ability and increase water supply.	[Pan, Tao; Wu, Shaohong; Liu, Yujie] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China; [Pan, Tao; Liu, Yujie] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Michigan State University	Pan, T (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China.	T.pantao@igsnrr.ac.cn; wush@igsnrr.ac.cn			National Natural Science Foundation of China [41301092]; National Science and Technology Support Program [2012BAC19B10, 2013BAC03B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	This study is supported by National Natural Science Foundation of China (41301092) http://www.nsfc.gov.cn/, National Science and Technology Support Program (2012BAC19B10 & 2013BAC03B04) http://www.most.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2013, P NATL ACAD SCI USA, V110, P372, DOI 10.1073/pnas.1213841110; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2005, EC HUM WELL BEING SY; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Budyko MI., 1974, CLIMATE LIFE; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chen Long, 2011, Journal of Resources and Ecology, V2, P322; Cowling Richard, 2010, P NATL ACAD SCI USA, V105, P9483; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Ennaanay D., 2006, THESIS U MINNESOTA; Evans J, 2004, J ARID ENVIRON, V57, P535, DOI 10.1016/S0140-1963(03)00121-6; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Fu BJ, 2011, ECOL COMPLEX, V8, P284, DOI 10.1016/j.ecocom.2011.07.003; [聂忆黄 Gong Bin], 2010, [地学前缘, Earth Science Frontiers], V17, P373; Guo ZW, 2000, ECOL APPL, V10, P925, DOI 10.1890/1051-0761(2000)010[0925:AAOESW]2.0.CO;2; Hamel P., 2014, HYDROL EARTH SYST SC, V11, P11001, DOI DOI 10.5194/hessd-11-11001-2014; Hutchinson M.F., 1991, BMRC RES REP, V27, P104; HUTCHINSON MF, 1994, GEODERMA, V62, P45, DOI 10.1016/0016-7061(94)90027-2; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Li Z, 2009, J HYDROL, V377, P35, DOI 10.1016/j.jhydrol.2009.08.007; Liu JY, 2010, J GEOGRAPHICAL SCI, V18, P259; Lorencova E, 2013, LAND USE POLICY, V33, P183, DOI 10.1016/j.landusepol.2012.12.012; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Minville M, 2010, J HYDROL, V358, P70; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; Pielke RA, 2011, WIRES CLIM CHANGE, V2, P828, DOI 10.1002/wcc.144; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Salhab J, 2010, J FOOD AGRIC ENVIRON, V8, P1367; Sanchez-Canales M, 2012, SCI TOTAL ENVIRON, V440, P140, DOI 10.1016/j.scitotenv.2012.07.071; Shi Y, 2012, CHINESE SCI BULL, V57, P2120, DOI 10.1007/s11434-012-4978-5; Su CH, 2012, ACTA OECOL, V44, P46, DOI 10.1016/j.actao.2011.11.006; Su CH, 2013, GLOBAL PLANET CHANGE, V101, P119, DOI 10.1016/j.gloplacha.2012.12.014; Tallis H. T., 2013, INVEST 2 5 3 USERS G; Tallis HM, 2006, TRENDS ECOL EVOL, V21, P562, DOI 10.1016/j.tree.2006.07.009; Wang GX, 2012, AGR FOREST METEOROL, V162, P44, DOI 10.1016/j.agrformet.2012.04.006; Wang GX, 2009, GEODERMA, V149, P280, DOI 10.1016/j.geoderma.2008.12.008; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058432; Wessels KJ, 2007, J ARID ENVIRON, V68, P271, DOI 10.1016/j.jaridenv.2006.05.015; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; Yin YH, 2010, AGR WATER MANAGE, V95, P77; Zhang CanQiang, 2012, Journal of Resources and Ecology, V3, P50; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang YY, 2012, J GEOGR SCI, V22, P781, DOI 10.1007/s11442-012-0963-9; Zhou GY, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008829; [Zhou Wenzuo 周文佐], 2005, Journal of Geographical Sciences, V15, P3, DOI 10.1007/BF02873101	47	26	29	6	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123793	10.1371/journal.pone.0123793	http://dx.doi.org/10.1371/journal.pone.0123793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906192	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000046
J	Wilson, JL; Yu, J; Taylor, L; Polgar, P				Wilson, Jamie L.; Yu, Jun; Taylor, Linda; Polgar, Peter			Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; PROTEIN-KINASE; PROLIFERATION; INHIBITION; RECEPTORS; THERAPY; FOXM1; TRANSDUCTION; CONTRIBUTES; PROGRESSION	Smooth muscle in the pulmonary artery of PAH subjects, both idiopathic and hereditary, is characterized by hyperplasia. Smooth muscle cells HPASMC) isolated from subjects with or without PAH retain their in vivo phenotype as illustrated by their expression of alphasmooth muscle actin and expression of H-caldesmon. Both non PAH and PAH HPASMC display a lengthy, approximately 94h, cell cycle. The HPASMC from both idiopathic and hereditary PAH display an abnormal proliferation characterized by continued growth under non-proliferative, non-growth stimulated conditions. This effector independent proliferation is JNK and p38 MAP kinase dependent. Blocking the activation of either abrogates the HPASMC growth. HPASMC from non PAH donors under quiescent conditions display negligible proliferation but divide upon exposure to growth factors such as PDGF-BB or FGF2 but not EGF. This growth does not involve the MAP kinases. Instead it routes via the tyrosine kinase receptor through mTOR and then 6SK. In the PAH cells PDGF-BB and FGF2 augment the dysregulated cell proliferation, also through mTOR/6SK. Additionally, blocking the activation of mTOR also modulates the MAP kinase promoted dysregulated growth. These results highlight key alterations in the growth of HPASMC from subjects with PAH which contribute to the etiology of the disease and can clearly be targeted at various regulatory points for future therapies.	[Wilson, Jamie L.; Yu, Jun; Taylor, Linda; Polgar, Peter] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Polgar, P (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	peterp@bu.edu	Wilson, Jamie/J-5913-2019		National Institutes of Health/National Lung, Heart, and Blood Institute [HL25776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025776] Funding Source: NIH RePORTER	National Institutes of Health/National Lung, Heart, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Lung, Heart, and Blood Institute Grant HL25776. All of the authors were supported by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, AM J RESP CELL MOL, V45, P804, DOI 10.1165/rcmb.2010-0371OC; Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC; Bertero T, 2014, J CLIN INVEST, V124, P3514, DOI 10.1172/JCI74773; Brown RD, 2013, AM J PHYSIOL-HEART C, V304, pH269, DOI 10.1152/ajpheart.00158.2012; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Comhair SAA, 2012, AM J RESP CELL MOL, V46, P723, DOI 10.1165/rcmb.2011-0416TE; Cronan MR, 2012, ONCOGENE, V31, P3889, DOI 10.1038/onc.2011.544; Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Frazier AA, 2012, SEMIN ULTRASOUND CT, V33, P535, DOI 10.1053/j.sult.2012.06.002; GABBIANI G, 1981, P NATL ACAD SCI-BIOL, V78, P298, DOI 10.1073/pnas.78.1.298; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Ghofrani HA, 2010, AM J RESP CRIT CARE, V182, P1171, DOI 10.1164/rccm.201001-0123OC; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Goncharova EA, 2002, AM J PHYSIOL-LUNG C, V283, pL354, DOI 10.1152/ajplung.00010.2002; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; Jonigk D, 2011, AM J PATHOL, V179, P167, DOI 10.1016/j.ajpath.2011.03.040; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Lu J, 2004, J THORAC CARDIOV SUR, V128, P850, DOI 10.1016/j.jtcvs.2004.03.003; Marcos E, 2004, CIRC RES, V94, P1263, DOI 10.1161/01.RES.0000126847.27660.69; Marcos E, 2005, CHEST, V128, p552S, DOI 10.1378/chest.128.6_suppl.552S; Mori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088891; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Ogasawara T, 2003, INT J HEMATOL, V77, P364, DOI 10.1007/BF02982645; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Ruan CH, 2010, TEX HEART I J, V37, P391; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Taylor CA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-35; Watanabe K, 2000, AM J CLIN PATHOL, V113, P663, DOI 10.1309/JNQX-F4KM-Q0Q0-7XK8; Wei L, 2010, AM J PHYSIOL-LUNG C, V298, pL863, DOI 10.1152/ajplung.00281.2009; Wilkins MR, 2008, EUR RESPIR J, V32, P198, DOI 10.1183/09031936.00124007; Wilson JL, 2012, EXP CELL RES, V318, P1125, DOI 10.1016/j.yexcr.2012.03.029; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yu J, 2015, CHEM BIOL DRUG DES, V85, P586, DOI 10.1111/cbdd.12446; Yu J, 2015, J CELL BIOCHEM, V116, P386, DOI 10.1002/jcb.24987; Yu J, 2013, J CELL PHYSIOL, V228, P322, DOI 10.1002/jcp.24132; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400; Zeng Z, 2010, CARDIOVASC THER, V28, P23, DOI 10.1111/j.1755-5922.2009.00115.x; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004	52	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123662	10.1371/journal.pone.0123662	http://dx.doi.org/10.1371/journal.pone.0123662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905460	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000040
J	Song, CL; Tang, H; Ran, LK; Ko, BCB; Zhang, ZZ; Chen, X; Ren, JH; Tao, NN; Li, WY; Huang, AL; Chen, J				Song, C-L; Tang, H.; Ran, L-K; Ko, B. C. B.; Zhang, Z-Z; Chen, X.; Ren, J-H; Tao, N-N; Li, W-Y; Huang, A-L; Chen, J.			Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3 beta/BCL2-associated X protein-dependent apoptotic pathway	ONCOGENE			English	Article							PROMOTES DNA-REPAIR; OXIDATIVE STRESS; CELL-DEATH; MITOCHONDRIAL-DNA; BREAST-CANCER; EXPRESSION; METABOLISM; ACTIVATION; BAX; DEACETYLATION	SIRT3 is a class III histone deacetylase that has been implicated in a variety of cancers. The role of SIRT3 in hepatocellular carcinoma (HCC) remains elusive. In this study, we found that SIRT3 expression was frequently repressed in HCC and its downregulation was closely associated with tumor grade and size. Ectopic expression of SIRT3 inhibited cell growth and induced apoptosis in HCC cells, whereas depletion of SIRT3 in immortalized hepatocyte promoted cell growth and decreased epirubicin-induced apoptosis. Mechanistic studies revealed that SIRT3 deacetylated and activated glycogen synthase kinase-3 beta (GSK-3 beta), which subsequently induced expression and mitochondrial translocation of the pro-apoptotic protein BCL2-associated X protein (Bax) to promote apoptosis. GSK-3 beta inhibitor or gene silencing of BAX reversed SIRT3-induced growth inhibition and apoptosis. Furthermore, SIRT3 overexpression also suppressed tumor growth in vivo. Together, this study reveals a role of SIRT3/GSK-3 beta/Bax signaling pathway in the suppression of HCC growth, and also suggests that targeting this pathway may represent a potential therapeutic approach for HCC treatment.	[Song, C-L; Tang, H.; Ran, L-K; Chen, X.; Ren, J-H; Tao, N-N; Li, W-Y; Huang, A-L; Chen, J.] Chongqing Med Univ, Chinese Minist Educ, Affiliated Hosp 2, Chongqing 400016, Peoples R China; [Song, C-L; Tang, H.; Ran, L-K; Chen, X.; Ren, J-H; Tao, N-N; Li, W-Y; Huang, A-L; Chen, J.] Chongqing Med Univ, Chinese Minist Educ, Key Lab Mol Biol Infect Dis Designated, Chongqing 400016, Peoples R China; [Ko, B. C. B.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Ko, B. C. B.] Hong Kong Polytech Univ, State Key Lab Chirosci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Z-Z] Chongqing Med Univ, Childrens Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Huang, A-L] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chongqing Medical University; Chongqing Medical University; Hong Kong Polytechnic University; Hong Kong Polytechnic University; Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Huang, AL; Chen, J (corresponding author), Chongqing Med Univ, Chinese Minist Educ, Affiliated Hosp 2, Chongqing 400016, Peoples R China.; Huang, AL; Chen, J (corresponding author), Chongqing Med Univ, Chinese Minist Educ, Key Lab Mol Biol Infect Dis Designated, Chongqing 400016, Peoples R China.	yixin_xinyuan@163.com; ahuang1964@163.com	Ko, Chi-bun/ACH-7514-2022	Ko, Ben Chi Bun/0000-0003-2027-5899	National Natural Science Foundation of China [81201282]; National Science and Technology Major Project [2013ZX10002002]; Chongqing Natural Science Foundation [cstc2012jjA10047]; Ministry of Education of China [20125503120004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (81201282), the National Science and Technology Major Project (2013ZX10002002), the Chongqing Natural Science Foundation (cstc2012jjA10047) and the PhD program through the Ministry of Education of China (Program 20125503120004).	Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012; Chen J, 2013, HEPATOLOGY, V57, P2287, DOI 10.1002/hep.26278; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; D'Aquila P, 2012, GENE, V497, P323, DOI 10.1016/j.gene.2012.01.042; Ding J, 2014, CANCER LETT, V346, P17, DOI 10.1016/j.canlet.2013.12.024; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Monteserin-Garcia J, 2013, FASEB J, V27, P1561, DOI 10.1096/fj.12-220129; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Wang JX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-297; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703; Zhang LL, 2010, J CELL PHYSIOL, V224, P218, DOI 10.1002/jcp.22123; Zhao Y, 2013, ANN DIAGN PATHOL, V17, P483, DOI 10.1016/j.anndiagpath.2013.06.001	38	32	34	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					631	641		10.1038/onc.2015.121	http://dx.doi.org/10.1038/onc.2015.121			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25915842				2022-12-26	WOS:000369548800010
J	Walliser, C; Tron, K; Clauss, K; Gutman, O; Kobitski, AY; Retlich, M; Schade, A; Rocker, C; Henis, YI; Nienhaus, GU; Gierschik, P				Walliser, Claudia; Tron, Kyrylo; Clauss, Karen; Gutman, Orit; Kobitski, Andrei Yu.; Retlich, Michael; Schade, Anja; Roecker, Carlheinz; Henis, Yoav I.; Nienhaus, G. Ulrich; Gierschik, Peter			Rac-mediated Stimulation of Phospholipase C gamma(2) Amplifies B Cell Receptor-induced Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; OF-FUNCTION MUTATION; ANTIGEN RECEPTOR; C-GAMMA; INOSITOL 1,4,5-TRISPHOSPHATE; DIFFERENTIAL REGULATION; C-BETA(2) ACTIVITY; CA2+ SIGNALS; T-CELLS; ACTIVATION	The Rho GTPase Rac is crucially involved in controlling multiple B cell functions, including those regulated by the B cell receptor ( BCR) through increased cytosolic Ca2+. The underlying molecular mechanisms and their relevance to the functions of intact B cells have thus far remained unknown. We have previously shown that the activity of phospholipase C gamma(2) ( PLC gamma(2)), a key constituent of the BCR signalosome, is stimulated by activated Rac through direct protein-protein interaction. Here, we use a Rac-resistant mutant of PLC gamma(2) to functionally reconstitute cultured PLC gamma(2)-deficient DT40 B cells and to examine the effects of the Rac-PLC gamma(2) interaction on BCR-mediated changes of intracellular Ca2+ and regulation of Ca2+-regulated and nuclear-factor-of-activated-T-cell-regulated gene transcription at the level of single, intact B cells. The results show that the functional Rac-PLC gamma(2) interaction causes marked increases in the following: ( i) sensitivity of B cells to BCR ligation; ( ii) BCR-mediated Ca2+ release from intracellular stores; ( iii) Ca2+ entry from the extracellular compartment; and ( iv) nuclear translocation of the Ca2+ regulated nuclear factor of activated T cells. Hence, Rac-mediated stimulation of PLC gamma(2) activity serves to amplify B cell receptor-induced Ca2+ signaling.	[Walliser, Claudia; Retlich, Michael; Schade, Anja; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89070 Ulm, Germany; [Tron, Kyrylo; Clauss, Karen; Roecker, Carlheinz] Univ Ulm, Inst Biophys, D-89069 Ulm, Germany; [Gutman, Orit; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Kobitski, Andrei Yu.; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76131 Karlsruhe, Germany; [Kobitski, Andrei Yu.; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Ctr Funct Nanostruct, D-76131 Karlsruhe, Germany; [Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Ulm University; Ulm University; Tel Aviv University; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Gierschik, P (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	peter.gierschik@uni-ulm.de	Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Henis, Yoav/0000-0002-1408-3877	Deutsche Forschungsgemeinschaft [SFB 497, SFB 1074]; International Graduate School in Molecular Medicine Ulm (IGradU)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School in Molecular Medicine Ulm (IGradU)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 497 and SFB 1074 (to the P.G. and the G.U.N. laboratories) and grants within the International Graduate School in Molecular Medicine Ulm (IGradU) to the P. G. laboratory. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Alkhairy OK, 2015, J ALLERGY CLIN IMMUN, V135, P1380, DOI 10.1016/j.jaci.2014.10.039; Amin RH, 2003, ENDOCRINOLOGY, V144, P4508, DOI 10.1210/en.2003-0106; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Bai L, 2007, MOL CELL BIOL, V27, P5957, DOI 10.1128/MCB.02273-06; Barrio L, 2013, J IMMUNOL, V191, P3867, DOI 10.4049/jimmunol.1301623; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, 1990, J IMMUNOL, V145, P13; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dupont G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004226; Efron B, 1993, INTRO BOOTSTRAP, P124; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Guidetti GF, 2009, J THROMB HAEMOST, V7, P1200, DOI 10.1111/j.1538-7836.2009.03444.x; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; Gutman O, 2010, J BIOL CHEM, V285, P3905, DOI 10.1074/jbc.M109.085100; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hao SL, 2003, EMBO J, V22, P4166, DOI 10.1093/emboj/cdg401; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Henderson RB, 2010, J EXP MED, V207, P837, DOI 10.1084/jem.20091489; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Hikida M, 2003, J EXP MED, V198, P581, DOI 10.1084/jem.20030280; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hoffman GR, 1998, J BIOL CHEM, V273, P4392, DOI 10.1074/jbc.273.8.4392; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Jiang X, 2010, J R SOC INTERFACE, V7, pS5, DOI 10.1098/rsif.2009.0272.focus; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kitajima N, 2011, BIOCHEM BIOPH RES CO, V409, P108, DOI 10.1016/j.bbrc.2011.04.124; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Kredel S, 2008, CHEM BIOL, V15, P224, DOI 10.1016/j.chembiol.2008.02.008; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Morita T, 2004, BIOCHEM J, V382, P793, DOI 10.1042/BJ20031970; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Petersen N. O., 1986, HDB EXPT IMMUNOLOGY; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Rossi AM, 2012, BBA-GEN SUBJECTS, V1820, P1214, DOI 10.1016/j.bbagen.2011.10.004; Salzer U, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4032; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Tedder TF, 2010, J IMMUNOL, V184, P2231, DOI 10.4049/jimmunol.1090001; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wen RR, 2006, MOL CELL BIOL, V26, P9364, DOI 10.1128/MCB.00839-06; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	88	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17056	17072		10.1074/jbc.M115.645739	http://dx.doi.org/10.1074/jbc.M115.645739			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25903139	Green Published, hybrid			2022-12-26	WOS:000357730900002
J	Morales, Y; Nitzel, DV; Price, OM; Gui, SY; Li, J; Qu, J; Hevel, JM				Morales, Yalemi; Nitzel, Damon V.; Price, Owen M.; Gui, Shanying; Li, Jun; Qu, Jun; Hevel, Joan M.			Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRICAL DIMETHYLARGININE; RISK-FACTOR; METHYLATION; DISEASE; ADMA; PHOSPHORYLATION; OLIGOMERIZATION; INACTIVATION; SPECIFICITY; DYSFUNCTION	Elevated levels of asymmetric dimethylarginine (ADMA) correlate with risk factors for cardiovascular disease. ADMA is generated by the catabolism of proteins methylated on arginine residues by protein arginine methyltransferases (PRMTs) and is degraded by dimethylarginine dimethylaminohydrolase. Reports have shown that dimethylarginine dimethylaminohydrolase activity is down-regulated and PRMT1 protein expression is up-regulated under oxidative stress conditions, leading many to conclude that ADMA accumulation occurs via increased synthesis by PRMTs and decreased degradation. However, we now report that the methyltransferase activity of PRMT1, the major PRMT isoform in humans, is impaired under oxidative conditions. Oxidized PRMT1 displays decreased activity, which can be rescued by reduction. This oxidation event involves one or more cysteine residues that become oxidized to sulfenic acid (-SOH). We demonstrate a hydrogen peroxide concentration-dependent inhibition of PRMT1 activity that is readily reversed under physiological H2O2 concentrations. Our results challenge the unilateral view that increased PRMT1 expression necessarily results in increased ADMA synthesis and demonstrate that enzymatic activity can be regulated in a redox-sensitive manner.	[Morales, Yalemi; Nitzel, Damon V.; Price, Owen M.; Gui, Shanying; Hevel, Joan M.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Li, Jun; Qu, Jun] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA	Utah System of Higher Education; Utah State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hevel, JM (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84322 USA.	Joanie.Hevel@usu.edu	Gui, Shanying/AAM-8633-2021; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Price, Owen/0000-0001-5894-9022; Morales, Yalemi/0000-0001-9697-099X; Hevel, Joan/0000-0002-9559-4635	Utah State University URCO award; Utah State University Dissertation fellowship; National Science Foundation [0920776, 1412405]	Utah State University URCO award; Utah State University Dissertation fellowship; National Science Foundation(National Science Foundation (NSF))	This work was supported by a Utah State University URCO award (to O. M. P.), a Utah State University Dissertation fellowship (to Y. M.), and National Science Foundation Awards 0920776 and 1412405 (to J. M. H.).	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Atmane N, 2003, J BIOL CHEM, V278, P35086, DOI 10.1074/jbc.M303813200; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Carter EL, 2014, J INORG BIOCHEM, V133, P92, DOI 10.1016/j.jinorgbio.2014.01.005; Chen X, 2006, BASIC RES CARDIOL, V101, P346, DOI 10.1007/s00395-006-0592-5; Chen YH, 2009, EXP EYE RES, V89, P1028, DOI 10.1016/j.exer.2009.09.004; Cheng Y, 2011, J MOL BIOL, V414, P106, DOI 10.1016/j.jmb.2011.09.040; Chobanyan-Jurgens K, 2011, HYPERTENSION, V58, pE184, DOI 10.1161/HYPERTENSIONAHA.111.180984; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; Di Simplicio P, 2003, AMINO ACIDS, V25, P323, DOI 10.1007/s00726-003-0020-1; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Huang BW, 2013, FASEB J, V27, P3763, DOI 10.1096/fj.12-226043; Jiang JL, 2006, CARDIOVASC DRUG THER, V20, P281, DOI 10.1007/s10557-006-9065-1; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Kolbel K, 2009, J BIOL CHEM, V284, P8274, DOI 10.1074/jbc.M809547200; Lafleur VN, 2014, MOL BIOL CELL, V25, P925, DOI 10.1091/mbc.E13-07-0423; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lim Y, 2008, J BIOCHEM, V144, P523, DOI 10.1093/jb/mvn097; Lu TM, 2003, CLIN CARDIOL, V26, P458, DOI 10.1002/clc.4960261006; Luneburg N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/501612; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; OGAWA T, 1987, BIOCHEM BIOPH RES CO, V148, P671, DOI 10.1016/0006-291X(87)90929-6; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suh-Lailam BB, 2010, ANAL BIOCHEM, V398, P218, DOI 10.1016/j.ab.2009.09.005; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wang R, 2011, MOL BIOSYST, V7, P2970, DOI 10.1039/c1mb05230f; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Wilcox CS, 2012, HYPERTENSION, V59, P375, DOI 10.1161/HYPERTENSIONAHA.111.187310; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	54	32	32	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14915	14926		10.1074/jbc.M115.651380	http://dx.doi.org/10.1074/jbc.M115.651380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911106	Green Published, hybrid			2022-12-26	WOS:000356177300011
J	Spelios, MG; Olsen, JA; Kenna, LA; Akirav, EM				Spelios, Michael G.; Olsen, John A.; Kenna, Lauren A.; Akirav, Eitan M.			Islet Endothelial Cells Induce Glycosylation and Increase Cell-surface Expression of Integrin beta 1 in beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN SECRETORY RESPONSES; IN-VITRO; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; BETA-1-INTEGRIN; RECEPTORS; APOPTOSIS; ADHESION	The co-culturing of insulinoma and islet-derived endothelial cell (iEC) lines results in the spontaneous formation of free-floating pseudoislets (PIs). We previously showed that iEC-induced PIs display improved insulin expression and secretion in response to glucose stimulation. This improvement was associated with a de novo deposition of extracellular matrix (ECM) proteins by iECs in and around the PIs. Here, iEC-induced PIs were used to study the expression and posttranslational modification of the ECM receptor integrin beta 1. A wide array of integrin beta subunits was detected in beta TC3 and NIT-1 insulinomas as well as in primary islets, with integrin beta 1 mRNA and protein detected in all three cell types. Interestingly, the formation of iEC-induced PIs altered the glycosylation patterns of integrin beta 1, resulting in a higher molecular weight form of the receptor. This form was found in native pancreas but was completely absent in monolayer beta-cells. Fluorescence-activated cell sorting analysis of monolayers and PIs revealed a higher expression of integrin beta 1 in PIs. Antibody-mediated blocking of integrin beta 1 led to alterations in beta-cell morphology, reduced insulin gene expression, and enhanced glucose secretion under baseline conditions. These results suggest that iEC-induced PI formation may alter integrin beta 1 expression and posttranslational modification by enhancing glycosylation, thereby providing a more physiological culture system for studying integrin-ECM interactions in beta cells.	[Spelios, Michael G.; Olsen, John A.; Kenna, Lauren A.; Akirav, Eitan M.] Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA; [Akirav, Eitan M.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Akirav, EM (corresponding author), 222 Stn Plaza North, Mineola, NY 11501 USA.	eakirav@winthrop.org			Novo Nordisk Diabetes Innovation Award; Winthrop-University Hospital	Novo Nordisk Diabetes Innovation Award; Winthrop-University Hospital	This work was supported by a Novo Nordisk Diabetes Innovation Award, 2012, and Winthrop-University Hospital.	AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Diaferia GR, 2013, DEVELOPMENT, V140, P3360, DOI 10.1242/dev.098533; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Jiang FX, 2002, J HISTOCHEM CYTOCHEM, V50, P1625, DOI 10.1177/002215540205001206; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kaas A, 2010, CLIN EXP IMMUNOL, V161, P444, DOI 10.1111/j.1365-2249.2010.04193.x; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kaido TJ, 2010, J CELL PHYSIOL, V224, P101, DOI 10.1002/jcp.22101; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Krishnamurthy M, 2008, J CELL COMMUN SIGNAL, V2, P67, DOI 10.1007/s12079-008-0030-6; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li TS, 2005, CARDIOVASC RES, V65, P64, DOI 10.1016/j.cardiores.2004.08.019; Luther MJ, 2006, BIOCHEM BIOPH RES CO, V343, P99, DOI 10.1016/j.bbrc.2006.02.003; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; MENDOLA JF, 1994, TRANSPLANTATION, V57, P725, DOI 10.1097/00007890-199403150-00015; Nanji SA, 2006, DIABETES OBES METAB, V8, P15, DOI 10.1111/j.1463-1326.2005.00476.x; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P492, DOI 10.1016/j.biocel.2005.06.021; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; PARR EL, 1980, TRANSPLANTATION, V30, P135, DOI 10.1097/00007890-198008000-00012; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; Spelios MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072260; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Wang RN, 2005, DIABETES, V54, P2080, DOI 10.2337/diabetes.54.7.2080; Yashpal NK, 2005, ENDOCRINOLOGY, V146, P1798, DOI 10.1210/en.2004-1292	38	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15250	15259		10.1074/jbc.M114.628784	http://dx.doi.org/10.1074/jbc.M114.628784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911095	hybrid, Green Published			2022-12-26	WOS:000356177300037
J	Kossyvakis, A; Tao, Y; Lu, XY; Pogka, V; Tsiodras, S; Emmanouil, M; Mentis, AF; Tong, SX; Erdman, DD; Antoniadis, A				Kossyvakis, Athanasios; Tao, Ying; Lu, Xiaoyan; Pogka, Vasiliki; Tsiodras, Sotirios; Emmanouil, Mary; Mentis, Andreas F.; Tong, Suxiang; Erdman, Dean D.; Antoniadis, Antonios			Laboratory Investigation and Phylogenetic Analysis of an Imported Middle East Respiratory Syndrome Coronavirus Case in Greece	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; PROTEIN	Rapid and reliable laboratory diagnosis of persons suspected of Middle East respiratory syndrome coronavirus (MERS-CoV) infection is important for timely implementation of infection control practices and disease management. In addition, monitoring molecular changes in the virus can help elucidate chains of transmission and identify mutations that might influence virus transmission efficiency. This was illustrated by a recent laboratory investigation we conducted on an imported MERS-CoV case in Greece. Two oropharyngeal swab specimens were collected on the 1st and 2nd day of patient hospitalization and tested using two real-time RT-PCR (rRT-PCR) assays targeting the UpE and Orf-1a regions of the MERS-CoV genome and RT-PCR and partial sequencing of RNA-dependent RNA polymerase and nucleocapsid genes. Serum specimens were also collected and serological test were performed. Results from the first swab sample were inconclusive while the second swab was strongly positive for MERS-CoV RNA by rRT-PCR and confirmed positive by RTPCR and partial gene sequencing. Positive serologic test results further confirmed MERSCoV infection. Full-length nucleocapsid and spike gene coding sequences were later obtained from the positive swab sample. Phylogenetic analysis revealed that the virus was closely related to recent human-derived MERS-CoV strains obtained in Jeddah and Makkah, Saudi Arabia, in April 2014 and dromedary camels in Saudi Arabia and Qatar. These findings were consistent with the patient's history. We also identified a unique amino acid substitution in the spike receptor binding domain that may have implications for receptor binding efficiency. Our initial inconclusive rRT-PCR results highlight the importance of collecting multiple specimens from suspect MERS-CoV cases and particularly specimens from the lower respiratory tract.	[Kossyvakis, Athanasios; Pogka, Vasiliki; Emmanouil, Mary; Mentis, Andreas F.; Antoniadis, Antonios] Hellenic Pasteur Inst, Natl Influenza Reference Lab Southern Greece, Athens, Greece; [Tao, Ying; Lu, Xiaoyan; Tong, Suxiang; Erdman, Dean D.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Tsiodras, Sotirios] Hellen Ctr Dis Control & Prevent, Dept Epidemiol Surveillance & Intervent, Athens, Greece	Centers for Disease Control & Prevention - USA	Mentis, AF (corresponding author), Hellenic Pasteur Inst, Natl Influenza Reference Lab Southern Greece, Athens, Greece.	mentis@pasteur.gr	TSIODRAS, SOTIRIOS/AAD-8273-2019; Pogka, Vasiliki/H-7602-2019	TSIODRAS, SOTIRIOS/0000-0002-0463-4321; POGKA, VASILIKI/0000-0002-1543-2418				Boheemen S, 2012, MBIO, V3; Briese T, 2014, MBIO, V5; Chen YQ, 2013, J VIROL, V87, P10777, DOI 10.1128/JVI.01756-13; Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299; Corman V. M., 2012, EUROSURVEILLANCE, V17, P49, DOI DOI 10.2807/ESE.17.49.20334-EN; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14; European CDC, 2015, SEV RESP DIS ASS MID; European Centre for Disease Prevention and Control, EP UPD MIDDL E RESP; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; LU L, 2014, NAT COMMUN, V5; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Tsiodras S, 2014, EURO SURVEILL, V19; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92	16	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125809	10.1371/journal.pone.0125809	http://dx.doi.org/10.1371/journal.pone.0125809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919137	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659400089
J	Beverborg, NG; Verweij, N; Klip, IT; van der Wal, HH; Voors, AA; van Veldhuisen, DJ; Gansevoort, RT; Bakker, SJL; van der Harst, P; van der Meer, P				Beverborg, Niels Grote; Verweij, Niek; Klip, IJsbrand T.; van der Wal, Haye H.; Voors, Adriaan A.; van Veldhuisen, Dirk J.; Gansevoort, Ron T.; Bakker, Stephan J. L.; van der Harst, Pim; van der Meer, Peter			Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates	PLOS ONE			English	Article							SERUM ERYTHROPOIETIN; TRANSFERRIN RECEPTOR; PLASMA ERYTHROPOIETIN; STIMULATING AGENTS; DARBEPOETIN ALPHA; ANEMIA; MORTALITY; HEMOGLOBIN; HYPERTENSION; EQUATION	Background Although erythropoietin has been used for decades in the treatment of anemia, data regarding endogenous levels in the general population are scarce. Therefore, we determined erythropoietin reference ranges and its clinical, biochemical and genetic associations in the general population. Methods We used data from 6,777 subjects enrolled in the Prevention of REnal and Vascular ENd-stage Disease (PREVEND) study. Fasting venous blood samples were obtained in the morning from all participants from 2001-2003. Serum erythropoietin concentrations were measured using a fully automated chemiluminescent enzyme-labeled immunometric assay. A genome-wide association study was performed to identify genetic determinants. Results Mean age (+/- SD) was 53 +/- 12 years and 50% were female. Median (IQR) erythropoietin concentrations were 7.6 (5.8-9.9) IU/L in men and 7.9 (6.0-10.6) IU/L in women. A strong positive correlation was found between erythropoietin and waist circumference, glucose and systolic blood pressure (all P < 0.05). In subjects with normal renal function there was a strong exponential relation between hemoglobin and erythropoietin, whereas in renal impairment (eGFR < 60 mL/min/1.73m(2)) this relation was linear (men) or absent (women) (P < 0.001 for interaction). Single-nucleotide polymorphisms at the HBS1L-MYB locus were shown to be related to erythropoietin levels (P < 9x10(-21)), more significantly than other erythrocyte parameters. Conclusion We provide age-specific reference ranges for endogenous serum erythropoietin. Erythropoietin levels are positively associated with the components of the metabolic syndrome, except cholesterol. We show that even mild renal failure blunts erythropoietin production and propose the HBS1L-MYB locus as a regulator of erythropoietin.	[Beverborg, Niels Grote; Verweij, Niek; Klip, IJsbrand T.; van der Wal, Haye H.; Voors, Adriaan A.; van Veldhuisen, Dirk J.; van der Harst, Pim; van der Meer, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Gansevoort, Ron T.; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of Groningen; University of Groningen	van der Meer, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	p.van.der.meer@umcg.nl	Voors, Adriaan/ABE-6784-2020; Verweij, Niek/A-4499-2017; van der Wal, Haye/AAR-4470-2020; van der Wal, Haye/V-7528-2019; Verweij, Niek/ABC-6249-2021; Bakker, Stephan J. L./J-4023-2015; Grote Beverborg, Niels/L-3809-2019	Verweij, Niek/0000-0002-4303-7685; Bakker, Stephan J. L./0000-0003-3356-6791; Grote Beverborg, Niels/0000-0003-4629-9960	Amgen Inc.; Vifor Pharma	Amgen Inc.(Amgen); Vifor Pharma	Dr. van Veldhuisen received board membership fees from Amgen Inc. Dr. Voors, Dr. van Veldhuisen and Dr. van der Meer received consultancy fees from Vifor Pharma. Dr. Voors and Dr. van der Meer received an unrestricted grant from Vifor Pharma. Dr. Klip received a speaker fee from Vifor Pharma. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	BEGUIN Y, 1993, BLOOD, V81, P1067; Benson EW, 2000, J CLIN LAB ANAL, V14, P271, DOI 10.1002/1098-2825(20001212)14:6<271::AID-JCLA4>3.0.CO;2-8; Bunn HF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011619; CHANDRA M, 1988, J PEDIATR-US, V113, P1015, DOI 10.1016/S0022-3476(88)80573-0; Charuruks Navapun, 2000, Journal of the Medical Association of Thailand, V83, P1267; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Cotroneo P, 2000, DIABETES-METAB RES, V16, P172, DOI 10.1002/1520-7560(200005/06)16:3<172::AID-DMRR117>3.3.CO;2-4; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DEKLERK G, 1981, BLOOD, V58, P1164; den Elzen WPJ, 2010, CAN MED ASSOC J, V182, P1953, DOI 10.1503/cmaj.100374; Dicato M, 2008, ONCOLOGIST, V13, P11, DOI 10.1634/theoncologist.13-S3-11; Dickson VV, 2008, EUR J CARDIOVASC NUR, V7, P171, DOI 10.1016/j.ejcnurse.2007.11.005; Ershler WB, 2005, J AM GERIATR SOC, V53, P1360, DOI 10.1111/j.1532-5415.2005.53416.x; ESCHBACH JW, 1989, KIDNEY INT, V35, P134, DOI 10.1038/ki.1989.18; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Ferrucci L, 2005, AM J MED, V118, DOI 10.1016/j.amjmed.2005.06.039; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hamalainen P, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-116; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; KRANTZ SB, 1991, BLOOD, V77, P419; Krapf R, 2009, CLIN J AM SOC NEPHRO, V4, P470, DOI 10.2215/CJN.05040908; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luft FC, 2000, CLIN NEPHROL, V53, pS61; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Mak RHK, 1998, PEDIATR NEPHROL, V12, P660, DOI 10.1007/s004670050524; Mastromarino V, 2011, CLIN SCI, V120, P51, DOI 10.1042/CS20100305; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Murphy WG, 2010, BLOOD, V116, P2861, DOI 10.1182/blood-2010-07-294595; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Roque ME, 2001, CLIN LAB HAEMATOL, V23, P291, DOI 10.1046/j.1365-2257.2001.00413.x; SCHAEFER RM, 1988, AM J NEPHROL, V8, P449, DOI 10.1159/000167652; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Sinkeler SJ, 2012, AM J TRANSPLANT, V12, P485, DOI 10.1111/j.1600-6143.2011.03825.x; Smilde TDJ, 2005, AM J HYPERTENS, V18, P342, DOI 10.1016/j.amjhyper.2004.09.015; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; van der Meer P, 2004, J AM COLL CARDIOL, V44, P63, DOI 10.1016/j.jacc.2004.03.052; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; VANDYKE D, 1961, BLOOD, V18, P187, DOI 10.1182/blood.V18.2.187.187; Wagner M, 2011, CLIN J AM SOC NEPHRO, V6, P1573, DOI 10.2215/CJN.00380111; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; WIDE L, 1989, BRIT J HAEMATOL, V72, P85, DOI 10.1111/j.1365-2141.1989.tb07657.x	43	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125215	10.1371/journal.pone.0125215	http://dx.doi.org/10.1371/journal.pone.0125215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915923	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100110
J	Chen, P; Yang, WK; Tian, YP; Sun, ST; Chen, GY; Zhang, CY; Ma, FX; Xun, YP; Shi, LL; Yang, CH; Zhao, LQ; Zhou, YB; Du, HW				Chen, Peng; Yang, Weikang; Tian, Yaping; Sun, Shutao; Chen, Guangyu; Zhang, ChunYan; Ma, Fuxin; Xun, Yiping; Shi, Lili; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin; Du, Hongwu			Electron Transfer Flavoprotein Subunit Beta Is a Candidate Endothelial Cell Autoantigen in Behcet's Disease	PLOS ONE			English	Article							FATTY ACYL COENZYME; ANTIBODIES; IDENTIFICATION; VASCULITIS; ANTIGEN	Behcet's disease (BD) is a chronic inflammatory disease with multisystem involvement, and it is listed as a rare disease in the United States but is common in the Middle East, China, and Japan. The aim of this study was to identify novel autoantigens in Chinese patients with BD. First, the candidate autoantigens were screened by Western blotting, and the sequences of putative antigens were identified by LC-MALDI-TOF/TOF mass spectrometry. Next, the screened protein was cloned, expressed and purified. Then, an optimized ELISA was developed, and the serological criteria were evaluated using a large number of confirmed patients. One antigen with a molecular weight of approximately 28 kDa was identified as electron transfer flavoprotein subunit beta (ETFB). Positive reactivity was detected in recombinant human ETFB sera from 38 of 92 BD patients (41 %) and 1 of 90 healthy controls (1%).	[Chen, Peng; Yang, Weikang; Ma, Fuxin; Xun, Yiping; Shi, Lili; Yang, Chunhe; Zhao, Lanqing; Zhou, Yabin; Du, Hongwu] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China; [Tian, Yaping; Zhang, ChunYan] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing 100853, Peoples R China; [Sun, Shutao] Chinese Acad Sci, Inst Microbiol, Core Facil, Beijing, Peoples R China; [Chen, Guangyu] ImmunoHunt Corp, Beijing 100071, Peoples R China	University of Science & Technology Beijing; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of Microbiology, CAS	Du, HW (corresponding author), Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing 100083, Peoples R China.	hongwudu@ustb.edu.cn		Xun, Yiping/0000-0001-6367-8407	Fundamental Research Funds for the Central universities; Program for New Century Excellent Talents in University; National Natural Science Foundation of China [31371203]; ImmunoHunt Corporation	Fundamental Research Funds for the Central universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ImmunoHunt Corporation	This work was supported by the Fundamental Research Funds for the Central universities, the Program for New Century Excellent Talents in University and the National Natural Science Foundation of China (31371203). Co-author Guangyu Chen is employed by ImmunoHunt Corporation. ImmunoHunt Corporation provided support in the form of salary for author GC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AYDINTUG AO, 1993, CLIN IMMUNOL IMMUNOP, V67, P157, DOI 10.1006/clin.1993.1059; Bax M, 2014, SEMIN IMMUNOPATHOL, V36, P313, DOI 10.1007/s00281-014-0429-5; BEINERT H, 1962, J BIOL CHEM, V237, P2988; Bin Cho S, 2012, J INVEST DERMATOL, V132, P601, DOI 10.1038/jid.2011.397; Chen P, 2015, BIOCHEM BIOPH RES CO, V456, P866, DOI 10.1016/j.bbrc.2014.12.064; CRANE FL, 1956, J BIOL CHEM, V218, P701; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Deng CY, 2014, MOL PLANT MICROBE IN, V27, P101, DOI 10.1094/MPMI-08-13-0234-R; Dinc A, 2003, CLIN EXP RHEUMATOL, V21, pS27; Du HW, 2013, BIOANALYSIS, V5, P2269, DOI 10.4155/bio.13.195; Du HW, 2012, BIOANALYSIS, V4, P2161, DOI 10.4155/BIO.12.188; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Karasawa R, 2011, EXPERT OPIN BIOL TH, V11, P77, DOI 10.1517/14712598.2011.540234; Lee SJ, 2006, J ALLERGY CLIN IMMUN, V117, pS445, DOI 10.1016/j.jaci.2005.06.023; LOEHR JP, 1990, PEDIATR RES, V27, P311, DOI 10.1203/00006450-199003000-00024; Mak T., 2008, PRIMER IMMUNE RESPON; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Mor F, 2002, EUR J IMMUNOL, V32, P356, DOI 10.1002/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9; Moutsopoulos HM, 2014, J AUTOIMMUN, V51, P1, DOI 10.1016/j.jaut.2014.01.001; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sakane T, 2011, NEW ENGL J MED, V341, P1284; Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009; Shin SJ, 2011, DIGEST DIS SCI, V56, P812, DOI 10.1007/s10620-010-1326-y; SILMAN AJ, 1990, LANCET, V335, P1078; Verity DH, 2003, BRIT J OPHTHALMOL, V87, P1175, DOI 10.1136/bjo.87.9.1175; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Xun YP, 2014, BIOCHEM BIOPH RES CO, V451, P389, DOI 10.1016/j.bbrc.2014.07.126	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124760	10.1371/journal.pone.0124760	http://dx.doi.org/10.1371/journal.pone.0124760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915519	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100065
J	Huang, YM; Zhang, Q; Yang, ZS; Conrad, T; Liu, YJ; Zhong, GM				Huang, Yumeng; Zhang, Qi; Yang, Zhangsheng; Conrad, Turner; Liu, Yuanjun; Zhong, Guangming			Plasmid-Encoded Pgp5 Is a Significant Contributor to Chlamydia muridarum Induction of Hydrosalpinx	PLOS ONE			English	Article							TRACHOMATIS; MICE; INFECTION; TRANSFORMATION; VIRULENCE; PATHOLOGY; DEFICIENT; IMMUNITY; STRAIN; CELL	We have previously shown that the plasmid-encoded Pgp3 is a major virulence factor for C. muridarum induction of hydrosalpinx. We now report that Pgp5 also plays a significant role in the development of hydrosalpinx following C. muridarum induction. Pgp5 deficiency was introduced via either in-frame deletion (CM-Delta pgp5) or premature stop codon installation (CM-pgp5S). Mice infected with either CM-Delta pgp5 or CM-pgp5S developed hydrosalpinges at significantly reduced levels with an incidence rate of <40% and a mean severity score of 2 or less. In contrast, 80% or more mice developed hydrosalpinx with a severity score of >3 when mice were infected with Pgp5-sufficient C. muridarum (plasmid-competent wild type or plasmid-free C. muridarum transformed with a full plasmid or depleted of pgp7 gene). The attenuated pathogenicity of the Pgp5-deficient C. muridarum correlated with a significantly reduced level of ascending infection in the oviduct tissue despite the similar overall shedding courses between mice infected with Pgp5-deficeint versus sufficient C. muridarum. Furthermore, in the oviducts of mice infected with Pgp5-deficient C. muridarum, significantly lower levels of inflammatory cell infiltration and cytokine production were detected. Thus, Pgp5 is a significant plasmid-encoded virulence factor for C. muridarum pathogenicity in the upper genital tract.	[Huang, Yumeng; Zhang, Qi; Yang, Zhangsheng; Conrad, Turner; Liu, Yuanjun; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Huang, Yumeng] Cent South Univ China, Xiangya Sch Med, Xiangya Hosp 2, Dept Dermatol, Changsha 410013, Hunan, Peoples R China; [Zhang, Qi] Cent South Univ China, Xiangya Sch Med, Xiangya Hosp 3, Dept Obstet & Gynecol, Changsha 410013, Hunan, Peoples R China; [Liu, Yuanjun] Tianjin Med Univ, Gen Hosp, Dept Dermatovenereol, Tianjin 300052, Peoples R China	University of Texas System; University of Texas Health San Antonio; Central South University; Central South University; Tianjin Medical University	Liu, YJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Liuyuanjun1980@126.com; Zhongg@UTHSCSA.EDU			US National Institutes of Health (NIH) [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537, R01AI047997] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research is supported by US National Institutes of Health (NIH) grants R01AI064537 and R01AI047997. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Chen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095076; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; de la Maza Luis M, 2002, Curr Opin Investig Drugs, V3, P980; Ding HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080534; Dong XH, 2014, INFECT IMMUN, V82, P1833, DOI 10.1128/IAI.01668-13; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Liu Y, 2014, INFECT IMMUN, V82, P5327, DOI 10.1128/IAI.02576-14; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lu CX, 2012, VACCINE, V30, P475, DOI 10.1016/j.vaccine.2011.10.059; Matsumoto A, 1998, J CLIN MICROBIOL, V36, P3013, DOI 10.1128/JCM.36.10.3013-3019.1998; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Murthy AK, 2011, INFECT IMMUN; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; Peng B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-347; Ramsey KH, 2014, INFECT IMMUN; RICCI S, 1995, GENE, V154, P93, DOI 10.1016/0378-1119(94)00825-D; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Sigar IM, 2014, PATHOG DIS, V70, P61, DOI 10.1111/2049-632X.12086; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Wang YB, 2013, PATHOG DIS, V67, P100, DOI 10.1111/2049-632X.12024; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377; Yang ZS, 2014, INFECT IMMUN, V82, P3154, DOI 10.1128/IAI.01833-14; Zhang HB, 2014, INFECT IMMUN, V82, P2688, DOI 10.1128/IAI.00055-14; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	35	23	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124840	10.1371/journal.pone.0124840	http://dx.doi.org/10.1371/journal.pone.0124840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915629	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100073
J	Yang, JJ; Li, XH; Yang, RM; Yu, X; Yu, CL; Qian, YF; Yu, YQ				Yang, Jinjing; Li, Xiaohu; Yang, Renmin; Yu, Xuen; Yu, Changliang; Qian, Yinfeng; Yu, Yongqiang			Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients	PLOS ONE			English	Article							IRON DEPOSITION; MULTIPLE-SCLEROSIS; CLINICAL CORRELATION; CRANIAL MRI; GREY-MATTER; CERULOPLASMIN; LIVER	Purpose It is well known that patients with Wilson's disease (WD) suffer copper metabolism disorder. However, recent studies point to an additional iron metabolism disorder in WD patients. The purpose of our study was to examine susceptibility-weighted imaging (SWI) manifestations of WD in the brains of WD patients. Methods A total of 33 patients with WD and 18 normal controls underwent conventional MRI (Magnetic resonance imaging) and SWI. The phase values were measured on SWI-filtered phase images of the bilateral head of the caudate nuclei, globus pallidus, putamen, thalamus, substantia nigra, and red nucleus. Student's t-tests were used to compare the phase values between WD groups and normal controls. Results The mean phase values for the bilateral head of the caudate nuclei, globus pallidus, putamen, thalamus, substantia nigra, and red nucleus were significantly lower than those in the control group (P < 0.001), and bilateral putamen was most strongly affected. Conclusions There is paramagnetic mineralization deposition in brain gray nuclei of WD patients and SWI is an effective method to evaluate these structures.	[Yang, Jinjing; Li, Xiaohu; Yu, Changliang; Qian, Yinfeng; Yu, Yongqiang] Anhui Med Univ, Dept Radiol, Affiliated Hosp 1, Hefei, Peoples R China; [Yang, Renmin; Yu, Xuen] Anhui Coll TCM, Dept Neurol, Hosp Affiliated, Hefei, Peoples R China	Anhui Medical University	Qian, YF (corresponding author), Anhui Med Univ, Dept Radiol, Affiliated Hosp 1, Hefei, Peoples R China.	ayfyqianyinfeng@126.com; ayfyyuyongqiang@126.com		Yu, Xu-En/0000-0003-1241-6962	National Natural Science Foundation of China [813012240]; Anhui Provincial Education Department [KJ2013A144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Education Department	This study was supported by the grant from National Natural Science Foundation of China (813012240) and Anhui Provincial Education Department (KJ2013A144).	Bruehlmeier M, 2000, J NUCL MED, V41, P781; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098303; Chen X, 2012, EUR J RADIOL, V81, pE633, DOI 10.1016/j.ejrad.2012.01.003; Duchen LW, 1992, GREENFIELDS NEUROPAT, P838; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Frazer DM, 2003, BLOOD CELL MOL DIS, V30, P288, DOI 10.1016/S1079-9796(03)00039-1; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HITOSHI S, 1991, J NEUROL NEUROSUR PS, V54, P624, DOI 10.1136/jnnp.54.7.624; Ishida S, 2012, INTERNAL MED, V51, P1759, DOI 10.2169/internalmedicine.51.7341; Kim TJ, 2006, AM J NEURORADIOL, V27, P1373; King AD, 1996, AM J ROENTGENOL, V167, P1579, DOI 10.2214/ajr.167.6.8956601; Kozic D, 2003, EUR J NEUROL, V10, P587, DOI 10.1046/j.1468-1331.2003.00661.x; Lee JH, 2012, J NEUROL SCI, V313, P54, DOI 10.1016/j.jns.2011.09.031; Lee JH, 2012, CLIN NEUROL NEUROSUR, V114, P47, DOI 10.1016/j.clineuro.2011.07.002; Li CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073626; Merle U, 2010, J GASTROEN HEPATOL, V25, P1144, DOI 10.1111/j.1440-1746.2009.06173.x; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Ogg RJ, 1999, MAGN RESON IMAGING, V17, P1141, DOI 10.1016/S0730-725X(99)00017-X; Rumzan R, 2013, EUR J RADIOL, V82, pE95, DOI 10.1016/j.ejrad.2012.09.006; Sargent PJ, CURR MED CHEM, V12, P2683; Shiono Y, 2001, AM J GASTROENTEROL, V96, P3147; Sinha S, 2006, NEURORADIOLOGY, V48, P613, DOI 10.1007/s00234-006-0101-4; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050706; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zivadinov R, 2010, INT ANGIOL, V29, P158	28	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125100	10.1371/journal.pone.0125100	http://dx.doi.org/10.1371/journal.pone.0125100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915414	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100099
J	Zhuang, CL; Wang, SL; Huang, DD; Pang, WY; Lou, N; Chen, BC; Chen, XL; Yu, Z; Shen, X				Zhuang, Cheng-Le; Wang, Su-Lin; Huang, Dong-Dong; Pang, Wen-Yang; Lou, Neng; Chen, Bi-Cheng; Chen, Xiao-Lei; Yu, Zhen; Shen, Xian			Risk Factors for Hospital Readmission after Radical Gastrectomy for Gastric Cancer: A Prospective Study	PLOS ONE			English	Article							AMERICAN-COLLEGE; MORTALITY; SURGERY; QUALITY; COMPLICATIONS; MANAGEMENT; MORBIDITY; PATIENT	Background Hospital readmission is gathering increasing attention as a measure of health care quality and a potential cost-saving target. The purpose of this prospective study was to determine risk factors for readmission within 30 days of discharge after gastrectomy for patients with gastric cancer. Methods We conducted a prospective study of patients undergoing radical gastrectomy for gastric cancer from October 2013 to November 2014 in our institution. The incidence, cause and risk factors for 30-day readmission were determined. Results A total of 376 patients were included in our analysis without loss in follow-up. The 30-day readmission rate after radical gastrectomy for gastric cancer was 7.2% (27of 376). The most common cause for readmission included gastrointestinal complications and postoperative infections. On the basis of multivariate logistic regression analysis, preoperative nutritional risk screening 2002 score >= 3 was an independent risk factor for 30-day readmission. Factors not associated with a higher readmission rate included a history of a major postoperative complication during the index hospitalization, prolonged primary length of hospital stay after surgery, a history of previous abdominal surgery, advanced age, body mass index, pre-existing cardiopulmonary comorbidities, American Society of Anesthesiology grade, type of resection, extent of node dissection and discharge disposition. Conclusions Readmission within 30 days of discharge after radical gastrectomy for gastric cancer is common. Patients with nutritional risk preoperatively are at high risk for 30-day readmission. Preoperative optimization of nutritional status of patients at nutritional risk may effectively decrease readmission rates.	[Zhuang, Cheng-Le; Wang, Su-Lin; Huang, Dong-Dong; Pang, Wen-Yang; Lou, Neng; Chen, Xiao-Lei; Yu, Zhen; Shen, Xian] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Peoples R China; [Chen, Bi-Cheng] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou Key Lab Surg, Wenzhou, Peoples R China; [Yu, Zhen] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastrointestinal Surg, Shanghai 200092, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Tongji University	Yu, Z (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Peoples R China.	yuzhen0577@gmail.com; shenxian5166@126.com			National Natural Science Foundation of China [81171857]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81171857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2014, J AM COLL SURGEONS, V218, P1215, DOI 10.1016/j.jamcollsurg.2014.02.015; Ahmad SA, 2012, ANN SURG, V256, P529, DOI 10.1097/SLA.0b013e318265ef0b; Bartlett EK, 2014, SURGERY, V156, P298, DOI 10.1016/j.surg.2014.03.022; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; Coburn N, 2014, ANN SURG, V259, P102, DOI 10.1097/SLA.0b013e318288dd2b; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Gavazzi C, 2011, BRIT J NUTR, V106, P1773, DOI 10.1017/S0007114511002509; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jie B, 2012, NUTRITION, V28, P1022, DOI 10.1016/j.nut.2012.01.017; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; Kerwel TG, 2014, DIS COLON RECTUM, V57, P98, DOI 10.1097/DCR.0000000000000007; Kim MC, 2012, ANN SURG ONCOL, V19, P2459, DOI 10.1245/s10434-012-2271-0; Kimbrough CW, 2014, SURGERY, V156, P1039, DOI 10.1016/j.surg.2014.06.057; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kulaylat AN, 2015, J SURG RES, V193, P528, DOI 10.1016/j.jss.2014.09.029; Kwaan MR, 2013, DIS COLON RECTUM, V56, P1087, DOI 10.1097/DCR.0b013e31829aa758; Mariette C, 2012, ANN SURG ONCOL, V19, P2128, DOI 10.1245/s10434-012-2225-6; Papenfuss WA, 2014, ANN SURG ONCOL, V21, P3008, DOI 10.1245/s10434-014-3664-z; Ryu SW, 2010, WORLD J GASTROENTERO, V16, P3310, DOI 10.3748/wjg.v16.i26.3310; Schneider EB, 2012, J AM COLL SURGEONS, V215, P607, DOI 10.1016/j.jamcollsurg.2012.07.007; Sellers MM, 2013, J AM COLL SURGEONS, V216, P420, DOI 10.1016/j.jamcollsurg.2012.11.013; Sutton JM, 2014, DIS COLON RECTUM, V57, P1371, DOI 10.1097/DCR.0000000000000227; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Worhunsky DJ, 2015, J NATL COMPR CANC NE, V13, P319, DOI 10.6004/jnccn.2015.0044; Yamamoto M, 2015, J GASTROINTEST ONCOL, V6, P79, DOI 10.3978/j.issn.2078-6891.2014.097; Zhou W, 2013, SURG ENDOSC, V27, P2569, DOI 10.1007/s00464-013-2790-1	29	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125572	10.1371/journal.pone.0125572	http://dx.doi.org/10.1371/journal.pone.0125572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915547	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100135
J	Hakim, AJ; Aho, J; Semde, G; Diarrassouba, M; Ehoussou, K; Vuylsteke, B; Murrill, CS; Thiam, M; Wingate, T				Hakim, Avi J.; Aho, Josephine; Semde, Gisele; Diarrassouba, Mamadou; Ehoussou, Konan; Vuylsteke, Bea; Murrill, Christopher S.; Thiam, Marguerite; Wingate, Therese		SHARM Study Grp	The Epidemiology of HIV and Prevention Needs of Men Who Have Sex with Men in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							PREVALENCE; INFECTION; RISKS	To determine HIV prevalence and associated risk factors among men who have sex with men (MSM) in Abidjan, C (o) over cap te d'Ivoire. We conducted a cross-sectional RDS survey of MSM in Abidjan from October 2011 to February 2012. Eligibility criteria included age >= 18 years and having had oral or anal sex with another man in the last 12 months. Weighted data analysis was conducted with RDSAT and SAS. We enrolled 603 participants, of whom 601 (99.7%) completed the questionnaire and 581 (96.7%) consented to HIV testing. HIV population prevalence was estimated as 18.0% (95% CI: 13.0-23.1); 86.4%(95% CI: 75.1-94.9) of HIV-positive MSM were unaware of their serostatus. In multivariable analysis, adjusting for age, education, and income, HIV infection was associated with unprotected sex at last sex with a woman, more than two male anal sex partners in last 12 months, inconsistent condom use during anal sex with a man, self-perceived risk of HIV, history of forced sex, history of physical abuse due to MSM status, and not receiving last HIV test result prior to study. HIV prevalence among MSM in Abidjan is more than four times as high as that of general population men. MSM engage in high-risk sexual behavior and most HIV-positive MSM are unaware of their serostatus. Greater access to HIV prevention, care, and treatment services targeted to MSM is necessary.	[Hakim, Avi J.; Murrill, Christopher S.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Aho, Josephine; Vuylsteke, Bea] Inst Trop Med, B-2000 Antwerp, Belgium; [Semde, Gisele] FHI 360, Abidjan, Cote Ivoire; [Diarrassouba, Mamadou; Ehoussou, Konan; Wingate, Therese] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Abidjan, Cote Ivoire; [Thiam, Marguerite] Minist Hlth & Fight HIV, Abidjan, Cote Ivoire	Centers for Disease Control & Prevention - USA; Institute of Tropical Medicine (ITM)	Hakim, AJ (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA.	hxv8@cdc.gov			U.S. President's Emergency Plan for AIDS Relief through U.S. Centers for Disease Control and Prevention (CDC) [FHI360]; Canadian Institutes for Health Research	U.S. President's Emergency Plan for AIDS Relief through U.S. Centers for Disease Control and Prevention (CDC); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The survey was funded by the U.S. President's Emergency Plan for AIDS Relief through the U.S. Centers for Disease Control and Prevention (CDC), which provided funding to FHI360. JA is a recipient of a postdoctoral fellowship by the Canadian Institutes for Health Research. CDC employees were involved in the study design, analysis, decision to publish, and preparation of the manuscript.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, pI1, DOI 10.1007/s11524-006-9108-8; Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; [Anonymous], 2012, REPUBLIQUE DE COTE D; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Berry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043071; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; Chapman J, 2011, AIDS CARE, V23, P449, DOI 10.1080/09540121.2010.507758; Dahoma M, 2011, AIDS BEHAV, V15, P186, DOI 10.1007/s10461-009-9646-7; DIOPNDIAYE H, 2009, 16 C RETR OPP INF MO; Hakim A, 2010, FORMATIVE ASSESSMENT; HECKATHORN D, 2004, SOCIAL METHODS, V34, P208; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Ministere de la Sante et de la Lutte contre le Sida INdlS Measure DHS ICF International, 2013, REP DE COT DIV ENQ D; Rispel LM CA, 2011, J ACQUIRED IMMUNE DE, V57; Smith A, 2009, STAND, V9, P21; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tovanabutra S SE, 2008, 15 INT WORKSH HIV DY; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276; Wejnert C, 2012, AIDS BEHAV, V16, P797, DOI 10.1007/s10461-012-0147-8	27	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125218	10.1371/journal.pone.0125218	http://dx.doi.org/10.1371/journal.pone.0125218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909484	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800135
J	Tang, N; Deng, W; Hu, GJ; Hu, N; Li, ZG				Tang, Ning; Deng, Wei; Hu, Guojian; Hu, Nan; Li, Zhengguo			Transcriptome Profiling Reveals the Regulatory Mechanism Underlying Pollination Dependent and Parthenocarpic Fruit Set Mainly Mediated by Auxin and Gibberellin	PLOS ONE			English	Article							DOWN-REGULATION; TOMATO; ARABIDOPSIS; EXPRESSION; ETHYLENE; SEED; VISUALIZATION; SENESCENCE; METABOLITE; PROTEIN	Background Fruit set is a key process for crop production in tomato which occurs after successful pollination and fertilization naturally. However, parthenocarpic fruit development can be uncoupled from fertilization triggered by exogenous auxin or gibberellins (GAs). Global transcriptome knowledge during fruit initiation would help to characterize the molecular mechanisms by which these two hormones regulate pollination-dependent and -independent fruit set. Principal Findings In this work, digital gene expression tag profiling (DGE) technology was applied to compare the transcriptomes from pollinated and 2,4-D/GA(3)-treated ovaries. Activation of carbohydrate metabolism, cell division and expansion as well as the down-regulation of MADS-box is a comprehensive regulatory pathway during pollination-dependent and parthenocarpic fruit set. The signaling cascades of auxin and GA are significantly modulated. The feedback regulations of Aux/IAAs and DELLA genes which functioned to fine-tune auxin and GA response respectively play fundamental roles in triggering fruit initiation. In addition, auxin regulates GA synthesis via up-regulation of GA20ox1 and down-regulation of KNOX. Accordingly, the effect of auxin on fruit set is mediated by GA via ARF2 and IAA9 down-regulation, suggesting that both pollination-dependent and parthenocarpic fruit set depend on the crosstalk between auxin and GA. Significance This study characterizes the transcriptomic features of ovary development and more importantly unravels the integral roles of auxin and GA on pollination-dependent and parthenocarpic fruit set.	[Tang, Ning; Deng, Wei; Hu, Guojian; Hu, Nan; Li, Zhengguo] Chongqing Univ, Genet Engn Res Ctr, Sch Life Sci, Key Lab Funct Gene & New Regulat Technol Chongqin, Chongqing 400030, Peoples R China	Chongqing University	Li, ZG (corresponding author), Chongqing Univ, Genet Engn Res Ctr, Sch Life Sci, Key Lab Funct Gene & New Regulat Technol Chongqin, Chongqing 400030, Peoples R China.	zgli6@163.com	Li, Zhengguo/A-5572-2017; Li, Zhengguo/AAR-5191-2020	HU, Guojian/0000-0002-7358-7805; Zhengguo, Li/0000-0002-4643-9540	National High Technology Research and Development Program of China [2012AA101702]; National Basic Research Program of China [2013CB127101, 2013CB127106]; National Natural Science Foundation of China [31272166]; Committee of Science and Technology of Chongqing [2011BA1024]; Fundamental Research Funds for the Central Universities [CDJXS11232245]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology of Chongqing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National High Technology Research and Development Program of China (2012AA101702), National Basic Research Program of China (2013CB127101, 2013CB127106), National Natural Science Foundation of China (31272166), the Committee of Science and Technology of Chongqing (2011BA1024) and Fundamental Research Funds for the Central Universities (CDJXS11232245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; Benjamini Y, 2001, ANN STAT, V29, P1165; Carbonell-Bejerano P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-84; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; Ding JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070080; Do PT, 2010, PLANT PHYSIOL, V154, P1128, DOI 10.1104/pp.110.163030; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Jin Y, 2009, PLANT CELL, V21, P2072, DOI 10.1105/tpc.108.063719; Kolotilin I, 2007, PLANT PHYSIOL, V145, P389, DOI 10.1104/pp.107.102962; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Marti C, 2007, PLANT J, V52, P865, DOI 10.1111/j.1365-313X.2007.03282.x; Martinez C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-139; Mazzucato A, 2008, PHYSIOL PLANTARUM, V132, P526, DOI 10.1111/j.1399-3054.2007.01035.x; Middleton AM, 2012, P NATL ACAD SCI USA, V109, P7571, DOI 10.1073/pnas.1113666109; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mounet F, 2012, J EXP BOT, V63, P4901, DOI 10.1093/jxb/ers167; Odanaka S, 2002, PLANT PHYSIOL, V129, P1119, DOI 10.1104/pp.000703; Olimpieri I, 2007, PLANTA, V226, P877, DOI 10.1007/s00425-007-0533-z; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pascual L, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-67; PIECHULLA B, 1987, PLANT PHYSIOL, V84, P911, DOI 10.1104/pp.84.3.911; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Richter R, 2013, P NATL ACAD SCI USA, V110, P13192, DOI 10.1073/pnas.1304250110; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Serrani JC, 2007, J PLANT GROWTH REGUL, V26, P211, DOI 10.1007/s00344-007-9014-7; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Switzenberg JA, 2014, TRANSGENIC RES, P1, DOI [10.1007/s11248-014-9843-7, DOI 10.1007/S11248-014-9843-7]; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Vivian-Smith A, 2000, MOL BASIS INITIATION; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Zanor MI, 2009, PLANT PHYSIOL, V150, P1204, DOI 10.1104/pp.109.136598; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	47	47	53	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125355	10.1371/journal.pone.0125355	http://dx.doi.org/10.1371/journal.pone.0125355			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909657	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800139
J	Young, K; Tweedie, E; Conley, B; Ames, J; FitzSimons, M; Brooks, P; Liaw, L; Vary, CPH				Young, Kira; Tweedie, Eric; Conley, Barbara; Ames, Jacquelyn; FitzSimons, MaryLynn; Brooks, Peter; Liaw, Lucy; Vary, Calvin P. H.			BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; PULMONARY ARTERIOVENOUS-MALFORMATIONS; TISSUE GROWTH-FACTOR; RECEPTOR-LIKE KINASE-1; FOCAL ADHESION KINASE; TGF-BETA; SIGNALING PATHWAYS; INTEGRIN ALPHA(6)BETA(1); VASCULAR DEVELOPMENT; ENDOGLIN EXPRESSION	Endoglin is a type III TGF beta auxiliary receptor that is upregulated in endothelial cells during angiogenesis and, when mutated in humans, results in the vascular disease hereditary hemorrhagic telangiectasia (HHT). Though endoglin has been implicated in cell adhesion, the underlying molecular mechanisms are still poorly understood. Here we show endoglin expression in endothelial cells regulates subcellular localization of zyxin in focal adhesions in response to BMP9. RNA knockdown of endoglin resulted in mislocalization of zyxin and altered formation of focal adhesions. The mechanotransduction role of focal adhesions and their ability to transmit regulatory signals through binding of the extracellular matrix are altered by endoglin deficiency. BMP/TGF beta transcription factors, SMADs, and zyxin have recently been implicated in a newly emerging signaling cascade, the Hippo pathway. The Hippo transcription coactivator, YAP1 (yes-associated protein 1), has been suggested to play a crucial role in mechanotransduction and cell-cell contact. Identification of BMP9-dependent nuclear localization of YAP1 in response to endoglin expression suggests a mechanism of crosstalk between the two pathways. Suppression of endoglin and YAP1 alters BMP9-dependent expression of YAP1 target genes CCN1 (cysteine-rich 61, CYR61) and CCN2 (connective tissue growth factor, CTGF) as well as the chemokine CCL2 (monocyte chemotactic protein 1, MCP-1). These results suggest a coordinate effect of endoglin deficiency on cell matrix remodeling and local inflammatory responses. Identification of a direct link between the Hippo pathway and endoglin may reveal novel mechanisms in the etiology of HHT.	[Young, Kira; Tweedie, Eric; Conley, Barbara; Ames, Jacquelyn; Brooks, Peter; Liaw, Lucy; Vary, Calvin P. H.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Young, Kira; Ames, Jacquelyn; FitzSimons, MaryLynn; Brooks, Peter; Liaw, Lucy; Vary, Calvin P. H.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA	Maine Medical Center; University of Maine System; University of Maine Orono	Vary, CPH (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.	varyc@mmc.org			American Heart Association [14GRNT20460045]; National Institutes of Health [HL083151, HL070865, HL109652, CA91645]; NIH / NIGMS [1P30 GM106391, P30GM103392]; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109652, R01HL070865, R01HL083151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P30GM106391] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH / NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This Research is supported in part through an American Heart Association grant 14GRNT20460045 (CV), National Institutes of Health grants HL083151 (CV), HL070865 and HL109652 (LL), and CA91645 (PB). Additional support was provided by the institute core facilities in Flow Cytometry and Progenitor Cell Analysis (as supported by NIH / NIGMS 1P30 GM106391, DM Wojchowski, PI) and Protein, Nucleic Acid and Cell Imaging (as supported by NIH / NIGMS P30GM103392, R Friesel, PI). The authors thank Ms. Sarah Coreau for help in the preparation of this manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Artemenko Y, 2012, P NATL ACAD SCI USA, V109, P13632, DOI 10.1073/pnas.1211304109; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Bianchi-Smiraglia A, 2013, CELL CYCLE, V12, DOI [10.4161/cc.26540, DOI 10.4161/CC.26540]; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Booy AT, 2005, J PROTEOME RES, V4, P325, DOI 10.1021/pr049840t; Bourdeau A, 2000, AM J PATHOL, V156, P911, DOI 10.1016/S0002-9440(10)64960-7; Bourdeau A, 2000, TRENDS CARDIOVAS MED, V10, P279, DOI 10.1016/S1050-1738(01)00062-7; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Burke JP, 2010, BRIT J SURG, V97, P892, DOI 10.1002/bjs.6996; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; Chopra A, 2014, BIOMATERIALS, V35, P71, DOI 10.1016/j.biomaterials.2013.09.066; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Cottin V, 2007, J VASC INTERV RADIOL, V18, P938, DOI 10.1016/j.jvir.2006.12.741; Cretu A, 2007, CLIN CANCER RES, V13, P3068, DOI 10.1158/1078-0432.CCR-06-2342; Dakeishi M, 2002, HUM MUTAT, V19, P140, DOI 10.1002/humu.10026; David L, 2008, CIRC RES; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Duarte CW, 2014, CANCER EPIDEM BIOMAR, V23, P117, DOI 10.1158/1055-9965.EPI-13-0665; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Duwel A, 2007, TUMOR BIOL, V28, P1, DOI 10.1159/000097040; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Enderle L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004208; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fujiyama S, 2003, CIRC RES; Gagne PJ, 2005, AM J PATHOL, V167, P1349, DOI 10.1016/S0002-9440(10)61222-9; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gong Y, 2013, ANGIOGENESIS, V16, P861, DOI 10.1007/s10456-013-9361-x; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; Herrera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069535; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Hitchcock JK, 2014, J CELL COMMUN SIGNAL, V8, P125, DOI 10.1007/s12079-014-0231-0; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hong W, 2012, SEMIN CELL DEV BIOL; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Kanellopoulou T, 2013, EXPERT OPIN BIOL TH, V13, P1315, DOI 10.1517/14712598.2013.813478; Kjeldsen A D, 2000, Ugeskr Laeger, V162, P3597; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lacombe P, 2009, CHEST, V135, P1031, DOI 10.1378/chest.08-1794; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Letteboer TGW, 2006, J MED GENET, V43, P371, DOI 10.1136/jmg.2005.035451; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu SC, 2013, BBA-MOL CELL RES, V1833, P1114, DOI 10.1016/j.bbamcr.2012.12.014; Livandovsky YA, 2005, Z NEVROL PSIKHIATRII, P51; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Mahmoud M, 2009, LAB INVEST, V89, P15, DOI 10.1038/labinvest.2008.112; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Matsubara S, 2000, STROKE, V31, P2653, DOI 10.1161/01.STR.31.11.2653; Mise N, 2012, J BIOL CHEM, V287, P31393, DOI 10.1074/jbc.M112.357624; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Pericacho M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054687; Peter MR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/767185; Pi LY, 2011, INVEST OPHTH VIS SCI, V52, P8701, DOI 10.1167/iovs.11-7870; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Quandt J, 2004, J NEUROPATH EXP NEUR, V63, P350, DOI 10.1093/jnen/63.4.350; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Ricard N, 2012, BLOOD; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Romero D, 2011, CANCER RES, V71, P3482, DOI 10.1158/0008-5472.CAN-10-2665; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Saluja S, 2004, RADIOLOGY, V230, P25, DOI 10.1148/radiol.2293031482; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Smerdel-Ramoya A, 2008, J BIOL CHEM, V283, P22690, DOI 10.1074/jbc.M710140200; STJACQUES S, 1994, BIOL REPROD, V51, P405, DOI 10.1095/biolreprod51.3.405; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; Torsney E, 2003, CIRCULATION, V107, P1653, DOI 10.1161/01.CIR.0000058170.92267.00; Torsney E, 2002, INFLAMM RES, V51, P464, DOI 10.1007/PL00012413; Turk T, 2009, J HISTOCHEM CYTOCHEM, V57, P623, DOI 10.1369/jhc.2009.953224; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Wu SH, 2008, GROWTH FACTORS, V26, P192, DOI 10.1080/08977190802227828; Wu XP, 2006, MICROVASC RES, V71, P12, DOI 10.1016/j.mvr.2005.11.004; Xu DJ, 2012, BMB REP, V45, P247, DOI 10.5483/BMBRep.2012.45.4.247; Ye L, 2008, MOL CANCER RES, V6, P1594, DOI 10.1158/1541-7786.MCR-08-0171; You JJ, 2014, CELL SIGNAL, V26, P133, DOI 10.1016/j.cellsig.2013.08.026; Young J'nelle S, 2012, Spermatogenesis, V2, P63; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784; Yu Y, 2008, EXP CELL RES, V314, P3198, DOI 10.1016/j.yexcr.2008.08.001; Yu YRA, 2013, AM J RESP CELL MOL, V48, P647, DOI 10.1165/rcmb.2012-0182OC; Yue T, 2012, DEV CELL, V22, P255, DOI 10.1016/j.devcel.2011.12.011; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043383	123	30	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122892	10.1371/journal.pone.0122892	http://dx.doi.org/10.1371/journal.pone.0122892			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909848	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800022
J	Darak, S; Mills, M; Kulkarni, V; Kulkarni, S; Hutter, I; Janssen, F				Darak, Shrinivas; Mills, Melinda; Kulkarni, Vinay; Kulkarni, Sanjeevani; Hutter, Inge; Janssen, Fanny			Trajectories of Childbearing among HIV Infected Indian Women: A Sequence Analysis Approach	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; ANDHRA-PRADESH; PREGNANCY; MOTHERHOOD; INTENTIONS; TRANSMISSION; FERTILITY; DESIRES; PEOPLE	Background HIV infection closely relates to and deeply affects the reproductive career of those infected. However, little is known about the reproductive career trajectories, specifically the interaction of the timing of HIV diagnosis with the timing and sequencing of reproductive events among HIV infected women. This is the first study to describe and typify this interaction. Methods Retrospective calendar data of ever married HIV infected women aged 15-45 attending a HIV clinic in Pune, Maharashtra, Western India (N=622) on reproductive events such as marriage, cohabitation with the partner, use of contraception, pregnancy, childbirth and HIV diagnosis were analyzed using sequence analysis and multinomial logistic regression. Results Optimal matching revealed three distinct trajectories: 1) HIV diagnosis concurrent with childbearing (40.7%), 2) HIV diagnosis after childbearing (32.1%), and 3) HIV diagnosis after husband's death (27.2%). Multinomial logistic regression (trajectory 1 = baseline) showed that women who got married before the age of 21 years and who had no or primary level education had a significantly higher risk of knowing their HIV status either after childbearing or close to their husband's death. The risk of HIV diagnosis after husband's death was also higher among rural women and those who were diagnosed before 2005. Conclusions Three distinct patterns of interaction of timing of HIV diagnosis with timing and sequencing of events in the reproductive career were observed that have clear implications for (i) understanding of the individual life planning process in the context of HIV, (ii) formulation of assumptions for estimating HIV infected women in need of PMTCT services, and (iii) provision of care services.	[Darak, Shrinivas; Hutter, Inge; Janssen, Fanny] Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands; [Darak, Shrinivas; Kulkarni, Vinay; Kulkarni, Sanjeevani] PRAYAS Hlth Grp, Pune, Maharashtra, India; [Mills, Melinda] Univ Oxford, Dept Sociol, Nuffield Coll, Oxford, England; [Janssen, Fanny] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands	University of Groningen; University of Oxford; Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW)	Darak, S (corresponding author), Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands.	shirishdarak@gmail.com	Darak, Shrinivas/AAB-4288-2021	Janssen, Fanny/0000-0002-3110-238X	Population Research Centre; Groningen and Eric Bluemink Foundation; University of Groningen, The Netherlands	Population Research Centre; Groningen and Eric Bluemink Foundation; University of Groningen, The Netherlands(Netherlands Government)	This study received financial support from Population Research Centre, Groningen and Eric Bluemink Foundation, University of Groningen, The Netherlands for conducting the field work.	Aassve A, 2007, EUR J POPUL, V23, P369, DOI 10.1007/s10680-007-9134-6; [Anonymous], ANN REPORT 2013 2014; [Anonymous], 2020, HIGH POSS COST COVID; Axinn WG, 1999, SOC SCI RES, V28, P243, DOI 10.1006/ssre.1998.0641; Bras H, 2010, DEMOGRAPHY, V47, P1013, DOI 10.1007/BF03213737; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Chen WJ, 2010, SEX TRANSM INFECT, V86, pI22, DOI 10.1136/sti.2010.043620; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; Cook R, 2014, CULT HEALTH SEX, V16, P741, DOI 10.1080/13691058.2014.902103; Craft SM, 2007, AIDS BEHAV, V11, P927, DOI 10.1007/s10461-007-9219-6; Gabadinho A., 2009, MINING SEQUENCE DATA; Gabadinho A, 2011, COMM COM INF SC, V128, P94; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Giele J. Z., 1998, METHODS LIFECOURSE R; Govindasamy P, 1997, 5 NATL FAM HLTH SURV; Hutter I, 2006, CHILD SPACING REPROD; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Kandwal R, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-18; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Liefbroer AC, 2012, ADV LIFE COURSE RES, V17, P1, DOI 10.1016/j.alcr.2012.01.002; Lopez M, 2012, AIDS, V26, P37, DOI 10.1097/QAD.0b013e32834db300; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Mills M., 2011, INTRO SURVIVAL EVENT; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Padmadas SS, 2004, INT FAM PLAN PERSPEC, V30, P12, DOI 10.1363/3001204; Panditrao M, 2011, AIDS CARE, V23, P593, DOI 10.1080/09540121.2010.516348; Patil S, 2011, AIDS CARE, V23, P1562, DOI 10.1080/09540121.2011.579948; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; Rahangdale L, 2014, JAIDS-J ACQ IMM DEF, V65, P306, DOI 10.1097/QAI.0000000000000014; Sandelowski M, 2003, RES NURS HEALTH, V26, P470, DOI 10.1002/nur.10109; Segurado AC, 2007, REPROD HEALTH MATTER, V15, P27, DOI 10.1016/S0968-8080(07)29032-9; Sharma R, 2012, INDIAN J PEDIATR, V79, P961, DOI 10.1007/s12098-011-0679-3; Tenkorang EY, 2014, INT HEALTH, V6, P46, DOI 10.1093/inthealth/ihu003; Townsend CL, 2010, BJOG-INT J OBSTET GY, V117, P1399, DOI 10.1111/j.1471-0528.2010.02689.x; UNAIDS, 2014, JC26811E UNAIDS; UNAIDS, 2014, GAP REP BEG END AIDS; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2014, DOWN DET FAST TRACK; WHO, 2014, GLOB UPD HIV TREAT 2; Wilson S, 2007, SOCIOL HEALTH ILL, V29, P610, DOI 10.1111/j.1467-9566.2007.01008.x; World Health Organization, 2021, ANT DRUGS TREAT PREG	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124537	10.1371/journal.pone.0124537	http://dx.doi.org/10.1371/journal.pone.0124537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906185	Green Published, gold			2022-12-26	WOS:000353332000073
J	Karam, C; Beauchet, A; Czernichow, S; de Roquefeuil, F; Bourez, A; Mansencal, N; Dubourg, O				Karam, Carma; Beauchet, Alain; Czernichow, Sebastien; de Roquefeuil, Florence; Bourez, Alain; Mansencal, Nicolas; Dubourg, Olivier			Trends in Cardiovascular Disease Risk Factor Prevalence and Estimated 10-Year Cardiovascular Risk Scores in a Large Untreated French Urban Population: The CARVAR 92 Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; SMOKING; STROKE; METAANALYSIS; PREVENTION; REDUCTION; PROMOTION	Background Surveys measuring effectiveness of public awareness campaigns in reducing cardiovascular disease (CVD) incidence have yielded equivocal findings. The aim of this study was to describe cardiovascular risk factors (CVRFs) changes over the years in an untreated population-based study. Methods Between 2007 and 2012, we conducted a screening campaign for CVRFs in men aged 40 to 65 yrs and women aged 50 to 70 yrs in the western suburbs of Paris. Data were complete for 20,324 participants of which 14,709 were untreated. Results The prevalence trend over six years was statistically significant for hypertension in men from 25.9% in 2007 to 21.1% in 2012 (p=0.002) and from 23% in 2007 to 12.7% in 2012 in women (p<0.0001). The prevalence trend of tobacco smoking decreased from 38.6% to 27.7% in men (p=0.0001) and from 22.6% to 16.8% in women (p=0.113). The Framingham 10-year risk for CVD decreased from 13.3 +/- 8.2% in 2007 to 11.7 +/- 9.0 % in 2012 in men and from 8.0 +/- 4.1 % to 5.9 +/- 3.4% in women. The 10-year risk of fatal CVD based on the European Systematic COronary Risk Evaluation (SCORE) decreased in men and in women (p<0.0001). Conclusions Over a 6-year period, several CVRFs have decreased in our screening campaign, leading to decrease in the 10-year risk for CVD and the 10-year risk of fatal CVD. Cardiologists should recognize the importance of community prevention programs and communication policies, particularly tobacco control and healthier diets to decrease the CVRFs in the general population.	[Karam, Carma; de Roquefeuil, Florence; Mansencal, Nicolas; Dubourg, Olivier] UVSQ, Hop Ambroise Pare, AP HP, Cardiol Dept,Ctr Reference Malad Cardiaques Hered, Boulogne, France; [Beauchet, Alain] UVSQ, Hop Ambroise Pare, AP HP, Dept Publ Hlth, Boulogne, France; [Czernichow, Sebastien] UVSQ, Hop Ambroise Pare, AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] INSERM UMS 011, Populat Based Epidemiol Cohorts, Villejuif, France; [Bourez, Alain] Local Hlth Insurance, Nanterre, France; [Mansencal, Nicolas; Dubourg, Olivier] UVSQ, INSERM U1018, CESP, Team 5,EpReC,Renal & Cardiovasc Epidemiol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Karam, C (corresponding author), UVSQ, Hop Ambroise Pare, AP HP, Cardiol Dept,Ctr Reference Malad Cardiaques Hered, Boulogne, France.	carma.karam@apr.aphp.fr	Mansencal, Nicolas/AAO-4549-2020					Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; [Anonymous], 2006, ET NAT NUTR SANT ENN; Artigao-Rodenas LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073529; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Bartecchi C, 2006, CIRCULATION, V114, P1490, DOI 10.1161/CIRCULATIONAHA.106.615245; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Bremner P, 2006, EVALUATION 5 DAY PRO; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Carter OBJ, 2011, PUBLIC HEALTH NUTR, V14, P982, DOI 10.1017/S1368980010003381; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Craig CL, 2010, HEALTH PROMOT INT, V25, P14, DOI 10.1093/heapro/dap048; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Ford ES, 2013, J AM COLL CARDIOL, V61, P2249, DOI 10.1016/j.jacc.2013.03.023; Guignard R., 2010, TABAGISME FRANCE ANA; Guignard R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078372; Hillsdon M, 2001, J EPIDEMIOL COMMUN H, V55, P755, DOI 10.1136/jech.55.10.755; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Marques-Vidal P, 2004, EUR J EPIDEMIOL, V19, P25, DOI 10.1023/B:EJEP.0000013393.11132.e8; Pivonka E, 2011, J AM DIET ASSOC, V111, P1570, DOI 10.1016/j.jada.2011.07.001; Pollard CM, 2008, PUBLIC HEALTH NUTR, V11, P314, DOI 10.1017/S1368980007000523; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Tunstall-Pedoe H, 2006, BRIT MED J, V332, P629, DOI 10.1136/bmj.38753.779005.BE; van Dis I, 2014, EUR J PREV CARDIOL, V21, P377, DOI 10.1177/2047487312443485; Wagner A, 2011, J HYPERTENS, V29, P43, DOI 10.1097/HJH.0b013e32833f9c4d; Wanner M, 2011, BRIT J SPORT MED, V45, P1202, DOI 10.1136/bjsm.2009.070201; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; World Health Organization, 2014, TOP 10 CAUS DEATH; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124817	10.1371/journal.pone.0124817	http://dx.doi.org/10.1371/journal.pone.0124817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906186	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000091
J	Wang, DN; Li, ZH; Xiao, JQ; Wang, JQ; Zhang, L; Liu, YJ; Fan, F; Xin, L; Wei, MX; Kong, ZB; Yu, H; Gu, Y; Zhang, J; Li, SW; Xia, NS				Wang, Daning; Li, Zhihai; Xiao, Jieqiong; Wang, Junqi; Zhang, Li; Liu, Yajing; Fan, Fei; Xin, Lu; Wei, Minxi; Kong, Zhibo; Yu, Hai; Gu, Ying; Zhang, Jun; Li, Shaowei; Xia, Ningshao			Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody	PLoS One			English	Article							MINOR CAPSID PROTEIN; HUMAN-PAPILLOMAVIRUS VACCINES; VIRUS-LIKE PARTICLES; MONOCLONAL-ANTIBODIES; DIPHTHERIA-TOXIN; INFECTION; EPITOPE; IMMUNOGENICITY; L1; PROTECTION	Human Papillomavirus (HPV), a non-enveloped, double-stranded DNA virus, is responsible for 5% of human cancers. The HPV capsid consists of major and minor structural proteins, L1 and L2. L1 proteins form an icosahedral shell with building blocks of the pentameric capsomere, and one L2 molecule extends outward from the central hole of the capsid. Thus, L2 is concealed within L1 and only becomes exposed when the capsid interacts with host cells. The low antigenic variation of L2 means that this protein could offer a target for the development of a pan-HPV vaccine. Toward this goal, here we describe an anti-L2 monoclonal antibody, 14H6, which broadly neutralizes at least 11 types of HPV, covering types 6, 11, 16, 18, 31, 33, 35, 45, 52, 58 and 59, in pseudovirion-based cell neutralization assay. The mAb 14H6 recognizes a minimal linear epitope located on amino acids 21 to 30 of the L2 protein. Alanine scanning mutagenesis and sequence alignment identified several conserved residues (Cys22, Lys23, Thr27, Cys28 and Pro29) that are involved in the 14H6 binding with L2. The epitope was grafted to several scaffolding proteins, including HPV16 L1 virus-like particles, HBV 149 core antigen and CRM197. The resultant chimeric constructs were expressed in Escherichia coli and purified with high efficiency. Immunization with these pan-HPV vaccine candidates elicited high titers of the L2-specific antibody in mice and conferred robust (3-log) titers of cross-genotype neutralization, including against HPV11, 16, 18, 45, 52, 58 and 59. These findings will help in the development of an L2based, pan-HPV vaccine.	[Wang, Daning; Wang, Junqi; Xin, Lu; Kong, Zhibo; Yu, Hai; Gu, Ying; Zhang, Jun; Li, Shaowei; Xia, Ningshao] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361005, Peoples R China; [Li, Zhihai; Xiao, Jieqiong; Zhang, Li; Liu, Yajing; Fan, Fei; Wei, Minxi; Gu, Ying; Li, Shaowei; Xia, Ningshao] Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University	Li, SW (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361005, Peoples R China.	shaowei@xmu.edu.cn; nsxia@xmu.edu.cn	Zhang, Jun/G-4598-2010	Zhang, Jun/0000-0002-6601-9180; Xia, Ningshao/0000-0003-0179-5266	Chinese government: the National Natural Science Foundation [81172885]; International Science and Technology Collaborative Program [2011DFG33050]; Key Program in New Drug RD [2012ZX09101316, 2014AA021302]; Institute Reconstruction Fund [2011FU125Z04]; Key Platform Project of Xiamen [3502Z20131001]	Chinese government: the National Natural Science Foundation; International Science and Technology Collaborative Program; Key Program in New Drug RD; Institute Reconstruction Fund; Key Platform Project of Xiamen	The authors acknowledge funding support from the Chinese government: the National Natural Science Foundation (Grants 81172885), the International Science and Technology Collaborative Program (Grant 2011DFG33050), the Key Program in New Drug R&D (Grants 2012ZX09101316, 2014AA021302), the Institute Reconstruction Fund (2011FU125Z04) and the Key Platform Project of Xiamen (3502Z20131001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Campos SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004463; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095448; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRAZIN R, 1971, J BIOL CHEM, V246, P1504; Fay A, 2004, J VIROL, V78, P13447, DOI 10.1128/JVI.78.24.13447-13454.2004; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; ISHIOKA GY, 1992, J IMMUNOL, V148, P2446; Jagu S, 2013, J VIROL, V87, P6127, DOI 10.1128/JVI.03218-12; Jagu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055538; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kalnin K, 2014, VACCINE, V32, P3540, DOI 10.1016/j.vaccine.2014.04.032; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Li SW, 2005, J BIOL CHEM, V280, P3400, DOI 10.1074/jbc.M410361200; Luo W X, 2000, Sheng Wu Gong Cheng Xue Bao, V16, P578; McClements WL, 2001, VIROLOGY, V289, P262, DOI 10.1006/viro.2001.1146; McGrath M, 2013, ARCH VIROL, V158, P2079, DOI 10.1007/s00705-013-1713-8; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Murata Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-81; Nakao S, 2012, VIROLOGY, V434, P110, DOI 10.1016/j.virol.2012.09.006; Nieto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039741; Orr N, 1999, INFECT IMMUN, V67, P4290, DOI 10.1128/IAI.67.8.4290-4294.1999; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pumpens P, 1995, INTERVIROLOGY, V38, P63, DOI 10.1159/000150415; Richards KF, 2013, J VIROL, V87, P11426, DOI 10.1128/JVI.01721-13; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller J T, 2001, J Natl Cancer Inst Monogr, P50; Skamperle M, 2013, ACTA DERMATOVEN ALP, V21, P1, DOI 10.2478/v10162-012-0024-1; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Tumban E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049751; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; VANNESS BG, 1980, J BIOL CHEM, V255, P710; VARECKOVA E, 1995, J IMMUNOL METHODS, V180, P107, DOI 10.1016/0022-1759(94)00307-I; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Xu LF, 2014, THERANOSTICS, V4, P498, DOI 10.7150/thno.7457; Yang RC, 2003, J BIOL CHEM, V278, P12546, DOI 10.1074/jbc.M208691200; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003	59	29	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123944	10.1371/journal.pone.0123944	http://dx.doi.org/10.1371/journal.pone.0123944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905781	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000052
J	Cooper, DE; Grevengoed, TJ; Klett, EL; Coleman, RA				Cooper, Daniel E.; Grevengoed, Trisha J.; Klett, Eric L.; Coleman, Rosalind A.			Glycerol-3-phosphate Acyltransferase Isoform-4 (GPAT4) Limits Oxidation of Exogenous Fatty Acids in Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; MICE; TRIACYLGLYCEROL; IDENTIFICATION; DEFICIENCY; ENZYME; THERMOGENESIS; EXPRESSION; CLEARANCE	Glycerol-3-phosphate acyltransferase-4 (GPAT4) null pups grew poorly during the suckling period and, as adults, were protected from high fat diet-induced obesity. To determine why Gpat4(-/-) mice failed to gain weight during these two periods of high fat feeding, we examined energy metabolism. Compared with controls, the metabolic rate of Gpat4(-/-) mice fed a 45% fat diet was 12% higher. Core body temperature was 1 degrees C higher after high fat feeding. Food intake, fat absorption, and activity were similar in both genotypes. Impaired weight gain in Gpat4(-/-) mice did not result from increased heat loss, because both cold tolerance and response to a beta 3-adrenergic agonist were similar in both genotypes. Because GPAT4 comprises 65% of the total GPAT activity in brown adipose tissue (BAT), we characterized BAT function. A 45% fat diet increased the Gpat4(-/-) BAT expression of peroxisome proliferator-activated receptor alpha (PPAR) target genes, Cpt1 alpha, Pgc1 alpha, and Ucp1, and BAT mitochondria oxidized oleate and pyruvate at higher rates than controls, suggesting that fatty acid signaling and flux through the TCA cycle were enhanced. To assess the role of GPAT4 directly, neonatal BAT preadipocytes were differentiated to adipocytes. Compared with controls, Gpat4(-/-) brown adipocytes incorporated 33% less fatty acid into triacylglycerol and 46% more into the pathway of beta-oxidation. The increased oxidation rate was due solely to an increase in the oxidation of exogenous fatty acids. These data suggest that in the absence of cold exposure, GPAT4 limits excessive fatty acid oxidation and the detrimental induction of a hypermetabolic state.	[Cooper, Daniel E.; Grevengoed, Trisha J.; Klett, Eric L.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Klett, Eric L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Coleman, RA (corresponding author), Univ N Carolina, 2301 MHRC,135 Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Regan, Clinton/E-6250-2012; Grevengoed, Trisha/AAA-3980-2021; Ariel, Pablo/AGJ-4118-2022	Klett, Eric/0000-0002-8000-6810; Grevengoed, Trisha/0000-0003-4433-3950	National Institutes of Health [DK56598, K08DK090141, DK56350]; American Heart Association [13PRE16910109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598, P30DK056350, K08DK090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56598 (to R. A. C.), K08DK090141 (to E. L. K.), and DK56350 (to the University of North Carolina Nutrition Obesity Research Center), and American Heart Association Predoctoral Grant 13PRE16910109 (to T. J. G.).	Aoki N, 1999, BIOSCI BIOTECH BIOCH, V63, P1749, DOI 10.1271/bbb.63.1749; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cao J., 2014, AM J PHYSIOL-ENDOC M, V306, pE1176; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cattaneo ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042986; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Ellis JM, 2012, TOXICOL PATHOL, V40, P513, DOI 10.1177/0192623311432298; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Khedoe PPSJ, 2015, J LIPID RES, V56, P51, DOI 10.1194/jlr.M052746; Klingenberg M, 1999, INT J OBESITY, V23, pS24, DOI 10.1038/sj.ijo.0800939; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; LINDBERG O, 1970, LIPIDS, V5, P204, DOI 10.1007/BF02532470; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang CB, 2014, AM J PHYSIOL-ENDOC M, V307, pE305, DOI 10.1152/ajpendo.00034.2014	30	22	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15112	15120		10.1074/jbc.M115.649970	http://dx.doi.org/10.1074/jbc.M115.649970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918168	hybrid, Green Published			2022-12-26	WOS:000356177300026
J	Habets, RAJ; Groot, AJ; Yahyanejad, S; Tiyanont, K; Blacklow, SC; Vooijs, M				Habets, Roger A. J.; Groot, Arjan J.; Yahyanejad, Sanaz; Tiyanont, Kittichoat; Blacklow, Stephen C.; Vooijs, Marc			Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARGINAL ZONE LYMPHOMA; NEGATIVE REGULATORY REGION; SQUAMOUS-CELL CARCINOMA; PROTEOLYTIC ACTIVATION; T-ALL; CLEAVAGE; MUTATIONS; DOMAIN; DROSOPHILA; RECEPTORS	Cell surface receptors of the NOTCH family of proteins are activated by ligand induced intramembrane proteolysis. Unfolding of the extracellular negative regulatory region (NRR), enabling successive proteolysis by the enzymes Adam10 and gamma-secretase, is rate-limiting in NOTCH activation. Mutations in the NOTCH1 NRR are associated with ligand-independent activation and frequently found in human T-cell malignancies. In mammals four NOTCH receptors and five Delta/Jagged ligands exist, but mutations in the NRR are only rarely reported for receptors other than NOTCH1. Using biochemical and functional assays, we compared the molecular mechanisms of ligand-independent signaling in NOTCH1 and the highly related NOTCH2 receptor. Both murine Notch1 and Notch2 require the metalloprotease protease Adam17, but not Adam10 during ligand-independent activation. Interestingly, the human NOTCH2 receptor is resistant to ligand-independent activation compared with its human homologs or murine orthologs. Taken together, our data reveal subtle but functionally important differences for the NRR among NOTCH paralogs and homologs.	[Habets, Roger A. J.; Groot, Arjan J.; Yahyanejad, Sanaz; Vooijs, Marc] Maastricht Univ, Dept Radiotherapy MaastRO GROW, Sch Dev Biol & Oncol, NL-6200 MD Maastricht, Netherlands; [Tiyanont, Kittichoat; Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Maastricht University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Vooijs, M (corresponding author), Maastricht Univ, Dept Radiotherapy MaastRO GROW, Sch Dev Biol & Oncol, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	marc.vooijs@maastrichtuniversity.nl	Vooijs, Marc/K-3522-2019		European Research Council (ERC) under the European Community Seventh Framework Program (FP7) ERC [208259, 334987]; NATIONAL CANCER INSTITUTE [R01CA092433] Funding Source: NIH RePORTER	European Research Council (ERC) under the European Community Seventh Framework Program (FP7) ERC(European Research Council (ERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the European Research Council (ERC) under the European Community Seventh Framework Program (FP7/2007-2013) ERC starting Grants 208259 and 334987 (to M. V.).	Aster JC, 1999, BIOCHEMISTRY-US, V38, P4736, DOI 10.1021/bi982713o; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; Chen JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022837; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dey A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/17/175101; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Ebsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076853; Egloff AM, 2012, CLIN CANCER RES, V18, P5188, DOI 10.1158/1078-0432.CCR-11-2258; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Groot AJ, 2013, J INVEST DERMATOL, V133, P2286, DOI 10.1038/jid.2013.162; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Stephenson NL, 2012, P NATL ACAD SCI USA, V109, pE2757, DOI 10.1073/pnas.1205788109; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Sulis ML, 2011, LEUKEMIA, V25, P1564, DOI 10.1038/leu.2011.130; Tiyanont K, 2011, STRUCTURE, V19, P546, DOI 10.1016/j.str.2011.01.016; Troen G, 2008, HAEMATOL-HEMATOL J, V93, P1107, DOI 10.3324/haematol.11635; van Tetering G, 2011, CURR MOL MED, V11, P255, DOI 10.2174/156652411795677972; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vardar D, 2003, BIOCHEMISTRY-US, V42, P7061, DOI 10.1021/bi034156y; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	44	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14705	14716		10.1074/jbc.M115.643676	http://dx.doi.org/10.1074/jbc.M115.643676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918160	Green Published, hybrid			2022-12-26	WOS:000355754600040
J	Kwon, Y; Kim, Y; Eom, S; Kim, M; Park, D; Kim, H; Noh, K; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Kwon, Yoojung; Kim, Youngmi; Eom, Sangkyung; Kim, Misun; Park, Deokbum; Kim, Hyuna; Noh, Kyeonga; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE FEEDBACK RELATIONSHIP; AIRWAY INFLAMMATION; PULMONARY INFLAMMATION; EXPERIMENTAL ASTHMA; LUNG INFLAMMATION; SKIN INFLAMMATION; COX-2 EXPRESSION; TUMOR-METASTASIS; MURINE MODEL; MAST-CELLS	Cyclooxgenase-2 (COX-2) knock-out mouse experiments showed that COX-2 was necessary for in vivo allergic inflammation, such as passive cutaneous anaphylaxis, passive systemic anaphylaxis, and triphasic cutaneous allergic reaction. Target-Scan analysis predicted COX-2 as a target of miR-26a and miR-26b. miR-26a/-26b decreased luciferase activity associated with COX-2-3' -UTR. miR-26a/-26b exerted negative effects on the features of in vitro and in vivo allergic inflammation by targeting COX-2. ChIP assays showed the binding of HDAC3 and SNAIL, but not COX-2, to the promoter sequences of miR-26a and miR-26b. Cytokine array analysis showed that the induction of chemokines, such as MIP-2, in the mouse passive systemic anaphylaxis model occurred in a COX-2-dependent manner. ChIP assays showed the binding of HDAC3 and COX-2 to the promoter sequences of MIP-2. In vitro and in vivo allergic inflammation was accompanied by the increased expression of MIP-2. miR-26a/-26b negatively regulated the expression of MIP-2. Allergic inflammation enhanced the tumorigenic and metastatic potential of cancer cells and induced positive feedback involving cancer cells and stromal cells, such as mast cells, macrophages, and endothelial cells. miR-26a mimic and miR-26b mimic negatively regulated the positive feedback between cancer cells and stromal cells and the positive feedback among stromal cells. miR-26a/-26b negatively regulated the enhanced tumorigenic potential by allergic inflammation. COX-2 was necessary for the enhanced metastatic potential of cancer cells by allergic inflammation. Taken together, our results indicate that the miR26a/-26b-COX-2-MIP-2 loop regulates allergic inflammation and the feedback relationship between allergic inflammation and the enhanced tumorigenic and metastatic potential.	[Kwon, Yoojung; Kim, Youngmi; Eom, Sangkyung; Kim, Misun; Park, Deokbum; Kim, Hyuna; Noh, Kyeonga; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation [2014R1A2A2A01002448]; BK21 Plus Program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]; Kangwon National University	National Research Foundation; BK21 Plus Program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; Kangwon National University	This work was supported by National Research Foundation Grant 2014R1A2A2A01002448; a grant from the BK21 Plus Program; and National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea Grant 1320160. This work was also supported by a grant from Kangwon National University.	Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Barrett EG, 1999, AM J PHYSIOL-LUNG C, V276, pL979, DOI 10.1152/ajplung.1999.276.6.L979; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Church RJ, 2012, J IMMUNOL, V188, P4093, DOI 10.4049/jimmunol.1101873; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Davaatseren M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102975; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Eom S, 2014, J BIOL CHEM, V289, P29483, DOI 10.1074/jbc.M114.603480; Eom S, 2014, J BIOL CHEM, V289, P12126, DOI 10.1074/jbc.M113.521245; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fogli LK, 2013, J IMMUNOL, V191, P3100, DOI 10.4049/jimmunol.1301360; Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061; Huang WC, 2011, CELL CALCIUM, V50, P27, DOI 10.1016/j.ceca.2011.04.004; Ito W, 2005, AM J RESP CELL MOL, V32, P268, DOI 10.1165/rcmb.2004-0058OC; Jeon CM, 2014, INT IMMUNOPHARMACOL, V22, P414, DOI 10.1016/j.intimp.2014.07.013; Kim Y, 2008, MOL IMMUNOL, V45, P2537, DOI 10.1016/j.molimm.2008.01.008; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Kim Y, 2011, MOL IMMUNOL, V48, P1035, DOI 10.1016/j.molimm.2011.01.013; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Li H, 2013, AM J RESP CRIT CARE, V187, P812, DOI 10.1164/rccm.201211-2073OC; Maeda K, 2010, J IMMUNOL, V185, P4252, DOI 10.4049/jimmunol.1001228; de Lima FM, 2010, PHOTOMED LASER SURG, V28, P763, DOI 10.1089/pho.2009.2638; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; McKinley L, 2005, CYTOKINE, V32, P178, DOI 10.1016/j.cyto.2005.09.006; Morin C, 2013, CLIN EXP ALLERGY, V43, P1071, DOI 10.1111/cea.12162; Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Olivera A, 2013, IMMUNOL LETT, V150, P89, DOI 10.1016/j.imlet.2013.01.005; Passos GF, 2013, EUR J PHARMACOL, V698, P413, DOI 10.1016/j.ejphar.2012.10.019; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Rebane A, 2014, J ALLERGY CLIN IMMUN, V134, P836, DOI 10.1016/j.jaci.2014.05.022; Reuter S, 2012, J IMMUNOL, V188, P5123, DOI 10.4049/jimmunol.1101618; Rose CE, 2010, CELL MOL IMMUNOL, V7, P361, DOI 10.1038/cmi.2010.31; Shi CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066814; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Starkhammar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104114; Tengroth L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098239; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wei J, 2014, FREE RADICAL BIO MED, V67, P91, DOI 10.1016/j.freeradbiomed.2013.10.811; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu ZL, 2014, J IMMUNOL, V192, P5130, DOI 10.4049/jimmunol.1301677; Xiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098139; Xu KM, 2013, MOL CANCER RES, V11, P875, DOI 10.1158/1541-7786.MCR-12-0706; Yadav UCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057442; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535; Yamada Y, 2014, BIOCHEM BIOPH RES CO, V443, P980, DOI 10.1016/j.bbrc.2013.12.078; Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097537; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941	54	49	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14245	14266		10.1074/jbc.M115.645580	http://dx.doi.org/10.1074/jbc.M115.645580			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25907560	Green Published, hybrid			2022-12-26	WOS:000355313000051
J	Atkinson, JM; Rank, KB; Zeng, Y; Capen, A; Yadav, V; Manro, JR; Engler, TA; Chedid, M				Atkinson, Jennifer M.; Rank, Kenneth B.; Zeng, Yi; Capen, Andrew; Yadav, Vipin; Manro, Jason R.; Engler, Thomas A.; Chedid, Marcio			Activating the Wnt/beta-Catenin Pathway for the Treatment of Melanoma - Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3	PLOS ONE			English	Article							BETA-CATENIN; TARGET; CANCER; EXPRESSION	It has previously been observed that a loss of beta-catenin expression occurs with melanoma progression and that nuclear beta-catenin levels are inversely proportional to cellular proliferation, suggesting that activation of the Wnt/beta-catenin pathway may provide benefit for melanoma patients. In order to further probe this concept we tested LY2090314, a potent and selective small-molecule inhibitor with activity against GSK3 alpha and GSK3 beta isoforms. In a panel of melanoma cell lines, nM concentrations of LY2090314 stimulated TCF/LEF TOP-Flash reporter activity, stabilized beta-catenin and elevated the expression of Axin2, a Wnt responsive gene and marker of pathway activation. Cytotoxicity assays revealed that melanoma cell lines are very sensitive to LY2090314 in vitro (IC50 similar to 10nM after 72hr of treatment) in contrast to other solid tumor cell lines (IC50 > 10 mu M) as evidenced by caspase activation and PARP cleavage. Cell lines harboring mutant B-RAF or N-RAS were equally sensitive to LY2090314 as were those with acquired resistance to the BRAF inhibitor Vemurafenib. shRNA studies demonstrated that beta-catenin stabilization is required for apoptosis following treatment with the GSK3 inhibitor since the sensitivity of melanoma cell lines to LY290314 could be overcome by beta-catenin knockdown. We further demonstrate that in vivo, LY2090314 elevates Axin2 gene expression after a single dose and produces tumor growth delay in A375 melanoma xenografts with repeat dosing. The activity of LY2090314 in preclinical models suggests that the role of Wnt activators for the treatment of melanoma should be further explored.	[Atkinson, Jennifer M.; Rank, Kenneth B.; Zeng, Yi; Capen, Andrew; Yadav, Vipin; Chedid, Marcio] Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA; [Manro, Jason R.] Eli Lilly & Co, Lilly Res Labs, Stat Discovery, Indianapolis, IN 46285 USA; [Engler, Thomas A.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Chedid, M (corresponding author), Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA.	chedid.marcio@lilly.com	Atkinson, Jennifer/AAE-5466-2019	Atkinson, Jennifer/0000-0001-5164-5114	Eli Lilly and Company Discovery Research	Eli Lilly and Company Discovery Research(Eli Lilly)	This work was supported by Eli Lilly and Company Discovery Research. The funder had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Engler TA, 2004, J MED CHEM, V47, P3934, DOI 10.1021/jm049768a; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gallagher SJ, 2012, ONCOGENE; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horvath LG, 2005, INT J CANCER, V113, P415, DOI 10.1002/ijc.20599; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Williams SP, 2011, CANCER RES, V71, P5374, DOI 10.1158/0008-5472.CAN-10-3026; Yadav V, 2012, J BIOL CHEM; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	31	65	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125028	10.1371/journal.pone.0125028	http://dx.doi.org/10.1371/journal.pone.0125028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915038	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100091
J	Fang, YX; He, M; Lin, JY; Ma, KJ; Zhao, H; Hong, Z; Li, BX				Fang, You-Xin; He, Meng; Lin, Jun-Yi; Ma, Kai-Jun; Zhao, Hai; Hong, Zhen; Li, Bei-Xu			Suicidal Drownings with Psychiatric Disorders in Shanghai: A Retrospective Study from 2010.1 to 2014.6	PLOS ONE			English	Article							SEASONAL-VARIATION; SCHIZOPHRENIA; RISK; MORTALITY; PSYCHOSIS; AUTOPSY; CHINA	Psychiatric disorders exhibited in 13% suicidal drownings in Southwestern Croatia and 63% in Milan, but in China is unknown. This study is committed to outline the feature of a suicidal drowning with psychiatric disorder, show mental status and reveal key factor to high incidence in China. Immersed corpses were handled by SPSBMPH in its jurisdiction range. Half of immersed corpses were suicidal, and nearly half of suicides had psychiatric disorders. 104 suicidal drownings with psychiatric disorders cases from 2010.1 to 2014.6 were reviewed (21.5% of all immersed corpses, 42.1% of suicides). Most victims clothed normally, and only 2 fastened attached weights. Male victims were more and younger than female. Psycho were prone to commit suicidal drowning in warm and hot season. Psycho were prone to choose familiar area to commit suicide, 45 decedents were found in their familiar areas. Suicidal drowings were occult without suicide attempts, suicide note or abnormal clothing, but showed abnormal mental or behavior changes prior to suicide. The three leading psychiatric disorders were depression (33.7%), depression status (30.8%) and schizophrenia (20.2%). Only 44.2% decedents had visited psychiatric disorder specialist, and merely less than 10% patients could adhere to regular medication. No regular medication on psychiatric disorder was the key factor contributing to high incidence of suicide in psycho. Professional psychiatric and psychological intervention should be taken as soon as possible when they had psychiatric symptoms or suffered misfortune. Guardians should be alert to patients' abnormality to detect their suicidal ideation and intervene, especially in warm season.	[Fang, You-Xin; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [He, Meng; Lin, Jun-Yi; Li, Bei-Xu] Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai 200433, Peoples R China; [Ma, Kai-Jun] Shanghai Publ Secur Bur, Inst Forens Sci, Shanghai Key Lab Crime Scene Evidence, Shanghai, Peoples R China; [Zhao, Hai] Shanghai Publ Secur Bur, Shanghai Publ Secur Bur Marine Police Headquarter, Shanghai, Peoples R China	Fudan University; Fudan University; Institute of Forensic Science Ministry of Justice PRC	Li, BX (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai 200433, Peoples R China.	libeixu@gmail.com			Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University [FY2014-04]	Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University	This study is supported by Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University (FY2014-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdacic-Gross V, 2003, SOC SCI MED, V57, P1173, DOI 10.1016/S0277-9536(02)00493-8; Bando DH, 2014, CRISIS, V35, P5, DOI 10.1027/0227-5910/a000222; Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502; CALDWELL CB, 1990, SCHIZOPHRENIA BULL, V16, P571, DOI 10.1093/schbul/16.4.571; Cantor CH, 2000, PSYCHOPATHOLOGY, V33, P303, DOI 10.1159/000029162; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Cheung YB, 2006, J AFFECT DISORDERS, V90, P193, DOI 10.1016/j.jad.2005.11.018; Dutta R, 2012, PSYCHOL MED, V42, P1649, DOI 10.1017/S0033291711002807; Grjibovski AM, 2013, MEDICINA-LITHUANIA, V49, P379, DOI 10.3390/medicina49080059; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; He M, 2014, AM J FOREN MED PATH, V35, P218, DOI 10.1097/PAF.0000000000000115; Jeon HJ, 2014, J AFFECT DISORDERS, V166, P206, DOI 10.1016/j.jad.2014.05.010; Law CK, 2013, INT J ENV RES PUB HE, V10, P2825, DOI 10.3390/ijerph10072825; Lopez-Morinigo JD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0213-z; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; Muccino E, 2015, INT J LEGAL MED, V129, P777, DOI 10.1007/s00414-014-1115-9; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Ran MS, 2003, ACTA PSYCHIAT SCAND, V107, P430, DOI 10.1034/j.1600-0447.2003.02014.x; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shibre T, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-150; Stemberga V, 2010, AM J FOREN MED PATH, V31, P52, DOI 10.1097/PAF.0b013e3181c215c8	24	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0121050	10.1371/journal.pone.0121050	http://dx.doi.org/10.1371/journal.pone.0121050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915853	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100005
J	Ramirez, P; Mosley, SB				Ramirez, Pedro, Jr.; Mosley, Sherri Baker			Oil and Gas Wells and Pipelines on US Wildlife Refuges: Challenges for Managers	PLOS ONE			English	Article							CHRONIC ANTHROPOGENIC NOISE; WINTER HABITAT SELECTION; GREATER SAGE-GROUSE; ENERGY DEVELOPMENT; SAGEBRUSH; EMISSIONS; ABUNDANCE; SONGBIRDS; IMPACTS	The increased demand for oil and gas places a burden on lands set aside for natural resource conservation. Oil and gas development alters the environment locally and on a much broader spatial scale depending on the intensity and extent of mineral resource extraction. The current increase in oil and gas exploration and production in the United States prompted an update of the number of pipelines and wells associated with oil and gas production on National Wildlife Refuge System (NWRS) lands. We obtained geospatial data on the location of oil and gas wells and pipelines within and close to the boundaries of NWRS lands (units) acquired as fee simple (i.e. absolute title to the surface land) by the U.S. Fish and Wildlife Service. We found that 5,002 wells are located in 107 NWRS units and 595 pipelines transect 149 of the 599 NWRS units. Almost half of the wells (2,196) were inactive, one-third (1,665) were active, and the remainder of the wells were either plugged and abandoned or the status was unknown. Pipelines crossed a total of 2,155 kilometers (1,339 miles) of NWRS fee simple lands. The high level of oil and gas activity warrants follow up assessments for wells lacking information on production type or well status with emphasis on verifying the well status and identifying abandoned and unplugged wells. NWRS fee simple lands should also be assessed for impacts from brine, oil and other hydrocarbon spills, as well as habitat alteration associated with oil and gas, including the identification of abandoned oil and gas facilities requiring equipment removal and site restoration.	[Ramirez, Pedro, Jr.] US Fish & Wildlife Serv, NWRS, Div Nat Resources & Conservat, Ft Collins, CO 80525 USA; [Mosley, Sherri Baker] US Fish & Wildlife Serv, NWRS, Nat Resource Program Ctr, Ft Collins, CO USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Ramirez, P (corresponding author), US Fish & Wildlife Serv, NWRS, Div Nat Resources & Conservat, Ft Collins, CO 80525 USA.	Pedro_Ramirez@fws.gov			U.S. Fish and Wildlife Service National Wildlife Refuge System	U.S. Fish and Wildlife Service National Wildlife Refuge System	Funding was provided by the U.S. Fish and Wildlife Service National Wildlife Refuge System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J., 2014, NUMERICAL SIMULATION; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Bentley RW, 2002, ENERG POLICY, V30, P189, DOI 10.1016/S0301-4215(01)00144-6; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Boyce MS, 2011, ENERGY DEV WILDLIFE, pix; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Esmoil Brent J., 1995, Prairie Naturalist, V27, P81; Fisher J.B., 2005, ENV GEOSCIENCES, V12, P89, DOI DOI 10.1306/EG.11160404039; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Ground Water Protection Council and ALL Consulting, 2009, MOD SHAL GAS DEV US; Harris T.M., 2005, ENV GEOSCI, V12, P101, DOI [10.1306/eg.11160404041, DOI 10.1306/EG.11160404041]; Hyne NJ., 2012, NONTECHNICAL GUIDE P, V3rd ed.; Interstate Oil and Gas Compact Commission, 2008, PROT OUR COUNTR RES; Jager HI, 2005, ENVIRONMETRICS, V16, P687, DOI 10.1002/env.730; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Knick ST, 2011, STUD AVIAN BIOL, P203; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; Miesener Thomas O., 2006, OIL GAS PIPELINES NO; North Dakota Department of Health, N DAK DEP HLTH ENV I; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Preston TM, 2014, SCI TOTAL ENVIRON, V472, P1152, DOI 10.1016/j.scitotenv.2013.09.027; Ramirez P, 2010, ENVIRON MANAGE, V46, P820, DOI 10.1007/s00267-010-9557-4; Reeves MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077467; Riley T.Z., 2012, WILDLIFE SOC TECHNIC, V1202; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; U.S. Bureau of Land Management, 2012, OIL GAS STAT; U.S. Department of Energy, 2011, PRES OB SETS GOAL RE; U.S. Department of the Interior, US DEP INT EC REP FY; U.S. Energy Information Administration, 2011, REV EM RES US SHAL G; U.S. Energy Information Administration, INT EN OUTL 2013 PRO; U.S. Energy Information Administration, ANN EN OUTL 2013 PRO; U.S. Energy Information Administration, US TOT DISTR WELLS P; U.S. Fish and Wildlife Service, 2008, COMPR CONS PLAN UPP; U.S. Fish and Wildlife Service, ANN REP LANDS CONTR; U.S. General Accounting Office, 2003, GAO03517 US GEN ACC; Warneke C, 2014, ATMOS CHEM PHYS, V14, P10977, DOI 10.5194/acp-14-10977-2014; Williams P, 2005, PROLIFIC PROUND CENT	39	8	8	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124085	10.1371/journal.pone.0124085	http://dx.doi.org/10.1371/journal.pone.0124085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915417	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100036
J	Rossi, E; Basso, D; Zambon, CF; Navaglia, F; Greco, E; Pelloso, M; Artuso, S; Padoan, A; Pescarin, M; Aita, A; Bozzato, D; Moz, S; Cananzi, M; Guariso, G; Plebani, M				Rossi, Elisa; Basso, Daniela; Zambon, Carlo-Federico; Navaglia, Filippo; Greco, Eliana; Pelloso, Michela; Artuso, Serena; Padoan, Andrea; Pescarin, Matilde; Aita, Ada; Bozzato, Dania; Moz, Stefania; Cananzi, Mara; Guariso, Graziella; Plebani, Mario			TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SMALL-INTESTINAL MUCOSA; IFN-GAMMA; CYTOKINE RESPONSE; INTERFERON-GAMMA; POLYMORPHISMS; ALPHA; VARIANTS; TIME; SUSCEPTIBILITY	Background TNF-alpha and IFN-gamma play a role in the development of mucosal damage in celiac disease (CD). Polymorphisms of TNFA and IFNG genes, as well as of the TNFRSF1A gene, encoding the TNF-a receptor 1, might underlie different inter-individual disease susceptibility over a common HLA risk background. The aims of this study were to ascertain whether five SNPs in the TNFA promoter (-1031T>C,-857C>T,-376G>A,-308G>A,-238G>A), sequence variants of the TNFRSF1A gene and IFNG +874A>T polymorphism are associated with CD in a HLA independent manner. Methods 511 children (244 CD, 267 controls) were genotyped for HLA, TNFA and INFG (Real Time PCR). TNFRSF1A variants were studied (DHPLC and sequence). Results Only the rare TNFA-1031C (OR=0.65, 95% CI:0.44-0.95), -857T (OR=0.42, 95% CI: 0.27-0.65), -376A (OR= 2.25, 95% CI:1.12-4.51) and -308A (OR= 4.76, 95% CI:3.12-7.26) alleles were significantly associated with CD. One TNFRSF1A variant was identified (c.625+10A>G, rs1800693), but not associated with CD. The CD-correlated TNFA SNPs resulted in six haplotypes. Two haplotypes were control-associated (CCGG and TTGG) and three were CD-associated (CCAG, TCGA and CCGA). The seventeen inferred haplotype combinations were grouped (A to E) based on their frequencies among CD. Binary logistic regression analysis documented a strong association between CD and HLA (OR for intermediate risk haplotypes=178; 95% CI:24-1317; OR for high risk haplotypes=2752; 95% CI:287-26387), but also an HLA-independent correlation between CD and TNFA haplotype combination groups. The CD risk for patients carrying an intermediate risk HLA haplotype could be sub-stratified by TNFA haplotype combinations. Conclusion TNFA promoter haplotypes associate with CD independently from HLA. We suggest that their evaluation might enhance the accuracy in estimating the CD genetic risk.	[Rossi, Elisa; Zambon, Carlo-Federico; Greco, Eliana; Pelloso, Michela; Padoan, Andrea; Aita, Ada; Bozzato, Dania; Moz, Stefania; Plebani, Mario] Univ Padua, Dept Med DIMED, Padua, Italy; [Basso, Daniela; Navaglia, Filippo; Plebani, Mario] Univ Hosp Padova, Dept Lab Med, Padua, Italy; [Artuso, Serena; Pescarin, Matilde; Cananzi, Mara; Guariso, Graziella] Univ Hosp Padova, Dept Women & Childrens Hlth, Unit Pediat Gastroenterol, Padua, Italy	University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova	Basso, D (corresponding author), Univ Hosp Padova, Dept Lab Med, Padua, Italy.	daniela.basso@sanita.padova.it	Plebani, Mario/AAF-4953-2020; Basso, Daniela/J-7855-2016; Padoan, Andrea/J-7869-2016; Bozzato, Dania/AAA-5142-2019; Zambon, Carlo Federico/J-8187-2016; cananzi, mara/AAS-8540-2020; pelloso, michela/K-5615-2018	Basso, Daniela/0000-0001-8745-6171; Padoan, Andrea/0000-0003-1284-7885; Zambon, Carlo Federico/0000-0002-4244-879X; moz, stefania/0000-0002-7485-520X; Pelloso, Michela/0000-0002-2853-4499; Aita, Ada/0000-0001-5497-7544; Cananzi, Mara/0000-0002-7177-2847				Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; Anand SP, 2010, CYTOKINE, V49, P130, DOI 10.1016/j.cyto.2009.11.009; Brottveit M, 2013, AM J GASTROENTEROL, V108, P842, DOI 10.1038/ajg.2013.91; Caruso R, 2014, CLIN SCI, V126, P451, DOI 10.1042/CS20130478; Caso F, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/513782; Cataldo F, 2005, DIGEST LIVER DIS, V37, P923, DOI 10.1016/j.dld.2005.08.001; Catassi C, 1996, ACTA PAEDIATR, V85, P29, DOI 10.1111/j.1651-2227.1996.tb14244.x; Chernavsky AC, 2008, CYTOKINE, V42, P48, DOI 10.1016/j.cyto.2008.01.015; Comabella M, 2013, NEUROLOGY, V80, P2010, DOI 10.1212/WNL.0b013e318294b2d6; D'Osualdo A, 2006, ARTHRITIS RHEUM-US, V54, P998, DOI 10.1002/art.21657; de la Concha EG, 2000, HUM IMMUNOL, V61, P513, DOI 10.1016/S0198-8859(99)00187-1; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Fernandez S, 2003, EUR J IMMUNOGENET, V30, P141, DOI 10.1046/j.1365-2370.2003.00376.x; Ferstl B, 2004, GENES IMMUN, V5, P405, DOI 10.1038/sj.gene.6364108; Garrote JA, 2002, IMMUNOGENETICS, V54, P551, DOI 10.1007/s00251-002-0498-9; Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q; Huang HR, 2012, GENE, V494, P96, DOI 10.1016/j.gene.2011.09.027; Huang Y, 2007, P NATL ACAD SCI USA, V104, P985, DOI 10.1073/pnas.0609954104; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Koning F, 2012, SEMIN IMMUNOPATHOL, V34, P541, DOI 10.1007/s00281-012-0321-0; Kupfer Sonia S, 2012, Gastrointest Endosc Clin N Am, V22, P639, DOI 10.1016/j.giec.2012.07.003; Lio D, 2005, DIGEST LIVER DIS, V37, P756, DOI 10.1016/j.dld.2005.04.027; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Louka AS, 2003, IMMUNOGENETICS, V55, P339, DOI 10.1007/s00251-003-0586-5; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Marchenko YV, 2008, STATA J, V8, P305, DOI 10.1177/1536867X0800800301; McGonagle D, 2009, PEDIATR RES, V65, p38R, DOI 10.1203/PDR.0b013e31819dbd0a; Megiorni F, 2009, HUM IMMUNOL, V70, P55, DOI 10.1016/j.humimm.2008.10.018; Mourao AF, 2009, J RHEUMATOL, V36, P837, DOI 10.3899/jrheum.080615; Negm OH, 2014, EUR J IMMUNOL, V44, P2096, DOI 10.1002/eji.201344328; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; O'Dwyer MJ, 2008, INT J IMMUNOGENET, V35, P279, DOI 10.1111/j.1744-313X.2008.00773.x; Oberhuber G, 2000, BIOMED PHARMACOTHER, V54, P368, DOI 10.1016/S0753-3322(01)80003-2; Ottoboni L, 2013, NEUROLOGY, V81, P1891, DOI 10.1212/01.wnl.0000436612.66328.8a; Palova-Jelinkova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062426; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Ruiz-Ortiz E, 2014, TISSUE ANTIGENS, V84, P545, DOI 10.1111/tan.12472; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sumnik Z, 2006, DIABETES CARE, V29, P858, DOI 10.2337/diacare.29.04.06.dc05-1923; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Villanacci V, 2015, DIGEST LIVER DIS, V47, P2, DOI 10.1016/j.dld.2014.09.022; Villanacci V, 2011, DIGEST LIVER DIS, V43, pS385, DOI 10.1016/S1590-8658(11)60594-X; Westerholm-Ormio M, 2003, DIABETES, V52, P2287, DOI 10.2337/diabetes.52.9.2287; Westerholm-Ormio M, 2002, CLIN EXP IMMUNOL, V128, P94, DOI 10.1046/j.1365-2249.2002.01798.x; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	48	3	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123244	10.1371/journal.pone.0123244	http://dx.doi.org/10.1371/journal.pone.0123244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915602	Green Published, gold			2022-12-26	WOS:000353659100017
J	Salm, F; Dimitrova, V; von Bueren, AO; Cwiek, P; Rehrauer, H; Djonov, V; Anderle, P; Arcaro, A				Salm, Fabiana; Dimitrova, Valeriya; von Bueren, Andre O.; Cwiek, Paulina; Rehrauer, Hubert; Djonov, Valentin; Anderle, Pascale; Arcaro, Alexandre			The Phosphoinositide 3-Kinase p110 alpha Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma	PLOS ONE			English	Article							GROWTH-FACTOR; ONCOGENIC TRANSFORMATION; CANCER; PATHWAY; PROGRESSION; MICRORNA; CHEMORESISTANCE; AMPLIFICATION; P110-GAMMA; SIGNATURES	Medulloblastoma (MB) is the most common malignant brain tumor in childhood and represents the main cause of cancer-related death in this age group. The phosphoinositide 3-kinase (PI3K) pathway has been shown to play an important role in the regulation of medulloblastoma cell survival and proliferation, but the molecular mechanisms and downstream effectors underlying PI3K signaling still remain elusive. The impact of RNA interference (RNAi)-mediated silencing of PI3K isoforms p110 alpha and p110 delta on global gene expression was investigated by DNA microarray analysis in medulloblastoma cell lines. A subset of genes with selectively altered expression upon p110 alpha silencing in comparison to silencing of the closely related p110 delta isoform was revealed. Among these genes, the leukemia inhibitory factor receptor alpha (LIFR alpha) was validated as a novel p110 alpha target in medullo-blastoma. A network involving c-Myc and miR-125b was shown to be involved in the control of LIFR alpha expression downstream of p110 alpha. Targeting the LIFR alpha by RNAi, or by using neutralizing reagents impaired medulloblastoma cell proliferation in vitro and induced a tumor volume reduction in vivo. An analysis of primary tumors revealed that LIFR alpha and p110 alpha expression were elevated in the sonic hedgehog (SHH) subgroup of medulloblastoma, indicating its clinical relevance. Together, these data reveal a novel molecular signaling network, in which PI3K isoform p110 alpha controls the expression of LIFR alpha via c-Myc and miR-125b to promote MB cell proliferation.	[Salm, Fabiana; Dimitrova, Valeriya; Cwiek, Paulina; Arcaro, Alexandre] Univ Bern, Dept Clin Res, Div Pediat Hematol Oncol, Bern, Switzerland; [von Bueren, Andre O.] Univ Gottingen, Dept Pediat, Gottingen, Germany; [von Bueren, Andre O.] Univ Gottingen, Dept Pediat Hematol & Oncol, D-37073 Gottingen, Germany; [Rehrauer, Hubert] ETH, Funct Genom Ctr Zurich, Zurich, Switzerland; [Rehrauer, Hubert] Univ Zurich, Zurich, Switzerland; [Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [Anderle, Pascale] Univ Bern, Inst Biochem & Mol Med, Swiss Natl Ctr Competence Res TransCure, Bern, Switzerland; [Anderle, Pascale] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Natl Ctr Competence Res Mol Oncol, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Anderle, Pascale] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Bern; University of Gottingen; University of Gottingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Arcaro, A (corresponding author), Univ Bern, Dept Clin Res, Div Pediat Hematol Oncol, Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	von Bueren, Andre/AAF-2065-2020; Arcaro, Alexandre/G-1711-2010	Arcaro, Alexandre/0000-0001-9107-2947; von Bueren, Andre/0000-0003-4197-6264; Djonov, Valentin/0000-0002-5062-1169; Bronnimann, Paulina/0000-0001-7574-8214; Cwiek, Paulina/0000-0002-0964-6364	European Union's Seventh Framework Programme (FP7) [259348]; Fondation FORCE; Hartmann Muller-Stiftung; Ida de Pottere-Leupold-Fonds zur Forderung der Krebsforschung; Berner Stiftung fur krebskranke Kinder und Jugendliche	European Union's Seventh Framework Programme (FP7); Fondation FORCE; Hartmann Muller-Stiftung; Ida de Pottere-Leupold-Fonds zur Forderung der Krebsforschung; Berner Stiftung fur krebskranke Kinder und Jugendliche	This work was supported by a grant from the Fondation FORCE, Hartmann Muller-Stiftung, Ida de Pottere-Leupold-Fonds zur Forderung der Krebsforschung, Berner Stiftung fur krebskranke Kinder und Jugendliche. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 259348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Ball S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018820; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; Baxter EW, 2010, J NEURO-ONCOL, V97, P373, DOI 10.1007/s11060-009-0043-x; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Castelletti D, 2010, MOL CANCER THER, V9, P3145, DOI 10.1158/1535-7163.MCT-10-0539; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Corno D, 2012, CANCER DISCOV, V2, P554, DOI 10.1158/2159-8290.CD-11-0199; David E, 2012, AM J PATHOL, V181, P1782, DOI 10.1016/j.ajpath.2012.07.023; Del Valle L, 2002, CLIN CANCER RES, V8, P1822; Dhingra K, 1998, BREAST CANCER RES TR, V48, P165, DOI 10.1023/A:1005942923757; Dudu V, 2012, CELL MOL BIOENG, V5, P402, DOI 10.1007/s12195-012-0253-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Fiaschetti G, 2011, ONCOGENE, V30, P2823, DOI 10.1038/onc.2011.10; FRIEDMAN HS, 1988, AM J PATHOL, V130, P472; Geoerger B, 2001, CANCER RES, V61, P1527; Gilbertson R, 2002, EUR J CANCER, V38, P675, DOI 10.1016/S0959-8049(01)00315-X; Grotzer MA, 2009, CURR CANCER DRUG TAR, V9, P176, DOI 10.2174/156800909787580962; Guerreiro AS, 2008, CLIN CANCER RES, V14, P6761, DOI 10.1158/1078-0432.CCR-08-0385; Guerreiro AS, 2011, MOL CANCER RES, V9, P925, DOI 10.1158/1541-7786.MCR-10-0200; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Henssen A, 2013, ONCOTARGET, V4, DOI 10.18632/oncotarget.1534; Hernan R, 2003, CANCER RES, V63, P140; Holand K, 2011, CURR CANCER DRUG TAR, V11, P894, DOI 10.2174/156800911797264743; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2012, ACTA NEUROPATHOL, V123, P515, DOI 10.1007/s00401-011-0918-8; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Liu J, 1999, J CANCER RES CLIN, V125, P475, DOI 10.1007/s004320050304; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Massimino M, 2011, CRIT REV ONCOL HEMAT, V79, P65, DOI 10.1016/j.critrevonc.2010.07.010; Morfouace M, 2014, CANCER CELL, V25, P516, DOI 10.1016/j.ccr.2014.02.009; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Peng SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102403; Pocza T, 2014, PATHOL ONCOL RES; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Reynolds CP, 2012, PEDIAT BLOOD CANC; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roussel MF, 2013, COLD SPRING HARB PER, V3, DOI [10.1101/cshperspecta015552, DOI 10.1101/CSHPERSPECTA015552]; Stearns D, 2006, CANCER RES, V66, P673, DOI 10.1158/0008-5472.CAN-05-1580; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Trouillas M, 2009, EUR CYTOKINE NETW, V20, P51, DOI 10.1684/ecn.2009.0148; von Bueren AO, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-19; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wetmore C, 2001, CANCER RES, V61, P513; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Wysoczynski M, 2007, CANCER RES, V67, P2131, DOI 10.1158/0008-5472.CAN-06-1021; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zhou LM, 2010, CANCER RES, V70, P8199, DOI 10.1158/0008-5472.CAN-09-4562	64	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123958	10.1371/journal.pone.0123958	http://dx.doi.org/10.1371/journal.pone.0123958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915540	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353659100030
J	Thavayogarajah, T; Gangopadhyay, P; Rahlfs, S; Becker, K; Lingelbach, K; Przyborski, JM; Holder, AA				Thavayogarajah, Thuvaraka; Gangopadhyay, Preetish; Rahlfs, Stefan; Becker, Katja; Lingelbach, Klaus; Przyborski, Jude M.; Holder, Anthony A.			Alternative Protein Secretion in the Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; MAURERS CLEFTS; STREPTOLYSIN-O; HOST ERYTHROCYTE; GOLGI-COMPLEX; ARF PROTEINS; MEMBRANE; EXPORT	Plasmodium falciparum invades human red blood cells, residing in a parasitophorous vacuole (PV), with a parasitophorous vacuole membrane (PVM) separating the PV from the host cell cytoplasm. Here we have investigated the role of N-myristoylation and two other N-terminal motifs, a cysteine potential S-palmitoylation site and a stretch of basic residues, as the driving force for protein targeting to the parasite plasma membrane (PPM) and subsequent translocation across this membrane. Plasmodium falciparum adenylate kinase 2 (Pf AK2) contains these three motifs, and was previously proposed to be targeted beyond the parasite to the PVM, despite the absence of a signal peptide for entry into the classical secretory pathway. Biochemical and microscopy analyses of PfAK2 variants tagged with green fluorescent protein (GFP) showed that these three motifs are involved in targeting the protein to the PPM and translocation across the PPM to the PV. It was shown that the N-terminal 37 amino acids of PfAK2 alone are sufficient to target and translocate GFP across the PPM. As a control we examined the N-myristoylated Plasmodium falciparum ADP-ribosylation factor 1 (PfARF1). PfARF1 was found to co-localise with a Golgi marker. To determine whether or not the putative palmitoylation and the cluster of lysine residues from the N-terminus of PfAK2 would modulate the subcellular localization of PfARF1, a chimeric fusion protein containing the N-terminus of PfARF1 and the two additional PfAK2 motifs was analysed. This chimeric protein was targeted to the PPM, but not translocated across the membrane into the PV, indicating that other features of the N-terminus of PfAK2 also play a role in the secretion process.	[Thavayogarajah, Thuvaraka; Gangopadhyay, Preetish; Lingelbach, Klaus; Przyborski, Jude M.] Univ Marburg, Div Parasitol, Fac Biol, D-35043 Marburg, Germany; [Rahlfs, Stefan; Becker, Katja] Univ Giessen, Biochem & Mol Biol, Interdisciplinary Res Ctr, D-35392 Giessen, Germany; [Holder, Anthony A.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	Philipps University Marburg; Justus Liebig University Giessen; Francis Crick Institute	Przyborski, JM (corresponding author), Univ Marburg, Div Parasitol, Fac Biol, Karl von Frisch Str 8, D-35043 Marburg, Germany.	przybors@staff.uni-marburg.de; aholder@nimr.mrc.ac.uk	Holder, Anthony A/A-7554-2013; Przyborski, Jude/ABC-9498-2021	Holder, Anthony A/0000-0002-8490-6058; Przyborski, Jude/0000-0002-3494-7767	Sonder forschungs bereich [593]; MRC [U117532067]; European Community's FP7 grant (EVIMalaR) [242095]; The Francis Crick Institute [10097] Funding Source: researchfish	Sonder forschungs bereich(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's FP7 grant (EVIMalaR); The Francis Crick Institute	This work was funded by the European Community's FP7 grant agreement 242095 (EVIMalaR; http://www.evimalar.org/) through a PhD studentship to TT, and by Sonder forschungs bereich 593 (www.dfg.de/sfb) to KL. AAH is funded through the MRC (U117532067; http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; BEAUMELLE BD, 1987, J PARASITOL, V73, P743, DOI 10.2307/3282405; BHAKDI S, 1985, INFECT IMMUN, V47, P52; BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Ezougou CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087695; Graewe S, 2012, FEMS MICROBIOL REV, V36, P111, DOI 10.1111/j.1574-6976.2011.00297.x; Guttery DS, 2014, CELL HOST MICROBE, V16, P128, DOI 10.1016/j.chom.2014.05.020; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LINGELBACH KR, 1993, EXP PARASITOL, V76, P318, DOI 10.1006/expr.1993.1039; Ma J, 2012, FEBS LETT, V586, P3037, DOI 10.1016/j.febslet.2012.07.013; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; PAUL F, 1981, LANCET, V2, P70; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Rahlfs S, 2009, MOL BIOCHEM PARASIT, V163, P77, DOI 10.1016/j.molbiopara.2008.09.008; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Stafford WHL, 1996, EUR J BIOCHEM, V242, P104, DOI 10.1111/j.1432-1033.1996.0104r.x; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	37	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125191	10.1371/journal.pone.0125191	http://dx.doi.org/10.1371/journal.pone.0125191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909331	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800132
J	Lin, X; Huang, CH; Shi, J; Wang, RF; Sun, X; Liu, XK; Zhao, LZ; Jin, ML				Lin, Xian; Huang, Canhui; Shi, Jian; Wang, Ruifang; Sun, Xin; Liu, Xiaokun; Zhao, Lianzhong; Jin, Meilin			Investigation of Pathogenesis of H1N1 Influenza Virus and Swine Streptococcus suis Serotype 2 Co-Infection in Pigs by Microarray Analysis	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; EPITHELIAL-CELLS; NADPH OXIDASES; NOX FAMILY; EXPRESSION; PNEUMONIA; INFECTION; CYTOKINE; OUTBREAK; LUNG	Swine influenza virus and Streptococcus suis are two important contributors to the porcine respiratory disease complex, and both have significant economic impacts. Clinically, influenza virus and Streptococcus suis co-infections in pigs are very common, which often contribute to severe pneumonia and can increase the mortality. However, the co-infection pathogenesis in pigs is unclear. In the present study, co-infection experiments were performed using swine H1N1 influenza virus and Streptococcus suis serotype 2 (SS2). The H1N1-SS2 co-infected pigs exhibited more severe clinical symptoms, serious pathological changes, and robust apoptosis of lungs at 6 days post-infection compared with separate H1N1 and SS2 infections. A comprehensive gene expression profiling using a microarray approach was performed to investigate the global host responses of swine lungs against the swine H1N1 infection, SS2 infection, co-infection, and phosphate-buffered saline control. Results showed 457, 411, and 844 differentially expressed genes in the H1N1, SS2, and H1N1-SS2 groups, respectively, compared with the control. Noticeably, genes associated with the immune, inflammatory, and apoptosis responses were highly overexpressed in the co-infected group. Pathway analysis indicated that the cytokine-cytokine receptor interactions, MAPK, toll-like receptor, complement and coagulation cascades, antigen processing and presentation, and apoptosis pathway were significantly regulated in the co-infected group. However, the genes related to these were less regulated in the separate H1N1 and SS2 infection groups. This observation suggested that a certain level of synergy was induced by H1N1 and SS2 co-infection with significantly stronger inflammatory and apoptosis responses, which may lead to more serious respiratory disease syndrome and pulmonary pathological lesion.	[Lin, Xian; Huang, Canhui; Shi, Jian; Wang, Ruifang; Sun, Xin; Liu, Xiaokun; Zhao, Lianzhong; Jin, Meilin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Jin, ML (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	jml8328@126.com			China National Basic Research Program (China "973" Program) [2012CB518805]	China National Basic Research Program (China "973" Program)(National Basic Research Program of China)	The study was supported by China National Basic Research Program (China "973" Program 2012CB518805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Greeff A, 2010, VET MICROBIOL, V141, P59, DOI 10.1016/j.vetmic.2009.07.031; Dessing MC, 2007, AM J RESP CELL MOL, V36, P609, DOI 10.1165/rcmb.2006-0166OC; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dybing JK, 2000, J VIROL, V74, P1443, DOI 10.1128/JVI.74.3.1443-1450.2000; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fearon DT, 1999, QJM-MON J ASSOC PHYS, V92, P235, DOI 10.1093/qjmed/92.5.235; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Galecka Elzbieta, 2008, Pol Merkur Lekarski, V24, P446; Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Golden-Mason L, 2011, HEPATOLOGY, V54, P1559, DOI 10.1002/hep.24556; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Hofshagen M, 2009, EURO SURVEILL, V14; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jung Y, 2005, J COMP PATHOL, V132, P179, DOI 10.1016/j.jcpa.2004.09.008; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lam WY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-344; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Li YT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-398; Loving CL, 2010, MICROB PATHOGENESIS, V49, P237, DOI 10.1016/j.micpath.2010.06.004; Martinez-Vila E, 2001, CEREBROVASC DIS, V11, P60, DOI 10.1159/000049127; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pauligk C, 2004, IMMUNOBIOLOGY, V209, P3, DOI 10.1016/j.imbio.2004.04.002; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Seki M, 2004, EUR RESPIR J, V24, P143, DOI 10.1183/09031936.04.00126103; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Smith MW, 2007, COMPARATIVE MED, V57, P82; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tenenbaum T, 2006, BRAIN RES, V1100, P1, DOI 10.1016/j.brainres.2006.05.041; Triantafilou K, 2001, J CELL SCI, V114, P2535; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; Williamson SM, 2012, VET REC, V171, P271, DOI 10.1136/vr.100673; Wilson SM, 2007, VET IMMUNOL IMMUNOP, V117, P116, DOI 10.1016/j.vetimm.2007.02.009; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang RJ, 2007, AIDS, V21, pS9, DOI 10.1097/01.aids.0000304691.32014.19; Zhou HB, 2011, EMERG INFECT DIS, V17, P1757, DOI 10.3201/eid1709.101916	62	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124086	10.1371/journal.pone.0124086	http://dx.doi.org/10.1371/journal.pone.0124086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906258	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000056
J	Pinto, IC; Sabido, M; Pereira, AB; Mello, MB; Shimizu, ADX; Protti, BL; Benzaken, AS				Pinto, Ione Conceicao; Sabido, Meritxell; Pereira, Analice Barbosa; Mello, Maeve B.; Xavier Shimizu, Andrea de Melo; Protti, Bruna Lovizutto; Benzaken, Adele Schwartz			Field Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil	PLOS ONE			English	Article							PERFORMANCE EVALUATION; CELL ENUMERATION; INSTRUMENT; PIMA(TM); BLOOD	Objective To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in comparison to the current CD4 count system (FACSCalibur), and to evaluate the operational suitability and acceptability of health professionals (HP) and HIV-patients in using the PIMA in health clinics in the Amazon Region. Methods CD4 counts were measured onsite by the PIMA using fingerprick blood and in the reference laboratory by both the PIMA and FACSCalibur using venous blood. We used the Bland-Altman method to estimate the mean bias, and calculated the sensitivity and specificity at <200 and <500 cell/mu L thresholds. Patients (n = 404) and HP (n = 7) were interviewed on the acceptability and operational suitability of the PIMA. Results Using fingerprick blood (n = 337), the PIMA showed a concordance correlation coefficient (Rc) of 0.81, mean difference of -111.9 cell/mu L, 93.1%/98.5% sensitivity, and 89.2%/56.7% specificity at <200 and <500 cell/mu L thresholds, respectively. Venous blood (n = 340) showed an Rc of 0.89, mean difference of -83.4 cell/mu L, 98.3%/97.5% sensitivity, and 93.9%/66.0% specificity at <200 and <500 cell/mu L thresholds, respectively. The capillary PIMA was well accepted and found operationally appropriate by patients and HP. Conclusions The agreement between both instruments was poor and the PIMA underestimated CD4 cell counts, which was more pronounced at CD4 counts >= 500 cell/mu l. The PIMA's performance with fingerprick blood was less reliable than its performance with venous blood. In Brazil, where antiretroviral treatment is initiated regardless of CD4 counts, the PIMA's systematic bias towards CD4 underestimation may limit its role for monitoring HIV-patients.	[Pinto, Ione Conceicao; Sabido, Meritxell; Xavier Shimizu, Andrea de Melo] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil; [Sabido, Meritxell] Univ Girona, Dept Med Sci, TransLab, Catalunya, Spain; [Pereira, Analice Barbosa] Fac Salle, Manaus, Amazonas, Brazil; [Mello, Maeve B.] Joint United Nations Programme HIV AIDS UNAIDS, Brasilia, DF, Brazil; [Protti, Bruna Lovizutto; Benzaken, Adele Schwartz] Minist Saude, Secretaria Vigilancia Saude, Dept DST Aids & Hepatites Virais, Brasilia, DF, Brazil; [Benzaken, Adele Schwartz] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universitat de Girona; Fundacao Oswaldo Cruz	Sabido, M (corresponding author), Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.	xellsabido@gmail.com		Schwartz Benzaken, Adele/0000-0002-5789-0695	Centers for Disease Control and Prevention [1U2GPS001204]; National Department of STD/Aids; Brazilian Ministry of Health; Foundation for Research Support of the Amazonas State (FAPEAM); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS001204] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Department of STD/Aids; Brazilian Ministry of Health; Foundation for Research Support of the Amazonas State (FAPEAM); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was co-funded by Centers for Disease Control and Prevention through the Cooperative Agreement Award #1U2GPS001204, and by the National Department of STD/Aids and Viral Hepatitis from the Brazilian Ministry of Health. Dr. Sabido has a fellowship as a visiting researcher at the Fundacao de Medicina Tropical Dr. Heitor Vieira Dourado, funded by the Foundation for Research Support of the Amazonas State (FAPEAM) through the Strategic Programme in Science, Technology & Innovation in Health Foundations (PECTI/AM SAUDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BD Beckton Dickinson, MULT CD3 FITC CD8 PF; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bride M, 2005, HAM2005062; Chesher Douglas, 2008, Clin Biochem Rev, V29 Suppl 1, pS23; Department of STDs AIDS and Viral Hepatitis. Health Surveillance Secretariat. Brazilian Ministry of Health, 2013, EP B; Department of STDs AIDS and Viral Hepatitis. Ministry of Health, 2013, PROT CLIN DIR TER; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Myer L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18649; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Rathunde L, 2014, INT J STD AIDS, V25, P956, DOI 10.1177/0956462414526862; Rocha GM, 2011, CAD SAUDE PUBLICA, V27, pS67, DOI 10.1590/S0102-311X2011001300008; Shott JP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/651927; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Van Schaik N, 2011, CROI 2011 18 C RETR; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; World Health Organisation, 2013, WHO CONS GUID US ANT; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	29	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0121400	10.1371/journal.pone.0121400	http://dx.doi.org/10.1371/journal.pone.0121400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905775	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000007
J	Japtok, L; Schmitz, EI; Fayyaz, S; Kramer, S; Hsu, LJ; Kleuser, B				Japtok, Lukasz; Schmitz, Elisabeth I.; Fayyaz, Susann; Kraemer, Stephanie; Hsu, Leigh J.; Kleuser, Burkhard			Sphingosine 1-phosphate counteracts insulin signaling in pancreatic beta-cells via the sphingosine 1-phosphate receptor subtype 2	FASEB JOURNAL			English	Article						type 2 diabetes mellitus; sphingolipids; survival; proliferation; Akt signaling	FUNCTIONAL-CHARACTERIZATION; DIABETES-MELLITUS; MOLECULAR-CLONING; INDUCED APOPTOSIS; FATTY-ACIDS; ACTIVATION; GLUCOSE; PALMITATE; KINASE; RESISTANCE	Glucolipotoxic stress has been identified as a key player in the progression of pancreatic beta-cell dysfunction contributing to insulin resistance and the development of type 2 diabetes mellitus (T2D). It has been suggested that bioactive lipid intermediates, formed under lipotoxic conditions, are involved in these processes. Here, we show that sphingosine 1-phosphate (S1P) levels are not only increased in palmitate-stimulated pancreatic beta-cells but also regulate beta-cell homeostasis in a divergent manner. Although S1P possesses a prosurvival effect in beta-cells, an enhanced level of the sphingolipid antagonizes insulin-mediated cell growth and survival via the sphingosine 1-phosphate receptor subtype 2 (S1P(2)) followed by an inhibition of Akt-signaling. In an attempt to investigate the role of the S1P/S1P(2) axis in vivo, the New Zealand obese (NZO) diabetic mouse model, characterized by beta-cell loss under high-fat diet (HFD) conditions, was used. The occurrence of T2D was accompanied by an increase of plasma S1P levels. To examine whether S1P contributes to the morphologic changes of islets via S1P(2), the receptor antagonist JTE-013 was administered. Most interestingly, JTE-013 rescued beta-cell damage clearly indicating an important role of the S1P(2) in beta-cell homeostasis. Therefore, the present study provides a new therapeutic strategy to diminish beta-cell dysfunction and the development of T2D.	[Japtok, Lukasz; Schmitz, Elisabeth I.; Fayyaz, Susann; Kleuser, Burkhard] Univ Potsdam, Dept Toxicol, Inst Nutr Sci, Fac Math & Nat Sci, D-14558 Potsdam, Germany; [Kraemer, Stephanie] German Inst Human Nutr, Max Rubner Lab, Nuthetal, Germany; [Hsu, Leigh J.] Lpath Inc, San Diego, CA USA	University of Potsdam; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Kleuser, B (corresponding author), Univ Potsdam, Dept Toxicol, Inst Nutr Sci, Fac Math & Nat Sci, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	kleuser@uni-potsdam.de		Kleuser, Burkhard/0000-0002-1888-9595	Deutsche Forschungsgemeinschaft [KL988/4-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft to B.K. (KL988/4-4).	Andreozzi F, 2004, ENDOCRINOLOGY, V145, P2845, DOI 10.1210/en.2003-0939; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Blot V, 2009, SYNTHESIS-STUTTGART, P759, DOI 10.1055/s-0028-1083373; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Fayyaz S, 2014, CELL PHYSIOL BIOCHEM, V34, P134, DOI 10.1159/000362990; Fayyaz S, 2014, DIABETOLOGIA, V57, P373, DOI 10.1007/s00125-013-3123-6; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Galadari S, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-98; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Imasawa T, 2010, BIOCHEM BIOPH RES CO, V392, P207, DOI 10.1016/j.bbrc.2010.01.016; Japtok L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049427; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449; Lanuza-Masdeu J, 2013, DIABETES, V62, P2308, DOI 10.2337/db12-1097; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maris M, 2013, J PROTEOME RES, V12, P347, DOI 10.1021/pr300596g; Mastrandrea LD, 2010, J LIPID RES, V51, P2171, DOI 10.1194/jlr.M000802; Mastrandrea LD, 2005, DIABETES, V54, P1429, DOI 10.2337/diabetes.54.5.1429; Moon H, 2013, DIABETES-METAB RES, V29, P19, DOI 10.1002/dmrr.2341; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Newsholme P, 2007, CLIN SCI, V112, P27, DOI 10.1042/CS20060115; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rutti S, 2009, ENDOCRINOLOGY, V150, P4521, DOI 10.1210/en.2009-0252; Schuppel M, 2008, J INVEST DERMATOL, V128, P1747, DOI 10.1038/sj.jid.5701259; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimizu H, 2000, ENDOCR J, V47, P261, DOI 10.1507/endocrj.47.261; Sommerweiss D, 2013, BIOCHEM BIOPH RES CO, V441, P770, DOI 10.1016/j.bbrc.2013.10.130; Stanford JC, 2012, J BIOL CHEM, V287, P13457, DOI 10.1074/jbc.M111.268185; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Virally M, 2007, DIABETES METAB, V33, P231, DOI 10.1016/j.diabet.2007.07.001; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359; Zhu Q, 2009, FEBS LETT, V583, P2136, DOI 10.1016/j.febslet.2009.05.047	44	42	42	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3357	3369		10.1096/fj.14-263194	http://dx.doi.org/10.1096/fj.14-263194			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911610				2022-12-26	WOS:000358796900023
J	Wang, SX; Song, KX; Srivastava, R; Dong, C; Go, GW; Li, N; Iwakiri, Y; Mani, A				Wang, Shuxia; Song, Kangxing; Srivastava, Roshni; Dong, Chao; Go, Gwang-Woong; Li, Na; Iwakiri, Yasuko; Mani, Arya			Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a	FASEB JOURNAL			English	Article						LRP6; PKC; hepatic steatosis; RhoA; ROCK	EPITHELIAL-MESENCHYMAL TRANSITION; METABOLIC SYNDROME; FIBROSIS PROGRESSION; RISK-FACTORS; TGF-BETA; MYOFIBROBLAST; ACTIVATION; CELLS; STEATOHEPATITIS; LIPOTOXICITY	Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, which begins with isolated steatosis and advances to nonalcoholic steatohepatitis (NASH), steatofibrosis, and cirrhosis. The pathways involved in disease progression are not understood. Loss-of-function mutations in Wnt coreceptor LDL receptor-related protein 6 (LRP6) underlie early-onset atherosclerosis, metabolic risk factors, and NAFLD in humans by unknown mechanisms. We generated mice with the human disease-associated LRP6(R611C) mutation and phenotypically characterized their liver. Homozygote LRP6(R611C) (LRP6(mut/mut)) mice exhibited both steatohepatitis and steatofibrosis. These traits were associated with increased activity of the noncanonical Wnt/Ras homolog family member A, Rho-associated protein kinase 2, and PKC-alpha/-mu pathways. Accordingly, there was increased TGF-beta 1 activity, coupled with enhanced expression of smooth muscle a-actin and vimentin that colocalized with albumin in LRP6(mut/mut) mouse liver. LRP6 knockdown reprogramed HepG2 cells to express both these markers, linking impaired Wnt signaling with hepatocyte transdifferentiation. The causal link between altered Wnt signaling and NASH was established by normalization of the disease pathways and rescue of the liver traits by Wnt3a administration to LRP6(mut/mut) mice. Thus, this study identifies diverse disease pathways that underlie a spectrum of NASH-related liver diseases and are linked by a single human genetic variant. LRP6 and noncanonical Wnt pathways are important potential therapeutic targets against NASH.	[Wang, Shuxia; Song, Kangxing; Srivastava, Roshni; Go, Gwang-Woong; Mani, Arya] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, New Haven, CT 06511 USA; [Dong, Chao; Iwakiri, Yasuko] Yale Univ, Sch Med, Yale Liver Ctr, New Haven, CT 06511 USA; [Mani, Arya] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06511 USA; [Wang, Shuxia] Chinese Peoples Liberat Army Gen Hosp & Med Sch, Dept Geriatr Cardiol, Beijing, Peoples R China; [Song, Kangxing] Chinese Peoples Liberat Army Gen Hosp & Med Sch, Dept Cardiol, Beijing, Peoples R China; [Li, Na] Kookmin Univ, Dept Food & Nutr, Seoul, South Korea	Yale University; Yale University; Yale University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Kookmin University	Mani, A (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, 300 George St,Room 759K, New Haven, CT 06511 USA.	arya.mani@yale.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL122830-01, R01HL122822-01]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK082600]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122822, R01HL122830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK082600] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants R01HL122830-01 and R01HL122822-01 (to A.M.) and by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK082600 (to Y.I.).	Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Go GW, 2014, CELL METAB, V19, P209, DOI 10.1016/j.cmet.2013.11.023; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gunaratnam K, 2014, ENDOCRINOLOGY, V155, P108, DOI 10.1210/en.2013-1712; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Idilman IS, 2015, J DIABETES, V7, P279, DOI 10.1111/1753-0407.12172; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kim NH, 2014, HEART, V100, P938, DOI 10.1136/heartjnl-2013-305099; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Lemoinne S, 2013, BBA-MOL BASIS DIS, V1832, P948, DOI 10.1016/j.bbadis.2013.02.019; LoGrasso PV, 2009, CURR TOP MED CHEM, V9, P704, DOI 10.2174/156802609789044452; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Morishima Y, 2001, AM J RESP CELL MOL, V24, P1; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Singh R, 2013, HUM MUTAT, V34, P1221, DOI 10.1002/humu.22360; Singh R, 2013, CELL METAB, V17, P197, DOI 10.1016/j.cmet.2013.01.009; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; Watsky MA, 2010, INT REV CEL MOL BIO, V282, P165, DOI 10.1016/S1937-6448(10)82004-0; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zeb I, 2013, J CARDIOVASC COMPUT, V7, P311, DOI 10.1016/j.jcct.2013.08.011	37	39	43	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3436	3445		10.1096/fj.15-271171	http://dx.doi.org/10.1096/fj.15-271171			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25917329	Green Published			2022-12-26	WOS:000358796900030
J	DeMartini, DG; Izumi, M; Weaver, AT; Pandolfi, E; Morse, DE				DeMartini, Daniel G.; Izumi, Michi; Weaver, Aaron T.; Pandolfi, Erica; Morse, Daniel E.			Structures, Organization, and Function of Reflectin Proteins in Dynamically Tunable Reflective Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSIOLOGICAL COLOR-CHANGE; SQUID IRIDOPHORES; IRIDESCENCE; LIGHT; SKIN; LEUCOPHORES; MECHANISMS; CAMOUFLAGE; MOLLUSCA	The reversible assembly of reflectin proteins drives dynamic iridescence in cephalopods. Squid dynamically tune the intensity and colors of iridescence generated by constructive interference from intracellular Bragg reflectors in specialized skin cells called iridocytes. Analysis of the tissue specificity of reflectin subtypes reveals that tunability is correlated with the presence of one specific reflectin sequence. Differential phosphorylation and dephosphorylation of the reflectins in response to activation by acetylcholine, as well as differences in their tissue-specific and subcellular spatial distributions, further support the suggestion of different roles for the different reflectin subtypes.	[DeMartini, Daniel G.; Morse, Daniel E.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [DeMartini, Daniel G.; Izumi, Michi; Morse, Daniel E.] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; [Weaver, Aaron T.; Pandolfi, Erica; Morse, Daniel E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Morse, DE (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.	d_morse@lifesci.ucsb.edu	DeMartini, Daniel/D-1264-2017	DeMartini, Daniel/0000-0002-2377-3749	Office of Naval Research via a Multidisciplinary University Research Initiative (MURI) award [N00014-09-1-1053]; Army Research Office [W911NF-10-1-0139]	Office of Naval Research via a Multidisciplinary University Research Initiative (MURI) award; Army Research Office	This work was supported by grants from the Office of Naval Research via a Multidisciplinary University Research Initiative (MURI) award to Duke University (Grant N00014-09-1-1053), and the Army Research Office (Grant W911NF-10-1-0139 to D. E. M.).	Andouche A, 2013, DEV DYNAM, V242, P560, DOI 10.1002/dvdy.23938; ARNOLD JM, 1967, J ULTRA MOL STRUCT R, V20, P410, DOI 10.1016/S0022-5320(67)80109-6; ARNOLD JM, 1974, BIOL BULL, V147, P507, DOI 10.2307/1540736; BARER R, 1954, NATURE, V173, P821, DOI 10.1038/173821b0; Bergersen LH, 2008, NAT PROTOC, V3, P144, DOI 10.1038/nprot.2007.525; Boal JG, 2004, BEHAVIOUR, V141, P837, DOI 10.1163/1568539042265662; BROCCO SL, 1980, CELL TISSUE RES, V205, P167; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; CLONEY RA, 1983, AM ZOOL, V23, P581, DOI 10.1093/icb/23.3.581; COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425; Crookes WJ, 2004, SCIENCE, V303, P235, DOI 10.1126/science.1091288; DeMartini DG, 2013, J EXP BIOL, V216, P3733, DOI 10.1242/jeb.090415; DeMartini DG, 2013, P NATL ACAD SCI USA, V110, P2552, DOI 10.1073/pnas.1217260110; DENTON EJ, 1971, PROC R SOC SER B-BIO, V178, P43, DOI 10.1098/rspb.1971.0051; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Fudouzi H, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/6/064704; Ghoshal A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0386; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon R. T., 1996, CEPHALOPOD BEHAV, p[31, 120]; HANLON RT, 1990, CELL TISSUE RES, V259, P3, DOI 10.1007/BF00571424; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Holt AL, 2011, J R SOC INTERFACE, V8, P1386, DOI 10.1098/rsif.2010.0702; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Izumi M, 2010, J R SOC INTERFACE, V7, P549, DOI 10.1098/rsif.2009.0299; Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Mathger LM, 2013, ADV FUNCT MATER, V23, P3980, DOI 10.1002/adfm.201203705; Mathger LM, 2003, J EXP BIOL, V206, P3607, DOI 10.1242/jeb.00599; Mathger LM, 2007, CELL TISSUE RES, V329, P179, DOI 10.1007/s00441-007-0384-8; Parker R, 2000, J OPT A-PURE APPL OP, V2, P15; Qin G., 2012, J POLYM SCI B, V51, P254; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Ruby EG, 1996, ANNU REV MICROBIOL, V50, P591, DOI 10.1146/annurev.micro.50.1.591; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Tao AR, 2010, BIOMATERIALS, V31, P793, DOI 10.1016/j.biomaterials.2009.10.038; Vigneron JP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031907; Walish J., 2009, ADV MATER, V21, P1, DOI DOI 10.1002/ADMA.200990117; Wardill TJ, 2012, P ROY SOC B-BIOL SCI, V279, P4243, DOI 10.1098/rspb.2012.1374; Weiss JL, 2005, BBA-BIOMEMBRANES, V1668, P164, DOI 10.1016/j.bbamem.2004.11.014; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	42	35	35	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15238	15249		10.1074/jbc.M115.638254	http://dx.doi.org/10.1074/jbc.M115.638254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918159	Green Published, hybrid			2022-12-26	WOS:000356177300036
J	Nakane, S; Iwamoto, A; Matsuda, Z				Nakane, Shuhei; Iwamoto, Aikichi; Matsuda, Zene			The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEMBRANE-SPANNING DOMAIN; CYTOPLASMIC TAIL; BETA-LACTAMASE; TYPE-1 GP120; FUSION; CLEAVAGE; REGIONS; SURFACE; CELLS	The mature human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) comprises the non-covalently associated gp120 and gp41 subunits generated from the gp160 precursor. Recent structural analyses have provided quaternary structural models for gp120/gp41 trimers, including the variable loops (V1-V5) of gp120. In these models, the V3 loop is located under V1/V2 at the apical center of the Env trimer, and the V4 and V5 loops project outward from the trimeric protomers. In addition, the V4 and V5 loops are predicted to have less movement upon receptor binding during membrane fusion events. We performed insertional mutagenesis using a GFP variant, GFPOPT, placed into the variable loops of HXB2 gp120. This allowed us to evaluate the current structural models and to simultaneously generate a GFP-tagged HIV-1 Env, which was useful for image analyses. All GFP-inserted mutants showed similar levels of whole-cell expression, although certain mutants, particularly V3 mutants, showed lower levels of cell surface expression. Functional evaluation of their fusogenicities in cell-cell and virus-like particle-cell fusion assays revealed that V3 was the most sensitive to the insertion and that the V1/V2 loops were less sensitive than V3. The V4 and V5 loops were the most tolerant to insertion, and certain tag proteins other than GFPOPT could also be inserted without functional consequences. Our results support the current structural models and provide a GFPOPT-tagged Env construct for imaging studies.	[Nakane, Shuhei; Iwamoto, Aikichi; Matsuda, Zene] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo 1088639, Japan; [Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Infect Dis, Tokyo 1088639, Japan; [Nakane, Shuhei; Matsuda, Zene] Chinese Acad Sci, Inst Biophys, China Japan Joint Lab Struct Virol & Immunol, Beijing 100101, Peoples R China	University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Biophysics, CAS	Matsuda, Z (corresponding author), Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	zmatsuda@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	This work was supported by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID).	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Bultmann A, 2001, J VIROL, V75, P5263, DOI 10.1128/JVI.75.11.5263-5276.2001; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan WE, 2004, J VIROL, V78, P5157, DOI 10.1128/JVI.78.10.5157-5169.2004; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; da Silva ES, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-54; Diaz-Aguilar B, 2013, BIOCHEMISTRY-US, V52, P3552, DOI 10.1021/bi400201h; Doucet N, 2004, J BIOL CHEM, V279, P46295, DOI 10.1074/jbc.M407606200; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Gallagher JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004373; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Niwa Y, 1996, EUR J BIOCHEM, V237, P64, DOI 10.1111/j.1432-1033.1996.0064n.x; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pereira CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017016; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Ren XP, 2005, J VIROL, V79, P5616, DOI 10.1128/JVI.79.9.5616-5624.2005; Royant A, 2011, J STRUCT BIOL, V174, P385, DOI 10.1016/j.jsb.2011.02.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096790; Wolf MC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-119; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yuan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069789; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	53	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15279	15291		10.1074/jbc.M114.628610	http://dx.doi.org/10.1074/jbc.M114.628610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911103	hybrid, Green Published			2022-12-26	WOS:000356177300039
J	Lin, YW; Chen, CC; Lin, LC; Lee, SP				Lin, Yu-Wei; Chen, Chia-Chun; Lin, Li-Ching; Lee, Steve P.			The Impact of Reduced-Volume, Intensity-Modulated Radiation Therapy on Disease Control in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							NECK-CANCER; CLINICAL-OUTCOMES; TARGET VOLUMES; RADIOTHERAPY; HEAD; EXPERIENCE; PATTERNS; FAILURE; IRRADIATION; DELINEATION	Objective To investigate the feasibility of using intensity-modulated radiotherapy (IMRT) with reduced, high-dose target volumes for nasopharyngeal carcinoma (NPC). Methods The first 57 patients (admitted from October 2005 to May 2008) were treated with large-target-volume IMRT (LV-IMRT). For the LV-IMRT group, the CTV at 70 Gy (CTV70) was delineated as the gross target volume (GTV) plus 7mm, with or without the first-echelon lymphnode region. The next 56 patients (admitted from June 2008 to November 2011) were treated with reduced-target-volume IMRT (RV-IMRT). For the RV-IMRT group, the CTV70 was delineated as the GTV alone. Results The 4-year local recurrence-free, regional recurrence-free, distant metastasis-free, progression-free, and overall survival rates were 77.2%, 80.1%, 83.2%, 61.2%, and 74.4% for the LV-IMRT group and 83.5%, 92.6%, 89.1%, 78.5, and 91.0% for the RV-IMRT group, respectively. Late toxicity scoring of xerostomia was lesser in the RV-IMRT group than the LV-IMRT group (P < 0.001). Conclusions The use of RV-IMRT for the treatment of NPC did not negatively affect survival rates but did reduce the late xerostomia events compared to LV-IMRT.	[Lin, Yu-Wei; Lin, Li-Ching] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Yu-Wei] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Lin, Yu-Wei] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chen, Chia-Chun] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Li-Ching] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Lee, Steve P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Lee, Steve P.] VA Greater Los Angeles Healthcare Syst, Dept Radiat Oncol, Los Angeles, CA USA	Chi Mei Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Chi Mei Hospital; Taipei Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lin, YW (corresponding author), Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan.	marklin1108@gmail.com; splee@mednet.ucla.edu	Lee, Steve Pai-hsun/AAU-8313-2020	Lee, Steve Pai-hsun/0000-0001-7168-1542				Apisarnthanarax S, 2006, INT J RADIAT ONCOL, V64, P678, DOI 10.1016/j.ijrobp.2005.08.020; Cannon DM, 2008, INT J RADIAT ONCOL, V70, P660, DOI 10.1016/j.ijrobp.2007.09.018; Cao CN, 2013, ORAL ONCOL, V49, P175, DOI 10.1016/j.oraloncology.2012.08.013; Caudell JJ, 2010, INT J RADIAT ONCOL, V76, P164, DOI 10.1016/j.ijrobp.2009.01.037; Chao KSC, 2002, INT J RADIAT ONCOL, V53, P1174, DOI 10.1016/S0360-3016(02)02881-X; Chen JZ, 2013, INT J RADIAT ONCOL, V85, P929, DOI 10.1016/j.ijrobp.2012.07.2356; Fang FM, 2008, INT J RADIAT ONCOL, V72, P356, DOI 10.1016/j.ijrobp.2007.12.054; Gregoire Vincent, 2003, Rays, V28, P217; HO JHC, 1978, INT J RADIAT ONCOL, V4, P182; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kong FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091362; Lee AWM, 2013, INT J RADIAT ONCOL, V85, P902, DOI 10.1016/j.ijrobp.2012.09.010; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lee N, 2003, INT J RADIAT ONCOL, V57, P49, DOI 10.1016/S0360-3016(03)00405-X; LEE N, 2002, MACWORLD         FEB, P15; Lee N, 2013, TARGET VOLUME DELINE, P1; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Lee NY, 2012, LANCET ONCOL, V13, P172, DOI 10.1016/S1470-2045(11)70303-5; Liao XB, 2008, INT J RADIAT ONCOL, V72, P1368, DOI 10.1016/j.ijrobp.2008.03.017; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Martinez-Monge R, 1999, RADIOLOGY, V211, P815, DOI 10.1148/radiology.211.3.r99jn40815; Ng WT, 2008, INT J RADIAT ONCOL, V72, P1082, DOI 10.1016/j.ijrobp.2008.02.006; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Teo P, 1996, INT J RADIAT ONCOL, V36, P291, DOI 10.1016/S0360-3016(96)00323-9; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Toledano I, 2012, RADIOTHER ONCOL, V103, P57, DOI 10.1016/j.radonc.2011.12.010; Vergeer MR, 2009, INT J RADIAT ONCOL, V74, P1, DOI 10.1016/j.ijrobp.2008.07.059; WITHERS HR, 1995, INT J RADIAT ONCOL, V31, P353, DOI 10.1016/0360-3016(94)00354-N; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057	32	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125283	10.1371/journal.pone.0125283	http://dx.doi.org/10.1371/journal.pone.0125283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919285	Green Published, gold			2022-12-26	WOS:000353659400079
J	Glaring, MA; Vester, JK; Lylloff, JE; Abu Al-Soud, W; Sorensen, SJ; Stougaard, P				Glaring, Mikkel A.; Vester, Jan K.; Lylloff, Jeanette E.; Abu Al-Soud, Waleed; Sorensen, Soren J.; Stougaard, Peter			Microbial Diversity in a Permanently Cold and Alkaline Environment in Greenland	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIA; SULFATE-REDUCING BACTERIUM; MEROMICTIC SODA LAKE; IKAITE TUFA COLUMNS; ARCTIC IKKA FJORD; SP-NOV.; MONO LAKE; PROKARYOTIC COMMUNITIES; SOUTHWEST GREENLAND; HALOALKALINE LAKE	The submarine ikaite columns located in the Ikka Fjord in Southern Greenland represent a unique, permanently cold (less than 6 degrees C) and alkaline (above pH 10) environment and are home to a microbial community adapted to these extreme conditions. The bacterial and archaeal community inhabiting the ikaite columns and surrounding fjord was characterised by high-throughput pyrosequencing of 16S rRNA genes. Analysis of the ikaite community structure revealed the presence of a diverse bacterial community, both in the column interior and at the surface, and very few archaea. A clear difference in overall taxonomic composition was observed between column interior and surface. Whereas the surface, and in particular newly formed ikaite material, was primarily dominated by Cyanobacteria and phototrophic Proteobacteria, the column interior was dominated by Proteobacteria and putative anaerobic representatives of the Firmicutes and Bacteroidetes. The results suggest a stratification of the ikaite columns similar to that of classical soda lakes, with a light-exposed surface inhabited by primary producers and an anoxic subsurface. This was further supported by identification of major taxonomic groups with close relatives in soda lake environments, including members of the genera Rhodobaca, Dethiobacter, Thioalkalivibrio and Tindallia, as well as very abundant groups related to uncharacterised environmental sequences originally isolated from Mono Lake in California.	[Glaring, Mikkel A.; Vester, Jan K.; Lylloff, Jeanette E.; Stougaard, Peter] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Abu Al-Soud, Waleed; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Stougaard, P (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark.	psg@plen.ku.dk	Abu Al-Soud, Waleed/K-4408-2014; Glaring, Mikkel/I-5789-2014; Sørensen, Søren J/J-5015-2014; Sørensen, Søren Johannes/N-2120-2019; Abu Al-Soud, Waleed/AAH-3477-2021; Stougaard, Peter/G-9978-2014; Vester, Jan/C-1631-2015	Abu Al-Soud, Waleed/0000-0002-1143-9233; Glaring, Mikkel/0000-0002-8003-4635; Sørensen, Søren J/0000-0001-6227-9906; Sørensen, Søren Johannes/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Stougaard, Peter/0000-0002-2796-7137; Vester, Jan/0000-0001-8272-9863	Danish Environmental Protection Agency [MST-112-00272]; Danish Council for Strategic Research; Novo Nordisk Fonden [NNF12OC0000797] Funding Source: researchfish	Danish Environmental Protection Agency; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Environmental Protection Agency (grant no. MST-112-00272) and the Danish Council for Strategic Research, project NOVENIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazard D, 2007, EXTREMOPHILES, V11, P33, DOI 10.1007/s00792-006-0006-5; [Anonymous], 2011, EXTREMOPHILES HDB, DOI DOI 10.1007/978-4-431-53898-1_3; Antony CP, 2014, GEOMICROBIOL J, V31, P519, DOI 10.1080/01490451.2013.849314; Antony CP, 2013, ISME J, V7, P468, DOI 10.1038/ismej.2012.137; Antony CP, 2012, FEMS MICROBIOL ECOL, V81, P43, DOI 10.1111/j.1574-6941.2011.01274.x; Asao M, 2011, ENVIRON MICROBIOL, V13, P2146, DOI 10.1111/j.1462-2920.2011.02449.x; BISCHOFF JL, 1993, GEOCHIM COSMOCHIM AC, V57, P3855, DOI 10.1016/0016-7037(93)90339-X; Brazelton WJ, 2013, APPL ENVIRON MICROB, V79, P3906, DOI 10.1128/AEM.00330-13; Buchardt B, 1997, NATURE, V390, P129, DOI 10.1038/36474; Buchardt B, 2001, J SEDIMENT RES, V71, P176, DOI 10.1306/042800710176; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavicchioli R, 2011, MICROB BIOTECHNOL, V4, P449, DOI 10.1111/j.1751-7915.2011.00258.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dahl K, 2006, J SEDIMENT RES, V76, P460, DOI 10.2110/jsr.2006.035; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dieckmann GS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033540; Dirnitriu PA, 2008, APPL ENVIRON MICROB, V74, P4877, DOI 10.1128/AEM.00455-08; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Foti M, 2007, APPL ENVIRON MICROB, V73, P2093, DOI 10.1128/AEM.02622-06; Fujinami S, 2010, ENVIRON TECHNOL, V31, P845, DOI 10.1080/09593331003762807; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hansen MO, 2011, J SEDIMENT RES, V81, P553, DOI 10.2110/jsr.2011.50; Hauptmann AL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01014-13; Horikoshi K, 2004, P JPN ACAD B-PHYS, V80, P166, DOI 10.2183/pjab.80.166; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Jungblut AD, 2012, FEMS MICROBIOL ECOL, V82, P356, DOI 10.1111/j.1574-6941.2012.01380.x; Kaluzhnaya M, 2001, SYST APPL MICROBIOL, V24, P166, DOI 10.1078/0723-2020-00028; Kevbrin VV, 1998, CURR MICROBIOL, V37, P94, DOI 10.1007/s002849900345; Kirchman DL, 2010, ENV MICROBIOLOGY, V12; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Lee DJ, 2014, APPL MICROBIOL BIOT, V98, P1301, DOI 10.1007/s00253-013-4976-9; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Margesin R, 2010, ENVIRON TECHNOL, V31, P835, DOI 10.1080/09593331003663328; Mesbah NM, 2007, INT J SYST EVOL MICR, V57, P2507, DOI 10.1099/ijs.0.65068-0; Mesbah NM, 2007, MICROB ECOL, V54, P598, DOI 10.1007/s00248-006-9193-y; Milford AD, 2000, ARCH MICROBIOL, V174, P18, DOI 10.1007/s002030000166; Mwirichia R, 2011, CURR MICROBIOL, V62, P209, DOI 10.1007/s00284-010-9692-4; Pedersen K, 2004, EXTREMOPHILES, V8, P151, DOI 10.1007/s00792-004-0374-7; Pikuta EV, 2003, INT J SYST EVOL MICR, V53, P1327, DOI 10.1099/ijs.0.02598-0; Pikuta EV, 2003, EXTREMOPHILES, V7, P327, DOI 10.1007/s00792-003-0326-7; Poser A, 2013, EXTREMOPHILES, V17, P1003, DOI 10.1007/s00792-013-0582-0; Rees HC, 2004, EXTREMOPHILES, V8, P63, DOI 10.1007/s00792-003-0361-4; Schmidt M, 2006, INT J SYST EVOL MICR, V56, P2887, DOI 10.1099/ijs.0.64450-0; Schmidt M, 2006, EXTREMOPHILES, V10, P551, DOI 10.1007/s00792-006-0529-9; Schmidt M, 2010, ENVIRON TECHNOL, V31, P1091, DOI 10.1080/09593331003770289; Schmidt M, 2010, ENVIRON TECHNOL, V31, P1107, DOI 10.1080/09593331003677872; Scholten JCM, 2005, MICROB ECOL, V50, P29, DOI 10.1007/s00248-004-0085-8; Sorensen Martin Vinther, 2000, Meddelelser om Gronland Bioscience, V51, P1; Sorokin DY, 2008, EXTREMOPHILES, V12, P431, DOI 10.1007/s00792-008-0148-8; Sorokin DY, 2007, APPL ENVIRON MICROB, V73, P451, DOI 10.1128/AEM.02087-06; Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9; Sorokin DY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00044; Sorokin DY, 2004, HYDROBIOLOGIA, V522, P235, DOI 10.1023/B:HYDR.0000029989.73279.e4; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Sorokin DY, 2000, EXTREMOPHILES, V4, P145, DOI 10.1007/s007920070029; Spring S, 2003, INT J SYST EVOL MICR, V53, P1019, DOI 10.1099/ijs.0.02554-0; Stougaard P, 2002, ENVIRON MICROBIOL, V4, P487, DOI 10.1046/j.1462-2920.2002.00327.x; SUESS E, 1982, SCIENCE, V216, P1128, DOI 10.1126/science.216.4550.1128; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Surakasi VP, 2010, J BASIC MICROB, V50, P465, DOI 10.1002/jobm.201000001; Suzuki S, 2014, NATURE COMMUNICATION, V5; Suzuki S, 2013, P NATL ACAD SCI USA, V110, P15336, DOI 10.1073/pnas.1302426110; Takai K, 2006, INT J SYST EVOL MICR, V56, P1725, DOI 10.1099/ijs.0.64255-0; Thorbjorn L, 2003, OPHELIA, V57, P177, DOI 10.1080/00785236.2003.10409513; Tiago I, 2004, APPL ENVIRON MICROB, V70, P7378, DOI 10.1128/AEM.70.12.7378-7387.2004; Tiago I, 2013, ENVIRON MICROBIOL, V15, P1687, DOI 10.1111/1462-2920.12034; Vester JK, 2015, APPL MICROBIOL BIOT, V99, P717, DOI 10.1007/s00253-014-5931-0; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Wand U, 2006, LIMNOL OCEANOGR, V51, P1180, DOI 10.4319/lo.2006.51.2.1180; Wani AA, 2006, RES MICROBIOL, V157, P928, DOI 10.1016/j.resmic.2006.08.005; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhilina TN, 2009, MICROBIOLOGY+, V78, P445, DOI 10.1134/S0026261709040080; Zhilina TN, 2005, MICROBIOLOGY+, V74, P557, DOI 10.1007/s11021-005-0103-y; Zhilina TN, 2005, INT J SYST EVOL MICR, V55, P1001, DOI 10.1099/ijs.0.63490-0	82	31	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124863	10.1371/journal.pone.0124863	http://dx.doi.org/10.1371/journal.pone.0124863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915866	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659100075
J	Gupta, N; Vashist, P; Malhotra, S; Senjam, SS; Misra, V; Bhardwaj, A				Gupta, Noopur; Vashist, Praveen; Malhotra, Sumit; Senjam, Suraj Singh; Misra, Vasundhara; Bhardwaj, Amit			Rapid Assessment of Visual Impairment in Urban Population of Delhi, India	PLOS ONE			English	Article							AVOIDABLE BLINDNESS; CATARACT-SURGERY; PREVALENCE; DISTRICT	Purpose To determine the prevalence, causes and associated demographic factors related to visual impairment amongst the urban population of New Delhi, India. Methods A population-based, cross-sectional study was conducted in East Delhi district using cluster random sampling methodology. This Rapid Assessment of Visual Impairment (RAVI) survey involved examination of all individuals aged 40 years and above in 24 randomly selected clusters of the district. Visual acuity (VA) assessment and comprehensive ocular examination were done during the door-to-door survey. A questionnaire was used to collect personal and demographic information of the study population. Blindness and Visual Impairment was defined as presenting VA <3/60 and <6/18 in the better eye, respectively. Descriptive statistics were computed along with multivariable logistic regression analysis to determine associated factors for visual impairment. Results Of 2421 subjects enumerated, 2331 (96.3%) were available for ophthalmic examination. Among those examined, 49.3% were males. The prevalence of visual impairment (VI) in the study population, was 11.4% (95% C.I. 10.1, 12.7) and that of blindness was 1.2% (95% C.I. 0.8, 1.6). Uncorrected refractive error was the leading cause of VI accounting for 53.4% of all VI followed by cataract (33.8%). With multivariable logistic regression, the odds of having VI increased with age (OR = 24.6[95% C.I.: 14.9, 40.7]; p<0.001). Illiterate participants were more likely to have VI [OR = 1.5 (95% C.I.: 1.1,2.1)] when compared to educated participants. Conclusions The first implementation of the RAVI methodology in a North Indian population revealed that the burden of visual impairment is considerable in this region despite availability of adequate eye care facilities. Awareness generation and simple interventions like cataract surgery and provision of spectacles will help to eliminate the major causes of blindness and visual impairment in this region.	[Gupta, Noopur; Vashist, Praveen; Malhotra, Sumit; Senjam, Suraj Singh; Misra, Vasundhara; Bhardwaj, Amit] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Vashist, P (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India.	praveenvashist@yahoo.com	GUPTA, NOOPUR/AAX-5043-2021; Senjam, Suraj Singh/GQI-1323-2022; senjam, suraj/AAL-9700-2021	GUPTA, NOOPUR/0000-0001-8022-6656; Senjam, Suraj Singh/0000-0001-8204-3669; 	Sightsavers India	Sightsavers India	Sightsavers India, a non-governmental organization funded the VISION DELHI project. The RAVI survey was conducted as part of this project to provide baseline information about the need of refractive error services in this region. PV was the principal investigator of the project and received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casson RJ, 2007, OPHTHALMOLOGY, V114, P2302, DOI 10.1016/j.ophtha.2007.02.004; CENSUS OF INDIA, 2011, PRIMARY CENSUS ABSTR; Guruprasad BS, 2013, OPHTHAL EPIDEMIOL, V20, P89, DOI 10.3109/09286586.2012.759597; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070120; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055924; Marmamula S, 2012, INDIAN J OPHTHALMOL, V60, P416, DOI 10.4103/0301-4738.100539; Marmamula S, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-26; Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751; Neena J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002867; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Patil S, 2014, INDIAN J OPHTHALMOL, V62, P240, DOI 10.4103/0301-4738.128633; Ramke J, 2007, BRIT J OPHTHALMOL, V91, P1117, DOI 10.1136/bjo.2006.106559; Robinson B, 2013, OPHTHAL EPIDEMIOL, V20, P123, DOI 10.3109/09286586.2013.789915; Sapkota YD, 2006, BRIT J OPHTHALMOL, V90, P411, DOI 10.1136/bjo.2005.082503; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408; Singh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100644; Vijaya L, 2006, BRIT J OPHTHALMOL, V90, P407, DOI 10.1136/bjo.2005.081406; World Health Organization, CUMULATIVE OFFICIAL; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zhu MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-311	21	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124206	10.1371/journal.pone.0124206	http://dx.doi.org/10.1371/journal.pone.0124206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915659	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100038
J	Hou, WG; Xu, ZK; Qin, NN; Xiong, DP; Ding, MY				Hou, Wenguang; Xu, Zekai; Qin, Nannan; Xiong, Dongping; Ding, Mingyue			Surface Reconstruction through Poisson Disk Sampling	PLOS ONE			English	Article							CRUST	This paper intends to generate the approximate Voronoi diagram in the geodesic metric for some unbiased samples selected from original points. The mesh model of seeds is then constructed on basis of the Voronoi diagram. Rather than constructing the Voronoi diagram for all original points, the proposed strategy is to run around the obstacle that the geodesic distances among neighboring points are sensitive to nearest neighbor definition. It is obvious that the reconstructed model is the level of detail of original points. Hence, our main motivation is to deal with the redundant scattered points. In implementation, Poisson disk sampling is taken to select seeds and helps to produce the Voronoi diagram. Adaptive reconstructions can be achieved by slightly changing the uniform strategy in selecting seeds. Behaviors of this method are investigated and accuracy evaluations are done. Experimental results show the proposed method is reliable and effective.	[Hou, Wenguang; Xu, Zekai; Xiong, Dongping; Ding, Mingyue] Huazhong Univ Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China; [Qin, Nannan] Elect Power Planning & Engn Inst Beijing North St, Beijing, Peoples R China	Huazhong University of Science & Technology	Qin, NN (corresponding author), Elect Power Planning & Engn Inst Beijing North St, 65-2 Ande Rd, Beijing, Peoples R China.	nnq1989@126.com	Xiong, Dongping/GSE-4248-2022	Xiong, Dongping/0000-0002-8081-1297	Natural Science Fund of People's Republic China [41371426]; Electric Power Planning & Engineering Institute Beijing North-Star Co., Ltd.	Natural Science Fund of People's Republic China; Electric Power Planning & Engineering Institute Beijing North-Star Co., Ltd.	Natural Science Fund of People's Republic China under contract 41371426 provides supports in preparation of this manuscript about algorithm design, experiments implementation and etc. The fund is a public welfare research fund. Electric Power Planning & Engineering Institute Beijing North-Star Co., Ltd., provided support in the form of a salary for author Nannan Qin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Alliez P, 2005, GRAPH MODELS, V67, P204, DOI 10.1016/j.gmod.2004.06.007; Alliez P, 2008, MATH VIS, P53, DOI 10.1007/978-3-540-33265-7_2; Amenta N, 1998, GRAPH MODEL IM PROC, V60, P125, DOI 10.1006/gmip.1998.0465; Amenta N, 1999, DISCRETE COMPUT GEOM, V22, P481, DOI 10.1007/PL00009475; Amenta N, 2001, COMP GEOM-THEOR APPL, V19, P127, DOI 10.1016/S0925-7721(01)00017-7; Boissonnat JD., 2006, EFFECTIVE COMPUTATIO; Bolitho M, 2009, LECT NOTES COMPUT SC, V5875, P678, DOI 10.1007/978-3-642-10331-5_63; Bowers J, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1866158.1866188; Chang DC, 2011, J GEOM PHYS, V61, P986, DOI 10.1016/j.geomphys.2011.01.011; Cline D, 2009, COMPUT GRAPH FORUM, V28, P1217, DOI 10.1111/j.1467-8659.2009.01499.x; COOK RL, 1986, ACM T GRAPHIC, V5, P51, DOI 10.1145/7529.8927; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Edelsbrunner Herbert, 2010, COMPUTATIONAL TOPOLO; Fleishman S, 2005, ACM T GRAPHIC, V24, P544, DOI 10.1145/1073204.1073227; Floater MS, 2001, COMPUT AIDED GEOM D, V18, P77, DOI 10.1016/S0167-8396(01)00013-9; Gopi M, 2000, COMPUT GRAPH FORUM, V19, pC467, DOI 10.1111/1467-8659.00439; Hoppe H., 1993, Computer Graphics Proceedings, P19, DOI 10.1145/166117.166119; Hoppe H., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P99, DOI 10.1145/237170.237216; HOPPE H, 1992, COMP GRAPH, V26, P71, DOI 10.1145/142920.134011; Hou WG, 2013, INT J APPL EARTH OBS, V23, P264, DOI 10.1016/j.jag.2012.09.008; Kazhdan M., 2006, P 4 EUROGRAPHICS S G, P61; Lagae A, 2008, COMPUT GRAPH FORUM, V27, P114, DOI 10.1111/j.1467-8659.2007.01100.x; Martinez D, 2004, XVII BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P210, DOI 10.1109/SIBGRA.2004.1352963; Moenning C, 2003, 562 U CAMBR; Mount MD, 2010, LIB APPROXIMATE NEAR; Ohtake Y, 2005, P 2005 ACM S SOL PHY; Peyre G, 2006, INT J COMPUT VISION, V69, P145, DOI 10.1007/s11263-006-6859-3; Samuel P., COMPUTING CONSTRAINE; Schmidt R, 2012, COMPUT GRAPH-UK, V36, P488, DOI 10.1016/j.cag.2012.03.030; Stanford, 2014, STANF 3D SCANN REP; Surazhsky V., 2003, Symposium on Geometry Processing, P20; Tamal K, 2007, CURVE SURFACE RECONS; Zagorchev LG, 2012, IEEE T VIS COMPUT GR, V18, P1460, DOI 10.1109/TVCG.2011.276	33	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0120151	10.1371/journal.pone.0120151	http://dx.doi.org/10.1371/journal.pone.0120151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915744	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100004
J	Kim, M; Lee, JS; Oh, JE; Nan, J; Lee, H; Jung, HS; Chung, SS; Park, KS				Kim, Min; Lee, Ji Seon; Oh, Joo En; Nan, Jinyan; Lee, Hakmo; Jung, Hye Seung; Chung, Sung Soo; Park, Kyong Soo			SIRT3 Overexpression Attenuates Palmitate-Induced Pancreatic beta-Cell Dysfunction	PLOS ONE			English	Article							ENZYME GENE-EXPRESSION; MITOCHONDRIAL; DEACETYLASE; PGC-1-ALPHA; DEATH	Abnormally high levels of circulating free fatty acids can lead to pancreatic islet beta-cell dysfunction and apoptosis, contributing to beta-cell failure in Type 2 diabetes. The NAD(+)-dependent protein deacetylase Sirtuin-3 (SIRT3) has been implicated in Type 2 diabetes. In this study, we tested whether SIRT3 overexpression affects palmitate-induced beta-cell dysfunction in cells of line NIT1, which are derived from mouse pancreatic beta-cells. Two different lengths of SIRT3 were overexpressed: full length SIRT3 (SIRT3LF), which was preferentially targeted to mitochondria and partially to the nucleus, and its N-terminal truncated form (SIRT3SF), which was located in the nucleus and cytoplasm. Overexpression of SIRT3LF and SIRT3SF using an adenoviral system alleviated palmitate-induced lipotoxicity such as reduction of cell viability and mitogen-activated protein kinase (MAPK) activation. Chronic exposure to low concentrations of palmitate suppressed glucose-stimulated insulin secretion, but the suppression was effectively reversed by overexpression of SIRT3LF or SIRT3SF. The mRNA levels of the endoplasmic reticulum (ER) stress responsive genes ATF4, GRP94 and FKBP11 were increased by palmitate treatment, but the increases were completely inhibited by SIRT3LF overexpression and less effectively inhibited by SIRT3SF overexpression. This result suggests that overexpression of SIRT3 inhibits induction of ER stress by palmitate. Collectively, we conclude that overexpression of SIRT3 alleviates palmitate-induced beta-cell dysfunction.	[Kim, Min; Lee, Ji Seon; Oh, Joo En; Nan, Jinyan; Lee, Hakmo; Jung, Hye Seung; Chung, Sung Soo; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Chung, SS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	suschung@snu.ac.kr; kspark@snu.ac.kr	Lee, Hakmo/V-8317-2019; Park, Kyong Soo/C-2265-2008	Lee, Hakmo/0000-0002-8861-4351; Park, Kyong Soo/0000-0003-3597-342X	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A062260, A110421, A120273]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by grants of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A062260), (A110421) and (A120273). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Cheng K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040868; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Elsner M, 2011, DIABETES, V60, P200, DOI 10.2337/db09-1401; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Frigerio F, 2010, DIABETOLOGIA, V53, P331, DOI 10.1007/s00125-009-1590-6; Hellemans K, 2007, FEBS J, V274, P6094, DOI 10.1111/j.1742-4658.2007.06131.x; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lin N, 2012, ENDOCRINE, V42, P107, DOI 10.1007/s12020-012-9633-z; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang Y, 2013, AUTOPHAGY, V9, P272, DOI 10.4161/auto.23628; Wu L, 2012, BBA-MOL BASIS DIS, V1822, P1815, DOI 10.1016/j.bbadis.2012.08.009; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	28	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124744	10.1371/journal.pone.0124744	http://dx.doi.org/10.1371/journal.pone.0124744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915406	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100064
J	Matusovsky, OS; Shevchenko, UV; Matusovskaya, GG; Sobieszek, A; Dobrzhanskaya, AV; Shelud'ko, NS				Matusovsky, Oleg S.; Shevchenko, Ulyana V.; Matusovskaya, Galina G.; Sobieszek, Apolinary; Dobrzhanskaya, Anna V.; Shelud'ko, Nikolay S.			Catch Muscle Myorod Modulates ATPase Activity of Myosin in a Phosphorylation-Dependent Way	PLOS ONE			English	Article							THICK-FILAMENT PROTEIN; MOLLUSCAN MUSCLES; SMOOTH MUSCLES; TWITCHIN; ACTIN; PARAMYOSIN; INTERACTS; MECHANISM; STATE; ROD	Myorod is expressed exclusively in molluscan catch muscle and localizes on the surface of thick filaments together with twitchin and myosin. Myorod is an alternatively spliced product of themyosin heavy-chain gene that contains the C-terminal rod part of myosin and a unique N-terminal domain. The unique domain is a target for phosphorylation by gizzard smooth myosin light chain kinase (smMLCK) and, perhaps, molluscan twitchin, which contains a MLCK-like domain. To elucidate the role of myorod and its phosphorylation in the catch muscle, the effect of chromatographically purified myorod on the actin-activated Mg2+-ATPase activity of myosin was studied. We found that phosphorylation at the N-terminus of myorod potentiated the actin-activated Mg2+-ATPase activity of mussel and rabbit myosins. This potentiation occurred only if myorod was phosphorylated and introduced into the ATPase assay as a co-filament with myosin. We suggest that myorod could be related to the catch state, a function specific to molluscan muscle.	[Matusovsky, Oleg S.; Shevchenko, Ulyana V.; Matusovskaya, Galina G.; Dobrzhanskaya, Anna V.; Shelud'ko, Nikolay S.] Russian Acad Sci, Far East Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Matusovsky, Oleg S.] Far Eastern Fed Univ, Sch Biomed, Vladivostok, Russia; [Sobieszek, Apolinary] Austrian Acad Sci, Inst Biomed Aging Res, Innsbruck, Austria	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University; Austrian Academy of Sciences	Matusovsky, OS (corresponding author), Russian Acad Sci, Far East Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia.	osmatusovsky@gmail.com; sheludko@stl.ru	Shelud'ko, Nikolay S./B-2573-2016; Dobrzhanskaya, Anna V/F-5214-2019; Shevchenko, Ulyana/U-8475-2018; Sobieszek, Apolinary/AAD-8985-2022; Matusovsky, Oleg/AAV-1062-2021	Shelud'ko, Nikolay S./0000-0002-2923-2206; Sobieszek, Apolinary/0000-0003-4915-9621; Matusovsky, Oleg/0000-0002-0824-9260	Russian Science Foundation [14-14-00080]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (No 14-14-00080).	Andersen O, 2009, J MUSCLE RES CELL M, V30, P233, DOI 10.1007/s10974-009-9192-y; Butler TM, 2011, J MUSCLE RES CELL M, V31, P349, DOI 10.1007/s10974-011-9240-2; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; CASTELLANI L, 1987, SCIENCE, V235, P334, DOI 10.1126/science.3026049; Franke AS, 2007, BIOPHYS J, V93, P554, DOI 10.1529/biophysj.107.105577; Funabara D, 2003, J BIOL CHEM, V278, P29308, DOI 10.1074/jbc.M303272200; Funabara D, 2001, BIOCHEMISTRY-US, V40, P2087, DOI 10.1021/bi0022691; Funabara D, 2007, J EXP BIOL, V210, P4399, DOI 10.1242/jeb.008722; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Matusovskii O. S., 2005, Biophysics, V50, P63; Matusovsky OS, 2011, ARCH BIOCHEM BIOPHYS, V509, P59, DOI 10.1016/j.abb.2011.02.010; Matusovsky OS, 2010, BBA-PROTEINS PROTEOM, V1804, P884, DOI 10.1016/j.bbapap.2009.12.020; OPLATKA A, 1975, BIOCHEM BIOPH RES CO, V66, P1323, DOI 10.1016/0006-291X(75)90504-5; Shelud'ko N, 2002, COMP BIOCHEM PHYS B, V133, P69, DOI 10.1016/S1096-4959(02)00108-2; Shelud'ko N, 2001, J MUSCLE RES CELL M, V22, P91, DOI 10.1023/A:1010359718304; Shelud'ko NS, 2007, ARCH BIOCHEM BIOPHYS, V466, P125, DOI 10.1016/j.abb.2007.07.014; Shelud'ko NS, 1999, COMP BIOCHEM PHYS B, V122, P277, DOI 10.1016/S0305-0491(99)00009-7; Shelud'ko NS, 2004, ARCH BIOCHEM BIOPHYS, V432, P269, DOI 10.1016/j.abb.2004.10.006; Sheng ST, 2003, J BIOL CHEM, V278, P39892, DOI 10.1074/jbc.M306094200; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; Sobieszek A, 2006, ARCH BIOCHEM BIOPHYS, V454, P197, DOI 10.1016/j.abb.2006.08.004; Sobieszek A, 2010, BIOCHEMISTRY-US, V49, P4191, DOI 10.1021/bi100143q; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; STEPKOWSKI D, 1994, BIOCHEM J, V300, P153, DOI 10.1042/bj3000153; SZENTGYORGYI AG, 1971, J MOL BIOL, V56, P239, DOI 10.1016/0022-2836(71)90462-1; VIBERT P, 1993, J MUSCLE RES CELL M, V14, P598, DOI 10.1007/BF00141557; Yamada A, 2004, J BIOL CHEM, V279, P40762, DOI 10.1074/jbc.M405191200; Yamada A, 2000, J MOL BIOL, V295, P169, DOI 10.1006/jmbi.1999.3349	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125379	10.1371/journal.pone.0125379	http://dx.doi.org/10.1371/journal.pone.0125379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915932	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100125
J	Perez-Nunez, D; Garcia-Urdiales, E; Martinez-Bonet, M; Nogal, ML; Barroso, S; Revilla, Y; Madrid, R				Perez-Nunez, Daniel; Garcia-Urdiales, Eduardo; Martinez-Bonet, Marta; Nogal, Maria L.; Barroso, Susana; Revilla, Yolanda; Madrid, Ricardo			CD2v Interacts with Adaptor Protein AP-1 during African Swine Fever Infection	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; COMPLEX CLASS-I; CELLULAR VIMENTIN; GOLGI MEMBRANES; BREFELDIN-A; VIRUS; NEF; BINDING; MOTIF; INHIBITION	African swine fever virus (ASFV) CD2v protein is believed to be involved in virulence enhancement, viral hemadsorption, and pathogenesis, although the molecular mechanisms of the function of this viral protein are still not fully understood. Here we describe that CD2v localized around viral factories during ASFV infection, suggesting a role in the generation and/or dynamics of these viral structures and hence in disturbing cellular traffic. We show that CD2v targeted the regulatory trans-Golgi network (TGN) protein complex AP-1, a key element in cellular traffic. This interaction was disrupted by brefeldin A even though the location of CD2v around the viral factory remained unchanged. CD2v-AP-1 binding was independent of CD2v glycosylation and occurred on the carboxy-terminal part of CD2v, where a canonical di-Leu motif previously reported to mediate AP-1 binding in eukaryotic cells, was identified. This motif was shown to be functionally interchangeable with the di-Leu motif present in HIV-Nef protein in an AP-1 binding assay. However, we demonstrated that it was not involved either in CD2v cellular distribution or in CD2v-AP-1 binding. Taken together, these findings shed light on CD2v function during ASFV infection by identifying AP-1 as a cellular factor targeted by CD2v and hence elucidate the cellular pathways used by the virus to enhance infectivity.	[Perez-Nunez, Daniel; Nogal, Maria L.; Barroso, Susana; Revilla, Yolanda; Madrid, Ricardo] CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain; [Garcia-Urdiales, Eduardo] Univ Dublin Trinity Coll, Mol Design Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Martinez-Bonet, Marta] Hosp Gen Gregorio Maranon, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Trinity College Dublin; General University Gregorio Maranon Hospital	Revilla, Y (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain.	yrevilla@cbm.csic.es	Pérez-Núñez, Daniel/S-4195-2018	Perez-Nunez, Daniel/0000-0002-0901-8309; Yolanda, Revilla/0000-0001-6555-6331; Madrid Gonzalez, Ricardo/0000-0002-1350-9864; Martinez Bonet, Marta/0000-0003-0715-403X	Ministerio de Ciencia e Innovacion of Spain [BFU2010-17794]; European Community's Seventh Framework Programme [KBBE.2012.1.3-02-ASFORCE]; Amarauto research program;  [FIS-641 PS09/01386]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community's Seventh Framework Programme(European Commission); Amarauto research program; 	This work was supported by Ministerio de Ciencia e Innovacion of Spain, BFU2010-17794 (YR); European Community's Seventh Framework Programme, KBBE.2012.1.3-02-ASFORCE (YR). Ricardo Madrid was funded by an Amarauto research program and by FIS-641 PS09/01386. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01813; Borca MV, 1998, J VIROL, V72, P2881, DOI 10.1128/JVI.72.4.2881-2889.1998; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; CARRASCOSA AL, 1982, J VIROL METHODS, V3, P303, DOI 10.1016/0166-0934(82)90034-9; Castello A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000562; Chapman DAG, 2008, J GEN VIROL, V89, P397, DOI 10.1099/vir.0.83343-0; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dixon LK, 2004, VET IMMUNOL IMMUNOP, V100, P117, DOI 10.1016/j.vetimm.2004.04.002; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; ENJUANES L, 1976, J GEN VIROL, V32, P471, DOI 10.1099/0022-1317-32-3-471; Fay N, 2013, VIROLOGY, V444, P181, DOI 10.1016/j.virol.2013.06.009; Galindo I, 2000, VIROLOGY, V266, P340, DOI 10.1006/viro.1999.0080; Gladue DP, 2013, J VIROL, V87, P6794, DOI 10.1128/JVI.00448-13; Goatley LC, 2011, J VIROL; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Granja AG, 2009, J VIROL, V83, P969, DOI 10.1128/JVI.01663-08; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Johnson DC, 2001, J VIROL, V75, P821, DOI 10.1128/JVI.75.2.821-833.2001; Kay-Jackson PC, 2004, J GEN VIROL, V85, P119, DOI 10.1099/vir.0.19435-0; Kulpa DA, 2013, J VIROL, V87, P8085, DOI 10.1128/JVI.00701-13; Laguette N, 2010, MOL ASPECTS MED, V31, P418, DOI 10.1016/j.mam.2010.05.003; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Netherton CL, 2006, J VIROL, V80, P11385, DOI 10.1128/JVI.00439-06; Nigsch A, 2013, PREV VET MED, V108, P262, DOI 10.1016/j.prevetmed.2012.11.003; Revilla Y, 1997, VIROLOGY, V228, P400, DOI 10.1006/viro.1996.8395; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; RODRIGUEZ JM, 1993, J VIROL, V67, P5312; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rowlands RJ, 2009, VIROLOGY, V393, P319, DOI 10.1016/j.virol.2009.07.040; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Stefanovic S, 2005, J VIROL, V79, P11766, DOI 10.1128/JVI.79.18.11766-11775.2005; Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13; Tong X, 1998, J VIROL, V72, P476, DOI 10.1128/JVI.72.1.476-482.1998; Tordo N., 2012, VIRUS TAXONOMY CLASS, P153; VINUELA E, 1985, CURR TOP MICROBIOL, V116, P151; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; YANEZ RJ, 1995, VIROLOGY, V208, P249, DOI 10.1006/viro.1995.1149	48	27	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123714	10.1371/journal.pone.0123714	http://dx.doi.org/10.1371/journal.pone.0123714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915900	Green Published, gold			2022-12-26	WOS:000353659100026
J	Tombolan, L; Zampini, M; Casara, S; Boldrin, E; Zin, A; Bisogno, G; Rosolen, A; De Pitta, C; Lanfranchi, G				Tombolan, Lucia; Zampini, Matteo; Casara, Silvia; Boldrin, Elena; Zin, Angelica; Bisogno, Gianni; Rosolen, Angelo; De Pitta, Cristiano; Lanfranchi, Gerolamo			MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA	PLOS ONE			English	Article							TRANS-RETINOIC ACID; ACUTE PROMYELOCYTIC LEUKEMIA; GENE-EXPRESSION SIGNATURE; EMBRYONAL RHABDOMYOSARCOMA; TRANSCRIPTION FACTORS; ONCOGENIC MICRORNA-27A; CANCER; ALVEOLAR; DIFFERENTIATION; TARGETS	Background Rhabdomyosarcomas (RMS) are rare but very aggressive childhood tumors that arise as a consequence of a regulatory disruption in the growth and differentiation pathways of myogenic precursor cells. According to morphological criteria, there are two major RMS subtypes: embryonal RMS (ERMS) and alveolar RMS (ARMS) with the latter showing greater aggressiveness and metastatic potential with respect to the former. Efforts to unravel the complex molecular mechanisms underlying RMS pathogenesis and progression have revealed that microRNAs (miRNAs) play a key role in tumorigenesis. Methodology/Principal Findings The expression profiles of 8 different RMS cell lines were analyzed to investigate the involvement of miRNAs in RMS. The miRNA population from each cell line was compared to a reference sample consisting of a balanced pool of total RNA extracted from those 8 cell lines. Sixteen miRNAs whose expression discriminates between translocation-positive ARMS and negative RMS were identified. Attention was focused on the role of miR-27a that is up-regulated in the more aggressive RMS cell lines (translocation-positive ARMS) in which it probably acts as an oncogene. MiR-27a overexpressing cells showed a significant increase in their proliferation rate that was paralleled by a decrease in the number of cells in the G1 phase of the cell cycle. It was possible to demonstrate that miR-27a is implicated in cell cycle control by targeting the retinoic acid alpha receptor (RARA) and retinoic X receptor alpha (RXRA). Conclusions Study results have demonstrated that miRNA expression signature profiling can be used to classify different RMS subtypes and suggest that miR-27a may have a therapeutic potential in RMS by modulating the expression of retinoic acid receptors.	[Tombolan, Lucia; Zampini, Matteo; De Pitta, Cristiano; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, Padua, Italy; [Tombolan, Lucia; Zampini, Matteo; Casara, Silvia; Boldrin, Elena; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Zin, Angelica] IRP, Pediat Res Inst, Padua, Italy; [Zin, Angelica; Bisogno, Gianni; Rosolen, Angelo] Univ Padua, Oncohematol Unit, Dept Womens & Childrens Hlth, Padua, Italy	University of Padua; University of Padua; Fondazione Citta della Speranza; University of Padua	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	cristiano.depitta@unipd.it; gerolamo.lanfranchi@unipd.it	De Pitta, Cristiano/AAY-7302-2020; Zampini, Matteo/L-9027-2018; Bisogno, Gianni/K-9282-2016	De Pitta, Cristiano/0000-0001-8013-8162; Zampini, Matteo/0000-0002-9952-1142; Bisogno, Gianni/0000-0003-4462-5523; Boldrin, Elena/0000-0001-6815-3060	Fondazione Citta della Speranza (the City of Hope Foundation); Associazione ltaliana per la Ricerca sul Cancro (The Italian Association for Cancer Research) [6014/2008, 13576/2012]	Fondazione Citta della Speranza (the City of Hope Foundation); Associazione ltaliana per la Ricerca sul Cancro (The Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Fondazione Citta della Speranza (the City of Hope Foundation) and the Associazione ltaliana per la Ricerca sul Cancro (The Italian Association for Cancer Research) (Grant No. 6014/2008 to AR and GL; Grant No. 13576/2012 to AR and GL). The funders played no role in designing the study, in collecting/analyzing the data, in drafting the manuscript or in the decision to submit it for publication	Ades L, 2010, BLOOD, V115, P1690, DOI 10.1182/blood-2009-07-233387; Al-Tahan A, 2012, PEDIATR BLOOD CANCER, V58, P877, DOI 10.1002/pbc.23246; Arisi MF, 2014, INT J ONCOL, V44, P1831, DOI 10.3892/ijo.2014.2354; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Barlow JW, 2006, PEDIATR BLOOD CANCER, V47, P773, DOI 10.1002/pbc.20650; Barr FG, 1997, CURR TOP MICROBIOL, V220, P113; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Biscontin A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-44; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonvini P, 2013, BRIT J CANCER, V109, P3084, DOI 10.1038/bjc.2013.653; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen Ji-ming, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P80; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; CROUCH GD, 1991, CANCER RES, V51, P4882; Dagher SM, 1999, J ENVIRON SCI HEAL B, V34, P849, DOI 10.1080/03601239909373230; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; De Pitta C, 2006, INT J CANCER, V118, P2772, DOI 10.1002/ijc.21698; DEGIOVANNI C, 1989, ANTICANCER RES, V9, P1943; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Garcia-Alonso I, 2005, REV ESP ENFERM DIG, V97, P240; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Gastaldi T, 2006, CARCINOGENESIS, V27, P1758, DOI 10.1093/carcin/bgl008; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gougelet Angelique, 2011, Sarcoma, V2011, P460650, DOI 10.1155/2011/460650; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; HAZELTON BJ, 1987, CANCER RES, V47, P4501; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DZ, 2014, J CELL BIOCHEM, V115, P549, DOI 10.1002/jcb.24689; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iolascon A, 1996, GENE CHROMOSOME CANC, V15, P217, DOI 10.1002/(SICI)1098-2264(199604)15:4<217::AID-GCC3>3.3.CO;2-X; Kouraklis G, 1999, PEDIATR RES, V45, P552, DOI 10.1203/00006450-199904010-00015; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leonardo TR, 2012, NAT CELL BIOL, V14, P1114, DOI 10.1038/ncb2613; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Masetti R, 2012, ADV THER, V29, P747, DOI 10.1007/s12325-012-0047-3; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Moretti A, 2002, EUR J CANCER, V38, P2290, DOI 10.1016/S0959-8049(02)00454-9; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Ricaud S, 2005, EXP CELL RES, V311, P192, DOI 10.1016/j.yexcr.2005.09.011; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Rocke DM, 2003, BIOINFORMATICS, V19, P966, DOI 10.1093/bioinformatics/btg107; Romualdi C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-287; Rota R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-120; Sabnis N, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00006; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Sarver AL, 2010, LAB INVEST, V90, P753, DOI 10.1038/labinvest.2010.53; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Siddikuzzaman, 2011, IMMUNOPHARM IMMUNOT, V33, P241, DOI 10.3109/08923973.2010.521507; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Toffolatti L, 2002, J PATHOL, V196, P450, DOI 10.1002/path.1068; Tombolan L, 2011, AM J PATHOL, V179, P2611, DOI 10.1016/j.ajpath.2011.07.018; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883; Zhang HW, 2010, DIGEST DIS SCI, V55, P2545, DOI 10.1007/s10620-009-1051-6; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	80	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125171	10.1371/journal.pone.0125171	http://dx.doi.org/10.1371/journal.pone.0125171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915942	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100104
J	Badr, G; Sayed, A; Abdel-Maksoud, MA; Mohamed, AO; El-Amir, A; Abdel-Ghaffar, FA; Al-Quraishy, S; Mahmoud, MH				Badr, Gamal; Sayed, Ayat; Abdel-Maksoud, Mostafa A.; Mohamed, Amany O.; El-Amir, Azza; Abdel-Ghaffar, Fathy A.; Al-Quraishy, Saleh; Mahmoud, Mohamed H.			Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NF kappa B and ERK	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR LEVELS; DISEASE-ACTIVITY; CHEMOKINE RECEPTORS; AUTOIMMUNE-DISEASE; ERYTHEMATOSUS; EXPRESSION; CXCR4/CXCL12; CHEMOTAXIS; NEPHRITIS; CYTOKINE	Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by abnormal autoreactivity in B cells. Lymphocytes and their soluble mediators contribute to the disease pathogenesis. We recently demonstrated that infecting lupus mice with malaria confers protection against lupus nephritis by attenuating oxidative stress in both liver and kidney tissues. In the current study, we further investigated B cell autoreactivity in female BWF1 lupus mice after infection with either live or gamma-irradiated malaria, using ELISA, flow cytometry and Western blot analysis. The lupus mice exhibited a significant elevation in plasma levels of IL-4, IL-6, IL-7, IL-12, IL-17, IFN-alpha, IFN-gamma,TGF-beta, BAFF and APRIL and a marked elevation of IgG2a, IgG3 and ant-dsDNA autoantibodies compared with normal healthy mice. Infecting lupus mice with live but not gamma-irradiated malaria parasite partially and significantly restored the levels of the soluble mediators that contribute to the progression of lupus. Furthermore, the B cells of lupus mice exhibited an increased proliferative capacity; aberrant overexpression of the chemokine receptor CXCR4; and a marked elevation in responsiveness to their cognate ligand (CXCL12) via aberrant activation of the PI3K/AKT, NF kappa B and ERK signaling pathways. Interestingly, infecting lupus mice with live but not gamma-irradiated malaria parasite restored a normal proliferative capacity, surface expression of CXCR4 and B cell response to CXCL-12. Taken together, our data present interesting findings that clarify, for the first time, the molecular mechanisms of how infection of lupus mice with malaria parasite controls B cell autoreactivity and thus confers protection against lupus severity.	[Badr, Gamal] Assiut Univ, Fac Sci, Dept Zool, Lab Immunol & Mol Physiol, Assiut, Egypt; [Sayed, Ayat; Mohamed, Amany O.] Assiut Univ, Dept Biochem, Fac Med, Assiut, Egypt; [Abdel-Maksoud, Mostafa A.; El-Amir, Azza; Abdel-Ghaffar, Fathy A.] Cairo Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Abdel-Maksoud, Mostafa A.; Al-Quraishy, Saleh] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Mahmoud, Mohamed H.] King Saud Univ, Deanship Sci Res, Riyadh, Saudi Arabia; [Mahmoud, Mohamed H.] Natl Res Ctr, Dept Food Sci & Nutr, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Cairo University; King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Badr, G (corresponding author), Assiut Univ, Fac Sci, Dept Zool, Lab Immunol & Mol Physiol, Assiut, Egypt.	badr73@yahoo.com	Mahmoud, Mohamed hassanein/J-4178-2015; Badr, Gamal/I-4891-2014; Alquraishy, Saleh A/R-3570-2016	Mahmoud, Mohamed hassanein/0000-0003-2928-3828; Badr, Gamal/0000-0002-6157-7319; Mahmoud, Mohamed/0000-0003-0629-9384; Abdel-Maksoud, Mostafa A./0000-0002-6964-4846; Mohamed, Amany/0000-0003-3131-3846	King Saud University [RG-1435-019]	King Saud University(King Saud University)	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this Research group NO (RG-1435-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebajo AO, 1997, LANCET, V349, P361, DOI 10.1016/S0140-6736(05)62867-X; Al-Quraishy S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/156562; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Badot V, 2013, ANN RHEUM DIS, V72, P453, DOI 10.1136/annrheumdis-2012-202364; Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Badr G, 2008, BLOOD, V111, P2744, DOI 10.1182/blood-2007-03-081232; Badr G, 2013, FREE RADICAL BIO MED, V65, P175, DOI 10.1016/j.freeradbiomed.2013.06.018; Badr G, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-236; Badr G, 2012, CELL IMMUNOL, V273, P10, DOI 10.1016/j.cellimm.2011.12.003; Badr G, 2011, CELL PHYSIOL BIOCHEM, V27, P381, DOI 10.1159/000327964; Bertsias GK, 2010, ANN RHEUM DIS, V69, P1603, DOI 10.1136/ard.2010.135186; Biajoux V, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-251; Bjorkander S, 2013, SCAND J IMMUNOL, V77, P200, DOI 10.1111/sji.12021; BLANCO F, 1992, LUPUS, V1, P391, DOI 10.1177/096120339200100609; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Criscione Lisa G, 2003, Curr Rheumatol Rep, V5, P264, DOI 10.1007/s11926-003-0004-x; Ezzat MHM, 2011, LUPUS, V20, P845, DOI 10.1177/0961203311398513; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1948, DOI 10.1002/eji.200837925; FerreiradaCruz MD, 1997, MEM I OSWALDO CRUZ, V92, P137; Garnica MR, 2002, IMMUNOL LETT, V83, P47, DOI 10.1016/S0165-2478(02)00067-6; Gomez D, 2004, SEMIN ARTHRITIS RHEU, V33, P404, DOI 10.1016/j.semarthrit.2003.11.002; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2004, ARTHRITIS RES THER, V6, P28, DOI 10.1186/ar1155; GREENWOOD BM, 1970, NATURE, V226, P266, DOI 10.1038/226266a0; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; HENTATI B, 1991, J AUTOIMMUN, V4, P341, DOI 10.1016/0896-8411(91)90029-C; HENTATI B, 1994, EUR J IMMUNOL, V24, P8, DOI 10.1002/eji.1830240103; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Khan Islam U, 2003, Curr Dir Autoimmun, V6, P89; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Launay O, 2013, VACCINE, V31, P3492, DOI 10.1016/j.vaccine.2013.05.095; Liu XQ, 2012, EUR J IMMUNOL, V42, P3291, DOI 10.1002/eji.201242689; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; Lourenco EV, 2009, CURR MOL MED, V9, P242, DOI 10.2174/156652409787847263; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Minaur N, 2004, J RHEUMATOL, V31, P965; Munroe ME, 2014, ARTHRITIS RHEUMATOL, V66, P1888, DOI 10.1002/art.38573; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Parrish YK, 2009, J IMMUNOL, V182, P4255, DOI 10.4049/jimmunol.0800489; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ramanujam M, 2009, ARTHRITIS RHEUM-US, V60, P1096, DOI 10.1002/art.24414; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Sen ES, 2014, ARTHRITIS RHEUMATOL, V66, pS155, DOI 10.1002/art.38539; Tobon GJ, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/827254; Tseng Jui-Cheng, 2007, Journal of Microbiology Immunology and Infection, V40, P50; Tsujimura M, 1997, Nihon Rinsho Meneki Gakkai Kaishi, V20, P8; Vadacca M, 2010, REUMATISMO, V62, P259; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang A, 2010, ARTHRITIS RHEUM-US, V62, P3436, DOI 10.1002/art.27685; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	57	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125340	10.1371/journal.pone.0125340	http://dx.doi.org/10.1371/journal.pone.0125340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909640	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800138
J	He, Y; Zheng, QL; Jiang, MM; Sun, S; Christiansen, TG; Kassem, M; Karsdal, MA; Bay-Jensen, AC				He, Yi; Zheng, Qinlong; Jiang, MengMeng; Sun, Shu; Christiansen, Thorbjorn G.; Kassem, Moustapha; Karsdal, Morten A.; Bay-Jensen, Anne C.			The Effect of Protease Inhibitors on the Induction of Osteoarthritis-Related Biomarkers in Bovine Full-Depth Cartilage Explants	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; ARTICULAR-CARTILAGE; AGGRECANASE ACTIVITY; CHONDROITIN SULFATE; GENE-EXPRESSION; CELL-SURFACE; ONCOSTATIN-M; ACTIVATION; DEGRADATION; CLEAVAGE	Objective The specific degradation of type II collagen and aggrecan by matrix metalloproteinase (MMP)-9, -13 and ADAMTS-4 and -5 (aggrecanase-1 and -2) in the cartilage matrix is a critical step in pathology of osteoarthritis (OA). The aims of this study were: i) To investigate the relative contribution of ADAMTS-4 and ADAMTS-5 to cartilage degradation upon catabolic stimulation; ii) To investigate the effect of regulating the activities of key enzymes by mean of broad-spectrum inhibitors. Methods Bovine full-depth cartilage explants stimulated with tumor necrosis factor alpha (TNF-alpha) and Oncostatin M (OSM) were cultured for 21 days with or without a number of inhibitors targeting different types of proteases. Monoclonal antibodies were raised against the active sites of ADAMTS-4, -5, MMP-9 and -13, and 4 ELISAs were developed and technically validated. In addition, the established AGNxI (ADAMTS-degraded aggrecan), AGNxII (MMP-degraded aggrecan), and CTX-II (MMP-derived type II collagen) were quantified in the explants-conditioned media. Results We found that: i) Active ADAMTS-4, MMP-9, -13 were released in the late stage of TNF-alpha/OSM stimulation, whereas no significant active ADAMTS-5 was detected in either extracts or supernatants; ii) Active ADAMTS-4 was primarily responsible for E-373-(374)A bond cleavage in aggrecan in this setting; and iii) The compensatory mechanism could be triggered following the blockage of the enzyme caused by inhibitors. Conclusions ADAMTS-4 appeared to be the major protease for the generation of (374)ARGS aggrecan fragment in the TNF-alpha/OSM stimulated bovine cartilage explants. This study addresses the need to determine the roles of ADAMTS-4 and ADAMTS-5 in human articular degradation in OA and hence identify the attractive target for slowing down human cartilage breakdown.	[He, Yi; Zheng, Qinlong; Sun, Shu; Karsdal, Morten A.; Bay-Jensen, Anne C.] NordicBiosci, Herlev, Denmark; [Jiang, MengMeng] NordicBiosci China, Beijing, Peoples R China; [Christiansen, Thorbjorn G.] Gentofte Univ Hosp, Dept Orthoped, Hellerup, Denmark; [Kassem, Moustapha] Odense Univ Hosp, Mol Endocrinol Lab KMEB, DK-5000 Odense, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Odense University Hospital	Bay-Jensen, AC (corresponding author), NordicBiosci, Herlev, Denmark.	acbj@nordicbioscience.com	He, Yi/GLV-0913-2022; Bay-Jensen, Anne-Christine/AEQ-7281-2022; Kassem, Moustapha/O-3819-2019; ZHENG, Qin/T-2925-2019; Kassem, Moustapha/J-7688-2013	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869; Sun, Shu/0000-0002-2477-8904; Karsdal, Morten/0000-0001-5026-8740	Danish Research foundation; Danish High Technology fund; Danish ministry of Innovation and science; Nordic Bioscience	Danish Research foundation; Danish High Technology fund; Danish ministry of Innovation and science; Nordic Bioscience	The study was funded by the Danish Research foundation and the Danish High Technology fund, as well as the Danish ministry of Innovation and science, which supported the PhD fellowship of Shu Sun and Yi He. Nordic Bioscience provided support in the form of salaries for authors YH, QZ, MMJ, SS, MAK and ACBJ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1999, MON ANT PROD; Bay-Jensen AC, 2010, RHEUMATOL INT, V30, P435, DOI 10.1007/s00296-009-1183-1; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Bondeson J, 2007, J RHEUMATOL, V34, P523; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan PS, 2006, J RHEUMATOL, V33, P1329; Chen-An P, 2013, RHEUMATOL INT, V33, P401, DOI 10.1007/s00296-012-2368-6; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Fosang AJ, 2010, METHODS MOL BIOL, V622, P305, DOI 10.1007/978-1-60327-299-5_19; Galasso O, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/834208; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P2613, DOI 10.1002/art.10576; He Y, 2013, MATRIX BIOL, V32, P143, DOI 10.1016/j.matbio.2012.12.001; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Karsdal MA, 2007, ARTHRITIS RHEUM-US, V56, P1549, DOI 10.1002/art.22599; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Mercuri FA, 2000, J BIOL CHEM, V275, P33038, DOI 10.1074/jbc.275.42.33038; Milner JM, 2001, ARTHRITIS RHEUM-US, V44, P2084, DOI 10.1002/1529-0131(200109)44:9<2084::AID-ART359>3.0.CO;2-R; Mort JS, 2003, BIOCHEM SOC SYMP, V70, P107, DOI 10.1042/bss0700107; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Powell AJ, 2007, ARTHRITIS RHEUM-US, V56, P3010, DOI 10.1002/art.22818; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Sandy JD, 2006, OSTEOARTHR CARTILAGE, V14, P95, DOI 10.1016/j.joca.2005.09.004; Sondergaard BC, 2006, OSTEOARTHR CARTILAGE, V14, P738, DOI 10.1016/j.joca.2006.01.016; Sumer EU, 2007, OSTEOARTHR CARTILAGE, V15, P212, DOI 10.1016/j.joca.2006.07.009; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Wang Bijue, 2009, BMC Res Notes, V2, P259, DOI 10.1186/1756-0500-2-259; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122700	10.1371/journal.pone.0122700	http://dx.doi.org/10.1371/journal.pone.0122700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909781	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800021
J	Saka, HA; Thompson, JW; Chen, YS; Dubois, LG; Haas, JT; Moseley, A; Valdivia, RH				Saka, Hector Alex; Thompson, J. Will; Chen, Yi-Shan; Dubois, Laura G.; Haas, Joel T.; Moseley, Arthur; Valdivia, Raphael H.			Chlamydia trachomatis Infection Leads to Defined Alterations to the Lipid Droplet Proteome in Epithelial Cells	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; PHOSPHOLIPID-COMPOSITION; PROTEINS; IDENTIFICATION; REVEALS; TRAFFICKING; ASSOCIATION; ADIPOCYTES; EXPRESSION; LOCALIZES	The obligate intracellular bacterium Chlamydia trachomatisis a major human pathogen and a main cause of genital and ocular diseases. During its intracellular cycle, C. trachomatisreplicates inside a membrane-bound vacuole termed an "inclusion". Acquisition of lipids (and other nutrients) from the host cell is a critical step in chlamydial replication. Lipid droplets (LD) are ubiquitous, ER-derived neutral lipid-rich storage organelles surrounded by a phospholipids monolayer and associated proteins. Previous studies have shown that LDs accumulate at the periphery of, and eventually translocate into, the chlamydial inclusion. These observations point out to Chlamydia-mediated manipulation of LDs in infected cells, which may impact the function and thereby the protein composition of these organelles. By means of a label-free quantitative mass spectrometry approach we found that the LD proteome is modified in the context of C. trachomatis infection. We determined that LDs isolated from C. trachomatis-infected cells were enriched in proteins related to lipid metabolism, biosynthesis and LD-specific functions. Interestingly, consistent with the observation that LDs intimately associate with the inclusion, a subset of inclusion membrane proteins co-purified with LD protein extracts. Finally, genetic ablation of LDs negatively affected generation of C. trachomatis infectious progeny, consistent with a role for LD biogenesis in optimal chlamydial growth.	[Saka, Hector Alex; Chen, Yi-Shan; Valdivia, Raphael H.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Saka, Hector Alex; Chen, Yi-Shan; Valdivia, Raphael H.] Duke Univ, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC USA; [Thompson, J. Will; Dubois, Laura G.; Moseley, Arthur] Duke Univ, Med Ctr, Prote & Metabol Core Facil, Durham, NC USA; [Haas, Joel T.] UCSF, Dept Biochem & Biophys, San Francisco, CA USA	Duke University; Duke University; Duke University; University of California System; University of California San Francisco	Saka, HA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, RA-5000 Cordoba, Argentina.	has@fcq.unc.edu.ar; raphael.valdivia@duke.edu	Saka, Hector Alex/AAQ-2424-2021; Haas, Joel/R-6379-2018; Valdivia, Raphael/R-5377-2019	Haas, Joel/0000-0002-0028-5988; Valdivia, Raphael/0000-0003-0961-073X	National Institutes of Health [AI068032]; Burroughs Wellcome Trust Program in Infectious Diseases; NCRR/NIH [UL1RR024128]; Pew Latin American Fellows Program in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Trust Program in Infectious Diseases; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Pew Latin American Fellows Program in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI068032) and the Burroughs Wellcome Trust Program in Infectious Diseases. The Duke Proteomics Core Facility is supported in part by Duke University's CTSA Grant UL1RR024128 from NCRR/NIH. Hector Alex Saka was supported by a fellowship from the Pew Latin American Fellows Program in the Biomedical Sciences.	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Beilstein F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053017; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; Capmany Anahi, 2011, Commun Integr Biol, V4, P590, DOI 10.4161/cib.4.5.16594; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Ding YF, 2012, J LIPID RES, V53, P399, DOI 10.1194/jlr.M021899; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P126, DOI 10.1128/9781555817329.ch6; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heid H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063061; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Katavic V, 2006, PROTEOMICS, V6, P4586, DOI 10.1002/pmic.200600020; Khor VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105047; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Larsson S, 2012, J PROTEOME RES, V11, P1264, DOI 10.1021/pr200957p; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Olive AJ, 2014, CELL HOST MICROBE, V15, P113, DOI 10.1016/j.chom.2013.12.009; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Snavely EA, 2014, PATHOG DIS, V71, P336, DOI 10.1111/2049-632X.12179; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Stamm WE, 1999, J INFECT DIS, V179, pS380, DOI 10.1086/513844; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; TEICHMAN RJ, 1972, BIOL REPROD, V7, P73, DOI 10.1093/biolreprod/7.1.73; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Wang CW, 2012, J CELL SCI, V125, P2930, DOI 10.1242/jcs.100230; WILLNOW TE, 1994, J CELL SCI, V107, P719; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Xie XT, 2010, J PROTEOME RES, V9, P4521, DOI 10.1021/pr100268f; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhang P, 2012, MOL CELL PROTEOMICS, V11, P317, DOI 10.1074/mcp.M111.016345	79	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124630	10.1371/journal.pone.0124630	http://dx.doi.org/10.1371/journal.pone.0124630			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909443	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800094
J	Yombi, JC; Schwab, PE; Thienpont, E				Yombi, Jean Cyr; Schwab, Pierre Emmanuel; Thienpont, Emmanuel			Serum C-Reactive Protein Distribution in Minimally Invasive Total Knee Arthroplasty Do Not Differ with Distribution in Conventional Total Knee Arthroplasty	PLOS ONE			English	Article							TOTAL HIP; SURGERY; INFECTION; CRP	Minimally invasive total knee arthroplasty (MITKA) has been developed to reduce surgical trauma and facilitate rehabilitation after arthroplasty. A plausible hypothesis is that this reduced trauma results in lower concentrations of circulating inflammatory biomarkers, such as C-reactive protein (CRP). In this study, we compared CRP concentrations in patients undergoing MITKA to those undergoing conventional TKA (CTKA). Eight hundred and seven patients undergoing MITKA were prospectively recruited. CRP was measured before operation and on days 2, 4, 21, and 42 after operation. Two hundred and forty-seven patients who had CTKA were collected retrospectively, with the same inclusion and exclusion criteria as those who had MITKA. We found in both groups, that CRP values rose abruptly after operation, with peak values reached on day 2 or 4. Values then declined so that by days 21 and 42 they were only modestly above baseline values. Throughout the entire study period, mean CRP in MITKA patients did not differ significantly from those in CTKA patients. However, a significantly higher proportion of CTKA patients than of MITKA patients had peak CRP values at day 4 rather than at day 2 (76.8% vs 42.5%), a difference that was more pronounced in women. Also, by day 42, CRP values were still above baseline in 18.5% of MITKA patients and 28.8% of CTKA patients without known complications. In conclusion, CRP distribution pattern was similar in patients who received MITKA or CTKA,. CRP values remained slightly elevated in both MITKA and CTKA patients for as long 42 days after operation. These findings suggest that MITKA is no less traumatic than CTKA, as determined by CRP values, and the patterns of postoperative CRP may be useful in the management of TKA patients.	[Yombi, Jean Cyr] Clin Univ St Luc, Dept Internal Med & Perioperat Med, B-1200 Brussels, Belgium; [Yombi, Jean Cyr; Schwab, Pierre Emmanuel; Thienpont, Emmanuel] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Schwab, Pierre Emmanuel; Thienpont, Emmanuel] Clin Univ St Luc, Dept Orthopaed & Traumatol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Yombi, JC (corresponding author), Clin Univ St Luc, Dept Internal Med & Perioperat Med, B-1200 Brussels, Belgium.	jean.yombi@uclouvain.be						Almeida Herrero Fernando, 2008, Acta Ortop Mex, V22, P80; Bagry H, 2008, REGION ANESTH PAIN M, V33, P17, DOI 10.1016/j.rapm.2007.06.398; Bergin PF, 2011, J BONE JOINT SURG AM, V93A, P1392, DOI 10.2106/JBJS.J.00557; Bilgen OF, 2001, J INT MED RES, V29, P7, DOI 10.1177/147323000102900102; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; CHOUDHRY RR, 1992, J BONE JOINT SURG BR, V74, P523, DOI 10.1302/0301-620X.74B4.1624508; Codine P., 2005, Annales de Readaptation et de Medecine Physique, V48, P590, DOI 10.1016/j.annrmp.2005.03.013; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Dupont C., 2008, Annales de Readaptation et de Medecine Physique, V51, P348, DOI 10.1016/j.annrmp.2008.01.014; ELLITSGAARD N, 1991, INT ORTHOP, V15, P311; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Honsawek S, 2011, INT ORTHOP, V35, P31, DOI 10.1007/s00264-010-0973-0; LARSSON S, 1992, CLIN ORTHOP RELAT R, P237; Limpisvasti O, 2004, J PEDIATR ORTHOPED, V24, P574, DOI 10.1097/01241398-200409000-00020; Moreschini O, 2001, INT J TISSUE REACT, V23, P151; Neumaier M, 2008, ACTA ORTHOP, V79, P428, DOI 10.1080/17453670710015355; Neumaier M, 2006, ACTA ORTHOP, V77, P788, DOI 10.1080/17453670610013006; Niki Y, 2009, J ARTHROPLASTY, V24, P499, DOI 10.1016/j.arth.2008.04.002; Niskanen RO, 1996, J BONE JOINT SURG BR, V78B, P431, DOI 10.1302/0301-620X.78B3.0780431; Orrego M, 2005, REV MED CHILE, V133, P1341; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Scherer MA, 2001, CLIN ORTHOP RELAT R, P287; Shah K, 2009, CLIN ORTHOP RELAT R, V467, P946, DOI 10.1007/s11999-008-0562-3; Shen H, 2009, ACTA ORTHOP, V80, P330, DOI 10.3109/17453670903066596; Thienpont E, 2013, KNEE SURG SPORT TR A, V21, P2603, DOI 10.1007/s00167-012-2345-3; Thienpont E, 2013, KNEE SURG SPORT TR A, V21, P2412, DOI 10.1007/s00167-012-1978-6; Tsuji S, 2010, J ARTHROPLASTY, V25, P970, DOI 10.1016/j.arth.2009.06.016; White J, 1998, J BONE JOINT SURG BR, V80B, P909, DOI 10.1302/0301-620X.80B5.8708	28	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124788	10.1371/journal.pone.0124788	http://dx.doi.org/10.1371/journal.pone.0124788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910083	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800107
J	Hadanny, A; Fishlev, G; Bechor, Y; Bergan, J; Friedman, M; Maliar, A; Efrati, S				Hadanny, Amir; Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony; Maliar, Amit; Efrati, Shai			Delayed Recompression for Decompression Sickness: Retrospective Analysis	PLoS One			English	Article							HYPERBARIC-OXYGEN; REPERFUSION INJURY; ISCHEMIA; ILLNESS; TIME; MECHANISMS; SEVERITY; EXPOSURE; THERAPY; TISSUES	Introduction Most cases of decompression sickness (DCS) occur soon after surfacing, with 98% within 24 hours. Recompression using hyperbaric chamber should be administrated as soon as feasible in order to decrease bubble size and avoid further tissue injury. Unfortunately, there may be a significant time delay from surfacing to recompression. The time beyond which hyperbaric treatment is non effective is unclear. The aims of the study were first to evaluate the effect of delayed hyperbaric treatment, initiated more than 48h after surfacing for DCS and second, to evaluate the different treatment protocols. Methods From January 2000 to February 2014, 76 divers had delayed hyperbaric treatment (>= 48h) for DCS in the Sagol center for Hyperbaric medicine and Research, Assaf-Harofeh Medical Center, Israel. Data were collected from their medical records and compared to data of 128 patients treated earlier than 48h after surfacing at the same hyperbaric institute. Results There was no significant difference, as to any of the baseline characteristics, between the delayed and early treatment groups. With respect to treatment results, at the delayed treatment divers, complete recovery was achieved in 76% of the divers, partial recovery in 17.1% and no improvement in 6.6%. Similar results were achieved when treatment started early, where 78% of the divers had complete recovery, 15.6% partial recovery and 6.2% no recovery. Delayed hyperbaric treatment using US Navy Table 6 protocol trended toward a better clinical outcome yet not statistically significant (OR=2.786, CI95%[0.896-8.66], p=0.07) compared to standard hyperbaric oxygen therapy of 90 minutes at 2 ATA, irrespective of the symptoms severity at presentation. Conclusions Late recompression for DCS, 48 hours or more after surfacing, has clinical value and when applied can achieve complete recovery in 76% of the divers. It seems that the preferred hyperbaric treatment protocol should be based on US Navy Table 6.	[Hadanny, Amir; Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony; Maliar, Amit; Efrati, Shai] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel; [Hadanny, Amir; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Efrati, Shai] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University	Hadanny, A (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel.	amir.had@gmail.com						[Anonymous], 1979, P 16 ANN SCI M EUR U, V28, P1; BALL R, 1993, UNDERSEA HYPERBAR M, V20, P133; Blatteau JE, 2011, DIVING HYPERB MED, V41, P129; Bosco G, 2001, UNDERSEA HYPERBAR M, V28, P207; Boussi-Gross R, 2014, NEUROPSYCHOLOGY; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Boussuges A, 1996, UNDERSEA HYPERBAR M, V23, P151; Buras JA, 2007, NEUROL RES, V29, P127, DOI 10.1179/016164107X174147; Burls A, 2011, EMERG MED J, V28, P917, DOI 10.1136/emj.2010.103564; Desola J, 1997, P 23 ANN SCI M EUR U; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Freiberger JJ, 2002, AVIAT SPACE ENVIR MD, V73, P980; Gempp E, 2010, J CRIT CARE, V25, P236, DOI 10.1016/j.jcrc.2009.05.011; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Hugon J, 2009, UNDERSEA HYPERBAR M, V36, P223; Jaeger K, 2002, ANASTH INTENSIV NOTF, V37, P24, DOI 10.1055/s-2001-20003; Jones SR, 2010, PLAST RECONSTR SURG, V126, P403, DOI 10.1097/PRS.0b013e3181df64a5; Kihara K, 2005, LIVER TRANSPLANT, V11, P1574, DOI 10.1002/lt.20533; KIZER KW, 1982, JAMA-J AM MED ASSOC, V247, P2555, DOI 10.1001/jama.247.18.2555; Millar I, 1996, SPUMS J, V26, P135; Nikolaev VP, 2013, AVIAT SPACE ENVIR MD, V84, P938, DOI 10.3357/ASEM.3579.2013; Nossum V, 2002, EUR J APPL PHYSIOL, V86, P209, DOI 10.1007/s00421-001-0531-y; RIVERA JC, 1964, MIL MED, V129, P314, DOI 10.1093/milmed/129.4.314; Ross JAS., 2000, CLIN AUDIT OUTCOME M; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; VANLIEW HD, 1993, AVIAT SPACE ENVIR MD, V64, P859; Vann R D, 1975, Undersea Biomed Res, V2, P185; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Vann RD, 2009, AVIAT SPACE ENVIR MD, V80, P466, DOI 10.3357/ASEM.2471.2009; Xu WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050079	31	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124919	10.1371/journal.pone.0124919	http://dx.doi.org/10.1371/journal.pone.0124919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906396	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000093
J	Holland, CE; Papworth, E; Billong, SC; Kassegne, S; Petitbon, F; Mondoleba, V; Moukam, LV; Macauley, I; Ntsama, SPE; Yomb, YR; Eloundou, J; Mananga, F; Tamoufe, U; Baral, SD				Holland, Claire E.; Papworth, Erin; Billong, Serge C.; Kassegne, Sethson; Petitbon, Fanny; Mondoleba, Valentin; Moukam, Laure Vartan; Macauley, Isaac; Ntsama, Simon Pierre Eyene; Yomb, Yves Roger; Eloundou, Jules; Mananga, Franz; Tamoufe, Ubald; Baral, Stefan D.			Access to HIV Services at Non-Governmental and Community-Based Organizations among Men Who Have Sex with Men (MSM) in Cameroon: An Integrated Biological and Behavioral Surveillance Analysis	PLOS ONE			English	Article							PREVENTION; CARE; RISK; EPIDEMIOLOGY; POPULATIONS; RELEVANCE; INFECTION; KNOWLEDGE; WORKERS; WEST	Background Men who have sex with men (MSM) are more likely to be living with HIV than other adult men in low- and middle-income countries. MSM experience barriers to accessing HIV services including a lack of available specialized care, and community-level stigma and discrimination. This study aims to examine the uptake of HIV services at non-governmental and community- based organizations (NGOs/CBOs) to identify ways to improve coverage of HIV prevention and treatment among MSM. Methods An Integrated Biological and Behavioral Surveillance (IBBS) survey was conducted in Yaounde and Douala, Cameroon in 2011 using the respondent driven sampling (RDS) method to recruit and interview 239 MSM in Yaounde and 272 MSM in Douala. Results MSM in Yaounde were statistically significantly more likely to have accessed NGO/CBO services or been reached by an outreach worker in the past 12 months if they had any STI symptoms (aOR 2.17 CI 1.02-4.59. p=0.04), or if they had a larger MSM social network (aOR 1.02 CI 1.01-1.04. p<0.01). MSM in Douala were more likely to have accessed NGO/CBO services or been reached by an outreach worker in the past 12 months if they were living with HIV (aOR 3.60 CI 1.35-9.60. p=0.01), or if they reported higher numbers of male sexual partners (aOR 1.17 CI 1.00-1.36. p=0.046). Compared to men in Douala, MSM in Yaounde were significantly less likely to have accessed NGO/CBO services or been reached by an outreach worker in the past 12 months ( aOR 0.22 CI 0.14-0.34. p=<0.01). Conclusions With appropriate funding and resources, community-based organizations that provide care specifically for MSM can improve access to HIV prevention, treatment, and care services. Additionally, using social networks to reach MSM can connect greater numbers of the population to effective HIV interventions, which will improve health outcomes and decrease onward transmission of HIV.	[Holland, Claire E.; Papworth, Erin; Baral, Stefan D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Billong, Serge C.] Minist Publ Hlth, Natl AIDS Control Comm, Cent Tech Grp, Yaounde, Cameroon; [Kassegne, Sethson] Populat Serv Int, Cotonou, Benin; [Petitbon, Fanny; Macauley, Isaac] CARE Int Cameroon, Yaounde, Cameroon; [Mondoleba, Valentin; Ntsama, Simon Pierre Eyene] Cameroon Natl Assoc Family Welf CAMNAFAW, Yaounde, Cameroon; [Moukam, Laure Vartan] Assoc Camerounaise Mkt Sociale, Yaounde, Cameroon; [Yomb, Yves Roger; Mananga, Franz] Alternat Cameroun, Douala, Cameroon; [Eloundou, Jules] Humanity First, Yaounde, Cameroon; [Tamoufe, Ubald] Global Viral Cameroon, Yaounde, Cameroon	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Holland, CE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cholland@jhu.edu	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419	United States Agency for International Development (USAID); Cameroonian National AIDS Control Committee; Ministry of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Cameroonian National AIDS Control Committee; Ministry of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the United States Agency for International Development (USAID) and by the Cameroonian National AIDS Control Committee and Ministry of Health.	[Anonymous], 2012, CAMERON INVESTIGATE; [Anonymous], 2013, HUMAN RIGHTS WATCH; [Anonymous], 2013, ALT CAM GRANT HIV HU; [Anonymous], 2008, MSM HIV ROAD UN ACC; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Baral SD, 2012, PUBLIC HEALTH REP, V127, P572, DOI 10.1177/003335491212700607; BBC, 2013, BBC; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2011, JAIDS-J ACQ IMM DEF, V57, pS96, DOI 10.1097/QAI.0b013e31821db944; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Clark H, 2012, MORE 70 COUNTRIES HO; Corporation S., 2011, STAT STAT SOFTW REL; Drame FM, 2013, CULT HEALTH SEX, V15, P7, DOI 10.1080/13691058.2012.748935; Duan YW, 2013, AIDS EDUC PREV, V25, P38, DOI 10.1521/aeap.2013.25.1.38; Eloundou J, 2013, MEMORANDUM; Elul B, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0549-5; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Furtado J, 2014, SAO PAULO MED J, V132, P383, DOI 10.1590/1516-3180.20141326T2; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gurung A, 2011, BMC PUBLIC HLTH S6, DOI [10.1186/1471-2458-11-S6-S16, DOI 10.1186/1471-2458-11-S6-S16]; Kong TSK, 2008, SEX TRANSM INFECT, V84, P444, DOI 10.1136/sti.2008.030650; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Araujo MAL, 2009, AIDS PATIENT CARE ST, V23, P663, DOI 10.1089/apc.2008.0123; Lorente N, 2012, AIDS CARE, V24, P1020, DOI 10.1080/09540121.2012.668172; Ma W, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-847; Malta M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-18; Mayer KH, 2013, JAIDS-J ACQ IMM DEF, V63, pS161, DOI 10.1097/QAI.0b013e318298700e; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Muraguri N, 2012, SAHARA J-J SOC ASP H, V9, P137, DOI 10.1080/17290376.2012.744176; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Nordberg E, 2012, AM U INT L REV, V27, P439; Papworth E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18751; Park JN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1220; Park JN, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18752; Rebe K, 2012, SAHARA J-J SOC ASP H, V9, P164, DOI 10.1080/17290376.2012.744168; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Semugoma P, 2012, SAHARA J-J SOC ASP H, V9, P173, DOI 10.1080/17290376.2012.744177; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thomas B, 2009, AIDS PATIENT CARE ST, V23, P981, DOI 10.1089/apc.2009.0092; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; UNAIDS, 2013, UNAIDS GLOB REP; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	48	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122881	10.1371/journal.pone.0122881	http://dx.doi.org/10.1371/journal.pone.0122881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906046	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000018
J	Ruschioni, S; Riolo, P; Verdolini, E; Peri, E; Guarino, S; Colazza, S; Romani, R; Isidoro, N				Ruschioni, Sara; Riolo, Paola; Verdolini, Elisa; Peri, Ezio; Guarino, Salvatore; Colazza, Stefano; Romani, Roberto; Isidoro, Nunzio			Fine Structure of Antennal Sensilla of Paysandisia archon and Electrophysiological Responses to Volatile Compounds Associated with Host Palms	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; CYDIA-POMONELLA LEPIDOPTERA; MOTH MANDUCA-SEXTA; SMALL ERMINE MOTHS; CODLING MOTH; PLANT VOLATILES; SENSE-ORGANS; OVIPOSITION BEHAVIOR; FLORAL VOLATILES; PHEROMONE	Paysandisia archon (Lepidoptera: Castniidae) is a serious pest of palm trees. A comprehensive knowledge of the insect olfactory system is essential for the development of efficient semiochemical-based control methods. The olfactory sensilla are located particularly on the antennae, and these can detect plant volatiles that provide important cues for the insects in the search for their host plants. To date, the fine structure of P. archon antennal sensilla studies and their role in host-plant perception have not been investigated in great detail. Using light microscopy and scanning and transmission electron microscopy, the antennae of both sexes of P. archon are described here in detail, according to the different types, quantities and distributions of the sensilla. Six types of sensilla were identified. The most widespread are sensilla trichoidea, sensilla basiconica and sensilla auricilica, which are associated with olfactory function. These have cuticular shafts characterised by numerous pores, and they are innervated by two or three sensory neurons. Sensilla coeloconica, sensilla chaetica and sensilla ampullacea are associated with olfactory or olfactory-thermoreception, mechano-gustatory, and thermo-hygroreception functions, respectively. Moreover, the role of P. archon antennae in locating of the host palms was evaluated using electroantennograms, to monitor responses to ester and terpene compounds previously identified as volatiles of damaged/fermenting palm tissues. P. archon showed responses to all of the synthetic chemicals tested, with greater responses in the females, providing a significant sex*dose effect. Among the compounds tested, ethyl isobutyrate elicited the strongest antenna responses. The fine structure of the cuticular and cellular components of the P. archon antenna sensory equipment is described for the first time. The results of this study form an important starting point and complement physiological and behavioural studies, to provide valuable information of practical importance for the development of efficient semiochemical-based control methods.	[Ruschioni, Sara; Riolo, Paola; Verdolini, Elisa; Isidoro, Nunzio] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, I-60131 Ancona, Italy; [Peri, Ezio; Guarino, Salvatore; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, I-90128 Palermo, Italy; [Romani, Roberto] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambientali, I-06121 Perugia, Italy; [Guarino, Salvatore] Ist Protez Sostenibile Piante CNR, I-50019 Sesto Fiorentino, FI, Italy	Marche Polytechnic University; University of Palermo; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR)	Riolo, P (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, I-60131 Ancona, Italy.	p.riolo@univpm.it	Romani, Roberto/O-4004-2019; Guarino, Salvatore/AAH-4217-2020; Romani, Roberto/F-4157-2014	Romani, Roberto/0000-0002-2059-4702; Romani, Roberto/0000-0002-2059-4702; colazza, stefano/0000-0001-8023-7814; Guarino, Salvatore/0000-0001-6670-3997; PERI, Ezio/0000-0002-1095-7258	European Community Seventh Framework Programme [FP7 KBBE 2011-5-289566]	European Community Seventh Framework Programme(European Commission)	European Community Seventh Framework Programme, under Grant Agreement No. FP7 KBBE 2011-5-289566 (PALM PROTECT). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarmalai J, 2009, J CHEM ECOL, V35, P542, DOI 10.1007/s10886-009-9636-2; ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; ALTNER H, 1981, CELL TISSUE RES, V215, P289; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Anderson P, 2000, ARTHROPOD STRUCT DEV, V29, P33, DOI 10.1016/S1467-8039(00)00011-6; Andersson S, 2003, J CHEM ECOL, V29, P2319, DOI 10.1023/A:1026278531806; Ansebo L, 2005, J INSECT PHYSIOL, V51, P1066, DOI 10.1016/j.jinsphys.2005.05.003; Ansebo L, 2004, J APPL ENTOMOL, V128, P488, DOI 10.1111/j.1439-0418.2004.00878.x; Bengtsson M, 2001, J AGR FOOD CHEM, V49, P3736, DOI 10.1021/jf0100548; Blight MM, 1997, J CHEM ECOL, V23, P1715, DOI 10.1023/B:JOEC.0000006446.21160.c1; Bourquin F., 1933, Revista de la Sociedad Entomologica Argentina, V5, P295; Caissard JC, 2004, AM J BOT, V91, P1190, DOI 10.3732/ajb.91.8.1190; Carlsson MA, 2013, CHEM SENSES, V38, P355, DOI 10.1093/chemse/bjt008; Gomez VRC, 2008, ANN ENTOMOL SOC AM, V101, P181, DOI 10.1603/0013-8746(2008)101[181:MCOASI]2.0.CO;2; Castrejon-Gomez VR, 1999, FLA ENTOMOL, V82, P546, DOI 10.2307/3496472; CUPERUS PL, 1985, INT J INSECT MORPHOL, V14, P179, DOI 10.1016/0020-7322(85)90004-2; Delle-Vedove R, 2012, EUR J ENTOMOL, V109, P289, DOI 10.14411/eje.2012.037; DENOTTER CJ, 1978, ENTOMOL EXP APPL, V24, P570, DOI 10.1007/BF02385110; Derksen S, 2007, ENTOMOL EXP APPL, V123, P101, DOI 10.1111/j.1570-7458.2007.00535.x; Ebbinghaus D, 1998, J INSECT PHYSIOL, V44, P49, DOI 10.1016/S0022-1910(97)00101-7; El-Sayed AM, 2005, J AGR FOOD CHEM, V53, P953, DOI 10.1021/jf048521j; EPPO, 2008, OEPP EPPO B, V3, P163; Frank DL, 2010, ANN ENTOMOL SOC AM, V103, P993, DOI 10.1603/AN09182; Fraser AM, 2003, J CHEM ECOL, V29, P1813, DOI 10.1023/A:1024898127549; Frerot B, 2013, CHEMOECOLOGY, V23, P137, DOI 10.1007/s00049-013-0128-z; Gomez VRC, 2003, ANN ENTOMOL SOC AM, V96, P672, DOI 10.1603/0013-8746(2003)096[0672:TASOZD]2.0.CO;2; GRANT AJ, 1989, J INSECT BEHAV, V2, P371, DOI 10.1007/BF01068062; Grula J.W, 1980, J KANSAS ENTOMOL SOC, P476; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HANSSON BS, 1995, J INSECT PHYSIOL, V41, P171, DOI 10.1016/0022-1910(94)00086-V; HANSSON BS, 1995, EXPERIENTIA, V51, P1003, DOI 10.1007/BF01946910; Hern A, 2004, NATURWISSENSCHAFTEN, V91, P77, DOI 10.1007/s00114-003-0484-6; Hillier NK, 2006, J COMP PHYSIOL A, V192, P199, DOI 10.1007/s00359-005-0061-x; Honda K, 1998, J CHEM ECOL, V24, P2167, DOI 10.1023/A:1020750029362; Hunger T, 1998, TISSUE CELL, V30, P14, DOI 10.1016/S0040-8166(98)80003-7; KAFKA WA, 1987, J COMP PHYSIOL A, V161, P867, DOI 10.1007/BF00610228; Karalius V., 1994, Pheromones, V4, P93; Keil Thomas A., 1999, P5; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; KOH YH, 1995, ANN ENTOMOL SOC AM, V88, P519, DOI 10.1093/aesa/88.4.519; Larsson MC, 2002, J EXP BIOL, V205, P989; Li J, 2010, BIOSCI BIOTECH BIOCH, V74, P1987, DOI 10.1271/bbb.100118; Light DM, 2001, NATURWISSENSCHAFTEN, V88, P333, DOI 10.1007/s001140100243; Lopes O, 2002, ARTHROPOD STRUCT DEV, V31, P1, DOI 10.1016/S1467-8039(02)00011-7; Malo EA, 2004, ANN ENTOMOL SOC AM, V97, P1273, DOI 10.1603/0013-8746(2004)097[1273:ASAERO]2.0.CO;2; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; MOCHIZUKI F, 1992, APPL ENTOMOL ZOOL, V27, P547, DOI 10.1303/aez.27.547; MYERS J, 1968, J MORPHOL, V125, P315, DOI 10.1002/jmor.1051250305; Nardi S., 2009, IOBC/WPRS Bulletin, V45, P375; ODENDAAL FJ, 1985, J MORPHOL, V184, P3; RAMACHANDRAN R, 1990, J CHEM ECOL, V16, P2647, DOI 10.1007/BF00988076; Reboucas LMC, 1999, QUIM NOVA, V22, P645, DOI 10.1590/S0100-40421999000500003; Riolo P, 2014, J ECON ENTOMOL, V107, P1009, DOI 10.1603/EC13298; Riolo P, 2012, J CHEM ECOL, V38, P1017, DOI 10.1007/s10886-012-0154-2; ROELOFS WL, 1971, J INSECT PHYSIOL, V17, P1969, DOI 10.1016/0022-1910(71)90141-7; Rojas JC, 1999, ENVIRON ENTOMOL, V28, P588, DOI 10.1093/ee/28.4.588; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; Rostelien T, 2005, CHEM SENSES, V30, P443, DOI 10.1093/chemse/bji039; Roux O, 2005, MICROSC RES TECHNIQ, V68, P36, DOI 10.1002/jemt.20220; Ruchty M, 2009, ARTHROPOD STRUCT DEV, V38, P195, DOI 10.1016/j.asd.2008.11.001; Monteys VSI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029282; Sarto i Monteys Victor, 2005, Nachrichten des Entomologischen Vereins Apollo, V26, P61; SCHNEIDER D, 1957, Z VERGL PHYSIOL, V40, P8, DOI 10.1007/BF00298148; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Silberglied R.E., 1984, Symposia of the Royal Entomological Society of London, P207; Steinbrecht R.A., 1987, P353; STEINBRECHT RA, 1980, TISSUE CELL, V12, P73, DOI 10.1016/0040-8166(80)90053-1; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Sun XL, 2014, J CHEM ECOL, V40, P1080, DOI 10.1007/s10886-014-0502-5; Trona F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0267; Vacas S, 2014, J AGR FOOD CHEM, V62, P6053, DOI 10.1021/jf502663y; VANDERPERS JNC, 1980, INT J INSECT MORPHOL, V9, P15, DOI 10.1016/0020-7322(80)90032-X; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; WALL C, 1978, INT J INSECT MORPHOL, V7, P237, DOI 10.1016/0020-7322(78)90006-5; War AR, 2011, PLANT SIGNAL BEHAV, V6, P1973, DOI 10.4161/psb.6.12.18053; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Yang ZH, 2004, J CHEM ECOL, V30, P619, DOI 10.1023/B:JOEC.0000018633.94002.af; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331; Zhang SG, 2001, CHEM SENSES, V26, P885, DOI 10.1093/chemse/26.7.885	82	18	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124607	10.1371/journal.pone.0124607	http://dx.doi.org/10.1371/journal.pone.0124607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905711	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000078
J	Schneider, JS; Sendek, S; Yang, CW				Schneider, Jay S.; Sendek, Stephanie; Yang, Chengwu			Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease	PLoS One			English	Article							IMPAIRMENT; PERFORMANCE; DYSFUNCTION; DEFICITS; BATTERY	Background Although Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized primarily by motor symptoms, PD patients, at all stages of the disease, can experience cognitive dysfunction. However, the relationships between cognitive and motor symptoms and specific demographic characteristics are not well defined, particularly for patients who have progressed to requiring dopaminergic medication. Objective To examine relationships between motor and cognitive symptoms and various demographic factors in mild to moderate, PD patients requiring anti-PD medication. Methods Cognitive function was assessed in 94 subjects with a variety of neuropsychological tests during baseline evaluations as part of an experimental treatment study. Data were analyzed in relation to Unified Parkinson's Disease Rating Scale motor scores and demographic variables. Results Of the UPDRS subscores analyzed, posture/balance/gait was associated with the highest number of adverse cognitive outcomes followed by speech/facial expression, bradykinesia, and rigidity. No associations were detected between any of the cognitive performance measures and tremor. Motor functioning assessed in the "off" condition correlated primarily with disease duration; neuropsychological performance in general was primarily related to age. Conclusion In PD patients who have advanced to requiring anti-PD therapies, there are salient associations between axial signs and cognitive performance and in particular, with different aspects of visuospatial function suggesting involvement of similar circuits in these functions. Associations between executive functions and bradykinesia also suggest involvement similar circuits in these functions.	[Schneider, Jay S.; Sendek, Stephanie] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Yang, Chengwu] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Schneider, JS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	jay.schneider@jefferson.edu	Yang, Chengwu/X-6178-2018	Yang, Chengwu/0000-0003-0561-2340	National Institutes of Health [NS038681]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Institutes of Health grant NS038681 (www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Barone P, 2011, MOVEMENT DISORD, V26, P2483, DOI 10.1002/mds.23919; Brand M, 2004, BEHAV NEUROL, V15, P77, DOI 10.1155/2004/578354; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Domellof ME, 2011, MOVEMENT DISORD, V26, P2183, DOI 10.1002/mds.23814; Huber S. J., 1991, NEUROPSY NEUROPSY BE, V4, P147; HUBER SJ, 1988, J NEUROL NEUROSUR PS, V51, P855, DOI 10.1136/jnnp.51.6.855; IWASAKI Y, 1989, INT J NEUROSCI, V47, P295, DOI 10.3109/00207458908987442; Katzen HL, 2006, MOVEMENT DISORD, V21, P1947, DOI 10.1002/mds.21105; Kulisevsky J, 2000, DRUG AGING, V16, P365, DOI 10.2165/00002512-200016050-00006; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; MORTIMER JA, 1982, NEUROLOGY, V32, P133, DOI 10.1212/WNL.32.2.133; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Ozonoff S, 2004, J AUTISM DEV DISORD, V34, P139, DOI 10.1023/B:JADD.0000022605.81989.cc; Poletti M, 2013, J CLIN EXP NEUROPSYC, V35, P124, DOI 10.1080/13803395.2012.751966; Portin RJ, 1989, J CLIN EXP NEUROPSYC, V11, P369; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Schneider JS, 2010, PARKINSONISM RELAT D, V16, P507, DOI 10.1016/j.parkreldis.2010.06.001; Sollinger AB, 2010, PARKINSONISM RELAT D, V16, P177, DOI 10.1016/j.parkreldis.2009.11.002; Verbaan D, 2007, J NEUROL NEUROSUR PS, V78, P1182, DOI 10.1136/jnnp.2006.112367; Yang CW, 2009, MOVEMENT DISORD, V24, P1453, DOI 10.1002/mds.22552	22	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123231	10.1371/journal.pone.0123231	http://dx.doi.org/10.1371/journal.pone.0123231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905783	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000025
J	Wang, X; Zhu, XH; Zhang, Y; Chen, W				Wang, Xiao; Zhu, Xiao-Hong; Zhang, Yi; Chen, Wei			Simultaneous Imaging of CBF Change and BOLD with Saturation-Recovery-T-1 Method	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; RAT-BRAIN; FAIR TECHNIQUE; PERFUSION; OXYGENATION; DIFFUSION; INVERSION; MODEL; MICROCIRCULATION	A neuroimaging technique based on the saturation-recovery (SR)-T-1 MRI method was applied for simultaneously imaging blood oxygenation level dependence (BOLD) contrast and cerebral blood flow change (Delta CBF), which is determined by CBF-sensitive T-1 relaxation rate change (Delta R-1(CBF)). This technique was validated by quantitatively examining the relationships among Delta R1CBF,Delta CBF, BOLD and relative CBF change (rCBF), which was simultaneously measured by laser Doppler flowmetry under global ischemia and hypercapnia conditions, respectively, in the rat brain. It was found that during ischemia, BOLD decreased 23.1 +/- 2.8% in the cortical area; Delta R-1(CBF) decreased 0.020 +/- 0.004s(-1) corresponding to a Delta CBF decrease of 1.07 +/- 0.24 ml/g/min and 89.5 +/- 1.8% CBF reduction (n=5), resulting in a baseline CBF value (=1.18 ml/g/min) consistent with the literature reports. The CBF change quantification based on temperature corrected Delta R-1 CBF had a better accuracy than apparent R-1 change (Delta R-1(app)); nevertheless, Delta R-1(app) without temperature correction still provides a good approximation for quantifying CBF change since perfusion dominates the evolution of the longitudinal relaxation rate (R-1(app)). In contrast to the excellent consistency between Delta CBF and rCBF measured during and after ischemia, the BOLD change during the post-ischemia period was temporally disassociated with Delta CBF, indicating distinct CBF and BOLD responses. Similar results were also observed for the hypercapnia study. The overall results demonstrate that the SR-T-1 MRI method is effective for noninvasive and quantitative imaging of both Delta CBF and BOLD associated with physiological and/or pathological changes.	[Wang, Xiao; Zhu, Xiao-Hong; Zhang, Yi; Chen, Wei] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Chen, W (corresponding author), Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	wei@cmrr.umn.edu			NIH [NS057560, NS041262, NS070839, P41 RR08079, EB015894, P30 NS057091, NS076408]; WM Keck Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041262, R01NS070839, R01NS057560, P30NS057091, P30NS076408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WM Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by NIH grants NS057560, NS041262, NS070839, P41 RR08079 & EB015894, P30 NS057091 & NS076408 and WM Keck Foundation.	ACKERMAN JJH, 1980, NATURE, V283, P167, DOI 10.1038/283167a0; Barbier EL, 2001, MAGNET RESON MED, V45, P1021, DOI 10.1002/mrm.1136; BELL BA, 1985, J NEUROSURG, V62, P31, DOI 10.3171/jns.1985.62.1.0031; Botnar R, 1998, MED RAD DIA IMG, P171; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Calamante F, 1999, MAGN RESON MED, V41, P479, DOI 10.1002/(SICI)1522-2594(199903)41:3<479::AID-MRM9>3.0.CO;2-2; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DICKINSON RJ, 1986, J COMPUT ASSIST TOMO, V10, P468; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; EDELMAN RR, 1994, RADIOLOGY, V192, P513, DOI 10.1148/radiology.192.2.8029425; Fabricius M, 1996, J CEREBR BLOOD F MET, V16, P156, DOI 10.1097/00004647-199601000-00018; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hazel RD, 2006, ISMRM P SEATTL WASH; IWAMA T, 1992, MAGN RESON MED, V25, P78, DOI 10.1002/mrm.1910250108; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kim SG, 1997, MAGN RESON MED, V38, P59, DOI 10.1002/mrm.1910380110; Kramer MS, 1996, NEUROSURGERY, V38, P355, DOI 10.1097/00006123-199602000-00024; Kreis D, 2011, NEUROL RES, V33, P389, DOI 10.1179/1743132810Y.0000000010; KWONG KK, 1995, MAGNET RESON MED, V34, P878, DOI 10.1002/mrm.1910340613; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Lythgoe MF, 2000, MAGN RESON MED, V44, P706, DOI 10.1002/1522-2594(200011)44:5<706::AID-MRM8>3.0.CO;2-1; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; PARKER DL, 1983, MED PHYS, V10, P321, DOI 10.1118/1.595307; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Schwarzbauer C, 1996, MAGNET RESON MED, V35, P540, DOI 10.1002/mrm.1910350413; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; STERN MD, 1975, NATURE, V254, P56, DOI 10.1038/254056a0; Strupp J.P., 1996, NEUROIMAGE, V3, pS607, DOI [10.1016/S1053-8119(96)80609-4, DOI 10.1016/S1053-8119(96)80609-4]; Tsekos NV, 1998, MAGNET RESON MED, V39, P564, DOI 10.1002/mrm.1910390409; vanderToorn A, 1995, NMR BIOMED, V8, P245, DOI 10.1002/nbm.1940080604; Wadhwani KC R., 1988, LASER DOPPLER BLOOD, P265; Wang X, 2012, J CEREBR BLOOD F MET, V32, P907, DOI 10.1038/jcbfm.2012.26; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; YOUNG W, 1987, STROKE, V18, P751, DOI 10.1161/01.STR.18.4.751; ZHANG WG, 1992, MAGNET RESON MED, V25, P362, DOI 10.1002/mrm.1910250216	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122563	10.1371/journal.pone.0122563	http://dx.doi.org/10.1371/journal.pone.0122563			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905715	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000015
J	Ordonez-Navadijo, A; Fuertes-Yebra, E; Acosta-Iborra, B; Balsa, E; Elorza, A; Aragones, J; Landazuri, MO				Ordonez-Navadijo, A.; Fuertes-Yebra, E.; Acosta-Iborra, B.; Balsa, E.; Elorza, A.; Aragones, J.; Landazuri, M. O.			Mutant versions of von Hippel-Lindau (VHL) can protect HIF1 alpha from SART1-mediated degradation in clear-cell renal cell carcinoma	ONCOGENE			English	Article							HIF-ALPHA; HYPOXIA; HIF-1-ALPHA; EXPRESSION; FACTOR-1-ALPHA; DESTRUCTION; MUTATIONS; PATTERNS; BINDING	Inactivation of the von Hippel-Lindau (VHL) tumor suppressor drives the development of clear-cell renal cell carcinoma (ccRCC) through hypoxia-inducible factors (HIFs). Although ccRCC cells exhibit constitutive normoxic HIF signaling, the potential role of hypoxia in this setting is not fully understood. We show here that the ccRCC cell lines RCC4 and RCC10, which express mutant versions of VHL, have reduced HIF1 alpha expression in hypoxia, whereas HIF2 alpha expression is increased or not affected. Similar findings were observed in normoxia after abrogation of prolyl hydroxylase activity by siRNA or pharmacological inhibition, and by siRNA inhibition of mutant VHL. This reduction of HIF1 alpha protein is due to proteasome-dependent degradation and is mediated by the E3 ubiquitin ligase SART1. HIF1 alpha degradation favors ccRCC proliferation, in line with the previously recognized tumor suppressor capability of HIF1 alpha. Our data indicate that mutant VHL can protect HIF1 alpha from SART1-dependent degradation in normoxic conditions, but this protection is lost in hypoxic settings, favoring hypoxia-dependent ccRCC proliferation. This mechanism of HIF1 alpha degradation might operate in some VHL-related clear-cell renal carcinomas in which the deletion of HIF1 alpha locus does not occur.	[Ordonez-Navadijo, A.; Fuertes-Yebra, E.; Acosta-Iborra, B.; Balsa, E.; Elorza, A.; Aragones, J.; Landazuri, M. O.] Univ Autonoma Madrid, Hosp Univ Princesa, Hosp Univ Santa Cristina, Inst Invest Sanitaria,Unidad Invest, C Maestro Amadeo Vives 2-3,Edificio B,5a Plant, Madrid 28009, Spain; [Landazuri, M. O.] Univ Cent Ecuador, Quito, Ecuador	Autonomous University of Madrid; Universidad Central del Ecuador	Landazuri, MO (corresponding author), Univ Autonoma Madrid, Hosp Univ Princesa, Hosp Univ Santa Cristina, Inst Invest Sanitaria,Unidad Invest, C Maestro Amadeo Vives 2-3,Edificio B,5a Plant, Madrid 28009, Spain.	manuel.ortiz@salud.madrid.org	Elorza, Ainara/I-1642-2015; Acosta-Iborra, M Bárbara/L-5570-2013	Acosta-Iborra, M Bárbara/0000-0002-1517-114X	MINECO [SAF 2010-14851, SAF 2013-48130]; Recava Network [RD12/0042/0065]; Metoxia Project-Health [F2 2009-222741]; Consepoc [S2014/BMD-2542 consepoc-CM]; MICINN [SAF 2011-29716]; Programa Prometeo Government of Ecuador	MINECO(Spanish Government); Recava Network(Instituto de Salud Carlos III); Metoxia Project-Health; Consepoc; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Programa Prometeo Government of Ecuador	This work was supported by MINECO (SAF 2010-14851), MINECO (SAF 2013-48130), Recava Network (RD12/0042/0065), Programa Prometeo Government of Ecuador and Metoxia Project-Health (F2 2009-222741) to MOL; Consepoc (S2014/BMD-2542 consepoc-CM) and MICINN (SAF 2011-29716) to JA. We thank M. Ohh (Laboratory Medicine & Pathobiology University of Toronto) for providing the RCC10 cell line.	Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lawrentschuk N, 2011, UROL ONCOL-SEMIN ORI, V29, P411, DOI 10.1016/j.urolonc.2009.03.028; Lidgren A, 2005, CLIN CANCER RES, V11, P1129; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; MAHER ER, 1990, Q J MED, V77, P1151, DOI 10.1093/qjmed/77.2.1151; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	31	7	9	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					587	594		10.1038/onc.2015.113	http://dx.doi.org/10.1038/onc.2015.113			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25915846				2022-12-26	WOS:000369548800006
J	Sciaccaluga, M; Moriconi, C; Martinello, K; Catalano, M; Bermudez, I; Stitzel, JA; Maskos, U; Fucile, S				Sciaccaluga, Miriam; Moriconi, Claudia; Martinello, Katiuscia; Catalano, Myriam; Bermudez, Isabel; Stitzel, Jerry A.; Maskos, Uwe; Fucile, Sergio			Crucial role of nicotinic alpha 5 subunit variants for Ca2+ fluxes in ventral midbrain neurons	FASEB JOURNAL			English	Article						nicotine dependence; nicotinic acetylcholine receptors; Ca2+ permeability; fractional Ca2+ current	ACETYLCHOLINE-RECEPTOR-CHANNELS; LUNG-CANCER; CALCIUM PERMEABILITY; DEPENDENCE; RISK; DESENSITIZATION; MODULATION; AVERSION; SUBTYPES; BINDING	Neuronal nicotinic acetylcholine receptors (nAChRs) containing the alpha 5 subunit modulate nicotine consumption, and the human CHRNA5 rs16969968 polymorphism, causing the replacement of the aspartic acid residue at position 398 with an asparagine (alpha 5DN), has recently been associated with increased use of tobacco and higher incidence of lung cancer. We show that in ventral midbrain neurons, the alpha 5 subunit is essential for heteromeric nAChR-induced intracellular-free Ca2+ concentration elevations and that in alpha 5(-/-) mice, a class of large-amplitude nicotine-evoked currents is lost. Furthermore, the expression of the alpha 5DN subunit is not able to restore nicotinic responses, indicating a loss of function by this subunit in native neurons. To understand how alpha 5DN impairs heteromeric nAChR functions, we coexpressed alpha 4, alpha 5, or alpha 5DN subunits with a dimeric concatemer (beta 2 alpha 4) in a heterologous system, to obtain nAChRs with fixed stoichiometry. Both alpha 5(beta 2 alpha 4)(2) and alpha 5DN(beta 2 alpha 4)(2) nAChRs yielded similar levels of functional expression and Ca2+ permeability, measured as fractional Ca2+ currents (8.2 +/- 0.7% and 8.0 +/- 1.9%, respectively), 2-fold higher than alpha 4 (beta 2 alpha 4)(2). Our results indicate that the loss of function of nicotinic responses observed in alpha 5DN-expressing ventral midbrain neurons is neither due to an intrinsic inability of this subunit to form functional nAChRs nor to an altered Ca2+ permeability but likely to intracellular modulation.	[Sciaccaluga, Miriam; Catalano, Myriam; Fucile, Sergio] Ist Ricovero & Cura Carattere Scient Neuromed, I-86077 Pozzilli, Italy; [Moriconi, Claudia] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Martinello, Katiuscia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Inst Pasteur Cenci Bolognetti Fdn, I-00185 Rome, Italy; [Bermudez, Isabel] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Stitzel, Jerry A.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Maskos, Uwe] Inst Pasteur, Neurobiol Integrat Syst Cholinerg, Paris, France; [Maskos, Uwe] Inst Pasteur, CNRS, Unites Mixtes Rech, Paris, France	Sapienza University Rome; Sapienza University Rome; Oxford Brookes University; University of Colorado System; University of Colorado Boulder; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fucile, S (corresponding author), Ist Ricovero & Cura Carattere Scient Neuromed, Via Tecn,Parco Tecnol,Localita Camerelle, I-86077 Pozzilli, Italy.	sergio.fucile@uniroma1.it	Fucile, Sergio/B-3934-2010; Sciaccaluga, Miriam/AAF-5535-2021; Martinello, Katiuscia/K-5899-2016	Fucile, Sergio/0000-0003-0698-1148; Martinello, Katiuscia/0000-0002-0423-5689; Sciaccaluga, Miriam/0000-0001-7951-8045; Bermudez, Isabel/0000-0001-7692-1509; Catalano, Myriam/0000-0003-4638-9202	European Research Area Net (ERA-NET) Neuron NicoGene project; U.S. National Institutes of Health (NIH) National Cancer Institute Grant [CA089392]; NIH National Institute on Drug Abuse Grant [DA015663]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA015663] Funding Source: NIH RePORTER	European Research Area Net (ERA-NET) Neuron NicoGene project; U.S. National Institutes of Health (NIH) National Cancer Institute Grant; NIH National Institute on Drug Abuse Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Ms. Giuseppina Chece for animal genotyping. This study has been supported by the European Research Area Net (ERA-NET) Neuron NicoGene project (to S.F. and U.M.). J.A.S. is supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant CA089392 and NIH National Institute on Drug Abuse Grant DA015663.	ADAMS DJ, 1992, J PHYSIOLOGY-PARIS, V86, P67, DOI 10.1016/S0928-4257(05)80009-9; Azam L, 2007, NEUROSCIENCE, V144, P1347, DOI 10.1016/j.neuroscience.2006.11.011; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Charpantier E, 1998, NEUROREPORT, V9, P3097, DOI 10.1097/00001756-199809140-00033; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; Fowler CD, 2014, NEUROPHARMACOLOGY, V76, P533, DOI 10.1016/j.neuropharm.2013.09.008; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Fucile S, 1997, NEUROREPORT, V8, P2433, DOI 10.1097/00001756-199707280-00005; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Girod R, 1999, ANN NY ACAD SCI, V868, P578, DOI 10.1111/j.1749-6632.1999.tb11331.x; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Guo XC, 2007, J NEUROPHYSIOL, V97, P93, DOI 10.1152/jn.01047.2005; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Morel C, 2014, MOL PSYCHIATR, V19, P930, DOI 10.1038/mp.2013.158; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Pruszak J., 2009, CURR PROTOC STEM CEL; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Tammimaki A, 2012, NEUROPHARMACOLOGY, V63, P1002, DOI 10.1016/j.neuropharm.2012.07.022; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Zhou Y, 2003, J NEUROSCI, V23, P9004; ZHOU Z, 1993, PFLUG ARCH EUR J PHY, V425, P511, DOI 10.1007/BF00374879; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	40	33	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3389	3398		10.1096/fj.14-268102	http://dx.doi.org/10.1096/fj.14-268102			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911614	Green Published			2022-12-26	WOS:000358796900026
J	Workman, E; Kalda, C; Patel, A; Battle, DJ				Workman, Eileen; Kalda, Caitlin; Patel, Aalapi; Battle, Daniel J.			Gemin5 Binds to the Survival Motor Neuron mRNA to Regulate SMN Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; neurodegenerative disease; post-transcriptional regulation; RNA-binding protein; translation; Gemin5; SMA; SMN; spinal muscular atrophy; survival motor neuron	SPINAL MUSCULAR-ATROPHY; DETERMINING GENE; PROTEIN; COMPLEX; IDENTIFICATION; LOCALIZATION; TRANSLATION; RIBONUCLEOPROTEINS; BIOGENESIS; TRANSPORT	Background: Spinal muscular atrophy (SMA), a neurodegenerative disease, is caused by low levels of expression of the survival motor neuron (SMN) protein. Results: Gemin5 binds to and regulates translation of the mature SMN mRNA. Conclusion: Gemin5 functions in the regulation of the SMN mRNA. Significance: Investigation of the regulation of SMN expression is critical for understanding SMA and developing therapeutics. Reduced expression of SMN causes spinal muscular atrophy, a severe neurodegenerative disease. Despite the importance of maintaining SMN levels, relatively little is known about the mechanisms by which SMN levels are regulated. We show here that Gemin5, the snRNA-binding protein of the SMN complex, binds directly to the SMN mRNA and regulates SMN expression. Gemin5 binds with high specificity, both in vitro and in vivo, to sequence and structural elements in the SMN mRNA 3-untranslated region that are reminiscent of the snRNP code to which Gemin5 binds on snRNAs. Reduction of Gemin5 redistributes the SMN mRNA from heavy polysomes to lighter polysomes and monosomes, suggesting that Gemin5 functions as an activator of SMN translation. SMN protein is not stoichiometrically present on the SMN mRNA with Gemin5, but the mRNA-binding activity of Gemin5 is dependent on SMN levels, providing a feedback mechanism for SMN to regulate its own expression via Gemin5. This work both reveals a new autoregulatory pathway governing SMN expression, and identifies a new mechanism through which SMN can modulate specific mRNA expression via Gemin5.	[Workman, Eileen; Kalda, Caitlin; Patel, Aalapi; Battle, Daniel J.] Ohio State Univ, Wexner Med Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Battle, Daniel J.] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Battle, DJ (corresponding author), Dept Mol & Cellular Biochem, 383 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	battle.59@osu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01NS077010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS077010 (to D. B.).	Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Arnold WD, 2013, ANN NEUROL, V74, P348, DOI 10.1002/ana.23995; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Bradrick SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007030; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Fischer U, 2011, WIRES RNA, V2, P718, DOI 10.1002/wrna.87; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Jablonka S, 2003, AMYOTROPH LATERAL SC, V4, P144, DOI 10.1080/14660820310011296; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Mukherjee C, 2012, CELL REP, V2, P674, DOI 10.1016/j.celrep.2012.07.011; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Pineiro D, 2013, NUCLEIC ACIDS RES, V41, P1017, DOI 10.1093/nar/gks1212; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Simic G, 2008, ACTA NEUROPATHOL, V116, P223, DOI 10.1007/s00401-008-0411-1; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Todd AG, 2013, HUM MOL GENET, V22, P729, DOI 10.1093/hmg/dds480; Todd AG, 2010, BIOCHEM BIOPH RES CO, V397, P479, DOI 10.1016/j.bbrc.2010.05.139; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2014, J BIOL CHEM, V289, P3703, DOI 10.1074/jbc.M113.538264; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	21	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15662	15669		10.1074/jbc.M115.646257	http://dx.doi.org/10.1074/jbc.M115.646257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25911097	hybrid, Green Published			2022-12-26	WOS:000356527400028
J	Costales, P; Fuentes-Prior, P; Castellano, J; Revuelta-Lopez, E; Corral-Rodriguez, MA; Nasarre, L; Badimon, L; Llorente-Cortes, V				Costales, Paula; Fuentes-Prior, Pablo; Castellano, Jose; Revuelta-Lopez, Elena; Angeles Corral-Rodriguez, Maria; Nasarre, Laura; Badimon, Lina; Llorente-Cortes, Vicenta			K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; LIGAND-BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; CHOLESTEROL ACCUMULATION; ATHEROSCLEROTIC LESIONS; UROKINASE RECEPTOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; EMBRYONIC FIBROBLASTS; SCAVENGER RECEPTOR; EXPRESSION	Low density lipoprotein receptor-related protein (LRP1) mediates the internalization of aggregated LDL (AgLDL), which in turn increases the expression of LRP1 in human vascular smooth muscle cells (hVSMCs). This positive feedback mechanism is thus highly efficient to promote the formation of hVSMC foam cells, a crucial vascular component determining the susceptibility of atherosclerotic plaque to rupture. Here we have determined the LRP1 domains involved in AgLDL recognition with the aim of specifically blocking AgLDL internalization in hVSMCs. The capacity of fluorescently labeled AgLDL to bind to functional LRP1 clusters was tested in a receptor-ligand fluorometric assay made by immobilizing soluble LRP1 "minireceptors" (sLRP1-II, sLRP1-III, and sLRP1-IV) recombinantly expressed in CHO cells. This assay showed that AgLDL binds to cluster II. We predicted three well exposed and potentially immunogenic peptides in the CR7-CR9 domains of this cluster (termed P1 (Cys(1051)-Glu(1066)), P2 (Asp(1090)-Cys(1104)), and P3 (Gly(1127)-Cys(1140))). AgLDL, but not native LDL, bound specifically and tightly to P3-coated wells. Rabbit polyclonal antibodies raised against P3 prevented AgLDL uptake by hVSMCs and were almost twice as effective as anti-P1 and anti-P2 Abs in reducing intracellular cholesteryl ester accumulation. Moreover, anti-P3 Abs efficiently prevented AgLDL-induced LRP1 up-regulation and counteracted the down-regulatory effect of AgLDL on hVSMC migration. In conclusion, domain CR9 appears to be critical for LRP1-mediated AgLDL binding and internalization in hVSMCs. Our results open new avenues for an innovative anti-VSMC foam cell-based strategy for the treatment of vascular lipid deposition in atherosclerosis.	[Costales, Paula; Castellano, Jose; Revuelta-Lopez, Elena; Nasarre, Laura; Badimon, Lina; Llorente-Cortes, Vicenta] CSIC ICCC, Biomed Res Inst St Pau IIB St Pau, Cardiovasc Res Ctr, Barcelona 08025, Spain; [Fuentes-Prior, Pablo; Angeles Corral-Rodriguez, Maria] Hosp Santa Cruz & San Pau, Biomed Res Inst St Pau IIB St Pau, Mol Bases Dis, Barcelona 08025, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Llorente-Cortes, V (corresponding author), CSIC ICCC, IIB St Pau Hosp Santa Creu & St Pau, Cardiovasc Res Ctr, Barcelona 08025, Spain.	cllorente@csic-iccc.org	López, Elena Revuelta/G-6632-2017; BADIMON, LINA/S-2950-2019; Revuelta-López, Elena/T-6282-2018; Badimon, Lina/O-4711-2014	López, Elena Revuelta/0000-0001-8962-5936; Revuelta-López, Elena/0000-0001-8962-5936; Fuentes-Prior, Pablo/0000-0002-6618-3204; Badimon, Lina/0000-0002-9162-2459	Instituto Salud Carlos III [FIS PI11/00747, FIS PI14/01729]; Red de Investigacion Cardiovascular [RD RD12/0042/0027]; European Fund for Regional Development;  [SAF2010-15668]	Instituto Salud Carlos III(Instituto de Salud Carlos III); Red de Investigacion Cardiovascular; European Fund for Regional Development(European Commission); 	This work was supported by FIS PI11/00747 and FIS PI14/01729 from Instituto Salud Carlos III, co-financed by the European Fund for Regional Development, by SAF2010-15668, and by Red de Investigacion Cardiovascular (RD RD12/0042/0027).	Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Andersen OM, 2000, BIOCHEMISTRY-US, V39, P10627, DOI 10.1021/bi000498h; Andersen OM, 2001, BIOCHEM J, V357, P289, DOI 10.1042/0264-6021:3570289; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Chait A, 2000, CURR OPIN LIPIDOL, V11, P457, DOI 10.1097/00041433-200010000-00003; Costales P, 2010, ATHEROSCLEROSIS, V213, P458, DOI 10.1016/j.atherosclerosis.2010.09.034; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; HUBER LA, 1991, EUR J IMMUNOL, V21, P2761, DOI 10.1002/eji.1830211117; Hussain MM, 2001, FRONT BIOSCI, V6, pD417, DOI 10.2741/Hussain1; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, pE35, DOI 10.1161/ATVBAHA.111.225623; Khan OM, 2013, CIRCULATION, V127, P782, DOI 10.1161/CIRCULATIONAHA.112.000588; Kuchenhoff A, 1997, AM J PHYSIOL-CELL PH, V272, pC369, DOI 10.1152/ajpcell.1997.272.2.C369; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Llorente-Cortes V, 1998, ARTERIOSCL THROM VAS, V18, P738, DOI 10.1161/01.ATV.18.5.738; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Llorente-Cortes V, 2006, ARTERIOSCL THROM VAS, V26, P117, DOI 10.1161/01.ATV.0000193618.32611.8b; Llorente-Cortes V, 2004, CIRCULATION, V110, P452, DOI 10.1161/01.CIR.0000136032.40666.3D; Llorente-Cortes V, 2004, EUR J CLIN INVEST, V34, P182, DOI 10.1111/j.1365-2362.2004.01316.x; Llorente-Cortes V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P1905, DOI 10.1161/01.ATV.0000035391.46201.9A; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; LUOMA J, 1994, J CLIN INVEST, V93, P2014, DOI 10.1172/JCI117195; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Oorni K, 2000, J LIPID RES, V41, P1703; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; Otero-Vinas M, 2007, ATHEROSCLEROSIS, V194, P326, DOI 10.1016/j.atherosclerosis.2006.10.021; Revuelta-Lopez E, 2013, ARTERIOSCL THROM VAS, V33, P2877, DOI 10.1161/ATVBAHA.113.302323; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Veniant MM, 1998, J CLIN INVEST, V102, P1559, DOI 10.1172/JCI4164; von Ballmoos MW, 2006, ARTERIOSCL THROM VAS, V26, P359, DOI 10.1161/01.ATV.0000198250.91406.6d; WARSHAWSKY I, 1995, BIOCHEMISTRY-US, V34, P3404, DOI 10.1021/bi00010a032; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Zhao JF, 2012, MOL NUTR FOOD RES, V56, P691, DOI 10.1002/mnfr.201100735	66	31	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14852	14865		10.1074/jbc.M115.638361	http://dx.doi.org/10.1074/jbc.M115.638361			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918169	Green Published, hybrid			2022-12-26	WOS:000356177300005
J	Liu, G; Liu, YX; Ali, T; Ferreri, M; Gao, J; Chen, W; Yin, JH; Su, JL; Fanning, S; Han, B				Liu, Gang; Liu, Yongxia; Ali, Tariq; Ferreri, Miro; Gao, Jian; Chen, Wei; Yin, Jinhua; Su, Jingliang; Fanning, Seamus; Han, Bo			Molecular and Phenotypic Characterization of Aerococcus viridans Associated with Subclinical Bovine Mastitis	PLOS ONE			English	Article							VAR. HOMARI; SEQUENCE; IDENTIFICATION; STREPTOCOCCI; RESISTANCE	Aerococcus viridans is a wide spread bacterium in the environment and clinically this organism is associated with different diseases in animals and humans. However, the geno- and phenotypic characterization of A. viridans associated with bovine mastitis has not yet been reported. The objectives of this study were to investigate the genetic and phenotypic diversity of A. viridans isolates using three different molecular methods including 16S rRNA gene sequencing, pulsed-field gel electrophoresis and random amplified polymorphic DNA (RAPD) along with biochemical tests, including antimicrobial susceptibility test. In total, 60 A. viridans strains were cultured from dairy herds presenting with subclinical mastitis. The results of biochemical tests revealed that most of the isolates (75.0%) were accurately identified by API Rapid 20 Strep system and the majority of A. viridans strains (96.7%) were found to be catalase negative, while two (3.3%) isolates were weakly positive. All isolates were resistant to trimethoprim-sulfamethoxazole, followed by streptomycin (96.7%), tetracycline (65.0%) and clindamycin (56.7%) by minimum inhibition concentration-determining broth microdilution technique. As compared to the sequence of 16S rRNA gene, both PFGE and RAPD showed their capacities to discriminate the intra-species diversity of A. viridans. Furthermore, most of the isolates obtained from the same herd or region belonged to the same major RAPD group, which indicated that RAPD is an appropriate assay for tracking the origins of isolates and epidemiological studies of A. viridans. This is a novel approach to use three molecular techniques and to compare their efficiency regarding the genetic diversity of A. viridans. The data suggest that A. viridans associated with subclinical mastitis has a considerable phenotypic and genotypic diversity.	[Liu, Gang; Liu, Yongxia; Ali, Tariq; Ferreri, Miro; Gao, Jian; Chen, Wei; Yin, Jinhua; Su, Jingliang; Han, Bo] China Agr Univ, Coll Vet Med, Dept Clin Vet Med, Beijing 100094, Peoples R China; [Fanning, Seamus] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Ctr Food Safety, Dublin 4, Ireland	China Agricultural University; University College Dublin	Han, B (corresponding author), China Agr Univ, Coll Vet Med, Dept Clin Vet Med, Beijing 100094, Peoples R China.	hanbo@cau.edu.cn	Han, Bo/AAF-4329-2020; Liu, Yongxia/AAJ-3181-2020	Liu, Yongxia/0000-0001-6125-8599	Chinese Twelfth "Five-year" National Science and Technology Support Project [2012BAD12B03]; National Education Ministry's Major Project [313054]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) State Education Ministry [20120008110042]; China Postdoctoral Science Foundation [2014M561102]; High-end Foreign Experts Recruitment Program [GDT20141100043]	Chinese Twelfth "Five-year" National Science and Technology Support Project; National Education Ministry's Major Project; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) State Education Ministry(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); High-end Foreign Experts Recruitment Program	This research was supported by the Chinese Twelfth "Five-year" National Science and Technology Support Project (No. 2012BAD12B03) BH, National Education Ministry's Major Project (No. 313054) BH, Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) State Education Ministry (No. 20120008110042) BH, China Postdoctoral Science Foundation (No. 2014M561102) JG and High-end Foreign Experts Recruitment Program (No. GDT20141100043) BH.	[Anonymous], 2009, PERFORMANCE STANDARD, V19; Bosshard PP, 2004, J CLIN MICROBIOL, V42, P2065, DOI 10.1128/JCM.42.5.2065-2073.2004; Chen LY, 2012, J MICROBIOL IMMUNOL, V45, P158, DOI 10.1016/j.jmii.2011.09.010; CLSI, 2008, M31A2 CLSI; de Vos P., 2009, BERGEYS MANUAL SYSTE, DOI [10.1002/9781118960608, DOI 10.1002/9781118960608]; Devriese LA, 1999, VET MICROBIOL, V70, P87, DOI 10.1016/S0378-1135(99)00124-8; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Duarte RS, 2004, J CLIN MICROBIOL, V42, P4214, DOI 10.1128/JCM.42.9.4214-4222.2004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Ghanbarpour R, 2010, RES VET SCI, V88, P6, DOI 10.1016/j.rvsc.2009.06.003; Greenwood SJ, 2005, DIS AQUAT ORGAN, V63, P237, DOI 10.3354/dao063237; Guccione J., 2013, Open Journal of Veterinary Medicine, V3, P131, DOI 10.4236/ojvm.2013.32021; Guerin-Faublee V, 2002, INT J ANTIMICROB AG, V19, P219, DOI 10.1016/S0924-8579(01)00485-X; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ke XL, 2012, AQUACULTURE, V342, P18, DOI 10.1016/j.aquaculture.2012.02.012; KERBAUGH MA, 1968, APPL MICROBIOL, V16, P519, DOI 10.1128/AEM.16.3.519-523.1968; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YX, 2014, RES MICROBIOL, V165, P273, DOI 10.1016/j.resmic.2014.03.007; Martin V, 2007, J CLIN MICROBIOL, V45, P3053, DOI 10.1128/JCM.00156-07; Munoz MA, 2007, J CLIN MICROBIOL, V45, P3964, DOI 10.1128/JCM.00795-07; NEI M, 1981, GENETICS, V97, P145; Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999; OWENS WE, 1990, J DAIRY SCI, V73, P1225, DOI 10.3168/jds.S0022-0302(90)78786-3; Pitkala A, 2004, J DAIRY SCI, V87, P2433, DOI 10.3168/jds.S0022-0302(04)73366-4; Rasmussen M, 2013, J INFECTION, V66, P467, DOI 10.1016/j.jinf.2012.12.006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Spakova T, 2012, POL J VET SCI, V15, P329, DOI 10.2478/v10181-012-0051-1; Stebbing PD, 2012, DIS AQUAT ORGAN, V100, P159, DOI 10.3354/dao02491; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Torrent A, 2002, J WILDLIFE DIS, V38, P221, DOI 10.7589/0090-3558-38.1.221; Wiedmann M, 2000, APPL ENVIRON MICROB, V66, P2085, DOI 10.1128/AEM.66.5.2085-2095.2000; WILLIAMS REO, 1953, J GEN MICROBIOL, V8, P475, DOI 10.1099/00221287-8-3-475; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067755; Zhou WQ, 2014, INDIAN J MED MICROBI, V32, P462, DOI 10.4103/0255-0857.142238	36	133	139	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125001	10.1371/journal.pone.0125001	http://dx.doi.org/10.1371/journal.pone.0125001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919289	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400068
J	Ohta, Y; Nakamoto, H; Ishii, Y; Ikudome, S; Takahashi, K; Shima, N				Ohta, Yoichi; Nakamoto, Hiroki; Ishii, Yasumitsu; Ikudome, Sachi; Takahashi, Kyohei; Shima, Norihiro			Muscle Activation Characteristics of the Front Leg During Baseball Swings with Timing Correction for Sudden Velocity Decrease	PLOS ONE			English	Article							MOVEMENT CORRECTION; ELECTROMYOGRAPHIC ACTIVITY; ONSET; TIME	This study aimed to clarify the activation characteristics of the vastus lateralis muscle in the front leg during timing correction for a sudden decrease in the velocity of a target during baseball swings. Eleven male collegiate baseball players performed coincident timing tasks that comprised constant velocity of 8 m/s (unchanged) and a sudden decrease in velocity from 8 to 4 m/s (decreased velocity). Electromyography (EMG) revealed that the muscle activation was typically monophasic when responding unchanged conditions. The type of muscle activation during swings in response to decreased velocity condition was both monophasic and biphasic. When biphasic activation appeared in response to decreased velocity, the impact time and the time to peak EMG amplitude were significantly prolonged and the timing error was significantly smaller than that of monophasic activation. However, the EMG onset from the target start was consistent both monophasic and biphasic activation in response to conditions of decreased velocity. In addition, batters with small timing errors in response to decreased velocity were more likely to generate biphasic EMG activation. These findings indicated that timing correction for a sudden decrease in the velocity of an oncoming target is achieved by modifying the muscle activation characteristics of the vastus lateralis muscle of front leg from monophasic to biphasic to delay reaching peak muscle activation and thus prolong impact time. Therefore, the present findings suggests that the extent of timing errors in response to decreased velocity is influenced by the ability to correct muscle activation after its initiation rather than by delaying the initiation timing of muscle activation during baseball swings.	[Ohta, Yoichi] Aichi Shukutoku Univ, Dept Sports & Hlth Sci, Fac Hlth & Med Sci, Nagoya, Aichi, Japan; [Nakamoto, Hiroki; Ikudome, Sachi] Natl Inst Fitness & Sports Kanoya, Fac Sports Humanities & Appl Social Sci, Dept Phys Educ, Kagoshima, Japan; [Ishii, Yasumitsu] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan; [Takahashi, Kyohei] Natl Inst Technol, Kumamoto Coll, Fac Liberal Studies, Kumamoto, Japan; [Shima, Norihiro] Tokai Gakuen Univ, Sch Sport & Hlth Sci, Nagoya, Aichi, Japan	Aichi Shukutoku University; National Institute Fitness & Sports Kanoya	Ohta, Y (corresponding author), Aichi Shukutoku Univ, Dept Sports & Hlth Sci, Fac Hlth & Med Sci, Nagoya, Aichi, Japan.	yohta@asu.aasa.ac.jp	Shima, Norihiro/O-5113-2019	Ohta, Yoichi/0000-0002-8351-3017; Nakamoto, Hiroki/0000-0002-3778-1571	Aichi Shukutoku University	Aichi Shukutoku University	The work was supported by research grant from Aichi Shukutoku University (http://www.aasa.ac.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benguigui N, 2003, J EXP PSYCHOL HUMAN, V29, P1083, DOI 10.1037/0096-1523.29.6.1083; Breen J. L., 1967, J HLTH PHYSICAL ED R, V38, P36; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cortina J.M., 2000, EFFECT SIZE ANOVA DE; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Fortenbaugh DM, 2011, THESIS U MIAMI; FROHLICH C, 1984, AM J PHYS, V52, P325, DOI 10.1119/1.13883; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Hubbard AW, 1954, RES QUART, V25, P42, DOI 10.1080/10671188.1954.10624942; Ikudome S, 2013, NEUROREPORT, V24, P879, DOI 10.1097/WNR.0000000000000010; Katsumata H, 2007, HUM MOVEMENT SCI, V26, P27, DOI 10.1016/j.humov.2006.09.005; Kudo K, 1998, EXP BRAIN RES, V122, P23, DOI 10.1007/s002210050487; Le Runigo C, 2005, HUM MOVEMENT SCI, V24, P429, DOI 10.1016/j.humov.2005.06.008; Mason B.R., 1987, BIOMECHANICS XB HUMA, P749; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; MESSIER SP, 1985, RES Q EXERCISE SPORT, V56, P138, DOI 10.1080/02701367.1985.10608448; Modenese L, 2012, MULTIBODY SYST DYN, V28, P157, DOI 10.1007/s11044-011-9274-7; Nakamoto H, 2012, HUM MOVEMENT SCI, V31, P1529, DOI 10.1016/j.humov.2012.04.005; Nakanishi H, 2008, J JPN SOC TRIBOLOGIS, V53, P39; Nakata H, 2012, J STRENGTH COND RES, V26, P1461, DOI 10.1519/JSC.0b013e318231ab12; Ohta Y, 2014, PERCEPT MOTOR SKILL, V118, P96, DOI 10.2466/23.25.PMS.118k15w8; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; SELIN C, 1959, RES QUART, V30, P232, DOI 10.1080/10671188.1959.10613029; Slater-Hammel AT, 1951, RES QUART, V22, P377, DOI 10.1080/10671188.1951.10621327; Slater-Hammel AT, 1950, RES QUART, V21, P353, DOI 10.1080/10671188.1950.10621292; Takatoku N, 2010, J ELECTROMYOGR KINES, V20, P290, DOI 10.1016/j.jelekin.2009.03.007; Vasseljen O, 2006, CLIN BIOMECH, V21, P905, DOI 10.1016/j.clinbiomech.2006.05.003; Williams T., 1986, SCI HITTING; YANG JF, 1985, ELECTROEN CLIN NEURO, V60, P485, DOI 10.1016/0013-4694(85)91108-3	30	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124113	10.1371/journal.pone.0124113	http://dx.doi.org/10.1371/journal.pone.0124113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918848	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659400042
J	Pei, XL; Li, MH; Zhan, J; Yu, Y; Wei, XF; Guan, LZ; Aydin, H; Elson, P; Zhou, M; He, HY; Zhang, HQ				Pei, Xuelian; Li, Muhan; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; Aydin, Hakan; Elson, Paul; Zhou, Ming; He, Huiying; Zhang, Hongquan			Enhanced IMP3 Expression Activates NF-kappa B Pathway and Promotes Renal Cell Carcinoma Progression	PLOS ONE			English	Article							PREDICT METASTASIS; PROTEIN IMP3; PROGNOSIS; MARKER; BIOMARKER; ADENOCARCINOMA; PROLIFERATION; MIGRATION	Background Insulin-like growth factor 2 mRNA binding protein 3 (IMP3) is expressed in metastatic and a subset of primary renal cell carcinoma (RCC). However, the role of IMP3 in RCC progression was poorly understood. We aim to uncover the mechanism of IMP3 in regulating clear cell RCC (CCRCC) progression and validate the prognostic significance of IMP3 in localized CCRCC. Methods Caki-1 cells stably overexpressing IMP3 and Achn cells with knockdown of IMP3 were analyzed for cell migration and invasion by Transwell assay. RNA-seq was used to profile gene expression in IMP3-expressing Caki-1 cells. A cohort of 469 localized CCRCC patients were examined for IMP3 expression by immunohistochemistry using tumor tissue array. Results IMP3 promoted Caki-1 cell migration and invasion, whereas knockdown of IMP3 by RNAi inhibited Achn cell migration and invasion. Enhanced IMP3 expression activated NF-kappa B pathway and through which, it functioned in promoting the RCC cell migration. IMP3 expression in localized CCRCC was found to be associated with higher nuclear grade, higher T stage, necrosis and sarcomatoid differentiation (p < 0.001). Enhanced IMP3 expression was correlated with shorter recurrence-free and overall survivals. Multivariable analysis validated IMP3 as an independent prognostic factor for localized CCRCC patients. Conclusion IMP3 promotes RCC cell migration and invasion by activation of NF-kappa B pathway. IMP3 is validated to be an independent prognostic marker for localized CCRCC.	[Pei, Xuelian; Li, Muhan; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; He, Huiying; Zhang, Hongquan] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Pei, Xuelian; Li, Muhan; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; He, Huiying; Zhang, Hongquan] Peking Univ, State Key Lab Nat & Biomimet Drugs, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Li, Muhan; He, Huiying] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Pei, Xuelian; Zhan, Jun; Yu, Yu; Wei, Xiaofan; Guan, Lizhao; Zhang, Hongquan] Peking Univ, Dept Anat Histol & Embryol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Aydin, Hakan; Zhou, Ming] Cleveland Clin, Inst Pathol & Lab Med, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Pei, Xuelian] Shihezi Univ, Sch Med, Dept Histol & Embryol, Minist Educ, Shihezi, Xinjiang, Peoples R China; [Pei, Xuelian] Shihezi Univ, Sch Med, Key Lab Xinjiang Endem & Ethn Dis, Minist Educ, Shihezi, Xinjiang, Peoples R China	Peking University; Peking University; Peking University; Peking University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Shihezi University; Shihezi University	He, HY (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Hlth Sci Ctr, Beijing 100871, Peoples R China.	huiyinghe@bjmu.edu.cn; Hongquan.Zhang@bjmu.edu.cn	Zhan, Jun/AAH-5499-2020		Natural Science Foundation of China [81001135, 81230051, 30830048, 31170711, 81321003]; Ministry of Science and Technology of China [2013CB910501, 2010CB912203, 2010CB529402]; Ministry of Education; Beijing Natural Science Foundation [7120002]; Peking University [BMU20120314, BMU20130364]; Beijing Education Bureau	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University(Peking University); Beijing Education Bureau	This work was supported by the Natural Science Foundation of China 81001135, 81230051, 30830048, 31170711 and 81321003, the Ministry of Science and Technology of China 2013CB910501, 2010CB912203 and 2010CB529402, the 111 Project of the Ministry of Education, Beijing Natural Science Foundation 7120002 and Peking University grants BMU20120314 and BMU20130364, and a Leading Academic Discipline Project of Beijing Education Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZW, 2010, INT J CANCER, V127, P1999, DOI 10.1002/ijc.25223; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Christofakis EP, 2008, ORAL ONCOL, V44, P920, DOI 10.1016/j.oraloncology.2007.12.002; Feng W, 2011, ARCH PATHOL LAB MED, V135, P1024, DOI 10.5858/2009-0617-OAR2; Findeis-Hosey JJ, 2010, HUM PATHOL, V41, P477, DOI 10.1016/j.humpath.2009.10.004; Hoffmann NE, 2008, CANCER-AM CANCER SOC, V112, P1471, DOI 10.1002/cncr.23296; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Jiang Z, 2008, CANCER-AM CANCER SOC, V112, P2676, DOI 10.1002/cncr.23484; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Li HG, 2011, J CRANIOFAC SURG, V22, P2022, DOI 10.1097/SCS.0b013e3182319750; Lu D, 2011, AM J SURG PATHOL, V35, P1638, DOI 10.1097/PAS.0b013e31823272d4; Morais C, 2011, INT J BIOCHEM CELL B, V43, P1537, DOI 10.1016/j.biocel.2011.08.003; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Oya M, 2003, CARCINOGENESIS, V24, P377, DOI 10.1093/carcin/24.3.377; Parihar Jaspreet S, 2014, Rev Urol, V16, P118; Patel AR, 2012, J UROLOGY, V187, P1978, DOI 10.1016/j.juro.2012.01.121; Perak RB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-165; Peri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076746; Pryor JG, 2008, MODERN PATHOL, V21, P431, DOI 10.1038/modpathol.3801016; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Samanta S, 2012, ONCOGENE, V31, P4689, DOI 10.1038/onc.2011.620; Schaeffer DF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-59; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sonpavde G, 2012, BRIT J CANCER, V107, P1009, DOI 10.1038/bjc.2012.399; Sung CH, 2013, TOXICOL LETT, V223, P109, DOI 10.1016/j.toxlet.2013.09.006; Vasudev NS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-112; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wang L, 2010, CHINESE MED J-PEKING, V123, P3554, DOI 10.3760/cma.j.issn.0366-6999.2010.24.010; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yoo JY, 2008, GENE THER, V15, P635, DOI 10.1038/gt.2008.3	33	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124338	10.1371/journal.pone.0124338	http://dx.doi.org/10.1371/journal.pone.0124338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919292	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400046
J	Tate, CM; Mc Entire, J; Pallini, R; Vakana, E; Wyss, L; Blosser, W; Ricci-Vitiani, L; D'Alessandris, QG; Morgante, L; Giannetti, S; Larocca, LM; Todaro, M; Benfante, A; Colorito, ML; Stassi, G; De Maria, R; Rowlinson, S; Stancato, L				Tate, Courtney M.; Mc Entire, Jacquelyn; Pallini, Roberto; Vakana, Eliza; Wyss, Lisa; Blosser, Wayne; Ricci-Vitiani, Lucia; D'Alessandris, Quintino Giorgio; Morgante, Liliana; Giannetti, Stefano; Larocca, Luigi Maria; Todaro, Matilde; Benfante, Antonina; Colorito, Maria Luisa; Stassi, Giorgio; De Maria, Ruggero; Rowlinson, Scott; Stancato, Louis			A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology	PLOS ONE			English	Article							STEM-LIKE CELLS; MORPHOGENETIC PROTEINS; ANTIANGIOGENIC THERAPY; INITIATING CELLS; BONE; CANCER; PATHWAY; VASCULATURE; KINASE; HETEROGENEITY	Bone morphogenetic proteins (BMPs), members of the TGF-beta superfamily, have numerous biological activities including control of growth, differentiation, and vascular development. Using an in vitro co-culture endothelial cord formation assay, we investigated the role of a BMP7 variant (BMP7v) in VEGF, bFGF, and tumor-driven angiogenesis. BMP7v treatment led to disruption of neo-endothelial cord formation and regression of existing VEGF and bFGF cords in vitro. Using a series of tumor cell models capable of driving angiogenesis in vitro, BMP7v treatment completely blocked cord formation. Pre-treatment of endothelial cells with BMP7v significantly reduced their cord forming ability, indicating a direct effect on endothelial cell function. BMP7v activated the canonical SMAD signaling pathway in endothelial cells but targeted gene knockdown using shRNA directed against SMAD4 suggests this pathway is not required to mediate the anti-angiogenic effect. In contrast to SMAD activation, BMP7v selectively decreased ERK and AKT activation, significantly decreased endothelial cell migration and down-regulated expression of critical RTKs involved in VEGF and FGF angiogenic signaling, VEGFR2 and FGFR1 respectively. Importantly, in an in vivo angiogenic plug assay that serves as a measurement of angiogenesis, BMP7v significantly decreased hemoglobin content indicating inhibition of neoangiogenesis. In addition, BMP7v significantly decreased angiogenesis in glioblastoma stem-like cell (GSLC) Matrigel plugs and significantly impaired in vivo growth of a GSLC xenograft with a concomitant reduction in microvessel density. These data support BMP7v as a potent anti-angiogenic molecule that is effective in the context of tumor angiogenesis.	[Tate, Courtney M.; Mc Entire, Jacquelyn; Vakana, Eliza; Wyss, Lisa; Blosser, Wayne; Rowlinson, Scott; Stancato, Louis] Eli Lilly & Co, Discovery Res, Indianapolis, IN 46285 USA; [Pallini, Roberto; D'Alessandris, Quintino Giorgio] Univ Cattolica Sacro Cuore, Dept Neurosurg, Rome, Italy; [Ricci-Vitiani, Lucia] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Morgante, Liliana; Giannetti, Stefano] Univ Cattolica Sacro Cuore, Inst Human Anat, Rome, Italy; [Larocca, Luigi Maria] Univ Cattolica Sacro Cuore, Inst Pathol, Rome, Italy; [Todaro, Matilde; Benfante, Antonina; Colorito, Maria Luisa; Stassi, Giorgio] Univ Palermo, Surg & Oncol Sci, Palermo, Italy; [De Maria, Ruggero] Regina Elena Inst Canc Res, Rome, Italy	Eli Lilly; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Palermo; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Stancato, L (corresponding author), Eli Lilly & Co, Discovery Res, Indianapolis, IN 46285 USA.	l.stancato@lilly.com	Ricci Vitiani, Lucia/J-8320-2016; Larocca, Luigi Maria/M-9590-2019; todaro, matilde/AAC-1003-2022; Pallini, Roberto/AAA-3760-2019; Larocca, Luigi M/A-1577-2008; D'Alessandris, Quintino Giorgio/J-8827-2018; Stassi, Giorgio/AAC-1175-2022; De Maria, Ruggero/S-6385-2019; PALLINI, Roberto/AAA-3747-2019	Ricci Vitiani, Lucia/0000-0001-7336-5615; Larocca, Luigi Maria/0000-0003-1739-4758; todaro, matilde/0000-0001-8686-8043; Larocca, Luigi M/0000-0003-1739-4758; D'Alessandris, Quintino Giorgio/0000-0002-2953-9291; De Maria, Ruggero/0000-0003-2255-0583; PALLINI, Roberto/0000-0002-4611-8827	Eli Lilly	Eli Lilly(Eli Lilly)	This study was supported by Eli Lilly. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Blosser W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096036; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; D'Amico L, 2013, BRIT J CANCER, V108, P2525, DOI 10.1038/bjc.2013.271; Dow JK, 2000, UROLOGY, V55, P800, DOI 10.1016/S0090-4295(00)00457-X; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Falchetti ML, 2008, INT J CANCER, V122, P1236, DOI 10.1002/ijc.23193; Falcon BL, 2013, DRUG DISCOV TODAY, V18, P510, DOI 10.1016/j.drudis.2012.08.008; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434; Heinke J, 2007, CARDIOVASC RES, V76, P390, DOI 10.1016/j.cardiores.2007.08.003; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Langenfeld EM, 2005, MOL CANCER RES, V3, P679, DOI 10.1158/1541-7786.MCR-05-0124; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meier T, 2011, MOL CANCER THER, V10, P2168, DOI 10.1158/1535-7163.MCT-11-0323; Miosge N, 2002, MATRIX BIOL, V21, P611, DOI 10.1016/S0945-053X(02)00070-7; Miosge N, 2001, HISTOCHEM J, V33, P523, DOI 10.1023/A:1014995523521; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rothhammer Tania, 2007, Cancer Biomarkers, V3, P111; Rush S, 2007, EXP CELL RES, V313, P121, DOI 10.1016/j.yexcr.2006.09.018; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Silinsky J, 2013, J SURG RES, V185, P113, DOI 10.1016/j.jss.2013.05.049; Sitohy B, 2011, CANCER RES, V71, P7021, DOI 10.1158/0008-5472.CAN-11-1693; Sobczak I, 2008, ONCOGENE, V27, P4779, DOI 10.1038/onc.2008.128; Tate CM, 2012, CELL DEATH DIFFER, V19, P1644, DOI 10.1038/cdd.2012.44; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wimmer R, 2012, DEV CELL, V22, P158, DOI 10.1016/j.devcel.2011.11.012	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125697	10.1371/journal.pone.0125697	http://dx.doi.org/10.1371/journal.pone.0125697			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919028	Green Published, gold			2022-12-26	WOS:000353659400088
J	Dettling, MD; Seavy, NE; Howell, CA; Gardali, T				Dettling, Mark D.; Seavy, Nathaniel E.; Howell, Christine A.; Gardali, Thomas			Current Status of Western Yellow-Billed Cuckoo along the Sacramento and Feather Rivers, California	PLOS ONE			English	Article							POPULATIONS; ABUNDANCE; PATTERNS; BIRDS	To evaluate the current status of the western population of the Yellow-billed Cuckoo (Coccyzus americanus) along the Sacramento and Feather rivers in California's Sacramento Valley, we conducted extensive call playback surveys in 2012 and 2013. We also quantified the amount and distribution of potential habitat. Our survey transects were randomly located and spatially balanced to sample representative areas of the potential habitat. We estimated that the total area of potential habitat was 8,134 ha along the Sacramento River and 2,052 ha along the Feather River, for a total of 10,186 ha. Large-scale restoration efforts have created potential habitat along both of these rivers. Despite this increase in the amount of habitat, the number of cuckoos we detected was extremely low. There were 8 detection occasions in 2012 and 10 occasions in 2013 on the Sacramento River, in both restored and remnant habitat. We had no detections on the Feather River in either year. We compared our results to 10 historic studies from as far back as 1972 and found that the Yellow-billed Cuckoo had unprecedentedly low numbers in 2010, 2012, and 2013. The current limiting factor for the Yellow-billed Cuckoo in the Sacramento Valley is likely not the amount of appropriate vegetation, as restoration has created more habitat over the last 30 years. Reasons for the cuckoo decline on the Sacramento and Feather rivers are unclear.	[Dettling, Mark D.; Seavy, Nathaniel E.; Howell, Christine A.; Gardali, Thomas] Point Blue Conservat Sci, Petaluma, CA 94954 USA		Dettling, MD (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	mdettling@pointblue.org			California Department of Fish and Wildlife [1182002]; US Fish and Wildlife Service	California Department of Fish and Wildlife; US Fish and Wildlife Service(US Fish & Wildlife Service)	Our research was funded by California Department of Fish and Wildlife grant #1182002 (www.dfg.ca.gov). We would like to acknowledge the US Fish and Wildlife Service (www.fws.gov) Traditional Section 6 - Threatened and Endangered Wildlife Program for providing the funding to the California Department of Fish and Wildlife. Canh Nguyen and David Wright of the California Department of Fish and Wildlife reviewed the manuscript before submission.	Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Birdlife International NatureServe, 2012, BIRD SPEC DISTR MAPS; Bouvier JC, 2011, ENVIRON TOXICOL CHEM, V30, P212, DOI 10.1002/etc.377; California Department of Fish and Wildlife. State and federally listed endangered and threatened animals of California, 2013, STAT FED LIST END TH; Dettling MD, 2011, 1794 PRBO CAL DEP FI; Dybala Kristen E., 2014, Ecological Restoration, V32, P239; GAINES D, 1974, CONDOR, V76, P204, DOI 10.2307/1366731; Gaines D., 1984, Western Birds, V15, P49; Gaines D., 1973, THESIS U CALIFORNIA; Gardali T, 2006, RESTOR ECOL, V14, P391, DOI 10.1111/j.1526-100X.2006.00147.x; Gardali T, 2011, ENVIRON MANAGE, V48, P28, DOI 10.1007/s00267-011-9623-6; Geographical Information Center. Medium-Scale Central Valley Riparian Vegetation Map, 2012, MED SCAL CENTR VALL; Girvetz EH, 2007, LANDSCAPE ECOL, V22, P1131, DOI 10.1007/s10980-007-9104-8; Girvetz EH, 2009, LANDSCAPE ECOL, V24, P1315, DOI 10.1007/s10980-009-9384-2; GOLET GH, 2008, SAN FRANCISCO ESTUAR, V6, P2; Greco SE, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P183; Grinnell J, 1944, PACIFIC COAST AVIFAU; Halterman M. D, 2001, STATUS YELLOW BILLED; Halterman MD, 2011, NATURAL HIS IN PRESS; Halterman MD., 1991, THESIS CALIFORNIA ST; Halterman MD., 2009, THESIS U NEVADA RENO; Hammond JE, 2011, THESIS CALIFORNIA ST; Holl KD, 2004, J APPL ECOL, V41, P922, DOI 10.1111/j.0021-8901.2004.00949.x; Holmes RT, 2007, IBIS, V149, P2, DOI 10.1111/j.1474-919X.2007.00685.x; Hughes J.M., 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.yebcuc.01, DOI 10.2173/BOW.YEBCUC.01]; Katibah E.F., 1984, CALIFORNIA RIPARIAN, P23; LAYMON S A, 1987, Western Birds, V18, P19; LAYMON SA, 1989, US FOR SERV T R PSW, V110, P272; Laymon SA., 1998, RIPARIAN BIRD CONSER; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McNeil SE., 2013, YELLOW BILLED CUCKOO; Ockendon N, 2012, BIRD STUDY, V59, P111, DOI 10.1080/00063657.2011.645798; Paquette SR, 2013, ECOL APPL, V23, P122, DOI 10.1890/12-0068.1; Penteriani V, 2008, ECOL MODEL, V213, P98, DOI [10.1016/j.ecolmodel.2007.11.009, 10.1016/j.ecolmode1.2007.11.009]; RHJV (Riparian Habitat Joint Venture), 2004, VERS 2 0 RIP BIRD CO; Rohwer S, 2009, P NATL ACAD SCI USA, V106, P19050, DOI 10.1073/pnas.0908121106; Sawyer J.O., 2009, MANUAL CALIFORNIA VE; Sechrist Juddson D., 2012, Western Birds, V43, P2; Singer MB, 2007, RIVER RES APPL, V23, P55, DOI 10.1002/rra.968; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens DL, 2003, ENVIRONMETRICS, V14, P593, DOI 10.1002/env.606; U.S. Fish and Wildlife Service, 2001, FED REGISTER, V66, P38611	43	3	3	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125198	10.1371/journal.pone.0125198	http://dx.doi.org/10.1371/journal.pone.0125198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915801	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100109
J	Greenwood, M; Greenwood, MP; Paton, JFR; Murphy, D				Greenwood, Mingkwan; Greenwood, Michael Paul; Paton, Julian F. R.; Murphy, David			Transcription Factor CREB3L1 Regulates Endoplasmic Reticulum Stress Response Genes in the Osmotically Challenged Rat Hypothalamus	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA; ER STRESS; SUBFORNICAL ORGAN; TRANSDUCER OASIS; CREB/ATF-FAMILY; EXPRESSION; ATF6; XBP1; CLEAVAGE	Arginine vasopressin (AVP) is synthesised in magnocellular neurons (MCNs) of supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus. In response to the hyperosmotic stressors of dehydration (complete fluid deprivation, DH) or salt loading (drinking 2% salt solution, SL), AVP synthesis increases in MCNs, which over-burdens the protein folding machinery in the endoplasmic reticulum (ER). ER stress and the unfolded protein response (UPR) are signaling pathways that improve ER function in response to the accumulation of misfold/unfold protein. We asked whether an ER stress response was activated in the SON and PVN of DH and SL rats. We observed increased mRNA expression for the immunoglobulin heavy chain binding protein (BiP), activating transcription factor 4 (Atf4), C/EBP-homologous protein (Chop), and cAMP responsive element binding protein 3 like 1 (Creb3l1) in both SON and PVN of DH and SL rats. Although we found no changes in the splicing pattern of X box-binding protein 1 (Xbp1), an increase in the level of the unspliced form of Xbp1 (Xbp1U) was observed in DH and SL rats. CREB3L1, a novel ER stress inducer, has been shown to be activated by ER stress to regulate the expression of target genes. We have previously shown that CREB3L1 is a transcriptional regulator of the AVP gene; however, a role for CREB3L1 in the response to ER stress has yet to be investigated in MCNs. Here, we used lentiviral vectors to introduce a dominant negative form of CREB3L1 (CREB3L1DN) in the rat SON. Expression of CREB3L1DN in the SON decreased Chop and Xbp1U mRNA levels, but not BiPand Atf4 transcript expression. CREB3L1 is thus implicated as a transcriptional mediator of the ER stress response in the osmotically stimulated SON.	[Greenwood, Mingkwan; Greenwood, Michael Paul; Murphy, David] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Paton, Julian F. R.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Murphy, David] Univ Malaya, Dept Physiol, Kuala Lumpur, Malaysia	University of Bristol; University of Bristol; Universiti Malaya	Greenwood, M (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	mingkwan.greenwood@bristol.ac.uk	Paton, Julian/AAM-2121-2020; Murphy, David/C-3967-2012	Murphy, David/0000-0003-2946-0353; Paton, Julian/0000-0001-7410-2913; Greenwood, Michael/0000-0003-0565-2748; Greenwood, Mingkwan/0000-0003-0463-6615	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G006156/1, BB/J015415/1]; University of Malaya (High Impact Research Chancellery Grant) [UM.C/625/1/HIR/MOHE/MED/22 H-20001-E0000865]; BBSRC [BB/G006156/1, BB/J015415/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006156/1, BB/J015415/1] Funding Source: researchfish; British Heart Foundation [RG/12/6/29670] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Malaya (High Impact Research Chancellery Grant); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; www.bbsrc.ac.uk), (BB/G006156/1, MPG, JP, DM; BB/J015415/1, MG, JP, DM), and the University of Malaya (High Impact Research Chancellery Grant UM.C/625/1/HIR/MOHE/MED/22 H-20001-E0000865, DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; [Anonymous], 2014, ENDOCRINOLOGY; Arima H, 1999, J NEUROENDOCRINOL, V11, P337; Arima H, 2010, J NEUROENDOCRINOL, DOI [10.1111/j.1365-2826.2010.02041.x, DOI 10.1111/J.1365-2826.2010.02041.X]; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Gainer H, 2012, J NEUROENDOCRINOL, V24, P528, DOI 10.1111/j.1365-2826.2011.02236.x; Greenwood M, 2014, J NEUROSCI, V34, P3810, DOI 10.1523/JNEUROSCI.4343-13.2014; Hagiwara D, 2012, PEPTIDES, V33, P346, DOI 10.1016/j.peptides.2011.12.011; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Hiramatsu N, 2011, METHOD ENZYMOL, V491, P183, DOI 10.1016/B978-0-12-385928-0.00011-0; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; MISELIS RR, 1981, BRAIN RES, V230, P1, DOI 10.1016/0006-8993(81)90388-7; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2014, ANAT SCI INT, V89, P11, DOI 10.1007/s12565-013-0214-x; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Shao DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056124; SUEMARU S, 1990, ACTA MED OKAYAMA, V44, P233; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402; Yan Zhongyu, 2011, Open Neuroendocrinol J, V4, P136; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yue CM, 2006, AM J PHYSIOL-REG I, V290, pR1233, DOI 10.1152/ajpregu.00709.2005	41	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124956	10.1371/journal.pone.0124956	http://dx.doi.org/10.1371/journal.pone.0124956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915053	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100084
J	Koutsoulidou, A; Kyriakides, TC; Papadimas, GK; Christou, Y; Kararizou, E; Papanicolaou, EZ; Phylactou, LA				Koutsoulidou, Andrie; Kyriakides, Tassos C.; Papadimas, George K.; Christou, Yiolanda; Kararizou, Evangelia; Papanicolaou, Eleni Zamba; Phylactou, Leonidas A.			Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress	PLOS ONE			English	Article							UNSTABLE CTG REPEAT; SKELETAL-MUSCLE; CIRCULATING MICRORNAS; TRINUCLEOTIDE REPEAT; SOMATIC INSTABILITY; BIOMARKERS; TYPE-1; AGE; EXPANSION; ONSET	The discovery of reliable and sensitive blood biomarkers is useful for the diagnosis, monitoring and potential future therapy of diseases. Recently, microRNAs (miRNAs) have been identified in blood circulation and might have the potential to be used as biomarkers for several diseases and clinical conditions. Myotonic Dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy primarily characterized by muscle myotonia, weakness and atrophy. Previous studies have shown an association between miRNAs and DM1 in muscle tissue and, recently, in plasma. The aim of this study was to detect and assess muscle-specific miRNAs as potential biomarkers of DM1 muscle wasting, an important parameter in the disease's natural history. Disease stable or progressive DM1 patients with muscle weakness and wasting were recruited and enrolled in the study. RNA isolated from participants' serum was used to assess miRNA levels. Results suggest that the levels of muscle-specific miRNAs are correlated with the progression of muscle wasting and weakness observed in the DM1 patients. Specifically, miR-1, miR-133a, miR133b and miR-206 serum levels were found elevated in DM1 patients with progressive muscle wasting compared to disease stable DM1 patients. Based on these results, we propose that muscle-specific miRNAs might be useful molecular biomarkers for monitoring the progress of muscle atrophy in DM1 patients.	[Koutsoulidou, Andrie; Phylactou, Leonidas A.] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, CY-1683 Nicosia, Cyprus; [Kyriakides, Tassos C.] Yale Univ, Sch Publ Hlth, Yale Ctr Analyt Sci, New Haven, CT 06520 USA; [Papadimas, George K.; Kararizou, Evangelia] Eginitio Hosp, Dept Neurol, Med Sch Athens, Athens 11528, Greece; [Christou, Yiolanda; Papanicolaou, Eleni Zamba] Cyprus Inst Neurol & Genet, Neurol Clin D, CY-1683 Nicosia, Cyprus	Yale University; National & Kapodistrian University of Athens	Phylactou, LA (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, POB 2346, CY-1683 Nicosia, Cyprus.	laphylac@cing.ac.cy	Kyriakides, Tassos/E-4980-2013; BOUGEA, ANASTASIA/P-8197-2017	Kyriakides, Tassos/0000-0001-8913-108X; Phylactou, Leonidas/0000-0002-1377-211X	A.G. Leventis Foundation	A.G. Leventis Foundation	This work was supported by a research grant from the A.G. Leventis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chau CH, 2008, CLIN CANCER RES, V14, P5967, DOI 10.1158/1078-0432.CCR-07-4535; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Fernandez-Costa JM, 2013, HUM MOL GENET, V22, P704, DOI 10.1093/hmg/dds478; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Gharehbaghi-Schnell EB, 1998, CLIN GENET, V53, P20, DOI 10.1034/j.1399-0004.1998.531530105.x; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hamshere MG, 1999, J MED GENET, V36, P59; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Higham CF, 2012, HUM MOL GENET, V21, P2450, DOI 10.1093/hmg/dds059; Holmberg J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00155; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li XH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.29; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Malpass Katy, 2012, Nat Rev Neurol, V8, P297, DOI 10.1038/nrneurol.2012.85; Martorell L, 1997, HUM MOL GENET, V6, P877, DOI 10.1093/hmg/6.6.877; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; Merlevede K, 2002, J NEUROL, V249, P693, DOI 10.1007/s00415-002-0692-6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Modoni A, 2004, ARCH NEUROL-CHICAGO, V61, P1943, DOI 10.1001/archneur.61.12.1943; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Morales F, 2012, HUM MOL GENET, V21, P3558, DOI 10.1093/hmg/dds185; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pavicevic DS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/391821; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Perfetti A, 2014, NEUROMUSCULAR DISORD, V24, P509, DOI 10.1016/j.nmd.2014.02.005; Pineiro E, 2003, NUCLEIC ACIDS RES, V31, P6733, DOI 10.1093/nar/gkg898; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; Savic D, 2002, HUM MUTAT, V19, P131, DOI 10.1002/humu.10027; Su YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037395; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; van den Broek WJAA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-61; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; WONG LJC, 1995, AM J HUM GENET, V56, P114; Yang Z, 2003, AM J HUM GENET, V73, P1092, DOI 10.1086/379523; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	64	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125341	10.1371/journal.pone.0125341	http://dx.doi.org/10.1371/journal.pone.0125341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915631	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100122
J	Nakahata, K; Uehara, S; Nishikawa, S; Kawatsu, M; Zenitani, M; Oue, T; Okuyama, H				Nakahata, Kengo; Uehara, Shuichiro; Nishikawa, Shimpei; Kawatsu, Miyoko; Zenitani, Masahiro; Oue, Takaharu; Okuyama, Hiroomi			Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma	PLOS ONE			English	Article							CD133; POPULATION; RESISTANCE; LINES	Cancer stem cells (CSCs) are defined as a small population of cancer cells with the properties of high self-renewal, differentiation, and tumor-initiating functions. Recent studies have demonstrated that aldehyde dehydrogenase 1 (ALDH1) is a marker for CSCs in adult cancers. Although CSCs have been identified in some different types of pediatric solid tumors, there have been no studies regarding the efficacy of ALDH1 as a marker for CSCs. Therefore, in order to elucidate whether ALDH1 can be used as a marker for CSCs of pediatric sarcoma, we examined the characteristics of a population of cells with a high ALDH1 activity (ALDH1(high) cells) in rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children. We used the human embryonal RMS (eRMS) cell lines RD and KYM-1, and sorted the cells into two subpopulations of ALDH1(high) cells and cells with a low ALDH1 activity (ALDH1(low) cells). Consequently, we found that the ALDH1(high) cells comprised 3.9% and 8.2% of the total cell population, respectively, and showed a higher capacity for self-renewal and tumor formation than the ALDH1(low) cells. With regard to chemoresistance, the survival rate of the ALDH1(high) cells was found to be higher than that of the ALDH1(low) cells following treatment with chemotherapeutic agents for RMS. Furthermore, the ALDH1(high) cells exhibited a higher degree of pluripotency and gene expression of Sox2, which is one of the stem cell markers. Taken together, the ALDH1(high) cells possessed characteristics of CSCs, including colony formation, chemoresistance, differentiation and tumor initiation abilities. These results suggest that ALDH1 is a potentially useful marker of CSCs in eRMS.	[Nakahata, Kengo; Uehara, Shuichiro; Kawatsu, Miyoko; Zenitani, Masahiro; Oue, Takaharu; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan; [Nishikawa, Shimpei] Osaka Univ, Grad Sch Med, Frontier Sci Canc & Chemotherapy, Osaka, Japan	Osaka University; Osaka University	Uehara, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan.	uehara@pedsurg.med.osaka-u.ac.jp			JSPS KAKENHI [23592630, 25861668]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by JSPS KAKENHI Grant Number 23592630 (SU) and 25861668 (KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2013, MICROSC RES TECHNIQ, V76, P844, DOI 10.1002/jemt.22237; Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Casarsa C, 2008, J ONCOL, V2008, DOI 10.1155/2008/492643; Chen Y, 2011, BIOCHEM BIOPH RES CO, V405, P173, DOI 10.1016/j.bbrc.2011.01.002; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haji MA, 2004, ONCOGENE, V23, P7274; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hwang YS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072023, 10.1371/annotation/b02313dc-840f-4f03-91a2-77cb55a3a4c9]; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Komuro H, 2007, J PEDIATR SURG, V42, P2040, DOI 10.1016/j.jpedsurg.2007.08.026; Lohberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043664; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Nishikawa S, 2013, INT J ONCOL, V42, P1437, DOI 10.3892/ijo.2013.1837; Oshima N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101735; Pressey JG, 2013, PEDIATR BLOOD CANCER, V60, P45, DOI 10.1002/pbc.24117; Rahadiani N, 2011, CANCER SCI, V102, P903, DOI 10.1111/j.1349-7006.2011.01864.x; Raney RB, 2001, J PEDIAT HEMATOL ONC, V23, P215, DOI 10.1097/00043426-200105000-00008; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rasper M, 2010, NEURO-ONCOLOGY, V12, P1024, DOI 10.1093/neuonc/noq070; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Smith MA, 2010, J CLIN ONCOL, V28, P2635, DOI [10.1200/JCO.2009.27.2443, DOI 10.1200/JCO.2009.27.2443]; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068187; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	34	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125454	10.1371/journal.pone.0125454	http://dx.doi.org/10.1371/journal.pone.0125454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915760	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100130
J	Valigurova, A; Paskerova, GG; Diakin, A; Kovacikova, M; Simdyanov, TG				Valigurova, Andrea; Paskerova, Gita G.; Diakin, Andrei; Kovacikova, Magdalena; Simdyanov, Timur G.			Protococcidian Eleutheroschizon duboscqi, an Unusual Apicomplexan Interconnecting Gregarines and Cryptosporidia	PLOS ONE			English	Article							HOST-CELL INVASION; FINE-STRUCTURE; LIFE-CYCLE; PARVUM; ULTRASTRUCTURE; ATTACHMENT; CYTOSKELETON; ORGANELLES; COCCIDIA; GOUSSIA	This study focused on the attachment strategy, cell structure and the host-parasite interactions of the protococcidian Eleutheroschizon duboscqi, parasitising the polychaete Scoloplos armiger. The attached trophozoites and gamonts of E. duboscqi were detected at different development stages. The parasite develops epicellularly, covered by a host cell-derived, two-membrane parasitophorous sac forming a caudal tipped appendage. Staining with Evans blue suggests that this tail is protein-rich, supported by the presence of a fibrous substance in this area. Despite the ultrastructural evidence for long filaments in the tail, it stained only weakly for F-actin, while spectrin seemed to accumulate in this area. The attachment apparatus consists of lobes arranged in one (trophozoites) or two (gamonts) circles, crowned by a ring of filamentous fascicles. During trophozoite maturation, the internal space between the parasitophorous sac and parasite turns translucent, the parasite trilaminar pellicle seems to reorganise and is covered by a dense fibrous glycocalyx. The parasite surface is organised in broad folds with grooves in between. Micropores are situated at the bottom of the grooves. A layer of filaments organised in bands, underlying the folds and ending above the attachment fascicles, was detected just beneath the pellicle. Confocal microscopy, along with the application of cytoskeletal drugs (jasplakinolide, cytochalasin D, oryzalin) confirmed the presence of actin and tubulin polymerised forms in both the parasitophorous sac and the parasite, while myosin labelling was restricted to the sac. Despite positive tubulin labelling, no microtubules were detected in mature stages. The attachment strategy of E. duboscqi shares features with that of cryptosporidia and gregarines, i.e. the parasite itself conspicuously resembles an epicellularly located gregarine, while the parasitophorous sac develops in a similar manner to that in cryptosporidia. This study provides a re-evaluation of epicellular development in other apicomplexans and directly compares their niche with that of E. duboscqi.	[Valigurova, Andrea; Diakin, Andrei; Kovacikova, Magdalena] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Paskerova, Gita G.] St Petersburg State Univ, Fac Biol, Dept Invertebrate Zool, St Petersburg 199034, Russia; [Simdyanov, Timur G.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow 119234, Russia	Masaryk University Brno; Saint Petersburg State University; Lomonosov Moscow State University	Valigurova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic.	andreav@sci.muni.cz	Simdyanov, Timur G/H-8279-2012; Paskerova, Gita G./H-3805-2014; Valigurová, Andrea/B-4522-2012	Simdyanov, Timur G/0000-0003-2478-9301; Paskerova, Gita G./0000-0002-1026-4216; Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation [P505/12/G112]; St. Petersburg State University [1.42.514.2013, 1.42.1277.2014]; Council of President of the Russian Federation [NSh-1801.2014.4]; Ministry of Education and Science of Russian Federation; Core Facility Centres 'Culturing of microorganisms' and 'Development of molecular and cell technologies' of St. Petersburg State University; Department of Botany and Zoology, Faculty of Science, Masaryk University	Czech Science Foundation(Grant Agency of the Czech Republic); St. Petersburg State University; Council of President of the Russian Federation; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Core Facility Centres 'Culturing of microorganisms' and 'Development of molecular and cell technologies' of St. Petersburg State University; Department of Botany and Zoology, Faculty of Science, Masaryk University	AV, AD and MK were supported by the Czech Science Foundation, Project no. P505/12/G112 (ECIP). GGP was supported with grants from St. Petersburg State University (1.42.514.2013, 1.42.1277.2014). TGS was supported by the grant of the Council of President of the Russian Federation NSh-1801.2014.4. A part of the electron microscopic analysis was performed at the User Facilities Center of Lomonosov Moscow State University under financial support of Ministry of Education and Science of Russian Federation and at the Core Facility Centres 'Culturing of microorganisms' and 'Development of molecular and cell technologies' of St. Petersburg State University. AV, AD and MK acknowledge support from the Department of Botany and Zoology, Faculty of Science, Masaryk University, towards the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Awerinzew S., 1908, T IMP ST PETERSBURG, V38, P1; Barta JR, 2006, TRENDS PARASITOL, V22, P463, DOI 10.1016/j.pt.2006.08.001; BAUDOIN J, 1969, Protistologica, V5, P431; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; BENAJIBA MH, 1994, J EUKARYOT MICROBIOL, V41, P215, DOI 10.1111/j.1550-7408.1994.tb01500.x; Bonnin A, 1999, EUR J CELL BIOL, V78, P794, DOI 10.1016/S0171-9335(99)80030-2; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Brasil L., 1906, ARCH ZOOL EXP GEN, V4, P17; Butaeva F, 2006, Tsitologiia, V48, P695; Carreno RA, 1999, PARASITOL RES, V85, P899, DOI 10.1007/s004360050655; Chatton E, 1936, CR HEBD ACAD SCI, V203, P833; COX FEG, 1994, INT J PARASITOL, V24, P1301, DOI 10.1016/0020-7519(94)90197-X; Desportes I., 1969, Annls Sci Nat, V11, P31; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; DYKOVA I, 1981, J FISH DIS, V4, P487, DOI 10.1111/j.1365-2761.1981.tb01161.x; Eli A., 2012, Research Journal of Applied Sciences Engineering and Technology, V4, P1438; Elliott DA, 2001, INFECT IMMUN, V69, P5940, DOI 10.1128/IAI.69.9.5940-5942.2001; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Ferguson DJP, 2008, EUKARYOT CELL, V7, P698, DOI 10.1128/EC.00021-08; Forney JR, 1999, INFECT IMMUN, V67, P844, DOI 10.1128/IAI.67.2.844-852.1999; Hashim A, 2006, INFECT IMMUN, V74, P99, DOI 10.1128/IAI.74.1.99-107.2006; HILDEBRAND HF, 1976, Z PARASITENKD, V49, P193, DOI 10.1007/BF00380590; Huang BQ, 2004, J PARASITOL, V90, P212, DOI 10.1645/GE-3204; Jirku M, 2002, PROTIST, V153, P379, DOI 10.1078/14344610260450118; KIM SH, 1992, DIS AQUAT ORGAN, V12, P191; Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x; LANDSBERG JH, 1986, DIS AQUAT ORGAN, V2, P13, DOI 10.3354/dao002013; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; LUKES J, 1993, FOLIA PARASIT, V40, P1; LUKES J, 1992, CAN J ZOOL, V70, P2382, DOI 10.1139/z92-320; LUKES J, 1992, J PROTOZOOL, V39, P484, DOI 10.1111/j.1550-7408.1992.tb04836.x; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; MACMILLAN WG, 1973, PARASITOLOGY, V66, P207, DOI 10.1017/S0031182000044553; Melicherova J, 2014, PARASITOLOGY, V141, P287, DOI 10.1017/S0031182013001637; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MOLNAR K, 1986, J FISH DIS, V9, P99, DOI 10.1111/j.1365-2761.1986.tb00988.x; Morrissette NS, 2004, MOL BIOL CELL, V15, P1960, DOI 10.1091/mbc.E03-07-0530; Morrissette NS, 2002, J CELL SCI, V115, P1017; O'Hara Steven P., 2008, V47, P92; OrtegaPierres G, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P1; PAPERNA I, 1987, DIS AQUAT ORGAN, V2, P239; Paperna I, 1996, DIS AQUAT ORGAN, V27, P95, DOI 10.3354/dao027095; PAPERNA I, 1989, S AFR J ZOOL, V24, P345; Paperna I, 1999, PARASITE, V6, P359, DOI 10.1051/parasite/1999064359; Perkins F. O., 2000, ILLUSTRATED GUIDE PR, V1, P190; Reis Y, 2006, FEBS LETT, V580, P4673, DOI 10.1016/j.febslet.2006.07.050; ROBERTS WL, 1972, Z PARASITENKD, V40, P183; Scholtyseck E., 1979, FINE STRUCTURE PARAS; Schrevel J., 1966, Protistologica, V2, P17; SCHREVEL J, 1968, J MICROSC-PARIS, V7, P391; SCHREVEL J, 1971, J PROTOZOOL, V18, P448, DOI 10.1111/j.1550-7408.1971.tb03355.x; Schrevel J, 2013, GREGARINES EARLY BRA, P26; SHEFFIEL.HG, 1971, J PROTOZOOL, V18, P98, DOI 10.1111/j.1550-7408.1971.tb03289.x; Simdyanov TG, 2007, EUR J PROTISTOL, V43, P17, DOI 10.1016/j.ejop.2006.09.003; Sokolova YY, 2014, PARASITOLOGY, V141, P1108, DOI 10.1017/S0031182014000420; TRONCHIN G, 1977, J PROTOZOOL, V24, P67, DOI 10.1111/j.1550-7408.1977.tb05282.x; Umemiya R, 2005, J PARASITOL, V91, P1034, DOI 10.1645/GE-508R.1; Valigurova A, 2005, EUR J PROTISTOL, V41, P209, DOI 10.1016/j.ejop.2005.05.005; Valigurova A, 2008, EUR J PROTISTOL, V44, P197, DOI 10.1016/j.ejop.2007.11.006; Valigurova A, 2008, INT J PARASITOL, V38, P913, DOI 10.1016/j.ijpara.2007.11.003; Valigurova A, 2007, J EUKARYOT MICROBIOL, V54, P495, DOI 10.1111/j.1550-7408.2007.00291.x; Valigurova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042606; Valigurova A, 2009, INT J PARASITOL, V39, P1235, DOI 10.1016/j.ijpara.2009.04.009; YOSHIKAWA H, 1992, J PROTOZOOL, V39, P539, DOI 10.1111/j.1550-7408.1992.tb04848.x	65	12	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125063	10.1371/journal.pone.0125063	http://dx.doi.org/10.1371/journal.pone.0125063			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915503	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100093
J	Zhang, XD; Xie, JJ; Liao, LD; Long, L; Xie, YM; Li, EM; Xu, LY				Zhang, Xiao-Dan; Xie, Jian-Jun; Liao, Lian-Di; Long, Lin; Xie, Yang-Min; Li, En-Min; Xu, Li-Yan			12-O-Tetradecanoylphorbol-13-Acetate Induces Up-Regulated Transcription of Variant 1 but Not Variant 2 of VIL2 in Esophageal Squamous Cell Carcinoma Cells via ERK1/2/AP-1/Sp1 Signaling	PLOS ONE			English	Article							EZRIN EXPRESSION; C-JUN; PHOSPHORYLATION; GENE; METASTASIS; ACTIVATION; PROTEIN; BINDING; SP1; PROLIFERATION	The membrane-cytoskeleton link organizer ezrin may be the most "dramatic" tumor marker, being strongly over-expressed in nearly one-third of human malignancies. However, the molecular mechanisms of aberrant ezrin expression still need to be clarified. Ezrin, encoded by the VIL2 gene, has two transcript variants that differ in the transcriptional start site (TSS): V1 and V2. Both V1 and V2 encode the same protein. Here, we found that 12-O-tetradecanoylphorbol-13-acetate (TPA) induced over-expression of human VIL2 in esophageal squamous cell carcinoma (ESCC) cells. Furthermore, VIL2V1 but not V2 was up-regulated after TPA stimulation in a time-dependent manner. AP-1 and Sp1 binding sites within the promoter region of VIL2V1 acted not only as basal transcriptional elements but also as a composite TPA-responsive element (TRE) for the transcription of VIL2V1. TPA stimulation enhanced c-Jun and Sp1 binding to the TRE via activation of the ERK1/2 pathway and increased protein levels of c-Jun, c-Fos, and Sp1, resulting in over-expression of VIL2V1, whereas the MEK1/2 inhibitor U0126 blocked these events. Finally, we showed that TPA promoted the migration of ESCC cells whereas MEK1/2 inhibitor or ezrin silencing could partially inverse this alteration. Taken together, these results suggest that TPA is able to induce VIL2V1 over-expression in ESCC cells by activating MEK/ERK1/2 signaling and increasing binding of Sp1 and c-Jun to the TRE of the VIL2V1 promoter, and that VIL2 is an important TPA-induced effector.	[Zhang, Xiao-Dan; Xie, Jian-Jun; Liao, Lian-Di; Long, Lin; Li, En-Min; Xu, Li-Yan] Shantou Univ, Coll Med, High Canc Incidence Coastal Chaoshan Area, Key Lab Mol Biol, Shantou 514041, Guangdong, Peoples R China; [Zhang, Xiao-Dan; Liao, Lian-Di; Xu, Li-Yan] Shantou Univ, Coll Med, Inst Oncol Pathol, Shantou 514041, Guangdong, Peoples R China; [Xie, Jian-Jun; Long, Lin; Li, En-Min] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou 514041, Guangdong, Peoples R China; [Xie, Yang-Min] Shantou Univ, Coll Med, Dept Expt Anim Ctr, Shantou 514041, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Li, EM (corresponding author), Shantou Univ, Coll Med, High Canc Incidence Coastal Chaoshan Area, Key Lab Mol Biol, Shantou 514041, Guangdong, Peoples R China.	nmli@stu.edu.cn	xu, li/GNH-3667-2022; Long, Lin/H-1917-2012	Long, Lin/0000-0002-9657-8645	National Natural Science Foundation of China [81172264, 81472613, 81472342]; Natural Science Foundation of China-Guangdong Joint Fund [U1301227]; Fok Ying-Tong Education Foundation [141034]; Science and Technology Program of Guangdong [2011B060300025, 2013B060300020]; Foundation for the Author of Excellent Doctoral Dissertation of Guangdong [sybzzxm201228]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China-Guangdong Joint Fund; Fok Ying-Tong Education Foundation(Fok Ying Tung Education Foundation); Science and Technology Program of Guangdong; Foundation for the Author of Excellent Doctoral Dissertation of Guangdong	This work was supported by grants from the National Natural Science Foundation of China (No. 81172264, No. 81472613 and No. 81472342), the Natural Science Foundation of China-Guangdong Joint Fund (No. U1301227), the Fok Ying-Tong Education Foundation (No. 141034), the Science and Technology Program of Guangdong (No. 2011B060300025, No. 2013B060300020), and the Foundation for the Author of Excellent Doctoral Dissertation of Guangdong (sybzzxm201228).	Ben-Shmuel A, 2013, ONCOGENE, V32, P3220, DOI 10.1038/onc.2012.340; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chung YW, 2011, J BIOL CHEM, V286, P29681, DOI 10.1074/jbc.M111.264945; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Griner EM, 2013, ONCOGENE, V32, P1010, DOI 10.1038/onc.2012.124; He H, 2014, J BIOL CHEM, V289, P9089, DOI 10.1074/jbc.M113.534271; Hu LC, 2013, TUMOR BIOL, V34, P2573, DOI 10.1007/s13277-013-0803-2; Iqbal J, 2013, J BIOL CHEM, V288, P36994, DOI 10.1074/jbc.M113.492314; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Jiang WG, 1996, ANTICANCER RES, V16, P861; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; MATSUI M, 1990, ONCOGENE, V5, P249; Meng YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-61; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Min HJ, 2014, CELL SIGNAL, V26, P398, DOI 10.1016/j.cellsig.2013.08.002; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Okamura D, 2008, MODERN PATHOL, V21, P847, DOI 10.1038/modpathol.2008.59; Park SY, 2012, J CELL BIOCHEM, V113, P3653, DOI 10.1002/jcb.24238; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; RYSECK RP, 1991, ONCOGENE, V6, P533; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Saito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054881; Shen ZY, 2003, WORLD J GASTROENTERO, V9, P1182, DOI 10.3748/wjg.v9.i6.1182; Shen ZY, 2000, J CANCER RES CLIN, V126, P589, DOI 10.1007/PL00008469; Teng HJ, 2009, J BIOL CHEM, V284, P26368, DOI 10.1074/jbc.M109.021360; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Velpula KK, 2013, NEOPLASIA, V15, P192, DOI 10.1593/neo.121334; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Xie JJ, 2011, J SURG ONCOL, V104, P538, DOI 10.1002/jso.21909; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Xu X, 2015, MOL CARCINOGEN, V54, P134, DOI 10.1002/mc.22081; Yu YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012710; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; Zhou JH, 2014, INT J ONCOL, V44, P2059, DOI 10.3892/ijo.2014.2381; Zhu CJ, 2012, ACTA PHARMACOL SIN, V33, P873, DOI 10.1038/aps.2012.36	47	43	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124680	10.1371/journal.pone.0124680	http://dx.doi.org/10.1371/journal.pone.0124680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915860	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100061
J	Chang, SL; Cavnar, SP; Takayama, S; Luker, GD; Linderman, JJ				Chang, S. Laura; Cavnar, Stephen P.; Takayama, Shuichi; Luker, Gary D.; Linderman, Jennifer J.			Cell, Isoform, and Environment Factors Shape Gradients and Modulate Chemotaxis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; BREAST-CANCER; TUMOR-GROWTH; BETA-ARRESTIN; SENSITIVITY-ANALYSIS; T-CELLS; CXCR4; CXCL12; DIMERIZATION; MODEL	Chemokine gradient formation requires multiple processes that include ligand secretion and diffusion, receptor binding and internalization, and immobilization of ligand to surfaces. To understand how these events dynamically shape gradients and influence ensuing cell chemotaxis, we built a multi-scale hybrid agent-based model linking gradient formation, cell responses, and receptor-level information. The CXCL12/CXCR4/CXCR7 signaling axis is highly implicated in metastasis of many cancers. We model CXCL12 gradient formation as it is impacted by CXCR4 and CXCR7, with particular focus on the three most highly expressed isoforms of CXCL12. We trained and validated our model using data from an in vitro microfluidic source-sink device. Our simulations demonstrate how isoform differences on the molecular level affect gradient formation and cell responses. We determine that ligand properties specific to CXCL12 isoforms (binding to the migration surface and to CXCR4) significantly impact migration and explain differences in in vitro chemotaxis data. We extend our model to analyze CXCL12 gradient formation in a tumor environment and find that short distance, steep gradients characteristic of the CXCL12-gamma isoform are effective at driving chemotaxis. We highlight the importance of CXCL12-gamma in cancer cell migration: its high effective affinity for both extracellular surface sites and CXCR4 strongly promote CXCR4+ cell migration. CXCL12-gamma is also more difficult to inhibit, and we predict that co-inhibition of CXCR4 and CXCR7 is necessary to effectively hinder CXCL12-gamma-induced migration. These findings support the growing importance of understanding differences in protein isoforms, and in particular their implications for cancer treatment.	[Chang, S. Laura; Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Cavnar, Stephen P.; Takayama, Shuichi; Luker, Gary D.; Linderman, Jennifer J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Takayama, Shuichi] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Radiol, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Linderman, JJ (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu		luker, gary/0000-0001-6832-2581	United States National Institutes of Health [R01CA136553, R01CA142750, R21CA182333, P50CA093990]; NSF Predoctoral Fellowship [DGE 0718128, F031543]; University of Michigan Rackham Merit Fellowship; Advanced Proteome informatics of Cancer Training Grant [T32 CA140044]; National Institutes of Health [EB012579, GM096040]; NATIONAL CANCER INSTITUTE [P50CA093990, T32CA140044, R01CA136553, R21CA182333, R01CA142750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096040] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Predoctoral Fellowship(National Science Foundation (NSF)); University of Michigan Rackham Merit Fellowship(University of Michigan System); Advanced Proteome informatics of Cancer Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health Grants R01CA136553, R01CA142750, R21CA182333, and P50CA093990. Both S.L.C. and S.P.C. were supported on NSF Predoctoral Fellowship Project Grants # DGE 0718128 and # F031543, respectively. S.L.C. was also supported under a University of Michigan Rackham Merit Fellowship and S.P.C. was supported under an Advanced Proteome informatics of Cancer Training Grant # T32 CA140044. J.J.L. was supported by National Institutes of Health grants EB012579 and GM096040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Altenburg JD, 2010, J VIROL, V84, P2563, DOI 10.1128/JVI.00342-09; AZNAVOORIAN S, 1990, J CELL BIOL, V110, P1427, DOI 10.1083/jcb.110.4.1427; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Bailly M, 2000, MOL BIOL CELL, V11, P3873, DOI 10.1091/mbc.11.11.3873; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bellmann-Sickert K, 2011, CHEMMEDCHEM, V6, P193, DOI 10.1002/cmdc.201000403; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Byrne MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085726; Cavnar SP, 2014, INTEGR BIOL-UK, V6, P564, DOI 10.1039/c4ib00015c; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Choi TJ, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764108; Cilfone NA, 2015, CELL MOL BIOENG, V8, P119, DOI 10.1007/s12195-014-0363-6; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Coggins NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098328; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; Fermas S, 2008, GLYCOBIOLOGY, V18, P1054, DOI 10.1093/glycob/cwn088; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027; Guo ZY, 2008, J THEOR BIOL, V255, P163, DOI 10.1016/j.jtbi.2008.08.008; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kirschner DE, 2014, WIRES SYST BIOL MED, V6, P225, DOI 10.1002/wsbm.1270; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lucas TA, 2008, SIAM J NUMER ANAL, V46, P3113, DOI 10.1137/070701595; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Luker KE, 2012, NAT MED, V18, P172, DOI 10.1038/nm.2590; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Mitha F, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-6; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nimmagadda S, 2010, CANCER RES, V70, P3935, DOI 10.1158/0008-5472.CAN-09-4396; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paskauskas S, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-64; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Quitub AA, 2009, IEEE ENG MED BIOL, V28, P14, DOI 10.1109/MEMB.2009.931791; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Riggs T, 2008, J THEOR BIOL, V250, P732, DOI 10.1016/j.jtbi.2007.10.015; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290; Rueda P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002543; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Sundnes J, 2005, MATH BIOSCI, V194, P233, DOI 10.1016/j.mbs.2005.01.001; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Torisawa YS, 2010, INTEGR BIOL-UK, V2, P680, DOI 10.1039/c0ib00041h; TRANQUILLO RT, 1987, J MATH BIOL, V25, P229, DOI 10.1007/BF00276435; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Walpole J, 2013, ANNU REV BIOMED ENG, V15, P137, DOI 10.1146/annurev-bioeng-071811-150104; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Woolf PJ, 2004, J THEOR BIOL, V229, P157, DOI 10.1016/j.jtbi.2004.03.012; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zhao S, 2014, TRANSL ONCOL, V7, P429, DOI 10.1016/j.tranon.2014.04.001; ZIGMOND SH, 1981, J CELL BIOL, V88, P644, DOI 10.1083/jcb.88.3.644	90	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123450	10.1371/journal.pone.0123450	http://dx.doi.org/10.1371/journal.pone.0123450			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909600	Green Published, gold			2022-12-26	WOS:000353376800037
J	Elgrabli, D; Beaudouin, R; Jbilou, N; Floriani, M; Pery, A; Rogerieux, F; Lacroix, G				Elgrabli, Dan; Beaudouin, Remy; Jbilou, Nawel; Floriani, Magali; Pery, Alexandre; Rogerieux, Francoise; Lacroix, Ghislaine			Biodistribution and Clearance of TiO2 Nanoparticles in Rats after Intravenous Injection	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; TISSUE DISTRIBUTION; PHARMACOKINETIC MODELS; ULTRAFINE PARTICLES; TOXICITY; BODY; LUNG; TRANSLOCATION; EXPOSURE; SIZE	Titanium dioxide (TiO2) nanoparticles are used in many applications. Due to their small size, easy body penetration and toxicological adverse effects have been suspected. Numerous studies have tried to characterize TiO2 translocation after oral, dermal or respiratory exposure. In this study, we focused on TiO2 nanoparticle biodistribution, clearance and toxicological effects after intravenous injection, considering TiO2 translocation in the blood occurs. Using ICP-OES, transmission electron microscopy, and histological methods, we found TiO2 accumulation in liver, lungs and spleen. We estimated TiO2 nanoparticles' half life in the body to about 10 days. Clinical biomarkers were also quantified for 56 days to identify potential toxicological impact on lungs, blood, liver, spleen and kidneys. Results showed absence of toxicological effects after TiO2 intravenous injection at concentrations of 7.7 to 9.4 mg/kg.	[Elgrabli, Dan; Beaudouin, Remy; Jbilou, Nawel; Pery, Alexandre; Rogerieux, Francoise; Lacroix, Ghislaine] Inst Natl Environm Ind & Risques INERIS, Parc Technol Alata, Verneuil Halatte, Verneuil En Halatte, France; [Elgrabli, Dan] Univ Paris Diderot, Lab Matisres & Syst complexes, CNRS UMR7057, Paris, France; [Floriani, Magali] Inst Radioprotect & Surete Nucl Cadarache IRSN, St Paul Les Durance, France	Institut National de l'Environnement Industriel et des Risques (INERIS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite	Elgrabli, D (corresponding author), Inst Natl Environm Ind & Risques INERIS, Parc Technol Alata, Verneuil Halatte, Verneuil En Halatte, France.	dan.elgrabli@univ-paris-diderot.fr	Beaudouin, Rémy/H-1491-2012; Lacroix, Ghislaine/Q-8005-2018	Beaudouin, Rémy/0000-0002-2855-1571; Lacroix, Ghislaine/0000-0002-3260-8526				Bois FY, 1997, J STAT SOFTW, V2, P1, DOI [10.18637/jss.v002.i09, DOI 10.18637/JSS.V002.I09]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Fabian E, 2008, ARCH TOXICOL, V82, P151, DOI 10.1007/s00204-007-0253-y; FERIN J, 1992, AM J RESP CELL MOL, V6, P535, DOI 10.1165/ajrcmb/6.5.535; Geraets L, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-30; Gontier E, 2004, 34 ANN EUR SOC DERM; Haddad S, 1998, ENVIRON TOXICOL PHAR, V5, P245, DOI 10.1016/S1382-6689(98)00008-8; Kertesz Z, 2005, NUCL INSTRUM METH B, V231, P280, DOI 10.1016/j.nimb.2005.01.071; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; KREYLING WG, 2000, LUNG BIOL HEALTH DIS, V143, P323; Lankveld DPK, 2010, BIOMATERIALS, V31, P8350, DOI 10.1016/j.biomaterials.2010.07.045; Lu MG, 2010, ACS NANO, V4, P6303, DOI 10.1021/nn1018818; Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036; Nestorov I, 2003, CLIN PHARMACOKINET, V42, P883, DOI 10.2165/00003088-200342100-00002; Oberdorster G, 2002, J TOXICOL ENV HEAL A, V65, P1531, DOI 10.1080/00984100290071658; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025; Pery ARR, 2009, INHAL TOXICOL, V21, P1099, DOI 10.3109/08958370902748542; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Shelley ML, 2008, INT J TOXICOL, V27, P359, DOI 10.1080/10915810802503487; Shvedova A.A., 2007, NANOTOXICOLOGY CHARA, P225; Stone PH, 1999, AM HEART J, V138, P804, DOI 10.1016/S0002-8703(99)70002-5; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang Y, 2013, SMALL, V9, P1742, DOI 10.1002/smll.201201185; Yang RSH, 2010, J NANOSCI NANOTECHNO, V10, P8482, DOI 10.1166/jnn.2010.2687	27	63	65	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124490	10.1371/journal.pone.0124490	http://dx.doi.org/10.1371/journal.pone.0124490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909957	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800084
J	Luo, XD; Cideciyan, AV; Iannaccone, A; Roman, AJ; Ditta, LC; Jennings, BJ; Yatsenko, SA; Sheplock, R; Sumaroka, A; Swider, M; Schwartz, SB; Wissinger, B; Kohl, S; Jacobson, SG				Luo, Xunda; Cideciyan, Artur V.; Iannaccone, Alessandro; Roman, Alejandro J.; Ditta, Lauren C.; Jennings, Barbara J.; Yatsenko, Svetlana A.; Sheplock, Rebecca; Sumaroka, Alexander; Swider, Malgorzata; Schwartz, Sharon B.; Wissinger, Bernd; Kohl, Susanne; Jacobson, Samuel G.			Blue Cone Monochromacy: Visual Function and Efficacy Outcome Measures for Clinical Trials	PLOS ONE			English	Article							GENE-THERAPY; SPECTRAL SENSITIVITY; COLOR-VISION; MOLECULAR-GENETICS; NULL MUTATION; ROD; MECHANISMS; PERIMETRY; PHOTORECEPTORS; ACHROMATOPSIA	Background Blue Cone Monochromacy (BCM) is an X-linked retinopathy caused by mutations in the OPN1LW / OPN1MW gene cluster, encoding long (L)- and middle (M)-wavelength sensitive cone opsins. Recent evidence shows sufficient structural integrity of cone photoreceptors in BCM to warrant consideration of a gene therapy approach to the disease. In the present study, the vision in BCM is examined, specifically seeking clinically-feasible outcomes for a future clinical trial. Methods BCM patients (n = 25, ages 5-72) were studied with kinetic and static chromatic perimetry, full-field sensitivity testing, and eye movement recordings. Vision at the fovea and parafovea was probed with chromatic microperimetry. Results Kinetic fields with a Goldmann size V target were generally full. Short-wavelength (S-) sensitive cone function was normal or near normal in most patients. Light-adapted perimetry results on conventional background lights were abnormally reduced; 600-nm stimuli were seen by rods whereas white stimuli were seen by both rods and S-cones. Under dark-adapted conditions, 500-nm stimuli were seen by rods in both BCM and normals. Spectral sensitivity functions in the superior retina showed retained rod and S-cone functions in BCM under dark-adapted and light-adapted conditions. In the fovea, normal subjects showed L/M-cone mediation using a 650-nm stimulus under dark-adapted conditions, whereas BCM patients had reduced sensitivity driven by rod vision. Full-field red stimuli on bright blue backgrounds were seen by L/M-cones in normal subjects whereas BCM patients had abnormally reduced and rod-mediated sensitivities. Fixation location could vary from fovea to parafovea. Chromatic microperimetry demonstrated a large loss of sensitivity to red stimuli presented on a cyan adapting background at the anatomical fovea and surrounding parafovea. Conclusions BCM rods continue to signal vision under conditions normally associated with daylight vision. Localized and retina-wide outcome measures were examined to evaluate possible improvement of L/M-cone-based vision in a clinical trial.	[Luo, Xunda; Cideciyan, Artur V.; Roman, Alejandro J.; Sheplock, Rebecca; Sumaroka, Alexander; Swider, Malgorzata; Schwartz, Sharon B.; Jacobson, Samuel G.] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Iannaccone, Alessandro; Ditta, Lauren C.; Jennings, Barbara J.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Hamilton Eye Inst, Memphis, TN 38163 USA; [Yatsenko, Svetlana A.] Univ Pittsburgh, Sch Med, Ctr Med Genet & Genom, Pittsburgh Cytogenet Lab, Pittsburgh, PA USA; [Wissinger, Bernd; Kohl, Susanne] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Cideciyan, AV (corresponding author), Univ Penn, Dept Ophthalmol, Perelman Sch Med, Scheie Eye Inst, Philadelphia, PA 19104 USA.	cideciya@mail.med.upenn.edu; jacobsos@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Iannaccone, Alessandro/0000-0001-5737-8424; Jacobson, Samuel/0000-0003-2122-169X; Kohl, Susanne/0000-0002-6438-6331	BCM Families Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001583] Funding Source: NIH RePORTER	BCM Families Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by BCM Families Foundation (SGJ) and Research to Prevent Blindness (grant to UTHSC Hamilton Eye Institute and Scheie Eye Institute; Physician Scientist Award to AI; Senior Scientific Scholar to AVC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi RV, 2000, INVEST OPHTH VIS SCI, V41, P3805; Aguilar M., 1954, OPT ACTA, V1, DOI [10.1080/713818657, DOI 10.1080/713818657]; Ayyagari R, 1999, MOL VIS, V5; Barthelmes D, 2006, INVEST OPHTH VIS SCI, V47, P1161, DOI 10.1167/iovs.05-0783; BERSON EL, 1983, AM J OPHTHALMOL, V95, P741, DOI 10.1016/0002-9394(83)90058-2; BLACKWELL HR, 1957, J OPT SOC AM, V47, P338; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Cideciyan AV, 2015, INVEST OPHTH VIS SCI, V56, P526, DOI 10.1167/iovs.14-15895; Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Cideciyan AV, 1997, INVEST OPHTH VIS SCI, V38, P1786; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; Crognale MA, 2004, VISUAL NEUROSCI, V21, P197, DOI 10.1017/S0952523804213384; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; ELENIUS V, 1985, ARCH OPHTHALMOL-CHIC, V103, P519, DOI 10.1001/archopht.1985.01050040061018; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; GOTTLOB I, 1994, GRAEF ARCH CLIN EXP, V232, P392, DOI 10.1007/BF00186579; HARWERTH RS, 1993, INVEST OPHTH VIS SCI, V34, P3011; HESS RF, 1989, J PHYSIOL-LONDON, V417, P123, DOI 10.1113/jphysiol.1989.sp017794; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7; KALLONIATIS M, 1990, J OPT SOC AM A, V7, P1912, DOI 10.1364/JOSAA.7.001912; Kay CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062097; Kazmi MA, 1997, INVEST OPHTH VIS SCI, V38, P1074; Kellner U, 2004, GRAEF ARCH CLIN EXP, V242, P729, DOI 10.1007/s00417-004-0921-z; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; MASSOF RW, 1979, INVEST OPHTH VIS SCI, V18, P263; Michaelides M, 2005, EYE, V19, P2, DOI 10.1038/sj.eye.6701391; Mizrahi-Meissonnier L, 2010, INVEST OPHTH VIS SCI, V51, P3884, DOI 10.1167/iovs.09-4592; Moskowitz A, 2009, INVEST OPHTH VIS SCI, V50, P950, DOI 10.1167/iovs.08-2544; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Roman AJ, 2005, EXP EYE RES, V80, P259, DOI 10.1016/j.exer.2004.09.008; Roman AJ, 2007, PHYSIOL MEAS, V28, pN51, DOI 10.1088/0967-3334/28/8/N02; Roman AJ, 2013, INVEST OPHTH VIS SCI, V54, P1378, DOI 10.1167/iovs.12-11341; ROSS DF, 1984, ARCH OPHTHALMOL-CHIC, V102, P1004; Rotenstreich Y, 2004, OPHTHALMOLOGY, V111, P1222, DOI 10.1016/j.ophtha.2003.10.025; Smithson HE, 2014, VISUAL NEUROSCI, V31, P211, DOI 10.1017/S0952523814000030; STABELL B, 1981, J OPT SOC AM, V71, P836, DOI 10.1364/JOSA.71.000836; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; Wiggins D, 2007, INVEST OPHTH VIS SCI, V48, P2089, DOI 10.1167/iovs.06-1108; Wyszecki G, 1982, COLOR SCI CONCEPTS M, P789	54	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125700	10.1371/journal.pone.0125700	http://dx.doi.org/10.1371/journal.pone.0125700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909963	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353376800144
J	Naville, D; Labaronne, E; Vega, N; Pinteur, C; Canet-Soulas, E; Vidal, H; Le Magueresse-Battistoni, B				Naville, Danielle; Labaronne, Emmanuel; Vega, Nathalie; Pinteur, Claudie; Canet-Soulas, Emmanuelle; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte			Metabolic Outcome of Female Mice Exposed to a Mixture of Low-Dose Pollutants in a Diet-Induced Obesity Model	PLOS ONE			English	Article							BISPHENOL-A; POLYCHLORINATED-BIPHENYLS; ENDOCRINE DISRUPTORS; PERINATAL EXPOSURE; INSULIN-RESISTANCE; FATTY LIVER; BODY-FAT; ADIPOSE; EXPRESSION; HEALTH	Pollutants are suspected to contribute to the etiology of obesity and related metabolic disorders. Apart from occupational exposure which concerns a subset of chemicals, humans are mostly exposed to a large variety of chemicals, all life-long and at low doses. Food ingestion is a major route of exposure and it is suggested that pollutants have a worsened impact when combined with a high-fat diet. In the experimental studies described herein, we aimed to add further evidence on the metabolic impact of food pollutants using a recently set up model in which mice are life-long fed a high-fat/high-sucrose diet (HFSD) with/without common food pollutants shown to exhibit metabolic disrupting activities. Specifically, this mixture comprised bisphenol A, dioxin, polychlorobiphenyl PCB153, and phthalate and was added in HFSD at doses resulting in mice exposure at the Tolerable Daily Intake dose range for each pollutant. We herein focused on the 7-week-old females which exhibited early signs of obesity upon HFSD feeding. We observed no signs of toxicity and no additional weight gain following exposure to the mixture but alleviated HFSD-induced glucose intolerance in the absence of alteration of gluconeogenesis and steatosis. It suggested that the observed metabolic improvement was more likely due to effects on muscle and/or adipose tissues rather than on the liver. Consistently, female mice exhibited enhanced lean/fat mass ratio and skeletal muscle insulin sensitivity. Moreover, expression levels of inflammatory markers were reduced in adipose tissue at 7 but enhanced at 12 weeks of age in agreement with the inverse alterations of glucose tolerance observed at these ages upon pollutant exposure in the HFSD-fed females. Collectively, these data suggest apparent biphasic effects of pollutants upon HFSD feeding along with obesity development. These effects were not observed in males and may depend on interactions between diet and pollutants.	[Naville, Danielle; Labaronne, Emmanuel; Vega, Nathalie; Pinteur, Claudie; Canet-Soulas, Emmanuelle; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte] Univ Lyon 1, INSA Lyon, INSERM, INRA,UMR1397,CarMeN Lab,U1060, Oullins, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Le Magueresse-Battistoni, B (corresponding author), Univ Lyon 1, INSA Lyon, INSERM, INRA,UMR1397,CarMeN Lab,U1060, Oullins, France.	brigitte.lemagueresse@inserm.fr	Carmen, Team1/Y-7382-2019; Carmen, Team3/Y-7384-2019; Vidal, Hubert/M-6674-2017; Naville, Danielle/N-1200-2017; Le Magueresse-Battistoni, Brigitte/AAZ-5601-2021; Le Magueresse-Battistoni, Brigitte/M-6927-2017	Carmen, Team1/0000-0003-4234-1746; Carmen, Team3/0000-0002-3614-0924; Vidal, Hubert/0000-0002-9467-0317; Naville, Danielle/0000-0003-2615-6161; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Lab, Carmen/0000-0002-5935-3236; Labaronne, Emmanuel/0000-0001-6314-7809	European Foundation of the Study of Diabetes (EFSD/Novo Nordisk, program); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Sante-Travail) [EST-2010/2/2007]; "Region Rhone-Alpes", France	European Foundation of the Study of Diabetes (EFSD/Novo Nordisk, program); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Sante-Travail)(French National Research Agency (ANR)); "Region Rhone-Alpes", France(Region Auvergne-Rhone-Alpes)	The authors declare that this research project was supported by grants from the European Foundation of the Study of Diabetes (EFSD/Novo Nordisk, program 2011) and the Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Sante-Travail, EST-2010/2/2007). Emmanuel Labaronne is a recipient of "Region Rhone-Alpes", France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alligier M, 2013, J CLIN ENDOCR METAB, V98, P802, DOI 10.1210/jc.2012-3289; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; [Anonymous], 2005, EFSA J, V243, P1; [Anonymous], 2006, EFSA J, P1; Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braniste V, 2010, P NATL ACAD SCI USA, V107, P448, DOI 10.1073/pnas.0907697107; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Choi YJ, 2010, ENVIRON HEALTH PERSP, V118, P976, DOI 10.1289/ehp.0901751; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Dorne JLCM, 2010, TOXICOLOGY, V268, P156, DOI 10.1016/j.tox.2009.11.004; Emond C, 2006, ENVIRON HEALTH PERSP, V114, P1394, DOI 10.1289/ehp.8805; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Gout J, 2010, MOL CELL ENDOCRINOL, V319, P99, DOI 10.1016/j.mce.2010.01.021; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Guyot E, 2013, DRUG DISCOV TODAY, V18, P479, DOI 10.1016/j.drudis.2012.11.014; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Janesick A, 2012, INT J ANDROL, V35, P437, DOI 10.1111/j.1365-2605.2012.01247.x; Kerr C. A., 2014, CRITICAL REV MICROBI; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lee DH, 2014, ENDOCR REV; List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009; Magre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040306; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Matthews Jason, 2006, Nucl Recept Signal, V4, pe016; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Milbrath MO, 2009, ENVIRON HEALTH PERSP, V117, P417, DOI 10.1289/ehp.11781; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Naville D, 2013, FASEB J, V27, P3860, DOI 10.1096/fj.13-231670; Naville D, 2011, TOXICOL LETT, V207, P251, DOI 10.1016/j.toxlet.2011.09.019; Nieuwdorp M, 2014, BRIT J SURG, V101, P887, DOI 10.1002/bjs.9549; Norstrom K, 2010, ENVIRON INT, V36, P855, DOI 10.1016/j.envint.2009.03.005; Rebourcet D, 2010, INT J ANDROL, V33, P413, DOI 10.1111/j.1365-2605.2009.01020.x; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Silins I, 2011, INT J ENV RES PUB HE, V8, P629, DOI 10.3390/ijerph8030629; Sun Q, 2014, ENVIRON HEALTH PERSP, V122, P616, DOI 10.1289/ehp.1307201; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Turner N, 2014, J ENDOCRINOL, V220, pT61, DOI 10.1530/JOE-13-0397; van Leeuwen FXR, 2000, CHEMOSPHERE, V40, P1095, DOI 10.1016/S0045-6535(99)00358-6; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandormael-Pournin S, 2014, CELL DEATH DIFFERENT; Wahlang B, 2013, J NUTR BIOCHEM, V24, P1587, DOI 10.1016/j.jnutbio.2013.01.009; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; *WHO, 2003, 55 WHO; Yoon M, 2010, PPAR RES, V2010, DOI 10.1155/2010/584296; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	59	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124015	10.1371/journal.pone.0124015	http://dx.doi.org/10.1371/journal.pone.0124015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909471	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800055
J	Teng, CF; Hsieh, WC; Wu, HC; Lin, YJ; Tsai, HW; Huang, WY; Su, IJ				Teng, Chiao-Fang; Hsieh, Wen-Chuan; Wu, Han-Chieh; Lin, Yih-Jyh; Tsai, Hung-Wen; Huang, Wenya; Su, Ih-Jen			Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade	PLOS ONE			English	Article							GROUND-GLASS HEPATOCYTES; CANCER-CELL METABOLISM; HEPATOCELLULAR-CARCINOMA; C-MYC; TISSUE METABOLOMICS; TRANSGENIC MICE; X-PROTEIN; S MUTANTS; MTOR; EXPRESSION	Hepatitis B virus (HBV) pre-S2 mutant can induce hepatocellular carcinoma (HCC) via the induction of endoplasmic reticulum stress to activate mammalian target of rapamycin (MTOR) signaling. The association of metabolic syndrome with HBV-related HCC raises the possibility that pre-S2 mutant-induced MTOR activation may drive the development of metabolic disorders to promote tumorigenesis in chronic HBV infection. To address this issue, glucose metabolism and gene expression profiles were analyzed in transgenic mice livers harboring pre-S2 mutant and in an in vitro culture system. The pre-S2 mutant transgenic HCCs showed glycogen depletion. The pre-S2 mutant initiated an MTOR-dependent glycolytic pathway, involving the eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1), Yin Yang 1 (YY1), and myelocytomatosis oncogene (MYC) to activate the solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1), contributing to aberrant glucose uptake and lactate production at the advanced stage of pre-S2 mutant transgenic tumorigenesis. Such a glycolysis-associated MTOR signal cascade was validated in human HBV-related HCC tissues and shown to mediate the inhibitory effect of a model of combined resveratrol and silymarin product on tumor growth. Our results provide the mechanism of pre-S2 mutant-induced MTOR activation in the metabolic switch in HBV tumorigenesis. Chemoprevention can be designed along this line to prevent HCC development in high-risk HBV carriers.	[Teng, Chiao-Fang; Hsieh, Wen-Chuan; Wu, Han-Chieh; Su, Ih-Jen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Lin, Yih-Jyh; Su, Ih-Jen] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Tsai, Hung-Wen; Su, Ih-Jen] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Huang, Wenya] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Su, IJ (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan.	suihjen@nhri.org.tw	Huang, Wenya/G-9115-2011; Wu, Han-Chieh/K-6928-2013; Teng, Chiao-Fang/L-6679-2013	Wu, Han-Chieh/0000-0003-2638-7883; Teng, Chiao-Fang/0000-0002-5218-0571	National Health Research Institutes [03A1-IVPP20-014]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	The authors received a grant from National Health Research Institutes (grant number: 03A1-IVPP20-014; http://www.nhri.org.tw/NHRI_WEB/nhriw001Action. do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, ANTICANCER RES, V26, P4457; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Bannasch P, 2012, WORLD J GASTROENTERO, V18, P6701, DOI 10.3748/wjg.v18.i46.6701; BEASLEY RP, 1981, LANCET, V2, P1129; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; Bishayee A, 2010, CANCER TREAT REV, V36, P43, DOI 10.1016/j.ctrv.2009.10.002; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feher J, 2012, CURR PHARM BIOTECHNO, V13, P210, DOI 10.2174/138920112798868818; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh WC, 2013, FUNCT FOODS HEALTH D, V3, P341, DOI 10.31989/ffhd.v3i9.41; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu HM, 2007, LEUKEMIA, V21, P747, DOI 10.1038/sj.leu.2404583; Huang Q, 2013, CANCER RES, V73, P4992, DOI 10.1158/0008-5472.CAN-13-0308; Jiang Hao, 2009, J Exp Ther Oncol, V8, P25; Joe AK, 2002, CLIN CANCER RES, V8, P893; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Su Ih-Jen, 2013, Hepatobiliary Surg Nutr, V2, P37, DOI 10.3978/j.issn.2304-3881.2012.10.08; Teng CF, 2011, HEPATOLOGY, V54, P1199, DOI 10.1002/hep.24529; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; TOSHKOV I, 1994, HEPATOLOGY, V20, P1162, DOI 10.1002/hep.1840200510; Tsai HW, 2011, CANCER-AM CANCER SOC, V117, P2951, DOI 10.1002/cncr.25837; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Wu HC, 2014, HUM PATHOL, V45, P1294, DOI 10.1016/j.humpath.2013.10.039; Yang JC, 2009, HEPATOLOGY, V49, P1962, DOI 10.1002/hep.22889; Zha XJ, 2011, CELL CYCLE, V10, P1015, DOI 10.4161/cc.10.7.15063; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163	37	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122373	10.1371/journal.pone.0122373	http://dx.doi.org/10.1371/journal.pone.0122373			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909713	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800020
J	Welkos, SL; Klimko, CP; Kern, SJ; Bearss, JJ; Bozue, JA; Bernhards, RC; Trevino, SR; Waag, DM; Amemiya, K; Worsham, PL; Cote, CK				Welkos, Susan L.; Klimko, Christopher P.; Kern, Steven J.; Bearss, Jeremy J.; Bozue, Joel A.; Bernhards, Robert C.; Trevino, Sylvia R.; Waag, David M.; Amemiya, Kei; Worsham, Patricia L.; Cote, Christopher K.			Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; COLONY MORPHOLOGY; YERSINIA-PESTIS; EXPERIMENTAL MELIOIDOSIS; INTRACELLULAR SURVIVAL; PULMONARY MELIOIDOSIS; VIRULENCE FACTORS; B. THAILANDENSIS; RISK-FACTORS; LIPOPOLYSACCHARIDE	Burkholderia pseudomallei, the etiologic agent of melioidosis, is a gram-negative facultative intracellular bacterium. This bacterium is endemic in Southeast Asia and Northern Australia and can infect humans and animals by several routes. It has also been estimated to present a considerable risk as a potential biothreat agent. There are currently no effective vaccines for B. pseudomallei, and antibiotic treatment can be hampered by nonspecific symptomology, the high incidence of naturally occurring antibiotic resistant strains, and disease chronicity. Accordingly, there is a concerted effort to better characterize B. pseudomallei and its associated disease. Before novel vaccines and therapeutics can be tested in vivo, a well characterized animal model is essential. Previous work has indicated that mice may be a useful animal model. In order to develop standardized animal models of melioidosis, different strains of bacteria must be isolated, propagated, and characterized. Using a murine intraperitoneal (IP) infection model, we tested the virulence of 11 B. pseudomallei strains. The IP route offers a reproducible way to rank virulence that can be readily reproduced by other laboratories. This infection route is also useful in distinguishing significant differences in strain virulence that may be masked by the exquisite susceptibility associated with other routes of infection (e.g., inhalational). Additionally, there were several pathologic lesions observed in mice following IP infection. These included varisized abscesses in the spleen, liver, and haired skin. This model indicated that commonly used laboratory strains of B. pseudomallei (i.e., K96243 and 1026b) were significantly less virulent as compared to more recently acquired clinical isolates. Additionally, we characterized in vitro strain-associated differences in virulence for macrophages and described a potential inverse relationship between virulence in the IP mouse model of some strains and in the macrophage phagocytosis assay. Strains which were more virulent for mice (e.g., HBPU10304a) were often less virulent in the macrophage assays, as determined by several parameters such as intracellular bacterial replication and host cell cytotoxicity.	[Welkos, Susan L.; Klimko, Christopher P.; Bozue, Joel A.; Bernhards, Robert C.; Trevino, Sylvia R.; Waag, David M.; Amemiya, Kei; Worsham, Patricia L.; Cote, Christopher K.] US Army, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD 21701 USA; [Kern, Steven J.] US Army, Med Res Inst Infect Dis, Div Biostat, Frederick, MD USA; [Bearss, Jeremy J.] US Army, Med Res Inst Infect Dis, Vet Pathol Div, Frederick, MD USA		Cote, CK (corresponding author), US Army, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD 21701 USA.	christopher.k.cote.civ@mail.mil	Bozue, Joel/AAE-4357-2022; Bozue, Joel/AAE-4363-2022	Bozue, Joel/0000-0001-6959-8176; Bozue, Joel/0000-0001-6959-8176; Bearss, David/0000-0002-4280-5670	Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA)	Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This research was funded by the Medical Biological Defense Research Program; Defense Threat Reduction Agency (DTRA). The funders had a role in selecting the bacterial strains which comprised the B. pseudomallei strain panel examined in this work.	Aardema H, 2005, EPIDEMIOL INFECT, V133, P871, DOI 10.1017/S0950268805004103; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Atkins T, 2002, J MED MICROBIOL, V51, P539, DOI 10.1099/0022-1317-51-7-539; Atkins T, 2002, INFECT IMMUN, V70, P5290, DOI 10.1128/IAI.70.9.5290-5294.2002; Barnes JL, 2005, EMERG INFECT DIS, V11, P638, DOI 10.3201/eid1104.041051; Bozue J, 2011, MICROB PATHOGENESIS, V50, P314, DOI 10.1016/j.micpath.2011.02.005; Breitbach K, 2003, CELL MICROBIOL, V5, P385, DOI 10.1046/j.1462-5822.2003.00277.x; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; Challacombe JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115951; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chantratita N, 2012, J PROTEOMICS, V75, P1031, DOI 10.1016/j.jprot.2011.10.015; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Chin CY, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00085; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Dance D, 2014, INT J ANTIMICROB AG, V43, P310, DOI 10.1016/j.ijantimicag.2014.01.005; DANNENBERG AM, 1958, J EXP MED, V107, P153, DOI 10.1084/jem.107.1.153; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P865; Doker TJ, 2015, CLIN INFECT DIS, V60, P243, DOI 10.1093/cid/ciu764; Evans E, 1999, J MED MICROBIOL, V48, P825, DOI 10.1099/00222615-48-9-825; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gan YH, 2005, J INFECT DIS, V192, P1845, DOI 10.1086/497382; Gee JE, 2014, EMERG INFECT DIS, V20, P682, DOI 10.3201/eid2004.130960; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Hara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006496; Harland DN, 2007, INFECT IMMUN, V75, P4173, DOI 10.1128/IAI.00404-07; Hassan MRA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-302; Haussler S, 2003, INFECT IMMUN, V71, P2970, DOI 10.1128/IAI.71.5.2970-2975.2003; Hoffman M.D., 2011, NO U TURN SAMPLER AD; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kronmann KC, 2009, AM J TROP MED HYG, V80, P182, DOI 10.4269/ajtmh.2009.80.182; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Liu X, 2015, EMERG INFECT DIS, V21, P159, DOI 10.3201/eid2101.140042; Lo TJ, 2009, EMERG INFECT DIS, V15, P1645, DOI 10.3201/eid1510.090246; Manzenyuk I. N., 1999, Antibiotiki i Khimioterapiya, V44, P21; Massey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04305; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Nandi T, 2013, MBIO, V4, DOI 10.1128/mBio.00709-13; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Nieves W, 2014, CLIN VACCINE IMMUNOL, V21, P747, DOI 10.1128/CVI.00119-14; O'Sullivan BP, 2011, CHEST, V140, P239, DOI 10.1378/chest.10-3336; Parkes JD, 2009, J FELINE MED SURG, V11, P724, DOI 10.1016/j.jfms.2008.09.009; Pegoraro G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-98; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Saonanon P, 2013, OPHTHAL PLAST RECONS, V29, pE81, DOI 10.1097/IOP.0b013e318275b601; Sarkar-Tyson M, 2009, VACCINE, V27, P4447, DOI 10.1016/j.vaccine.2009.05.040; Scott AE, 2014, INFECT IMMUN, V82, P3206, DOI 10.1128/IAI.01847-14; Scott AE, 2013, CLIN VACCINE IMMUNOL, V20, P1041, DOI 10.1128/CVI.00113-13; SHAW D, 1995, FEMS IMMUNOL MED MIC, V11, P99, DOI 10.1016/0928-8244(95)00012-V; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Sprague LD, 2004, J VET MED B, V51, P305, DOI 10.1111/j.1439-0450.2004.00797.x; Srilunchang T, 2009, SE ASIAN J TROP MED, V40, P123; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; TARLOW MJ, 1971, P ROY SOC MED, V64, P19, DOI 10.1177/003591577106400111; Team SD, 2013, ATNA C LIB PROBABILI; Team SD, 2014, RSTAN R INTERFACE ST; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V136, P277, DOI 10.1111/j.1365-2249.2004.02445.x; Utaisincharoen P, 2000, CLIN EXP IMMUNOL, V122, P324, DOI 10.1046/j.1365-2249.2000.01386.x; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; Van Zandt KE, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00120; Vietri N. J., 2007, MED ASPECTS BIOL WAR, P147; Wand ME, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-11; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; WELKOS SL, 2011, BACILLUS ANTHRACIS A, P179; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wikraiphat C, 2009, FEMS IMMUNOL MED MIC, V56, P253, DOI 10.1111/j.1574-695X.2009.00574.x; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; YABUUCHI E, 1993, MICROBIOL IMMUNOL, V37, P823, DOI 10.1111/j.1348-0421.1993.tb01712.x; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; Yingst SL, 2014, J MED MICROBIOL, V63, P118, DOI 10.1099/jmm.0.059063-0; Zehnder AM, 2014, EMERG INFECT DIS, V20, P304, DOI 10.3201/eid2002.131314; Zhang BX, 2012, MIL MED, V177, P216, DOI 10.7205/MILMED-D-11-00232	97	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124667	10.1371/journal.pone.0124667	http://dx.doi.org/10.1371/journal.pone.0124667			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909629	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800098
J	Wu, SY; Liu, SY; Liu, ZM; Huang, JF; Pu, XY; Li, J; Yang, DH; Deng, HJ; Yang, N; Xu, JS				Wu, Shiyang; Liu, Suyan; Liu, Zhiming; Huang, Jiefeng; Pu, Xiaoyu; Li, Jing; Yang, Dinghua; Deng, Haijun; Yang, Ning; Xu, Jiasen			Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers	PLOS ONE			English	Article							BREAST-CANCER; METASTASIS; VIMENTIN; TWIST; MIGRATION; EPCAM	In cancer, epithelial-mesenchymal transition (EMT) is associated with metastasis. Characterizing EMT phenotypes in circulating tumor cells (CTCs) has been challenging because epithelial marker-based methods have typically been used for the isolation and detection of CTCs from blood samples. The aim of this study was to use the optimized CanPatrol CTC enrichment technique to classify CTCs using EMT markers in different types of cancers. The first step of this technique was to isolate CTCs via a filter-based method; then, an RNA in situ hybridization (RNA-ISH) method based on the branched DNA signal amplification technology was used to classify the CTCs according to EMT markers. Our results indicated that the efficiency of tumor cell recovery with this technique was at least 80%. When compared with the non-optimized method, the new method was more sensitive and more CTCs were detected in the 5-ml blood samples. To further validate the new method, 164 blood samples from patients with liver, nasopharyngeal, breast, colon, gastric cancer, or nonsmall-cell lung cancer (NSCLC) were collected for CTC isolation and characterization. CTCs were detected in 107(65%) of 164 blood samples, and three CTC subpopulations were identified using EMT markers, including epithelial CTCs, biophenotypic epithelial/mesenchymal CTCs, and mesenchymal CTCs. Compared with the earlier stages of cancer, mesenchymal CTCs were more commonly found in patients in the metastatic stages of the disease in different types of cancers. Circulating tumor microemboli (CTM) with a mesenchymal phenotype were also detected in the metastatic stages of cancer. Classifying CTCs by EMT markers helps to identify the more aggressive CTC subpopulation and provides useful evidence for determining an appropriate clinical approach. This method is suitable for a broad range of carcinomas.	[Wu, Shiyang; Liu, Suyan; Liu, Zhiming; Huang, Jiefeng; Pu, Xiaoyu; Xu, Jiasen] SurExam Biotech, Guangzhou Technol Innovat Base, Guangzhou, Guangdong, Peoples R China; [Li, Jing] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Yang, Dinghua] Guangzhou Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Deng, Haijun] Guangzhou Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Yang, Ning] Guangdong Coll Pharm, Hosp 1, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Guangdong Pharmaceutical University	Xu, JS (corresponding author), SurExam Biotech, Guangzhou Technol Innovat Base, 80 Lan Yue Rd, Guangzhou, Guangdong, Peoples R China.	jsx_surexam@sina.cn	Liu, Zhiming/GXG-6785-2022; Liu, Zhiming/AGO-6824-2022		SurExam BioTech	SurExam BioTech	This study was funded by SurExam BioTech. The funder provided support in the form of salaries for authors SW, SL, ZL, JH, XP and JX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; DOMAGALA W, 1990, AM J PATHOL, V136, P219; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsongalis GJ, 2006, AM J CLIN PATHOL, V126, P448, DOI 10.1039/90BU6KDXANFLN4RJ; Wu SY, 2014, CLIN CHEM LAB MED, V52, P243, DOI 10.1515/cclm-2013-0558; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu WL, 2008, DEV DYNAM, V237, P2716, DOI 10.1002/dvdy.21627; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao Y, 2008, CELL BIOCHEM FUNCT, V26, P571, DOI 10.1002/cbf.1478	26	183	202	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123976	10.1371/journal.pone.0123976	http://dx.doi.org/10.1371/journal.pone.0123976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909322	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800052
J	Chen, J; Lin, MY; Hrabovsky, A; Pedrosa, E; Dean, J; Jain, S; Zheng, DY; Lachman, HM				Chen, Jian; Lin, Mingyan; Hrabovsky, Anastasia; Pedrosa, Erika; Dean, Jason; Jain, Swati; Zheng, Deyou; Lachman, Herbert M.			ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; GENOME-WIDE ASSOCIATION; AUTISM SPECTRUM DISORDERS; BIPOLAR DISORDER; PRENATAL INFECTION; CANDIDATE GENES; NEURODEVELOPMENTAL PATHWAYS; INFLAMMATORY CYTOKINES; INCREASED EXPRESSION; PREFRONTAL CORTEX	ZNF804A (Zinc Finger Protein 804A) has been identified as a candidate gene for schizophrenia (SZ), autism spectrum disorders (ASD), and bipolar disorder (BD) in replicated genome wide association studies (GWAS) and by copy number variation (CNV) analysis. Although its function has not been well-characterized, ZNF804A contains a C2H2-type zinc-finger domain, suggesting that it has DNA binding properties, and consequently, a role in regulating gene expression. To further explore the role of ZNF804A on gene expression and its downstream targets, we used a gene knockdown (KD) approach to reduce its expression in neural progenitor cells (NPCs) derived from induced pluripotent stem cells (iPSCs). KD was accomplished by RNA interference (RNAi) using lentiviral particles containing shRNAs that target ZNF804A mRNA. Stable transduced NPC lines were generated after puromycin selection. A control cell line expressing a random (scrambled) shRNA was also generated. Neuronal differentiation was induced, RNA was harvested after 14 days and transcriptome analysis was carried out using RNA-seq. 1815 genes were found to be differentially expressed at a nominally significant level (p<0.05); 809 decreased in expression in the KD samples, while 1106 increased. Of these, 370 achieved genome wide significance (FDR<0.05); 125 were lower in the KD samples, 245 were higher. Pathway analysis showed that genes involved in interferon-signaling were enriched among those that were down-regulated in the KD samples. Correspondingly, ZNF804A KD was found to affect interferon-alpha 2 (IFNA2)-mediated gene expression. The findings suggest that ZNF804A may affect a differentiating neuron's response to inflammatory cytokines, which is consistent with models of SZ and ASD that support a role for infectious disease, and/or autoimmunity in a subgroup of patients.	[Chen, Jian; Hrabovsky, Anastasia; Pedrosa, Erika; Dean, Jason; Jain, Swati; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lin, Mingyan; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zheng, DY (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	Deyou.Zheng@einstein.yu.edu; Herb.Lachman@einstein.yu.edu	lin, mingyan/HDL-9420-2022	Zheng, Deyou/0000-0003-4354-5337	National Institute of Mental Health [MH073164, MH097893, MH099427, MH087840]; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087840, R21MH087840, R01MH073164, R01MH099427, R21MH097893] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (MH073164, MH097893, MH099427, and MH087840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazyan B, 2014, SCHIZOPHRENIA BULL, V40, P575, DOI 10.1093/schbul/sbt071; Abdallah MW, 2012, BRAIN BEHAV IMMUN, V26, P170, DOI 10.1016/j.bbi.2011.09.003; AL-Ayadhi LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-158; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Arrode-Bruses G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-83; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Bachus SE, 1997, J PSYCHIATR RES, V31, P233, DOI 10.1016/S0022-3956(96)00041-6; Barry G, 2014, MOL PSYCHIATR, V19, P486, DOI 10.1038/mp.2013.45; Bek MJ, 2003, J IMMUNOL, V170, P931, DOI 10.4049/jimmunol.170.2.931; Beumer W, 2012, PSYCHONEUROENDOCRINO, V37, P1901, DOI 10.1016/j.psyneuen.2012.04.001; Blake J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090894; Borovcanin M, 2012, J PSYCHIATR RES, V46, P1421, DOI 10.1016/j.jpsychires.2012.08.016; Boulanger LM, 2004, NEURON GLIA BIOL, V1, P283, DOI 10.1017/S1740925X05000128; Brimberg L, 2013, MOL PSYCHIATR, V18, P1171, DOI 10.1038/mp.2013.101; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Canetta SE, 2012, TRANSL NEUROSCI, V3, P320, DOI 10.2478/s13380-012-0045-6; Carter CJ, 2009, SCHIZOPHRENIA BULL, V35, P1163, DOI 10.1093/schbul/sbn054; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075682; Chen XX, 2011, BIOCHEM BIOPH RES CO, V404, P1029, DOI 10.1016/j.bbrc.2010.12.104; Chiang SSW, 2013, PSYCHIAT CLIN NEUROS, V67, P228, DOI 10.1111/pcn.12040; Chintawar S, 2009, STEM CELLS, V27, P838, DOI 10.1002/stem.25; Connor CM, 2012, SCHIZOPHR RES, V140, P175, DOI 10.1016/j.schres.2012.06.037; Corvin A, 2014, BIOL PSYCHIAT, V75, P276, DOI 10.1016/j.biopsych.2013.09.018; Davis LK, 2012, AM J MED GENET A, V158A, P1654, DOI 10.1002/ajmg.a.35396; Debnath M, 2014, SCHIZOPHRENIA BULL, V40, P1412, DOI 10.1093/schbul/sbu049; Declercq J, 2013, STEM CELLS DEV, V22, P2017, DOI 10.1089/scd.2012.0651; Del Boca C, 2012, NEUROSCIENCE, V218, P185, DOI 10.1016/j.neuroscience.2012.05.022; Desbonnet L, 2012, BRAIN BEHAV IMMUN, V26, P660, DOI 10.1016/j.bbi.2012.02.010; Di Schiavi E, 2013, CURR GENOMICS, V14, P2, DOI 10.2174/138920213804999174; Dimitrov DH, 2013, SCHIZOPHR RES, V151, P29, DOI 10.1016/j.schres.2013.10.019; Ding ML, 2014, PROG NEURO-PSYCHOPH, V51, P78, DOI 10.1016/j.pnpbp.2014.01.001; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Drexhage RC, 2008, SCHIZOPHR RES, V102, P352, DOI 10.1016/j.schres.2008.03.018; Drummond DL, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-31; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fatjo-Vilas M, 2012, BIOL PSYCHIAT, V72, P758, DOI 10.1016/j.biopsych.2012.04.035; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gesundheit B, 2013, J AUTOIMMUN, V44, P1, DOI 10.1016/j.jaut.2013.05.005; Ghanizadeh A, 2011, INT J HYPERTHER, V27, P737, DOI 10.3109/02656736.2011.604665; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Guyon A, 2009, NEUROSCIENCE, V162, P1072, DOI 10.1016/j.neuroscience.2009.05.048; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hicks DJ, 2013, J COMP PATHOL, V149, P446, DOI 10.1016/j.jcpa.2013.04.001; Hill MJ, 2012, HUM MOL GENET, V21, P1018, DOI 10.1093/hmg/ddr532; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hornberg M, 2009, J NEUROCHEM, V110, P1263, DOI 10.1111/j.1471-4159.2009.06216.x; Horvath S, 2014, BIOL PSYCHIAT, V75, P316, DOI 10.1016/j.biopsych.2013.06.010; Hovey D, 2014, SOC NEUROSCI-UK, V9, P378, DOI 10.1080/17470919.2014.897995; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Jyonouchi H, 2011, J NEUROIMMUNOL, V238, P73, DOI 10.1016/j.jneuroim.2011.07.001; Kalman S, 2014, EXP CELL RES, V320, P343, DOI 10.1016/j.yexcr.2013.10.019; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Khorooshi R, 2008, J IMMUNOL, V181, P7284, DOI 10.4049/jimmunol.181.10.7284; Kim DS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00109; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Kuo YL, 2012, J CLIN NEUROSCI, V19, P896, DOI 10.1016/j.jocn.2011.10.006; Kutzleb C, 2007, HISTOCHEM CELL BIOL, V127, P13, DOI 10.1007/s00418-006-0209-y; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lacerda HR, 2014, J INTERF CYTOK RES, V34, P385, DOI 10.1089/jir.2013.0029; Landreau F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051068; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lee SY, 2011, DEV NEUROBIOL, V71, P83, DOI 10.1002/dneu.20815; Lee Y, 2012, PSYCHIAT GENET, V22, P206, DOI 10.1097/YPG.0b013e328353ae3d; Lee YH, 2013, GENE, V525, P107, DOI 10.1016/j.gene.2013.04.014; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lin MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094968; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Listwak SJ, 2013, NEUROSCIENCE, V250, P282, DOI 10.1016/j.neuroscience.2013.07.013; Loe-Mie Y, 2010, HUM MOL GENET, V19, P2841, DOI 10.1093/hmg/ddq184; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marchetto MC, 2011, HUM MOL GENET, V20, pR109, DOI 10.1093/hmg/ddr336; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Matsumoto K, 2012, NEUROSCI RES, V73, P257, DOI 10.1016/j.neures.2012.04.004; McAllister AK, 2014, BIOL PSYCHIAT, V75, P262, DOI 10.1016/j.biopsych.2013.10.003; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Miya K, 2013, BRAIN DEV; Miya K, 2014, BRAIN DEV-JPN, V36, P645, DOI 10.1016/j.braindev.2013.10.005; Modinos G, 2013, SCHIZOPHR RES, V150, P356, DOI 10.1016/j.schres.2013.09.010; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P277, DOI 10.1016/j.pnpbp.2012.10.022; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Leary C, 2014, NEUROSCIENCE, V277, P294, DOI 10.1016/j.neuroscience.2014.06.028; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Olechnowicz SWZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044564; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Parker-Athill EC, 2010, NEUROSIGNALS, V18, P113, DOI 10.1159/000319828; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pinciroli P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-508; Pirnik Z, 2010, PEPTIDES, V31, P139, DOI 10.1016/j.peptides.2009.09.035; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Ramos PS, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-4; Rao JS, 2013, SCHIZOPHR RES, V147, P24, DOI 10.1016/j.schres.2013.02.017; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Riordan JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003441; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosito M, 2012, J NEUROSCI, V32, P3154, DOI 10.1523/JNEUROSCI.4046-11.2012; Ross HE, 2013, BRAIN BEHAV IMMUN, V31, P76, DOI 10.1016/j.bbi.2012.12.021; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Roumier A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002595; Saben J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1, DOI 10.1152/ajpendo.00076.2013; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Seibt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048675; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Siegel BI, 2014, BIOL PSYCHIAT, V76, P160, DOI 10.1016/j.biopsych.2013.09.019; Soronen P, 2010, MOL PSYCHIATR, V15, P4, DOI 10.1038/mp.2009.86; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Steinecke A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00190; Steiner J, 2014, PROG NEURO-PSYCHOPH, V48, P287, DOI 10.1016/j.pnpbp.2012.09.016; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaccarino FM, 2011, NEUROPHARMACOLOGY, V60, P1355, DOI 10.1016/j.neuropharm.2011.02.021; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/825364; Wei H, 2013, NEUROSCIENCE, V252, P320, DOI 10.1016/j.neuroscience.2013.08.025; Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Wojkowska DW, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/590409; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhang YB, 2013, J NEUROIMMUNOL, V258, P51, DOI 10.1016/j.jneuroim.2013.02.019; Zwanzger P, 2012, DEPRESS ANXIETY, V29, P762, DOI 10.1002/da.21919	165	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124597	10.1371/journal.pone.0124597	http://dx.doi.org/10.1371/journal.pone.0124597			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905630	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000077
J	Kabakov, AY; Lisman, JE				Kabakov, Anatoli Y.; Lisman, John E.			Catalytically Dead aCaMKII K42M Mutant Acts as a Dominant Negative in the Control of Synaptic Strength	PLoS One			English	Article							LONG-TERM POTENTIATION; KINASE-II; PROTEIN-KINASE; AUTONOMOUS CAMKII; PHOSPHORYLATION; LTP; AUTOPHOSPHORYLATION; CONDUCTANCE; INHIBITION; PLASTICITY	During long-term potentiation (LTP) of excitatory synapses, Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated by Ca2+ influx through NMDA receptors that potentiate AMPA receptor currents by insertion of additional GluR1-containing receptors at the synapse and by increasing AMPA channel conductance, as well as by stimulating structural changes. CaMKII is also involved in the maintenance of LTP and contributes to maintenance of behavioral sensitization by cocaine or amphetamine. Recent studies show that transient expression of catalytically dead alpha CaMKII K42M mutant after exposure to amphetamine persistently reverses the behavioral effects of the addiction. A suggested interpretation is that this mutant acts as a dominant negative in the control of synaptic strength, but this interpretation has not been physiologically tested. Here we investigate the effect of alpha CaMKII K42M mutant expressed in single CA1 pyramidal neurons on basal excitatory neurotransmission in cultured rat hippocampal organotypic slices. The mutant caused nearly 50% reduction in the basal CA3-CA1 transmission, while overexpression of the wild-type alpha CaMKII had no effect. This result is consistent with the dominant negative hypothesis, but there are complexities. We found that the decrease in basal transmission did not occur when activity in the slices was suppressed after transfection by TTX or when NMDA receptors were blocked by APV. Thus, the dominant negative effect requires neural activity for its expression.	[Lisman, John E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Lisman, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	lisman@brandeis.edu			National Institute on Drug Abuse (NIDA) Collaborative Research in Computational Neuroscience (CRCNS) [R01DA027807];  [NIH-U01NS090583]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA) Collaborative Research in Computational Neuroscience (CRCNS); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse (NIDA) Collaborative Research in Computational Neuroscience (CRCNS) Grant R01DA027807 and by NIH-U01NS090583. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Barcomb K, 2014, FASEB J, V28, P3810, DOI 10.1096/fj.14-250407; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Loweth JA, 2013, J NEUROSCI, V33, P1411, DOI 10.1523/JNEUROSCI.4386-13.2013; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Stratton M, 2014, ELIFE, V3, DOI 10.7554/eLife.01610; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	25	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123718	10.1371/journal.pone.0123718	http://dx.doi.org/10.1371/journal.pone.0123718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905720	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000042
J	Kaddumukasa, M; Lwanira, C; Lugaajju, A; Katabira, E; Persson, KEM; Wahlgren, M; Kironde, F				Kaddumukasa, Mark; Lwanira, Catherine; Lugaajju, Allan; Katabira, Elly; Persson, Kristina E. M.; Wahlgren, Mats; Kironde, Fred			Parasite Specific Antibody Increase Induced by an Episode of Acute P-falciparum Uncomplicated Malaria	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; MEROZOITE SURFACE PROTEIN-1; VACCINE CANDIDATE GMZ2; BLOOD-STAGE ANTIGENS; NEW-GUINEAN CHILDREN; CLINICAL MALARIA; IMMUNE-RESPONSES; ACQUIRED-IMMUNITY; SEASONAL MALARIA; IMMUNOGLOBULIN-G	Introduction There is no approved vaccine for malaria, and precisely how human antibody responses to malaria parasite components and potential vaccine molecules are developed and maintained remains poorly defined. In this study, antibody anamnestic or memory response elicited by a single episode of P. falciparum infection was investigated. Methods This study involved 362 malaria patients aged between 6 months to 60 years, of whom 19% were early-diagnosed people living with HIV/AIDS (PLWHA). On the day malaria was diagnosed and 42 days later, blood specimens were collected. Parasite density, CD4(+) cells, and antibodies specific to synthetic peptides representing antigenic regions of the P. falciparum proteins GLURP, MSP3 and HRPII were measured. Results On the day of malaria diagnosis, Immunoglobulin (IgG) antibodies against GLURP, MSP3 and HRP II peptides were present in the blood of 75%, 41% and 60% of patients, respectively. 42 days later, the majority of patients had boosted their serum IgG antibody more than 1.2 fold. The increase in level of IgG antibody against the peptides was not affected by parasite density at diagnosis. The median CD4(+) cell counts of PLWHAs and HIV negative individuals were not statistically different, and median post-infection increases in anti-peptide IgG were similar in both groups of patients. Conclusion In the majority (70%) of individuals, an infection of P. falciparum elicits at least 20% increase in level of anti-parasite IgG. This boost in anti-P. falciparum IgG is not affected by parasite density on the day of malaria diagnosis, or by HIV status.	[Kaddumukasa, Mark; Katabira, Elly] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Lwanira, Catherine; Lugaajju, Allan; Kironde, Fred] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Persson, Kristina E. M.; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden; [Persson, Kristina E. M.] Lund Univ, Dept Lab Med, Stockholm, Sweden; [Kironde, Fred] IUIU, Habib Med Sch, Kampala, Uganda	Makerere University; Makerere University; Karolinska Institutet; Lund University	Kaddumukasa, M (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	kaddumark@yahoo.co.uk		Kironde, Fred/0000-0003-4981-6417; Lugaajju, Allan/0000-0003-4841-0538; Nassozi Lwanira, Catherine/0000-0003-1767-6851; Persson, Kristina E M/0000-0003-2661-3115	European & Developing Countries Clinical Trials Partnership (EDCTP) grant [IP.2007.31100.001]; Makerere Sida-SAREC collaborative grant for research and training; European Community's Seventh Framework Programme (FP7) [242095]	European & Developing Countries Clinical Trials Partnership (EDCTP) grant; Makerere Sida-SAREC collaborative grant for research and training; European Community's Seventh Framework Programme (FP7)	This research was conducted with funding from the European & Developing Countries Clinical Trials Partnership (EDCTP) grant (number IP.2007.31100.001) and from Makerere Sida-SAREC collaborative grant for research and training. The research leading to these results has also received funding (to FK and MW) from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N<SUP>o</SUP> 242095 (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 2003, ASS MON ANT DRUG EFF; Avila Sandra L. M., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P309, DOI 10.1590/S0036-46651998000500008; Baumann A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-46; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Boutlis CS, 2003, J INFECT DIS, V187, P862, DOI 10.1086/367897; BROWN H, 1987, MOL BIOL MED, V4, P365; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; BUTCHER GA, 1992, PARASITOL TODAY, V8, P307, DOI 10.1016/0169-4758(92)90104-A; Cavanagh DR, 1998, J IMMUNOL, V161, P347; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; de Souza W, 2008, CURR PHARM DESIGN, V14, P822, DOI 10.2174/138161208784041123; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; GARNHAM PCC, 1949, ANN TROP MED PARASIT, V43, P47, DOI 10.1080/00034983.1949.11685394; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hochman S, 2012, J NEUROPARASITOLOGY, P3; Jepsen MPG, 2013, J INFECT DIS, V208, P479, DOI 10.1093/infdis/jit185; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Kinyanjui SM, 2003, J INFECT DIS, V187, P667, DOI 10.1086/373994; KIRONDE FAS, 1991, INFECT IMMUN, V59, P3909, DOI 10.1128/IAI.59.11.3909-3916.1991; Laman M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-145; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lousada-Dietrich S, 2011, VACCINE, V29, P3284, DOI 10.1016/j.vaccine.2011.02.022; Mamo H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-51; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MCBRIDE JS, 1982, SCIENCE, V217, P254, DOI 10.1126/science.6178159; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Migot F, 1996, PARASITE IMMUNOL, V18, P333, DOI 10.1046/j.1365-3024.1996.d01-116.x; Mordmuller B, 2010, VACCINE, V28, P6698, DOI 10.1016/j.vaccine.2010.07.085; Mulumba JGT, 2012, J COMMUN HEALTH, V37, P1234, DOI 10.1007/s10900-012-9559-7; Ndungu FM, 2013, EUR J IMMUNOL, V43, P2919, DOI 10.1002/eji.201343630; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Perraut R, 2002, MICROBES INFECT, V4, P31, DOI 10.1016/S1286-4579(01)01506-4; Pinder M, 2010, VACCINE, V28, P4695, DOI 10.1016/j.vaccine.2010.04.091; RAY P, 1994, INFECT IMMUN, V62, P2354, DOI 10.1128/IAI.62.6.2354-2361.1994; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Tall A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-161; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096098; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; WHO, 2006, WHO GUID TREATM MAL; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174; Zerpa NC, 2006, EXP PARASITOL, V113, P227, DOI 10.1016/j.exppara.2006.01.007	58	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124297	10.1371/journal.pone.0124297	http://dx.doi.org/10.1371/journal.pone.0124297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906165	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000064
J	Jin, NN; Yin, XM; Gu, JL; Zhang, XH; Shi, JH; Qian, W; Ji, YH; Cao, MH; Gu, XS; Ding, F; Iqbal, K; Gong, CX; Liu, F				Jin, Nana; Yin, Xiaomin; Gu, Jianlan; Zhang, Xinhua; Shi, Jianhua; Qian, Wei; Ji, Yuhua; Cao, Maohong; Gu, Xiaosong; Ding, Fei; Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei			Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; NEUTRAL PROTEINASE CALPAIN; AMYLOID PRECURSOR PROTEIN; DOWN-SYNDROME; HUMAN-BRAIN; FUNCTIONAL-LINK; MESSENGER-RNA; EXON 10; NEUROFIBRILLARY PATHOLOGY; ABNORMAL PHOSPHORYLATION	Hyperphosphorylation and dysregulation of exon 10 splicing of Tau are pivotally involved in pathogenesis of Alzheimer disease (AD) and/or other tauopathies. Alternative splicing of Tau exon 10, which encodes the second microtubule-binding repeat, generates Tau isoforms containing three and four microtubule-binding repeats, termed 3R-Taus and 4R-Taus, respectively. Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) lies at the Down syndrome critical region of chromosome 21. Overexpression of this kinase may contribute to the early Tau pathology in Down syndrome via phosphorylation of Tau and dysregulation of Tau exon 10. Here, we report that Dyrk1A was truncated at the C terminus and was associated with overactivation of calpain I in AD brain. Calpain I proteolyzed Dyrk1A in vitro first at the C terminus and further at the N terminus and enhanced its kinase activity toward Tau via increased V-max but not K-m. C-terminal truncation of Dyrk1A resulted in stronger activity than its full-length protein in promotion of exon 10 exclusion and phosphorylation of Tau. Dyrk1A was truncated in kainic acid-induced excitotoxic mouse brains and coincided with an increase in 3R-Tau expression and phosphorylation of Tau via calpain activation. Moreover, truncation of Dyrk1A was correlated with an increase in the ratio of 3R-Tau/4R-Tau and Tau hyperphosphorylation in AD brain. Collectively, these findings suggest that truncation/activation of Dyrk1A by Ca2+/calpain I might contribute to Tau pathology via promotion of exon 10 exclusion and hyperphosphorylation of Tau in AD brain.	[Gu, Xiaosong; Ding, Fei; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Jin, Nana; Yin, Xiaomin; Gu, Jianlan; Zhang, Xinhua; Shi, Jianhua; Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Shi, Jianhua; Qian, Wei] Nantong Univ, Sch Med Sci, Dept Biochem & Mol Biol, Nantong 226001, Jiangsu, Peoples R China; [Cao, Maohong] Nantong Univ, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Institute for Basic Research in Developmental Disabilities; Nantong University; Nantong University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com	Regan, Clinton/E-6250-2012; Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X	Nantong University; New York State Office of People with Developmental Disabilities; National Natural Science Foundation of China [81030059]; United States Alzheimer's Association [IIRG-10-173154]; Jiangsu Education Department [10KJA310040]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Institutes of Health [P30 AG19610]; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610] Funding Source: NIH RePORTER	Nantong University; New York State Office of People with Developmental Disabilities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States Alzheimer's Association; Jiangsu Education Department; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Nantong University and the New York State Office of People with Developmental Disabilities and by grants from the National Natural Science Foundation of China (Grant 81030059), the United States Alzheimer's Association (Grant IIRG-10-173154), the Basic Research Program of the Jiangsu Education Department (Grant 10KJA310040), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The Brain Donation Program is supported in part by National Institutes of Health Grant P30 AG19610 (Arizona Alzheimer's Disease Core Center).	Adayev T, 2007, BIOCHEMISTRY-US, V46, P7614, DOI 10.1021/bi700251n; Adayev T, 2006, BIOCHEMISTRY-US, V45, P12011, DOI 10.1021/bi060632j; ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Alonso AD, 2001, J BIOL CHEM, V276, P37967; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alvarez M, 2007, MOL BIOL CELL, V18, P1167, DOI 10.1091/mbc.E06-08-0668; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H., 1995, NEUROBIOL AGING, V16, P278, DOI DOI 10.1016/0197-4580(95)00021-6; Chambers CB, 1999, ANN NEUROL, V46, P325, DOI 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO;2-V; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fath T, 2002, J NEUROSCI, V22, P9733; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Glenner G G, 1984, Appl Pathol, V2, P357; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; IQBAL K, 1986, LANCET, V2, P421; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; MATTSON MP, 1992, NEUROBIOL AGING, V13, P617, DOI 10.1016/0197-4580(92)90068-9; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Perez M, 2002, EUR J BIOCHEM, V269, P1484, DOI 10.1046/j.1432-1033.2002.02794.x; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Rodriguez-Martin T, 2013, NEUROBIOL AGING, V34, P2146, DOI 10.1016/j.neurobiolaging.2013.03.015; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Singh TJ, 1997, MOL CELL BIOCHEM, V168, P141, DOI 10.1023/A:1006807105059; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; Wiechmann S, 2003, BIOCHEM BIOPH RES CO, V302, P403, DOI 10.1016/S0006-291X(03)00148-7; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x; Yasojima K, 1999, BRAIN RES, V831, P301, DOI 10.1016/S0006-8993(99)01486-9; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	89	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15219	15237		10.1074/jbc.M115.645507	http://dx.doi.org/10.1074/jbc.M115.645507			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918155	Green Published, hybrid			2022-12-26	WOS:000356177300035
J	Lee, HK; Ji, S; Park, SJ; Choung, HW; Choi, Y; Lee, HJ; Park, SY; Park, JC				Lee, Hye-Kyung; Ji, Suk; Park, Su-Jin; Choung, Han-Wool; Choi, Youngnim; Lee, Hyo-Jung; Park, Shin-Young; Park, Joo-Cheol			Odontogenic Ameloblast-associated Protein (ODAM) Mediates Junctional Epithelium Attachment to Teeth via Integrin-ODAM-Rho Guanine Nucleotide Exchange Factor 5 (ARHGEF5)-RhoA Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT INCISOR; ALPHA-V-BETA-6 INTEGRIN; ENAMEL MINERALIZATION; PERIODONTAL-DISEASE; TOOTH DEVELOPMENT; CELL-ADHESION; FIBRONECTIN; LAMININ; EXPRESSION; MATURATION	Adhesion of the junctional epithelium (JE) to the tooth surface is crucial for maintaining periodontal health. Although odontogenic ameloblast-associated protein (ODAM) is expressed in the JE, its molecular functions remain unknown. We investigated ODAM function during JE development and regeneration and its functional significance in the initiation and progression of periodontitis and peri-implantitis. ODAM was expressed in the normal JE of healthy teeth but absent in the pathologic pocket epithelium of diseased periodontium. In periodontitis and peri-implantitis, ODAM was extruded from the JE following onset with JE attachment loss and detected in gingival crevicular fluid. ODAM induced RhoA activity and the expression of downstream factors, including ROCK (Rho-associated kinase), by interacting with Rho guanine nucleotide exchange factor 5 (ARHGEF5). ODAM-mediated RhoA signaling resulted in actin filament rearrangement. Reduced ODAM and RhoA expression in integrin beta(3)- and beta(6)-knockout mice revealed that cytoskeleton reorganization in the JE occurred via integrin-ODAM-ARHGEF5-RhoA signaling. Fibronectin and laminin activated RhoA signaling via the integrin-ODAM pathway. Finally, ODAM was re-expressed with RhoA in regenerating JE after gingivectomy in vivo. These results suggest that ODAM expression in the JE reflects a healthy periodontium and that JE adhesion to the tooth surface is regulated via fibronectin/laminin-integrin-ODAM-ARHGEF5-RhoA signaling. We also propose that ODAM could be used as a biomarker of periodontitis and peri-implantitis.	[Lee, Hye-Kyung; Park, Su-Jin; Choung, Han-Wool; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Seoul 110744, South Korea; [Choi, Youngnim] Seoul Natl Univ, Sch Dent, Dept Immunol & Mol Microbiol, Seoul 110744, South Korea; Seoul Natl Univ, Dent Res Inst, Seoul 110744, South Korea; [Ji, Suk] Korea Univ, Anam Hosp, Dept Periodontol, Seoul 136713, South Korea; [Lee, Hyo-Jung; Park, Shin-Young] Seoul Natl Univ, Bundang Hosp, Sect Dent, Dept Periodontol, Songnam 463707, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Park, JC (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, 101 Daehagro, Seoul 110749, South Korea.	jcapark@snu.ac.kr	Park, Joo Cheol/D-6437-2012; Choi, Youngnim/AAL-8140-2020	Park, Joo Cheol/0000-0002-3162-7557; Choi, Youngnim/0000-0002-6496-5560; LEE, HYE KYUNG/0000-0002-7785-5942; Lee, Hyo-Jung/0000-0002-0439-7389	Bio AMP; Medical Technology Development Program of the National Research Foundation - Korean government (MSIP) [NRF-2013M34A9B2076480]	Bio AMP; Medical Technology Development Program of the National Research Foundation - Korean government (MSIP)	This research was supported by Bio & Medical Technology Development Program of the National Research Foundation Grant NRF-2013M34A9B2076480 funded by the Korean government (MSIP).	Atsuta I, 2013, J BIOMED MATER RES A, V101, P2896, DOI 10.1002/jbm.a.34608; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Bosshardt DD, 2005, J DENT RES, V84, P9, DOI 10.1177/154405910508400102; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; CAFFESSE RG, 1979, J PERIODONTOL, V50, P1, DOI 10.1902/jop.1979.50.1.1; Casavecchia P, 2004, J PERIODONTOL, V75, P770, DOI 10.1902/jop.2004.75.5.770; Dean JW, 1997, J PERIODONTOL, V68, P750, DOI 10.1902/jop.1997.68.8.750; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Ganss B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00371; Ghannad F, 2008, AM J PATHOL, V172, P1271, DOI 10.2353/ajpath.2008.071068; Hormia M, 2001, J PERIODONTOL, V72, P788, DOI 10.1902/jop.2001.72.6.788; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961; Jue SS, 2014, ANGLE ORTHOD, V84, P534, DOI 10.2319/051613-378.1; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kestler DP, 2011, BREAST CANCER-BASIC, V5, P73, DOI 10.4137/BCBCR.S6859; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Larjava H, 2014, EXP CELL RES, V325, P104, DOI 10.1016/j.yexcr.2014.03.010; Lee HK, 2012, GENE EXPR PATTERNS, V12, P102, DOI 10.1016/j.gep.2012.02.002; Lee HK, 2012, J CELL BIOCHEM, V113, P1754, DOI 10.1002/jcb.24047; Lee HK, 2010, J CELL BIOCHEM, V111, P755, DOI 10.1002/jcb.22766; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Masaoka T, 2009, J PERIODONTAL RES, V44, P489, DOI 10.1111/j.1600-0765.2008.01142.x; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Mohazab L, 2013, J CELL SCI, V126, P732, DOI 10.1242/jcs.112599; Nakaya H, 1989, Nihon Shishubyo Gakkai Kaishi, V31, P462; Narani N, 2007, EUR J ORAL SCI, V115, P288, DOI 10.1111/j.1600-0722.2007.00467.x; Neves JD, 2012, HISTOCHEM CELL BIOL, V137, P329, DOI 10.1007/s00418-011-0901-4; NISHIKAWA S, 1986, DIFFERENTIATION, V30, P237, DOI 10.1111/j.1432-0436.1986.tb00786.x; NISHIKAWA S, 1988, EUR J CELL BIOL, V47, P222; Nishio C, 2010, J PERIODONTAL RES, V45, P709, DOI 10.1111/j.1600-0765.2010.01288.x; Nishio C, 2010, EUR CELLS MATER, V20, P393; Park JC, 2007, EUR J ORAL SCI, V115, P153, DOI 10.1111/j.1600-0722.2007.00435.x; Redlich M, 1999, AM J ORTHOD DENTOFAC, V116, P152, DOI 10.1016/S0889-5406(99)70212-X; SABAG N, 1984, J PERIODONTOL, V55, P135, DOI 10.1902/jop.1984.55.3.135; Sakai T, 1996, ARCH ORAL BIOL, V41, P885, DOI 10.1016/S0003-9969(96)00014-3; Salmivirta K, 1996, DEV DYNAM, V205, P104, DOI 10.1002/(SICI)1097-0177(199602)205:2<104::AID-AJA2>3.0.CO;2-M; SAWADA T, 1995, ARCH ORAL BIOL, V40, P1029, DOI 10.1016/0003-9969(95)00073-X; Schroeder HE, 2003, J DENT RES, V82, P158, DOI 10.1177/154405910308200302; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Shimono M, 2003, J ELECTRON MICROSC, V52, P627, DOI 10.1093/jmicro/52.6.627; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; STENMAN S, 1978, J EXP MED, V147, P1054, DOI 10.1084/jem.147.4.1054; Tabata MJ, 2003, J HISTOCHEM CYTOCHEM, V51, P1673, DOI 10.1177/002215540305101211; THESLEFF I, 1987, J DENT RES, V66, P1107, DOI 10.1177/00220345870660060401; THESLEFF I, 1981, DEV BIOL, V81, P182, DOI 10.1016/0012-1606(81)90361-4; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Xue H, 2013, EUR J ORAL SCI, V121, P293, DOI 10.1111/eos.12059; Yoshida T, 2012, J DENT RES, V91, P1154, DOI 10.1177/0022034512462722; Yoshida T, 2013, J CELL BIOCHEM, V114, P2138, DOI 10.1002/jcb.24564	55	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14740	14753		10.1074/jbc.M115.648022	http://dx.doi.org/10.1074/jbc.M115.648022			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911094	Green Published, hybrid			2022-12-26	WOS:000355754600043
J	Shiomi, Y; Yamauchi, T; Iwabu, M; Okada-Iwabu, M; Nakayama, R; Orikawa, Y; Yoshioka, Y; Tanaka, K; Ueki, K; Kadowaki, T				Shiomi, Yoshihiro; Yamauchi, Toshimasa; Iwabu, Masato; Okada-Iwabu, Miki; Nakayama, Ryo; Orikawa, Yuki; Yoshioka, Yoshichika; Tanaka, Koichiro; Ueki, Kohjiro; Kadowaki, Takashi			A Novel Peroxisome Proliferator-activated Receptor (PPAR)alpha Agonist and PPAR gamma Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE HYPERTROPHY; TRANSGENIC MICE; M2 MACROPHAGES; LIVER; ADIPONECTIN; SENSITIVITY	A novel peroxisome proliferator-activated receptor (PPAR) modulator, Z-551, having both PPAR alpha agonistic and PPAR alpha antagonistic activities, has been developed for the treatment of obesity and obesity-related metabolic disorders. We examined the effects of Z-551 on obesity and the metabolic disorders in wild-type mice on the high-fat diet (HFD). In mice on the HFD, Z-551 significantly suppressed body weight gain and ameliorated insulin resistance and abnormal glucose and lipid metabolisms. Z-551 inhibited visceral fat mass gain and adipocyte hypertrophy, and reduced molecules involved in fatty acid uptake and synthesis, macrophage infiltration, and inflammation in adipose tissue. Z-551 increased molecules involved in fatty acid combustion, while reduced molecules associated with gluconeogenesis in the liver. Furthermore, Z-551 significantly reduced fasting plasma levels of glucose, triglyceride, free fatty acid, insulin, and leptin. To elucidate the significance of the PPAR combination, we examined the effects of Z-551 in PPAR alpha-deficient mice and those of a synthetic PPAR gamma antagonist in wild-type mice on the HFD. Both drugs showed similar, but weaker effects on body weight, insulin resistance and specific events provoked in adipose tissue compared with those of Z-551 as described above, except for lack of effects on fasting plasma triglyceride and free fatty acid levels. These findings suggest that Z-551 ameliorates HFD-induced obesity, insulin resistance, and impairment of glucose and lipid metabolisms by PPAR alpha agonistic and PPAR gamma antagonistic activities, and therefore, might be clinically useful for preventing or treating obesity	[Shiomi, Yoshihiro; Yamauchi, Toshimasa; Iwabu, Masato; Okada-Iwabu, Miki; Nakayama, Ryo; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo 1138655, Japan; [Yamauchi, Toshimasa] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, 22nd Century Med & Res Ctr, Tokyo 1138655, Japan; [Orikawa, Yuki; Tanaka, Koichiro] Zeria Pharmaceut Co Ltd, Cent Res Labs, Saitama 3600111, Japan; [Yoshioka, Yoshichika] Osaka Univ, Lab Biofunct Imaging, Immunol Frontier Res Ctr, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; Zeria Pharmaceutical Co Ltd; Osaka University	Kadowaki, T (corresponding author), Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp			Zeria Pharmaceutical Co., Ltd.	Zeria Pharmaceutical Co., Ltd.(Zeria Pharmaceutical Co Ltd)	The joint research project was funded by Zeria Pharmaceutical Co., Ltd.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cariou B, 2012, TRENDS ENDOCRIN MET, V23, P205, DOI 10.1016/j.tem.2012.03.001; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Haluzik MM, 2006, PHYSIOL RES, V55, P115, DOI 10.33549/physiolres.930744; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; IKEMOTO S, 1995, P NATL ACAD SCI USA, V92, P3096, DOI 10.1073/pnas.92.8.3096; Inoue I, 1997, BIOCHEM BIOPH RES CO, V237, P606, DOI 10.1006/bbrc.1997.7196; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Minnich A, 2001, AM J PHYSIOL-ENDOC M, V280, pE270, DOI 10.1152/ajpendo.2001.280.2.E270; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Mori Y, 2014, INT IMMUNOL, V26, P93, DOI 10.1093/intimm/dxt044; Morimura K, 2006, CARCINOGENESIS, V27, P1074, DOI 10.1093/carcin/bgi329; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; Nakano R, 2006, BIOCHEM PHARMACOL, V72, P42, DOI 10.1016/j.bcp.2006.03.023; Nio Y, 2012, DIABETOLOGIA, V55, P3350, DOI 10.1007/s00125-012-2710-2; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nonaka Kiichi, 2011, Clin Calcium, V21, P1003, DOI CliCa110710031009; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Watanabe T, 2009, J BIOL CHEM, V284, P1803, DOI 10.1074/jbc.M807120200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	55	37	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14567	14581		10.1074/jbc.M114.622191	http://dx.doi.org/10.1074/jbc.M114.622191			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25907553	Green Published, hybrid			2022-12-26	WOS:000355754600028
J	Song, WJ; Cho, Y; Watt, D; Cavalli, V				Song, Wenjun; Cho, Yongcheol; Watt, Dana; Cavalli, Valeria			Tubulin-tyrosine Ligase (TTL)-mediated Increase in Tyrosinated alpha-Tubulin in Injured Axons Is Required for Retrograde Injury Signaling and Axon Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS ENDS; GROWTH CONE; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN-SYNTHESIS; PERIPHERAL-NERVE; MAP KINASE; TRANSPORT; PHOSPHORYLATION; INITIATION; AXOTOMY	Injured peripheral neurons successfully activate a pro-regenerative program to enable axon regeneration and functional recovery. The microtubule-dependent retrograde transport of injury signals from the lesion site in the axon back to the cell soma stimulates the increased growth capacity of injured neurons. However, the mechanisms initiating this retrograde transport remain poorly understood. Here we show that tubulin-tyrosine ligase (TTL) is required to increase the levels of tyrosinated alpha-tubulin at the axon injury site and plays an important role in injury signaling. Preventing the injury-induced increase in tyrosinated alpha-tubulin by knocking down TTL impairs retrograde organelle transport and delays activation of the pro-regenerative transcription factor c-Jun. In the absence of TTL, axon regeneration is reduced severely. We propose a model in which TTL increases the levels of tyrosinated alpha-tubulin locally at the injury site to facilitate the retrograde transport of injury signals that are required to activate a pro-regenerative program.	[Song, Wenjun; Cho, Yongcheol; Watt, Dana; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA	Washington University (WUSTL)	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu	Song, Wenjun/HGB-4891-2022		NINDS/National Institutes of Health [R01 NS082446]; National Research Foundation of Korea [NRF-2012R1A6A3A03039290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grant R01 NS082446 (to V. C.). This work was also supported by National Research Foundation of Korea Grant NRF-2012R1A6A3A03039290 (to Y. C.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; BARRA HS, 1988, MOL NEUROBIOL, V2, P133, DOI 10.1007/BF02935343; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; DEANIN GG, 1980, EUR J BIOCHEM, V109, P207, DOI 10.1111/j.1432-1033.1980.tb04786.x; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Finelli MJ, 2013, J NEUROSCI, V33, P19664, DOI 10.1523/JNEUROSCI.0589-13.2013; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; HALL GF, 1991, P NATL ACAD SCI USA, V88, P5016, DOI 10.1073/pnas.88.11.5016; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Idriss HT, 2000, CELL MOTIL CYTOSKEL, V46, P1; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kidd G, 1996, J NEUROSCI, V16, P946; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Lomakin AJ, 2009, DEV CELL, V17, P323, DOI 10.1016/j.devcel.2009.07.010; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Marcos S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005405; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; MULLINS FH, 1994, J NEUROCHEM, V62, P227; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Poirier K, 2013, EUR J HUM GENET, V21, P381, DOI 10.1038/ejhg.2012.195; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Puttagunta R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4527; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; SCHRODER HC, 1985, J CELL BIOL, V100, P276, DOI 10.1083/jcb.100.1.276; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Yan D, 2012, NEURON, V76, P534, DOI 10.1016/j.neuron.2012.08.043	51	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14765	14775		10.1074/jbc.M114.622753	http://dx.doi.org/10.1074/jbc.M114.622753			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911101	Green Published, hybrid			2022-12-26	WOS:000355754600045
J	Eiler, JH; Evans, AN; Schreck, CB				Eiler, John H.; Evans, Allison N.; Schreck, Carl B.			Migratory Patterns of Wild Chinook Salmon Oncorhynchus tshawytscha Returning to a Large, Free-Flowing River Basin	PLOS ONE			English	Article							SOCKEYE-SALMON; PACIFIC SALMON; FRASER-RIVER; YUKON RIVER; BEHAVIORAL THERMOREGULATION; BRITISH-COLUMBIA; NERKA SALMON; STEELHEAD; RATES; GORBUSCHA	Upriver movements were determined for Chinook salmon Oncorhynchus tshawytscha returning to the Yukon River, a large, virtually pristine river basin. These returns have declined dramatically since the late 1990s, and information is needed to better manage the run and facilitate conservation efforts. A total of 2,860 fish were radio tagged during 2002-2004. Most (97.5%) of the fish tracked upriver to spawning areas displayed continual upriver movements and strong fidelity to the terminal tributaries entered. Movement rates were substantially slower for fish spawning in lower river tributaries (28-40 km d(-1)) compared to upper basin stocks (52-62 km d(-1)). Three distinct migratory patterns were observed, including a gradual decline, pronounced decline, and substantial increase in movement rate as the fish moved upriver. Stocks destined for the same region exhibited similar migratory patterns. Individual fish within a stock showed substantial variation, but tended to reflect the regional pattern. Differences between consistently faster and slower fish explained 74% of the within-stock variation, whereas relative shifts in sequential movement rates between "hares" (faster fish becoming slower) and "tortoises" (slow but steady fish) explained 22% of the variation. Pulses of fish moving upriver were not cohesive. Fish tagged over a 4-day period took 16 days to pass a site 872 km upriver. Movement rates were substantially faster and the percentage of atypical movements considerably less than reported in more southerly drainages, but may reflect the pristine conditions within the Yukon River, wild origins of the fish, and discrete run timing of the returns. Movement data can provide numerous insights into the status and management of salmon returns, particularly in large river drainages with widely scattered fisheries where management actions in the lower river potentially impact harvests and escapement farther upstream. However, the substantial variation exhibited among individual fish within a stock can complicate these efforts.	[Eiler, John H.] NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries, Juneau, AK 99801 USA; [Evans, Allison N.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Schreck, Carl B.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey	Eiler, JH (corresponding author), NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries, Juneau, AK 99801 USA.	john.eiler@noaa.gov			National Marine Fisheries Service; Alaska Department of Fish and Game; U.S./Canada Yukon River Treaty Implementation Fund [03NMF4380185]; Alaska Sustainable Salmon Fund Project [45224]	National Marine Fisheries Service; Alaska Department of Fish and Game; U.S./Canada Yukon River Treaty Implementation Fund; Alaska Sustainable Salmon Fund Project	Funding: Funding for this study was provided by the National Marine Fisheries Service and Alaska Department of Fish and Game. Additional support was provided by the U.S./Canada Yukon River Treaty Implementation Fund Grant No. 03NMF4380185, and the Alaska Sustainable Salmon Fund Project No. 45224. Annual study plans were reviewed by the National Marine Fisheries Service (Alaska Fisheries Science Center), Alaska Department of Fish and Game (Division of Commercial Fisheries), and the Joint Technical Committee of the U.S-Canada Yukon River Panel. Editorial review of the paper was provided by the Alaska Fisheries Science Center.	Ahliman DL, 2003, AESOPS FABLES, P113; Aidley DJ, 1981, ANIMAL MIGRATIONS; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; BERMAN CH, 1991, J FISH BIOL, V39, P301, DOI 10.1111/j.1095-8649.1991.tb04364.x; Blem C.R., 1980, P175; Brabets T.P., 2000, USGS WATER RESOURCES; Brett J.R., 1983, P29; Brett J.R., 1995, P3; Bronmark C, 2014, CAN J ZOOL, V92, P467, DOI 10.1139/cjz-2012-0277; BURGER CV, 1985, CAN J FISH AQUAT SCI, V42, P693, DOI 10.1139/f85-089; Connor WP, 2006, T AM FISH SOC, V135, P297, DOI 10.1577/T05-097.1; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Daum David W., 1998, North American Journal of Fisheries Management, V18, P477, DOI 10.1577/1548-8675(1998)018<0477:UOFLSB>2.0.CO;2; DeCovitch NA, 2011, FISHERY DATA SERIES, V11-65; Dingle H, 1996, MIGRATION BIOL LIFE; Eiler J.H., 1990, American Fisheries Society Symposium, P364; EILER JH, 1995, T AM FISH SOC, V124, P184, DOI 10.1577/1548-8659(1995)124<0184:ARSLTS>2.3.CO;2; EILER JH, 1992, T AM FISH SOC, V121, P701, DOI 10.1577/1548-8659(1992)121<0701:RSBSSI>2.3.CO;2; Eiler JH, 2013, THESIS OREGON STATE; Eiler JH, 2014, T AM FISH SOC, V143, P1476, DOI 10.1080/00028487.2014.959997; Eiler JH, 2012, TELEMETRY TECHNIQUES: A USER GUIDE FOR FISHERIES RESEARCH, P163; Eiler John H., 2000, P138; ENS (Envirnomental News Service), 2010, DIS DECL AL YUK RIV; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Federal Columbia River Power System, 2001, COL RIV SYST INS STO; Flannery BG, 2012, N AM J FISH MANAGE, V32, P720, DOI 10.1080/02755947.2012.686954; Fulton LA, 1968, 571 US FISH WILDL SE, P1; Gilhousen, 1990, INT PAC SALMON FISH, V26, P1; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Hasler A.D., 1971, P429; Healey M.C., 1991, P311; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hinch Scott G., 2006, Fish Physiology, V24, P239; Hinch SG, 2002, HYDROBIOLOGIA, V483, P147, DOI 10.1023/A:1021327511881; JTC (Joint Technical Committee of the Yukon River US/Canada Panel), 2012, 3A1201 JTC AL DEP FI; JTC (Joint Technical Committee of the Yukon River US/Canada Panel), 2006, 3A0607 JTC AL DEP FI; JTC (Joint Technical Committee of the Yukon River US/Canada Panel), 2001, 3A0135 JTC AL DEP FI; Karpovich S, 2007, FISHERY DATA SERIES, V07-05; Keefer ML, 2004, T AM FISH SOC, V133, P1413, DOI 10.1577/T03-223.1; Keefer ML, 2004, J FISH BIOL, V65, P1126, DOI 10.1111/j.0022-1112.2004.00522.x; Kocan R, 2006, J FISH DIS, V29, P497, DOI 10.1111/j.1365-2761.2006.00743.x; Kocan R, 2006, J FISH DIS, V29, P521, DOI 10.1111/j.1365-2761.2006.00745.x; Kocan R, 2009, J FISH DIS, V32, P835, DOI 10.1111/j.1365-2761.2009.01059.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Lucas M, 2001, MIGRATION FRESHWATER; Macdonald JS, 2000, 2326 FISH OC CAN; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; Myers J, 1998, AM POETRY REV, V27, P27; Northcote T.G., 1978, P326; Peterson EB, 2001, J VEG SCI, V12, P511, DOI 10.2307/3237003; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 1997, CAN J FISH AQUAT SCI, V54, P1349, DOI 10.1139/f97-038; Rand PS, 1998, CAN J FISH AQUAT SCI, V55, P1832, DOI 10.1139/cjfas-55-8-1832; RAYMOND HL, 1979, T AM FISH SOC, V108, P505, DOI 10.1577/1548-8659(1979)108<505:EODAIO>2.0.CO;2; Reischel TS, 2003, N AM J FISH MANAGE, V23, P1215, DOI 10.1577/M02-113; Schultz KD, 1994, 3A9431 AL DEP FISH G; Spencer TR, 2009, FISHERY DATA SERIES, V09-32; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; Strange JS, 2010, T AM FISH SOC, V139, P1091, DOI 10.1577/T09-171.1; Turchin Peter, 1998; Wedemeyer G.A., 1996, PHYSL FISH INTENSIVE; Westley PAH, 2013, CAN J FISH AQUAT SCI, V70, P735, DOI 10.1139/cjfas-2012-0536; Wydoski R., 1983, P215; Yang DQ, 2009, HYDROL PROCESS, V23, P109, DOI 10.1002/hyp.7216; Yoshiyama Ronald M., 1998, North American Journal of Fisheries Management, V18, P487, DOI 10.1577/1548-8675(1998)018<0487:HAADOC>2.0.CO;2	69	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123127	10.1371/journal.pone.0123127	http://dx.doi.org/10.1371/journal.pone.0123127			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919286	gold, Green Published			2022-12-26	WOS:000353659400024
J	Li, W; Xia, YY; Wang, CZ; Tang, YT; Guo, WY; Li, JL; Zhao, X; Sun, YP; Hu, J; Zhen, HF; Zhang, XD; Chen, C; Shi, YJ; Li, L; Cao, HZ; Du, HL; Li, J				Li, Wei; Xia, Yingying; Wang, Chongzhi; Tang, Y. Tom; Guo, Wenying; Li, Jinliang; Zhao, Xia; Sun, Yepeng; Hu, Juan; Zhen, Hefu; Zhang, Xiandong; Chen, Chao; Shi, Yujian; Li, Lin; Cao, Hongzhi; Du, Hongli; Li, Jian			Identifying Human Genome-Wide CNV, LOH and UPD by Targeted Sequencing of Selected Regions	PLOS ONE			English	Article							COPY-NUMBER VARIATION; STRUCTURAL VARIATION; HETEROZYGOSITY; VARIANTS; MICROARRAY; DISCOVERY; DISEASE; FORMAT; BIAS	Copy-number variations (CNV), loss of heterozygosity (LOH), and uniparental disomy (UPD) are large genomic aberrations leading to many common inherited diseases, cancers, and other complex diseases. An integrated tool to identify these aberrations is essential in understanding diseases and in designing clinical interventions. Previous discovery methods based on whole-genome sequencing (WGS) require very high depth of coverage on the whole genome scale, and are cost-wise inefficient. Another approach, whole exome genome sequencing (WEGS), is limited to discovering variations within exons. Thus, we are lacking efficient methods to detect genomic aberrations on the whole genome scale using next-generation sequencing technology. Here we present a method to identify genome-wide CNV, LOH and UPD for the human genome via selectively sequencing a small portion of genome termed Selected Target Regions (SeTRs). In our experiments, the SeTRs are covered by 99.73%similar to 99.95% with sufficient depth. Our developed bioinformatics pipeline calls genome-wide CNVs with high confidence, revealing 8 credible events of LOH and 3 UPD events larger than 5M from 15 individual samples. We demonstrate that genome-wide CNV, LOH and UPD can be detected using a cost-effective SeTRs sequencing approach, and that LOH and UPD can be identified using just a sample grouping technique, without using a matched sample or familial information.	[Du, Hongli] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Li, Wei; Xia, Yingying; Wang, Chongzhi; Tang, Y. Tom; Li, Jinliang; Zhao, Xia; Sun, Yepeng; Hu, Juan; Zhen, Hefu; Zhang, Xiandong; Chen, Chao; Shi, Yujian; Li, Lin; Cao, Hongzhi; Li, Jian] BGI Shenzhen, Shenzhen, Peoples R China; [Guo, Wenying] Weifang Hosp Tradit Chinese Med, Weifang, Shandong, Peoples R China; [Tang, Y. Tom] Complete Genom Inc, Mountain View, CA 94043 USA; [Xia, Yingying] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Hongzhi; Li, Jian] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	South China University of Technology; Beijing Genomics Institute (BGI); Sun Yat Sen University; University of Copenhagen	Du, HL (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China.	hldu@scut.edu.cn; lijian@genomics.cn		Wang, Chongzhi/0000-0003-1494-2552				Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Chen HIH, 2008, BIOINFORMATICS, V24, P1749, DOI 10.1093/bioinformatics/btn321; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Choi CH, 2007, CANCER LETT, V255, P26, DOI 10.1016/j.canlet.2007.03.015; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Coin LJM, 2012, BIOINFORMATICS, V28, pI370, DOI 10.1093/bioinformatics/bts379; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dalca AV, 2010, BRIEF BIOINFORM, V11, P3, DOI 10.1093/bib/bbp058; Deng FY, 2010, OSTEOPOROSIS INT, V21, P579, DOI 10.1007/s00198-009-0998-7; Fitzgerald TW, 2011, BIOINFORMATICS, V27, P1195, DOI 10.1093/bioinformatics/btr107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085096; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Rancoita PMV, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-321; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054236, DOI 10.1371/J0URNAL.P0NE.0054236]	45	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123081	10.1371/journal.pone.0123081	http://dx.doi.org/10.1371/journal.pone.0123081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919136	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400023
J	Zou, D; Liu, P; Chen, K; Xie, Q; Liang, XY; Bai, Q; Zhou, QC; Liu, K; Zhang, T; Zhu, JD; Mi, MT				Zou, Dan; Liu, Peng; Chen, Ka; Xie, Qi; Liang, Xinyu; Bai, Qian; Zhou, Qicheng; Liu, Kai; Zhang, Ting; Zhu, Jundong; Mi, Mantian			Protective Effects of Myricetin on Acute Hypoxia-Induced Exercise Intolerance and Mitochondrial Impairments in Rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENERGY-METABOLISM; OXIDATIVE STRESS; PGC-1-ALPHA; PERFORMANCE; DYSFUNCTION; BIOGENESIS; SIRT1; COACTIVATORS; EXPRESSION	Purpose Exercise tolerance is impaired in hypoxia. The aim of this study was to evaluate the effects of myricetin, a dietary flavonoid compound widely found in fruits and vegetables, on acute hypoxia-induced exercise intolerance in vivo and in vitro. Methods Male rats were administered myricetin or vehicle for 7 days and subsequently spent 24 hours at a barometric pressure equivalent to 5000 m. Exercise capacity was then assessed through the run-to-fatigue procedure, and mitochondrial morphology in skeletal muscle cells was observed by transmission electron microscopy (TEM). The enzymatic activities of electron transfer complexes were analyzed using an enzyme-linked immuno-sorbent assay (ELISA). mtDNA was quantified by real-time-PCR. Mitochondrial membrane potential was measured by JC-1 staining. Protein expression was detected through western blotting, immunohistochemistry, and immunofluorescence. Results Myricetin supplementation significantly prevented the decline of run-to-fatigue time of rats in hypoxia, and attenuated acute hypoxia-induced mitochondrial impairment in skeletal muscle cells in vivo and in vitro by maintaining mitochondrial structure, mtDNA content, mitochondrial membrane potential, and activities of the respiratory chain complexes. Further studies showed that myricetin maintained mitochondrial biogenesis in skeletal muscle cells under hypoxic conditions by up-regulating the expressions of mitochondrial biogenesis-related regluators, in addition, AMP-activated protein kinase(AMPK) plays a crucial role in this process. Conclusions Myricetin may have important applications for improving physical performance under hypoxic environment, which may be attributed to the protective effect against mitochondrial impairment by maintaining mitochondrial biogenesis.	[Zou, Dan; Liu, Peng; Chen, Ka; Xie, Qi; Liang, Xinyu; Bai, Qian; Zhou, Qicheng; Liu, Kai; Zhang, Ting; Zhu, Jundong; Mi, Mantian] Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing, Peoples R China	Army Medical University	Zhu, JD (corresponding author), Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing, Peoples R China.	zjdnfs@126.com; mimantian@sina.cn			key projects of the "Twelfth Five-Year Plan" for Medical Science Development of People's Liberation Army, China [BWS12J034]	key projects of the "Twelfth Five-Year Plan" for Medical Science Development of People's Liberation Army, China	This work was funded by research grants from the key projects of the "Twelfth Five-Year Plan" for Medical Science Development of People's Liberation Army, China (BWS12J034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Burtscher M, 2006, INT J SPORTS MED, V27, P629, DOI 10.1055/s-2005-872823; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR291, DOI 10.1152/ajpregu.00155.2002; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; DeLellis SM, 2013, CURR SPORT MED REP, V12, P110, DOI 10.1249/JSR.0b013e3182874d0f; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fulco CS, 1998, AVIAT SPACE ENVIR MD, V69, P793; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gomes AP, 2012, BBA-MOL BASIS DIS, V1822, P185, DOI 10.1016/j.bbadis.2011.10.008; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hensel M, 1997, INT J MICROCIRC, V17, P67, DOI 10.1159/000179209; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Huang JH, 2010, TOXICOL IN VITRO, V24, P21, DOI 10.1016/j.tiv.2009.09.015; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534; Lin Tsu-Kung, 2009, Chang Gung Med J, V32, P589; Magalhaes J, 2007, CLIN SCI, V113, P459, DOI 10.1042/CS20070075; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nieman DC, 2010, MED SCI SPORT EXER, V42, P338, DOI 10.1249/MSS.0b013e3181b18fa3; Nouette-Gaulain K, 2005, CARDIOVASC RES, V66, P132, DOI 10.1016/j.cardiores.2004.12.023; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pandey KB, 2009, NAT PROD COMMUN, V4, P221; Panickar KS, 2011, NEUROSCIENCE, V183, P1, DOI 10.1016/j.neuroscience.2011.03.064; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Rasbach KA, 2007, BIOCHEM BIOPH RES CO, V355, P734, DOI 10.1016/j.bbrc.2007.02.023; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Scicchitano BM, 2005, MOL BIOL CELL, V16, P3632, DOI 10.1091/mbc.E05-01-0055; Shaw JM, 2009, EMBO REP, V10, P1301, DOI 10.1038/embor.2009.247; Wang ZH, 2010, ENVIRON TOXICOL PHAR, V29, P12, DOI 10.1016/j.etap.2009.08.007; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	44	13	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124727	10.1371/journal.pone.0124727	http://dx.doi.org/10.1371/journal.pone.0124727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919288	Green Published, gold			2022-12-26	WOS:000353659400058
J	Cheng, SJ; Swanson, K; Eliaz, I; McClintick, JN; Sandusky, GE; Sliva, D				Cheng, Shujie; Swanson, Kristen; Eliaz, Isaac; McClintick, Jeanette N.; Sandusky, George E.; Sliva, Daniel			Pachymic Acid Inhibits Growth and Induces Apoptosis of Pancreatic Cancer In Vitro and In Vivo by Targeting ER Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; PORIA-COCOS; MEDIATED APOPTOSIS; GENE-EXPRESSION; POLY(ADP-RIBOSE) POLYMERASE; ANTICANCER STRATEGY; PROTEOTOXIC STRESS; PROSTATE-CANCER; CELL-DEATH	Pachymic acid (PA) is a purified triterpene extracted from medicinal fungus Poria cocos. In this paper, we investigated the anticancer effect of PA on human chemotherapy resistant pancreatic cancer. PA triggered apoptosis in gemcitabine-resistant pancreatic cancer cells PANC-1 and MIA PaCa-2. Comparative gene expression array analysis demonstrated that endoplasmic reticulum (ER) stress was induced by PA through activation of heat shock response and unfolded protein response related genes. Induced ER stress was confirmed by increasing expression of XBP-1s, ATF4, Hsp70, CHOP and phospho-eIF2 alpha. Moreover, ER stress inhibitor tauroursodeoxycholic acid (TUDCA) blocked PA induced apoptosis. In addition, 25 mg kg(-1) of PA significantly suppressed MIA PaCa-2 tumor growth in vivo without toxicity, which correlated with induction of apoptosis and expression of ER stress related proteins in tumor tissues. Taken together, growth inhibition and induction of apoptosis by PA in gemcitabine-resistant pancreatic cancer cells were associated with ER stress activation both in vitro and in vivo. PA may be potentially exploited for the use in treatment of chemotherapy resistant pancreatic cancer.	[Cheng, Shujie; Swanson, Kristen; Sliva, Daniel] Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN 46202 USA; [Eliaz, Isaac] Amitabha Med Clin & Healing Ctr, Santa Rosa, CA USA; [McClintick, Jeanette N.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA; [Sandusky, George E.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46204 USA; [Sliva, Daniel] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46204 USA; [Sliva, Daniel] DSTest Labs, Indianapolis, IN USA	Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Sliva, D (corresponding author), Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN 46202 USA.	dsliva@dstest-lab.com		Eliaz, Isaac/0000-0002-7935-2038	China Scholarship Council; EcoNugenics, Inc., Santa Rosa, CA, USA; Indiana Genomics Initiative at Indiana University (INGEN); Econugenics, Inc.; Lilly Endowment, Inc.	China Scholarship Council(China Scholarship Council); EcoNugenics, Inc., Santa Rosa, CA, USA; Indiana Genomics Initiative at Indiana University (INGEN); Econugenics, Inc.; Lilly Endowment, Inc.	This study was supported by research grants from China Scholarship Council and EcoNugenics, Inc., Santa Rosa, CA, USA. The Center for Medical Genomics is supported in part by the Indiana Genomics Initiative at Indiana University (INGEN, which is supported in part by the Lilly Endowment, Inc.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, Econugenics, Inc., provided support in the form of salary for Dr. Isaac Eliaz, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Boelens J, 2007, IN VIVO, V21, P215; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Cheng SJ, 2013, INT J ONCOL, V42, P1869, DOI 10.3892/ijo.2013.1902; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Gajate C, 2012, ONCOGENE, V31, P2627, DOI 10.1038/onc.2011.446; Gapter L, 2005, BIOCHEM BIOPH RES CO, V332, P1153, DOI 10.1016/j.bbrc.2005.05.044; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Grant S, 2011, ONCOTARGET, V2, P284; Gungor C, 2014, BRIT J PHARMACOL, V171, P849, DOI 10.1111/bph.12401; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hering J, 2007, ANN SURG ONCOL, V14, P3620, DOI 10.1245/s10434-007-9556-8; Hong R, 2012, ASIAN PAC J CANCER P, V13, P1877, DOI 10.7314/APJCP.2012.13.5.1877; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang JH, 2004, NUTR CANCER, V49, P209, DOI 10.1207/s15327914nc4902_13; Kandala PK, 2012, ONCOTARGET, V3, P435; Kim DG, 2002, J BIOL CHEM, V277, P38930, DOI 10.1074/jbc.M205941200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KLIMSTRA DS, 1992, AM J SURG PATHOL, V16, P815, DOI 10.1097/00000478-199209000-00001; Lee SM, 2012, J ETHNOPHARMACOL, V141, P368, DOI 10.1016/j.jep.2012.02.048; Lei P, 2008, MOL CANCER THER, V7, P3363, DOI 10.1158/1535-7163.MCT-08-0439; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li JJ, 2012, ONCOL REP, V28, P501, DOI 10.3892/or.2012.1827; Ling H, 2011, BREAST CANCER RES TR, V126, P609, DOI 10.1007/s10549-010-0929-5; Ling H, 2010, MOL CARCINOGEN, V49, P271, DOI 10.1002/mc.20597; Ling Y, 2012, BIOMED CHROMATOGR, V26, P1109, DOI 10.1002/bmc.1756; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Lust S, 2009, ANTICANCER RES, V29, P3797; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Malo A, 2010, AM J PHYSIOL-GASTR L, V299, pG877, DOI 10.1152/ajpgi.00423.2009; Mujumdar N, 2014, AM J PHYSIOL-GASTR L, V306, pG1011, DOI 10.1152/ajpgi.00466.2013; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Neznanov N, 2011, ONCOTARGET, V2, P209, DOI 10.18632/oncotarget.246; O'Reilly EM, 2007, SEMIN ONCOL, V34, P347, DOI 10.1053/j.seminoncol.2007.05.009; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Rios JL, 2011, PLANTA MED, V77, P681, DOI 10.1055/s-0030-1270823; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Searle JS, 2010, ONCOTARGET, V1, P228; Sekiya N, 2003, PHYTOTHER RES, V17, P160, DOI 10.1002/ptr.1097; Siegelin MD, 2012, EXPERT OPIN THER TAR, V16, P801, DOI 10.1517/14728222.2012.703655; SKARDA JS, 1994, DIAGN CYTOPATHOL, V10, P20, DOI 10.1002/dc.2840100106; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Workman P, 2011, ONCOTARGET, V2, P277; Xu LY, 2012, MOL CANCER THER, V11, P2174, DOI 10.1158/1535-7163.MCT-12-0602; Yang Y, 2014, J MOL CELL CARDIOL, V67, P103, DOI 10.1016/j.yjmcc.2013.12.018; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Youns M, 2009, BIOCHEM PHARMACOL, V78, P273, DOI 10.1016/j.bcp.2009.04.014; Zhang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040433; Zhao YY, 2012, J ETHNOPHARMACOL, V144, P775, DOI 10.1016/j.jep.2012.09.033; Zhou L, 2008, CHEM PHARM BULL, V56, P1459, DOI 10.1248/cpb.56.1459; Zhu WB, 2012, PANCREAS, V41, P1029, DOI 10.1097/MPA.0b013e31824abdc0	65	33	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122270	10.1371/journal.pone.0122270	http://dx.doi.org/10.1371/journal.pone.0122270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915041	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100007
J	Gale, CR; Eadie, E; Thomas, A; Bastin, ME; Starr, JM; Wardlaw, J; Deary, IJ				Gale, Catharine R.; Eadie, Elizabeth; Thomas, Avril; Bastin, Mark E.; Starr, John M.; Wardlaw, Joanna; Deary, Ian J.			Intelligence in Childhood and Atherosclerosis of the Carotid and Peripheral Arteries in Later Life: The Lothian Birth Cohort 1936	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; MIDDLE-AGE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PREMATURE MORTALITY; VIETNAM EXPERIENCE; ABERDEEN CHILDREN; EARLY ADULTHOOD; MENTAL-ABILITY	Objective There is some evidence that people who score higher on tests of intelligence in childhood have lower carotid intima-media thickness and higher ankle brachial index in middle age. These findings need replicating in other, older populations. We investigated the prospective relationship between intelligence in childhood and atherosclerosis in the carotid and peripheral arteries at age 73 years. Methods Participants were 713 members of the Lothian Birth Cohort 1936 whose intelligence was assessed at age 11 years. At age 73 years, carotid intima-media thickness and degree of stenosis were measured using ultrasound imaging; ankle-brachial index was measured using Doppler ultrasound. Results There were no significant associations between intelligence at age 11 and measures of atherosclerosis at age 73. In age-and sex-adjusted analyses, for a standard deviation higher score in intelligence, intima-media thickness (x 10) was lower by 0.07 (-0.20, 0.06) mm and ankle brachial index (x 10) was lower by 0.09 (-0.24, 0.07); odds ratios for having carotid stenosis >25% or peripheral arterial disease were 0.98 (0.82, 1.16) and 1.05 (0.81, 1.36) respectively. Conclusion In this study of people aged 73 years, higher childhood intelligence was not associated with reduced risk of atherosclerosis in the carotid or peripheral arteries.	[Gale, Catharine R.; Bastin, Mark E.; Starr, John M.; Wardlaw, Joanna; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Gale, Catharine R.] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Eadie, Elizabeth; Thomas, Avril; Bastin, Mark E.; Wardlaw, Joanna] Univ Edinburgh, Western Gen Hosp, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Western Gen Hosp, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Eadie, Elizabeth; Thomas, Avril] Western Gen Hosp, Dept Neuroradiol, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Southampton; University of Edinburgh; University of Edinburgh; University of Edinburgh	Gale, CR (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	crg@mrc.soton.ac.uk	Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019; Deary, Ian J/C-6297-2009	Wardlaw, Joanna M/0000-0002-9812-6642; Deary, Ian J/0000-0002-1733-263X; Bastin, Mark/0000-0002-0490-0845; Gale, Catharine/0000-0002-3361-8638	Research Into Ageing [251]; Lifelong Health and Wellbeing Initiative [MR/K026992/1]; Scottish Funding Council SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence); MRC [G1001245, G0700704, MC_UU_12011/2, MC_UP_A620_1015, G0701120] Funding Source: UKRI; Medical Research Council [MC_UU_12011/2, G0700704, MC_UP_A620_1015, MR/K026992/1, G1001245, U1475000002, G0701120] Funding Source: researchfish	Research Into Ageing; Lifelong Health and Wellbeing Initiative; Scottish Funding Council SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the following: Research Into Ageing, grant number 251 (IJD, JMS); Lifelong Health and Wellbeing Initiative, grant number MR/K026992/1 (IJD); and Scottish Funding Council SINAPSE Collaboration (Scottish Imaging Network, A Platform for Scientific Excellence), no grant number (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2005, INTRO VASCULAR SONOG, P107; Ariansen I, 2014, J EPIDEMIOL COMMUNIT; Batty GD, 2008, EUR J CARDIOV PREV R, V15, P359, DOI 10.1097/HJR.0b013e3282f738a6; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P997, DOI 10.1136/jech.2006.054494; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P241, DOI 10.1136/jech.2006.048215; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; Calvin CM, 2011, HEALTH PSYCHOL, V30, P710, DOI 10.1037/a0023940; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Deary I.J., 2009, LIFETIME INTELLIGENC; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gale CR, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.109835; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Graner M, 2006, AM J CARDIOL, V97, P624, DOI 10.1016/j.amjcard.2005.09.098; Haller C, 2007, ATHEROSCLEROSIS, V195, pE203, DOI 10.1016/j.atherosclerosis.2007.07.017; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Hemmingsson T, 2007, SOC SCI MED, V65, P1410, DOI 10.1016/j.socscimed.2007.05.006; Kajantie E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046841; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P695, DOI 10.1007/s10654-008-9281-z; Office of Population Censuses and Surveys, 1980, CLASS OCC 1980; Roberts BA, 2013, ATHEROSCLEROSIS, V231, P234, DOI 10.1016/j.atherosclerosis.2013.09.018; Schmidt M, 2013, EPIDEMIOLOGY, V24, P632, DOI 10.1097/EDE.0b013e31829e0ea2; Silventoinen K, 2007, EUR J CARDIOV PREV R, V14, P555, DOI 10.1097/HJR.0b013e328014672e; SONNEHOLM S, 1989, J EPIDEMIOL COMMUN H, V43, P369, DOI 10.1136/jech.43.4.369; Starr JM, 2004, J HYPERTENS, V22, P893, DOI 10.1097/00004872-200405000-00009; van den Oord SCH, 2013, ATHEROSCLEROSIS, V228, P1, DOI 10.1016/j.atherosclerosis.2013.01.025; Wardlaw JA, 2005, EUR J RADIOL, V56, P205, DOI 10.1016/j.ejrad.2005.04.021; Zuo G, 2014, CELL BIOCH BIOPHYSIC	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125280	10.1371/journal.pone.0125280	http://dx.doi.org/10.1371/journal.pone.0125280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915652	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100115
J	Hernandez-Medrano, JH; Copping, KJ; Hoare, A; Wapanaar, W; Grivell, R; Kuchel, T; Miguel-Pacheco, G; McMillen, IC; Rodgers, RJ; Perry, VEA				Hernandez-Medrano, Juan H.; Copping, Katrina J.; Hoare, Andrew; Wapanaar, Wendela; Grivell, Rosalie; Kuchel, Tim; Miguel-Pacheco, Giuliana; McMillen, I. Caroline; Rodgers, Raymond J.; Perry, Viv E. A.			Gestational Dietary Protein Is Associated with Sex Specific Decrease in Blood Flow, Fetal Heart Growth and Post-Natal Blood Pressure of Progeny	PLOS ONE			English	Article							TRANSRECTAL DOPPLER SONOGRAPHY; PLACENTAL DEVELOPMENT; NUTRIENT INTAKE; MATERNAL UNDERNUTRITION; VASCULAR DEVELOPMENT; EMBRYO DEVELOPMENT; EARLY-PREGNANCY; HEIFERS; BOVINE; COWS	Study Overview The incidence of adverse pregnancy outcomes is higher in pregnancies where the fetus is male. Sex specific differences in feto-placental perfusion indices identified by Doppler assessment have recently been associated with placental insufficiency and fetal growth restriction. This study aims to investigate sex specific differences in placental perfusion and to correlate these changes with fetal growth. It represents the largest comprehensive study under field conditions of uterine hemodynamics in a monotocous species, with a similar long gestation period to the human. Primiparous 14mo heifers in Australia (n=360) and UK (n=180) were either individually or group fed, respectively, diets with differing protein content (18, 14, 10 or 7% crude protein (CP)) from 60d prior to 98 days post conception (dpc). Fetuses and placentae were excised at 98dpc (n=48). Fetal development an median uterine artery blood flow were assessed monthly from 36dpc until term using B-mode and Doppler ultrasonography. MUA blood flow to the male feto-placental unit increased in early pregnancy associated with increased fetal growth. Protein restriction before and shortly after conception (-60d up to 23dpc) increased MUA diameter and indices of velocity during late pregnancy, reduced fetal heart weight in the female fetus and increased heart rate at birth, but decreased systolic blood pressure at six months of age. Conclusion and Significance Sex specific differences both in feto-placental Doppler perfusion indices and response of these indices to dietary perturbations were observed. Further, maternal diet affected development of fetal cardiovascular system associated with altered fetal haemodynamics in utero, with such effects having a sex bias. The results from this study provide further insight into the gender specific circulatory differences present in the fetal period and developing cardiovascular system.	[Hernandez-Medrano, Juan H.; Wapanaar, Wendela; Miguel-Pacheco, Giuliana; Perry, Viv E. A.] Univ Nottingham, Sch Vet & Med Sci, Loughborough, England; [Copping, Katrina J.; Grivell, Rosalie; Rodgers, Raymond J.] Univ Adelaide, Sch Paediat, Adelaide, SA, Australia; [Copping, Katrina J.; Grivell, Rosalie; Rodgers, Raymond J.] Univ Adelaide, Reprod Hlth Robinson Inst, Adelaide, SA, Australia; [Hoare, Andrew] South East Vets, Mt Gambier, SA, Australia; [McMillen, I. Caroline] Univ Newcastle, The Chancellory, Newcastle, NSW 2300, Australia; [Kuchel, Tim] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Grivell, Rosalie] Womens & Childrens Hosp, Dept Perinatal Med, Adelaide, SA, Australia	University of Nottingham; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Newcastle; South Australian Health & Medical Research Institute (SAHMRI); Womens & Childrens Hospital Australia	Perry, VEA (corresponding author), Univ Nottingham, Sch Vet & Med Sci, Loughborough, England.	viv.perry@nottingham.ac.uk	Hernandez-Medrano, Juan/AAG-2703-2019; perry, viv/AAB-8020-2019; Miguel-Pacheco, Giuliana G/I-1977-2016; Hernandez-Medrano, Juan H/AAI-8027-2020; Hernandez-Medrano, Juan H/A-1818-2012; McMillen, Isabella Caroline/N-5540-2019; Rodgers, Raymond J/C-3476-2009; Hernandez-Medrano, Juan H/HDO-6887-2022; Grivell, Rosalie/N-6852-2015	perry, viv/0000-0003-1330-6204; Miguel-Pacheco, Giuliana G/0000-0003-2765-1324; Hernandez-Medrano, Juan H/0000-0002-2907-2441; Hernandez-Medrano, Juan H/0000-0002-2907-2441; Hernandez-Medrano, Juan H/0000-0002-2907-2441; Grivell, Rosalie/0000-0002-2447-6519	Australian Research Council (ARC) [LP110100649]; EBLEX (English Beef and Lamb Executive) a division of the Agriculture and Horticulture Development Board (AHDB) [RC3815]	Australian Research Council (ARC)(Australian Research Council); EBLEX (English Beef and Lamb Executive) a division of the Agriculture and Horticulture Development Board (AHDB)	This work was supported by the Australian Research Council (ARC) grant number: LP110100649 given to VP, ICM, and RR (www.arc.gov.au); and EBLEX (English Beef and Lamb Executive) a division of the Agriculture and Horticulture Development Board (AHDB) - grant numberRC3815: given to VP (http://www.eblex.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RP, 2007, PEDIATR RES, V62, P385; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; Bermejo-Alvarez P, 2011, REPRODUCTION, V141, P563, DOI 10.1530/REP-10-0482; Bollwein H, 2002, THERIOGENOLOGY, V57, P2053, DOI 10.1016/S0093-691X(02)00706-9; Borowczyk E, 2006, J ANIM SCI, V84, P1593, DOI 10.2527/2006.8461593x; Bridges GA, 2014, THERIOGENOLOGY, V81, P632, DOI 10.1016/j.theriogenology.2013.11.020; Camacho LE, 2014, J ANIM SCI, V92, P520, DOI 10.2527/jas.2013-7017; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Copping KJ, 2014, ANIM PROD SCI, V54, P1333, DOI 10.1071/AN14278; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; FERRELL CL, 1991, J ANIM SCI, V69, P1954, DOI 10.2527/1991.6951954x; Herzog K, 2007, REPROD DOMEST ANIM, V42, P51, DOI 10.1111/j.1439-0531.2007.00903.x; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Long NM, 2009, J ANIM SCI, V87, P1950, DOI 10.2527/jas.2008-1672; MacLaughlin SM, 2007, ENDOCRINOLOGY, V148, P1911, DOI 10.1210/en.2006-0761; Micke G, 2014, THERIOGENOL IN PRESS; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; Micke GC, 2010, ANIM REPROD SCI, V121, P208, DOI 10.1016/j.anireprosci.2010.05.017; Micke GC, 2010, ANIM REPROD SCI, V118, P163, DOI 10.1016/j.anireprosci.2009.08.006; Micke GC, 2010, ANIM REPROD SCI, V117, P1, DOI 10.1016/j.anireprosci.2009.03.010; Micke GC, 2011, REPRODUCTION, V141, P697, DOI 10.1530/REP-10-0332; Mossa F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107235; O'Connell BA, 2013, PLACENTA, V34, P119, DOI 10.1016/j.placenta.2012.11.009; Panarace M, 2006, THERIOGENOLOGY, V66, P2113, DOI 10.1016/j.theriogenology.2006.03.040; Perry VEA, 1999, ANIM REPROD SCI, V55, P13, DOI 10.1016/S0378-4320(98)00157-2; Prior T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056933; Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006; REYNOLDS LP, 1995, J ANIM SCI, V73, P1839; Stark MJ, 2011, PLACENTA, V32, P865, DOI 10.1016/j.placenta.2011.08.010; Sullivan TM, 2010, ANIM REPROD SCI, V118, P131, DOI 10.1016/j.anireprosci.2009.07.005; Sullivan TM, 2009, THERIOGENOLOGY, V72, P427, DOI 10.1016/j.theriogenology.2009.03.018; Sullivan TM, 2009, REPROD FERT DEVELOP, V21, P773, DOI 10.1071/RD09004; Sullivan TM, 2009, PLACENTA, V30, P348, DOI 10.1016/j.placenta.2009.01.008; Vonnahme KA, 2007, J ANIM SCI, V85, P2464, DOI 10.2527/jas.2006-805; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	35	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125694	10.1371/journal.pone.0125694	http://dx.doi.org/10.1371/journal.pone.0125694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915506	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100142
J	Torres-Costoso, A; Gracia-Marco, L; Sanchez-Lopez, M; Notario-Pacheco, B; Arias-Palencia, N; Martinez-Vizcaino, V				Torres-Costoso, Ana; Gracia-Marco, Luis; Sanchez-Lopez, Mairena; Notario-Pacheco, Blanca; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente			Physical Activity and Bone Health in Schoolchildren: The Mediating Role of Fitness and Body Fat	PLOS ONE			English	Article							MINERAL DENSITY; LEAN MASS; CHILDREN; ADOLESCENTS; GROWTH; OVERWEIGHT; PREVENTION; ACCRETION; OBESITY; WEIGHT	Background The relationship between physical activity (PA) and bone health is well known, although the role of percent body fat (%BF) and fitness as confounders or mediators in this relationship remains uncertain. Objective To examine whether the association between PA and bone mineral content (BMC) is mediated by %BF and cardiorespiratory fitness (CRF). Methods In this cross sectional study, BMC, total %BF (by DXA), vigorous PA (VPA), CRF, age and height were measured in 132 schoolchildren (62 boys, aged 8-11 years). ANCOVA was used to test differences in BMC by %BF, CRF and VPA, controlling for different sets of confounders. Simple mediation analyses and serial multiple mediation analyses were fitted to examine whether the relationship between PA and BMC is mediated by %BF and fitness. Results Children with high %BF had higher total body BMC than their peers after controlling for all sets of confounders. Children with good CRF or VPA had significantly less total body BMC after controlling for age and sex but in children with good CRF this inverse relation disappeared after adjusting by %BF. %BF and CRF both act as a full mediator in the association between VPA and BMC, after inclusion of the potential confounders in the models. Conclusion Fitness and %BF seem to have a mediator role on the relationship between physical activity and bone mass.	[Torres-Costoso, Ana] Univ Castilla La Mancha, Sch Nursing & Physiotherapy, Toledo, Spain; [Gracia-Marco, Luis] Univ Exeter, CHERC Childrens Hlth & Exercise Res Ctr Sport & H, Exeter, Devon, England; [Gracia-Marco, Luis] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Sanchez-Lopez, Mairena; Notario-Pacheco, Blanca; Arias-Palencia, Natalia; Martinez-Vizcaino, Vicente] Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain; [Sanchez-Lopez, Mairena] Univ Castilla La Mancha, Fac Educ, E-13071 Ciudad Real, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; University of Exeter; University of Zaragoza; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Martinez-Vizcaino, V (corresponding author), Univ Castilla La Mancha, Social & Hlth Care Res Ctr, Cuenca, Spain.	Vicente.Martinez@uclm.es	Torres-Costoso, Ana/R-4847-2019; SANCHEZ-LOPEZ, MAIRENA/J-7933-2016; VIZCAINO, VICENTE MARTINEZ/AAZ-9034-2021; Palencia, Natalia María Arias/Q-5070-2017; Gracia-Marco, Luis/A-8845-2018; Gracia-Marco, Luis/R-4899-2019; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Notario Pacheco, Blanca/G-2583-2016	VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Palencia, Natalia María Arias/0000-0001-5004-3197; Gracia-Marco, Luis/0000-0002-4020-0256; Gracia-Marco, Luis/0000-0002-4020-0256; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Sanchez Lopez, Mairena/0000-0002-0217-0623; Torres-Costoso, Ana/0000-0001-8961-3169; Notario Pacheco, Blanca/0000-0001-8406-6952	Ministry of Education and Science - Junta de Comunidades de Castilla-La Mancha [PII1I09-0259-9898, POII10-0208-5325]; Ministry of Health (FIS grant) [PI081297]; Research Network on Preventative Activities and Health Promotion [RD06/0018/0038]	Ministry of Education and Science - Junta de Comunidades de Castilla-La Mancha; Ministry of Health (FIS grant); Research Network on Preventative Activities and Health Promotion	This study was funded by grant numbers PII1I09-0259-9898 and POII10-0208-5325 from the Ministry of Education and Science - Junta de Comunidades de Castilla-La Mancha, and Ministry of Health (FIS grant number PI081297). Additional funding was provided by the Research Network on Preventative Activities and Health Promotion (RD06/0018/0038).	Baptista F, 2012, J BONE MINER METAB, V30, P100, DOI 10.1007/s00774-011-0294-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baxter-Jones ADG, 2008, J APPL PHYSIOL, V105, P734, DOI 10.1152/japplphysiol.00869.2007; Cobayashi Fernanda, 2005, J. Pediatr. (Rio J.), V81, P337, DOI [10.2223/JPED.1372, 10.1590/S0021-75572005000500013]; Cole ZA, 2012, BONE, V50, P562, DOI 10.1016/j.bone.2011.05.005; Cole Zoe A, 2008, Curr Rheumatol Rep, V10, P92, DOI 10.1007/s11926-008-0017-6; Diez-Fernandez A, 2014, DIABETES CARE, V37, P855, DOI 10.2337/dc13-0416; El Hage RP, 2009, EUR J APPL PHYSIOL, V105, P759, DOI 10.1007/s00421-008-0959-4; Ellis KJ, 2003, ACTA DIABETOL, V40, pS274, DOI 10.1007/s00592-003-0085-z; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Gracia-Marco L, 2012, OSTEOPOROSIS INT, V23, P937, DOI 10.1007/s00198-011-1649-3; Gracia-Marco L, 2011, EUR J APPL PHYSIOL, V111, P2671, DOI 10.1007/s00421-011-1897-0; Gracia-Marco L, 2011, AM J PREV MED, V40, P599, DOI 10.1016/j.amepre.2011.03.001; Hrafnkelsson H, 2013, J BONE MINER METAB, V31, P442, DOI 10.1007/s00774-013-0423-3; Ischander M, 2007, MED SCI SPORT EXER, V39, P1131, DOI 10.1249/mss.0b013e318053e7a2; Ivuskans A, 2013, RHEUMATOL INT, V33, P1681, DOI 10.1007/s00296-012-2612-0; Kemper HCG, 2000, BONE, V27, P847, DOI 10.1016/S8756-3282(00)00397-5; Kennedy K, 2013, ARCH DIS CHILD, V98, P204, DOI 10.1136/archdischild-2012-302823; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; MacKelvie KJ, 2003, PEDIATRICS, V112, pE447, DOI 10.1542/peds.112.6.e447; Maggio ABR, 2014, J PEDIATR GASTR NUTR, V58, P723, DOI 10.1097/MPG.0000000000000297; Martinez-Vizcaino V, 2012, REV ESP CARDIOL, V65, P427, DOI [10.1016/j.recesp.2011.12.008, 10.1016/j.rec.2011.12.009]; McVeigh JA, 2007, ACTA PAEDIATR, V96, P874, DOI 10.1111/j.1651-2227.2007.00285.x; Mosca LN, 2013, NUTRIENTS, V5, P2047, DOI 10.3390/nu5062047; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reid IR, 2004, CALCIFIED TISSUE INT, V74, P313, DOI 10.1007/s00223-002-0015-z; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Rocher E, 2008, J BONE MINER METAB, V26, P73, DOI 10.1007/s00774-007-0786-4; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Ruiz JR, 2006, AM J CLIN NUTR, V84, P299; Sardinha LB, 2008, PEDIATRICS, V122, pE728, DOI 10.1542/peds.2007-2573; Sayers A, 2011, J CLIN ENDOCR METAB, V96, pE793, DOI 10.1210/jc.2010-2550; Shaikh MG, 2014, CLIN ENDOCRINOL, V80, P85, DOI 10.1111/cen.12263; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Tobias JH, 2007, J BONE MINER RES, V22, P101, DOI 10.1359/JBMR.060913; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Valtuena J, 2012, OSTEOPOROSIS INT, V23, P2227, DOI 10.1007/s00198-011-1884-7; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; Vicente-Rodriguez G, 2004, MED SCI SPORT EXER, V36, P1789, DOI 10.1249/01.MSS.0000142311.75866.D7; Vicente-Rodriguez G, 2008, J BONE MINER METAB, V26, P288, DOI 10.1007/s00774-007-0818-0; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Wetzsteon RJ, 2011, BONE, V48, P1103, DOI 10.1016/j.bone.2011.01.005	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123797	10.1371/journal.pone.0123797	http://dx.doi.org/10.1371/journal.pone.0123797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915941	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100027
J	Caruso, M; Ferranti, F; Scheri, KC; Dobrowolny, G; Ciccarone, F; Grammatico, P; Catizone, A; Ricci, G				Caruso, Maria; Ferranti, Francesca; Scheri, Katia Corano; Dobrowolny, Gabriella; Ciccarone, Fabio; Grammatico, Paola; Catizone, Angela; Ricci, Giulia			R-Spondin 1/Dickkopf-1/Beta-Catenin Machinery Is Involved in Testicular Embryonic Angiogenesis	PLOS ONE			English	Article							WNT/BETA-CATENIN; BETA-CATENIN; TESTIS DEVELOPMENT; CELL-MIGRATION; WNT4; R-SPONDIN1; EXPRESSION; DIFFERENTIATION; RSPO1; GENE	Testicular vasculogenesis is one of the key processes regulating male gonad morphogenesis. The knowledge of the molecular cues underlining this phenomenon is one of today's most challenging issues and could represent a major contribution toward a better understanding of the onset of testicular morphogenetic disorders. R-spondin 1 has been clearly established as a candidate for mammalian ovary determination. Conversely, very little information is available on the expression and role of R-spondin 1 during testicular morphogenesis. This study aims to clarify the distribution pattern of R-spondin 1 and other partners of its machinery during the entire period of testicular morphogenesis and to indicate the role of this system in testicular development. Our whole mount immunofluorescence results clearly demonstrate that R-spondin 1 is always detectable in the testicular coelomic partition, where testicular vasculature is organized, while Dickkopf-1 is never detectable in this area. Moreover, organ culture experiments of embryonic male UGRs demonstrated that Dickkopf- 1 acted as an inhibitor of testis vasculature formation. Consistent with this observation, real-time PCR analyses demonstrated that DKK1 is able to slightly but significantly decrease the expression level of the endothelial marker Pecam1. The latter experiments allowed us to observe that DKK1 administration also perturbs the expression level of the Pdgf-b chain, which is consistent with some authors' observations relating this factor with prenatal testicular patterning and angiogenesis. Interestingly, the DKK1 induced inhibition of testicular angiogenesis was rescued by the co-administration of R-spondin 1. In addition, R-spondin 1 alone was sufficient to enhance, in culture, testicular angiogenesis.	[Caruso, Maria; Ferranti, Francesca; Scheri, Katia Corano; Dobrowolny, Gabriella; Catizone, Angela] Univ Roma La Sapienza, Sect Histol & Med Embryol, Dept Anat Histol Forens Med & Orthoped, I-00185 Rome, Italy; [Ferranti, Francesca] Italian Space Agcy, Rome, Italy; [Dobrowolny, Gabriella] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Ciccarone, Fabio] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy; [Grammatico, Paola] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Ricci, Giulia] Univ Naples 2, Dept Expt Med, Histol & Embryol Lab, Naples, Italy	Sapienza University Rome; Agenzia Spaziale Italiana (ASI); Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Sapienza University Rome; Universita della Campania Vanvitelli	Ricci, G (corresponding author), Univ Naples 2, Dept Expt Med, Histol & Embryol Lab, Naples, Italy.	giulia.ricci@unina2.it	Ricci, Giulia/AAO-1856-2020; CICCARONE, FABIO/K-4225-2016; Ciccarone, Fabio/AAR-9128-2021	Ricci, Giulia/0000-0002-2199-170X; Ciccarone, Fabio/0000-0002-2425-2240; Corano Scheri, Katia/0000-0002-2999-6556; Dobrowolny, Gabriella/0000-0001-8693-0724; catizone, angela/0000-0002-7836-9495	Italian Ministero per l'Universita e la Ricerca scientifica e tecnologica (M.U.R.S.T.) Cofin	Italian Ministero per l'Universita e la Ricerca scientifica e tecnologica (M.U.R.S.T.) Cofin(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministero per l'Universita e la Ricerca scientifica e tecnologica (M.U.R.S.T.) Cofin 2008 to Paola Grammatico and Angela Catizone.	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Biason-Lauber A, 2008, SEX DEV, V2, P210, DOI 10.1159/000152037; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Biason-Lauber A, 2010, BEST PRACT RES CL EN, V24, P163, DOI 10.1016/j.beem.2009.12.002; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Boudin E, 2013, SEMIN ARTHRITIS RHEU, V43, P220, DOI 10.1016/j.semarthrit.2013.01.004; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2012, DEVELOPMENT, V139, P4461, DOI 10.1242/dev.078972; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Chen JZ, 2002, MOL BIOL REP, V29, P287, DOI 10.1023/A:1020479301379; Ciccarone F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046927; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Combes AN, 2011, SEX DEV, V5, P124, DOI 10.1159/000327709; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Dor Y, 2003, ANN NY ACAD SCI, V995, P208, DOI 10.1111/j.1749-6632.2003.tb03224.x; ERICKSON RP, 1993, DEV GENET, V14, P274, DOI 10.1002/dvg.1020140405; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gore AV, 2011, DEVELOPMENT, V138, P4875, DOI 10.1242/dev.068460; Han XH, 2011, J BIOL CHEM, V286, P10649, DOI 10.1074/jbc.M110.169391; Jameson SA, 2012, DEV BIOL, V370, P24, DOI 10.1016/j.ydbio.2012.06.009; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Katoh M, 2001, INT J ONCOL, V19, P977; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Kuppan P, 2011, BIOMACROMOLECULES, V12, P3156, DOI 10.1021/bm200618w; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nagamine CM, 1996, DEVELOPMENT, V122, P3597; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; PESCE M, 1995, DEV BIOL, V170, P722, DOI 10.1006/dbio.1995.1250; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Ricci G, 2004, J CELL PHYSIOL, V200, P458, DOI 10.1002/jcp.20035; Tilmann C, 1999, DEVELOPMENT, V126, P2883; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomaselli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016366; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	60	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124213	10.1371/journal.pone.0124213	http://dx.doi.org/10.1371/journal.pone.0124213			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910078	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800067
J	Dadson, K; Turdi, S; Boo, S; Hinz, B; Sweeney, G				Dadson, Keith; Turdi, Subat; Boo, Stellar; Hinz, Boris; Sweeney, Gary			Temporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient Mice	PLOS ONE			English	Article							ALPHA-SKELETAL ACTIN; ANGIOTENSIN-II; TRANSENDOTHELIAL TRANSPORT; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; HEART; ACTIVATION; FIBROSIS; GLUCOSE; HYPERTROPHY	Adiponectin, circulating levels of which are reduced in obesity and diabetes, mediates cardiac extracellular matrix (ECM) remodeling in response to pressure overload (PO). Here, we performed a detailed temporal analysis of progressive cardiac ECM remodelling in adiponectin knockout (AdKO) and wild-type (WT) mice at 3 days and 1, 2, 3 and 4 weeks following the induction of mild PO via minimally invasive transverse aortic banding. We first observed that myocardial adiponectin gene expression was reduced after 4 weeks of PO, whereas increased adiponectin levels were detected in cardiac homogenates at this time despite decreased circulating levels of adiponectin. Scanning electron microscopy and Masson's trichrome staining showed collagen accumulation increased in response to 2 and 4 weeks of PO in WT mice, while fibrosis in AdKO mice was notably absent after 2 weeks but highly apparent after 4 weeks of PO. Time and intensity of fibroblast appearance after PO was not significantly different between AdKO and WT animals. Gene array analysis indicated that MMP2, TIMP2, collagen 1 alpha 1 and collagen 1 alpha 3 were induced after 2 weeks of PO in WT but not AdKO mice. After 4 weeks MMP8 was induced in both genotypes, MMP9 only in WT mice and MMP1 alpha only in AdKO mice. Direct stimulation of primary cardiac fibroblasts with adiponectin induced a transient increase in total collagen detected by picrosirius red staining and collagen III levels synthesis, as well as enhanced MMP2 activity detected via gelatin zymography. Adiponectin also enhanced fibroblast migration and attenuated angiotensin-II induced differentiation to a myofibroblast phenotype. In conclusion, these data indicate that increased myocardial bioavailability of adiponectin mediates ECM remodeling following PO and that adiponectin deficiency delays these effects.	[Dadson, Keith; Turdi, Subat; Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Boo, Stellar; Hinz, Boris] Univ Toronto, Fac Dent, Matrix Dynam Grp, Lab Tissue Repair & Regenerat, Toronto, ON, Canada	York University - Canada; University of Toronto	Sweeney, G (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	gsweeney@yorku.ca		Hinz, Boris/0000-0002-0526-393X	Canadian Diabetes Association; Heart & Stroke Foundation of Canada; Canadian Institutes of Health Research (CIHR) [210820, 286920]	Canadian Diabetes Association; Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant to GS from the Canadian Diabetes Association. GS also acknowledges support via a Career Investigator Award from Heart & Stroke Foundation of Canada and BH the Canadian Institutes of Health Research (CIHR) grants #210820 and #286920. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Benaitreau D, 2010, J ENDOCRINOL, V207, P45, DOI 10.1677/JOE-10-0170; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; BLACK FM, 1991, J CLIN INVEST, V88, P1581, DOI 10.1172/JCI115470; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Clement S, 1999, CIRC RES, V85, pE51; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Dadson K, 2014, J CELL BIOCHEM, V115, P785, DOI 10.1002/jcb.24722; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Davis J, 2013, J MOL CELL CARDIOL; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; Eguchi M, 2012, J CELL MOL MED, V16, P2925, DOI 10.1111/j.1582-4934.2012.01613.x; Eguchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030450; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Fang F, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4070; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P109, DOI 10.1016/j.carpath.2005.03.004; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P49, DOI 10.1016/j.carpath.2005.01.005; Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Guo XH, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.230; Hao G, 2013, ATHEROSCLEROSIS; Hattori Y, 2007, DIABETES, V56, P804, DOI 10.2337/db06-1405; Hecker PA, 2011, HORM METAB RES, V43, P100, DOI 10.1055/s-0030-1269898; Ishikawa Y, 2003, HISTOPATHOLOGY, V42, P43, DOI 10.1046/j.1365-2559.2003.01518.x; Kern S, 2014, FEBS OPEN BIO, V4, P11, DOI 10.1016/j.fob.2013.11.002; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; O'Shea KM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-95; O'Shea KM, 2010, AM J PHYSIOL-HEART C, V298, pH1639, DOI 10.1152/ajpheart.00957.2009; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Park M, 2012, HEART FAIL REV; Park M, 2013, HEART FAIL REV, V18, P631, DOI 10.1007/s10741-012-9337-8; Qi GM, 2014, ENDOCRINOLOGY, V155, P2254, DOI 10.1210/en.2013-2011; Rutkowski JM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-47; Sahebkar A, 2013, METABOLISM, V62, P1876, DOI 10.1016/j.metabol.2013.08.017; Sarrazy V, 2014, CARDIOVASC RES, V102, P407, DOI 10.1093/cvr/cvu053; Schram K, 2008, TRENDS CARDIOVAS MED, V18, P199, DOI 10.1016/j.tcm.2008.10.001; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Suzuki H, 2006, KIDNEY INT, V70, P1678, DOI 10.1038/sj.ki.5001936; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turner NA, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-5; van Stijn CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086404; Vu V, 2011, INT J OBESITY, V35, P355, DOI 10.1038/ijo.2010.160; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Wu ML, 2009, EUR J PHARMACOL, V616, P155, DOI 10.1016/j.ejphar.2009.05.016; Wu ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078485; Yoon N, 2014, DIABETES METAB J, V38, P92, DOI 10.4093/dmj.2014.38.2.92	58	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121049	10.1371/journal.pone.0121049	http://dx.doi.org/10.1371/journal.pone.0121049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910275	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800010
J	Pietersen, E; Peter, J; Streicher, E; Sirgel, F; Rockwood, N; Mastrapa, B; Te Riele, J; Davids, M; van Helden, P; Warren, R; Dheda, K				Pietersen, Elize; Peter, Jonny; Streicher, Elizabeth; Sirgel, Frik; Rockwood, Neesha; Mastrapa, Barbara; Te Riele, Julian; Davids, Malika; van Helden, Paul; Warren, Robin; Dheda, Keertan			High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; COHORT	Background There are limited data about the epidemiology and treatment-related outcomes associated with capreomycin resistance in patients with XDR-TB. Capreomycin achieves high serum concentrations relative to MIC but whether capreomycin has therapeutic benefit despite microbiological resistance remains unclear. Methods We reviewed the susceptibility profiles and outcomes associated with capreomycin usage in patients diagnosed with XDR-TB between August 2002 and October 2012 in two provinces of South Africa. Patients whose isolates were genotypically tested for capreomycin resistance were included in the analysis. Results Of 178 XDR-TB patients 41% were HIV-infected. 87% (154/178) isolates contained a capreomycin resistance-conferring mutation [80% (143/178) rrs A1401G and 6% (11/178) were heteroresistant (containing both the rrs A1401G mutation and wild-type sequences)]. Previous MDR-TB treatment, prior usage of kanamycin, or strain type was not associated with capreomycin resistance. 92% (163/178) of XDR-TB patients were empirically treated with capreomycin. Capreomycin resistance decreased the odds of sputum culture conversion. In capreomycin sensitive and resistant persons combined weight at diagnosis was the only independent predictor for survival (p=<0.001). By contrast, HIV status and use of co-amoxicillin/clavulanic acid were independent predictors of mortality (p=<0.05). Capreomycin usage was not associated with survival or culture conversion when the analysis was restricted to those whose isolates were resistant to capreomycin. Conclusion In South Africa the frequency of capreomycin conferring mutations was extremely high in XDR-TB isolates. In those with capreomycin resistance there appeared to be no therapeutic benefit of using capreomycin. These data inform susceptibility testing and the design of treatment regimens for XDR-TB in TB endemic settings.	[Pietersen, Elize; Peter, Jonny; Davids, Malika; Dheda, Keertan] Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Pietersen, Elize; Peter, Jonny; Davids, Malika; Dheda, Keertan] Univ Cape Town, Dept Med, Lung Inst, ZA-7925 Cape Town, South Africa; [Streicher, Elizabeth; Sirgel, Frik; van Helden, Paul; Warren, Robin] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,South African MRC,Ctr, Dept Sci & Technol,Natl Res Fdn,Ctr Excellence Bi, ZA-7505 Tygerberg, South Africa; [Mastrapa, Barbara] Gordonia Prov Hosp, Upington, South Africa; [Rockwood, Neesha] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Te Riele, Julian] Brooklyn Chest Hosp, Cape Town, South Africa	University of Cape Town; University of Cape Town; National Research Foundation - South Africa; Stellenbosch University; Imperial College London	Dheda, K (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Streicher, Elizabeth M/I-7780-2018; Streicher, Elizabeth/O-9597-2019	Streicher, Elizabeth M/0000-0003-3901-1981; Streicher, Elizabeth/0000-0003-3901-1981; Rockwood, Neesha/0000-0002-7830-1394; Peter, Jonathan/0000-0002-2658-0723; Warren, Robin/0000-0001-5741-7358	South African National Research Foundation; South African Research Chair Initiative (SARChI); Opperheimer Foundation	South African National Research Foundation(National Research Foundation - South Africa); South African Research Chair Initiative (SARChI); Opperheimer Foundation	This study was funded by the South African National Research Foundation, South African Research Chair Initiative (SARChI), and the Opperheimer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, TUBERCULOSIS EDINB, V88, P89, DOI DOI 10.1016/S1472-9792(08)70004-0; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; PELOQUIN CA, 1993, MED CLIN N AM, V77, P1253, DOI 10.1016/S0025-7125(16)30191-2; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Sirgel FA, 2012, MICROB DRUG RESIST, V18, P193, DOI 10.1089/mdr.2011.0063; Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; WHO, GLOB TUB REP 2014; World Health organization, 2008, POL GUID DRUG SUSC T	22	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123655	10.1371/journal.pone.0123655	http://dx.doi.org/10.1371/journal.pone.0123655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909847	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800042
J	Singh, P; Wadhwa, N; Lodha, R; Sommerfelt, H; Aneja, S; Natchu, UCM; Chandra, J; Rath, B; Sharma, VK; Kumari, M; Saini, S; Kabra, SK; Bhatnagar, S; Strand, TA				Singh, Prashant; Wadhwa, Nitya; Lodha, Rakesh; Sommerfelt, Halvor; Aneja, Satinder; Natchu, Uma Chandra Mouli; Chandra, Jagdish; Rath, Bimbadhar; Sharma, Vinod Kumar; Kumari, Mohini; Saini, Savita; Kabra, Sushil Kumar; Bhatnagar, Shinjini; Strand, Tor A.			Predictors of Time to Recovery in Infants with Probable Serious Bacterial Infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEONATAL SEPSIS; MORTALITY; MALNUTRITION; CHILDREN; GROWTH; LENGTH; ZINC	Introduction Serious bacterial infections continue to be an important cause of death and illness among infants in developing countries. Time to recovery could be considered a surrogate marker of severity of the infection. We therefore aimed to identify clinical and laboratory predictors of time to recovery in infants with probable serious bacterial infection (PSBI). Methods We used the dataset of 700 infants (7-120 days) enrolled in a randomised controlled trial in India in which 10mg of oral zinc or placebo was given to infants with PSBI. PSBI was defined as signs/symptoms of possible serious bacterial infection along with baseline C-reactive protein(CRP) level >12mg/L. Time to recovery was defined as time from enrolment to the end of a 2-day period with no symptoms/signs of PSBI and daily weight gain of at least 10g over 2 succesive days on exclusive oral feeding. Cox proportional hazard regression was used to measure the associations between relevant variables and time to recovery. Results Infants who were formula fed prior to illness episode had 33% longer time to recovery (HR-0.67, 95% CI-0.52, 0.87) than those who were not. Being underweight (HR-0.84, 95% CI-0.70, 0.99), lethargic (HR-0.77, 95% CI-0.62, 0.96) and irritable (HR-0.81, 95% CI-0.66, 0.99) were independent predictors of time to recovery. Baseline CRP was significantly associated with time to recovery (P<0.001), higher CRP was associated with longer time to recovery and this association was nearly linear. Conclusion Simple clinical and laboratory parameters such as formula feeding prior to the illness, being underweight, lethargic, irritable and having elevated CRP levels could be used for early identification of infants with PSBI at risk for protracted illness and could guide prompt referral to higher centers in resource limited settings. This also provides prognostic information to clinicians and family as longer recovery time has economic and social implications on the family in our setting.	[Singh, Prashant; Wadhwa, Nitya; Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini] Translat Hlth Sci & Technol Inst, Gurgaon, India; [Singh, Prashant; Wadhwa, Nitya; Lodha, Rakesh; Saini, Savita; Kabra, Sushil Kumar; Bhatnagar, Shinjini] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Bergen, Norway; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Aneja, Satinder; Chandra, Jagdish; Rath, Bimbadhar] Lady Hardinge Med Coll & Hosp, Dept Pediat, New Delhi, India; [Aneja, Satinder; Chandra, Jagdish; Rath, Bimbadhar] Kalawati Saran Childrens Hosp, New Delhi, India; [Sharma, Vinod Kumar; Kumari, Mohini] Deen Dayal Upadhyay Hosp, Dept Pediat, New Delhi, India; [Strand, Tor A.] Innlandet Hosp Trust, Div Med Serv, Lillehammer, Norway	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); All India Institute of Medical Sciences (AIIMS) New Delhi; University of Bergen; Norwegian Institute of Public Health (NIPH); Lady Hardinge Medical College & Hospital; Innlandet Hospital Trust	Bhatnagar, S (corresponding author), Translat Hlth Sci & Technol Inst, Gurgaon, India.	shinjini.bhatnagar@gmail.com	singh, prashant/AAQ-4412-2020; Sommerfelt, Halvor/ABD-3552-2020; Strand, Tor/D-9836-2016	Sommerfelt, Halvor/0000-0002-5670-9786; Strand, Tor/0000-0002-4038-151X; bhatnagar, shinjini/0000-0003-1703-5296	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR5238/MED/14/610/2004]; European Commission [INCO-FP6-003740]; Research Council of Norway [172226]; Meltzer foundation (Bergen, Norway); South-Eastern Norway Regional Health Authority [2012090]; Research Council of Norway's Centre of Excellence Scheme [223269]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council of Norway(Research Council of Norway); Meltzer foundation (Bergen, Norway); South-Eastern Norway Regional Health Authority; Research Council of Norway's Centre of Excellence Scheme(Research Council of Norway)	Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/PR5238/MED/14/610/2004); the European Commission (EU-INCO-DC contract number INCO-FP6-003740); the Research Council of Norway (Project No. 172226); and the Meltzer foundation (Bergen, Norway); TAS and HS were funded through grants from the South-Eastern Norway Regional Health Authority (Grant No. 2012090) and The Research Council of Norway's Centre of Excellence Scheme (Grant No. 223269), respectively.	Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhatnagar S, 2012, LANCET, V379, P2072, DOI 10.1016/S0140-6736(12)60477-2; Bilavsky E, 2009, ACTA PAEDIATR, V98, P1776, DOI 10.1111/j.1651-2227.2009.01469.x; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; Child Trends, 2013, FAM LIF DIFF CENTR S; Coles CL, 2007, AM J CLIN NUTR, V86, P397, DOI 10.1093/ajcn/86.2.397; Devran O, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-47; Gradel KO, 2011, CLIN MICROBIOL INFEC, V17, P627, DOI 10.1111/j.1469-0691.2010.03284.x; Hengstermann S, 2010, J HUM LACT, V26, P19, DOI 10.1177/0890334409344078; Hofer N, 2012, NEONATOLOGY, V102, P25, DOI 10.1159/000336629; Kaur S, 2011, INDIAN PEDIATR, V48, P955, DOI 10.1007/s13312-011-0155-1; KORPPI M, 1993, SCAND J INFECT DIS, V25, P207, DOI 10.3109/00365549309008486; Kyle UG, 2010, CAN MED ASSOC J, V182, P1831, DOI 10.1503/cmaj.101256; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Ministry of Health and Family Welfare Government of India, 2003, INT MAN NEON CHILDH; National Center for Health Statistics, 2000, IND GROWTH CHARTS; SIRISINHA S, 1975, PEDIATRICS, V55, P166; SURI M, 1991, Indian Pediatrics, V28, P1159; UNICEF, 2003, GLOB STRAT INF YOUNG; Venkataseshan S, 2007, PEDIATR INFECT DIS J, V26, P684, DOI 10.1097/INF.0b013e3180f616f0; Vesel L, 2010, B WORLD HEALTH ORGAN, V88, P39, DOI 10.2471/BLT.08.057901; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124594	10.1371/journal.pone.0124594	http://dx.doi.org/10.1371/journal.pone.0124594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909192	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800091
J	Ahn, JH; Kim, JS; Kim, S; Soh, HY; Shin, H; Jang, H; Ryu, JH; Kim, A; Yun, KY; Kim, S; Kim, KS; Choi, D; Huh, JH				Ahn, Jong Hwa; Kim, June-Sik; Kim, Seungill; Soh, Hye Yeon; Shin, Hosub; Jang, Hosung; Ryu, Ju Hyun; Kim, Ahyeong; Yun, Kil-Young; Kim, Shinje; Kim, Ki Sun; Choi, Doil; Huh, Jin Hoe			De Novo Transcriptome Analysis to Identify Anthocyanin Biosynthesis Genes Responsible for Tissue-Specific Pigmentation in Zoysiagrass (Zoysia japonica Steud.)	PLOS ONE			English	Article							MOLECULAR-CLONING; TRANSPOSABLE ELEMENTS; EXPRESSION; PATHWAY; TOOL; DNA; ANNOTATION; BLAST2GO; MUTANTS; CLONES	Zoysiagrass (Zoysia japonica Steud.) is commonly found in temperate climate regions and widely used for lawns, in part, owing to its uniform green color. However, some zoysiagrass cultivars accumulate red to purple pigments in their spike and stolon tissues, thereby decreasing the aesthetic value. Here we analyzed the anthocyanin contents of two zoysiagrass cultivars 'Anyang-jungji' (AJ) and 'Greenzoa' (GZ) that produce spikes and stolons with purple and green colors, respectively, and revealed that cyanidin and petunidin were primarily accumulated in the pigmented tissues. In parallel, we performed a de novo transcriptome assembly and identified differentially expressed genes between the two cultivars. We found that two anthocyanin biosynthesis genes encoding anthocyanidin synthase (ANS) and dihydroflavonol 4-reductase (DFR) were preferentially upregulated in the purple AJ spike upon pigmentation. Both ANS and DFR genes were also highly expressed in other zoysiagrass cultivars with purple spikes and stolons, but their expression levels were significantly low in the cultivars with green tissues. We observed that recombinant ZjDFR1 and ZjANS1 proteins successfully catalyze the conversions of dihydroflavonols into leucoanthocyanidins and leucoanthocyanidins into anthocyanidins, respectively. These findings strongly suggest that upregulation of ANS and DFR is responsible for tissue-specific anthocyanin biosynthesis and differential pigmentation in zoysiagrass. The present study also demonstrates the feasibility of a de novo transcriptome analysis to identify the key genes associated with specific traits, even in the absence of reference genome information.	[Ahn, Jong Hwa; Shin, Hosub; Jang, Hosung; Ryu, Ju Hyun; Kim, Ki Sun; Choi, Doil; Huh, Jin Hoe] Seoul Natl Univ, Dept Plant Sci, Seoul 151921, South Korea; [Kim, June-Sik; Kim, Ki Sun; Choi, Doil; Huh, Jin Hoe] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kim, Seungill; Soh, Hye Yeon; Choi, Doil; Huh, Jin Hoe] Seoul Natl Univ, Interdisciplinary Program Agr Genom, Seoul 151921, South Korea; [Kim, Ahyeong; Yun, Kil-Young; Kim, Shinje] FnP Co Ltd, Jeungpyeong 368811, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Huh, JH (corresponding author), Seoul Natl Univ, Dept Plant Sci, Seoul 151921, South Korea.	huhjh@snu.ac.kr	Kim, Seungill/AAR-1099-2021; Kim, June-Sik/R-6474-2017; Choi, Doil/F-5002-2011	Kim, Seungill/0000-0001-6287-8693; Kim, June-Sik/0000-0002-4703-609X; Shin, Hosub/0000-0001-6488-8430	Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Korea [110005-05-4-HD110]; FnP Co. Ltd.	Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Korea; FnP Co. Ltd.	The work was supported by a Grant from the Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (No. 110005-05-4-HD110), Korea to JHH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FnP Co. Ltd. provided support in the form of salaries for authors AK, KYY and SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Arumuganathan K, 1999, CROP SCI, V39, P1518; Awika JM, 2005, FOOD CHEM, V90, P293, DOI 10.1016/j.foodchem.2004.03.058; Cai H, 2004, PLANT BREEDING, V123, P543, DOI 10.1111/j.1439-0523.2004.01022.x; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Chen Z., 2009, FLORICULTURE ORNAMEN, V1, P20; Choi JS, 2006, WEED TURF SCI, V20, P1; Choi JS, 2004, WEED TURF SCI, V18, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dixon RA, 2013, CURR OPIN BIOTECH, V24, P329, DOI 10.1016/j.copbio.2012.07.004; Doyle J. J., 1987, PHYTOCHEM B, P11; Emmons RD, 1995, TURFGRASS SCI MANAGE, P40; Engelke M.C., 2003, TURFGRASS BIOL GENET, P271; FORBES I, 1952, AGRON J, V44, P194, DOI 10.2134/agronj1952.00021962004400040008x; GOIFFON JP, 1991, J CHROMATOGR, V537, P101, DOI 10.1016/S0021-9673(01)88890-7; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Inokuma C, 1996, PLANT CELL REP, V15, P737, DOI 10.1007/BF00232218; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2014, NUCLEIC ACIDS RES, V42, P11408, DOI 10.1093/nar/gku834; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li ML, 2009, EUPHYTICA, V170, P327, DOI 10.1007/s10681-009-9990-8; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Mazza G., 1993, Anthocyanins in fruits, vegetables, and grains.; MENSSEN A, 1990, EMBO J, V9, P3051, DOI 10.1002/j.1460-2075.1990.tb07501.x; Neill SO, 2003, FUNCT PLANT BIOL, V30, P865, DOI 10.1071/FP03118; OREILLY C, 1985, EMBO J, V4, P877, DOI 10.1002/j.1460-2075.1985.tb03713.x; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; REDDY AR, 1987, PLANT SCI, V52, P7, DOI 10.1016/0168-9452(87)90098-7; Ruemmele BA, 1990, GROUNDS MAINTENANCE, V25, P92; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SCHWARZSOMMER Z, 1987, EMBO J, V6, P287, DOI 10.1002/j.1460-2075.1987.tb04752.x; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Shikazono N, 2003, GENETICS, V163, P1449; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Singh K, 2008, TREE PHYSIOL, V28, P1349, DOI 10.1093/treephys/28.9.1349; Sleper DA, 1989, CSSA SPECIAL PUBLICA, V15, P56; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANAKA Y, 1995, PLANT CELL PHYSIOL, V36, P1023, DOI 10.1093/oxfordjournals.pcp.a078844; Tsuruta Shin-Ichi, 2005, Grassland Science, V51, P249, DOI 10.1111/j.1744-697X.2005.00033.x; Tulio AZ, 2008, J AGR FOOD CHEM, V56, P1880, DOI 10.1021/jf072313k; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Yaneshita M, 1999, THEOR APPL GENET, V98, P751, DOI 10.1007/s001220051131; Yang YN, 2013, TREE GENET GENOMES, V9, P1351, DOI 10.1007/s11295-013-0644-6; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Z, 2004, J AGR FOOD CHEM, V52, P688, DOI 10.1021/jf034596w; Zhou B, 2013, AM J BOT, V100, P2458, DOI 10.3732/ajb.1300305; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	53	89	97	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124497	10.1371/journal.pone.0124497	http://dx.doi.org/10.1371/journal.pone.0124497			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905914	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000071
J	Galvao, LCC; Miller, JH; Kajfasz, JK; Scott-Anne, K; Freires, IA; Franco, GCN; Abranches, J; Rosalen, PL; Lemos, JA				Galvao, Lvia C. C.; Miller, James H.; Kajfasz, Jessica K.; Scott-Anne, Kathy; Freires, Irlan A.; Franco, Gilson C. N.; Abranches, Jacqueline; Rosalen, Pedro L.; Lemos, Jose A.			Transcriptional and Phenotypic Characterization of Novel Spx-Regulated Genes in Streptococcus mutans	PLOS ONE			English	Article							IRON-BINDING PROTEIN; OXIDATIVE STRESS; RNA-POLYMERASE; ENERGY-METABOLISM; OXYGEN TOLERANCE; ASSEMBLY SYSTEM; NADH OXIDASE; FERROUS IRON; VIRULENCE; CARIES	In oral biofilms, two of the major environmental challenges encountered by the dental pathogen Streptococcus mutans are acid and oxidative stresses. Previously, we showed that the S. mutans transcriptional regulators SpxA1 and SpxA2 (formerly SpxA and SpxB, respectively) are involved in stress survival by activating the expression of classic oxidative stress genes such as dpr, nox, sodA and tpx. We reasoned that some of the uncharacterized genes under SpxA1/A2 control are potentially involved in oxidative stress management. Therefore, the goal of this study was to use Spx-regulated genes as a tool to identify novel oxidative stress genes in S. mutans. Quantitative real-time PCR was used to evaluate the responses of ten Spx-regulated genes during H2O2 stress in the parent and Delta spx strains. Transcription activation of the H2O2-induced genes (8 out of 10) was strongly dependent on SpxA1 and, to a lesser extent, SpxA2. In vitro transcription assays revealed that one or both Spx proteins directly regulate three of these genes. The gene encoding the FeoB ferrous permease was slightly repressed by H2O2 but constitutively induced in strains lacking SpxA1. Nine genes were selected for downstream mutational analysis but inactivation of smu127, encoding a subunit of the acetoin dehydrogenase was apparently lethal. In vitro and in vivo characterization of the viable mutants indicated that, in addition to the transcriptional activation of reducing and antioxidant pathways, Spx performs an important role in iron homeostasis by regulating the intracellular availability of free iron. In particular, inactivation of the genes encoding the Fe-S biogenesis SUF system and the previously characterized iron-binding protein Dpr resulted in impaired growth under different oxidative stress conditions, increased sensitivity to iron and lower infectivity in rats. These results serve as an entryway into the characterization of novel genes and pathways that allow S. mutans to cope with oxidative stress.	[Galvao, Lvia C. C.; Miller, James H.; Kajfasz, Jessica K.; Scott-Anne, Kathy; Freires, Irlan A.; Abranches, Jacqueline; Lemos, Jose A.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Galvao, Lvia C. C.; Abranches, Jacqueline; Lemos, Jose A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Freires, Irlan A.; Rosalen, Pedro L.] Univ Estadual Campinas, Dent Sch Piracicaba, Dept Physiol Sci, Piracicaba, SP, Brazil; [Franco, Gilson C. N.] Univ Estadual Ponta Grossa, Lab Physiol & Pathophysiol, Dept Gen Biol, Ponta Grossa, PR, Brazil	University of Rochester; University of Rochester; Universidade Estadual de Campinas; Universidade Estadual de Ponta Grossa	Lemos, JA (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	jose_lemos@urmc.rochester.edu	Freires, Irlan/M-9214-2014; de Carvalho Galvao, Livia Camara/AAU-1109-2020; Rosalen, Pedro Luiz/I-3718-2012	Freires, Irlan/0000-0002-1079-6941; de Carvalho Galvao, Livia Camara/0000-0001-9540-649X; Rosalen, Pedro Luiz/0000-0003-0812-4027; Lemos, Jose/0000-0003-0791-5863	National Institute of Dental and Craniofacial Research [DE019783]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [6849-12-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/032278-3, 2014/03816-4]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019783] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research DE019783 (JAL), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - 6849-12-1 (LCCG), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - 2012/032278-3 (LCCG), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - 2014/03816-4 (LCCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2006, J BACTERIOL, V188, P3748, DOI 10.1128/JB.00169-06; Aranda J, 2009, INT MICROBIOL, V12, P137, DOI 10.2436/20.1501.01.91; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barendt S, 2013, MICROBIOLOGYOPEN, V2, P695, DOI 10.1002/mbo3.109; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Biswas S, 2011, ANTIMICROB AGENTS CH, V55, P1460, DOI 10.1128/AAC.01094-10; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; BOWEN WH, 1988, J DENT RES, V67, P1316, DOI 10.1177/00220345880670101401; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Caufield PW, 2000, INFECT IMMUN, V68, P4018, DOI 10.1128/IAI.68.7.4018-4023.2000; Chen LH, 2012, J NANOMATER, V2012, DOI 10.1155/2012/491051; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Fujishima K, 2013, APPL ENVIRON MICROB, V79, P1436, DOI 10.1128/AEM.03306-12; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Jain R, 2005, CURR MED CHEM, V12, P1607, DOI 10.2174/0929867054367194; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kajfasz JK, 2012, INFECT IMMUN, V80, P2265, DOI 10.1128/IAI.00026-12; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Lin AA, 2012, J BACTERIOL, V194, P1697, DOI 10.1128/JB.06660-11; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Marco S, 2013, BIOCHIMIE, V95, P2145, DOI 10.1016/j.biochi.2013.08.008; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; MIKX FHM, 1972, CARIES RES, V6, P211, DOI 10.1159/000259801; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Riboldi GP, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-3; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tsou CC, 2008, INFECT IMMUN, V76, P4038, DOI 10.1128/IAI.00477-08; Turlan C, 2009, MOL MICROBIOL, V73, P492, DOI 10.1111/j.1365-2958.2009.06789.x; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Vergauwen B, 2013, MOL MICROBIOL, V89, P288, DOI 10.1111/mmi.12274; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Yamamoto Y, 2000, J BACTERIOL, V182, P3740, DOI 10.1128/JB.182.13.3740-3747.2000; Yamamoto Y, 2000, BIOSCI BIOTECH BIOCH, V64, P1106, DOI 10.1271/bbb.64.1106; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; Zhang JQ, 2009, J BACTERIOL, V191, P4330, DOI 10.1128/JB.00184-09; Zheng CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108197; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004; Zuber P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025066	55	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124969	10.1371/journal.pone.0124969	http://dx.doi.org/10.1371/journal.pone.0124969			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905865	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000098
J	Ohno, S; Naito, Y; Mukai, S; Yabuta, N; Nojima, H				Ohno, S.; Naito, Y.; Mukai, S.; Yabuta, N.; Nojima, H.			ELAS1-mediated inhibition of the cyclin G1-B 'gamma interaction promotes cancer cell apoptosis via stabilization and activation of p53	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; DNA-DAMAGE; PHOSPHOINOSITIDE 3-KINASE; COLORECTAL-CANCER; MEDIATED TRANSFER; G2 EXPRESSION; TUMOR-GROWTH; G1; ARREST; PHOSPHORYLATION	Radiation therapy (RT) is useful for selectively killing cancer cells. However, because high levels of ionizing radiation (IR) are toxic to normal cells, RT cannot be applied repeatedly to cancer patients. Therefore, novel chemicals that enhance the efficacy of chemoradiotherapy (CRT) would be valuable. Here, we report that ELAS1, a peptide corresponding to the protein phosphatase 2A (PP2A) association domain of cyclin G1 (CycG1), can enhance the efficacy of CRT. ELAS1 interacts with the PP2A B'gamma-subunit and competitively inhibits association with CycG1, thereby preventing the PP2A holoenzyme from dephosphorylating target proteins, Mdm2 (pT218) and p53 (pS46), following DNA double-strand break (DSB) insults. Doxycycline (Dox)-induced overexpression of Myc-ELAS1 caused.-irradiation to induce apoptosis in human osteosarcoma (U2OS) cells, at 1/10th the effective dosage of.-irradiation required for apoptosis in Myc-vector-expressing cells; ELAS1 peptide incorporation into U2OS cells also showed similar apoptotic effects. Moreover, administration of DSB-inducing chemicals, camptothecin (CPT) or irinotecan, to Myc-ELAS1-expressing U2OS cells also induced efficient apoptosis with only 1/100th (CPT) or 1/5th (irinotecan) of the amounts of drugs required for this effect in Myc-vector-expressing cells. Taken together, ELAS1 may be important for the design of ELAS1-mimetic compounds to improve CRT efficacy.	[Ohno, S.; Naito, Y.; Mukai, S.; Yabuta, N.; Nojima, H.] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Suita, Osaka 5650871, Japan	Osaka University	Nojima, H (corresponding author), Osaka Univ, Reasearch Inst Microbial Dis, Dept Mol Genet, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	snj-0212@biken.osaka-u.ac.jp			Osaka University; Ministry of Education, Culture, Sports, Science and Technology of Japan [23370086]	Osaka University; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Patrick Hughes for critically reading the manuscript and Ms Yuki Ozaki for technical assistance. This work was supported by the Drug Discovery Gap Fund from Osaka University (to HN) and Grants-in-aid for Scientific Research (to HN) (No. 23370086) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Baek WK, 2003, AM J OBSTET GYNECOL, V188, P634, DOI 10.1067/mob.2003.140; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Chen DS, 1997, HUM GENE THER, V8, P1667, DOI 10.1089/hum.1997.8.14-1667; Chen WB, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/675429; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Gordon EM, 2000, CANCER RES, V60, P3343; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Ito Y, 2003, ANTICANCER RES, V23, P2335; Jensen MR, 2003, HEPATOLOGY, V37, P862, DOI 10.1053/jhep.2003.50137; Kalev P, 2011, ANTI-CANCER AGENT ME, V11, P38, DOI 10.2174/187152011794941172; Kampmeier J, 2000, HUM GENE THER, V11, P1, DOI 10.1089/10430340050016102; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Liu C, 2014, NUCLEIC ACIDS RES, V42, P6106, DOI 10.1093/nar/gku284; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Mi J, 2009, MOL CANCER THER, V8, P135, DOI 10.1158/1535-7163.MCT-08-0457; Naito Y, 2013, CELL CYCLE, V12, P1773, DOI 10.4161/cc.24878; Naito Y, 2012, CELL CYCLE, V11, P604, DOI 10.4161/cc.11.3.19114; Okamoto K, 1999, ONCOGENE, V18, P4606, DOI 10.1038/sj.onc.1202821; Okamoto K, 1996, MOL CELL BIOL, V16, P6593; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Park IJ, 2014, WORLD J GASTROENTERO, V20, P2023, DOI 10.3748/wjg.v20.i8.2023; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Perez R, 2003, J GASTROINTEST SURG, V7, P884, DOI 10.1016/j.gassur.2003.08.001; Piscopo DM, 2008, CANCER RES, V68, P5581, DOI 10.1158/0008-5472.CAN-07-6346; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Reimers L, 1999, J BIOL CHEM, V274, P11022, DOI 10.1074/jbc.274.16.11022; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Shimizu A, 1998, BIOCHEM BIOPH RES CO, V242, P529, DOI 10.1006/bbrc.1997.8004; SKOTZKO M, 1995, CANCER RES, V55, P5493; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; TAMURA K, 1993, ONCOGENE, V8, P2113; Todo T, 2001, P NATL ACAD SCI USA, V98, P6396, DOI 10.1073/pnas.101136398; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wen W, 2012, HEPATOLOGY, V55, P1787, DOI 10.1002/hep.25596; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003; Zhang Qingxiu, 2012, Enzyme Res, V2012, P659649, DOI 10.1155/2012/659649; Zhang TT, 2001, J BIOL CHEM, V276, P29702, DOI 10.1074/jbc.M011326200; Zhao L, 2003, MOL CANCER RES, V1, P195; Zimmermann M, 2012, J BIOL CHEM, V287, P22838, DOI 10.1074/jbc.M112.376855	48	6	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2015	34	49					5983	5996		10.1038/onc.2015.47	http://dx.doi.org/10.1038/onc.2015.47			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RO	25915850				2022-12-26	WOS:000366113500005
J	Kraus, BJ; Sartoretto, JL; Polak, P; Hosooka, T; Shiroto, T; Eskurza, I; Lee, SA; Jiang, HF; Michel, T; Kahn, BB				Kraus, Bettina J.; Sartoretto, Juliano L.; Polak, Pazit; Hosooka, Tetsuya; Shiroto, Takashi; Eskurza, Iratxe; Lee, Seung-Ah; Jiang, Hongfeng; Michel, Thomas; Kahn, Barbara B.			Novel role for retinol-binding protein 4 in the regulation of blood pressure	FASEB JOURNAL			English	Article						angiotensin II; hypertension; obesity; endothelial NO-synthase	CORONARY-HEART-DISEASE; METABOLIC SYNDROME; VITAMIN-A; CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; PLASMA RETINOL; BETA-CAROTENE; MICE	Elevated levels of serum retinol-binding protein 4 (RBP4) contribute to insulin resistance and correlate with increased prevalence of hypertension and myocardial infarction. We sought to determine whether lowering RBP4 would improve blood pressure (BP) and protect against obesity-or angiotensin (Ang)-II-induced hypertension. Systolic and diastolic BP were lower in the RBP4-knockout (RBP4-KO) mice and higher in the RBP4-overexpressing (RBP4-Tg) mice compared with BP in the wild-type (WT) littermates. Carbachol-induced vasodilatation was increased in arteries from the RBP4-KO compared with the WT mice and was impaired in the RBP4-Tg mice. Aortic eNOS(Ser1177) phosphorylation was enhanced similar to 50% in the RBP4-KO mice, with no change in total eNOS protein. Feeding a high-fat diet increased BP in the RBP4-KO mice only to the level in the WT mice fed chow and had no effect on aortic eNOS(Ser1177) phosphorylation. Ang-II infusion resulted in 22 mmHg lower systolic BP in the RBP4-KO than in the WT mice, although the relative BP increase over saline infusion was similar to 30% in both. Ang-II treatment decreased aortic eNOS(Ser1177) phosphorylation in the WT and RBP4-KO mice, but phosphorylation remained higher in the RBP4-KO mice. Cardiac hypertrophy with Ang-II treatment was diminished by 56% in the RBP4-KO mice. Thus, elevated serum RBP4 raises BP and lack of RBP4 reduces it, with commensurate changes in aortic eNOS(Ser1177) phosphorylation. Lowering RBP4 may reduce BP through enhanced eNOS-mediated vasodilatation and may be a novel therapeutic approach for hypertension.	[Kraus, Bettina J.; Polak, Pazit; Hosooka, Tetsuya; Eskurza, Iratxe; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kraus, Bettina J.; Sartoretto, Juliano L.; Polak, Pazit; Hosooka, Tetsuya; Shiroto, Takashi; Eskurza, Iratxe; Michel, Thomas; Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Sartoretto, Juliano L.; Shiroto, Takashi; Michel, Thomas] Brigham & Womens Hosp, Cardiovasc Med Div, Boston, MA 02115 USA; [Lee, Seung-Ah; Jiang, Hongfeng] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Columbia University	Kahn, BB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	jiang, hongfeng/I-6188-2013	Polak, Pazit/0000-0001-8363-0734	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R37DK43051, R24DK83938, P30DK57521]; NIH National Heart, Lung, and Blood Institute [HL46457, HL48743]; German Cardiac Society; MSD Sharp Dohme, GmbH; EMBO long-term fellowship; Manpei Suzuki Diabetes Foundation; Japan Heart Foundation; Uehara Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046457, T32HL007343, P01HL048743, R29HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043051, P30DK057521, R37DK043051, R24DK083938] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Cardiac Society; MSD Sharp Dohme, GmbH; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Manpei Suzuki Diabetes Foundation; Japan Heart Foundation; Uehara Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank William Blaner (Columbia Medical School, New York, NY, USA) for helpful discussions; Odile Peroni, Anna Lee, and Ed Hadro (Beth Israel Deaconess Medical Center, Boston, MA, USA) for technical assistance with mouse breeding, phenotyping, and euthanasia; Anthony Rosenzweig (Beth Israel Deaconess Medical Center) for use of his echo machine; and Pratik Aryal (Beth Israel Deaconess Medical Center) for kindly providing the recombinant RBP4 that was used for cell culture studies. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R37DK43051, R24DK83938, and P30DK57521 (to B.B.K.); NIH National Heart, Lung, and Blood Institute Grants HL46457 and HL48743 (to T.M.); a postdoctoral Bayer fellowship from the German Cardiac Society and a research grant from MSD Sharp & Dohme, GmbH (to B.J.K.); an EMBO long-term fellowship (to P.P.); a research grant from the Manpei Suzuki Diabetes Foundation (to T.H.); and the Japan Heart Foundation and Uehara Medical Foundation (to T.S.). B.B. Kahn is an inventor on a patent related to RBP4 and insulin resistance.	BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bobbert T, 2010, ATHEROSCLEROSIS, V213, P549, DOI 10.1016/j.atherosclerosis.2010.07.063; Brazionis L, 2012, NUTR METAB CARDIOVAS, V22, P914, DOI 10.1016/j.numecd.2011.08.009; Chavarria N, 2012, CIRC J, V76, P2148, DOI 10.1253/circj.CJ-12-0350; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; Dantas APV, 2003, AM J PHYSIOL-HEART C, V284, pH2045, DOI 10.1152/ajpheart.01089.2002; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forstermann U., 2012, EUR HEART J, V33, p837a; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Ingelsson E, 2009, DIABETES CARE, V32, P733, DOI 10.2337/dc08-1656; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lambadiari V, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0121-z; Maier LS, 2008, AM J PHYSIOL-HEART C, V294, pH588, DOI 10.1152/ajpheart.00002.2008; Mallat Z, 2009, J CLIN ENDOCR METAB, V94, P255, DOI 10.1210/jc.2008-0253; Meisinger C, 2011, DIABETES CARE, V34, P1648, DOI 10.2337/dc11-0118; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; NORSEEN J, 1932, MOL CELL BIOL, V4, P2010; Park SE, 2009, ATHEROSCLEROSIS, V204, P23, DOI 10.1016/j.atherosclerosis.2008.08.012; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Rhee EJ, 2012, BBA-MOL CELL BIOL L, V1821, P230, DOI 10.1016/j.bbalip.2011.07.001; Romero JC, 1999, HYPERTENSION, V34, P943, DOI 10.1161/01.HYP.34.4.943; Solini A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-103; Solini A, 2009, AM J HYPERTENS, V22, P1001, DOI 10.1038/ajh.2009.116; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Sun Q, 2013, CIRCULATION, V127, P1938, DOI 10.1161/CIRCULATIONAHA.113.002073; Takebayashi K, 2011, BIOCHEM BIOPH RES CO, V408, P58, DOI 10.1016/j.bbrc.2011.03.116; Tan Y, 2011, BBA-MOL CELL BIOL L, V1811, P1045, DOI 10.1016/j.bbalip.2011.09.011; Tornwall ME, 2004, EUR HEART J, V25, P1171, DOI 10.1016/j.ehj.2004.05.007; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wongsiriroj N, 2014, J LIPID RES, V55, P104, DOI 10.1194/jlr.M043844; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yu X., 2008, 68 SCI SESS M	41	26	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3133	3140		10.1096/fj.14-266064	http://dx.doi.org/10.1096/fj.14-266064			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911613	Green Published			2022-12-26	WOS:000358796900003
J	Wu, KF; Luo, T; Li, L; Zhang, QQ; Zhu, JH; Gao, Q; Chen, M; Zhu, M				Wu, Kefei; Luo, Tao; Li, Li; Zhang, Qiangqiang; Zhu, Junhao; Gao, Qian; Chen, Min; Zhu, Min			Multilocus Sequence Typing of Pathogenic Candida albicans Isolates Collected from a Teaching Hospital in Shanghai, China: A Molecular Epidemiology Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM; POPULATION; PHYLOGENETICS	Molecular typing of Candida albicansis important for studying the population structure and epidemiology of this opportunistic yeast, such as population dynamics, nosocomial infections, multiple infections and microevolution. The genetic diversity of C. albicanshas been rarely studied in China. In the present study, multilocus sequence typing (MLST) was used to characterize the genetic diversity and population structure of 62 C. albicansisolates collected from 40 patients from Huashan Hospital in Shanghai, China. A total of 50 diploid sequence types (DSTs) were identified in the 62 C. albicansisolates, with 41 newly identified DSTs. Based on cluster analysis, the 62 isolates were classified into nine existing clades and two new clades (namely clades New 1 and New 2). The majority of the isolates were clustered into three clades, clade 6 (37.5%), clade 1 (15.0%) and clade 17 (15.0%). Isolates of clade New 2 were specifically identified in East Asia. We identified three cases of potential nosocomial transmission based on association analysis between patients' clinical data and the genotypes of corresponding isolates. Finally, by analyzing the genotypes of serial isolates we further demonstrated that the microevolution of C. albicans was due to loss of heterozygosity. Our study represents the first molecular typing of C. albicansin eastern China, and we confirmed that MLST is a useful tool for studying the epidemiology and evolution of C. albicans.	[Wu, Kefei; Li, Li; Zhang, Qiangqiang; Zhu, Junhao; Zhu, Min] Fudan Univ, Huashan Hosp, Dept Dermatol, Ctr Med Mycol, Shanghai 200040, Peoples R China; [Wu, Kefei; Luo, Tao; Gao, Qian] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Wu, Kefei; Luo, Tao; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Chen, Min] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Dermatol, Shanghai Key Lab Mol Med Mycol, Shanghai 200003, Peoples R China	Fudan University; Fudan University; Fudan University; Naval Medical University	Zhu, M (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Ctr Med Mycol, Shanghai 200040, Peoples R China.	zhumin3000@hotmail.com	, 罗涛/AHA-1191-2022					Asticcioli S, 2007, NEW MICROBIOL, V30, P303; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Cliff PR, 2008, J HOSP INFECT, V69, P24, DOI 10.1016/j.jhin.2008.02.006; Da Matta DA, 2010, J CLIN MICROBIOL, V48, P3062, DOI 10.1128/JCM.00262-10; Dalle F, 2000, J CLIN MICROBIOL, V38, P4554, DOI 10.1128/JCM.38.12.4554-4559.2000; Dodgson AR, 2004, ANTIMICROB AGENTS CH, V48, P2223, DOI 10.1128/AAC.48.6.2223-2227.2004; Forche A, 2005, EUKARYOT CELL, V4, P156, DOI 10.1128/EC.4.1.156-165.2005; Forche A, 2004, EUKARYOT CELL, V3, P705, DOI 10.1128/EC.3.3.705-714.2004; Ge SH, 2012, FUNGAL GENET BIOL, V49, P86, DOI 10.1016/j.fgb.2011.10.006; Gong YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035311; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Pittet D, 1997, CLIN INFECT DIS, V24, P1068, DOI 10.1086/513640; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Xiao Yu-Ling, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P697	19	13	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125245	10.1371/journal.pone.0125245	http://dx.doi.org/10.1371/journal.pone.0125245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919124	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400078
J	Fill, JM; Waldron, JL; Welch, SM; Gibbons, JW; Bennett, SH; Mousseau, TA				Fill, Jennifer M.; Waldron, Jayme L.; Welch, Shane M.; Gibbons, J. Whitfield; Bennett, Stephen H.; Mousseau, Timothy A.			Using Multiscale Spatial Models to Assess Potential Surrogate Habitat for an Imperiled Reptile	PLOS ONE			English	Article							HOME-RANGE SIZE; BANDWIDTH SELECTION; MOVEMENT PATTERNS; FOREST; VULNERABILITY; SPECIFICITY; ATTRIBUTES; ESTIMATORS; HISTORY; REGIME	In evaluating conservation and management options for species, practitioners might consider surrogate habitats at multiple scales when estimating available habitat or modeling species' potential distributions based on suitable habitats, especially when native environments are rare. Species' dependence on surrogates likely increases as optimal habitat is degraded and lost due to anthropogenic landscape change, and thus surrogate habitats may be vital for an imperiled species' survival in highly modified landscapes. We used spatial habitat models to examine a potential surrogate habitat for an imperiled ambush predator (eastern diamondback rattlesnake, Crotalus adamanteus; EDB) at two scales. The EDB is an apex predator indigenous to imperiled longleaf pine ecosystems (Pinus palustris) of the southeastern United States. Loss of native open-canopy pine savannas and woodlands has been suggested as the principal cause of the species' extensive decline. We examined EDB habitat selection in the Coastal Plain tidewater region to evaluate the role of marsh as a potential surrogate habitat and to further quantify the species' habitat requirements at two scales: home range (HR) and within the home range (WHR). We studied EDBs using radiotelemetry and employed an information-theoretic approach and logistic regression to model habitat selection as use vs. availability. We failed to detect a positive association with marsh as a surrogate habitat at the HR scale; rather, EDBs exhibited significantly negative associations with all landscape patches except pine savanna. Within home range selection was characterized by a negative association with forest and a positive association with ground cover, which suggests that EDBs may use surrogate habitats of similar structure, including marsh, within their home ranges. While our HR analysis did not support tidal marsh as a surrogate habitat, marsh may still provide resources for EDBs at smaller scales.	[Fill, Jennifer M.; Mousseau, Timothy A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Waldron, Jayme L.; Welch, Shane M.] Marshall Univ, Dept Biol Sci, Huntington, WV USA; [Gibbons, J. Whitfield] Savannah River Ecol Lab, Aiken, SC USA; [Bennett, Stephen H.] South Carolina Dept Nat Resources, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Marshall University; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Fill, JM (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	jenna999@gmail.com	Mousseau, Timothy A/A-1253-2011	Mousseau, Timothy/0000-0002-2235-4868	South Carolina Department of Natural Resources; National Science Foundation [NSF DGE-0929297]; University of South Carolina (sc.edu); Snake Advisory Group (snaketag.org); Riverbanks Zoo	South Carolina Department of Natural Resources; National Science Foundation(National Science Foundation (NSF)); University of South Carolina (sc.edu); Snake Advisory Group (snaketag.org); Riverbanks Zoo	Funding for this project was provided by the South Carolina Department of Natural Resources (www.dnr.sc.gov) to SHB. The National Science Foundation (www.nsf.gov) awarded NSF DGE-0929297 to JMF, who also received the Presidential Fellowship from the University of South Carolina (sc.edu). The Snake Advisory Group (snaketag.org) awarded the Dana Payne Grant to JMF, and Riverbanks Zoo provided assistance from their Conservation Support Fund to JLW (www.riverbanks.org).	Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Berndt LA, 2008, BIODIVERS CONSERV, V17, P1171, DOI 10.1007/s10531-008-9379-3; Bertram N, 2001, IDENTIFICATION CRITI; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Bowne DR, 1999, LANDSCAPE ECOL, V14, P53, DOI 10.1023/A:1008025827895; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Chase J.M., 2009, ECOLOGICAL NICHES LI; Clark RW, 2008, MOL ECOL, V17, P719; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dillard LO, 2008, BIODIVERS CONSERV, V17, P1475, DOI 10.1007/s10531-008-9356-x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Ford WM, 2002, FOREST ECOL MANAG, V155, P131, DOI 10.1016/S0378-1127(01)00553-9; FROST CC, 1993, P TALL TIMB FIR EC C, V18, P17; Frost C, 2006, SPRINGER SER ENV MAN, P9; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gienger CM, 2011, CAN J ZOOL, V89, P1084, DOI 10.1139/Z11-086; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; GLITZENSTEIN JS, 1995, ECOL MONOGR, V65, P441, DOI 10.2307/2963498; Golley F. B., 1965, Journal of Mammalogy, V46, P1, DOI 10.2307/1377811; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hoss SK, 2010, J HERPETOL, V44, P110, DOI 10.1670/08-277.1; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Jenkins CL, 2008, BIOL RATTLESNAKES, P265; Jenness Enterprises, 2013, DEM SURF TOOLS ARCGI; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones MC, 1996, J AM STAT ASSOC, V91, P401, DOI 10.2307/2291420; Jose S, 2006, SPRINGER SER ENV MAN, P3; KINCAID WB, 1985, ECOLOGY, V66, P1769, DOI 10.2307/2937373; Kochanny CO, 2009, J WILDLIFE MANAGE, V73, P779, DOI 10.2193/2008-394; Kreye JK, 2013, ECOL APPL, V23, P1976, DOI 10.1890/13-0503.1; Lim K, 2003, PROG PHYS GEOG, V27, P88, DOI 10.1191/0309133303pp360ra; Listopad CMCS, 2011, THESIS U CENTRAL FLO; Manly B.F.J., 2002, RESOURCE SELECTION A; Martin W.H., 2000, HERPETOL NAT HIST, V7, P9; Means DB, 2006, SPRINGER SER ENV MAN, P157; Merola-Zwartjes M, 2005, WILDLIFE SOC B, V33, P435, DOI 10.2193/0091-7648(2005)33[435:ASAONM]2.0.CO;2; MORRIS DW, 1987, ECOLOGY, V68, P362, DOI 10.2307/1939267; Platt William J., 1999, P23; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Pringle RM, 2003, ECOLOGY, V84, P2668, DOI 10.1890/02-0482; Raudenbush SW, 2000, J COMPUT GRAPH STAT, V9, P141, DOI 10.2307/1390617; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Rysava-Novakova M, 2009, FISHERIES MANAG ECOL, V16, P468, DOI 10.1111/j.1365-2400.2009.00698.x; SAS Institute, 2011, SAS V 9 3; Schweiger EW, 2000, ECOL MONOGR, V70, P383, DOI 10.1890/0012-9615(2000)070[0383:TIOHFP]2.0.CO;2; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Sorrie BA, 2006, APPL VEG SCI, V9, P59, DOI 10.1658/1402-2001(2006)9[59:COTEPP]2.0.CO;2; Stohlgren KM, 2013, THESIS U GEORGIA; Swihart Robert K., 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P48, DOI 10.2307/1400640; Timmerman W.W., 2003, 32 SOC STUD AMPH REP; Timmerman Walter W., 1995, Bulletin of the Florida Museum of Natural History, V38, P127; Torre I, 2004, ACTA OECOL, V25, P137, DOI 10.1016/j.actao.2003.10.007; United States Fish and Wildlife Service, 2012, FED REGISTER, V77, P27403; Waldron JL, 2006, ANIM CONSERV, V9, P414, DOI 10.1111/j.1469-1795.2006.00050.x; Waldron JL, 2008, BIOL CONSERV, V141, P2477, DOI 10.1016/j.biocon.2008.07.008; Waldron JL, 2006, HERPETOLOGICA, V62, P389, DOI 10.1655/0018-0831(2006)62[389:UBSTIC]2.0.CO;2; Waldron JL, 2013, BIOL CONSERV, V159, P530, DOI 10.1016/j.biocon.2012.11.021; Waldron Jayme L., 2013, Human Dimensions of Wildlife, V18, P138, DOI 10.1080/10871209.2012.719173; Ware Stewart, 1993, P447; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Zimble DA, 2003, REMOTE SENS ENVIRON, V87, P171, DOI 10.1016/S0034-4257(03)00139-1	65	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123307	10.1371/journal.pone.0123307	http://dx.doi.org/10.1371/journal.pone.0123307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915926	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100020
J	Pinacho, R; Saia, G; Fuste, M; Melendez-Perez, I; Villalta-Gil, V; Haro, JM; Gill, G; Ramos, B				Pinacho, Raquel; Saia, Gregory; Fuste, Montserrat; Melendez-Perez, Iria; Villalta-Gil, Victoria; Haro, Josep Maria; Gill, Grace; Ramos, Belen			Phosphorylation of Transcription Factor Specificity Protein 4 Is Increased in Peripheral Blood Mononuclear Cells of First-Episode Psychosis	PLOS ONE			English	Article							FACTOR SP4; BIPOLAR DISORDER; REDUCED EXPRESSION; SP-FAMILY; BRAIN; SCHIZOPHRENIA; GENE	Background Altered expression of transcription factor specificity protein 4 (SP4) has been found in the postmortem brain of patients with psychiatric disorders including schizophrenia and bipolar disorder. Reduced levels of SP4 protein have recently been reported in peripheral blood mononuclear cells in first-episode psychosis. Also, SP4 levels are modulated by lithium treatment in cultured neurons. Phosphorylation of SP4 at S770 is increased in the cerebellum of bipolar disorder subjects and upon inhibition of NMDA receptor signaling in cultured neurons. The aim of this study was to investigate whether SP4 S770 phosphorylation is increased in lymphocytes of first-episode psychosis patients and the effect of lithium treatment on this phosphorylation. Methods A cross-sectional study of S770 phosphorylation relative to total SP4 immunoreactivity using specific antibodies in peripheral blood mononuclear cells in first-episode psychosis patients (n = 14, treated with lithium or not) and matched healthy controls (n = 14) by immunoblot was designed. We also determined the effects of the prescribed drugs lithium, olanzapine or valproic acid on SP4 phosphorylation in rat primary cultured cerebellar granule neurons. Results We found that SP4 S770 phosphorylation was significantly increased in lymphocytes in first-episode psychosis compared to controls and decreased in patients treated with lithium compared to patients who did not receive lithium. Moreover, incubation with lithium but not olanzapine or valproic acid reduced SP4 phosphorylation in rat cultured cerebellar granule neurons. Conclusions The findings presented here indicate that SP4 S770 phosphorylation is increased in lymphocytes in first-episode psychosis which may be reduced by lithium treatment in patients. Moreover, our study shows lithium treatment prevents this phosphorylation in vitro in neurons. This pilot study suggests that S770 SP4 phosphorylation could be a peripheral biomarker of psychosis, and may be regulated by lithium treatment in first-episode psychosis.	[Pinacho, Raquel; Fuste, Montserrat; Melendez-Perez, Iria; Villalta-Gil, Victoria; Haro, Josep Maria; Ramos, Belen] Univ Barcelona, Unitat Recerca, Fundacio St Joan de Deu, Ctr Invest Biomed Red Salud Mental,CIBERSAM, Barcelona, Spain; [Saia, Gregory; Gill, Grace] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Saia, Gregory] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Cell Mol & Dev Biol Program, Boston, MA 02111 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Tufts University; Tufts University	Gill, G (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	Grace.Gill@tufts.edu; bramos@fsjd.org	Ramos, Belen/K-8067-2015; Haro, Josep Maria/D-1423-2011	Ramos, Belen/0000-0002-4577-2106; Haro, Josep Maria/0000-0002-3984-277X; Fuste, Montserrat/0000-0002-4508-1022; Pinacho, Raquel/0000-0001-6417-5983	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria [PI07/0401]; Centro de Investigacion Biomedica en Red de Salud Mental; Ministerio de Ciencia e Innovacion-Spain: Plan Nacional de I+D [BFU2008-01103, T32 NS061764]; National Institutes of Health [RO1 HD043364]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061764] Funding Source: NIH RePORTER	Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red de Salud Mental; Ministerio de Ciencia e Innovacion-Spain: Plan Nacional de I+D(Ministry of Science and Innovation, Spain (MICINN)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Instituto de Salud Carlos III-Fondo de Investigacion Sanitaria: Predoctoral fellowship to R.P., Rio Hortega fellowship to M.F., Grant PI07/0401 to J.M.H., the Centro de Investigacion Biomedica en Red de Salud Mental (B. R. and J.M.H.); by the T32 NS061764 training grant to G.S.; and grants from Ministerio de Ciencia e Innovacion-Spain: Plan Nacional de I+D BFU2008-01103 to B. R., and the National Institutes of Health: RO1 HD043364 to G.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bilimoria Parizad M, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5107; Fountoulakis KN, 2008, INT J NEUROPSYCHOPH, V11, P999, DOI 10.1017/S1461145708009231; Fuste M, 2016, BRIT J PSYCHIAT, V208, P591, DOI 10.1192/bjp.bp.114.152140; Fuste M, 2013, J PSYCHIATR RES, V47, P1608, DOI 10.1016/j.jpsychires.2013.07.019; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Ji BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066327; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI 10.1016/j.brainresbull.2010.04.006; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lenox RH, 2000, J CLIN PSYCHIAT, V61, P5; Mao XR, 2007, J NEUROCHEM, V100, P1300, DOI 10.1111/j.1471-4159.2006.04297.x; Pinacho R, EUR NEUROPSYCHOPHARM; Pinacho R, 2014, J PSYCHIATR RES, V58, P189, DOI 10.1016/j.jpsychires.2014.08.006; Pinacho R, 2013, J PSYCHIATR RES, V47, P926, DOI 10.1016/j.jpsychires.2013.03.004; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Ramos B, 2007, P NATL ACAD SCI USA, V104, P9882, DOI 10.1073/pnas.0701946104; Ross SM, 2003, J ENG TECHNOL, V20, P38; Saia G, 2014, J NEUROCHEM, V129, P743, DOI 10.1111/jnc.12657; Shastry BS, 2005, NEUROCHEM INT, V46, P273, DOI 10.1016/j.neuint.2004.10.007; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Sun XX, 2015, DEV NEUROBIOL, V75, P93, DOI 10.1002/dneu.22212; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Woods SW, 2003, PSYCHIAT SERV, V54, P177, DOI 10.1176/appi.ps.54.2.177; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2010, HUM MOL GENET, V19, P3797, DOI 10.1093/hmg/ddq298; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125115	10.1371/journal.pone.0125115	http://dx.doi.org/10.1371/journal.pone.0125115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915526	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100100
J	Wang, GR; Guo, L; Jiang, B; Huang, M; Zhang, J; Qin, Y				Wang, Guorong; Guo, Ling; Jiang, Bin; Huang, Min; Zhang, Jian; Qin, Ying			Factors Influencing Intracavitary Electrocardiographic P-Wave Changes during Central Venous Catheter Placement	PLOS ONE			English	Article							GUIDANCE	Amplitude changes in the P-wave of intracavitary electrocardiography have been used to assess the tip placement of central venous catheters. The research assessed the sensitivity and specificity of this sign in comparison with standard radiographic techniques for tip location, focusing on factors influencing its clinical utility. Both intracavitary electrocardiography guided tip location and X-ray positioning were used to verify catheter tip locations in patients undergoing central venous catheter insertion. Intracavitary electrocardiograms from 1119 patients (of a total 1160 subjects) showed specific amplitude changes in the P-wave. As the results show, compared with X-ray positioning, the sensitivity of electrocardiography-guided tip location was 97.3%, with false negative rate of 2.7%; the specificity was 1, with false positive rate of zero. Univariate analyses indicated that features including age, gender, height, body weight, and heart rate have no statistically significant influence on P-wave amplitude changes (P>0.05). Multivariate logistic regression revealed that catheter insertion routes (OR = 2.280, P = 0.003) and basal P-wave amplitude (OR = 0.553, P = 0.003) have statistically significant impacts on P-wave amplitude changes. As a reliable indicator of tip location, amplitude change in the P-wave has proved of good sensitivity and excellent specificity, and the minor, zero, false positive rate supports the clinical utility of this technique in early recognition of malpositioned tips. A better sensitivity was achieved in placement of centrally inserted central catheters (CICCs) than that of peripherally inserted central catheters (PICCs). In clinical practice, a combination of intracavitary electrocardiography, ultrasonic inspection and the anthropometric measurement method would further improve the accuracy.	[Wang, Guorong; Huang, Min] Sichuan Canc Hosp, Dept Nursing, Chengdu, Peoples R China; [Guo, Ling] Sichuan Canc Hosp, Chengdu, Peoples R China; [Jiang, Bin] Sichuan Canc Hosp, Dept Thorac Surg, Chengdu, Peoples R China; [Zhang, Jian] Sichuan Canc Hosp, Dept Radiotherapy, Chengdu, Peoples R China; [Qin, Ying] Sichuan Canc Hosp, Dept Med Oncol, Chengdu, Peoples R China		Qin, Y (corresponding author), Sichuan Canc Hosp, Dept Med Oncol, Chengdu, Peoples R China.	wangguorong_000@163.com						Andropoulos DB, 1999, ANESTH ANALG, V89, P65, DOI 10.1097/00000539-199907000-00012; Infusion Nurses Society, 2011, J INFUSION NURSING, V34, pS40; Kremser J, 2011, BRIT J ANAESTH, V107, P567, DOI 10.1093/bja/aer189; Lee JH, 2009, BRIT J ANAESTH, V102, P662, DOI 10.1093/bja/aep046; Moureau NL., 2010, J ASS VASC ACCESS, V15, P8, DOI [10.2309/java.15-1-3, DOI 10.2309/JAVA.15-1-3]; Pittiruti M, 2012, J VASC ACCESS, V13, P357, DOI 10.5301/JVA.2012.9020; Qin Y., 2014, SICHUAN MED J, V35, P709; Wen Q, 2012, CLIN APPL SECURITY M; Zhao R, 2013, CHINESE J EMERGENCY, V22, P428	9	12	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124846	10.1371/journal.pone.0124846	http://dx.doi.org/10.1371/journal.pone.0124846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915758	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100074
J	Wu, AM; Shao, ZX; Wang, JS; Yang, XD; Weng, WQ; Wang, XY; Xu, HZ; Chi, YL; Lin, ZK				Wu, Ai-Min; Shao, Zhen-Xuan; Wang, Jian-Shun; Yang, Xin-Dong; Weng, Wan-Qing; Wang, Xiang-Yang; Xu, Hua-Zi; Chi, Yong-Long; Lin, Zhong-Ke			The Accuracy of a Method for Printing Three-Dimensional Spinal Models	PLOS ONE			English	Article							TRANSLAMINAR SCREW FIXATION; MORPHOMETRIC-ANALYSIS; THORACIC SPINE; CERVICAL-SPINE; PEDICLE; ANATOMY; PLACEMENT; DONATION; SCIENCE; LUMBAR	Background To study the morphology of the human spine and new spinal fixation methods, scientists require cadaveric specimens, which are dependent on donation. However, in most countries, the number of people willing to donate their body is low. A 3D printed model could be an alternative method for morphology research, but the accuracy of the morphology of a 3D printed model has not been determined. Methods Forty-five computed tomography (CT) scans of cervical, thoracic and lumbar spines were obtained, and 44 parameters of the cervical spine, 120 parameters of the thoracic spine, and 50 parameters of the lumbar spine were measured. The CT scan data in DICOM format were imported into Mimics software v10.01 for 3D reconstruction, and the data were saved in .STL format and imported to Cura software. After a 3D digital model was formed, it was saved in Gcode format and exported to a 3D printer for printing. After the 3D printed models were obtained, the above-referenced parameters were measured again. Results Paired t-tests were used to determine the significance, set to P<0.05, of all parameter data from the radiographic images and 3D printed models. Furthermore, 88.6% of all parameters of the cervical spine, 90% of all parameters of the thoracic spine, and 94% of all parameters of the lumbar spine had Intraclass Correlation Coefficient (ICC) values >0.800. The other ICC values were <0.800 and >0.600; none were <0.600. Conclusion In this study, we provide a protocol for printing accurate 3D spinal models for surgeons and researchers. The resulting 3D printed model is inexpensive and easily obtained for spinal fixation research.	[Wu, Ai-Min; Shao, Zhen-Xuan; Wang, Jian-Shun; Weng, Wan-Qing; Wang, Xiang-Yang; Xu, Hua-Zi; Chi, Yong-Long; Lin, Zhong-Ke] Wenzhou Med Univ, Affiliated Hosp 2, Zhejiang Spinal Res Ctr, Dept Orthopaed, Wenzhou, Zhejiang, Peoples R China; [Yang, Xin-Dong] Wenzhou Med Univ, Dept Anat, Higher Educ Zone, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Chi, YL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Zhejiang Spinal Res Ctr, Dept Orthopaed, 109 Xue Yuan Western Rd, Wenzhou, Zhejiang, Peoples R China.	spinechi@163.com; zhongkelin@163.com			National Natural Science Foundation of China [81372014]; Natural Science Foundation of Zhejiang Province [LY14H060008]; Scientific research project for student of Wenzhou Medical University [WYX201401020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific research project for student of Wenzhou Medical University	This work is supported by National Natural Science Foundation of China (81372014), Natural Science Foundation of Zhejiang Province (LY14H060008), and Scientific research project for student of Wenzhou Medical University (WYX201401020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvin MD, 2012, SPINE, V37, pE745, DOI 10.1097/BRS.0b013e31824c70ef; Asad AL, 2014, SOC SCI MED, V106, P53, DOI 10.1016/j.socscimed.2014.01.041; Boulware LE, 2004, CLIN ANAT, V17, P570, DOI 10.1002/ca.10225; Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588; Guo SZ, 2014, LANGMUIR, V30, P1142, DOI 10.1021/la4036425; Halou H, 2013, ANAT SCI EDUC, V6, P48, DOI 10.1002/ase.1304; Haverman T M, 2013, Ned Tijdschr Tandheelkd, V120, P136; Horn Timothy J., 2012, Science Progress, V95, P255, DOI 10.3184/003685012X13420984463047; Ji W, 2012, EUR SPINE J, V21, P1483, DOI 10.1007/s00586-012-2151-0; Kabins MB, 1991, IOWA ORTHOPAEDIC J, V11, P127; Kanna PR, 2011, SPINE, V36, P1297, DOI 10.1097/BRS.0b013e3181fb3c17; Lin SL, 2014, SPINE, V39, pE147, DOI 10.1097/BRS.0000000000000105; Puchwein P, 2013, BONE JOINT J, V95B, P536, DOI 10.1302/0301-620X.95B4.30949; Robertson PA, 2000, SPINE, V25, P709, DOI 10.1097/00007632-200003150-00010; Tian NF, 2010, SPINE, V35, P1514, DOI 10.1097/BRS.0b013e3181c6d9ae; VACCARO AR, 1995, J BONE JOINT SURG AM, V77A, P1193, DOI 10.2106/00004623-199508000-00008; Webb PA, 2000, J MED ENG TECHNOL, V24, P149, DOI 10.1080/03091900050163427; Wu AM, 2013, BONE JOINT J, V95B, P977, DOI 10.1302/0301-620X.95B7.31393; Xia DD, 2014, EUR SPINE J, V23, P606, DOI 10.1007/s00586-013-3130-9; YAHIRO MA, 1994, SPINE, V19, pS2274; Zhang LQ, 2008, ANAT SCI EDUC, V1, P56, DOI 10.1002/ase.15	21	62	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124291	10.1371/journal.pone.0124291	http://dx.doi.org/10.1371/journal.pone.0124291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915641	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100045
J	Zwart, L; Potgieter, CA; Clift, SJ; van Staden, V				Zwart, Lizahn; Potgieter, Christiaan A.; Clift, Sarah J.; van Staden, Vida			Characterising Non-Structural Protein NS4 of African Horse Sickness Virus	PLOS ONE			English	Article							BLUETONGUE VIRUS; HORSESICKNESS VIRUS; CELLS; VP6; LOCALIZATION; REPLICATION; ORBIVIRUS; CORE; INFECTION; SEQUENCE	African horse sickness is a serious equid disease caused by the orbivirus African horse sickness virus (AHSV). The virus has ten double-stranded RNA genome segments encoding seven structural and three non-structural proteins. Recently, an additional protein was predicted to be encoded by genome segment 9 (Seg-9), which also encodes VP6, of most orbiviruses. This has since been confirmed in bluetongue virus and Great Island virus, and the non-structural protein was named NS4. In this study, in silico analysis of AHSV Seg-9 sequences revealed the existence of two main types of AHSV NS4, designated NS4-I and NS4-II, with different lengths and amino acid sequences. The AHSV NS4 coding sequences were in the +1 reading frame relative to that of VP6. Both types of AHSV NS4 were expressed in cultured mammalian cells, with sizes close to the predicted 17-20 kDa. Fluorescence microscopy of these cells revealed a dual cytoplasmic and nuclear, but not nucleolar, distribution that was very similar for NS4-I and NS4-II. Immunohistochemistry on heart, spleen, and lung tissues from AHSV-infected horses showed that NS4 occurs in microvascular endothelial cells and mononuclear phagocytes in all of these tissues, localising to the both the cytoplasm and the nucleus. Interestingly, NS4 was also detected in stellate-shaped dendritic macrophage-like cells with long cytoplasmic processes in the red pulp of the spleen. Finally, nucleic acid protection assays using bacterially expressed recombinant AHSV NS4 showed that both types of AHSV NS4 bind dsDNA, but not dsRNA. Further studies will be required to determine the exact function of AHSV NS4 during viral replication.	[Zwart, Lizahn; van Staden, Vida] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Potgieter, Christiaan A.] Deltamune Pty Ltd, Lyttelton, Centurion, South Africa; [Potgieter, Christiaan A.] North West Univ, Ctr Human Metabon, Dept Biochem, Potchefstroom, South Africa; [Clift, Sarah J.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa	University of Pretoria; North West University - South Africa; University of Pretoria	van Staden, V (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	vida.vanstaden@up.ac.za	Clift, Sarah J/P-9497-2016	Clift, Sarah J/0000-0003-1368-1215	Deltamune (Pty) Ltd	Deltamune (Pty) Ltd	Deltamune (Pty) Ltd provided support in the form of salaries for authors (CAP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Beaton AR, 2002, P NATL ACAD SCI USA, V99, P13154, DOI 10.1073/pnas.192432299; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Boyce M, 2004, J VIROL, V78, P3994, DOI 10.1128/JVI.78.8.3994-4002.2004; Boyce M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-178; Clift SJ, 2010, VET PATHOL, V47, P690, DOI 10.1177/0300985810370010; Clift SJ, 2009, J VET DIAGN INVEST, V21, P655, DOI 10.1177/104063870902100510; Coetzer J., 1994, INFECT DIS LIVESTOCK, P601; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; de Waal PJ, 2005, ARCH VIROL, V150, P2037, DOI 10.1007/s00705-005-0547-4; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HOUSE JA, 1993, VET CLIN N AM-EQUINE, V9, P355, DOI 10.1016/S0749-0739(17)30402-9; HOWELL P. G., 1962, ONDERSTEPOORT JOUR VET RES, V29, P139; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; HYATT AD, 1991, J GEN VIROL, V72, P2263, DOI 10.1099/0022-1317-72-9-2263; Kar AK, 2003, J VIROL, V77, P11347, DOI 10.1128/JVI.77.21.11347-11356.2003; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Manole V, 2012, J VIROL, V86, P7858, DOI 10.1128/JVI.00517-12; Maree FF, 1997, J GEN VIROL, V78, P1077, DOI 10.1099/0022-1317-78-5-1077; Martinez-Costas J, 1998, J MOL BIOL, V280, P859, DOI 10.1006/jmbi.1998.1926; McINTOSH B. M., 1958, ONDERSTEPOORT JOUR VET RES, V27, P465; MELLOR PS, 1995, ANN TROP MED PARASIT, V89, P1; OELLERMA.RA, 1970, ARCH GES VIRUSFORSCH, V29, P163, DOI 10.1007/BF01249302; Owens RJ, 2004, J VIROL, V78, P6649, DOI 10.1128/JVI.78.12.6649-6656.2004; Patel A, 2014, VIRUS RES, V182, P5, DOI 10.1016/j.virusres.2013.12.017; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Salvetti A, 2014, BBA-MOL BASIS DIS, V1842, P840, DOI 10.1016/j.bbadis.2013.12.010; SATO M, 1976, VIROLOGY, V69, P691, DOI 10.1016/0042-6822(76)90497-9; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Stassen L, 2011, VIRUS RES; Stoltz MA, 1996, ONDERSTEPOORT J VET, V63, P57; Turnbull PJ, 1996, J GEN VIROL, V77, P1421, DOI 10.1099/0022-1317-77-7-1421; UITENWEERDE JM, 1995, VIROLOGY, V209, P624, DOI 10.1006/viro.1995.1294; van Gennip RGP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085788	43	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124281	10.1371/journal.pone.0124281	http://dx.doi.org/10.1371/journal.pone.0124281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915516	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100044
J	Jin, HX; Go, ML; Yin, P; Qiu, XT; Zhu, P; Yan, XJ				Jin, Hai-Xiao; Go, Mei-Lin; Yin, Peng; Qiu, Xiao-Ting; Zhu, Peng; Yan, Xiao-Jun			Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PHOSPHORYL TRANSFER-REACTION; AMBER FORCE-FIELD; P-TEFB; CRYSTAL-STRUCTURE; ACTIVE-SITE; STRUCTURAL-CHARACTERIZATION; CONFORMATIONAL PLASTICITY; CATALYTIC SUBUNIT; ATP HYDROLYSIS	The current paradigm of cyclin-dependent kinase (CDK) regulation based on the well-established CDK2 has been recently expanded. The determination of CDK9 crystal structures suggests the requirement of an additional regulatory protein, such as human immunodeficiency virus type 1 (HIV-1) Tat, to exert its physiological functions. In most kinases, the exact number and roles of the cofactor metal ions remain unappreciated, and the repertoire has thus gained increasing attention recently. Here, molecular dynamics (MD) simulations were implemented on CDK9 to explore the functional roles of HIV-1 Tat and the second Mg2+ ion at site 1 (Mg-1(2+)). The simulations unveiled that binding of HIV-1 Tat to CDK9 not only stabilized hydrogen bonds (H-bonds) between ATP and hinge residues Asp104 and Cys106, as well as between ATP and invariant Lys48, but also facilitated the salt bridge network pertaining to the phosphorylated Thr186 at the activation loop. By contrast, these H-bonds cannot be formed in CDK9 owing to the absence of HIV-1 Tat. MD simulations further revealed that the Mg-1(2+) ion, coupled with the Mg-2(2+) ion, anchored to the triphosphate moiety of ATP in its catalytic competent conformation. This observation indicates the requirement of the Mg-1(2+) ion for CDK9 to realize its function. Overall, the introduction of HIV-1 Tat and Mg-1(2+) ion resulted in the active site architectural characteristics of phosphorylated CDK9. These data highlighted the functional roles of HIV-1 Tat and Mg-1(2+) ion in the regulation of CDK9 activity, which contributes an important complementary understanding of CDK molecular underpinnings.	[Jin, Hai-Xiao; Qiu, Xiao-Ting; Zhu, Peng; Yan, Xiao-Jun] Ningbo Univ, Sch Marine Sci, Key Lab Appl Marine Biotechnol, Minist Educ, Ningbo 315211, Zhejiang, Peoples R China; [Go, Mei-Lin] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Yin, Peng] Hunan Normal Univ, Coll Chem & Chem Engn, Key Lab Chem Biol & Tradit Chinese Med Res, Minist Educ, Changsha, Hunan, Peoples R China	Ningbo University; National University of Singapore; Hunan Normal University	Yan, XJ (corresponding author), Ningbo Univ, Sch Marine Sci, Key Lab Appl Marine Biotechnol, Minist Educ, Ningbo 315211, Zhejiang, Peoples R China.	yanxiaojun@nbu.edu.cn	Mei Lin, Go/C-5500-2014	Jin, Haixiao/0000-0002-0087-4651; Yan, Xiaojun/0000-0003-0257-0157	Natural Science Foundation of Ningbo [2010A610025]; National Science Foundation of China [20903058, 31400683]; Zhejiang Provincial Natural Science Foundation of China [LQ14C050001]; Public Science and Technology Research Funds Projects of Ocean [201305013]; K.C. Wong Magna Fund in Ningbo University	Natural Science Foundation of Ningbo; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Public Science and Technology Research Funds Projects of Ocean; K.C. Wong Magna Fund in Ningbo University	This work was supported by Natural Science Foundation of Ningbo (2010A610025), National Science Foundation of China (20903058, 31400683), Zhejiang Provincial Natural Science Foundation of China (LQ14C050001), Public Science and Technology Research Funds Projects of Ocean (201305013) and K.C. Wong Magna Fund in Ningbo University.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Afanasyeva A, 2014, STRUCTURE, V22, P549, DOI 10.1016/j.str.2014.02.002; [Anonymous], 2012, MOL OP ENV MONTR QUE; Bao ZQ, 2011, STRUCTURE, V19, P675, DOI 10.1016/j.str.2011.02.016; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Baumli S, 2012, STRUCTURE, V20, P1788, DOI 10.1016/j.str.2012.08.011; Baumli S, 2012, ACS CHEM BIOL, V7, P811, DOI 10.1021/cb2004516; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; Bettayeb Karima, 2010, Genes Cancer, V1, P369, DOI 10.1177/1947601910369817; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Case D.A., 2022, AMBER 2020; Cheng YH, 2005, J AM CHEM SOC, V127, P1553, DOI 10.1021/ja0464084; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Endicott JA, 2013, BIOCHEM SOC T, V41, P1008, DOI 10.1042/BST20130097; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gerlits O, 2013, BIOCHEMISTRY-US, V52, P3721, DOI 10.1021/bi400066a; Grigorenko BL, 2008, BBA-PROTEINS PROTEOM, V1784, P1908, DOI 10.1016/j.bbapap.2008.08.003; Grigorenko BL, 2007, P NATL ACAD SCI USA, V104, P7057, DOI 10.1073/pnas.0701727104; Grigorenko BL, 2011, J MOL GRAPH MODEL, V31, P1, DOI 10.1016/j.jmgm.2011.07.005; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; Hole AJ, 2013, J MED CHEM, V56, P660, DOI 10.1021/jm301495v; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacobsen DM, 2012, J AM CHEM SOC, V134, P15357, DOI 10.1021/ja304419t; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jin HX, 2007, J MOL STRUC-THEOCHEM, V805, P9, DOI 10.1016/j.theochem.2006.10.020; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ko TP, 2010, ACTA CRYSTALLOGR D, V66, P145, DOI 10.1107/S0907444909047507; Krystof V, 2010, MED RES REV, V30, P646, DOI 10.1002/med.20172; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097668; Lu SY, 2013, PROTEINS, V81, P740, DOI 10.1002/prot.24221; Lu SY, 2011, J CHEM INF MODEL, V51, P1025, DOI 10.1021/ci100493j; Lu SY, 2011, PHYS CHEM CHEM PHYS, V13, P7014, DOI 10.1039/c0cp02498h; Lu SY, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003831; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Lu SY, 2012, J CHEM INF MODEL, V52, P2398, DOI 10.1021/ci300172r; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Montenegro M, 2011, PHYS CHEM CHEM PHYS, V13, P530, DOI 10.1039/c0cp01062f; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Perez-Gallegos A, 2014, J COMPUT AID MOL DES, V28, P1077, DOI 10.1007/s10822-014-9786-3; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schulze-Gahmen U, 2014, ELIFE, V3, DOI 10.7554/eLife.02375; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Shao H, 2013, J MED CHEM, V56, P640, DOI 10.1021/jm301475f; Sun HY, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003729; Szarek P, 2008, J PHYS CHEM B, V112, P11819, DOI 10.1021/jp8040633; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000761; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Wang PF, 2006, BIOCHEMISTRY-US, V45, P11464, DOI 10.1021/bi0607002; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang B, 2007, BIOCHEMISTRY-US, V46, P10841, DOI 10.1021/bi700890t; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	68	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124673	10.1371/journal.pone.0124673	http://dx.doi.org/10.1371/journal.pone.0124673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909811	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800101
J	Singh, DJ				Singh, David Joseph			Multiband Semimetallic Electronic Structure of Superconducting Ta2PdSe5	PLOS ONE			English	Article							UPPER CRITICAL FIELDS; DIRTY; MGB2; TEMPERATURE; STATE	We report the electronic structure and related properties of the superconductor Ta2PdSe5 as determined from density functional calculations. The Fermi surface has two disconnected sheets, both derived from bands of primarily chalcogenide p states. These are a corrugated hole cylinder and a heavier complex shaped electron sheet. The sheets contain 0.048 holes and a compensating number of electrons per formula unit, making the material a semimetallic superconductor. The results support the presence of two band superconductivity, although a discrepancy in the specific heat is noted. This discrepancy is discussed as a possible consequence of Pd deficiency in samples.	Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Singh, DJ (corresponding author), Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA.	singhdj@ornl.gov			Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division	Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	This work was funded by the Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, AUGMENTED PLANE WAVE, P60; Goyal R, 2014, ARXIV14124890; Gurevich A, 2004, SUPERCOND SCI TECH, V17, P278, DOI 10.1088/0953-2048/17/2/008; Gurevich A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.184515; Gurevich A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184504; Hunte F, 2008, NATURE, V453, P903, DOI 10.1038/nature07058; Jha R, 2014, J APPL PHYS, V115, DOI 10.1063/1.4881278; Khim S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123031; KONDO J, 1963, PROG THEOR PHYS, V29, P1, DOI 10.1143/PTP.29.1; Koshelev AE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.177002; Kuroki K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024501; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lu YF, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.023702; Madsen GKH, 2006, COMPUT PHYS COMMUN, V175, P67, DOI 10.1016/j.cpc.2006.03.007; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Mazin II, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107002; Niu CQ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104507; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Shi H, 2014, ARXIV14125407; SINGH D, 1991, PHYS REV B, V43, P6388, DOI 10.1103/PhysRevB.43.6388; Singh DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.237003; Singh D. J., 2006, PLANEWAVES PSEUDOPOT, V2nd, DOI DOI 10.1007/978-1-4757-2312-0; Singh DJ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.144501; Singh DJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.174508; Singh DJ, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123003; SQUATTRITO PJ, 1986, J SOLID STATE CHEM, V64, P261, DOI 10.1016/0022-4596(86)90070-8; SUHL H, 1959, PHYS REV LETT, V3, P552, DOI 10.1103/PhysRevLett.3.552; WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295; Yu HY, 2013, J AM CHEM SOC, V135, P12987, DOI 10.1021/ja4062079; Zehetmayer M, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/4/043001; Zhang J, 2014, ARXIV14126983; Zhang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01446; Zhang QR, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.024508; Zhou N, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.094520	35	6	6	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123667	10.1371/journal.pone.0123667	http://dx.doi.org/10.1371/journal.pone.0123667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909894	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800043
J	De Marco, P; Batista, JD; Cabette, HSR				De Marco Junior, Paulo; Batista, Joana Darc; Ramos Cabette, Helena Soares			Community Assembly of Adult Odonates in Tropical Streams: An Ecophysiological Hypothesis	PLOS ONE			English	Article							RIVER CONTINUUM CONCEPT; DRAGONFLIES ODONATA; SPECIES RICHNESS; NEOTROPICAL STREAMS; MICROHABITAT USE; HABITAT SPLIT; FOOD WEBS; THERMOREGULATION; PATTERNS; ANISOPTERA	Community assembly theory is founded on the premise that the relative importance of local environmental processes and dispersal shapes the compositional structure of metacommunities. The species sorting model predicts that assemblages are dominated by the environmental filtering of species that are readily able to disperse to suitable sites. We propose an ecophysiological hypothesis (EH) for the mechanism underlying the organization of species-sorting odonate metacommunities based on the interplay of thermoregulation, body size and the degree of sunlight availability in small-to-medium tropical streams. Due to thermoregulatory restrictions, the EH predicts (i) that larger species are disfavored in small streams and (ii) that streams exhibit a nested compositional pattern characterized by species' size distribution. To test the EH, we evaluate the longitudinal distribution of adult Odonata at 19 sites in 1(st)- to 6(th)-order streams in the Tropical Cerrado of Brazil. With increasing channel width, the total abundance and species richness of Anisoptera increased, while the abundance of Zygoptera decreased. The first axis of an ordination analysis of the species abundance data was directly related to channel width. Mean and maximum thorax size are positively correlated to channel width, but no relationship was found for the minimum thorax size, suggesting that there is no lower size constraint on the occurrence of these species. Additionally, a nested compositional pattern related to body size was observed. Our results support the EH and its use as an ecological assembly rule based on abiotic factors. Forest cover functions as a filter to determine which species successfully colonize a given site within a metacommunity. As a consequence, the EH also indicates higher treats for small-bodied zygopterans in relation to the loss of riparian forests in tropical streams.	[De Marco Junior, Paulo] Univ Fed Goias, ICB, Dept Ecol, Lab Teoria Metacomunidades & Ecol Paisa, Goiania, Go, Brazil; [Batista, Joana Darc] Univ Estado Mato Grosso UNEMAT, Entomol Lab, Nova Xavantina, MT, Brazil; [Ramos Cabette, Helena Soares] Univ Estado Mato Grosso UNEMAT, Dept Biol, Nova Xavantina, MT, Brazil	Universidade Federal de Goias; Universidade do Estado de Mato Grosso; Universidade do Estado de Mato Grosso	De Marco, P (corresponding author), Univ Fed Goias, ICB, Dept Ecol, Lab Teoria Metacomunidades & Ecol Paisa, Goiania, Go, Brazil.	pdemarco@pq.cnpq.br	De Marco, Paulo/B-2209-2009	De Marco, Paulo/0000-0002-3628-6405	UNEMAT/FAPEMAT/FIDPEX; CAPES; CNPq [305542/2010-9]	UNEMAT/FAPEMAT/FIDPEX; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by UNEMAT/FAPEMAT/FIDPEX. J.D. Batista was funded by CAPES and P. De Marco by continuous productivity CNPq grants (305542/2010-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Agarwal DK, 2005, ECOL MODEL, V185, P105, DOI 10.1016/j.ecolmodel.2004.11.023; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Azeria ET, 2008, OIKOS, V117, P1006, DOI [10.1111/j.0030-1299.2008.16529.x, 10.1111/j.2008.0030-1299.16529.x]; Bartholomew GA, 1981, INSECT THERMOREGULAT, P46; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Becker CG, 2010, CONSERV BIOL, V24, P287, DOI 10.1111/j.1523-1739.2009.01324.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Biggs TW, 2008, ECOL APPL, V18, P31, DOI 10.1890/06-1689.1; Bojsen BH, 2003, ARCH HYDROBIOL, V158, P317, DOI 10.1127/0003-9136/2003/0158-0317; Borror Donald J., 1945, ANN ENT SOC AMERICA, V38, P168; Brown BL, 2011, J N AM BENTHOL SOC, V30, P310, DOI 10.1899/10-129.1; Carvalho A. L., 2000, MUSEU ZOOLOGIA U SAO, V41, P223; Carvalho FMV, 2009, BIOL CONSERV, V142, P1392, DOI 10.1016/j.biocon.2009.01.031; Clausnitzer V, 2003, BIODIVERS CONSERV, V12, P333, DOI 10.1023/A:1021920402913; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Conneil J.H., 1975, P460; CONNERS ME, 1984, CAN J FISH AQUAT SCI, V41, P1473, DOI 10.1139/f84-181; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet PS, 2008, INT J ODONATOL, V11, P155, DOI 10.1080/13887890.2008.9748320; COVICH AP, 1988, J N AM BENTHOL SOC, V7, P361, DOI 10.2307/1467297; Craig CN, 2008, WETLANDS, V28, P995, DOI 10.1672/07-214.1; CROWLEY PH, 1982, ECOLOGY, V63, P1064, DOI 10.2307/1937245; CUMMINS KW, 1979, ANNU REV ECOL SYST, V10, P147, DOI 10.1146/annurev.es.10.110179.001051; Damm S, 2010, MOL PHYLOGENET EVOL, V54, P870, DOI 10.1016/j.ympev.2009.12.006; De Marco P, 2005, NEOTROP ENTOMOL, V34, P155, DOI 10.1590/S1519-566X2005000200002; De Marco P, 2004, ODONATOLOGICA, V33, P73; De Marco P, 1998, ODONATOLOGICA, V27, P239; De Marco P, 2002, ODONATOLOGICA, V31, P129; De Marco P, 2008, ODONATOLOGICA, V37, P1; Diamond J.M., 1975, P342; Ferreira-Peruquetti Patrícia Santos, 2002, Rev. Bras. Zool., V19, P317, DOI 10.1590/S0101-81752002000200002; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Franken RJM, 2005, FRESHWATER BIOL, V50, P459, DOI 10.1111/j.1365-2427.2005.01333.x; GLEASON H. A., 1939, AMER MIDLAND NAT, V21, P92, DOI 10.2307/2420377; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gotelli NJ, 1999, SCIENCE, V286, P1684; Grubaugh JW, 1996, CAN J FISH AQUAT SCI, V53, P896, DOI 10.1139/cjfas-53-4-896; Heino J, 2005, HYDROBIOLOGIA, V539, P121, DOI 10.1007/s10750-004-3914-3; HEINRICH B, 1978, J EXP BIOL, V74, P17; Hellmann JJ, 1999, ECOL APPL, V9, P824, DOI 10.1890/1051-0761(1999)009[0824:BPAAOF]2.0.CO;2; Helson JE, 2006, HYDROBIOLOGIA, V559, P413, DOI 10.1007/s10750-005-0977-8; HELTSHE JF, 1983, BIOMETRICS, V39, P1, DOI 10.2307/2530802; Henriques-Silva R, 2013, ECOLOGY, V94, P627, DOI 10.1890/12-0683.1; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Holdaway RJ, 2006, J ECOL, V94, P1092, DOI 10.1111/j.1365-2745.2006.01170.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hubbell Stephen P., 2001, V32, pi; Ishizawa Naoya, 1994, Gekkan-Mushi, V281, P13; Juen L, 2011, INSECT CONSERV DIVER, V4, P265, DOI 10.1111/j.1752-4598.2010.00130.x; Kadoya T, 2008, LANDSCAPE ECOL, V23, P149, DOI 10.1007/s10980-007-9151-1; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KLOPFER PH, 1961, AM NAT, V95, P223, DOI 10.1086/282179; Layer K, 2013, OECOLOGIA, V171, P459, DOI 10.1007/s00442-012-2421-x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lencioni F. A. A., 2006, BIOTA NEOTROP, V1, DOI DOI 10.1590/1676-0611-BN-2018-0609; Lencioni FAA, 2005, DAMSELFLIES BRAZIL I, V1; MAC ARTHUR ROBERT H., 1967; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; May M.L., 1991, Advances in Odonatology, V5, P71; MAY ML, 1979, J EXP BIOL, V83, P79; MAY ML, 1977, ECOLOGY, V58, P787, DOI 10.2307/1936214; MAY ML, 1979, ANNU REV ENTOMOL, V24, P313, DOI 10.1146/annurev.en.24.010179.001525; MAY ML, 1976, ECOL MONOGR, V46, P1, DOI 10.2307/1942392; Mckay T, 2008, ODONATOLOGICA, V37, P29; Melo AS, 2001, J N AM BENTHOL SOC, V20, P1, DOI 10.2307/1468184; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Mouillot D, 2007, J APPL ECOL, V44, P760, DOI 10.1111/j.1365-2664.2007.01330.x; NAIMAN RJ, 1987, ECOLOGY, V68, P1139, DOI 10.2307/1939199; POLCYN DM, 1994, FUNCT ECOL, V8, P441, DOI 10.2307/2390067; Remsburg AJ, 2008, J INSECT BEHAV, V21, P460, DOI 10.1007/s10905-008-9138-z; Rith-Najarian JC, 1998, ODONATOLOGICA, V27, P335; Ruhi A, 2013, OECOLOGIA, V171, P545, DOI 10.1007/s00442-012-2440-7; Sformo T, 2006, FUNCT ECOL, V20, P114, DOI 10.1111/j.1365-2435.2006.01064.x; Shurin JB, 2004, J THEOR BIOL, V227, P359, DOI 10.1016/j.jtbi.2003.11.013; Silva DD, 2010, ECOL INDIC, V10, P744, DOI 10.1016/j.ecolind.2009.12.004; STATZNER B, 1985, CAN J FISH AQUAT SCI, V42, P1038, DOI 10.1139/f85-129; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; TRACY CR, 1979, PHYSIOL ZOOL, V52, P565, DOI 10.1086/physzool.52.4.30155947; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; WATANABE M, 1991, ZOOL SCI, V8, P983; Winemiller KO, 2010, J N AM BENTHOL SOC, V29, P84, DOI 10.1899/08-048.1; Yang J, 2011, LANDSCAPE ECOL, V26, P381, DOI 10.1007/s10980-010-9565-z; Zar JH, 1999, BIOSTATISTICAL ANAL	89	40	44	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123023	10.1371/journal.pone.0123023	http://dx.doi.org/10.1371/journal.pone.0123023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906243	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000020
J	Kooiman, J; van Hagen, N; del Sol, AI; Planken, EV; Lip, GYH; van der Meer, FJM; Cannegieter, SC; Klok, FA; Huisman, MV				Kooiman, Judith; van Hagen, Nadja; del Sol, Antonio Iglesias; Planken, Erwin V.; Lip, Gregory Y. H.; van der Meer, Felix J. M.; Cannegieter, Suzanne C.; Klok, Frederikus A.; Huisman, Menno V.			The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; PREDICTION SCORES; ANTITHROMBOTIC THERAPY; VALIDATION; WARFARIN; PERFORMANCE; HEMORRHAGE; EVENTS; HEMORR(2)HAGES; POPULATION	Objective The HAS-BLED score enables a risk estimate of major bleeds in patients with atrial fibrillation on vitamin K-antagonists (VKA) treatment, but has not been validated for patients with venous thromboembolism (VTE). We analyzed whether the HAS-BLED score accurately identifies patients at high risk of major bleeds during VKA treatment for acute VTE. Methods Medical records of 537 patients with acute VTE (primary diagnosis pulmonary embolism in 223, deep vein thrombosis in 314) starting VKA treatment between 2006-2007 were searched for items on the HAS-BLED score and the occurrence of major bleeds during the first 180 days of follow-up. The hazard ratio (HR) for the occurrence of major bleeds comparing non-high with high-risk patients as defined by a HAS-BLED score >= 3 points was calculated using Cox-regression analysis. Results Major bleeds occurred in 11/537 patients (2.0%, 5.2/100 person years, 95% CI 2.8-9.2). Cumulative incidences of major bleeds were 1.3% (95% CI 0.1-2.5) in the non-high (HASBLED <3) and 9.6% (95% CI 2.2-17.0) in the high-risk group (HAS-BLED > 3), (p < 0.0001 by Log-Rank test), with a HR of 8.7 (95% CI 2.7-28.4). Of the items in the HAS-BLED score, abnormal renal function (HR 10.8, 95% CI 1.9-61.7) and a history of bleeding events (HR 10.4, 95% CI 2.5-42.5) were independent predictors of major bleeds during follow-up. Conclusion Acute VTE patients with a HAS-BLED score >= 3 points are at increased risk of major bleeding. These results warrant for correction of the potentially reversible risk factors for major bleeding and careful International Normalized Ratio monitoring in acute VTE patients with a high HAS-BLED score.	[Kooiman, Judith; van Hagen, Nadja; van der Meer, Felix J. M.; Cannegieter, Suzanne C.; Klok, Frederikus A.; Huisman, Menno V.] Leiden Univ, Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands; [del Sol, Antonio Iglesias] Rijnland Hosp, Dept Internal Med, Leiderdorp, Netherlands; [Planken, Erwin V.] Diaconessenhuis, Dept Internal Med, Leiden, Netherlands; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Cannegieter, Suzanne C.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnland Hospital; University of Birmingham; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kooiman, J (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands.	j.kooiman@lumc.nl	Klok, Erik/U-4870-2019; Cannegieter, Suzanne/W-3696-2019; del Sol, Antonio/M-7431-2017	Klok, Erik/0000-0001-9961-0754; Cannegieter, Suzanne/0000-0003-4707-2303; del Sol, Antonio/0000-0002-9926-617X				Nieto JA, 2008, THROMB HAEMOSTASIS, V100, P789, DOI 10.1160/TH08-06-0390; Apostolakis S, 2013, J AM COLL CARDIOL, V61, P386, DOI 10.1016/j.jacc.2012.10.010; Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Burgess S, 2013, J THROMB HAEMOST, V11, P1647, DOI 10.1111/jth.12352; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gallego P, 2012, CIRC-ARRHYTHMIA ELEC, V5, P312, DOI 10.1161/CIRCEP.111.967000; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kuijer PMM, 1999, ARCH INTERN MED, V159, P457, DOI 10.1001/archinte.159.5.457; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Lip GYH, 2013, INT J CARDIOL, V168, P1832, DOI 10.1016/j.ijcard.2012.12.076; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Omran H, 2012, THROMB HAEMOSTASIS, V108, P65, DOI 10.1160/TH11-12-0827; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2013, J THROMB HAEMOST, V11, P1053, DOI 10.1111/jth.12239; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Scherz N, 2013, J THROMB HAEMOST, V11, P435, DOI 10.1111/jth.12111; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Seet RCS, 2013, J STROKE CEREBROVASC, V22, P561, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.019; Shireman TI, 2006, CHEST, V130, P1390, DOI 10.1378/chest.130.5.1390; Smith JG, 2012, EUROINTERVENTION, V8, P672, DOI 10.4244/EIJV8I6A105; Wells PS, 2003, ARCH INTERN MED, V163, P917, DOI 10.1001/archinte.163.8.917; White RH, 1999, AM J MED, V107, P414, DOI 10.1016/S0002-9343(99)00267-3; Wong PYH, 2013, J THROMB HAEMOST, V11, P491, DOI 10.1111/jth.12107	36	55	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122520	10.1371/journal.pone.0122520	http://dx.doi.org/10.1371/journal.pone.0122520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905638	gold, Green Submitted, Green Published			2022-12-26	WOS:000353332000014
J	Marwick, JA; Tudor, C; Khorasani, N; Michaeloudes, C; Bhavsar, PK; Chung, KF				Marwick, John A.; Tudor, Corina; Khorasani, Nadia; Michaeloudes, Charalambos; Bhavsar, Pankaj K.; Chung, Kian F.			Oxidants Induce a Corticosteroid-Insensitive Phosphorylation of Histone 3 at Serine 10 in Monocytes	PLOS ONE			English	Article							STRESS-INDUCED PHOSPHORYLATION; KAPPA-B ACTIVATION; OXIDATIVE STRESS; CYTOKINE RELEASE; P38 MAPK; ASTHMA; INHIBITOR; GENES; H3; PHOSPHATASES	Oxidative stress enhances inflammation and reduces the effectiveness of corticosteroids, but the inflammatory signalling pathways induced by oxidants remain III-defined. Phosphorylation of histone 3 at serine 10 (H3-Pser10) marks out a subset of inflammatory genes for transcription, several of which are induced in oxidant-associated inflammation. However, the influence of oxidants or of corticosteroids on this modification remains unknown. We assessed the regulation of H3-Pser10 by oxidants and lipopolysaccharide (LPS) in human blood monocytes and lung macrophages and the effectiveness of its abolition in controlling inflammatory gene expression in cells from asthmatic subjects compared to corticosteroids alone. Both oxidants and LPS promoted the induction of H3-Pser10 which was unaffected by corticosteroids. The induction of H3-Pser10 was mediated through p38 alpha mitogen-activated protein kinase (MAPK) and I kappa B kinase 2 (IKK-2) signalling. Consequently, inhibitors of p38 alpha MAPK or IKK-2 used in combination with dexamethasone were more effective at controlling inflammatory gene expression from monocytes and lung macrophages from asthmatic patients than the corticosteroid alone. Therefore, reduction of H3-Pser10 by inhibition of p38 alpha MAPK or of IKK-2 may provide greater anti-inflammatory control than corticosteroids alone in oxidant-associated inflammation such as severe asthma.	[Marwick, John A.; Tudor, Corina; Khorasani, Nadia; Michaeloudes, Charalambos; Bhavsar, Pankaj K.; Chung, Kian F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Airways Dis, London, England; [Marwick, John A.] Univ Edinburgh, Sch Med, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Chung, Kian F.] Royal Brompton Hosp, NIHR Biomed Res Unit, London SW3 6LY, England	Imperial College London; University of Edinburgh; Royal Brompton Hospital	Marwick, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Airways Dis, London, England.	John.Marwick@eda.c.uk	Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Michaeloudes, Charalambos/0000-0002-4107-4028	UK Medical Research Council [G0700900]; Medical Research Council [G0700900] Funding Source: researchfish; MRC [G0700900] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (Grant G0700900 to KFC). http://www.mrc.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; American Thoracic Society, 2000, AM J RESP CRIT CARE, V162, P2341; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Chung KF, 1999, EUR RESPIR J, V13, P1198; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Evans DJ, 1997, NEW ENGL J MED, V337, P1412, DOI 10.1056/NEJM199711133372002; Gagliardo R, 2011, J ALLERGY CLIN IMMUN, V128, P635, DOI 10.1016/j.jaci.2011.03.045; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ito K., 2001, FASEB Journal, V15, P1110; LaHair MM, 2006, ANTIOXID REDOX SIGN, V8, P1749, DOI 10.1089/ars.2006.8.1749; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Marwick JA, 2010, J ALLERGY CLIN IMMUN, V125, P1146, DOI 10.1016/j.jaci.2010.02.003; Medicherla S, 2008, J PHARMACOL EXP THER, V324, P921, DOI 10.1124/jpet.107.127092; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Rahman I, 2002, MOL CELL BIOCHEM, V234, P239, DOI 10.1023/A:1015905010086; Rajendrasozhan S, 2010, PULM PHARMACOL THER, V23, P172, DOI 10.1016/j.pupt.2010.01.002; Rastrick JMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054128; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; Yamada T, 2012, FREE RADICAL BIO MED, V52, P1285, DOI 10.1016/j.freeradbiomed.2012.02.003; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124961	10.1371/journal.pone.0124961	http://dx.doi.org/10.1371/journal.pone.0124961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905622	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000095
J	Singh, A; Kett, WC; Severin, IC; Agyekum, I; Duan, JN; Amster, IJ; Proudfoot, AEI; Coombe, DR; Woods, RJ				Singh, Arunima; Kett, Warren C.; Severin, India C.; Agyekum, Isaac; Duan, Jiana; Amster, I. Jonathan; Proudfoot, Amanda E. I.; Coombe, Deirdre R.; Woods, Robert J.			The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CCL5; RANTES; CCL5-CCR1 binding; chemokine; heparin; heparan sulfate; CCL5-GAG interaction; pH dependence; molecular modeling; heparin sulfation pattern	GLYCOSAMINOGLYCAN-PROTEIN INTERACTIONS; GENERALIZED BORN MODEL; MOLECULAR-DYNAMICS; BINDING-SITES; PK(A) VALUES; MASS-SPECTROMETRY; DOCKING; RANTES; OLIGOMERIZATION; RATIONALIZATION	Background: Chemokine-glycosaminoglycan (GAG) binding regulates leukocyte migration. Results: Heparin tetrasaccharides are examined for their ability to inhibit CCL5-CCR1 binding, and key interactions between the heparin fragments and CCL5 are identified. Conclusion: Binding modes and inhibitory capabilities depend on the extent and pattern of sulfation of the heparin fragments. Significance: Inhibition of CCL5-CCR1 binding requires heparin to interact with specific residues on the CCL5 surface. Interactions between chemokines such as CCL5 and glycosaminoglycans (GAGs) are essential for creating haptotactic gradients to guide the migration of leukocytes into inflammatory sites, and the GAGs that interact with CCL5 with the highest affinity are heparan sulfates/heparin. The interaction between CCL5 and its receptor on monocytes, CCR1, is mediated through residues Arg-17 and -47 in CCL5, which overlap with the GAG-binding (RKNR47)-R-44 BBXB motifs. Here we report that heparin and tetrasaccharide fragments of heparin are able to inhibit CCL5-CCR1 binding, with IC50 values showing strong dependence on the pattern and extent of sulfation. Modeling of the CCL5-tetrasaccharide complexes suggested that interactions between specific sulfate and carboxylate groups of heparin and residues Arg-17 and -47 of the protein are essential for strong inhibition; tetrasaccharides lacking the specific sulfation pattern were found to preferentially bind CCL5 in positions less favorable for inhibition of the interaction with CCR1. Simulations of a 12-mer heparin fragment bound to CCL5 indicated that the oligosaccharide preferred to interact simultaneously with both (RKNR47)-R-44 motifs in the CCL5 homodimer and engaged residues Arg-47 and -17 from both chains. Direct engagement of these residues by the longer heparin oligosaccharide provides a rationalization for its effectiveness as an inhibitor of CCL5-CCR1 interaction. In this mode, histidine (His-23) may contribute to CCL5-GAG interactions when the pH drops just below neutral, as occurs during inflammation. Additionally, an examination of the contribution of pH to modulating CCL5-heparin interactions suggested a need for careful interpretation of experimental results when experiments are performed under non-physiological conditions.	[Singh, Arunima; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Agyekum, Isaac; Duan, Jiana; Amster, I. Jonathan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Kett, Warren C.; Coombe, Deirdre R.] Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Sch Biomed Sci,Mol Immunol, Perth, WA 6102, Australia; [Severin, India C.; Proudfoot, Amanda E. I.] Merck Serono Geneva Res Ctr, CH-1202 Geneva, Switzerland	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Curtin University; Merck KGaA; EMD Serono Inc.	Coombe, DR (corresponding author), Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Sch Biomed Sci,Mol Immunol, Perth, WA 6102, Australia.	d.coombe@curtin.edu.au; rwoods@ccrc.uga.edu	Regan, Clinton/E-6250-2012; Amster, Jon/D-6957-2011; Severin, India/J-1558-2017	Amster, Jon/0000-0001-7523-5144; Singh, Arunima/0000-0001-5885-7478; Coombe, Deirdre/0000-0001-9729-7549; Woods, Robert/0000-0002-2400-6293	National Institutes of Health [R01 GM094919, P41 GM103390]; Science Foundation of Ireland [08/IN.1/B2070]; European Union [LSHB-CT-2005-518167]; European Research Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094919, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); European Union(European Commission); European Research Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM094919 (EUREKA) and P41 GM103390. This work was also supported by Science Foundation of Ireland Grant 08/IN.1/B2070, European Union FP6 INNOCHEM award LSHB-CT-2005-518167, and the European Research Development Fund.	Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; [Anonymous], 1929, KLIN WOCHENSCHR; Atkovska K, 2014, INT J MOL SCI, V15, P2622, DOI 10.3390/ijms15022622; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballut L, 2013, J MOL RECOGNIT, V26, P76, DOI 10.1002/jmr.2250; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; Brandner B, 2009, PROTEIN ENG DES SEL, V22, P367, DOI 10.1093/protein/gzp013; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; Carpentier M, 2014, GLYCOCONJUGATE J, V31, P161, DOI 10.1007/s10719-013-9512-8; Case D. A., 2012, AMBER 12; CHAI WG, 1995, CARBOHYD RES, V269, P139, DOI 10.1016/0008-6215(94)00349-K; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Forster M, 2006, BIOCHEM SOC T, V34, P431, DOI 10.1042/BST0340431; Frank M, 2014, TOP MED CHEM SER, V12, P53, DOI 10.1007/7355_2014_42; Gandhi NS, 2009, GLYCOBIOLOGY, V19, P1103, DOI 10.1093/glycob/cwp101; Ge XN, 2014, GLYCOBIOLOGY, V24, P715, DOI 10.1093/glycob/cwu035; Genheden S, 2012, J CHEM INF MODEL, V52, P2079, DOI 10.1021/ci3001919; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kailemia MJ, 2013, MOL CELL PROTEOMICS, V12, P979, DOI 10.1074/mcp.M112.026880; Kailemia MJ, 2012, ANAL CHEM, V84, P5475, DOI 10.1021/ac3015824; Kett WC, 2004, SPECTROSC-INT J, V18, P185, DOI 10.1155/2004/392536; Kim JK, 2005, J LEUKOCYTE BIOL, V78, P442, DOI 10.1189/jlb.0305161; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Marques RE, 2013, EXPERT OPIN THER TAR, V17, P1439, DOI 10.1517/14728222.2013.837886; Martin L, 2001, BIOCHEMISTRY-US, V40, P6303, DOI 10.1021/bi002670n; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Mishra SK, 2012, J CHEM INF MODEL, V52, P1250, DOI 10.1021/ci200529n; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Mourier PAJ, 2004, ANAL BIOCHEM, V332, P299, DOI 10.1016/j.ab.2004.06.020; Nivedha AK, 2014, J COMPUT CHEM, V35, P526, DOI 10.1002/jcc.23517; Nonaka M, 2014, P NATL ACAD SCI USA, V111, P8173, DOI 10.1073/pnas.1319870111; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Peer L. A., 1955, TRANSPLANTATION TISS, V1I; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; R Development Core Team, 2012, R LANG ENV STAT COMP; Remko M, 2013, CHEM PHYS LETT, V590, P187, DOI 10.1016/j.cplett.2013.10.062; Revici E., 1949, B I APPL BIOL, V1, P21; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Samsonov SA, 2014, J CHEM INF MODEL, V54, P582, DOI 10.1021/ci4006047; Samsonov SA, 2011, J COMPUT AID MOL DES, V25, P477, DOI 10.1007/s10822-011-9433-1; Severin IC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00293; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; WANG HM, 1991, BIOCHEM J, V278, P689, DOI 10.1042/bj2780689; Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wolff JJ, 2007, J AM SOC MASS SPECTR, V18, P234, DOI 10.1016/j.jasms.2006.09.020; Wood E.J., 1987, BIOCHEM EDUC, V15, P97, DOI [10.1016/0307-4412(87)90110-5, DOI 10.1016/0307-4412(87)90110-5]	91	45	45	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15421	15436		10.1074/jbc.M115.655845	http://dx.doi.org/10.1074/jbc.M115.655845			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907556	Green Published, hybrid			2022-12-26	WOS:000356527400010
J	Hori, Y; Hashimoto, T; Nomoto, H; Hyman, BT; Iwatsubo, T				Hori, Yukiko; Hashimoto, Tadafumi; Nomoto, Hidetoshi; Hyman, Bradley T.; Iwatsubo, Takeshi			Role of Apolipoprotein E in beta-Amyloidogenesis ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF A beta IN VITRO AND BRAIN A beta DEPOSITION IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA; MOUSE MODEL; PROTEIN FIBRILLOGENESIS; STABLE COMPLEXES; TRANSGENIC MICE; TYPE-4 ALLELE; PEPTIDE; PATHOGENESIS	Human APOE beta 4 allele is a strong genetic risk factor of Alzheimer disease. Neuropathological and genetic studies suggested that apolipoprotein E4 (apoE4) protein facilitates deposition of amyloid beta peptide (A beta) in the brain, although the mechanism whereby apoE4 increases amyloid aggregates remains elusive. Here we show that injection of A beta protofibrils induced A beta deposition in the brain of APP transgenic mice, suggesting that A beta protofibrils acted as a seed for aggregation and deposition of A beta in vivo. Injection of A beta protofibrils together with apoE3 significantly attenuated A beta deposition, whereas apoE4 did not have this effect. In vitro assays revealed that the conversion of A beta protofibrils to fibrils progressed more slowly upon coincubation with apoE2 or apoE3 compared with that with apoE4. A beta protofibrils complexed with apoE4 were less stable than those with apoE2 or apoE3. These data suggest that the suppression effect of apoE2 or apoE3 on the structural conversion of A beta protofibrils to fibrils is stronger than those of apoE4, thereby impeding beta-amyloid deposition.	[Hori, Yukiko; Hashimoto, Tadafumi; Nomoto, Hidetoshi; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; [Hashimoto, Tadafumi; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan; [Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Unit, Charlestown, MA 02129 USA	University of Tokyo; University of Tokyo; Harvard University; Massachusetts General Hospital	Iwatsubo, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@m.u-tokyo.ac.jp		Hashimoto, Tadafumi/0000-0001-5442-4800	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Strategic Research Program for Brain Science from MEXT; Health Labor Sciences Research Grant on Amyloidosis; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Strategic Research Program for Brain Science from MEXT; Health Labor Sciences Research Grant on Amyloidosis; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Core Research for Evolutional Science and Technology of Japan Science and Technology Agency, the Strategic Research Program for Brain Science from MEXT, and the Health Labor Sciences Research Grant on Amyloidosis.	Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; GomezIsla T, 1996, ANN NEUROL, V39, P62, DOI 10.1002/ana.410390110; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Nakai M, 1996, NEUROSCI LETT, V211, P41, DOI 10.1016/0304-3940(96)12716-6; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; REBECK GW, 1993, NEURON, V11, P575; Ribalta J, 2003, CURR OPIN CLIN NUTR, V6, P177, DOI 10.1097/00075197-200303000-00006; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yamada K, 2009, J NEUROSCI, V29, P11393, DOI 10.1523/JNEUROSCI.2021-09.2009; Yang DS, 1997, J NEUROCHEM, V68, P721	47	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15163	15174		10.1074/jbc.M114.622209	http://dx.doi.org/10.1074/jbc.M114.622209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918154	hybrid, Green Published			2022-12-26	WOS:000356177300030
J	Kaushansky, N; Eisenstein, M; Boura-Halfon, S; Hansen, BE; Nielsen, CH; Milo, R; Zeilig, G; Lassmann, H; Altmann, DM; Ben-Nun, A				Kaushansky, Nathali; Eisenstein, Miriam; Boura-Halfon, Sigalit; Hansen, Bjarke Endel; Nielsen, Claus Henrik; Milo, Ron; Zeilig, Gabriel; Lassmann, Hans; Altmann, Daniel M.; Ben-Nun, Avraham			Role of a Novel Human Leukocyte Antigen-DQA1*01:02; DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE-SPECIFIC PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; II TRANSGENIC MICE; T-CELL RESPONSES; SJL/J MICE; OSP/CLAUDIN-11-INDUCED EAE; MOLECULAR EVIDENCE; GENE CONVERSION; HLA-DR	Gene-wide association and candidate gene studies indicate that the greatest effect on multiple sclerosis (MS) risk is driven by the HLA-DRB1*15:01 allele within the HLA-DR15 haplotype (HLA-DRB1*15:01-DQA1*01:02-DQB1*0602-DRB5*01:01). Nevertheless, linkage disequilibrium makes it difficult to define, without functional studies, whether the functionally relevant effect derives from DRB1*15:01 only, from its neighboring DQA1*01:02-DQB1*06:02 or DRB5*01:01 genes of HLA-DR15 haplotype, or from their combinations or epistatic interactions. Here, we analyzed the impact of the different HLA-DR15 haplotype alleles on disease susceptibility in a new "humanized" model of MS induced in HLA-transgenic (Tg) mice by human oligodendrocyte-specific protein (OSP)/claudin-11 (hOSP), one of the bona fide potential primary target antigens in MS. We show that the hOSP-associated MS-like disease is dominated by the DRB1*15: 01 allele not only as the DRA1*01:01; DRB1*15: 01 isotypic heterodimer but also, unexpectedly, as a functional DQA1*01: 02; DRB1*15: 01 mixed isotype heterodimer. The contribution of HLA-DQA1/DRB1 mixed isotype heterodimer to OSP pathogenesis was revealed in (DRB1*1501xDQB1*0602)F1 double-Tg mice immunized with hOSP(142-161) peptide, where the encephalitogenic potential of prevalent DRB1*1501/hOSP(142-161)-reactive Th1/Th17 cells is hindered due to a single amino acid difference in the OSP(142-161) region between humans and mice; this impedes binding of DRB1*1501 to the mouse OSP(142-161) epitope in the mouse CNS while exposing functional binding of mouse OSP(142-161) to DQA1*01: 02; DRB1*15: 01 mixed isotype heterodimer. This study, which shows for the first time a functional HLA-DQA1/DRB1 mixed isotype heterodimer and its potential association with disease susceptibility, provides a rationale for a potential effect on MS risk from DQA1*01: 02 through functional DQA1*01: 02; DRB1*15: 01 antigen presentation. Furthermore, it highlights a potential contribution to MS risk also from interisotypic combination between products of neighboring HLA-DR15 haplotype alleles, in this case the DQA1/DRB1 combination.	[Kaushansky, Nathali; Boura-Halfon, Sigalit; Ben-Nun, Avraham] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-7610001 Rehovot, Israel; [Hansen, Bjarke Endel; Nielsen, Claus Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Milo, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Med Ctr, Dept Neurol, IL-78278 Ashqelon, Israel; [Zeilig, Gabriel] Chaim Sheba Med Ctr, Dept Neurol Rehabil, IL-52621 Tel Hashomer, Israel; [Zeilig, Gabriel] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Lassmann, Hans] Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, A-1090 Vienna, Austria; [Altmann, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Hammersmith Hosp, London W12 0HS, England	Weizmann Institute of Science; Weizmann Institute of Science; Rigshospitalet; University of Copenhagen; Ben Gurion University; Barzilai Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Medical University of Vienna; Imperial College London	Ben-Nun, A (corresponding author), Weizmann Inst Sci, Dept Immunol, 234 Herzl St, IL-7610001 Rehovot, Israel.	avi.ben-nun@weizmann.ac.il	Milo, Ron/AAH-7504-2020; Lassmann, Hans/Z-2269-2019; Hansen, Bjarke/D-3663-2018	Lassmann, Hans/0000-0001-8617-5052; Hansen, Bjarke/0000-0002-8167-8459; Nielsen, Claus Henrik/0000-0001-7543-9016; Altmann, Daniel/0000-0002-2436-6192	Israel Science Foundation; National Multiple Sclerosis Society of New York [RG 3195B8/2]; Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Adiel Eleanor foundation; Nella and Leon Benoziyo Center for Neurological Diseases; Wellcome Trust [WT087999MA]	Israel Science Foundation(Israel Science Foundation); National Multiple Sclerosis Society of New York(National Multiple Sclerosis Society); Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Adiel Eleanor foundation; Nella and Leon Benoziyo Center for Neurological Diseases; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Israel Science Foundation, National Multiple Sclerosis Society of New York Grant RG 3195B8/2, the Israel Ministry of Health, the Estate of the Late Florence Blau, the William Sahm Foundation, the Adiel Eleanor foundation, and the Nella and Leon Benoziyo Center for Neurological Diseases. The work in the laboratory of D. M. A. was supported by Wellcome Trust award WT087999MA.	ALTMANN DM, 1995, J EXP MED, V181, P867, DOI 10.1084/jem.181.3.867; Bajramovic JJ, 2008, EUR J IMMUNOL, V38, P1452, DOI 10.1002/eji.200737164; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; Ben-Shimon A, 2010, J MOL BIOL, V402, P259, DOI 10.1016/j.jmb.2010.07.021; BENNUN A, 1983, J IMMUNOL, V130, P1205; BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; Bronstein JM, 1996, NEUROLOGY, V47, P772, DOI 10.1212/WNL.47.3.772; Bronstein JM, 1997, J NEUROSCI RES, V50, P713, DOI 10.1002/(SICI)1097-4547(19971201)50:5<713::AID-JNR8>3.3.CO;2-Q; Bronstein JM, 1999, NEUROLOGY, V53, P154, DOI 10.1212/WNL.53.1.154; CHARRON DJ, 1984, NATURE, V312, P157, DOI 10.1038/312157a0; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; de Rosbo NK, 2004, J IMMUNOL, V173, P1426, DOI 10.4049/jimmunol.173.2.1426; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; GILES RC, 1985, P NATL ACAD SCI USA, V82, P1776, DOI 10.1073/pnas.82.6.1776; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; HOCHMAN PS, 1984, J EXP MED, V160, P1925, DOI 10.1084/jem.160.6.1925; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156; Kaushansky N, 2008, INT IMMUNOL, V20, P1439, DOI 10.1093/intimm/dxn099; Kaushansky N, 2007, EUR J IMMUNOL, V37, P2018, DOI 10.1002/eji.200636965; Kaushansky N, 2006, J IMMUNOL, V177, P7364, DOI 10.4049/jimmunol.177.10.7364; Kaushansky N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-29; Kaushansky N, 2009, J IMMUNOL, V183, P3531, DOI 10.4049/jimmunol.0900784; Khare M, 2005, J NEUROIMMUNOL, V169, P1, DOI 10.1016/j.jneuroim.2005.07.023; Khare M, 2003, INT IMMUNOL, V15, P535, DOI 10.1093/intimm/dxg053; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; LOCK CB, 1988, IMMUNOGENETICS, V27, P449, DOI 10.1007/BF00364432; LOTTEAU V, 1989, J EXP MED, V169, P351, DOI 10.1084/jem.169.1.351; LOTTEAU V, 1987, NATURE, V329, P339, DOI 10.1038/329339a0; MALISSEN B, 1986, P NATL ACAD SCI USA, V83, P3958, DOI 10.1073/pnas.83.11.3958; Mangalam A, 2008, J IMMUNOL, V180, P7747, DOI 10.4049/jimmunol.180.11.7747; MARSH SGE, 1992, HUM IMMUNOL, V35, P1, DOI 10.1016/0198-8859(92)90090-A; MENGLEGAW L, 1984, J EXP MED, V160, P1184, DOI 10.1084/jem.160.4.1184; Morris-Downes MM, 2002, J NEUROIMMUNOL, V122, P20, DOI 10.1016/S0165-5728(01)00460-X; Morse K, 2012, IMMUNOGENETICS, V64, P507, DOI 10.1007/s00251-012-0606-4; Oksenberg JR, 2010, NAT REV NEUROL, V6, P429, DOI 10.1038/nrneurol.2010.91; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rich C, 2004, EUR J IMMUNOL, V34, P1251, DOI 10.1002/eji.200324354; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vu T, 2001, J NEUROSCI RES, V66, P506, DOI 10.1002/jnr.1241; ZAMVIL SS, 1985, J EXP MED, V162, P2107, DOI 10.1084/jem.162.6.2107; Zhong MC, 2000, J NEUROIMMUNOL, V105, P39, DOI 10.1016/S0165-5728(00)00186-7	51	5	5	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15260	15278		10.1074/jbc.M115.641209	http://dx.doi.org/10.1074/jbc.M115.641209			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911099	hybrid, Green Published			2022-12-26	WOS:000356177300038
J	Pronker, MF; Bos, TGAA; Sharp, TH; Thies-Weesie, DME; Janssen, BJC				Pronker, Matti F.; Bos, Trusanne G. A. A.; Sharp, Thomas H.; Thies-Weesie, Dominique M. E.; Janssen, Bert J. C.			Olfactomedin-1 Has a V-shaped Disulfide-linked Tetrameric Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COMPLEX; NA+ CHANNELS; GLYCOPROTEIN; GLIOMEDIN; PROTEINS; RANVIER; ULTRACENTRIFUGATION; VISUALIZATION; REFINEMENT; SCATTERING	Olfactomedin-1 (Olfm1; also known as noelin and pancortin) is a member of the olfactomedin domain-containing superfamily and a highly expressed neuronal glycoprotein important for nervous system development. It binds a number of secreted proteins and cell surface-bound receptors to induce cell signaling processes. Using a combined approach of x-ray crystallography, solution scattering, analytical ultracentrifugation, and electron microscopy we determined that full-length Olfm1 forms disulfide-linked tetramers with a distinctive V-shaped architecture. The base of the "V" is formed by two disulfide-linked dimeric N-terminal domains. Each of the two V legs consists of a parallel dimeric disulfide-linked coiled coil with a C-terminal beta-propeller dimer at the tips. This agrees with our crystal structure of a C-terminal coiled-coil segment and beta-propeller combination (Olfm1(coil-Olf)) that reveals a disulfide-linked dimeric arrangement with the beta-propeller top faces in an outward exposed orientation. Similar to its family member myocilin, Olfm1 is stabilized by calcium. The dimer-of-dimers architecture suggests a role for Olfm1 in clustering receptors to regulate signaling and sheds light on the conformation of several other olfactomedin domain family members.	[Pronker, Matti F.; Bos, Trusanne G. A. A.; Janssen, Bert J. C.] Univ Utrecht, Fac Sci, Dept Chem, Crystal & Struct Chem,Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Thies-Weesie, Dominique M. E.] Univ Utrecht, Fac Sci, Dept Chem, Vant Hoff Lab Phys & Colloid Chem,Debye Inst Nano, NL-3584 CH Utrecht, Netherlands; [Sharp, Thomas H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Sect Elect Microscopy, NL-2300 RC Leiden, Netherlands	Utrecht University; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Janssen, BJC (corresponding author), Univ Utrecht, Fac Sci, Dept Chem, Crystal & Struct Chem,Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	b.j.c.janssen@uu.nl	Pronker, Matti/AAB-1821-2020; Janssen, Bert/I-3338-2016	Pronker, Matti/0000-0001-5268-7690; Janssen, Bert/0000-0002-8101-8370; Sharp, Thomas/0000-0002-1990-2333	Netherlands Organization for Scientific Research (NWO) VIDI Grant [723.012.002]	Netherlands Organization for Scientific Research (NWO) VIDI Grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research (NWO) VIDI Grant 723.012.002.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amor V, 2014, J NEUROSCI, V34, P5089, DOI 10.1523/JNEUROSCI.4752-13.2014; Ando K, 2005, NEUROSCIENCE, V133, P947, DOI 10.1016/j.neuroscience.2005.03.009; Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Han HJ, 2015, J BIOL CHEM, V290, P3612, DOI 10.1074/jbc.M114.627547; Jackson VA, 2015, STRUCTURE, V23, P774, DOI 10.1016/j.str.2015.01.013; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Moreno TA, 2001, DEV BIOL, V240, P340, DOI 10.1006/dbio.2001.0472; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakaya N, 2008, J NEUROSCI, V28, P7900, DOI 10.1523/JNEUROSCI.0617-08.2008; Nakaya N, 2013, EXP NEUROL, V250, P205, DOI 10.1016/j.expneurol.2013.09.019; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice HC, 2012, DEVELOPMENT, V139, P3986, DOI 10.1242/dev.082909; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SNYDER DA, 1991, BIOCHEMISTRY-US, V30, P9143, DOI 10.1021/bi00102a004; Sultana A, 2014, EXP NEUROL, V261, P802, DOI 10.1016/j.expneurol.2014.09.002; Sultana A, 2011, INVEST OPHTH VIS SCI, V52, P2584, DOI 10.1167/iovs.10-6356; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655	41	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15092	15101		10.1074/jbc.M115.653485	http://dx.doi.org/10.1074/jbc.M115.653485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25903135	Green Published, hybrid			2022-12-26	WOS:000356177300024
J	Jeng, MJ; Lee, YS; Tsao, PC; Yang, CF; Soong, WJ				Jeng, Mei-Jy; Lee, Yu-Sheng; Tsao, Pei-Chen; Yang, Chia-Feng; Soong, Wen-Jue			A Longitudinal Study on Early Hospitalized Airway Infections and Subsequent Childhood Asthma	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; IMPORTANT RISK-FACTOR; RSV BRONCHIOLITIS; YOUNG-CHILDREN; FOLLOW-UP; AGE 13; INFANCY; ALLERGY; TAIWAN; ASSOCIATION	Background Acute airway infections, including bronchiolitis, are common causes of early childhood hospitalization. The development of later asthma may be related to early airway infections in young children. This study is to investigate the relationship between hospitalized airway infections (HAI) in young children (< 3 years old) and later childhood asthma. Methods Hospitalized children (< 3 years old) with bronchiolitis or other acute airway infections (other HAI group) from 1997-2000 were retrieved from the National Health Insurance Research Database of Taiwan, and compared to age-and gender-matched subjects with regards to asthma until 10 years of age; and potential comorbidities and medical care conditions. Results In total, 3,264 children (1,981 with bronchiolitis; 1,283 with other HAIs) were compared to 18,527 controls. The incidence of childhood asthma was higher in the study (16.2%) than the control (11.7%) group, and most cases were diagnosed between 3-5 years old. The hazard ratios were 1.583 (95% CI: 1.414-1.772) and 1.226 (95% CI: 1.053-1.428) for the bronchiolitis and other HAI subgroups, respectively, compared to the control group, and 1.228 (95% CI: 1.075-1.542) in the bronchiolitis subgroup compared to the other HAIs subgroup. A significantly higher odds ratio (1.973, 95% CI: 1.193-3.263) for the children with congenital heart disease (CHD) in the bronchiolitis subgroup was found at an age of 3-5 years compared to the control group. Conclusions and Clinical Relevance Young children (< 3 years old) hospitalized due to acute HAIs are at a higher risk of developing childhood asthma at age 3 to 10 years. The parents of children with HAIs at age 0 to 2 years should be informed for the higher risk of developing childhood asthma, especially in children with CHD and bronchiolitis.	[Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Jeng, Mei-Jy; Lee, Yu-Sheng; Tsao, Pei-Chen; Yang, Chia-Feng; Soong, Wen-Jue] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Pediat, Taipei 112, Taiwan; [Jeng, Mei-Jy; Lee, Yu-Sheng; Tsao, Pei-Chen; Yang, Chia-Feng; Soong, Wen-Jue] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Jeng, MJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan.	mjjeng@vghtpe.gov.tw			Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. [V101C-11, V102C-069]	Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.(Taipei Veterans General Hospital)	Funding: This study was supported by the grants from Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. (research grants V101C-11 and V102C-069). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamko DJ, 2012, J ALLERGY CLIN IMMUN, V130, P101, DOI 10.1016/j.jaci.2012.05.024; [Anonymous], BACKGROUND; [Anonymous], FREE ONL SEARCH 2009; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Backman K, 2014, ACTA PAEDIATR, V103, P850, DOI 10.1111/apa.12662; Bode-Thomas F, 2010, CLIN MED INSIGHT-CAS, V3, P5; Bush A, 2007, BMJ-BRIT MED J, V335, P1037, DOI 10.1136/bmj.39374.600081.AD; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Chang JW, 2015, KIDNEY INT, V87, P632, DOI 10.1038/ki.2014.299; Chen Chun-Jen, 2005, Acta Paediatrica Taiwanica, V46, P72; Chen CY, 2003, PHARMACOEPIDEM DR S, V12, P129, DOI 10.1002/pds.810; Chen TC, 2012, EPILEPSY RES, V102, P188, DOI 10.1016/j.eplepsyres.2012.06.003; Chou YC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-64; Chuang CM, 2014, PEDIAT NEONATOLOGY; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Garcia CG, 2010, PEDIATRICS, V126, pE1453, DOI 10.1542/peds.2010-0507; Garcia-Garcia ML, 2007, PEDIATR PULM, V42, P458, DOI 10.1002/ppul.20597; Haland G, 2009, PEDIAT ALLERG IMM-UK, V20, P254, DOI 10.1111/j.1399-3038.2008.00781.x; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Hsu CL, 2015, J MICROBIOL IMMUNOL, V48, P153, DOI 10.1016/j.jmii.2013.07.007; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jartti T, 2011, PEDIAT ALLERG IMM-UK, V22, P350, DOI 10.1111/j.1399-3038.2011.01170.x; Jeng MJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-100; Jung YM, 2014, J MOL STRUCT, V1069, P1, DOI 10.1016/j.molstruc.2014.02.020; Kneyber M, 2000, ACTA PAEDIATR, V89, P654, DOI 10.1080/080352500750043945; Koponen P, 2014, PEDIATR INFECT DIS J, V33, P463, DOI 10.1097/INF.0000000000000253; Koponen P, 2012, PEDIATR INT, V54, P619, DOI 10.1111/j.1442-200X.2012.03651.x; Lauhkonen E, 2015, PEDIATR PULM, V50, P389, DOI 10.1002/ppul.23039; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Liao JN, 2015, KIDNEY INT, V87, P1209, DOI 10.1038/ki.2014.393; Lin HW, 2012, EUR J PEDIATR, V171, P1645, DOI 10.1007/s00431-012-1788-3; Lin SC, 2015, J ASTHMA, V52, P273, DOI 10.3109/02770903.2014.958854; Lin WS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107694; Mahamid J, 2007, HAREFUAH, V146, P99; Mahamid Jamal, 2007, Harefuah, V146, P480; Montgomery S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004034; Nasreen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089978; National Health Insurance Research Database, DAT SUBS; Pattemore PK, 2013, J PAEDIATR CHILD H, V49, P991, DOI 10.1111/jpc.12395; Ricart S, 2013, PEDIATR PULM, V48, P456, DOI 10.1002/ppul.22633; Schroeckenstein D C, 1988, Semin Respir Infect, V3, P40; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2002, RESP RES, V3, DOI 10.1186/rr186; Sigurs N, 2001, AM J RESP CRIT CARE, V163, pS2, DOI 10.1164/ajrccm.163.supplement_1.2011109; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2007, ACTA PAEDIATR, V96, P156, DOI 10.1111/j.1651-2227.2007.00105.x; Sigurs Nele, 2002, Paediatr Respir Rev, V3, P177, DOI 10.1016/S1526-0542(02)00191-4; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stein RT, 2010, THORAX, V65, P1033, DOI 10.1136/thx.2009.133967; Sung CC, 2011, J MICROBIOL IMMUNOL, V44, P184, DOI 10.1016/j.jmii.2011.01.025; Takeyama A, 2014, EUROPEAN J PEDIAT; Teshome G, 2013, PEDIATR CLIN N AM, V60, P1019, DOI 10.1016/j.pcl.2013.06.005; Tormanen S, 2015, PEDIATR PULM, V50, P424, DOI 10.1002/ppul.23053; Valkonen H, 2009, ALLERGY, V64, P1359, DOI 10.1111/j.1398-9995.2009.02022.x; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Wang JY, 2012, ASIA PAC ALLERGY, V2, P167, DOI 10.5415/apallergy.2012.2.3.167; Wennergren G, 2001, EUR RESPIR J, V18, P1044, DOI 10.1183/09031936.01.00254101; Yeh KW, 2008, PEDIAT ALLERG IMM-UK, V19, P13, DOI 10.1111/j.1399-3038.2007.00598.x; Zomer-Kooijker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087162	60	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121906	10.1371/journal.pone.0121906	http://dx.doi.org/10.1371/journal.pone.0121906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919024	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400011
J	Wells, JCK; Stocks, J; Bonner, R; Raywood, E; Legg, S; Lee, S; Treleaven, P; Lum, S				Wells, Jonathan C. K.; Stocks, Janet; Bonner, Rachel; Raywood, Emma; Legg, Sarah; Lee, Simon; Treleaven, Philip; Lum, Sooky			Acceptability, Precision and Accuracy of 3D Photonic Scanning for Measurement of Body Shape in a Multi-Ethnic Sample of Children Aged 5-11 Years: The SLIC Study	PLOS ONE			English	Article							UK CHILDREN; WAIST CIRCUMFERENCE; MASS INDEX; ADIPOSITY; OBESITY; HEALTH; ADOLESCENTS; VARIABILITY; OVERWEIGHT; PHENOTYPES	Background Information on body size and shape is used to interpret many aspects of physiology, including nutritional status, cardio-metabolic risk and lung function. Such data have traditionally been obtained through manual anthropometry, which becomes time-consuming when many measurements are required. 3D photonic scanning (3D-PS) of body surface topography represents an alternative digital technique, previously applied successfully in large studies of adults. The acceptability, precision and accuracy of 3D-PS in young children have not been assessed. Methods We attempted to obtain data on girth, width and depth of the chest and waist, and girth of the knee and calf, manually and by 3D-PS in a multi-ethnic sample of 1484 children aged 5-11 years. The rate of 3D-PS success, and reasons for failure, were documented. Precision and accuracy of 3D-PS were assessed relative to manual measurements using the methods of Bland and Altman. Results Manual measurements were successful in all cases. Although 97.4% of children agreed to undergo 3D-PS, successful scans were only obtained in 70.7% of these. Unsuccessful scans were primarily due to body movement, or inability of the software to extract shape outputs. The odds of scan failure, and the underlying reason, differed by age, size and ethnicity. 3D-PS measurements tended to be greater than those obtained manually (p<0.05), however ranking consistency was high (r(2)>0.90 for most outcomes). Conclusions 3D-PS is acceptable in children aged >= 5 years, though with current hardware/software, and body movement artefacts, approximately one third of scans may be unsuccessful. The technique had poorer technical success than manual measurements, and had poorer precision when the measurements were viable. Compared to manual measurements, 3D-PS showed modest average biases but acceptable limits of agreement for large surveys, and little evidence that bias varied substantially with size. Most of the issues we identified could be addressed through further technological development.	[Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Stocks, Janet; Bonner, Rachel; Raywood, Emma; Legg, Sarah; Lee, Simon; Lum, Sooky] UCL Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, Portex Unit, London, England; [Treleaven, Philip] UCL Dept Comp Sci, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Wells, JCK (corresponding author), UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England.	jonathan.wells@ucl.ac.uk	Wells, Jonathan/A-4604-2009; Raywood, Emma/AAK-2852-2020	Wells, Jonathan/0000-0003-0411-8025; Raywood, Emma/0000-0002-0993-5115	Wellcome Trust [WT094129MA]; Asthma UK [10/013]; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network	Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust [WT094129MA], Asthma UK [10/013] and the Child Growth Foundation. The SLIC study team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Douros I, 1999, P SOC PHOTO-OPT INS, V3640, P234, DOI 10.1117/12.341065; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Feng K, 2012, RESPIROLOGY, V17, P1114, DOI 10.1111/j.1440-1843.2012.02219.x; Lum S, 2014, EXPLORING ETHNIC DIF; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; McCarthy HD, 2006, P NUTR SOC, V65, P385, DOI 10.1079/PNS2006514; McKeigue PM, 1996, CIBA F SYMP, V201, P54; Mesa JL, 2006, ANN NUTR METAB, V50, P519, DOI 10.1159/000098144; Nightingale CM, 2013, DIABETES CARE, V36, P1712, DOI 10.2337/dc12-1726; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Raju P Sitarama, 2003, Indian Pediatr, V40, P705; Rush EC, 2003, EUR J CLIN NUTR, V57, P1394, DOI 10.1038/sj.ejcn.1601701; Treleaven P, 2004, IEEE SPECTRUM, V41, P29; Treleaven P, 2007, COMPUTER, V40, P28, DOI 10.1109/MC.2007.225; Wang J, 2006, AM J CLIN NUTR, V83, P809; Wells JCK, 2008, INT J OBESITY, V32, P152, DOI 10.1038/sj.ijo.0803685; Wells JCK, 2008, INT J OBESITY, V32, P232, DOI 10.1038/sj.ijo.0803727; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wells JCK, 2012, OBES REV, V13, P14, DOI 10.1111/j.1467-789X.2012.01034.x; Wells JCK, 2012, INT J OBESITY, V36, P148, DOI 10.1038/ijo.2011.51; Wells JCK, 2000, INT J OBESITY, V24, P325, DOI 10.1038/sj.ijo.0801132; Wells JCK, 2008, OBESITY, V16, P435, DOI 10.1038/oby.2007.62; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; Wells JCK, 2011, AM J HUM BIOL, V23, P291, DOI 10.1002/ajhb.21151; Wells JCK, 2010, AM J HUM BIOL, V22, P456, DOI 10.1002/ajhb.21017	26	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124193	10.1371/journal.pone.0124193	http://dx.doi.org/10.1371/journal.pone.0124193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919034	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659400044
J	Bergmann, A; Trefz, P; Fischer, S; Klepik, K; Walter, G; Steffens, M; Ziller, M; Schubert, JK; Reinhold, P; Kohler, H; Miekisch, W				Bergmann, Andreas; Trefz, Phillip; Fischer, Sina; Klepik, Klaus; Walter, Gudrun; Steffens, Markus; Ziller, Mario; Schubert, Jochen K.; Reinhold, Petra; Koehler, Heike; Miekisch, Wolfram			In Vivo Volatile Organic Compound Signatures of Mycobacterium avium subsp. paratuberculosis	PLOS ONE			English	Article							JOHNES-DISEASE; CROHNS-DISEASE; METHIONINE; LIPOARABINOMANNAN; METABOLITES; EXTRACTION; PATHWAYS; ORIGIN; THIOLS; GROWTH	Mycobacterium avium ssp. paratuberculosis (MAP) is the causative agent of a chronic enteric disease of ruminants. Available diagnostic tests are complex and slow. In vitro, volatile organic compound (VOC) patterns emitted from MAP cultures mirrored bacterial growth and enabled distinction of different strains. This study was intended to determine VOCs in vivo in the controlled setting of an animal model. VOCs were pre-concentrated from breath and feces of 42 goats (16 controls and 26 MAP-inoculated animals) by means of needle trap microextraction (breath) and solid phase microextraction (feces) and analyzed by gas chromatography/mass spectrometry. Analyses were performed 18, 29, 33, 41 and 48 weeks after inoculation. MAP-specific antibodies and MAP-specific interferon-gamma-response were determined from blood. Identities of all marker-VOCs were confirmed through analysis of pure reference substances. Based on detection limits in the high pptV and linear ranges of two orders of magnitude more than 100 VOCs could be detected in breath and in headspace over feces. Twenty eight substances differed between inoculated and non-inoculated animals. Although patterns of most prominent substances such as furans, oxygenated substances and hydrocarbons changed in the course of infection, differences between inoculated and non-inoculated animals remained detectable at any time for 16 substances in feces and 3 VOCs in breath. Differences of VOC concentrations over feces reflected presence of MAP bacteria. Differences in VOC profiles from breath were linked to the host response in terms of interferon-gamma-response. In a perspective in vivo analysis of VOCs may help to overcome limitations of established tests.	[Bergmann, Andreas; Trefz, Phillip; Klepik, Klaus; Steffens, Markus; Schubert, Jochen K.; Miekisch, Wolfram] Univ Med Rostock, Dept Anaesthesia & Intens Care, Rostock, Germany; [Fischer, Sina; Walter, Gudrun; Reinhold, Petra; Koehler, Heike] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany; [Ziller, Mario] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Ziller, Mario] Biomath Working Grp, Insel Riems, Germany	University of Rostock; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Miekisch, W (corresponding author), Univ Med Rostock, Dept Anaesthesia & Intens Care, Rostock, Germany.	wolfram.miekisch@uni-rostock.de	Miekisch, Wolfram/I-1300-2019; Schubert, Jochen/F-4788-2016	Schubert, Jochen/0000-0002-0956-9506; Trefz, Phillip/0000-0001-6138-6515; Miekisch, Wolfram/0000-0003-1619-0315	German Research Foundation (DFG) [RE 1098/4-1, SCHU 1960/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are very grateful to the German Research Foundation (DFG, www.dfg.de, Grant number RE 1098/4-1, SCHU 1960/4-1) for their trust in work of the whole project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058204, 10.1371/journal.pone.0077869]; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Bonnarme P, 2000, APPL ENVIRON MICROB, V66, P5514, DOI 10.1128/AEM.66.12.5514-5517.2000; BORJESSON T, 1992, APPL ENVIRON MICROB, V58, P2599; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chiodini RJ, 2012, CRIT REV MICROBIOL, V38, P52, DOI 10.3109/1040841X.2011.638273; De Preter V, 2009, J CHROMATOGR A, V1216, P1476, DOI 10.1016/j.chroma.2008.12.095; Dhiman RK, 2011, J BACTERIOL, V193, P5802, DOI 10.1128/JB.05299-11; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Dias B, 1998, APPL ENVIRON MICROB, V64, P3327; Dickschat JS, 2004, CHEMBIOCHEM, V5, P778, DOI 10.1002/cbic.200300813; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hanniffy SB, 2009, INT J FOOD MICROBIOL, V135, P223, DOI 10.1016/j.ijfoodmicro.2009.08.009; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P3292, DOI 10.1128/AEM.56.11.3292-3297.1990; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P156, DOI 10.1128/AEM.56.1.156-161.1990; Knobloch H, 2009, AIP CONF PROC, V1137, P195, DOI 10.1063/1.3156505; Kruger C, 2015, VET PATHOL, V52, P276, DOI 10.1177/0300985814533804; Mendoza JL, 2009, WORLD J GASTROENTERO, V15, P417, DOI 10.3748/wjg.15.417; Miekisch W, 2014, BIOANALYSIS, V6, P1275, DOI 10.4155/bio.14.86; Mieth M, 2010, ANAL CHEM, V82, P2541, DOI 10.1021/ac100061k; Mieth M, 2009, ANAL CHEM, V81, P5851, DOI 10.1021/ac9009269; Miller TR, 2003, RES MICROBIOL, V154, P85, DOI 10.1016/S0923-2508(03)00027-5; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; PEREIRA SP, 1992, ANN TROP PAEDIATR, V12, P177, DOI 10.1080/02724936.1992.11747566; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Pollak FC, 1996, APPL ENVIRON MICROB, V62, P1295, DOI 10.1128/AEM.62.4.1295-1299.1996; Probert CSJ, 2004, GUT, V53, P58, DOI 10.1136/gut.53.1.58; Proudman CJ, 2014, EQUINE VET J; Purkhart R, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027103; Rafidinarivo E, 2009, J LIPID RES, V50, P477, DOI 10.1194/jlr.M800384-JLR200; Saito Y, 2006, J CHROMATOGR A, V1106, P190, DOI 10.1016/j.chroma.2005.08.048; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Scholler CEG, 2002, J AGR FOOD CHEM, V50, P2615, DOI 10.1021/jf0116754; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Tait E, 2014, J APPL MICROBIOL, V116, P1010, DOI 10.1111/jam.12418; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; Trefz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076868; Trefz P, 2013, ANAL BIOANAL CHEM, V405, P3105, DOI 10.1007/s00216-013-6781-9; Walton C, 2013, INFLAMM BOWEL DIS, V19, P2069, DOI 10.1097/MIB.0b013e31829a91f6; Zhu JJ, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/016003	47	41	42	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123980	10.1371/journal.pone.0123980	http://dx.doi.org/10.1371/journal.pone.0123980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915653	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100031
J	Birtel, J; Walser, JC; Pichon, S; Burgmann, H; Matthews, B				Birtel, Julia; Walser, Jean-Claude; Pichon, Samuel; Buergmann, Helmut; Matthews, Blake			Estimating Bacterial Diversity for Ecological Studies: Methods, Metrics, and Assumptions	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; SPECIES RICHNESS; MICROBIAL BIOGEOGRAPHY; GUT MICROBIOME; COMMUNITY; MICROORGANISMS; PATTERNS; LAKE; BIODIVERSITY; ABUNDANCE	Methods to estimate microbial diversity have developed rapidly in an effort to understand the distribution and diversity of microorganisms in natural environments. For bacterial communities, the 16S rRNA gene is the phylogenetic marker gene of choice, but most studies select only a specific region of the 16S rRNA to estimate bacterial diversity. Whereas biases derived from from DNA extraction, primer choice and PCR amplification are well documented, we here address how the choice of variable region can influence a wide range of standard ecological metrics, such as species richness, phylogenetic diversity, beta-diversity and rank-abundance distributions. We have used Illumina paired-end sequencing to estimate the bacterial diversity of 20 natural lakes across Switzerland derived from three trimmed variable 16S rRNA regions (V3, V4, V5). Species richness, phylogenetic diversity, community composition, beta-diversity, and rank-abundance distributions differed significantly between 16S rRNA regions. Overall, patterns of diversity quantified by the V3 and V5 regions were more similar to one another than those assessed by the V4 region. Similar results were obtained when analyzing the datasets with different sequence similarity thresholds used during sequences clustering and when the same analysis was used on a reference dataset of sequences from the Greengenes database. In addition we also measured species richness from the same lake samples using ARISA Fingerprinting, but did not find a strong relationship between species richness estimated by Illumina and ARISA. We conclude that the selection of 16S rRNA region significantly influences the estimation of bacterial diversity and species distributions and that caution is warranted when comparing data from different variable regions as well as when using different sequencing techniques.	[Birtel, Julia; Matthews, Blake] Eawag, Dept Aquat Ecol, Kastanienbaum, Switzerland; [Birtel, Julia] ETH, Swiss Fed Insitute Technol, Dept Environm Syst Sci D USYS, Zurich, Switzerland; [Walser, Jean-Claude] ETH, GDC, Dept Environm Syst Sci D USYS, Zurich, Switzerland; [Pichon, Samuel] Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland; [Buergmann, Helmut] Eawag, Dept Surface Waters, Kastanienbaum, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Birtel, J (corresponding author), Eawag, Dept Aquat Ecol, Kastanienbaum, Switzerland.	julia.birtel@eawag.ch	Matthews, Blake/B-5608-2009; PICHON, Samuel/C-4031-2013	Matthews, Blake/0000-0001-9089-704X; PICHON, Samuel/0000-0002-7161-9666; Walser, Jean-Claude/0000-0003-1513-0783; Burgmann, Helmut/0000-0002-5651-5906	SNF [31003A-125006]	SNF	Financial support was provided by the SNF grant 31003A-125006: "Food-web and ecosystem responses to global change". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2009, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0005210; AOKI I, 1995, ECOL MODEL, V82, P21, DOI 10.1016/0304-3800(94)00076-T; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Besemer K, 2012, ISME J, V6, P1459, DOI 10.1038/ismej.2011.205; Burgmann H, 2011, APPL ENVIRON MICROB, V77, P5897, DOI 10.1128/AEM.02986-10; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Declerck SAJ, 2013, ISME J, V7, P533, DOI 10.1038/ismej.2012.138; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Gobet A, 2013, ENVIRON MICROBIOL; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Guo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076185; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Horner-Devine MC, 2003, ECOL LETT, V6, P613; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jankowski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086991; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LECHEVALLIER MW, 1980, APPL ENVIRON MICROB, V40, P922, DOI 10.1128/AEM.40.5.922-930.1980; LEGENDRE P, 2013, MODEL II REGRESSION, P41; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Pace NR, 1985, ADVANCES IN MICROBIA, P1; Pedros-Alio C, 2011, ANNU REV MAR SCI, V4; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pillar VD, 2010, ECOL LETT, V13, P587, DOI 10.1111/j.1461-0248.2010.01456.x; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; R Core Team, 2013, R A LANGUAGE AND ENV; Rainey F. A., 1994, EXPERIENTIA, V50, P796, DOI DOI 10.1007/BF01956450; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schuster S. C., 2007, NATURE, V200; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Venail PA, 2013, ECOLOGY; Vinje Hilde, 2014, Microb Inform Exp, V4, P2, DOI 10.1186/2042-5783-4-2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	77	50	50	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125356	10.1371/journal.pone.0125356	http://dx.doi.org/10.1371/journal.pone.0125356			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915756	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100123
J	Dirk, BS; Jacob, RA; Johnson, AL; Pawlak, EN; Cavanagh, PC; Van Nynatten, L; Haeryfar, SMM; Dikeakos, JD				Dirk, Brennan S.; Jacob, Rajesh Abraham; Johnson, Aaron L.; Pawlak, Emily N.; Cavanagh, P. Craig; Van Nynatten, Logan; Haeryfar, S. M. Mansour; Dikeakos, Jimmy D.			Viral Bimolecular Fluorescence Complementation: A Novel Tool to Study Intracellular Vesicular Trafficking Pathways	PLOS ONE			English	Article							HIV-1 NEF; DOWN-REGULATION; PROTEIN INTERACTIONS; LENTIVIRAL VECTORS; MHC-I; EXPRESSION; CLEAVAGE; CELLS; GENE; SITE	The Human Immunodeficiency Virus type 1 (HIV-1) accessory protein Nef interacts with a multitude of cellular proteins, manipulating the host membrane trafficking machinery to evade immune surveillance. Nef interactions have been analyzed using various in vitro assays, co-immunoprecipitation studies, and more recently mass spectrometry. However, these methods do not evaluate Nef interactions in the context of viral infection nor do they define the sub-cellular location of these interactions. In this report, we describe a novel bimolecular fluorescence complementation (BiFC) lentiviral expression tool, termed viral BiFC, to study Nef interactions with host cellular proteins in the context of viral infection. Using the F2A cleavage site from the foot and mouth disease virus we generated a viral BiFC expression vector capable of concurrent expression of Nef and host cellular proteins; PACS-1, MHC-I and SNX18. Our studies confirmed the interaction between Nef and PACS-1, a host membrane trafficking protein involved in Nef-mediated immune evasion, and demonstrated co-localization of this complex with LAMP-1 positive endolysosomal vesicles. Furthermore, we utilized viral BiFC to localize the Nef/MHC-I interaction to an AP-1 positive endosomal compartment. Finally, viral BiFC was observed between Nef and the membrane trafficking regulator SNX18. This novel demonstration of an association between Nef and SNX18 was localized to AP-1 positive vesicles. In summary, viral BiFC is a unique tool designed to analyze the interaction between Nef and host cellular proteins by mapping the sub-cellular locations of their interactions during viral infection.	[Dirk, Brennan S.; Jacob, Rajesh Abraham; Johnson, Aaron L.; Pawlak, Emily N.; Cavanagh, P. Craig; Van Nynatten, Logan; Haeryfar, S. M. Mansour; Dikeakos, Jimmy D.] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	Dikeakos, JD (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada.	Jimmy.Dikeakos@uwo.ca			Canadian Institutes of Health Research [CIHR-MOP 286719]; Natural Sciences and Engineering Council (NSERC) [435677]; Canadian Foundation for Innovation; CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants to JDD from the Canadian Institutes of Health Research (CIHR-MOP 286719), the Natural Sciences and Engineering Council (NSERC Discovery grant 435677) and infrastructure grants to JDD from the Canadian Foundation for Innovation. ENP is supported by a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Cai CY, 2011, J IMMUNOL, V186, P5807, DOI 10.4049/jimmunol.1003506; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cordelieres FP, 2014, METHOD CELL BIOL, V123, P395, DOI [10.1016/B978-0-12.420138-5.00021-S, 10.1016/B978-0-12-420138-5.00021-5]; Dikeakos JD, 2012, MOL BIOL CELL, V23, P2184, DOI 10.1091/mbc.E11-11-0928; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kafri Tal, 2004, Methods Mol Biol, V246, P367; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Martinez-Salas E, 1999, CURR OPIN BIOTECH, V10, P458, DOI 10.1016/S0958-1669(99)00010-5; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Pawlak EN, 2015, BBA-GEN SUBJECTS, V1850, P733, DOI 10.1016/j.bbagen.2015.01.003; Pfeffer SR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005272; Poe JA, 2014, J BIOMOL SCREEN, V19, P556, DOI 10.1177/1087057113513640; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Roberts LO, 1998, RNA, V4, P520, DOI 10.1017/S1355838298971989; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Singer O, 2008, CURR GENE THER, V8, P483, DOI 10.2174/156652308786848067; Swanson CM, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.005; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016	58	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125619	10.1371/journal.pone.0125619	http://dx.doi.org/10.1371/journal.pone.0125619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915798	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100137
J	Hao, WM; Fan, LJ; Chen, QQ; Chen, XX; Zhang, SC; Lan, K; Lu, J; Zhang, CY				Hao, Weiming; Fan, Lujuan; Chen, Qianqian; Chen, Xiaoxiang; Zhang, Sichao; Lan, Ke; Lu, Jian; Zhang, Chiyu			Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; ALLELE-SPECIFIC AMPLIFICATION; RESOLUTION MELTING ANALYSIS; ULTRA-RARE MUTATIONS; DNA-SEQUENCES; PYROPHOSPHOROLYSIS; DISCRIMINATION; POLYMERASES; SENSITIVITY; GENE	The development of simple, accurate, rapid and cost-effective technologies for mutation detection is crucial to the early diagnosis and prevention of numerous genetic diseases, pharmacogenetics, and drug resistance. Proofreading PCR (PR-PCR) was developed for mutation detection in 1998 but is rarely applied due to its low efficiency in allele discrimination. Here we developed a modified PR-PCR method using a ddNTP-blocked primer and a mixture of DNA polymerases with and without the 3'-5' proofreading function. The ddNTP-blocked primer exhibited the best blocking efficiency to avoid nonspecific primer extension while the mixture of a tiny amount of high-fidelity DNA polymerase with a routine amount of Taq DNA polymerase provided the best discrimination and amplification effects. The modified PR-PCR method is quite capable of detecting various mutation types, including point mutations and insertions/deletions (indels), and allows discrimination amplification when the mismatch is located within the last eight nucleotides from the 3'-end of the ddNTP-blocked primer. The modified PR-PCR has a sensitivity of 1-5 x 10(2) copies and a selectivity of 5 x 10(-5) mutant among 10(7) copies of wild-type DNA. It showed a 100% accuracy rate in the detection of P72R germ-line mutation in the TP53 gene among 60 clinical blood samples, and a high potential to detect rifampin-resistant mutations at low frequency in Mycobacterium tuberculosis using an adaptor and a fusion-blocked primer. These results suggest that the modified PR-PCR technique is effective in detection of various mutations or polymorphisms as a simple, sensitive and promising approach.	[Hao, Weiming; Fan, Lujuan; Lu, Jian] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Hao, Weiming; Fan, Lujuan; Chen, Qianqian; Zhang, Chiyu] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Chen, Xiaoxiang] Nanjing Med Univ, Dept Gynecol Oncol, Jiangsu Canc Hosp, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Zhang, Sichao] Jiangsu Univ, Huzhou Ctr Dis Control & Prevent, Huzhou, Zhejiang, Peoples R China; [Lu, Jian] Jiangsu Univ, Sch Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Nanjing Medical University; Jiangsu University; Jiangsu University	Lu, J (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	lujian@ujs.edu.cn; zhangcy1999@ips.ac.cn						Bi WL, 1998, NUCLEIC ACIDS RES, V26, P3073, DOI 10.1093/nar/26.12.3073; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cao WG, 2004, TRENDS BIOTECHNOL, V22, P38, DOI 10.1016/j.tibtech.2003.11.001; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Knoll A, 1996, HUM GENET, V98, P539, DOI 10.1007/s004390050256; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Lin-Ling C, 2005, J BIOCHEM MOL BIOL, V38, P24; Liu Q, 2004, HUM MUTAT, V23, P426, DOI 10.1002/humu.20036; Liu Q, 2000, BIOTECHNIQUES, V29, P1072, DOI 10.2144/00295rr03; Markoff A, 1997, CLIN CHEM, V43, P30; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; POURZAND C, 1993, MUTAT RES, V288, P113, DOI 10.1016/0027-5107(93)90213-Y; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shi JX, 2007, HUM MUTAT, V28, P131, DOI 10.1002/humu.20423; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; WU DY, 1989, GENOMICS, V4, P560, DOI 10.1016/0888-7543(89)90280-2; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; Zhang J, 2005, TRENDS BIOTECHNOL, V23, P92, DOI 10.1016/j.tibtech.2004.12.009; Zhang J, 2004, J BIOCHEM MOL BIOL, V37, P269; Zhang L, 2004, MOL BIOTECHNOL, V27, P75, DOI 10.1385/MB:27:1:75	30	9	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123468	10.1371/journal.pone.0123468	http://dx.doi.org/10.1371/journal.pone.0123468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915410	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100022
J	Chen, HW; Liu, GD; Ou, S; Fei, J; Zhao, GS; Wu, LJ; Pan, J				Chen, Hong-wei; Liu, Guo-dong; Ou, Shan; Fei, Jun; Zhao, Gang-sheng; Wu, Li-jun; Pan, Jun			Operative Treatment of Terrible Triad of the Elbow via Posterolateral and Anteromedial Approaches	PLOS ONE			English	Article							MEDIAL COLLATERAL LIGAMENT; CORONOID PROCESS; RADIAL HEAD; FRACTURE-DISLOCATIONS; FIXATION; INJURY; REPAIR; INSTABILITY	The aim of the study was to explore the clinical outcome of posterolateral and anteromedial approaches in treatment of terrible triad of the elbow. The study involved 12 patients with closed terrible triad of the elbow treated by posterolateral and anteromedial approaches between January 2010 and June 2012. The mechanism of injury included fall from height in 9 patients and traffic accident in 3. According to O'Driscoll classification for fractures of the ulnar coronoid, there were 11 patients with type. and 1 with type. fractures. According to Mason classification for fractures of the radial head, there were 3 patients with type., 7 with type. and 2 with type. fractures. All patients were followed up for 12-27 months (average 15.5 months), which showed no pain or severe pain in all patients except for 2 patients with mild pain. At the last follow-up, the mean flexion was for 125 degrees(range, 90 degrees-140 degrees), the mean extension loss for 20 degrees(range, 0 degrees-70 degrees), the mean pronation for 66 degrees(range, 20 degrees-85 degrees) and the mean supination for 60 degrees(range, 30 degrees-85 degrees). The bony union time was 8-14 weeks (average 11 weeks) and the elbows were stable in flexion-extension and varus-valgus in all patients. The elbows maintained a concentric reduction of both the ulnotrochlear and the radiocapitellar articulation. Mild heterotopic ossification of the elbow occurred in 3 patients at 6 months after operation and mild degenerative change in 1 patient at 18 months after operation. The Broberg and Morrey elbow performance score was 82 points (range, 58-98 points). The results were excellent in 6 patients, good in 4, fair in 1 and poor in 1, with excellence rate of 83.3%. The results showed that the combined posterolateral and anteromedial approaches can facilitate the reduction and fixation of terrible triad of the elbow. Repair of radial head, coronoid, medial and lateral collateral ligaments can sufficiently restore the elbow stability, allow early postoperative motion and enhance the functional recovery.	[Chen, Hong-wei; Zhao, Gang-sheng] Cent Hosp Yiwu City, Dept Orthoped, Yiwu 322000, Peoples R China; [Liu, Guo-dong] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing 400042, Peoples R China; [Ou, Shan] Chengdu Mil Command, Dept Anesthesiol, Gen Hosp, Chengdu 610083, Peoples R China; [Fei, Jun] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Traumat Ctr, Chongqing 400042, Peoples R China; [Wu, Li-jun] Wenzhou Med Coll, Digital Med Res Inst, Wenzhou 325027, Peoples R China; [Pan, Jun] Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthoped, Wenzhou 325027, Peoples R China	Army Medical University; Army Medical University; Wenzhou Medical University; Wenzhou Medical University	Liu, GD (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing 400042, Peoples R China.	frankliugd@163.com						Beingessner DM, 2007, J SHOULDER ELB SURG, V16, P213, DOI 10.1016/j.jse.2006.06.015; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Doornberg JN, 2007, J SHOULDER ELB SURG, V16, P667, DOI 10.1016/j.jse.2007.03.013; Egol KA, 2007, BULL HOSP JT DIS, V65, P263; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Garrigues GE, 2011, J BONE JOINT SURG AM, V93A, P1873, DOI 10.2106/JBJS.I.01673; Kalicke T, 2007, ARCH ORTHOP TRAUM SU, V127, P925, DOI 10.1007/s00402-007-0424-6; Kraig YB, 2006, J HAND THER, V19, P114; Mathew PK, 2009, J AM ACAD ORTHOP SUR, V17, P137, DOI 10.5435/00124635-200903000-00003; McKee MD, 2003, J SHOULDER ELB SURG, V12, P391, DOI 10.1016/S1058-2746(03)00027-2; McKee MD, 2001, SKELETAL TRAUMA, P1455; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Pai V, 2009, J Orthop Surg (Hong Kong), V17, P31; Papandrea RF, 2007, J SHOULDER ELB SURG, V16, P68, DOI 10.1016/j.jse.2006.03.011; Reichel Lee M, 2012, Tech Hand Up Extrem Surg, V16, P98, DOI 10.1097/BTH.0b013e31824e6a74; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; Rodriguez-Martin J, 2011, INT ORTHOP, V35, P851, DOI 10.1007/s00264-010-1024-6; Seth D, 2013, ORTHOP CLIN N AM, V44, P47, DOI [10.1016/j.ocl.2012.08.006, DOI 10.1016/J.OCL.2012.08.006]; Steinmann SP, 2008, J AM ACAD ORTHOP SUR, V16, P519; Thomas K, 2007, ARCH ORTHOP TRAUMA S, V127, P925; Toros T, 2012, ACTA ORTHOP TRAUMATO, V46, P96, DOI 10.3944/AOTT.2012.2632; Zeiders GJ, 2008, J BONE JOINT SURG AM, V90A, P75, DOI 10.2106/JBJS.H.00893	23	9	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124821	10.1371/journal.pone.0124821	http://dx.doi.org/10.1371/journal.pone.0124821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910196	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800108
J	Chen, W; He, Z; Ji, XL; Tang, ST; Hu, HY				Chen, Wei; He, Zhang; Ji, Xiao-Li; Tang, Si-Ting; Hu, Hao-Yuan			Hyperparasitism in a Generalist Ectoparasitic Pupal Parasitoid, Pachycrepoideus vindemmiae (Hymenoptera: Pteromalidae), on Its Own Conspecifics: When the Lack of Resource Lead to Cannibalism	PLOS ONE			English	Article							SEX-RATIO; HOST SELECTION; BODY-SIZE; VINDEMIAE HYMENOPTERA; NATURAL-POPULATIONS; BIOLOGICAL-CONTROL; FRUIT-FLY; DROSOPHILA; EVOLUTION; QUALITY	Hyperparasitism is a normal behavior of parasitoids, which often happens among species. Conspecific hyperparasitism, such as some kinds of heteronomous hyperparasitic behaviors, has been only reported in some species belonging to Aphelinidae. In this article, the conspecific hyperparasitism of Pachycrepoideus vindemmiae (Pteromalidae) is reported, with Drosophila puparia as hosts. Hosts were exposed to Pachycrepoideus vindemmiae females twice to parasitism with nine, twelve, and fifteen day intervals between the two exposures. None of the infested hosts emerged more than one offspring, and emergence of parasitoid offspring occurred in two obvious events, synchronously with the exposure time intervals, which suggested that offspring emerging during the first and second events would come from the primary and secondary parasitoids, respectively, and the inference with the developmental duration of offspring also indicated this. With two Pachycrepoideus vindemmiae strains that could be identified by a simple sequence repeat marker, the above speculation of the origin of those offspring emerging during the two events was confirmed. Dissection of hosts exposed twice revealed a cannibalism behavior of larvae from the secondary foundresses on the primary conspecific pupae. Our results suggested a conspecific hyperparasitism behavior of the secondary parasitoids on the primary conspecifics. Measures showed a reduced body size for the adults from the conspecific hyperparasitism. Foundresses from the conspecific hyperparasitism had less fitness variables than those from primary parasitism, with shorter longevity, less life time fecundity, lower values of infestation degree, and lower success rate of parasitism. However, when the parasitoids from the conspecific hyperparasitism met healthy Drosophila puparia, their offspring would recover to normal size. Frequency of the conspecific hyperparasitism behavior enhanced with the decreasing of proportion of healthy hosts in the oviposition patch. The conspecific hyperparasitism of Pachycrepoideus vindemmiae on the primary conspecifics would be helpful to last the population when healthy hosts are absent in the oviposition patch.	[Chen, Wei; He, Zhang; Ji, Xiao-Li; Tang, Si-Ting; Hu, Hao-Yuan] Anhui Normal Univ, Coll Life Sci, Key Lab Biot Environm & Ecol Safety Anhui Prov, Wuhu, Anhui, Peoples R China	Anhui Normal University	Hu, HY (corresponding author), Anhui Normal Univ, Coll Life Sci, Key Lab Biot Environm & Ecol Safety Anhui Prov, Wuhu, Anhui, Peoples R China.	haoyuanhu@126.com			National Natural Science Foundation of China [31172145]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113424120005]; Natural Science Foundation of Anhui Province [1408085MKL24]; Provincial Key Laboratory of Conservation and Utilization for Important Biological Resource in Anhui Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Provincial Key Laboratory of Conservation and Utilization for Important Biological Resource in Anhui Province	This work was supported by the National Natural Science Foundation of China (31172145), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20113424120005), the Natural Science Foundation of Anhui Province (1408085MKL24), and the Provincial Key Laboratory of Conservation and Utilization for Important Biological Resource in Anhui Province.	Brown PH, 2011, ESA 59 ANN M REN NV; Burton-Chellew MN, 2008, AM NAT, V172, P393, DOI 10.1086/589895; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; CHARNOV E L, 1982; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Crawley M.J., 2007, R BOOK; Cusumano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064768; DAVID JEAN, 1965, BULL BIOL FRANCE BELG, V99, P369; Duron O, 2010, ECOL LETT, V13, P1139, DOI 10.1111/j.1461-0248.2010.01502.x; Ellers J, 2003, OIKOS, V102, P164, DOI 10.1034/j.1600-0706.2003.12285.x; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P281, DOI 10.1046/j.1365-2311.1998.00137.x; Gibert P, 2010, EVOL ECOL RES, V12, P873; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goubault M, 2005, BEHAV ECOL, V16, P693, DOI 10.1093/beheco/ari043; Goubault M, 2003, ENTOMOL EXP APPL, V109, P123, DOI 10.1046/j.1570-7458.2003.00101.x; Goubault M, 2007, ETHOLOGY, V113, P334, DOI 10.1111/j.1439-0310.2006.01325.x; Grandgirard J, 2002, ENTOMOL EXP APPL, V103, P239, DOI 10.1023/A:1021193329749; Grillenberger BK, 2008, MOL ECOL, V17, P2854, DOI 10.1111/j.1365-294X.2008.03800.x; He Zhang, 2013, Yingyong Shengtai Xuebao, V24, P795; HOCHBERG ME, 1992, SCIENCE, V255, P973, DOI 10.1126/science.255.5047.973; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Kageyama D, 2006, APPL ENVIRON MICROB, V72, P6667, DOI 10.1128/AEM.00803-06; MESSING RH, 1993, BIOL CONTROL, V3, P140, DOI 10.1006/bcon.1993.1021; Mills NJ, 1996, J APPL ECOL, V33, P1379, DOI 10.2307/2404778; Morris RJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P386, DOI 10.1007/s00265-001-0439-x; Moynihan AM, 2011, J EVOLUTION BIOL, V24, P2002, DOI 10.1111/j.1420-9101.2011.02343.x; NADEL H, 1985, ANN ENTOMOL SOC AM, V78, P410, DOI 10.1093/aesa/78.3.410; Noyes J.S., 2002, INTERACTIVE CATALOGU; Perez-Lachaud G, 2004, BIOL CONTROL, V30, P149, DOI 10.1016/j.biocontrol.2004.03.003; Petersen JJ, 1992, BIOL CONTROL, V2, P44, DOI 10.1016/1049-9644(92)90074-N; PHILLIPS DS, 1993, ENTOMOL EXP APPL, V69, P75, DOI 10.1007/BF02380676; Quicke D. L. J., 1997, PARASITIC WASPS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rojas-Rousse D, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10101; ROTH JP, 1991, J ECON ENTOMOL, V84, P94, DOI 10.1093/jee/84.1.94; Sagarra LA, 2001, B ENTOMOL RES, V91, P363, DOI 10.1079/BER2001121; SULLIVAN DJ, 1987, ANNU REV ENTOMOL, V32, P49, DOI 10.1146/annurev.en.32.010187.000405; Sullivan DJ, 1999, ANNU REV ENTOMOL, V44, P291, DOI 10.1146/annurev.ento.44.1.291; Tormos J, 2009, MICROSC MICROANAL, V15, P422, DOI 10.1017/S1431927609090801; VANALPHEN JJM, 1983, NETH J ZOOL, V33, P497, DOI 10.1163/002829683X00228; Wang XG, 2004, BEHAV ECOL SOCIOBIOL, V56, P513, DOI 10.1007/s00265-004-0829-y; Wang XG, 2004, BIOL CONTROL, V31, P227, DOI 10.1016/j.biocontrol.2004.04.019; Williams T, 1996, BIOL J LINN SOC, V57, P35, DOI 10.1111/j.1095-8312.1996.tb01694.x; WILLIAMS T, 1991, ECOL ENTOMOL, V16, P377, DOI 10.1111/j.1365-2311.1991.tb00230.x; Wyckhuys KAG, 2011, BIOCONTROL SCI TECHN, V21, P953, DOI 10.1080/09583157.2011.591923; Zang LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020324; Zhang YB, 2014, INSECT SCI, DOI 101111/1744-791712152	47	11	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124305	10.1371/journal.pone.0124305	http://dx.doi.org/10.1371/journal.pone.0124305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909476	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800075
J	Sanroman-Junquera, M; Mora-Jimenez, I; Almendral, J; Garcia-Alberola, A; Rojo-Alvarez, JL				Sanroman-Junquera, Margarita; Mora-Jimenez, Inmaculada; Almendral, Jesus; Garcia-Alberola, Arcadio; Luis Rojo-Alvarez, Jose			Automatic Supporting System for Regionalization of Ventricular Tachycardia Exit Site in Implantable Defibrillators	PLOS ONE			English	Article							ORIGIN; ELECTROGRAMS; REGRESSION	Electrograms stored in Implantable Cardioverter Defibrillators (ICD-EGM) have been proven to convey useful information for roughly determining the anatomical location of the Left Ventricular Tachycardia exit site (LVTES). Our aim here was to evaluate the possibilities from a machine learning system intended to provide an estimation of the LVTES anatomical region with the use of ICD-EGM in the situation where 12-lead electrocardiogram of ventricular tachycardia are not available. Several machine learning techniques were specifically designed and benchmarked, both from classification (such as Neural Networks (NN), and Support Vector Machines (SVM)) and regression (Kernel Ridge Regression) problem statements. Classifiers were evaluated by using accuracy rates for LVTES identification in a controlled number of anatomical regions, and the regression approach quality was studied in terms of the spatial resolution. We analyzed the ICD-EGM of 23 patients (18 +/- 10 EGM per patient) during left ventricular pacing and simultaneous recording of the spatial coordinates of the pacing electrode with a navigation system. Several feature sets extracted from ICD-EGM (consisting of times and voltages) were shown to convey more discriminative information than the raw waveform. Among classifiers, the SVM performed slightly better than NN. In accordance with previous clinical works, the average spatial resolution for the LVTES was about 3 cm, as in our system, which allows it to support the faster determination of the LVTES in ablation procedures. The proposed approach also provides with a framework suitable for driving the design of improved performance future systems.	[Sanroman-Junquera, Margarita; Mora-Jimenez, Inmaculada; Luis Rojo-Alvarez, Jose] Univ Rey Juan Carlos, Dept Signal Theory & Commun Telemat & Comp, Fuenlabrada 28943, Spain; [Almendral, Jesus] Hosp Madrid Monteprincipe, Arrhythmia Unit, Boadilla Del Monte 28660, Spain; [Garcia-Alberola, Arcadio] Hosp Univ Virgen Arrixaca, Arrhythmia Unit, Murcia 30120, Spain; [Luis Rojo-Alvarez, Jose] Univ Fuerzas Armadas ESPE, Sangolqui, Ecuador	Universidad Rey Juan Carlos; Hospital Clinico Universitario Virgen de la Arrixaca; Escuela Politecnica Superior del Ejercito	Sanroman-Junquera, M (corresponding author), Univ Rey Juan Carlos, Dept Signal Theory & Commun Telemat & Comp, Fuenlabrada 28943, Spain.	margarita.sanroman@urjc.es	Rojo-Álvarez, José-Luis/F-6520-2016; Garcia-Alberola, Arcadi/F-3201-2016; MORA JIMENEZ, INMACULADA/F-9254-2016	Rojo-Álvarez, José-Luis/0000-0003-0426-8912; MORA JIMENEZ, INMACULADA/0000-0003-0735-367X	Spanish Government [TEC2010-19263/TCM, TEC2013-48439-C4-1-R, TSI-020100-2010-0469]; Rey Juan Carlos University [PRIN13\_IYA12]; public Prometeo Project of the Secretariat for Higher Education, Science, Technology and Innovation of the Republic of Ecuador	Spanish Government(Spanish GovernmentEuropean Commission); Rey Juan Carlos University; public Prometeo Project of the Secretariat for Higher Education, Science, Technology and Innovation of the Republic of Ecuador	This work has been partly supported by TEC2010-19263/TCM, TEC2013-48439-C4-1-R, and TSI-020100-2010-0469 public research projects from the Spanish Government; and by PRIN13\_IYA12 project from Rey Juan Carlos University. JLRA has been temporally supported by public Prometeo Project of the Secretariat for Higher Education, Science, Technology and Innovation of the Republic of Ecuador.	Almendral J, 2012, J CARDIOVASC ELECTR, V23, P506, DOI 10.1111/j.1540-8167.2011.02233.x; An S., 2007, P IEEE C COMP VIS PA, V2007, P1, DOI DOI 10.1109/CVPR.2007.383105; BakIr G., 2007, PREDICTING STRUCTURE; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Cristianini N, 2000, INTRO SUPPORT VECTOR; Douak F, 2013, APPL ENERG, V103, P328, DOI 10.1016/j.apenergy.2012.09.055; Duda R.O., 2006, PATTERN CLASSIFICATI; Haykin S., 2009, NEURAL NETWORKS LEAR; Meng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103181; MILLER JM, 1988, CIRCULATION, V77, P759, DOI 10.1161/01.CIR.77.4.759; Sanroman-Junquera M, 2010, COMPUT CARDIOL CONF, V37, P749; Sanroman-Junquera M, 2012, SIGNAL PROCESS, V92, P43, DOI 10.1016/j.sigpro.2011.05.023; Sanroman-Junquera M, 2009, COMPUT CARDIOL, V36, P801; Segal OR, 2007, J CARDIOVASC ELECTR, V18, P161, DOI 10.1111/j.1540-8167.2007.00721.x; Shenasa M., 2012, CARDIAC MAPPING; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Streitner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063911; Tschabrunn CM, 2013, J INTERV CARD ELECTR, V36, P243, DOI 10.1007/s10840-012-9731-0; Vapnik V., 2013, NATURE STAT LAERNING; Wilcoxon F, 1964, WILCOXON SIGNED RANK; Yoshida K, 2010, J AM COLL CARDIOL, V56, P969, DOI 10.1016/j.jacc.2010.04.043	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124514	10.1371/journal.pone.0124514	http://dx.doi.org/10.1371/journal.pone.0124514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910170	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800087
J	Ward, LM; Aitchison, RT; Tawse, M; Simmers, AJ; Shahani, U				Ward, Laura McKernan; Aitchison, Ross Thomas; Tawse, Melisa; Simmers, Anita Jane; Shahani, Uma			Reduced Haemodynamic Response in the Ageing Visual Cortex Measured by Absolute fNIRS	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; AGE-RELATED-CHANGES; EVOKED POTENTIALS; BRAIN ACTIVITY; FREQUENCY; STIMULATION; OXYGENATION; HEMOGLOBIN; DEPENDENCY; ACTIVATION	The effect of healthy ageing on visual cortical activation is still to be fully explored. This study aimed to elucidate whether the haemodynamic response (HDR) of the visual cortex altered as a result of ageing. Visually normal (healthy) participants were presented with a simple visual stimulus (reversing checkerboard). Full optometric screening was implemented to identify two age groups: younger adults (n = 12, mean age 21) and older adults (n = 13, mean age 71). Frequency-domain Multi-distance (FD-MD) functional Near-Infrared Spectroscopy (fNIRS) was used to measure absolute changes in oxygenated [HbO] and deoxygenated [HbR] haemoglobin concentrations in the occipital cortices. Utilising a slow event-related design, subjects viewed a full field reversing checkerboard with contrast and check size manipulations (15 and 30 minutes of arc, 50% and 100% contrast). Both groups showed the characteristic response of increased [HbO] and decreased [HbR] during stimulus presentation. However, older adults produced a more varied HDR and often had com parable levels of [HbO] and [HbR] during both stimulus presentation and baseline resting state. Younger adults had significantly greater concentrations of both [HbO] and [HbR] in every investigation regardless of the type of stimulus displayed (p<0.05). The average variance associated with this age-related effect for [HbO] was 88% and [HbR] 91%. Passive viewing of a visual stimulus, without any cognitive input, showed a marked age-related decline in the cortical HDR. Moreover, regardless of stimulus parameters such as check size, the HDR was characterised by age. In concurrence with present neuroimaging literature, we conclude that the visual HDR decreases as healthy ageing proceeds.	[Ward, Laura McKernan; Aitchison, Ross Thomas; Tawse, Melisa; Simmers, Anita Jane; Shahani, Uma] Glasgow Caledonian Univ, Dept Vis Sci, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Ward, LM (corresponding author), Glasgow Caledonian Univ, Dept Vis Sci, Glasgow G4 0BA, Lanark, Scotland.	Laura.McKernanWard@gcu.ac.uk	Shahani, Uma/V-9096-2019	Shahani, Uma/0000-0003-2597-9334; Aitchison, Ross Thomas/0000-0003-0192-9965; Ward, Laura/0000-0003-0880-0662	Glasgow Caledonian University	Glasgow Caledonian University	LMW is funded by a Glasgow Caledonian University studentship for a 3 year PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Bakker SLM, 2004, NEUROEPIDEMIOLOGY, V23, P178, DOI 10.1159/000078503; Bertsch K, 2009, BRAIN RES, V1267, P77, DOI 10.1016/j.brainres.2009.02.053; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brodtmann A, 2003, NEUROIMAGE, V20, P520, DOI 10.1016/S1053-8119(03)00237-4; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Chen XP, 2012, NEUROSCI BULL, V28, P737, DOI 10.1007/s12264-012-1292-9; Cliff M, 2013, CORTEX, V49, P1304, DOI 10.1016/j.cortex.2012.04.003; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Gatto R, 2006, J NEUROSCI METH, V157, P274, DOI 10.1016/j.jneumeth.2006.04.013; Gatto R, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804705; Hallacoglu B, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081406; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103, DOI 10.1038/jcbfm.1995.137; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; KATO T, 1993, J CEREBR BLOOD F MET, V13, P516, DOI 10.1038/jcbfm.1993.66; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; McIntosh MA, 2010, INVEST OPHTH VIS SCI, V51, P4856, DOI 10.1167/iovs.09-4940; McKendrick AM, 2013, INVEST OPHTH VIS SCI, V54, P1730, DOI 10.1167/iovs.12-10974; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Mirzajani A, 2007, PHYSIOL MEAS, V28, P547, DOI 10.1088/0967-3334/28/5/008; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Oudegeest-Sander MH, 2014, EXP PHYSIOL, V99, P586, DOI 10.1113/expphysiol.2013.076455; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Peca S, 2013, NEUROLOGY, V81, P1659, DOI 10.1212/01.wnl.0000435291.49598.54; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Rosengarten B, 2003, J NEUROIMAGING, V13, P43, DOI 10.1177/1051228402239716; Ross MH, 1997, NEUROLOGY, V48, P173, DOI 10.1212/WNL.48.1.173; Safonova LP, 2004, ARCH GERONTOL GERIAT, V39, P207, DOI 10.1016/j.archger.2004.03.007; Schroeter ML, 2004, J CEREBR BLOOD F MET, V24, P1183, DOI 10.1097/01.WCB.0000135231.90164.40; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; SEKULER R, 1982, AM J OPTOM PHYS OPT, V59, P961; Sergio Fantini, 1995, OPT ENG, V34, P32; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sun BL, 2014, NEUROIMAGE, V87, P190, DOI 10.1016/j.neuroimage.2013.11.003; Tobimatsu S., 1999, OPTOMETRY VISION SCI, V72, P192; Toronov VY, 2007, NEUROIMAGE, V34, P1136, DOI 10.1016/j.neuroimage.2006.08.048; Vermeij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046210; Wijeakumar S, 2012, INVEST OPHTH VIS SCI, V53, P2266, DOI 10.1167/iovs.11-8680; Wolf M, 2003, PSYCHOPHYSIOLOGY, V40, P521, DOI 10.1111/1469-8986.00054; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Yadav NK, 2013, BRAIN INJURY, V27, P1631, DOI 10.3109/02699052.2013.844856; Zaletel M, 2005, FUNCT NEUROL, V20, P115	49	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125012	10.1371/journal.pone.0125012	http://dx.doi.org/10.1371/journal.pone.0125012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909849	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353376800122
J	Gonzalez, Y; Herrera, MT; Juarez, E; Salazar-Lezama, MA; Bobadilla, K; Torres, M				Gonzalez, Yolanda; Teresa Herrera, Mara; Juarez, Esmeralda; Angel Salazar-Lezama, Miguel; Bobadilla, Karen; Torres, Martha			CD161 Expression Defines a Th1/Th17 Polyfunctional Subset of Resident Memory T Lymphocytes in Bronchoalveolar Cells	PLOS ONE			English	Article							HUMAN TH17 CELLS; NKRP1A MOLECULE; IFN-GAMMA; MIGRATION; LUNG; NK; TUBERCULOSIS; MAINTENANCE; SARCOIDOSIS; ACCUMULATE	Alveolar resident memory T cells (TRM) comprise a currently uncharacterized mixture of cell subpopulations. The CD3(+)CD161(+) T cell subpopulation resides in the liver, intestine and skin, but it has the capacity for tissue migration; however, the presence of resident CD3(+)CD161(+) T cells in the bronchoalveolar space under normal conditions has not been reported. Bronchoalveolar cells (BACs) from healthy volunteers were evaluated and found that 8.6% (range 2.5%-21%) of these cells were CD3(+) T lymphocytes. Within the CD3(+) population, 4.6% of the cells (2.1-11.3) expressed CD161 on the cell surface, and 74.2% of the CD161(+)CD3(+) T cells expressed CD45RO. The number of CD3(+)CD161(+) T cells was significantly lower in the bronchoalveolar space than in the blood (4.6% of BACs vs 8.4% of peripheral blood mononuclear cells (PBMCs); P<0.05). We also found that 2.17% of CD4(+) T lymphocytes and 1.52% of CD8(+) T lymphocytes expressed CD161. Twenty-two percent of the alveolar CD3(+)CD161(+) T lymphocytes produced cytokines upon stimulation by PMA plus ionomycin, and significantly more interferon gamma (IFN-gamma) was produced compared with other cytokines (P = 0.05). Most alveolar CD3(+)CD161(+) T cells produced interleukin-17 (IL-17) and IFN-gamma simultaneously, and the percentage of these cells was significantly higher than the percentage of CD3(+)CD161(-) T cells. Moreover, the percentage of alveolar CD3(+)CD161(+) T lymphocytes that produced IFN-gamma/IL-17 was significantly higher than those in the peripheral blood (p<0.05). In conclusion, Th1/Th17-CD3(+)CD161(+) T-RM could contribute to compartment-specific immune responses in the lung.	[Gonzalez, Yolanda; Teresa Herrera, Mara; Juarez, Esmeralda; Bobadilla, Karen; Torres, Martha] Natl Inst Resp Dis INER, Dept Microbiol Res, Mexico City, DF, Mexico; [Angel Salazar-Lezama, Miguel] Natl Inst Resp Dis INER, TB Clin, Mexico City, DF, Mexico		Torres, M (corresponding author), Natl Inst Resp Dis INER, Dept Microbiol Res, Mexico City, DF, Mexico.	marthatorres98@yahoo.com	Juárez, Esmeralda/GQP-7703-2022; González, Yolanda/AAC-3329-2021	González, Yolanda/0000-0002-7066-6188; Juarez, Esmeralda/0000-0001-9036-004X; Torres, Martha/0000-0003-3217-9407				Agostini C, 2005, AM J RESP CRIT CARE, V172, P1290, DOI 10.1164/rccm.200501-142OC; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; Day CE, 2010, IMMUNOLOGY, V130, P564, DOI 10.1111/j.1365-2567.2010.03257.x; Gonzalez-Hernandez Y, 2007, SCAND J IMMUNOL, V65, P368, DOI 10.1111/j.1365-3083.2006.01885.x; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; HIRSCH CS, 1994, J IMMUNOL, V152, P743; Hogan RJ, 2002, J IMMUNOL, V169, P4976, DOI 10.4049/jimmunol.169.9.4976; Iiai T, 2002, CLIN EXP IMMUNOL, V129, P92, DOI 10.1046/j.1365-2249.2002.01886.x; Iliopoulou EG, 2006, CLIN CANCER RES, V12, P6901, DOI 10.1158/1078-0432.CCR-06-0977; Ishihara S, 1999, EUR J IMMUNOL, V29, P2406, DOI 10.1002/(SICI)1521-4141(199908)29:08<2406::AID-IMMU2406>3.3.CO;2-6; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kolopp-Sarda MN, 2000, LAB INVEST, V80, P1065, DOI 10.1038/labinvest.3780111; Korosec P, 2007, CHEST, V132, P1291, DOI 10.1378/chest.07-0128; LANIER LL, 1994, J IMMUNOL, V153, P2417; Loza MJ, 2002, EUR J IMMUNOL, V32, P3453, DOI 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Northfield JW, 2008, HEPATOLOGY, V47, P396, DOI 10.1002/hep.22040; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Poggi A, 1997, IMMUNOL LETT, V57, P121, DOI 10.1016/S0165-2478(97)00050-3; Poggi A, 1997, EUR J IMMUNOL, V27, P2965, DOI 10.1002/eji.1830271132; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057746; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Herrera MT, 2009, TUBERCULOSIS, V89, P38, DOI 10.1016/j.tube.2008.08.002; Woodland David L, 2005, Proc Am Thorac Soc, V2, P126; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Zhao Z, 2011, ATHEROSCLEROSIS, V217, P518, DOI 10.1016/j.atherosclerosis.2011.03.043	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123591	10.1371/journal.pone.0123591	http://dx.doi.org/10.1371/journal.pone.0123591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906076	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000036
J	Semlitsch, RD; Peterman, WE; Anderson, TL; Drake, DL; Ousterhout, BH				Semlitsch, Raymond D.; Peterman, William E.; Anderson, Thomas L.; Drake, Dana L.; Ousterhout, Brittany H.			Intermediate Pond Sizes Contain the Highest Density, Richness, and Diversity of Pond-Breeding Amphibians	PLoS One			English	Article							COMPLEX LIFE-CYCLES; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; HYLA-CHRYSOSCELIS; TEMPORARY PONDS; DISTURBANCE; PREDATORS; WETLANDS; FORESTS; SYSTEMS	We present data on amphibian density, species richness, and diversity from a 7140-ha area consisting of 200 ponds in the Midwestern U.S. that represents most of the possible lentic aquatic breeding habitats common in this region. Our study includes all possible breeding sites with natural and anthropogenic disturbance processes that can be missing from studies where sampling intensity is low, sample area is small, or partial disturbance gradients are sampled. We tested whether pond area was a significant predictor of density, species richness, and diversity of amphibians and if values peaked at intermediate pond areas. We found that in all cases a quadratic model fit our data significantly better than a linear model. Because small ponds have a high probability of pond drying and large ponds have a high probability of fish colonization and accumulation of invertebrate predators, drying and predation may be two mechanisms driving the peak of density and diversity towards intermediate values of pond size. We also found that not all intermediate sized ponds produced many larvae; in fact, some had low amphibian density, richness, and diversity. Further analyses of the subset of ponds represented in the peak of the area distribution showed that fish, hydro-period, invertebrate density, and canopy are additional factors that drive density, richness and diversity of ponds up or down, when extremely small or large ponds are eliminated. Our results indicate that fishless ponds at intermediate sizes are more diverse, produce more larvae, and have greater potential to recruit juveniles into adult populations of most species sampled. Further, hylid and chorus frogs are found predictably more often in ephemeral ponds whereas bullfrogs, green frogs, and cricket frogs are found most often in permanent ponds with fish. Our data increase understanding of what factors structure and maintain amphibian diversity across large landscapes.	[Semlitsch, Raymond D.; Peterman, William E.; Anderson, Thomas L.; Drake, Dana L.; Ousterhout, Brittany H.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Semlitsch, RD (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	SemlitschR@missouri.edu	Peterman, William/H-7809-2013	Peterman, William/0000-0001-5229-9268; Ousterhout, Brittany/0000-0001-5303-515X	U.S. Department of Defense, Strategic Environmental Research and Development Program [RC-2155]	U.S. Department of Defense, Strategic Environmental Research and Development Program(United States Department of Defense)	Funding was provided by the U.S. Department of Defense, Strategic Environmental Research and Development Program, RC-2155, PI RDS, and co-PI WEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Anderson T.L., 2015, ECOLOGICAL IN PRESS, DOI [10.1890/14-2096.1, DOI 10.1890/14-2096.1]; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; BRADFORD DF, 1989, COPEIA, P775, DOI 10.2307/1445515; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dahl TE, 2011, STATUS TRENDS WETLAN; Drake DL, 2015, AM MIDLAND IN PRESS; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; HEYER W R, 1975, Biotropica, V7, P100, DOI 10.2307/2989753; Heyer W.R., 1994, MEASURING MONITORING; Hocking DJ, 2008, AM MIDL NAT, V160, P41, DOI 10.1674/0003-0031(2008)160[41:BARPOA]2.0.CO;2; Huston MA, 2014, ECOLOGY, V95, P2382, DOI 10.1890/13-1397.1; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Lawler SP, 1999, CONSERV BIOL, V13, P613, DOI 10.1046/j.1523-1739.1999.98075.x; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.1890/0012-9658(2001)082[3479:TDDRII]2.0.CO;2; Miller AD, 2011, P NATL ACAD SCI USA, V108, P5643, DOI 10.1073/pnas.1018594108; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pechmann J.H.K., 1989, Wetlands Ecology and Management, V1, P3; Peterman WE, 2013, ANIMAL CONSERVATION, V17, P275; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Pilliod DS, 2010, DIVERS DISTRIB, V16, P959, DOI 10.1111/j.1472-4642.2010.00699.x; RESETARITS WJ, 1989, ECOLOGY, V70, P220, DOI 10.2307/1938428; RESETARITS WJ, 1991, ECOLOGY, V72, P778, DOI 10.2307/1940580; Ricklefs RE., 1990, ECOLOGY; Schneider DW, 1996, J N AM BENTHOL SOC, V15, P64, DOI 10.2307/1467433; Schriever TA, 2013, FRESHW SCI, V32, P964, DOI 10.1899/13-008.1; Semlitsch Raymond D., 1996, P217, DOI 10.1016/B978-012178075-3/50010-6; Semlitsch RD, 1998, CONSERV BIOL, V12, P1129, DOI 10.1046/j.1523-1739.1998.98166.x; Shulse CD, 2013, J APPL ECOL, V50, P1244, DOI 10.1111/1365-2664.12126; Shulse CD, 2012, ECOL APPL, V22, P1675, DOI 10.1890/11-0212.1; Shulse CD, 2010, WETLANDS, V30, P915, DOI 10.1007/s13157-010-0069-z; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; Skelly DK, 1996, COPEIA, P599; SKELLY DK, 1995, ECOLOGY, V76, P150, DOI 10.2307/1940638; Smith GR, 1999, FRESHWATER BIOL, V41, P829, DOI 10.1046/j.1365-2427.1999.00445.x; Snodgrass JW, 2000, ECOL APPL, V10, P1219, DOI 10.1890/1051-0761(2000)010[1219:DOEOLA]2.0.CO;2; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Van Buskirk J, 2003, DIVERS DISTRIB, V9, P399; VANBUSKIRK J, 1988, ECOLOGY, V69, P857, DOI 10.2307/1941035; Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Werner EE, 2009, ECOL MONOGR, V79, P503, DOI 10.1890/08-1047.1; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; WILBUR HM, 1990, TRENDS ECOL EVOL, V5, P37, DOI 10.1016/0169-5347(90)90043-D; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; WILBUR HM, 1987, ECOLOGY, V68, P1437, DOI 10.2307/1939227; Wilbur HM, 1997, ECOLOGY, V78, P2279, DOI 10.1890/0012-9658(1997)078[2279:EEOFWC]2.0.CO;2; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	55	57	59	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123055	10.1371/journal.pone.0123055	http://dx.doi.org/10.1371/journal.pone.0123055			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906355	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000021
J	Surmeli, NB; Muskens, FM; Marletta, MA				Suermeli, Nur Basak; Muskens, Frederike M.; Marletta, Michael A.			The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitric oxide; guanylate cyclase (guanylyl cyclase); cyclic GMP (cGMP); ATP; signal transduction; heme	CATALYTIC DOMAINS; ADENYLYL-CYCLASE; ACTIVATION; MECHANISM; RECEPTOR; BINDING; HEME; NO; ATP; DIMERIZATION	Background: ATP regulates soluble guanylate cyclase (sGC), which mediates NO signaling. Results: ATP inhibition of sGC is dependent on NO levels; the pseudosymmetric site is involved in ATP regulation. Conclusion: A new kinetic model for sGC activity in the presence of excess NO is proposed. Significance: Cooperativity between the pseudosymmetric and catalytic site results in a more specific cyclase in vivo. Activation of soluble guanylate cyclase (sGC) by the signaling molecule nitric oxide (NO) leads to formation of the second messenger cGMP, which mediates numerous physiological processes. NO activates sGC by binding to the ferrous heme cofactor; the relative amount of NO with respect to sGC heme affects the enzyme activity. ATP can also influence the activity by binding to an allosteric site, most likely the pseudosymmetric site located in the catalytic domain. Here, the role of the pseudosymmetric site on nucleotide regulation was investigated by point mutations at this site. ATP inhibition kinetics of wild type and a pseudosymmetric site (1-C594A/1-D477A) variant of sGC was determined at various levels of NO. Results obtained show that in the presence of less than 1 eq of NO, there appears to be less than complete activation and little change in the nucleotide binding parameters. The most dramatic effects are observed for the addition of excess NO, which results in an increase in the affinity of GTP at the catalytic site and full activation of sGC. The pseudosymmetric site mutation only affected nucleotide affinities in the presence of excess NO; there was a decrease in the affinity for ATP in both the allosteric and catalytic sites. These observations led to a new kinetic model for sGC activity in the presence of excess NO. This model revealed that the active and allosteric sites show cooperativity. This new comprehensive model gives a more accurate description of sGC regulation by NO and nucleotides in vivo.	[Suermeli, Nur Basak; Marletta, Michael A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Muskens, Frederike M.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Med Chem & Chem Biol, NL-3584 CG Utrecht, Netherlands	Scripps Research Institute; Utrecht University	Marletta, MA (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	marletta@scripps.edu	Surmeli, Nur/K-1717-2015; Surmeli, Nur/AAE-2315-2022	Surmeli, Nur/0000-0002-1841-4004; Surmeli, Nur/0000-0002-1841-4004	American Heart Association [11POST7150020]; Jo Kolk Foundation; Dutch Heart Association; Nora Baart Foundation; K. F. Hein Fund	American Heart Association(American Heart Association); Jo Kolk Foundation; Dutch Heart Association; Nora Baart Foundation; K. F. Hein Fund	Supported by American Heart Association Grant 11POST7150020.; Present address: School of Chemistry, Joseph Black Bldg., University of Glasgow, University Ave., Glasgow G12 8QQ, United Kingdom. Supported by the Jo Kolk Foundation, Dutch Heart Association, Nora Baart Foundation, and K. F. Hein Fund.	Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; Bellamy TC, 2000, P NATL ACAD SCI USA, V97, P2928, DOI 10.1073/pnas.97.6.2928; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; Buvinic S, 2001, EUR J PHARMACOL, V424, P221, DOI 10.1016/S0014-2999(01)01165-7; Buys ES, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00038; Cals-Grierson MM, 2004, NITRIC OXIDE-BIOL CH, V10, P179, DOI 10.1016/j.niox.2004.04.005; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Greene S., 2013, PROBL POST-COMMUNISM, V60, P2; Herzik MA, 2014, P NATL ACAD SCI USA, V111, pE4156, DOI 10.1073/pnas.1416936111; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Kurtz A, 1998, AM J PHYSIOL-RENAL, V275, pF849, DOI 10.1152/ajprenal.1998.275.6.F849; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Martin E, 2012, BIOCHEMISTRY-US, V51, P2737, DOI 10.1021/bi300105s; MARTIN W, 1986, J PHARMACOL EXP THER, V237, P529; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Robinson JW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003253; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Ruiz-Stewart I, 2002, EUR J BIOCHEM, V269, P2186, DOI 10.1046/j.1432-1033.2002.02874.x; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Seeger F, 2014, BIOCHEMISTRY-US, V53, P2153, DOI 10.1021/bi500129k; Segel IH., 1993, ENZYME KINETICS BEHA; Shah AM, 2000, PHARMACOL THERAPEUT, V86, P49, DOI 10.1016/S0163-7258(99)00072-8; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Suzuki T, 2001, FEBS LETT, V507, P49, DOI 10.1016/S0014-5793(01)02943-X; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Toda N, 2003, PHARMACOL REV, V55, P271, DOI 10.1124/pr.55.2.3; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsai AL, 2011, J BIOL CHEM, V286, P43182, DOI 10.1074/jbc.M111.290304; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	58	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15570	15580		10.1074/jbc.M115.641431	http://dx.doi.org/10.1074/jbc.M115.641431			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907555	Green Published, hybrid			2022-12-26	WOS:000356527400022
J	Brand, OJ; Somanath, S; Moermans, C; Yanagisawa, H; Hashimoto, M; Cambier, S; Markovics, J; Bondesson, AJ; Hill, A; Jablons, D; Wolters, P; Lou, JL; Marks, JD; Baron, JL; Nishimura, SL				Brand, Oliver J.; Somanath, Sangeeta; Moermans, Catherine; Yanagisawa, Haruhiko; Hashimoto, Mitsuo; Cambier, Stephanie; Markovics, Jennifer; Bondesson, Andrew J.; Hill, Arthur; Jablons, David; Wolters, Paul; Lou, Jianlong; Marks, James D.; Baron, Jody L.; Nishimura, Stephen L.			Transforming Growth Factor-beta and Interleukin-1 beta Signaling Pathways Converge on the Chemokine CCL20 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACTIVATES LATENT TGF-BETA-1; AIRWAY EPITHELIAL-CELLS; NF-KAPPA-B; DENDRITIC CELLS; TGF-BETA; EXTRACELLULAR-MATRIX; LUNG INJURY; INTEGRIN; INFLAMMATION	CCL20 is the only chemokine ligand for the chemokine receptor CCR6, which is expressed by the critical antigen presenting cells, dendritic cells. Increased expression of CCL20 is likely involved in the increased recruitment of dendritic cells observed in fibroinflammatory diseases such as chronic obstructive pulmonary disease (COPD). CCL20 expression is increased by the proinflammatory cytokine IL-1 beta. We have determined that IL-1 beta-dependent CCL20 expression is also dependent on the multifunctional cytokine TGF-beta. TGF-beta is expressed in a latent form that must be activated to function, and activation is achieved through binding to the integrin alpha v beta 8 (itgb8). Here we confirm correlative increases in alpha v beta 8 and IL-1 beta with CCL20 protein in lung parenchymal lysates of a large cohort of COPD patients. How IL-1 beta- and alpha v beta 8-mediated TGF-beta activation conspire to increase fibroblast CCL20 expression remains unknown, because these pathways have not been shown to directly interact. We evaluate the 5'-flanking region of CCL20 to determine that IL-1 beta -driven CCL20 expression is dependent on alpha v beta 8-mediated activation of TGF-beta. We identify a TGF-beta-responsive element (i. e. SMAD) located on an upstream enhancer of the human CCL20 promoter required for efficient IL-1 beta-dependent CCL20 expression. By chromatin immunoprecipitation, this upstream enhancer complexes with the p50 subunit of NF-kappa B-on a NF-kappa B-binding element close to the transcriptional start site of CCL20. These interactions are confirmed by electromobility shift assays in nuclear extracts from human lung fibroblasts. These data define a mechanism by which alpha v beta 8-dependent activation of TGF-beta regulates IL-1 beta-dependent CCL20 expression in COPD.	[Brand, Oliver J.; Somanath, Sangeeta; Moermans, Catherine; Yanagisawa, Haruhiko; Hashimoto, Mitsuo; Cambier, Stephanie; Markovics, Jennifer; Bondesson, Andrew J.; Nishimura, Stephen L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94110 USA; [Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94110 USA; [Wolters, Paul; Baron, Jody L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Hill, Arthur; Jablons, David] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nishimura, SL (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Bldg 3,Rm 211,1001 Potrero Ave, San Francisco, CA 94110 USA.	stephen.nishimura@ucsf.edu	Regan, Clinton/E-6250-2012	Moermans, Catherine/0000-0002-9558-5878	National Institutes of Health [HL113032, HL063993, HL090662, NS044155]; University of California-Center for Accelerated Innovation [U54HL119893]; University of California; University of California San Francisco Liver Center [P30DK026743]; University of California Tobacco Related Disease Research Program; University of California San Francisco Academic Senate; Nina Ireland Lung Disease Program; Leon Fredericq Foundation; Belgian Respiratory Society; University of Liege; European Union; regional, national, and international programmes (COFUND)-BeIPD Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL119893, R01HL090662, R01HL113032, R01HL063993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Center for Accelerated Innovation; University of California(University of California System); University of California San Francisco Liver Center(University of California System); University of California Tobacco Related Disease Research Program(University of California System); University of California San Francisco Academic Senate(University of California System); Nina Ireland Lung Disease Program; Leon Fredericq Foundation; Belgian Respiratory Society; University of Liege(University of Liege); European Union(European Commission); regional, national, and international programmes (COFUND)-BeIPD Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL113032, HL063993, HL090662, and NS044155; University of California-Center for Accelerated Innovation Grant U54HL119893; University of California Proof of Concept Award; University of California San Francisco Liver Center Grant P30DK026743 (to S. L. N. and J. L. B.); and by funds from the University of California Tobacco Related Disease Research Program, the University of California San Francisco Academic Senate, the Nina Ireland Lung Disease Program (to P. W.), the Leon Fredericq Foundation, the Belgian Respiratory Society, the University of Liege, and the European Union Seventh Framework Programme for Research (FP7), Co-funding of regional, national, and international programmes (COFUND)-BeIPD Project (to C. M.). J. L., J. D. M., J. L. B., and S. N. have received royalty payments from the Regents of the University of California for beta 8 neutralizing antibodies used in this work.	Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Alverdi V, 2014, P NATL ACAD SCI USA, V111, P225, DOI 10.1073/pnas.1318115111; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Araya J, 2006, AM J PATHOL, V169, P405, DOI 10.2353/ajpath.2006.060049; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Caramori G, 2014, INT J CHRONIC OBSTR, V9, P397, DOI 10.2147/COPD.S42544; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Hashimoto M, 2015, J IMMUNOL, V194, P3962, DOI 10.4049/jimmunol.1403043; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kitamura H, 2011, J CLIN INVEST, V121, P2863, DOI 10.1172/JCI45589; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Markovics JA, 2011, J BIOL CHEM, V286, P36864, DOI 10.1074/jbc.M111.276790; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Minagawa S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008074; Minino Arialdi M, 2010, Natl Vital Stat Rep, V59, P1; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; Munoz-Felix JM, 2014, BBA-MOL CELL RES, V1843, P1111, DOI 10.1016/j.bbamcr.2014.02.017; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Podowski M, 2012, J CLIN INVEST, V122, P229, DOI 10.1172/JCI46215; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Siegel R, 2011, J IMMUNOL, V187, P5636, DOI 10.4049/jimmunol.1003988; Singh B., 2010, SECONDO ATENEO, V73, P86; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Varona R, 1998, FEBS LETT, V440, P188, DOI 10.1016/S0014-5793(98)01450-1; Vitsky A, 2009, AM J PATHOL, V174, P2137, DOI 10.2353/ajpath.2009.080723; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu SH, 2011, CURR OPIN INFECT DIS, V24, P235, DOI 10.1097/QCO.0b013e328344c0e3	54	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14717	14728		10.1074/jbc.M114.630368	http://dx.doi.org/10.1074/jbc.M114.630368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918170	Green Published, hybrid			2022-12-26	WOS:000355754600041
J	Rudisch, A; Dewhurst, MR; Horga, LG; Kramer, N; Harrer, N; Dong, M; van der Kuip, H; Wernitznig, A; Bernthaler, A; Dolznig, H; Sommergruber, W				Rudisch, Albin; Dewhurst, Matthew Richard; Horga, Luminita Gabriela; Kramer, Nina; Harrer, Nathalie; Dong, Meng; van der Kuip, Heiko; Wernitznig, Andreas; Bernthaler, Andreas; Dolznig, Helmut; Sommergruber, Wolfgang			High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NF kappa B Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-CELLS; IN-VITRO; GM-CSF; PREDICTS RESISTANCE; POOR-PROGNOSIS; OVARIAN-CANCER; HUMAN BREAST; EXPRESSION; MACROPHAGE	We established co-cultures of invasive or non-invasive NSCLC cell lines and various types of fibroblasts (FBs) to more precisely characterize the molecular mechanism of tumor-stroma crosstalk in lung cancer. The HGF-MET-ERK1/2-CREB-axis was shown to contribute to the onset of the invasive phenotype of Calu-1 with HGF being secreted by FBs. Differential expression analysis of the respective mono-and co-cultures revealed an upregulation of NF.B-related genes exclusively in co-cultures with Calu-1. Cytokine Array-and ELISA-based characterization of the "cytokine fingerprints" identified CSF2 (GM-CSF), CXCL1, CXCL6, VEGF, IL6, RANTES and IL8 as being specifically upregulated in various co-cultures. Whilst CXCL6 exhibited a strictly FB-type-specific induction profile regardless of the invasiveness of the tumor cell line, CSF2 was only induced in co-cultures of invasive cell lines regardless of the partnered FB type. These cultures revealed a clear link between the induction of CSF2 and the EMT signature of the cancer cell line. The canonical NF kappa B signaling in FBs, but not in tumor cells, was shown to be responsible for the induced and constitutive CSF2 expression. In addition to CSF2, cytokine IL6, IL8 and IL1B, and chemokine CXCL1 and CXCL6 transcripts were also shown to be increased in co-cultured FBs. In contrast, their induction was not strictly dependent on the invasiveness of the co-cultured tumor cell. In a multi-reporter assay, additional signaling pathways (AP-1, HIF1-alpha, KLF4, SP-1 and ELK-1) were found to be induced in FBs co-cultured with Calu-1. Most importantly, no difference was observed in the level of inducibility of these six signaling pathways with regard to the type of FBs used. Finally, upon tumor fibroblast interaction the massive induction of chemokines such as CXCL1 and CXCL6 in FBs might be responsible for increased recruitment of a monocytic cell line (THP-1) in a transwell assay.	[Rudisch, Albin; Dewhurst, Matthew Richard; Horga, Luminita Gabriela; Harrer, Nathalie; Wernitznig, Andreas; Bernthaler, Andreas; Sommergruber, Wolfgang] Boehringer Ingelheim RCV GmbH & Co KG, Dept Lead Discovery, Vienna, Austria; [Rudisch, Albin] Univ Vienna, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Max F Perutz Labs, Vienna, Austria; [Kramer, Nina; Dolznig, Helmut] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Dong, Meng; van der Kuip, Heiko] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Baden Wurttembe, Germany; [Dong, Meng; van der Kuip, Heiko] Univ Tubingen, Stuttgart, Baden Wurttembe, Germany	Boehringer Ingelheim; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Sommergruber, W (corresponding author), Boehringer Ingelheim RCV GmbH & Co KG, Dept Lead Discovery, Vienna, Austria.	wolfgang.sommergruber@boehringer-ingelheim.com	Dolznig, Helmut/L-7005-2015	Dolznig, Helmut/0000-0002-6063-3585; Dewhurst, Matthew/0000-0003-4667-4070	Boehringer Ingelheim RCV GmbH Co KG; European Union [115188]; EFPIA [115188]	Boehringer Ingelheim RCV GmbH Co KG(Boehringer Ingelheim); European Union(European Commission); EFPIA	This work has been supported by the Innovative Medicines Initiative Joint undertaking under grant agreement no 115188, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. Boehringer Ingelheim RCV GmbH & Co KG provided support in the form of salaries for authors AR, NH, AW, WS, MRD, LGH and AB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baronzio G, 2003, SEMIN THROMB HEMOST, V29, P489; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beyer C, 2013, BBA-MOL BASIS DIS, V1832, P897, DOI 10.1016/j.bbadis.2012.06.008; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burger JA, 2011, EXPERT REV ANTICANC, V11, P621, DOI [10.1586/era.11.11, 10.1586/ERA.11.11]; Busuttil RA, 2014, CLIN CANCER RES, V20, P2761, DOI 10.1158/1078-0432.CCR-13-3049; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Chandrakesan P, 2010, J BIOL CHEM, V285, P33485, DOI 10.1074/jbc.M110.129353; Chen W-J, 2014, NATURE COMMUNICATION, V5; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Cheng TY, 2014, ANTICANCER RES, V34, P2223; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Wever O, 2014, SEMIN CANCER BIOL, V25, P33, DOI 10.1016/j.semcancer.2013.12.009; Dearing KR, 2014, WORLD J CLIN ONCOL, V5, P103, DOI 10.5306/wjco.v5.i2.103; Dolznig H, 2011, AM J PATHOL, V179, P487, DOI 10.1016/j.ajpath.2011.03.015; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Eddy SF, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-3665; El-Nikhely N, 2012, EXPERT OPIN INV DRUG, V21, P1107, DOI 10.1517/13543784.2012.693478; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Erez N, 2013, BIOCHEM BIOPH RES CO, V437, P397, DOI 10.1016/j.bbrc.2013.06.089; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Fitzgerald SM, 2003, J INTERF CYTOK RES, V23, P57, DOI 10.1089/107999003321455453; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haubeiss S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-168; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Huang JF, 2013, AM J TRANSL RES, V5, P336; Huber Margit A, 2010, Genes Cancer, V1, P101, DOI 10.1177/1947601910361749; Irani S, 2014, CRIT REV ONCOL HEMAT, V89, P314, DOI 10.1016/j.critrevonc.2013.08.011; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Jiang WG, 2003, CLIN CANCER RES, V9, P4274; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; La Monica S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078656; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee MH, 2013, CANCER PREV RES, V6, P455, DOI 10.1158/1940-6207.CAPR-12-0425; Liao ZJ, 2014, INT J ONCOL, V45, P651, DOI 10.3892/ijo.2014.2464; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Loessner D, 2014, ADV DRUG DELIVER REV, V79-80, P193, DOI 10.1016/j.addr.2014.06.001; Lou Z, 2005, CANCER RES, V65, P1007; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P4152, DOI 10.4161/cc.22226; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Nakamura T, 1997, CANCER RES, V57, P3305; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Nonaka M, 1999, INT ARCH ALLERGY IMM, V119, P314, DOI 10.1159/000024209; O'Brien AD, 1998, J LAB CLIN MED, V131, P417, DOI 10.1016/S0022-2143(98)90142-1; O'Mahony D, 2005, J CLIN ONCOL, V23, P9022, DOI 10.1200/JCO.2005.02.3101; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PROOST P, 1993, J IMMUNOL, V150, P1000; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; RODEMANN HP, 1991, AM J KIDNEY DIS, V17, P684, DOI 10.1016/S0272-6386(12)80352-0; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rupp C., 2014, ONCOGENE; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Santos-Valle P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039097; Saxena R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066246; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Shang XZ, 1999, EUR J IMMUNOL, V29, P3571, DOI 10.1002/(SICI)1521-4141(199911)29:11<3571::AID-IMMU3571>3.0.CO;2-V; Sheu BC, 2008, FRONT BIOSCI-LANDMRK, V13, P6255, DOI 10.2741/3152; Siletz A, 2013, CANCER MICROENVIRON, V6, P91, DOI 10.1007/s12307-012-0121-z; Sipos F, 2014, EUR J CANCER PREV, V23, P336, DOI 10.1097/CEJ.0000000000000058; Song J, 2003, INT J MOL MED, V11, P547; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yi S, 1998, BRIT J CANCER, V77, P2162, DOI 10.1038/bjc.1998.361; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579; Zarkoob H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064169; Zeiser R, 2014, RECENT RESULTS CANC, V201, P241, DOI 10.1007/978-3-642-54490-3_15; Zheng MZ, 2011, J CANCER, V2, P478, DOI 10.7150/jca.2.478; Zhong L, 2008, CANCER RES, V68, P7237, DOI 10.1158/0008-5472.CAN-08-1529; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	92	33	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124283	10.1371/journal.pone.0124283	http://dx.doi.org/10.1371/journal.pone.0124283			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919140	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400045
J	Rizk, MA; El-Sayed, SA; Terkawi, MA; Youssef, MA; El Said, EE; Elsayed, G; El-Khodery, S; El-Ashker, M; Elsify, A; Omar, M; Salama, A; Yokoyama, N; Igarashi, I				Rizk, Mohamed Abdo; El-Sayed, Shimaa Abd El-Salam; Terkawi, Mohamed Alaa; Youssef, Mohamed Ahmed; El Said, El Said El Shirbini; Elsayed, Gehad; El-Khodery, Sabry; El-Ashker, Maged; Elsify, Ahmed; Omar, Mosaab; Salama, Akram; Yokoyama, Naoaki; Igarashi, Ikuo			Optimization of a Fluorescence-Based Assay for Large-Scale Drug Screening against Babesia and Theileria Parasites	PLOS ONE			English	Article							IN-VITRO; GROWTH; INFECTION; VALIDATION; QUERCETIN; DYE	A rapid and accurate assay for evaluating antibabesial drugs on a large scale is required for the discovery of novel chemotherapeutic agents against Babesia parasites. In the current study, we evaluated the usefulness of a fluorescence-based assay for determining the efficacies of antibabesial compounds against bovine and equine hemoparasites in in vitro cultures. Three different hematocrits (HCTs; 2.5%, 5%, and 10%) were used without daily replacement of the medium. The results of a high-throughput screening assay revealed that the best HCT was 2.5% for bovine Babesia parasites and 5% for equine Babesia and Theileria parasites. The IC50 values of diminazene aceturate obtained by fluorescence and microscopy did not differ significantly. Likewise, the IC50 values of luteolin, pyronaridine tetraphosphate, nimbolide, gedunin, and enoxacin did not differ between the two methods. In conclusion, our fluorescence-based assay uses low HCT and does not require daily replacement of culture medium, making it highly suitable for in vitro large-scale drug screening against Babesia and Theileria parasites that infect cattle and horses.	[Rizk, Mohamed Abdo; El-Sayed, Shimaa Abd El-Salam; Terkawi, Mohamed Alaa; Elsify, Ahmed; Yokoyama, Naoaki; Igarashi, Ikuo] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Rizk, Mohamed Abdo; Youssef, Mohamed Ahmed; El-Khodery, Sabry; El-Ashker, Maged] Mansoura Univ, Fac Vet Med, Dept Internal Med & Infect Dis, Mansoura, Egypt; [El-Sayed, Shimaa Abd El-Salam; El Said, El Said El Shirbini; Elsayed, Gehad] Mansoura Univ, Fac Vet Med, Dept Biochem & Chem Nutr, Mansoura, Egypt; [Elsify, Ahmed; Salama, Akram] Minoufiya Univ, Fac Vet Med, Dept Anim Med & Infect Dis, Sadat City, Minoufiya, Egypt; [Omar, Mosaab] South Valley Univ, Fac Vet Med, Dept Parasitol, Qena, Egypt	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); South Valley University Egypt	Igarashi, I (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan.	igarcpmi@obihiro.ac.jp	Omar, Mosaab A./AAF-2216-2019; El-Ashker, Maged/P-5071-2018; Al-Inany, Hesham/AAF-1089-2020; ElSify, Ahmed/ABH-4969-2020; Rizk, Mohamed Abdo/J-7232-2019; Elsify, Ahmed Mahmoud/B-2082-2019; El-khodery, Sabry A/S-8175-2018; Elsayed, Shimaa/P-3399-2018	Omar, Mosaab A./0000-0003-1553-1763; El-Ashker, Maged/0000-0002-3217-9864; ElSify, Ahmed/0000-0003-0660-9071; Rizk, Mohamed Abdo/0000-0002-5250-6172; Elsify, Ahmed Mahmoud/0000-0003-0660-9071; El-khodery, Sabry A/0000-0002-0545-5827; elsayed, gehad/0000-0002-1121-6865; elsherbini, elsaid/0000-0003-2720-8955; Salama, Akram/0000-0002-8047-8965; Elsayed, Shimaa/0000-0001-9224-5731; Terkawi, Alaa/0000-0002-5481-8516	Ministry of Higher Education Egypt; Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Higher Education Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Higher Education Egypt, the Japanese Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	AbouLaila M, 2012, ANTIMICROB AGENTS CH, V56, P3196, DOI 10.1128/AAC.05488-11; AbouLaila M, 2010, VET PARASITOL, V167, P19, DOI 10.1016/j.vetpar.2009.09.049; Avarzed A, 1997, J VET MED SCI, V59, P479, DOI 10.1292/jvms.59.479; Azirwan G, 2013, J PROTOZOOL RES, V23, P1; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bork S, 2004, ANTIMICROB AGENTS CH, V48, P236, DOI 10.1128/AAC.48.1.236-241.2004; Chavalitshewinkoon-Petmitr Porntip, 2000, Parasitology International, V48, P275, DOI 10.1016/S1383-5769(99)00028-8; DIVO AA, 1988, ANTIMICROB AGENTS CH, V32, P1182, DOI 10.1128/AAC.32.8.1182; FU S, 1986, BRIT J CLIN PHARMACO, V22, P93; Guswanto A, 2014, ANTIMICROB AGENTS CH, V58, P4713, DOI 10.1128/AAC.00022-14; Hasenkamp S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-58; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; HINES SA, 1992, MOL BIOCHEM PARASIT, V55, P85, DOI 10.1016/0166-6851(92)90129-8; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Hotzel I, 1997, MOL BIOCHEM PARASIT, V90, P479, DOI 10.1016/S0166-6851(97)00182-5; Igarashi I, 1998, EXP PARASITOL, V90, P290, DOI 10.1006/expr.1998.4331; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kuttler K.L, 1981, BABESIOSIS, P25; Lehane Adele M, 2008, BMC Res Notes, V1, P26, DOI 10.1186/1756-0500-1-26; Mahmoudi N, 2003, ANTIMICROB AGENTS CH, V47, P2636, DOI 10.1128/AAC.47.8.2636-2639.2003; MAKLER MT, 1991, AM J TROP MED HYG, V44, P11, DOI 10.4269/ajtmh.1991.44.11; Mamani-Matsuda M, 2004, ANTIMICROB AGENTS CH, V48, P924, DOI 10.1128/AAC.48.3.924-929.2004; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; Mosqueda J, 2012, CURR MED CHEM, V19, P1504, DOI 10.2174/092986712799828355; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; ROCHANAKIJ S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P66; RUEBUSH TK, 1979, AM J TROP MED HYG, V28, P184, DOI 10.4269/ajtmh.1979.28.184; Salama AA, 2013, VET PARASITOL, V191, P1, DOI 10.1016/j.vetpar.2012.08.022; Schein E., 1988, P197; Sen G, 2005, FREE RADICAL BIO MED, V38, P1257, DOI 10.1016/j.freeradbiomed.2005.01.014; Silva MG, 2013, INT J PARASITOL-DRUG, V3, P59, DOI 10.1016/j.ijpddr.2013.01.003; SKEIDSVOLL J, 1995, ANAL BIOCHEM, V231, P359, DOI 10.1006/abio.1995.9986; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; Weiss LM, 1998, INFECT IMMUN, V66, P3295, DOI 10.1128/IAI.66.7.3295-3302.1998; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng X.Y., 1982, ACTA PHARMACOL SIN, V17, P118	37	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125276	10.1371/journal.pone.0125276	http://dx.doi.org/10.1371/journal.pone.0125276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915529	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100114
J	Schiessl-Weyer, J; Roa, P; Laccone, F; Kluge, B; Tichy, A; Ribeiro, ED; Prohaska, R; Stoeter, P; Siegl, C; Salzer, U				Schiessl-Weyer, Jasmin; Roa, Pedro; Laccone, Franco; Kluge, Britta; Tichy, Alexander; Ribeiro, Euripedes De Almeida; Prohaska, Rainer; Stoeter, Peter; Siegl, Claudia; Salzer, Ulrich			Acanthocytosis and the c.680 A > G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic	PLOS ONE			English	Article							KINASE-ASSOCIATED NEURODEGENERATION; BRAIN IRON ACCUMULATION; PANTOTHENATE KINASE-2; ERYTHROCYTES; ACETYLATION; MEMBRANE; PROTEOME; CELLS	Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a form of Neurodegeneration with Brain Iron Accumulation (NBIA) associated with mutations in the pantothenate kinase 2 gene (PANK2). Pantothenate kinases catalyze the rate-limiting step of coenzyme A synthesis and Pank2 is the only pantothenate kinase isoform in humans that is localized to mitochondria. Acanthocytosis, the occurrence of spiculated erythrocytes, is observed in about 10% of the PKAN patients. Therefore PKAN is also classified together with other rare neurodegenerative diseases like Chorea Acanthocytosis (ChAc) and McLeod syndrome (MLS) into the Neuroacanthocytosis (NA) syndromes. It has not been investigated yet whether acanthocytosis in PKAN is associated with a specific subset of Pank2 mutations. In this study, we analyzed acanthocytosis of a cohort of 25 PKAN patients from the Dominican Republic that are homozygous for the c.680 A>G mutation in the PANK2 gene as compared to control donors that are heterozygous or wild-type with respect to this mutation. 3D modeling of this mutation indicated that the replacement of a tyrosine by a cysteine at position 227 in Pank2 disrupts a polar interaction within the A domain of the enzyme. Mean acanthocyte count was elevated in the cohort of patients, however, acanthocytosis varied among the patients with nearly half of them showing high (>20%) or elevated acanthocytosis and the rest showing mild (6-10%) or no (<6%) acanthocytosis. Heterozygous control donors revealed a tendency to mild acanthocytosis. Based on the insight that Pank2 is a normal constituent of red blood cells and de novo biosynthesis of coenzyme A is likely to take place in the erythrocyte cytosol we propose a hypothetical model that accounts for the variability in the occurrence of acanthocytic cells in PKAN.	[Schiessl-Weyer, Jasmin; Prohaska, Rainer; Siegl, Claudia; Salzer, Ulrich] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria; [Roa, Pedro; Stoeter, Peter] Ctr Diagnost Med Avanzada Lab & Telemed, Santo Domingo, Dominican Rep; [Laccone, Franco; Kluge, Britta] Med Univ Vienna, Dept Med Genet, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Platform Bioinformat & Biostat, Vienna, Austria; [Ribeiro, Euripedes De Almeida] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Salzer, U (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Vienna, Austria.	ulrich.salzer@meduniwien.ac.at	Laccone, Franco A/B-3655-2018	Salzer, Ulrich/0000-0002-3721-7225	NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund FWF [I 438-B13]; Austrian Science Fund (FWF) [I 438] Funding Source: researchfish	NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding by the "NBIA Disorders Association (http://www.nbiadisorders.org/) and the "Herzfelder'sche Familienstiftung" to US, and by the Austrian Science Fund FWF (grant I 438-B13)/ERAnet/E-Rare consortium EMINA (European Multidisciplinary Initiative on Neuroacanthocytosis (www.e-rare.eu/financed-projects/emina)) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; BRECHER G, 1972, BLOOD-J HEMATOL, V40, P333, DOI 10.1182/blood.V40.3.333.333; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; Delgado RF, 2012, J MAGN RESON IMAGING, V35, P788, DOI 10.1002/jmri.22884; Dusek P, 2012, CURR OPIN NEUROL, V25, P499, DOI 10.1097/WCO.0b013e3283550cac; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Jung HH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-68; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Lach A, 2012, J BIOL CHEM, V287, P18974, DOI 10.1074/jbc.M111.332981; Lange PF, 2014, J PROTEOME RES, V13, P2028, DOI 10.1021/pr401191w; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Siegl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076715; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Zhang YM, 2006, J BIOL CHEM, V281, P107, DOI 10.1074/jbc.M508825200	24	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125861	10.1371/journal.pone.0125861	http://dx.doi.org/10.1371/journal.pone.0125861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915509	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100149
J	Ali, BH; Adham, SA; Al Za'abi, M; Waly, MI; Yasin, J; Nemmar, A; Schupp, N				Ali, Badreldin H.; Adham, Sirin A.; Al Za'abi, Mohammed; Waly, Mostafa I.; Yasin, Javed; Nemmar, Abderrahim; Schupp, Nicole			Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; INDOXYL SULFATE; WISTAR RATS; UREMIC RATS; KAPPA-B; INFLAMMATION; INJURY; PATHWAY; PLASMA	Chrysin (5, 7-dihydroxyflavone) is a flavonoid with several pharmacological properties that include antioxidant, anti-inflammatory and antiapoptotic activities. in this work, we investigated some effects of three graded oral doses of chrysin (10, 50 and 250 mg/kg) on kidney structure and function in rats with experimental chronic renal disease (CKD) induced by adenine (0.25% w/w in feed for 35 days), which is known to involve inflammation and oxidative stress. Using several indices in plasma, urine and kidney homogenates, adenine was found to impair kidney function as it lowered creatinine clearance and increased plasma concentrations of creatinine, urea, neutrophil gelatinase-associated lipocalin and N-Acetyl-beta-D-glucosaminidase activity. Furthermore, it raised plasma concentrations of the uremic toxin indoxyl sulfate, some inflammatory cytokines and urinary albumin concentration. Renal morphology was severely damaged and histopathological markers of inflammation and fibrosis were especially increased. In renal homogenates, antioxidant indices, including superoxide dismutase and catalase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine - induced actions were moderately and dose - dependently mitigated by chrysin, especially at the highest dose. Chrysin did not cause any overt adverse effect on the treated rats. The results suggest that different doses of chrysin produce variable salutary effects against adenine-induced CKD in rats, and that, pending further pharmacological and toxicological studies, its usability as a possible ameliorative agent in human CKD should be considered.	[Ali, Badreldin H.; Al Za'abi, Mohammed] Sultan Qaboos Univ, Dept Pharmacol, Coll Med & Hlth Sci, Muscat, Oman; [Ali, Badreldin H.; Al Za'abi, Mohammed] Sultan Qaboos Univ, Dept Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman; [Adham, Sirin A.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Waly, Mostafa I.] Sultan Qaboos Univ, Dept Food Sci & Nutr, Coll Agr & Marine Sci, Muscat, Oman; [Yasin, Javed] UAE Univ, Dept Internal Med, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Nemmar, Abderrahim] Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates; [Schupp, Nicole] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University; United Arab Emirates University; Heinrich Heine University Dusseldorf	Ali, BH (corresponding author), Sultan Qaboos Univ, Dept Pharmacol, Coll Med & Hlth Sci, Muscat, Oman.	alibadreldin@hotmail.com	PATHAN, JAVED YASIN/GOE-4396-2022; Adham, Sirin A/ABB-8842-2020; Waly, Mostafa/P-7516-2016; Za'abi, Mohammed Al/C-6591-2013	Adham, Sirin A/0000-0002-8349-6202; Waly, Mostafa/0000-0002-8197-3378; Za'abi, Mohammed Al/0000-0002-2019-1022; PATHAN, JAVED YASIN/0000-0002-5867-2833	Research Council of Oman [RC/MED/PHARM/13/01]	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This study was financially supported by The Research Council of Oman (RC/MED/PHARM/13/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem S, 2014, J BIOCHEM MOL TOXIC, V28, P510, DOI 10.1002/jbt.21592; Ahad A, 2014, TOXICOL APPL PHARM, V279, P1, DOI 10.1016/j.taap.2014.05.007; Ahmad QZ, 2014, J NEPHROL THER, V4, P170; Al Za'abi M, 2013, J CHROMATOGR SCI, V51, P40, DOI 10.1093/chromsci/bms103; Ali BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102528; Ali BH, 2014, FOOD CHEM TOXICOL, V65, P321, DOI 10.1016/j.fct.2013.12.038; Ali BH, 2013, J PHARMACOL TOX MET, V68, P384, DOI 10.1016/j.vascn.2013.05.001; Ali BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055242; Ali BH, 2010, EXP BIOL MED, V235, P373, DOI 10.1258/ebm.2009.009214; Ali N, 2014, MOL CELL BIOCHEM, V385, P215, DOI 10.1007/s11010-013-1830-4; Almquist T, 2014, EUR J CLIN INVEST, V44, P276, DOI 10.1111/eci.12230; Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x; Anand KV, 2011, TOXICOL IND HEALTH, V27, P923, DOI 10.1177/0748233711399324; Anandhi R, 2014, MOL CELL BIOCHEM, V385, P103, DOI 10.1007/s11010-013-1819-z; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Delanaye P, 2014, NEPHRON CLIN PRACT, V128, P127, DOI 10.1159/000366449; Desjardins L, 2014, NEPHROL THER, V10, P463, DOI 10.1016/j.nephro.2014.04.002; Diwan V, 2014, PHARMACOL RES, V79, P104, DOI 10.1016/j.phrs.2013.11.007; Feng XJ, 2014, BIOCHEM PHARMACOL, V89, P503, DOI 10.1016/j.bcp.2014.03.016; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079721; Garcia-Garcia PM, 2014, WORLD J DIABETES, V5, P431, DOI 10.4239/wjd.v5.i4.431; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hanson L, 2014, AM J PUBLIC HEALTH, V104, pE9, DOI 10.2105/AJPH.2014.301984; Holmes David, 2014, Nat Rev Endocrinol, V10, P577, DOI 10.1038/nrendo.2014.145; Huang Y, 2013, MOL MED REP, V8, P1831, DOI 10.3892/mmr.2013.1715; Jablonski KL, 2014, JOVE-J VIS EXP, P16; Jiang Y, 2014, INT J MOL SCI, V15, P12270, DOI 10.3390/ijms150712270; Kazancioglu R, 2013, KIDNEY INT SUPPL, V3, P368, DOI 10.1038/kisup.2013.79; Martin-Pardillos A, 2014, TOXICOLOGY, V318, P40, DOI 10.1016/j.tox.2014.01.012; Owada S, 2008, AM J NEPHROL, V28, P446, DOI 10.1159/000112823; Rashid S, 2013, TOXICOL MECH METHOD, V23, P337, DOI 10.3109/15376516.2012.759306; Rehman MU, 2013, TOXICOL LETT, V216, P146, DOI 10.1016/j.toxlet.2012.11.013; Romier B, 2008, BRIT J NUTR, V100, P542, DOI 10.1017/S0007114508966666; Sengul S, 2011, KIDNEY INT S, V3, P308; Seron D, 2012, TRANSPLANT REV-ORLAN, V26, P20, DOI 10.1016/j.trre.2011.07.009; Taki K, 2006, J RENAL NUTR, V16, P199, DOI 10.1053/j.jrn.2006.04.020; Tu Y, 2014, J ETHNOPHARMACOL, V156, P115, DOI 10.1016/j.jep.2014.08.035; Walle T, 2001, BRIT J CLIN PHARMACO, V51, P143, DOI 10.1111/j.1365-2125.2001.01317.x; Yamagata K, 2015, CLIN EXP NEPHROL, V19, P54, DOI 10.1007/s10157-014-0978-x; Yamaguchi S, 2013, EUR J PHARMACOL, V714, P325, DOI 10.1016/j.ejphar.2013.07.032; Yao Y, 2014, INT J MOL SCI, V15, P20913, DOI 10.3390/ijms151120913; Yilmaz MI, 2014, KIDNEY INT, V86, P1213, DOI 10.1038/ki.2014.227	42	36	36	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125285	10.1371/journal.pone.0125285	http://dx.doi.org/10.1371/journal.pone.0125285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909514	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800136
J	Hoa, NN; Kobayashi, J; Omura, M; Hirakawa, M; Yang, H; Komatsu, K; Paull, TT; Takeda, S; Sasanuma, H				Hoa, Nguyen Ngoc; Kobayashi, Junya; Omura, Masato; Hirakawa, Mayumi; Yang, Soo-Hyun; Komatsu, Kenshi; Paull, Tanya T.; Takeda, Shunichi; Sasanuma, Hiroyuki			BRCA1 and CtIP Are Both Required to Recruit Dna2 at Double-Strand Breaks in Homologous Recombination	PLOS ONE			English	Article							END-RESECTION; REPAIR PATHWAY; MRE11; PROTEIN; MAINTENANCE; COMPLEX; 53BP1; EXO1	Homologous recombination plays a key role in the repair of double-strand breaks (DSBs), and thereby significantly contributes to cellular tolerance to radiotherapy and some chemotherapy. DSB repair by homologous recombination is initiated by 5' to 3' strand resection (DSB resection), with nucleases generating the 3' single-strand DNA (3' ssDNA) at DSB sites. Genetic studies of Saccharomyces cerevisiae demonstrate a two-step DSB resection, wherein CtIP and Mre11 nucleases carry out short-range DSB resection followed by long-range DSB resection done by Dna2 and Exo1 nucleases. Recent studies indicate that CtIP contributes to DSB resection through its non-catalytic role but not as a nuclease. However, it remains elusive how CtIP contributes to DSB resection. To explore the non-catalytic role, we examined the dynamics of Dna2 by developing an immuno-cytochemical method to detect ionizing-radiation (IR)-induced Dna2-subnuclear-focus formation at DSB sites in chicken DT40 and human cell lines. Ionizing-radiation induced Dna2 foci only in wild-type cells, but not in Dna2 depleted cells, with the number of foci reaching its maximum at 30 minutes and being hardly detectable at 120 minutes after IR. Induced foci were detectable in cells in the G2 phase but not in the G1 phase. These observations suggest that Dna2 foci represent the recruitment of Dna2 to DSB sites for DSB resection. Importantly, the depletion of CtIP inhibited the recruitment of Dna2 to DSB sites in both human cells and chicken DT40 cells. Likewise, a defect in breast cancer 1 (BRCA1), which physically interacts with CtIP and contributes to DSB resection, also inhibited the recruitment of Dna2. Moreover, CtIP physically associates with Dna2, and the association is enhanced by IR. We conclude that BRCA1 and CtIP contribute to DSB resection by recruiting Dna2 to damage sites, thus ensuring the robust DSB resection necessary for efficient homologous recombination.	[Hoa, Nguyen Ngoc; Omura, Masato; Hirakawa, Mayumi; Takeda, Shunichi; Sasanuma, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan; [Kobayashi, Junya; Komatsu, Kenshi] Kyoto Univ, Ctr Radiat Biol, Dept Genome Repair Dynam, Sakyo Ku, Kyoto 606, Japan; [Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Dept Mol Biosci, Austin, TX 78712 USA; [Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Kyoto University; Kyoto University; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Takeda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan.	stakeda@rg.med.kyoto-u.ac.jp; hiroysasa@rg.med.kyoto-u.ac.jp	Kobayashi, Junjiro/J-8547-2015; Kobayashi, Junya/AAX-6390-2021	Kobayashi, Junya/0000-0003-4645-7500; Paull, Tanya/0000-0002-2991-651X; Takeda, Shunichi/0000-0002-7924-7991	Japanese Ministry of Education, Science, Sport and Culture	Japanese Ministry of Education, Science, Sport and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Japanese Ministry of Education, Science, Sport and Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Delia D, 2004, HUM MOL GENET, V13, P2155, DOI 10.1093/hmg/ddh221; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Iijima J, 2010, CANCER RES, V70, P8467, DOI 10.1158/0008-5472.CAN-10-0267; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Makharashvili N, 2014, MOL CELL, V54, P1022, DOI 10.1016/j.molcel.2014.04.011; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152; Peterson SE, 2013, MOL CELL, V49, P657, DOI 10.1016/j.molcel.2012.11.020; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HL, 2014, MOL CELL, V54, P1012, DOI 10.1016/j.molcel.2014.04.012; Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	38	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124495	10.1371/journal.pone.0124495	http://dx.doi.org/10.1371/journal.pone.0124495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909997	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800085
J	Legido-Quigley, H; Lopez, PAC; Balabanova, D; Perel, P; Lopez-Jaramillo, P; Nieuwlaat, R; Schwalm, JD; McCready, T; Yusuf, S; McKee, M				Legido-Quigley, Helena; Camacho Lopez, Paul Anthony; Balabanova, Dina; Perel, Pablo; Lopez-Jaramillo, Patricio; Nieuwlaat, Robby; Schwalm, J-D; McCready, Tara; Yusuf, Salim; McKee, Martin			Patients' Knowledge, Attitudes, Behaviour and Health Care Experiences on the Prevention, Detection, Management and Control of Hypertension in Colombia: A Qualitative Study	PLOS ONE			English	Article							STRATEGIES; TRUST	Hypertension is a leading cause of premature death worldwide and the most important modifiable risk factor for cardiovascular disease. Effective screening programs, communication with patients, regular monitoring, and adherence to treatment are essential to successful management but may be challenging in health systems facing resource constraints. This qualitative study explored patients' knowledge, attitudes, behaviour and health care seeking experiences in relation to detection, treatment and control of hypertension in Colombia. We conducted in-depth interviews and focus group discussions with 26 individuals with hypertension and 4 family members in two regions. Few participants were aware of ways to prevent high blood pressure. Once diagnosed, most reported taking medication but had little information about their condition and had a poor understanding of their treatment regime. The desire for good communication and a trusting relationship with the doctor emerged as key themes in promoting adherence to medication and regular attendance at medical appointments. Barriers to accessing treatment included co-payments for medication; costs of transport to health care facilities; unavailability of drugs; and poor access to specialist care. Some patients overcame these barriers with support from social networks, family members and neighbours. However, those who lacked such support, experienced loneliness and struggled to access health care services. The health insurance scheme was frequently described as administratively confusing and those accessing the state subsidized system believed that the treatment was inferior to that provided under the compulsory contributory system. Measures that should be addressed to improve hypertension management in Colombia include better communication between health care professionals and patients, measures to improve understanding of the importance of adherence to treatment, reduction of co-payments and transport costs, and easier access to care, especially in rural areas.	[Legido-Quigley, Helena; Balabanova, Dina; Perel, Pablo; McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Camacho Lopez, Paul Anthony; Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Inst Masira, Sch Med, Bucaramanga, Colombia; [Nieuwlaat, Robby; Schwalm, J-D; McCready, Tara; Yusuf, Salim] Populat Hlth Res Inst, Hamilton, ON, Canada	University of London; London School of Hygiene & Tropical Medicine; Universidad Industrial de Santander; Population Health Research Institute	Legido-Quigley, H (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England.	Helena.legido-quigley@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; /0000-0002-2342-301X; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Camacho, Paul Anthony/0000-0002-6233-9582; Yusuf, Salim/0000-0003-4776-5601	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institute of Health Research.	Anthony H, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-24; Bernal O, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e802; Borzecki AM, 2005, CURR HYPERTENS REP, V7, P439, DOI 10.1007/s11906-005-0039-7; Calnan M, 2003, SOC SCI MED, V57, P757, DOI 10.1016/S0277-9536(03)00128-X; Charmaz K., 2006, CONSTRUCTING GROUNDE, DOI [10.1093/geront/gns046, DOI 10.1093/GERONT/GNS046]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; CIES, AS VAM SAL TABL GRAF; Connell P, 2005, BRIT J GEN PRACT, V55, P357; Giedion U, 2009, HEALTH AFFAIR, V28, P853, DOI 10.1377/hlthaff.28.3.853; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Legido-Quigley H, 2014, SOCIOL HEALTH ILL, V36, P1243, DOI 10.1111/1467-9566.12163; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lucumi Cuesta D. I., 2014, DISPARITIES HYPERTEN; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Mechanic D, 1998, MILBANK Q, V76, P281, DOI 10.1111/1468-0009.00089; Ministerio de Salud, 1999, SER DOC TECN, VIII; Ministry of Social Protection (Colombia), 2008, COL NAT HLTH SURV 20; Oli N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24023; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; Tlili F, 2014, INT J PUBLIC HLTH; Turnbull F, 2008, EUR HEART J, V29, P2669, DOI 10.1093/eurheartj/ehn427; WHO, 2013, WHODCOWHD20132	24	50	53	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122112	10.1371/journal.pone.0122112	http://dx.doi.org/10.1371/journal.pone.0122112			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909595	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000353376800017
J	Osuna-Mascaro, AJ; Cruz-Bustos, T; Marin, F; Checa, AG				Osuna-Mascaro, Antonio J.; Cruz-Bustos, Teresa; Marin, Frederic; Checa, Antonio G.			Ultrastructure of the Interlamellar Membranes of the Nacre of the Bivalve Pteria hirundo, Determined by Immunolabelling	PLOS ONE			English	Article							MOLLUSK SHELL FORMATION; ORGANIC MATRIX; MACROMOLECULAR STRUCTURE; HALIOTIS-RUFESCENS; CHITIN; COMPONENTS; FRAMEWORK; GROWTH; NUCLEATION; MYTILUS	The current model for the ultrastructure of the interlamellar membranes of molluscan nacre imply that they consist of a core of aligned chitin fibers surrounded on both sides by acidic proteins. This model was based on observations taken on previously demineralized shells, where the original structure had disappeared. Despite other earlier claims, no direct observations exist in which the different components can be unequivocally discriminated. We have applied different labeling protocols on non-demineralized nacreous shells of the bivalve Pteria. With this method, we have revealed the disposition and nature of the different fibers of the interlamellar membranes that can be observed on the surface of the nacreous shell of the bivalve Pteria hirundo by high resolution scanning electron microscopy (SEM). The minor chitin component consists of very thin fibers with a high aspect ratio and which are seemingly disoriented. Each fiber has a protein coat, which probably forms a complex with the chitin. The chitin-protein-complex fibers are embedded in an additional proteinaceous matrix. This is the first time in which the sizes, positions and distribution of the chitin fibers have been observed in situ.	[Osuna-Mascaro, Antonio J.; Checa, Antonio G.] Univ Granada, Dept Estratig & Paleontol, Fac Ciencias, E-18071 Granada, Spain; [Cruz-Bustos, Teresa] Univ Granada, Dept Bioquim & Parasitol Mol, Fac Ciencias, E-18071 Granada, Spain; [Marin, Frederic] Univ Bourgogne, UMR CNRS 6282 Biogeosci, F-21000 Dijon, France	University of Granada; University of Granada; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Osuna-Mascaro, AJ (corresponding author), Univ Granada, Dept Estratig & Paleontol, Fac Ciencias, Av Fuentenueva S-N, E-18071 Granada, Spain.	tay@ugr.es	Checa, Antonio/A-6157-2008	Checa, Antonio/0000-0001-7873-7545; Cruz Bustos, Teresa/0000-0002-6976-4354; Osuna Mascaro, Antonio Jose/0000-0002-6954-6453; Marin, Francisco/0000-0001-7246-7708	FPI program from the Spanish Ministerio de Ciencia e Innovacion; Projects of mentioned Ministry [CGL2010-20748-C02-01, CGL2013-48247-P]; Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia [RNM6433]	FPI program from the Spanish Ministerio de Ciencia e Innovacion; Projects of mentioned Ministry; Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia	AJOM was financed by a PhD Grant of the FPI program from the Spanish Ministerio de Ciencia e Innovacion; TCB's PhD Grant belonged to the FPU Program of the same Ministry. AJOM and AGC were supported by Projects CGL2010-20748-C02-01 and CGL2013-48247-P of the mentioned Ministry, and RNM6433 of the Consejeria de Economia, Innovacion y Ciencia of the Junta de Andalucia. The European COST Action TD0903 contributed via two Short Term Scientific Missions to AJOM in FM's lab in Dijon.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Bezares J, 2008, J STRUCT BIOL, V163, P61, DOI 10.1016/j.jsb.2008.04.009; Bezares J, 2012, THEOR APPL MECH, V39, P343, DOI 10.2298/TAM1204343B; Bezares J, 2011, THEOR APPL MECH, V38, P75, DOI 10.2298/TAM1102075B; Bezares J, 2010, J STRUCT BIOL, V170, P484, DOI 10.1016/j.jsb.2010.01.006; BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001; BLACKWELL J, 1980, J MOL BIOL, V137, P49, DOI 10.1016/0022-2836(80)90156-4; Box GE.P., 1986, EMPIRICAL MODEL BUIL; Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188; Checa AG, 2005, BIOMATERIALS, V26, P6404, DOI 10.1016/j.biomaterials.2005.04.016; Checa AG, 2008, MATER RES SOC S P, V1094, DOI [10.1557/PROC-1094-DD01-02, DOI 10.1557/PROC-1094-DD01-02]; Checa AG, 2013, J STRUCT BIOL, V183, P368, DOI 10.1016/j.jsb.2013.07.014; Checa AG, 2011, J STRUCT BIOL, V176, P330, DOI 10.1016/j.jsb.2011.09.011; Farre B, 2009, COMP BIOCHEM PHYS B, V152, P103, DOI 10.1016/j.cbpb.2008.10.003; GOFFINET G, 1969, COMP BIOCHEM PHYSIOL, V29, P835, DOI 10.1016/0010-406X(69)91635-1; GOFFINET G, 1979, CAH BIOL MAR, V20, P341; GREGOIRE C, 1957, J BIOPHYS BIOCHEM CY, V3, P797, DOI 10.1083/jcb.3.5.797; Gregoire C., 1972, P45; Hackman R. H., 1960, AUST J BIOL SCI, V13, P568, DOI DOI 10.1071/B19600568; HACKMAN RH, 1965, AUST J BIOL SCI, V18, P935, DOI 10.1071/BI9650935; Hare PE, 1964, REP DIR GEOPHYS LAB, V63, P267; Harper EM, 2009, ACTA ZOOL-STOCKHOLM, V90, P132, DOI 10.1111/j.1463-6395.2008.00338.x; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Meyer W.T., 1913, TINTENFISCHE BESONDE; MUTVEI H, 1977, CALC TISS RES, V24, P11, DOI 10.1007/BF02223291; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008; OKAFOR N, 1965, BIOCHIM BIOPHYS ACTA, V101, P193, DOI 10.1016/0926-6534(65)90050-3; PETERS W, 1972, COMP BIOCHEM PHYSIOL, V41, P541, DOI 10.1016/0305-0491(72)90117-4; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; WEINER S, 1980, FEBS LETT, V111, P311, DOI 10.1016/0014-5793(80)80817-9; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; Zentz F, 2001, MAR BIOTECHNOL, V3, P36, DOI 10.1007/s101260000042	35	15	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122934	10.1371/journal.pone.0122934	http://dx.doi.org/10.1371/journal.pone.0122934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909912	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800023
J	Southwell, C; Emmerson, L; Newbery, K; McKinlay, J; Kerry, K; Woehler, E; Ensor, P				Southwell, Colin; Emmerson, Louise; Newbery, Kym; McKinlay, John; Kerry, Knowles; Woehler, Eric; Ensor, Paul			Re-Constructing Historical Adelie Penguin Abundance Estimates by Retrospectively Accounting for Detection Bias	PLOS ONE			English	Article							CLIMATE-CHANGE; ANTARCTIC PENINSULA; POPULATION-SIZE; PACIFIC SECTOR; AERIAL SURVEYS; SEA-ICE; AVAILABILITY; ENVIRONMENTS; SEABIRDS; BEHAVIOR	Seabirds and other land-breeding marine predators are considered to be useful and practical indicators of the state of marine ecosystems because of their dependence on marine prey and the accessibility of their populations at breeding colonies. Historical counts of breeding populations of these higher-order marine predators are one of few data sources available for inferring past change in marine ecosystems. However, historical abundance estimates derived from these population counts may be subject to unrecognised bias and uncertainty because of variable attendance of birds at breeding colonies and variable timing of past population surveys. We retrospectively accounted for detection bias in historical abundance estimates of the colonial, land-breeding Adelie penguin through an analysis of 222 historical abundance estimates from 81 breeding sites in east Antarctica. The published abundance estimates were de-constructed to retrieve the raw count data and then re-constructed by applying contemporary adjustment factors obtained from remotely operating time-lapse cameras. The re-construction process incorporated spatial and temporal variation in phenology and attendance by using data from cameras deployed at multiple sites over multiple years and propagating this uncertainty through to the final revised abundance estimates. Our re-constructed abundance estimates were consistently higher and more uncertain than published estimates. The re-constructed estimates alter the conclusions reached for some sites in east Antarctica in recent assessments of long-term Adelie penguin population change. Our approach is applicable to abundance data for a wide range of colonial, land-breeding marine species including other penguin species, flying seabirds and marine mammals.	[Southwell, Colin; Emmerson, Louise; Newbery, Kym; McKinlay, John; Kerry, Knowles; Woehler, Eric; Ensor, Paul] Australian Antarctic Div, Dept Environm, Kingston, Tas 7050, Australia	Australian Antarctic Division	Southwell, C (corresponding author), Australian Antarctic Div, Dept Environm, 203 Channel Highway, Kingston, Tas 7050, Australia.	colin.southwell@aad.gov.au		McKinlay, John/0000-0003-4858-2604; Chiaradia, Andre/0000-0002-6178-4211; Woehler, Eric/0000-0002-1125-0748	Australian Antarctic Division [4088]	Australian Antarctic Division	The work was funded by the Australian Antarctic Division (www.aad.gov.au) for approved AAS project 4088.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barbraud C, 2011, ANTARCT SCI, V23, P461, DOI 10.1017/S0954102011000356; BASSETT JA, 1990, EMU, V90, P58, DOI 10.1071/MU9900058; Borchers D.L., 2002, ESTIMATING ANIMAL AB; CCAMLR, 2004, CCAMLR EC MON PROGR; Croxall JP, 1979, DISTRIBUTION PENGUES; Emmerson L, 2011, MAR ECOL PROG SER, V440, P203, DOI 10.3354/meps09265; Ensor PH, 1987, BREEDING STATUS ADEL; Falla RA, 1937, BANZARE REPORT; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; FRASER WR, 1992, POLAR BIOL, V11, P525; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Horne, 1983, DISTRIBUTION PENGUIN; Kerry Knowles, 1993, Proceedings of the NIPR Symposium on Polar Biology, V6, P62; KERRY KR, 1993, WILDLIFE RES, V20, P725, DOI 10.1071/WR9930725; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; LINK WA, 1994, OIKOS, V69, P539, DOI 10.2307/3545869; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Lynch HJ, 2009, CCAMLR SCI, V16, P149; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lyver PO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091188; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; McKinlay J, 2010, CCAMLR SCI, V17, P213; Montevecchi W.A., 1993, P217; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Newbery KB, 2009, COLD REG SCI TECHNOL, V55, P47, DOI 10.1016/j.coldregions.2008.06.001; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; ORTON M. N., 1963, EMU, V63, P15; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Pollock Kenneth H., 2004, P43; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Southwell C, 2010, CCAMLR SCI, V17, P229; Southwell C, 2014, HIST ADELIE PENGUIN; Southwell C, 2015, J NAT CONSERV, V23, P1, DOI 10.1016/j.jnc.2014.11.002; Southwell C, 2013, POLAR BIOL, V36, P843, DOI 10.1007/s00300-013-1310-z; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Thomson JA, 2012, METHODS ECOL EVOL, V3, P378, DOI 10.1111/j.2041-210X.2011.00163.x; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WHITEHEAD MD, 1990, P NIPR S POLAR BIOL, V0003; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler E.J., 1991, Marine Ornithology, V19, P1; Woehler EJ, 2001, STAT ASSESSMEN STATU; Woehler EJ, 1989, DISTRIBUTION ABUNDAN, V2, P71; Woehler EJ, 1993, DISTRIBUTION ABUNDAN	53	5	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123540	10.1371/journal.pone.0123540	http://dx.doi.org/10.1371/journal.pone.0123540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909636	Green Published, gold			2022-12-26	WOS:000353376800038
J	Chatzidaki, A; Fouillet, A; Li, JL; Dage, J; Millar, NS; Sher, E; Ursu, D				Chatzidaki, Anna; Fouillet, Antoine; Li, Jingling; Dage, Jeffrey; Millar, Neil S.; Sher, Emanuele; Ursu, Daniel			Pharmacological Characterisation of Nicotinic Acetylcholine Receptors Expressed in Human iPSC-Derived Neurons	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ALLOSTERIC TRANSMEMBRANE SITE; PARTIAL DUPLICATION; ALZHEIMERS-DISEASE; SINGLE-CHANNEL; GENE CHRFAM7A; ION CHANNELS; ALPHA-7; SCHIZOPHRENIA; CHRNA7	Neurons derived from human induced pluripotent stem cells (iPSCs) represent a potentially valuable tool for the characterisation of neuronal receptors and ion channels. Previous studies on iPSC-derived neuronal cells have reported the functional characterisation of a variety of receptors and ion channels, including glutamate receptors, gamma-aminobutyric acid (GABA) receptors and several voltage-gated ion channels. In the present study we have examined the expression and functional properties of nicotinic acetylcholine receptors (nAChRs) in human iPSC-derived neurons. Gene expression analysis indicated the presence of transcripts encoding several nAChR subunits, with highest levels detected for alpha 3-alpha 7, beta 1, beta 2 and beta 4 subunits (encoded by CHRNA3-CHRNA7, CHRNB1, CHRNB2 and CHRNB4 genes). In addition, similarly high transcript levels were detected for the truncated dupa7 subunit transcript, encoded by the partially duplicated gene CHRFAM7A, which has been associated with psychiatric disorders such as schizophrenia. The functional properties of these nAChRs have been examined by calcium fluorescence and by patch-clamp recordings. The data obtained suggest that the majority of functional nAChRs expressed in these cells have pharmacological properties typical of alpha 7 receptors. Large responses were induced by a selective alpha 7 agonist (compound B), in the presence of the alpha 7-selective positive allosteric modulator (PAM) PNU-120596, which were blocked by the alpha 7-selective antagonist methyllycaconitine (MLA). In addition, a small proportion of the neurons express nAChRs with properties typical of heteromeric (non-alpha 7 containing) nAChR subtypes. These cells therefore represent a great tool to advance our understanding of the properties of native human nAChRs, alpha 7 in particular.	[Chatzidaki, Anna; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Fouillet, Antoine; Sher, Emanuele; Ursu, Daniel] Eli Lilly & Co, Lilly Res Ctr, Windlesham, Surrey, England; [Li, Jingling; Dage, Jeffrey] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	University of London; University College London; Eli Lilly; Eli Lilly	Ursu, D (corresponding author), Eli Lilly & Co, Lilly Res Ctr, Windlesham, Surrey, England.	Ursu_Daniel@lilly.com			Industrial CASE Studentship; Medical Research Council (MRC) [G1001602]; Medical Research Council [1069300] Funding Source: researchfish	Industrial CASE Studentship; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an Industrial CASE Studentship awarded by the Medical Research Council (MRC; G1001602). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Gill JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055047; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Gundisch D, 2011, EXPERT OPIN THER PAT, V21, P1867, DOI 10.1517/13543776.2011.637919; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Haythornthwaite A, 2012, J BIOMOL SCREEN, V17, P1264, DOI 10.1177/1087057112457821; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jindrichova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032073; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Palczynska MM, 2012, MOL PHARMACOL, V82, P910, DOI 10.1124/mol.112.080259; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; PHILLIPS E, Patent No. 0160821; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Sitzia F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00081; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Wilens TE, 2007, BIOCHEM PHARMACOL, V74, P1212, DOI 10.1016/j.bcp.2007.07.002; Williams DK, 2012, MOL PHARMACOL, V82, P746, DOI 10.1124/mol.112.080317; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	42	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125116	10.1371/journal.pone.0125116	http://dx.doi.org/10.1371/journal.pone.0125116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906356	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000102
J	Lin, J; Karlsson, M; Olofson, AS; Belak, S; Malmsten, J; Dalin, AM; Widen, F; Norder, H				Lin, Jay; Karlsson, Marie; Olofson, Ann-Sophie; Belak, Sandor; Malmsten, Jonas; Dalin, Anne-Marie; Widen, Frederik; Norder, Helene			High Prevalence of Hepatitis E Virus in Swedish Moose - A Phylogenetic Characterization and Comparison of the Virus from Different Regions	PLOS ONE			English	Article							GENOTYPE 4; MOLECULAR CHARACTERIZATION; INFECTION; HEV; FAMILY; TRANSMISSION; GENOME; HEPEVIRIDAE; DEER; PIGS	Background Hepatitis E virus (HEV) infects a range of species, including humans, pigs, wild boars and deer. Zoonotic transmission may contribute to the high HEV seroprevalence in the human population of many countries. A novel divergent HEV from moose (Alces alces) in Sweden was recently identified by partial genome sequencing. Since only one strain was found, its classification within the HEV family, prevalence in moose and zoonotic potential was unclear. We therefore investigated samples from 231 moose in seven Swedish counties for HEV, and sequenced a near complete moose HEV genome. Phylogenetic analysis to classify this virus within the family Hepeviridae and to explore potential host specific determinants was performed. Methods and Findings The HEV prevalence of moose was determined by PCR (marker for active infection) and serological assays (marker of past infection) of sera and 51 fecal samples from 231 Swedish moose. Markers of active and past infection were found in 67 (29%) animals, while 34 (15%) were positive for HEV RNA, 43 (19%) were seropositive for anti-HEV antibodies, and 10 (4%) had both markers. The number of young individuals positive for HEV RNA was larger than for older individuals, and the number of anti-HEV antibody positive individuals increased with age. The high throughput sequenced moose HEV genome was 35-60% identical to existing HEVs. Partial ORF1 sequences from 13 moose strains showed high similarity among them, forming a distinct monophyletic clade with a common ancestor to HEV genotype 1-6 group, which includes members known for zoonotic transmission. Conclusions This study demonstrates a high frequency of HEV in moose in Sweden, with markers of current and past infection demonstrated in 30% of the animals. Moose is thus an important animal reservoir of HEV. The phylogenetic relationship demonstrated that the moose HEV belonged to the genotype 1-6 group, which includes strains that also infect humans, and therefore may signify a potential for zoonotic transmission of this HEV.	[Lin, Jay; Olofson, Ann-Sophie; Belak, Sandor; Widen, Frederik] Natl Vet Inst SVA, Dept Virol Immunobiol & Parasitol VIP, Uppsala, Sweden; [Lin, Jay; Belak, Sandor; Widen, Frederik] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Karlsson, Marie; Norder, Helene] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Sect Clin Virol, Gothenburg, Sweden; [Malmsten, Jonas] Natl Vet Inst SVA, Dept Pathol andWildlife Dis, Uppsala, Sweden; [Malmsten, Jonas; Dalin, Anne-Marie] Swedish Univ Agr Sci SLU, Dept Clin Sci, Div Reprod, Uppsala, Sweden	National Veterinary Institute SVA; Swedish University of Agricultural Sciences; University of Gothenburg; National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Lin, J (corresponding author), Natl Vet Inst SVA, Dept Virol Immunobiol & Parasitol VIP, Uppsala, Sweden.	jay.lin@sva.se	Norder, Helene/GSD-5853-2022; Belak, Sandor/AAP-4759-2021	Norder, Helene/0000-0002-7528-3872; Malmsten, Jonas/0000-0003-1868-3746; widen, frederik/0000-0002-6484-3408	Swedish Research Council FORMAS [2009747]; 'PREDEMICS' [278433]; Wildtech Project of the EU Seventh Framework Program [222633]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); 'PREDEMICS'; Wildtech Project of the EU Seventh Framework Program	This study was supported by a grant 2009747 from the Swedish Research Council FORMAS (FW), and part of this study was supported under the project 'PREDEMICS', (7th Framework Program, grant agreement no. 278433) (HN) and the Wildtech Project of the EU Seventh Framework Program, (FP7/2007-2013) grant agreement no. 222633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, VIRUS RES, V161, P15, DOI 10.1016/j.virusres.2011.03.017; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Choi JY, 2013, CLIN MOL HEPATOL, V19, P309, DOI 10.3350/cmh.2013.19.3.309; Colson P, 2012, EMERG INFECT DIS, V18, P1361, DOI 10.3201/eid1808.111827; de Deus N, 2008, VET MICROBIOL, V129, P163, DOI 10.1016/j.vetmic.2007.11.002; Dremsek P, 2012, MED MICROBIOL IMMUN, V201, P189, DOI 10.1007/s00430-011-0221-2; Drexler JF, 2012, J VIROL, V86, P9134, DOI 10.1128/JVI.00800-12; Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0; Garbuglia AR, 2013, EMERG INFECT DIS, V19, P110, DOI 10.3201/eid1901.120983; Guo QS, 2010, J CLIN MICROBIOL, V48, P317, DOI 10.1128/JCM.01466-09; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Holla RP, 2013, SEMIN LIVER DIS, V33, P3, DOI 10.1055/s-0033-1338110; Holmes K, 2011, CERVIDAE; Jagarforbundet, 2012, ALGAVSKJUTNING SHOOT; Johne R, 2014, INFECT GENET EVOL, V27, P212, DOI 10.1016/j.meegid.2014.06.024; Johne R, 2010, EMERG INFECT DIS, V16, P1452, DOI 10.3201/eid1609.100444; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Krawczynski K, 2011, VIRUS RES, V161, P78, DOI 10.1016/j.virusres.2011.03.007; Kukielka D, 2016, TRANSBOUND EMERG DIS, V63, pE360, DOI 10.1111/tbed.12311; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; La Rosa G, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-72; Lin J, 2014, J GEN VIROL, V95, P557, DOI 10.1099/vir.0.059238-0; Liu P, 2012, INFECT GENET EVOL, V12, P428, DOI 10.1016/j.meegid.2012.01.017; Malmsten J, 2014, EPIDEMIOL INFECT, V142, P1205, DOI 10.1017/S0950268813002094; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Midgley S, 2014, EMERG INFECT DIS, V20, P156, DOI 10.3201/eid2001.130600; Miyashita K, 2012, HEPATOL RES, V42, P870, DOI 10.1111/j.1872-034X.2012.01006.x; National Center for Biotechnology Information (NCBI), 2014, OP READ FRAM FIND OR; Norder H, 2009, EUROSURVEILLANCE, V14, P20; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Reuter G, 2009, J CLIN VIROL, V44, P277, DOI 10.1016/j.jcv.2009.01.008; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Takahashi K, 2004, VIROLOGY, V330, P501, DOI 10.1016/j.virol.2004.10.006; Takahashi M, 2007, J CLIN MICROBIOL, V45, P3671, DOI 10.1128/JCM.01086-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Widen F, 2011, EPIDEMIOL INFECT, V139, P361, DOI 10.1017/S0950268810001342; World Health Organization (WHO), 2014, ZOONOSES; Xia HY, 2008, VIRUS GENES, V37, P39, DOI 10.1007/s11262-008-0246-9; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	47	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122102	10.1371/journal.pone.0122102	http://dx.doi.org/10.1371/journal.pone.0122102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906163	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000353332000010
J	Netten, AP; Rieffe, C; Theunissen, SCPM; Soede, W; Dirks, E; Briaire, JJ; Frijns, JHM				Netten, Anouk P.; Rieffe, Carolien; Theunissen, Stephanie C. P. M.; Soede, Wim; Dirks, Evelien; Briaire, Jeroen J.; Frijns, Johan H. M.			Low Empathy in Deaf and Hard of Hearing (Pre)Adolescents Compared to Normal Hearing Controls	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; SOCIAL NEUROSCIENCE; FRIENDSHIP QUALITY; IMPAIRED CHILDREN; ADOLESCENTS; BEHAVIOR; VALIDATION; AWARENESS; RESPONSES; EMOTIONS	Objective The purpose of this study was to examine the level of empathy in deaf and hard of hearing (pre)adolescents compared to normal hearing controls and to define the influence of language and various hearing loss characteristics on the development of empathy. Methods The study group (mean age 11.9 years) consisted of 122 deaf and hard of hearing children (52 children with cochlear implants and 70 children with conventional hearing aids) and 162 normal hearing children. The two groups were compared using self-reports, a parent-report and observation tasks to rate the children's level of empathy, their attendance to others' emotions, emotion recognition, and supportive behavior. Results Deaf and hard of hearing children reported lower levels of cognitive empathy and prosocial motivation than normal hearing children, regardless of their type of hearing device. The level of emotion recognition was equal in both groups. During observations, deaf and hard of hearing children showed more attention to the emotion evoking events but less supportive behavior compared to their normal hearing peers. Deaf and hard of hearing children attending mainstream education or using oral language show higher levels of cognitive empathy and prosocial motivation than deaf and hard of hearing children who use sign (supported) language or attend special education. However, they are still outperformed by normal hearing children. Conclusions Deaf and hard of hearing children, especially those in special education, show lower levels of empathy than normal hearing children, which can have consequences for initiating and maintaining relationships.	[Netten, Anouk P.; Theunissen, Stephanie C. P. M.; Soede, Wim; Briaire, Jeroen J.; Frijns, Johan H. M.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands; [Rieffe, Carolien] Leiden Univ, Dept Dev Psychol, Leiden, Netherlands; [Rieffe, Carolien; Dirks, Evelien] Dutch Fdn Deaf & Hard Hearing Child, Amsterdam, Netherlands; [Frijns, Johan H. M.] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Netten, AP (corresponding author), Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands.	a.p.netten@lumc.nl	Briaire, Jeroen/A-7972-2008; dirks, evelien/M-9914-2017; Frijns, Johan H.M./H-6249-2011	Briaire, Jeroen/0000-0003-4302-817X; Frijns, Johan H.M./0000-0002-1180-3314; Rieffe, Carolien/0000-0002-7584-6698	Netherlands Organisation for Scientific Research (NWO) [452-07-004]; Stichting Het Heinsius-Houbolt Fonds, the Netherlands	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Stichting Het Heinsius-Houbolt Fonds, the Netherlands(Netherlands Government)	This research was supported by the Innovational Research Incentives Scheme (a VIDI grant) by The Netherlands Organisation for Scientific Research (NWO), no. 452-07-004 to CR. AN is supported by the Stichting Het Heinsius-Houbolt Fonds, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHARA GH, 1980, AM ANN DEAF, V125, P38, DOI 10.1353/aad.2012.1175; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Berndt TJ, 2002, CURR DIR PSYCHOL SCI, V11, P7, DOI 10.1111/1467-8721.00157; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Brownell CA, 2002, BEHAV BRAIN SCI, V25, P28, DOI 10.1017/S0140525X02300013; Calderson Rosemary, 2003, OXFORD HDB DEAF STUD; Chow CM, 2013, J ADOLESCENCE, V36, P191, DOI 10.1016/j.adolescence.2012.10.004; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety J, 2014, PERSPECT PSYCHOL SCI, V9, P525, DOI 10.1177/1745691614545130; Dyck MJ, 2004, J CHILD PSYCHOL PSYC, V45, P789, DOI 10.1111/j.1469-7610.2004.00272.x; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Hall JA, 2009, J NONVERBAL BEHAV, V33, P149, DOI 10.1007/s10919-009-0070-5; Harris P.L., 1989, CHILDREN EMOTION DEV; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hermans D, 2010, J DEAF STUD DEAF EDU, V15, P107, DOI 10.1093/deafed/enp030; Hoffman M. L., 1987, EMPATHY ITS DEV, P47; Jolliffe D, 2006, AGGRESSIVE BEHAV, V32, P540, DOI 10.1002/ab.20154; Ketelaar L, 2012, J PEDIATR PSYCHOL, V37, P1041, DOI 10.1093/jpepsy/jss086; Kort W., 2008, CELF4NL PEARS ASS IN; Kouwenberg M, DEAF HARD HEAR UNPUB; Lamm C, 2015, NEUROSCI RES, V90, P15, DOI 10.1016/j.neures.2014.10.008; Lovett BJ, 2007, CLIN PSYCHOL REV, V27, P1, DOI 10.1016/j.cpr.2006.03.003; Moeller MP, 2007, EAR HEARING, V28, P729, DOI 10.1097/AUD.0b013e318157f033; Overgaauw S, VALIDATION EMP UNPUB; Pfeifer JH, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P183; Pouw LBC, 2013, RES DEV DISABIL, V34, P1256, DOI 10.1016/j.ridd.2012.12.022; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rieffe C, TEACHING DEAF LEARNE; Rieffe C, 2008, PERS INDIV DIFFER, V45, P756, DOI 10.1016/j.paid.2008.08.001; Rieffe C, 2012, BRIT J DEV PSYCHOL, V30, P477, DOI 10.1111/j.2044-835X.2011.02057.x; Rieffe C, 2010, PERS INDIV DIFFER, V49, P362, DOI 10.1016/j.paid.2010.03.046; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Smith RL, 2011, DEV PSYCHOL, V47, P1792, DOI 10.1037/a0025309; Spinella M, 2005, BIOL PSYCHOL, V70, P175, DOI 10.1016/j.biopsycho.2004.01.005; Stevenson J, 2010, J CHILD PSYCHOL PSYC, V51, P77, DOI 10.1111/j.1469-7610.2009.02124.x; Tellegen P., 1993, EUROPEAN J PSYCHOL A, V9, P147, DOI DOI 10.1016/J.AJHG.2016.01.016; Theunissen SC, 2013, EUR CHILD ADOLESC PS; Theunissen SCPM, 2011, INT J PEDIATR OTORHI, V75, P1313, DOI 10.1016/j.ijporl.2011.07.023; Van Eldik T, 2005, AM ANN DEAF, V150, P11, DOI 10.1353/aad.2005.0024; Van Eldik T, 2004, AM ANN DEAF, V148, P390, DOI 10.1353/aad.2004.0002; van Gent T, 2007, J CHILD PSYCHOL PSYC, V48, P950, DOI 10.1111/j.1469-7610.2007.01775.x; Wechsler D., 1991, WISC 3 WECHSLER INTE; Whitt A, 2013, PSYCHOL REP, V112, P325, DOI 10.2466/16.08.20.PR0.112.1.325-339; Wiefferink CH, 2013, J DEAF STUD DEAF EDU, V18, P175, DOI 10.1093/deafed/ens042; Yoshinaga-Itano C, 2003, MENT RETARD DEV D R, V9, P252, DOI 10.1002/mrdd.10088; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	50	51	54	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124102	10.1371/journal.pone.0124102	http://dx.doi.org/10.1371/journal.pone.0124102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906365	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000057
J	Savage, CR; Arnold, WK; Gjevre-Nail, A; Koestler, BJ; Bruger, EL; Barker, JR; Waters, CM; Stevenson, B				Savage, Christina R.; Arnold, William K.; Gjevre-Nail, Alexandra; Koestler, Benjamin J.; Bruger, Eric L.; Barker, Jeffrey R.; Waters, Christopher M.; Stevenson, Brian			Intracellular Concentrations of Borrelia burgdorferi Cyclic Di-AMP Are Not Changed by Altered Expression of the CdaA Synthase	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; AFFECT BACTERIAL-GROWTH; GENE-EXPRESSION; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; BINDING PROTEINS; GENOME SEQUENCE; YDAO RIBOSWITCH; I IFN	The second messenger nucleotide cyclic diadenylate monophosphate (c-di-AMP) has been identified in several species of Gram positive bacteria and Chlamydia trachomatis. This molecule has been associated with bacterial cell division, cell wall biosynthesis and phosphate metabolism, and with induction of type I interferon responses by host cells. We demonstrate that B. burgdorferi produces a c-di-AMP synthase, which we designated CdaA. Both CdaA and c-di-AMP levels are very low in cultured B. burgdorferi, and no conditions were identified under which cdaA mRNA was differentially expressed. A mutant B. burgdorferi was produced that expresses high levels of CdaA, yet steady state borrelial cdi-AMP levels did not change, apparently due to degradation by the native DhhP phosphodiesterase. The function(s) of c-di-AMP in the Lyme disease spirochete remains enigmatic.	[Savage, Christina R.; Arnold, William K.; Gjevre-Nail, Alexandra; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA; [Koestler, Benjamin J.; Bruger, Eric L.; Waters, Christopher M.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Barker, Jeffrey R.] Duke Univ, Dept Mol Genet & Microbiol, Ctr Microbial Pathogenesis, Durham, NC USA	University of Kentucky; Michigan State University; Duke University	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA.	brian.stevenson@uky.edu		Arnold, Will/0000-0003-2447-3489; Koestler, Benjamin/0000-0001-7213-0953; Nail, Alexandra/0000-0002-8008-3891	University of Kentucky College of Medicine; National Science Foundation [MCB1253684]	University of Kentucky College of Medicine; National Science Foundation(National Science Foundation (NSF))	Funded by an exploratory grant from the University of Kentucky College of Medicine to B. Stevenson, and National Science Foundation grant MCB1253684 to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2013, EMBO REP, V14, P900, DOI 10.1038/embor.2013.132; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Bian J, 2011, J BACTERIOL, V193, P3912, DOI 10.1128/JB.00386-11; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Bono JL, 1998, MICROBIOL-UK, V144, P1033, DOI 10.1099/00221287-144-4-1033; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Campeotto I, J BIOL CHEM, V2-15, P2888; Casjens S, 1997, J BACTERIOL, V179, P217, DOI 10.1128/jb.179.1.217-227.1997; Choi PH, 2015, MICROBIOLOG IN PRESS, DOI [10.1002/mbo1003.1243, DOI 10.1002/MBO1003.1243]; Corrigan RM, 2015, J BIOL CHEM, V290, P5826, DOI 10.1074/jbc.M114.598300; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Fang M, 2009, NUCLEIC ACIDS RES, V37, P5114, DOI 10.1093/nar/gkp527; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gandara C, 2015, DNA REPAIR, V27, P1, DOI 10.1016/j.dnarep.2014.12.007; Gao A, 2014, NAT CHEM BIOL, V10, P787, DOI [10.1038/NCHEMBIO.1607, 10.1038/nchembio.1607]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hastey CJ, 2014, INFECT IMMUN, V82, P1548, DOI 10.1128/IAI.00969-13; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones CP, 2014, EMBO J, V33, P2692, DOI 10.15252/embj.201489209; Jutras BL, 2012, J BACTERIOL, V194, P3395, DOI 10.1128/JB.00252-12; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kamegaya T, 2011, NAGOYA J MED SCI, V73, P49; Liu MF, 2012, MICROBIOL-SGM, V158, P886, DOI 10.1099/mic.0.054619-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Massie JP, 2012, P NATL ACAD SCI USA, V109, P12746, DOI 10.1073/pnas.1115663109; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller Jennifer C, 2005, Curr Protoc Microbiol, VChapter 1D, DOI 10.1002/9780471729259.mc01d03s00; Miller JC, 2010, INFECT IMMUN, V78, P3144, DOI 10.1128/IAI.01070-09; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Muller M, 2015, FEBS LETT, V589, P45, DOI 10.1016/j.febslet.2014.11.022; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Nickels BE, 2012, TRANSCR-AUSTIN, V3, P300, DOI 10.4161/trns.21903; Nickels BE, 2011, J MOL BIOL, V412, P772, DOI 10.1016/j.jmb.2011.06.015; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ren AM, 2014, NAT CHEM BIOL, V10, P780, DOI [10.1038/NCHEMBIO.1606, 10.1038/nchembio.1606]; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Rosenberg J, 2015, J BIOL CHEM; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Srivastav R, 2014, NUCLEIC ACIDS RES, V42, P7894, DOI 10.1093/nar/gku425; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; SUZUKI H, 1978, P NATL ACAD SCI USA, V75, P664, DOI 10.1073/pnas.75.2.664; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilly K, 1997, MOL MICROBIOL, V25, P361, DOI 10.1046/j.1365-2958.1997.4711838.x; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Vvedenskaya IO, 2012, GENE DEV, V26, P1498, DOI 10.1101/gad.192732.112; Whetstine CR, 2009, APPL ENVIRON MICROB, V75, P6553, DOI 10.1128/AEM.02825-08; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	74	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125440	10.1371/journal.pone.0125440	http://dx.doi.org/10.1371/journal.pone.0125440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906393	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000111
J	Naik, RR; Singh, AK; Mali, AM; Khirade, MF; Bapat, SA				Naik, R. R.; Singh, A. K.; Mali, A. M.; Khirade, M. F.; Bapat, S. A.			A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses	ONCOGENE			English	Article							STEM-CELLS; CANCER; HETEROGENEITY; CONTRIBUTE; ANEUPLOIDY	Tumor heterogeneity and the presence of drug-sensitive and refractory populations within the same tumor are almost never assessed in the drug discovery pipeline. Such incomplete assessment of drugs arising from spatial and temporal tumor cell heterogeneity reflects on their failure in the clinic and considerable wasted costs in the drug discovery pipeline. Here we report the derivation of a flow cytometry-based tumor deconstruction platform for resolution of at least 18 discrete tumor cell fractions. This is achieved through concurrent identification, quantification and analysis of components of cancer stem cell hierarchies, genetically instable clones and differentially cycling populations within a tumor. We also demonstrate such resolution of the tumor cytotype to be a potential value addition in drug screening through definitive cell target identification. Additionally, this real-time definition of intra-tumor heterogeneity provides a convenient, incisive and analytical tool for predicting drug efficacies through profiling perturbations within discrete tumor cell subsets in response to different drugs and candidates. Consequently, possible applications in informed therapeutic monitoring and drug repositioning in personalized cancer therapy would complement rational design of new candidates besides achieving a re-evaluation of existing drugs to derive non-obvious combinations that hold better chances of achieving remission.	[Naik, R. R.; Singh, A. K.; Mali, A. M.; Khirade, M. F.; Bapat, S. A.] Natl Ctr Cell Sci, NCCS Complex, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Bapat, SA (corresponding author), Natl Ctr Cell Sci, NCCS Complex, Pune 411007, Maharashtra, India.	sabapat@nccs.res.in	Bapat, Sharmila/AGU-4130-2022	Bapat, Sharmila/0000-0002-9557-2233	NCCS	NCCS	We appreciate the efforts of Dr Mrunalini Moghe (Deenanath Mangeshkar Hospital, Pune) and Dr Anjali Kusumbe in karyotyping, Mr Swapnil Kamble in cryosectioning and thank Dr Shona Nag (Jehangir Hospital, Pune) for providing gemcitabine. This research is supported by NCCS intra-mural grants to SAB.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bian ML, 2010, SCI CHINA LIFE SCI, V53, P1322, DOI 10.1007/s11427-010-4086-1; Bouchet BP, 2007, BRIT J CANCER, V97, P1218, DOI 10.1038/sj.bjc.6603936; Cavanagh BL, 2011, MOLECULES, V9, P7980; Centenera MM, 2013, NAT REV UROL, V10, P483, DOI 10.1038/nrurol.2013.126; Chiang YP, 1996, BBA-MOL CELL RES, V1313, P295, DOI 10.1016/0167-4889(96)00103-6; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Cree IA, 2010, CURR OPIN PHARMACOL, V10, P375, DOI 10.1016/j.coph.2010.05.001; Diaz-Cano SJ, 2012, INT J MOL SCI, V13, P1951, DOI 10.3390/ijms13021951; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kunos CA, 2011, RADIAT RES, V176, P425, DOI 10.1667/RR2556.1; Kusumbe AP, 2009, CANCER RES, V69, P9245, DOI 10.1158/0008-5472.CAN-09-2802; Kusumbe AP, 2009, STEM CELLS, V27, P498, DOI 10.1634/stemcells.2008-0868; Li B, 2012, CLIN CANCER RES, V18, P5595, DOI 10.1158/1078-0432.CCR-12-1427; Lin D, 2014, ASIAN J ANDROL, V16, P407, DOI 10.4103/1008-682X.125394; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Natrajan R, 2013, CANCER RES, V73, P3483, DOI 10.1158/0008-5472.CAN-12-4717; Navin NE, 2010, MOL ONCOL, V4, P267, DOI 10.1016/j.molonc.2010.04.010; Niu DD, 2009, PROTEOMICS, V9, P3856, DOI 10.1002/pmic.200900071; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schoenborn JR, 2013, CLIN CANCER RES, V19, P4058, DOI 10.1158/1078-0432.CCR-12-3606; Shan-Cheng R, 2013, ASIAN J ANDROL, V15, P729; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang B, 2010, EXPERT OPIN DRUG DEL, V7, P1159, DOI 10.1517/17425247.2010.513968; Wani AA, 2006, ONCOGENE, V25, P6336, DOI 10.1038/sj.onc.1209649; Ye Neng-Sheng, 2006, Genomics Proteomics & Bioinformatics, V4, P18, DOI 10.1016/S1672-0229(06)60012-0	33	6	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					727	737		10.1038/onc.2015.130	http://dx.doi.org/10.1038/onc.2015.130			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25915841				2022-12-26	WOS:000370331300006
J	Alontaga, AY; Ambaye, ND; Li, YJ; Vega, R; Chen, CH; Bzymek, KP; Williams, JC; Hu, WD; Chen, Y				Alontaga, Aileen Y.; Ambaye, Nigus D.; Li, Yi-Jia; Vega, Ramir; Chen, Chih-Hong; Bzymek, Krzysztof P.; Williams, John C.; Hu, Weidong; Chen, Yuan			RWD Domain as an E2 (Ubc9)-Interaction Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE MODIFICATIONS; E1-E2 INTERACTION; CYS DOMAIN; UBC9; PROTEIN; SUMO; BINDING; E1; IDENTIFICATION; CONJUGATION	An RWD domain is a well conserved domain found through bioinformatic analysis of the human proteome sequence; however, its function has been unknown. Ubiquitin-like modifications require the catalysis of three enzymes generally known as E1, E2, and E3. We solved the crystal structure of the E2 for the small ubiquitin-like modifiers (SUMO) in complex with an RWD domain and confirmed the structure using solution NMR analysis. The binding surface of RWD on Ubc9 is located near the N terminus of Ubc9 that is known to be involved in non-covalent binding of the proteins in the conjugation machinery, including a domain of E1, SUMO, and an E3 ligase. NMR data indicate that the RWD domain does not bind to SUMO and E1. The interaction between RWD and Ubc9 has a K-d of 32 +/- 4 mu M. Consistent with the structure and binding affinity and in contrast to a previous report, the RWD domain and RWDD3 have minimal effects on global SUMOylation. The structural and biochemical information presented here forms the basis for further investigation of the functions of RWD-containing proteins.	[Alontaga, Aileen Y.; Ambaye, Nigus D.; Li, Yi-Jia; Vega, Ramir; Chen, Chih-Hong; Bzymek, Krzysztof P.; Williams, John C.; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Hu, Weidong] City Hope Natl Med Ctr, Beckman Res Inst, NMR Core Facil, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1450 East Duarte Rd, Duarte, CA 91010 USA.	ychen@coh.org	Regan, Clinton/E-6250-2012	Li, Yi-Jia/0000-0002-8791-8097; Ambaye, Nigus/0000-0001-5026-6542	National Institutes of Health [GM102538, GM086171]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086171, R01GM102538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102538 and GM086171. The authors declare that they have no conflicts of interest with the contents of this article.	Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chen YA, 2007, BIOSCI TRENDS, V1, P16; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garciade la Torre J. G., 1981, Q REV BIOPHYS, V14, P81; Gerez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057795; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Liu Q, 1999, BIOCHEMISTRY-US, V38, P1415, DOI 10.1021/bi981840h; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Yasugi T, 1996, NUCLEIC ACIDS RES, V24, P2005, DOI 10.1093/nar/24.11.2005; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	27	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16550	16559		10.1074/jbc.M115.644047	http://dx.doi.org/10.1074/jbc.M115.644047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25918163	Green Published, hybrid			2022-12-26	WOS:000357572800008
J	Samant, SA; Pillai, VB; Sundaresan, NR; Shroff, SG; Gupta, MP				Samant, Sadhana A.; Pillai, Vinodkumar B.; Sundaresan, Nagalingam R.; Shroff, Sanjeev G.; Gupta, Mahesh P.			Histone Deacetylase 3 (HDAC3)-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; molecular cell biology; molecular motor; myosin; signal transduction	MUSCLE-CONTRACTION; ATPASE ACTIVITY; HEART-FAILURE; ACTIN; PURIFICATION; EXPRESSION; PROTEINS; HYPOXIA; COMPLEX; FAMILY	Background: Reversible lysine acetylation has emerged as an important post-translational modification regulating activity of the target protein. Results: Upon lysine acetylation, enzymatic activity of both cardiac myosin heavy chain (MHC) isoforms is up-regulated. Conclusion: As an early response to stress, cardiac MHCs are acetylated. Significance: Contractile performance of the heart can be improved by regulating MHC acetylation without isoform switch. Reversible lysine acetylation is a widespread post-translational modification controlling the activity of proteins in different subcellular compartments. We previously demonstrated that a class II histone deacetylase (HDAC), HDAC4, and a histone acetyltransferase, p300/CREB-binding protein-associated factor, associate with cardiac sarcomeres and that a class I and II HDAC inhibitor, trichostatin A, enhances contractile activity of myofilaments. In this study we show that a class I HDAC, HDAC3, is also present at cardiac sarcomeres. By immunohistochemical and electron microscopic analyses, we found that HDAC3 was localized to A-band of sarcomeres and capable of deacetylating myosin heavy chain (MHC) isoforms. The motor domains of both cardiac - and -MHC isoforms were found to be reversibly acetylated. Biomechanical studies revealed that lysine acetylation significantly decreased the K-m for the actin-activated ATPase activity of MHC isoforms. By in vitro motility assay, we found that lysine acetylation increased the actin-sliding velocity of -myosin by 20% and -myosin by 36% compared with their respective non-acetylated isoforms. Moreover, myosin acetylation was found to be sensitive to cardiac stress. During induction of hypertrophy, myosin isoform acetylation increased progressively with duration of stress stimuli independently of isoform shift, suggesting that lysine acetylation of myosin could be an early response of myofilaments to increase contractile performance of the heart. These studies provide the first evidence for localization of HDAC3 at myofilaments and uncover a novel mechanism modulating the motor activity of cardiac MHC isoforms.	[Samant, Sadhana A.; Pillai, Vinodkumar B.; Sundaresan, Nagalingam R.; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Shroff, Sanjeev G.] Univ Pittsburg, Dept Bioengn, Pittsburgh, PA 15261 USA	University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, MC 5040,5841 South Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1-HL83423, RO1-HL117041, RO1-HL111455]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117041, R01HL083423, R01HL111455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL83423, RO1-HL117041, and RO1-HL111455.	Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; CLARK WA, 1982, J BIOL CHEM, V257, P5449; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Jacques AM, 2008, CARDIOVASC RES, V79, P481, DOI 10.1093/cvr/cvn094; Kamitomo M, 2002, J SOC GYNECOL INVEST, V9, P335, DOI 10.1016/S1071-5576(02)00180-6; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krenz M, 2007, J BIOL CHEM, V282, P24057, DOI 10.1074/jbc.M704574200; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Pillai JB, 2008, AM J PHYSIOL-HEART C, V294, pH1388, DOI 10.1152/ajpheart.01339.2007; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Roels B, 2008, AM J PHYSIOL-REG I, V294, pR1911, DOI 10.1152/ajpregu.00210.2006; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; SCHLUTER JM, 1994, AM J PHYSIOL, V266, pC1699, DOI 10.1152/ajpcell.1994.266.6.C1699; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; UCHIDA K, 1977, J BIOCHEM, V82, P469; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	33	27	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15559	15569		10.1074/jbc.M115.653048	http://dx.doi.org/10.1074/jbc.M115.653048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25911107	Green Published, hybrid			2022-12-26	WOS:000356527400021
J	Kissing, S; Hermsen, C; Repnik, U; Nesset, CK; von Bargen, K; Griffiths, G; Ichihara, A; Lee, BS; Schwake, M; De Brabander, J; Haas, A; Saftig, P				Kissing, Sandra; Hermsen, Christina; Repnik, Urska; Nesset, Cecilie Kasi; von Bargen, Kristine; Griffiths, Gareth; Ichihara, Atsuhiro; Lee, Beth S.; Schwake, Michael; De Brabander, Jef; Haas, Albert; Saftig, Paul			Vacuolar ATPase in Phagosome-Lysosome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; V-ATPASE; H+-ATPASE; A3 ISOFORM; NEUROTRANSMITTER RELEASE; PRORENIN RECEPTOR; IN-VIVO; SUBUNIT; ACIDIFICATION; MICE	The vacuolar H+ -ATPase (v-ATPase) complex is instrumental in establishing and maintaining acidification of some cellular compartments, thereby ensuring their functionality. Recently it has been proposed that the transmembrane V-0 sector of v-ATPase and its a-subunits promote membrane fusion in the endocytic and exocytic pathways independent of their acidification functions. Here, we tested if such a proton-pumping independent role of v-ATPase also applies to phagosome-lysosome fusion. Surprisingly, endo(lyso)somes in mouse embryonic fibroblasts lacking the V-0 a3 subunit of the v-ATPase acidified normally, and endosome and lysosome marker proteins were recruited to phagosomes with similar kinetics in the presence or absence of the a3 subunit. Further experiments used macrophages with a knockdown of v-ATPase accessory protein 2 (ATP6AP2) expression, resulting in a strongly reduced level of the V-0 sector of the v-ATPase. However, acidification appeared undisturbed, and fusion between latex bead-containing phagosomes and lysosomes, as analyzed by electron microscopy, was even slightly enhanced, as was killing of non-pathogenic bacteria by V-0 mutant macrophages. Pharmacologically neutralized lysosome pH did not affect maturation of phagosomes in mouse embryonic cells or macrophages. Finally, locking the two large parts of the v-ATPase complex together by the drug saliphenylhalamide A did not inhibit in vitro and in cellulo fusion of phagosomes with lysosomes. Hence, our data do not suggest a fusion-promoting role of the v-ATPase in the formation of phagolysosomes.	[Kissing, Sandra; Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Hermsen, Christina; von Bargen, Kristine; Haas, Albert] Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany; [Repnik, Urska; Nesset, Cecilie Kasi; Griffiths, Gareth] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Med 2, Tokyo 162866, Japan; [Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Schwake, Michael] Univ Bielefeld, Dept Chem, Biochem 3, D-33615 Bielefeld, Germany; [De Brabander, Jef] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Kiel; University of Bonn; University of Oslo; Tokyo Women's Medical University; University System of Ohio; Ohio State University; University of Bielefeld; University of Texas System; University of Texas Southwestern Medical Center Dallas	Haas, A (corresponding author), Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany.	albert.haas@uni-bonn.de; psaftig@biochem.uni-kiel.de	Saftig, Paul/A-7966-2010; Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387; Schwake, Michael/0000-0002-4173-2166	Deutsche Forschungsgemeinschaft [GRK1459, SPP1580]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GRK1459 (to P.S. and S.K.) and SPP1580 (to A.H., G.G., and P.S).	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Becken U, 2010, P NATL ACAD SCI USA, V107, P20726, DOI 10.1073/pnas.1007295107; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coonrod EM, 2013, DEV CELL, V27, P462, DOI 10.1016/j.devcel.2013.10.014; Del Fattore A, 2006, J MED GENET, V43, P315, DOI 10.1136/jmg.2005.036673; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; DIMENT S, 1987, J LEUKOCYTE BIOL, V42, P485, DOI 10.1002/jlb.42.5.485; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Ichihara A, 2011, J RENIN-ANGIO-ALDO S, V12, P638, DOI 10.1177/1470320311429227; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kluge C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-29; Korfali N, 2012, NUCLEUS-PHILA, V3, P552, DOI 10.4161/nucl.22257; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; MARKS SC, 1985, J HERED, V76, P171, DOI 10.1093/oxfordjournals.jhered.a110059; NEZU J, 1992, J BIOCHEM, V112, P212, DOI 10.1093/oxfordjournals.jbchem.a123879; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sato K, 2006, MOL IMMUNOL, V43, P1443, DOI 10.1016/j.molimm.2005.07.035; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Strasser B, 2011, EMBO J, V30, P4126, DOI 10.1038/emboj.2011.335; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wang D, 2014, J CELL BIOL, V205, P21, DOI 10.1083/jcb.201312109; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	52	55	55	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14166	14180		10.1074/jbc.M114.628891	http://dx.doi.org/10.1074/jbc.M114.628891			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25903133	hybrid, Green Published			2022-12-26	WOS:000355313000044
J	Lohbeck, M; Lebrija-Trejos, E; Martinez-Ramos, M; Meave, JA; Poorter, L; Bongers, F				Lohbeck, Madelon; Lebrija-Trejos, Edwin; Martinez-Ramos, Miguel; Meave, Jorge A.; Poorter, Lourens; Bongers, Frans			Functional Trait Strategies of Trees in Dry and Wet Tropical Forests Are Similar but Differ in Their Consequences for Succession	PLOS ONE			English	Article							PLANT ECONOMICS SPECTRUM; LEAF LIFE-SPANS; SEED SIZE; SECONDARY SUCCESSION; TRADE-OFF; DROUGHT; SHADE; TOLERANCE; RESPONSES; SEEDLINGS	Global plant trait studies have revealed fundamental trade-offs in plant resource economics. We evaluated such trait trade-offs during secondary succession in two species-rich tropical ecosystems that contrast in precipitation: dry deciduous and wet evergreen forests of Mexico. Species turnover with succession in dry forest largely relates to increasing water availability and in wet forest to decreasing light availability. We hypothesized that while functional trait trade-offs are similar in the two forest systems, the successful plant strategies in these communities will be different, as contrasting filters affect species turnover. Research was carried out in 15 dry secondary forest sites (5-63 years after abandonment) and in 17 wet secondary forest sites (<1-25 years after abandonment). We used 11 functional traits measured on 132 species to make species-trait PCA biplots for dry and wet forest and compare trait trade-offs. We evaluated whether multivariate plant strategies changed during succession, by calculating a 'Community-Weighted Mean' plant strategy, based on species scores on the first two PCA-axes. Trait spectra reflected two main trade-off axes that were similar for dry and wet forest species: acquisitive versus conservative species, and drought avoiding species versus evergreen species with large animal-dispersed seeds. These trait associations were consistent when accounting for evolutionary history. Successional changes in the most successful plant strategies reflected different functional trait spectra depending on the forest type. In dry forest the community changed from having drought avoiding strategies early in succession to increased abundance of evergreen strategies with larger seeds late in succession. In wet forest the community changed from species having mainly acquisitive strategies to those with more conservative strategies during succession. These strategy changes were explained by increasing water availability during dry forest succession and increasing light scarcity during wet forest succession. Although similar trait spectra were observed among dry and wet secondary forest species, the consequences for succession were different resulting from contrasting environmental filters.	[Lohbeck, Madelon; Lebrija-Trejos, Edwin; Poorter, Lourens; Bongers, Frans] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AA Wageningen, Netherlands; [Lebrija-Trejos, Edwin] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Lohbeck, Madelon; Martinez-Ramos, Miguel] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia 58190, Michoacan, Mexico; [Lebrija-Trejos, Edwin; Meave, Jorge A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico	Wageningen University & Research; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Lohbeck, M (corresponding author), Wageningen Univ, Forest Ecol & Forest Management Grp, POB 47, NL-6700 AA Wageningen, Netherlands.	madelon.lohbeck@wur.nl	Poorter, Lourens/AAL-1709-2021; Martínez-Ramos, Miguel/G-8451-2019; Meave, Jorge/B-3673-2008; Lohbeck, Madelon/M-6390-2014	Martínez-Ramos, Miguel/0000-0002-7785-1917; Meave, Jorge/0000-0002-6241-8803; Lohbeck, Madelon/0000-0002-3959-1800; Lebrija-Trejos, Edwin/0000-0003-1511-1718; Poorter, Lourens/0000-0003-1391-4875	Wageningen University; Wageningen Research Center; NSF-LTREB [DEB-0639393, DEB 1147429]; SEMARNAT-CONACYT [2002-C01-0597]; SEP-CONACYT [CB-2005-01-51043, 2009-129740]; CONACYT; CONACYT-SEMARNAT [2002-C01-0267]; PAPIIT [IN216007]; SNI, Panama; SENACYT, Panama; Nucleo DiverSus project by Inter-American Institute for Global Change Research (IAI)CRN; SGP-CRA (National Science Foundation) [GEO-0452325, GEO-1138881];  [SEP CONACYT-2009-01-128136]; Directorate For Geosciences [1138881] Funding Source: National Science Foundation; Division Of Environmental Biology [1147429] Funding Source: National Science Foundation	Wageningen University(European Commission); Wageningen Research Center; NSF-LTREB(National Science Foundation (NSF)); SEMARNAT-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT-SEMARNAT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); SNI, Panama; SENACYT, Panama; Nucleo DiverSus project by Inter-American Institute for Global Change Research (IAI)CRN; SGP-CRA (National Science Foundation); ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: ML and FB were supported by a research grant from Wageningen University and Research Center. FB and MMR were supported by NSF-LTREB DEB-0639393 and #DEB 1147429. MMR was supported by grants SEMARNAT-CONACYT 2002-C01-0597, SEP-CONACYT CB-2005-01-51043, SEP-CONACYT 2009-129740. ELT acknowledges support by CONACYT (personal scholarship), CONACYT-SEMARNAT (grant 2002-C01-0267), PAPIIT (grant IN216007) and SNI, SENACYT, Panama. JAM was supported by SEP CONACYT-2009-01-128136. LP was partly supported by the Nucleo DiverSus project, which was supported by the Inter-American Institute for Global Change Research (IAI)CRN 2015 and SGP-CRA2015 (through National Science Foundation grants GEO-0452325 and GEO-1138881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Baltzer JL, 2008, FUNCT ECOL, V22, P221, DOI 10.1111/j.1365-2435.2007.01374.x; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bullock Stephen H., 1995, P277, DOI 10.1017/CBO9780511753398.011; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Dahlgren JP, 2006, J VEG SCI, V17, P577, DOI 10.1111/j.1654-1103.2006.tb02481.x; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; FAO, 2020, GLOBAL FOREST RESOUR; Fortunel C, 2012, FUNCT ECOL, V26, P1153, DOI 10.1111/j.1365-2435.2012.02020.x; FOSTER SA, 1985, ECOLOGY, V66, P773, DOI 10.2307/1940538; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; HAMMOND DS, 1995, ECOLOGY, V76, P2544, DOI 10.2307/2265827; Holmgren M, 2000, OIKOS, V90, P67, DOI 10.1034/j.1600-0706.2000.900107.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; Jager MM, 2015, J ECOL, V103, P374, DOI 10.1111/1365-2745.12366; Jansen PA, 2008, ECOGRAPHY, V31, P43, DOI 10.1111/j.2007.0906-7590.05156.x; Kahmen S, 2004, J VEG SCI, V15, P21, DOI 10.1111/j.1654-1103.2004.tb02233.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kitajima K, 2012, NEW PHYTOL, V195, P640, DOI 10.1111/j.1469-8137.2012.04203.x; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; Lebrija-Trejos E, 2008, BIOTROPICA, V40, P422, DOI 10.1111/j.1744-7429.2008.00398.x; Lebrija-Trejos E, 2011, J TROP ECOL, V27, P477, DOI 10.1017/S0266467411000253; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Lohbeck M, 2013, ECOLOGY, V94, P1211, DOI 10.1890/12-1850.1; MA, 2005, MILL EC ASS; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Mendez-Alonzo R, 2013, TREES-STRUCT FUNCT, V27, P745, DOI 10.1007/s00468-012-0829-x; Mendez-Alonzo R, 2012, ECOLOGY, V93, P2397, DOI 10.1890/11-1213.1; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Nicotra AB, 1999, ECOLOGY, V80, P1908, DOI 10.1890/0012-9658(1999)080[1908:SHOLAW]2.0.CO;2; Niinemets U, 1998, PLANT ECOL, V134, P1, DOI 10.1023/A:1009773704558; Oksanen J, 2011, R PACKAGE VEGAN COMM; Pakeman RJ, 2007, APPL VEG SCI, V10, P91, DOI 10.1111/j.1654-109X.2007.tb00507.x; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Garcia E. A., 2001, Acta Botanica Mexicana, P19; Perez-Garcia EA, 2010, FOLIA GEOBOT, V45, P143, DOI 10.1007/s12224-010-9064-7; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pineda-Garcia F, 2013, PLANT CELL ENVIRON, V36, P405, DOI 10.1111/j.1365-3040.2012.02582.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, ECOLOGY IN PRESS; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUR0IMAGE.2011.01.013]; REICH PB, 1991, OECOLOGIA, V86, P16, DOI 10.1007/BF00317383; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Romero C, 2008, CAN J FOREST RES, V38, P611, DOI 10.1139/X07-205; Ross MS, 2001, BIOTROPICA, V33, P23, DOI 10.1111/j.1744-7429.2001.tb00154.x; Sack L, 2004, OIKOS, V107, P110, DOI 10.1111/j.0030-1299.2004.13184.x; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yates MJ, 2010, FUNCT ECOL, V24, P485, DOI 10.1111/j.1365-2435.2009.01678.x; YOUNG KR, 1987, VEGETATIO, V71, P157; Zieminska K, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt046	72	82	90	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123741	10.1371/journal.pone.0123741	http://dx.doi.org/10.1371/journal.pone.0123741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919023	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659400033
J	Fischer, R; Ensslin, A; Rutten, G; Fischer, M; Costa, DS; Kleyer, M; Hemp, A; Paulick, S; Huth, A				Fischer, Rico; Ensslin, Andreas; Rutten, Gemma; Fischer, Markus; Costa, David Schellenberger; Kleyer, Michael; Hemp, Andreas; Paulick, Sebastian; Huth, Andreas			Simulating Carbon Stocks and Fluxes of an African Tropical Montane Forest with an Individual-Based Forest Model	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; LONG-TERM IMPACTS; CLIMATE-CHANGE; RAIN-FOREST; MT. KILIMANJARO; BIOMASS; TEMPERATE; DYNAMICS; GROWTH; PRODUCTIVITY	Tropical forests are carbon-dense and highly productive ecosystems. Consequently, they play an important role in the global carbon cycle. In the present study we used an individual-based forest model (FORMIND) to analyze the carbon balances of a tropical forest. The main processes of this model are tree growth, mortality, regeneration, and competition. Model parameters were calibrated using forest inventory data from a tropical forest at Mt. Kilimanjaro. The simulation results showed that the model successfully reproduces important characteristics of tropical forests (aboveground biomass, stem size distribution and leaf area index). The estimated aboveground biomass (385 t/ha) is comparable to biomass values in the Amazon and other tropical forests in Africa. The simulated forest reveals a gross primary production of 24 t(c)ha(-1)yr(-1). Modeling above-and belowground carbon stocks, we analyzed the carbon balance of the investigated tropical forest. The simulated carbon balance of this old-growth forest is zero on average. This study provides an example of how forest models can be used in combination with forest inventory data to investigate forest structure and local carbon balances.	[Fischer, Rico; Paulick, Sebastian; Huth, Andreas] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, D-04318 Leipzig, Germany; [Ensslin, Andreas; Rutten, Gemma; Fischer, Markus] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Costa, David Schellenberger; Kleyer, Michael] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, D-26111 Oldenburg, Germany; [Hemp, Andreas] Univ Bayreuth, Dept Plant Systemat, D-95440 Bayreuth, Germany; [Huth, Andreas] Univ Osnabruck, Inst Environm Syst Res, D-49076 Osnabruck, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bern; Carl von Ossietzky Universitat Oldenburg; University of Bayreuth; University Osnabruck	Fischer, R (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Permoserstr 15, D-04318 Leipzig, Germany.	rico.fischer@ufz.de	Fischer, Rico/AAI-4543-2021; Fischer, Markus/C-6411-2008; Schellenberger Costa, David/AAT-5413-2020	Fischer, Rico/0000-0002-0482-0095; Fischer, Markus/0000-0002-5589-5900; Schellenberger Costa, David/0000-0003-1747-1506; Rutten, Gemma/0000-0001-9552-4605	German Research Foundation (DFG) within the Research Unit FOR1246	German Research Foundation (DFG) within the Research Unit FOR1246	This study was financially supported by the German Research Foundation (DFG) within the Research Unit FOR1246 (Kilimanjaro ecosystems under global changes: linking biodiversity, biotic interactions and biogeochemical ecosystem processes; www.kilimanjaro.biozentrum.uni-wuerzburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch JK, 2014, NATURE, V506, P41, DOI 10.1038/506041a; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bennett ND, 2013, ENVIRON MODELL SOFTW, V40, P1, DOI 10.1016/j.envsoft.2012.09.011; Bohn FJ, 2014, ECOL MODEL, V278, P9, DOI 10.1016/j.ecolmodel.2014.01.021; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Botkin D. B., 1993, FOREST DYNAMICS; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Dislich C, 2009, ERDKUNDE, V63, P347, DOI 10.3112/erdkunde.2009.04.05; FAO, 2011, STAT WORLDS FOR, P179; Fischer R, 2014, ENVIRON MODELL SOFTW, V52, P200, DOI 10.1016/j.envsoft.2013.10.026; Granier A, 1999, ECOL MODEL, V116, P269, DOI 10.1016/S0304-3800(98)00205-1; Grant RF, 2009, ECOL MONOGR, V79, P445, DOI 10.1890/08-0074.1; Gutierrez AG, 2012, PERSPECT PLANT ECOL, V14, P243, DOI 10.1016/j.ppees.2012.01.004; Hartig F, 2014, BIOGEOSCIENCES, V11, P1261, DOI 10.5194/bg-11-1261-2014; Hemp A, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P51, DOI 10.1201/9781420002874.ch4; Hemp A, 2005, GLOBAL CHANGE BIOL, V11, P1013, DOI 10.1111/j.1365-2486.2005.00968.x; Hemp A, 2002, PLANT ECOL, V159, P211, DOI 10.1023/A:1015569125417; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hemp A, 2006, PLANT ECOL, V184, P27, DOI 10.1007/s11258-005-9049-4; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; Houghton R.A., 2009, J GEOPHYS RES-BIOGEO, V114; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Huth A, 2000, ECOL MODEL, V134, P1, DOI 10.1016/S0304-3800(00)00328-8; Huth A, 2001, FOREST ECOL MANAG, V142, P33, DOI 10.1016/S0378-1127(00)00338-8; Kammesheidt L, 2001, J APPL ECOL, V38, P756, DOI 10.1046/j.1365-2664.2001.00629.x; Kazmierczak M, 2014, ECOL MODEL, V288, P94, DOI 10.1016/j.ecolmodel.2014.05.002; Kohler P, 2010, BIOGEOSCIENCES, V7, P2531, DOI 10.5194/bg-7-2531-2010; Kohler P, 2007, ECOL MODEL, V203, P511, DOI 10.1016/j.ecolmodel.2006.11.023; Kohler P, 2004, CLIMATIC CHANGE, V67, P95, DOI 10.1007/s10584-004-0713-9; Kohler P, 2003, ECOSYSTEMS, V6, P114, DOI 10.1007/s10021-002-0121-9; Kohler P, 2000, J TROP ECOL, V16, P591, DOI 10.1017/S0266467400001590; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Lehmann S, 2015, ECOL MODEL, V301, P98, DOI 10.1016/j.ecolmodel.2015.01.013; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; MARTINEZRAMOS M, 1989, ECOLOGY, V70, P555, DOI 10.2307/1940203; Pabst H, 2013, APPL SOIL ECOL, V67, P10, DOI 10.1016/j.apsoil.2013.02.006; Pacala S, 2002, MG POP BIOL, V33, P169; Pachauri R.K., 2008, CLIMATE CHANGE 2007, P104; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; PRENTICE IC, 1993, ECOL MODEL, V65, P51, DOI 10.1016/0304-3800(93)90126-D; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Ruger N, 2008, ECOSYSTEMS, V11, P868, DOI 10.1007/s10021-008-9166-8; Ruger N, 2007, FOREST ECOL MANAG, V252, P52, DOI 10.1016/j.foreco.2007.06.020; Rutten G, 2015, FOREST ECOL MANAG, V337, P61, DOI 10.1016/j.foreco.2014.10.036; Shugart H. H., 2003, THEORY FOREST DYNAMI; Shugart H.H., 1984, THEORY FOREST DYNAMI; Smith T. M, 1997, PLANT FUNCTIONAL TYP; Taubert F, 2012, ECOL MODEL, V245, P84, DOI 10.1016/j.ecolmodel.2012.04.007; Verbeeck H, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001544; WHITMORE TC, 1998, INTRO TROPICAL RAIN; Wright SJ, 2013, GLOBAL CHANGE BIOL, V19, P337, DOI 10.1111/gcb.12052	65	15	15	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123300	10.1371/journal.pone.0123300	http://dx.doi.org/10.1371/journal.pone.0123300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915854	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100019
J	Fomda, BA; Khan, A; Thokar, MA; Malik, AA; Fazili, A; Dar, RA; Sharma, M; Malla, N				Fomda, Bashir Ahmad; Khan, Asiya; Thokar, Manzoor Ahmad; Malik, Ajaz Ahmad; Fazili, Anjum; Dar, Rayees Ahmad; Sharma, Monika; Malla, Nancy			Sero-Epidemiological Survey of Human Cystic Echinococcosis in Kashmir, North India	PLOS ONE			English	Article							HUMAN HYDATIDOSIS; PERCUTANEOUS DRAINAGE; GRANULOSUS CYSTS; SEROPREVALENCE; POPULATION; MANAGEMENT; INFECTION; DIAGNOSIS; BULGARIA; ALVEOLAR	Background Echinococcosis is a human and animal health problem in many endemic areas worldwide. There are numerous reports and hospital-based studies from Kashmir, North India, yet there has been no epidemiological study conducted in Kashmir, the apparently endemic area for human hydatidosis. This study was designed to determine the seroprevalence of hydatid infection in Kashmir Valley and to find out association of risk factors for acquisition of this infection. Methodology Fourteen hundred and twenty-nine samples were collected from different districts in the Kashmir region (North India) using systematic random sampling. The 130 control samples included were from apparently healthy blood donors (100), patients with other parasitic infections (20), surgically confirmed hydatidosis patients (5), and apparently healthy subjects excluded for hydatidosis and intestinal parasitic infections (5). Hydatid-specific IgG antibody was detected by enzyme-linked immunosorbent assay, and seropositive samples were analysed further by Western blotting. Results Out of 1,429 samples, 72 (5.03%) were IgG positive by ELISA. The percentage occurrence of the highly immunoreactive antigenic fractions in IgG ELISA positive samples was 57 kDa (72.2%) followed by 70 kDa (66.7%) and 39kDa (58.3%) by immunoblotting. Samples with other parasitic infections were reactive with the cluster of 54-59 kDa antigenic fractions. Age <15 years, male gender, contact with dog, and rural residence were the most significant factors associated with the seropositivity. Conclusion The study revealed that 72 (5.03%) out of 1,429 subjects asymptomatic for hydatidosis were seropositve to E. granulosus antigen by ELISA. Western blot analysis of 72 ELISA seropositive samples showed that 66.7% and 58.3% of samples were immunoreactive with 70 and 39kDa specific antigenic fractions, respectively. The seropositivity was significantly higher (5.79%) in the younger age group (<15 years) as compared to the 16-55 years (4.07%) and >55 years (3.05%) age groups, suggesting ongoing transmission of this infection in the younger age group. The number of seropositive males was significantly higher as compared to females. The risk factors identified were rural residence and contact with dogs. The study suggests the presence of asymptomatic infection in subjects in Kashmir, North India, and efforts need to be made for implementation of effective prevention measures to reduce the infection burden, which may otherwise lead to symptomatology and complications in the infected subjects.	[Fomda, Bashir Ahmad; Khan, Asiya; Thokar, Manzoor Ahmad] Sherikashmir Inst Med Sci, Dept Microbiol, Srinagar, Jammu & Kashmir, India; [Malik, Ajaz Ahmad] Sherikashmir Inst Med Sci, Dept Gen Surg, Srinagar, Jammu & Kashmir, India; [Fazili, Anjum] Sherikashmir Inst Med Sci, Dept Community Med, Srinagar, Jammu & Kashmir, India; [Dar, Rayees Ahmad] Sherikashmir Inst Med Sci, Dept Biostat, Srinagar, Jammu & Kashmir, India; [Sharma, Monika; Malla, Nancy] Post Grad Inst Med Educ & Res, Dept Med Parasitol, Chandigarh, India	Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Fomda, BA (corresponding author), Sherikashmir Inst Med Sci, Dept Microbiol, Srinagar, Jammu & Kashmir, India.	bashirfomda@gmail.com			Indian Council of Medical Research, New Delhi, India [5/3/3/5/2006-ECD 1]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by a grant from the Indian Council of Medical Research, New Delhi, India (grant no 5/3/3/5/2006-ECD 1), sanctioned to BAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambulo P, 1997, ACTA TROP, V67, P113, DOI 10.1016/S0001-706X(97)00049-1; Arif Sajad Hussain, 2008, Int J Surg, V6, P448, DOI 10.1016/j.ijsu.2008.08.003; Asghari M, 2013, IRAN J PUBLIC HEALTH, V42, P391; Chiraga S., 2014, J HELMINTHOL, P1; Craig P. S., 2007, Tropical Medicine and Health, V35, P283, DOI 10.2149/tmh.35.283; Dhar SN, 1988, RESP MED, V9, P409; Doiz O, 2001, DIAGN MICR INFEC DIS, V41, P139, DOI 10.1016/S0732-8893(01)00293-0; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Eckert J, 2000, INT J PARASITOL, V30, P1283, DOI 10.1016/S0020-7519(00)00130-2; Fomda B. A., 2002, Journal of Parasitic Diseases, V26, P34; Fotiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037112; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Grosso G, 2012, WORLD J GASTROENTERO, V18, P1425, DOI 10.3748/wjg.v18.i13.1425; Gutierrez MP, 2003, ENFERM INFEC MICR CL, V21, P563, DOI 10.1157/13054549; Hanillo A, 2004, J ZANJAN U MED SCI H, V12, P41; Heidari Z, 2011, IRAN J PARASITOL, V6, P19; KANWAR JR, 1992, J MED MICROBIOL, V36, P46, DOI 10.1099/00222615-36-1-46; Kaur M, 1999, INDIAN J MED RES, V110, P18; Kaur Manjit, 1995, Immunology and Infectious Diseases (Oxford), V5, P67; Kayal Ankit, 2014, ISRN Gastroenterol, V2014, P514757, DOI 10.1155/2014/514757; Khurana S, 2007, TROP DOCT, V37, P100, DOI 10.1258/004947507780609149; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; KHUROO MS, 1993, GASTROENTEROLOGY, V104, P1452, DOI 10.1016/0016-5085(93)90355-G; KHUROO MS, 1991, RADIOLOGY, V180, P141, DOI 10.1148/radiology.180.1.2052682; Kouser Sideeq, 2014, National Journal of Community Medicine, V5, P66; Logar J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-63; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malik AA, 2010, WORLD J GASTRO SURG, V2, P78, DOI 10.4240/wjgs.v2.i3.78; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Parikh Falguni, 2012, J Assoc Physicians India, V60, P9; Shams-Ul-Bari, 2011, SAUDI J GASTROENTERO, V17, P343, DOI 10.4103/1319-3767.84493; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082904; Sharma M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002262; Siddharth SR, 2012, ANN TROP MED PUBLIC, V5, P225; Sudarshan M K, 2006, J Commun Dis, V38, P32; Todorov T, 1999, B WORLD HEALTH ORGAN, V77, P110; Todorov T, 2000, ANN TROP MED PARASIT, V94, P135, DOI 10.1080/00034980057473; Torgerson PR, 2003, RES VET SCI, V74, P191, DOI 10.1016/S0034-5288(03)00006-7; WATTAL C, 1986, J CLIN MICROBIOL, V24, P41, DOI 10.1128/JCM.24.1.41-46.1986; Yang YR, 2008, TROP MED INT HEALTH, V13, P1086, DOI 10.1111/j.1365-3156.2008.02101.x; Yang YR, 2006, B WORLD HEALTH ORGAN, V84, P714, DOI 10.2471/BLT.05.025718; Yu SH, 2008, JPN J INFECT DIS, V61, P242; ZARGAR SA, 1992, GASTROINTEST RADIOL, V17, P41, DOI 10.1007/BF01888506	43	16	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124813	10.1371/journal.pone.0124813	http://dx.doi.org/10.1371/journal.pone.0124813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915867	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100068
J	Amin, ARMR; Haque, A; Rahman, MA; Chen, ZG; Khuri, FR; Shin, DM				Amin, A. R. M. Ruhul; Haque, Abedul; Rahman, Mohammad Aminur; Chen, Zhuo Georgia; Khuri, Fadlo Raja; Shin, Dong Moon			Curcumin Induces Apoptosis of Upper Aerodigestive Tract Cancer Cells by Targeting Multiple Pathways	PLOS ONE			English	Article							BCL-2; INHIBITION; P53; PERSPECTIVES; INDUCTION; GROWTH; ASSAY	Curcumin, a natural compound isolated from the Indian spice "Haldi" or "curry powder", has been used for centuries as a traditional remedy for many ailments. Recently, the potential use of curcumin in cancer prevention and therapy urges studies to uncover the molecular mechanisms associated with its anti-tumor effects. In the current manuscript, we investigated the mechanism of curcumin-induced apoptosis in upper aerodigestive tract cancer cell lines and showed that curcumin-induced apoptosis is mediated by the modulation of multiple pathways such as induction of p73, and inhibition of p-AKT and Bcl-2. Treatment of cells with curcumin induced both p53 and the related protein p73 in head and neck and lung cancer cell lines. Inactivation of p73 by dominant negative p73 significantly protected cells from curcumin-induced apoptosis, whereas ablation of p53 by shRNA had no effect. Curcumin treatment also strongly inhibited p-AKT and Bcl-2 and overexpression of constitutively active AKT or Bcl-2 significantly inhibited curcumin-induced apoptosis. Taken together, our findings suggest that curcumin-induced apoptosis is mediated via activating tumor suppressor p73 and inhibiting p-AKT and Bcl-2.	[Amin, A. R. M. Ruhul; Haque, Abedul; Rahman, Mohammad Aminur; Chen, Zhuo Georgia; Khuri, Fadlo Raja; Shin, Dong Moon] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University	Amin, ARMR (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	aamin9@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Shin, Dong Moon/G-9649-2013	Khuri, Fadlo R./0000-0002-8638-7618; Shin, Dong Moon/0000-0002-8245-4174; AMIN, ARM/0000-0001-9144-2960	Robbins Scholar Award of the Emory Winship Cancer Institute;  [NCI R03CA159369];  [NCI R03CA171663];  [NCI P50 CA128613]; NATIONAL CANCER INSTITUTE [R03CA159369, P50CA128613, R03CA171663] Funding Source: NIH RePORTER	Robbins Scholar Award of the Emory Winship Cancer Institute; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NCI R03CA159369, NCI R03CA171663, NCI P50 CA128613 and a Robbins Scholar Award of the Emory Winship Cancer Institute.	Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; Amin ARMR, 2007, P NATL ACAD SCI USA, V104, P5419, DOI 10.1073/pnas.0700642104; Amin ARMR, 2013, ONCOGENE, V32, P920, DOI 10.1038/onc.2012.96; Amin ARMR, 2010, J BIOL CHEM, V285, P34557, DOI 10.1074/jbc.M110.141135; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Botchkarev VA, 2014, COLD SPRING HARB PER, V4, DOI [10.1101/cshperspect.a019802, DOI 10.1101/CSHPERSPECT.A019802]; Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Houghton P, 2007, METHODS, V42, P377, DOI 10.1016/j.ymeth.2007.01.003; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Loriot Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.365; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Park W, 2013, CANCER PREV RES, V6, P387, DOI 10.1158/1940-6207.CAPR-12-0410; Perkins S, 2002, CANCER EPIDEM BIOMAR, V11, P535; Pillai GR, 2004, CANCER LETT, V208, P163, DOI 10.1016/j.canlet.2004.01.008; Qu MH, 2014, INT J PHARMACEUT, V474, P112, DOI 10.1016/j.ijpharm.2014.08.019; Rahman MA, 2013, CLIN CANCER RES, V19, P3416, DOI 10.1158/1078-0432.CCR-13-0073; Saha A, 2010, CANCER PREV RES, V3, P953, DOI 10.1158/1940-6207.CAPR-09-0247; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singletary K, 1996, CANCER LETT, V103, P137, DOI 10.1016/0304-3835(96)04224-3; Slade N, 2011, CURR PHARM DESIGN, V17, P591, DOI 10.2174/138161211795222621; Sreepriya M, 2006, MOL CELL BIOCHEM, V284, P49, DOI 10.1007/s11010-005-9012-7; Tekedereli I, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.45; Ushida J, 2000, JPN J CANCER RES, V91, P893, DOI 10.1111/j.1349-7006.2000.tb01031.x; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wu JJ, 2014, INT J ONCOL, V45, P95, DOI 10.3892/ijo.2014.2420	30	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124218	10.1371/journal.pone.0124218	http://dx.doi.org/10.1371/journal.pone.0124218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910231	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800069
J	Crespo, A; Pedraz, L; Torrents, E				Crespo, Anna; Pedraz, Lucas; Torrents, Eduard			Function of the Pseudomonas aeruginosa NrdR Transcription Factor: Global Transcriptomic Analysis and Its Role on Ribonucleotide Reductase Gene Expression	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; STREPTOMYCES; INFECTION; SEQUENCE; ENZYMES	Ribonucleotide reductases (RNRs) are a family of sophisticated enzymes responsible for the synthesis of the deoxyribonucleotides (dNTPs), the building blocks for DNA synthesis and repair. Although any living cell must contain one RNR activity to continue living, bacteria have the capacity to encode different RNR classes in the same genome, allowing them to adapt to different environments and growing conditions. Pseudomonas aeruginosa is well known for its adaptability and surprisingly encodes all three known RNR classes (Ia, II and III). There must be a complex transcriptional regulation network behind this RNR activity, dictating which RNR class will be expressed according to specific growing conditions. In this work, we aim to uncover the role of the transcriptional regulator NrdR in P. aeruginosa. We demonstrate that NrdR regulates all three RNR classes, being involved in differential control depending on whether the growth conditions are aerobic or anaerobic. Moreover, we also identify for the first time that NrdR is not only involved in controlling RNR expression but also regulates topoisomerase I (topA) transcription. Finally, to obtain the entire picture of NrdR regulon, we performed a global transcriptomic analysis comparing the transcription profile of wild-type and nrdR mutant strains. The results provide many new data about the regulatory network that controls P. aeruginosa RNR transcription, bringing us a step closer to the understanding of this complex system.	[Crespo, Anna; Pedraz, Lucas; Torrents, Eduard] Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies Grp, Barcelona 08028, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Torrents, E (corresponding author), Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies Grp, Baldiri Reixac 15-21, Barcelona 08028, Spain.	etorrents@ibecbarcelona.eu	Torrents, Eduard/C-7184-2008; Pedraz, Lucas/T-1731-2019	Torrents, Eduard/0000-0002-3010-1609; Pedraz, Lucas/0000-0003-3666-3343	Ministerio de Economia y Competitividad [BFU2011-24066]; Generalitat de Catalunya [2014-SGR01260]; Ministerio de Ciencia e Innovacion	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part through Project: BFU2011-24066. Ministerio de Economia y Competitividad. Principal Investigator: Eduard Torrents; Project: 2014-SGR01260. Generalitat de Catalunya. Principal Investigator: Eduard Torrents; Project: Ramon y Cajal program + I3. Ministerio de Ciencia e Innovacion. Principal Investigator: Eduard Torrents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKLEY RL, 1966, J BIOL CHEM, V241, P176; Borovok I, 2004, MOL MICROBIOL, V54, P1022, DOI 10.1111/j.1365-2958.2004.04325.x; Case ED, 2011, J BACTERIOL, V193, P4396, DOI 10.1128/JB.00294-11; Chuanchuen R, 2002, BIOTECHNIQUES, V33, P760, DOI 10.2144/02334bm08; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; Grinberg I, 2009, J BACTERIOL, V191, P1169, DOI 10.1128/JB.01145-08; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jordan A, 1999, J BACTERIOL, V181, P3974, DOI 10.1128/JB.181.13.3974-3980.1999; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; McKethan BL, 2013, MOL MICROBIOL, V90, P278, DOI 10.1111/mmi.12364; Mowa MB, 2009, J BACTERIOL, V191, P985, DOI 10.1128/JB.01409-08; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Panosa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011328; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Van Alst NE, 2007, INFECT IMMUN, V75, P3780, DOI 10.1128/IAI.00201-07; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123571	10.1371/journal.pone.0123571	http://dx.doi.org/10.1371/journal.pone.0123571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909779	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800041
J	Gutierrez, A; Bento, L; Bautista-Gili, AM; Garcia, F; Martinez-Serra, J; Sanchez, B; Martorell, C; Gines, J; Garcia, L; Gimeno, E; Ferraro, M; Del Campo, R; Bargay, J; Perez, A; Vercher, J; Scaff, M; Pacheco, A; Ballester, C; Garcia, F; Ramos, R; Salar, A; Besalduch, J				Gutierrez, Antonio; Bento, Leyre; Maria Bautista-Gili, Antonia; Garcia, Francesc; Martinez-Serra, Jordi; Sanchez, Blanca; Martorell, Clara; Gines, Jordi; Garcia, Lucia; Gimeno, Eva; Ferraro, Mariana; Del Campo, Raquel; Bargay, Joan; Perez, Albert; Vercher, Javier; Scaff, Miguel; Pacheco, Ana; Ballester, Carmen; Garcia, Florencia; Ramos, Rafael; Salar, Antonio; Besalduch, Joan			Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; PROGNOSTIC-SIGNIFICANCE; PREDICTIVE MODEL; RITUXIMAB-CHOP; DOXORUBICIN; TRIAL; SURVIVAL; DISEASE	DLBCL is an aggressive lymphoma treated with R-CHOP. Recently, attempts have been made to improve the outcome by increasing both dose-density and intensity but there have been no benefits in terms of survival. When treating malignancies RDI is important to consider but there is little published information on DLBCL. The purpose of this study was to analyze the differential prognostic impact of RDI in two cohorts of DLBCL patients treated with R-CHOP21 or R-CHOP14. From January 2001 to August 2013 we included DLBCL patients homogenously treated with R-CHOP21 or R-CHOP14, with or without radiotherapy, at University Hospital Son Espases, Hospital Son Llatzer of Palma and Hospital del Mar of Barcelona (N = 157). In order to avoid selection bias the patients were retrospectively identified from the Pathology Department and Pharmacy registries. Median follow-up was 68 months. There was no difference in the response or survival between the two cohorts. In the R-CHOP21 group, both a reduction higher than 15% in RDI (RR 7.41) and R-IPI (RR 2.99) were independently associated with OS. However, a reduction higher than 15% in RDI (RR 4.41) was only noted for PFS. In the R-CHOP14 group, NCCN-IPI (RR 7.09) and B-symptoms (RR 5.37) for OS; AA stage III-IV (RR 6.26) and bulky disease (RR 4.05) for PFS. There was a trend towards a higher rate of RDI reduction observed in the R-CHOP14 group but it only made an impact in the R-CHOP21 group. We conclude that R-CHOP21 and R-CHOP14 are equivalent regimens in terms of response and survival, but only if RDI reductions are avoided. For patients receiving R-CHOP21 we recommend using clinical and support measures in order to avoid RDI reductions.	[Gutierrez, Antonio; Bento, Leyre; Maria Bautista-Gili, Antonia; Martinez-Serra, Jordi; Garcia, Lucia; Ferraro, Mariana; Perez, Albert; Ballester, Carmen; Besalduch, Joan] Son Espases Univ Hosp, Dept Hematol, Palma De Mallorca, Spain; [Garcia, Francesc; Sanchez, Blanca; Gimeno, Eva; Salar, Antonio] Hosp del Mar, Dept Hematol, Barcelona, Spain; [Martorell, Clara; Gines, Jordi] Son Espases Univ Hosp, Dept Pharm, Palma De Mallorca, Spain; [Del Campo, Raquel; Bargay, Joan] Son Llatzer Hosp, Dept Hematol, Palma De Mallorca, Spain; [Vercher, Javier] Can Misses Hosp, Dept Hematol, Ibiza, Spain; [Scaff, Miguel] Hosp Manacor, Dept Hematol, Manacor, Spain; [Pacheco, Ana] Mateu Orfila Hosp, Dept Hematol, Mahon, Spain; [Garcia, Florencia] Univ Hosp Son Espases, Dept Oncol, Palma De Mallorca, Spain; [Ramos, Rafael] Univ Hosp Son Espases, Dept Pathol, Palma De Mallorca, Spain	Hospital Universitari Son Espases; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Son Espases; Hospital Universitari Son Llatzer; Hospital Can Misses; Hospital de Manacor; Hospital Mateu Orfila; Hospital Universitari Son Espases; Hospital Universitari Son Espases	Gutierrez, A (corresponding author), Son Espases Univ Hosp, Dept Hematol, Palma De Mallorca, Spain.	antoniom.gutierrez@ssib.es	Gutiérrez, Antonio/AAL-9381-2021; Llàtzer, Son/ABG-1829-2020; garcia, lucia/GXV-8296-2022	Llàtzer, Son/0000-0002-6739-3916; Salar, Antonio/0000-0002-4652-4825				Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Bosly A, 2008, ANN HEMATOL, V87, P277, DOI 10.1007/s00277-007-0399-y; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; COX DR, 1972, J R STAT SOC B, V34, P187; Cunningham D, 2013, LANCET, V381, P1817, DOI 10.1016/S0140-6736(13)60313-X; Delarue R, 2013, LANCET ONCOL, V14, P525, DOI 10.1016/S1470-2045(13)70122-0; Doorduijn JK, 2003, J CLIN ONCOL, V21, P3041, DOI 10.1200/JCO.2003.01.076; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; GREEN JA, 1980, BRIT J CLIN PHARMACO, V9, P511, DOI 10.1111/j.1365-2125.1980.tb05847.x; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hershman DL, 2008, J CLIN ONCOL, V26, P3159, DOI 10.1200/JCO.2007.14.1242; HRYNIUK W, 1984, J CLIN ONCOL, V2, P1281, DOI 10.1200/JCO.1984.2.11.1281; Hryniuk W M, 1988, Important Adv Oncol, P121; HRYNIUK WM, 1990, J CLIN ONCOL, V8, P1935, DOI 10.1200/JCO.1990.8.12.1935; Intragumtornchai T, 2000, LEUKEMIA LYMPHOMA, V37, P351, DOI 10.3109/10428190009089435; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KWAK LW, 1990, J CLIN ONCOL, V8, P963, DOI 10.1200/JCO.1990.8.6.963; Landgren O, 2003, HAEMATOLOGICA, V88, P438; LEPAGE E, 1993, ANN ONCOL, V4, P651, DOI 10.1093/oxfordjournals.annonc.a058619; Linch DC, 2010, BRIT J HAEMATOL, V149, P237, DOI 10.1111/j.1365-2141.2010.08081.x; Luminari S, 2010, ANN ONCOL, V21, P1492, DOI 10.1093/annonc/mdp544; Lyman GH, 2004, J CLIN ONCOL, V22, P4302, DOI 10.1200/JCO.2004.03.213; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; ROBERT J, 1983, CANCER RES, V43, P4467; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Swerdlow SH, 2008, WHO CLASSIFICATION T; VANRIJSWIJK REN, 1989, J CLIN ONCOL, V7, P1776, DOI 10.1200/JCO.1989.7.12.1776; Yamaguchi H, 2011, J CLIN EXP HEMATOP, V51, P1, DOI 10.3960/jslrt.51.1; Zelenetz Andrew D, 2003, Oncology (Williston Park), V17, P21; Zhou Z, 2014, BLOOD, V123, P837, DOI 10.1182/blood-2013-09-524108	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123978	10.1371/journal.pone.0123978	http://dx.doi.org/10.1371/journal.pone.0123978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909361	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800053
J	Heeren, A; Baeken, C; Vanderhasselt, MA; Philippot, P; de Raedt, R				Heeren, Alexandre; Baeken, Chris; Vanderhasselt, Marie-Anne; Philippot, Pierre; de Raedt, Rudi			Impact of Anodal and Cathodal Transcranial Direct Current Stimulation over the Left Dorsolateral Prefrontal Cortex during Attention Bias Modification: An Eye-Tracking Study	PLOS ONE			English	Article							SOCIAL ANXIETY; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; CAUSAL ROLE; TIME-COURSE; THREAT; INDIVIDUALS; VALIDATION; GAZE; DISENGAGEMENT	People with anxiety disorders show an attentional bias for threat (AB), and Attention Bias Modification (ABM) procedures have been found to reduce this bias. However, the underlying processes accounting for this effect remain poorly understood. One explanation suggests that ABM requires the modification of attention control, driven by the recruitment of the dorsolateral prefrontal cortex (DLPFC). In the present double-blind study, we examined whether modifying left DLPFC activation influences the effect of ABM on AB. We used transcranial direct current stimulation (tDCS) to directly modulate cortical excitability of the left DLPFC during an ABM procedure designed to reduce AB to threat. Anodal tDCS increases excitability, whereas cathodal tDCS decreases it. We randomly assigned highly trait-anxious individuals to one of three conditions: 1) ABM combined with cathodal tDCS, 2) ABM combined with anodal tDCS, or 3) ABM combined with sham tDCS. We assessed the effects of these manipulations on both reaction times and eye-movements on a task indexing AB. Results indicate that combining ABM and anodal tDCS over the left DLPFC reduces the total duration that participants' gaze remains fixated on threat, as assessed using eye-tracking measurement. However, in contrast to previous studies, there were no changes in AB from baseline to post-training for participants that received ABM without tDCS. As the tendency to maintain attention to threat is known to play an important role in the maintenance of anxiety, the present findings suggest that anodal tDCS over the left DLPFC may be considered as a promising tool to reduce the maintenance of gaze to threat. Implications for future translational research combining ABM and tDCS are discussed.	[Heeren, Alexandre; Philippot, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, Louvain La Neuve, Belgium; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Vanderhasselt, Marie-Anne; de Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Universite Catholique Louvain; Ghent University; Ghent University	Heeren, A (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, Louvain La Neuve, Belgium.	Alexandre.Heeren@uclouvain.be	De Raedt, Rudi/AAL-4093-2021; Heeren, Alexandre/U-9748-2019; De Raedt, Rudi/A-3269-2012; Baeken, Chris/D-6790-2013	De Raedt, Rudi/0000-0001-6781-4808; Heeren, Alexandre/0000-0003-0553-6149; De Raedt, Rudi/0000-0001-6781-4808; Vanderhasselt, Marie-Anne/0000-0002-4045-1055	Belgian National Fund for Scientific Research [FC 78142]; Research Foundation Flanders [FWO08/PDO/168]; Concerted Research Action of Ghent University [BOF10/GOA/014]; Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Belgian University Foundation [IS179]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Research Foundation Flanders(FWO); Concerted Research Action of Ghent University; Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; Belgian University Foundation	This research was supported by a Grant (FC 78142) from the Belgian National Fund for Scientific Research (awarded to Dr. Alexandre Heeren), a Grant (FWO08/PDO/168) from the Research Foundation Flanders (awarded to Dr. Marie- Anne Vanderhasselt), a Grant (BOF10/GOA/014) for a Concerted Research Action of Ghent University (awarded to Prof. Rudi De Raedt). This research was also supported by the Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control". The open-access publication of this paper also received the support (IS179) from the Belgian University Foundation (awarded to Dr. Alexandre Heeren). These funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; [Anonymous], 1980, HANDLEIDING BIJ ZELF; Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Browning M, 2010, BIOL PSYCHIAT, V67, P919, DOI 10.1016/j.biopsych.2009.10.031; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Calvo MG, 2005, COGNITION EMOTION, V19, P433, DOI 10.1080/02699930441000157; Chen Nigel T. M., 2012, Cognitive Behaviour Therapy, V41, P96, DOI 10.1080/16506073.2012.666562; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003; Clarke PJF, 2013, ANXIETY STRESS COPIN, V26, P1, DOI 10.1080/10615806.2011.638054; Cohen J.E., 1988, STAT POWER ANAL BEHA; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Dear BF, 2011, J PAIN, V12, P1247, DOI 10.1016/j.jpain.2011.07.003; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Eldar S, 2010, PSYCHOL MED, V40, P667, DOI 10.1017/S0033291709990766; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Heeren A, J BEHAV THE IN PRESS; Heeren A, 2012, BEHAV RES THER, V50, P30, DOI 10.1016/j.brat.2011.10.005; Heeren A, 2015, J ANXIETY DISORD, V29, P35, DOI 10.1016/j.janxdis.2014.10.007; Heeren A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00119; Heeren A, 2012, COGNITIVE THER RES, V36, P512, DOI 10.1007/s10608-011-9394-7; Heeren A, 2011, J ANXIETY DISORD, V25, P1108, DOI 10.1016/j.janxdis.2011.08.001; Kuckertz JM, 2014, BEHAV RES THER, V53, P30, DOI 10.1016/j.brat.2013.12.003; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C, 2015, CLIN PSYCHOL SCI, V3, P58, DOI 10.1177/2167702614560749; Maoz K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00389; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mogg K, 2003, ADDICTION, V98, P825, DOI 10.1046/j.1360-0443.2003.00392.x; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Raes F, 2007, REVISED VERSION DUTC; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reese HE, 2010, J ANXIETY DISORD, V24, P657, DOI 10.1016/j.janxdis.2010.04.006; Rohner JC, 2002, COGNITION EMOTION, V16, P837, DOI 10.1080/02699930143000572; Roy AK, 2008, J AM ACAD CHILD PSY, V47, P1189, DOI 10.1097/CHI.0b013e3181825ace; Salemink E, 2007, BEHAV RES THER, V45, P607, DOI 10.1016/j.brat.2006.04.004; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Schofield CA, 2012, COGNITION EMOTION, V26, P300, DOI 10.1080/02699931.2011.602050; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spielberger DC, 1983, MANUAL FOR THE STATE; Staugaard SR., 2009, PSYCHOL SCI Q, V51, P339, DOI [DOI 10.1080/02699930903205698, 10.4081/mi.2011.e5, DOI 10.4081/MI.2011.E5]; Van Bockstaele B, 2014, PSYCHOL BULL, V140, P682, DOI 10.1037/a0034834; Van Bockstaele B, 2011, J BEHAV THER EXP PSY, V42, P211, DOI 10.1016/j.jbtep.2010.12.004; Van der Does A. J. W., 2002, HANDLEIDING NEDERLAN; Vervoort T, 2013, PAIN, V154, P836, DOI 10.1016/j.pain.2013.02.017	63	56	57	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124182	10.1371/journal.pone.0124182	http://dx.doi.org/10.1371/journal.pone.0124182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909846	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800062
J	Xiao, SJ; Han, ZF; Wang, PP; Han, F; Liu, Y; Li, JT; Wang, Y				Xiao, Shijun; Han, Zhaofang; Wang, Panpan; Han, Fang; Liu, Yang; Li, Jiongtang; Wang, Yong			Functional Marker Detection and Analysis on a Comprehensive Transcriptome of Large Yellow Croaker by Next Generation Sequencing	PLOS ONE			English	Article							GENE-ASSOCIATED MARKERS; PROTEIN-CODING REGIONS; RNA-SEQ DATA; PSEUDOSCIAENA-CROCEA; CRASSOSTREA-VIRGINICA; LARIMICHTHYS-CROCEA; REFERENCE GENOME; EASTERN OYSTER; IN-SILICO; IDENTIFICATION	Large yellow croaker (Larimichthys crocea) is an important economic fish in China and Eastern Asia. Because of the exhaustive fishing and overdense aquaculture, the wild population and the mariculture of the species are facing serious challenges on germplasm degeneration and susceptibility to infectious disease agents. However, a comprehensive transcriptome from multi-tissues of the species has not been reported and functional molecular markers have not yet been detected and analyzed. In this work, we applied RNA-seq with the Illumina Hiseq2000 platform for a multi-tissue sample of large yellow croaker and assembled the transcriptome into 88,103 transcripts. Of them, 52,782 transcripts have been successfully annotated by nt/nr, InterPro, GO and KEGG database. Comparing with public fish proteins, we have found that 34,576 protein coding transcripts are shared in large yellow croaker with zebrafish, medaka, pufferfish, and stickleback. For functional markers, we have discovered 1,276 polymorphic SSRs and 261, 000 SNPs. The functional impact analysis of SNPs showed that the majority (similar to 75%) of small variants cause synonymous mutations in proteins, followed by variations in 3' UTR region. The functional enrichment analysis illuminated that transcripts involved in DNA bindings, enzyme activities, and signal pathways prominently exhibit less single-nucleotide variants but genes for the constituent of the muscular tissue, the cytoskeleton, and the immunity system contain more frequent SNP mutations, which may reflect the structural and functional selections of the translated proteins. This is the first work for the high-throughput detection and analysis of functional polymorphic SSR and SNP markers in a comprehensive transcriptome of large yellow croaker. Our study provides valuable transcript sequence and functional marker resources for the quantitative trait locus (QTL) identification and molecular selection of the species in the research community.	[Xiao, Shijun; Han, Zhaofang; Wang, Panpan; Han, Fang; Liu, Yang; Wang, Yong] Jimei Univ, Key Lab Hlth Mariculture East China Sea, Minist Agr, Coll Fisheries, Xiamen, Fujian, Peoples R China; [Li, Jiongtang] Chinese Acad Fishery Sci, Beijing, Peoples R China	Jimei University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences	Wang, Y (corresponding author), Jimei Univ, Key Lab Hlth Mariculture East China Sea, Minist Agr, Coll Fisheries, Xiamen, Fujian, Peoples R China.	zywang@jmu.edu.cn			National "863" Project of China [2012AA10A403]; National Natural Science Foundation of China [U1205122]; Natural Science Foundation of Fujian Province [2014J05040]; Foundation for Innovation Research Team of Jimer University [2010A02]	National "863" Project of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Foundation for Innovation Research Team of Jimer University	This work was supported by grants from National "863" Project of China (2012AA10A403), National Natural Science Foundation of China (U1205122), Natural Science Foundation of Fujian Province (2014J05040), and the Foundation for Innovation Research Team of Jimer University (2010A02).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bioinformatics B., 2012, FASTQC QUAL CONTR TO; Cao M, 2014, BRIEF BIOINFORM; Chen YL, 2014, NUCLEIC ACIDS RES, V42, P7330, DOI 10.1093/nar/gku357; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092502; Duran C, 2013, MOL ECOL RESOUR, V13, P538, DOI 10.1111/1755-0998.12078; FISHER RA, 1949, HEREDITY, V3, P229, DOI 10.1038/hdy.1949.16; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linke WA, 2002, J STRUCT BIOL, V137, P194, DOI 10.1006/jsbi.2002.4468; Liu F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07256; Liu J, 2004, MAR SCI, V2, P001; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu XD, 2013, J FISH BIOL, V82, P34, DOI 10.1111/j.1095-8649.2012.03472.x; Lu ZM, 2013, BIOCHEM SYST ECOL, V51, P314, DOI 10.1016/j.bse.2013.09.019; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mu YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097471; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; O'Dushlaine CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r69; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Serapion J, 2004, MAR BIOTECHNOL, V6, P364, DOI 10.1007/s10126-003-0039-z; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Sun LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109666; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Wang J, 2014, AQUACULTURE, V432, P321, DOI 10.1016/j.aquaculture.2014.05.027; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wang W, 2014, MAR BIOTECHNOL, V16, P547, DOI 10.1007/s10126-014-9573-0; Wang XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066522; Wang XX, 2015, AQUAC RES, V46, P272, DOI 10.1111/are.12176; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xia JH, 2014, AQUACULTURE, V432, P67, DOI 10.1016/j.aquaculture.2014.04.028; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Ye H, 2010, ACTA OCEANOL SIN, V29, P83, DOI 10.1007/s13131-010-0079-y; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zeng K, 2010, J MOL EVOL, V70, P116, DOI 10.1007/s00239-009-9314-6; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhou P, 2010, COMP BIOCHEM PHYS D, V5, P89, DOI 10.1016/j.cbd.2010.01.002; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147	58	32	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124432	10.1371/journal.pone.0124432	http://dx.doi.org/10.1371/journal.pone.0124432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909910	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800083
J	Yoo, K; Chung, SJ; Kim, HS; Choung, OH; Lee, YB; Kim, MJ; You, S; Jeong, Y				Yoo, Kwangsun; Chung, Sun Ju; Kim, Ho Sung; Choung, Oh-Hyeon; Lee, Young-Beom; Kim, Mi-Jung; You, Sooyeoun; Jeong, Yong			Neural Substrates of Motor and Non-Motor Symptoms in Parkinson's Disease: A Resting fMRI Study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ANTERIOR CINGULATE; FUNCTIONAL CONNECTIVITY; DEPRESSED-PATIENTS; CEREBRAL ATROPHY; FRONTAL-LOBE; LEWY BODY; BRAIN; ASYMMETRY; CORTEX	Background Recently, non-motor symptoms of Parkinson's disease (PD) have been considered crucial factors in determining a patient's quality of life and have been proposed as the predominant features of the premotor phase. Researchers have investigated the relationship between non-motor symptoms and the motor laterality; however, this relationship remains disputed. This study investigated the neural connectivity correlates of non-motor and motor symptoms of PD with respect to motor laterality. Methods Eight-seven patients with PD were recruited and classified into left-more-affected PD (n = 44) and right-more affected PD (n = 37) based on their MDS-UPDRS (Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale) motor examination scores. The patients underwent MRI scanning, which included resting fMRI. Brain regions were labeled as ipsilateral and contralateral to the more-affected body side. Correlation analysis between the functional connectivity across brain regions and the scores of various symptoms was performed to identify the neural connectivity correlates of each symptom. Results The resting functional connectivity centered on the ipsilateral inferior orbito-frontal area was negatively correlated with the severity of non-motor symptoms, and the connectivity of the contralateral inferior parietal area was positively correlated with the severity of motor symptoms (p < 0.001, vertical bar r vertical bar > 0.3). Conclusions These results suggest that the inferior orbito-frontal area may play a crucial role in non-motor dysfunctions, and that the connectivity information may be utilized as a neuroimaging biomarker for the early diagnosis of PD.	[Yoo, Kwangsun; Choung, Oh-Hyeon; Lee, Young-Beom; Jeong, Yong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Lab Cognit Neurosci & NeuroImaging, Taejon 305701, South Korea; [Chung, Sun Ju; Kim, Mi-Jung; You, Sooyeoun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Ho Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Jeong, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Lab Cognit Neurosci & NeuroImaging, Taejon 305701, South Korea.	yong@kaist.ac.kr	Yoo, Kwangsun/F-1408-2014; Jeong, Yong/C-1677-2011	Yoo, Kwangsun/0000-0002-5213-4575; Jeong, Yong/0000-0002-5907-3787	World Class University program [R32-2008-000-10218-0]; Brain Research Program [NRF-2010-0018843]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [NRF-2012R1A1A2044776]; Asan Institute for Life Sciences, Seoul, South Korea [2012-0416]	World Class University program; Brain Research Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; Asan Institute for Life Sciences, Seoul, South Korea	This research was supported by World Class University program (R32-2008-000-10218-0), the Brain Research Program (NRF-2010-0018843), Basic Science Research Program (NRF-2012R1A1A2044776) through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning, and a grant (2012-0416) from the Asan Institute for Life Sciences, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bezzola L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00067; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brown RG, 1996, EUR NEUROL, V36, P24, DOI 10.1159/000118880; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Critchley HD, 2001, BRAIN, V124, P1003, DOI 10.1093/brain/124.5.1003; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Cubo E, 2010, MOVEMENT DISORD, V25, P70, DOI 10.1002/mds.22896; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; FLEMINGER S, 1991, PSYCHOL MED, V21, P629, DOI 10.1017/S0033291700022261; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; GROSSMAN M, 1991, NEUROLOGY, V41, P1620; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hubbard PS, 2007, J ANAT, V211, P117, DOI 10.1111/j.1469-7580.2007.00748.x; HUBER SJ, 1989, CORTEX, V25, P461, DOI 10.1016/S0010-9452(89)80059-0; Kalbe E, 2009, NEUROLOGY, V72, P42, DOI 10.1212/01.wnl.0000338536.31388.f0; Kendi ATK, 2008, AM J NEURORADIOL, V29, P501, DOI 10.3174/ajnr.A0850; Kovari E, 2003, ACTA NEUROPATHOL, V106, P83, DOI 10.1007/s00401-003-0705-2; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Prakash BD, 2012, PARKINSONISM RELAT D, V18, P1029, DOI 10.1016/j.parkreldis.2012.05.021; Ramirez-Ruiz B, 2008, MOVEMENT DISORD, V23, P2335, DOI 10.1002/mds.22258; Reijnders JSAM, 2010, MOVEMENT DISORD, V25, P2318, DOI 10.1002/mds.23268; Rinne JO, 1993, MOVEMENT DISORD, V8, P34; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sohn WS, 2014, ALZ DIS ASSOC DIS, V28, P239, DOI 10.1097/WAD.0000000000000027; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Tolosa E, 2009, NEUROLOGY, V72, pS12, DOI 10.1212/WNL.0b013e318198db11; TOMER R, 1993, ANN NEUROL, V34, P579, DOI 10.1002/ana.410340412; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; van Eimeren T, 2010, NEUROLOGY, V75, P1711, DOI 10.1212/WNL.0b013e3181fc27fa; Williams LN, 2007, MOVEMENT DISORD, V22, P141, DOI 10.1002/mds.21220; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Yoo K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00049; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032	44	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125455	10.1371/journal.pone.0125455	http://dx.doi.org/10.1371/journal.pone.0125455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909812	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800141
J	Xu, LY; Qi, JN; Liu, X; Ma, HX; Yuan, W; Zhao, PQ; Liang, XH; Xu, Y; Wang, HX; Xu, XY; Wang, W; Ma, CH; Gao, LF				Xu, Li-yun; Qi, Jian-ni; Liu, Xiao; Ma, Hong-xin; Yuan, Wei; Zhao, Pei-qing; Liang, Xiao-hong; Xu, Yong; Wang, Hong-xing; Xu, Xiao-yan; Wang, Wei; Ma, Chun-hong; Gao, Li-fen			Tim-4 Inhibits NO Generation by Murine Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; T-CELL IMMUNOGLOBULIN; DOMAIN-CONTAINING MOLECULE-4; NF-KAPPA-B; PHOSPHATIDYLSERINE; EXPRESSION; ACTIVATION; LIPOPOLYSACCHARIDE	Objective T cell immunoglobulin-and mucin-domain-containing molecule-4 (Tim-4) receives much attention as a potentially negative regulator of immune responses. However, its modulation on macrophages has not been fully elucidated so far. This study aimed to identify the role of Tim-4 in nitric oxide (NO) modulation. Methods Macrophages were stimulated with 100 ng/ml LPS or 100 U/ml IFN-gamma. RT-PCR was performed to detect TIM-4 mRNA expression. Tim-4 blocking antibody and NF-kappa B inhibitory ligand were involved in the study. NO levels were assayed by Griess reaction. Phosphorylation of NF-kappa B, Jak2 or Stat1 was verified by western blot. Results Tim-4 was up-regulated in murine macrophages after interferon-gamma (IFN-gamma) stimulation. Tim-4 over-expression decreased NO production and inducible nitric oxide synthase (iNOS) expression in lipopolysaccharide (LPS) or IFN-gamma-stimulated macrophages. Consistently, Tim-4 blockade promoted LPS or IFN-gamma-induced NO secretion and iNOS expression. Tim-4 over-expression decreased LPS-induced nuclear factor kappa B (NF-kappa B) p65 phosphorylation in macrophages, which was abrogated by NF-kappa B inhibitory ligand. On the contrary, Tim-4 blocking increased LPS-induced NF-kappa B signaling, which was also abrogated by NF-kappa B inhibition. In addition, Tim-4 blockade promoted Jak2 and Stat1 phosphorylation in IFN-gamma stimulated macrophages. Conclusion These results indicate that Tim-4 is involved in negative regulation of NO production in macrophages, suggesting the critical role of Tim-4 in immune related diseases.	[Xu, Li-yun; Qi, Jian-ni; Liu, Xiao; Ma, Hong-xin; Zhao, Pei-qing; Liang, Xiao-hong; Xu, Yong; Wang, Hong-xing; Xu, Xiao-yan; Wang, Wei; Ma, Chun-hong; Gao, Li-fen] Shandong Univ, Key Lab Expt Teratol, Shandong Prov Key Lab Infect & Immunol, Dept Immunol,Minist Educ,Sch Med, Jinan 250012, Shandong, Peoples R China; [Xu, Li-yun] Zhoushan Hosp, Cell & Mol Biol Lab, Zhoushan 316000, Zhejiang, Peoples R China; [Yuan, Wei] Zhangqiu Hosp, Dept Bone Surg, Jinan 250200, Shandong, Peoples R China	Shandong University	Gao, LF (corresponding author), Shandong Univ, Key Lab Expt Teratol, Shandong Prov Key Lab Infect & Immunol, Dept Immunol,Minist Educ,Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	glfflg@sdu.edu.cn	zhao, peiqing/E-6602-2014; ma, chunhong/C-6043-2008	ma, chunhong/0000-0002-8121-4718; Zhao, Peiqing/0000-0002-9311-1927	National Nature Science Foundation of China [30872298, 81172862]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20110131110034]; Shandong Provincial Natural Science Foundation [ZR2010HM025]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported in part by grants from the National Nature Science Foundation of China (No. 30872298, 81172862), Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20110131110034) and the Shandong Provincial Natural Science Foundation (No. ZR2010HM025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baghdadi M, 2013, IMMUNITY, V39, P1070, DOI 10.1016/j.immuni.2013.09.014; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Cam A, 2012, MOL NUTR FOOD RES, V56, P1569, DOI 10.1002/mnfr.201200301; Czuczman MA, 2014, NATURE, V509, P230, DOI 10.1038/nature13168; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Flannagan RS, 2014, MOL BIOL CELL, V25, P1511, DOI 10.1091/mbc.E13-04-0212; Hein RM, 2007, IMMUNOL LETT, V108, P103, DOI 10.1016/j.imlet.2006.11.004; Hou YC, 1999, CURR PHARM DESIGN, V5, P417; Ji HF, 2014, HEPATOLOGY, V60, P2052, DOI 10.1002/hep.27334; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kim HS, 2010, J IMMUNOL, V184, P4095, DOI 10.4049/jimmunol.0901991; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; KOLB JP, 1994, J BIOL CHEM, V269, P9811; Lee SH, 2004, BIOCHEM BIOPH RES CO, V323, P125, DOI 10.1016/j.bbrc.2004.08.063; Lei J, 2013, NITRIC OXIDE-BIOL CH, V35, P175, DOI 10.1016/j.niox.2013.09.004; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Mazaheri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5046; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mizui M, 2008, INT IMMUNOL, V20, P695, DOI 10.1093/intimm/dxn029; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; PONS F, 1993, EUR J PHARMACOL, V239, P23, DOI 10.1016/0014-2999(93)90971-J; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Rawlingson A, 2003, BURNS, V29, P631, DOI 10.1016/S0305-4179(03)00079-2; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Saika S, 2005, AM J PATHOL, V166, P1393, DOI 10.1016/S0002-9440(10)62357-7; Singh S, 2011, CANCER CHEMOTH PHARM, V67, P1211, DOI 10.1007/s00280-011-1654-4; dos Santos TAT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027867; Thornley TB, 2014, J CLIN INVEST, V124, P3443, DOI 10.1172/JCI73527; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Xu LY, 2010, J LEUKOCYTE BIOL, V88, P329, DOI 10.1189/jlb.1209797; Zhao PQ, 2010, CELL MOL IMMUNOL, V7, P152, DOI 10.1038/cmi.2009.118	39	14	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124771	10.1371/journal.pone.0124771	http://dx.doi.org/10.1371/journal.pone.0124771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905790	gold, Green Submitted, Green Published			2022-12-26	WOS:000353332000088
J	Krementsov, DN; Case, LK; Hickey, WF; Teuscher, C				Krementsov, Dimitry N.; Case, Laure K.; Hickey, William F.; Teuscher, Cory			Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific	FASEB JOURNAL			English	Article						environment; experimental autoimmune encephalomyelitis; mouse model; multiple sclerosis; risk factor	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; RENIN-ANGIOTENSIN SYSTEM; PATHOGENIC T(H)17 CELLS; HIGH-SALT DIET; MULTIPLE-SCLEROSIS; CIRCUMVENTRICULAR ORGANS; BLOOD-PRESSURE; DISEASE; MICE	Multiple sclerosis (MS) is a debilitating autoimmune neuroinflammatory disease influenced by genetics and the environment. MSincidence in female subjects has approximately tripled in the last century, suggesting a sex-specific environmental influence. Recent animal and human studies have implicated dietary sodium as a risk factor in MS, whereby high sodium augmented the generation of T helper (T-h) 17 cells and exacerbated experimental autoimmune encephalomyelitis (EAE), the principal model of MS. However, whether dietary sodium interacts with sex or genetics remains unknown. Here, we show that high dietary sodium exacerbates EAE in a strain- and sex-specific fashion. In C57BL6/J mice, exposure to a high-salt diet exacerbated disease in both sexes, while in SJL/JCrHsd mice, it did so only in females. In further support of a genetic component, we found that sodium failed to modify EAE course in C57BL6/J mice carrying a 129/Sv-derived interval on chromosome 17. Furthermore, we found that the high-sodium diet did not augment T(h)17 or T(h)1 responses, but it did result in increased blood-brain barrier permeability and brain pathology. Our results demonstrate that the effects of dietary sodium on autoimmune neuroinflammation are sex specific, genetically controlled, and CNS mediated.-Krementsov, D. N., Case, L. K., Hickey, W. F., Teuscher, C. Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific.	[Krementsov, Dimitry N.; Case, Laure K.; Teuscher, Cory] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Hickey, William F.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pathol, Hanover, NH 03756 USA	University of Vermont; Dartmouth College	Krementsov, DN (corresponding author), Univ Vermont, D305 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	dkrement@uvm.edu; c.teuscher@uvm.edu	Krementsov, Dimitry/Y-8288-2019	Krementsov, Dimitry/0000-0003-2709-7466	U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke [NS069628, NS076200]; U.S. National Multiple Sclerosis Society [FG1911-A-1, PP2123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069628, R21NS076200] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke Grants NS069628 and NS076200 (to C.T). This work was also supported postdoctoral Fellowship FG1911-A-1 from the U.S. National Multiple Sclerosis Society to (D.N.K.), and Pilot Project Grant PP2123 from the U.S. National Multiple Sclerosis Society (to C.T.).	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; ARTZT K, 1986, HUM IMMUNOL, V15, P374, DOI 10.1016/0198-8859(86)90014-5; Bearoff F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117993; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Brown I. J., 2009, INT J EPIDEMIOL, V467, P465; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Engelhardt B, 2008, CURR PHARM DESIGN, V14, P1555, DOI 10.2174/138161208784705432; Farez MF, 2015, J NEUROL NEUROSUR PS, V86, P26, DOI 10.1136/jnnp-2014-307928; Friedman M, 1939, J AM STAT ASSOC, V34, P109, DOI 10.2307/2279169; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Gene J. R., 1972, REV EDUC RES, V42, P237, DOI DOI 10.3102/00346543042003237; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; HAMMER MF, 1989, P NATL ACAD SCI USA, V86, P3261, DOI 10.1073/pnas.86.9.3261; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Krementsov DN, 2014, ANN NEUROL, V75, P50, DOI 10.1002/ana.24020; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu L., 2008, J VIS EXP; Lyon M., 1989, GENETIC VARIANTS STR; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; McGuire S, 2010, ADV NUTR, V1, P49, DOI 10.3945/an.110.1002; Miller RL, 2013, AM J PHYSIOL-REG I, V305, pR1141, DOI 10.1152/ajpregu.00242.2013; Mostafavi S, 2014, J IMMUNOL, V193, P4485, DOI 10.4049/jimmunol.1401280; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Noda M., 2015, PFLUGERS ARCH; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Ochoa-Reparaz J, 2011, ANN NEUROL, V69, P240, DOI 10.1002/ana.22344; Paling D, 2013, BRAIN, V136, P2305, DOI 10.1093/brain/awt149; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Ramagopalan SV, 2011, NEUROL CLIN, V29, P207, DOI 10.1016/j.ncl.2010.12.010; Schlote J, 2013, KIDNEY BLOOD PRESS R, V37, P379, DOI 10.1159/000355716; Schulz Martina, 2005, Cerebrospinal Fluid Res, V2, P8, DOI 10.1186/1743-8454-2-8; Spach KM, 2009, J IMMUNOL, V182, P7776, DOI 10.4049/jimmunol.0900142; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wuerfel E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-70	49	40	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3446	3457		10.1096/fj.15-272542	http://dx.doi.org/10.1096/fj.15-272542			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25917331	Green Published			2022-12-26	WOS:000358796900031
J	Moilanen, AM; Rysa, J; Kaikkonen, L; Karvonen, T; Mustonen, E; Serpi, R; Szabo, Z; Tenhunen, O; Bagyura, Z; Napankangas, J; Ohukainen, P; Tavi, P; Kerkela, R; Leosdottir, M; Wahlstrand, B; Hedner, T; Melander, O; Ruskoaho, H				Moilanen, Anne-Mari; Rysa, Jaana; Kaikkonen, Leena; Karvonen, Teemu; Mustonen, Erja; Serpi, Raisa; Szabo, Zoltan; Tenhunen, Olli; Bagyura, Zsolt; Napankangas, Juha; Ohukainen, Pauli; Tavi, Pasi; Kerkela, Risto; Leosdottir, Margret; Wahlstrand, Bjorn; Hedner, Thomas; Melander, Olle; Ruskoaho, Heikki			WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NATRIURETIC-PEPTIDE; IMMUNE-RESPONSES; GENE-EXPRESSION; WD-REPEAT; IN-VIVO; AFRICAN ANCESTRY; BLOOD-PRESSURE; AGING RESEARCH; FAILURE	Aims In a recent genome-wide association study, WD-repeat domain 12 (WDR12) was associated with early-onset myocardial infarction (MI). However, the function of WDR12 in the heart is unknown. Methods and Results We characterized cardiac expression of WDR12, used adenovirus-mediated WDR12 gene delivery to examine effects of WDR12 on left ventricular (LV) remodeling, and analyzed relationship between MI associated WDR12 allele and cardiac function in human subjects. LV WDR12 protein levels were increased in patients with dilated cardiomyopathy and rats post-infarction. In normal adult rat hearts, WDR12 gene delivery into the anterior wall of the LV decreased interventricular septum diastolic and systolic thickness and increased the diastolic and systolic diameters of the LV. Moreover, LV ejection fraction (9.1%, P<0.05) and fractional shortening (12.2%, P<0.05) were declined. The adverse effects of WDR12 gene delivery on cardiac function were associated with decreased cellular proliferation, activation of p38 mitogen-activated protein kinase (MAPK)/heat shock protein (HSP) 27 pathway, and increased protein levels of Block of proliferation 1 (BOP1), essential for ribosome biogenesis. Post-infarction WDR12 gene delivery decreased E/A ratio (32%, P<0.05) suggesting worsening of diastolic function. In human subjects, MI associated WDR12 allele was associated significantly with diastolic dysfunction and left atrial size. Conclusions WDR12 triggers distinct deterioration of cardiac function in adult rat heart and the MI associated WDR12 variant is associated with diastolic dysfunction in human subjects.	[Moilanen, Anne-Mari; Rysa, Jaana; Kaikkonen, Leena; Karvonen, Teemu; Mustonen, Erja; Serpi, Raisa; Szabo, Zoltan; Tenhunen, Olli; Ohukainen, Pauli; Kerkela, Risto; Ruskoaho, Heikki] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Moilanen, Anne-Mari; Napankangas, Juha] Univ Oulu, Dept Pathol, Inst Diagnost, Oulu, Finland; [Serpi, Raisa] Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, Oulu, Finland; [Bagyura, Zsolt] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary; [Tavi, Pasi] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Moilanen, Anne-Mari; Kerkela, Risto] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Moilanen, Anne-Mari; Kerkela, Risto] Univ Oulu, Oulu, Finland; [Wahlstrand, Bjorn; Hedner, Thomas] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Leosdottir, Margret; Melander, Olle] Lund Univ, Dept Clin Sci, Lund, Sweden; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden; [Leosdottir, Margret] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden; [Ruskoaho, Heikki] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; Semmelweis University; University of Eastern Finland; University of Oulu; University of Oulu; University of Gothenburg; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Helsinki	Ruskoaho, H (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland.	heikki.ruskoaho@helsinki.fi	Ohukainen, Pauli/P-7811-2019	Ohukainen, Pauli/0000-0002-0919-7204; Rysa, Jaana/0000-0003-2205-6323; Melander, Olle/0000-0002-2581-484X; Serpi, Raisa/0000-0002-8207-4673; Szabo, Zoltan/0000-0003-0778-1113; Napankangas, Juha/0000-0003-3088-5180; Leosdottir, Margret/0000-0003-1677-1566	Academy of Finland (Center of Excellence); Academy of Finland; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; National Technology Foundation TEKES; Biocenter Finland; European Research Council [StG-282255]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Novo Nordisk Foundation; LUA/ALF [ALFGBG151121]; Novo Nordisk Fonden [NNF14OC0009819, NNF13OC0005339] Funding Source: researchfish	Academy of Finland (Center of Excellence)(Academy of Finland); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; National Technology Foundation TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Biocenter Finland; European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); LUA/ALF; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Academy of Finland (Center of Excellence) (HR), Academy of Finland (JR), Sigrid Juselius Foundation (HR), Finnish Foundation for Cardiovascular Research (HR, JR and RS), the National Technology Foundation TEKES (HR), Biocenter Finland (HR and RS) and European Research Council StG-282255 (OM), the Swedish Medical Research Council (OM), the Swedish Heart and Lung Foundation (OM), the Novo Nordisk Foundation (OM) and LUA/ALF - ALFGBG151121 (TH and BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; Blattmann P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003338; Cataliotti A, 2008, CIRCULATION, V118, P1729, DOI 10.1161/CIRCULATIONAHA.107.759241; Cohn JN, 1997, CIRCULATION, V95, P766; Connelly S, 1996, BLOOD, V88, P3846, DOI 10.1182/blood.V88.10.3846.bloodjournal88103846; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; dUscio LV, 1997, HYPERTENSION, V29, P435, DOI 10.1161/01.HYP.29.1.435; Fava C, 2013, HYPERTENSION, V61, P319, DOI 10.1161/HYPERTENSIONAHA.112.202655; Fields PA, 2000, MOL THER, V1, P225, DOI 10.1006/mthe.2000.0032; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Hautala N, 2001, CIRCULATION, V103, P730; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; HUELSEMANN JL, 1985, HYPERTENSION, V7, P374, DOI 10.1161/01.HYP.7.3_Pt_1.374; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koivisto E, 2011, CAN J PHYSIOL PHARM, V89, P539, DOI [10.1139/Y11-049, 10.1139/y11-049]; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; Lako-Futo Z, 2003, CIRCULATION, V108, P2414, DOI 10.1161/01.CIR.0000093193.63314.D9; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Leosdottir M, 2010, AM HEART J, V159, P414, DOI 10.1016/j.ahj.2009.12.028; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Magga J, 1997, CIRC RES, V81, P694; McGuigan FEA, 2002, PSYCHIATR GENET, V12, P133, DOI 10.1097/00041444-200209000-00003; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Moilanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041404; Moilanen AM, 2011, CIRC-HEART FAIL, V4, P483, DOI 10.1161/CIRCHEARTFAILURE.110.958033; Morrison AC, 2010, CIRC-CARDIOVASC GENE, V3, P248, DOI 10.1161/CIRCGENETICS.109.895995; Nal B, 2002, GENOMICS, V79, P77, DOI 10.1006/geno.2001.6682; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pfeffer MA, 1979, CIRC RES, V13, P293; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Smith NL, 2010, CIRC-CARDIOVASC GENE, V3, P256, DOI 10.1161/CIRCGENETICS.109.895763; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SMITS GJ, 1991, HYPERTENSION, V18, P17, DOI 10.1161/01.HYP.18.1.17; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Suo M, 2002, HYPERTENSION, V39, P803, DOI 10.1161/hy0302.105214; Szatkowski ML, 2001, J CLIN INVEST, V107, P191, DOI 10.1172/JCI9862; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; TOKOLA H, 1994, EUR J PHARM-MOLEC PH, V267, P195, DOI 10.1016/0922-4106(94)90171-6; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Wang JW, 2009, CIRCULATION, V119, P1146, DOI 10.1161/CIRCULATIONAHA.108.822676; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250	55	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124907	10.1371/journal.pone.0124907	http://dx.doi.org/10.1371/journal.pone.0124907			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915632	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100080
J	Trussoni, CE; Tabibian, JH; Splinter, PL; O'Hara, SP				Trussoni, Christy E.; Tabibian, James H.; Splinter, Patrick L.; O'Hara, Steven P.			Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR)	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; INCREASED INTESTINAL PERMEABILITY; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN-COUPLED RECEPTORS; TOLL-LIKE RECEPTOR; CRYPTOSPORIDIUM-PARVUM; MULTIPLE TLRS; BILE-DUCT; CONTRIBUTES; PATHOGENESIS	Cholangiocytes (biliary epithelial cells) actively participate in microbe-induced proinflammatory responses in the liver and contribute to inflammatory and infectious cholangiopathies. We previously demonstrated that cholangiocyte TLR-dependent NRas activation contributes to proinflammatory/proliferative responses. We test the hypothesis that LPS-induced activation of NRas requires the EGFR. SV40-transformed human cholangiocytes (H69 cells), or low passage normal human cholangiocytes (NHC), were treated with LPS in the presence or absence of EGFR or ADAM metallopeptidase domain 17 (TACE) inhibitors. Ras activation assays, quantitative RT-PCR, and proliferation assays were performed in cells cultured with or without inhibitors or an siRNA to Grb2. Immunofluorescence for phospho-EGFR was performed on LPS-treated mouse samples and specimens from patients with primary sclerosing cholangitis, primary biliary cirrhosis, hepatitis C, and normal livers. LPS-treatment induced an association between the TLR/MyD88 and EGFR/Grb2 signaling apparatus, NRas activation, and EGFR phosphorylation. NRas activation was sensitive to EGFR and TACE inhibitors and correlated with EGFR phosphorylation. The TACE inhibitor and Grb2 depletion prevented LPS-induced IL6 expression (p<0.05) and proliferation (p<0.01). Additionally, cholangiocytes from LPS-treated mouse livers and human primary sclerosing cholangitis (PSC) livers exhibited increased phospho-EGFR (p<0.01). Moreover, LPS-induced mouse cholangiocyte proliferation was inhibited by concurrent treatment with the EGFR inhibitor, Erlotinib. Our results suggest that EGFR is essential for LPS-induced, TLR4/MyD88-mediated NRas activation and induction of a robust proinflammatory cholangiocyte response. These findings have implications not only for revealing the signaling potential of TLRs, but also implicate EGFR as an integral component of cholangiocyte TLR-induced proinflammatory processes.	[O'Hara, Steven P.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	O'Hara, SP (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	ohara.steven@mayo.edu		Trussoni, Christy/0000-0002-4247-076X	NIH [R01 AI089713]; Mayo Foundation; Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants R01 AI089713 to S.P.O., the Mayo Foundation, and the Clinical and Optical Microscopy Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agley CC, 2012, J HISTOCHEM CYTOCHEM, V60, P428, DOI 10.1369/0022155412442897; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alpini G, 1997, AM J PHYSIOL-GASTR L, V273, pG518, DOI 10.1152/ajpgi.1997.273.2.G518; Alpini G, 1999, GASTROENTEROLOGY, V116, P179, DOI 10.1016/S0016-5085(99)70242-8; Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Finzi L, 2009, J IMMUNOL, V182, P2269, DOI 10.4049/jimmunol.0801768; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Gwak GY, 2005, J CANCER RES CLIN, V131, P649, DOI 10.1007/s00432-005-0016-1; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harada K, 2006, J CLIN PATHOL, V59, P184, DOI 10.1136/jcp.2004.023507; Harada K, 2004, HEPATOLOGY, V40, P925, DOI 10.1002/hep.20379; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Hiramatsu K, 2000, J HEPATOL, V33, P9, DOI 10.1016/S0168-8278(00)80153-1; JOPLIN R, 1989, IN VITRO CELL DEV B, V25, P1189; Karrar A, 2007, GASTROENTEROLOGY, V132, P1504, DOI 10.1053/j.gastro.2007.01.039; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Leone F, 2006, CLIN CANCER RES, V12, P1680, DOI 10.1158/1078-0432.CCR-05-1692; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Modlin RL, 2004, NAT MED, V10, P1173, DOI 10.1038/nm1104-1173; Mueller T, 2011, LIVER INT, V31, P1574, DOI 10.1111/j.1478-3231.2011.02635.x; Ngu JH, 2011, CLIN GASTROENTEROL H, V9, P1092, DOI 10.1016/j.cgh.2011.08.027; O'Hara SP, 2011, J PARASITOL, V97, P813, DOI 10.1645/GE-2703.1; O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464; Olsson R, 1998, J HEPATOL, V28, P426, DOI 10.1016/S0168-8278(98)80316-4; Pohl J, 2006, EUR J GASTROEN HEPAT, V18, P69, DOI 10.1097/00042737-200601000-00012; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sasatomi K, 1998, J HEPATOL, V29, P409, DOI 10.1016/S0168-8278(98)80058-5; Seo DW, 2004, AM J PHYSIOL-GASTR L, V287, pG1247, DOI 10.1152/ajpgi.00013.2004; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993; Tabibian JH, 2013, LAB INVEST, V93, P733, DOI 10.1038/labinvest.2013.52; Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019; Tabibian JH, 2013, EXPERT REV GASTROENT, V7, P103, DOI [10.1586/egh.12.80, 10.1586/EGH.12.80]; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Welcker K, 2004, EUR J MED RES, V9, P456; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; WIESNER RH, 1980, GASTROENTEROLOGY, V79, P200; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x; Yoon JH, 2004, J HEPATOL, V41, P808, DOI 10.1016/j.jhep.2004.07.016	47	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125793	10.1371/journal.pone.0125793	http://dx.doi.org/10.1371/journal.pone.0125793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915403	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100148
J	Freitas, EO; Nico, D; Guan, R; Meyer-Fernandes, JR; Clinch, K; Evans, GB; Tyler, PC; Schramm, VL; Palatnik-de-Sousa, CB				Freitas, Elisangela Oliveira; Nico, Dirlei; Guan, Rong; Meyer-Fernandes, Jose Roberto; Clinch, Keith; Evans, Gary B.; Tyler, Peter C.; Schramm, Vern L.; Palatnik-de-Sousa, Clarisa B.			Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro	PLOS ONE			English	Article							NUCLEOSIDE HYDROLASE; VISCERAL LEISHMANIASIS; PYRIMIDINE METABOLISM; CRYSTAL-STRUCTURES; PURINE METABOLISM; VIVO ACTIVITY; DONOVANI; INHIBITORS; COMPLEX; ENZYMES	Chemotherapy against visceral leishmaniasis is associated with high toxicity and drug resistance. Leishmania parasites are purine auxotrophs that obtain their purines from exogenous sources. Nucleoside hydrolases release purines from nucleosides and are drug targets for anti-leishmanial drugs, absent in mammal cells. We investigated the substrate specificity of the Leishmania (L.) donovani recombinant nucleoside hydrolase NH36 and the inhibitory effect of the immucillins IA (ImmA), DIA (DADMe-ImmA), DIH (DADMe-ImmH), SMIH (SerMe-ImmH), IH (ImmH), DIG (DADMe-ImmG), SMIG (SerMe-ImmG) and SMIA (SerMEImmA) on its enzymatic activity. The inhibitory effects of immucillins on the in vitro multiplication of L. (L.) infantum chagasi and L. (L.) amazonensis promastigotes were determined using 0.05-500 mu M and, when needed, 0.01-50 nM of each drug. The inhibition on multiplication of L. (L.) infantum chagasi intracellular amastigotes in vitro was assayed using 0.5, 1, 5 and 10 mu M of IA, IH and SMIH. The NH36 shows specificity for inosine, guanosine, adenosine, uridine and cytidine with preference for adenosine and inosine. IA, IH, DIH, DIG, SMIH and SMIG immucillins inhibited L. (L.) infantum chagasi and L. (L.) amazonensis promastigote growth in vitro at nanomolar to micromolar concentrations. Promastigote replication was also inhibited in a chemically defined medium without a nucleoside source. Addition of adenosine decreases the immucillin toxicity. IA and IH inhibited the NH36 enzymatic activity (Ki = 0.080 mu M for IA and 0.019 mu M for IH). IA, IH and SMIH at 10 mu M concentration, reduced the in vitro amastigote replication inside mice macrophages by 95% with no apparent effect on macrophage viability. Transmission electron microscopy revealed global alterations and swelling of L. (L.) infantum chagasi promastigotes after treatment with IA and IH while SMIH treatment determined intense cytoplasm vacuolization, enlarged vesicles and altered kinetoplasts. Our results suggest that IA, IH and SMIH may provide new chemotherapy agents for leishmaniasis.	[Freitas, Elisangela Oliveira; Nico, Dirlei; Palatnik-de-Sousa, Clarisa B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Microbiol Geral, Rio De Janeiro, Brazil; [Freitas, Elisangela Oliveira; Guan, Rong; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, New York, NY 10033 USA; [Meyer-Fernandes, Jose Roberto] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Clinch, Keith; Evans, Gary B.; Tyler, Peter C.] Victoria Univ Wellington, Ferrier Res Inst, Wellington, New Zealand	Universidade Federal do Rio de Janeiro; Yeshiva University; Universidade Federal do Rio de Janeiro; Victoria University Wellington	Palatnik-de-Sousa, CB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Microbiol Geral, Rio De Janeiro, Brazil.	immgcpa@micro.ufrj.br	Evans, Gary/I-4123-2019; Nico, Dirlei/GZA-3726-2022; Freitas, Elisangela/I-7384-2017; Evans, Gary/B-8343-2011	Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002; Clinch, Keith/0000-0002-3300-4396; Palatnik-de-Sousa, Clarisa B./0000-0002-6231-0608	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [301215-2007-3, 302039/2010-4, 559756/2010-0, 404400/2012-4]; Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) [E-26/102733/2008, E-26/102957/2011, E-26/102415/2010, E-26/110535/2010]; PROLAB Award PABMB/ASBMB PROLAB (Promoting Research Opportunities For Latin American Biochemists (PROLAB) of the American Society for Biochemistry and Molecular Biology)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PROLAB Award PABMB/ASBMB PROLAB (Promoting Research Opportunities For Latin American Biochemists (PROLAB) of the American Society for Biochemistry and Molecular Biology)	This work has been supported by: EOF, DN, JRMF, CPS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ, Fellowships 301215-2007-3, 302039/2010-4, 559756/2010-0 and grant 404400/2012-4), by Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ, grants E-26/102733/2008 and E-26/102957/2011 and Fellowships E-26/102415/2010 and E-26/110535/2010). EOF, VLS, RG, CPS: PROLAB Award PABMB/ASBMB PROLAB (Promoting Research Opportunities For Latin American Biochemists (PROLAB) of the American Society for Biochemistry and Molecular Biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Barrett MP, 2012, BRIT MED BULL, V104, P175, DOI 10.1093/bmb/lds031; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Carvalho AK, 2012, PARASITE IMMUNOL, V34, P395, DOI 10.1111/j.1365-3024.2012.01370.x; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Clinch K, 2009, J MED CHEM, V52, P1126, DOI 10.1021/jm801421q; Soares DC, 2007, PARASITOL INT, V56, P135, DOI 10.1016/j.parint.2007.01.004; Cui LW, 2001, GENE, V280, P153, DOI 10.1016/S0378-1119(01)00768-5; de Morais-Teixeira E, 2008, MEM I OSWALDO CRUZ, V103, P358, DOI 10.1590/S0074-02762008000400008; de Morais-Teixeira E, 2014, J ANTIMICROB CHEMOTH, V69, P150, DOI 10.1093/jac/dkt318; Donaldson TM, 2014, EUKARYOT CELL, V13, P572, DOI 10.1128/EC.00308-13; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Giannese F, 2013, ACTA CRYSTALLOGR D, V69, P1553, DOI 10.1107/S0907444913010792; HASSAN HF, 1986, MOL BIOCHEM PARASIT, V19, P19, DOI 10.1016/0166-6851(86)90061-7; Kiffer-Moreira T, 2010, FEMS YEAST RES, V10, P735, DOI 10.1111/j.1567-1364.2010.00641.x; KRUG EC, 1989, J BIOL CHEM, V264, P10601; LO HS, 1985, J PARASITOL, V71, P662, DOI 10.2307/3281440; Lovane E, 2008, BIOCHEMISTRY-US, V47, P4418, DOI 10.1021/bi702448s; Maia C, 2013, EXP PARASITOL, V135, P36, DOI 10.1016/j.exppara.2013.05.015; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Martin JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003938; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Mlika RB, 2012, DERMATOL THER, V25, P615, DOI 10.1111/j.1529-8019.2012.01522.x; Nico D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00189; Nico D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000866; Nogueira RC, 2013, ENVIRON TOXICOL PHAR, V36, P1304, DOI 10.1016/j.etap.2013.10.013; Paladi CD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001626; Palatnik-de-Sousa CB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-197; PARKIN DW, 1991, J BIOL CHEM, V266, P20658; Parkin DW, 1996, J BIOL CHEM, V271, P21713, DOI 10.1074/jbc.271.36.21713; Ramirez-Macias I, 2012, MEM I OSWALDO CRUZ, V107, P370, DOI 10.1590/S0074-02762012000300012; Real F, 2013, DNA RES, V20, P567, DOI 10.1093/dnares/dst031; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Rodrigues RF, 2012, J ANTIMICROB CHEMOTH, V67, P182, DOI 10.1093/jac/dkr409; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Santana DM, 2002, MOL BIOCHEM PARASIT, V120, P315, DOI 10.1016/S0166-6851(02)00010-5; Santos LO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004918; Sarver AE, 2002, J BIOL CHEM, V277, P39973, DOI 10.1074/jbc.M205595200; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shokri A, 2012, PARASITOL RES, V110, P1113, DOI 10.1007/s00436-011-2599-6; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Stauch Anette, 2012, PLoS Negl Trop Dis, V6, pe1973, DOI 10.1371/journal.pntd.0001973; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2013, EXPERT OPIN PHARMACO, V14, P53, DOI 10.1517/14656566.2013.755515; Todd SJ, 2003, J BACTERIOL, V185, P3373, DOI 10.1128/JB.185.11.3373-3378.2003; Versees W, 2009, BBA-PROTEINS PROTEOM, V1794, P953, DOI 10.1016/j.bbapap.2009.02.011; Wright PK, 2010, FRONT ANTI-CANC DRUG, V1, P758, DOI 10.2174/978160805161811001010758	49	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124183	10.1371/journal.pone.0124183	http://dx.doi.org/10.1371/journal.pone.0124183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909893	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800063
J	Kalies, S; Antonopoulos, GC; Rakoski, MS; Heinemann, D; Schomaker, M; Ripken, T; Meyer, H				Kalies, Stefan; Antonopoulos, Georgios C.; Rakoski, Mirko S.; Heinemann, Dag; Schomaker, Markus; Ripken, Tammo; Meyer, Heiko			Investigation of Biophysical Mechanisms in Gold Nanoparticle Mediated Laser Manipulation of Cells Using a Multimodal Holographic and Fluorescence Imaging Setup	PLOS ONE			English	Article							PHOTOTHERMAL THERAPY; CALCIUM WAVES; LIVING CELLS; GENERATION; RESPONSES	Laser based cell manipulation has proven to be a versatile tool in biomedical applications. In this context, combining weakly focused laser pulses and nanostructures, e.g. gold nanoparticles, promises to be useful for high throughput cell manipulation, such as transfection and photothermal therapy. Interactions between laser pulses and gold nanoparticles are well understood. However, it is still necessary to study cell behavior in gold nanoparticle mediated laser manipulation. While parameters like cell viability or perforation efficiency are commonly addressed, the influence of the manipulation process on other essential cell parameters is not sufficiently investigated yet. Thus, we set out to study four relevant cell properties: cell volume and area, ion exchange and cytoskeleton structure after gold nanoparticle based laser manipulation. For this, we designed a multimodal imaging and manipulation setup. 200 nm gold nanoparticles were attached unspecifically to canine cells and irradiated by weakly focused 850 ps laser pulses. Volume and area change in the first minute post laser manipulation was monitored using digital holography. Calcium imaging and cells expressing a marker for filamentous actin (F-actin) served to analyze the ion exchange and the cytoskeleton, respectively. High radiant exposures led to cells exhibiting a tendency to shrink in volume and area, possibly due to outflow of cytoplasm. An intracellular raise in calcium was observed and accompanied by an intercellular calcium wave. This multimodal approach enabled for the first time a comprehensive analysis of the cell behavior in gold nanoparticle mediated cell manipulation. Additionally, this work can pave the way for a better understanding and the evaluation of new applications in the context of cell transfection or photothermal therapy.	[Kalies, Stefan; Antonopoulos, Georgios C.; Rakoski, Mirko S.; Heinemann, Dag; Schomaker, Markus; Ripken, Tammo; Meyer, Heiko] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Meyer, Heiko] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany	Hannover Medical School	Kalies, S (corresponding author), Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany.	s.kalies@lzh.de	Heinemann, Dag/A-2861-2019; Heinemann, Dag/AAZ-9970-2021	Heinemann, Dag/0000-0003-3506-1762; Kalies, Stefan/0000-0003-3025-264X	German Research Foundation (DFG); REBIRTH Cluster of Excellence; "Industrielle Gemeinschaftsforschung" (IGF) of the German Federal Ministry for Economic Affairs and Energy (BMWi) [18129N]; Hannover Biomedical Research School (HBRS)	German Research Foundation (DFG)(German Research Foundation (DFG)); REBIRTH Cluster of Excellence; "Industrielle Gemeinschaftsforschung" (IGF) of the German Federal Ministry for Economic Affairs and Energy (BMWi); Hannover Biomedical Research School (HBRS)	The authors gratefully acknowledge the German Research Foundation (DFG) and the REBIRTH Cluster of Excellence for funding. Further funding was provided by the "Industrielle Gemeinschaftsforschung" (IGF, grant number 18129N) of the German Federal Ministry for Economic Affairs and Energy (BMWi). SK receives a stipend by the Hannover Biomedical Research School (HBRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkowiak M, 2010, J BIOPHOTONICS, V3, P696, DOI 10.1002/jbio.201000052; Bisker G, 2012, J OPT SOC AM B, V29, P1383, DOI 10.1364/JOSAB.29.001383; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Boulais E, 2012, NANO LETT, V12, P4763, DOI 10.1021/nl302200w; Cacace VI, 2014, CELL PHYSIOL BIOCHEM, V33, P1745, DOI 10.1159/000362955; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chen X, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0071; Cuche E, 1996, P SOC PHOTO-OPT INS, V2927, P61, DOI 10.1117/12.260653; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Ding HF, 2011, SPRINGER SER SURF SC, V46, P229, DOI 10.1007/978-3-642-15813-1_9; Escobar HM, 2003, CYTOGENET GENOME RES, V101, P33, DOI 10.1159/000073415; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Freitas RA, 2005, NANOMED-NANOTECHNOL, V1, P2, DOI 10.1016/j.nano.2004.11.003; Gnaiger E, 2000, Transpl Int, V13 Suppl 1, pS555, DOI 10.1111/j.1432-2277.2000.tb02103.x; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hashimoto S, 2012, J PHOTOCH PHOTOBIO C, V13, P28, DOI 10.1016/j.jphotochemrev.2012.01.001; Heinemann D, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245101; Heinemann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058604; Herraez MA, 2002, APPL OPTICS, V41, P7437, DOI 10.1364/AO.41.007437; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Iserovich P, 1998, ADV EXP MED BIOL, V438, P687; Kalies S, 2013, J BIOPHOTONICS; Kalies S, 2014, BIOMED OPT EXPRESS, V5, P2686, DOI 10.1364/BOE.5.002686; Kemper B, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3540674; Kim MK, 2011, SPRINGER SER OPT SCI, V162, P1, DOI 10.1007/978-1-4419-7793-9; Lapotko D, 2009, INT J HEAT MASS TRAN, V52, P1540, DOI 10.1016/j.ijheatmasstransfer.2008.08.010; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Lukianova-Hleb EY, 2011, J SURG RES, V166, pE3, DOI 10.1016/j.jss.2010.10.039; Minai L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02146; Mitchell CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079235; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Pavillon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030912; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roderick HL, 2003, CURR BIOL, V13, pR425, DOI 10.1016/S0960-9822(03)00358-0; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaked NT, 2011, QUANTITATIVE ANAL BI; Smith NI, 2001, APPL PHYS LETT, V79, P1208, DOI 10.1063/1.1397255; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Tseeb V, 2009, HFSP J, V3, P117, DOI 10.2976/1.3073779; Weichsel J, 2010, CYTOM PART A, V77A, P52, DOI 10.1002/cyto.a.20818; Xiong RH, 2014, ACS NANO, V8, P6288, DOI 10.1021/nn5017742	47	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124052	10.1371/journal.pone.0124052	http://dx.doi.org/10.1371/journal.pone.0124052			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909631	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800058
J	Konrad, FM; Bury, A; Schick, MA; Ngamsri, KC; Reutershan, J				Konrad, Franziska M.; Bury, Annette; Schick, Martin A.; Ngamsri, Kristian-Christos; Reutershan, Joerg			The Unrecognized Effects of Phosphodiesterase 4 on Epithelial Cells in Pulmonary Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PDE4 INHIBITOR ROFLUMILAST; GRO-ALPHA; MICE; EXPRESSION; ROLIPRAM; DISEASE; 4D; INFILTRATION	Acute pulmonary inflammation is characterized by migration of polymorphonuclear neutrophils (PMNs) into the different compartments of the lung, passing an endothelial and epithelial barrier. Recent studies showed evidence that phosphodiesterase (PDE) 4-inhibitors stabilized endothelial cells. PDE4B and PDE4D subtypes play a pivotal role in inflammation, whereas blocking PDE4D is suspected to cause gastrointestinal side effects. We thought to investigate the particular role of the PDE4-inhibitors roflumilast and rolipram on lung epithelium. Acute pulmonary inflammation was induced by inhalation of LPS. PDE4-inhibitors were administered i.p. or nebulized after inflammation. The impact of PDE4-inhibitors on PMN migration was evaluated in vivo and in vitro. Microvascular permeability, cytokine levels, and PDE4B and PDE4D expression were analyzed. In vivo, both PDE4-inhibitors decreased transendothelial and transepithelial migration even when administered after inflammation, whereas roflumilast showed a superior effect compared to rolipram on the epithelium. Both inhibitors decreased TNF beta, IL6, and CXCL2/3. CXCL1, the strong PMN chemoattractant secreted by the epithelium, was significantly more reduced by roflumilast. In vitro assays with human epithelium also emphasized the pivotal role of roflumilast on the epithelium. Additionally, LPS-induced stress fibers, an essential requirement for a direct migration of PMNs into the alveolar space, were predominantly reduced by roflumilast. Expression of PDE4B and PDE4D were both increased in the lungs by LPS, PDE4-inhibitors decreased mainly PDE4B. The topical administration of PDE4-inhibitors was also effective in curbing down PMN migration, further highlighting the clinical potential of these compounds. In pulmonary epithelial cells, both subtypes were found coexistent around the nucleus and the cytoplasm. In these epithelial cells, LPS increased PDE4B and, to a lesser extend, PDE4D, whereas the effect of the inhibitors was prominent on the PDE4B subtype. In conclusion, we determined the pivotal role of the PDE4-inhibitor roflumilast on lung epithelium and emphasized its main effect on PDE4B in hyperinflammation.	[Konrad, Franziska M.; Bury, Annette; Ngamsri, Kristian-Christos; Reutershan, Joerg] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Schick, Martin A.] Univ Hosp Wurzburg, Dept Anesthesiol & Intens Care Med, Wurzburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg	Reutershan, J (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	joerg.reutershan@uni-tuebingen.de	Schick, Martin/ABH-6971-2020		German Research Foundation [RE 1683/4-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant RE 1683/4-1 (to J. Reutershan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Gobejishvili L, 2013, J PHARMACOL EXP THER, V347, P80, DOI 10.1124/jpet.113.204933; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Konrad FM, 2013, FASEB J, V27, P3524, DOI 10.1096/fj.13-228122; Konrad FM, 2012, AM J PHYSIOL-LUNG C, V303, pL425, DOI 10.1152/ajplung.00387.2011; Kranz M, 2009, BIOORGAN MED CHEM, V17, P5336, DOI 10.1016/j.bmc.2009.03.061; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Mamiya T, 2001, BRIT J PHARMACOL, V132, P1111, DOI 10.1038/sj.bjp.0703912; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Michalski JM, 2012, CLIN PHARMACOL THER, V91, P134, DOI 10.1038/clpt.2011.266; Moodley T, 2013, MOL PHARMACOL, V83, P894, DOI 10.1124/mol.112.083493; MORGAN AJ, 1993, BIOCHEM PHARMACOL, V45, P2373, DOI 10.1016/0006-2952(93)90216-J; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Rennard SI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-18; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Reutershan J, 2007, AM J RESP CRIT CARE, V175, P1027, DOI 10.1164/rccm.200612-1822OC; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Sanz MJ, 2007, BRIT J PHARMACOL, V152, P481, DOI 10.1038/sj.bjp.0707428; Schick MA, 2012, J PHYSIOL-LONDON, V590, P2693, DOI 10.1113/jphysiol.2012.232116; Schmal H, 1996, J IMMUNOL, V156, P1963; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Suzuki O, 2013, J PHARMACOL SCI, V123, P219, DOI 10.1254/jphs.13103FP; Tang HF, 2010, INT IMMUNOPHARMACOL, V10, P406, DOI 10.1016/j.intimp.2010.01.003; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zimmerman NP, 2012, INFLAMM BOWEL DIS, V18, P1081, DOI 10.1002/ibd.21898	39	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121725	10.1371/journal.pone.0121725	http://dx.doi.org/10.1371/journal.pone.0121725			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909327	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800012
J	Lefebvre, B; Levesque, S; Bourgault, AM; Mulvey, MR; Mataseje, L; Boyd, D; Doualla-Bell, F; Tremblay, C				Lefebvre, Brigitte; Levesque, Simon; Bourgault, Anne-Marie; Mulvey, Michael R.; Mataseje, Laura; Boyd, David; Doualla-Bell, Florence; Tremblay, Cecile			Carbapenem Non-Susceptible Enterobacteriaceae in Quebec, Canada: Results of a Laboratory Surveillance Program (2010-2012)	PLOS ONE			English	Article							OXA-48-PRODUCING KLEBSIELLA-PNEUMONIAE; METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; EMERGENCE; OUTBREAK; DISSEMINATION; RESISTANCE; ONTARIO	The emergence and spread of carbapenemase-producing Enterobacteriaceae (CPE) represent a major public health concern because these bacteria are usually extensively resistant to most antibiotics. In order to evaluate their dissemination in Quebec, a surveillance program was introduced in 2010. We report the molecular and epidemiological profiles of CPE isolates collected. Between August 2010 and December 2012, a total of 742 non-duplicate isolates non-susceptible to carbapenems were analysed. AmpC beta-lactamase and metallo-beta-lactamase production were detected by Etest and carbapenemase production by the modified Hodge test (MHT). Antibiotic susceptibility profiles were determined using broth microdilution or Etest. Clonality of Klebsiella pneumoniae carbapenemase (KPC) strains was analyzed by pulsed-field gel electrophoresis (PFGE). The presence of genes encoding carbapenemases as well as other beta-lactamases was detected using PCR. Of the 742 isolates tested, 169 (22.8%) were CPE. Of these 169 isolates, 151 (89.3%) harboured a bla(KPC) gene while the remaining isolates carried bla(SME) (n = 9), bla(OXA-48) (n = 5), bla(NDM) (n = 3), and bla(NMC) (n = 1) genes. Among the 93 KPC strains presenting with a unique pattern (unique PFGE pattern and/or unique antibiotics susceptibility profile), 99% were resistant to ertapenem, 95% to imipenem, 87% to meropenem, 97% to aztreonam, 31% to colistin and 2% to tigecycline. In 19 patients, 2 to 5 KPC strains from different species or with a different PFGE pattern were isolated. CPE strains were present in the province of Quebec with the majority of strains harbouring KPC. Alternately, SME, OXA-48 and NMC containing strains were rarely found.	[Lefebvre, Brigitte; Levesque, Simon; Doualla-Bell, Florence; Tremblay, Cecile] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Bourgault, Anne-Marie] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Bourgault, Anne-Marie] McGill Univ, Dept Med, Montreal, PQ, Canada; [Mulvey, Michael R.; Mataseje, Laura; Boyd, David] Publ Hlth Agcy Canada, Bacteriol & Enter Dis Program, Natl Microbiol Lab, Winnipeg, MB, Canada; [Tremblay, Cecile] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); McGill University; McGill University; Public Health Agency of Canada; Universite de Montreal	Lefebvre, B (corresponding author), Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.	brigitte.lefebvre@inspq.qc.ca		Levesque, Simon/0000-0002-4356-9702; Boyd, David/0000-0001-8618-4848	LSPQ; NML internal	LSPQ; NML internal	This work was supported by LSPQ and NML internal funding and was done as a part of the routine work.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Barlow M, 2002, ANTIMICROB AGENTS CH, V46, P1190, DOI 10.1128/AAC.46.5.1190-1198.2002; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; CLSI, 2012, M100S22 CLSI; CLSI, 2011, PERFORMANCE STANDARD; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Perez JAE, 2013, ANTIMICROB AGENTS CH, V57, P1957, DOI 10.1128/AAC.01447-12; Haraoui LP, 2013, J CLIN MICROBIOL, V51, P2406, DOI 10.1128/JCM.02480-12; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Leung V, 2012, CAN J INFECT DIS MED, V23, P117, DOI 10.1155/2012/725151; Lowe CF, 2013, INFECT CONT HOSP EP, V34, P49, DOI 10.1086/668778; Mataseje LF, 2012, J ANTIMICROB CHEMOTH, V67, P1359, DOI 10.1093/jac/dks046; Mataseje LF, 2013, EMERG INFECT DIS, V19, P157, DOI 10.3201/eid1901.120706; Mnif B, 2013, J ANTIMICROB CHEMOTH, V68, P329, DOI 10.1093/jac/dks386; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Mushtaq S, 2011, J ANTIMICROB CHEMOTH, V66, P2002, DOI 10.1093/jac/dkr226; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Oteo J, 2013, J ANTIMICROB CHEMOTH, V68, P317, DOI 10.1093/jac/dks383; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Peirano G, 2011, DIAGN MICR INFEC DIS, V71, P106, DOI 10.1016/j.diagmicrobio.2011.06.013; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pisney L, 2013, MMWR-MORBID MORTAL W, V62, P108; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Potron A, 2011, CLIN MICROBIOL INFEC, V17, pE24, DOI 10.1111/j.1469-0691.2011.03669.x; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Pano-Pardo JR, 2013, J ANTIMICROB CHEMOTH, V68, P89, DOI 10.1093/jac/dks364; Samuelsen O, 2009, J ANTIMICROB CHEMOTH, V63, P654, DOI 10.1093/jac/dkp018; Tijet N, 2011, EMERG INFECT DIS, V17, P306, DOI 10.3201/eid1702.101561; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125076	10.1371/journal.pone.0125076	http://dx.doi.org/10.1371/journal.pone.0125076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910041	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800126
J	Negassa, WC; Guber, AK; Kravchenko, AN; Marsh, TL; Hildebrandt, B; Rivers, ML				Negassa, Wakene C.; Guber, Andrey K.; Kravchenko, Alexandra N.; Marsh, Terence L.; Hildebrandt, Britton; Rivers, Mark L.			Properties of Soil Pore Space Regulate Pathways of Plant Residue Decomposition and Community Structure of Associated Bacteria	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; ORGANIC-MATTER; NITROGEN MINERALIZATION; MICROBIAL COMMUNITIES; SPATIAL-DISTRIBUTION; CARBON MINERALIZATION; IMAGE-ANALYSIS; AGGREGATE; DYNAMICS; MECHANISMS	Physical protection of soil carbon (C) is one of the important components of C storage. However, its exact mechanisms are still not sufficiently lucid. The goal of this study was to explore the influence of soil structure, that is, soil pore spatial arrangements, with and without presence of plant residue on (i) decomposition of added plant residue, (ii) CO2 emission from soil, and (iii) structure of soil bacterial communities. The study consisted of several soil incubation experiments with samples of contrasting pore characteristics with/without plant residue, accompanied by X-ray micro-tomographic analyses of soil pores and by microbial community analysis of amplified 16S-18S rRNA genes via pyrosequencing. We observed that in the samples with substantial presence of air-filled well-connected large (>30 mu m) pores, 75-80% of the added plant residue was decomposed, cumulative CO2 emission constituted 1,200 mu m C g(-1) soil, and movement of C from decomposing plant residue into adjacent soil was insignificant. In the samples with greater abundance of water-filled small pores, 60% of the added plant residue was decomposed, cumulative CO2 emission constituted 2,000 mu m C g(-1) soil, and the movement of residue C into adjacent soil was substantial. In the absence of plant residue the influence of pore characteristics on CO2 emission, that is on decomposition of the native soil organic C, was negligible. The microbial communities on the plant residue in the samples with large pores had more microbial groups known to be cellulose decomposers, that is, Bacteroidetes, Proteobacteria, Actinobacteria, and Firmicutes, while a number of oligotrophic Acidobacteria groups were more abundant on the plant residue from the samples with small pores. This study provides the first experimental evidence that characteristics of soil pores and their air/water flow status determine the phylogenetic composition of the local microbial community and directions and magnitudes of soil C decomposition processes.	[Negassa, Wakene C.] Inst Adv Sustainabil Studies, IASS Global Soil Forum, Potsdam, Germany; [Guber, Andrey K.; Kravchenko, Alexandra N.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Marsh, Terence L.; Hildebrandt, Britton] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI USA; [Rivers, Mark L.] Univ Chicago, Argonne Natl Lab, Ctr Adv Radiat Sources, Argonne, IL USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Kravchenko, AN (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	kravche1@msu.edu	Negassa, Wakene/J-9445-2019; Guber, Andrey/AAP-3576-2021	Negassa, Wakene/0000-0001-8629-8239; Marsh, Terence/0000-0002-7015-975X	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award [2011-68002-301907]; U.S. National Science Foundation Long-Term Ecological Research (LTER) Program at the Kellogg Biological Station [DEB 1027253]; Kellogg Biological Station; Michigan State University's "Project GREEEN" Program; Michigan State University's "Discretionary Fund Initiative" Program; Division Of Environmental Biology [1027253] Funding Source: National Science Foundation	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award; U.S. National Science Foundation Long-Term Ecological Research (LTER) Program at the Kellogg Biological Station(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Kellogg Biological Station; Michigan State University's "Project GREEEN" Program; Michigan State University's "Discretionary Fund Initiative" Program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this research was provided in parts by the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) award No. 2011-68002-301907 cropping systems Coordinated Agricultural Project (CAP); by the U.S. National Science Foundation Long-Term Ecological Research (LTER) Program at the Kellogg Biological Station (DEB 1027253); by Kellogg Biological Station; by Michigan State University's "Project GREEEN" Program; and by Michigan State University's "Discretionary Fund Initiative" Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADU JK, 1978, SOIL BIOL BIOCHEM, V10, P109, DOI 10.1016/0038-0717(78)90080-9; Ananyeva K, 2013, SOIL BIOL BIOCHEM, V57, P868, DOI 10.1016/j.soilbio.2012.10.019; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baldock Jeffrey A., 2007, V10, P1; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; Bertrand I, 2007, SOIL BIOL BIOCHEM, V39, P276, DOI 10.1016/j.soilbio.2006.07.016; Blagodatskaya EV, 2009, EUR J SOIL SCI, V60, P186, DOI 10.1111/j.1365-2389.2008.01103.x; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chenu C, 2001, BIOL FERT SOILS, V34, P349, DOI 10.1007/s003740100419; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Conant RT, 2007, SOIL TILL RES, V95, P1, DOI 10.1016/j.still.2006.12.006; Crum JR, 1995, KELLOGG BIOL STATION; CURRIE JA, 1984, J SOIL SCI, V35, P1, DOI 10.1111/j.1365-2389.1984.tb00253.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Gryze S, 2006, GEODERMA, V134, P82, DOI 10.1016/j.geoderma.2005.09.002; De Neve S, 2000, BIOL FERT SOILS, V30, P544, DOI 10.1007/s003740050034; De Troyer I, 2011, SOIL BIOL BIOCHEM, V43, P513, DOI 10.1016/j.soilbio.2010.11.016; Dechesne A, 2003, SOIL BIOL BIOCHEM, V35, P1537, DOI 10.1016/S0038-0717(03)00243-8; Dechesne A, 2008, FEMS MICROBIOL ECOL, V64, P1, DOI 10.1111/j.1574-6941.2008.00446.x; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Espana M, 2011, PEDOBIOLOGIA, V54, P187, DOI 10.1016/j.pedobi.2011.03.001; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fan FL, 2014, SOIL BIOL BIOCHEM, V70, P12, DOI 10.1016/j.soilbio.2013.12.002; Feeney DS, 2006, MICROB ECOL, V52, P151, DOI 10.1007/s00248-006-9062-8; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Flavel RJ, 2012, J EXP BOT, V63, P2503, DOI 10.1093/jxb/err421; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Gaillard V, 2003, SOIL BIOL BIOCHEM, V35, P93, DOI 10.1016/S0038-0717(02)00241-9; Gaillard V, 1999, EUR J SOIL SCI, V50, P567, DOI 10.1046/j.1365-2389.1999.00266.x; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Haling RE, 2013, PLANT SOIL, V372, P619, DOI 10.1007/s11104-013-1777-y; HASSINK J, 1992, BIOL FERT SOILS, V14, P126, DOI 10.1007/BF00336262; Helliwell JR, 2014, SOIL BIOL BIOCHEM, V74, P138, DOI 10.1016/j.soilbio.2014.03.009; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Juarez S, 2013, EUR J SOIL BIOL, V58, P81, DOI 10.1016/j.ejsobi.2013.06.005; Juarez S, 2013, BIOL FERT SOILS, V49, P939, DOI 10.1007/s00374-013-0784-8; Kravchenko AN, 2014, SOIL SCI SOC AM J, V78, P1177, DOI 10.2136/sssaj2014.01.0039; Kravchenko AN, 2011, SOIL SCI SOC AM J, V75, P1658, DOI 10.2136/sssaj2011.0096; Kravchenko A, 2011, ECOL APPL, V21, P1202, DOI 10.1890/10-0525.1; Kravchenko AN, 2014, SOIL SCI SOC AM J, V78, P1924, DOI 10.2136/sssaj2014.07.0308; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; LADD JN, 1993, GEODERMA, V56, P401, DOI 10.1016/0016-7061(93)90124-4; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Lindquist WB, 2000, J GEOPHYS RES-SOL EA, V105, P21509, DOI 10.1029/2000JB900208; McMahon SK, 2005, SOIL SCI SOC AM J, V69, P1238, DOI 10.2136/sssaj2004.0289; Moldrup P, 2001, SOIL SCI SOC AM J, V65, P613, DOI 10.2136/sssaj2001.653613x; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; Mooney SJ, 2008, CATENA, V73, P204, DOI 10.1016/j.catena.2007.09.003; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Nunan N, 2003, FEMS MICROBIOL ECOL, V44, P203, DOI 10.1016/S0168-6496(03)00027-8; Oh W, 1999, IEEE T PATTERN ANAL, V21, P590, DOI 10.1109/34.777370; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Pascault N, 2013, ECOSYSTEMS, V16, P810, DOI 10.1007/s10021-013-9650-7; Peth S., 2010, DEV SOIL SCI, V34, P73, DOI [10.1016/S0166-2481(10)34003-7, DOI 10.1016/S0166-2481(10)34003-7]; Potthoff M, 2005, SOIL BIOL BIOCHEM, V37, P1259, DOI 10.1016/j.soilbio.2004.11.022; POWLSON DS, 1980, J SOIL SCI, V31, P77, DOI 10.1111/j.1365-2389.1980.tb02066.x; Quinn GP, 2001, EXPT DESIGN DATA ANA; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Rasband W.S., 1997, IMAGEJ; Resurreccion AC, 2010, SOIL SCI SOC AM J, V74, P481, DOI 10.2136/sssaj2009.0055; Rivers ML, 2006, SPIE, VJ3180, DOI [10.1007/s00259-013-2614-5, DOI 10.1007/S00259-013-2614-5]; Rivers ML, 2012, P SOC PHOTO-OPT INS, V8505; Ruamps LS, 2013, FEMS MICROBIOL ECOL, V86, P26, DOI 10.1111/1574-6941.12078; Ruamps LS, 2011, SOIL BIOL BIOCHEM, V43, P280, DOI 10.1016/j.soilbio.2010.10.010; Salome C, 2010, GLOBAL CHANGE BIOL, V16, P416, DOI 10.1111/j.1365-2486.2009.01884.x; SAS Institute, 2009, SAS US GUID VERS 9 2; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt B., 2007, IMAGEJ 3D VIEWER; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Semenov AV, 2012, SOIL BIOL BIOCHEM, V49, P88, DOI 10.1016/j.soilbio.2012.02.016; SEXSTONE AJ, 1985, SOIL SCI SOC AM J, V49, P645, DOI 10.2136/sssaj1985.03615995004900030024x; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Sleutel S, 2008, COMPUT GEOSCI-UK, V34, P931, DOI 10.1016/j.cageo.2007.10.006; Stenger R, 2002, AUST J SOIL RES, V40, P149, DOI 10.1071/SR01003; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Strong DT, 2004, EUR J SOIL SCI, V55, P739, DOI 10.1111/j.1365-2389.2004.00639.x; Taina IA, 2008, CAN J SOIL SCI, V88, P1, DOI 10.4141/CJSS06027; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; Thomson BC, 2010, J MICROBIOL METH, V83, P69, DOI 10.1016/j.mimet.2010.07.021; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wang W, 2012, SOIL SCI SOC AM J, V76, P1159, DOI 10.2136/sssaj2011.0281; Wang W, 2011, GEODERMA, V162, P231, DOI 10.1016/j.geoderma.2011.01.006	92	73	78	2	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123999	10.1371/journal.pone.0123999	http://dx.doi.org/10.1371/journal.pone.0123999			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909444	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800054
J	Rossi, O; Khan, MT; Schwarzer, M; Hudcovic, T; Srutkova, D; Duncan, SH; Stolte, EH; Kozakova, H; Flint, HJ; Samsom, JN; Harmsen, HJM; Wells, JM				Rossi, Oriana; Khan, M. Tanweer; Schwarzer, Martin; Hudcovic, Tomas; Srutkova, Dagmar; Duncan, Sylvia H.; Stolte, Ellen H.; Kozakova, Hana; Flint, Harry J.; Samsom, Janneke N.; Harmsen, Hermie J. M.; Wells, Jerry M.			Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis	PLOS ONE			English	Article							COMMENSAL BACTERIUM; DENDRITIC CELLS; MICROBIOTA; DISEASE; BUTYRATE; GROWTH	A decrease in the abundance and biodiversity of intestinal bacteria within the Firmicutes phylum has been associated with inflammatory bowel disease (IBD). In particular, the anti-inflammatory bacterium Faecalibacterium prausnitzii, member of the Firmicutes phylum and one of the most abundant species in healthy human colon, is underrepresented in the microbiota of IBD patients. The aim of this study was to investigate the immunomodulatory properties of F. prausnitzii strain A2-165, the biofilm forming strain HTF-F and the extracellular polymeric matrix (EPM) isolated from strain HTF-F. For this purpose, the immunomodulatory properties of the F. prausnitzii strains and the EPM were studied in vitro using human monocyte-derived dendritic cells. Then, the capacity of the F. prausnitzii strains and the EPM of HTF-F to suppress inflammation was assessed in vivo in the mouse dextran sodium sulphate (DSS) colitis model. The F. prausnitzii strains and the EPM had anti-inflammatory effects on the clinical parameters measured in the DSS model but with different efficacy. The immunomodulatory effects of the EPM were mediated through the TLR2-dependent modulation of IL-12 and IL-10 cytokine production in antigen presenting cells, suggesting that it contributes to the anti-inflammatory potency of F. prausnitzii HTF-F. The results show that F. prausnitzii HTF-F and its EPM may have a therapeutic use in IBD.	[Rossi, Oriana; Stolte, Ellen H.; Wells, Jerry M.] Wageningen Univ, Host Microbe Interact Grp, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands; [Khan, M. Tanweer; Harmsen, Hermie J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Membrane Cell Biol, NL-9713 AV Groningen, Netherlands; [Schwarzer, Martin; Hudcovic, Tomas; Srutkova, Dagmar; Kozakova, Hana] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Duncan, Sylvia H.; Flint, Harry J.] Univ Aberdeen, Microbial Ecol Grp, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Samsom, Janneke N.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Div Gastroenterol & Nutr, Rotterdam, Netherlands	Wageningen University & Research; University of Groningen; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Aberdeen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Wells, JM (corresponding author), Wageningen Univ, Host Microbe Interact Grp, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands.	jerry.wells@wur.nl	Srutkova, Dagmar/H-8511-2014; Schwarzer, Martin/P-9871-2017	Srutkova, Dagmar/0000-0003-0054-5396; Duncan, Sylvia/0000-0002-4903-0978; Schwarzer, Martin/0000-0002-1401-6578				Barcenilla A, 2000, APPL ENV MICROBIOLOG; COOPER HS, 1993, LAB INVEST, V69, P238; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macfarlane GT, 2009, CURR PHARM DESIGN, V15, P1528, DOI 10.2174/138161209788168146; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; Martin R, 2014, INFLAMM BOWEL DIS, V20, P417, DOI 10.1097/01.MIB.0000440815.76627.64; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ricciardi A, 1998, BIOTECHNOL TECH, V12, P649, DOI 10.1023/A:1008896400383; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rozen S, 2000, Methods Mol Biol, V132, P365; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Veenbergen S, 2012, CURR OPIN IMMUNOL, V24, P269, DOI 10.1016/j.coi.2012.03.004; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118	27	70	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123013	10.1371/journal.pone.0123013	http://dx.doi.org/10.1371/journal.pone.0123013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910186	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800027
J	Stemmer, M; Thumberger, T; Keyer, MD; Wittbrodt, J; Mateo, JL				Stemmer, Manuel; Thumberger, Thomas; Keyer, Maria del Sol; Wittbrodt, Joachim; Mateo, Juan L.			CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool	PLOS ONE			English	Article							GENOME; ZEBRAFISH; MEDAKA; SYSTEM; ENDONUCLEASE; BACTERIA; GENE	Engineering of the CRISPR/Cas9 system has opened a plethora of new opportunities for site-directed mutagenesis and targeted genome modification. Fundamental to this is a stretch of twenty nucleotides at the 5' end of a guide RNA that provides specificity to the bound Cas9 endonuclease. Since a sequence of twenty nucleotides can occur multiple times in a given genome and some mismatches seem to be accepted by the CRISPR/Cas9 complex, an efficient and reliable in silico selection and evaluation of the targeting site is key prerequisite for the experimental success. Here we present the CRISPR/Cas9 target online predictor (CCTop, http://crispr.cos.uni-heidelberg.de) to overcome limitations of already available tools. CCTop provides an intuitive user interface with reasonable default parameters that can easily be tuned by the user. From a given query sequence, CCTop identifies and ranks all candidate sgRNA target sites according to their off-target quality and displays full documentation. CCTop was experimentally validated for gene inactivation, non-homologous end-joining as well as homology directed repair. Thus, CCTop provides the bench biologist with a tool for the rapid and efficient identification of high quality target sites.	[Stemmer, Manuel; Thumberger, Thomas; Keyer, Maria del Sol; Wittbrodt, Joachim; Mateo, Juan L.] Heidelberg Univ, COS, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Thumberger, T (corresponding author), Heidelberg Univ, COS, Heidelberg, Germany.	thomas.thumberger@cos.uni-heidelberg.de; jochen.wittbrodt@cos.uni-heidelberg.de; juan.mateo@cos.uni-heidelberg.de	Cerdan, Juan Luis Mateo/N-2550-2015; Thumberger, Thomas/P-7772-2019; Thumberger, Thomas/E-3823-2014; Wittbrodt, Joachim/D-4735-2014	Cerdan, Juan Luis Mateo/0000-0001-9902-6048; Thumberger, Thomas/0000-0001-8485-457X; Thumberger, Thomas/0000-0001-8485-457X; Wittbrodt, Joachim/0000-0001-8550-7377; Stemmer, Manuel/0000-0003-1607-3573	European Research Council; German Research Foundation (DFG) [SFB873]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg; cluster of excellence CellNetworks	European Research Council(European Research Council (ERC)European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg; cluster of excellence CellNetworks	TT received a Postdoctoral Fellowship of the cluster of excellence CellNetworks. The project was supported by the European Research Council (JW: ManISteC) and the German Research Foundation (DFG: SFB873, JW). The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Baena-Lopez L a., 2013, DEVELOPMENT; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Centanin L, 2011, CELL STEM CELL, V9, P553, DOI 10.1016/j.stem.2011.11.004; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cong L, 2013, MULTIPLEX GENOME ENG; Farboud B, 2015, DRAMATIC ENHANCEMENT; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirchner SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071030, 10.1371/journal.pone.0076117]; Koster R, 1997, DEVELOPMENT, V124, P3147; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loosli F, 2001, DEVELOPMENT, V128, P4035; Mali P, 2013, SCIENCE; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vopalensky P, 2010, BIOTECHNIQUES, V48, P235, DOI 10.2144/000113368; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yoshinari N, 2012, DEV GROWTH DIFFER, V54, P818, DOI 10.1111/dgd.12013; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200	36	484	502	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124633	10.1371/journal.pone.0124633	http://dx.doi.org/10.1371/journal.pone.0124633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909470	Green Published, gold			2022-12-26	WOS:000353376800095
J	Tripathi, S; Wang, GS; White, M; Qi, L; Taubenberger, J; Hartshorn, KL				Tripathi, Shweta; Wang, Guangshun; White, Mitchell; Qi, Li; Taubenberger, Jeffery; Hartshorn, Kevan L.			Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; HEMAGGLUTININ; MECHANISM; INFECTION; COLLECTIN; BINDING	Human LL-37, a cationic antimicrobial peptide, was recently shown to have antiviral activity against influenza A virus (IAV) strains in vitro and in vivo. In this study we compared the anti-influenza activity of LL-37 with that of several fragments derived from LL-37. We first tested the peptides against a seasonal H3N2 strain and the mouse adapted H1N1 strain, PR-8. The N-terminal fragment, LL-23, had slight neutralizing activity against these strains. In LL-23V9 serine 9 is substituted by valine creating a continuous hydrophobic surface. LL-23V9 has been shown to have increased anti-bacterial activity compared to LL-23 and we now show slightly increased antiviral activity compared to LL-23 as well. The short central fragments, FK-13 and KR-12, which have anti-bacterial activity did not inhibit IAV. In contrast, a longer 20 amino acid central fragment of LL-37 (GI-20) had neutralizing activity similar to LL-37. None of the peptides inhibited viral hemagglutination or neuraminidase activity. We next tested activity of the peptides against a strain of pandemic H1N1 of 2009 (A/California/04/09/H1N1 or "Cal09"). Unexpectedly, LL-37 had markedly reduced activity against Cal09 using several cell types and assays of antiviral activity. A mutant viral strain containing just the hemagglutinin (HA) of 2009 pandemic H1N1 was inhibited by LL-37, suggested that genes other than the HA are involved in the resistance of pH1N1. In contrast, GI-20 did inhibit Cal09. In conclusion, the central helix of LL-37 incorporated in GI-20 appears to be required for optimal antiviral activity. The finding that GI-20 inhibits Cal09 suggests that it may be possible to engineer derivatives of LL-37 with improved antiviral properties.	[Tripathi, Shweta; White, Mitchell; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Wang, Guangshun] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Qi, Li; Taubenberger, Jeffery] NIAID, Bethesda, MD 20892 USA	Boston University; University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hartshorn, KL (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02215 USA.	khartsho@bu.edu	Taubenberger, Jeffery/AAQ-1407-2021		NIH [AI-83222, HL069031]; NIH intramural funds (JKT); Nebraska Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986, P01AI083222, R56AI105147, R01AI105147] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural funds (JKT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grant AI-83222 (KLH) and Grant HL069031 (KLH), NIH intramural funds (JKT) and the Nebraska Research Initiative (GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Currie SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073659; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1988, J IMMUNOL, V141, P1295; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Hou M, 2013, CELL PHYSIOL BIOCHEM, V32, P614, DOI 10.1159/000354465; Iwaarden J., 1993, AM REV RESPIR DIS, V148, pA146; Job ER, 2013, J IMMUNOL, V190, P2169, DOI 10.4049/jimmunol.1202433; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; SMITH H, 1988, REV INFECT DIS, V10, P56; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tecle T, 2007, ARCH VIROL, V152, P1731, DOI 10.1007/s00705-007-0983-4; Tripathi S, 2013, J GEN VIROL, V94, P40, DOI 10.1099/vir.0.045013-0; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Wang G., 2008, OPEN MAGN RESON J, V1, P9; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang GS, 2012, BIOCHEMISTRY-US, V51, P653, DOI 10.1021/bi2016266; Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11; Wang GS, 2010, BBA-BIOMEMBRANES, V1798, P114, DOI 10.1016/j.bbamem.2009.07.028; White MR, 2000, J IMMUNOL, V165, P2108, DOI 10.4049/jimmunol.165.4.2108; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com	34	51	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124706	10.1371/journal.pone.0124706	http://dx.doi.org/10.1371/journal.pone.0124706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909853	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800102
J	Vermeer-de Bondt, PE; Schoffelen, T; Vanrolleghem, AM; Isken, LD; van Deuren, M; Sturkenboom, MCJM; Timen, A				Vermeer-de Bondt, Patricia E.; Schoffelen, Teske; Vanrolleghem, Ann M.; Isken, Leslie D.; van Deuren, Marcel; Sturkenboom, Miriam C. J. M.; Timen, Aura			Coverage of the 2011 Q Fever Vaccination Campaign in the Netherlands, Using Retrospective Population-Based Prevalence Estimation of Cardiovascular Risk-Conditions for Chronic Q Fever	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; ABDOMINAL AORTIC-ANEURYSM; INFECTIVE ENDOCARDITIS; PATIENT RECORDS; DETERMINANTS; IMMUNIZATION; PROGRAM	Background In 2011, a unique Q fever vaccination campaign targeted people at risk for chronic Q fever in the southeast of the Netherlands. General practitioners referred patients with defined cardiovascular risk-conditions (age >15 years). Prevalence rates of those risk-conditions were lacking, standing in the way of adequate planning and coverage estimation. We aimed to obtain prevalence rates retrospectively in order to estimate coverage of the Q fever vaccination campaign. Methods With broad search terms for these predefined risk-conditions, we extracted patient-records from a large longitudinal general-practice research-database in the Netherlands (IPCI-database). After validation of these records, obtained prevalence rates (stratified for age and sex) extrapolated to the Q fever high-incidence area population, gave an approximation of the size of the targeted patient-group. Coverage calculation addressed people actually screened by a pre-vaccination Q fever skin test and serology (coverage) and patients referred by their general practitioners (adjusted-coverage) in the 2011 campaign. Results Our prevalence estimate of any risk-condition was 3.1% (lower-upper limits 2.9-3.3%). For heart valve defects, aorta aneurysm/prosthesis, congenital anomalies and endocarditis, prevalence was 2.4%, 0.6%, 0.4% and 0.1%, respectively. Estimated number of eligible people in the Q fever high-incidence area was 11,724 (10,965-12,532). With 1330 people screened for vaccination, coverage of the vaccination campaign was 11%. For referred people, the adjusted coverage was 18%. Coverage was lowest among the very-old and highest for people aged 50-70 years. Conclusion The estimated coverage of the vaccination campaign was limited. This should be interpreted in the light of the complexity of this target-group with much co-morbidity, and of the vaccine that required invasive pre-vaccination screening. Calculation of prevalence rates of risk-conditions based on the IPCI-database was feasible. This procedure proved an efficient tool for future use, when prevalence estimates for policy, implementation or surveillance of subgroup-vaccination or other health-care interventions are needed.	[Vermeer-de Bondt, Patricia E.; Isken, Leslie D.; Timen, Aura] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Schoffelen, Teske; van Deuren, Marcel] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Vanrolleghem, Ann M.; Sturkenboom, Miriam C. J. M.] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Vermeer-de Bondt, PE (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	patricia.vermeer@rivm.nl	Timen, Aura/GLV-4130-2022	Sturkenboom, Miriam/0000-0003-1360-2388	Netherlands Organisation for Health Research and Development [205520002]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The Netherlands Organisation for Health Research and Development (http://www.zonmw.nl/en/), grant number 205520002: TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other authors received any funding for this work.	[Anonymous], 2010, PUBL HLTH COUNC NETH; [Anonymous], 2013, PUBL HLTH COUNC NETH; [Anonymous], 2010, PUBL HLTH COUNC NETH; Boudoulas Harisios, 2003, Expert Rev Cardiovasc Ther, V1, P523; Brearley S, 2008, BMJ-BRIT MED J, V336, P862, DOI 10.1136/bmj.39517.443796.AD; Bults M, 2012, VACCINE, V30, P3369, DOI 10.1016/j.vaccine.2012.03.056; Byrd KK, 2012, VACCINE, V30, P3376, DOI 10.1016/j.vaccine.2012.03.055; COLLIN J, 1988, LANCET, V2, P613; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Fernandez-Hidalgo N, 2013, REV ESP CARDIOL, V66, P728, DOI [10.1016/j.rec.2013.05.002, 10.1016/j.recesp.2013.05.003]; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Isken LD, 2013, VACCINE, V31, P2617, DOI 10.1016/j.vaccine.2013.03.062; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kampschreur LM, 2013, EPIDEMIOL INFECT, V141, P847, DOI 10.1017/S0950268812001203; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; LAMBERTS H, 1992, FAM PRACT, V9, P330, DOI 10.1093/fampra/9.3.330; LINDROOS M, 1993, J AM COLL CARDIOL, V21, P1220, DOI 10.1016/0735-1097(93)90249-Z; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Marmion, 2009, GUIDE Q FEVER Q FEVE; MARMION BP, 1990, EPIDEMIOL INFECT, V104, P275, DOI 10.1017/S0950268800059458; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Patel DK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000879; Q-VAX Q fever vaccine and Q-VAX skin test, 2008, PROD INF TGA APPR; Rasmussen TA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5823; Reiter PL, 2011, SEX TRANSM DIS, V38, P235, DOI 10.1097/OLQ.0b013e3181f422bb; Schoffelen T, 2014, VACCINE, V32, P6622, DOI 10.1016/j.vaccine.2014.09.061; Schoffelen T, 2013, J INFECTION, V67, P565, DOI 10.1016/j.jinf.2013.08.008; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; Shen AK, 2013, VACCINE, V31, P279, DOI 10.1016/j.vaccine.2012.11.033; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Vahanian A, 2011, INT J CARDIOVAS IMAG, V27, P1115, DOI 10.1007/s10554-011-9804-7; van der Bom T, 2012, AM HEART J, V164, P568, DOI 10.1016/j.ahj.2012.07.023; Van der Graaf Y, 1998, BRIT J SURG, V85, P778; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P20059; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; van Lier A, 2014, EUR J PUBLIC HEALTH, V24, P304, DOI 10.1093/eurpub/ckt042; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Verweij MF, 2014, VACCINE, V32, P7163, DOI 10.1016/j.vaccine.2014.10.008; Vlug AE, 1999, METHOD INFORM MED, V38, P339; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Williams WW, 2012, MMWR-MORBID MORTAL W, V2014, P95; Wolfe RM, 2012, J AM BOARD FAM MED, V25, P496, DOI 10.3122/jabfm.2012.04.100274; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123570	10.1371/journal.pone.0123570	http://dx.doi.org/10.1371/journal.pone.0123570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909712	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800040
J	Wang, JQ; Qi, RR; Zhou, W; Tang, YF; Pan, LL; Cai, YL				Wang, Jun-Qin; Qi, Rui-Rui; Zhou, Wei; Tang, Yi-Fan; Pan, Lei-Lei; Cai, Yi-Ling			Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility	PLOS ONE			English	Article							OTOLITH-RELATED NEURONS; MULTIMODAL INTEGRATION; DELIVERY SYSTEMS; BRAIN-STEM; RESPONSES; STIMULATION; PROJECTIONS; ANTAGONIST; RECEPTORS; ROTATION	Objective To identify differentially expressed genes associated with motion sickness (MS) susceptibility in the rat caudal vestibular nucleus. Methods We identified MS susceptible (MSS) and insusceptible (inMSS) rats by quantifying rotation-induced MS symptoms: defecation and spontaneous locomotion activity. Microarray analysis was used to screen differentially expressed genes in the caudal vestibular nucleus (CVN) after rotation. Plasma stress hormones were identified by radioimmunoassay. Candidate genes were selected by bioinformatics analysis and the microarray results were verified by real-time quantitative-PCR (RT-qPCR) methods. By using Elvax implantation, receptor antagonists or recombinant adenovirus targeting the candidate genes were applied to the CVN to evaluate their contribution to MS susceptibility variability. Validity of gene expression manipulation was verified by RT-qPCR and western blot analysis. Results A total of 304 transcripts were differentially expressed in the MSS group compared with the inMSS group. RT-qPCR analysis verified the expression pattern of candidate genes, including nicotinic cholinergic receptor (nAchR) alpha 3 subunit, 5-hydroxytryptamine receptor 4 (5-HT4R), tachykinin neurokinin-1 (NK1R),gamma-aminobutyric acid A receptor (GABA(A)R) alpha 6 subunit, olfactory receptor 81 (Olr81) and homology 2 domain-containing transforming protein 1 (Shc1). In MSS animals, the nAchR antagonist mecamylamine significantly alleviated rotation- induced MS symptoms and the plasma beta-endorphin response. The NK1R antagonist CP99994 and Olr81 knock-down were effective for the defecation response, while the 5-HT4R antagonist RS39604 and Shc1 over-expression showed no therapeutic effect. In inMSS animals, rotation-induced changes in spontaneous locomotion activity and the plasma beta-endorphin level occurred in the presence of the GABA(A)R antagonist gabazine. Conclusion Our findings suggested that the variability of the CVN gene expression profile aftermotion stimulation might be a putative molecular basis for individual differences in MS susceptibility and provide information for the development of new therapeutic strategies for MSS individuals.	[Wang, Jun-Qin; Qi, Rui-Rui; Zhou, Wei; Tang, Yi-Fan; Pan, Lei-Lei; Cai, Yi-Ling] Second Mil Med Univ, Fac Navy Med, Dept Naut Injury Prevent, Shanghai, Peoples R China	Naval Medical University	Cai, YL (corresponding author), Second Mil Med Univ, Fac Navy Med, Dept Naut Injury Prevent, Shanghai, Peoples R China.	yilingcai1@sohu.com			National Natural Science Foundation of China [81272178]; Natural Science Foundation of Shanghai [12ZR1437300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study is supported by grants from the National Natural Science Foundation of China (81272178) and the Natural Science Foundation of Shanghai (12ZR1437300).	Aleksandrov VG, 1998, NEUROSCI LETT, V250, P66, DOI 10.1016/S0304-3940(98)00408-X; Anomal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064208; Arshian MS, 2013, EXP BRAIN RES, V228, P353, DOI 10.1007/s00221-013-3568-3; Balaban CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086730; Balaban CD, 1996, EXP BRAIN RES, V108, P367; BALABAN CD, 1994, EXP BRAIN RES, V98, P200; Balaban CD, 1999, CURR OPIN NEUROL, V12, P29, DOI 10.1097/00019052-199902000-00005; Beraneck M, 2007, J NEUROPHYSIOL, V98, P1549, DOI 10.1152/jn.00590.2007; Berry A, 2013, NEUROSCI BIOBEHAV R, V37, P790, DOI 10.1016/j.neubiorev.2013.03.005; Cai YL, 2007, NEUROSCI LETT, V417, P132, DOI 10.1016/j.neulet.2007.01.079; Cai YL, 2010, NEUROSCI LETT, V480, P87, DOI 10.1016/j.neulet.2010.06.011; CHAN YS, 1992, ANN NY ACAD SCI, V656, P755, DOI 10.1111/j.1749-6632.1992.tb25254.x; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Coelho CM, 2015, NEUROSCI BIOBEHAV R, V48, P148, DOI 10.1016/j.neubiorev.2014.10.023; Conder GA, 2008, J VET PHARMACOL THER, V31, P528, DOI 10.1111/j.1365-2885.2008.00990.x; CONTRUCCI RB, 1985, ANN OTO RHINOL LARYN, V94, P322; Cordick N, 1999, NEUROREPORT, V10, P1557, DOI 10.1097/00001756-199905140-00030; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Dornhoffer J, 2004, OTOL NEUROTOL, V25, P740, DOI 10.1097/00129492-200409000-00016; Glick SD, 2008, EUR J PHARMACOL, V599, P91, DOI 10.1016/j.ejphar.2008.09.038; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Goddard M, 2008, BEHAV NEUROSCI, V122, P448, DOI 10.1037/0735-7044.122.2.448; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Golding JF, 2005, AVIAT SPACE ENVIR MD, V76, P970; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Golding JF, 2011, AUTON NEUROSCI-BASIC, V160, P53, DOI 10.1016/j.autneu.2010.09.009; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Horii A, 2004, J NEUROCHEM, V91, P975, DOI 10.1111/j.1471-4159.2004.02781.x; Horn CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060537; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Javid FA, 2001, PHARMACOL BIOCHEM BE, V68, P761, DOI 10.1016/S0091-3057(01)00470-1; Javid FA, 2002, PHARMACOL BIOCHEM BE, V73, P979, DOI 10.1016/S0091-3057(02)00955-3; Johnson WH, 1999, J VESTIBUL RES-EQUIL, V9, P83; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Keshavarz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101016; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; KOHL RL, 1992, AVIAT SPACE ENVIR MD, V63, P986; Kraemer S, 2004, PHYSIOL BEHAV, V81, P435, DOI 10.1016/j.physbeh.2004.01.012; Lai CH, 2004, J COMP NEUROL, V470, P282, DOI 10.1002/cne.11048; LANGER R, 1981, J BIOMED MATER RES, V15, P267, DOI 10.1002/jbm.820150212; Limebeer CL, 2008, BEHAV BRAIN RES, V187, P33, DOI 10.1016/j.bbr.2007.08.024; LUCOT JB, 1989, LIFE SCI, V44, P1239, DOI 10.1016/0024-3205(89)90359-7; Lucot JB, 1997, BRIT J PHARMACOL, V120, P116, DOI 10.1038/sj.bjp.0700888; Markia B, 2008, BRAIN STRUCT FUNCT, V213, P239, DOI 10.1007/s00429-008-0172-6; MCCAFFREY RJ, 1985, PHYSIOL BEHAV, V35, P151, DOI 10.1016/0031-9384(85)90329-4; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Miller DM, 2008, EXP BRAIN RES, V188, P175, DOI 10.1007/s00221-008-1359-z; Mo FF, 2012, PHYSIOL BEHAV, V105, P394, DOI 10.1016/j.physbeh.2011.08.024; Mori RL, 2005, J APPL PHYSIOL, V98, P526, DOI 10.1152/japplphysiol.00970.2004; Morley BJ, 1997, MOL BRAIN RES, V48, P407, DOI 10.1016/S0169-328X(97)00159-9; Nakayama H, 2005, J PHARMACOL SCI, V98, P396, DOI 10.1254/jphs.FPJ05001X; Nickell JR, 2013, PHARMACOL BIOCHEM BE, V108, P28, DOI 10.1016/j.pbb.2013.04.005; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Nodal FR, 2012, J PHYSIOL-LONDON, V590, P3965, DOI 10.1113/jphysiol.2011.222828; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; OSSENKOPP KP, 1982, PHYSIOL PSYCHOL, V10, P355, DOI 10.3758/BF03332964; Ossenkopp KP, 2003, BEHAV NEUROSCI, V117, P105, DOI 10.1037/0735-7044.117.1.105; OSSENKOPP KP, 1994, PHYSIOL BEHAV, V56, P319, DOI 10.1016/0031-9384(94)90201-1; Paillard AC, 2013, J VESTIBUL RES-EQUIL, V23, P203, DOI 10.3233/VES-130501; Park MK, 2012, ANN OTO RHINOL LARYN, V121, P761, DOI 10.1177/000348941212101110; Persico AM, 1997, J NEUROSCI METH, V76, P105, DOI 10.1016/S0165-0270(97)00087-3; PHELAN KD, 1992, SYNAPSE, V10, P349, DOI 10.1002/syn.890100410; Pompeiano O, 2004, NEUROSCIENCE, V124, P53, DOI 10.1016/j.neuroscience.2003.09.027; Rahn EJ, 2013, NEUROBIOL LEARN MEM, V105, P133, DOI 10.1016/j.nlm.2013.06.008; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Sadeghi SG, 2009, EXP BRAIN RES, V195, P45, DOI 10.1007/s00221-009-1751-3; Schmal F, 2013, PHARMACOLOGY, V91, P229, DOI 10.1159/000350185; SEFTON MV, 1984, J PHARM SCI-US, V73, P1859, DOI 10.1002/jps.2600731258; Shupak A, 2006, AVIAT SPACE ENVIR MD, V77, P1213; Shytle RD, 2002, J HUM HYPERTENS, V16, P453, DOI 10.1038/sj.jhh.1001416; SILBERSTEIN GB, 1982, DEV BIOL, V93, P272, DOI 10.1016/0012-1606(82)90259-7; Smart LJ, 1998, BRAIN RES BULL, V47, P449, DOI 10.1016/S0361-9230(98)00103-8; Stiles L, 2014, BRAIN RES; Stoffregen TA, 2014, EXP BRAIN RES, V232, P1389, DOI 10.1007/s00221-014-3859-3; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; TAKEDA N, 1990, AVIAT SPACE ENVIR MD, V61, P1018; Talsma H, 1997, INT J PHARMACEUT, V157, P233, DOI 10.1016/S0378-5173(97)00244-5; Tu SC, 2000, J NEUROSCI, V20, P5346, DOI 10.1523/JNEUROSCI.20-14-05346.2000; Wang JQ, 2012, BRAIN RES, V1461, P30, DOI 10.1016/j.brainres.2012.04.041; Wang XC, 2013, J MOL NEUROSCI, V51, P514, DOI 10.1007/s12031-013-0087-4; Wang XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047308; Wei X, 2011, CNS NEUROSCI THER, V17, P790, DOI 10.1111/j.1755-5949.2011.00272.x; Yu XH, 2007, PHYSIOL BEHAV, V92, P702, DOI 10.1016/j.physbeh.2007.05.067; Zhang FX, 2005, BRAIN RES, V1062, P92, DOI 10.1016/j.brainres.2005.09.025; Zhang Lei, 2014, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V30, P279; Zingler VC, 2007, J NEUROL, V254, P1689, DOI 10.1007/s00415-007-0621-9	86	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124203	10.1371/journal.pone.0124203	http://dx.doi.org/10.1371/journal.pone.0124203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910039	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800066
J	Duarte, A; Queiroz, ATL; Tosta, R; Carvalho, AM; Barbosa, CH; Bellio, M; de Oliveira, CI; Barral-Netto, M				Duarte, Angelo; Queiroz, Artur T. L.; Tosta, Rafael; Carvalho, Augusto M.; Barbosa, Carlos Henrique; Bellio, Maria; de Oliveira, Camila I.; Barral-Netto, Manoel			Prediction of CD8(+) Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation	PLOS ONE			English	Article							HUMAN CUTANEOUS LEISHMANIASIS; T-CELL RESPONSE; VACCINE CANDIDATES; BINDING PEPTIDES; INFECTION; NETWORKS; ANTIGENS; IMMUNITY; DATABASE; VIANNIA	Background Leishmaniasis is caused by intracellular Leishmania parasites that induce a T-cell mediated response associated with recognition of CD4(+) and CD8(+) T cell Line 1Lineepitopes. Identification of CD8(+) antigenic determinants is crucial for vaccine and therapy development. Herein, we developed an open-source software dedicated to search and compile data obtained from currently available on line prediction algorithms. Methodology/Principal Findings We developed a two-phase algorithm and implemented in an open source software called EPIBOT, that consolidates the results obtained with single prediction algorithms, generating a final output in which epitopes are ranked. EPIBOT was initially trained using a set of 831 known epitopes from 397 proteins from IEDB. We then screened 63 Leishmania braziliensis vaccine candidates with the EPIBOT trained tool to search for CD8(+) T cell epitopes. A proof-of-concept experiment was conducted with the top eight CD8(+) epitopes, elected by EPIBOT. To do this, the elected peptides were synthesized and validated for their in vivo cytotoxicity. Among the tested epitopes, three were able to induce lysis of pulsed-target cells. Conclusion Our results show that EPIBOT can successfully search across existing prediction tools, generating a compiled list of candidate CD8(+) epitopes. This software is fast and a simple search engine that can be customized to search over different MHC alleles or HLA haplotypes.	[Duarte, Angelo; Tosta, Rafael] Univ Estadual Feira de Santana, Dept Tecnol, BR-44036900 Feira De Santana, BA, Brazil; [Queiroz, Artur T. L.; Carvalho, Augusto M.; de Oliveira, Camila I.; Barral-Netto, Manoel] CPqGM FIOCRUZ, BR-40296710 Salvador, BA, Brazil; [Barbosa, Carlos Henrique; Bellio, Maria] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, BR-21941902 Rio de Janeiro, RJ, Brazil; [de Oliveira, Camila I.; Barral-Netto, Manoel] Inst Invest Imunol, Sao Paulo, Brazil	Universidade Estadual de Feira de Santana; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	de Oliveira, CI (corresponding author), CPqGM FIOCRUZ, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.	camila@bahia.fiocruz.br; mbarral@bahia.fiocruz.br	Bellio, Maria/N-8525-2018; Barral-Netto, Manoel/B-3904-2009; Queiroz, Artur/AAT-9330-2021; de Oliveira, Camila I/B-4358-2009	Bellio, Maria/0000-0002-3360-2740; Barral-Netto, Manoel/0000-0002-5823-7903; de Oliveira, Camila I/0000-0002-7868-5164	FAPESB (Fundacao de Amparo a Pesquisa da Bahia) [SUS0003/2009]	FAPESB (Fundacao de Amparo a Pesquisa da Bahia)	This work was supported with a grant from FAPESB (Fundacao de Amparo a Pesquisa da Bahia) (SUS0003/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agallou M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00268; Alvar J, 2013, VACCINE, V31, pB244, DOI 10.1016/j.vaccine.2012.11.080; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Brodskyn CI, 1997, J IMMUNOL, V159, P4467; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; CUENTAS EAL, 1984, T ROY SOC TROP MED H, V78, P845, DOI 10.1016/0035-9203(84)90043-9; Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; Guerfali FZ, 2009, INFECT GENET EVOL, V9, P344, DOI 10.1016/j.meegid.2008.02.011; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; Herrera-Najera C, 2009, PROTEOMICS, V9, P1293, DOI 10.1002/pmic.200800533; Hughey R, 1996, COMPUT APPL BIOSCI, V12, P95; Jayakumar A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001204; Kronenberg K, 2010, J INVEST DERMATOL, V130, P2602, DOI 10.1038/jid.2010.171; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Maroof A, 2012, J INFECT DIS, V205, P853, DOI 10.1093/infdis/jir842; Costa CHN, 2011, PLOS NEGLECT TROP D, V5, DOI [10.1371/journal.pntd.0000965, 10.1371/journal.pntd.0000943]; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Novais FO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003504; Okwor I, 2009, HUM VACCINES, V5, P291, DOI 10.4161/hv.5.5.7607; PARKER KC, 1994, J IMMUNOL, V152, P163; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; PRESNELL SR, 1993, ANNU REV BIOPH BIOM, V22, P283, DOI 10.1146/annurev.bb.22.060193.001435; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Resende DM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-309; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; Santos CDS, 2013, J INVEST DERMATOL, V133, P1533, DOI 10.1038/jid.2013.4; Seyed N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001295; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004	33	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124786	10.1371/journal.pone.0124786	http://dx.doi.org/10.1371/journal.pone.0124786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905908	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000089
J	Putranto, RA; Duan, CF; Kuswanhadi; Chaidamsari, T; Rio, M; Piyatrakul, P; Herlinawati, E; Pirrello, J; Dessailly, F; Leclercq, J; Bonnot, F; Tang, CR; Hu, SN; Montoro, P				Putranto, Riza-Arief; Duan, Cuifang; Kuswanhadi; Chaidamsari, Tetty; Rio, Maryannick; Piyatrakul, Piyanuch; Herlinawati, Eva; Pirrello, Julien; Dessailly, Florence; Leclercq, Julie; Bonnot, Francois; Tang, Chaorong; Hu, Songnian; Montoro, Pascal			Ethylene Response Factors Are Controlled by Multiple Harvesting Stresses in Hevea brasiliensis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RUBBER TREE; GENE-EXPRESSION; SOMATIC EMBRYOGENESIS; METHYL JASMONATE; LATEX YIELD; ARABIDOPSIS; FAMILY; COLD; IDENTIFICATION	Tolerance of recurrent mechanical wounding and exogenous ethylene is a feature of the rubber tree. Latex harvesting involves tapping of the tree bark and ethephon is applied to increase latex flow. Ethylene is an essential element in controlling latex production. The ethylene signalling pathway leads to the activation of Ethylene Response Factor (ERF) transcription factors. This family has been identified in Hevea brasiliensis. This study set out to understand the regulation of ERF genes during latex harvesting in relation to abiotic stress and hormonal treatments. Analyses of the relative transcript abundance were carried out for 35 HbERF genes in latex, in bark from mature trees and in leaves from juvenile plants under multiple abiotic stresses. Twenty-one HbERF genes were regulated by harvesting stress in laticifers, revealing an overrepresentation of genes in group IX. Transcripts of three HbERF-IX genes from HbERF-IXc4, HbERF-IXc5 and HbERF-IXc6 were dramatically accumulated by combining wounding, methyl jasmonate and ethylene treatments. When an ethylene inhibitor was used, the transcript accumulation for these three genes was halted, showing ethylene-dependent induction. Subcellular localization and transactivation experiments confirmed that several members of HbERF-IX are activator-type transcription factors. This study suggested that latex harvesting induces mechanisms developed for the response to abiotic stress. These mechanisms probably depend on various hormonal signalling pathways. Severalmembers of HbERF-IX could be essential integrators of complex hormonal signalling pathways in Hevea.	[Putranto, Riza-Arief; Duan, Cuifang; Rio, Maryannick; Piyatrakul, Piyanuch; Pirrello, Julien; Dessailly, Florence; Leclercq, Julie; Montoro, Pascal] CIRAD, UMR DAP, Montpellier, France; [Putranto, Riza-Arief; Chaidamsari, Tetty] IBRIEC, Bogor, Indonesia; [Duan, Cuifang; Tang, Chaorong] CATAS, RRI, Danzhou, Hainan, Peoples R China; [Kuswanhadi; Herlinawati, Eva] IRRI, Sembawa, Palembang, Indonesia; [Piyatrakul, Piyanuch] Rubber Res Inst, Bangkok, Thailand; [Bonnot, Francois] CIRAD, UMR BGPI, Montpellier, France; [Hu, Songnian] BIG CAS, Beijing, Peoples R China	CIRAD; Chinese Academy of Tropical Agricultural Sciences; Riset Perkebunan Nusantara; Indonesian Rubber Research Institute (IRRI); CIRAD	Montoro, P (corresponding author), CIRAD, UMR DAP, Montpellier, France.	pascal.montoro@cirad.fr	Putranto, Riza-Arief/X-3130-2019; Tang, Chaorong/V-1483-2019; Pirrello, Julien/AAI-1692-2020	Putranto, Riza-Arief/0000-0002-1327-1200; Pirrello, Julien/0000-0002-5725-885X; Leclercq, Julie/0000-0001-8110-3762; RIO, Maryannick/0000-0002-4573-1371	French Government; Chinese Scholarship Council; Institut Francais du Caoutchouc (IFC); Michelin; Socfinco; Societe Internationale de PLantations d'Heveas (SIPH)	French Government; Chinese Scholarship Council(China Scholarship Council); Institut Francais du Caoutchouc (IFC); Michelin; Socfinco; Societe Internationale de PLantations d'Heveas (SIPH)	The French Government (BGF scholarship) provided a 18-month scholarship to Mr. Riza-Arief Putranto. The Chinese Scholarship Council provided a 3-year scholarship to Mrs. Cuifang Duan. The Institut Francais du Caoutchouc (IFC), and the Michelin, Socfinco and Societe Internationale de PLantations d'Heveas (SIPH) companies provided a 18-month scholarship to Mr. Riza-Arief Putranto, and funded all bench fees for experiments related to this paper. CATAS and the Beijing Institute of Genomics provided access to the Hevea genome sequence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The IFC agreed to publish this manuscript.	Akhtar M, 2012, J GENET, V91, P385, DOI 10.1007/s12041-012-0201-3; Cai HB, 2008, TROPICAL AGR SCI TEC, V31, P424; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Champion A, 2009, MOL PLANT PATHOL, V10, P471, DOI [10.1111/J.1364-3703.2009.00549.X, 10.1111/j.1364-3703.2009.00549.x]; Chen YC, 2011, BREAKING FEM WAVES, P1, DOI 10.1057/9780230119185; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YY, 2011, AFR J BIOTECHNOL, V10, P9751; Cheng M-C, 2013, PLANT PHYSL; d'Auzac J, 1992, CELLULAR MOL ASPECTS, P205; d'Auzac J, 1989, PHYSL RUBBER TREE LA, P58; De Fay E, 1989, PHYSL RUBBER TREE LA, P4; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Etheridge Naomi, 2005, Briefings in Functional Genomics & Proteomics, V3, P372, DOI 10.1093/bfgp/3.4.372; GIDROL X, 1994, J BIOL CHEM, V269, P9278; Hao BingZhong, 2004, Journal of Rubber Research, V7, P281; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kadow D, 2012, ANN BOT-LONDON, V109, P1253, DOI 10.1093/aob/mcs057; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Kuswanhadi, 2010, J RUBBER RES, V13, P185; Lardet L, 2009, TREE PHYSIOL, V29, P291, DOI 10.1093/treephys/tpn027; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Licausi F, 2013, J INTEGR PLANT BIOL, V55, P31, DOI 10.1111/jipb.12011; Lim CJ, 2007, BIOCHEM BIOPH RES CO, V362, P431, DOI 10.1016/j.bbrc.2007.08.007; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Okoma K. M., 2011, Agriculture and Biology Journal of North America, V2, P559, DOI 10.5251/abjna.2011.2.3.559.569; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pauwels L, 2008, PLANT SIGNAL BEHAV, V3, P846, DOI 10.4161/psb.3.10.5993; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Piyatrakul P, DNA RES IN PRESS; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Pollier J, 2013, NATURE, V504, P148, DOI 10.1038/nature12685; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Riechmann JL, 1998, BIOL CHEM, V379, P633; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schippers JHM, 2012, CELL MOL LIFE SCI, V69, P3245, DOI 10.1007/s00018-012-1092-4; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; Shoji T, 2013, PLANT PHYSIOL, V162, P977, DOI 10.1104/pp.113.217455; SIVAKUMARAN S, 1984, J RUBBER RES I MALAY, V32, P155; Tsai K-J, 2014, PLANT CELL ENVIRON; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; van der Fits L, 2001, PLANT J, V25, P43, DOI 10.1046/j.1365-313x.2001.00932.x; Vogel MO, 2012, INT J MOL SCI, V13, P5933, DOI 10.3390/ijms13055933; Wu H., 2010, CHINESE AGR SCI B, V5; Xiao XH, 2014, FEBS J, V281, P291, DOI 10.1111/febs.12595; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Zhu D, 2013, MOL PLANT	54	17	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123618	10.1371/journal.pone.0123618	http://dx.doi.org/10.1371/journal.pone.0123618			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906196	Green Published, gold			2022-12-26	WOS:000353332000037
J	Stokol, T; Yeo, WM; Burnett, D; DeAngelis, N; Huang, T; Osterrieder, N; Catalfamo, J				Stokol, Tracy; Yeo, Wee Ming; Burnett, Deborah; DeAngelis, Nicole; Huang, Teng; Osterrieder, Nikolaus; Catalfamo, James			Equid Herpesvirus Type 1 Activates Platelets	PLOS ONE			English	Article							COMPLEX CLASS-I; GLYCOPROTEIN-C; TISSUE FACTOR; P-SELECTIN; ENVELOPED VIRUS; DENGUE VIRUS; INFECTION; SIMPLEX; COAGULATION; ENDOTHELIUM	Equid herpesvirus type 1 (EHV-1) causes outbreaks of abortion and neurological disease in horses. One of the main causes of these clinical syndromes is thrombosis in placental and spinal cord vessels, however the mechanism for thrombus formation is unknown. Platelets form part of the thrombus and amplify and propagate thrombin generation. Here, we tested the hypothesis that EHV-1 activates platelets. We found that two EHV-1 strains, RacL11 and Ab4 at 0.5 or higher plaque forming unit/cell, activate platelets within 10 minutes, causing alpha-granule secretion (surface P-selectin expression) and platelet microvesiculation (increased small events double positive for CD41 and Annexin V). Microvesiculation was more pronounced with the RacL11 strain. Virus-induced P-selectin expression required plasma and 1.0 mM exogenous calcium. P-selectin expression was abolished and microvesiculation was significantly reduced in factor VII- or X-deficient human plasma. Both Pselectin expression and microvesiculation were re-established in factor VII-deficient human plasma with added purified human factor VIIa (1 nM). A glycoprotein C-deficient mutant of the Ab4 strain activated platelets as effectively as non-mutated Ab4. P-selectin expression was abolished and microvesiculation was significantly reduced by preincubation of virus with a goat polyclonal anti-rabbit tissue factor antibody. Infectious virus could be retrieved from washed EHV-1-exposed platelets, suggesting a direct platelet-virus interaction. Our results indicate that EHV-1 activates equine platelets and that alpha-granule secretion is a consequence of virus-associated tissue factor triggering factor X activation and thrombin generation. Microvesiculation was only partly tissue factor and thrombin-dependent, suggesting the virus causes microvesiculation through other mechanisms, potentially through direct binding. These findings suggest that EHV-1-induced platelet activation could contribute to the thrombosis that occurs in clinically infected horses and provides a new mechanism by which viruses activate hemostasis.	[Stokol, Tracy; Yeo, Wee Ming; Burnett, Deborah; DeAngelis, Nicole; Catalfamo, James] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Huang, Teng; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany	Cornell University; Free University of Berlin	Stokol, T (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	tracy.stokol@cornell.edu		Osterrieder, Nikolaus/0000-0002-5313-2176	Harold M. Zweig Memorial Fund for Research, College of Veterinary Medicine, Cornell University	Harold M. Zweig Memorial Fund for Research, College of Veterinary Medicine, Cornell University	This work was supported by Harold M. Zweig Memorial Fund for Research, College of Veterinary Medicine, Cornell University (TS), (http://www.vet.cornell.edu/zweig/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBANYO FR, 1994, J INFECT DIS, V170, P1120, DOI 10.1093/infdis/170.5.1120; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Alonzo MTG, 2012, J INFECT DIS, V205, P1321, DOI 10.1093/infdis/jis180; Brooks MB, 2013, AM J VET RES, V74, P1212, DOI 10.2460/ajvr.74.9.1212; Bunce PE, 2011, CLIN INFECT DIS, V52, pE14, DOI 10.1093/cid/ciq125; Choi W, 2010, PLATELETS, V21, P167, DOI 10.3109/09537101003611385; de Witt SM, 2014, THROMB RES, V133, pS139, DOI 10.1016/S0049-3848(14)50024-2; EDINGTON N, 1986, ARCH VIROL, V90, P111, DOI 10.1007/BF01314149; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Gershom ES, 2010, J THROMB HAEMOST, V8, P1037, DOI 10.1111/j.1538-7836.2010.03789.x; HIRNI H, 1988, ANIM GENET, V19, P391, DOI 10.1111/j.1365-2052.1988.tb00830.x; Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Kim SK, 2003, J VIROL, V77, P2675, DOI 10.1128/JVI.77.4.2675-2685.2003; Koupenova M, 2014, BLOOD, V124, P791, DOI 10.1182/blood-2013-11-536003; Kurtz BM, 2010, J VIROL, V84, P9027, DOI 10.1128/JVI.00287-10; Lunn DP, 2009, J VET INTERN MED, V23, P450, DOI 10.1111/j.1939-1676.2009.0304.x; Ma GG, 2012, J VIROL, V86, P3554, DOI 10.1128/JVI.06994-11; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; MCSORLEY J, 1974, INT J DERMATOL, V13, P69, DOI 10.1111/j.1365-4362.1974.tb01769.x; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Noisakran S, 2009, SE ASIAN J TROP MED, V40, P253; Oostingh GJ, 2007, HAEMATOLOGICA, V92, P502, DOI 10.3324/haematol.10741; Osterrieder N, 1999, VIRUS RES, V59, P165, DOI 10.1016/S0168-1702(98)00134-8; Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; PRYZDIAL ELG, 1994, BLOOD, V84, P3749, DOI 10.1182/blood.V84.11.3749.bloodjournal84113749; Pugliese A, 2004, CELL BIOCHEM FUNCT, V22, P353, DOI 10.1002/cbf.1113; Reczko E, ARCH GES VIRUSFORSCH, V13, P591; Segura D, 2005, VET J, V170, P108, DOI 10.1016/j.tvjl.2004.05.013; Shah MD, 2008, PLATELETS, V19, P365, DOI 10.1080/09537100802054107; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Slotta JE, 2009, PLATELETS, V20, P505, DOI 10.3109/09537100903215417; Smith KC, 1996, J COMP PATHOL, V114, P231, DOI 10.1016/S0021-9975(96)80045-4; SMITH KC, 1993, EQUINE VET J, V25, P36, DOI 10.1111/j.2042-3306.1993.tb02898.x; Sutherland MR, 2012, BLOOD, V119, P3638, DOI 10.1182/blood-2011-08-376814; Sutherland MR, 1997, P NATL ACAD SCI USA, V94, P13510, DOI 10.1073/pnas.94.25.13510; Sutherland MR, 2004, THROMB HAEMOSTASIS, V92, P947, DOI 10.1160/TH04-04-0242; Szeredi L, 2003, J COMP PATHOL, V129, P147, DOI 10.1016/S0021-9975(03)00022-7; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; VERCELLOTTI GM, 1990, BLOOD CELLS, V16, P209; Wang J, 2011, J THROMB HAEMOST, V9, P562, DOI 10.1111/j.1538-7836.2010.04168.x; Yang J, 1999, THROMB HAEMOSTASIS, V81, P1; Yeo WM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-16; Youssefian T, 2002, BLOOD, V99, P4021, DOI 10.1182/blood-2001-12-0191	45	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122640	10.1371/journal.pone.0122640	http://dx.doi.org/10.1371/journal.pone.0122640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905776	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000016
J	Tian, MM; Wang, H; Tong, XT; Zhu, K; Zhang, XJ; Chen, X				Tian, Miaomiao; Wang, Heng; Tong, Xuetao; Zhu, Kun; Zhang, Xiaojuan; Chen, Xi			Essential Public Health Services' Accessibility and its Determinants among Adults with Chronic Diseases in China	PLOS ONE			English	Article							CARE	Background Along with three years implementation of health reform in China, this study aimed at providing the up-to-date evidence about the accessibility of essential public health services (EPHS) among adults with chronic diseases (CDs) in both urban and rural areas, as well as determinants in access to EPHS. Methods The data were collected from a cross-sectional survey conducted in 2013, which used a multistage stratified random sampling method to select 54 urban communities and 54 rural villages. Hypertension patients and diabetes patients were the target population who are the main beneficiaries of EPHS. Single factor analysis of influencing factors on difference access to EPHS was performed by Chi-Square analysis. Logistic regression analysis was used to determine the predictors of effective management and effective control. Results Patients with hypertension or diabetes were predominantly middle-aged or older persons and had a mean age of 65.26 year. People with CDs in China have a higher basic accessibility rate in EPHS with more than 90% of them having experience in receiving EPHS. And those who are willing to receive services from doctors have the most positive influence on effective management and control in blood pressure or blood glucose. But unsatisfied quality and equity of EPHS still exist in primary health system. 90% of participants could receive EPHS, but just 44% of them could control their diseases effectively. And participants from cities had the higher rates in effective management (urban: rural = 57%: 50.6%) and effective control (urban: rural = 39.5%: 27.8%). Conclusion People with CDs have a high level in geography and economic accessibility to EPHS, but the effectiveness of health management also needs to be improved, especially for those living in rural areas. Our study highlights the continuing need for improving ability to provide EPHS and the equality among regions. Meanwhile, strengthen health education and promotion for patients with CDs to improve their willingness to receive EPHS is also highlighted.	[Tian, Miaomiao; Zhu, Kun; Zhang, Xiaojuan] Chinese Acad Med Sci, Ctr Hlth Policy & Management, Inst Med Informat, Beijing 100020, Peoples R China; [Wang, Heng] Anhui Med Univ, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China; [Tong, Xuetao] Guiyang Med Univ, Guiyang 550004, Guizhou, Peoples R China; [Chen, Xi] Jiangsu Univ, Sch Management, Zhanjiang 212013, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Information - CAMS; Anhui Medical University; Guizhou Medical University; Jiangsu University	Wang, H (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China.	857203662@qq.com						Anthony F, 2005, HARRISONS PRINCIPLES, P1463; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Bergsten U, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i4.8473; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Center for Health Statistics and Information, 2004, REP NAT HLTH SERV SU; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Communist Party of China Central Committee, 2013, STT COUNC IMPL PLAN; Communist Party of China Central Committee, 2009, IMPL PLAN REC PRIOR, V2009, P38; Diderichsen F, 2004, RESOURCE ALLOCATION, P20; Haggerty Jeannie L, 2011, Healthc Policy, V7, P94; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Lu Z, 2012, BMC HEALTH SERV RES, V24, P212; MacGregor JCD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-726; Ministry of Health PRC, 2009, OP PROM ESS PUBL HLH; Ministry of Health PRC, 2013, CHIN HLTH STAT YB 20; Ministry of Health PRC, 2014, CHIN HLTH STAT DIG 2; *NAT BUR STAT CHIN, 2009, CHIN STAT YB 2009; National bureau of statistics of China, 2013, CHIN HLTH STAT YB 20; National Bureau of Statistics of China, 2014, CHIN STAT YB 2013; National Bureau of Statistics of China, 2014, CHIN HLTH STAT YB 20; National health and family planning commission of the People's Republic of China, 2011, NAT ESS PUBL HLTH SE; Niu HL, 2014, CHINESE MED J-PEKING, V127, P1626, DOI 10.3760/cma.j.issn.0366-6999.20132786; Qian G, 2011, CHINESE J PUBLIC HLT, V28, P986; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Teng L, 2011, CHINESE J NEW CLIN M, V4, P909; The Central People's Government of PRC, 2012, 12 5 YEAR PER DEEP H; Tian MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083822; Tian MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-948; UNDP, 2010, CHIN HUM DEV REP 200; World Health Organization, 2014, DIABETES MELLITUS; World Health Organization, 1999, DEF DIAGN CLASS DIAB, P52; Yang J, 2008, ANN FAM MED, V6, P421, DOI 10.1370/afm.888	33	24	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125262	10.1371/journal.pone.0125262	http://dx.doi.org/10.1371/journal.pone.0125262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906073	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000108
J	Zhou, SM; Kong, XZ; Kang, HH; Sun, XD; Wang, W				Zhou, Shu-Mei; Kong, Xiang-Zhu; Kang, Han-Han; Sun, Xiu-Dong; Wang, Wei			The Involvement of Wheat F-Box Protein Gene TaFBA1 in the Oxidative Stress Tolerance of Plants	PLOS ONE			English	Article							TRANSGENIC TOBACCO PLANTS; LIPID-PEROXIDATION; UBIQUITIN LIGASE; DROUGHT STRESS; ARABIDOPSIS; ENHANCEMENT; SENSITIVITY; RESISTANCE; ELEMENTS; DATABASE	As one of the largest gene families, F-box domain proteins have been found to play important roles in abiotic stress responses via the ubiquitin pathway. TaFBA1 encodes a homologous F-box protein contained in E3 ubiquitin ligases. In our previous study, we found that the overexpression of TaFBA1 enhanced drought tolerance in transgenic plants. To investigate the mechanisms involved, in this study, we investigated the tolerance of the transgenic plants to oxidative stress. Methyl viologen was used to induce oxidative stress conditions. Real-time PCR and western blot analysis revealed that TaFBA1 expression was up-regulated by oxidative stress treatments. Under oxidative stress conditions, the transgenic tobacco plants showed a higher germination rate, higher root length and less growth inhibition than wild type (WT). The enhanced oxidative stress tolerance of the transgenic plants was also indicated by lower reactive oxygen species (ROS) accumulation, malondialdehyde (MDA) content and cell membrane damage under oxidative stress compared with WT. Higher activities of antioxidant enzymes, including superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX) and peroxidase (POD), were observed in the transgenic plants than those in WT, which may be related to the upregulated expression of some antioxidant genes via the overexpression of TaFBA1. In others, some stress responsive elements were found in the promoter region of TaFBA1, and TaFBA1 was located in the nucleus, cytoplasm and plasma membrane. These results suggest that TaFBA1 plays an important role in the oxidative stress tolerance of plants. This is important for understanding the functions of F-box proteins in plants' tolerance to multiple stress conditions.	[Zhou, Shu-Mei; Kong, Xiang-Zhu; Kang, Han-Han; Wang, Wei] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Sun, Xiu-Dong] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Wang, W (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	wangw@sdau.edu.cn			National Natural Science Foundation of China [31370304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (Grant number: 31370304), and the URL is http://www.nsfc.gov.cn/. W.W. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AONO M, 1995, PLANT PHYSIOL, V107, P645, DOI 10.1104/pp.107.2.645; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderon-Villalobos LIA, 2007, GENE, V392, P106, DOI 10.1016/j.gene.2006.11.016; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; DODGE AD, 1994, CAUSES PHOTOOXIDATIV, P219; Iannone MF, 2012, BIOL TRACE ELEM RES, V146, P246, DOI 10.1007/s12011-011-9244-1; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Griffiths J.W.R., 1983, ABSTR APPL ANAL, V130, P3, DOI DOI 10.1371/J0URNAL.P0NE.0054002; Guerra D, 2012, PLANT PHYSIOL, V158, P777, DOI 10.1104/pp.111.183988; Hemavathi, 2010, BIOTECHNOL LETT, V32, P321, DOI 10.1007/s10529-009-0140-0; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jia YY, 2012, MOL BIOL REP, V39, P2337, DOI 10.1007/s11033-011-0984-y; Lee DG, 2007, CR BIOL, V330, P215, DOI 10.1016/j.crvi.2007.01.001; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Mito T, 2011, PLANT BIOTECHNOL J, V9, P736, DOI 10.1111/j.1467-7652.2010.00578.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Morel J, 2004, PLANT J, V37, P282, DOI 10.1046/j.1365-313X.2003.01957.x; Neto ADD, 2006, ENVIRON EXP BOT, V56, P87, DOI 10.1016/j.envexpbot.2005.01.008; Pasqualini S, 2007, PLANT CELL ENVIRON, V30, P1545, DOI 10.1111/j.1365-3040.2007.01730.x; Qiu QS, 2008, PHOTOSYNTH RES, V97, P155, DOI 10.1007/s11120-008-9310-5; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; SLOOTEN L, 1995, PLANT PHYSIOL, V107, P737, DOI 10.1104/pp.107.3.737; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Terauchi R, 2000, MOL GEN GENET, V263, P554, DOI 10.1007/s004380051201; Maldonado-Calderon MT, 2012, PLANT SCI, V185, P208, DOI 10.1016/j.plantsci.2011.10.013; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Yan JQ, 2003, PLANT PHYSIOL, V132, P861, DOI 10.1104/pp.103.020800; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Yun BW, 2000, J PLANT PHYSIOL, V156, P504, DOI 10.1016/S0176-1617(00)80165-0; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang J, 2012, PLANT BIOLOGY, V14, P315, DOI 10.1111/j.1438-8677.2011.00512.x; Zhang Y, 2008, PLANT PHYSIOL, V148, P2121, DOI 10.1104/pp.108.126912; Zhou SM, 2014, PLANT PHYSIOL BIOCH, V84, P213, DOI 10.1016/j.plaphy.2014.09.017	43	41	52	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122117	10.1371/journal.pone.0122117	http://dx.doi.org/10.1371/journal.pone.0122117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906259	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000011
J	Liu, MY; Chen, YL; Zhang, L; Wang, QX; Ma, XZ; Li, XJ; Xiang, R; Zhu, Y; Qin, SC; Yu, Y; Jiang, XC; Duan, YJ; Han, JH				Liu, Mengyang; Chen, Yuanli; Zhang, Ling; Wang, Qixue; Ma, Xingzhe; Li, Xiaoju; Xiang, Rong; Zhu, Yan; Qin, Shucun; Yu, Yang; Jiang, Xian-cheng; Duan, Yajun; Han, Jihong			Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; MACROPHAGE ABCA1 EXPRESSION; APOLIPOPROTEIN-A-I; LIVER-X-RECEPTORS; CETP EXPRESSION; ATHEROSCLEROTIC LESIONS; ETOPOSIDE TREATMENT; SCAVENGER RECEPTOR; UP-REGULATION; ACTIVATION	Cholesteryl ester transfer protein (CETP) transfers cholesteryl esters from high density lipoprotein to triglyceride-rich lipoproteins. CETP expression can be transcriptionally activated by liver X receptor (LXR). Etoposide and teniposide are DNA topoisomerase II (Topo II) inhibitors. Etoposide has been reported to inhibit atherosclerosis in rabbits with unfully elucidated mechanisms. In this study we determined if Topo II activity can influence cholesterol metabolism by regulating hepatic CETP expression. Inhibition of Topo II by etoposide, teniposide, or Topo II siRNA increased CETP expression in human hepatic cell line, HepG2 cells, which was associated with increased CETP secretion and mRNA expression. Meanwhile, inhibition of LXR expression by LXR siRNA attenuated induction of CETP expression by etoposide and teniposide. Etoposide and teniposide induced LXR alpha expression and LXR alpha/beta nuclear translocation while inhibiting expression of receptor interacting protein 140 (RIP140), an LXR co-repressor. In vivo, administration of teniposide moderately reduced serum lipid profiles, induced CETP expression in the liver, and activated reverse cholesterol transport in CETP transgenic mice. Our study demonstrates a novel function of Topo II inhibitors in cholesterol metabolism by activating hepatic CETP expression and reverse cholesterol transport.	[Liu, Mengyang; Chen, Yuanli; Duan, Yajun; Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Liu, Mengyang; Zhang, Ling; Wang, Qixue; Ma, Xingzhe; Li, Xiaoju; Duan, Yajun; Han, Jihong] Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Chen, Yuanli; Xiang, Rong] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Chen, Yuanli; Xiang, Rong; Duan, Yajun; Han, Jihong] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China; [Zhu, Yan] Tianjin Univ Tradit Chinese Med, Tianjin 300193, Peoples R China; [Qin, Shucun; Yu, Yang] Taishan Med Univ, Tai An 271000, Shandong, Peoples R China; [Jiang, Xian-cheng] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA	Nankai University; Nankai University; Nankai University; Nankai University; Tianjin University of Traditional Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Duan, YJ (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yajundun@nankai.edu.cn; jihonghan2008@nankai.edu.cn	Liu, Mengyang/AAA-6289-2019; Zhu, Yan/A-1548-2017	Liu, Mengyang/0000-0002-3790-923X; Zhu, Yan/0000-0002-3197-7936	Ministry of Science and Technology of China [2010CB945003]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13023]; 111 Project [B08011]; National Science Foundation of China (NSFC) [81272460, 81473204, 31400694]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2010CB945003, the Program for Changjiang Scholars and Innovative Research Team in University (no. IRT13023), and 111 Project B08011 (to J. H.) and National Science Foundation of China (NSFC) Grants 81272460 and 81473204 (to J. H.) and 31400694 (to Y. C.).	Bell TA, 2013, J LIPID RES, V54, P2647, DOI 10.1194/jlr.M036509; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Casquero AC, 2006, J LIPID RES, V47, P1526, DOI 10.1194/jlr.M600135-JLR200; Cazita PM, 2003, J LIPID RES, V44, P33, DOI 10.1194/jlr.M100440-JLR200; Chikamori K, 2010, CURR CANCER DRUG TAR, V10, P758, DOI 10.2174/156800910793605785; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; DELALLERAMOYA M, 1992, ARTERIOSCLER THROMB, V12, P1363, DOI 10.1161/01.ATV.12.11.1363; Docquier A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035839; Duan YJ, 2012, J BIOL CHEM, V287, P23667, DOI 10.1074/jbc.M112.350181; Favari E, 2004, J BIOL CHEM, V279, P9930, DOI 10.1074/jbc.M312476200; Gauthier A, 2005, ARTERIOSCL THROM VAS, V25, P2177, DOI 10.1161/01.ATV.0000183613.13929.13; Gautier T, 2013, J LIPID RES, V54, P2195, DOI 10.1194/jlr.M038141; HAYEK T, 1995, J CLIN INVEST, V96, P2071, DOI 10.1172/JCI118255; Heisig P, 2009, MUTAGENESIS, V24, P465, DOI 10.1093/mutage/gep035; IKEWAKI K, 1993, J CLIN INVEST, V92, P1650, DOI 10.1172/JCI116750; Ishimaru C, 2008, LIPIDS, V43, P373, DOI 10.1007/s11745-007-3149-y; Jakobsson T, 2007, BIOCHEM J, V405, P31, DOI 10.1042/BJ20070004; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Park SH, 2011, CANCER LETT, V310, P232, DOI 10.1016/j.canlet.2011.07.009; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Ratni H, 2010, CURR OPIN DRUG DISC, V13, P403; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 1997, J BIOL CHEM, V272, P3953, DOI 10.1074/jbc.272.7.3953; Shah PK, 2007, EUR HEART J, V28, P5, DOI 10.1093/eurheartj/ehl392; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Tavares ER, 2011, INT J NANOMED, V6, P2297, DOI 10.2147/IJN.S24048; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853; Villard EF, 2012, ARTERIOSCL THROM VAS, V32, P2341, DOI 10.1161/ATVBAHA.112.252841; Wang Q, 2014, BIOCHEM J, V459, P345, DOI 10.1042/BJ20131442; Zhang L, 2013, BBA-MOL CELL BIOL L, V1831, P1134, DOI 10.1016/j.bbalip.2013.02.007; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; Zhou HW, 2006, BBA-MOL CELL BIOL L, V1761, P1482, DOI 10.1016/j.bbalip.2006.09.008; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601	41	4	4	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14418	14429		10.1074/jbc.M115.643015	http://dx.doi.org/10.1074/jbc.M115.643015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25914138	Green Published, hybrid			2022-12-26	WOS:000355754600013
J	Quinteiro, J; Manent, P; Perez-Dieguez, L; Gonzalez, JA; Almeida, C; Lopes, E; Araujo, R; Carreira, GP; Rey-Mendez, M; Gonzalez-Henriquez, N				Quinteiro, Javier; Manent, Pablo; Perez-Dieguez, Lois; Gonzalez, Jose A.; Almeida, Corrine; Lopes, Evandro; Araujo, Ricardo; Carreira, Gilberto P.; Rey-Mendez, Manuel; Gonzalez-Henriquez, Nieves			Phylogeography of a Marine Insular Endemic in the Atlantic Macaronesia: The Azorean Barnacle, Megabalanus azoricus (Pilsbry, 1916)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; GENETIC-STRUCTURE; CIRRIPEDIA BALANOMORPHA; CRUSTACEA; OCEAN; DIVERGENCE; SOFTWARE; DIFFERENTIATION; SUBSTITUTIONS	The Azorean barnacle, Megabalanus azoricus (Pilsbry, 1916), is a Macaronesian endemic whose obscure taxonomy and the unknown relationships among forms inhabiting isolated Northern Atlantic oceanic islands is investigated by means of molecular analysis herein. Mitochondrial data from the 16S rRNA and COX1 genes support its current species status, tropical ancestry, and the taxonomic homogeneity throughout its distribution range. In contrast, at the intraspecific level and based on control region sequences, we detected an overall low level of genetic diversity and three divergent lineages. The haplogroups a and. were sampled in the Azores, Madeira, Canary, and Cabo Verde archipelagos; whereas haplogroup beta was absent from Cabo Verde. Consequently, population analysis suggested a differentiation of the Cabo Verde population with respect to the genetically homogenous northern archipelagos generated by current oceanographic barriers. Furthermore, haplogroup a, beta, and. demographic expansions occurred during the interglacial periods MIS5 (130 Kya - thousands years ago -), MIS3 (60 Kya), and MIS7 (240 Kya), respectively. The evolutionary origin of these lineages is related to its survival in the stable southern refugia and its demographic expansion dynamics are associated with the glacial-interglacial cycles. This phylogeographic pattern suggests the occurrence of genetic discontinuity informative to the delimitation of an informally defined biogeographic entity, Macaronesia, and its generation by processes that delineate genetic diversity of marine taxa in this area.	[Quinteiro, Javier; Perez-Dieguez, Lois; Rey-Mendez, Manuel] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Mol Systemat Lab, La Coruna, Galicia, Spain; [Manent, Pablo; Gonzalez, Jose A.; Gonzalez-Henriquez, Nieves] Univ Las Palmas Gran Canaria, Dept Biol, Las Palmas Gran Canaria, Spain; [Almeida, Corrine; Lopes, Evandro] Univ Cabo Verde, Dept Enginery & Sea Sci, Mindelo, Sao Vicente, Cape Verde; [Araujo, Ricardo] Nat Hist Museum Funchal, Funchal, Madeira, Portugal; [Carreira, Gilberto P.] Reg Secretary Nat Resources, Reg Directorate Sea Affaires, Horta, Acores, Portugal	Universidade de Santiago de Compostela; Universidad de Las Palmas de Gran Canaria	Quinteiro, J (corresponding author), Univ Santiago de Compostela, Dept Biochem & Mol Biol, Mol Systemat Lab, La Coruna, Galicia, Spain.	javier.quinteiro@gmail.com	GONZÁLEZ-HENRÍQUEZ, NIEVES/AAA-4911-2019; Quinteiro, Javier/C-4410-2011; GONZÁLEZ, JOSE/H-2187-2015	GONZÁLEZ-HENRÍQUEZ, NIEVES/0000-0003-1110-0448; Quinteiro, Javier/0000-0002-8683-9522; GONZÁLEZ, JOSE/0000-0001-8584-6731; Lopes, Evandro/0000-0003-3938-1560	EU project BANGEN BANGEMAC Network: Genetic Bank for Macaronesia Transnational Cooperation 702 Program Azores-Madeira-Canaries (PCT-MAC) [(MAC/1/C070) 701]	EU project BANGEN BANGEMAC Network: Genetic Bank for Macaronesia Transnational Cooperation 702 Program Azores-Madeira-Canaries (PCT-MAC)	This work was supported by the EU project BANGEN (MAC/1/C070) 701 BANGEMAC Network: Genetic Bank for Macaronesia Transnational Cooperation 702 Program Azores-Madeira-Canaries (PCT-MAC 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 1995, GLOBAL BIOGEOGRAPHY, pxvii; BRIGGS JOHN C., 1966, SYST ZOOL, V15, P153, DOI 10.2307/2411634; Buckeridge J. S., 1983, NZ GEOLOGICAL SURVEY, V50, P1; Caldeira RMA, 2002, REMOTE SENS ENVIRON, V80, P336, DOI 10.1016/S0034-4257(01)00316-9; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Carlton JT, 2011, INVAD NAT SPRING SER, V6, P159, DOI 10.1007/978-94-007-0591-3_5; Chan BKK, 2007, ZOOL SCR, V36, P79, DOI 10.1111/j.1463-6409.2007.00260.x; Chan BKK, 2009, RAFFLES B ZOOL, P83; Chan BKK, 2007, ZOOL STUD, V46, P46; DANSEREAU PIERRE, 1961, AGRON LUSITANA, V23, P151; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DARWIN C, 1854, BALANIDAE SESSILE CI, P1; Dawson MN, 2010, MOL ECOL, V19, P1585, DOI 10.1111/j.1365-294X.2010.04588.x; De Wolf H, 2000, J EXP MAR BIOL ECOL, V246, P69, DOI 10.1016/S0022-0981(99)00177-X; Dionisio M., 2012, Marine Biodiversity Records, V5, pe110, DOI 10.1017/S1755267212000590; Dionisio M, 2007, INVERTEBR REPROD DEV, V50, P155, DOI 10.1080/07924259.2007.9652240; Dowle EJ, 2013, HEREDITY, V110, P501, DOI 10.1038/hdy.2013.4; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ENGLER A, 1879, VERSUCH EINER ENTWIC; Ewers C, 2012, INTEGR COMP BIOL, V52, P410, DOI 10.1093/icb/ics047; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flight PA, 2012, J HERED, V103, P153, DOI 10.1093/jhered/esr083; Flores JA, 2000, PALAEOGEOGR PALAEOCL, V161, P459, DOI 10.1016/S0031-0182(00)00099-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foltz DW, 2003, J MOL EVOL, V57, P607, DOI 10.1007/s00239-003-2495-5; Fu YX, 1997, GENETICS, V147, P915; Gonzalez JA, 2012, J MAR BIOL ASSOC UK, V92, P129, DOI 10.1017/S002531541100066X; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hawkins SJ, 2000, HYDROBIOLOGIA, V440, P3, DOI 10.1023/A:1004118220083; Hayashi R, 2013, MOL PHYLOGENET EVOL, V67, P9, DOI 10.1016/j.ympev.2012.12.018; Henry DP, 1986, ZOOLOGISCHE VERHANDE, V235, P3; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoek PPC, 1913, SIBOGA EXPED, V31b, P129, DOI DOI 10.5962/BHL.TI-TLE.12959; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leung PTY, 2011, J MAR BIOL ASSOC UK, V91, P173, DOI 10.1017/S0025315410000937; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lloris D., 1991, Boletim do Museu Municipal do Funchal, V43, P191; Lopez DA, 2010, AQUAC RES, V41, pe367, DOI 10.1111/j.1365-2109.2010.02508.x; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Martin PR, 2004, EVOLUTION, V58, P938; Meckler AN, 2013, NATURE, V495, P495, DOI 10.1038/nature12006; Meunier T, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007905; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; Morri C, 2000, ARQUIPELAGO-LIFE AND MARINE SCIENCES, SUPPLEMENT 2, PART A, 2000, PROCEEDINGS, P157; Morton B, 2000, ARQUIPEL LIFE MAR S, V2, P22; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; Newman WA, 1976, SAN DIEGO SOC NAT HI, P108; O'Riordan RM, 2004, J EXP MAR BIOL ECOL, V304, P243, DOI 10.1016/j.jembe.2003.12.005; OSPAR, 2010, QUAL STAT REP 2010; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Pastor MV, 2012, CIENC MAR, V38, P223, DOI 10.7773/cm.v38i1B.1831; Pena-Izquierdo J, 2012, SCI MAR, V76, P65, DOI 10.3989/scimar.03607.18C; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M, 2008, MOL PHYLOGENET EVOL, V46, P328, DOI 10.1016/j.ympev.2007.10.004; Pham Christopher K., 2011, Arquipelago-Life and Marine Sciences, P47; Pilsbry HA., 1916, B US NATN MUS, V93, P1, DOI DOI 10.5479/SI.03629236.93.1; Quinteiro J, 2007, MAR BIOL, V153, P47, DOI 10.1007/s00227-007-0783-0; Quinteiro J, 2011, J MAR BIOL ASSOC UK, V91, P1537, DOI 10.1017/S0025315411000166; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogerson M, 2004, EARTH PLANET SC LETT, V222, P779, DOI 10.1016/j.epsl.2004.03.039; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruddiman W., 1976, MEM GEOL SOC AM, V145, P111, DOI [DOI 10.1130/MEM145-P111, 10.1130/MEM145-p111]; Ruiz S, 2014, J GEOPHYS RES-OCEANS, V119, P1257, DOI 10.1002/2013JC009169; Santos RS, 1995, AQUAT CONSERV, V5, P311, DOI 10.1002/aqc.3270050406; Schneider S, 1999, GENETICS, V152, P1079; Simon-Blecher N, 2007, MOL PHYLOGENET EVOL, V44, P1333, DOI 10.1016/j.ympev.2007.03.026; SLATKIN M, 1991, GENETICS, V129, P555; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Southward Alan J., 1998, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V16A, P11; Stearn W. T., 1973, MONOGRAPHIAE BIOL CA, V4, P15; Sunding P., 1979, PLANTS ISLANDS, P13; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres P, 2012, HELGOLAND MAR RES, V66, P513, DOI 10.1007/s10152-011-0287-7; Tsang LM, 2012, INTEGR COMP BIOL, V52, P388, DOI 10.1093/icb/ics044; Van den Broeck H, 2008, MAR BIOL, V153, P421, DOI 10.1007/s00227-007-0820-z; Vanderpoorten A, 2007, AM J BOT, V94, P625, DOI 10.3732/ajb.94.4.625; Wares JP, 2011, J CRUSTACEAN BIOL, V31, P339, DOI 10.1651/10-3407.1; Wares JP, 2001, MOL PHYLOGENET EVOL, V18, P104, DOI 10.1006/mpev.2000.0857; Whittaker RJ, 2007, ISLAND BIOGEOGRAPHY, pxii; Wirtz P, 2006, HELGOLAND MAR RES, V60, P207, DOI 10.1007/s10152-006-0036-5; Xavier RJ, 2010, CONTRIB ZOOL, V79, P10; Yamaguchi T, 2009, BIOFOULING, V25, P325, DOI 10.1080/08927010902738048	96	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124707	10.1371/journal.pone.0124707	http://dx.doi.org/10.1371/journal.pone.0124707			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919141	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400057
J	Chawla, A; Stobdan, T; Srivastava, RB; Jaiswal, V; Chauhan, RS; Kant, A				Chawla, Aseem; Stobdan, Tsering; Srivastava, Ravi B.; Jaiswal, Varun; Chauhan, Rajinder S.; Kant, Anil			Sex-Biased Temporal Gene Expression in Male and Female Floral Buds of Seabuckthorn (Hippophae rhamnoides)	PLOS ONE			English	Article							CONTROL CARPEL DEVELOPMENT; ZINC-FINGER PROTEIN; FLOWER DEVELOPMENT; HOMEOTIC GENE; PHYTOCHROME-B; MOLECULAR-MECHANISMS; ARABIDOPSIS-THALIANA; LINKED MARKERS; RABBIT-EARS; MERISTEM	Seabuckthorn is an economically important dioecious plant in which mechanism of sex determination is unknown. The study was conducted to identify seabuckthorn homologous genes involved in floral development which may have role in sex determination. Forty four putative Genes involved in sex determination (GISD) reported in model plants were short-listed from literature survey, and twenty nine seabuckthorn homologous sequences were identified from available seabuckthorn genomic resources. Of these, 21 genes were found to differentially express in either male or female flower bud stages. HrCRY2 was significantly expressed in female flower buds only while HrCO had significant expression in male flowers only. Among the three male and female floral development stages (FDS), male stage II had significant expression of most of the GISD. Information on these sex-specific expressed genes will help in elucidating sex determination mechanism in seabuckthorn.	[Chawla, Aseem; Jaiswal, Varun; Chauhan, Rajinder S.; Kant, Anil] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Waknaghat, Solan, India; [Stobdan, Tsering; Srivastava, Ravi B.] Def R&D Org, Def Inst High Altitude Res, Leh, Jammu & Kashmir, India	Jaypee University of Information Technology; Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR)	Kant, A (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Waknaghat, Solan, India.	anil_kantv@yahoo.com	Jaiswal, Varun/AAE-4853-2019; Chauhan, Rajinder Singh/HGB-5642-2022	Jaiswal, Varun/0000-0001-8068-0672; Stobdan, Tsering/0000-0002-7859-3868	Defence Institute of High Altitude Research, DRDO, Leh, Jammu and Kashmir, India [118/JUIT-4/DIHAR]	Defence Institute of High Altitude Research, DRDO, Leh, Jammu and Kashmir, India	The current study was funded by Defence Institute of High Altitude Research, DRDO, Leh, Jammu and Kashmir, India and the funding was received by AK under the Sanction No: 118/JUIT-4/DIHAR. URL of agency - http://drdo.gov.in/drdo/labs/DIHAR/English/index.jsp?pg = homebody.	Adhikari S, 2012, NUCLEUS CALCUTTA, V55, P115, DOI 10.1007/s13237-012-0061-5; AINSWORTH C, 1995, PLANT CELL, V7, P1583, DOI 10.1105/tpc.7.10.1583; Alvarez J, 1999, DEVELOPMENT, V126, P2377; ALVAREZ J, 1992, PLANT J, V2, P103, DOI 10.1111/j.1365-313X.1992.00103.x; Amit Sharma, 2010, Forestry Studies in China, V12, P62, DOI 10.1007/s11632-010-0012-7; Ariizumi T, 2004, PLANT J, V39, P170, DOI 10.1111/j.1365-313X.2004.02118.x; BOWMAN JL, 1992, DEVELOPMENT, V114, P599; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; Caporali E, 2000, SEX PLANT REPROD, V13, P151, DOI 10.1007/s004970000049; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Chawla A, 2014, SCI HORTIC-AMSTERDAM, V170, P281, DOI 10.1016/j.scienta.2014.03.013; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2010, ADV BOT RES, V54, P53, DOI 10.1016/S0065-2296(10)54002-3; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Di Stilio VS, 2005, PLANT J, V41, P755, DOI 10.1111/j.1365-313X.2005.02336.x; Dinneny JR, 2006, DEVELOPMENT, V133, P1645, DOI 10.1242/dev.02335; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Esumi T, 2005, SEX PLANT REPROD, V17, P277, DOI 10.1007/s00497-004-0239-3; Fan JL, 2007, FOOD CHEM, V102, P168, DOI 10.1016/j.foodchem.2006.05.049; Fatima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034099; Foucart Camille, 2012, Biologie Aujourd hui, V206, P57, DOI 10.1051/jbio/2012005; Fraser LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-102; GAISER JC, 1995, PLANT CELL, V7, P333, DOI 10.1105/tpc.7.3.333; Ghangal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072516; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Gupta Sanjay Mohan, 2012, Physiology and Molecular Biology of Plants, V18, P377, DOI 10.1007/s12298-012-0133-7; HALLIDAY KJ, 1994, PLANT PHYSIOL, V104, P1311, DOI 10.1104/pp.104.4.1311; HARDENACK S, 1994, PLANT CELL, V6, P1775, DOI 10.1105/tpc.6.12.1775; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Iovene M, 2014, GENETICS; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Jain Ankit, 2010, Physiology and Molecular Biology of Plants, V16, P375, DOI 10.1007/s12298-010-0037-3; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kalia RK, 2011, TREES-STRUCT FUNCT, V25, P559, DOI 10.1007/s00468-011-0543-0; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim HB, 2010, AFR J BIOTECHNOL, V9, P6684; Koizumi A, 2010, PLANT CELL PHYSIOL, V51, P282, DOI 10.1093/pcp/pcp187; Korekar G, 2012, BIOTECHNOL LETT, V34, P973, DOI 10.1007/s10529-012-0852-4; Krizek BA, 2006, PLANT J, V45, P369, DOI 10.1111/j.1365-313X.2005.02633.x; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laux T, 1996, DEVELOPMENT, V122, P87; Lebel-Hardenack S, 2002, GENETICS, V160, P717; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Li CY, 2007, TREE PHYSIOL, V27, P399, DOI 10.1093/treephys/27.3.399; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel MA, 1992, MOL CHARACTERIZATION; Matsunaga S, 1996, PLANT J, V10, P679, DOI 10.1046/j.1365-313X.1996.10040679.x; Matsunaga S, 2006, GENES GENET SYST, V81, P219, DOI 10.1266/ggs.81.219; Miko I, 2008, NATURE ED, V1, P108; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Nole-Wilson S, 2006, PLANT PHYSIOL, V141, P977, DOI 10.1104/pp.106.076604; Payne T, 2004, DEVELOPMENT, V131, P3737, DOI 10.1242/dev.01216; Perl-Treves R., 1999, MALE FEMALE CONVERSI; Persson HA, 1998, HEREDITAS, V129, P45, DOI 10.1111/j.1601-5223.1998.00045.x; Ray A, 1996, DEVELOPMENT, V122, P2631; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Reeves PH, 2000, CURR OPIN PLANT BIOL, V3, P37, DOI 10.1016/S1369-5266(99)00041-2; Sakai H, 2000, PLANT CELL, V12, P1607, DOI 10.1105/tpc.12.9.1607; Sakai H, 1995, ROLE SUPERMAN MAINTA; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sandhu KS, 2012, G3-GENES GENOM GENET, V2, P1585, DOI 10.1534/g3.112.004580; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; SCHULTZ EA, 1991, PLANT CELL, V3, P1221, DOI 10.1105/tpc.3.11.1221; Semerikov V, 2003, HEREDITY, V91, P293, DOI 10.1038/sj.hdy.6800327; Shepard H., 1999, SEX DETERMINATION PL, V8, P139; Shephard HL, 1998, MADS BOX EXPRESSION, P70; SIMON R, 1994, CELL, V78, P99, DOI 10.1016/0092-8674(94)90576-2; Song YP, 2013, PLANT MOL BIOL, V83, P559, DOI 10.1007/s11103-013-0108-2; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Stobdan T, 2008, SEABUCKTHOM EMERGING; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Yamasaki S, 2000, PLANT CELL PHYSIOL, V41, P608, DOI 10.1093/pcp/41.5.608; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; YANOFSKY MF, 1995, ANNU REV PLANT PHYS, V46, P167, DOI 10.1146/annurev.pp.46.060195.001123; Zhao HX, 2009, PLANT CELL ENVIRON, V32, P1401, DOI 10.1111/j.1365-3040.2009.02007.x; Zubarev YA, 2008, SEABUCKTHORN HIPPOPH, V3, P49	93	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124890	10.1371/journal.pone.0124890	http://dx.doi.org/10.1371/journal.pone.0124890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915052	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100077
J	Klumpers, DD; Smit, TH; Mooney, DJ				Klumpers, Darinka D.; Smit, Theo H.; Mooney, David J.			The Effect of Growth-Mimicking Continuous Strain on the Early Stages of Skeletal Development in Micromass Culture	PLOS ONE			English	Article							LIMB CHONDROGENESIS; CARTILAGE FORMATION; CELLS; DIFFERENTIATION; CONDENSATIONS; MORPHOGENESIS; MESENCHYME; PATHWAYS; MOUSE; BUDS	Embryonic skeletogenesis involves proliferation, condensation and subsequent chondrogenic differentiation of mesenchymal precursor cells, and the strains and stresses inherent to these processes have been hypothesized to influence skeletal development. The aim of this study was to determine the effect of growth-mimicking strain on the process of early skeletal development in vitro. To this end, we applied continuous uniaxial strain to embryonic skeletal precursor cells in micromass culture. Strain was applied at different times of culture to specifically address the effect of mechanical loading on the sequential stages of cellular proliferation, condensation and differentiation. We found that growth-mimicking strain at all three times did not affect proliferation or chondrogenic differentiation under the tested conditions. However, the timing of the applied strain did play a role in the density of mesenchymal condensations. This finding suggests that a mechanically dynamic environment, and specifically strain, can influence skeletal patterning. The growth-mimicking micromass model presented here may be a useful tool for further studies into the role of mechanical loading in early skeletal development.	[Klumpers, Darinka D.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Klumpers, Darinka D.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Klumpers, Darinka D.; Smit, Theo H.] Vrije Univ Amsterdam, Med Ctr, Res Inst MOVE, Dept Orthoped Surg, NL-1081 HV Amsterdam, Netherlands	Harvard University; Harvard University; Vrije Universiteit Amsterdam	Mooney, DJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St, Cambridge, MA 02138 USA.	mooneyd@seas.harvard.edu	Smit, Theo/N-7534-2019; Smit, Theodoor/AAX-6657-2020	Smit, Theo/0000-0002-8906-7433; Mooney, David/0000-0001-6299-1194	National Institutes of Health [R37 DE013033]; ZonMW-VICI grant (The Netherlands) [918.11.635]; Research Institute MOVE at the VU University, Amsterdam; Wyss Institute at Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW-VICI grant (The Netherlands); Research Institute MOVE at the VU University, Amsterdam; Wyss Institute at Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by National Institutes of Health (R37 DE013033), ZonMW-VICI grant 918.11.635 (The Netherlands), and Research Institute MOVE at the VU University, Amsterdam. T.H.S. was supported by a visiting scholarship from the Wyss Institute at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Centola M, 2013, STEM CELLS DEV, V22, P2849, DOI 10.1089/scd.2013.0216; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; DeLise AM, 2000, METH MOL B, V137, P359; EdwallArvidsson C, 1996, ANAT EMBRYOL, V193, P453; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Henderson JH, 2002, BONE, V31, P645, DOI 10.1016/S8756-3282(02)00911-0; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; JANNERS MY, 1970, DEV BIOL, V23, P136, DOI 10.1016/S0012-1606(70)80011-2; Juhasz T, 2014, CELL SIGNAL, V26, P468, DOI 10.1016/j.cellsig.2013.12.001; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Klumpers DD, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0215; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; NEWMAN SA, 1985, SCIENCE, V228, P885, DOI 10.1126/science.4001925; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Onodera K, 2005, EUR J CELL BIOL, V84, P45, DOI 10.1016/j.ejcb.2004.09.004; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RODRIGUEZ JI, 1988, J BONE JOINT SURG AM, V70A, P1052, DOI 10.2106/00004623-198870070-00014; Sart S, 2013, TISSUE ENG B; WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yung YC, 2009, J BIOMECH, V42, P178, DOI 10.1016/j.jbiomech.2008.10.038; ZIMMERMANN B, 1984, HISTOCHEMISTRY, V81, P353, DOI 10.1007/BF00514329	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124948	10.1371/journal.pone.0124948	http://dx.doi.org/10.1371/journal.pone.0124948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915898	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100082
J	Stansell, E; Panico, M; Canis, K; Pang, PC; Bouche, L; Binet, D; O'Connor, MJ; Chertova, E; Bess, J; Lifson, JD; Haslam, SM; Morris, HR; Desrosiers, RC; Dell, A				Stansell, Elizabeth; Panico, Maria; Canis, Kevin; Pang, Poh-Choo; Bouche, Laura; Binet, Daniel; O'Connor, Michael-John; Chertova, Elena; Bess, Julian; Lifson, Jeffrey D.; Haslam, Stuart M.; Morris, Howard R.; Desrosiers, Ronald C.; Dell, Anne			Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; STRUCTURAL-CHARACTERIZATION; ENDOPROTEOLYTIC CLEAVAGE; PROTEOLYTIC CLEAVAGE; GLYCOSYLATION SITES; PROTEINS; INFECTIVITY; RECOMBINANT; ACTIVATION	As HIV-1-encoded envelope protein traverses the secretory pathway, it may be modified with N- and O-linked carbohydrate. When the gp120s of HIV-1 NL4-3, HIV-1 YU2, HIV-1 Bal, HIV-1 JRFL, and HIV-1 JRCSF were expressed as secreted proteins, the threonine at consensus position 499 was found to be O-glycosylated. For SIVmac239, the corresponding threonine was also glycosylated when gp120 was recombinantly expressed. Similarlypositioned, highly-conserved threonines in the influenza A virus H1N1 HA1 and H5N1 HA1 envelope proteins were also found to carry O-glycans when expressed as secreted proteins. In all cases, the threonines were modified predominantly with disialylated core 1 glycans, together with related core 1 and core 2 structures. Secreted HIV-1 gp140 was modified to a lesser extent with mainly monosialylated core 1 O-glycans, suggesting that the ectodomain of the gp41 transmembrane component may limit the accessibility of Thr499 to glycosyltransferases. In striking contrast to these findings, gp120 on purified virions of HIV-1 Bal and SIV CP-MAC lacked any detectable O-glycosylation of the C-terminal threonine. Our results indicate the absence of O-linked carbohydrates on Thr499 as it exists on the surface of virions and suggest caution in the interpretation of analyses of post-translational modifications that utilize recombinant forms of envelope protein.	[Stansell, Elizabeth; Desrosiers, Ronald C.] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Panico, Maria; Canis, Kevin; Pang, Poh-Choo; Bouche, Laura; Haslam, Stuart M.; Morris, Howard R.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Chertova, Elena; Bess, Julian; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA	Harvard University; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Desrosiers, RC (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA.	r.desrosiers@med.miami.edu; a.dell@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347	National Institutes of Health (NIH) [R01-AI025328, R01-AI104523, P30-AI060354, P51-RR000168]; National Cancer Institute, NIH [HHSN261200800001E]; Biotechnology and Biological Sciences Research Council [BBF0083091, BBK016164/1, BB/K015164/1]; Wellcome Trust [082098]; Leidos Biomedical Research Inc.; BBSRC [BB/F008309/1, BB/K016164/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104523, P30AI060354, R01AI025328] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leidos Biomedical Research Inc.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institutes of Health (NIH) R01-AI025328 (ES and RCD), R01-AI104523 (ES and RCD), P30-AI060354 (ES), and P51-RR000168 (ES and RCD), federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E (EC and JDL), the Biotechnology and Biological Sciences Research Council, grants BBF0083091, BBK016164/1 and BB/K015164/1 (to AD, SMH and HRM) and the Wellcome Trust (grant 082098 to SMH and AD) supported this work. Leidos Biomedical Research Inc., provided support in the form of salaries for authors EC, JB and JDL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ahmed AA, 2014, J MOL BIOL, V426, P3166, DOI 10.1016/j.jmb.2014.07.006; Arthur LO, 1998, AIDS RES HUM RETROV, V14, pS311; BERNSTEIN HB, 1994, J VIROL, V68, P463, DOI 10.1128/JVI.68.1.463-468.1994; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; DAMONTE EB, 1994, VIRUS RES, V34, P317, DOI 10.1016/0168-1702(94)90131-7; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; FENOUILLET E, 1992, VIROLOGY, V187, P825, DOI 10.1016/0042-6822(92)90487-A; Go EP, 2014, J PROTEOME RES, V13, P4012, DOI 10.1021/pr5003643; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Guttman M, 2012, J VIROL, V86, P8750, DOI 10.1128/JVI.07224-11; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HANSEN JES, 1992, ARCH VIROL, V126, P11, DOI 10.1007/BF01309680; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KIELY ML, 1976, J BIOL CHEM, V251, P5490; Kuiken C, 2010, HIV SEQUENCE COMPEND; LAZAROWI.SG, 1973, VIROLOGY, V52, P199, DOI 10.1016/0042-6822(73)90409-1; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; SASTRY MVK, 1986, J BIOL CHEM, V261, P1726; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Stansell E, 2011, GLYCOBIOLOGY, V21, P1454; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; STEIN BS, 1990, J BIOL CHEM, V265, P2640; STROUS GJAM, 1979, P NATL ACAD SCI USA, V76, P2694, DOI 10.1073/pnas.76.6.2694; Tachibana K, 2006, GLYCOBIOLOGY, V16, P46, DOI 10.1093/glycob/cwj038; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Tissot B, 2009, FEBS LETT, V583, P1728, DOI 10.1016/j.febslet.2009.03.049; Yang WM, 2014, ANAL CHEM, V86, P6959, DOI 10.1021/ac500876p; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006	34	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124784	10.1371/journal.pone.0124784	http://dx.doi.org/10.1371/journal.pone.0124784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915761	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100067
J	Yang, FC; Kuang, WD; Li, C; Sun, WW; Qu, D; Wang, JH				Yang, Fu-Chun; Kuang, Wen-Dong; Li, Chuan; Sun, Wei-Wei; Qu, Di; Wang, Jian-Hua			Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; T-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; IL-1 RECEPTOR; INFECTION; ACTIVATION; MACROPHAGES; UBIQUITIN	Toll-interacting protein (Tollip) is a host adaptor protein for negatively regulating Toll-like receptor 2-, 4-, and IL-1R (interleukin-1 receptor)-mediated signaling. We found that Tollip expression could be induced in MDDCs (monocyte-derived dendritic cells) by HIV-1 particles and recombinant gp120 glycoprotein. Hence, we investigated the role of Tollip in modulating HIV-1 infection. We found that Tollip expression suppressed NF-kappa B-dependent HIV-1 long terminal repeat (LTR)-driven transcription and thus inhibited HIV-1 infection. Our protein truncation experiments proved that the intact C-terminus of Tollip was required for inhibition of both NF-kappa B activity and HIV-1 LTR-driven gene expression. Intriguingly, Tollip silenced the post-integrational transcription of HIV-1 proviral DNA, indicating the potential role of Tollip in maintaining viral persistence. Our results reveal the novel role of host factor Tollip in modulating HIV-1 infection, and may suggest the hijacking of Tollip as the negative regulator of the TLR pathway and even the downstream signaling, by HIV-1 for maintaining persistent infection. Further elucidation of the mechanisms by which HIV-1 induces Tollip expression and identification of the role of Tollip in modulating HIV-1 latency will facilitate the understanding of host regulation in viral replication and benefit the exploration of novel strategies for combating HIV-1 infection.	[Yang, Fu-Chun; Kuang, Wen-Dong; Li, Chuan; Sun, Wei-Wei; Qu, Di; Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	Jh_wang@sibs.ac.cn						Ahmed N, 2010, J GEN VIROL, V91, P2804, DOI 10.1099/vir.0.022442-0; Beima-Sofie KM, 2013, AIDS, V27, P2431, DOI 10.1097/QAD.0b013e3283629117; Berg RS, 2009, APMIS, V117, P124, DOI 10.1111/j.1600-0463.2008.00024.x; Bochud PY, 2007, AIDS, V21, P441, DOI 10.1097/QAD.0b013e328012b8ac; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Carrithers MD, 2014, HAND CLINIC, V123, P215, DOI 10.1016/B978-0-444-53488-0.00009-2; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Diao LR, 2005, CELL SIGNAL, V17, P217, DOI 10.1016/j.cellsig.2004.07.003; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Ellegard R, 2011, CURR OPIN HIV AIDS, V6, P435, DOI 10.1097/COH.0b013e32834970d8; Huik K, 2013, INFECT GENET EVOL, V20, P78, DOI 10.1016/j.meegid.2013.08.008; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kumar A, 2014, VIRUSES-BASEL, V6, P1837, DOI 10.3390/v6041837; Lehner T, 2008, VACCINE, V26, P2997, DOI 10.1016/j.vaccine.2007.11.060; Lehner T, 2011, Adv Dent Res, V23, P19, DOI 10.1177/0022034511399081; Liu LH, 2011, J VIROL, V85, P8467, DOI 10.1128/JVI.00520-11; Lu KF, 2014, AUTOPHAGY, V10, P2381, DOI 10.4161/15548627.2014.981919; Mackelprang RD, 2014, J INFECT DIS, V209, P1623, DOI 10.1093/infdis/jit807; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Mosoian A, 2010, P NATL ACAD SCI USA, V107, P10178, DOI 10.1073/pnas.0914870107; Mukherjee S, 2014, CELL SIGNAL, V26, P2674, DOI 10.1016/j.cellsig.2014.08.009; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Oguro A, 2011, NEUROSCI LETT, V503, P234, DOI 10.1016/j.neulet.2011.08.043; Pace MJ, 2011, VIROLOGY, V411, P344, DOI 10.1016/j.virol.2010.12.041; PATTERSON S, 1987, J GEN VIROL, V68, P1177, DOI 10.1099/0022-1317-68-4-1177; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; Qin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027609; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Reuven EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004248; Rustagi A, 2014, J MOL BIOL, V426, P1161, DOI 10.1016/j.jmb.2013.12.003; Sang M, 2014, ANTIVIR RES, V112, P103, DOI 10.1016/j.antiviral.2014.10.008; Schlaepfer E, 2014, J VIROL, V88, P9769, DOI 10.1128/JVI.01053-14; Shen CJ, 2012, FASEB J, V26, P4755, DOI 10.1096/fj.12-209023; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Victoria S, 2013, IMMUNOBIOLOGY, V218, P1529, DOI 10.1016/j.imbio.2013.06.006; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; Willie B, 2014, GENES IMMUN, V15, P569, DOI 10.1038/gene.2014.54; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; ZEICHNER SL, 1991, J VIROL, V65, P2436, DOI 10.1128/JVI.65.5.2436-2444.1991; Zhai RR, 2013, VIROLOGY, V442, P163, DOI 10.1016/j.virol.2013.04.009; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125563	10.1371/journal.pone.0125563	http://dx.doi.org/10.1371/journal.pone.0125563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915421	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100134
J	Nanthavong, N; Black, AP; Nouanthong, P; Souvannaso, C; Vilivong, K; Muller, CP; Goossens, S; Quet, F; Buisson, Y				Nanthavong, Naphavanh; Black, Antony P.; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Vilivong, Keooudomphone; Muller, Claude P.; Goossens, Sylvie; Quet, Fabrice; Buisson, Yves			Diphtheria in Lao PDR: Insufficient Coverage or Ineffective Vaccine?	PLOS ONE			English	Article							CHILD IMMUNIZATION; MATERNAL ANTIBODIES; DETERMINANTS; HEALTH; ERADICATION; BANGLADESH; RESPONSES; EDUCATION; INFANTS; PROGRAM	Background During late 2012 and early 2013 several outbreaks of diphthe-ria were notified in the North of the Lao People's Democratic Republic. The aim of this study was to determine whether the re-emergence of this vaccine-preventable disease was due to insufficient vaccination coverage or reduction of vaccine effectiveness within the affected regions. Methods A serosurvey was conducted in the Huaphan Province on a cluster sampling of 132 children aged 12-59 months. Serum samples, socio-demographic data, nutri-tional status and vaccination history were collected when available. Anti-diphtheria and anti-tetanus IgG antibody levels were measured by ELISA. Results Overall, 63.6% of participants had detectable diphtheria antibodies and 71.2% tetanus antibodies. Factors independently associated with non-vaccination against diphtheria were the distance from the health centre (OR: 6.35 [95% CI: 1.4-28.8], p = 0.01), the Lao Theung ethnicity (OR: 12.2 [95% CI: 1,74-85, 4], p = 0.01) and the lack of advice on vac-cination given at birth (OR: 9.8 [95% CI: 1.5-63.8], (p = 0.01) while the level of maternal edu-cation was a protective factor (OR: 0.08 [95% CI: 0.008-0.81], p = 0.03). Most respondents claimed financial difficulties as the main reason for non-vaccination. Out of 55 children whose vaccination certificates stated that they were given all 3 doses of diphtheria-containing vaccine, 83.6% had diphtheria antibodies and 92.7% had tetanus antibodies. Furthermore, despite a high prevalence of stunted and underweight children (53% and 25.8%, respectively), the low levels of anti-diphtheria antibodies were not correlated to the nutritional status. Conclusions Our data highlight a significant deficit in both the vaccination coverage and diphtheria vaccine effectiveness within the Huaphan Province. Technical defi-ciencies in the methods of storage and distribution of vaccines as well as unreliability of vac-cination cards are discussed. Several hypotheses are advanced to explain such a decline in immunity against diphtheria and recommendations are provided to prevent future outbreaks.	[Nanthavong, Naphavanh; Quet, Fabrice; Buisson, Yves] Inst Francophonie Med Trop, Viangchan, Laos; [Black, Antony P.; Nouanthong, Phonethipsavanh; Souvannaso, Chanthasone; Vilivong, Keooudomphone; Muller, Claude P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos; [Black, Antony P.; Muller, Claude P.] Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, Dudelange, Luxembourg	Luxembourg Institute of Health	Buisson, Y (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	yvesbuisson@hotmail.com	QUET, Fabrice/AAT-5871-2021	QUET, Fabrice/0000-0003-4777-5527	Agence Universitaire de la Francophonie; Ministry of Cooperation in Luxembourg, Institut Pasteur du Laos	Agence Universitaire de la Francophonie; Ministry of Cooperation in Luxembourg, Institut Pasteur du Laos	The field Survey was funded by the Agence Universitaire de la Francophonie. The lab analyses were funded by Ministry of Cooperation in Luxembourg, Institut Pasteur du Laos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu G, 2011, INTERNET JOURNAL OF, V9; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; BHUIYA A, 1995, HEALTH POLICY PLANN, V10, P304, DOI 10.1093/heapol/10.3.304; Chan J, 2011, VACCINE, V29, P1242, DOI 10.1016/j.vaccine.2010.11.087; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; Cutts FT, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001404; Department of Planning and International Cooperation M Lao PDR, 2011, NATIONAL HEALTH STAT; Galazka A, 1998, THERMOSTABILITY OF V; Gans HA, 2013, J INFECT DIS, V208, P1, DOI 10.1093/infdis/jit144; Kamiya Y, 2011, J HEALTH POPUL NUTR, V29, P339, DOI 10.3329/jhpn.v29i4.8449; Kanra G, 2006, HUM VACCINES, V2, P155, DOI 10.4161/hv.2.4.2942; Kaufman DR, 2011, J IMMUNOL, V187, P1877, DOI 10.4049/jimmunol.1101248; Khor Geok Lin, 2003, Nepal Med Coll J, V5, P113; Kitamura T, 2013, BIOSCI TRENDS, V7, P178, DOI 10.5582/bst.2013.v7.4.178; Kristensen D, 2011, VACCINE, V29, P7122, DOI 10.1016/j.vaccine.2011.05.070; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Lalor MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016709; Maekawa M, 2007, BIOSCI TRENDS, V1, P43; Messerli P., 2008, SOCIOECONOMIC ATLAS; National Statistics Centre of the Lao PDR, 2005, POPULATION CENSUS; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; Parashar S, 2005, SOC SCI MED, V61, P989, DOI 10.1016/j.socscimed.2004.12.023; Phimmasane M, 2010, VACCINE, V28, P6723, DOI 10.1016/j.vaccine.2010.07.077; Rey-Cuille MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038153; Rogers B, 2010, AAOHN J, V58, P391, DOI 10.3928/08910162-20100816-02; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; STREATFIELD K, 1990, DEMOGRAPHY, V27, P447, DOI 10.2307/2061378; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Sychareun V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-255; WHO, 2012, INTERNATIONAL REVIEW; Xie JP, 2005, SOC SCI MED, V61, P601, DOI 10.1016/j.socscimed.2004.12.016; Zasada AA, 2013, EUR J CLIN MICROBIOL, V32, P891, DOI 10.1007/s10096-013-1823-y	33	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121749	10.1371/journal.pone.0121749	http://dx.doi.org/10.1371/journal.pone.0121749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909365	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800013
J	Vysniauskaite, M; Hertfelder, HJ; Oldenburg, J; Dressen, P; Brettner, S; Homann, J; Molderings, GJ				Vysniauskaite, Milda; Hertfelder, Hans-Joerg; Oldenburg, Johannes; Dressen, Peter; Brettner, Stefan; Homann, Juergen; Molderings, Gerhard J.			Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease	PLOS ONE			English	Article							SERUM TRYPTASE LEVELS; DIFFERENTIAL RELEASE; SEROTONIN LEVELS; MASTOCYTOSIS; HISTAMINE; MARKERS; URINE; DIAGNOSIS; CRITERIA; CLASSIFICATION	Diagnosis of mast cell activation disease (MCAD), i.e. systemic mastocytosis (SM) and idiopathic systemic mast cell activation syndrome (MCAS), usually requires demonstration of increased mast cell (MC) mediator release. Since only a few MC mediators are currently established as biomarkers of MCAD, the sensitivity of plasma heparin level (pHL) as an indicator of increased MC activation was compared with that of serum tryptase, chromogranin A and urinary N-methylhistamine levels in 257 MCAD patients. Basal pHL had a sensitivity of 41% in MCAS patients and 27% in SM patients. Non-pharmacologic stimulation of MC degranulation by obstruction of venous flow for 10 minutes increased the sensitivity of pHL in MCAS patients to 59% and in SM patients to 47%. In MCAS patients tryptase, chromogranin A, and N-methylhistamine levels exhibited low sensitivities (10%, 12%, and 22%, respectively), whereas sensitivities for SM were higher (73%, 63%, and 43%, respectively). Taken together, these data suggest pHL appears more sensitive than the other mediators for detecting systemic MC activity in patients with MCAS. The simple, brief venous occlusion test appears to be a useful indicator of the presence of pathologically irritable MCs, at least in the obstructed compartment of the body.	[Vysniauskaite, Milda; Hertfelder, Hans-Joerg; Oldenburg, Johannes] Univ Hosp Bonn, Inst Exp Haematol & Transfus Med, Bonn, Germany; [Dressen, Peter] St Franziskus Hosp, Dept Internal Med, Eitorf, Germany; [Brettner, Stefan] Cty Hosp, Dept Oncol Hematol & Palliat Care, Waldbrol, Germany; [Homann, Juergen] Community Hosp St Elisabeth, Bonn, Germany; [Molderings, Gerhard J.] Univ Hosp Bonn, Inst Human Genet, Bonn, Germany	University of Bonn; University of Bonn	Molderings, GJ (corresponding author), Univ Hosp Bonn, Inst Human Genet, Bonn, Germany.	molderings@uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020	Oldenburg, Johannes/0000-0002-1585-4100				Afrin LB, 2011, AM J MED SCI, V342, P44, DOI 10.1097/MAJ.0b013e31821d41dd; Afrin LB, 2014, WORLD J HEMATOL, V3, P1, DOI [10.5315/wjh.v3.i1.1, DOI 10.5315/WJH.V3.I1.1]; Akhavein A, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/950582; Akin C, 2002, INT ARCH ALLERGY IMM, V127, P133, DOI 10.1159/000048184; Alfter K, 2009, LIVER INT, V29, P181, DOI 10.1111/j.1478-3231.2008.01839.x; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Bochenek G, 2004, THORAX, V59, P459, DOI 10.1136/thx.2003.013573; Butterfield J, 2011, J ALLERGY CLIN IMMUN, V127, pAB132, DOI 10.1016/j.jaci.2010.12.528; Butterfield JH, 2008, INT ARCH ALLERGY IMM, V147, P338, DOI 10.1159/000144042; Butterfield JH, 2010, PROSTAG OTH LIPID M, V92, P73, DOI 10.1016/j.prostaglandins.2010.03.003; Butterfield JH, 2009, PROSTAG OTH LIPID M, V88, P122, DOI 10.1016/j.prostaglandins.2009.01.001; Cohen SS, 2014, BRIT J HAEMATOL, V166, P521, DOI 10.1111/bjh.12916; CRAIG SS, 1993, LAB INVEST, V69, P552; Dahlen SE, 2004, THORAX, V59, P453, DOI 10.1136/thx.2004.026641; Di Lorenzo G, 2002, ALLERGY, V57, P1180, DOI 10.1034/j.1398-9995.2002.23767.x; Sirvent AE, 2010, J NEPHROL, V23, P282; Fowlkes V, 2013, J BIOMECH, V46, P788, DOI 10.1016/j.jbiomech.2012.11.014; Frieling T, 2011, Z GASTROENTEROL, V49, P191, DOI 10.1055/s-0029-1245707; Haenisch B, 2012, IMMUNOLOGY, V137, P197, DOI 10.1111/j.1365-2567.2012.03627.x; Hamilton MJ, 2011, J ALLERGY CLIN IMMUN, V128, P147, DOI 10.1016/j.jaci.2011.04.037; Hogan AD, 1997, METHODS, V13, P43, DOI 10.1006/meth.1997.0494; Ibelgaufts H, COPE CYTOKINES CELLS; JAQUES LB, 1978, SEMIN THROMB HEMOST, V4, P326; Kassab D, 2008, J ALLERGY CLIN IMMUN, V121, pS67, DOI 10.1016/j.jaci.2007.12.268; Kushnir-Sukhov NM, 2008, EUR J CLIN INVEST, V38, P953, DOI 10.1111/j.1365-2362.2008.02047.x; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; METCALFE DD, 1979, J CLIN INVEST, V64, P1537, DOI 10.1172/JCI109613; Molderings GJ, 2012, ARZNEIMITTELFORSCH, V62, P157, DOI 10.1055/s-0032-1306321; Molderings GJ, 2015, CRIT REV ONCOL HEMAT, V93, P75, DOI 10.1016/j.critrevonc.2014.09.001; Molderings GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076241; Molderings GJ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-10; MORROW JD, 1995, J INVEST DERMATOL, V104, P937, DOI 10.1111/1523-1747.ep12606209; O'Sullivan S, 1999, ACTA PHYSIOL SCAND, V166, P1; Pardanani A, 2013, LEUKEMIA, V27, P2091, DOI 10.1038/leu.2013.227; Prasad P, 2008, J IMMUNOL, V181, P5024, DOI 10.4049/jimmunol.181.7.5024; Quintas-Cardama A, 2013, LEUKEMIA LYMPHOMA, V54, P1959, DOI 10.3109/10428194.2012.763121; Raithel M, 2011, J PHYSIOL PHARMACOL, V62, P469; Ravi A, 2014, J ALLER CL IMM-PRACT, V2, P775, DOI 10.1016/j.jaip.2014.06.011; Ravi A, 2013, J ALLERGY CLIN IMMUN, V131, pAB117, DOI 10.1016/j.jaci.2012.12.1088; Ronnberg E, 2012, J HISTOCHEM CYTOCHEM, V60, P950, DOI 10.1369/0022155412458927; Sargur R, 2011, CLIN EXP IMMUNOL, V163, P339, DOI 10.1111/j.1365-2249.2010.04287.x; Schafer D, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0213-2; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; Seidel H, 2011, THROMB HAEMOSTASIS, V106, P987, DOI 10.1160/TH11-05-0351; Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404; Stefanov S, 2013, REV MED VET, V164, P453, DOI [10.1016/j.bulcan.2015.01.010, DOI 10.1016/J.BULCAN.2015.01.010]; STUDER A, 1954, EXPERIENTIA, V10, P148, DOI 10.1007/BF02158526; THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; van Doormaal JJ, 2012, ALLERGY, V67, P683, DOI 10.1111/j.1398-9995.2012.02809.x; van Doormaal JJ, 2013, J ALLERGY CLIN IMMUN, V131, P1429, DOI 10.1016/j.jaci.2012.10.015; van Toorenenbergen AW, 2005, CLIN CHIM ACTA, V359, P72, DOI 10.1016/j.cccn.2005.03.041; Wladyslaw S, 2002, CORONARY ARTERY DIS, V13, P423, DOI 10.1097/00019501-200212000-00007; Yang WZ, 2009, J ENVIRON PATHOL TOX, V28, P223, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i3.30	57	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124912	10.1371/journal.pone.0124912	http://dx.doi.org/10.1371/journal.pone.0124912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909362	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800113
J	Zhu, XM; Wu, LJ; Yao, J; Jiang, H; Wang, QF; Yang, ZJ; Wu, FS				Zhu, Xiuming; Wu, Lingjiao; Yao, Jian; Jiang, Han; Wang, Qiangfeng; Yang, Zhijian; Wu, Fusheng			MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPRESSION; CANCER; APOPTOSIS; INVASION; FAMILY; SIGNATURES; MIGRATION; PATHWAY; GROWTH	Down-regulation of the microRNA let-7c plays an important role in the pathogenesis of human hepatocellular carcinoma (HCC). The aim of the present study was to determine whether the cell cycle regulator CDC25A is involved in the antitumor effect of let-7c in HCC. The expression levels of let-7c in HCC cell lines were examined by quantitative real-time PCR, and a let-7c agomir was transfected into HCC cells to overexpress let-7c. The effects of let-7c on HCC proliferation, apoptosis and cell cycle were analyzed. The in vivo tumor-inhibitory efficacy of let-7c was evaluated in a xenograft mouse model of HCC. Luciferase reporter assays and western blotting were conducted to identify the targets of let-7c and to determine the effects of let-7c on CDC25A, CyclinD1, CDK6, pRb and E2F2 expression. The results showed that the expression levels of let-7c were significantly decreased in HCC cell lines. Overexpression of let-7c repressed cell growth, induced cell apoptosis, led to G1 cell cycle arrest in vitro, and suppressed tumor growth in a HepG2 xenograft model in vivo. The luciferase reporter assay showed that CDC25A was a direct target of let-7c, and that let-7c inhibited the expression of CDC25A protein by directly targeting its 3' UTR. Restoration of CDC25A induced a let-7c-mediated G1-to-S phase transition. Western blot analysis demonstrated that overexpression of let-7c decreased CyclinD1, CDK6, pRb and E2F2 protein levels. In conclusion, this study indicates that let-7c suppresses HCC progression, possibly by directly targeting the cell cycle regulator CDC25A and indirectly affecting its downstream target molecules. Let-7c may therefore be an effective therapeutic target for HCC.	[Zhu, Xiuming; Jiang, Han; Wang, Qiangfeng; Wu, Fusheng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Xiuming] Zhejiang Prov Peoples Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Wu, Lingjiao; Yao, Jian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Yang, Zhijian] Origin Biosci Inc, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Zhejiang Provincial People's Hospital; Zhejiang University	Wu, FS (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	wufusheng@zju.edu.cn	zhu, xm/K-5002-2019; Jian, YAO/AAT-4231-2021	Jian, YAO/0000-0002-3746-1279	National 863 Program of China [2008AA02Z109]; National Natural Science Foundation of China [81272354]; Medicine Foundation of Zhejiang Province [2013RCA006]	National 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medicine Foundation of Zhejiang Province	The work was supported by the National 863 Program of China (FSW, Grant No. 2008AA02Z109), and National Natural Science Foundation of China (FSW, Grant No. 81272354), as well as in part by Medicine Foundation of Zhejiang Province (XMZ, Grant No. 2013RCA006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bae HJ, 2014, ONCOGENE, V33, P2557, DOI 10.1038/onc.2013.216; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Gong Fang-xiao, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P853, DOI 10.3760/cma.j.issn.1007-3418.2011.11.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landrieu I, 2004, P NATL ACAD SCI USA, V101, P13380, DOI 10.1073/pnas.0405248101; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Peghini PL, 2002, CLIN CANCER RES, V8, P2273; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shen T, 2012, ANTI-CANCER AGENT ME, V12, P631, DOI 10.2174/187152012800617678; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Wong JV, 2011, CELL CYCLE, V10; Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Xui XD, 2008, INT J MOL MED, V21, P145; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091661; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zhu XM, 2011, J INT MED RES, V39, P2323, DOI 10.1177/147323001103900631	46	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124266	10.1371/journal.pone.0124266	http://dx.doi.org/10.1371/journal.pone.0124266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909324	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800072
J	McEvoy, J; While, GM; Jones, SM; Wapstra, E				McEvoy, Jo; While, Geoffrey M.; Jones, Susan M.; Wapstra, Erik			Examining the Role of Testosterone in Mediating Short-Term Aggressive Responses to Social Stimuli in a Lizard	PLOS ONE			English	Article							TERRITORIAL AGGRESSION; INDIVIDUAL VARIATION; PLASMA TESTOSTERONE; BEHAVIORAL SYNDROMES; ANIMAL PERSONALITY; FEMALE AGGRESSION; STEROID-HORMONES; TREE LIZARDS; EVOLUTIONARY; SEX	Hormones have been suggested as a key proximate mechanism that organize and maintain consistent individual differences in behavioural traits such as aggression. The steroid hormone testosterone in particular has an important activational role in mediating short-term aggressive responses to social and environmental stimuli within many vertebrate systems. We conducted two complementary experiments designed to investigate the activational relationship between testosterone and aggression in male Egernia whitii, a social lizard species. First, we investigated whether a conspecific aggressive challenge induced a testosterone response and second, we artificially manipulated testosterone concentrations to examine whether this changed aggression levels. We found that at the mean level, plasma T concentration did not appear to be influenced by an aggression challenge. However, there was a slight indication that receiving a challenge may influence intra-individual consistency of plasma T concentrations, with individuals not receiving an aggression challenge maintaining consistency in their circulating testosterone concentrations, while those individuals that received a challenge did not. Manipulating circulating testosterone concentrations had no influence on either mean-level or individual-level aggression. Combined with our previous work, our study adds increasing evidence that the relationship between testosterone and aggression is not straightforward, and promotes the investigation of alternative hormonal pathways and differences in neuro-synthesis and neuroendocrine pathways to account for species variable testosterone - aggression links.	[McEvoy, Jo; While, Geoffrey M.; Jones, Susan M.; Wapstra, Erik] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [While, Geoffrey M.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford, England	University of Tasmania; University of Oxford	McEvoy, J (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	jmcevoy@utas.edu.au	McEvoy, Jo/M-7204-2015; While, Geoffrey M/O-6306-2017; Wapstra, Erik/J-7482-2014	McEvoy, Jo/0000-0001-9591-1824; While, Geoffrey M/0000-0001-8122-9322; Wapstra, Erik/0000-0002-2050-8026	Holsworth Wildlife Research Endowment; Winifred Violet Scott Estate; Ecological Society of Australia; Bookend Trust; Australian Research Council	Holsworth Wildlife Research Endowment; Winifred Violet Scott Estate; Ecological Society of Australia; Bookend Trust; Australian Research Council(Australian Research Council)	This work was funded in part by the Holsworth Wildlife Research Endowment, the Winifred Violet Scott Estate, the Ecological Society of Australia, the Bookend Trust (JM), and the Australian Research Council (EW, GMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Apfelbeck B, 2011, P ROY SOC B-BIOL SCI, V278, P3233, DOI 10.1098/rspb.2011.0098; Ball GF, 2008, PHILOS T R SOC B, V363, P1699, DOI 10.1098/rstb.2007.0010; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; Bell AM, 2007, NATURE, V447, P539, DOI 10.1038/447539a; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; CLEMENS LG, 1982, J COMP PHYSIOL PSYCH, V96, P114, DOI 10.1037/h0077859; Cramer ERA, 2012, ETHOLOGY, V118, P975, DOI 10.1111/j.1439-0310.2012.02091.x; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Davis ES, 2003, HORM BEHAV, V44, P185, DOI 10.1016/S0018-506X(03)00128-4; DENARDO DF, 1994, HORM BEHAV, V28, P273, DOI 10.1006/hbeh.1994.1023; DeVries MS, 2012, HORM BEHAV, V62, P99, DOI 10.1016/j.yhbeh.2012.05.008; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Duckworth RA, 2006, P ROY SOC B-BIOL SCI, V273, P1789, DOI 10.1098/rspb.2006.3517; Duckworth RA, 2012, FUNCT ECOL, V26, P559, DOI 10.1111/j.1365-2435.2012.01966.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Hau M, 2000, GEN COMP ENDOCR, V117, P20, DOI 10.1006/gcen.1999.7390; Isaksson C, 2011, BEHAVIOUR, V148, P713, DOI 10.1163/000579511X574204; JOHNSON F, 1993, J NEUROBIOL, V24, P400, DOI 10.1002/neu.480240311; Jones SM, 2004, COMP BIOCHEM PHYS A, V137, P105, DOI 10.1016/S1095-6433(03)00267-8; Kempenaers B, 2008, PHILOS T R SOC B, V363, P1711, DOI 10.1098/rstb.2007.0001; Knapp R, 1997, GEN COMP ENDOCR, V107, P273, DOI 10.1006/gcen.1997.6923; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Landys MM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P228, DOI 10.1086/510564; Langkilde T, 2005, ECOLOGY, V86, P1650, DOI 10.1890/04-1331; Langkilde T, 2007, AUSTRAL ECOL, V32, P869, DOI 10.1111/j.1442-9993.2007.01771.x; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; LINCOLN GA, 1972, HORM BEHAV, V3, P375, DOI 10.1016/0018-506X(72)90027-X; Magnhagen C, 2012, J ANIM ECOL, V81, P1311, DOI 10.1111/j.1365-2656.2012.02007.x; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McEvoy J, 2015, J ZOOL, V296, P58, DOI 10.1111/jzo.12217; McEvoy J, 2013, BEHAV ECOL SOCIOBIOL, V67, P79, DOI 10.1007/s00265-012-1427-z; McGlothlin JW, 2008, PHILOS T R SOC B, V363, P1611, DOI 10.1098/rstb.2007.0002; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; MOORE MC, 1987, GEN COMP ENDOCR, V65, P225, DOI 10.1016/0016-6480(87)90170-5; Mougeot F, 2003, NATURE, V421, P737, DOI 10.1038/nature01395; Nicol S, 2005, GEN COMP ENDOCR, V144, P204, DOI 10.1016/j.ygcen.2005.05.013; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 2002, COMP BIOCHEM PHYS B, V132, P203, DOI 10.1016/S1096-4959(01)00523-1; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Development Team, 2008, R LANG ENV STAT COMP; Remage-Healey L, 2005, HORM BEHAV, V47, P297, DOI 10.1016/j.yhbeh.2004.11.017; Rubenstein DR, 2005, HORM BEHAV, V48, P329, DOI 10.1016/j.yhbeh.2005.04.006; SCHLINGER BA, 1990, COMP BIOCHEM PHYS A, V97, P307, DOI 10.1016/0300-9629(90)90616-Z; Scriba MF, 2010, J ORNITHOL, V151, P607, DOI 10.1007/s10336-010-0493-0; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Simpson K., 2001, MCGILL J MED, V6; Sinn DL, 2008, ANIM BEHAV, V76, P1249, DOI 10.1016/j.anbehav.2008.06.009; Soma KK, 2006, J NEUROENDOCRINOL, V18, P543, DOI 10.1111/j.1365-2826.2006.01440.x; Soma KK, 2000, P ROY SOC B-BIOL SCI, V267, P1089, DOI 10.1098/rspb.2000.1113; Soma KK, 1999, GEN COMP ENDOCR, V115, P442, DOI 10.1006/gcen.1999.7334; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Stapley J, 2006, J THERM BIOL, V31, P362, DOI 10.1016/j.jtherbio.2006.01.008; Thaker M, 2009, ANIM BEHAV, V77, P395, DOI 10.1016/j.anbehav.2008.10.014; Ubuka T, 2014, GEN COMP ENDOCR, V205, P49, DOI 10.1016/j.ygcen.2014.03.014; Weiss SL, 2004, GEN COMP ENDOCR, V136, P282, DOI 10.1016/j.ygcen.2004.01.001; While GM, 2011, MOL ECOL, V20, P844, DOI 10.1111/j.1365-294X.2010.04976.x; While GM, 2010, HORM BEHAV, V58, P208, DOI 10.1016/j.yhbeh.2010.03.016; While GM, 2009, AUSTRAL ECOL, V34, P938, DOI 10.1111/j.1442-9993.2009.02002.x; While GM, 2009, FUNCT ECOL, V23, P818, DOI 10.1111/j.1365-2435.2009.01544.x; While GM, 2009, P ROY SOC B-BIOL SCI, V276, P2021, DOI 10.1098/rspb.2008.1926; While GM, 2009, BEHAV ECOL, V20, P245, DOI 10.1093/beheco/arp015; Wikelski M, 1999, P ROY SOC B-BIOL SCI, V266, P551, DOI 10.1098/rspb.1999.0671; Wikelski M, 2005, BEHAV ECOL, V16, P260, DOI 10.1093/beheco/arh160; Wingfield J.C., 2006, BIOL AGGRESSION, P179, DOI DOI 10.1093/ACPRO6OSO/9780195168261.0030008; WINGFIELD JC, 1985, HORM BEHAV, V19, P174, DOI 10.1016/0018-506X(85)90017-0; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1987, AM SCI, V75, P602; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Yang EJ, 2002, HORM BEHAV, V42, P192, DOI 10.1006/hbeh.2002.1811	80	1	1	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125015	10.1371/journal.pone.0125015	http://dx.doi.org/10.1371/journal.pone.0125015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906149	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000100
J	Brenig, J; de Boor, S; Knyphausen, P; Kuhlmann, N; Wroblowski, S; Baldus, L; Scislowski, L; Artz, O; Trauschies, P; Baumann, U; Neundorf, I; Lammers, M				Brenig, Julian; de Boor, Susanne; Knyphausen, Philipp; Kuhlmann, Nora; Wroblowski, Sarah; Baldus, Linda; Scislowski, Lukas; Artz, Oliver; Trauschies, Philip; Baumann, Ulrich; Neundorf, Ines; Lammers, Michael			Structural and Biochemical Basis for the Inhibitory Effect of Liprin-alpha 3 on Mouse Diaphanous 1 (mDia1) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMIN HOMOLOGY-2 DOMAIN; ACTIN-FILAMENT ELONGATION; LIPRIN-ALPHA PROTEINS; AUTOREGULATORY DOMAIN; STRUCTURE VALIDATION; INDUCED NUCLEATION; CRYSTAL-STRUCTURES; COILED COILS; FH1 DOMAIN; BINDING	Diaphanous-related formins are eukaryotic actin nucleation factors regulated by an autoinhibitory interaction between the N-terminal RhoGTPase-binding domain (mDia(N)) and the C-terminal Diaphanous-autoregulatory domain (DAD). Although the activation of formins by Rho proteins is well characterized, its inactivation is only marginally understood. Recently, liprin-alpha 3 was shown to interact with mDia1. Overexpression of liprin-alpha 3 resulted in a reduction of the cellular actin filament content. The molecular mechanisms of how liprin-alpha 3 exerts this effect and counteracts mDia1 activation by RhoA are unknown. Here, we functionally and structurally define a minimal liprin-alpha 3 core region, sufficient to recapitulate the liprin-alpha 3 determined mDia1-respective cellular functions. We show that liprin-alpha 3 alters the interaction kinetics and thermodynamics of mDia(N) with RhoA center dot GTP and DAD. RhoA displaces liprin-alpha 3 allosterically, whereas DAD competes with liprin-alpha 3 for a highly overlapping binding site on mDia(N). Liprin-alpha 3 regulates actin polymerization by lowering the regulatory potency of RhoA and DAD on mDia(N). We present a model of a mechanistically unexplored and new aspect of mDia(N) regulation by liprin-alpha 3.	[Brenig, Julian; de Boor, Susanne; Knyphausen, Philipp; Kuhlmann, Nora; Wroblowski, Sarah; Baldus, Linda; Scislowski, Lukas; Artz, Oliver; Trauschies, Philip; Lammers, Michael] Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Brenig, Julian; de Boor, Susanne; Knyphausen, Philipp; Kuhlmann, Nora; Wroblowski, Sarah; Baldus, Linda; Scislowski, Lukas; Artz, Oliver; Trauschies, Philip; Lammers, Michael] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Baumann, Ulrich; Neundorf, Ines] Univ Cologne, Inst Biochem, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Lammers, M (corresponding author), Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.	michael.lammers@uni-koeln.de	Artz, Oliver/AAZ-8384-2021; Baumann, Ulrich/B-1220-2013; Lammers, Michael/AAX-1164-2020	Artz, Oliver/0000-0002-5708-1281; Lammers, Michael/0000-0003-4168-4640; Neundorf, Ines/0000-0001-6450-3991	European BIOSTRUCTX_5870	European BIOSTRUCTX_5870	We thank the beamline groups at the SLS Villingen/Switzerland, whose outstanding efforts have made these experiments possible. Support by the European BIOSTRUCTX_5870 is gratefully acknowledged. We thank the ESRF/Grenoble for being able to perform and support the first BioSAXS measurements at beamline BM29 ( BAG: MX-1479). We thank Anncharlott Berglar for the design of the graphical abstract and Astrid Schauss and Nikolay Kladt (CECAD Imaging Facility) for critical discussions of the cell biological experiments. Wealso thank Prof. Dr. A. Wittinghofer for providing the RhoA and mDia constructs.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Astigarraga S, 2010, J NEUROSCI, V30, P15358, DOI 10.1523/JNEUROSCI.1862-10.2010; Astro V, 2011, ONCOGENE, V30, P1841, DOI 10.1038/onc.2010.562; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bogdan Sven, 2013, Commun Integr Biol, V6, pe27634, DOI 10.4161/cib.27634; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Machaidze G, 2010, J MOL BIOL, V403, P529, DOI 10.1016/j.jmb.2010.09.017; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nachat R, 2009, J CELL SCI, V122, P4035, DOI 10.1242/jcs.047266; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Nezami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012992; Nomura H, 2011, IMMUNOL LETT, V139, P110, DOI 10.1016/j.imlet.2011.05.010; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sakamoto Satoko, 2012, Bioarchitecture, V2, P43; Sakamoto S, 2012, J CELL SCI, V125, P108, DOI 10.1242/jcs.087411; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Shannon Katie B, 2012, Int J Cell Biol, V2012, P894817, DOI 10.1155/2012/894817; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Spangler SA, 2011, J COMP NEUROL, V519, P3040, DOI 10.1002/cne.22665; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Taru H, 2011, J NEUROSCI, V31, P16261, DOI 10.1523/JNEUROSCI.0002-11.2011; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zurner M, 2011, J COMP NEUROL, V519, P3019, DOI 10.1002/cne.22664	65	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14314	14327		10.1074/jbc.M114.621946	http://dx.doi.org/10.1074/jbc.M114.621946			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911102	Green Published, hybrid			2022-12-26	WOS:000355754600005
J	Guo, J; Shi, X; Yang, WL; Gong, SG; Zhao, QH; Wang, L; He, J; Shi, XF; Sun, XG; Liu, JM				Guo, Jian; Shi, Xue; Yang, Wenlan; Gong, Sugang; Zhao, Qinhua; Wang, Lan; He, Jing; Shi, Xiaofang; Sun, Xingguo; Liu, Jinming			Exercise Physiology and Pulmonary Hemodynamic Abnormality in PH Patients with Exercise Induced Venous-To-Systemic Shunt	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; PATENT FORAMEN OVALE; UPTAKE EFFICIENCY PLATEAU; VENTILATORY EFFICIENCY; OXYGEN-UPTAKE; ATRIAL SEPTOSTOMY; GAS-EXCHANGE; CAPACITY; SURVIVAL; PREVALENCE	Objectives To identify the pulmonary hypertension (PH) patients who develop an exercise induced venous-to-systemic shunt (EIS) by performing the cardiopulmonary exercise test (CPET), analyse the changes of CPET measurements during exercise and compare the exercise physiology and resting pulmonary hemodynamics between shunt-PH and no-shunt-PH patients. Methods Retrospectively, resting pulmonary function test (PFT), right heart catheterization (RHC), and CPET for clinical evaluation of 104 PH patients were studied. Results Considering all 104 PH patients by three investigators, 37 were early EIS+, 61 were EIS-, 3 were late EIS+, and 3 others were placed in the discordant group. PeakVO(2), AT and OUES were all reduced in the shunt-PH patients compared with the no-shunt-PH subjects, whereas VE/VCO2 slope and the lowest VE/VCO2 increased. Besides, the changes and the response characteristics of the key CPET parameters at the beginning of exercise in the shunt group were notably different from those of the no shunt one. At cardiac catheterization, the shunt patients had significantly increased mean pulmonary artery pressure (mPAP), mean right atrial pressure (mRAP) and pulmonary vascular resistance (PVR), reduced cardiac output (CO) and cardiac index (CI) compared with the no shunt ones (P<0.05). Resting CO was significantly correlated with exercise parameters of AT (r = 0.527, P<0.001), OUES (r = 0.410, P<0.001) and Peak VO2 (r = 0.405, P<0.001). PVR was significantly, but weakly, correlated with the above mentioned CPET parameters. In Conclusions CPET may allow a non-invasive method for detecting an EIS and assessing the severity of the disease in PH patients.	[Guo, Jian; Shi, Xue; Yang, Wenlan; Shi, Xiaofang; Liu, Jinming] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pulm Funct Test, Shanghai 200433, Peoples R China; [Gong, Sugang; Zhao, Qinhua; Wang, Lan; He, Jing; Liu, Jinming] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pulm Circulat, Shanghai 200433, Peoples R China; [Sun, Xingguo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Lung Funct Testing Ctr, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100037, Peoples R China; [Sun, Xingguo] Peking Union Med Coll, Beijing 100037, Peoples R China	Tongji University; Tongji University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Sun, XG (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Heart Lung Funct Testing Ctr, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing 100037, Peoples R China.	xgsun@labiomed.org; jinmingliu2013@126.com						American Thoracic Society, 2002, AM J RESP CRIT CARE, V166; Arena R, 2008, HEART FAIL REV, V13, P245, DOI 10.1007/s10741-007-9067-5; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Barst RJ, 2000, THORAX, V55, P95, DOI 10.1136/thorax.55.2.95; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Davies LC, 2006, EUR HEART J, V27, P684, DOI 10.1093/eurheartj/ehi672; DEBELDER MA, 1992, AM J CARDIOL, V69, P1316, DOI 10.1016/0002-9149(92)91228-V; Fleg JL, 2000, CIRCULATION, V102, P1591, DOI 10.1161/01.CIR.102.13.1591; Groepenhoff H, 2008, MED SCI SPORT EXER, V40, P1725, DOI 10.1249/MSS.0b013e31817c92c0; Guazzi M, 2005, J AM COLL CARDIOL, V46, P1883, DOI 10.1016/j.jacc.2005.07.051; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; LYNCH JJ, 1984, AM J CARDIOL, V53, P1478, DOI 10.1016/S0002-9149(84)91617-5; MOORTHY SS, 1974, ANESTHESIOLOGY, V41, P405, DOI 10.1097/00000542-197410000-00022; Mortara A, 1997, CIRCULATION, V96, P3450; Opitz CF, 2005, EUR HEART J, V26, P1895, DOI 10.1093/eurheartj/ehi283; Oudiz RJ, 2007, EUR J HEART FAIL, V9, P917, DOI 10.1016/j.ejheart.2007.06.013; Oudiz RJ, 2010, AM J CARDIOL, V105, P1186, DOI 10.1016/j.amjcard.2009.12.024; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Reindl I, 1998, AM HEART J, V136, P778, DOI 10.1016/S0002-8703(98)70121-8; RHODES J, 1991, J AM COLL CARDIOL, V18, P1738, DOI 10.1016/0735-1097(91)90513-9; RICH S, 1983, AM J CARDIOL, V51, P1560, DOI 10.1016/0002-9149(83)90678-1; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SIETSEMA KE, 1988, J APPL PHYSIOL, V64, P234, DOI 10.1152/jappl.1988.64.1.234; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; SUE DY, 1991, CHEST, V99, P981, DOI 10.1378/chest.99.4.981; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Sun XG, 2012, CHEST, V141, P1284, DOI 10.1378/chest.11-1270; Sun XG, 2012, EUR J APPL PHYSIOL, V112, P919, DOI 10.1007/s00421-011-2030-0; Ting H, 2001, CHEST, V119, P824, DOI 10.1378/chest.119.3.824; Wensel R, 2000, CIRCULATION, V101, P2388, DOI 10.1161/01.CIR.101.20.2388; Yasunobu Y, 2005, CHEST, V127, P1637, DOI 10.1378/chest.127.5.1637; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50	38	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121690	10.1371/journal.pone.0121690	http://dx.doi.org/10.1371/journal.pone.0121690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918847	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400009
J	Singh, SK; Mishra, S; Aspi, J; Kvist, L; Nigam, P; Pandey, P; Sharma, R; Goyal, SP				Singh, Sujeet Kumar; Mishra, Sudhanshu; Aspi, Jouni; Kvist, Laura; Nigam, Parag; Pandey, Puneet; Sharma, Reeta; Goyal, Surendra Prakash			Tigers of Sundarbans in India: Is the Population a Separate Conservation Unit?	PLOS ONE			English	Article							MICROSATELLITE LOCI; COMPUTER-PROGRAM; GENE FLOW; SIZE; INFERENCE; SOFTWARE; RATES; EVOLUTION; SELECTION; SAMPLES	The Sundarbans tiger inhabits a unique mangrove habitat and are morphologically distinct from the recognized tiger subspecies in terms of skull morphometrics and body size. Thus, there is an urgent need to assess their ecological and genetic distinctiveness and determine if Sundarbans tigers should be defined and managed as separate conservation unit. We utilized nine microsatellites and 3 kb from four mitochondrial DNA (mtDNA) genes to estimate genetic variability, population structure, demographic parameters and visualize historic and contemporary connectivity among tiger populations from Sundarbans and mainland India. We also evaluated the traits that determine exchangeability or adaptive differences among tiger populations. Data from both markers suggest that Sundarbans tiger is not a separate tiger subspecies and should be regarded as Bengal tiger (P. t. tigris) subspecies. Maximum likelihood phylogenetic analyses of the mtDNA data revealed reciprocal monophyly. Genetic differentiation was found stronger for mtDNA than nuclear DNA. Microsatellite markers indicated low genetic variation in Sundarbans tigers (He=0.58) as compared to other mainland populations, such as northern and Peninsular (Hebetween 0.67-0.70). Molecular data supports migration between mainland and Sundarbans populations until very recent times. We attribute this reduction in gene flow to accelerated fragmentation and habitat alteration in the landscape over the past few centuries. Demographic analyses suggest that Sundarbans tigers have diverged recently from peninsular tiger population within last 2000 years. Sundarbans tigers are the most divergent group of Bengal tigers, and ecologically non-exchangeable with other tiger populations, and thus should be managed as a separate "evolutionarily significant unit" (ESU) following the adaptive evolutionary conservation (AEC) concept.	[Singh, Sujeet Kumar; Aspi, Jouni; Kvist, Laura] Univ Oulu, Dept Biol, Oulu, Finland; [Singh, Sujeet Kumar; Mishra, Sudhanshu; Nigam, Parag; Pandey, Puneet; Goyal, Surendra Prakash] Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, India; [Sharma, Reeta] Inst Gulbenkian Ciencias, Populat & Conservat Genet, P-2780156 Oeiras, Portugal	University of Oulu; Wildlife Institute of India; Instituto Gulbenkian de Ciencia	Goyal, SP (corresponding author), Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, India.	goyalsp@wii.gov.in	Singh, Sujeet Kumar/ABC-2594-2020; Aspi, Jouni O/B-3087-2012; MISHRA, SUDHANSHU/E-6732-2011	Singh, Sujeet Kumar/0000-0002-3671-1328; PANDEY, PUNEET/0000-0001-5891-3927; Sharma, Reeta/0000-0001-9862-9218; Aspi, Jouni/0000-0002-2451-3201	Wildlife Institute of India, Dehra Dun, India	Wildlife Institute of India, Dehra Dun, India	Funding: This work was supported by the Wildlife Institute of India, Dehra Dun, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Allendorf F, 2013, CONSERV GENET, V2nd; Balloux F, 2000, ACTA THERIOL, V45, P93, DOI 10.4098/AT.arch.00-65; Balow DCA, 2009, THESIS U MINNESOTA, P29; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barlow ACD, 2010, MAMMALIA, V74, P329, DOI 10.1515/MAMM.2010.040; Bera G. K., 2010, LAGOONS GANGETIC DEL; Borthakur U, 2010, NONINVASIVE GENETIC, DOI [10.1007/s10344-010-0471-0, DOI 10.1007/S10344-010-0471-0]; Chakrabarti K., 1992, MAN EATING TIGERS; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Coyne J.A., 2004, SPECIATION; CRANDALL KA, 1993, GENETICS, V134, P959; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eaton R.M., 1990, AGR HUM VALUES, V7, P6, DOI [10.1007/BF01530432, DOI 10.1007/BF01530432]; England PR, 2010, CONSERV GENET, V11, P2425, DOI 10.1007/s10592-010-0112-x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Fernando P, 2003, PLOS ONE, V3, P382; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hedrick PW, 2013, J HERED, V104, P713, DOI 10.1093/jhered/est047; Hemmer H, 2004, NEUES JB GEOLOGIE PA, V233, P97; Holycross AT, 2007, BIOL CONSERV, V134, P142, DOI 10.1016/j.biocon.2006.07.020; Hoogesteijn Rafael, 1996, Bulletin of the Florida Museum of Natural History, V39, P195; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; Jackson P., 1996, BIOL CONSERVATION; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jhala Y, 2008, STATUS TIGERS COPRED; Jhala Y. V., 2011, STATUS TIGERS COPRED; Johnsingh A., 2004, RR04001 WILDL I IND; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth K. Ullas, 2003, Journal of the Bombay Natural History Society, V100, P169; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kershaw F, 2013, J HERED, V104, P755, DOI 10.1093/jhered/est057; Khan H, 2008, J BOMBAY NAT HIST SO, V105; Khan M.M.H., 2004, THESIS U CAMBRIDGE THESIS U CAMBRIDGE; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loucks C, 2010, CLIMATIC CHANGE, V98, P291, DOI 10.1007/s10584-009-9761-5; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; Mayr E, 1942, SYSTEMATICS ORIGIN S; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Mishra S, 2014, AFRI J BIOT, DOI [10.5897/AJB12.2977, DOI 10.5897/AJB12.2977]; Mishra S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-4; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Najman Y, 2008, EARTH PLANET SC LETT, V273, P1, DOI 10.1016/j.epsl.2008.04.028; Nunn PD, 2006, COAST SYST CONT MARG, V10, P93; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; PRAGER EM, 1975, P NATL ACAD SCI USA, V72, P200, DOI 10.1073/pnas.72.1.200; Pritchard JK, 2000, GENETICS, V155, P945; Qureshi Q, 2006, EVALUATING TIGER HAB; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Reza A, 2001, J ZOOL, V29, P173; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sanderson E., 2006, SETTING PRIORITIES C; Sharma R, 2008, MOL ECOL RESOUR, V8, P1480, DOI 10.1111/j.1755-0998.2008.02292.x; Sharma R, 2011, MAMM BIOL, V76, P484, DOI 10.1016/j.mambio.2010.10.005; Sharma R, 2009, CONSERV GENET, V10, P909, DOI 10.1007/s10592-008-9568-3; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; SLATKIN M, 1995, GENETICS, V139, P457; SMITH JLD, 1991, CONSERV BIOL, V5, P484, DOI 10.1111/j.1523-1739.1991.tb00355.x; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples R.S., 1991, MAR FISH REV, V53, P11; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1931, GENETICS, V16, P0097; Zhu Y, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-227	93	27	28	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0118846	10.1371/journal.pone.0118846	http://dx.doi.org/10.1371/journal.pone.0118846			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919139	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400001
J	Agaisse, H; Derre, I				Agaisse, Herve; Derre, Isabelle			STIM1 Is a Novel Component of ER-Chlamydia trachomatis Inclusion Membrane Contact Sites	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; WADDLIA-CHONDROPHILA; GOLGI-APPARATUS; PLASMA-MEMBRANE; CELLS; TRAFFICKING; SPHINGOLIPIDS; COMPLEX; ENTRY; ORGANIZATION	Productive developmental cycle of the obligate intracellular bacterial pathogen Chlamydia trachomatis depends on the interaction of the replicative vacuole, named the inclusion, with cellular organelles. We have recently reported the formation of ER-Inclusion membrane contact sites (MCSs), where the endoplasmic reticulum (ER) is in apposition to the inclusion membrane. These platforms contain the C. trachomatis inclusion membrane protein IncD, the mammalian ceramide transfer protein CERT and the ER resident proteins VAPA/B and were proposed to play a role in the non-vesicular trafficking of lipids to the inclusion. Here, we identify STIM1 as a novel component of ER-Inclusion MCSs. STIM1, an ER calcium (Ca2+) sensor that relocate to ER-Plasma Membrane (PM) MCSs upon Ca2+ store depletion, associated with C. trachomatis inclusion. STIM1, but not the general ER markers Rtn3C and Sec61 beta, was enriched at the inclusion membrane. Ultra-structural studies demonstrated that STIM1 localized to ER-Inclusion MCSs. Time-course experiments showed that STIM1, CERT and VAPB co-localized throughout the developmental cycle. By contrast, Orai1, the PM Ca2+ channel that interacts with STIM1 at ER-PM MCSs, did not associate with C. trachomatis inclusion. Upon ER Ca2+ store depletion, a pool of STIM1 relocated to ER-PM MCSs, while the existing ER-Inclusion MCSs remained enriched in STIM1. Finally, we have identified the CAD domain, which mediates STIM1-Orai1 interaction, as the minimal domain required for STIM1 enrichment at ER-Inclusion MCSs. Altogether this study identifies STIM1 as a novel component of ER-C. trachomatis inclusion MCSs. We discuss the potential role(s) of STIM1 during the infection process.	[Agaisse, Herve; Derre, Isabelle] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Derre, I (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	isabelle.derre@yale.edu			National Institute of Allergy and Infectious Diseases (NIAID) [AI101441]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101441] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) grant AI101441 to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Barsy M, 2013, MICROBES INFECT, V15, P1033, DOI 10.1016/j.micinf.2013.09.010; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hyser JM, 2013, J VIROL, V87, P13579, DOI 10.1128/JVI.02629-13; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Lewis RS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003970; Majeed M, 1999, J CELL SCI, V112, P35; Mehlitz A, 2014, CELL MICROBIOL, V16, P1224, DOI 10.1111/cmi.12278; Mogelsvang S, 2004, TRAFFIC, V5, P338, DOI 10.1111/j.1398-9219.2004.00186.x; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Pilhofer M, 2014, ENVIRON MICROBIOL, V16, P417, DOI 10.1111/1462-2920.12299; Prakriya M, 2013, CURR TOP MEMBR, V71, P1, DOI 10.1016/B978-0-12-407870-3.00001-9; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Schwan C, 2014, P NATL ACAD SCI USA, V111, P2313, DOI 10.1073/pnas.1311589111; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Srikanth S, 2012, J PHYSIOL-LONDON, V590, P4169, DOI 10.1113/jphysiol.2012.231522; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014	41	16	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125671	10.1371/journal.pone.0125671	http://dx.doi.org/10.1371/journal.pone.0125671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915399	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100141
J	Ni, GZ; Qin, JM; Li, HL; Chen, ZY; Zhou, YF; Fang, ZY; Chen, YS; Zhou, JQ; Huang, M; Zhou, LM				Ni, Guanzhong; Qin, Jiaming; Li, Hongliang; Chen, Ziyi; Zhou, Yafang; Fang, Ziyan; Chen, Yishu; Zhou, Jueqian; Huang, Min; Zhou, Liemin			Effects of Antiepileptic Drug Monotherapy on One-Carbon Metabolism and DNA Methylation in Patients with Epilepsy	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; SODIUM VALPROATE; RISK-FACTORS; SERUM-LEVELS; FOLATE; HYPERHOMOCYSTEINEMIA; VITAMIN-B12; EXPOSURE; CHILDREN	Purpose The aim of this study was to compare the serum levels of one-carbon metabolism (OCM) nutrients (e.g., folate, homocysteine and vitamin B12) and peripheral blood DNA methylation in epileptic patients under treatment with antiepileptic drugs (AEDs) and in healthy controls. Methods In this cross-sectional study, 60 patients with epilepsy who were receiving valproate (VPA) (n = 30) or lamotrigine (LTG) (n = 30) monotherapy were enrolled. Thirty age and sex matched healthy subjects served as the controls. Serum concentrations of OCM nutrients and peripheral blood DNA methylation status were measured. Results Compared to the control group, the VPA group had higher serum levels of homocysteine (p<0.05). No difference in homocysteine concentration was observed in the LTG group. Patients receiving VPA or LTG had significantly lower serum folate levels in comparison with controls (p<0.001). The level of methylation of long interspersed nucleotide element-1 (LINE-1) in peripheral blood was not significantly different between the AED monotherapy group and healthy controls. A difference in the methylation levels of methylenetetrahydrofolate reductase (MTHFR) amplicon was observed between AED-treated patients with epilepsy and controls (p<0.01). A positive correlation between serum folate levels and peripheral blood MTHFR amplicon methylation status was also observed (r = 0.25, p = 0.023). Conclusion Our findings suggest that the effects of AED monotherapy on OCM may induce specific regions of DNA hypomethylation.	[Ni, Guanzhong; Qin, Jiaming; Chen, Ziyi; Fang, Ziyan; Chen, Yishu; Zhou, Jueqian; Zhou, Liemin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Hongliang; Zhou, Yafang; Huang, Min] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	lmzhou56@163.com		Ni, Guanzhong/0000-0002-2334-3423	National Natural Science Foundation of China [81071050]; Natural Science Foundation of Guangdong Province [S2011020005483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was funded by grants from the National Natural Science Foundation of China (81071050, http://isisn.nsfc.gov.cn) and the Natural Science Foundation of Guangdong Province (S2011020005483, http://gdsf.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apeland T, 2001, EPILEPSY RES, V47, P27, DOI 10.1016/S0920-1211(01)00288-1; Belcastro V, 2010, EPILEPSIA, V51, P274, DOI 10.1111/j.1528-1167.2009.02303.x; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Chang SY, 2013, J CELL BIOCHEM, V114, P1549, DOI 10.1002/jcb.24496; Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Emes RD, 2013, EPILEPSIA, V54, pe16, DOI 10.1111/j.1528-1167.2012.03673.x; Felkner M, 2009, BIRTH DEFECTS RES A, V85, P574, DOI 10.1002/bdra.20545; Gidal BE, 2005, EPILEPSY RES, V64, P161, DOI 10.1016/j.eplepsyres.2005.03.005; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Iqbal MM, 2001, SOUTH MED J, V94, P304; Karabiber H, 2003, BRAIN DEV-JPN, V25, P113, DOI 10.1016/S0387-7604(02)00163-8; Kim YI, 2004, ENVIRON MOL MUTAGEN, V44, P10, DOI 10.1002/em.20025; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Mintzer S, 2010, CURR OPIN NEUROL, V23, P164, DOI 10.1097/WCO.0b013e32833735e7; Ni G, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-004936, DOI 10.1136/BMJ0PEN-2014-004936]; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Perng W, 2014, NUTR METAB CARDIOVAS, V24, P614, DOI 10.1016/j.numecd.2013.11.011; Roy M, 2008, J CELL BIOCHEM, V105, P467, DOI 10.1002/jcb.21847; Semmler A, 2013, CLIN CHEM LAB MED, V51, P665, DOI 10.1515/cclm-2012-0580; Shah S, 2014, GENOME RES, V24, P1725, DOI 10.1101/gr.176933.114; Sheng W, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-20; Smith AK, 2012, EPIGENETICS-US, V7, P458, DOI 10.4161/epi.19617; Stolk L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078462; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tremolizzo L, 2012, PROG NEURO-PSYCHOPH, V39, P47, DOI 10.1016/j.pnpbp.2012.04.016; Tumer L, 2002, ACTA PAEDIATR, V91, P923, DOI 10.1080/080352502760272597; Verrotti A, 2000, EPILEPSY RES, V41, P253, DOI 10.1016/S0920-1211(00)00150-9; Verrotti A, 2011, EPILEPSIA, V52, P199, DOI 10.1111/j.1528-1167.2010.02897.x; Yoo JH, 1999, METABOLISM, V48, P1047, DOI 10.1016/S0026-0495(99)90204-4	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125656	10.1371/journal.pone.0125656	http://dx.doi.org/10.1371/journal.pone.0125656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915064	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100140
J	Ogihara, MH; Hikiba, J; Suzuki, Y; Taylor, D; Kataoka, H				Ogihara, Mari Horigane; Hikiba, Juri; Suzuki, Yutaka; Taylor, Demar; Kataoka, Hiroshi			Ovarian Ecdysteroidogenesis in Both Immature and Mature Stages of an Acari, Ornithodoros moubata	PLOS ONE			English	Article							SOFT TICK; MOLTING HORMONE; BOMBYX-MORI; PROTHORACIC GLANDS; ECDYSONE; EXPRESSION; ARGASIDAE; BIOSYNTHESIS; DROSOPHILA; SILKWORM	Ecdysteroidogenesis is essential for arthropod development and reproduction. Although the importance of ecdysteroids has been demonstrated, there is little information on the sites and enzymes for synthesis of ecdysteroids from Chelicerates. Ecdysteroid functions have been well studied in the soft tick Ornithodoros moubata, making this species an excellent candidate for elucidating ecdysteroidogenesis in Chelicerates. Results showed that O. moubata has at least two ecdysteroidogenic enzymes, Spook (OmSpo) and Shade (OmShd). RNAi showed both enzymes were required for ecdysteroidogenesis. Enzymatic assays demonstrated OmShd has the conserved functions of ecdysone 20-hydroxylase. OmSpo showed specific expression in the ovaries of final nymphal and adult stages, indicating O. moubata utilizes the ovary as an ecdysteroidogenic tissue instead of specific tissues as seen in other arthropods. On the other hand, OmShd expression was observed in various tissues including the midgut, indicating functional ecdysteroids can be produced in these tissues. In nymphal stages, expression of both OmSpo and OmShd peaked before molting corresponding with high ecdysteroid titers in the hemolymph. In fed adult females, OmSpo expression peaked at 8-10 days after engorgement, while OmShd expression peaked immediately after engorgement. Mated females showed more frequent surges of OmShd than virgin females. These results indicate that the regulation of synthesis of ecdysteroids differs in nymphs and adult females, and mating modifies adult female ecdysteroidogenesis. This is the first report to focus on synthesis of ecdysteroids in ticks and provides essential knowledge for understanding the evolution of ecdysteroidogenesis in arthropods.	[Ogihara, Mari Horigane; Hikiba, Juri; Suzuki, Yutaka; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Taylor, Demar] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tokyo; University of Tsukuba	Ogihara, MH (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	m-h-ogihara@ib.k.u-tokyo.ac.jp; taylor.de.mar.ge@u.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23-5268]; Promotion of Basic Research Activities for Innovation Biosciences; Suntory Foundation for Life Sciences	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Basic Research Activities for Innovation Biosciences; Suntory Foundation for Life Sciences	A Grants-in-Aid (23-5268) for Japan Society for the Promotion of Science (JSPS) Fellows from The Ministry of Education, Culture, Sports, Science and Technology, Japan (to MHO) had main role for the study design, data collection and analysis and preparation of the manuscript. This study was also supported in part for the study design and preparation of the manuscript by Promotion of Basic Research Activities for Innovation Biosciences (to HK). A SUNBOR GRANT from the Suntory Foundation for Life Sciences (to MHO) supported for the manuscript preparation.	Ali MS, 2013, GENE, V512, P337, DOI 10.1016/j.gene.2012.09.126; Belles X, 2015, BBA-GENE REGUL MECH, V1849, P181, DOI 10.1016/j.bbagrm.2014.05.025; Cabrera AR, 2015, INSECT MOL BIOL, V24, P277, DOI 10.1111/imb.12155; CHINZEI Y, 1983, J COMP PHYSIOL, V152, P13, DOI 10.1007/BF00689722; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Harshman LG, 1999, J INSECT PHYSIOL, V45, P571, DOI 10.1016/S0022-1910(99)00038-4; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; Horigane M, 2007, INSECT MOL BIOL, V16, P601, DOI 10.1111/j.1365-2583.2007.00754.x; Horigane M, 2010, INSECT MOL BIOL, V19, P501, DOI 10.1111/j.1365-2583.2010.01007.x; Horigane M, 2008, GEN COMP ENDOCR, V156, P298, DOI 10.1016/j.ygcen.2008.01.021; Horigane M, 2007, ARCH INSECT BIOCHEM, V64, P186, DOI 10.1002/arch.20170; Iga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103239; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lomas LO, 1997, P ROY SOC B-BIOL SCI, V264, P589, DOI 10.1098/rspb.1997.0084; Marchal E, 2012, J INSECT PHYSIOL, V58, P890, DOI 10.1016/j.jinsphys.2012.03.013; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ogihara K, 2007, GEN COMP ENDOCR, V150, P371, DOI 10.1016/j.ygcen.2006.09.007; Ogihara MH, 2014, TICK BIOL, V1, P416; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Rewitz KF, 2006, MOL CELL ENDOCRINOL, V247, P166, DOI 10.1016/j.mce.2005.12.053; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; ZHU XX, 1991, P NATL ACAD SCI USA, V88, P3744, DOI 10.1073/pnas.88.9.3744	35	17	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124953	10.1371/journal.pone.0124953	http://dx.doi.org/10.1371/journal.pone.0124953			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915939	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659100083
J	Zhang, W; Zhu, YH; Yang, JC; Yang, GY; Zhou, D; Wang, JF				Zhang, Wei; Zhu, Yao-Hong; Yang, Jin-Cai; Yang, Gui-Yan; Zhou, Dong; Wang, Jiu-Feng			A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; TIGHT JUNCTION PROTEINS; BARRIER FUNCTION; SOLUBLE-PROTEIN; NISSLE 1917; INFLAMMATION; RECOGNITION; EXPRESSION; CONTRIBUTES; DISRUPTION	Enterotoxigenic Escherichia coli (ETEC) are important intestinal pathogens that cause diarrhea in humans and animals. Although probiotic bacteria may protect against ETEC-induced enteric infections, the underlying mechanisms are unknown. In this study, porcine intestinal epithelial J2 cells (IPEC-J2) were pre-incubated with and without Lactobacillus rhamnosus ATCC 7469 and then exposed to F4(+) ETEC. Increases in TLR4 and NOD2 mRNA expression were observed at 3 h after F4(+) ETEC challenge, but these increases were attenuated by L. rhamnosus treatment. Expression of TLR2 and NOD1 mRNA was upregulated in cells pre-treated with L. rhamnosus. Pre-treatment with L. rhamnosus counteracted F4(+) ETEC-induced increases in TNF-alpha concentration. Increased PGE2. concentrations were observed in cells infected with F4(+) ETEC and in cells treated with L. rhamnosus only. A decrease in phosphorylated epidermal growth factor receptor (EGFR) was observed at 3 h after F4(+) ETEC challenge in cells treated with L. rhamnosus. Pre-treatment with L. rhamnosus enhanced Akt phosphorylation and increased ZO-1 and occludin protein expression. Our findings suggest that L. rhamnosus protects intestinal epithelial cells from F4(+) ETEC-induced damage, partly through the anti-inflammatory response involving synergism between TLR2 and NOD1. In addition, L. rhamnosus promotes EGFR-independent Akt activation, which may activate intestinal epithelial cells in response to bacterial infection, in turn increasing tight junction integrity and thus enhancing the barrier function and restricting pathogen invasion. Pre-incubation with L. rhamnosus was superior to co-incubation in reducing the adhesion of F4(+) ETEC to IPEC-J2 cells and subsequently attenuating F4(+) ETEC-induced mucin layer destruction and suppressing apoptosis. Our data indicate that a selected L. rhamnosus strain interacts with porcine intestinal epithelial cells to maintain the epithelial barrier and promote intestinal epithelial cell activation in response to bacterial infection, thus protecting cells from the deleterious effects of F4(+) ETEC.	[Zhang, Wei; Zhu, Yao-Hong; Yang, Jin-Cai; Yang, Gui-Yan; Zhou, Dong; Wang, Jiu-Feng] China Agr Univ, Coll Vet Med, Dept Vet Clin Sci, Beijing 100094, Peoples R China	China Agricultural University	Wang, JF (corresponding author), China Agr Univ, Coll Vet Med, Dept Vet Clin Sci, Beijing 100094, Peoples R China.	jiufeng_wang@hotmail.com			National Natural Science Foundation of China [31372493, 31472242]; Special Fund for Agro-Scientific Research in the Public Interest (China) [201003060-07, 201403054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest (China)	This work was supported by grants from the National Natural Science Foundation of China (Project Nos. 31372493 and 31472242), and the Special Fund for Agro-Scientific Research in the Public Interest (China; Project Nos. 201003060-07 and 201403054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chen XY, 2014, APPL ENVIRON MICROB, V80, P5752, DOI 10.1128/AEM.01782-14; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Corr SC, 2014, MUCOSAL IMMUNOL, V7, P57, DOI 10.1038/mi.2013.24; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Ey B, 2013, J IMMUNOL, V190, P5676, DOI 10.4049/jimmunol.1201592; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Finamore A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094891; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jensen H, 2014, MICROBIOL-SGM, V160, P671, DOI 10.1099/mic.0.073551-0; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kleta S, 2014, INFECT IMMUN, V82, P1801, DOI 10.1128/IAI.01431-13; Kumar P, 2014, INFECT IMMUN, V82, P500, DOI 10.1128/IAI.01078-13; Kuo IH, 2013, J INVEST DERMATOL, V133, P988, DOI 10.1038/jid.2012.437; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Mathias A, 2010, J BIOL CHEM, V285, P33906, DOI 10.1074/jbc.M110.135111; McLamb BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059838; Mukiza CN, 2013, INFECT IMMUN, V81, P2819, DOI 10.1128/IAI.00455-13; Oppong GO, 2013, INFECT IMMUN, V81, P478, DOI 10.1128/IAI.00453-12; Orlando A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-19; Otte JM, 2009, NUTR CANCER, V61, P103, DOI 10.1080/01635580802372625; Pan Q, 2013, J BIOL CHEM, V288, P5407, DOI 10.1074/jbc.M112.408245; Prince T, 2012, APPL ENVIRON MICROB, V78, P5119, DOI 10.1128/AEM.00595-12; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rieu A, 2014, CELL MICROBIOL, V16, P1836, DOI 10.1111/cmi.12331; Roxas JL, 2007, INFECT IMMUN, V75, P2316, DOI 10.1128/IAI.01690-06; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Seo GS, 2014, BIOCHEM PHARMACOL, V90, P115, DOI 10.1016/j.bcp.2014.05.006; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang LH, 2014, J BIOL CHEM, V289, P20234, DOI 10.1074/jbc.M114.553800; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Yang KM, 2014, J ANIM SCI, V92, P1496, DOI 10.2527/jas.2013-6619; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhu YH, 2014, APPL ENVIRON MICROB, V80, P1787, DOI 10.1128/AEM.03668-13; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	56	44	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125717	10.1371/journal.pone.0125717	http://dx.doi.org/10.1371/journal.pone.0125717			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915861	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100145
J	Hattori, M; Komatsu, S; Noda, H; Matsumoto, Y				Hattori, Makoto; Komatsu, Setsuko; Noda, Hiroaki; Matsumoto, Yukiko			Proteome Analysis of Watery Saliva Secreted by Green Rice Leafhopper, Nephotettix cincticeps	PLOS ONE			English	Article							MOLECULAR-CLONING; BROWN PLANTHOPPER; LONGICORN BEETLE; RUSSIAN WHEAT; PROTEINS; GLANDS; TRANSFERRIN; APHIDS; IDENTIFICATION; PURIFICATION	The green rice leafhopper, Nephotettix cincticeps, is a vascular bundle feeder that discharges watery and gelling saliva during the feeding process. To understand the potential functions of saliva for successful and safe feeding on host plants, we analyzed the complexity of proteinaceous components in the watery saliva of N. cincticeps. Salivary proteins were collected from a sucrose diet that adult leafhoppers had fed on through a membrane of stretched parafilm. Protein concentrates were separated using SDS-PAGE under reducing and non-reducing conditions. Six proteins were identified by a gas-phase protein sequencer and two proteins were identified using LC-MS/MS analysis with reference to expressed sequence tag (EST) databases of this species. Full -length cDNAs encoding these major proteins were obtained by rapid amplification of cDNA ends-PCR (RACE-PCR) and degenerate PCR. Furthermore, gel-free proteome analysis that was performed to cover the broad range of salivary proteins with reference to the latest RNA-sequencing data from the salivary gland of N. cincticeps, yielded 63 additional protein species. Out of 71 novel proteins identified from the watery saliva, about 60% of those were enzymes or other functional proteins, including GH5 cellulase, transferrin, carbonic anhydrases, aminopeptidase, regucalcin, and apolipoprotein. The remaining proteins appeared to be unique and species-specific. This is the first study to identify and characterize the proteins in watery saliva of Auchenorrhyncha species, especially sheath-producing, vascular bundle-feeders.	[Hattori, Makoto; Noda, Hiroaki; Matsumoto, Yukiko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Komatsu, Setsuko] Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Hattori, M (corresponding author), Natl Inst Agrobiol Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	hatto@affrc.go.jp			Kakenhi fund of Japan [25450075]	Kakenhi fund of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Kakenhi fund of Japan (No. 25450075) to MH and YM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; ANDERSEN PC, 1989, ENTOMOL EXP APPL, V50, P149, DOI 10.1007/BF00365399; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; BAUMANN L, 1995, ENTOMOL EXP APPL, V77, P57, DOI 10.1007/BF02383018; Brennan M, 2011, MOL PLANT, V4, P144, DOI 10.1093/mp/ssq067; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; Chino M, 1986, PHLOEM TRANSPORT, P463; Cooper WR, 2011, ENVIRON ENTOMOL, V40, P151, DOI 10.1603/EN10153; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Habibi J, 2001, ENTOMOL EXP APPL, V98, P369, DOI 10.1023/A:1018971827110; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hattori M, 2005, J INSECT PHYSIOL, V51, P1359, DOI 10.1016/j.jinsphys.2005.08.010; Hattori M, 2012, INSECT BIOCHEM MOLEC, V42, P1, DOI 10.1016/j.ibmb.2011.10.001; Hattori M, 2010, INSECT BIOCHEM MOLEC, V40, P331, DOI 10.1016/j.ibmb.2010.02.009; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hirai M, 2000, ARCH INSECT BIOCHEM, V44, P17, DOI 10.1002/(SICI)1520-6327(200005)44:1&lt;17::AID-ARCH3&gt;3.0.CO;2-O; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; JAMROZ RC, 1993, P NATL ACAD SCI USA, V90, P1320, DOI 10.1073/pnas.90.4.1320; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalume DE, 2005, PROTEOMICS, V5, P3765, DOI 10.1002/pmic.200401210; KAWABE S, 1985, JARQ-JPN AGR RES Q, V19, P115; Kawabe S., 1994, KENKYU SEIKA, V295, P52; Kim BY, 2008, COMP BIOCHEM PHYS B, V150, P161, DOI 10.1016/j.cbpb.2008.02.009; Konishi H, 2009, APPL ENTOMOL ZOOL, V44, P525, DOI 10.1303/aez.2009.525; Leopold RA, 2003, ARTHROPOD STRUCT DEV, V32, P189, DOI 10.1016/S1467-8039(03)00047-1; MA R, 1990, J INSECT PHYSIOL, V36, P507, DOI 10.1016/0022-1910(90)90102-L; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; MILES P. W., 1965, J INSECT PHYSIOL, V11, P1261, DOI 10.1016/0022-1910(65)90119-8; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1989, J INSECT PHYSIOL, V35, P865, DOI 10.1016/0022-1910(89)90102-9; MILES PW, 1959, NATURE, V183, P756, DOI 10.1038/183756b0; MILES PW, 1991, ENTOMOL EXP APPL, V59, P123, DOI 10.1007/BF00351957; Moreno A, 2011, ENTOMOL EXP APPL, V139, P145, DOI 10.1111/j.1570-7458.2011.01117.x; NABA K, 1988, JPN J APPL ENTOMOL Z, V32, P31, DOI 10.1303/jjaez.32.31; Naito A, 1964, SHOKUBUTSU BOEKI, V18, P482; Nakamura M, 2013, APPL ENTOMOL ZOOL, V48, P489, DOI 10.1007/s13355-013-0210-6; Nanjo Y, 2013, J PROTEOME RES, V12, P4785, DOI 10.1021/pr4002349; Nicholson SJ, 2014, J PROTEOMICS, V105, P186, DOI 10.1016/j.jprot.2013.12.005; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Noda H, 2012, APPL ENTOMOL ZOOL, V47, P217, DOI 10.1007/s13355-012-0110-1; Ong SE, 2001, BIOMOL ENG, V18, P195, DOI 10.1016/S1389-0344(01)00095-8; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Rao SAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057413; Shi F, 2008, PHYTOCHEMISTRY, V69, P1295, DOI 10.1016/j.phytochem.2008.01.007; SOGAWA K, 1968, Applied Entomology and Zoology, V3, P13; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P13; Sugimura M, 2003, EUR J BIOCHEM, V270, P3455, DOI 10.1046/j.1432-1033.2003.03735.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Vandermoten S, 2014, INSECT MOL BIOL, V23, P67, DOI 10.1111/imb.12061; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Wei YD, 2006, COMP BIOCHEM PHYS B, V145, P220, DOI 10.1016/j.cbpb.2006.07.007; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Yamaguchi M, 2005, INT J MOL MED, V15, P371; Yokoyama R., 2014, BSJ REV, V5, P45; Yoshiga T, 1997, P NATL ACAD SCI USA, V94, P12337, DOI 10.1073/pnas.94.23.12337; Yun EY, 1999, BIOL CHEM, V380, P1455, DOI 10.1515/BC.1999.188	67	40	41	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123671	10.1371/journal.pone.0123671	http://dx.doi.org/10.1371/journal.pone.0123671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909947	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800044
J	Santana, CD; Silva, DDT; Deana, AM; Prates, RA; Souza, AP; Gomes, MT; Sampaio, BPD; Shibuya, JF; Bussadori, SK; Mesquita-Ferrari, RA; Fernandes, KPS; Franca, CM				Santana, Cristiano de Loura; Teixeira Silva, Daniela de Fatima; Deana, Alessandro Melo; Prates, Renato Araujo; Souza, Amanda Pires; Gomes, Mariana Teixeira; de Azevedo Sampaio, Brunna Pileggi; Shibuya, Josiane Ferraretto; Bussadori, Sandra Kalil; Mesquita-Ferrari, Raquel Agnelli; Santos Fernandes, Kristianne Porta; Franca, Cristiane Miranda			Tissue Responses to Postoperative Laser Therapy in Diabetic Rats Submitted to Excisional Wounds	PLOS ONE			English	Article							LEVEL DIODE-LASER; COLLAGEN; CELLS; IRRADIATION; REPAIR; MICE; RED; ANGIOGENESIS; INFLAMMATION; RADIATION	In a previous study about low-level laser therapy biomodulation on a full-thickness burn model we showed that single and fractionated dose regimens increased wound healing and leukocyte influx similarly when compared with untreated control. In order to verify if this finding would be similar in an impaired wound model, we investigated the effect of single and multiple irradiations on wound closure rate, type of inflammatory infiltrate, myofibroblasts, collagen deposition, and optical retardation of collagen in diabetic rats. Female Wistar rats in the same estrous cycle had diabetes induced with streptozotocin and an 8-mm excisional wound performed with a punch. The experimental groups were: control group - untreated ulcer; single-dose group - ulcer submitted to single dose of diode laser therapy (lambda = 660 +/- 2 nm; P = 30 mW; energy density: 4 J/cm(2)) and fractionated-dose group - ulcer submitted to 1 J/cm(2) laser therapy on Days 1, 3, 8, and 10. The ulcers were photographed on the experimental days and after euthanasia tissue samples were routinely processed for histological and immunohistochemistry analyses. Independently of the energy density, laser therapy accelerated wound closure by approximately 40% in the first three days in comparison to the control group. Laser therapy increased acute inflammatory infiltrate until Day 3. Both laser groups exhibited more myofibroblasts and better collagen organization than the control group. The findings demonstrate that low-level laser therapy in the immediate postoperative period can enhance the tissue repair process in a diabetes model. Similar effects were achieved with laser therapy applied a single time with an energy density of 4 J/cm(2) and applied four times with an energy density of 1 J/cm(2). The application of laser therapy in the inflammatory phase was the most important factor to the enhancement of the tissue repair process.	[Santana, Cristiano de Loura; Teixeira Silva, Daniela de Fatima; Deana, Alessandro Melo; Prates, Renato Araujo; Souza, Amanda Pires; Gomes, Mariana Teixeira; de Azevedo Sampaio, Brunna Pileggi; Shibuya, Josiane Ferraretto; Bussadori, Sandra Kalil; Mesquita-Ferrari, Raquel Agnelli; Santos Fernandes, Kristianne Porta; Franca, Cristiane Miranda] Univ Nove de Julho UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, SP, Brazil	Universidade Nove de Julho	Franca, CM (corresponding author), Univ Nove de Julho UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, SP, Brazil.	cristiane321@gmail.com	Ferrari, Raquel/I-4419-2016; Deana, Alessandro M/K-4787-2012; Franca, Cristiane/B-2563-2014; Fernandes, Kristianne Porta Santos/I-4417-2016; Prates, Renato A/F-8235-2014; Bussadori, Sandra/J-5458-2014; da Silva, Daniela de Fátima Teixeira/K-3071-2012	Ferrari, Raquel/0000-0001-5142-9526; Franca, Cristiane/0000-0002-9285-4622; Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; Prates, Renato A/0000-0002-8115-9237; Bussadori, Sandra/0000-0002-9853-1138; da Silva, Daniela de Fátima Teixeira/0000-0002-7228-6146; Deana, Alessandro Melo/0000-0002-0014-6953	State of Sao Paulo Research Foundation (FAPESP), Brazil [2012/01944-0, 2012/02801-8, 2012/03334-4]	State of Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Research Grants # 2012/01944-0 (CMF), 2012/02801-8 (BPAS) and 2012/03334-4 (JAFS) from the State of Sao Paulo Research Foundation (FAPESP), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, DIAB STAT DAT 2011 N; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Chen J, 2005, DIABETES, V54, P2143, DOI 10.2337/diabetes.54.7.2143; Cury V, 2013, J PHOTOCH PHOTOBIO B, V125, P164, DOI 10.1016/j.jphotobiol.2013.06.004; Deana AM, 2013, WOUND REPAIR REGEN, V21, P755, DOI 10.1111/wrr.12085; Dixit Snehil, 2012, Adv Biomed Res, V1, P38, DOI 10.4103/2277-9175.100132; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Firat ET, 2013, PHOTOMED LASER SURG, V31, P315, DOI 10.1089/pho.2012.3406; Franca CM, 2013, LASER MED SCI, V28, P1331, DOI 10.1007/s10103-012-1249-2; Fukuda TY, 2013, LASER MED SCI, V28, P1305, DOI 10.1007/s10103-012-1231-z; Fukuda TY, 2010, LASER SURG MED, V42, P584, DOI 10.1002/lsm.20949; Giannopoulou C, 2012, J PERIODONTOL, V83, P1018, DOI 10.1902/jop.2011.110281; Ribeiro MAG, 2009, PHOTOMED LASER SURG, V27, P49, DOI 10.1089/pho.2007.2215; Houreld NN, 2014, SCI WORLD J, DOI 10.1155/2014/398412; Junker JPE, 2014, WOUND REPAIR REGEN, V22, P2, DOI 10.1111/wrr.12162; Kajagar BM, 2012, INDIAN J SURG, V74, P359, DOI 10.1007/s12262-011-0393-4; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Kataoka M, 2013, BIOCHEM BIOPH RES CO, V430, P1103, DOI 10.1016/j.bbrc.2012.12.030; Kaviani A, 2011, PHOTOMED LASER SURG, V29, P109, DOI 10.1089/pho.2009.2680; Kim BM, 2000, LASER SURG MED, V27, P329, DOI 10.1002/1096-9101(2000)27:4<329::AID-LSM5>3.0.CO;2-C; Leal EC, 2011, LASER MED SCI, V26, P493, DOI 10.1007/s10103-010-0866-x; Buchleitner AM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007315.pub2; Nunez SC, 2013, LASER MED SCI, V28, P633, DOI 10.1007/s10103-012-1105-4; Oberoi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107418; Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011; Peppa M, 2009, WOUND REPAIR REGEN, V17, P461, DOI 10.1111/j.1524-475X.2009.00518.x; Pereira AN, 2002, LASER SURG MED, V31, P263, DOI 10.1002/lsm.10107; Pinto FC, 2010, PEDIATR NEUROSURG, V46, P249, DOI 10.1159/000319363; Ribeiro MS, 2002, J CLIN LASER MED SUR, V20, P37, DOI 10.1089/104454702753474995; Rosado P, 2014, HEAD NECK; Silva DFT, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2187418; Silveira PCL, 2009, J PHOTOCH PHOTOBIO B, V95, P89, DOI 10.1016/j.jphotobiol.2009.01.004; Szymanska J, 2013, J PHYSIOL PHARMACOL, V64, P387; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Silva DFT, 2013, ANN BIOMED ENG, V41, P752, DOI 10.1007/s10439-012-0720-3; VIDAL BD, 1982, HISTOCHEM J, V14, P857, DOI 10.1007/BF01005229; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103348; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	38	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122042	10.1371/journal.pone.0122042	http://dx.doi.org/10.1371/journal.pone.0122042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909480	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800015
J	Teixeira, AL; Dias, F; Ferreira, M; Gomes, M; Santos, JI; Lobo, F; Mauricio, J; Machado, JC; Medeiros, R				Teixeira, Ana L.; Dias, Francisca; Ferreira, Marta; Gomes, Monica; Santos, Juliana I.; Lobo, Francisco; Mauricio, Joaquina; Machado, Jose Carlos; Medeiros, Rui			Combined Influence of EGF+61G > A and TGFB+869T > C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression	PLOS ONE			English	Article							FACTOR EGF POLYMORPHISM; GROWTH-FACTOR-BETA; GENE-EXPRESSION; POOR-PROGNOSIS; SERUM-LEVELS; PROTEIN; CANCER; ASSOCIATION; RESISTANCE; PROMOTES	The epidermal growth factor (EGF) is responsible for the activation of intracellular signal transducers that act on cell-cycle progression, cell motility, angiogenesis and inhibition of apoptosis. However, cells can block these effects activating opposite signaling pathways, such as the transforming growth factor beta 1 (TGF beta 1) pathway. Thus changes in expression levels of EGF and TGFB1 in renal cells might modulate the renal cell carcinoma (RCC) development, in consequence of changes in regulatory elements of signaling networks such as the microRNAs (miRNAs). Our purpose was to investigate the synergic role of EGF+61G>A and TGFB1+869T>C polymorphisms in RCC development. Genetic polymorphisms were studied by allelic discrimination using real-time PCR in 133 RCC patients vs. 443 healthy individuals. The circulating EGF/EGFR-MAPK-related miR-7, miR-221 and miR-222 expression was analyzed by a quantitative real-time PCR in plasma from 22 RCC patients vs. 27 healthy individuals. The intermediate/high genetic proliferation profile patients carriers present a significantly reduced time-to-progression and a higher risk of an early relapse compared with the low genetic proliferation profile carriers (HR = 8.8, P = 0.038) with impact in a lower overall survival (Log rank test, P = 0.047). The RCC patients presented higher circulating expression levels of miR-7 than healthy individuals (6.1-fold increase, P<0.001). Moreover, the intermediate/high genetic proliferation profile carriers present an increase in expression levels of miR-7, miR-221 and miR-222 during the RCC development and this increase is not observed in low genetic proliferation profile (P<0.001, P = 0.004, P<0.001, respectively). The stimulus to angiogenesis, cell-cycle progression and tumoral cells invasion, through activation of EGFR/MAPK signaling pathway in intermediate/high proliferation profile carriers is associated with an early disease progression, resulting in a poor overall survival. We also demonstrated that the intermediate/high proliferation profile is an unfavorable prognostic factor of RCC and miR-7, miR-221 and miR-222 expressions may be useful phenotype biomarkers of EGFR/MAPK activation.	[Teixeira, Ana L.; Dias, Francisca; Gomes, Monica; Santos, Juliana I.; Medeiros, Rui] Portuguese Inst Oncol Porto, Mol Oncol Grp & Virol Pathol, Porto, Portugal; [Teixeira, Ana L.; Dias, Francisca; Gomes, Monica; Santos, Juliana I.; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci ICBAS, P-4100 Porto, Portugal; [Teixeira, Ana L.; Dias, Francisca; Gomes, Monica; Medeiros, Rui] Portuguese League Canc NRNorte, Res Dept, Porto, Portugal; [Ferreira, Marta; Mauricio, Joaquina] Portuguese Inst Oncol Porto, Dept Oncol, Porto, Portugal; [Lobo, Francisco] Portuguese Inst Oncol Porto, Dept Urol, Porto, Portugal; [Machado, Jose Carlos] Univ Porto, Inst Mol Pathol & Immunol IPATIMUP, P-4100 Porto, Portugal; [Machado, Jose Carlos] Univ Porto, Fac Med, P-4100 Porto, Portugal; [Medeiros, Rui] Fernando Pessoa Univ, Fac Hlth Sci, Porto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Universidade Fernando Pessoa	Medeiros, R (corresponding author), Portuguese Inst Oncol Porto, Mol Oncol Grp & Virol Pathol, Porto, Portugal.	ruimedei@ipoporto.min-saude.pt	Teixeira, Ana Luísa/ABB-3437-2020; Dias, Francisca/AAH-4148-2021; Dias, Francisca/P-1272-2018; Medeiros, Rui/C-7938-2009; Machado, Jose Carlos/C-5907-2009	Dias, Francisca/0000-0002-4993-4467; Dias, Francisca/0000-0002-4993-4467; Medeiros, Rui/0000-0003-3010-8373; Machado, Jose Carlos/0000-0003-4741-8415; Gomes, Monica/0000-0001-9947-5775; Teixeira, Ana L/0000-0002-7489-2211; Santos, Juliana Ines/0000-0001-8613-6942	Liga Portuguesa Contra o Cancro-Centro Regional do Norte (Portuguese League Against Cancer); FCT -Fundacao para a Ciencia e Tecnologia; FCT [SFRH/BD/47381/2008]; AstraZeneca Foundation	Liga Portuguesa Contra o Cancro-Centro Regional do Norte (Portuguese League Against Cancer); FCT -Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); AstraZeneca Foundation(AstraZeneca)	The authors would like to thank the Liga Portuguesa Contra o Cancro-Centro Regional do Norte (Portuguese League Against Cancer) and FCT -Fundacao para a Ciencia e Tecnologia. ALT is a Doctoral degree grant holder from FCT (SFRH/BD/47381/2008). This project was partially sponsored by an unrestricted educational grant for basic research in Molecular Oncology from AstraZeneca Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gallego GA, 2012, INT J MOL SCI, V13, P12710, DOI 10.3390/ijms131012710; Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Avraham R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000876; Bex A, 2010, EUR UROL, V58, P819, DOI 10.1016/j.eururo.2010.08.029; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Brannon A Rose, 2010, Genes Cancer, V1, P152; Brooks SA, 2014, EUR UROL, V25; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dias F, 2013, PHARMACOGENOMICS, V14, P1793, DOI 10.2217/pgs.13.184; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fukasawa H, 2010, INT J CANCER, V127, P1517, DOI 10.1002/ijc.25164; Hegele A, 2002, UROL RES, V30, P126, DOI 10.1007/s00240-002-0245-6; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Kominsky SL, 2007, J BONE MINER RES, V22, P37, DOI 10.1359/JBMR.061005; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lanuti M, 2008, CLIN CANCER RES, V14, P3216, DOI 10.1158/1078-0432.CCR-07-4932; Liang L, 2012, ONCOL REP, V28, P999, DOI 10.3892/or.2012.1874; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lu X, 2010, BRIT J CANCER, V102, P457, DOI 10.1038/sj.bjc.6605490; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mitropoulos D, 2004, UROL RES, V32, P317, DOI 10.1007/s00240-003-0360-z; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; O-charoenrat P, 2000, CANCER RES, V60, P1121; Ravaud A, 2008, EUR UROL, V54, P315, DOI 10.1016/j.eururo.2008.04.056; Ravaud A, 2012, CANCER TREAT REV, V38, P996, DOI 10.1016/j.ctrv.2012.01.003; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-18; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah MY, 2011, GENOME MED, V3, DOI 10.1186/gm272; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Smaldone MC, 2009, UROL ONCOL-SEMIN ORI, V27, P238, DOI 10.1016/j.urolonc.2007.12.001; Teixeira AL, 2013, TUMOR BIOL, V31, P31; Teixeira AL, 2008, CLIN CANCER RES, V14, P3367, DOI 10.1158/1078-0432.CCR-07-5119; Teixeira AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072419; Teixeira Ana L., 2012, Frontiers in Genetics, V3, P286, DOI 10.3389/fgene.2012.00286; Villaamil VM, 2012, J MOL SIGNAL, V7, P1750; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Yu Z, 2013, J MOL HISTOL, V21, P21; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-119; Zhang Y, 2012, CANCER SCI, V103, P1084, DOI 10.1111/j.1349-7006.2012.02265.x; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023936; Zhu J, 2010, J HUM GENET, V55, P236, DOI 10.1038/jhg.2010.12	48	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0103258	10.1371/journal.pone.0103258	http://dx.doi.org/10.1371/journal.pone.0103258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909813	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800001
J	Fiser, C; Lustrik, R; Sarbu, S; Flot, JF; Trontelj, P				Fiser, Cene; Lustrik, Roman; Sarbu, Serban; Flot, Jean-Francois; Trontelj, Peter			Morphological Evolution of Coexisting Amphipod Species Pairs from Sulfidic Caves Suggests Competitive Interactions and Character Displacement, but No Environmental Filtering and Convergence	PLOS ONE			English	Article							NIPHARGUS CRUSTACEA; LIMITING SIMILARITY; PARALLEL EVOLUTION; FRASASSI CAVES; BODY-SIZE; DIVERSITY; FISH; IMPROVEMENT; HABITAT; TRAITS	Phenotypically similar species coexisting in extreme environments like sulfidic water are subject to two opposing eco-evolutionary processes: those favoring similarity of environmentspecific traits, and those promoting differences of traits related to resource use. The former group of processes includes ecological filtering and convergent or parallel evolution, the latter competitive exclusion, character displacement and divergent evolution. We used a unique eco-evolutionary study system composed of two independent pairs of coexisting amphipod species (genus Niphargus) from the sulfidic caves Movile in Romania and Frasassi in Italy to study the relative contribution and interaction of both processes. We looked at the shape of the multifunctional ventral channel as a trait ostensibly related to oxygenation and sulfide detoxification, and at body size as a resource-related trait. Phylogenetic analysis suggests that the sulfidic caves were colonized separately by ancestors of each species. Species within pairs were more dissimilar in their morphology than expected according to a null model based on regional species pool. This might indicate competitive interactions shaping the morphology of these amphipod species. Moreover, our results suggest that the shape of the ventral channel is not subject to long-term convergent selection or to the process of environmental filtering, and as such probably does not play a role in sulfide tolerance. Nevertheless, the ancestral conditions reconstructed using the comparative method tended to be more similar than null-model expectations. This shift in patterns may reflect a temporal hierarchy of ecoevolutionary processes, in which initial environmental filtering became later on superseded by character displacement or other competition-driven divergent evolutionary processes.	[Fiser, Cene; Lustrik, Roman; Trontelj, Peter] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia; [Sarbu, Serban] Grp Explorari Subacvatice & Speol, Bucharest, Romania; [Flot, Jean-Francois] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Trontelj, Peter] Humboldt Univ, Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, D-10115 Berlin, Germany	University of Ljubljana; University of London; University College London; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Fiser, C (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana 1000, Slovenia.	cene.fiser@bf.uni-lj.si		Flot, Jean-Francois/0000-0003-4091-7916; sarbu, serban m/0000-0001-8126-7193	Slovenian Research Agency Program [P1-0184]; European Research Council [ERC-2012-AdG 322790]	Slovenian Research Agency Program(Slovenian Research Agency - Slovenia); European Research Council(European Research Council (ERC)European Commission)	The research was partially funded by the Slovenian Research Agency Program P1-0184 (CF and PT); JFF is supported by the European Research Council (ERC-2012-AdG 322790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauermeister J, 2013, INT J SPELEOL, V42, P141, DOI 10.5038/1827-806X.42.2.6; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; DAHL E, 1977, ZOOL SCR, V6, P221; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fiser C, 2008, ZOOL SCR, V37, P665, DOI 10.1111/j.1463-6409.2008.00347.x; Fiser C, 2008, ORG DIVERS EVOL, V8, P146, DOI 10.1016/j.ode.2007.06.002; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2009, ZOOTAXA, P1; Flot JF, 2014, MOL ECOL, V23, P1405, DOI 10.1111/mec.12461; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-171; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Hervant F, 1998, J CRUSTACEAN BIOL, V18, P717, DOI 10.2307/1549148; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Latella Leonardo, 1999, Memoires de Biospeologie, V26, P131; Lawniczak M, 2013, COMP BIOCHEM PHYS A, V165, P299, DOI 10.1016/j.cbpa.2013.03.028; LOSOS JB, 1995, PHILOS T ROY SOC B, V349, P69, DOI 10.1098/rstb.1995.0092; Malard F, 2012, ENCY CAVES, P651; Martin RA, 2009, AM NAT, V174, P268, DOI 10.1086/600090; Martins E. P., 2004, COMPARE VERSION 4 6B; Moen DS, 2009, EVOLUTION, V63, P3228, DOI 10.1111/j.1558-5646.2009.00810.x; Mouchet MA, 2013, OIKOS, V122, P247, DOI 10.1111/j.1600-0706.2012.20411.x; NICHOLLS P, 1975, BIOCHIM BIOPHYS ACTA, V396, P24, DOI 10.1016/0005-2728(75)90186-3; Niphargus Fiser C., 2012, ENCY CAVES, P555; Olson SL, 2010, BIOL LETTERS, V6, P807, DOI 10.1098/rsbl.2010.0423; Pfenninger M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4873; Plath M, 2007, NATURWISSENSCHAFTEN, V94, P991, DOI 10.1007/s00114-007-0279-2; R Development Core Team, 2014, R LANG ENV STAT COMP; Rabosky DL, 2007, OECOLOGIA, V154, P561, DOI 10.1007/s00442-007-0849-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruffo S, 2005, MEMOIRE MUSEO CIVICO; Sarbu SM, 2000, ECOSY WORLD, V30, P319; Sarbu SM, 2000, ECOSY WORLD, V30, P359; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SKET B, 1981, Bioloski Vestnik, V29, P87; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Tobler M, 2006, EXTREMOPHILES, V10, P577, DOI 10.1007/s00792-006-0531-2; Tobler M, 2014, COMP BIOCHEM PHYS A, V175, P7, DOI 10.1016/j.cbpa.2014.04.012; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vergnon R, 2013, AM NAT, V182, P67, DOI 10.1086/670589; Weiher E, 2011, PHIL T R SOC B, V366; Wiens JJ, 2008, ECOL LETT, V11, P1004, DOI 10.1111/j.1461-0248.2008.01238.x; Wilson JB, 2012, J ECOL, V100, P210, DOI 10.1111/j.1365-2745.2011.01891.x; Zagmajster M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1135, DOI 10.1111/geb.12200	61	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123535	10.1371/journal.pone.0123535	http://dx.doi.org/10.1371/journal.pone.0123535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905793	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000034
J	Yang, H; Long, F; Zhang, Y; Yu, R; Zhang, P; Li, W; Li, S; Jin, X; Xia, J; Dong, L; Zhu, N; Huang, Y; Gong, Y; Chen, X				Yang, Haihua; Long, Feng; Zhang, Youzhi; Yu, Ronghuan; Zhang, Peng; Li, Wenjing; Li, Shuijun; Jin, Xianqiao; Xia, Jingwen; Dong, Liang; Zhu, Ning; Huang, Ying; Gong, Yi; Chen, Xiaodong			1 alpha,25-Dihydroxyvitamin D3 Induces Neutrophil Apoptosis through the p38 MAPK Signaling Pathway in Chronic Obstructive Pulmonary Disease Patients	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; VITAMIN-D; SYSTEMIC INFLAMMATION; COPD; ASTHMA; EXACERBATION	Background Reduced neutrophil apoptosis plays an important role in the pathogenesis of acute exacerbation chronic obstructive pulmonary disease (AECOPD). The p38 mitogen-activated protein kinase (MAPK) signaling pathway is involved in neutrophil apoptosis. 1 alpha,25-Dihydroxyvitamin D3 (1 alpha,25VitD3) can induce tumor cell apoptosis. The aim of this study was to assess the effects of 1 alpha,25VitD3 on peripheral blood neutrophil apoptosis in AECOPD and examine the role of the p38 MAPK signaling pathway. Methods The study enrolled 36 AECOPD patients and 36 healthy volunteers. Venous blood samples were obtained from both groups. Serum 25-hydroxyvitamin D (25-(OH) D) levels in peripheral venous blood were assayed using liquid chromatography-tandem mass spectrometry (LC-MS/MS); the neutrophils were separated and cultured with SB203580 (a p38 inhibitor) and 1 alpha,25VitD3. Neutrophil apoptosis was measured using flow cytometry, and phosphop-38 MAPK protein expression was detected by Western blot. Statistical analysis was performed using analysis of variance. Student's t-test and Pearson's correlation coefficient were used for the between-group differences and correlation analysis, respectively. Results The 25-(OH) D levels were lower in AECOPD patients than in healthy controls, and the peripheral blood neutrophil apoptosis results were similar. 1 alpha,25VitD3 increased the apoptosis rate and the level of phospho-p38 MAPK in peripheral blood neutrophils of AECOPD patients. SB203580 partly inhibited 1 alpha,25VitD3-induced peripheral blood neutrophil apoptosis and phospho-p38 MAPK overexpression. The 25-(OH) D levels were positively correlated with increased peripheral blood neutrophil apoptosis and phospho-p38 MAPK levels. In addition, expression of the phospho-p38 MAPK protein was also positively correlated with peripheral blood neutrophil apoptosis. Conclusion Our results suggest that 1 alpha,25VitD3 induces peripheral blood neutrophil apoptosis through the p38 MAPK signaling pathway in AECOPD patients.	[Yang, Haihua; Long, Feng; Zhang, Youzhi; Zhang, Peng; Li, Wenjing] Fudan Univ, Dept Resp Med, Huashan Hosp North, Shanghai 200433, Peoples R China; [Yu, Ronghuan; Huang, Ying] Xuhui Cent Hosp, Dept Resp Med, Shanghai, Peoples R China; [Li, Shuijun] Xuhui Cent Hosp, Dept Cent Lab, Shanghai, Peoples R China; [Jin, Xianqiao; Xia, Jingwen; Dong, Liang; Zhu, Ning; Gong, Yi; Chen, Xiaodong] Fudan Univ, Huashan Hosp, Dept Resp Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Gong, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Resp Med, Shanghai 200433, Peoples R China.	gongyi1978@hotmail.com; xiaodongchendoctor@163.com			Shanghai Municipal commission of Health and Family Planning of the Youth Scientific Research Project [20134Y003]; Xuhui District Center Hospital Project [2012XHCH07]; Huashan Hospital Project	Shanghai Municipal commission of Health and Family Planning of the Youth Scientific Research Project; Xuhui District Center Hospital Project; Huashan Hospital Project	This study was supported by 20000 yuan, http://www.wsjsw.gov.cn/wsj/n429/n432/n1487/n1508/userobject1ai123523.html, Shanghai Municipal commission of Health and Family Planning of the Youth Scientific Research Project, 20134Y003; 50000 yuan, 2012XHCH07 from Xuhui District Center Hospital Project; 10000 yuan, Huashan Hospital Project. The projects funding receiver is Haihua Yang. The funders had no role in study design, collection and analysis, decision to publish, or preparation of the manuscript.	Berg I, 2013, RESP MED, V107, P1578, DOI 10.1016/j.rmed.2013.05.010; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Carboni I, 2012, CLIN TER, V163, pE441; Chen Tai C, 2011, ISRN Urol, V2011, P301490, DOI 10.5402/2011/301490; Chiang KC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/310872; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Finklea JD, 2011, ADV NUTR, V2, P244, DOI 10.3945/an.111.000398; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gaffey K, 2013, EUR RESPIR J, V42, P28, DOI 10.1183/09031936.00170711; de Tena JG, 2014, ARCH BRONCONEUMOL, V50, P179, DOI 10.1016/j.arbres.2013.11.023; Herr C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-31; Hirsch D, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/598345; Hoenderdos K, 2013, AM J RESP CELL MOL, V48, P531, DOI 10.1165/rcmb.2012-0492TR; Janssens W, 2009, AM J RESP CRIT CARE, V179, P630, DOI 10.1164/rccm.200810-1576PP; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006/clim.2000.4998; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; Oudijk EJD, 2003, EUR RESPIR J, V22, p5S, DOI 10.1183/09031936.03.00004603a; Oudijk EJD, 2006, RESP MED, V100, P1791, DOI 10.1016/j.rmed.2006.01.022; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Pletz MWR, 2004, EUR RESPIR J, V23, P532, DOI 10.1183/09031936.04.00089004; Ratcliffe MJ, 2012, BMC PHARMACOL TOXICO, V13, DOI 10.1186/2050-6511-13-15; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; TESTA U, 1994, CANCER RES, V54, P4508; Vestbo J, 2012, CLIN RESPIR J, V6, P208, DOI 10.1111/crj.12002; Vestbo Jorgen, 2012, Zhonghua Yi Xue Za Zhi, V92, P937	26	19	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0120515	10.1371/journal.pone.0120515	http://dx.doi.org/10.1371/journal.pone.0120515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905635	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000005
J	Zhang, X; An, LJ; Nguyen, TH; Liang, H; Wang, R; Liu, XY; Li, TH; Qi, YF; Yu, F				Zhang, Xiang; An, Lijun; Thi Hung Nguyen; Liang, Huike; Wang, Rui; Liu, Xiayan; Li, Tianhong; Qi, Yafei; Yu, Fei			The Cloning and Functional Characterization of Peach CONSTANS and FLOWERING LOCUS T Homologous Genes PpCO and PpFT	PLOS ONE			English	Article							FLORAL INDUCTION; FT PROTEIN; TRANSCRIPTION FACTOR; ARABIDOPSIS; TIME; SIGNAL; INTEGRATION; INITIATION; REPRESSOR; PHLOEM	Flowering is an essential stage of plant growth and development. The successful transition to flowering not only ensures the completion of plant life cycles, it also serves as the basis for the production of economically important seeds and fruits. CONSTANS (CO) and FLOWERING LOCUS T (FT) are two genes playing critical roles in flowering time control in Arabidopsis. Through homology-based cloning and rapid-amplifications of cDNA ends (RACE), we obtained full-lengths cDNA sequences of Prunus Persica CO (PpCO) and Prunus Persica FT(PpFT) from peach (Prunus persica (L.) Batsch) and investigated their functions in flowering time regulation. PpCO and PpFT showed high homologies to Arabidopsis CO and FT at DNA, mRNA and protein levels. We showed that PpCO and PpFT were nucleus-localized and both showed transcriptional activation activities in yeast cells, consistent with their potential roles as transcription activators. Moreover, we established that the over-expression of PpCO could restore the late flowering phenotype of the Arabidopsis co-2 mutant, and the late flowering defect of the Arabidopsis ft-1 mutant can be rescued by the overexpression of PpFT, suggesting functional conservations of CO and FT genes in peach and Arabidopsis. Our results suggest that PpCO and PpFT are homologous genes of CO and FT in peach and they may function in regulating plant flowering time.	[Zhang, Xiang; An, Lijun; Thi Hung Nguyen; Liang, Huike; Wang, Rui; Liu, Xiayan; Qi, Yafei; Yu, Fei] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Xiang; An, Lijun; Thi Hung Nguyen; Liang, Huike; Wang, Rui; Liu, Xiayan; Qi, Yafei; Yu, Fei] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Li, Tianhong] China Agr Univ, Coll Agron & Biotechnol, Dept Fruit Sci, Beijing 100193, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; China Agricultural University	Yu, F (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.	flyfeiyu@gmail.com		Wang, Rui/0000-0002-6196-0780	National Natural Science Foundation of China [31071073, 31170219, 31100864, 31300988, 31470290]; Natural Science Foundation of Shaanxi Province, China [2011JQ3004, 2012JQ3015, 2013JQ3014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by funds from the National Natural Science Foundation of China (31071073, 31170219 to F.Y., 31100864 to X.L., 31300988 to Y.Q. and 31470290 to L.A.), and by grants from the Natural Science Foundation of Shaanxi Province, China (2011JQ3004 to X.L., 2012JQ3015 to Y.Q. and 2013JQ3014 to L.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Arus Pere, 2007, P357, DOI 10.1007/978-1-4020-6297-1_14; Blazquez MA, 2005, SCIENCE, V309, P1024, DOI 10.1126/science.1117203; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Chen J, 2012, GENE, V496, P110, DOI 10.1016/j.gene.2012.01.008; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Fukuda M, 2011, J PLANT PHYSIOL, V168, P1602, DOI 10.1016/j.jplph.2011.02.004; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Huang GW, 2011, PLANT MOL BIOL REP, V29, P352, DOI 10.1007/s11105-010-0240-y; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Laurie RE, 2011, PLANT PHYSIOL, V156, P2207, DOI 10.1104/pp.111.180182; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Milec Z, 2014, BIOTECHNOL ADV, V32, P200, DOI 10.1016/j.biotechadv.2013.09.008; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Tan FC, 2006, PHYSIOL PLANTARUM, V128, P8, DOI 10.1111/j.1399-3054.2006.00724.x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; WHITESIDE ST, 1993, J CELL SCI, V104, P949; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; ZEEVAART JAD, 1977, PLANT PHYSIOL, V60, P747, DOI 10.1104/pp.60.5.747; Zhang JX, 2011, ACTA PHYSIOL PLANT, V33, P409, DOI 10.1007/s11738-010-0560-4	43	11	13	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124108	10.1371/journal.pone.0124108	http://dx.doi.org/10.1371/journal.pone.0124108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905637	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000059
J	Li, J; Yu, Q; Ahooghalandari, P; Gribble, FM; Reimann, F; Tengholm, A; Gylfe, E				Li, Jia; Yu, Qian; Ahooghalandari, Parvin; Gribble, Fiona M.; Reimann, Frank; Tengholm, Anders; Gylfe, Erik			Submembrane ATP and Ca2+ kinetics in alpha-cells: unexpected signaling for glucagon secretion	FASEB JOURNAL			English	Article						oscillations; islet of Langerhans; signal transduction; paracrine	BETA-CELLS; PULSATILE INSULIN; SOMATOSTATIN RECEPTOR; CYTOPLASMIC CA2+; INTACT ISLETS; DELTA-CELLS; GLUCOSE; OSCILLATIONS; RELEASE; CHANNELS	Cytoplasmic ATP and Ca2+ are implicated in current models of glucose's control of glucagon and insulin secretion from pancreatic alpha- and beta-cells, respectively, but little is known about ATP and its relation to Ca2+ in alpha-cells. We therefore expressed the fluorescent ATP biosensor Perceval in mouse pancreatic islets and loaded them with a Ca2+ indicator. With total internal reflection fluorescence microscopy, we recorded subplasma membrane concentrations of Ca2+ and ATP ([Ca2+](pm); [ATP](pm)) in superficial alpha- and beta-cells of intact islets and related signaling to glucagon and insulin secretion by immunoassay. Consistent with ATP's controlling glucagon and insulin secretion during hypo- and hyperglycemia, respectively, the dose-response relationship for glucoseinduced [ATP](pm) generation was left shifted in alpha-cells compared to beta-cells. Both cell types showed [Ca2+](pm) and [ATP](pm) oscillations in opposite phase, probably reflecting energy-consuming Ca2+ transport. Although pulsatile insulin and glucagon release are in opposite phase, [Ca2+](pm) synchronized in the same phase between alpha- and beta-cells. This paradox can be explained by the overriding of Ca2+ stimulation by paracrine inhibition, because somatostatin receptor blockade potently stimulated glucagon release with little effect on Ca2+. The data indicate that an alpha-cell-intrinsic mechanism controls glucagon in hypoglycemia and that paracrine factors shape pulsatile secretion in hyperglycemia.	[Li, Jia; Yu, Qian; Ahooghalandari, Parvin; Tengholm, Anders; Gylfe, Erik] Uppsala Univ, Dept Med Cell Biol, SE-75123 Uppsala, Sweden; [Gribble, Fiona M.; Reimann, Frank] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England	Uppsala University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gylfe, E (corresponding author), Uppsala Univ, Dept Med Cell Biol, BMC Box 571, SE-75123 Uppsala, Sweden.	erik.gylfe@mcb.uu.se		Gribble, Fiona/0000-0002-4232-2898; YU, QIAN/0000-0003-4888-9446; Reimann, Frank/0000-0001-9399-6377	European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Novo Nordisk Foundation; Swedish Diabetes Association; Swedish Research Council [67X-14643, 67P-21262, 325-2012-6778, 12X-6240]; MRC [MC_UU_12012/3] Funding Source: UKRI; Medical Research Council [MC_UU_12012/3] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010363] Funding Source: researchfish; European Foundation for the Study of Diabetes [MSD 2014_2] Funding Source: researchfish	European Foundation for the Study of Diabetes/MSD; Family Ernfors Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	The authors thank Dr. Limin Yang for implementing the MATLAB routine for asymmetric sliding-filament cross-correlation and Dr. Oleg Dyachok for advice regarding the implementation. This work was supported by grants from the European Foundation for the Study of Diabetes/MSD, the Family Ernfors Foundation, the Novo Nordisk Foundation, the Swedish Diabetes Association and Grants 67X-14643, 67P-21262, 325-2012-6778, and 12X-6240 from the Swedish Research Council.	Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Backer A., ASYMMETRIC SLIDING W; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Bavamian S, 2007, DIABETES OBES METAB, V9, P118, DOI 10.1111/j.1463-1326.2007.00780.x; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Bode HP, 1999, PFLUG ARCH EUR J PHY, V437, P324, DOI 10.1007/s004240050786; Braun M, 2014, VITAM HORM, V95, P165, DOI 10.1016/B978-0-12-800174-5.00007-7; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; GOODNER CJ, 1977, SCIENCE, V195, P177, DOI 10.1126/science.401543; GOODNER CJ, 1988, DIABETES, V37, P1316, DOI 10.2337/diabetes.37.10.1316; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; Gylfe E, 2014, DIABETES RES CLIN PR, V103, P1, DOI 10.1016/j.diabres.2013.11.019; Hellman B, 2012, BIOCHEM BIOPH RES CO, V417, P1219, DOI 10.1016/j.bbrc.2011.12.113; Hellman B, 2009, ENDOCRINOLOGY, V150, P5334, DOI 10.1210/en.2009-0600; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kailey B, 2012, AM J PHYSIOL-ENDOC M, V303, pE1107, DOI 10.1152/ajpendo.00207.2012; KLAFF LJ, 1987, DIABETES, V36, P592, DOI 10.2337/diabetes.36.5.592; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; Le Marchand SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047084; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Leclerc I, 2011, DIABETOLOGIA, V54, P125, DOI 10.1007/s00125-010-1929-z; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x; MATTHEWS DR, 1987, BIOCHEM SOC T, V15, P1021, DOI 10.1042/bst0151021; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; OSTENSON CG, 1979, DIABETOLOGIA, V17, P325, DOI 10.1007/BF01235889; Parker HE, 2012, DIABETOLOGIA, V55, P2445, DOI 10.1007/s00125-012-2585-2; Ramracheya R, 2010, DIABETES, V59, P2198, DOI 10.2337/db09-1505; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rohrer S, 2012, J CLIN ENDOCR METAB, V97, pE791, DOI 10.1210/jc.2011-3439; Rui CX, 2013, DIABETES, V62, P1612, DOI 10.2337/db12-0347; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014	53	47	49	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3379	3388		10.1096/fj.14-265918	http://dx.doi.org/10.1096/fj.14-265918			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911612	Green Published			2022-12-26	WOS:000358796900025
J	Puto, LA; Brognard, J; Hunter, T				Puto, Lorena A.; Brognard, John; Hunter, Tony			Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; biomarker; cell death; prostate cancer; tumor cell biology; tumor promoter; tumor suppressor gene; DAXX	DOMAIN-ASSOCIATED PROTEIN; CELL-LINES; TUMOR SUPPRESSION; LUNG-TUMORS; BECLIN 1; CARCINOMA; APOPTOSIS; PROGRESSION; INHIBITION; EXPRESSION	Background: Transcriptional repressor DAXX suppresses several tumor suppressor genes and is up-regulated in many cancers. Results: We demonstrate that DAXX has potent growth-enhancing effects on primary prostatic malignancy through inhibition of autophagy. Conclusion: In the early stages of tumorigenesis, autophagy suppresses prostate tumor formation. Significance: This is the first study to link prostate cancer development to autophagy suppression by DAXX. The DAXX transcriptional repressor was originally associated with apoptotic cell death. However, recent evidence that DAXX represses several tumor suppressor genes, including the DAPK1 and DAPK3 protein kinases, and is up-regulated in many cancers argues that a pro-survival role may predominate in a cancer context. Here, we report that DAXX has potent growth-enhancing effects on primary prostatic malignancy through inhibition of autophagy. Through stable gene knockdown and mouse subcutaneous xenograft studies, we demonstrate that DAXX promotes tumorigenicity of human ALVA-31 and PC3 prostate cancer (PCa) cells in vivo. Importantly, DAXX represses expression of essential autophagy modulators DAPK3 and ULK1 in vivo, revealing autophagy suppression as a mechanism through which DAXX promotes PCa tumorigenicity. Furthermore, DAXX knockdown increases autophagic flux in cultured PCa cells. Finally, interrogation of the Oncomine(TM) database suggests that DAXX overexpression is associated with malignant transformation in several human cancers, including prostate and pancreatic cancers. Thus, DAXX may represent a new cancer biomarker for the detection of aggressive disease, whose tissue-specific down-regulation can serve as an improved therapeutic modality. Our results establish DAXX as a pro-survival protein in PCa and reveal that, in the early stages of tumorigenesis, autophagy suppresses prostate tumor formation.	[Puto, Lorena A.; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Brognard, John] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England	Salk Institute; Cancer Research UK; University of Manchester	Hunter, T (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu	PUTO, LORENA A./ABB-6941-2021; Brognard, John/T-5099-2019	Brognard, John/0000-0002-9243-6615	National Institutes of Health, NCI [CA14195, CA082683, 5T32CA009523-28]; Department of Defense [DoD-W81XWH-08-1-0209]; Cancer Research UK Manchester Institute; Cancer Research UK [12936] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA014195, T32CA009523, R01CA082683] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Cancer Research UK Manchester Institute; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA14195 and CA082683 (to T. H.) and Fellowship 5T32CA009523-28 (to L. A. P.). This work was also supported by Department of Defense Prostate Cancer Research Program Fellowship DoD-W81XWH-08-1-0209 (to L. A. P.) and a grant from the Cancer Research UK Manchester Institute (to J. B.).	Chang MA, 2014, PROSTATE, V74, P149, DOI 10.1002/pros.22737; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Festuccia C, 2005, ENDOCR-RELAT CANCER, V12, P983, DOI 10.1677/erc.1.00986; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo Jinjin, 2010, Genes Cancer, V1, P836, DOI 10.1177/1947601910381645; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Horvilleur E, 2014, LEUKEMIA, V28, P1092, DOI 10.1038/leu.2013.295; Hostanska K, 2005, ANTICANCER RES, V25, P139; Jenkins RB, 1997, CANCER RES, V57, P524; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kitanaka C, 2002, J NATL CANCER I, V94, P358; Kohli L, 2013, AUTOPHAGY, V9, P1438, DOI 10.4161/auto.25837; Kwan PS, 2013, CARCINOGENESIS, V34, P750, DOI 10.1093/carcin/bgs391; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu XD, 2015, ONCOGENE, V34, P2450, DOI 10.1038/onc.2014.199; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; LOOP SM, 1993, PROSTATE, V22, P93, DOI 10.1002/pros.2990220202; LOWE BA, 1988, J UROLOGY, V140, P1340, DOI 10.1016/S0022-5347(17)42039-8; Magee JA, 2001, CANCER RES, V61, P5692; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; MOUL JW, 1992, PROSTATE, V20, P327, DOI 10.1002/pros.2990200407; Ouyang DY, 2013, AUTOPHAGY, V9, P20, DOI 10.4161/auto.22397; Pan WW, 2013, J BIOL CHEM, V288, P13620, DOI 10.1074/jbc.M112.446369; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Puissant A, 2012, AM J CANCER RES, V2, P397; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Puto Lorena A, 2015, Oncoscience, V2, P362; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sakurai T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0701-x; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tsourlakis MC, 2013, HUM PATHOL, V44, P1789, DOI 10.1016/j.humpath.2013.01.022; Tsuji T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009885; Ueno T, 2008, AUTOPHAGY, V4, P692, DOI 10.4161/auto.6085; van Bokhoven A, 2001, PROSTATE, V47, P36; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Welsh JB, 2001, CANCER RES, V61, P5974; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zizzi A, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-111	60	27	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15406	15420		10.1074/jbc.M115.658765	http://dx.doi.org/10.1074/jbc.M115.658765			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25903140	Green Published, hybrid			2022-12-26	WOS:000356527400009
J	Chojnacka, M; Gornicka, A; Oeljeklaus, S; Warscheid, B; Chacinska, A				Chojnacka, Magdalena; Gornicka, Agnieszka; Oeljeklaus, Silke; Warscheid, Bettina; Chacinska, Agnieszka			Cox17 Protein Is an Auxiliary Factor Involved in the Control of the Mitochondrial Contact Site and Cristae Organizing System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE PROTEINS; CYTOCHROME-C-OXIDASE; INNER-MEMBRANE; MITOFILIN COMPLEXES; OUTER-MEMBRANE; YEAST; BIOGENESIS; ORGANIZATION; ARCHITECTURE; MORPHOLOGY	The mitochondrial contact site and cristae organizing system (MICOS) is a recently discovered protein complex that is crucial for establishing and maintaining the proper inner membrane architecture and contacts with the outer membrane of mitochondria. The ways in which the MICOS complex is assembled and its integrity is regulated remain elusive. Here, we report a direct link between Cox17, a protein involved in the assembly of cytochrome c oxidase, and the MICOS complex. Cox17 interacts with Mic60, thereby modulating MICOS complex integrity. This interaction does not involve Sco1, a partner of Cox17 in transferring copper ions to cytochrome c oxidase. However, the Cox17-MICOS interaction is regulated by copper ions. We propose that Cox17 is a newly identified factor involved in maintaining the architecture of the MICOS complex.	[Chojnacka, Magdalena; Gornicka, Agnieszka; Chacinska, Agnieszka] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Dept Biochem & Funct Prote, Inst Biol 2, Fac Biol, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Freiburg; University of Freiburg	Chacinska, A (corresponding author), Int Inst Mol & Cell Biol, Lab Mitochondrial Biogenesis, Ks Trojdena 4, PL-02109 Warsaw, Poland.	achacinska@iimcb.gov.pl		Warscheid, Bettina/0000-0001-5096-1975	National Science Centre (NCN) [2011/02/B/NZ2/01402]; Foundation for Polish Science - Welcome Programme; European Union (EU) within the European Regional Development Fund; Welcome Programme; Deutsche Forschungsgemeinschaft (DFG); Excellence Initiative of the German Federal Government Centre for Biological Signalling Studies (EXC 294) [EXC 294 BIOSS]; Excellence Initiative of the German State Government Centre for Biological Signalling Studies (EXC 294) [EXC 294 BIOSS]	National Science Centre (NCN); Foundation for Polish Science - Welcome Programme; European Union (EU) within the European Regional Development Fund; Welcome Programme; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government Centre for Biological Signalling Studies (EXC 294); Excellence Initiative of the German State Government Centre for Biological Signalling Studies (EXC 294)	This work was supported by a National Science Centre (NCN) grant (2011/02/B/NZ2/01402) and the Foundation for Polish Science - Welcome Programme co-financed by the European Union (EU) within the European Regional Development Fund. This work was also supported by stipends within the Welcome Programme (to M. C. and A. G.) and the Deutsche Forschungsgemeinschaft (DFG) and Excellence Initiative of the German Federal and State Governments Grant EXC 294 BIOSS Centre for Biological Signalling Studies (EXC 294) (to B. W.).	Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bottinger L, 2012, MOL BIOL CELL, V23, P3957, DOI 10.1091/mbc.E12-05-0358; Bohnert M, 2012, MOL BIOL CELL, V23, P3948, DOI 10.1091/mbc.E12-04-0295; Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Harner ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01684; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Korner C, 2012, MOL BIOL CELL, V23, P2143, DOI 10.1091/mbc.E11-10-0831; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Rigby K, 2008, J BIOL CHEM, V283, P15015, DOI 10.1074/jbc.M710072200; SIKORSKI RS, 1989, GENETICS, V122, P19; Stojanovski D, 2012, BBA-MOL CELL RES, V1823, P1142, DOI 10.1016/j.bbamcr.2012.04.014; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012; Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	43	25	26	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15304	15312		10.1074/jbc.M115.645069	http://dx.doi.org/10.1074/jbc.M115.645069			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918166	Green Published, hybrid			2022-12-26	WOS:000356177300041
J	Little, KM; Pal, M; Dowdy, DW				Little, Kristen M.; Pal, Madhukar; Dowdy, David W.			Costs and Consequences of Using Interferon-gamma Release Assays for the Diagnosis of Active Tuberculosis in India	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; SMEAR MICROSCOPY; PREDICTIVE-VALUE; INFECTION; LATENT; ANTIGENS; TESTS	Background There is growing concern that interferon-gamma release assays (IGRAs) are being used off-label for the diagnosis of active tuberculosis (TB) disease in many high-burden settings, including India, where the background prevalence of latent TB infection is high. We analyzed the costs and consequences of using IGRAs for the diagnosis of active TB in India from the perspective of the Indian TB control sector. Methods and Findings We constructed a decision analytic model to estimate the incremental cost and effectiveness of IGRAs for the diagnosis of active TB in India. We compared a reference scenario of clinical examination and non-microbiological tests against scenarios in which clinical diagnosis was augmented by the addition of either sputum smear microscopy, IGRA, or Xpert MTB/RIF. We examined costs (in 2013 US dollars) and consequences from the perspective of the Indian healthcare sector. Relative to sputum smear microscopy, use of IGRA for active TB resulted in 23,700 (95% uncertainty range, UR: 3,800 - 38,300) additional truepositive diagnoses, but at the expense of 315,700 (95% UR: 118,300 - 388,400) additional false-positive diagnoses and an incremental cost of US$49.3 million (95% UR: $34.9 - $58.0 million) (2.9 billion Indian Rupees). Relative to Xpert MTB/RIF (including the cost of treatment for drug resistant TB), use of IGRA led to 400 additional TB cases treated (95% UR: [-8,000] - 16,200), 370,600 (95% UR: 252,200 - 441,700) more false-positive diagnoses, 70,400 (95% UR: [-7,900] - 247,200) fewer disability-adjusted life years averted, and US$14.6 million (95% UR: [-$7.2] - $28.7 million) (854 million Indian Rupees) in additional costs. Conclusion Using IGRAs for diagnosis of active TB in a setting like India results in tremendous over-treatment of people without TB, and substantial incremental cost with little gain in health. These results support the policies by WHO and Standards for TB Care in India, which discourage the use of IGRAs for the diagnosis of active TB in India and similar settings.	[Little, Kristen M.; Dowdy, David W.] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Pal, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pal, Madhukar] McGill Int TB Ctr, Montreal, PQ, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; McGill University	Little, KM (corresponding author), Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	klittl11@jhu.edu	Pai, Madhukar/AAX-9901-2021	Pai, Madhukar/0000-0003-3667-4536	Canadian Institutes of Health Research [MOP 123291, MOP-130330]; Fonds de recherche du Quebec - Sante (FRQS)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec)	MP is funded by Canadian Institutes of Health Research (MOP 123291 and MOP-130330). MP is also supported by the Fonds de recherche du Quebec - Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	[Anonymous], HIST EXCH RAT; Babu K, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-9; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Clinton Health Access Initiative Social and Rural Research Institute IMRB International, 2014, TB DIAGN IND PRIV SE, P1; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Creek TL, 2000, INT J TUBERC LUNG D, V4, P956; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001074; Foundation for Innovative New Diagnostics. Special Programme for Research and Training in Tropical DiseasesWorld Health Organization, 2006, DIAGN TUB GLOB DEM M; Institute of Actuaries of India, 2010, PUBL MORT TABL; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Joint United Nations Programme on HIV/AIDS, 2010, UNAIDS REP GLOB EP 2; Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611; Kay M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2161; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kik SV, 2014, EUR RESPIR J, V43, P1793, DOI 10.1183/09031936.00217313; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lu CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056074; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Menon S, 2012, 2012 JUL 16 MONTR CA; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Ministry of Health and Family Welfare, 2010, RNTCP STAT REP; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Prasad R., 2013, HINDU; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Qian FC, 2013, INDIAN J PATHOL MICR, V56, P125, DOI 10.4103/0377-4929.118694; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rabita A, SCI SPEAKS; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Revised National Tuberculosis Control Programme, 2010, DOTS PLUS GUID, P1; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Stall N, 2011, INT J TUBERC LUNG D, V15, P641, DOI 10.5588/ijtld.10.0195; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Treatment Action Group and Global TB Community Advisory Board, 2013, COMMUNICATION; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Bank, 2013, INFL GDP DEFL ANN; World Health Organization, 2014, STAND TB CAR IND; World Health Organization, WHO GLOB TUB CONTR E; World Health Organization, 2012, COUNTR TB REP IND; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	51	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124525	10.1371/journal.pone.0124525	http://dx.doi.org/10.1371/journal.pone.0124525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918999	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400054
J	Camacho-Ortiz, A; Lopez-Barrera, D; Hernandez-Garcia, R; Galvan-De los Santos, AM; Flores-Trevino, SM; Llaca-Diaz, JM; Maldonado Garza, HJ; Bosques-Padilla, FJ; Garza-Gonzalez, E				Camacho-Ortiz, Adrian; Lopez-Barrera, Daniel; Hernandez-Garcia, Raul; Galvan-De los Santos, Alejandra M.; Flores-Trevino, Samantha M.; Llaca-Diaz, Jorge M.; Maldonado Garza, Hector J.; Bosques-Padilla, Francisco J.; Garza-Gonzalez, Elvira			First Report of Clostridium difficile NAP1/027 in a Mexican Hospital	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; TOXIN PRODUCTION; NORTH-AMERICA; INFECTION; GENE; EPIDEMIC; DIARRHEA; POLYMORPHISM; STRAINS; DISEASE	Background and Objective Clostridium difficile NAP1/ribotype 027 is associated with severe disease and high mortality rates. Our aim was to determine the prevalence of NAP1/ribotype 027 among C. difficile isolates in a tertiary care hospital, and review the main clinical data. Methods We included 106 stool samples from 106 patients. Samples were tested for A&B toxins and were cultured on CCFA agar. The genes tcdA, tcdB, tcdC, cdtA, and cdtB were amplified using PCR in clinical isolates. The tcdA 3 '-end deletion analysis, PCR-ribotyping, and pulsed-field gel electrophoresis (PFGE) were also performed. Stool samples that were positive for culture were tested by the GeneXpert C. difficile assay. Clinical data were collected. Results Thirty-six patients tested positive for A&B toxins; and 22 patients had positive culture for C. difficile, 14 of which tested positive for the A&B toxins and all 22 patients tested positive by the GeneXpert C. difficile assay. Risk factors included an average hospital stay of 16.1 days prior to toxin detection, average antibiotic use for 16.2 days, and a median of 3 antibiotics used. The 30-day crude mortality rate was 8.4%. Six of the 22 patients died, and 3 of those deaths were directly attributed to C. difficile infection. The majority of isolates, 90.9% (20/22), carried genes tcdB, tcdA, cdtA, and cdtB; and these strains carried the corresponding downregulator gene tcdC, with an 18-bp deletion. PFGE was performed on 17 isolates, and one main pattern was observed. Analysis of the ribotyping data showed similar results. Conclusion The above findings represent the clonal spread of C. difficile in our institution, which mainly includes the NAP1/027 strain. This is the first report of C. difficile ribotype NAP1/027 in Mexico.	[Camacho-Ortiz, Adrian; Hernandez-Garcia, Raul; Galvan-De los Santos, Alejandra M.] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Infectol, Monterrey, Nuevo Leon, Mexico; [Lopez-Barrera, Daniel; Flores-Trevino, Samantha M.; Maldonado Garza, Hector J.; Bosques-Padilla, Francisco J.; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Llaca-Diaz, Jorge M.; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Clin Pathol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Flores-Treviño, Samantha M/E-8601-2019; Flores-Treviño, Samantha/AAB-4537-2020	Flores-Treviño, Samantha M/0000-0003-1259-7425; Flores-Treviño, Samantha/0000-0003-1259-7425; Maldonado-Garza, Hector Jesus/0000-0001-9217-7169; Bosques, Francisco/0000-0002-9795-7209; Llaca Diaz, Jorge Martin/0000-0001-6875-2530				Alonso R, 2005, J MED MICROBIOL, V54, P155, DOI 10.1099/jmm.0.45808-0; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Heinlen L, 2010, AM J MED SCI, V340, P247, DOI 10.1097/MAJ.0b013e3181e939d8; Hernandez-Rocha C, 2012, EMERG INFECT DIS, V18, P1370, DOI 10.3201/eid1808.120211; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525; O'Horo JC, 2012, MAYO CLIN PROC, V87, P643, DOI 10.1016/j.mayocp.2012.02.024; Oake N, 2010, ARCH INTERN MED, V170, P1804, DOI 10.1001/archinternmed.2010.405; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Persson S, 2011, J CLIN MICROBIOL, V49, P4299, DOI 10.1128/JCM.05161-11; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	19	29	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122627	10.1371/journal.pone.0122627	http://dx.doi.org/10.1371/journal.pone.0122627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915544	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000353659100009
J	Donadio, G; Sarcinelli, C; Pizzo, E; Notomista, E; Pezzella, A; Di Cristo, C; De Lise, F; Di Donato, A; Izzo, V				Donadio, Giuliana; Sarcinelli, Carmen; Pizzo, Elio; Notomista, Eugenio; Pezzella, Alessandro; Di Cristo, Carlo; De Lise, Federica; Di Donato, Alberto; Izzo, Viviana			The Toluene o-Xylene Monooxygenase Enzymatic Activity for the Biosynthesis of Aromatic Antioxidants	PLOS ONE			English	Article							PSEUDOMONAS-STUTZERI OX1; H9C2 CELL-LINE; OXIDATIVE STRESS; HYDROXYTYROSOL; GRANULES; HYDROXYLASE; SPECIFICITY; POLYPHENOLS; BACTERIAL	Monocyclic phenols and catechols are important antioxidant compounds for the food and pharmaceutic industries; their production through biotransformation of low-added value starting compounds is of major biotechnological interest. The toluene o-xylene monooxygenase (ToMO) from Pseudomonas sp. OX1 is a bacterial multicomponent monooxygenase (BMM) that is able to hydroxylate a wide array of aromatic compounds and has already proven to be a versatile biochemical tool to produce mono-and dihydroxylated derivatives of aromatic compounds. The molecular determinants of its regioselectivity and substrate specificity have been thoroughly investigated, and a computational strategy has been developed which allows designing mutants able to hydroxylate non-natural substrates of this enzyme to obtain high-added value compounds of commercial interest. In this work, we have investigated the use of recombinant ToMO, expressed in cells of Escherichia coli strain JM109, for the biotransformation of non-natural substrates of this enzyme such as 2-phenoxyethanol, phthalan and 2-indanol to produce six hydroxylated derivatives. The hydroxylated products obtained were identified, isolated and their antioxidant potential was assessed both in vitro, using the DPPH assay, and on the rat cardiomyoblast cell line H9c2. Incubation of H9c2 cells with the hydroxylated compounds obtained from ToMO-catalyzed biotransformation induced a differential protective effect towards a mild oxidative stress induced by the presence of sodium arsenite. The results obtained confirm once again the versatility of the ToMO system for oxyfunctionalization reactions of biotechnological importance. Moreover, the hydroxylated derivatives obtained possess an interesting antioxidant potential that encourages the use of the enzyme for further functionalization reactions and their possible use as scaffolds to design novel bioactive molecules.	[Donadio, Giuliana; Sarcinelli, Carmen; Pizzo, Elio; Notomista, Eugenio; De Lise, Federica; Di Donato, Alberto; Izzo, Viviana] Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy; [Pezzella, Alessandro] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Di Cristo, Carlo] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Izzo, Viviana] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, SA, Italy	University of Naples Federico II; University of Naples Federico II; University of Sannio; University of Salerno	Izzo, V (corresponding author), Univ Naples Federico II, Dept Biol, Via Cinthia I, I-80126 Naples, Italy.	vizzo@unisa.it	De Lise, Federica/L-6904-2019; Izzo, Viviana/Q-2076-2015; Pizzo, Elio/Q-4722-2017; Pezzella, Alessandro/E-1440-2011; De Lise, Federica/AAN-6065-2021	Izzo, Viviana/0000-0001-6066-7569; Pizzo, Elio/0000-0002-3652-8865; Pezzella, Alessandro/0000-0001-6925-922X; De Lise, Federica/0000-0002-9614-9226; DI DONATO, Alberto/0000-0001-9129-9850; NOTOMISTA, Eugenio/0000-0003-0097-6487	FARB ORSA [132082]; POR CAMPANIA FSE, Progetto CARINA CUP [B25B0900080007]	FARB ORSA; POR CAMPANIA FSE, Progetto CARINA CUP	This research was supported by FARB 2013 ORSA 132082. Dr. C. Sarcinelli was supported by grant POR CAMPANIA FSE 2007/2013, Progetto CARINA CUP B25B0900080007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bernini R, 2013, CURR MED CHEM, V20, P655, DOI 10.2174/092986713804999367; Brouk M, 2009, FOOD CHEM, V116, P114, DOI 10.1016/j.foodchem.2009.02.020; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cafaro V, 2002, EUR J BIOCHEM, V269, P5689, DOI 10.1046/j.1432-1033.2002.03281.x; Cafaro V, 2004, APPL ENVIRON MICROB, V70, P2211, DOI 10.1128/AEM.70.4.2211-2219.2004; Cafaro V, 2005, APPL ENVIRON MICROB, V71, P4744, DOI 10.1128/AEM.71.8.4744-4750.2005; Conti V, 2012, MED SCI SPORT EXER, V44, P39, DOI 10.1249/MSS.0b013e318227f69c; Dror A, 2012, COMPUT STRUCT BIOTEC, V2, DOI 10.5936/csbj.201209011; Feingersch R, 2008, APPL ENVIRON MICROB, V74, P1555, DOI 10.1128/AEM.01849-07; Foti MC, 2007, J PHARM PHARMACOL, V59, P1673, DOI 10.1211/jpp.59.12.0010; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Gulcin I, 2012, ARCH TOXICOL, V86, P345, DOI 10.1007/s00204-011-0774-2; Huang CH, 2011, J AM CHEM SOC, V133, P17630, DOI 10.1021/ja208572v; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; INGOLD KU, 1961, CHEM REV, V61, P563, DOI 10.1021/cr60214a002; Jimenez-Escrig A, 2000, J SCI FOOD AGR, V80, P1686, DOI 10.1002/1097-0010(20000901)80:11<1686::AID-JSFA694>3.0.CO;2-Y; Kedare SB, 2011, J FOOD SCI TECH MYS, V48, P412, DOI 10.1007/s13197-011-0251-1; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Manna C, 2005, J AGR FOOD CHEM, V53, P9602, DOI 10.1021/jf058110i; Marco S, 2013, BIOCHIMIE, V95, P2145, DOI 10.1016/j.biochi.2013.08.008; Mohajeri A, 2009, J MOL STRUCT, V930, P15, DOI 10.1016/j.molstruc.2009.04.031; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; Notomista E, 2011, APPL ENVIRON MICROB, V77, P5428, DOI 10.1128/AEM.00461-11; Notomista E, 2009, APPL ENVIRON MICROB, V75, P823, DOI 10.1128/AEM.01951-08; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016/S1470-2045(00)00015-2; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Raederstorff D, 2009, INT J VITAM NUTR RES, V79, P152, DOI 10.1024/0300-9831.79.3.152; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Rietjens SJ, 2007, J AGR FOOD CHEM, V55, P7609, DOI 10.1021/jf0706934; Sambrook J., 1989, MOLECULAR CLONING A; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Vardar G, 2004, APPL ENVIRON MICROB, V70, P3253, DOI 10.1128/AEM.70.6.3253-3262.2004; Vardar G, 2005, J BIOTECHNOL, V115, P145, DOI 10.1016/j.jbiotec.2004.08.008; Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885; Waterman E, 2007, ALTERN MED REV, V12, P331; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Yang DP, 2007, MOLECULES, V12, P878, DOI 10.3390/12040878; Zhang HY, 2005, CURR COMPUT-AID DRUG, V1, P257, DOI 10.2174/1573409054367691; Zhang HY, 2000, QUANT STRUCT-ACT REL, V19, P50, DOI 10.1002/(SICI)1521-3838(200002)19:1<50::AID-QSAR50>3.0.CO;2-#; Zordoky Beshay N. M., 2007, Journal of Pharmacological and Toxicological Methods, V56, P317, DOI 10.1016/j.vascn.2007.06.001	48	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124427	10.1371/journal.pone.0124427	http://dx.doi.org/10.1371/journal.pone.0124427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915063	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100049
J	Falcini, F; Palatella, L; Cuttitta, A; Nardelli, BB; Lacorata, G; Lanotte, AS; Patti, B; Santoleri, R				Falcini, Federico; Palatella, Luigi; Cuttitta, Angela; Nardelli, Bruno Buongiorno; Lacorata, Guglielmo; Lanotte, Alessandra S.; Patti, Bernardino; Santoleri, Rosalia			The Role of Hydrodynamic Processes on Anchovy Eggs and Larvae Distribution in the Sicily Channel (Mediterranean Sea): A Case Study for the 2004 Data Set	PLOS ONE			English	Article							SMALL PELAGIC FISH; ENGRAULIS-ENCRASICOLUS; OCEANOGRAPHIC CONDITIONS; MESOSCALE VARIABILITY; LIFE-HISTORY; STRAIT; CIRCULATION; MIGRATION; TRANSPORT; PATTERNS	Knowledge of the link between ocean hydrodynamics and distribution of small pelagic fish species is fundamental for the sustainable management of fishery resources. Both commercial and scientific communities are indeed seeking to provide services that could "connect the dots" among in situ and remote observations, numerical ocean modelling, and fisheries. In the Mediterranean Sea and, in particular, in the Sicily Channel the reproductive strategy of the European Anchovy (Engraulis encrasicolus) is strongly influenced by the oceanographic patterns, which are often visible in sea surface temperature satellite data. Based on these experimental evidences, we propose here a more general approach where the role of ocean currents, wind effects, and mesoscale activity are tied together. To investigate how these features affect anchovy larvae distribution, we pair ichthyoplankton observations to a wide remote sensing data set, and to Lagrangian numerical simulations for larval transport. Our analysis shows that while the wind-induced coastal current is able to transport anchovy larvae from spawning areas to the recruiting area off the Sicilian south-eastern tip, significant cross-shore transport due to the combination of strong northwesterly mistral winds and topographic effects delivers larvae away from the coastal conveyor belt. We then use a potential vorticity approach to describe the occurrence of larvae cross-shore transport. We conclude that monitoring and quantifying the upwelling on the southern Sicilian coast during the spawning season allows to estimate the cross-shore transport of larvae and the consequent decrease of individuals within the recruiting area.	[Falcini, Federico; Nardelli, Bruno Buongiorno; Santoleri, Rosalia] CNR, Ist Sci Atmosfera & Clima, Rome, Italy; [Palatella, Luigi; Lacorata, Guglielmo; Lanotte, Alessandra S.] CNR, Ist Sci Atmosfera & Clima, Lecce, Italy; [Cuttitta, Angela; Patti, Bernardino] CNR, Ist Ambiente Marino Costiero, Capo Granitola, TP, Italy; [Nardelli, Bruno Buongiorno] CNR, Ist Ambiente Marino Costiero, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Falcini, F (corresponding author), CNR, Ist Sci Atmosfera & Clima, Rome, Italy.	f.falcini@isac.cnr.it	Palatella, Luigi Nicola Antonio/ABE-3647-2020; Nardelli, Bruno Buongiorno/AAY-4289-2020; Nardelli, Bruno Buongiorno/I-4810-2012; Lacorata, Guglielmo/AAW-9410-2020; Lacorata, Guglielmo/B-7202-2009; Cuttitta, Angela/AAK-2097-2020; Patti, Bernardo/ABG-7214-2020; SANTOLERI, ROSALIA/B-8711-2015; Lanotte, Alessandra S./C-5238-2009	Nardelli, Bruno Buongiorno/0000-0002-3416-7189; Lacorata, Guglielmo/0000-0002-8594-3934; Lacorata, Guglielmo/0000-0002-8594-3934; Cuttitta, Angela/0000-0002-4896-5114; SANTOLERI, ROSALIA/0000-0002-2900-5054; Falcini, Federico/0000-0001-8105-2491; Patti, Bernardo/0000-0003-0193-5628; Palatella, Luigi Nicola/0000-0003-0075-8287; Lanotte, Alessandra S./0000-0001-7201-2965	SSD PESCA; RITMARE Italian Research Ministry (MIUR) Projects	SSD PESCA; RITMARE Italian Research Ministry (MIUR) Projects	This work has been funded supported by the SSD PESCA and the RITMARE Italian Research Ministry (MIUR) Projects.	Allain G, 2001, FISH OCEANOGR, V10, P151, DOI 10.1046/j.1365-2419.2001.00164.x; Basilone G, 2013, FISH OCEANOGR, V22, P309, DOI 10.1111/fog.12024; Buongiorno Nardelli B, 2001, J PHYS OCEANOGR, V31, P2227, DOI 10.1175/1520-0485(2001)031<2227:SMFAAM>2.0.CO;2; Buongiorno Nardelli B, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003191; Buongiorno Nardelli B, 1999, J GEOPHYS RES-OCEANS, V104, P20585, DOI 10.1029/1999JC900103; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Coombs SH, 2003, MAR ECOL PROG SER, V248, P221, DOI 10.3354/meps248221; CRISANTI A, 1991, RIV NUOVO CIMENTO, V14, P1, DOI 10.1007/BF02811193; CSANADY GT, 1982, J PHYS OCEANOGR, V12, P84, DOI 10.1175/1520-0485(1982)012<0084:OTSOTU>2.0.CO;2; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; Garcia A, 1996, SCI MAR, V60, P155; Garcia A., 1994, NW MEDITERRANEAN ANC; Hays GC, 2014, ECOL LETT, V17, P137, DOI 10.1111/ele.12219; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Iudicone D, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001647; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lacorata G, 2008, J ATMOS SCI, V65, P2389, DOI 10.1175/2007JAS2410.1; Lacorata G, 2014, J GEOPHYS RES-OCEANS, V119, P8029, DOI 10.1002/2014JC010313; Lafuente JG, 2005, FISH OCEANOGR, V14, P32, DOI 10.1111/j.1365-2419.2004.00304.x; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; Lee ZP, 2002, APPL OPTICS, V41, P5755, DOI 10.1364/AO.41.005755; Lermusiaux PFJ, 1999, DYNAM ATMOS OCEANS, V29, P255, DOI 10.1016/S0377-0265(99)00008-1; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Lett C, 2007, J MARINE SYST, V64, P189, DOI 10.1016/j.jmarsys.2006.03.012; Lloret J, 2000, ICES J MAR SCI, V57, P171, DOI 10.1006/jmsc.2000.0570; Marullo S, 2007, OCEAN SCI, V3, P299, DOI 10.5194/os-3-299-2007; Mazzola S, 2000, DISTRIBUTION BIOL BI; MAZZOLA S, 2002, SICILIAN CHANNEL ANC; MCCLAIN CR, 1993, J GEOPHYS RES-OCEANS, V98, P12327, DOI 10.1029/93JC00868; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; OLIVAR M-P, 1991, Scientia Marina, V55, P1; OLIVAR MP, 1993, B MAR SCI, V53, P450; Onken R, 1998, J GEOPHYS RES-OCEANS, V103, P24799, DOI 10.1029/98JC00891; Orensanz J. M. Lobo, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P143; Palatella L, 2014, J GEOPHYS RES-OCEANS, V119, P1306, DOI 10.1002/2013JC009384; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pedlosky J., 1982, GEOPHYS FLUID DYNAMI; Pickett MH, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001902; Pierini S, 1996, J GEOPHYS RES-OCEANS, V101, P6429, DOI 10.1029/95JC03138; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Poulain PM, 2007, CONT SHELF RES, V27, P981, DOI 10.1016/j.csr.2007.01.005; Pratt L. J., 2007, ROTATING HYDRAULICS, V36; RE P, 1986, Ciencia Biologica Ecology and Systematics, V6, P9; Re P, 1987, PUBLICACION TECNICA, V12, P257; Re P, 1990, 1 C TEJ, V2, P231; Rinaldi E, 2014, CONT SHELF RES, V77, P61, DOI 10.1016/j.csr.2014.01.010; Robinson AR, 1999, J MARINE SYST, V20, P129, DOI 10.1016/S0924-7963(98)00079-7; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Santos AMP, 2007, PROG OCEANOGR, V74, P192, DOI 10.1016/j.pocean.2007.04.008; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Smith P. E., 1977, STANDARD TECHNIQUES; SOLOMON TH, 1988, PHYS REV A, V38, P6280, DOI 10.1103/PhysRevA.38.6280; Somarakis S, 2002, J PLANKTON RES, V24, P339, DOI 10.1093/plankt/24.4.339; Tonani M, 2008, OCEAN SCI, V4, P1, DOI 10.5194/os-4-1-2008; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x	60	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123213	10.1371/journal.pone.0123213	http://dx.doi.org/10.1371/journal.pone.0123213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915489	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100016
J	Jungmann, PM; Ganter, C; Schaeffeler, CJ; Bauer, JS; Baum, T; Meier, R; Nittka, M; Pohlig, F; Rechl, H; von Eisenhart-Rothe, R; Rummeny, EJ; Woertler, K				Jungmann, Pia M.; Ganter, Carl; Schaeffeler, Christoph J.; Bauer, Jan S.; Baum, Thomas; Meier, Reinhard; Nittka, Mathias; Pohlig, Florian; Rechl, Hans; von Eisenhart-Rothe, Ruediger; Rummeny, Ernst J.; Woertler, Klaus			View-Angle Tilting and Slice-Encoding Metal Artifact Correction for Artifact Reduction in MRI: Experimental Sequence Optimization for Orthopaedic Tumor Endoprostheses and Clinical Application	PLOS ONE			English	Article							MAGNETIC-SUSCEPTIBILITY; MALIGNANT-TUMOR; LIMB-SALVAGE; OSTEOSARCOMA; REPLACEMENT; MANAGEMENT; RESECTION; FEMUR; ARTHROPLASTY; IMPLANTS	Background MRI plays a major role in follow-up of patients with malignant bone tumors. However, after limb salvage surgery, orthopaedic tumor endoprostheses might cause significant metalinduced susceptibility artifacts. Purposes To evaluate the benefit of view-angle tilting (VAT) and slice-encoding metal artifact correction (SEMAC) for MRI of large-sized orthopaedic tumor endoprostheses in an experimental model and to demonstrate clinical benefits for assessment of periprosthetic soft tissue abnormalities. Methods In an experimental setting, tumor endoprostheses (n=4) were scanned at 1.5T with three versions of optimized high-bandwidth turbo-spin-echo pulse sequences: (i) standard, (ii) VAT and (iii) combined VAT and SEMAC (VAT&SEMAC). Pulse sequences included coronal short-tau-inversion-recovery (STIR), coronal T1-weighted (w), transverse T1-w and T2-w TSE sequences. For clinical evaluation, VAT& SEMAC was compared to conventional metal artifact-reducing MR sequences (conventional MR) in n=25 patients with metal implants and clinical suspicion of tumor recurrence or infection. Diameters of artifacts were measured quantitatively. Qualitative parameters were assessed on a five-point scale (1=best, 5=worst): "image distortion", "artificial signal changes at the edges" and "diagnostic confidence". Imaging findings were correlated with pathology. T-tests and Wilcoxon-signed rank tests were used for statistical analyses. Results The true size of the prostheses was overestimated on MRI (P<0.05). A significant reduction of artifacts was achieved by VAT (P<0.001) and VAT&SEMAC (P=0.003) compared to the standard group. Quantitative scores improved in the VAT and VAT&SEMAC group (P<0.05). On clinical MR images, artifact diameters were significantly reduced in the VAT&SEMAC-group as compared with the conventional-group (P<0.001). Distortion and artificial signal changes were reduced and diagnostic confidence improved (P<0.05). In two cases, tumor-recurrence, in ten cases infection and in thirteen cases other pathologies were diagnosed. Conclusions Significant reduction of metallic artifacts was achieved by VAT and SEMAC. Clinical results suggest, that these new techniques will be beneficial for detecting periprosthetic pathologies during postoperative follow-up.	[Jungmann, Pia M.; Ganter, Carl; Schaeffeler, Christoph J.; Bauer, Jan S.; Baum, Thomas; Meier, Reinhard; Rummeny, Ernst J.; Woertler, Klaus] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany; [Schaeffeler, Christoph J.] Kantonsspital Graubuenden, Musculoskeletal Imaging, CH-7000 Chur, Switzerland; [Bauer, Jan S.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, D-81675 Munich, Germany; [Nittka, Mathias] Siemens AG, Healthcare Sect, D-91052 Erlangen, Germany; [Pohlig, Florian; Rechl, Hans; von Eisenhart-Rothe, Ruediger] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthopaed Surg, D-81675 Munich, Germany	Technical University of Munich; Kantonsspital Graubunden; Technical University of Munich; Siemens AG; Siemens Germany; Technical University of Munich	Jungmann, PM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Ismaninger Str 22, D-81675 Munich, Germany.	pia.jungmann@tum.de	Ganter, Carl/U-6895-2017; Baum, Thomas/M-6522-2014; Kirschke, Jan/E-2550-2012; von Eisenhart-Rothe, Ruediger/E-4839-2017; Meier, Reinhard/B-2882-2014	Ganter, Carl/0000-0002-6735-7448; Baum, Thomas/0000-0002-4574-5212; Kirschke, Jan/0000-0002-7557-0003; Meier, Reinhard/0000-0002-2169-4780; Jungmann, Pia/0000-0003-2198-3678; Pohlig, Florian/0000-0002-8867-2973	German Research Foundation (DFG); Technische Universitat Munchen within the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOULAFIA AJ, 1993, CANCER-AM CANCER SOC, V71, P3358, DOI 10.1002/1097-0142(19930515)71:10+<3358::AID-CNCR2820711738>3.0.CO;2-O; Beaman FD, 2013, SEMIN MUSCULOSKEL R, V17, P168, DOI 10.1055/s-0033-1343094; BERQUIST TH, 1989, CLIN ORTHOP RELAT R, P101; Butts K, 2005, MAGNET RESON MED, V53, P418, DOI 10.1002/mrm.20375; CHO ZH, 1988, MED PHYS, V15, P7, DOI 10.1118/1.596162; Choong PFM, 1996, ACTA ORTHOP SCAND, V67, P345, DOI 10.3109/17453679609002328; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; ECKARDT JJ, 1991, CLIN ORTHOP RELAT R, P202; Fayad LM, 2012, RADIOLOGY, V265, P340, DOI 10.1148/radiol.12111740; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Hargreaves BA, 2011, AM J ROENTGENOL, V197, P547, DOI 10.2214/AJR.11.7364; Kawai A, 1998, J BONE JOINT SURG AM, V80A, P636, DOI 10.2106/00004623-199805000-00004; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; Lu WM, 2009, MAGN RESON MED, V62, P66, DOI 10.1002/mrm.21967; Manaster B J, 2000, Radiology, V215 Suppl, P379; MORRIS HG, 1994, INT ORTHOP, V18, P90, DOI 10.1007/BF02484417; Oldrini G, 2011, J RADIOL, V92, P915, DOI 10.1016/j.jradio.2011.07.003; QUILL G, 1990, CLIN ORTHOP RELAT R, P242; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; SIM FH, 1995, CLIN ORTHOP RELAT R, P160; Simon MA, 2005, J BONE JOINT SURG AM, V87A, P2822, DOI 10.2106/JBJS.8712.cl; Starcukova J, 2008, DENT MATER, V24, P715, DOI 10.1016/j.dental.2007.07.002; Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5; Sutter R, 2013, AM J ROENTGENOL, V201, P1315, DOI 10.2214/AJR.13.10531; Sutter R, 2012, RADIOLOGY, V265, P204, DOI 10.1148/radiol.12112408; Viano AM, 2000, MAGN RESON IMAGING, V18, P287, DOI 10.1016/S0730-725X(99)00135-6; Wafa H, 2006, EXPERT REV ANTICANC, V6, P239, DOI 10.1586/14737140.6.2.239; WENDT RE, 1988, RADIOLOGY, V168, P837, DOI 10.1148/radiology.168.3.3406413	29	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124922	10.1371/journal.pone.0124922	http://dx.doi.org/10.1371/journal.pone.0124922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909472	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800115
J	Li, LY; Yang, WM; Chen, HZ; Wu, YH; Fang, X; Zhang, J; Wang, Z; Han, YS; Wang, Y				Li, Liang-Yong; Yang, Wen-Ming; Chen, Huai-Zhen; Wu, Yun-Hu; Fang, Xiang; Zhang, Jing; Wang, Zhen; Han, Yong-Sheng; Wang, Yu			Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China	PLOS ONE			English	Article							BLEEDING ESOPHAGEAL-VARICES; BLOOD-BRAIN-BARRIER; LIVER-TRANSPLANTATION; HEPATITIS-C; NEUROLOGICAL DETERIORATION; INTERFERON THERAPY; COPPER; CIRRHOSIS; PENICILLAMINE; DIAGNOSIS	Splenomegaly and pancytopenia are common in Wilson's disease (WD) and splenectomy is one of the conventional treatments for splenomegaly and the associated pancytopenia. However, splenectomy remained controversial for hypersplenism in WD as it was reported that splenectomy leaded to serious emotional and neurological deterioration in WD patients with hypersplenism. In the current study, we present our experiences in 70 WD patients with hypersplenism who had undergone splenectomy, outlining the safety and efficacy of splenectomy in WD. The clinical database of 70 WD patients with hypersplenism who had undergone splenectomy in our hospital between 2009 and 2013 were reviewed and followed-up regularly. Before splenectomy, all the patients accepted a short period of anti-copper treatment with intravenous sodium 2, 3-dimercapto-1-propane sulfonate (DMPS). All the patients demonstrated a marked improvement in platelet and leucocyte counts after splenectomy. No severe postoperative complication was observed. In particular, none of the 37 patients with mixed neurologic and hepatic presentations experienced neurological deterioration after splenectomy, and none of the patients with only hepatic presentations newly developed neurological symptoms. During the one year follow-up period, no patient presented hepatic failure or hepatic encephalopathy, no hepatic patient newly developed neurological presentations, and only 3 patients with mixed neurologic and hepatic presentations suffered neurological deterioration and these 3 patients had poor compliance of anti-copper treatment. Quantative analysis of the neurological symptoms in the 37 patients using the Unified Wilson's Disease Rating Scale (UWDRS) showed that the neurological symptoms were not changed in a short-term of one week after splenectomy but significantly improved in a long-term of one year after splenectomy. Additionally, compared to that before splenectomy, the esophageal gastric varices in most patients significantly improved one year after splenectomy. Thus, we may conclude that splenectomy is a safe and effective therapeutic measure for hypersplenism in WD patients who had been preoperatively treated with DMPS for powerful anti-copper therapy.	[Li, Liang-Yong; Yang, Wen-Ming; Chen, Huai-Zhen; Wu, Yun-Hu; Fang, Xiang; Zhang, Jing] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Neurol, Hefei 230031, Peoples R China; [Wang, Zhen] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Gen Surg, Hefei 230031, Peoples R China; [Han, Yong-Sheng] Anhui Univ Tradit Chinese Med, Inst Neurol, Hefei 230061, Peoples R China; [Wang, Yu] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei 230022, Peoples R China	Anhui University of Chinese Medicine; Anhui University of Chinese Medicine; Anhui University of Chinese Medicine; Anhui Medical University	Wang, Y (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei 230022, Peoples R China.	yw4d@hotmail.com						Akahoshi T, 2012, J GASTROEN HEPATOL, V27, P286, DOI 10.1111/j.1440-1746.2011.06870.x; Aposhian HV, 1998, ENVIRON HEALTH PERSP, V106, P1017, DOI 10.2307/3434146; Baykal Mehmet, 2010, J Clin Med Res, V2, P99, DOI 10.4021/jocmr2010.04.292w; Brauer DL, 2014, BONE MARROW TRANSPL, V49, P717, DOI 10.1038/bmt.2013.238; Brewer GJ, 2006, ARCH NEUROL-CHICAGO, V63, P521, DOI 10.1001/archneur.63.4.521; Brewer GJ, 2006, EXPERT OPIN PHARMACO, V7, P317, DOI 10.1517/14656566.7.3.317; Casale M, 2013, EUR J HAEMATOL, V91, P69, DOI 10.1111/ejh.12121; Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; Cztonkowska A, 2007, NEUROL NEUROCHIR POL, V41, P1; Deng XG, 2012, PEDIATR SURG INT, V28, P1201, DOI 10.1007/s00383-012-3215-2; Digestive Endoscopy Branch of the Chinese Medical Association, 2000, CHIN J DIG ENDOSC, V17, P198; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2004, ALIMENT PHARM THER, V19, P157, DOI 10.1046/j.1365-2036.2003.01813.x; Guillaud O, 2014, J HEPATOL, V60, P579, DOI 10.1016/j.jhep.2013.10.025; Harada M, 2014, HEPATOL RES; Hirooka M, 2008, HEPATOL RES, V38, P1172, DOI 10.1111/j.1872-034X.2008.00389.x; Hu J, 2001, J RADIOIMMUNOLOGY, V14, P1; Inagaki Y, 2014, MOL MED REP, V9, P487, DOI 10.3892/mmr.2013.1856; Iwamoto T, 2012, J GASTROENTEROL, V47, P300, DOI 10.1007/s00535-011-0486-7; Iwanski S, 2014, NEUROPSYCHOLOGY; Jiang XZ, 2009, WORLD J GASTROENTERO, V15, P3421, DOI 10.3748/wjg.15.3421; Kaetz H W, 1966, Conn Med, V30, P338; Kalita J, 2014, EUR NEUROL, V71, P126, DOI 10.1159/000355276; Kedia S, 2012, ANN HEPATOL, V11, P921, DOI 10.1016/S1665-2681(19)31419-X; Kim B, 2013, J CLIN NEUROSCI, V20, P606, DOI 10.1016/j.jocn.2012.02.041; Kim YE, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-127; Kleinig TJ, 2008, J CLIN NEUROSCI, V15, P575, DOI 10.1016/j.jocn.2007.03.001; Kuriyama N, 2012, LIVER TRANSPLANT, V18, P1361, DOI 10.1002/lt.23519; LANG CJG, 1993, ARCH NEUROL-CHICAGO, V50, P1008; Leinweber B, 2008, MOVEMENT DISORD, V23, P54, DOI 10.1002/mds.21761; Limenta LMG, 2011, CLIN PHARMACOKINET, V50, P41, DOI 10.2165/11536630-000000000-00000; Loudianos Georgios, 2014, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V35, P93; Masuya M, 2014, HEPATOL RES, V44, pE376, DOI 10.1111/hepr.12319; Monnot AD, 2011, TOXICOL APPL PHARM, V256, P249, DOI 10.1016/j.taap.2011.02.003; Nomura Y, 2014, HEPATOL RES, V44, pE100, DOI 10.1111/hepr.12234; Peedikayil MC, 2013, WORLD J HEPATOL, V5, P127, DOI 10.4254/wjh.v5.i3.127; Pfeiffer RF, 2007, SEMIN NEUROL, V27, P123, DOI 10.1055/s-2007-971173; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rosencrantz R, 2011, SEMIN LIVER DIS, V31, P245, DOI 10.1055/s-0031-1286056; Sandberg M, 1934, J EXP MED, V60, P395, DOI 10.1084/jem.60.3.395; Schilsky ML, 2014, ANN NY ACAD SCI, V1315, P45, DOI 10.1111/nyas.12454; STEINER P, 1975, SCHWEIZ MED WSCHR, V105, P872; STERNLIEB I, 1970, LANCET, V1, P638; STRICKLAND GT, 1972, GUT, V13, P220, DOI 10.1136/gut.13.3.220; Stuerenburg HJ, 2000, J NEURAL TRANSM, V107, P321, DOI 10.1007/s007020050026; Tokgoz Orhan, 2013, Middle East Journal of Anesthesiology, V22, P103; UMEKI S, 1985, ARCH INTERN MED, V145, P2271, DOI 10.1001/archinte.1985.00360120143044; Weiss KH, 2013, CLIN TRANSPLANT, V27, P914, DOI 10.1111/ctr.12259; Wenisch E, 2013, REV NEUROL-FRANCE, V169, P944, DOI 10.1016/j.neurol.2013.06.002; Xu SQ, 2013, J HUAZHONG U SCI-MED, V33, P743, DOI 10.1007/s11596-013-1190-z; Yalaz M, 2003, Minerva Pediatr, V55, P625	51	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124569	10.1371/journal.pone.0124569	http://dx.doi.org/10.1371/journal.pone.0124569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910248	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800089
J	Momose, H; Mizukami, T; Kuramitsu, M; Takizawa, K; Masumi, A; Araki, K; Furuhata, K; Yamaguchi, K; Hamaguchi, I				Momose, Haruka; Mizukami, Takuo; Kuramitsu, Madoka; Takizawa, Kazuya; Masumi, Atsuko; Araki, Kumiko; Furuhata, Keiko; Yamaguchi, Kazunari; Hamaguchi, Isao			Establishment of a New Quality Control and Vaccine Safety Test for Influenza Vaccines and Adjuvants Using Gene Expression Profiling	PLOS ONE			English	Article							CELL-LINE; CULTURE; SYSTEM; RATS	We have previously identified 17 biomarker genes which were upregulated by whole virion influenza vaccines, and reported that gene expression profiles of these biomarker genes had a good correlation with conventional animal safety tests checking body weight and leukocyte counts. In this study, we have shown that conventional animal tests showed varied and no dose-dependent results in serially diluted bulk materials of influenza HA vaccines. In contrast, dose dependency was clearly shown in the expression profiles of biomarker genes, demonstrating higher sensitivity of gene expression analysis than the current animal safety tests of influenza vaccines. The introduction of branched DNA based-concurrent expression analysis could simplify the complexity of multiple gene expression approach, and could shorten the test period from 7 days to 3 days. Furthermore, upregulation of 10 genes, Zbp1, Mx2, Irf7, Lgals9, Ifi47, Tapbp, Timp1, Trafd1, Psmb9, and Tap2, was seen upon virosomal-adjuvanted vaccine treatment, indicating that these biomarkers could be useful for the safety control of virosomal-adjuvanted vaccines. In summary, profiling biomarker gene expression could be a useful, rapid, and highly sensitive method of animal safety testing compared with conventional methods, and could be used to evaluate the safety of various types of influenza vaccines, including adjuvanted vaccine.	[Momose, Haruka; Mizukami, Takuo; Kuramitsu, Madoka; Takizawa, Kazuya; Masumi, Atsuko; Araki, Kumiko; Furuhata, Keiko; Yamaguchi, Kazunari; Hamaguchi, Isao] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Hamaguchi, I (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan.	130hama@niid.go.jp	Mizukami, Takuo/F-9248-2016	Mizukami, Takuo/0000-0001-6105-6049	Ministry of Health, Labor, and Welfare of Japan [09000019, 10650301]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	HM and IH received the Grants-in-Aid from Ministry of Health, Labor, and Welfare of Japan (09000019 and 10650301, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Calabro S, 2013, VACCINE, V31, P3363, DOI 10.1016/j.vaccine.2013.05.007; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chan CYY, 2012, EXPERT REV VACCINES, V11, P759, DOI [10.1586/erv.12.55, 10.1586/ERV.12.55]; Ching LK, 2011, J IMMUNOL METHODS, V373, P54, DOI 10.1016/j.jim.2011.07.021; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; Couch Robert B., 1997, Journal of Infectious Diseases, V176, pS38, DOI 10.1086/514173; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; Fiore AE, 2013, VACCINES, P257; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Hamaguchi I, 2008, VACCINE, V26, P4686, DOI 10.1016/j.vaccine.2008.06.086; Hamaguchi I, 2007, VACCINE, V25, P3355, DOI 10.1016/j.vaccine.2006.12.059; Hamamoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059892; Hicks SD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-128; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Magnusson SE, 2013, VACCINE, V31, P1725, DOI 10.1016/j.vaccine.2013.01.039; Mizukami T, 2008, VACCINE, V26, P2270, DOI 10.1016/j.vaccine.2008.02.031; Mizukami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101835; Mizukami T, 2009, BIOLOGICALS, V37, P8, DOI 10.1016/j.biologicals.2008.07.007; Momose H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/361841; Momose H, 2010, JPN J INFECT DIS, V63, P25; Moser C, 2013, EXPERT REV VACCINES, V12, P779, DOI 10.1586/14760584.2013.811195; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; National Institute of Infectious Diseases J, 2006, MIN REQ BIOL PROD; Nichols JE, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P497, DOI 10.1016/B978-0-12-369408-9.00027-5; Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9; Pletneva LM, 2006, J INTERF CYTOK RES, V26, P914, DOI 10.1089/jir.2006.26.914; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; REIMER C. B., 1967, J VIROL, V1, P1207; REIMER CB, 1966, SCIENCE, V152, P1379, DOI 10.1126/science.152.3727.1379; Tsai TF, 2011, YAKUGAKU ZASSHI, V131, P1733, DOI 10.1248/yakushi.131.1733; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Zeiger RS, 2002, J ALLERGY CLIN IMMUN, V110, P834, DOI 10.1067/mai.2002.129372	37	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124392	10.1371/journal.pone.0124392	http://dx.doi.org/10.1371/journal.pone.0124392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909814	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800081
J	Qi, HY; Liu, MD; Emery, DW; Stamatoyannopoulos, G				Qi, Heyuan; Liu, Mingdong; Emery, David W.; Stamatoyannopoulos, George			Functional Validation of a Constitutive Autonomous Silencer Element	PLOS ONE			English	Article							REGULATORY ELEMENTS; CHAIN GENE; EXPRESSION; SEQUENCE; TRANSCRIPTION; REPRESSION; INSULATOR	Sequences of the genome that are capable of silencing gene expression are thought to play a key role in gene regulation. However, very few silencer elements capable of functioning in mammalian cells have been described, and only a fraction of these have been tested for the ability to function in an autonomous fashion. We report here the characterization and functional validation of a constitutive autonomous silencer element from the human genome called T39, and the comparison of T39 to three other putative silencer elements previously described by others. Functional analysis included one assay for enhancer-blocking insulator activity and two independent assays for silencer activity, all based on stable transfection and comparison to a neutral spacer control. In erythroid K562 cells, T39 exhibited potent silencer activity, the previously described element PRE2-S5 exhibited modest silencer activity, and the two other previously described elements exhibited no silencer activity. T39 was further found to be capable of silencing three disparate promoters, of silencing gene expression in three disparate cell lines, and of functioning as a single copy in a topology-independent manner. Of the four elements analyzed, only T39 exhibits a constitutive pattern of DNase hypersensitivity and binding by CTCF. In its native location the T39 element also exhibits a unique interaction profile with a subset of distal putative regulatory elements. Taken together, these studies validate T39 as a constitutive autonomous silencer, identify T39 as a defined control for future studies of other regulatory elements such as insulators, and provide a basic chromatin profile for one highly potent silencer element.	[Qi, Heyuan] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Qi, Heyuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Qi, Heyuan; Liu, Mingdong; Emery, David W.; Stamatoyannopoulos, George] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Emery, David W.] WIRB Copernicus Grp, Inst Biosafety Comm Serv, Puyallup, WA USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Washington; University of Washington Seattle	Stamatoyannopoulos, G (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	gstam@uw.edu			National Institutes of Health [PO1 HL53750]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant PO1 HL53750. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dean A, 2011, BRIEF FUNCT GENOMICS, V10, P3, DOI 10.1093/bfgp/elq033; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Groth AC, 2007, PLOS ONE; Gupta M, 1998, MOL CELL BIOL, V18, P7243, DOI 10.1128/MCB.18.12.7243; HAECKER SAE, 1995, MOL ENDOCRINOL, V9, P1113, DOI 10.1210/me.9.9.1113; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Kim MK, 1996, MOL CELL BIOL, V16, P4366; Klochkov D, 2006, MOL CELL BIOL, V26, P1589, DOI 10.1128/MCB.26.5.1589-1597.2006; Liu B, 1996, J BIOL CHEM, V271, P26281, DOI 10.1074/jbc.271.42.26281; Liu J, 2006, HUM MOL GENET, V15, P1769, DOI 10.1093/hmg/ddl099; Liu MD, 2015, NAT BIOTECHNOL, V33, P198, DOI 10.1038/nbt.3062; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Ogbourne S, 1998, BIOCHEM J, V331, P1; Raab JR, 2012, EMBO J, V31, P330, DOI 10.1038/emboj.2011.406; Tubb J, 2005, BIOTECHNIQUES, V39, P553, DOI 10.2144/000112030; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	20	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124588	10.1371/journal.pone.0124588	http://dx.doi.org/10.1371/journal.pone.0124588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910277	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800090
J	Achterberg, S; Kappelle, LJ; de Bakker, PIW; Traylor, M; Algra, A				Achterberg, Sefanja; Kappelle, L. Jaap; de Bakker, Paul I. W.; Traylor, Matthew; Algra, Ale		SMART Study Group; METASTROKE Consortium	No Additional Prognostic Value of Genetic Information in the Prediction of Vascular Events after Cerebral Ischemia of Arterial Origin: The PROMISe Study	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ASPIRIN RESISTANCE; STROKE; RISK; ASSOCIATION; ATTACK; METAANALYSIS; VARIANTS	Background Patients who have suffered from cerebral ischemia have a high risk of recurrent vascular events. Predictive models based on classical risk factors typically have limited prognostic value. Given that cerebral ischemia has a heritable component, genetic information might improve performance of these risk models. Our aim was to develop and compare two models: one containing traditional vascular risk factors, the other also including genetic information. Methods and Results We studied 1020 patients with cerebral ischemia and genotyped them with the Illumina Immunochip. Median follow-up time was 6.5 years; the annual incidence of new ischemic events (primary outcome, n=198) was 3.0%. The prognostic model based on classical vascular risk factors had an area under the receiver operating characteristics curve (AUC-ROC) of 0.65 (95% confidence interval 0.61-0.69). When we added a genetic risk score based on prioritized SNPs from a genome-wide association study of ischemic stroke (using summary statistics from the METASTROKE study which included 12389 cases and 62004 controls), the AUC-ROC remained the same. Similar results were found for the secondary outcome ischemic stroke. Conclusions We found no additional value of genetic information in a prognostic model for the risk of ischemic events in patients with cerebral ischemia of arterial origin. This is consistent with a complex, polygenic architecture, where many genes of weak effect likely act in concert to influence the heritable risk of an individual to develop (recurrent) vascular events. At present, genetic information cannot help clinicians to distinguish patients at high risk for recurrent vascular events.	[Achterberg, Sefanja; Kappelle, L. Jaap; Algra, Ale] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht Stroke Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands; [de Bakker, Paul I. W.; Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Traylor, Matthew] Univ Cambridge, Clin Neurosci, Cambridge CB2 0QQ, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cambridge	Achterberg, S (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht Stroke Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands.	s.achterberg-2@umcutrecht.nl	Boncoraglio, Giorgio Battista/B-8647-2011; de Bakker, Paul IW/B-8730-2009	Boncoraglio, Giorgio Battista/0000-0002-2551-525X; de Bakker, Paul IW/0000-0001-7735-7858; Hopewell, Jemma/0000-0002-3870-8018; Visseren, Frank/0000-0003-3951-5223; Seshadri, Sudha/0000-0001-6135-2622; Traylor, Matthew/0000-0001-6624-8621; Levi, Christopher/0000-0002-9474-796X; Mitchell, Braxton/0000-0003-4920-4744	Netherlands Heart Foundation [2005B031]; Dutch Brain Foundation [2008(1).10]; British Heart Foundation [FS/14/55/30806] Funding Source: researchfish	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Brain Foundation; British Heart Foundation(British Heart Foundation)	S. Achterberg is supported in part by a grant from the Netherlands Heart Foundation, (grant No. 2005B031) and a grant from the Dutch Brain Foundation (project 2008(1).10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg S, 2008, EUR NEUROL, V59, P243, DOI 10.1159/000115638; Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Alberts MJ, 2010, STROKE, V41, P2400, DOI 10.1161/STROKEAHA.110.595637; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Eikelboom JW, 2010, STROKE, V41, P2398, DOI 10.1161/STROKEAHA.110.593582; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Gurbel PA, 2012, CIRCULATION, V125, P1276, DOI 10.1161/CIRCULATIONAHA.111.031195; Kilarski LL, 2014, NEUROLOGY, V83, P678, DOI 10.1212/WNL.0000000000000707; Kuzniatsova N, 2012, ANN MED, V44, P773, DOI 10.3109/07853890.2011.605388; Pruissen DMO, 2009, CEREBROVASC DIS, V27, P290, DOI 10.1159/000199467; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sharma P, 2013, J NEUROL NEUROSUR PS, V84, P1302, DOI 10.1136/jnnp-2012-304834; Simons PCG, 1999, EUR J EPIDEMIOL, V15, P773, DOI 10.1023/A:1007621514757; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; Wijnhoud AD, 2010, STROKE, V41, P2178, DOI 10.1161/STROKEAHA.110.580985; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	22	5	5	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119203	10.1371/journal.pone.0119203	http://dx.doi.org/10.1371/journal.pone.0119203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906364	Green Published, gold			2022-12-26	WOS:000353332000003
J	Chimura, T; Launey, T; Yoshida, N				Chimura, Takahiko; Launey, Thomas; Yoshida, Nobuaki			Calpain-Mediated Degradation of Drebrin by Excitotoxicity In vitro and In vivo	PLoS One			English	Article							ACTIN-BINDING-PROTEIN; VASCULAR COGNITIVE IMPAIRMENT; ISCHEMIC BRAIN-DAMAGE; D-ASPARTATE RECEPTOR; NR2B-CONTAINING NMDA RECEPTORS; DENDRITIC SPINE MORPHOGENESIS; CHANNEL BLOCKER MEMANTINE; FOCAL CEREBRAL-ISCHEMIA; LONG-TERM POTENTIATION; ADULT-RAT BRAIN	The level of drebrin, an evolutionarily conserved f-actin-binding protein that regulates synaptic structure and function, is reduced in the brains of patients with chronic neurodegenerative diseases such as Alzheimer's disease (AD) and Down's syndrome (DS). It was suggested that excitotoxic neuronal death caused by overactivation of NMDA-type glutamate receptors (NMDARs) occurs in AD and DS; however, the relationship between excitotoxicity and drebrin loss is unknown. Here, we show that drebrin is a novel target of calpain-mediated proteolysis under excitotoxic conditions induced by the overactivation of NMDARs. In cultured rodent neurons, degradation of drebrin was confirmed by the detection of proteolytic fragments, as well as a reduction in the amount of full-length drebrin. Notably, the NMDA-induced degradation of drebrin in mature neurons occurred concomitantly with a loss of f-actin. Furthermore, pharmacological inhibition of f-actin loss facilitated the drebrin degradation, suggesting a functional linkage between f-actin and drebrin degradation. Biochemical analyses using purified drebrin and calpain revealed that calpain degraded drebrin directly in vitro. Furthermore, cerebral ischemia also induced the degradation of drebrin in vivo. These findings suggest that calpain-mediated degradation of drebrin is a fundamental pathology of neurodegenerative diseases mediated by excitotoxicity, regardless of whether they are acute or chronic. Drebrin regulates the synaptic clustering of NMDARs; therefore, degradation of drebrin under excitotoxic conditions may modulate NMDAR-mediated signal transductions, including pro-survival signaling. Overall, the results presented here provide novel insights into the molecular basis of cellular responses to excitotoxicity in vitro and in vivo.	[Chimura, Takahiko; Yoshida, Nobuaki] Univ Tokyo, Inst Med Sci, Lab Dev Genet, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Launey, Thomas] RIKEN, Brain Sci Inst, Launey Res Unit, Wako, Saitama, Japan	University of Tokyo; RIKEN	Chimura, T (corresponding author), Univ Tokyo, Inst Med Sci, Lab Dev Genet, Ctr Expt Med & Syst Biol, Tokyo, Japan.	takahiko@ims.u-tokyo.ac.jp	Launey, Thomas/A-2605-2010	Launey, Thomas/0000-0001-9153-9260	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant from Ministry of Education, Culture, Sports, Science and Technology, Japan [to TC and NY]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; ASADA H, 1994, J NEUROSCI RES, V38, P149, DOI 10.1002/jnr.490380205; Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Biou V, 2008, EUR J NEUROSCI, V27, P2847, DOI 10.1111/j.1460-9568.2008.06269.x; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, J NEUROSCI, V8, P185; Counts SE, 2012, NEURODEGENER DIS, V10, P216, DOI 10.1159/000333122; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Etherton-Beer CD, 2014, MATURITAS, V79, P220, DOI 10.1016/j.maturitas.2014.06.004; Faddis BT, 1997, J NEUROSCI, V17, P951; FURUKAWA K, 1995, EXP NEUROL, V133, P153, DOI 10.1006/exnr.1995.1018; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Gascon S, 2008, MOL PSYCHIATR, V13, P99, DOI 10.1038/sj.mp.4002017; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; GILL R, 1987, J NEUROSCI, V7, P3343; Gouix E, 2009, MOL CELL NEUROSCI, V40, P463, DOI 10.1016/j.mcn.2009.01.002; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KOJIMA N, 1993, MOL BRAIN RES, V19, P101, DOI 10.1016/0169-328X(93)90154-H; Kojima N, 2010, NEUROSCIENCE, V165, P138, DOI 10.1016/j.neuroscience.2009.10.016; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lesort M, 1997, NEUROSCI LETT, V221, P213, DOI 10.1016/S0304-3940(96)13310-3; Levine DA, 2011, NEUROTHERAPEUTICS, V8, P361, DOI 10.1007/s13311-011-0047-z; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Lynch DR, 2007, NEURON, V53, P317, DOI 10.1016/j.neuron.2007.01.014; MAEKAWA S, 1988, EXP CELL RES, V178, P127, DOI 10.1016/0014-4827(88)90384-9; MANN DMA, 1990, ACTA NEUROPATHOL, V80, P318, DOI 10.1007/BF00294651; MANN DMA, 1988, MECH AGEING DEV, V43, P99, DOI 10.1016/0047-6374(88)90041-3; McShane R., 2006, COCHRANE DATABASE SY, V2; MELDRUM BS, 1987, MED BIOL, V65, P153; Mikati MA, 2013, J BIOL CHEM, V288, P19926, DOI 10.1074/jbc.M113.472647; Mizui T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085367; Mizui T, 2009, J NEUROCHEM, V109, P611, DOI 10.1111/j.1471-4159.2009.05993.x; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schroeter M, 2002, J NEUROSCI METH, V117, P43, DOI 10.1016/S0165-0270(02)00072-9; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; SHIRAO T, 1986, DEV BRAIN RES, V29, P233, DOI 10.1016/0165-3806(86)90099-4; Shirao T, 1990, Neurosci Res Suppl, V13, pS106, DOI 10.1016/0921-8696(90)90039-6; SHIRAO T, 1985, J NEUROCHEM, V44, P1210, DOI 10.1111/j.1471-4159.1985.tb08745.x; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Song M, 2008, NEUROSCIENCE, V152, P670, DOI 10.1016/j.neuroscience.2007.10.068; Stieg PE, 1999, EUR J PHARMACOL, V375, P115, DOI 10.1016/S0014-2999(99)00214-9; SWAN JH, 1990, J CEREBR BLOOD F MET, V10, P343, DOI 10.1038/jcbfm.1990.63; Takahashi H, 2006, J NEUROCHEM, V97, P110, DOI 10.1111/j.1471-4159.2005.03536.x; Takahashi H, 2003, J NEUROSCI, V23, P6586; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang XL, 2013, NEUROTOXICOLOGY, V35, P106, DOI 10.1016/j.neuro.2013.01.003; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Yamazaki H, 2014, J NEUROCHEM, V128, P507, DOI 10.1111/jnc.12486; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	84	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125119	10.1371/journal.pone.0125119	http://dx.doi.org/10.1371/journal.pone.0125119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905636	gold, Green Submitted, Green Published			2022-12-26	WOS:000353332000104
J	Lemesle, G; Maury, F; Beseme, O; Ovart, L; Amouyel, P; Lamblin, N; de Groote, P; Bauters, C; Pinet, F				Lemesle, Gilles; Maury, Fleur; Beseme, Olivia; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence			Multimarker Proteomic Profiling for the Prediction of Cardiovascular Mortality in Patients with Chronic Heart Failure	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; RISK STRATIFICATION; SURVIVAL; SERUM; BIOMARKERS; PROTEINS; MODELS; CANCER	Risk stratification of patients with systolic chronic heart failure (HF) is critical to better identify those who may benefit from invasive therapeutic strategies such as cardiac transplantation. Proteomics has been used to provide prognostic information in various diseases. Our aim was to investigate the potential value of plasma proteomic profiling for risk stratification in HF. A proteomic profiling using surface enhanced laser desorption ionization - time of flight - mass spectrometry was performed in a case/control discovery population of 198 patients with systolic HF (left ventricular ejection fraction <45%): 99 patients who died from cardiovascular cause within 3 years and 99 patients alive at 3 years. Proteomic scores predicting cardiovascular death were developed using 3 regression methods: support vector machine, sparse partial least square discriminant analysis, and lasso logistic regression. Forty two ion m/z peaks were differentially intense between cases and controls in the discovery population and were used to develop proteomic scores. In the validation population, score levels were higher in patients who subsequently died within 3 years. Similar areas under the curves (0.66 - 0.68) were observed for the 3 methods. After adjustment on con-founders, proteomic scores remained significantly associated with cardiovascular mortality. Use of the proteomic scores allowed a significant improvement in discrimination of HF patients as determined by integrated discrimination improvement and net reclassification improvement indexes. In conclusion, proteomic analysis of plasma proteins may help to improve risk prediction in HF patients.	[Lemesle, Gilles; Maury, Fleur; Beseme, Olivia; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence] INSERM, UMR1167, F-59045 Lille, France; [Lemesle, Gilles; Maury, Fleur; Beseme, Olivia; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Lemesle, Gilles; Beseme, Olivia; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe; Pinet, Florence] Univ Lille Nord France, Lille, France; [Lemesle, Gilles; Maury, Fleur; Ovart, Lionel; Amouyel, Philippe; Lamblin, Nicolas; de Groote, Pascal; Bauters, Christophe] CHRU Lille, F-59037 Lille, France; [Lemesle, Gilles; Amouyel, Philippe; Lamblin, Nicolas; Bauters, Christophe] Fac Med Lille, F-59045 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Pinet, F (corresponding author), INSERM, UMR1167, F-59045 Lille, France.	florence.pinet@pasteur-lille.fr	Pinet, Florence/F-2892-2013	Pinet, Florence/0000-0002-5471-1487; Amouyel, Philippe/0000-0001-9088-234X; Lemesle, Gilles/0000-0002-2917-9273; de Groote, Pascal/0000-0002-6211-0147; Bauters, christophe/0000-0001-8268-8467; LAMBLIN, NICOLAS/0000-0003-3754-1241	Agence Nationale de la Recherche" [ANR-11-EMMA-029-01]; E.U. FP7 HOMAGE [305507]	Agence Nationale de la Recherche"(French National Research Agency (ANR)); E.U. FP7 HOMAGE	This work was funded by Agence Nationale de la Recherche" (ANR-11-EMMA-029-01), E.U. FP7 HOMAGE (305507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluco C, 2007, ANN SURG ONCOL, V14, P2470, DOI 10.1245/s10434-007-9354-3; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Chung D., 2013, SPLS SPARSE PARTIAL; CINTRON G, 1993, CIRCULATION, V87, P17; de Groote P, 2004, EUR HEART J, V25, P656, DOI 10.1016/j.ehj.2004.01.010; de Groote P, 2004, J AM COLL CARDIOL, V43, P1584, DOI 10.1016/j.jacc.2003.11.059; de Groote P, 2014, CIRC-HEART FAIL, V7, P434, DOI 10.1161/CIRCHEARTFAILURE.113.000813; de Groote P, 2012, EUR HEART J, V33, P2672, DOI 10.1093/eurheartj/ehs080; Dubois E, 2011, PROTEOM CLIN APPL, V5, P57, DOI 10.1002/prca.201000056; Fertin M, 2010, PROTEOM CLIN APPL, V4, P654, DOI 10.1002/prca.200900178; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guerrier L, 2006, J CHROMATOGR B, V833, P33, DOI 10.1016/j.jchromb.2005.12.048; Hernandez B, 2014, PROTEOMICS, V14, P1587, DOI 10.1002/pmic.201300377; Hillege HL, 2000, CIRCULATION, V102, P203, DOI 10.1161/01.CIR.102.2.203; Hoes A. W., 1998, European Heart Journal, V19, pL2; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Motiwala SR, 2014, CLIN CHEM, V60, P35, DOI 10.1373/clinchem.2013.202531; Myers J, 2014, INT J CARDIOL, V171, P265, DOI 10.1016/j.ijcard.2013.12.031; Nkuipou-Kenfack E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096955; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Peterman S, 2014, PROTEOMICS, V14, P1445, DOI 10.1002/pmic.201300300; Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Thulasiraman V, 2005, ELECTROPHORESIS, V26, P3561, DOI 10.1002/elps.200500147; Vermaat JS, 2010, ANN ONCOL, V21, P1472, DOI 10.1093/annonc/mdp559	28	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119265	10.1371/journal.pone.0119265	http://dx.doi.org/10.1371/journal.pone.0119265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905469	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000004
J	Melcer, T; Danielewska, ME; Iskander, DR				Melcer, Tomasz; Danielewska, Monika E.; Iskander, D. Robert			Wavelet Representation of the Corneal Pulse for Detecting Ocular Dicrotism	PLOS ONE			English	Article							INDENTATION PULSE; TIME-FREQUENCY; SYSTEM	Purpose To develop a reliable and powerful method for detecting the ocular dicrotism from non-invasively acquired signals of corneal pulse without the knowledge of the underlying cardiopulmonary information present in signals of ocular blood pulse and the electrical heart activity. Methods Retrospective data from a study on glaucomatous and age-related changes in corneal pulsation [PLOS ONE 9(7),(2014):e102814] involving 261 subjects was used. Continuous wavelet representation of the signal derivative of the corneal pulse was considered with a complex Gaussian derivative function chosen as mother wavelet. Gray-level Co-occurrence Matrix has been applied to the image (heat-maps) of CWT to yield a set of parameters that can be used to devise the ocular dicrotic pulse detection schemes based on the Conditional Inference Tree and the Random Forest models. The detection scheme was first tested on synthetic signals resembling those of a dicrotic and a non-dicrotic ocular pulse before being used on all 261 real recordings. Results A detection scheme based on a single feature of the Continuous Wavelet Transform of the corneal pulse signal resulted in a low detection rate. Conglomeration of a set of features based on measures of texture (homogeneity, correlation, energy, and contrast) resulted in a high detection rate reaching 93%. Conclusion It is possible to reliably detect a dicrotic ocular pulse from the signals of corneal pulsation without the need of acquiring additional signals related to heart activity, which was the previous state-of-the-art. The proposed scheme can be applied to other non-stationary biomedical signals related to ocular dynamics.	[Melcer, Tomasz; Danielewska, Monika E.; Iskander, D. Robert] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland	Wroclaw University of Science & Technology	Melcer, T (corresponding author), Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland.	tomasz.melcer@pwr.edu.pl	Iskander, D Robert/E-3576-2017	Iskander, D Robert/0000-0002-5962-6206				Aha D.W., 1996, LEARNING DATALECTURE, P199, DOI DOI 10.1007/978-1-4612-2404-4_19; Asejczyk-Widlicka M, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-30; Boudaoud S, 2005, IEEE T SIGNAL PROCES, V53, P3644, DOI 10.1109/TSP.2005.855106; Bracic M, 1998, B MATH BIOL, V60, P919, DOI 10.1006/bulm.1998.0047; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Christopoulos C, 2000, IEEE T CONSUM ELECTR, V46, P1103, DOI 10.1109/30.920468; COHEN L, 1989, P IEEE, V77, P941, DOI 10.1109/5.30749; Danielewska ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102814; Danielewska ME, 2014, OPTOMETRY VISION SCI, V91, P54, DOI 10.1097/OPX.0000000000000113; Danielsson R, 2002, ANAL CHIM ACTA, V454, P167, DOI 10.1016/S0003-2670(01)01574-4; Dion C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054207; Ducla-Soares JL, 2007, EXP PHYSIOL, V92, P677, DOI 10.1113/expphysiol.2007.038026; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; Gargour C, 2009, IEEE CIRC SYST MAG, V9, P57, DOI 10.1109/MCAS.2009.932556; GROSSMANN A, 1986, ANN I H POINCARE-PHY, V45, P293; Grunwald JE, 1998, ARCH OPHTHALMOL-CHIC, V116, P150; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HORVEN I, 1972, NEUROLOGY, V22, P92, DOI 10.1212/WNL.22.1.92; HORVEN I, 1971, ARCH OPHTHALMOL-CHIC, V86, P5, DOI 10.1001/archopht.1971.01000010007002; Hothorn T, 2014, TECHNICAL REPORT; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kasprzak HT, 2007, EYE, V21, P1212, DOI 10.1038/sj.eye.6702578; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097943; Kowalska MA, 2011, IEEE T BIO-MED ENG, V58, P674, DOI 10.1109/TBME.2010.2100819; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Licznerski TJ, 2011, ULTRASONICS, V51, P960, DOI 10.1016/j.ultras.2011.05.011; Mainardi LT, 2009, PHILOS T R SOC A, V367, P255, DOI 10.1098/rsta.2008.0188; MEADOWS WR, 1971, AM HEART J, V82, P596, DOI 10.1016/0002-8703(71)90328-0; NORTHROP RB, 1977, IEEE T BIO-MED ENG, V24, P139, DOI 10.1109/TBME.1977.326118; ORCHARD RC, 1980, CIRCULATION, V62, P1107, DOI 10.1161/01.CIR.62.5.1107; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Ravalico G, 1996, INVEST OPHTH VIS SCI, V37, P2645; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; SMITH D, 1986, BRIT HEART J, V56, P531; Unser M, 1996, P IEEE, V84, P626, DOI 10.1109/5.488704; Zeitz O, 2006, BRIT J OPHTHALMOL, V90, P1245, DOI 10.1136/bjo.2006.093633; ZUCKERMAN JL, 1977, INVEST OPHTH VIS SCI, V16, P1018	40	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124721	10.1371/journal.pone.0124721	http://dx.doi.org/10.1371/journal.pone.0124721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906236	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000083
J	Zieminska, K; Westoby, M; Wright, IJ				Zieminska, Kasia; Westoby, Mark; Wright, Ian J.			Broad Anatomical Variation within a Narrow Wood Density Range-A Study of Twig Wood across 69 Australian Angiosperms	PLOS ONE			English	Article							EMBOLISM REPAIR; SAPWOOD CAPACITANCE; JAPANESE HARDWOODS; XYLEM EMBOLISM; TRAITS; TREES; BIOMECHANICS; DIMENSIONS; STORAGE; STEMS	Objectives Just as people with the same weight can have different body builds, woods with the same wood density can have different anatomies. Here, our aim was to assess the magnitude of anatomical variation within a restricted range of wood density and explore its potential ecological implications. Methods Twig wood of 69 angiosperm tree and shrub species was analyzed. Species were selected so that wood density varied within a relatively narrow range (0.38- 0.62 g cm(-3)). Anatomical traits quantified included wood tissue fractions (fibres, axial parenchyma, ray parenchyma, vessels, and conduits with maximum lumen diameter below 15 mu m), vessel properties, and pith area. To search for potential ecological correlates of anatomical variation the species were sampled across rainfall and temperature contrasts, and several other ecologically-relevant traits were measured (plant height, leaf area to sapwood area ratio, and modulus of elasticity). Results Despite the limited range in wood density, substantial anatomical variation was observed. Total parenchyma fraction varied from 0.12 to 0.66 and fibre fraction from 0.20 to 0.74, and these two traits were strongly inversely correlated (r = -0.86, P < 0.001). Parenchyma was weakly (0.24 <= |r| <= 0.35, P < 0.05) or not associated with vessel properties nor with height, leaf area to sapwood area ratio, and modulus of elasticity (0.24 <= |r| <= 0.41, P < 0.05). However, vessel traits were fairly well correlated with height and leaf area to sapwood area ratio (0.47 <= |r| <= 0.65, all P < 0.001). Modulus of elasticity was mainly driven by fibre wall plus vessel wall fraction rather than by the parenchyma component. Conclusions Overall, there seem to be at least three axes of variation in xylem, substantially independent of each other: a wood density spectrum, a fibre-parenchyma spectrum, and a vessel area spectrum. The fibre-parenchyma spectrum does not yet have any clear or convincing ecological interpretation.	[Zieminska, Kasia; Westoby, Mark; Wright, Ian J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Zieminska, K (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	kasia.s.zieminska@gmail.com	Wright, Ian J/G-4979-2012; Yang, Da/L-6267-2013	Wright, Ian J/0000-0001-8338-9143; Yang, Da/0000-0001-7306-3289; Westoby, Mark/0000-0001-7690-4530	International Macquarie University; James Cook University	International Macquarie University; James Cook University	This study was funded by an International Macquarie University Research Excellence Scholarship awarded to Kasia Zieminska. Work at the Daintree Rainforest Observatory was sponsored by a James Cook University student grant awarded jointly to Kasia Zieminska and Julieta Rosell (for two separate projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameglio T, 2004, TREE PHYSIOL, V24, P785, DOI 10.1093/treephys/24.7.785; [Anonymous], 2009, GLOBAL WOOD DENSITY; BEERY WH, 1983, WOOD FIBER SCI, V15, P395; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Burgert I, 2001, TREES-STRUCT FUNCT, V15, P168, DOI 10.1007/s004680000086; Carlquist S., 2001, COMP WOOD ANATOMY; Chapotin SM, 2006, AM J BOT, V93, P1251, DOI 10.3732/ajb.93.9.1251; CHATTAWAY MM, 1949, AUST J SCI RES SER B, V2, P227; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cochard H, 2015, PLANT CELL ENVIRON, V38, P201, DOI 10.1111/pce.12391; Delzon S, 2014, NEW PHYTOL, V203, P355, DOI 10.1111/nph.12798; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; Fichtler E, 2012, IAWA J, V33, P119, DOI 10.1163/22941932-90000084; Fortunel C, 2014, NEW PHYTOL, V202, P79, DOI 10.1111/nph.12632; FUJIWARA S, 1991, IAWA BULL, V12, P419, DOI 10.1163/22941932-90000544; FUJIWARA S, 1992, IAWA BULL, V13, P397, DOI 10.1163/22941932-90001295; GERLACH D., 1972, ZARYS MIKROTECHNIKI; GORDON R, 1987, J THEOR BIOL, V126, P419, DOI 10.1016/S0022-5193(87)80149-2; Grime J.P., 2006, PLANT STRATEGIES VEG; Grote K.H., 2009, SPRINGER HDB MECH EN, V1st; Grubb Peter J., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P3, DOI 10.1078/1433-8319-00049; Hepworth DG, 2002, PHILOS T ROY SOC A, V360, P255, DOI 10.1098/rsta.2001.0927; Holbrook N. Michelle, 1995, P151; IAWA Committee, 1989, IAWA B N S, V10, P219, DOI DOI 10.1163/22941932-90000496; Jacobsen AL, 2007, J ECOL, V95, P171, DOI 10.1111/j.1365-2745.2006.01186.x; Martinez-Cabrera HI, 2011, AM J BOT, V98, P915, DOI 10.3732/ajb.1000335; Martinez-Cabrera HI, 2009, AM J BOT, V96, P1388, DOI 10.3732/ajb.0800237; Meinzer FC, 2003, PLANT CELL ENVIRON, V26, P1147, DOI 10.1046/j.1365-3040.2003.01039.x; Meinzer FC, 2008, TREE PHYSIOL, V28, P1609, DOI 10.1093/treephys/28.11.1609; Mitchell P, 2008, OECOLOGIA, V158, P385, DOI 10.1007/s00442-008-1152-5; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; Nardini A, 2011, PLANT SCI, V180, P604, DOI 10.1016/j.plantsci.2010.12.011; Onoda Y, 2010, NEW PHYTOL, V185, P493, DOI 10.1111/j.1469-8137.2009.03088.x; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Pratt RB, 2007, NEW PHYTOL, V174, P787, DOI 10.1111/j.1469-8137.2007.02061.x; Rana R, 2009, TREES-STRUCT FUNCT, V23, P521, DOI 10.1007/s00468-008-0298-4; Richards AE, 2014, FUNCT ECOL, V28, P734, DOI 10.1111/1365-2435.12193; Rodriguez-Perez MA, 2011, J APPL POLYM SCI, V121, P2324, DOI 10.1002/app.33946; Romero C, 2008, CAN J FOREST RES, V38, P611, DOI 10.1139/X07-205; Rosell JA, 2014, NEW PHYTOL, V201, P486, DOI 10.1111/nph.12541; Salleo S, 2004, PLANT CELL ENVIRON, V27, P1065, DOI 10.1111/j.1365-3040.2004.01211.x; Scholz FG, 2007, PLANT CELL ENVIRON, V30, P236, DOI 10.1111/j.1365-3040.2006.01623.x; Secchi F, 2011, PLANT CELL ENVIRON, V34, P514, DOI 10.1111/j.1365-3040.2010.02259.x; SHIGO AL, 1984, ANNU REV PHYTOPATHOL, V22, P189, DOI 10.1146/annurev.py.22.090184.001201; Smith DM, 1967, 79 FPL US FOR SERV, V79; Sperry J, 2013, PLANT CELL ENVIRON, V36, P1916, DOI 10.1111/pce.12148; SPERRY JS, 1994, ECOLOGY, V75, P1736, DOI 10.2307/1939633; Spicer R, 2014, J EXP BOT, V65, P1829, DOI 10.1093/jxb/ert459; Torres-Ruiz JM, 2015, PLANT PHYSIOL, V167, P40, DOI 10.1104/pp.114.249706; Trifilo P, 2014, PLANT CELL ENVIRON, V37, P2491, DOI 10.1111/pce.12313; Trifilo P, 2014, TREE PHYSIOL, V34, P109, DOI 10.1093/treephys/tpt119; Tyree MT, 2002, XYLEM STRUCTURE AND; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wheeler JK, 2013, PLANT CELL ENVIRON, V36, P1938, DOI 10.1111/pce.12139; Woodrum CL, 2003, AM J BOT, V90, P693, DOI 10.3732/ajb.90.5.693; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zheng JM, 2013, ANN BOT-LONDON, V112, P927, DOI 10.1093/aob/mct153; Zieminska K, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt046; Zimmermann MH, 1979, IAWA B, V2-3, P51; Zwieniecki MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00265	61	48	50	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124892	10.1371/journal.pone.0124892	http://dx.doi.org/10.1371/journal.pone.0124892			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906320	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000092
J	von Bargen, K; Gagnaire, A; Arce-Gorvel, V; de Bovis, B; Baudimont, F; Chasson, L; Bosilkovski, M; Papadopoulos, A; Martirosyan, A; Henri, S; Mege, JL; Malissen, B; Gorvel, JP				von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Bosilkovski, Mile; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Mege, Jean-Louis; Malissen, Bernard; Gorvel, Jean-Pierre			Cervical Lymph Nodes as a Selective Niche for Brucella during Oral Infections	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PERITONEAL-MACROPHAGES; ABORTUS INFECTION; GAMMA-INTERFERON; IMMUNE-RESPONSE; DENDRITIC CELLS; T-CELLS; IN-VIVO; TOLERANCE; SALMONELLA	Cervical lymph nodes (CLN) are the first lymph nodes encountered by material taking the oral route. To study their role in orally acquired infections, we analyzed 307 patients of up to 14 years treated in the university clinic of Skopje, Macedonia, for brucellosis, a zoonotic bacterial disease frequently acquired by ingestion of contaminated dairy products. From these children, 36% had lymphadenopathy. Among orally infected children, lymphadenopathy with CLN being the only lymph nodes affected was significantly more frequent as compared to those infected by contact with animals (83% vs. 63%), suggesting a possible involvement of CLN during orally acquired human brucellosis. Using a murine model where bacteria are delivered into the oral cavity, we show that Brucella quickly and selectively colonize the CLN where they proliferate and persist over long periods of time for up to 50 days post-infection. A similar efficient though less specific drainage to CLN was found for Brucella, Salmonella typhimurium and fluorescent microspheres delivered by gavage, a pathway likely representing a mixed infection mode of intragastric and oral infection, suggesting a central pathway of drained material. Microspheres as well as bacteria drained to CLN predominately reside in cells expressing CD68 and no or low levels of CD11c. Even though no systemic response could be detected, Brucella induced a locally restricted inflammatory reaction with increased expression levels of interferon., interleukin (IL)-6, IL-12, granzyme B and a delayed induction of Nos2. Inflammation led to pronounced lymphadenopathy, infiltration of macrophages/monocytes expressing high levels of major histocompatibility complex II and to formation of epitheloid granulomas. Together, these results highlight the role of CLN in oral infections as both, an initial and efficient trap for bacterial invaders and as possible reservoir for chronic pathogens. They likewise cast a new light on the significance of oral routes for means of vaccination.	[von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Malissen, Bernard; Gorvel, Jean-Pierre] Aix Marseille Univ, CIML, UM2, Marseille, France; [von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Malissen, Bernard; Gorvel, Jean-Pierre] INSERM, U1104, F-13258 Marseille, France; [von Bargen, Kristine; Gagnaire, Aurelie; Arce-Gorvel, Vilma; de Bovis, Beatrice; Baudimont, Fannie; Chasson, Lionel; Papadopoulos, Alexia; Martirosyan, Anna; Henri, Sandrine; Malissen, Bernard; Gorvel, Jean-Pierre] CNRS, UMR7280, Marseille, France; [Bosilkovski, Mile] Univ Clin Infect Dis & Febrile Condit, Skopje, North Macedonia; [Mege, Jean-Louis] Aix Marseille Univ, CNRS, Fac Med, Unite Rickettsies,UMR6020, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gorvel, JP (corresponding author), Aix Marseille Univ, CIML, UM2, Marseille, France.	gorvel@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; Henri, Sandrine/O-3045-2016; MEGE, JEAN-LOUIS/O-6063-2016; Malissen, Bernard/AAK-4659-2020	Gorvel, Jean-Pierre/0000-0002-2829-9804; Arce-Gorvel, Vilma/0000-0003-0090-837X; HENRI, Sandrine/0000-0002-8980-9193; Malissen, Bernard/0000-0003-1340-9342; Gagnaire, Aurelie/0000-0001-9536-8438	Fondation pour la recherche Medicale; Institut National Pour la sante et la Recherche Medicale; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche	Fondation pour la recherche Medicale(Fondation pour la Recherche Medicale); Institut National Pour la sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Funding: Funding was provided by Fondation pour la recherche Medicale to AM; Institut National Pour la sante et la Recherche Medicale to JPG BM JLM; Centre National de la Recherche Scientifique to JPG BM JLM; Agence Nationale de la Recherche to JPG KvB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; CARON E, 1994, INFECT IMMUN, V62, P5267, DOI 10.1128/IAI.62.12.5267-5274.1994; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; Corbel M.J, 2006, BRUC HUM AN; Corthesy-Theulaz IE, 1998, INFECT IMMUN, V66, P581; Dasaraju PV, 1996, MED MICROBIOLOGY; Dokuzoguz B, 2005, J INFECTION, V50, P41, DOI 10.1016/j.jinf.2004.02.005; Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003; Eze MO, 2000, INFECT IMMUN, V68, P257, DOI 10.1128/IAI.68.1.257-263.2000; Fernandez-Lago L, 2005, J MED MICROBIOL, V54, P527, DOI 10.1099/jmm.0.45936-0; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487; Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761; Gorvel JP, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2012-c1; Gosche John R, 2006, Semin Pediatr Surg, V15, P99, DOI 10.1053/j.sempedsurg.2006.02.007; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Gross A, 1998, INFECT IMMUN, V66, P1309, DOI 10.1128/IAI.66.4.1309-1316.1998; Gur A, 2003, YONSEI MED J, V44, P33, DOI 10.3349/ymj.2003.44.1.33; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; JONES SM, 1992, INFECT IMMUN, V60, P3011, DOI 10.1128/IAI.60.7.3011-3014.1992; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lee JJ, 2012, COMP IMMUNOLOGY MICR; LULU AR, 1988, Q J MED, V66, P39; MCCABE RE, 1987, REV INFECT DIS, V9, P754; MCCULLOUGH N B, 1970, P324; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; MOUSA ARM, 1988, REV INFECT DIS, V10, P211; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Neelakantan S, 2013, BMJ CASE REP, V2013; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; Nobrega C, 2007, MICROBES INFECT, V9, P1521, DOI 10.1016/j.micinf.2007.08.006; Nobrega C, 2010, J IMMUNOL, V184, P351, DOI 10.4049/jimmunol.0902152; Nunes-Alves C, 2013, TRENDS IMMUNOL, V34, P502, DOI 10.1016/j.it.2013.06.004; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Plommet M, 1976, Ann Rech Vet, V7, P1; Plommet M., 1977, STUDIES EXPT BRUCELL; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Spink WW, 1956, NATURE BRUCELLOSIS; Tessaro SV, 2004, J WILDLIFE DIS, V40, P60, DOI 10.7589/0090-3558-40.1.60; Troy SB, 2005, MEDICINE, V84, P174, DOI 10.1097/01.md.0000165659.20988.25; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van Helvoort JMLM, 2004, ALLERGY, V59, P1211, DOI 10.1111/j.1398-9995.2004.00510.x; Wolvers DAW, 1999, J IMMUNOL, V162, P1994; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yamazaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051665; YINNON AM, 1993, ISRAEL J MED SCI, V29, P11; Zhan YF, 1996, INFECT IMMUN, V64, P2782, DOI 10.1128/IAI.64.7.2782-2786.1996; Zumla A, 1996, CLIN INFECT DIS, V23, P146, DOI 10.1093/clinids/23.1.146	66	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0121790	10.1371/journal.pone.0121790	http://dx.doi.org/10.1371/journal.pone.0121790			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919005	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400010
J	Dai, YC; Zhang, XF; Xia, M; Tan, M; Quigley, C; Lei, W; Fang, H; Zhong, WM; Lee, B; Pang, XL; Nie, J; Jiang, X				Dai, Ying-Chun; Zhang, Xu-Fu; Xia, Ming; Tan, Ming; Quigley, Christina; Lei, Wen; Fang, Hao; Zhong, Weiming; Lee, Bonita; Pang, Xiaoli; Nie, Jun; Jiang, Xi			Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; CAPSID PROTEIN FORMS; UNITED-STATES; STRUCTURAL BASIS; ACUTE GASTROENTERITIS; BINDING SPECIFICITY; P-DOMAIN; OUTBREAKS; STRAIN; RECOGNITION	The GII.4 noroviruses (NoVs) are a single genotype that is responsible for over 50% of NoV gastroenteritis epidemics worldwide. However, GII.4 NoVs have been found to undergo antigenic drifts, likely selected by host herd immunity, which raises an issue for vaccine strategies against NoVs. We previously characterized GII.4 NoV antigenic variations and found significant levels of antigenic relatedness among different GII.4 variants. Further characterization of the genetic and antigenic relatedness of recent GII.4 variants (2008b and 2010 cluster) was performed in this study. The amino acid sequences of the receptor binding interfaces were highly conserved among all GII.4 variants from the past two decades. Using serum samples from patients enrolled in a GII.4 virus challenge study, significant cross-reactivity between major GII.4 variants from 1998 to 2012 was observed using enzyme-linked immunosorbent assays and HBGA receptor blocking assays. The overall abilities of GII.4 NoVs to bind to the A/B/H HBGAs were maintained while their binding affinities to individual ABH antigens varied. These results highlight the importance of human HBGAs in NoV evolution and how conserved antigenic types impact vaccine development against GII.4 variants.	[Dai, Ying-Chun; Nie, Jun] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Xu-Fu] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Dai, Ying-Chun; Zhang, Xu-Fu; Xia, Ming; Tan, Ming; Quigley, Christina; Lei, Wen; Fang, Hao; Zhong, Weiming; Jiang, Xi] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Tan, Ming; Jiang, Xi] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Lee, Bonita; Pang, Xiaoli] Prov Lab Publ Hlth ProvLab, Edmonton, AB, Canada; [Lee, Bonita; Pang, Xiaoli] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada	Southern Medical University - China; Southern Medical University - China; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Alberta	Nie, J (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	niejun@fimmu.com; jason.jiang@cchmc.org	Xia, Ming/AAY-7154-2021	Zhang, Xufu/0000-0002-7178-2412	National Institutes of Health of the United States [R01 AI 055649, R01 AI 37093, R01 AI 089634, P01 HD 13021]; Agriculture and Food Research Initiative Competitive Grants Program of the USDA National Institute of Food and Agriculture, NIFA [2011-68003-30005]; National Natural Science Foundation of China [81473402]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD013021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055649, R01AI089634, R01AI037093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agriculture and Food Research Initiative Competitive Grants Program of the USDA National Institute of Food and Agriculture, NIFA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: the National Institutes of Health of the United States (R01 AI 055649, R01 AI 37093, R01 AI 089634 and P01 HD 13021); the Agriculture and Food Research Initiative Competitive Grants Program of the USDA National Institute of Food and Agriculture, NIFA Award No.: 2011-68003-30005; and the National Natural Science Foundation of China (81473402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Dai YC, 2012, J VIROL METHODS, V186, P126, DOI 10.1016/j.jviromet.2012.07.002; Dai YC, 2011, ARCH VIROL, V156, P1641, DOI 10.1007/s00705-011-1010-3; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Fang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063269; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fonager J, 2013, EURO SURVEILL, V18; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall AJ, 2012, EMERG INFECT DIS, V18, P1566, DOI 10.3201/eid1810.120833; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Kitamoto N, 2002, J CLIN MICROBIOL, V40, P2459, DOI 10.1128/JCM.40.7.2459-2465.2002; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Le VP, 2010, J MED VIROL, V82, P1065, DOI 10.1002/jmv.21761; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Parra GI, 2012, J VIROL, V86, P7414, DOI 10.1128/JVI.06729-11; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Schwartz S, 2011, BLOOD, V117, P5850, DOI 10.1182/blood-2010-12-325886; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.2; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005058; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Wikswo Mary E., 2012, Morbidity and Mortality Weekly Report, V61, P1; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Zhang XF, 2012, BIOORGAN MED CHEM, V20, P1616, DOI 10.1016/j.bmc.2011.11.040; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	50	10	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124945	10.1371/journal.pone.0124945	http://dx.doi.org/10.1371/journal.pone.0124945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915764	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100081
J	Gleason, RL; Caulk, AW; Seifu, D; Parker, I; Vidakovic, B; Getenet, H; Assefa, G; Amogne, W				Gleason, Rudolph L., Jr.; Caulk, Alexander W.; Seifu, Daniel; Parker, Ivana; Vidakovic, Brani; Getenet, Helena; Assefa, Getachew; Amogne, Wondwossen			Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; ENDOTHELIAL FUNCTION; MYOCARDIAL-INFARCTION; ARTERIAL STIFFNESS; RISK-FACTORS; ADHESION MOLECULES; ISCHEMIC-STROKE	Background HIV patients on antiretroviral therapy have shown elevated incidence of dyslipidemia, lipodystrophy, and cardiovascular disease (CVD). Most studies, however, focus on cohorts from developed countries, with less data available for these co-morbidities in Ethiopia and sub-Saharan Africa. Methods Adult HIV-negative (n = 36), treatment naive (n = 51), efavirenz (EFV)-treated (n = 91), nevi-rapine (NVP)-treated (n = 95), or ritonavir-boosted lopinavir (LPV/r)-treated (n= 44) subjects were recruited from Black Lion Hospital in Addis Ababa, Ethiopia. Aortic pressure, augmentation pressure, and pulse wave velocity (PWV) were measured via applanation tonometry and carotid intima-media thickness (cIMT) and carotid arterial stiffness, and brachial artery flow-mediated dilation (FMD) were measured via non-invasive ultrasound. Body mass index, waist-to-hip circumference ratio (WHR), skinfold thickness, and self-reported fat redistribution were used to quantify lipodystrophy. CD4+ cell count, plasma HIV RNA levels, fasting glucose, total-, HDL-, and LDL-cholesterol, triglycerides, hsCRP, sVCAM-1, sICAM-1, leptin and complete blood count were measured. Results PWV and normalized cIMT were elevate and FMD impaired in EFV- and LPV/r-treated subjects compared to NVP-treated subjects; normalized cIMT was also elevated and FMD impaired in the EFV- and LPV/r-treated subjects compared to treatment-naive subjects. cIMT was not statistically different across groups. Treated subjects exhibited elevated markers of dyslipidemia, inflammation, and lipodystrophy. PWV was associated with age, current EFV and LPV/r used, heart rate, blood pressure, triglycerides, LDL, and hsCRP, FMD with age, HIV duration, WHR, and glucose, and cIMT with age, current EFV use, skin-fold thickness, and blood pressure. Conclusions Current EFV- or LPV/r-treatment, but not NVP-treatment, correlated with elevated markers of atherosclerosis, which may involve mechanisms distinct from traditional risk factors.	[Gleason, Rudolph L., Jr.; Caulk, Alexander W.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Gleason, Rudolph L., Jr.; Parker, Ivana; Vidakovic, Brani] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Gleason, Rudolph L., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Seifu, Daniel] Univ Addis Ababa, Fac Med, Dept Biochem, Addis Ababa, Ethiopia; [Getenet, Helena; Amogne, Wondwossen] Univ Addis Ababa, Fac Med, Dept Internal Med, Addis Ababa, Ethiopia; [Assefa, Getachew] Univ Addis Ababa, Fac Med, Dept Radiol, Addis Ababa, Ethiopia	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Addis Ababa University; Addis Ababa University; Addis Ababa University	Gleason, RL (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	rudy.gleason@me.gatech.edu	Amogne, Wondwossen/AGM-9855-2022; Degu, Wondwossen Amogne/GON-3590-2022		Fulbright Scholars Program [11-21255]; American Heart Association [11GRNT7990055]	Fulbright Scholars Program; American Heart Association(American Heart Association)	Funding from Fulbright Scholars Program (11-21255, RLG) and American Heart Association (11GRNT7990055, RLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT DK, 1994, AM J EPIDEMIOL, V140, P669, DOI 10.1093/oxfordjournals.aje.a117315; Baker J, 2010, J INFECT DIS, V201, P285, DOI 10.1086/649560; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Blum A, 2005, CLIN CARDIOL, V28, P149, DOI 10.1002/clc.4960280311; Bonnet D, 2004, AIDS, V18, P1037, DOI 10.1097/00002030-200404300-00012; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P304, DOI 10.1097/QAI.0b013e31815e7453; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Charakida M, 2005, CIRCULATION; Chironi G, 2003, JAIDS-J ACQ IMM DEF, V32, P490, DOI 10.1097/00126334-200304150-00004; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Currier JS, 2005, AIDS, V19, P927, DOI 10.1097/01.aids.0000171406.53737.f9; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; Dolan SE, 2005, JAIDS-J ACQ IMM DEF, V39, P44, DOI 10.1097/01.qai.0000159323.59250.83; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Estrada V, 2011, AIDS REV, V13, P49; Falcone EL, 2011, ANTIVIR THER, V16, P1, DOI 10.3851/IMP1682; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; GATTEGNO L, 1995, CELL ADHES COMMUN, V3, P179, DOI 10.3109/15419069509081285; Gougeon ML, 2004, ANTIVIR THER, V9, P161; Grubb JR, 2006, J INFECT DIS, V193, P1516, DOI 10.1086/503807; Gupta SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045716; Hansen L, AZT INDUCES INTIMA M; Hansen L, 2013, J BIOMECHAN IN PRESS; Hansen L, 2013, J BIOMECH, V46, P1540, DOI 10.1016/j.jbiomech.2013.03.021; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Johnsen S, 2006, J CLIN ENDOCR METAB, V91, P4916, DOI 10.1210/jc.2006-1140; JOSHI V V, 1987, Pediatric Pathology, V7, P261; Kaplan RC, 2011, T CELL ACTIVATION PR; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kline ER, 2008, J INVEST MED, V56, P752, DOI 10.1097/JIM.0b013e3181788d15; Kowalska JD, 2010, HIV MED, V11, P200, DOI 10.1111/j.1468-1293.2009.00763.x; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Lichtner Miriam, 2009, Atherosclerosis, V204, pe1, DOI 10.1016/j.atherosclerosis.2008.12.025; Longenecker C, 2013, HIV MED; Loonam CR, 2012, NUTR RES REV, V25, P267, DOI 10.1017/S0954422411000138; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Lorenz MW, 2007, ATHEROSCLEROSIS; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Maggi P, 2004, AIDS, V18, P1023, DOI 10.1097/00002030-200404300-00010; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Maniker AH, 1996, SURG NEUROL, V46, P49, DOI 10.1016/0090-3019(96)00030-4; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Masia M, 2007, ATHEROSCLEROSIS, V195, P167, DOI 10.1016/j.atherosclerosis.2006.09.013; Masia M, 2010, ANTIVIR THER, V15, P101, DOI 10.3851/IMP1491; Mastroianni CM, 2000, CLIN IMMUNOL, V95, P212, DOI 10.1006/clim.2000.4865; Matarese G, 2007, CURR PHARM DESIGN, V13, P3676, DOI 10.2174/138161207783018635; Mercie P, 2005, HIV MED, V6, P380, DOI 10.1111/j.1468-1293.2005.00324.x; Miller TL, 2010, JAIDS-J ACQ IMM DEF, V55, P182, DOI 10.1097/QAI.0b013e3181e222c9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nolan D, 2003, QJM-INT J MED, V96, P825, DOI 10.1093/qjmed/hcg145; Oliviero U, 2009, ATHEROSCLEROSIS, V204, P586, DOI 10.1016/j.atherosclerosis.2008.10.012; PATON P, 1993, RES VIROLOGY, V144, P225, DOI 10.1016/S0923-2516(06)80033-6; Perez-Atayde AR, 2004, PEDIATR DEVEL PATHOL, V7, P61, DOI 10.1007/s10024-003-1001-9; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rios Blanco JJ, 2006, J ANTIMICROB CHEMOTH, V58, P133, DOI 10.1093/jac/dkl190; Ross AC, 2010, ATHEROSCLEROSIS, V211, P492, DOI 10.1016/j.atherosclerosis.2010.04.008; Ross AC, 2008, JAIDS-J ACQ IMM DEF, V49, P499, DOI 10.1097/QAI.0b013e318189a794; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Seaberg EC, 2010, STROKE, V41, P2163, DOI 10.1161/STROKEAHA.110.583856; Sevastianova K, 2005, ANTIVIR THER, V10, P925; Shankar SS, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.06.005; Solages A, 2006, CLIN INFECT DIS, V42, P1325, DOI 10.1086/503261; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Sutliff RL, 2002, AM J PHYSIOL-HEART C, V283, pH2363, DOI 10.1152/ajpheart.00151.2002; Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; UNAIDS, 2012, REP GLOB AIDS EP; van Vonderen MGA, 2009, J INFECT DIS, V199, P1186, DOI 10.1086/597475; van Vonderen MGA, 2009, JAIDS-J ACQ IMM DEF, V50, P153, DOI 10.1097/QAI.0b013e31819367cd; van Wijk JPH, 2006, J AM COLL CARDIOL, V47, P1117, DOI 10.1016/j.jacc.2005.09.073; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	80	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0117125	10.1371/journal.pone.0117125	http://dx.doi.org/10.1371/journal.pone.0117125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915208	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100001
J	Kee, MF; Myers, DR; Sakurai, Y; Lam, WA; Qiu, YZ				Kee, Matthew F.; Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi			Platelet Mechanosensing of Collagen Matrices	PLOS ONE			English	Article							ALPHA(2)BETA(1) INTEGRIN; ARTERIAL STIFFNESS; GLYCOPROTEIN-VI; ACTIVATION; GPVI; ADHESION; KINASE; PHOSPHATIDYLSERINE; ATHEROSCLEROSIS; ALPHA-2-BETA-1	During vascular injury, platelets adhere to exposed subendothelial proteins, such as collagen, on the blood vessel walls to trigger clot formation. Although the biochemical signalings of platelet-collagen interactions have been well characterized, little is known about the role microenvironmental biomechanical properties, such as vascular wall stiffness, may have on clot formation. To that end, we investigated how substrates of varying stiffness conjugated with the same concentration of Type I collagen affect platelet adhesion, spreading, and activation. Using collagen-conjugated polyacrylamide (PA) gels of different stiffnesses, we observed that platelets do in fact mechanotransduce the stiffness cues of collagen substrates, manifesting in increased platelet spreading on stiffer substrates. In addition, increasing substrate stiffness also increases phosphatidylserine exposure, a key aspect of platelet activation that initiates coagulation on the platelet surface. Mechanistically, these collagen substrate stiffness effects are mediated by extracellular calcium levels and actomyosin pathways driven by myosin light chain kinase but not Rho-associated protein kinase. Overall, our results improve our understanding of how the mechanics of different tissues and stroma affect clot formation, what role the increased vessel wall stiffness in atherosclerosis may directly have on thrombosis leading to heart attacks and strokes, and how age-related increased vessel wall stiffness affects hemostasis and thrombosis.	[Kee, Matthew F.; Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Kee, Matthew F.; Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Atlanta, GA 30322 USA; [Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Aflac Canc Ctr, Div Pediat Hematol Oncol, Dept Pediat,Sch Med, Atlanta, GA 30322 USA; [Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Blood Disorders Serv Childrens Healthcare Atlanta, Sch Med, Atlanta, GA 30322 USA; [Myers, David R.; Sakurai, Yumiko; Lam, Wilbur A.; Qiu, Yongzhi] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Lam, Wilbur A.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Qiu, YZ (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	yongzhi.qiu@emory.edu	Myers, David Richard/G-7542-2017	Myers, David Richard/0000-0001-9659-3274	National Science Foundation CAREER Award [1150235]; American Heart Association Innovative Research Grant; National Institutes of Health [U54HL112309, R01HL121264]; American Heart Association Postdoctoral Fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112309, R01HL121264] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); American Heart Association Innovative Research Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowships(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support for this work was provided by National Science Foundation CAREER Award 1150235 (to W.A.L.); an American Heart Association Innovative Research Grant (to W.A.L.); National Institutes of Health grants U54HL112309 (to W.A.L.) and R01HL121264 (to W.A.L.); and an American Heart Association Postdoctoral Fellowships (to D.R.M.). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; BRACE LD, 1985, AM J PHYSIOL, V249, pH1, DOI 10.1152/ajpheart.1985.249.1.H1; Cecelja M, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012016; Chen H, 2003, MOL CELL BIOL, V23, P4764, DOI 10.1128/MCB.23.14.4764-4777.2003; Chen H, 2002, J BIOL CHEM, V277, P3011, DOI 10.1074/jbc.M109714200; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Claridge MW, 2009, ATHEROSCLEROSIS, V205, P477, DOI 10.1016/j.atherosclerosis.2008.12.030; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FOX JEB, 1991, J BIOL CHEM, V266, P13289; HATHAWAY DR, 1979, P NATL ACAD SCI USA, V76, P1653, DOI 10.1073/pnas.76.4.1653; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jung SM, 2000, TRENDS CARDIOVAS MED, V10, P285, DOI 10.1016/S1050-1738(01)00064-0; Kuchay SM, 2012, J THROMB HAEMOST, V10, P1120, DOI 10.1111/j.1538-7836.2012.04715.x; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Mangin P, 2003, FEBS LETT, V542, P53, DOI 10.1016/S0014-5793(03)00337-5; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Ohayon J, 2011, AM J PHYSIOL-HEART C, V301, pH1097, DOI 10.1152/ajpheart.01120.2010; Ohlmann P, 2000, BLOOD, V96, P2134, DOI 10.1182/blood.V96.6.2134.h8002134_2134_2139; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Polanowska-Grabowska R, 2003, ARTERIOSCL THROM VAS, V23, P1934, DOI 10.1161/01.ATV.0000086937.46974.70; Qiu YZ, 2014, P NATL ACAD SCI USA, V111, P14430, DOI 10.1073/pnas.1322917111; Reed GL, 2000, BLOOD, V96, P3334; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Safar ME, 2000, STROKE, V31, P782, DOI 10.1161/01.STR.31.3.782; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361	40	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126624	10.1371/journal.pone.0126624	http://dx.doi.org/10.1371/journal.pone.0126624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915413	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100155
J	Pinhassi, RI; Kallmann, D; Soper, G; Larom, S; Linkov, A; Boulouis, A; Schottler, MA; Bock, R; Rothschild, A; Adir, N; Schuster, G				Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Larom, Shirley; Linkov, Artyom; Boulouis, Alix; Schoettler, Mark-Aurel; Bock, Ralph; Rothschild, Avner; Adir, Noam; Schuster, Gadi			Photosynthetic Membranes of Synechocystis or Plants Convert Sunlight to Photocurrent through Different Pathways due to Different Architectures	PLOS ONE			English	Article							PHOTOSYSTEM-II; THYLAKOID MEMBRANES; TOBACCO; PROTEINS; CRYSTALLIZATION; EVOLUTION	Thylakoid membranes contain the redox active complexes catalyzing the light-dependent reactions of photosynthesis in cyanobacteria, algae and plants. Crude thylakoid membranes or purified photosystems from different organisms have previously been utilized for generation of electrical power and/or fuels. Here we investigate the electron transferability from thylakoid preparations from plants or the cyanobacterium Synechocystis. We show that upon illumination, crude Synechocystis thylakoids can reduce cytochrome c. In addition, this crude preparation can transfer electrons to a graphite electrode, producing an un-mediated photocurrent of 15 mu A/cm(2). Photocurrent could be obtained in the presence of the PSII inhibitor DCMU, indicating that the source of electrons is Q(A), the primary Photosystem II acceptor. In contrast, thylakoids purified from plants could not reduce cyt c, nor produced a photocurrent in the photocell in the presence of DCMU. The production of significant photocurrent (100 mu A/cm(2)) from plant thylakoids required the addition of the soluble electron mediator DCBQ. Furthermore, we demonstrate that use of crude thylakoids from the D1-K238E mutant in Synechocystis resulted in improved electron transferability, increasing the direct photocurrent to 35 mu A/cm(2). Applying the analogous mutation to tobacco plants did not achieve an equivalent effect. While electron abstraction from crude thylakoids of cyanobacteria or plants is feasible, we conclude that the site of the abstraction of the electrons from the thylakoids, the architecture of the thylakoid preparations influence the site of the electron abstraction, as well as the transfer pathway to the electrode. This dictates the use of different strategies for production of sustainable electrical current from photosynthetic thylakoid membranes of cyanobacteria or higher plants.	[Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Rothschild, Avner; Adir, Noam; Schuster, Gadi] Technion Israel Inst Technol, Grand Tech Energy Program, IL-32000 Haifa, Israel; [Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Larom, Shirley; Schuster, Gadi] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Linkov, Artyom; Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Pinhassi, Roy I.; Kallmann, Dan; Soper, Gadiel; Rothschild, Avner] Technion Israel Inst Technol, Dept Sci & Mat Engn, IL-32000 Haifa, Israel; [Boulouis, Alix; Schoettler, Mark-Aurel; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Max Planck Society	Adir, N (corresponding author), Technion Israel Inst Technol, Grand Tech Energy Program, IL-32000 Haifa, Israel.	noam@cc.technion.ac.il; gadis@cc.technion.ac.il	Bock, Ralph/B-4352-2009; Rothschild, Avner/F-6476-2011; Adir, Noam/ABE-6990-2020; Schuster, Gadi/AAE-2010-2019; Rothschild, Avner/B-7896-2009	Bock, Ralph/0000-0001-7502-6940; Rothschild, Avner/0000-0002-2512-0370; Rothschild, Avner/0000-0002-2512-0370; Boulouis, Alix/0000-0002-2552-3938; Schottler, Mark Aurel/0000-0003-3210-0260	Nancy & Stephen Grand Technion Energy Program (GTEP); Adelis Foundation; Israeli Ministry of Science, Technology and Space; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [152/11]; US-Israel Binational Science Foundation [2011556]; DIP grant from the Deutsche Forschungsgemeinschaft [LU315/17-1]	Nancy & Stephen Grand Technion Energy Program (GTEP); Adelis Foundation; Israeli Ministry of Science, Technology and Space; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); DIP grant from the Deutsche Forschungsgemeinschaft	RP, DK and G. Saper are supported by fellowships of The Nancy & Stephen Grand Technion Energy Program (GTEP). The authors thank the Adelis Foundation for their support. RIP fellowship is supported in addition by The Israeli Ministry of Science, Technology and Space. This work was funded by The I-CORE Program of the Planning and Budgeting Committee, The Israel Science Foundation (Grant No. 152/11), a grant from the transformative program of US-Israel Binational Science Foundation (2011556), and a DIP grant (LU315/17-1) from the Deutsche Forschungsgemeinschaft.	Adir N, 1999, ACTA CRYSTALLOGR D, V55, P891, DOI 10.1107/S0907444998016497; ANDREASSON E, 1988, BIOCHIM BIOPHYS ACTA, V936, P339, DOI 10.1016/0005-2728(88)90010-2; [Anonymous], 2015, PHOTOSYNTH RES; [Anonymous], 1991, MOL TECHNIQUES TAXON; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Calkins JO, 2013, ENERG ENVIRON SCI, V6, P1891, DOI 10.1039/c3ee40634b; Croce R, 2012, ADV PHOTOSYNTH RESP, V34, P127, DOI 10.1007/978-94-007-1579-0_6; Dekker JP, 2002, PHOTOSYNTH RES, V72, P203, DOI 10.1023/A:1016188818591; Elghabi Z, 2011, PLANT BIOTECHNOL J, V9, P599, DOI 10.1111/j.1467-7652.2011.00598.x; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Hasan K, 2014, CHEMELECTROCHEM, V1, P131, DOI 10.1002/celc.201300148; Higuchi R, 1990, PCR PROTOCOLS GUIDE, V177; HOGANSON CW, 1988, BIOCHEMISTRY-US, V27, P5848, DOI 10.1021/bi00416a005; Kato M, 2012, J AM CHEM SOC, V134, P8332, DOI 10.1021/ja301488d; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kirchhoff H, 2004, BBA-BIOENERGETICS, V1659, P63, DOI 10.1016/j.bbabio.2004.08.004; Komenda J, 2000, PLANT MOL BIOL, V42, P635, DOI 10.1023/A:1006305308196; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; Larom S, 2010, P NATL ACAD SCI USA, V107, P9650, DOI 10.1073/pnas.1000187107; Lebedev N, 2006, J AM CHEM SOC, V128, P12044, DOI 10.1021/ja063367y; McKone JR, 2014, CHEM MATER, V26, P407, DOI 10.1021/cm4021518; Mulo P, 1997, PLANT MOL BIOL, V33, P1059, DOI 10.1023/A:1005765305956; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Pagliano C, 2013, PHOTOSYNTH RES, V116, P167, DOI 10.1007/s11120-013-9803-8; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rukhman V, 2000, PHOTOSYNTH RES, V65, P249, DOI 10.1023/A:1010618527974; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; STRALEY SC, 1973, BIOCHIM BIOPHYS ACTA, V305, P597, DOI 10.1016/0005-2728(73)90079-0; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Terasaki N, 2008, THIN SOLID FILMS, V516, P2553, DOI 10.1016/j.tsf.2007.04.127; Terazono Y, 2009, J PHYS CHEM B, V113, P7147, DOI 10.1021/jp900835s	38	19	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122616	10.1371/journal.pone.0122616	http://dx.doi.org/10.1371/journal.pone.0122616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915422	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100008
J	Rochat, T; Delumeau, O; Figueroa-Bossi, N; Noirot, P; Bossi, L; Dervyn, E; Bouloc, P				Rochat, Tatiana; Delumeau, Olivier; Figueroa-Bossi, Nara; Noirot, Philippe; Bossi, Lionello; Dervyn, Etienne; Bouloc, Philippe			Tracking the Elusive Function of Bacillus subtilis Hfq	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS REVEALS; ENVELOPE STRESS-RESPONSE; BINDING PROTEIN HFQ; SMALL RNA; LISTERIA-MONOCYTOGENES; NONCODING RNAS; GENES; IDENTIFICATION; GENOME; REPLICATION	RNA-binding protein Hfq is a key component of the adaptive responses of many proteobacterial species including Escherichia coli, Salmonella enterica and Vibrio cholera. In these organisms, the importance of Hfq largely stems from its participation to regulatory mechanisms involving small non-coding RNAs. In contrast, the function of Hfq in Gram-positive bacteria has remained elusive and somewhat controversial. In the present study, we have further addressed this point by comparing growth phenotypes and transcription profiles between wild-type and an hfq deletion mutant of the model Gram-positive bacterium, Bacillus subtilis. The absence of Hfq had no significant consequences on growth rates under nearly two thousand metabolic conditions and chemical treatments. The only phenotypic difference was a survival defect of B. subtilis hfq mutant in rich medium in stationary phase. Transcriptomic analysis correlated this phenotype with a change in the levels of nearly one hundred transcripts. Albeit a significant fraction of these RNAs (36%) encoded sporulation-related functions, analyses in a strain unable to sporulate ruled out sporulation per se as the basis of the hfq mutant's stationary phase fitness defect. When expressed in Salmonella, B. subtilis hfq complemented the sharp loss of viability of a degP hfq double mutant, attenuating the chronic sigma(E)-activated phenotype of this strain. However, B. subtilis hfq did not complement other regulatory deficiencies resulting from loss of Hfq-dependent small RNA activity in Salmonella indicating a limited functional overlap between Salmonella and B. subtilis Hfqs. Overall, this study confirmed that, despite structural similarities with other Hfq proteins, B. subtilis Hfq does not play a central role in post-transcriptional regulation but might have a more specialized function connected with stationary phase physiology. This would account for the high degree of conservation of Hfq proteins in all 17 B. subtilis strains whose genomes have been sequenced.	[Rochat, Tatiana; Bouloc, Philippe] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91405 Orsay, France; [Rochat, Tatiana] INRA, UR892, Virol & Immunol Mol, F-78352 Jouy En Josas, France; [Delumeau, Olivier; Noirot, Philippe; Dervyn, Etienne] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Delumeau, Olivier; Noirot, Philippe; Dervyn, Etienne] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Figueroa-Bossi, Nara; Bossi, Lionello] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91190 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bouloc, P (corresponding author), Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91405 Orsay, France.	philippe.bouloc@u-psud.fr	Bouloc, Philippe/ABA-5732-2021	Bouloc, Philippe/0000-0003-4601-3387; Rochat, Tatiana/0000-0002-4533-1220	Agence Nationale pour la Recherche [ANR-2010-BLAN-1602-01, ANR-12-BSV6-0008]; European Commission [LSHG-CT-2006-037469]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/) (ANR-2010-BLAN-1602-01 'Duplex-Omics' and ANR-12-BSV6-0008 'ReadRNA') to PB and by the European Commission funded BaSysBio project (http://ec.europa.eu/research/fp6/index_en.cfm) (LSHG-CT-2006-037469) to PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Bossi L, 2008, BIOCHIMIE, V90, P1539, DOI 10.1016/j.biochi.2008.06.001; Bossi L, 2007, MOL MICROBIOL, V65, P799, DOI 10.1111/j.1365-2958.2007.05829.x; Boudry P, 2014, J BACTERIOL, V196, P3234, DOI 10.1128/JB.01923-14; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Caillet J, 2014, RNA, V20, P1567, DOI 10.1261/rna.043372.113; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; CHEDIN F, 1994, MOL MICROBIOL, V12, P561, DOI 10.1111/j.1365-2958.1994.tb01042.x; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200; Durand S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004957; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gonzalez-Pastor JE, 2011, FEMS MICROBIOL REV, V35, P415, DOI 10.1111/j.1574-6976.2010.00253.x; FERNANDEZ MT, 1972, J BIOL CHEM, V247, P824; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; FigueroaBossi N, 1997, MOL MICROBIOL, V25, P161, DOI 10.1046/j.1365-2958.1997.4451807.x; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Hammerle H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098661; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; Kovach AR, 2014, RNA, V20, P1548, DOI 10.1261/rna.044032.113; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Liu YX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010020; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nielsen JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019019; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Robinson KE, 2014, NUCLEIC ACIDS RES, V42, P2736, DOI 10.1093/nar/gkt1171; Rochat T, 2012, NUCL ACIDS RES; Rochat T, 2012, BIOCHIMIE, V94, P1554, DOI 10.1016/j.biochi.2012.01.016; Schmalisch M, 2010, J BACTERIOL, V192, P5402, DOI 10.1128/JB.00534-10; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tanaka K, 2013, NUCLEIC ACIDS RES, V41, P687, DOI 10.1093/nar/gks963; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	68	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124977	10.1371/journal.pone.0124977	http://dx.doi.org/10.1371/journal.pone.0124977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915524	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100086
J	Tan, YQ; Wang, YX; Li, L; Xia, JY; Peng, SG; He, YL				Tan, Yaqi; Wang, Yixuan; Li, Li; Xia, Jinyu; Peng, Shiguang; He, Yanling			Chemokine-Like Factor 1-Derived C-Terminal Peptides Induce the Proliferation of Dermal Microvascular Endothelial Cells in Psoriasis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FOCAL CEREBRAL-ISCHEMIA; ATOPIC-DERMATITIS; MESANGIAL CELLS; MUSCLE-CELLS; MIGRATION; CYTOKINE; INFLAMMATION; ANGIOGENESIS; CONTRIBUTES	Psoriasis is an inflammatory disease characterized by the abnormal proliferation of skin cells, including dermal microvascular endothelial cells. Recently, chemokine-like factor 1 (CKLF1) was found to participate in the local inflammation and cell proliferation. To explore its role in the pathogenesis of psoriasis, the expression of both CKLF1 and its receptor (CCR4) was determined in the psoriatic lesions. Also, the effect of the C-terminal peptides (C19 and C27) of CKLF1 on the proliferation of human umbilical vein endothelial cells was studied in vitro. By immunohistochemistry and immunofluorescence, the expression of both CKLF1 and CCR4 was determined in the psoriatic lesions. The effect of C-terminal peptides on human umbilical vein endothelial cells (HUVECs) was studied in vitro by the evaluation of cell proliferation and apoptosis. The in vivo assessment was performed accordingly through the subcutaneous injection peptides on BALB/c mice. The results showed that, by immunohistochemistry, both CKLF1 and CCR4 were increasingly expressed in psoriatic lesions as compared to normal skins. Moreover, the primary umbilical vein endothelial cells exhibited higher proliferation ratio under the C19 or C27 stimulation, which was even enhanced by the addition of psoriatic sera or TNF-alpha. Furthermore, the enhancement of peptide simulation was accompanied with the activation of ERK1/2-MAPKs pathway. In addition, such effect of C19 and C27 was mirrored by the hyperproliferation of cutaneous microvessels in BALB/c mice that were subcutaneously injected with the two peptides. Therefore, we concluded that CKLF1 plays a role in the pathogenesis of psoriasis by promoting the proliferation of microvascular endothelial cells that possibly correlates with ERK1/2-MAPKs activation.	[Tan, Yaqi; Wang, Yixuan; Li, Li; Xia, Jinyu; Peng, Shiguang; He, Yanling] Capital Med Univ, Beijing Chao Yang Hosp, Dept Dermatol, Beijing, Peoples R China	Capital Medical University	He, YL (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Dermatol, Beijing, Peoples R China.	heyldoc@163.com	Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022; wang, yixuan/GXW-2866-2022		 [30972653];  [81371733]	; 	This study was supported by grant numbers: 30972653 and 81371733 (URLs. http://www.nsfc.gov.cn) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salahi OSA, 2013, MICROVASC RES, V90, P30, DOI 10.1016/j.mvr.2013.07.007; Bhushan M, 1999, BRIT J DERMATOL, V141, P1054, DOI 10.1046/j.1365-2133.1999.03205.x; Brotas AM, 2012, AN BRAS DERMATOL, V87, P673, DOI 10.1590/S0365-05962012000500001; ETTEHADI P, 1994, CLIN EXP IMMUNOL, V96, P146, DOI 10.1111/j.1365-2249.1994.tb06244.x; Han WL, 2001, BIOCHEM J, V357, P127, DOI 10.1042/0264-6021:3570127; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Kong LL, 2014, NEUROCHEM INT, V76, P91, DOI 10.1016/j.neuint.2014.07.004; Kong LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-112; Kong LL, 2012, NEUROSCI LETT, V508, P13, DOI 10.1016/j.neulet.2011.11.048; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li T, 2006, LIFE SCI, V79, P519, DOI 10.1016/j.lfs.2006.01.042; Lo IC, 2005, J BIOMED SCI, V12, P377, DOI 10.1007/s11373-005-1703-2; Loai Yasir, 2012, Int J Mol Imaging, V2012, P230942, DOI 10.1155/2012/230942; MacDonald A, 2007, POSTGRAD MED J, V83, P690, DOI 10.1136/pgmj.2007.061473; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Peplow PV, 2013, CYTOKINE, V62, P1, DOI 10.1016/j.cyto.2013.02.015; Petch D, 2012, BIOORGAN MED CHEM, V20, P5901, DOI 10.1016/j.bmc.2012.07.048; Rottman JB, 2001, LAB INVEST, V81, P335, DOI 10.1038/labinvest.3780242; Shao LN, 2010, CELL IMMUNOL, V263, P188, DOI 10.1016/j.cellimm.2010.03.015; Singh M, 2010, ASIAN PAC J CANCER P, V11, P257; Tan YX, 2004, CHINESE MED J-PEKING, V117, P1123; Tian L, 2011, ALLERGY, V66, P287, DOI 10.1111/j.1398-9995.2010.02478.x; Wang KP, 2013, ANN RHEUM DIS, V72, P100, DOI 10.1136/annrheumdis-2012-202201; Wang Y, 2006, LIFE SCI, V78, P614, DOI 10.1016/j.lfs.2005.05.070; Wang Y, 2008, INT J BIOCHEM CELL B, V40, P909, DOI 10.1016/j.biocel.2007.10.028; Wang ZZ, 2012, NEUROSCI LETT, V519, P51, DOI 10.1016/j.neulet.2012.05.019; Wang ZZ, 2010, BRAIN RES, V1308, P24, DOI 10.1016/j.brainres.2009.10.047; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Xia DL, 2002, BBA-MOL CELL RES, V1591, P163, DOI 10.1016/S0167-4889(02)00270-7; Yang GY, 2013, INT J BIOL SCI, V9, P759, DOI 10.7150/ijbs.6291; Yasuda K, 2014, EXP DERMATOL, V23, P119, DOI 10.1111/exd.12324; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zhang T, 2013, MOL BIOL REP, V40, P2939, DOI 10.1007/s11033-012-2309-1; Zhang T, 2013, ATHEROSCLEROSIS, V226, P49, DOI 10.1016/j.atherosclerosis.2012.09.023; Zhang Y, 2008, GROWTH FACTORS, V26, P125, DOI 10.1080/08977190802105909; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V409, P356, DOI 10.1016/j.bbrc.2011.05.047; Zhang Y, 2012, J CLIN IMMUNOL, V32, P1270, DOI 10.1007/s10875-012-9724-x; Zheng Y, 2011, INT IMMUNOPHARMACOL, V11, P2188, DOI 10.1016/j.intimp.2011.09.017; Zou XY, 2015, J INVEST DERMATOL, V135, P589, DOI 10.1038/jid.2014.377; Zou XY, 2012, EXP BIOL MED, V237, P1023, DOI 10.1258/ebm.2012.012033	43	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125073	10.1371/journal.pone.0125073	http://dx.doi.org/10.1371/journal.pone.0125073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915746	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100095
J	Wang, H; Luo, X; Meng, SQ; Bei, YJ; Song, T; Meng, T; Li, GF; Zhang, BW				Wang, Hui; Luo, Xia; Meng, Shaoquan; Bei, Yongjian; Song, Tao; Meng, Tao; Li, Guifen; Zhang, Baowei			The Phylogeography and Population Demography of the Yunnan Caecilian (Ichthyophis bannanicus): Massive Rivers as Barriers to Gene Flow	PLOS ONE			English	Article							GEGENEOPHIS-RAMASWAMII AMPHIBIA; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; SPECIES GROUP; GYMNOPHIONA; FROG; SOFTWARE; BIOGEOGRAPHY; HYPOTHESES; DIVERSITY	Ichthyophis bannanicus is the only caecilian species in China. In this study, the phylogeography and population demography of I. bannanicus were explored, based on the mitochondrial DNA genes (cyt b and ND2) and 15 polymorphic microsatellite loci. Altogether 158 individuals were collected from five populations in Yunnan province, Guangxi province, Guangdong province, and Northern Vietnam. Phylogeographical and population structure analysis identified either two groups (Xishuangbanna, Northern Vietnam-Yulin-Yangchun-Deqing) or three groups (Xishuangbanna, Northern Vietnam-Yulin-Yangchun, and Deqing), indicating that the Red River and Pearl River systems may have acted as gene-flow barriers for I. bannanicus. Historical population expansion that happened 15-17 Ka ago was detected for mtDNA data and was possibly triggered by warmer weather after the Last Glacial Maximum. However, the Bayesian simulations of population history based on microsatellite data pinpointed population decline in all populations since 19,123 to 1,029 years ago, demonstrating a significant influence of anthropogenic habitat alteration on I. bannanicus.	[Wang, Hui; Luo, Xia; Song, Tao; Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei 230601, Anhui, Peoples R China; [Meng, Shaoquan; Bei, Yongjian; Li, Guifen] Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Guangxi, Peoples R China; [Meng, Tao] Guangxi Forestry Inventory & Planning Inst, Nanning 530011, Guangxi, Peoples R China	Anhui University; Yulin Normal University	Li, GF (corresponding author), Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Guangxi, Peoples R China.	ylsylgf@163.com; zhangbw@ahu.edu.cn			National Natural Science Foundation of China [31260509]; Natural Science Foundation of Guangxi Province [GXNSFSA018107]; Outstanding Young Talents in Colleges and Universities Support Plan, Anhui Province; Foundation for Young and Key Teachers Project of Anhui University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Outstanding Young Talents in Colleges and Universities Support Plan, Anhui Province; Foundation for Young and Key Teachers Project of Anhui University	The research was supported by the National Natural Science Foundation of China (No. 31260509) and the Natural Science Foundation of Guangxi Province (No. GXNSFSA018107), Outstanding Young Talents in Colleges and Universities Support Plan, Anhui Province (2014), the Foundation for Young and Key Teachers Project of Anhui University (2011-2014).	Agudo R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-384; AmphibiaWeb, 2014, INF AMPH BIOL CONS; [Anonymous], 1996, 5000 CNRS UMR; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Burland T G, 2000, Methods Mol Biol, V132, P71; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Carmichael LE, 2001, MOL ECOL, V10, P2787, DOI 10.1046/j.1365-294X.2001.t01-1-01408.x; Chen SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033378; Cornell JD, 2011, SLASH AND BURN; Cornuet JM, 1996, GENETICS, V144, P2001; Daniels RJR, 2002, SOME ASPECTS THREATE; Deng Xiao-Bao, 2003, Acta Ecologica Sinica, V23, P130; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Emel SL, 2012, CONSERV GENET, V13, P1685, DOI 10.1007/s10592-012-0407-1; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gower DJ, 2002, P ROY SOC B-BIOL SCI, V269, P1563, DOI 10.1098/rspb.2002.2050; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hofer D., 2000, FROGLOG, P1; Kettle AJ, 2008, QUATERNARY SCI REV, V27, P1309, DOI 10.1016/j.quascirev.2008.03.005; Kupfer A, 2004, BIOL J LINN SOC, V83, P207, DOI 10.1111/j.1095-8312.2004.00382.x; Kupfer A, 2004, AMPHIBIA-REPTILIA, V25, P87, DOI 10.1163/156853804322992869; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Li Gui-Fen, 2010, Acta Zootaxonomica Sinica, V35, P494; Li Gui-fen, 2010, Sichuan Journal of Zoology, V29, P81; Li GF, 2010, CONSERV GENET RESOUR, V2, P129, DOI 10.1007/s12686-010-9246-x; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li R, 2009, J ZOOL, V277, P309, DOI 10.1111/j.1469-7998.2008.00543.x; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034013; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036334; Loader C., 2007, LOCFIT LOCAL REGRESS; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Measey G. John, 2004, Journal of East African Natural History, V93, P1, DOI 10.2982/0012-8317(2004)93[1:ACRAEA]2.0.CO;2; Measey GJ, 2003, APPL SOIL ECOL, V23, P43, DOI 10.1016/S0929-1393(02)00175-0; Meng S, 2006, J YULIN TEACHERS COL, V127, P114; Meng Shao-quan, 2006, Sichuan Journal of Zoology, V25, P423; Nguyen V. S., 2009, HERPETOFAUNA VIETNAM; Nishikawa K, 2012, MOL PHYLOGENET EVOL, V63, P714, DOI 10.1016/j.ympev.2012.02.017; Nussbaum RA, 1989, HERPETOL MONOGR, V3, P1, DOI [10.2307/1466984, DOI 10.2307/1466984]; Nylander JAA., 2004, BIOINFORMATICS; Oommen OV, 2000, CURR SCI INDIA, V79, P1386; Pan J, 1985, J S CHINA NORMAL U N, V1, P111; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Rambaut A., 2007, TRACER PROGRAM ANAL; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shi Wenbo, 2010, Acta Theriologica Sinica, V30, P390; Shi Y.F., 2011, NEW UNDERSTANDING QU; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Storz JF, 2002, EVOLUTION, V56, P154; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan AM, 1995, MOL PHYLOGENET EVOL, V4, P383, DOI 10.1006/mpev.1995.1036; Taylor E.H., 1968, CAECILIANS WORLD TAX; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041579; Wang S, 2006, CHINA SPECIES RED LI, V1; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Wen Yetang, 1985, Acta Herpetologica Sinica, V4, P147; Xiang A, 2005, AGR ARCHAEOLOGY CHIN, V1, P149; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yang D, 1986, ACTA GEOGRAPHICA SIN, V41, P302, DOI DOI 10.11821/XB198604002); Yang D, 1976, ACTA ZOOL SINICA, V22, P175; Yang D, 1984, J HERPETOLOGICA CHIN, V3, P73; Yang Yu-Hui, 2004, Acta Zoologica Sinica, V50, P193; Yu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056066; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang WenXu, 1998, Acta Agronomica Sinica, V24, P416; Zhao E., 1998, CHINA RED DATA BOOK; Zhao S, 2009, J ZOOL, V279, P270, DOI 10.1111/j.1469-7998.2009.00615.x; [郑卓 Zheng Zhuo], 2004, [第四纪研究, Quaternary Sciences], V24, P387	89	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125770	10.1371/journal.pone.0125770	http://dx.doi.org/10.1371/journal.pone.0125770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915933	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100146
J	Zhu, CY; Yang, HL; Geng, QS; Ma, QL; Long, Y; Zhou, C; Chen, M				Zhu, Chunyan; Yang, Hongling; Geng, Qingshan; Ma, Qingling; Long, Yan; Zhou, Cheng; Chen, Ming			Association of Oxidative Stress Biomarkers with Gestational Diabetes Mellitus in Pregnant Women: A Case-Control Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INSULIN-RESISTANCE; CERULOPLASMIN; INFLAMMATION; ACTIVATION; RELEASE	Objective The relationship between gestational diabetes mellitus (GDM) and oxidative stress has not been fully elucidated. This study examined the association between biomarkers of oxidative stress and GDM. Methods We conducted a case-control study which included 36 women presenting with GDM and 36 asymptomatic matched control subjects who visited Guangzhou Women and Children's Medical Centre, China, from June 2012 to December 2012. Pregnant women were prospectively recruited to the study, and blood samples were collected at the time of a routine oral glucose tolerance test. These samples were then analyzed for levels of endocrine and surrogate markers of oxidative stress. Results Compared to control subjects, women with GDM exhibited elevated values for plasma glucose, insulin, and insulin resistance (IR), and showed reduced HOMA pancreatic beta-cell function (HOMA-B), insulin sensitivity index (ISI), insulinogenic index, and corrected insulin response at 24-28 weeks gestation. A bivariate logistic regression analysis showed that levels of high-sensitivity C reactive protein (hs-CRP) and high fluorescence reticulocytes at fasting, and hs-CRP in a 1-h OGTT, were significantly associated with GDM. A linear regression analysis showed that levels of hs-CRP (P = 0.003) and reticulocytes (P = 0.029) at fasting were associated with IR, and levels of hs-CRP (P = 0.002) and monocytes (P = 0.006) in a 1-h OGTT were associated with ISI. Conclusions Pregnant women with GDM developed a pathological IR and exhibited beta-cell dysfunction. Their decreased ability to compensate for oxidative stress was associated with increased IR and a reduced ISI, which might be important factors in GDM.	[Zhu, Chunyan; Zhou, Cheng; Chen, Ming] Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou 510182, Guangdong, Peoples R China; [Yang, Hongling; Ma, Qingling; Long, Yan] Guangzhou Med Univ, Dept Lab, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China; [Geng, Qingshan] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou 510080, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Yang, HL (corresponding author), Guangzhou Med Univ, Dept Lab, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.	hlyang62@163.com		Yang, Hongling/0000-0001-6303-4193	National Natural Science Fund of China [81102197]; Science and Technology Fund of Guangzhou [2012J4100015]; college scientific research project of Guangzhou [1201410026]; Science and Technology Fund of Guangdong Province [20120318067]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Science and Technology Fund of Guangzhou; college scientific research project of Guangzhou; Science and Technology Fund of Guangdong Province	This study was supported by the National Natural Science Fund of China (81102197; CYZ; http://www.nsfc.gov.cn/), the Science and Technology Fund of Guangzhou (2012J4100015; CYZ; http://apply.gzkj.gov.cn/), the college scientific research project of Guangzhou (1201410026; CYZ; http://gxky.gzsjks.com/), and the Science and Technology Fund of Guangdong Province (20120318067; HLY; http://www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; [Anonymous], 2008, ACTA DIABETOL, DOI DOI 10.1007/400592.0087; Atalay Mustafa, 2002, J Sports Sci Med, V1, P1; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Bo S, 2005, J ENDOCRINOL INVEST, V28, P779, DOI 10.1007/BF03347566; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Coughlan MT, 2004, PLACENTA, V25, P78, DOI 10.1016/S0143-4004(03)00183-8; CUNNINGHAM J, 1995, METABOLISM, V44, P996, DOI 10.1016/0026-0495(95)90095-0; Daci A, 2003, MED ARH, p[67, 88]; Hu FB, 2003, ARTERIOSCL THROM VAS, V23, P1715, DOI 10.1161/01.ATV.0000094360.38911.71; Kabiri N., 2012, Journal of Medicinal Plants Research, V6, P2540; Kelstrup L, 2013, J CLIN ENDOCR METAB, V98, P3793, DOI 10.1210/jc.2013-1536; Lopez-Tinoco C, 2013, ACTA DIABETOL, V50, P201, DOI 10.1007/s00592-011-0264-2; Memisogullari R, 2004, J DIABETES COMPLICAT, V18, P193, DOI 10.1016/S1056-8727(03)00032-1; Pattanathaiyanon P, 2014, J OBSTET GYNAECOL RE, V40, P976, DOI 10.1111/jog.12306; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Rasanen JP, 2013, OBSTET GYNECOL, V122, P586, DOI 10.1097/AOG.0b013e3182a0c88b; Roebuck KA, 1999, INT J MOL MED, V4, P223; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Vrachnis N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/549748; Wang J, 2012, CHINESE J PERINATAL, V15, P705; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zhang Z, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00433	28	59	60	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126490	10.1371/journal.pone.0126490	http://dx.doi.org/10.1371/journal.pone.0126490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915047	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100154
J	Ali, B; Gill, RA; Yang, S; Gill, MB; Farooq, MA; Liu, D; Daud, MK; Ali, S; Zhou, WJ				Ali, Basharat; Gill, Rafaqat A.; Yang, Su; Gill, Muhammad B.; Farooq, Muhammad A.; Liu, Dan; Daud, Muhammad K.; Ali, Shafaqat; Zhou, Weijun			Regulation of Cadmium-Induced Proteomic and Metabolic Changes by 5-Aminolevulinic Acid in Leaves of Brassica napus L.	PLOS ONE			English	Article							SALINITY-INDUCED CHANGES; ULTRASTRUCTURAL-CHANGES; ANTIOXIDATIVE ENZYMES; GENE-EXPRESSION; STRESS; ACCUMULATION; TOLERANCE; RESPONSES; TOXICITY; PROLINE	It is evident from previous reports that 5-aminolevulinic acid (ALA), like other known plant growth regulators, is effective in countering the injurious effects of heavy metal-stress in oilseed rape (Brassica napus L.). The present study was carried out to explore the capability of ALA to improve cadmium (Cd2+) tolerance in B. napus through physiological, molecular, and proteomic analytical approaches. Results showed that application of ALA helped the plants to adjust Cd2+-induced metabolic and photosynthetic fluorescence changes in the leaves of B. napus under Cd2+ stress. The data revealed that ALA treatment enhanced the gene expressions of antioxidant enzyme activities substantially and could increase the expression to a certain degree under Cd2+ stress conditions. In the present study, 34 protein spots were identified that differentially regulated due to Cd2+ and/or ALA treatments. Among them, 18 proteins were significantly regulated by ALA, including the proteins associated with stress related, carbohydrate metabolism, catalysis, dehydration of damaged protein, CO2 assimilation/photosynthesis and protein synthesis/regulation. From these 18 ALA-regulated proteins, 12 proteins were significantly down-regulated and 6 proteins were up-regulated. Interestingly, it was observed that ALA-induced the up-regulation of dihydrolipoyl dehydrogenase, light harvesting complex photo-system II subunit 6 and 30S ribosomal proteins in the presence of Cd2+ stress. In addition, it was also observed that ALA-induced the down-regulation in thioredoxin-like protein, 2, 3-bisphosphoglycerate, proteasome and thiamine thiazole synthase proteins under Cd2+ stress. Taken together, the present study sheds light on molecular mechanisms involved in ALA-induced Cd2+ tolerance in B. napus leaves and suggests a more active involvement of ALA in plant physiological processes than previously proposed.	[Ali, Basharat; Gill, Rafaqat A.; Yang, Su; Gill, Muhammad B.; Farooq, Muhammad A.; Liu, Dan; Daud, Muhammad K.; Zhou, Weijun] Zhejiang Univ, Inst Crop Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ali, Basharat; Gill, Rafaqat A.; Yang, Su; Gill, Muhammad B.; Farooq, Muhammad A.; Liu, Dan; Daud, Muhammad K.; Zhou, Weijun] Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Hangzhou 310058, Zhejiang, Peoples R China; [Daud, Muhammad K.] Kohat Univ Sci & Technol, Dept Biotechnol & Genet Engn, Kohat 26000, Pakistan; [Ali, Shafaqat] Govt Coll Univ, Dept Environm Sci & Engn, Faisalabad 38000, Pakistan	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Zhejiang University; Kohat University of Science & Technology; Government College University Faisalabad	Zhou, WJ (corresponding author), Zhejiang Univ, Inst Crop Sci, Hangzhou 310058, Zhejiang, Peoples R China.	wjzhou@zju.edu.cn	Ali, Basharat/K-5274-2019; Khan, Muhammad Daud/AAF-1011-2021; Gill, Muhammad/AAT-8380-2020; Gill, Rafaqat Ali/ABG-3689-2021; Ali, Shafaqat/G-3298-2017; Gill, Rafaqat Ali/AAE-2960-2020; Farooq, Muhammad Ahsan/R-7334-2017; Ali, Basharat/M-4478-2017	Gill, Rafaqat Ali/0000-0001-6553-9312; Ali, Shafaqat/0000-0003-0272-7097; Farooq, Muhammad Ahsan/0000-0002-7183-2379; Ali, Basharat/0000-0002-5965-7352; Ali, Shafaqat/0000-0002-3773-5196	Special Fund for Agro-scientific Research in the Public Interest [201303022]; Jiangsu Collaborative Innovation Center for Modern Crop Production; National Natural Science Foundation of China [31170405, 31301678]; Science and Technology Department of Zhejiang Province [2012C12902-1, 2011R50026-25]	Special Fund for Agro-scientific Research in the Public Interest; Jiangsu Collaborative Innovation Center for Modern Crop Production; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303022), Jiangsu Collaborative Innovation Center for Modern Crop Production, the National Natural Science Foundation of China (31170405, 31301678), and the Science and Technology Department of Zhejiang Province (2012C12902-1, 2011R50026-25).	Aebi H, 1984, Methods Enzymol, V105, P121; Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935; Ali B, 2014, IND CROP PROD, V52, P617, DOI 10.1016/j.indcrop.2013.11.033; Ali B, 2013, ENVIRON SCI POLLUT R, V20, P7256, DOI 10.1007/s11356-013-1735-5; Ali B, 2013, J PLANT GROWTH REGUL, V32, P604, DOI 10.1007/s00344-013-9328-6; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Arnon DI, 1940, SOIL SCI, V50, P463; Asada K., 1994, CAUSES PHOTO OXIDATI; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bah AM, 2010, J HAZARD MATER, V184, P191, DOI 10.1016/j.jhazmat.2010.08.023; Basile A, 2005, GENE, V356, P153, DOI 10.1016/j.gene.2005.04.017; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Dai QL, 2009, PLANT GROWTH REGUL, V59, P273, DOI 10.1007/s10725-009-9402-z; Daud MK, 2009, J HAZARD MATER, V161, P463, DOI 10.1016/j.jhazmat.2008.03.128; de Lacerda CF, 2003, ENVIRON EXP BOT, V49, P107, DOI 10.1016/S0098-8472(02)00064-3; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Durand TC, 2010, PROTEOMICS, V10, P349, DOI 10.1002/pmic.200900484; El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; GUCCI R, 1991, PHYSIOL PLANTARUM, V83, P497, DOI 10.1111/j.1399-3054.1991.tb00126.x; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; HULL HM, 1975, BOT REV, V41, P421, DOI 10.1007/BF02860832; Inostroza-Blancheteau C, 2011, PLANT PHYSIOL BIOCH, V49, P1005, DOI 10.1016/j.plaphy.2011.04.009; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Johnsen U, 2007, EXTREMOPHILES, V11, P647, DOI 10.1007/s00792-007-0094-x; Kanazawa S, 2000, PHYSIOL PLANTARUM, V109, P211, DOI 10.1034/j.1399-3054.2000.100214.x; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Lage-Pinto F, 2008, ENVIRON EXP BOT, V64, P307, DOI 10.1016/j.envexpbot.2008.07.007; LATXAGUE L, 1991, J CHROMATOGR, V586, P166, DOI 10.1016/0021-9673(91)80037-H; Lin CC, 2000, PLANT GROWTH REGUL, V30, P151, DOI 10.1023/A:1006345126589; Liu D, 2011, J AGRON CROP SCI, V197, P284, DOI 10.1111/j.1439-037X.2011.00465.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Millan AF, 2009, ENVIRON EXP BOT, V65, P376, DOI 10.1016/j.envexpbot.2008.11.010; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; Milone MT, 2003, ENVIRON EXP BOT, V50, P265, DOI 10.1016/S0098-8472(03)00037-6; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Naeem MS, 2011, ACTA PHYSIOL PLANT, V33, P517, DOI 10.1007/s11738-010-0575-x; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Najeeb U, 2011, J HAZARD MATER, V186, P565, DOI 10.1016/j.jhazmat.2010.11.037; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nayyar H, 2003, BIOL PLANTARUM, V46, P275, DOI 10.1023/A:1022867030790; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Nwugo CC, 2008, PLANT SOIL, V311, P73, DOI 10.1007/s11104-008-9659-4; Nwugo CC, 2011, J PROTEOME RES, V10, P518, DOI 10.1021/pr100716h; Papazoglou EG, 2005, ENVIRON INT, V31, P243, DOI 10.1016/j.envint.2004.09.022; Rafiq MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111461; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Romero-Puertas MC, 2007, J PLANT PHYSIOL, V164, P1346, DOI 10.1016/j.jplph.2006.06.018; ROYMACAULEY H, 1992, PHYSIOL PLANTARUM, V85, P90, DOI 10.1111/j.1399-3054.1992.tb05268.x; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Sung DY, 2009, PLANT J, V59, P802, DOI 10.1111/j.1365-313X.2009.03914.x; van Keulen H, 2008, ENVIRON EXP BOT, V63, P281, DOI 10.1016/j.envexpbot.2007.11.012; Wang LJ, 2005, J INTEGR PLANT BIOL, V47, P1084, DOI 10.1111/j.1744-7909.2005.00150.x; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.0031-9317.2004.00319.x; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209; Yusuf M, 2008, J INTEGR PLANT BIOL, V50, P1096, DOI 10.1111/j.1744-7909.2008.00697.x; Zhang WF, 2008, J PLANT GROWTH REGUL, V27, P159, DOI 10.1007/s00344-008-9042-y; Zhang ZJ, 2006, PLANT GROWTH REGUL, V49, P27, DOI 10.1007/s10725-006-0011-9; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; Zhou WJ, 1999, PLANT GROWTH REGUL, V27, P99, DOI 10.1023/A:1006165603300; Zhou WJ, 2001, CROP PRODUCTION, P153	67	121	124	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123328	10.1371/journal.pone.0123328	http://dx.doi.org/10.1371/journal.pone.0123328			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909456	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800034
J	Pruller, S; Fromke, C; Kaspar, H; Klein, G; Kreienbrock, L; Kehrenberg, C				Prueller, Sandra; Froemke, Cornelia; Kaspar, Heike; Klein, Guenter; Kreienbrock, Lothar; Kehrenberg, Corinna			Recommendation for a Standardised Method of Broth Microdilution Susceptibility Testing for Porcine Bordetella bronchiseptica	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIMICROBIAL SUSCEPTIBILITY; LISTERIA-MONOCYTOGENES; RESISTANCE; CRITERIA	The objective was to establish and standardise a broth microdilution susceptibility testing method for porcine Bordetella(B.) bronchiseptica. B. bronchiseptica isolates from different geographical regions and farms were genotyped by macrorestriction analysis and subsequent pulsed-field gel electrophoresis. One reference and one type strain plus two field isolates of B. bronchiseptica were chosen to analyse growth curves in four different media: cation-adjusted Mueller-Hinton broth (CAMHB) with and without 2% lysed horse blood, Brain-Heart-Infusion (BHI), and Caso broth. The growth rate of each test strain in each medium was determined by culture enumeration and the suitability of CAMHB was confirmed by comparative statistical analysis. Thereafter, reference and type strain and eight epidemiologically unrelated field isolates of B. bronchiseptica were used to test the suitability of a broth microdilution susceptibility testing method following CLSI-approved performance standards given in document VET01-A4. Susceptibility tests, using 20 antimicrobial agents, were performed in five replicates, and data were collected after 20 and 24 hours incubation and statistically analysed. Due to the low growth rate of B. bronchiseptica, an incubation time of 24 hours resulted in significantly more homogeneous minimum inhibitory concentrations after five replications compared to a 20-hour incubation. An interlaboratory comparison trial including susceptibility testing of 24 antimicrobial agents revealed a high mean level of reproducibility (97.9%) of the modified method. Hence, in a harmonization for broth microdilution susceptibility testing of B. bronchiseptica, an incubation time of 24 hours in CAMHB medium with an incubation temperature of 35 degrees C and an inoculum concentration of approximately 5 x 10(5)cfu/ml was proposed.	[Prueller, Sandra; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, D-30173 Hannover, Germany; [Froemke, Cornelia] Univ Vet Med Hannover, WHO Collaborating Ctr Res & Training Vet Publ Hlt, Dept Biometry Epidemiol & Informat Proc, D-30173 Hannover, Germany; [Kaspar, Heike; Kreienbrock, Lothar] Fed Off Consumer Protect & Food Safety, Berlin, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Bischofsholer Damm 15, D-30173 Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Klein, Günter/G-5321-2013; Kehrenberg, Corinna/GSI-9835-2022	Klein, Günter/0000-0003-1931-2701; 	Federal Ministry of Food and Agriculture (BMEL) through the DART project [FKZ 2811HS020]	Federal Ministry of Food and Agriculture (BMEL) through the DART project	This study was financially supported by the Federal Ministry of Food and Agriculture (BMEL) through the DART project (grant number FKZ 2811HS020). The funders had no role in study design, data colection and analysis, decision to publish, or preparation of the manuscript.	Brockmeier S.L., 2012, DIS SWINE, P670; Brown, 2006, APPL MIXED MODELS ME; Burton PJ, 1996, J VET DIAGN INVEST, V8, P464, DOI 10.1177/104063879600800411; Clinical and Laboratory Standards Institute, 2013, VET01A4 CLIN LAB STA; Coutinho TA, 2009, BRAZ J MICROBIOL, V40, P470, DOI 10.1590/S1517-83822009000300009; DEEB BJ, 1990, J CLIN MICROBIOL, V28, P70, DOI 10.1128/JCM.28.1.70-75.1990; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fenwick BW, 2013, VET MICROBIOL, P120; Francois K, 2005, J APPL MICROBIOL, V99, P1503, DOI 10.1111/j.1365-2672.2005.02727.x; Friedman LE, 2001, LETT APPL MICROBIOL, V33, P285, DOI 10.1046/j.1472-765X.2001.00997.x; GILES CJ, 1980, VET REC, V106, P25, DOI 10.1136/vr.106.2.25; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; He Q, 2006, PRINCIPLES PRACTICE, P253; Hozbor D, 1999, RES MICROBIOL, V150, P333, DOI 10.1016/S0923-2508(99)80059-X; Kadlec K, 2005, J ANTIMICROB CHEMOTH, V56, P485, DOI 10.1093/jac/dki262; Kadlec K, 2007, J ANTIMICROB CHEMOTH, V59, P396, DOI 10.1093/jac/dkl515; Koidl C, 2007, J CLIN MICROBIOL, V45, P347, DOI 10.1128/JCM.01303-06; MCCANDLISH IAP, 1978, VET REC, V102, P298, DOI 10.1136/vr.102.14.293; Rajeev S, 2002, THESIS U TENNESSEE; Rensch U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078310; Roorda Lieuwe, 2011, BMC Res Notes, V4, P11, DOI 10.1186/1756-0500-4-11; SAS Institute Inc, 2011, SAS STAT 9 3 USERS G; Shin EK, 2007, J VET SCI, V8, P65, DOI 10.4142/jvs.2007.8.1.65; Speakman AJ, 1997, VET MICROBIOL, V54, P63, DOI 10.1016/S0378-1135(96)01256-4; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tyrovouzis NA, 2014, INT J FOOD MICROBIOL, V186, P110, DOI 10.1016/j.ijfoodmicro.2014.06.021	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123883	10.1371/journal.pone.0123883	http://dx.doi.org/10.1371/journal.pone.0123883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910232	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800049
J	Stimac, M; Dolinsek, T; Lampreht, U; Cemazar, M; Sersa, G				Stimac, Monika; Dolinsek, Tanja; Lampreht, Ursa; Cemazar, Maja; Sersa, Gregor			Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; HUMAN SOLID TUMORS; CD105 MONOCLONAL-ANTIBODIES; ANTI-ANGIOGENIC THERAPY; LEWIS LUNG-CARCINOMA; ENDOTHELIAL-CELLS; INTRATUMORAL DELIVERY; MELANOMA TUMORS; INTERLEUKIN-12 GENE; COMPLETE REGRESSION	Vascular targeted therapies, targeting specific endothelial cell markers, are promising approaches for the treatment of cancer. One of the targets is endoglin, transforming growth factor-beta (TGF-beta) co-receptor, which mediates proliferation, differentiation and migration of endothelial cells forming neovasculature. However, its specific, safe and long-lasting targeting remains the challenge. Therefore, in our study we evaluated the transfection efficacy, vascular targeted effects and therapeutic potential of the plasmid silencing endoglin with the tissue specific promoter, specific for endothelial cells marker endothelin-1 (ET) (TS plasmid), in comparison to the plasmid with constitutive promoter (CON plasmid), in vitro and in vivo. Tissue specificity of TS plasmid was demonstrated in vitro on several cell lines, and its antiangiogenic efficacy was demonstrated by reducing tube formation of 2H11 endothelial cells. In vivo, on a murine mammary TS/A tumor model, we demonstrated good antitumor effect of gene electrotransfer (GET) of either of both plasmids in treatment of smaller tumors still in avascular phase of growth, as well as on bigger tumors, already well vascularized. In support to the observations on predominantly vascular targeted effects of endoglin, histological analysis has demonstrated an increase in necrosis and a decrease in the number of blood vessels in therapeutic groups. A significant antitumor effect was observed in tumors in avascular and vascular phase of growth, possibly due to both, the antiangiogenic and the vascular disrupting effect. Furthermore, the study indicates on the potential use of TS plasmid in cancer gene therapy since the same efficacy as of CON plasmid was determined.	[Stimac, Monika; Dolinsek, Tanja; Lampreht, Ursa; Cemazar, Maja; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia	Institute of Oncology - Slovenia; University of Primorska	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.	gsersa@onko-i.si	Savarin, Monika/V-5451-2017; Cemazar, Maja/K-6182-2013	Savarin, Monika/0000-0002-8316-8110; Cemazar, Maja/0000-0002-1418-1928	Slovenian Research Agency [P3-0003, J3-4211, J3-4259]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (program no. P3-0003 (GS), projects no. J3-4211 (GS), J3-4259 (MC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadvand D, 2009, MOL IMMUNOL, V46, P1814, DOI 10.1016/j.molimm.2009.01.021; Ahmadvand D, 2008, HYBRIDOMA, V27, P353, DOI 10.1089/hyb.2008.0014; Bagnato A, 2011, BRIT J PHARMACOL, V163, P220, DOI 10.1111/j.1476-5381.2011.01217.x; Bosnjak M, 2013, J MEMBRANE BIOL, V246, P803, DOI 10.1007/s00232-013-9550-y; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Dancer A, 2003, GENE THER, V10, P1170, DOI 10.1038/sj.gt.3301981; Danda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083398; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Dean DA, 2013, J MEMBRANE BIOL, V246, P737, DOI 10.1007/s00232-013-9534-y; Dolinsek T, 2015, CURR GENE T IN PRESS; Dolinsek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058723; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Elez R, 2003, ONCOGENE, V22, P69, DOI 10.1038/sj.onc.1206038; Faurie C, 2010, J GENE MED, V12, P117, DOI 10.1002/jgm.1414; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4; Hanari N, 2007, ANTICANCER RES, V27, P2305; Heller L, 2013, CANCER GENE THER, V20, P695, DOI 10.1038/cgt.2013.71; Heller LC, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P159, DOI 10.1007/978-1-4419-8363-3_14; Heller LC, 2002, TECHNOL CANCER RES T, V1, P205, DOI 10.1177/153303460200100305; Heller LC, 2010, CURR GENE THER, V10, P312; Huang C, 2008, EXPERT OPIN THER TAR, V12, P637, DOI 10.1517/14728222.12.5.637 ; Kishida T, 2003, MOL THER, V8, P738, DOI 10.1016/j.ymthe.2003.08.002; Kuzmin D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-58; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li F, 2011, ADV DRUG DELIVER REV, V63, P47, DOI 10.1016/j.addr.2010.11.003; Lucas ML, 2002, MOL THER, V5, P668, DOI 10.1006/mthe.2002.0601; Mali B, 2013, RADIOL ONCOL, V47, P32, DOI 10.2478/raon-2013-0002; Marrero B, 2014, TECHNOL CANCER RES T, V13, P551, DOI 10.7785/tcrtexpress.2013.600252; Matsuno F, 1999, CLIN CANCER RES, V5, P371; McCray AN, 2004, MOL THER, V9, pS363; Mitchell DC, 2010, J CELL BIOCHEM, V111, P543, DOI 10.1002/jcb.22764; Munoz R, 2013, CANCER IMMUNOL IMMUN, V62, P541, DOI 10.1007/s00262-012-1357-7; NANNI P, 1983, CLIN EXP METASTAS, V1, P373, DOI 10.1007/BF00121199; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Niu GL, 1999, CANCER RES, V59, P5059; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Paganin-Gioanni A, 2011, P NATL ACAD SCI USA, V108, P10443, DOI 10.1073/pnas.1103519108; Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077; Qiao J, 2002, GENE THER, V9, P168, DOI 10.1038/sj.gt.3301618; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Roodink I, 2010, CANCER LETT, V299, P1, DOI 10.1016/j.canlet.2010.09.004; Rosen LS, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0365-x; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Sedlar A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-38; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Seon BK, 1997, CLIN CANCER RES, V3, P1031; She XW, 2004, INT J CANCER, V108, P251, DOI 10.1002/ijc.11551; Shibata MA, 2008, CANCER GENE THER, V15, P776, DOI 10.1038/cgt.2008.43; Spanggaard I, 2013, HUM GENE THER CL DEV, V24, P99, DOI 10.1089/humc.2012.240; Tabata M, 1999, INT J CANCER, V82, P737, DOI 10.1002/(SICI)1097-0215(19990827)82:5<737::AID-IJC18>3.3.CO;2-#; Takahashi N, 2001, CANCER RES, V61, P7846; Tan GH, 2007, WORLD J GASTROENTERO, V13, P2479, DOI 10.3748/wjg.v13.i17.2479; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tesic N, 2013, J MEMBRANE BIOL, V246, P783, DOI 10.1007/s00232-013-9548-5; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Tsujie M, 2006, INT J ONCOL, V29, P1087; Ugen KE, 2006, CANCER GENE THER, V13, P969, DOI 10.1038/sj.cgt.7700973; Uneda S, 2009, INT J CANCER, V125, P1446, DOI 10.1002/ijc.24482; Wannenes F, 2005, CANCER GENE THER, V12, P926, DOI 10.1038/sj.cgt.7700862; Xu Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-39	68	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124913	10.1371/journal.pone.0124913	http://dx.doi.org/10.1371/journal.pone.0124913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909447	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800114
J	Yin, ST; Jiang, HY; Chen, DR; Murchie, AIH				Yin, Sitao; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.			Substrate Recognition and Modification by the Nosiheptide Resistance Methyltransferase	PLOS ONE			English	Article							TRANSFER-RNA RECOGNITION; ELONGATION-FACTOR-G; 23S RIBOSOMAL-RNA; ACID-SEQUENCE MOTIFS; HIV-1 TAR RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GM18 METHYLTRANSFERASE; BACTERIAL RIBOSOME; AQUIFEX-AEOLICUS	Background The proliferation of antibiotic resistant pathogens is an increasing threat to the general public. Resistance may be conferred by a number of mechanisms including covalent or mutational modification of the antibiotic binding site, covalent modification of the drug, or the over-expression of efflux pumps. The nosiheptide resistance methyltransferase (NHR) confers resistance to the thiazole antibiotic nosiheptide in the nosiheptide producer organism Streptomyces actuosus through 2'O-methylation of 23S rRNA at the nucleotide A1067. Although the crystal structures of NHR and the closely related thiostrepton-resistance methyltransferase (TSR) in complex with the cofactor S-Adenosyl-L-methionine (SAM) are available, the principles behind NHR substrate recognition and catalysis remain unclear. Methodology/Principal Findings We have analyzed the binding interactions between NHR and model 58 and 29 nucleotide substrate RNAs by gel electrophoresis mobility shift assays (EMSA) and fluorescence anisotropy. We show that the enzyme binds to RNA as a dimer. By constructing a heterodimer complex composed of one wild-type subunit and one inactive mutant NHR-R135A subunit, we show that only one functional subunit of the NHR homodimer is required for its enzymatic activity. Mutational analysis suggests that the interactions between neighbouring bases (G1068 and U1066) and A1067 have an important role in methyltransfer activity, such that the substitution of a deoxy sugar spacer (5') to the target nucleotide achieved near wild-type levels of methylation. A series of atomic substitutions at specific positions on the substrate adenine show that local base-base interactions between neighbouring bases are important for methylation. Conclusion/Significance Taken together these data suggest that local base-base interactions play an important role in aligning the substrate 2' hydroxyl group of A1067 for methyl group transfer. Methylation of nucleic acids is playing an increasingly important role in fundamental biological processes and we anticipate that the approach outlined in this manuscript may be useful for investigating other classes of nucleic acid methyltransferases.	[Yin, Sitao; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Dept Biochem & Mol Biol, Key Lab Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China; [Yin, Sitao; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Chen, DR (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Key Lab Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China.	drchen@fudan.edu.cn; aihm@fudan.edu.cn			National Key 973 grant [2010CB912602]; Natural Science Foundation [31170749, 31100543]	National Key 973 grant(National Basic Research Program of China); Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Key 973 grant (2010CB912602) and Natural Science Foundation grants 31170749 and 31100543.	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Bower J, 2003, BIOORG MED CHEM LETT, V13, P2455, DOI 10.1016/S0960-894X(03)00495-5; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Coward J, 1977, CHEMICAL MECHANISMS; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; Dunstan MS, 2009, J BIOL CHEM, V284, P17013, DOI 10.1074/jbc.M901618200; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Fu Y, 2012, CURR OPIN CHEM BIOL, V16, P516, DOI 10.1016/j.cbpa.2012.10.002; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; Green R, 1996, RNA, V2, P1011; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; HOUNTONDJI C, 1979, EUR J BIOCHEM, V102, P247, DOI 10.1111/j.1432-1033.1979.tb06286.x; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jia X, 2013, CELL, V152, P68, DOI 10.1016/j.cell.2012.12.019; Jonker HRA, 2007, NUCLEIC ACIDS RES, V35, P441, DOI 10.1093/nar/gkl1066; Knowles DJC, 2002, CURR OPIN PHARMACOL, V2, P501, DOI 10.1016/S1471-4892(02)00205-9; Kuiper EG, 2014, J BIOL CHEM, V289, P26189, DOI 10.1074/jbc.M114.574780; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Lentzen G, 2003, CHEM BIOL, V10, P769, DOI 10.1016/S1074-5521(03)00173-X; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu MF, 2000, MOL MICROBIOL, V37, P811, DOI 10.1046/j.1365-2958.2000.02046.x; Mikhailov SN, 2002, NUCLEIC ACIDS RES, V30, P1124, DOI 10.1093/nar/30.5.1124; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; MURCHIE AIH, 1987, NUCLEIC ACIDS RES, V15, P9641, DOI 10.1093/nar/15.23.9641; MURCHIE AIH, 1989, J MOL BIOL, V205, P593, DOI 10.1016/0022-2836(89)90228-3; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Ochi A, 2010, J BIOL CHEM, V285, P9018, DOI 10.1074/jbc.M109.065698; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; Ragsdale SW, 2008, VITAM HORM, V79, P293, DOI 10.1016/S0083-6729(08)00410-X; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Sakaguchi R, 2012, RNA, V18, P1687, DOI 10.1261/rna.032029.111; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SCHMIDT FJ, 1981, J BIOL CHEM, V256, P2301; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SKOLD SE, 1983, NUCLEIC ACIDS RES, V11, P4923, DOI 10.1093/nar/11.14.4923; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Thomas SR, 2011, NUCLEIC ACIDS RES, V39, P2445, DOI 10.1093/nar/gkq1131; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Wu TP, 1996, NUCLEIC ACIDS RES, V24, P3472, DOI 10.1093/nar/24.17.3472; Yang HR, 2010, BIOCHEMISTRY-US, V49, P6440, DOI 10.1021/bi1005915; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	65	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122972	10.1371/journal.pone.0122972	http://dx.doi.org/10.1371/journal.pone.0122972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910005	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800025
J	Gutmann, S; Hinniger, A; Fendrich, G; Druckes, P; Antz, S; Mattes, H; Mobitz, H; Ofner, S; Schmiedeberg, N; Stojanovic, A; Rieffel, S; Strauss, A; Troxler, T; Glatthar, R; Sparrer, H				Gutmann, Sascha; Hinniger, Alexandra; Fendrich, Gabriele; Drueckes, Peter; Antz, Sylvie; Mattes, Henri; Moebitz, Henrik; Ofner, Silvio; Schmiedeberg, Niko; Stojanovic, Aleksandar; Rieffel, Sebastien; Strauss, Andre; Troxler, Thomas; Glatthar, Ralf; Sparrer, Helmut			The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; TUMOR PROGRESSION LOCUS-2; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; TPL2 KINASE; LIPOPOLYSACCHARIDE ACTIVATION; TP12 KINASE; INHIBITION; INFLAMMATION; PHOSPHORYLATION	Macrophages are important cellular effectors in innate immune responses and play a major role in autoimmune diseases such as rheumatoid arthritis. Cancer Osaka thyroid (COT) kinase, also known as mitogen-activated protein kinase kinase kinase 8 (MAP3K8) and tumor progression locus 2 (Tpl-2), is a serine-threonine (ST) kinase and is a key regulator in the production of pro-inflammatory cytokines in macrophages. Due to its pivotal role in immune biology, COT kinase has been identified as an attractive target for pharmaceutical research that is directed at the discovery of orally available, selective, and potent inhibitors for the treatment of autoimmune disorders and cancer. The production of monomeric, recombinant COT kinase has proven to be very difficult, and issues with solubility and stability of the enzyme have hampered the discovery and optimization of potent and selective inhibitors. We developed a protocol for the production of recombinant human COT kinase that yields pure and highly active enzyme in sufficient yields for biochemical and structural studies. The quality of the enzyme allowed us to establish a robust in vitro phosphorylation assay for the efficient biochemical characterization of COT kinase inhibitors and to determine the x-ray co-crystal structures of the COT kinase domain in complex with two ATP-binding site inhibitors. The structures presented in this study reveal two distinct ligand binding modes and a unique kinase domain architecture that has not been observed previously. The structurally versatile active site significantly impacts the design of potent, low molecular weight COT kinase inhibitors.	[Gutmann, Sascha; Hinniger, Alexandra; Fendrich, Gabriele; Drueckes, Peter; Antz, Sylvie; Rieffel, Sebastien; Strauss, Andre] Novartis Pharma AG, Novartis Inst BioMed Res, Ctr Prote Chem, CH-4002 Basel, Switzerland; [Mattes, Henri; Moebitz, Henrik; Ofner, Silvio; Schmiedeberg, Niko; Stojanovic, Aleksandar; Troxler, Thomas; Glatthar, Ralf] Novartis Pharma AG, Novartis Inst BioMed Res, Global Discovery Chem, CH-4002 Basel, Switzerland; [Sparrer, Helmut] Novartis Pharma AG, Novartis Inst BioMed Res, Autoimmun Transplantat Inflammat, CH-4002 Basel, Switzerland	Novartis; Novartis; Novartis	Gutmann, S (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Ctr Prote Chem, CH-4002 Basel, Switzerland.	sascha.gutmann@novartis.com		Gutmann, Sascha/0000-0002-4242-8510; Moebitz, Henrik/0000-0002-8398-6121				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Ben-Addi A, 2014, P NATL ACAD SCI USA, V111, pE2394, DOI 10.1073/pnas.1320440111; Bricogne G., 2011, BUSTER VERSION 1 11; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; Cusack K, 2009, BIOORG MED CHEM LETT, V19, P1722, DOI 10.1016/j.bmcl.2009.01.088; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Hu YH, 2006, BIOORG MED CHEM LETT, V16, P6067, DOI 10.1016/j.bmcl.2006.08.102; Hu YH, 2011, BIOORG MED CHEM LETT, V21, P4758, DOI 10.1016/j.bmcl.2011.06.065; Jia Y, 2005, ARCH BIOCHEM BIOPHYS, V441, P64, DOI 10.1016/j.abb.2005.06.020; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaila N, 2007, BIOORGAN MED CHEM, V15, P6425, DOI 10.1016/j.bmc.2007.06.054; Kim JY, 2015, ONCOGENE, V34, P4928, DOI 10.1038/onc.2014.418; Lee HW, 2015, INT J CANCER, V136, P2065, DOI 10.1002/ijc.29248; Liu JS, 2012, J BIOL CHEM, V287, P27326, DOI 10.1074/jbc.M112.366658; Matsumoto T, 2010, BIOCHEM BIOPH RES CO, V400, P369, DOI 10.1016/j.bbrc.2010.08.071; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min XS, 2009, STRUCTURE, V17, P96, DOI 10.1016/j.str.2008.11.007; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Roget K, 2012, MOL CELL BIOL, V32, P4684, DOI 10.1128/MCB.01065-12; Sriskantharajah S, 2014, J IMMUNOL, V192, P3518, DOI 10.4049/jimmunol.1300172; Strauss A, 2007, PROTEIN EXPRES PURIF, V56, P167, DOI 10.1016/j.pep.2007.06.008; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiao YC, 2014, J EXP MED, V211, P1689, DOI 10.1084/jem.20132640; Yang HT, 2012, MOL CELL BIOL, V32, P3438, DOI 10.1128/MCB.00564-12; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	38	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					15210	15218		10.1074/jbc.M115.648097	http://dx.doi.org/10.1074/jbc.M115.648097			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918157	Green Published, hybrid			2022-12-26	WOS:000356177300034
J	Raychaudhuri, S; Espenshade, PJ				Raychaudhuri, Sumana; Espenshade, Peter J.			Endoplasmic Reticulum Exit of Golgi-resident Defective for SREBP Cleavage (Dsc) E3 Ligase Complex Requires Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; UBIQUITIN-CONJUGATING ENZYMES; FISSION YEAST; SECRETORY PATHWAY; DOMAIN; DEGRADATION; TRANSPORT; ER; SUBUNIT; CDC48	Layers of quality control ensure proper protein folding and complex formation prior to exit from the endoplasmic reticulum. The fission yeast Dsc E3 ligase is a Golgi-localized complex required for sterol regulatory element-binding protein (SREBP) transcription factor activation that shows architectural similarity to endoplasmic reticulum-associated degradation E3 ligases. The Dsc E3 ligase consists of five integral membrane proteins (Dsc1-Dsc5) and functionally interacts with the conserved AAA-ATPase Cdc48. Utilizing an in vitro ubiquitination assay, we demonstrated that Dsc1 has ubiquitin E3 ligase activity that requires the E2 ubiquitin-conjugating enzyme Ubc4. Mutations that specifically block Dsc1-Ubc4 interaction prevent SREBP cleavage, indicating that SREBP activation requires Dsc E3 ligase activity. Surprisingly, Golgi localization of the Dsc E3 ligase complex also requires Dsc1 E3 ligase activity. Analysis of Dsc E3 ligase complex formation, glycosylation, and localization indicated that Dsc1 E3 ligase activity is specifically required for endoplasmic reticulum exit of the complex. These results define enzyme activity-dependent sorting as an autoregulatory mechanism for protein trafficking.	[Raychaudhuri, Sumana; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol Rm 107B, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol Rm 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Regan, Clinton/E-6250-2012	Raychaudhuri, Sumana/0000-0002-3164-0057; Espenshade, Peter/0000-0002-6433-0178	National Institutes of Health [HL077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant HL077588 from the National Institutes of Health (to P. J. E.).	Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Bourgeois-Daigneault MC, 2013, J CELL SCI, V126, P989, DOI 10.1242/jcs.117804; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Cheung R, 2013, J BIOL CHEM, V288, P20351, DOI 10.1074/jbc.M113.482224; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Janoo RTK, 2001, GENETICS, V157, P1205; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Le Fourn V, 2013, CELL MOL LIFE SCI, V70, P1985, DOI 10.1007/s00018-012-1236-6; Lloyd SJA, 2013, J BIOL CHEM, V288, P21043, DOI 10.1074/jbc.M113.468215; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Matynia A, 2002, J CELL SCI, V115, P421; Ossareh-Nazari B, 2010, EXP CELL RES, V316, P3351, DOI 10.1016/j.yexcr.2010.09.005; Rankin CA, 2014, BIOCHEMISTRY-US, V53, P225, DOI 10.1021/bi401378p; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Stanley Pamela, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005199; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vjestica A, 2008, MOL BIOL CELL, V19, P1125, DOI 10.1091/mbc.E07-07-0663; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	39	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14430	14440		10.1074/jbc.M114.630863	http://dx.doi.org/10.1074/jbc.M114.630863			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918164	Green Published, hybrid			2022-12-26	WOS:000355754600014
J	Thomson, SJ; Hansen, A; Sanguinetti, MC				Thomson, Steven J.; Hansen, Angela; Sanguinetti, Michael C.			Identification of the Intracellular Na+ Sensor in Slo2.1 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED K+ CHANNELS; KIR CHANNELS; SODIUM; SENSITIVITY; ISCHEMIA	Slo2 potassium channels have a very low open probability under normal physiological conditions, but are readily activated in response to an elevated [Na+](i) (e.g. during ischemia). An intracellular Na+ coordination motif ( DX(R/K)XXH) was previously identified in Kir3.2, Kir3.4, Kir5.1, and Slo2.2 channel subunits. Based loosely on this sequence, we identified five potential Na+ coordination motifs in the C terminus of the Slo2.1 subunit. The Asp residue in each sequence was substituted with Arg, and single mutant channels were heterologously expressed in Xenopus oocytes. The Na+ sensitivity of each of the mutant channels was assessed by voltage clamp of oocytes using micropipettes filled with 2 M NaCl. Wild-type channels and four of the mutant Slo2.1 channels were rapidly activated by leakage of NaCl solution into the cytoplasm. D757R Slo2.1 channels were not activated by NaCl, but were activated by the fenamate niflumic acid, confirming their functional expression. In whole cell voltage clamp recordings of HEK293 cells, wild-type but not D757R Slo2.1 channels were activated by a [NaCl](i) of 70 mM. Thus, a single Asp residue can account for the sensitivity of Slo2.1 channels to intracellular Na+. In excised inside-out macropatches of HEK293 cells, activation of wild-type Slo2.1 currents by 3 mM niflumic acid was 14-fold greater than activation achieved by increasing [NaCl](i) from 3 to 100 mM. Thus, relative to fenamates, intracellular Na+ is a poor activator of Slo2.1.	[Thomson, Steven J.; Hansen, Angela; Sanguinetti, Michael C.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA; [Sanguinetti, Michael C.] Univ Utah, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Sanguinetti, MC (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA.	sanguinetti@cvrti.utah.edu		Sanguinetti, Michael/0000-0001-8974-0969	National Institutes of Health NHLBI [R01 HL103877]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103877] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health NHLBI Grant R01 HL103877 (to M. C. S.).	Anderson SE, 1996, AM J PHYSIOL-CELL PH, V270, pC608, DOI 10.1152/ajpcell.1996.270.2.C608; BADER CR, 1985, NATURE, V317, P540, DOI 10.1038/317540a0; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Dai L, 2010, J GEN PHYSIOL, V135, P275, DOI 10.1085/jgp.200910316; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; EGAN TM, 1992, J NEUROSCI, V12, P1964; Garg P, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12118; Garg P, 2013, J GEN PHYSIOL, V142, P523, DOI 10.1085/jgp.201311064; Garg P, 2012, MOL PHARMACOL, V82, P795, DOI 10.1124/mol.112.079194; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Leonetti MD, 2012, P NATL ACAD SCI USA, V109, P19274, DOI 10.1073/pnas.1215078109; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; PIKE MM, 1990, AM J PHYSIOL, V259, pH1767, DOI 10.1152/ajpheart.1990.259.6.H1767; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833; Thomson SJ, 2014, J BIOL CHEM, V289, P23428, DOI 10.1074/jbc.M114.582437; WENDTGALLITELLI MF, 1993, J PHYSIOL-LONDON, V472, P33, DOI 10.1113/jphysiol.1993.sp019934; Yan YY, 2012, J MEMBRANE BIOL, V245, P667, DOI 10.1007/s00232-012-9425-7; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang Z, 2010, J NEUROSCI, V30, P7554, DOI 10.1523/JNEUROSCI.0525-10.2010	27	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14528	14535		10.1074/jbc.M115.653089	http://dx.doi.org/10.1074/jbc.M115.653089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903137	Green Published, hybrid			2022-12-26	WOS:000355754600024
J	Jay, L; Bourget, JM; Goyer, B; Singh, K; Brunette, I; Ozaki, T; Proulx, S				Jay, Louis; Bourget, Jean-Michel; Goyer, Benjamin; Singh, Kanwarpal; Brunette, Isabelle; Ozaki, Tsuneyuki; Proulx, Stephanie			Characterization of Tissue-Engineered Posterior Corneas Using Second- and Third-Harmonic Generation Microscopy	PLOS ONE			English	Article							SELF-ASSEMBLY APPROACH; 2ND-HARMONIC GENERATION; HARMONIC-GENERATION; IMAGING MICROSCOPY; COLLAGEN; CELLS; REGENERATION; ORIENTATION; EQUIVALENT; RESOLUTION	Three-dimensional tissues, such as the cornea, are now being engineered as substitutes for the rehabilitation of vision in patients with blinding corneal diseases. Engineering of tissues for translational purposes requires a non-invasive monitoring to control the quality of the resulting biomaterial. Unfortunately, most current methods still imply invasive steps, such as fixation and staining, to clearly observe the tissue-engineered cornea, a transparent tissue with weak natural contrast. Second-and third-harmonic generation imaging are well known to provide high-contrast, high spatial resolution images of such tissues, by taking advantage of the endogenous contrast agents of the tissue itself. In this article, we imaged tissue-engineered corneal substitutes using both harmonic microscopy and classic histopathology techniques. We demonstrate that second-and third-harmonic imaging can non-invasively provide important information regarding the quality and the integrity of these partial-thickness posterior corneal substitutes (observation of collagen network, fibroblasts and endothelial cells). These two nonlinear imaging modalities offer the new opportunity of monitoring the engineered corneas during the entire process of production.	[Jay, Louis; Singh, Kanwarpal; Ozaki, Tsuneyuki] Inst Natl Rech Sci, Ctr Energie Mat Telecommun, Varennes, PQ, Canada; [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada; [Jay, Louis; Bourget, Jean-Michel; Singh, Kanwarpal; Brunette, Isabelle] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Goyer, Benjamin; Proulx, Stephanie] CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada; [Goyer, Benjamin; Proulx, Stephanie] Univ Laval, LOEX, Ctr Rech Organogenese Exprt, Quebec City, PQ, Canada; [Proulx, Stephanie] Univ Laval, Fac Med, Dept Ophtalmol & Otorhinolaryngol, Quebec City, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University	Proulx, S (corresponding author), CHU Quebec, Hop St Sacrement, Ctr Rech, Axe Med Regeneratrice, Quebec City, PQ, Canada.	stephanie.proulx@fmed.ulaval.ca	Singh, Kanwarpal/P-3789-2019	Ozaki, Tsuneyuki/0000-0001-8857-3900; Proulx, Stephanie/0000-0002-1227-4039; Singh, Kanwarpal/0000-0002-6884-8089	Canadian Institutes for Health Research (CIHR) [CPG121034]; Natural Sciences and Engineering Research Council of Canada (NSERC) [414484-2012]; FRQS Vision Health Research Network;  [CHRPJ 313019-05]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQS Vision Health Research Network; 	This work was supported by the Canadian Institutes for Health Research (CIHR grant #CPG121034) in partnership with the Natural Sciences and Engineering Research Council of Canada (NSERC grant #414484-2012) (SP, IB) and grant #CHRPJ 313019-05 (TO). The Eye Bank Banque d'yeux du Centre Universitaire d'Ophtalmologie" is partly supported by the FRQS Vision Health Research Network (SP, IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586; Auxenfans C, 2009, EUR J DERMATOL, V19, P107, DOI 10.1684/ejd.2008.0573; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Barzda V, 2005, OPT EXPRESS, V13, P8263, DOI 10.1364/OPEX.13.008263; Buhrmann R., 2007, FDN CANADIAN HLTH ST; Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904; Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; EBAA, 2013, 2013 EYE BANK STAT R, P1; Gauvin R, 2010, TISSUE ENG PT A, V16, P1737, DOI [10.1089/ten.tea.2009.0313, 10.1089/ten.TEA.2009.0313]; Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7; Germain L, 2004, TISSUE ENG CORNEA EN, P1533; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g; Howat WJ, 2014, METHODS, V70, P12, DOI 10.1016/j.ymeth.2014.01.022; Hsueh CM, 2009, BIOPHYS J, V97, P1198, DOI 10.1016/j.bpj.2009.05.040; Jay L, 2008, OPT EXPRESS, V16, P16284, DOI 10.1364/OE.16.016284; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Larouche Danielle, 2009, V482, P233, DOI 10.1007/978-1-59745-060-7_15; Lee GG, 2013, IEEE T BIOMED CIRC S, V7, P158, DOI 10.1109/TBCAS.2013.2253463; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Mega Y, 2012, OPT LETT, V37, P3312, DOI 10.1364/OL.37.003312; Mimura T, 2013, PROG RETIN EYE RES, V35, P1, DOI 10.1016/j.preteyeres.2013.01.003; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; Morishige N, 2009, CORNEA, V28, pS46, DOI 10.1097/ICO.0b013e3181ae9f37; Muller M, 1998, J MICROSC-OXFORD, V191, P266, DOI 10.1046/j.1365-2818.1998.00399.x; Pankert MB, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14720; PIHLAJANIEMI T, 1991, J HEPATOL, V13, pS2, DOI 10.1016/0168-8278(91)90002-S; Proulx S, 2012, EXP EYE RES, V95, P68, DOI 10.1016/j.exer.2011.06.013; Proulx S, 2010, MOL VIS, V16, P2192; Su PJ, 2010, BIOMATERIALS, V31, P9415, DOI 10.1016/j.biomaterials.2010.08.055; TAYLOR MJ, 1981, BRIT J OPHTHALMOL, V65, P815, DOI 10.1136/bjo.65.12.815; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Tserevelakis GJ, 2010, MICRON, V41, P444, DOI 10.1016/j.micron.2010.02.006; Vielreicher M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0263; Yelin D, 1999, OPT EXPRESS, V5, P169, DOI 10.1364/OE.5.000169; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	41	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125564	10.1371/journal.pone.0125564	http://dx.doi.org/10.1371/journal.pone.0125564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918849	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400086
J	Mecenero, S; Altwegg, R; Colville, JF; Beale, CM				Mecenero, Silvia; Altwegg, Res; Colville, Jonathan F.; Beale, Colin M.			Roles of Spatial Scale and Rarity on the Relationship between Butterfly Species Richness and Human Density in South Africa	PLOS ONE			English	Article							HUMAN-POPULATION DENSITY; CONSERVATION CONFLICTS; HABITAT HETEROGENEITY; PRIMARY PRODUCTIVITY; EUROPEAN COUNTRIES; NATIONAL SCALE; BIODIVERSITY; PATTERNS; PEOPLE; DIVERSITY	Wildlife and humans tend to prefer the same productive environments, yet high human densities often lead to reduced biodiversity. Species richness is often positively correlated with human population density at broad scales, but this correlation could also be caused by unequal sampling effort leading to higher species tallies in areas of dense human activity. We examined the relationships between butterfly species richness and human population density at five spatial resolutions ranging from 2' to 60' across South Africa. We used atlas-type data and spatial interpolation techniques aimed at reducing the effect of unequal spatial sampling. Our results confirm the general positive correlation between total species richness and human population density. Contrary to our expectations, the strength of this positive correlation did not weaken at finer spatial resolutions. The patterns observed using total species richness were driven mostly by common species. The richness of threatened and restricted range species was not correlated to human population density. None of the correlations we examined were particularly strong, with much unexplained variance remaining, suggesting that the overlap between butterflies and humans is not strong compared to other factors not accounted for in our analyses. Special consideration needs to be made regarding conservation goals and variables used when investigating the overlap between species and humans for biodiversity conservation.	[Mecenero, Silvia] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Mecenero, Silvia; Altwegg, Res; Colville, Jonathan F.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Claremont, South Africa; [Mecenero, Silvia] Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa; [Altwegg, Res; Colville, Jonathan F.] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7700 Rondebosch, South Africa; [Beale, Colin M.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Pretoria; South African National Biodiversity Institute; University of the Western Cape; University of Cape Town; University of York - UK	Altwegg, R (corresponding author), South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Claremont, South Africa.	res.altwegg@gmail.com		Beale, Colin Michael/0000-0002-2960-5666	University of Pretoria; South African National Biodiversity Institute; National Research Foundation of South Africa [85802]; National Research Foundation of South Africa's Research Career Award Fellowship	University of Pretoria; South African National Biodiversity Institute; National Research Foundation of South Africa(National Research Foundation - South Africa); National Research Foundation of South Africa's Research Career Award Fellowship	SM was supported by a postdoctoral fellowship from the University of Pretoria (www.up.ac.za), followed by one from the South African National Biodiversity Institute (www.sanbi.org.za). RA was supported by the National Research Foundation of South Africa (Grant 85802; www.nrf.ac.za). JFC was supported by a National Research Foundation of South Africa's Research Career Award Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Research Foundation accepts no liability for opinions, findings and conclusions or recommendations expressed in this publication.	ACKERY PR, 1995, CARCASSONS AFRICAN B; [Anonymous], 1997, VEGETATION SO AFRICA; Araujo MB, 2003, GLOBAL ECOL BIOGEOGR, V12, P5, DOI 10.1046/j.1466-822X.2003.00314.x; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Balmford A, 2001, SCIENCE, V293, P1591; Barbosa AM, 2010, ANIM CONSERV, V13, P432, DOI 10.1111/j.1469-1795.2010.00363.x; Bates MF, 2014, ATLAS RED LIST REPTI, V1; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Cantarello E, 2010, NATURWISSENSCHAFTEN, V97, P265, DOI 10.1007/s00114-009-0636-4; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chown SL, 2003, ECOL APPL, V13, P1233, DOI 10.1890/02-5105; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Colville JF, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P73; COWLING RM, 1989, BIOTIC DIVERSITY SO; Crainiceanu C. M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I14; Cressie N., 2011, STAT SPATIO TEMPORAL; Dennis R. L., 1993, BUTTERFLIES CLIMATE; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Edge DA, 2015, J INSECT CONSERV, V19, P325, DOI 10.1007/s10841-015-9758-5; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P625, DOI 10.1111/j.1466-8238.2006.00253.x; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Evans KL, 2005, GLOBAL ECOL BIOGEOGR, V14, P187, DOI 10.1111/j.1466-822X.2004.00139.x; Fairbanks DHK, 2004, AGR ECOSYST ENVIRON, V101, P269, DOI 10.1016/j.agee.2003.09.009; Fjeldsa J, 2008, AFR J ECOL, V46, P33, DOI 10.1111/j.1365-2028.2008.00927.x; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Gaston K.J., 1994, RARITY, P1; Gaston KJ, 2005, PROG PHYS GEOG, V29, P239, DOI 10.1191/0309133305pp445pr; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hardy PB, 1999, BIODIVERS CONSERV, V8, P1261, DOI 10.1023/A:1008984905413; Hengl T, 2009, ECOL MODEL, V220, P3499, DOI 10.1016/j.ecolmodel.2009.06.038; Henning G. A., 2009, SANBI BIODIVERSITY S, V13; Hugo S, 2008, GLOBAL ECOL BIOGEOGR, V17, P611, DOI 10.1111/j.1466-8238.2008.00391.x; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Lennon JJ, 2011, ECOGRAPHY, V34, P529, DOI 10.1111/j.1600-0587.2010.06669.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Luck GW, 2007, J BIOGEOGR, V34, P201, DOI 10.1111/j.1365-2699.2006.01575.x; Luck GW, 2004, P NATL ACAD SCI USA, V101, P182, DOI 10.1073/pnas.2237148100; Barbosa AM, 2013, DIVERS DISTRIB, V19, P1188, DOI 10.1111/ddi.12106; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mecenero S., 2013, CONSERVATION ASSESSM; Minter L.R., 2004, ATLAS RED DATA BOOK, V9; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; NEW TR, 1995, ANNU REV ENTOMOL, V40, P57, DOI 10.1146/annurev.en.40.010195.000421; Pautasso M, 2009, BIODIVERS CONSERV, V18, P473, DOI 10.1007/s10531-008-9511-4; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Pautasso M, 2009, OECOLOGIA, V160, P839, DOI 10.1007/s00442-009-1329-6; Pearman PB, 2007, BIOL CONSERV, V138, P109, DOI 10.1016/j.biocon.2007.04.005; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; R-project, R LANG ENV STAT COMP; Samways M.J., 2005, INSECT DIVERSITY CON; Samways MJ., 2010, TECHNIQUES ECOLOGY C; Schlick-Steiner BC, 2008, J BIOGEOGR, V35, P2195, DOI 10.1111/j.1365-2699.2008.01968.x; Schulze R. E, 2001, S AFRICAN ATLAS AGRO; Slotow R, 2000, S AFR J SCI, V96, P222; Steck CE, 2008, ACTA OECOL, V34, P303, DOI 10.1016/j.actao.2008.06.003; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; van Rensburg BJ, 2002, AM NAT, V159, P566, DOI 10.1086/339464; Vazquez LB, 2004, GLOBAL ECOL BIOGEOGR, V13, P535, DOI 10.1111/j.1466-822X.2004.00126.x; Vazquez LB, 2006, BIODIVERS CONSERV, V15, P2397, DOI 10.1007/s10531-004-3954-z; Vernon CJ, 1999, KAROO ECOLOGICAL PAT; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; White PJT, 2007, GLOBAL ECOL BIOGEOGR, V16, P290, DOI 10.1111/j.1466-8238.2007.00298.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	73	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124327	10.1371/journal.pone.0124327	http://dx.doi.org/10.1371/journal.pone.0124327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915899	Green Published, gold, Green Accepted			2022-12-26	WOS:000353659100047
J	Piao, J; Lee, JY; Weon, JB; Ma, CJ; Ko, HJ; Kim, DD; Kang, WS; Cho, HJ				Piao, Jingpei; Lee, Jae-Young; Weon, Jin Bae; Ma, Choong Je; Ko, Hyun-Jeong; Kim, Dae-Duk; Kang, Wie-Soo; Cho, Hyun-Jong			Angelica gigas Nakai and Soluplus-Based Solid Formulations Prepared by Hot-Melting Extrusion: Oral Absorption Enhancing and Memory Ameliorating Effects	PLOS ONE			English	Article							DISSOLUTION; DECURSINOL; DISPERSIONS; SCOPOLAMINE; EXTRACT	Oral solid formulations based on Angelica gigas Nakai (AGN) and Soluplus were prepared by the hot-melting extrusion (HME) method. AGN was pulverized into coarse and ultrafine particles, and their particle size and morphology were investigated. Ultrafine AGN particles were used in the HME process with high shear to produce AGN-based formulations. In simulated gastrointestinal fluids (pH 1.2 and pH 6.8) and water, significantly higher amounts of the major active components of AGN, decursin (D) and decursinol angelate (DA), were extracted from the HME-processed AGN/Soluplus (F8) group than the AGN EtOH extract (ext) group (p < 0.05). Based on an in vivo pharmacokinetic study in rats, the relative oral bioavailability of decursinol (DOH), a hepatic metabolite of D and DA, in F8-administered mice was 8.75-fold higher than in AGN EtOH ext-treated group. In scopolamine-induced memory- impaired mice, F8 exhibited a more potent cognitive enhancing effect than AGN EtOH ext in both a Morris water maze test and a passive avoidance test. These findings suggest that HME-processed AGN/Soluplus formulation (F8) could be a promising therapeutic candidate for memory impairment.	[Piao, Jingpei; Kang, Wie-Soo] Kangwon Natl Univ, Sch Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Jae-Young; Kang, Wie-Soo] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Lee, Jae-Young; Kim, Dae-Duk] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Weon, Jin Bae; Ma, Choong Je] Kangwon Natl Univ, Coll Biomed Sci, Dept Med Biomat Engn, Chunchon 200701, South Korea; [Ma, Choong Je] Kangwon Natl Univ, Biotechnol Res Inst, Chunchon 200701, South Korea; [Ko, Hyun-Jeong; Cho, Hyun-Jong] Kangwon Natl Univ, Coll Pharm, Chunchon 200701, South Korea	Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kangwon National University; Kangwon National University	Kang, WS (corresponding author), Kangwon Natl Univ, Sch Biosci & Biotechnol, Chunchon 200701, South Korea.	kangwiso@kangwon.ac.kr; hjcho@kangwon.ac.kr	Kim, Dae Duk/D-8864-2013	Ko, Hyun-Jeong/0000-0002-3844-928X; Lee, Jae-Young/0000-0002-8093-043X; Cho, Hyun-Jong/0000-0002-5070-9371	Kangwon National University; National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2012R1A1A1038944]	Kangwon National University; National Research Foundation of Korea (NRF) - Korean government (MSIP)	This study is supported by Kangwon National University (http://www.kangwon.ac.kr) and the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP) (No. NRF-2012R1A1A1038944, URL http://www.nrf.re.kr/nrf tot cms/index.jsp?pmi-sso-return2=none&pmi-sso-return2=none).	Bae IY, 2011, FOOD SCI BIOTECHNOL, V20, P1113, DOI 10.1007/s10068-011-0151-1; Cho HJ, 2014, INT J NANOMED, V9, P495, DOI 10.2147/IJN.S56648; Choi KO, 2012, J MED FOOD, V15, P863, DOI 10.1089/jmf.2011.2047; Crowley MM, 2007, DRUG DEV IND PHARM, V33, P909, DOI 10.1080/03639040701498759; Djuris J, 2013, EUR J PHARM BIOPHARM, V84, P228, DOI 10.1016/j.ejpb.2012.12.018; Doh HJ, 2013, COLLOID SURFACE B, V101, P475, DOI 10.1016/j.colsurfb.2012.07.019; Godavarti S, 1997, J AGR ENG RES, V67, P277, DOI 10.1006/jaer.1997.0172; Hughey JR, 2013, EUR J PHARM SCI, V48, P758, DOI 10.1016/j.ejps.2013.01.004; Joo SS, 2010, ENVIRON TOXICOL PHAR, V30, P127, DOI 10.1016/j.etap.2010.04.007; Kang SY, 2007, J PHARM PHARMACOL, V59, P863, DOI 10.1211/jpp.59.6.0013; Kang SY, 2003, NEUROBIOL LEARN MEM, V79, P11, DOI 10.1016/S1074-7427(02)00007-2; KITE FRANCIS E., 1957, BAKER S DIGEST, V31, P42; Li L, 2013, PLANTA MED, V79, P275, DOI 10.1055/s-0032-1328202; Linn M, 2012, EUR J PHARM SCI, V45, P336, DOI 10.1016/j.ejps.2011.11.025; Liu X, 2012, PHARM RES-DORDR, V29, P806, DOI 10.1007/s11095-011-0605-4; Mu HL, 2013, INT J PHARMACEUT, V453, P215, DOI 10.1016/j.ijpharm.2013.03.054; Park HS, 2012, PLANTA MED, V78, P909, DOI 10.1055/s-0031-1298517; Park SJ, 2012, J ETHNOPHARMACOL, V143, P611, DOI 10.1016/j.jep.2012.07.019; Pina MF, 2014, J PHARM SCI-US, V103, P1214, DOI 10.1002/jps.23894; Repka MA, 2007, DRUG DEV IND PHARM, V33, P1043, DOI 10.1080/03639040701525627; Repka MA, 2008, EXPERT OPIN DRUG DEL, V5, P1357, DOI [10.1517/17425240802583421, 10.1517/17425240802583421 ]; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Seo YJ, 2009, ARCH PHARM RES, V32, P937, DOI 10.1007/s12272-009-1617-z; Song JS, 2011, XENOBIOTICA, V41, P895, DOI 10.3109/00498254.2011.587551; Weon JB, 2014, PHARMACOGN MAG, V10, P249, DOI 10.4103/0973-1296.133266; Weon JB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/464576; Wilson M, 2012, THER DELIV, V3, P787, DOI 10.4155/TDE.12.26; Yan JJ, 2004, PROG NEURO-PSYCHOPH, V28, P25, DOI 10.1016/S0278-5846(03)00168-4; Yun F, 2014, INT J PHARMACEUT, V465, P436, DOI 10.1016/j.ijpharm.2014.02.040; Zhang JH, 2012, ANTI-CANCER AGENT ME, V12, P1239, DOI 10.2174/187152012803833071; Zhang KR, 2013, EUR J PHARM BIOPHARM, V85, P1285, DOI 10.1016/j.ejpb.2013.03.002	31	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124447	10.1371/journal.pone.0124447	http://dx.doi.org/10.1371/journal.pone.0124447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915423	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100050
J	de Jager, P; Chirwa, T; Naidoo, S; Perovic, O; Thomas, J				de Jager, Pieter; Chirwa, Tobias; Naidoo, Shan; Perovic, Olga; Thomas, Juno			Nosocomial Outbreak of New Delhi Metallo-beta-Lactamase-1-Producing Gram-Negative Bacteria in South Africa: A Case-Control Study	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; KLEBSIELLA-PNEUMONIAE; EMERGING CARBAPENEMASES; RISK-FACTORS; INFECTIONS; EMERGENCE; MORTALITY; NDM-1; 21ST-CENTURY	Objective New Delhi metallo-beta-lactamase (NDM)-producing Gram-negative bacteria have spread globally and pose a significant public health threat. There is a need to better define risk factors and outcomes of NDM-1 clinical infection. We assessed risk factors for nosocomial infection with NDM-1-producers and associated in-hospital mortality. Methods A matched case-control study was conducted during a nosocomial outbreak of NDM-1-producers in an adult intensive care unit (ICU) in South Africa. All patients from whom NDM-1-producers were identified were considered (n=105). Cases included patients admitted during the study period in whom NDM-1 producing Gram-negative bacteria were isolated from clinical specimens collected >= 48 hours after admission, and where surveillance definitions for healthcare-associated infections were met. Controls were matched for age, sex, date of hospital admission and intensive-care admission. Conditional logistic regression was used to identify risk factors for NDM-1 clinical infection and associated in-hospital mortality. Findings 38 cases and 68 controls were included. Klebsiella pneumoniae was the most common NDM-1-producer (28/38, 74%). Cases had longer mean hospital stays (44.0 vs. 13.3 days; P < 0.001) and ICU stays (32.5 vs. 8.3 days; P < 0.001). Adjusting for co-morbid disease, the in-hospital mortality of cases was significantly higher than controls (55.3% vs. 14.7%; AOR, 11.29; P < 0.001). Higher Charlson co-morbidity index score (5.2 vs. 4.1; AOR, 1.59; P = 0.005), mechanical ventilation days (7.47 vs. 0.94 days; AOR, 1.32; P = 0.003) and piperacillin/tazobactam exposure (11.03 vs. 1.05 doses; AOR, 1.08; P = 0.013) were identified as risk factors on multivariate analysis. Cases had a significantly higher likelihood of in-hospital mortality when the NDM-1-producer was Klebsiella pneumoniae (AOR, 16.57; P = 0.007), or when they had a bloodstream infection (AOR, 8.84; P = 0.041). Conclusion NDM- 1 infection is associated with significant in-hospital mortality. Risk factors for hospital-associated infection include the presence of co-morbid disease, mechanical ventilation and piperacillin/tazobactam exposure.	[de Jager, Pieter] Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Epidemiol & Surveillance Unit, Johannesburg, South Africa; [de Jager, Pieter; Naidoo, Shan] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Community Hlth, Johannesburg, South Africa; [Chirwa, Tobias] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa; [Perovic, Olga] Natl Inst Communicable Dis, Trop & Hosp Infect, Ctr Opportunist, Natl Hlth Lab Serv, Johannesburg, South Africa; [Perovic, Olga] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Thomas, Juno] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Outbreak Response Unit, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	de Jager, P (corresponding author), Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Epidemiol & Surveillance Unit, Johannesburg, South Africa.	Pieter.deJager@wits.ac.za	Perovic, Olga/AAN-8276-2021; Chirwa, Tobias/AAI-9087-2021		School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg	School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg	This work was supported by the School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Borgia S, 2012, CLIN INFECT DIS, V55, pE109, DOI 10.1093/cid/cis737; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brink AJ, 2012, J CLIN MICROBIOL, V50, P525, DOI 10.1128/JCM.05956-11; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Hirakata Y, 2003, CLIN INFECT DIS, V37, P26, DOI 10.1086/375594; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hyle EP, 2010, INFECT CONT HOSP EP, V31, P1242, DOI 10.1086/657138; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Lowe CF, 2013, INFECT CONT HOSP EP, V34, P49, DOI 10.1086/668778; Marais E, 2006, SAMJ S AFR MED J, V96, P813; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2012, CLIN INFECT DIS, V54, P150, DOI 10.1093/cid/cir720; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, J ANTIMICROB CHEMOTH, V66, P689, DOI 10.1093/jac/dkq520; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Peleg AY, 2005, CLIN INFECT DIS, V41, P1549, DOI 10.1086/497831; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Szilagyi E, 2010, ACTA MICROBIOL IMM H, V57, P43, DOI 10.1556/AMicr.57.2010.1.4; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tuon FF, 2012, BRAZ J INFECT DIS, V16, P416, DOI 10.1016/j.bjid.2012.08.006; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	35	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123337	10.1371/journal.pone.0123337	http://dx.doi.org/10.1371/journal.pone.0123337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909482	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800035
J	Tonkin, JD; Shah, DN; Kuemmerlen, M; Li, FQ; Cai, Q; Haase, P; Jahnig, SC				Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Cai, Qinghua; Haase, Peter; Jaehnig, Sonja C.			Climatic and Catchment-Scale Predictors of Chinese Stream Insect Richness Differ between Taxonomic Groups	PLOS ONE			English	Article							MACROINVERTEBRATE DIVERSITY; GLOBAL PATTERNS; HEADWATER STREAMS; SPECIES RICHNESS; LAND-USE; BIODIVERSITY; PRODUCTIVITY; DETERMINANTS; RIVER; DISTURBANCE	Little work has been done on large-scale patterns of stream insect richness in China. We explored the influence of climatic and catchment-scale factors on stream insect (Ephemeroptera, Plecoptera, Trichoptera; EPT) richness across mid-latitude China. We assessed the predictive ability of climatic, catchment land cover and physical structure variables on genus richness of EPT, both individually and combined, in 80 mid-latitude Chinese streams, spanning a 3899-m altitudinal gradient. We performed analyses using boosted regression trees and explored the nature of their influence on richness patterns. The relative importance of climate, land cover, and physical factors on stream insect richness varied considerably between the three orders, and while important for Ephemeroptera and Plecoptera, latitude did not improve model fit for any of the groups. EPT richness was linked with areas comprising high forest cover, elevation and slope, large catchments and low temperatures. Ephemeroptera favoured areas with high forest cover, medium-to-large catchment sizes, high temperature seasonality, and low potential evapotranspiration. Plecoptera richness was linked with low temperature seasonality and annual mean, and high slope, elevation and warm-season rainfall. Finally, Trichoptera favoured high elevation areas, with high forest cover, and low mean annual temperature, seasonality and aridity. Our findings highlight the variable role that catchment land cover, physical properties and climatic influences have on stream insect richness. This is one of the first studies of its kind in Chinese streams, thus we set the scene for more in-depth assessments of stream insect richness across broader spatial scales in China, but stress the importance of improving data availability and consistency through time.	[Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Haase, Peter] Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany; [Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Haase, Peter] Nat Hist Museum Frankfurt, Gelnhausen, Germany; [Tonkin, Jonathan D.; Shah, Deep Narayan; Kuemmerlen, Mathias; Li, Fengqing; Haase, Peter] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Cai, Qinghua] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Jaehnig, Sonja C.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecosyst Res, Berlin, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Tonkin, JD (corresponding author), Senckenberg Res Inst, Dept River Ecol & Conservat, Gelnhausen, Germany.	jonathan.tonkin@senckenberg.de	Tonkin, Jonathan D/J-4120-2013; Haase, Peter/A-5644-2011; Jähnig, Sonja C/D-7126-2011; Kuemmerlen, Mathias/D-9093-2016	Tonkin, Jonathan D/0000-0002-6053-291X; Jähnig, Sonja C/0000-0002-6349-9561; Kuemmerlen, Mathias/0000-0003-1362-3701; Cai, Qinghua/0000-0002-0224-7256	Deutsche Bundesstiftung Umwelt (DBU); Hesse's Ministry of Environment; research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts; German Federal Ministry of Education and Research; German Academic Exchange Service (BMBF) within the program 'Study and research for sustainability: Yangtze region'; Young scientist research award of the University of Duisburg-Essen, Germany; DFG (German Research Foundation) project 'Integrated modelling of the response of aquatic ecosystems to land use and climate change in the Poyang Lake region, China'", NSFC/DFG joint [F0 301/14-1, JA 1827/2-1]; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-427]; National Natural Science Foundation of China [30330140]; German Academic Exchange Service (DAAD) within the program 'Study and research for sustainability: Yangtze region'	Deutsche Bundesstiftung Umwelt (DBU); Hesse's Ministry of Environment; research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Academic Exchange Service (BMBF) within the program 'Study and research for sustainability: Yangtze region'; Young scientist research award of the University of Duisburg-Essen, Germany; DFG (German Research Foundation) project 'Integrated modelling of the response of aquatic ecosystems to land use and climate change in the Poyang Lake region, China'", NSFC/DFG joint; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); German Academic Exchange Service (DAAD) within the program 'Study and research for sustainability: Yangtze region'(Deutscher Akademischer Austausch Dienst (DAAD))	This study was financed by Deutsche Bundesstiftung Umwelt (DBU), Hesse's Ministry of Environment, and the research funding program LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-oekonomischer Exzellenz) of Hesse's Ministry of Higher Education, Research, and the Arts. During initial fieldwork SCJ was funded by the German Federal Ministry of Education and Research and German Academic Exchange Service (BMBF and DAAD) within the program 'Study and research for sustainability: Yangtze region' with a research fellowship, and by the Young scientist research award 2008 of the University of Duisburg-Essen, Germany. SCJ also acknowledges funding through the DFG (German Research Foundation) project 'Integrated modelling of the response of aquatic ecosystems to land use and climate change in the Poyang Lake region, China'" (F0 301/14-1, JA 1827/2-1) as part of the NSFC/DFG joint funding program 'Land Use and Water Resources Management under Changing Environmental Conditions', and support for fieldtrips within the framework of the DFG-NSF cooperation group 'EcoChange' (GZ465). QC and FL acknowledge funding by the Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (No. KZCX2-YW-427) and the National Natural Science Foundation of China (No. 30330140).	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Astorga A, 2011, ECOGRAPHY, V34, P705, DOI 10.1111/j.1600-0587.2010.06427.x; Barber-James HM, 2008, HYDROBIOLOGIA, V595, P339, DOI 10.1007/s10750-007-9028-y; Barbour Michael T., 2006, Limnetica, V25, P839; Beche LA, 2009, BIODIVERS CONSERV, V18, P3909, DOI 10.1007/s10531-009-9688-1; Besemer K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1760; Brittain J.E., 1990, MAYFLIES STONEFLIES, P1, DOI DOI 10.1007/978-94-009-2397-3_1; Brosse S, 2003, BIODIVERS CONSERV, V12, P2057, DOI 10.1023/A:1024107915183; Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Clarke A, 2008, FRESHWATER BIOL, V53, P1707, DOI 10.1111/j.1365-2427.2008.02041.x; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; de Moor FC, 2008, HYDROBIOLOGIA, V595, P393, DOI 10.1007/s10750-007-9113-2; Dudgeon D., 1999, TROPICAL ASIAN STREA; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fang JY, 2012, ECOGRAPHY, V35, P1059, DOI 10.1111/j.1600-0587.2013.00161.x; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Finn DS, 2011, J N AM BENTHOL SOC, V30, P963, DOI 10.1899/11-012.1; Fochetti R, 2008, HYDROBIOLOGIA, V595, P365, DOI 10.1007/s10750-007-9031-3; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Haidekker A, 2008, AQUAT ECOL, V42, P463, DOI 10.1007/s10452-007-9097-z; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Heino J, 2003, J ANIM ECOL, V72, P425, DOI 10.1046/j.1365-2656.2003.00711.x; Heino J, 2008, ECOL ENTOMOL, V33, P614, DOI 10.1111/j.1365-2311.2008.01012.x; Heino Jani, 2009, Freshwater Reviews, V2, P1, DOI 10.1608/FRJ-2.1.1; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huston M. A., 1994, BIOL DIVERSITY; Jacobsen D, 2004, FRESHWATER BIOL, V49, P1293, DOI 10.1111/j.1365-2427.2004.01274.x; Jacobsen D, 2008, OECOLOGIA, V154, P795, DOI 10.1007/s00442-007-0877-x; Jahnig SC, 2010, J EARTH SCI-CHINA, V21, P876, DOI 10.1007/s12583-010-0140-y; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kuemmerlen M, 2014, ECOL MODEL, V277, P77, DOI 10.1016/j.ecolmodel.2014.01.020; Kuemmerlen M, 2012, HYDROL WASSERBEWIRTS, V56, P185, DOI 10.5675/HyWa_2012,4_3; Lehner B, 2006, HYDROSHEDS TECHNICAL; LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422; Li FQ, 2012, ECOL INDIC, V23, P394, DOI 10.1016/j.ecolind.2012.04.017; Li FQ, 2010, INT REV HYDROBIOL, V95, P171, DOI 10.1002/iroh.200911212; Liu JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021649; Mekong River Commission, 2006, ID FRESHW INV MEK RI; Morse J.C., 1994, AQUATIC INSECTS CHIN; Mykra H, 2007, GLOBAL ECOL BIOGEOGR, V16, P149, DOI 10.1111/j.1466-8238.2006.00272.x; Nesemann H, 2007, AQUATIC INVERTEBRATE; Pausas JG, 2001, J VEG SCI, V12, P153, DOI 10.2307/3236601; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Schmalz B, 2015, ECOHYDROLOGY, V8, P1119, DOI 10.1002/eco.1569; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; de Figueroa JMT, 2010, BIODIVERS CONSERV, V19, P1269, DOI 10.1007/s10531-009-9753-9; Tonkin JD, 2014, FRESHWATER BIOL, V59, P1843, DOI 10.1111/fwb.12387; Tonkin JD, 2014, PEERJ, V2, DOI 10.7717/peerj.465; Tonkin JD, 2013, FUND APPL LIMNOL, V182, P283, DOI 10.1127/1863-9135/2013/0402; Tonkin JD, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00243.1; Tonkin JD, 2013, AQUAT ECOL, V47, P109, DOI 10.1007/s10452-013-9429-0; Tonkin JD, 2013, HYDROBIOLOGIA, V701, P159, DOI 10.1007/s10750-012-1248-0; Vinson MR, 2003, ECOGRAPHY, V26, P751, DOI 10.1111/j.0906-7590.2003.03397.x; Vinson MR, 1998, ANNU REV ENTOMOL, V43, P271, DOI 10.1146/annurev.ento.43.1.271; Wang X, 2011, J FRESHWATER ECOL, V27, P37; Wang ZH, 2012, ECOGRAPHY, V35, P1124, DOI 10.1111/j.1600-0587.2011.06781.x; Wang ZH, 2012, ECOGRAPHY, V35, P1160, DOI 10.1111/j.1600-0587.2012.07786.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yule C.M., 2004, FRESHWATER INVERTEBR; Zhao SQ, 2006, ECOL RES, V21, P890, DOI 10.1007/s11284-006-0048-2; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	72	12	12	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123250	10.1371/journal.pone.0123250	http://dx.doi.org/10.1371/journal.pone.0123250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909190	Green Published, gold			2022-12-26	WOS:000353376800031
J	Zhu, K; Yang, SN; Ma, FF; Gu, XF; Zhu, YC; Zhu, YZ				Zhu, Kai; Yang, Su-Na; Ma, Fen-Fen; Gu, Xian-Feng; Zhu, Yi-Chun; Zhu, Yi-Zhun			The Novel Analogue of Hirsutine as an Anti-Hypertension and Vasodilatary Agent Both In Vitro and In Vivo	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; MESENTERIC-ARTERY; ENDOTHELIUM; RELAXATION; NIFEDIPINE; CHANNELS	In this paper, an analogue of hirsutine (compound 1) has been synthesized and evaluated as an anti-hypertension agent, which exhibits extraordinary effects on the contractile response of thoracic aorta rings from male SD rats in vitro (IC50 = 1.129x10(-9)+/- 0.5025) and the abilities of reducing the systolic blood pressure (SBP) and heart rate (HR) of SHR in vivo. The mechanism investigation reveals that the vasodilatation induced by compound 1 is mediated by both endothelium-dependent and -independent manners. The relaxation in endothelium-intact aortic rings induced by compound 1 can be inhibited by L-NAME (1x10(-6) mol.L-1) and ODQ (1x10(-6) mol.L-1). Moreover, compound 1 can also block Ca2+ influx through L-type Ca2+ channels and inhibit intracellular Ca2+ release while no effect on K+ channel has been observed. All these data demonstrated that the NO/cyclic GMP pathway can be involved in endothelium-dependent manner induced by compound 1. Meanwhile the mechanism on the vasodilatation of compound 1 probably also related to blockade of Ca2+ influx through L-type Ca2+ channels and inhibition of intracellular Ca2+ release may have no relationship with K+ channels.	[Zhu, Kai; Yang, Su-Na; Ma, Fen-Fen; Zhu, Yi-Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China; [Gu, Xian-Feng] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China; [Zhu, Kai; Yang, Su-Na; Ma, Fen-Fen; Gu, Xian-Feng; Zhu, Yi-Zhun] Fudan Univ, Inst Biomed Sci, Shanghai 201203, Peoples R China; [Zhu, Yi-Chun] Fudan Univ, Shanghai Coll Med, Dept Physiol, Shanghai 201203, Peoples R China; [Zhu, Yi-Chun] Fudan Univ, Shanghai Coll Med, Dept Pathophysiol, Shanghai 201203, Peoples R China; [Zhu, Yi-Zhun] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; National University of Singapore	Gu, XF (corresponding author), Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China.	xfgu@fudan.edu.cn; zhuyz@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Nature Science Foundation of China [21002013]; National Basic Research Program of China (973 Program) [2010CB912600]; Science and Technology Commission of Shanghai Municipality [10431903200, 12431900201]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	ZYZ received the funding from National Nature Science Foundation of China (No. 21002013), National Basic Research Program of China (973 Program) (No. 2010CB912600), The Science and Technology Commission of Shanghai Municipality (No. 10431903200), The Science and Technology Commission of Shanghai Municipality (No. 12431900201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cacanyiova S, 2013, J PHYSIOL PHARMACOL, V64, P241; Magalhaes PJ, 2008, FUND CLIN PHARMACOL, V22, P169, DOI 10.1111/j.1472-8206.2008.00571.x; Egan BM, 2013, J HYPERTENS, V31, P2123, DOI 10.1097/HJH.0b013e328365b932; Kaimoto T, 2010, HYPERTENSION, V56, P247, DOI 10.1161/HYPERTENSIONAHA.110.149781; Karaki H, 1997, PHARMACOL REV, V49, P157; Li PY, 2013, N-S ARCH PHARMACOL, V386, P973, DOI 10.1007/s00210-013-0888-6; Lu Y, 2002, LIFE SCI, V71, P1465, DOI 10.1016/S0024-3205(02)01922-7; Ndagijimana A, 2013, FITOTERAPIA, V86, P35, DOI 10.1016/j.fitote.2013.01.018; Pereira SL, 2014, FUND CLIN PHARMACOL, V28, P29, DOI 10.1111/j.1472-8206.2012.01076.x; Pinto NV, 2009, PHYTOMEDICINE, V16, P1151, DOI 10.1016/j.phymed.2009.04.007; Tietze LF, 1999, ANGEW CHEM INT EDIT, V38, P2045, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2045::AID-ANIE2045>3.0.CO;2-U; Venturi E, 2013, PFLUG ARCH EUR J PHY, V465, P187, DOI 10.1007/s00424-012-1197-5; Vergara-Galicia J, 2008, VASC PHARMACOL, V49, P26, DOI 10.1016/j.vph.2008.04.002; Wu LX, 2011, EUR J PHARMACOL, V650, P290, DOI 10.1016/j.ejphar.2010.09.057; Xin H, 2009, EUR J PHARMACOL, V612, P75, DOI 10.1016/j.ejphar.2009.03.067; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yeh JL, 2005, J CARDIOVASC PHARM, V46, P130, DOI 10.1097/01.fjc.0000167016.61845.c8; Zhu XM, 2007, VASC PHARMACOL, V46, P160, DOI 10.1016/j.vph.2006.09.003; Ziegelhoffer A, 2012, CAN J PHYSIOL PHARM, V90, P1311, DOI [10.1139/Y2012-107, 10.1139/y2012-107]	19	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0119477	10.1371/journal.pone.0119477	http://dx.doi.org/10.1371/journal.pone.0119477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909998	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800005
J	Kiguba, R; Karamagi, C; Waako, P; Ndagije, HB; Bird, SM				Kiguba, Ronald; Karamagi, Charles; Waako, Paul; Ndagije, Helen B.; Bird, Sheila M.			Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda	PLOS ONE			English	Article							HEMOPTYSIS	Background Lack of adequate detail compromises analysis of reported suspected adverse drug reactions (ADRs). We investigated how comprehensively Ugandan healthcare professionals (HCPs) described their most recent previous-month suspected ADR, and determined the characteristics of HCPs who provided comprehensive ADR descriptions. We also identified rare, serious, and unanticipated suspected ADR descriptions with medication safety-alerting potential. Methods During 2012/13, this survey was conducted in purposively selected Ugandan health facilities (public/private) including the national referral and six regional referral hospitals representative of all regions. District hospitals, health centres II to IV, and private health facilities in the catchment areas of the regional referral hospitals were conveniently selected. Healthcare professionals involved in prescribing, transcribing, dispensing, and administration of medications were approached and invited to self-complete a questionnaire on ADR reporting. Two-thirds of issued questionnaires (1,345/2,000) were returned. Results Ninety per cent (241/268) of HCPs who suspected ADRs in the previous month provided information on five higher-level descriptors as follows: body site (206), drug class (203), route of administration (127), patient age (133), and ADR severity (128). Comprehensiveness (explicit provision of at least four higher-level descriptors) was achieved by at least two-fifths (46%, 124/268) of HCPs. Received descriptions were more likely to be comprehensive from HCPs in private health facilities, regions other than central, and those not involved in teaching medical students. Overall, 106 serious and 51 rare previous-month suspected ADRs were described. The commonest serious and rare ADR was Stevens-Johnson syndrome (SJS); mostly associated with oral nevirapine or cotrimoxazole, but haemoptysis after diclofenac analgesia and paralysis after quinine injection were also described. Conclusion Surveyed Ugandan HCPs who had suspected at least one ADR in the previous month competently provided comprehensive ADR descriptions: more, indeed, than are received per annum nationally. Properly analyzed, and with local feed-back, voluntary ADR reports by HCPs could be an essential alerting tool for identifying rare and serious suspected ADRs in Uganda.	[Kiguba, Ronald; Waako, Paul] Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda; [Karamagi, Charles] Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Kampala, Uganda; [Ndagije, Helen B.] Natl Drug Author, Natl Pharmacovigilance Ctr, Kampala, Uganda; [Bird, Sheila M.] MRC, Biostat Unit, Cambridge CB2 2BW, England	Makerere University; Makerere University; MRC Biostatistics Unit	Kiguba, R (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda.	kiguba@gmail.com		Ndagije, Helen/0000-0001-5802-4791; Kiguba, Ronald/0000-0002-2636-4115	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa [087540]; Wellcome Trust; OGAC, National Institutes of Health (NIH) and (Health Resources and Services Administration (HRSA) [5R24TW008886]; African Doctoral Dissertation Research Fellowship (ADDRF); Medical Research Council programme [MC_U105260794]; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER; Medical Research Council [MC_U105260794] Funding Source: researchfish; MRC [MC_U105260794] Funding Source: UKRI	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa; Wellcome Trust(Wellcome TrustEuropean Commission); OGAC, National Institutes of Health (NIH) and (Health Resources and Services Administration (HRSA); African Doctoral Dissertation Research Fellowship (ADDRF); Medical Research Council programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Training Health Researchers into Vocational Excellence (THRiVE) in East Africa, grant number 087540, funded by the Wellcome Trust to RK; grant number 5R24TW008886 supported by OGAC, National Institutes of Health (NIH) and (Health Resources and Services Administration (HRSA) to RK; and an African Doctoral Dissertation Research Fellowship (ADDRF) award 2013-2015 ADF 006 offered by the African Population and Health Research Centre (APHRC) in partnership with the International Development Research Centre (IDRC) to RK. In UK, SMB is funded by Medical Research Council programme number MC_U105260794. The work here reported is solely the responsibility of the authors and does not necessarily represent the official views of the supporting offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actavis UK Ltd, 2013, SUMM PROD CHAR QUIN; [Anonymous], 2009, TABLE GRADING SEVERI; [Anonymous], 2011, CAUSALITY ASSESSMENT; Barvaliya M, 2011, J POSTGRAD MED, V57, P115, DOI 10.4103/0022-3859.81865; BNF, 2013, BRIT NATL FORMULARY; Council for International Organizations of Medical Sciences, 1998, BEN RISK BAL MARK DR; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Ekure J, 2006, E CTR AFR J SURG, V12, P144; Etminan M, 2006, J CLIN PHARMACOL, V46, P6, DOI 10.1177/0091270005283285; Gavaza P, 2011, BRIT J CLIN PHARMACO, V72, P143, DOI 10.1111/j.1365-2125.2011.03944.x; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Kiguba R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005869; National Pharmacovigilance Centre, 2012, WHAT IS CURR PRACT P; National Pharmacovigilance Centre, 2010, WORK TOG PUBL HLTH P; Patel K J, 2007, BMC Clin Pharmacol, V7, P8, DOI 10.1186/1472-6904-7-8; Pradel Editions, 1994, ADVERSE DRUG REACTIO; StataCorp, 2011, STAT STAT SOFTW REL; Talisuna AO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-50; Tumwikirize WA, 2011, AFR HEALTH SCI, V11, P72; Van Renterghem D, 2012, PHARMACOLOGY, V89, P103, DOI 10.1159/000336059; World Health Organization, 2005, WHO DRAFT GUID ADV E; World Health Organization Collaborating Centre for International Drug Monitoring (UMC), 2000, SAF MON MED PROD GUI; World Health Organization (WHO), DEF; World Health Organization (WHO)-Uppsala Monitoring Centre (UMC), 2011, DOC GRAD COMPL AR RE; Yiannakopoulou EC, 2011, PHARMACOLOGY, V87, P1, DOI 10.1159/000321728	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123974	10.1371/journal.pone.0123974	http://dx.doi.org/10.1371/journal.pone.0123974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905889	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000053
J	Swanepoel, LH; Somers, MJ; Dalerum, F				Swanepoel, Lourens H.; Somers, Michael J.; Dalerum, Fredrik			Functional Responses of Retaliatory Killing versus Recreational Sport Hunting of Leopards in South Africa	PLOS ONE			English	Article							PREDATION; CONSERVATION; CARNIVORES; DENSITIES; HABITAT; HARVEST; MODELS; RISK	Predation strategies in response to altering prey abundances can dramatically influence the demographic effects of predation. Despite this, predation strategies of humans are rarely incorporated into quantitative assessments of the demographic impacts of humans killing carnivores. This scarcity largely seems to be caused by a lack of data. In this study, we contrasted predation strategies exhibited by people involved in retaliatory killing and recreational sport hunting of leopards (Panthera pardus) in the Waterberg District Municipality, South Africa. We predicted a specialist predation strategy exemplified by a type II functional response for retaliatory killing, and a generalist strategy exemplified by a type III functional response for recreational sport hunting. We could not distinguish between a type I, a type II, or a type III functional response for retaliatory killing, but the most parsimonious model for recreational sport hunting corresponded to a type I functional response. Kill rates were consistently higher for retaliatory killing than for recreational sport hunting. Our results indicate that retaliatory killing of leopards may have severe demographic consequences for leopard populations, whereas the demographic consequences of recreational sport hunting likely are less dramatic.	[Swanepoel, Lourens H.; Somers, Michael J.] Univ Venda, Dept Zool, ZA-0950 Thohoyandou, South Africa; [Swanepoel, Lourens H.; Dalerum, Fredrik] Univ Pretoria, Ctr Wildlife Management, Hatfield Expt Farm, ZA-0028 Pretoria, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0028 Pretoria, South Africa; [Dalerum, Fredrik] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0028 Pretoria, South Africa	University of Venda; University of Pretoria; University of Pretoria; University of Pretoria	Swanepoel, LH (corresponding author), Univ Venda, Dept Zool, Private Bag X5050, ZA-0950 Thohoyandou, South Africa.	lourens.swanepoel.univen@gmail.com	Swanepoel, L H/O-3226-2019; Dalerum, Fredrik/M-6068-2017; /A-1523-2008	Swanepoel, L H/0000-0002-9955-8076; Dalerum, Fredrik/0000-0001-9737-8242; /0000-0002-5836-8823	IFS [D/4984-1]; Wild Foundation [2008011]; Wilson Foundation; University of Pretoria; National Research Foundation (NRF) [74819, 88179]; NRF; MJS; DST-NRF Centre of Excellence for Invasion Biology and NRF	IFS(International Foundation for Science); Wild Foundation; Wilson Foundation; University of Pretoria; National Research Foundation (NRF); NRF; MJS; DST-NRF Centre of Excellence for Invasion Biology and NRF	This work was funded by IFS grant nr. D/4984-1 (www.ifs.se), Wild Foundation grant nr. 2008011 (www.wild.org), Wilson Foundation (www.thewilsonfoundation.org) and the University of Pretoria (www.up.ac.za). LHS was supported by the National Research Foundation (NRF; www.nrf.ac.za) grant nrs. 74819 & 88179, FD by a research fellowship from the University of Pretoria and NRF, and MJS by the DST-NRF Centre of Excellence for Invasion Biology and NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSSON M, 1977, OIKOS, V29, P591, DOI 10.2307/3543597; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; BANKS HT, 1987, OECOLOGIA, V74, P356, DOI 10.1007/BF00378930; Baty F, 2015, NLSTOOLS TOOLS NONLI; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Crawley M. J, 2002, STAT COMPUTING INTRO; Dalerum F, 2015, ARBOR IN PRESS; Dalerum F, 2008, J WILDLIFE MANAGE, V72, P1125, DOI 10.2193/2007-336; Daly B., 2005, CONSERVATION BREEDIN; De Klerk A., 2003, THESIS U PRETORIA; Development WR, 2005, AGR DEV STRAT WAT MU; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Eggleston DB, 2008, ECOL APPL, V18, P258, DOI 10.1890/06-1409.1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elzhov TV, 2012, MINPACK IM R INTERFA; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Funston PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059044; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Henschel P., 2008, IUCN 2010 IUCN RED L; Holling C. S., 1959, Canadian Entomologist, V91, P385; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; JOHNSON BM, 1994, ECOL APPL, V4, P808, DOI 10.2307/1942010; Johnson PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012866; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Lindsey PA, 2011, NONDETRIMENT FINDING; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; Mateo-Tomas P, 2012, J APPL ECOL, V49, P376, DOI 10.1111/j.1365-2664.2012.02119.x; McManus JS, 2015, ORYX, V49, P687, DOI 10.1017/S0030605313001610; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mucina L., 2006, VEGETATION S AFRICA; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Palazy L, 2012, ANIM CONSERV, V15, P4, DOI 10.1111/j.1469-1795.2011.00476.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; REAL LA, 1979, ECOLOGY, V60, P481, DOI 10.2307/1936067; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; Smith R. M., 1978, ARNOLDIA, V8, P1; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Swanepoel LH, 2013, THESIS U PRETORIA; Swanepoel LH, 2014, S AFR J WILDL RES, V44, P115, DOI 10.3957/056.044.0210; Thorn M, 2012, BIOL CONSERV, V150, P23, DOI 10.1016/j.biocon.2012.02.017; Tobler MW, 2014, ORYX, V48, P410, DOI 10.1017/S0030605312001652; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Tobler MW, 2010, CAMERA BASE VERSION; Van Deelen Timothy R., 2003, Human Dimensions of Wildlife, V8, P97, DOI 10.1080/10871200304306; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Zabel A, 2011, ENVIRON RESOUR ECON, V48, P287, DOI 10.1007/s10640-010-9411-4	58	11	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125539	10.1371/journal.pone.0125539	http://dx.doi.org/10.1371/journal.pone.0125539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905623	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000113
J	Yang, Y; Wu, SF; Wang, Y; Pan, S; Lan, B; Liu, YH; Zhang, LM; Leng, QL; Chen, D; Zhang, CZ; He, B; Cao, YJ				Yang, Yin; Wu, Songfang; Wang, Yu; Pan, Shuang; Lan, Bei; Liu, Yaohui; Zhang, Liming; Leng, Qianli; Chen, Da; Zhang, Cuizhu; He, Bin; Cao, Youjia			The Us3 Protein of Herpes Simplex Virus 1 Inhibits T Cell Signaling by Confining Linker for Activation of T Cells (LAT) Activation via TRAF6 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HSV-1; TCR; LAT; signaling; Us3; TRAF6; ubiquitination; interleukin	GAMMA(1)34.5 PROTEIN; ANTIGEN RECEPTOR; RING FINGER; KINASE; TYPE-1; U(S)3; GENE; TRANSLATION; ICP0; HERPES-SIMPLEX-VIRUS-1	Background: HSV-1 inhibits T cell functions, but the underlying mechanism is unclear. Results: The HSV-1 Us3 protein disrupts T cell signal transduction by inhibiting the ubiquitination of LAT. Conclusion: The Us3 protein is a crucial factor to suppress T cell activation in HSV-1 infection. Significance: Inhibition of T cell immunity may promote HSV-1 replication or persistence. Herpes simplex virus 1 (HSV-1) is the most prevalent human virus and causes global morbidity because the virus is able to infect multiple cell types. Remarkably, HSV infection switches between lytic and latent cycles, where T cells play a critical role. However, the precise way of virus-host interactions is incompletely understood. Here we report that HSV-1 productively infected Jurkat T-cells and inhibited antigen-induced T cell receptor activation. We discovered that HSV-1-encoded Us3 protein interrupted TCR signaling and interleukin-2 production by inactivation of the linker for activation of T cells. This study unveils a mechanism by which HSV-1 intrudes into early events of TCR-mediated cell signaling and may provide novel insights into HSV infection, during which the virus escapes from host immune surveillance.	[Yang, Yin; Wu, Songfang; Wang, Yu; Pan, Shuang; Lan, Bei; Liu, Yaohui; Zhang, Liming; Leng, Qianli; Chen, Da; Zhang, Cuizhu; Cao, Youjia] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [He, Bin] Univ Illinois, Dept Microbiol & Immunol, Coll Med, Chicago, IL 60612 USA	Nankai University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhang, CZ (corresponding author), Nankai Univ, Inst Mol Biol, Rm 224,94 Weijin Rd, Tianjin 300071, Peoples R China.	czz912@aliyun.com; tshuo@uic.edu; caoyj@nankai.edu.cn	Zhang, Li/GWM-7501-2022		National Natural Science Foundation of China [81171556, 31370862]; Ministry of Science and Technology of China [2012CB917204]; Program of Introducing Talents of Discipline to Universities [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China Grants 81171556 and 31370862 (to Y. C.) and Ministry of Science and Technology of China Grant 2012CB917204 (to Y. C.). This work was also supported by Program of Introducing Talents of Discipline to Universities B08011.	Aubert M, 2009, J VIROL, V83, P6171, DOI 10.1128/JVI.02163-08; Barcy S, 2001, J IMMUNOL, V166, P6242, DOI 10.4049/jimmunol.166.10.6242; BRAUN RW, 1984, J IMMUNOL, V132, P914; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; HAMMER SM, 1982, INFECT IMMUN, V38, P795, DOI 10.1128/IAI.38.2.795-797.1982; Hata S, 1999, MICROBES INFECT, V1, P601, DOI 10.1016/S1286-4579(99)80059-8; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; Jin HL, 2011, J VIROL, V85, P3397, DOI 10.1128/JVI.02373-10; Jin HL, 2009, J VIROL, V83, P4984, DOI 10.1128/JVI.02535-08; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Leopardi R, 1997, P NATL ACAD SCI USA, V94, P7891, DOI 10.1073/pnas.94.15.7891; Li YP, 2011, J BIOL CHEM, V286, P24785, DOI 10.1074/jbc.M111.232439; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Ma YJ, 2012, J VIROL, V86, P2188, DOI 10.1128/JVI.05376-11; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P758, DOI 10.1067/mai.2002.124259; Neumann J, 2003, J IMMUNOL, V171, P3075, DOI 10.4049/jimmunol.171.6.3075; Ogg PD, 2004, VIROLOGY, V319, P212, DOI 10.1016/j.virol.2003.10.019; Piroozmand A, 2004, INT J MOL MED, V14, P641; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Poppers J, 2000, J VIROL, V74, P11215, DOI 10.1128/JVI.74.23.11215-11221.2000; POSAVAD CM, 1994, J VIROL, V68, P4072, DOI 10.1128/JVI.68.6.4072-4074.1994; POSAVAD CM, 1992, J VIROL, V66, P6264, DOI 10.1128/JVI.66.11.6264-6272.1992; POSAVAD CM, 1993, J IMMUNOL, V151, P4865; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sen J, 2013, VIROLOGY, V439, P65, DOI 10.1016/j.virol.2013.01.026; Sloan DD, 2006, J IMMUNOL, V176, P1825, DOI 10.4049/jimmunol.176.3.1825; Sloan DD, 2003, J IMMUNOL, V171, P6733, DOI 10.4049/jimmunol.171.12.6733; Taylor KE, 2014, J VIROL, V88, P8091, DOI 10.1128/JVI.00944-14; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Walters MS, 2010, J VIROL, V84, P9666, DOI 10.1128/JVI.00981-10; Wang KZ, 2014, J VIROL, V88, P7941, DOI 10.1128/JVI.03394-13; Wang SM, 2013, J SPECTROSC, V2013, P1, DOI 10.1155/2013/646050; Wang Y, 2014, J BIOL CHEM, V289, P35795, DOI 10.1074/jbc.M114.603845; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Xie JJ, 2013, J IMMUNOL, V190, P4027, DOI 10.4049/jimmunol.1202742; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	47	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15670	15678		10.1074/jbc.M115.646422	http://dx.doi.org/10.1074/jbc.M115.646422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907557	Green Published, hybrid			2022-12-26	WOS:000356527400029
J	Lai, KO; Liang, ZY; Fei, EK; Huang, HQ; Ip, NY				Lai, Kwok-On; Liang, Zhuoyi; Fei, Erkang; Huang, Huiqian; Ip, Nancy Y.			Cyclin-dependent Kinase 5 (Cdk5)-dependent Phosphorylation of p70 Ribosomal S6 Kinase 1 (S6K) Is Required for Dendritic Spine Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; TRKB PHOSPHORYLATION; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; RAPAMYCIN; ACTIVATION; CDK5; MORPHOLOGY; MEMORY	The maturation and maintenance of dendritic spines depends on neuronal activity and protein synthesis. One potential mechanism involves mammalian target of rapamycin, which promotes protein synthesis through phosphorylation of eIF4E-binding protein and p70 ribosomal S6 kinase 1 (S6K). Upon extracellular stimulation, mammalian target of rapamycin phosphorylates S6K at Thr-389. S6K also undergoes phosphorylation at other sites, including four serine residues in the autoinhibitory domain. Despite extensive biochemical studies, the importance of phosphorylation in the autoinhibitory domain in S6K function remains unresolved, and its role has not been explored in the cellular context. Here we demonstrated that S6K in neuron was phosphorylated at Ser-411 within the autoinhibitory domain by cyclin-dependent kinase 5. Ser-411 phosphorylation was regulated by neuronal activity and brain-derived neurotrophic factor (BDNF). Knockdown of S6K in hippocampal neurons by RNAi led to loss of dendritic spines, an effect that mimics neuronal activity blockade by tetrodotoxin. Notably, coexpression of wild type S6K, but not the phospho-deficient S411A mutant, could rescue the spine defects. These findings reveal the importance of cyclin-dependent kinase 5-mediated phosphorylation of S6K at Ser-411 in spine morphogenesis driven by BDNF and neuronal activity.	Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Lai, KO (corresponding author), Univ Hong Kong, Dept Physiol, State Key Lab Brain & Cognit Sci, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	laiko@hku.hk; boip@ust.hk	FEI, Erkang/AAI-9825-2021; Lai, Kwok-On/L-7468-2019; Lai, Kwok On/ABC-8046-2021	Lai, Kwok-On/0000-0002-4069-054X; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Liang, Zhuoyi/0000-0003-1622-524X; FEI, Erkang/0000-0002-3581-9521	Research Grants Council of Hong Kong (Hong Kong University of Science and Technology) [660810, 660110, 661010, 661111]; National Key Basic Research Program of China [2013CB530900]; Theme-based Research Scheme [T13-607/12R]; S. H. Ho Foundation	Research Grants Council of Hong Kong (Hong Kong University of Science and Technology); National Key Basic Research Program of China(National Basic Research Program of China); Theme-based Research Scheme; S. H. Ho Foundation	This study was supported in part by the Research Grants Council of Hong Kong (Hong Kong University of Science and Technology Grants 660810, 660110, 661010, and 661111), the National Key Basic Research Program of China (Grant 2013CB530900), Theme-based Research Scheme (Grant T13-607/12R), and the S. H. Ho Foundation.	Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Chen YL, 2014, NEURON, V83, P431, DOI 10.1016/j.neuron.2014.05.027; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mahalingam M, 1996, MOL CELL BIOL, V16, P405; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	31	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14637	14646		10.1074/jbc.M114.627117	http://dx.doi.org/10.1074/jbc.M114.627117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903132	Green Published, hybrid			2022-12-26	WOS:000355754600034
J	Hola, M; Jezek, M; Kusta, T; Kosatova, M				Hola, Michaela; Jezek, Milos; Kusta, Tomas; Kosatova, Michaela			Trophic Discrimination Factors of Stable Carbon and Nitrogen Isotopes in Hair of Corn Fed Wild Boar	PLOS ONE			English	Article							SUS-SCROFA L.; FACTORS DELTA-C-13; DIET CHANGES; CROP DAMAGE; DELTA-N-15; FRACTIONATION; DIGESTIBILITY; MIGRATION; TURNOVER; PATTERNS	Stable isotope measurements are increasingly being used to gain insights into the nutritional ecology of many wildlife species and their role in ecosystem structure and function. Such studies require estimations of trophic discrimination factors (i.e. differences in the isotopic ratio between the consumer and its diet). Although trophic discrimination factors are tissue-and species- specific, researchers often rely on generalized, and fixed trophic discrimination factors that have not been experimentally derived. In this experimental study, captive wild boar (Sus scrofa) were fed a controlled diet of corn (Zea mays), a popular and increasingly dominant food source for wild boar in the Czech Republic and elsewhere in Europe, and trophic discrimination factors for stable carbon (Delta C-13) and nitrogen (Delta N-15) isotopes were determined from hair samples. The mean Delta C-13 and Delta N-15 in wild boar hair were -2.3 parts per thousand and +3.5 parts per thousand, respectively. Also, in order to facilitate future derivations of isotopic measurements along wild boar hair, we calculated the average hair growth rate to be 1.1 mm d(-1). Our results serve as a baseline for interpreting isotopic patterns of free-ranging wild boar in current European agricultural landscapes. However, future research is needed in order to provide a broader understanding of the processes underlying the variation in trophic discrimination factors of carbon and nitrogen across of variety of diet types.	[Hola, Michaela; Jezek, Milos; Kusta, Tomas] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic; [Kosatova, Michaela] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Hola, M (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic.	mhola@fld.czu.cz	Ježek, Miloš/AAB-8880-2021	Ježek, Miloš/0000-0002-4127-9947	Grant Agency of the Czech University of Life Sciences Prague, CIGA [20134314]; Ministry of Agriculture of the Czech Republic [QJ1220314]	Grant Agency of the Czech University of Life Sciences Prague, CIGA(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Grant Agency of the Czech University of Life Sciences Prague, CIGA (Project No. 20134314) and by the Ministry of Agriculture of the Czech Republic, Grant No. QJ1220314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2010, ECOL APPL, V20, P251, DOI 10.1890/08-1437.1; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; Amici A, 2012, AGRON SUSTAIN DEV, V32, P683, DOI 10.1007/s13593-011-0057-6; ARENTSON RA, 1995, J ANIM SCI, V73, P1077; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Bradfield RB, 1981, HAIR RES STATUS FUTU, P251; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Codron D, 2007, EUR J WILDLIFE RES, V53, P161, DOI 10.1007/s10344-006-0075-x; Codron D, 2011, CAN J ZOOL, V89, P453, DOI [10.1139/Z11-010, 10.1139/z11-010]; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darr RL, 2008, J WILDLIFE MANAGE, V72, P1525, DOI 10.2193/2006-293; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Fry B., 2006, STABLE ISOTOPE ECOLO; Giuffra E, 2000, GENETICS, V154, P1785; HATCH MD, 1967, BIOCHEM J, V102, P417, DOI 10.1042/bj1020417; Hemmer H., 1990, DOMESTICATION DECLIN; Herrero J, 2006, EUR J WILDLIFE RES, V52, P245, DOI 10.1007/s10344-006-0045-3; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2014, ISOT ENVIRON HEALT S, V50, P300, DOI 10.1080/10256016.2014.867852; Iacumin P, 2005, PALAEOGEOGR PALAEOCL, V218, P317, DOI 10.1016/j.palaeo.2004.12.021; Johnson E, 1977, PHYSL PATHOPHYSIOLOG, P1237; Jones GF, 1998, GENETICS OF THE PIG, P17; JONES RJ, 1981, SEARCH, V12, P85; Kelly DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053071; Keuling O, 2010, 8 S WILD BOAR OTH SU; Kurle CM, 2014, ISOT ENVIRON HEALT S, V50, P307, DOI 10.1080/10256016.2014.908872; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; LYNFIELD YL, 1970, J INVEST DERMATOL, V55, P170, DOI 10.1111/1523-1747.ep12280667; Marques TS, 2014, J HERPETOL, V48, P332, DOI 10.1670/12-274; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MOHN MP, 1958, BIOLOGY HAIR GROWTH, P336; Murray PJ, 1997, RECENT ADV ANIMAL NU, V14, P253; Nardoto GB, 2006, SCI AGR, V63, P579, DOI 10.1590/S0103-90162006000600012; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Parng E, 2014, J MAMMAL, V95, P151, DOI 10.1644/13-MAMM-A-014.1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2014, LANG ENV STAT COMP V; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Therrien JF, 2011, CAN J ZOOL, V89, P343, DOI 10.1139/Z11-008; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; VANSCOTT EJ, 1957, J INVEST DERMATOL, V29, P197, DOI 10.1038/jid.1957.87; Venables WN., 2002, MODERN APPL STAT S 4; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; WEILER U, 1995, ANAT HISTOL EMBRYOL, V24, P77, DOI 10.1111/j.1439-0264.1995.tb00013.x; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; Wildauer L, 2007, 28 INT UN GAM BIOL C; Wurster CM, 2012, PLOS ONE, V7, DOI [10.1371/joumal.pone.0043538, DOI 10.1371/JOUMAL.PONE.0043538]; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110	67	11	11	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125042	10.1371/journal.pone.0125042	http://dx.doi.org/10.1371/journal.pone.0125042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915400	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100092
J	Li, B; Wang, L; Lu, MS; Mo, XF; Lin, FY; Ho, SC; Zhang, CX				Li, Bin; Wang, Lian; Lu, Min-Shan; Mo, Xiong-Fei; Lin, Fang-Yu; Ho, Suzanne C.; Zhang, Cai-Xia			Passive Smoking and Breast Cancer Risk among Non-Smoking Women: A Case-Control Study in China	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CIGARETTE-SMOKING; ACTIVE SMOKING; EXPOSURE; ESTROGEN; ALCOHOL; ADDUCTS; CANADA	Background The role of passive smoking on breast cancer risk was unclear. This study aimed to evaluate the association between passive smoking and breast cancer risk among Chinese women. Methods/Principal Findings A hospital-based case-control study, including 877 breast cancer cases and 890 controls, frequency-matched by age and residence, was conducted. A structured questionnaire was used to collect information on passive smoking history through face-to-face interview by trained interviewers. Unconditional logistic regression models were used to estimate the association between passive smoking and breast cancer risk. A positive association between any passive smoking exposure and breast cancer risk was observed. Compared with women who were never exposed to passive smoking, women who were ever exposed had a higher breast cancer risk, with the adjusted odds ratio (OR) and 95% confidence interval (CI) of 1.35 (1.11-1.65). Similar result was found on home passive smoking exposure and breast cancer risk, but not on workplace passive smoking exposure. Women who were ever exposed to tobacco smoke at home had a higher risk of breast cancer compared with never exposed women, with the adjusted OR (95% CI) of 1.30 (1.05-1.61). Home passive smoking exposure showed significant dose-response relationships with breast cancer risk in smoker-years, cigarettes/day and total pack-years (P-trend=0.003, 0.006 and 0.009, respectively). An increased total smoker-years of any passive exposure significantly elevated the risk of breast cancer (P-trend<0.001). Positive associations and dose-response relationships were found among postmenopausal women and all subtypes of estrogen receptor (ER) and progesterone receptor (PR) status of breast cancer. Conclusions Passive smoking was associated with an increased risk of breast cancer among non-smoking Chinese women. A stronger positive association with breast cancer risk was seen mainly among postmenopausal women.	[Li, Bin; Wang, Lian; Lu, Min-Shan; Zhang, Cai-Xia] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Li, Bin] Sun Yat Sen Univ, Affiliated Hosp 1, Epidemiol Res Unit, Guangzhou 510275, Guangdong, Peoples R China; [Mo, Xiong-Fei] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Fang-Yu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nursing, Guangzhou 510275, Guangdong, Peoples R China; [Ho, Suzanne C.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong	Ho, SC (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China.	suzanneho@cuhk.edu.hk; zhangcx3@mail.sysu.edu.cn			National Natural Science Foundation of China [81102188]; New Teachers' Fund for Doctor Stations, Ministry of Education of China [20100171120057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund for Doctor Stations, Ministry of Education of China	This study was supported by the National Natural Science Foundation of China (no. 81102188), the New Teachers' Fund for Doctor Stations, Ministry of Education of China (no. 20100171120057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2008, CANCER EPIDEM BIOMAR, V17, P15, DOI 10.1158/1055-9965.EPI-07-0598; *CA ENV PROT AG, 2005, PROP ID ENV TOB SMOK; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Chen Z, 2013, ASIA PAC J IN PRESS; Collishaw NE, 2009, CANADIAN EXPERT PANE; Conway K, 2002, CANCER RES, V62, P1987; Cui Y, 2006, BREAST CANCER RES TR, V100, P293, DOI 10.1007/s10549-006-9255-3; Delfino RJ, 2000, PHARMACOGENETICS, V10, P461, DOI 10.1097/00008571-200007000-00009; Egan KM, 2002, EPIDEMIOLOGY, V13, P138, DOI 10.1097/00001648-200203000-00007; Faraglia B, 2003, CARCINOGENESIS, V24, P719, DOI 10.1093/carcin/bgg013; Firozi PF, 2002, CARCINOGENESIS, V23, P301, DOI 10.1093/carcin/23.2.301; Gammon MD, 2004, ENVIRON RES, V96, P176, DOI 10.1016/j.envres.2003.08.009; Gao CM, 2013, ASIAN PAC J CANCER P, V14, P993, DOI 10.7314/APJCP.2013.14.2.993; He Qian, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P159; Hu MB, 2013, CANCER CAUSE CONTROL, V24, P629, DOI 10.1007/s10552-012-0137-1; IARC (International Agency for Research on Cancer), 1986, IARC MON EV CARC RIS, P127; Jee SH, 1999, INT J EPIDEMIOL, V28, P824, DOI 10.1093/ije/28.5.824; Johnson KC, 1999, EPIDEMIOLOGY, V10, pS61; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Kropp S, 2002, AM J EPIDEMIOL, V156, P616, DOI 10.1093/aje/kwf093; Lash TL, 1999, AM J EPIDEMIOL, V149, P5; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Ma JM, 2005, CHIN J EPIDEMIOL, V26, P77; MACMAHON B, 1982, NEW ENGL J MED, V307, P1062, DOI 10.1056/NEJM198210213071707; McKenzie F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063132; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Morabia A, 1996, AM J EPIDEMIOL, V143, P918, DOI 10.1093/oxfordjournals.aje.a008835; Morabia A, 1998, INT J CANCER, V75, P339, DOI 10.1002/(SICI)1097-0215(19980130)75:3<339::AID-IJC2>3.0.CO;2-3; Nishino Y, 2001, CANCER CAUSE CONTROL, V12, P797, DOI 10.1023/A:1012273806199; Nishino Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-65; PERERA FP, 1995, CANCER EPIDEM BIOMAR, V4, P233; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Prescott J, 2007, CANCER EPIDEM BIOMAR, V16, P620, DOI 10.1158/1055-9965.EPI-06-0873; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Reynolds P, 2013, J MAMMARY GLAND BIOL, V18, P15, DOI 10.1007/s10911-012-9269-x; Reynolds P, 2009, CANCER EPIDEM BIOMAR, V18, P3389, DOI 10.1158/1055-9965.EPI-09-0936; Roddam AW, 2007, BRIT J CANCER, V97, P434, DOI 10.1038/sj.bjc.6603859; Rollison DE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-157; SANDLER DP, 1985, AM J EPIDEMIOL, V121, P37, DOI 10.1093/oxfordjournals.aje.a113980; Shrubsole MJ, 2004, INT J CANCER, V110, P605, DOI 10.1002/ijc.20168; SMITH SJ, 1994, BRIT J CANCER, V70, P112, DOI 10.1038/bjc.1994.258; Tang LY, 2013, GENE, V524, P84, DOI 10.1016/j.gene.2013.04.064; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Tong JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097498; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; [王萍玉 Wang Pingyu], 2011, [中国现代医学杂志, China Journal of Modern Medicine], V21, P3271; Xu Tao, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P229; Zhang CX, 2009, INT J CANCER, V125, P181, DOI 10.1002/ijc.24358; [No title captured]	51	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125894	10.1371/journal.pone.0125894	http://dx.doi.org/10.1371/journal.pone.0125894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915759	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659100151
J	Sazanavets, I; Warwicker, J				Sazanavets, Ivan; Warwicker, Jim			Computational Tools for Interpreting Ion Channel pH-Dependence	PLOS ONE			English	Article							POTASSIUM CHANNELS; PROTON SENSITIVITY; BINDING-SITES; OPEN STATE; ACID; PROTEIN; RESIDUES; ROMK; IDENTIFICATION; ACTIVATION	Activity in many biological systems is mediated by pH, involving proton titratable groups with pKas in the relevant pH range. Experimental analysis of pH-dependence in proteins focusses on particular sidechains, often with mutagenesis of histidine, due to its pKa near to neutral pH. The key question for algorithms that predict pKas is whether they are sufficiently accurate to effectively narrow the search for molecular determinants of pH-dependence. Through analysis of inwardly rectifying potassium (Kir) channels and acid-sensing ion channels (ASICs), mutational effects on pH-dependence are probed, distinguishing between groups described as pH-coupled or pH-sensor. Whereas mutation can lead to a shift in transition pH between open and closed forms for either type of group, only for pH-sensor groups does mutation modulate the amplitude of the transition. It is shown that a hybrid Finite Difference Poisson-Boltzmann (FDPB) - Debye-Hckel continuum electrostatic model can filter mutation candidates, providing enrichment for key pH-coupled and pH-sensor residues in both ASICs and Kir channels, in comparison with application of FDPB alone.	[Sazanavets, Ivan; Warwicker, Jim] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Warwicker, J (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	jim.warwicker@manchester.ac.uk		Warwicker, Jim/0000-0002-1302-0815	UK BBSRC; Astra Zeneca	UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Astra Zeneca(AstraZeneca)	The authors thank the UK BBSRC and Astra Zeneca for the award of a CASE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov E, 2011, PROTEINS, V79, P3260, DOI 10.1002/prot.23189; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BEROZA P, 1991, P NATL ACAD SCI USA, V88, P5804, DOI 10.1073/pnas.88.13.5804; Bollepalli MK, 2014, STRUCTURE, V22, P1037, DOI 10.1016/j.str.2014.04.018; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Choe H, 1997, AM J PHYSIOL-RENAL, V273, pF516, DOI 10.1152/ajprenal.1997.273.4.F516; Cole C, 2002, PROTEIN SCI, V11, P2860, DOI 10.1110/ps.0222702; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Fakler B, 1996, EMBO J, V15, P4093, DOI 10.1002/j.1460-2075.1996.tb00784.x; Garcia-Moreno Bertrand, 2009, Journal of Biology (London), V8, P98, DOI 10.1186/jbiol199; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Gonzalez W, 2012, BIOCHEM J, V442, P57, DOI 10.1042/BJ20111498; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Ishikita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016920; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kemp LR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0323; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Liu BB, 2007, J MOL BIOL, V368, P328, DOI 10.1016/j.jmb.2007.02.041; Ojemalm K, 2013, J CELL SCI, V126, P464, DOI 10.1242/jcs.111773; Onufriev AV, 2013, Q REV BIOPHYS, V46, P181, DOI 10.1017/S0033583513000024; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Petukh M, 2013, CURR PHARM DESIGN, V19, P4182, DOI 10.2174/1381612811319230004; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Sackin H, 2006, BIOPHYS J, V90, P3582, DOI 10.1529/biophysj.105.076653; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Spassov VZ, 2013, PROTEINS, V81, P704, DOI 10.1002/prot.24230; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Starkus JG, 2003, PFLUG ARCH EUR J PHY, V447, P44, DOI 10.1007/s00424-003-1121-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Talley K, 2010, PROTEINS, V78, P2699, DOI 10.1002/prot.22786; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang L, 2013, COMMUN COMPUT PHYS, V13, P13, DOI 10.4208/cicp.300611.120911s; Warwicker J, 1999, PROTEIN SCI, V8, P418; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Warwicker J, 2004, PROTEIN SCI, V13, P2793, DOI 10.1110/ps.04785604; WARWICKER J, 1986, J THEOR BIOL, V121, P199, DOI 10.1016/S0022-5193(86)80093-5; Warwicker J, 2011, PROTEINS, V79, P3374, DOI 10.1002/prot.23078; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]	65	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125293	10.1371/journal.pone.0125293	http://dx.doi.org/10.1371/journal.pone.0125293			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915903	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100117
J	Simhadri, VR; Dimitrova, M; Mariano, JL; Zenarruzabeitia, O; Zhong, WM; Ozawa, T; Muraguchi, A; Kishi, H; Eichelberger, MC; Borrego, F				Simhadri, Venkateswara R.; Dimitrova, Milena; Mariano, John L.; Zenarruzabeitia, Olatz; Zhong, Weimin; Ozawa, Tatsuhiko; Muraguchi, Atsushi; Kishi, Hiroyuki; Eichelberger, Maryna C.; Borrego, Francisco			A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells	PLOS ONE			English	Article							INFLUENZA-A VIRUS; HUMAN MONOCLONAL-ANTIBODY; MATRIX PROTEIN-2; M2 PROTEIN; EXTRACELLULAR DOMAIN; SEASONAL INFLUENZA; ADAPTIVE IMMUNITY; UNIVERSAL VACCINE; INFECTION; PROTECTION	The highly conserved matrix protein 2 (M2) is a good candidate for the development of a broadly protective influenza vaccine that induces long-lasting immunity. In animal models, natural killer (NK) cells have been proposed to play an important role in the protection provided by M2-based vaccines through a mechanism of antibody-dependent cell-mediated cytotoxicity (ADCC). We investigated the ability of the human anti-M2 Ab1-10 monoclonal antibody (mAb) to activate human NK cells. They mediated ADCC against M2-expressing cells in the presence of Ab1-10 mAb. Furthermore, NK cell pro-inflammatory cytokine and chemokine secretion is also enhanced when Ab1-10 mAb is present. We also generated cytokine-preactivated NK cells and showed that they still displayed increased effector functions in the presence of Ab1-10 mAb. Thus, our study has demonstrated that human resting and cytokine-preactivated NK cells may have a very important role in the protection provided by anti-M2 Abs.	[Simhadri, Venkateswara R.; Dimitrova, Milena; Mariano, John L.; Borrego, Francisco] US FDA, Div Biotechnol Review & Res 1, Off Biotechnol Prod Review & Res, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA; [Zenarruzabeitia, Olatz] BioCruces Hlth Res Inst, Immunopathol Grp, Baracaldo, Basque Country, Spain; [Zenarruzabeitia, Olatz] Basque Ctr Transfus & Human Tissues, Cell Therapy & Stem Cell Grp, Galdakao, Basque Country, Spain; [Zhong, Weimin] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Ozawa, Tatsuhiko; Muraguchi, Atsushi; Kishi, Hiroyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama, Japan; [Eichelberger, Maryna C.] Food & Drug Adm, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Borrego, Francisco] Basque Fdn Sci, Ikerbasque, Bilbao, Basque Country, Spain	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA; University of Toyama; US Food & Drug Administration (FDA); Basque Foundation for Science	Simhadri, VR (corresponding author), US FDA, Div Biotechnol Review & Res 1, Off Biotechnol Prod Review & Res, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA.	venkateswara.simhadri@fda.hhs.gov; francisco.borregorabasco@osakidetza.net	Zenarruzabeitia, Olatz/AAD-6772-2019; Borrego, Francisco/ABI-1391-2020	Zenarruzabeitia, Olatz/0000-0002-0869-9034; Borrego, Francisco/0000-0002-3105-981X; Ozawa, Tatsuhiko/0000-0002-3112-452X	Medical Counter Measure Initiatives (MCMi), U.S. Food and Drug Administration (FDA)	Medical Counter Measure Initiatives (MCMi), U.S. Food and Drug Administration (FDA)	This work was funded by the Medical Counter Measure Initiatives (MCMi), U.S. Food and Drug Administration (FDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Ge MQ, 2012, J IMMUNOL, V189, P2099, DOI 10.4049/jimmunol.1103474; Jegaskanda S, 2014, J IMMUNOL, V193, P469, DOI 10.4049/jimmunol.1400432; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kaufmann A, 2001, IMMUNOBIOLOGY, V204, P603, DOI 10.1078/0171-2985-00099; Kim MC, 2013, ANTIVIR RES, V99, P328, DOI 10.1016/j.antiviral.2013.06.010; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Nieto M, 1998, J IMMUNOL, V161, P3330; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Ozawa T, 2011, ANTIVIR RES, V91, P283, DOI 10.1016/j.antiviral.2011.06.012; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Schultz-Cherry S, 2015, CURR TOP MICROBIOL, V386, P109, DOI 10.1007/82_2014_403; Simhadri VR, 2014, J ALLERGY CLIN IMMUN, V134, P1190, DOI 10.1016/j.jaci.2014.06.006; Srivastava V, 2013, J VIROL, V87, P5831, DOI 10.1128/JVI.00273-13; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; van Helden MJG, 2012, J IMMUNOL, V189, P2333, DOI 10.4049/jimmunol.1200008; VERHOEYEN M, 1980, NATURE, V286, P771, DOI 10.1038/286771a0; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yewdell JW, 2013, CURR OPIN VIROL, V3, P316, DOI 10.1016/j.coviro.2013.05.008; Zhong WM, 2011, J IMMUNOL METHODS, V369, P115, DOI 10.1016/j.jim.2011.04.010; Zhou Q, 2013, CLIN EXP IMMUNOL, V173, P131, DOI 10.1111/cei.12095	49	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124677	10.1371/journal.pone.0124677	http://dx.doi.org/10.1371/journal.pone.0124677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915748	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100060
J	Vezzulli, L; Stauder, M; Grande, C; Pezzati, E; Verheye, HM; Owens, NJP; Pruzzo, C				Vezzulli, Luigi; Stauder, Monica; Grande, Chiara; Pezzati, Elisabetta; Verheye, Hans M.; Owens, Nicholas J. P.; Pruzzo, Carla			gbpA as a Novel qPCR Target for the Species-Specific Detection of Vibrio cholerae O1, O139, Non-O1/Non-O139 in Environmental, Stool, and Historical Continuous Plankton Recorder Samples	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; COLONIZATION FACTOR; REACTION ASSAY; WATER SAMPLES; PARAHAEMOLYTICUS; DIVERSITY; SURVIVAL; CELLS; COLI	The Vibrio cholerae N-acetyl glucosamine-binding protein A (GbpA) is a chitin-binding protein involved in V. cholerae attachment to environmental chitin surfaces and human intestinal cells. We previously investigated the distribution and genetic variations of gbpA in a large collection of V. cholerae strains and found that the gene is consistently present and highly conserved in this species. Primers and probe were designed from the gbpA sequence of V. cholerae and a new Taq-based qPCR protocol was developed for diagnostic detection and quantification of the bacterium in environmental and stool samples. In addition, the positions of primers targeting the gbpA gene region were selected to obtain a short amplified fragment of 206 bp and the protocol was optimized for the analysis of formalin-fixed samples, such as historical Continuous Plankton Recorder (CPR) samples. Overall, the method is sensitive (50 gene copies), highly specific for V. cholerae and failed to amplify strains of the closely-related species Vibrio mimicus. The sensitivity of the assay applied to environmental and stool samples spiked with V. cholerae ATCC 39315 was comparable to that of pure cultures and was of 10(2) genomic units/l for drinking and seawater samples, 10(1) genomic units/g for sediment and 10(2) genomic units/g for bivalve and stool samples. The method also performs well when tested on artificially formalin-fixed and degraded genomic samples and was able to amplify V. cholerae DNA in historical CPR samples, the earliest of which date back to August 1966. The detection of V. cholerae in CPR samples collected in cholera endemic areas such as the Benguela Current Large Marine Ecosystem (BCLME) is of particular significance and represents a proof of concept for the possible use of the CPR technology and the developed qPCR assay in cholera studies.	[Vezzulli, Luigi; Stauder, Monica; Grande, Chiara; Pezzati, Elisabetta; Pruzzo, Carla] Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy; [Verheye, Hans M.] Univ Cape Town, Dept Environm Affairs, Oceans & Coastal Res, ZA-7925 Cape Town, South Africa; [Verheye, Hans M.] Univ Cape Town, Marine Res Inst, ZA-7925 Cape Town, South Africa; [Owens, Nicholas J. P.] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England	University of Genoa; Department of Environment, Forestry & Fisheries; University of Cape Town; University of Cape Town	Vezzulli, L (corresponding author), Univ Genoa, Dept Earth Environm & Life Sci DISTAV, Genoa, Italy.	luigi.vezzulli@unige.it	Vezzulli, Luigi/J-2312-2015; Owens, Nicholas John Paul/GRX-5013-2022	Vezzulli, Luigi/0000-0002-4368-1454; Owens, Nicholas John Paul/0000-0001-7972-7285	FP7-AQUAVALENS project [311846]; Royal Society "International Exchanges R2 (inc CNRS)" [IE130623]; UK Natural Environment Research Council; UK Department for Environment, Food and Rural Affairs	FP7-AQUAVALENS project; Royal Society "International Exchanges R2 (inc CNRS)"; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by the FP7-AQUAVALENS project (grant number 311846) and the Royal Society "International Exchanges 2013/R2 (inc CNRS)" (grant number IE130623). The Continuous Plankton Recorder Survey is supported by the UK Natural Environment Research Council and the UK Department for Environment, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZURIN JC, 1967, B WORLD HEALTH ORGAN, V37, P745; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bopp CA, 1999, LAB METHODS DIAGNOSI; Choopun N, 2002, APPL ENVIRON MICROB, V68, P995, DOI 10.1128/AEM.68.2.995-998.2002; Chun J, 1999, APPL ENVIRON MICROB, V65, P2202; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Colwell RR, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P297; Coombs N J, 1999, Nucleic Acids Res, V27, pe12, DOI 10.1093/nar/27.16.e12; DAVIS BR, 1981, J CLIN MICROBIOL, V14, P631, DOI 10.1128/JCM.14.6.631-639.1981; DEGIORGI C, 1994, MOL CELL PROBE, V8, P459, DOI 10.1006/mcpr.1994.1065; Devault AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMoa1308663; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Fakruddin M D, 2013, Pak J Biol Sci, V16, P267, DOI 10.3923/pjbs.2013.267.274; Fykse EM, 2012, MAR POLLUT BULL, V64, P200, DOI 10.1016/j.marpolbul.2011.12.007; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hossain MT, 2013, J APPL MICROBIOL, V114, P448, DOI 10.1111/jam.12056; Huq A, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P301; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kurakawa T, 2012, MICROBIOL IMMUNOL, V56, P10, DOI 10.1111/j.1348-0421.2011.00405.x; Lam JT, 2014, J WATER HEALTH, V12, P51, DOI 10.2166/wh.2013.038; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Low KF, 2013, BIOSENS BIOELECTRON, V47, P38, DOI 10.1016/j.bios.2013.03.004; Lyon WJ, 2001, APPL ENVIRON MICROB, V67, P4685, DOI 10.1128/AEM.67.10.4685-4693.2001; Malayil L, 2011, J APPL MICROBIOL, V110, P1470, DOI 10.1111/j.1365-2672.2011.04996.x; Neogi SB, 2010, LETT APPL MICROBIOL, V51, P293, DOI 10.1111/j.1472-765X.2010.02895.x; Oliver JD, 2005, J MICROBIOL, V43, P93; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Ripley SJ, 2008, J MICROBIOL METH, V73, P118, DOI 10.1016/j.mimet.2008.02.001; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schauer S, 2012, APPL ENVIRON MICROB, V78, P7369, DOI 10.1128/AEM.02190-12; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stauder M, 2012, ENV MICROBIOL REP, V4, P439, DOI 10.1111/j.1758-2229.2012.00356.x; Tamrakar AK, 2006, INT J ENVIRON HEAL R, V16, P305, DOI 10.1080/09603120600734303; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Utsalo SJ, 1999, EUR J EPIDEMIOL, V15, P379, DOI 10.1023/A:1007541317104; Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2; Vezzulli L, 2012, ISME J, V6, P21, DOI 10.1038/ismej.2011.89; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Vezzulli L, 2009, CHEM ECOL, V25, P285, DOI 10.1080/02757540903062509; Vezzulli L, 2009, MICROB ECOL, V58, P808, DOI 10.1007/s00248-009-9542-8; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wang DC, 2010, APPL ENVIRON MICROB, V76, P5520, DOI 10.1128/AEM.02559-09; World Health Organization, 2014, Weekly Epidemiological Record, V89, P345; Zampini M, 2005, FEMS MICROBIOL LETT, V244, P267, DOI 10.1016/j.femsle.2005.01.052	49	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123983	10.1371/journal.pone.0123983	http://dx.doi.org/10.1371/journal.pone.0123983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915771	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100032
J	Zhou, T; Chen, XF; Li, ZZ; Li, LZ				Zhou, Tao; Chen, Xiaofang; Li, Zhanzhan; Li, Lezhi			Relationship between Serum Bilirubin and Left Ventricular Hypertrophy in Patients with Essential Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; AMERICAN SOCIETY; HEART-DISEASE; RISK; ECHOCARDIOGRAPHY; ASSOCIATION; ANTIOXIDANT; UPDATE; STROKE; LEVEL	Background Prospective studies have found low bilirubin levels were an important predictive factor of cardiovascular events. However, few have yet investigated possible association between serum bilirubin level and LVH in essential hypertension. The aim of the present study was to evaluate the relationship between serum bilirubin levels with LVH in newly diagnosed hypertension patients. Methods The present study evaluated the relationship between serum total bilirubin level and left ventricle hypertrophy (LVH) in newly diagnosed hypertensive patients with a sample size of 344. We divided subjects into LVH group (n=138) and non-LVH group (n=206). Physical examination, laboratory tests and echocardiography were conducted. The multivariate logistic regression model was used to verify the independent association between RDW and LVH. Results Our results found that patients with LVH had lower bilirubin levels than non-LVH ones. Step-wise multiple linear regression analysis showed total bilirubin level (B=-0.017, P=0.008) was negatively associated with left ventricle mass index (LVMI) even adjusting for some confounders. The multiples logistic regression found total bilirubin level was independently related with of LVH, as a protective factors (OR=0.91, P=0.010). Conclusion As a routine and quick laboratory examination index, serum bilirubin may be treated as novel marker for evaluating LVH risk in hypertensive patients. Cohort study with larger sample size are needed.	[Zhou, Tao] Southern Med Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hosp 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Li, Lezhi] Cent South Univ, Xiangya Med Sch, Affiliated Hosp 2, Dept Nursing, Changsha, Hunan, Peoples R China	Southern Medical University - China; Central South University; Southern Medical University - China; Central South University; Central South University	Zhou, T (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	taozhou1965@126.com						Abbasi A, 2015, DIABETES, V64, P1459, DOI 10.2337/db14-0228; [Anonymous], 2001, Am J Kidney Dis, V37, pS182; [Anonymous], 2001, REGRESSION MODELING; Ayaz T, 2014, KOREAN CIRC J, V44, P336, DOI 10.4070/kcj.2014.44.5.336; Faraco G, 2013, HYPERTENSION, V62, P810, DOI 10.1161/HYPERTENSIONAHA.113.01063; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Kawamoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114281; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Kotani K, 2014, ANN ACAD MED SINGAP, V43, P216; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leoncini G, 2004, J HUM HYPERTENS, V18, P511, DOI 10.1038/sj.jhh.1001689; LEVY D, 1992, CLIN EXP HYPERTENS A, V14, P85, DOI 10.3109/10641969209036173; Lippi G, 2012, CLIN CHEM LAB MED, V50, P2229, DOI 10.1515/cclm-2012-0343; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Mayer M, 2000, CLIN CHEM, V46, P1723; Muntner P, 2009, HYPERTENSION, V53, P617, DOI 10.1161/HYPERTENSIONAHA.108.120154; Ndisang JF, 2009, J CARD FAIL, V15, P616, DOI 10.1016/j.cardfail.2009.02.003; Parfenova H, 2012, J CEREBR BLOOD F MET, V32, P1024, DOI 10.1038/jcbfm.2012.13; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Porter TR, 2014, J AM SOC ECHOCARDIOG, V27, P797, DOI 10.1016/j.echo.2014.05.011; Sahin DY, 2013, BLOOD PRESSURE, V22, P329, DOI 10.3109/08037051.2013.778006; Song YS, 2014, AM J CARDIOL, V114, P1695, DOI 10.1016/j.amjcard.2014.08.043; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Varis JP, 2014, BLOOD PRESSURE, V23, P39, DOI 10.3109/08037051.2013.803313; Verdecchia P, 2015, HYPERTENSION, V65, P108, DOI 10.1161/HYPERTENSIONAHA.114.04310; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055	32	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125275	10.1371/journal.pone.0125275	http://dx.doi.org/10.1371/journal.pone.0125275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915415	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100113
J	Lin, CH; Shen, CY; Lee, JH; Huang, CS; Yang, CH; Kuo, WH; Chang, DY; Hsiung, CN; Kuo, KT; Chen, WW; Chen, IC; Wu, PF; Kuo, SH; Chen, CJ; Lu, YS; Cheng, AL				Lin, Ching-Hung; Shen, Chen-Yang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; Yang, Chih-Hsin; Kuo, Wen-Hung; Chang, Dwan-Ying; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Chen, Chien-Jen; Lu, Yen-Shen; Cheng, Ann-Lii			High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country	PLOS ONE			English	Article							CELL LUNG-CANCER; KINASE INHIBITORS; INDUCED APOPTOSIS; BCL-2 FAMILY; PROTEIN BIM; RESISTANCE; ANOIKIS; INDUCTION; DEATH; MORPHOGENESIS	Background A rapid surge of female breast cancer has been observed in young women in several East Asian countries. The BIM deletion polymorphism, which confers cell resistance to apoptosis, was recently found exclusively in East Asian people with prevalence rate of 12%. We aimed to evaluate the possible role of this genetic alteration in carcinogenesis of breast cancer in East Asians. Method Female healthy volunteers (n = 307), patients in one consecutive stage I-III breast cancer cohort (n = 692) and one metastatic breast cancer cohort (n = 189) were evaluated. BIM wild-type and deletion alleles were separately genotyped in genomic DNAs. Results Both cancer cohorts consistently showed inverse associations between the BIM deletion polymorphism and patient age (<= 35 y vs. 36-50 y vs. >50 y: 29% vs. 22% vs. 15%, P = 0.006 in the consecutive cohort, and 40% vs. 23% vs. 13%, P = 0.023 in the metastatic cohort). In healthy volunteers, the frequencies of the BIM deletion polymorphism were similar (13%-14%) in all age groups. Further analyses indicated that the BIM deletion polymorphism was not associated with specific clinicopathologic features, but it was associated with poor overall survival (adjusted hazard ratio 1.71) in the consecutive cohort. Conclusions BIM deletion polymorphism may be involved in the tumorigenesis of the early-onset breast cancer among East Asians.	[Lin, Ching-Hung; Lee, Jih-Hsiang; Yang, Chih-Hsin; Chang, Dwan-Ying; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Lin, Ching-Hung; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan; [Shen, Chen-Yang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Huang, Chiun-Sheng; Kuo, Wen-Hung] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yang, Chih-Hsin; Kuo, Sung-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Yang, Chih-Hsin; Kuo, Sung-Hsin; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Canc Res Ctr, Taipei, Taiwan; [Kuo, Kuan-Ting] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Academia Sinica - Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan	Cheng, AL (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.	alcheng@ntu.edu.tw	Yang, James Chih-Hsin/W-1587-2019; Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	Chen, Tom Wei-Wu/0000-0003-4112-4029; Kuo, Sung-Hsin/0000-0003-0054-887X; Huang, Chiun-Sheng/0000-0002-6557-211X; KUO, WEN-HUNG/0000-0002-9881-4605; LIN, CHING-HUNG/0000-0003-2403-4056; Cheng, Ann-Lii/0000-0002-9152-6512; KUO, KUAN-TING/0000-0002-3657-1652; Chen, I-Chun/0000-0001-9342-7596; Lu, Yen-Shen/0000-0001-7461-1291	National Taiwan University, Taiwan [NTU-ICRP-103R7557]; National Center of Excellence for Clinical Trial and Research, Taiwan [DOH102-TD-B-001]	National Taiwan University, Taiwan(National Taiwan University); National Center of Excellence for Clinical Trial and Research, Taiwan	This study was supported by grants from the National Taiwan University, Taiwan (grant number: NTU-ICRP-103R7557, URL: (http://irice-ca.mc.ntu.edu.tw/aboutICECR.php), and the National Center of Excellence for Clinical Trial and Research, Taiwan (grant DOH102-TD-B-001, URL: (http://www.mohw.gov.tw/CHT/TDU/DM1_P.aspx?f_list_no=740&fod_list_no=0&doc_no=29307). ALC received the grants mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajabnoor GMA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.139; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Isobe K, 2014, J THORAC ONCOL, V9, P483, DOI 10.1097/JTO.0000000000000125; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Lin CH, 2009, CANCER EPIDEM BIOMAR, V18, P1807, DOI 10.1158/1055-9965.EPI-09-0096; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Matsuno RK, 2007, CANCER EPIDEM BIOMAR, V16, P1437, DOI 10.1158/1055-9965.EPI-07-0108; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Sim XL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-261; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Tanizaki J, 2011, ONCOGENE, V30, P4097, DOI 10.1038/onc.2011.111; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Wickenden JA, 2008, ONCOGENE, V27, P7150, DOI 10.1038/onc.2008.335; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yoo Keun-Young, 2006, Asian Pac J Cancer Prev, V7, P679; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821; Zhao MC, 2014, CANCER-AM CANCER SOC, V120, P2299, DOI 10.1002/cncr.28725	32	5	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124908	10.1371/journal.pone.0124908	http://dx.doi.org/10.1371/journal.pone.0124908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909194	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800111
J	Pincus, NB; Reckhow, JD; Saleem, D; Jammeh, ML; Datta, SK; Myles, IA				Pincus, Nathan B.; Reckhow, Jensen D.; Saleem, Danial; Jammeh, Momodou L.; Datta, Sandip K.; Myles, Ian A.			Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; LONG-TERM IMPACTS; BACTERIOPHAGE THERAPY; METHICILLIN-RESISTANT; HUMAN MICROBIOME; COCKTAIL; DISEASE; MICE; KERATINOCYTES; ANTIBIOTICS	The response to multi-drug resistant bacterial infections must be a global priority. While mounting resistance threatens to create what the World Health Organization has termed a "post-antibiotic era", the recent discovery that antibiotic use may adversely impact the microbiome adds further urgency to the need for new developmental approaches for anti-pathogen treatments. Methicillin-resistant Staphylococcus aureus (MRSA), in particular, has declared itself a serious threat within the United States and abroad. A potential solution to the problem of antibiotic resistance may not entail looking to the future for completely novel treatments, but instead looking into our history of bacteriophage therapy. This study aimed to test the efficacy, safety, and commercial viability of the use of phages to treat Staphylococcus aureus infections using the commercially available phage SATA-8505. We found that SATA-8505 effectively controls Staphylococcus aureus growth and reduces bacterial viability both in vitro and in a skin infection mouse model. However, this killing effect was not observed when phage was cultured in the presence of human whole blood. SATA-8505 did not induce inflammatory responses in peripheral blood mononuclear cultures. However, phage did induce IFN gamma production in primary human keratinocyte cultures and induced inflammatory responses in our mouse models, particularly in a mouse model of chronic granulomatous disease. Our findings support the potential efficacy of phage therapy, although regulatory and market factors may limit its wider investigation and use.	[Pincus, Nathan B.; Reckhow, Jensen D.; Saleem, Danial; Jammeh, Momodou L.; Datta, Sandip K.; Myles, Ian A.] NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Myles, IA (corresponding author), NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mylesi@niaid.nih.gov	Myles, Ian/AAE-7623-2019	Myles, Ian/0000-0001-9316-3703; Datta, Sandip/0000-0003-0243-7815; Pincus, Nathan/0000-0002-3134-7176	Intramural Research Program of The National Institutes of Health; National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001043] Funding Source: NIH RePORTER	Intramural Research Program of The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of The National Institutes of Health and The National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Blaser M, 2013, NAT REV MICROBIOL, V11, P213, DOI 10.1038/nrmicro2973; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Hanberger H, 2011, INT J ANTIMICROB AG, V38, P331, DOI 10.1016/j.ijantimicag.2011.05.013; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klem J, 2013, ACTA MICROBIOL IMM H, V60, P411, DOI 10.1556/AMicr.60.2013.4.3; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; Kraushaar B, 2013, ARCH VIROL, V158, P2341, DOI 10.1007/s00705-013-1707-6; Lungren MP, 2013, BACTERIOPHAGE, V3; Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001; Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Myles I, 2013, PLOS ONE, V9; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Myles IA, 2013, NAT IMMUNOL, V14, P804, DOI 10.1038/ni.2637; Myles IA, 2012, SEMIN IMMUNOPATHOL, V34, P181, DOI 10.1007/s00281-011-0301-9; O'Flaherty S, 2005, APPL ENVIRON MICROB, V71, P1836, DOI 10.1128/AEM.71.4.1836-1842.2005; Pastagia M, 2012, EMERG INFECT DIS, V18, P1072, DOI 10.3201/eid1807.101371; Pasternack GR, 2010, STAPHYLOCOCCUS AUREU; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pirnay JP, 2015, PHARM RES; Rieber N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/252460; ROUNTREE PM, 1955, J GEN MICROBIOL, V12, P275, DOI 10.1099/00221287-12-2-275; Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Seo MD, 2012, BIOMOL THER, V20, P171, DOI 10.4062/biomolther.2012.20.2.171; Song E, 2011, CLIN MOL ALLERGY, V9, P10, DOI [10.1186/1476-7961-9-10, DOI 10.1186/1476-7961-9-10]; Sprenger A, 2013, MOL CELL PROTEOMICS, V12, P2509, DOI 10.1074/mcp.M112.025478; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Takemura-Uchiyama I, 2014, MICROBES INFECT; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Thiel K, 2004, NAT BIOTECHNOL, V22, P31, DOI 10.1038/nbt0104-31; UDoHaH Services, 2013, ANT RES THREATS US 2; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; World Health Organization, 2014, ANT RES GLOB REP SUR; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4	52	46	47	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124280	10.1371/journal.pone.0124280	http://dx.doi.org/10.1371/journal.pone.0124280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909449	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800074
J	Szczepaniak, P; Zabczyk, M; Undas, A				Szczepaniak, Piotr; Zabczyk, Michal; Undas, Anetta			Increased Plasma Clot Permeability and Susceptibility to Lysis Are Associated with Heavy Menstrual Bleeding of Unknown Cause: A Case-Control Study	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; VENOUS THROMBOSIS; BLOOD-LOSS; FIBRIN; MENORRHAGIA; WOMEN; HYPOFIBRINOLYSIS; ARCHITECTURE; PLASMINOGEN; DEFICIENCY	Background Formation of compact and poorly lysable clots has been reported in thromboembolic disorders. Little is known about clot properties in bleeding disorders. Objectives We hypothesized that more permeable and lysis-sensitive fibrin clots can be detected in women with heavy menstrual bleeding (HMB). Methods We studied 52 women with HMB of unknown cause and 52 age-matched control women. Plasma clot permeability (K-s), turbidity and efficiency of fibrinolysis, together with coagulation factors, fibrinolysis proteins, and platelet aggregation were measured. Results Women with HMB formed looser plasma fibrin clots (+16%[95% CI 7-18%] Ks) that displayed lower maximum absorbancy (-7% [95% CI -9- -1%]Delta Abs(max)), and shorter clot lysis time (-17% [95% CI -23 - -11%] CLT). The HMB patients and controls did not differ with regard to coagulation factors, fibrinogen, von Willebrand antigen, thrombin generation markers and the proportion of subjects with defective platelet aggregation. The patients had lower platelet count (-12% [95% CI -19 - -2%]), tissue plasminogen activator antigen (-39% [95% CI -41 - -29%] tPA: Ag), and plasminogen activator inhibitor-1 antigen (-28% [95% CI -38 - -18%] PAI-1:Ag) compared with the controls. Multiple regression analysis upon adjustment for age, body mass index, glucose, and fibrinogen showed that decreased tPA: Ag and shortened CLT were the independent predictors of HMB. Conclusions Increased clot permeability and susceptibility to fibrinolysis are associated with HMB, suggesting that altered plasma fibrin clot properties might contribute to bleeding disorders of unknown origin.	[Szczepaniak, Piotr; Zabczyk, Michal; Undas, Anetta] John Paul 2 Hosp, Krakow, Poland; [Zabczyk, Michal; Undas, Anetta] Jagiellonian Univ, Inst Cardiol, Coll Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Undas, A (corresponding author), John Paul 2 Hosp, Krakow, Poland.	mmundas@cyf-kr.edu.pl	Ząbczyk, Michał/AHA-6044-2022; Szczepaniak, Piotr/GYD-8024-2022	Ząbczyk, Michał/0000-0003-1762-308X; Szczepaniak, Piotr/0000-0003-2622-7337	 [K/ZDS/002936]		The university (grant no. K/ZDS/002936) supported the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 1999, THROMB HAEMOSTASIS, V82, P1482; Comerota AJ, 1997, ANN SURG, V226, P306, DOI 10.1097/00000658-199709000-00010; Cote I, 2002, OBSTET GYNECOL, V100, P683, DOI 10.1016/S0029-7844(02)02094-X; Gajos G, 2010, J AM COLL CARDIOL, V55, P1671, DOI 10.1016/j.jacc.2009.11.080; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; James AH, 2010, HAEMOPHILIA, V16, P160, DOI 10.1111/j.1365-2516.2010.02315.x; Jayo A, 2009, THROMB HAEMOSTASIS, V101, P770, DOI 10.1160/TH08-11-0777; Knol HM, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.059; Kujovich JL, 2005, AM J HEMATOL, V79, P220, DOI 10.1002/ajh.20372; Kyrle PA, 2014, POL ARCH MED WEWN, V124, P65; Lisman T, 2001, GASTROENTEROLOGY, V121, P131, DOI 10.1053/gast.2001.25481; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Marret H, 2010, EUR J OBSTET GYN R B, V152, P133, DOI 10.1016/j.ejogrb.2010.07.016; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Mutch NJ, 2010, BLOOD, V115, P3980, DOI 10.1182/blood-2009-11-254029; O'Flynn N, 2000, SOC SCI MED, V50, P651, DOI 10.1016/S0277-9536(99)00318-4; Okraska-Bylica A, 2012, POL ARCH MED WEWN, V122, P608, DOI 10.20452/pamw.1535; Oriel KA, 1999, AM FAM PHYSICIAN, V60, P1371; Pankiw-Bembenek O, 2012, THROMB HAEMOSTASIS, V107, P513, DOI 10.1160/TH11-09-0662; Peyvandi F, 2011, J THROMB HAEMOST, V9, P236, DOI 10.1111/j.1538-7836.2011.04372.x; Philipp CS, 2003, J THROMB HAEMOST, V1, P477, DOI 10.1046/j.1538-7836.2003.00061.x; Repine T, 2004, CLIN APPL THROMB-HEM, V10, P293, DOI 10.1177/107602960401000316; Undas A, 2006, J THROMB HAEMOST, V4, P1029, DOI 10.1111/j.1538-7836.2006.01882.x; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Undas A, 2014, THROMB HAEMOSTASIS, V112, P32, DOI 10.1160/TH14-01-0032; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; VANEIJKEREN MA, 1991, LAB INVEST, V64, P284; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x; Warner PE, 2004, AM J OBSTET GYNECOL, V190, P1216, DOI 10.1016/j.ajog.2003.11.015; Wiewel-Verschueren S, 2014, J THROMB HAEMOST, V12, P1488, DOI 10.1111/jth.12645; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125069	10.1371/journal.pone.0125069	http://dx.doi.org/10.1371/journal.pone.0125069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909989	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800125
J	Cozzolino, D; Grandone, A; Cittadini, A; Palmiero, G; Esposito, G; De Bellis, A; Furlan, R; Perrotta, S; Perrone, L; Torella, D; del Giudice, EM				Cozzolino, Domenico; Grandone, Anna; Cittadini, Antonio; Palmiero, Giuseppe; Esposito, Giovanni; De Bellis, Annamaria; Furlan, Raffaello; Perrotta, Silverio; Perrone, Laura; Torella, Daniele; del Giudice, Emanuele Miraglia			Subclinical Myocardial Dysfunction and Cardiac Autonomic Dysregulation Are Closely Associated in Obese Children and Adolescents: The Potential Role of Insulin Resistance	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; VENTRICULAR-FUNCTION; MIXED MEAL; HYPERTENSION; METABOLISM; STANDARDS; WEIGHT; NERVE; RISK; MASS	Background The prevalence of obesity is increasing among children/adolescents. Subtle cardiovascular abnormalities, responsible for a higher mortality later in life, have been reported in obese children/adolescents. The aims of the study were to evaluate cardiovascular autonomic regulation, by means of spectrum analysis of R-R interval variability, and myocardial function, by means of standard and tissue Doppler echocardiography, in a group of non-hypertensive asymptomatic obese children and adolescents; furthermore, the influence of insulin resistance was tested. Subjects and Methods R-R interval variability was analyzed during both the 70 degrees head-up tilt and 24-hour electrocardiographic holter monitoring. Spectrum analysis of R-R interval variability provided the indices of sympathetic (low frequency [LFRR]) and vagal (high frequency [HFRR]) modulation of the sinoatrial node. Homeostasis model assessment of insulin resistance (HOMA-IR) was used to classify obese children/adolescents (n = 72) as insulin resistant (n = 37) and non-insulin resistant (n = 35). Results In obese subjects: a) left ventricular mass was significantly (p < 0.05) increased, whereas both the e/a ratio and the e'/a' ratio were decreased; b) at rest, HFRR was lower, and the LFRR/HFRR ratio was higher; c) during tilting, magnitude of tilt-induced inhibition of HFRR was lower; d) during 24-hour electrocardiographic holter monitoring, LFRR and the LFRR/ HFRR ratio were higher, whereas HFRR was lower; e) HOMA-IR inversely correlated with both the e'/a' ratio (r = -0.655; p < 0.001) and the tilt-induced LFRR/HFRR ratio (r = -0.933; p < 0.001); and, f) the e'/a' ratio correlated with the tilt-induced LFRR/HFRR ratio (r = 0.501; p < 0.001). Moreover, HFRR at rest, magnitude of tilt-induced HFRR reduction, and the e'/a' ratio in insulin resistant obese children/adolescents were markedly lower when compared with the remaining subjects. Conclusions Subclinical abnormalities of myocardial function and of cardiac autonomic regulation were closely associated in obese children/adolescents and both correlated with the degree of insulin resistance.	[Cozzolino, Domenico; Palmiero, Giuseppe] Univ Naples 2, Dept Internal Med, Naples, Italy; [Grandone, Anna; Perrotta, Silverio; Perrone, Laura; del Giudice, Emanuele Miraglia] Univ Naples 2, Dept Women Child & Gen & Specialized Surg, Naples, Italy; [Cittadini, Antonio] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Esposito, Giovanni] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [De Bellis, Annamaria] Univ Naples 2, Dept Cardiothorac & Resp Sci, Naples, Italy; [Furlan, Raffaello] Univ Milan, Humanitas Res Hosp, Internal Med, Rozzano, Italy; [Torella, Daniele] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; IRCCS Humanitas Research Hospital; University of Milan; Magna Graecia University of Catanzaro	Cozzolino, D (corresponding author), Univ Naples 2, Dept Internal Med, Naples, Italy.	domenico.cozzolino@unina2.it	Cittadini, Antonio/I-8426-2012; Furlan, Raffaello/AAH-3167-2021; del Giudice, Emanuele Muraglia/AAC-2824-2019; Palmiero, Giuseppe/I-1087-2019; ESPOSITO, Giovanni/F-2880-2010	Cittadini, Antonio/0000-0002-9905-9277; Furlan, Raffaello/0000-0001-5209-6786; Palmiero, Giuseppe/0000-0002-5102-7460; Perrotta, Silverio/0000-0001-6149-6845; DE BELLIS, Annamaria/0000-0002-0611-4506; GRANDONE, Anna/0000-0002-6343-4768; ESPOSITO, Giovanni/0000-0003-0565-7127; Perrone, Laura/0000-0002-8647-3938; TORELLA, Daniele/0000-0002-4915-5084				Baum P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054546; Bloomgarden ZT, 2002, DIABETES CARE, V25, P2088, DOI 10.2337/diacare.25.11.2088; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cozzolino D, 1996, J CLIN ENDOCR METAB, V81, P713, DOI 10.1210/jc.81.2.713; Cozzolino D, 2014, J CLIN ENDOCR METAB, V99, P3199, DOI 10.1210/jc.2013-4211; Cozzolino D, 2010, J CLIN ENDOCR METAB, V95, P194, DOI 10.1210/jc.2009-1663; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Di Salvo G, 2006, EUR HEART J, V27, P2689, DOI 10.1093/eurheartj/ehl163; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Kiviniemi AM, 2007, ANN MED, V39, P54, DOI 10.1080/07853890600990375; Kurtoglu Selim, 2010, J Clin Res Pediatr Endocrinol, V2, P100, DOI 10.4274/jcrpe.v2i3.100; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Martini G, 2001, CLIN AUTON RES, V11, P87, DOI 10.1007/BF02322051; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nikitin NP, 2003, J AM SOC ECHOCARDIOG, V16, P906, DOI 10.1016/S0894-7317(03)00279-7; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pagani M, 1997, CIRCULATION, V95, P1441; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Rabbone I, 2009, ACTA BIOMED, V1, P29; Reinehr T, 2006, METABOLISM, V55, P113, DOI 10.1016/j.metabol.2005.07.016; Santoro N, 2008, J HYPERTENS, V26, P1590, DOI 10.1097/HJH.0b013e32830413ed; Sasso FC, 2005, EUR HEART J, V26, P1205, DOI 10.1093/eurheartj/ehi271; SCAGLIONE R, 1992, EUR HEART J, V13, P738, DOI 10.1093/oxfordjournals.eurheartj.a060249; Scott EM, 2002, CLIN SCI, V102, P523, DOI 10.1042/CS20010239; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Thiyagarajan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041889; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Van Putte-Katier N, 2008, PEDIATR RES, V64, P205, DOI 10.1203/PDR.0b013e318176182b; Wong CY, 2006, J AM COLL CARDIOL, V47, P611, DOI 10.1016/j.jacc.2005.11.015; Zeybek C, 2009, PEDIATR CARDIOL, V30, P946, DOI 10.1007/s00246-009-9472-8; Zhang YM, 2011, HYPERTENSION, V57, P148, DOI 10.1161/HYPERTENSIONAHA.110.164178	33	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123916	10.1371/journal.pone.0123916	http://dx.doi.org/10.1371/journal.pone.0123916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906397	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000048
J	Kakumoto, K; Ikeda, JI; Okada, M; Morii, E; Oneyama, C				Kakumoto, Kyoko; Ikeda, Jun-Ichiro; Okada, Masato; Morii, Eiichi; Oneyama, Chitose			mLST8 Promotes mTOR-Mediated Tumor Progression	PLoS One			English	Article							TRANSLATION INITIATION; PI3K-AKT-MTOR PATHWAY; GENETIC-VARIATIONS; SIGNALING PATHWAY; BLADDER-CANCER; KINASE; RAPTOR; TOR; PHOSPHORYLATION; MICRORNA	The activity of the mechanistic target of rapamycin (mTOR) is elevated in various types of human cancers, implicating a role in tumor progression. However, the molecular mechanisms underlying mTOR upregulation remain unclear. In this study, we found that the expression of mLST8, a required subunit of both mTOR complex 1 (mTORC1) and complex 2 (mTORC2), was upregulated in several human colon and prostate cancer cell lines and tissues. Knockdown of mLST8 significantly suppressed mTORC1 and mTORC2 complex formation, and it also inhibited tumor growth and invasiveness in human colon carcinoma (HCT116) and prostate cancer (LNCaP) cells. Overexpression of mLST8 induced anchor-age-independent cell growth in normal epithelial cells (HaCaT), although mLST8 knockdown had no effect on normal cell growth. mLST8 knockdown reduced mTORC2-mediated phosphorylation of AKT in both cancer and normal cells, whereas it potently inhibited mTORC1-mediated phosphorylation of 4E-BP1 specifically in cancer cells. These results suggest that mLST8 plays distinct roles in normal and cancer cells, depending upon its expression level, and that mLST8 upregulation may contribute to tumor progression by constitutively activating both the mTORC1 and mTORC2 pathways.	[Kakumoto, Kyoko; Okada, Masato; Oneyama, Chitose] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Ikeda, Jun-Ichiro; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan	Osaka University; Osaka University	Oneyama, C (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan.	coneyama@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Exciting Leading-Edge Research Project at Osaka University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Exciting Leading-Edge Research Project at Osaka University	This work was supported by a Grant-in-aid for P-DIRECT from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by The Exciting Leading-Edge Research Project at Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Evren S, 2011, J CLIN PATHOL, V64, P683, DOI 10.1136/jclinpath-2011-200083; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Frey JW, 2014, CELL SIGNAL, V26, P313, DOI 10.1016/j.cellsig.2013.11.009; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Lin J, 2010, CANCER PREV RES, V3, P505, DOI 10.1158/1940-6207.CAPR-09-0263; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Madhunapantula SV, 2007, CANCER RES, V67, P3626, DOI 10.1158/0008-5472.CAN-06-4234; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nakashima A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-24; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Oneyama C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080300; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Xu JF, 2013, CANCER-AM CANCER SOC, V119, P2247, DOI 10.1002/cncr.28023; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	39	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119015	10.1371/journal.pone.0119015	http://dx.doi.org/10.1371/journal.pone.0119015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906254	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000002
J	Lin, YH; Yuan, J; Pei, HD; Liu, TZ; Ann, DK; Lou, ZK				Lin, Yi-Hui; Yuan, Jian; Pei, Huadong; Liu, Tongzheng; Ann, David K.; Lou, Zhenkun			KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; CELL-CYCLE; CHROMATIN RELAXATION; CALORIE RESTRICTION; 53BP1; PROTEIN; BRCA1; ATM	Homologous recombination and non-homologous end joining are two major DNA double-strand-break repair pathways. While HR-mediated repair requires a homologous sequence as the guiding template to restore the damage site precisely, NHEJ-mediated repair ligates the DNA lesion directly and increases the risk of losing nucleotides. Therefore, how a cell regulates the balance between HR and NHEJ has become an important issue for maintaining genomic integrity over time. Here we report that SIRT1-dependent KAP1 deacetylation positively regulates NHEJ. We show that up-regulation of KAP1 attenuates HR efficiency while promoting NHEJ repair. Moreover, SIRT1-mediated KAP1 deacetylation further enhances the effect of NHEJ by stabilizing its interaction with 53BP1, which leads to increased 53BP1 focus formation in response to DNA damage. Taken together, our study suggests a SIRT1-KAP1 regulatory mechanism for HR-NHEJ repair pathway choice.	[Lin, Yi-Hui] Mayo Grad Sch, Dept Biochem & Mol Biol, Rochester, MN USA; [Yuan, Jian] Tongji Univ, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China; [Yuan, Jian] Tongji Univ, Sch Med, China East Hosp, Key Lab Arrhythmias,Minist Educ, Shanghai 200092, Peoples R China; [Pei, Huadong] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; [Liu, Tongzheng; Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA; [Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA USA; [Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA	Mayo Clinic; Tongji University; Tongji University; Academy of Military Medical Sciences - China; Mayo Clinic; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Lou, ZK (corresponding author), Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA.	lou.zhenkun@mayo.edu		Yuan, Jian/0000-0002-2801-8849	National Institutes of Health [CA130996, CA129344, CA148940]; Mayo Graduate School; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA129344, R01CA148940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA130996, CA129344, and CA148940 (to ZL). YL acknowledges fellowship funding from Mayo Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cruz-Garcia A, 2014, CELL REP, V9, P451, DOI 10.1016/j.celrep.2014.08.076; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Garvin AJ, 2013, EMBO REP, V14, P975, DOI 10.1038/embor.2013.141; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Harding SM, 2012, CELL CYCLE, V11, P1432, DOI 10.4161/cc.19824; Hinz JM, 2005, DNA REPAIR, V4, P782, DOI 10.1016/j.dnarep.2005.03.005; Huber LJ, 2001, MOL CELL BIOL, V21, P4005, DOI 10.1128/MCB.21.12.4005-4015.2001; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu JP, 2012, CELL CYCLE, V11, P2643, DOI 10.4161/cc.20957; Liu TZ, 2014, MOL CELL, V56, P681, DOI 10.1016/j.molcel.2014.10.007; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Uhl M, 2010, DNA REPAIR, V9, P383, DOI 10.1016/j.dnarep.2009.12.020; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang Z, 2013, ONCOGENE, V32, P589, DOI 10.1038/onc.2012.83; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Xia ZF, 2001, J BIOL CHEM, V276, P2708, DOI 10.1074/jbc.M007665200; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	94	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123935	10.1371/journal.pone.0123935	http://dx.doi.org/10.1371/journal.pone.0123935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905708	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000051
J	Pomraning, KR; Wei, SW; Karagiosis, SA; Kim, YM; Dohnalkova, AC; Arey, BW; Bredeweg, EL; Orr, G; Metz, TO; Baker, SE				Pomraning, Kyle R.; Wei, Siwei; Karagiosis, Sue A.; Kim, Young-Mo; Dohnalkova, Alice C.; Arey, Bruce W.; Bredeweg, Erin L.; Orr, Galya; Metz, Thomas O.; Baker, Scott E.			Comprehensive Metabolomic, Lipidomic and Microscopic Profiling of Yarrowia lipolytica during Lipid Accumulation Identifies Targets for Increased Lipogenesis	PLOS ONE			English	Article							PROTEIN EXPRESSION; YEAST; ACID; TOOL; GLUCOSE; MICROORGANISMS; BIOSYNTHESIS; CEREVISIAE; SECRETION	Yarrowia lipolytica is an oleaginous ascomycete yeast that accumulates large amounts of lipids and has potential as a biofuel producing organism. Despite a growing scientific literature focused on lipid production by Y. lipolytica, there remain significant knowledge gaps regarding the key biological processes involved. We applied a combination of metabolomic and lipidomic profiling approaches as well as microscopic techniques to identify and characterize the key pathways involved in de novo lipid accumulation from glucose in batch cultured, wild-type Y. lipolytica. We found that lipids accumulated rapidly and peaked at 48 hours during the five day experiment, concurrent with a shift in amino acid metabolism. We also report that exhaustion of extracellular sugars coincided with thickening of the cell wall, suggesting that genes involved in cell wall biogenesis may be a useful target for improving the efficiency of lipid producing yeast strains.	[Pomraning, Kyle R.; Dohnalkova, Alice C.; Arey, Bruce W.; Bredeweg, Erin L.; Orr, Galya; Baker, Scott E.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Wei, Siwei; Kim, Young-Mo; Metz, Thomas O.] Pacific NW Natl Lab, Fundamental & Comp Sci Directorate, Richland, WA 99352 USA; [Karagiosis, Sue A.] Pacific NW Natl Lab, Energy & Environm Directorate, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Baker, SE (corresponding author), Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA.	Scott.Baker@pnnl.gov	Kim, Young-Mo/AAG-2866-2019; Baker, Scott E/X-2065-2018; Baker, Scott E./ABB-1635-2020; Kim, Young-Mo/D-3282-2009	Kim, Young-Mo/0000-0002-8972-7593; Baker, Scott E/0000-0001-5085-3106; Baker, Scott E./0000-0001-5085-3106; Kim, Young-Mo/0000-0002-8972-7593; Bredeweg, Erin/0000-0001-7827-8342; Metz, Tom/0000-0001-6049-3968; Pomraning, Kyle/0000-0003-2324-2881	US Department of Energy Office of Biological and Environmental Research Genome Science Program; US Department of Energy [DE-AC05-76RL01830]; Office of Biological and Environmental Research	US Department of Energy Office of Biological and Environmental Research Genome Science Program(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research performed in this study was funded by the US Department of Energy Office of Biological and Environmental Research Genome Science Program. It was conducted at Pacific Northwest National Laboratory operated by Battelle for the US Department of Energy under Contract DE-AC05-76RL01830. The research was performed using Environmental Molecular Sciences Laboratory (EMSL), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. KRP is a William R. Wiley Postdoctoral Fellow at EMSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageitos JM, 2011, APPL MICROBIOL BIOT, V90, P1219, DOI 10.1007/s00253-011-3200-z; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Beopoulos A, 2009, BIOCHIMIE, V91, P692, DOI 10.1016/j.biochi.2009.02.004; Bionutrients BD, 2006, BIONUTRIENTS BD TM T, P28; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Christen S, 2011, FEMS YEAST RES, V11, P263, DOI 10.1111/j.1567-1364.2010.00713.x; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Finogenova TV, 2005, APPL BIOCHEM MICRO+, V41, P418, DOI 10.1007/s10438-005-0076-7; FRANKERINKER D, 1983, Z ALLG MIKROBIOL, V23, P9, DOI 10.1002/jobm.3630230103; Gao XL, 2012, ANAL BIOANAL CHEM, V402, P2923, DOI 10.1007/s00216-012-5773-5; Garay LA, 2014, J AGR FOOD CHEM, V62, P2709, DOI 10.1021/jf4042134; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Hein EM, 2012, METABOLITES, V2, P254, DOI 10.3390/metabo2010254; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kim YM, 2013, MOL BIOSYST, V9, P1522, DOI 10.1039/c3mb25598k; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Knothe G, 2005, FUEL PROCESS TECHNOL, V86, P1059, DOI 10.1016/j.fuproc.2004.11.002; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LaMarche BL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-49; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mironczuk AM, 2014, J IND MICROBIOL BIOT, V41, P57, DOI 10.1007/s10295-013-1380-5; Morin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027966; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; OGRYDZIAK DM, 1988, CRIT REV BIOTECHNOL, V8, P177, DOI 10.3109/07388558809147555; OOGAKI M, 1983, AGR BIOL CHEM TOKYO, V47, P2619, DOI 10.1080/00021369.1983.10865999; Papanikolaou S, 2003, CURR MICROBIOL, V46, P398, DOI 10.1007/s00284-002-3907-2; Papanikolaou S, 2002, APPL MICROBIOL BIOT, V58, P308, DOI 10.1007/s00253-001-0897-0; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sitepu IR, 2014, APPL MICROBIOL BIOT, V98, P7645, DOI 10.1007/s00253-014-5944-8; Sitepu IR, 2013, BIORESOURCE TECHNOL, V144, P360, DOI 10.1016/j.biortech.2013.06.047; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Tomaszewska L, 2012, J IND MICROBIOL BIOT, V39, P1333, DOI 10.1007/s10295-012-1145-6; Zhao C, 2014, BIOCHEM ENG J, V82, P63, DOI 10.1016/j.bej.2013.11.004	44	43	44	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123188	10.1371/journal.pone.0123188	http://dx.doi.org/10.1371/journal.pone.0123188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905710	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000024
J	Villela, DAM; Codeco, CT; Figueiredo, F; Garcia, GA; Maciel-de-Freitas, R; Struchiner, CJ				Villela, Daniel A. M.; Codeco, Claudia T.; Figueiredo, Felipe; Garcia, Gabriela A.; Maciel-de-Freitas, Rafael; Struchiner, Claudio J.			A Bayesian Hierarchical Model for Estimation of Abundance and Spatial Density of Aedes aegypti	PLOS ONE			English	Article							RIO-DE-JANEIRO; MARK-RELEASE-RECAPTURE; DAILY SURVIVAL RATES; POPULATION-SIZE; DENGUE VECTOR; DISPERSAL; CULICIDAE; DIPTERA; VILLAGE; BRAZIL	Strategies to minimize dengue transmission commonly rely on vector control, which aims to maintain Ae. aegypti density below a theoretical threshold. Mosquito abundance is traditionally estimated from mark-release-recapture (MRR) experiments, which lack proper analysis regarding accurate vector spatial distribution and population density. Recently proposed strategies to control vector-borne diseases involve replacing the susceptible wild population by genetically modified individuals' refractory to the infection by the pathogen. Accurate measurements of mosquito abundance in time and space are required to optimize the success of such interventions. In this paper, we present a hierarchical probabilistic model for the estimation of population abundance and spatial distribution from typical mosquito MRR experiments, with direct application to the planning of these new control strategies. We perform a Bayesian analysis using the model and data from two MRR experiments performed in a neighborhood of Rio de Janeiro, Brazil, during both low-and high-dengue transmission seasons. The hierarchical model indicates that mosquito spatial distribution is clustered during the winter (0.99 mosquitoes/premise 95% CI: 0.80-1.23) and more homogeneous during the high abundance period (5.2 mosquitoes/premise 95% CI: 4.3-5.9). The hierarchical model also performed better than the commonly used Fisher-Ford's method, when using simulated data. The proposed model provides a formal treatment of the sources of uncertainty associated with the estimation of mosquito abundance imposed by the sampling design. Our approach is useful in strategies such as population suppression or the displacement of wild vector populations by refractory Wolbachia-infected mosquitoes, since the invasion dynamics have been shown to follow threshold conditions dictated by mosquito abundance. The presence of spatially distributed abundance hotspots is also formally addressed under this modeling framework and its knowledge deemed crucial to predict the fate of transmission control strategies based on the replacement of vector populations.	[Villela, Daniel A. M.; Codeco, Claudia T.; Figueiredo, Felipe; Struchiner, Claudio J.] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Garcia, Gabriela A.; Maciel-de-Freitas, Rafael] Fundacao Oswaldo Cruz, Dept Entomol, Lab Transmissores Hematozoarios, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Villela, DAM (corresponding author), Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.	dvillela@fiocruz.br	Figueiredo, Felipe/L-9463-2015; Struchiner, Claudio J/M-9360-2013; Villela, Daniel/AAG-6445-2019; Maciel-de-Freitas, Rafael/J-1997-2012; Struchiner, Claudio Jose/HGB-9492-2022	Figueiredo, Felipe/0000-0002-7309-9844; Struchiner, Claudio J/0000-0003-2114-847X; Villela, Daniel/0000-0001-8371-2959; Maciel-de-Freitas, Rafael/0000-0002-2198-6492	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative of the Bill and Melinda Gates Foundation; CNPq-Brazil [PRONEX Dengue 550030/2010-7]; FAPERJ [Rede Dengue-E26-110.977/2011]	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative of the Bill and Melinda Gates Foundation; CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was partially supported by grants received from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative of the Bill and Melinda Gates Foundation, from CNPq-Brazil (PRONEX Dengue 550030/2010-7) and from FAPERJ (Rede Dengue-E26-110.977/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; BAILEY NTJ, 1952, J ANIM ECOL, V21, P120, DOI 10.2307/1913; Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Cianci D, 2013, J MED ENTOMOL, V50, P533, DOI 10.1603/ME12126; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cooch E., 2013, PROGRAM MARK GENTLE; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; Dowdeswell WH, 1940, ANN EUGENIC, V10, P123, DOI 10.1111/j.1469-1809.1940.tb02242.x; Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Getis A, 2010, ADV SPAT SCI, P203, DOI 10.1007/978-3-642-01976-0_15; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; JUDSON OP, 1994, TRENDS ECOL EVOL, V9, P9, DOI 10.1016/0169-5347(94)90225-9; Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Laake JL, 2013, METHODS ECOL EVOL, V4, P885, DOI 10.1111/2041-210X.12065; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; MCDONALD PT, 1977, J MED ENTOMOL, V14, P42, DOI 10.1093/jmedent/14.1.42; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Plummer M., 2003, P 3 INT WORKSH DISTR; Royle JA, 2011, METHODS ECOL EVOL, V2, P602, DOI 10.1111/j.2041-210X.2011.00116.x; Royle J. Andrew, 2012, Journal of Ornithology, V152, pS521, DOI 10.1007/s10336-010-0619-4; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Tsuda Y, 2001, J MED ENTOMOL, V38, P93, DOI 10.1603/0022-2585-38.1.93; van Dyk DA, 2001, J COMPUT GRAPH STAT, V10, P1, DOI 10.1198/10618600152418584; Williams C, 2012, MED VET ENTOMOLOGY; Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730	50	22	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123794	10.1371/journal.pone.0123794	http://dx.doi.org/10.1371/journal.pone.0123794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906323	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000047
J	Balmus, G; Lim, PX; Oswald, A; Hume, KR; Cassano, A; Pierre, J; Hill, A; Huang, W; August, A; Stokol, T; Southard, T; Weiss, RS				Balmus, G.; Lim, P. X.; Oswald, A.; Hume, K. R.; Cassano, A.; Pierre, J.; Hill, A.; Huang, W.; August, A.; Stokol, T.; Southard, T.; Weiss, R. S.			HUS1 regulates in vivo responses to genotoxic chemotherapies	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; CELL-CYCLE CHECKPOINT; LUNG-CARCINOMA CELLS; STRAND BREAK REPAIR; ATAXIA-TELANGIECTASIA; GENOMIC INSTABILITY; MOUSE HUS1; CHROMOSOMAL FRAGMENTATION; TRANSLESION SYNTHESIS; SYNTHETIC LETHALITY	Cells are under constant attack from genotoxins and rely on a multifaceted DNA damage response (DDR) network to maintain genomic integrity. Central to the DDR are the ATM and ATR kinases, which respond primarily to double-strand DNA breaks (DSBs) and replication stress, respectively. Optimal ATR signaling requires the RAD9A-RAD1-HUS1 (9-1-1) complex, a toroidal clamp that is loaded at damage sites and scaffolds signaling and repair factors. Whereas complete ATR pathway inactivation causes embryonic lethality, partial Hus1 impairment has been accomplished in adult mice using hypomorphic (Hus1(neo)) and null (Hus1(Delta 1)) Hus1 alleles, and here we use this system to define the tissue- and cell type-specific actions of the HUS1-mediated DDR in vivo. Hus1(neo/Delta 1) mice showed hypersensitivity to agents that cause replication stress, including the crosslinking agent mitomycin C (MMC) and the replication inhibitor hydroxyurea, but not the DSB inducer ionizing radiation. Analysis of tissue morphology, genomic instability, cell proliferation and apoptosis revealed that MMC treatment caused severe damage in highly replicating tissues of mice with partial Hus1 inactivation. The role of the 9-1-1 complex in responding to MMC was partially ATR-independent, as a HUS1 mutant that was proficient for ATR-induced checkpoint kinase 1 phosphorylation nevertheless conferred MMC hypersensitivity. To assess the interplay between the ATM and ATR pathways in responding to replication stress in vivo, we used Hus1/Atm double mutant mice. Whereas Hus1(neo/neo) and Atm(-/-) single mutant mice survived low-dose MMC similar to wild-type controls, Hus1(neo/neo) Atm(-/-) double mutants showed striking MMC hypersensitivity, consistent with a model in which MMC exposure in the context of Hus1 dysfunction results in DSBs to which the ATM pathway normally responds. This improved understanding of the inter-dependency between two major DDR mechanisms during the response to a conventional chemotherapeutic illustrates how inhibition of checkpoint factors such as HUS1 may be effective for the treatment of ATM-deficient and other cancers.	[Balmus, G.; Lim, P. X.; Oswald, A.; Hume, K. R.; Cassano, A.; Pierre, J.; Hill, A.; Southard, T.; Weiss, R. S.] Cornell Univ, Dept Biomed Sci, T2-006C Vet Res Tower, Ithaca, NY 14853 USA; [Hume, K. R.] Cornell Univ, Dept Clin Sci, T2-006C Vet Res Tower, Ithaca, NY 14853 USA; [Huang, W.; August, A.] Cornell Univ, Dept Microbiol & Immunol, T2-006C Vet Res Tower, Ithaca, NY 14853 USA; [Stokol, T.] Cornell Univ, Dept Populat Med & Diagnost Sci, T2-006C Vet Res Tower, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Weiss, RS (corresponding author), Cornell Univ, Dept Biomed Sci, T2-006C Vet Res Tower, Ithaca, NY 14853 USA.	rsw26@cornell.edu	Huang, Weishan/J-3127-2014; Balmus, Gabriel/GZM-2145-2022; Balmus, Gabriel/G-3497-2017	Huang, Weishan/0000-0002-1330-1131; Balmus, Gabriel/0000-0003-2872-4468; Balmus, Gabriel/0000-0003-2872-4468; Lim, Pei Xin/0000-0001-5742-3539	National Institutes of Health [R01 CA108773]; Cornell University College of Veterinary Medicine Graduate Research Assistantship; Cornell University College of Veterinary Medicine Clinical Fellowship; National Center for Research Resources grant [S10RR023781]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University College of Veterinary Medicine Graduate Research Assistantship; Cornell University College of Veterinary Medicine Clinical Fellowship; National Center for Research Resources grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Amy Lyndaker, Steve Jackson and Yaron Galanti for helpful discussions and comments on the manuscript; Natasha Karp for help with statistical analysis and the staff of the Cornell Lab Animal Services and CARE programs for excellent animal care. This work was supported by a National Institutes of Health grant R01 CA108773 to RSW; a Cornell University College of Veterinary Medicine Graduate Research Assistantship to GB; a Cornell University College of Veterinary Medicine Clinical Fellowship to KRH; and a National Center for Research Resources grant (S10RR023781) for instrumentation.	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Bai HB, 2010, DNA REPAIR, V9, P478, DOI 10.1016/j.dnarep.2010.01.011; Balmus G, 2012, HUM MOL GENET, V21, P3408, DOI 10.1093/hmg/dds173; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartek J, 2012, NAT STRUCT MOL BIOL, V19, P5, DOI 10.1038/nsmb.2220; Brooks K, 2013, ONCOGENE, V32, P788, DOI 10.1038/onc.2012.72; Broustas CG, 2014, RADIAT RES, V181, P111, DOI 10.1667/RR13515.1; Broustas CG, 2012, J BIOL CHEM, V287, P41324, DOI 10.1074/jbc.M112.402784; Brown EJ, 2000, GENE DEV, V14, P397; Church D, 2014, NAT REV CANCER, V14, P440, DOI 10.1038/nrc3729; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; De la Torre J, 2008, INT J GYNECOL PATHOL, V27, P24, DOI 10.1097/pgp.0b013e31812dfaef; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Ellisen LW, 2011, CANCER CELL, V19, P165, DOI 10.1016/j.ccr.2011.01.047; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Fokas E, 2014, CANCER TREAT REV, V40, P109, DOI 10.1016/j.ctrv.2013.03.002; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Hall AB, 2014, ONCOTARGET, V5, P5674, DOI 10.18632/oncotarget.2158; Han L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-67; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jeon Y, 2011, J BIOL CHEM, V286, P5414, DOI 10.1074/jbc.M110.189704; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kass EM, 2013, P NATL ACAD SCI USA, V110, P5564, DOI 10.1073/pnas.1216824110; Kawasumi M, 2011, P NATL ACAD SCI USA, V108, P13716, DOI 10.1073/pnas.1111378108; Kinzel B, 2005, CANCER, V94, P1808; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Levitt PS, 2007, MOL CELL BIOL, V27, P2189, DOI 10.1128/MCB.01763-06; Levitt PS, 2005, GENOMICS, V86, P212, DOI 10.1016/j.ygeno.2005.04.007; Liu QH, 2000, GENE DEV, V14, P1448; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Lyndaker AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003320; Ma CX, 2012, J CLIN INVEST, V122, P1541, DOI 10.1172/JCI58765; Maniwa Y, 2005, CANCER-AM CANCER SOC, V103, P126, DOI 10.1002/cncr.20740; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012773; Origanti S, 2013, ONCOGENE, V32, P577, DOI 10.1038/onc.2012.84; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Shiotani B, 2009, J CELL SCI, V122, P301, DOI 10.1242/jcs.035105; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Tang Y, 2012, CANCER BIOL THER, V13, P379, DOI 10.4161/cbt.19240; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; Weiss RS, 2000, GENE DEV, V14, P1886; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Xu XJ, 2013, NUCLEIC ACIDS RES, V41, P10020, DOI 10.1093/nar/gkt810; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yazinski SA, 2009, P NATL ACAD SCI USA, V106, P21282, DOI 10.1073/pnas.0904965106; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhu A, 2008, CANCER RES, V68, P1267, DOI 10.1158/0008-5472.CAN-07-2304	68	8	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					662	669		10.1038/onc.2015.118	http://dx.doi.org/10.1038/onc.2015.118			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25915840				2022-12-26	WOS:000369548800013
J	Riley, MF; You, MJ; Multani, AS; Lozano, G				Riley, M. F.; You, M. J.; Multani, A. S.; Lozano, G.			Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma	ONCOGENE			English	Article							GENE-EXPRESSION; P53; MICE; TAP73; BCL-2; INACTIVATION; DELTA-NP73; LEUKEMIA; PATHWAY; ABSENCE	Many human tumors express high levels of the p53 inhibitor Mdm2, resulting from amplification of the Mdm2 locus or aberrant post-translational regulation of the Mdm2 protein. While the importance of Mdm2 in regulating p53 is clear, Mdm2 also has p53-independent roles. For example, overexpression of Mdm2 results in genomic instability in a p53-independent manner. In addition, Mdm2 has many additional binding partners, some of which, such as the tumor suppressor p73, have also been implicated in genomic instability. In this study, cells and tumors with Mdm2 overexpression and p73 loss exhibit increased genomic instability as compared with either alteration alone and cooperate in development of B-cell lymphomagenesis. Cytogenetic analysis of mouse embryonic fibroblasts and pre-malignant B cells demonstrates that loss of p73 exacerbates the chromosome breaks and fusions observed in Mdm2(Tg) cells. B-cell lymphomas from Mdm2(Tg);p73(+/-) mice retain the remaining p73 allele, exhibit elevated levels of the antiapoptotic protein Bcl2 and thus dampen apoptosis. In summary, Mdm2 overexpression and p73 loss cooperate in genomic instability and tumor development, indicating that the oncogenic function of Mdm2 is a combined effect of inhibiting p53 and p73 functions. Given that p73 is lost or silenced in human B-cell lymphomas, the Mdm2(Tg);p73(+/-) mouse serves as a model for human disease and may provide additional insight into the pathways that contribute to B-cell lymphomagenesis.	[Riley, M. F.; Multani, A. S.; Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd,Unit 1010, Houston, TX 77030 USA; [You, M. J.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lozano, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd,Unit 1010, Houston, TX 77030 USA.	gglozano@mdanderson.org			National Institutes of Health [CA47296]; T32 Training Grant [CA009299]; American Cancer Society; NIH/NCI [R01 CA164346]; Center for Genetics and Genomics; Sister Institution Network fund of MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA164346, R29CA047296, R01CA047296, T32CA009299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Training Grant; American Cancer Society(American Cancer Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Genetics and Genomics; Sister Institution Network fund of MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Elsa Flores for the p73<SUP>+/-</SUP> mice, Stephen Jones for the Mdm2<SUP>Tg</SUP> mice, and Frederick W Alt for the J<INF>H</INF> plasmid. This work was supported by a National Institutes of Health grant (CA47296 to GL), and a T32 Training Grant (CA009299) and an American Cancer Society postdoctoral fellowships to MFR. MJY is supported in part by NIH/NCI R01 CA164346, and the Center for Genetics and Genomics and the Sister Institution Network fund of MD Anderson Cancer Center.	Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Corn PG, 1999, CANCER RES, V59, P3352; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Findley HW, 1997, BLOOD, V89, P2986, DOI 10.1182/blood.V89.8.2986; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gostissa M, 2013, P NATL ACAD SCI USA, V110, P2934, DOI 10.1073/pnas.1222570110; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kawano S, 1999, BLOOD, V94, P1113; Levrero M, 2000, J CELL SCI, V113, P1661; LUNA RMD, 1995, NATURE, V378, P203; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Lushnikova T, 2011, ONCOGENE, V30, P4622, DOI 10.1038/onc.2011.172; Martinez-Delgado B, 2002, INT J CANCER, V102, P15, DOI 10.1002/ijc.10618; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moller MB, 1999, MODERN PATHOL, V12, P1010; Pluta A, 2006, LEUKEMIA, V20, P757, DOI 10.1038/sj.leu.2404166; Riley Maurisa F, 2012, Genes Cancer, V3, P226, DOI 10.1177/1947601912455322; Talos F, 2007, MOL CELL, V27, P647, DOI 10.1016/j.molcel.2007.06.036; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang P, 2008, ONCOGENE, V27, P1590, DOI 10.1038/sj.onc.1210788; Wang TTY, 1997, CANCER LETT, V116, P61, DOI 10.1016/S0304-3835(97)00175-4; Watanabe T, 1996, LEUKEMIA LYMPHOMA, V21, P391, DOI 10.3109/10428199609093436; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zdzalik M, 2010, CELL CYCLE, V9, P4584, DOI 10.4161/cc.9.22.13871; Zeng XY, 1999, MOL CELL BIOL, V19, P3257	36	12	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2016	35	3					358	365		10.1038/onc.2015.88	http://dx.doi.org/10.1038/onc.2015.88			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OF	25915849	Green Accepted			2022-12-26	WOS:000369055300009
J	Andreeva, ER; Andrianova, IV; Sotnezova, EV; Buravkov, SV; Bobyleva, PI; Romanov, YA; Buravkova, LB				Andreeva, Elena R.; Andrianova, Irina V.; Sotnezova, Elena V.; Buravkov, Sergey V.; Bobyleva, Polina I.; Romanov, Yury A.; Buravkova, Ludmila B.			Human Adipose-Tissue Derived Stromal Cells in Combination with Hypoxia Effectively Support Ex Vivo Expansion of Cord Blood Haematopoietic Progenitors	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO; MONONUCLEAR-CELLS; OXYGEN; MICROENVIRONMENT; PROLIFERATION; EXPRESSION; COCULTURE; MAINTAIN; CULTURE	The optimisation of haematopoietic stem and progenitor cell expansion is on demand in modern cell therapy. In this work, haematopoietic stem/progenitor cells (HSPCs) have been selected from unmanipulated cord blood mononuclear cells (cbMNCs) due to adhesion to human adipose-tissue derived stromal cells (ASCs) under standard (20%) and tissue-related (5%) oxygen. ASCs efficiently maintained viability and supported further HSPC expansion at 20% and 5% O-2. During co-culture with ASCs, a new floating population of differently committed HSPCs (HSPCs-1) grew. This suspension was enriched with CD34(+) cells up to 6 (20% O-2) and 8 (5% O-2) times. Functional analysis of HSPCs-1 revealed cobble-stone area forming cells (CAFCs) and lineage-restricted colony-forming cells (CFCs). The number of CFCs was 1.6 times higher at tissue-related O-2, than in standard cultivation (20% O-2). This increase was related to a rise in the number of multipotent precursors -BFU-E, CFU-GEMM and CFU-GM. These changes were at least partly ensured by the increased concentration of MCP-1 and IL-8 at 5% O-2. In summary, our data demonstrated that human ASCs enables the selection of functionally active HSPCs from unfractionated cbMNCs, the further expansion of which without exogenous cytokines provides enrichment with CD34+ cells. ASCs efficiently support the viability and proliferation of cord blood haematopoietic progenitors of different commitment at standard and tissue-related O-2 levels at the expense of direct and paracrine cell-to-cell interactions.	[Andreeva, Elena R.; Andrianova, Irina V.; Sotnezova, Elena V.; Bobyleva, Polina I.; Buravkova, Ludmila B.] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia; [Andrianova, Irina V.; Romanov, Yury A.] Cardiol Res Ctr, Inst Expt Cardiol, Moscow 121552, Russia; [Buravkov, Sergey V.] Moscow MV Lomonosov State Univ, Fac Basic Med, Moscow, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; National Medical Research Center of Cardiology; Lomonosov Moscow State University	Andreeva, ER (corresponding author), Russian Acad Sci, Inst Biomed Problems, Moscow, Russia.	andreeva_er@mail.ru	Sotnezova, Elena/GOP-0041-2022; Buravkova, Ludmila/B-2211-2017; Romanov, Yuri/AAB-2828-2020; Buravkov, Sergey V/K-3083-2013; Bobyleva, Polina/F-4053-2017; Andreeva, Elena/H-2512-2011	Buravkov, Sergey V/0000-0002-1461-464X; Buravkova, Ludmila/0000-0001-6994-557X; Andreeva, Elena/0000-0002-1000-5804; Romanov, Yuri/0000-0003-3748-6860; Sotnezova, Elena/0000-0002-2091-0218	Presidium of Russian Academy of Sciences; Russian Basic Research Foundation [13-04-00791]	Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR))	This work was supported by Grant "BRMT" from Presidium of Russian Academy of Sciences (https://www.ras.ru/presidium.aspx) and Grant #13-04-00791 from Russian Basic Research Foundation (http://www.rfbr.ru/rffi/ru/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PZ, 2015, J TISSUE ENG REGEN M, V9, P988, DOI 10.1002/term.1741; Andreeva ER, 2013, AM J BIOMEDICAL RES, V1, P7; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; BROXMEYER HE, 1990, BLOOD, V76, P1110; Buravkova LB, 2014, MITOCHONDRION, V19, P105, DOI 10.1016/j.mito.2014.07.005; Buravkova LB, 2013, BBA-GEN SUBJECTS, V1830, P4418, DOI 10.1016/j.bbagen.2013.05.029; [Буравкова Л.Б. Buravkova L.B.], 2009, [Цитология, Cell and Tissue Biology, Tsitologiya], V51, P5; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; Dexter T M, 1984, Prog Clin Biol Res, V148, P13; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Guitart AV, 2010, EXP HEMATOL, V38, P847, DOI 10.1016/j.exphem.2010.06.002; Hammoud M, 2012, J CELL PHYSIOL, V227, P2750, DOI 10.1002/jcp.23019; Han ZC, 1997, BLOOD, V89, P2328, DOI 10.1182/blood.V89.7.2328; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jing DH, 2012, HAEMATOL-HEMATOL J, V97, P331, DOI 10.3324/haematol.2011.050815; Jing DH, 2010, HAEMATOL-HEMATOL J, V95, P542, DOI 10.3324/haematol.2009.010736; Kanai M, 2000, BONE MARROW TRANSPL, V26, P837, DOI 10.1038/sj.bmt.1702634; Koller M R, 1995, J Hematother, V4, P159, DOI 10.1089/scd.1.1995.4.159; KOLLER MR, 1992, BLOOD, V80, P403; KOLLER MR, 1993, BLOOD, V82, P378; Li T, 2011, BONE MARROW RES, DOI 10.1155/2011/353878; Magin AS, 2009, STEM CELLS DEV, V18, P173, DOI 10.1089/scd.2007.0273; Maslova EV, 2014, B EXP BIOL MED+, V156, P584, DOI 10.1007/s10517-014-2400-9; McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nishiwaki S, 2012, INT J HEMATOL, V96, P295, DOI 10.1007/s12185-012-1140-8; Punzel M, 2003, EXP HEMATOL, V31, P339, DOI 10.1016/S0301-472X(03)00024-9; Robinson S, 2005, CYTOTHERAPY, V7, P243, DOI 10.1080/14653240510027172; Singh RP, 2012, HIGH ALT MED BIOL, V13, P162, DOI 10.1089/ham.2012.1043; Song KD, 2009, BIOTECHNOL LETT, V31, P923, DOI 10.1007/s10529-009-9961-0; Steiner D, 2009, STEM CELLS, V27, P1932, DOI 10.1002/stem.111; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; van Os Ronald P., 2008, V430, P143, DOI 10.1007/978-1-59745-182-6_10; Wagner W, 2005, STEM CELLS, V23, P1180, DOI 10.1634/stemcells.2004-0361; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Zanjani ED, 2003, EXP HEMATOL, V31, P406, DOI 10.1016/S0301-472X(03)00051-1; Zanjani ED, 1998, EXP HEMATOL, V26, P353; Zhambalova AP, 2009, B EXP BIOL MED+, V147, P525, DOI 10.1007/s10517-009-0542-y; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124939	10.1371/journal.pone.0124939	http://dx.doi.org/10.1371/journal.pone.0124939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919031	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400066
J	Li, N; An, LL; Hang, HY				Li, Nan; An, Lili; Hang, Haiying			Increased Sensitivity of DNA Damage Response-Deficient Cells to Stimulated Microgravity-Induced DNA Lesions	PLOS ONE			English	Article							SENSOR RAD9-RAD1-HUS1 INTERACTS; RAD9 PLAYS; CHECKPOINT CLAMP; LIGASE-I; REPAIR; STABILITY; MDC1; PROLIFERATION; DELETION; PROTEIN	Microgravity is a major stress factor that astronauts have to face in space. In the past, the effects of microgravity on genomic DNA damage were studied, and it seems that the effect on genomic DNA depends on cell types and the length of exposure time to microgravity or simulated microgravity (SMG). In this study we used mouse embryonic stem (MES) and mouse embryonic fibroblast (MEF) cells to assess the effects of SMG on DNA lesions. To acquire the insight into potential mechanisms by which cells resist and/or adapt to SMG, we also included Rad9-deleted MES and Mdc1-deleted MEF cells in addition to wild type cells in this study. We observed significant SMG-induced DNA double strand breaks (DSBs) in Rad9(-/-) MES and Mdc1(-/-) MEF cells but not in their corresponding wild type cells. A similar pattern of DNA single strand break or modifications was also observed in Rad9(-/-) MES. As the exposure to SMG was prolonged, Rad9(-/-) MES cells adapted to the SMG disturbance by reducing the induced DNA lesions. The induced DNA lesions in Rad9(-/-) MES were due to SMG-induced reactive oxygen species (ROS). Interestingly, Mdc1(-/-) MEF cells were only partially adapted to the SMG disturbance. That is, the induced DNA lesions were reduced over time, but did not return to the control level while ROS returned to a control level. In addition, ROS was only partially responsible for the induced DNA lesions in Mdc1(-/-) MEF cells. Taken together, these data suggest that SMG is a weak genomic DNA stress and can aggravate genomic instability in cells with DNA damage response (DDR) defects.	[Li, Nan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China; [Li, Nan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	An, LL (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China.	afxdxz@163.com; hh91@sun5.ibp.ac.cn			Chinese Academy of Sciences [XDA04020202-13, XDA04020413]; National Natural Science Foundation of China [111790400, 31370792]; Ministry of Science and Technology of People's Republic of China [2011YQ03013404]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the Strategic Priority Research Program on Space Science, the Chinese Academy of Sciences (XDA04020202-13 and XDA04020413, HYH); the National Natural Science Foundation of China (No. 111790400, LLA); the National Natural Science Foundation of China (No. 31370792, HYH); and the Ministry of Science and Technology of People's Republic of China (No. 2011YQ03013404, HYH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LL, 2010, J BIOL CHEM, V285, P35267, DOI 10.1074/jbc.M110.161208; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Bai HB, 2010, DNA REPAIR, V9, P478, DOI 10.1016/j.dnarep.2010.01.011; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Degan P, 2005, J CELL BIOCHEM, V94, P460, DOI 10.1002/jcb.20302; Durante M, 2003, CYTOGENET GENOME RES, V103, P40, DOI 10.1159/000076288; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; He W, 2008, NUCLEIC ACIDS RES, V36, P6406, DOI 10.1093/nar/gkn686; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Hu Z, 2008, CANCER RES, V68, P5552, DOI 10.1158/0008-5472.CAN-07-5670; Huang Xuan, 2006, Methods Mol Biol, V314, P73; [蒋远大 JIANG Yuanda], 2008, [航天医学与医学工程, Space Medicine & Medical Engineering], V21, P368; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Li TP, 2013, DNA REPAIR, V12, P284, DOI 10.1016/j.dnarep.2013.01.006; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Matise M, 2000, APPROACH GTAP, P111; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Ohnishi T, 1999, Biol Sci Space, V13, P82; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Roberts JE, 2006, MOL VIS, V12, P633; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Wang JH, 2009, NEUROCHEM INT, V55, P710, DOI 10.1016/j.neuint.2009.07.002; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P1, DOI 10.3978/j.issn.2223-4292.2011.09.01; Yildiz L, 2002, CLIN CHEM LAB MED, V40, P612, DOI 10.1515/CCLM.2002.106; Yin YX, 2004, P NATL ACAD SCI USA, V101, P8864, DOI 10.1073/pnas.0403130101; Zhang CB, 2008, CELL PHYSIOL BIOCHEM, V22, P295, DOI 10.1159/000149808	44	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125236	10.1371/journal.pone.0125236	http://dx.doi.org/10.1371/journal.pone.0125236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915950	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100111
J	Park, JS; Halegoua, S; Kishida, S; Neiman, AM				Park, Jae-Sook; Halegoua, Simon; Kishida, Shosei; Neiman, Aaron M.			A Conserved Function in Phosphatidylinositol Metabolism for Mammalian Vps13 Family Proteins	PLOS ONE			English	Article							PHEOCHROMOCYTOMA CELLS; CHOREA-ACANTHOCYTOSIS; PLASMA-MEMBRANE; ACTIN; POLYMERIZATION; LOCALIZATION; SPORULATION; SENSITIVITY; DOMAINS; SYSTEM	The Vps13 protein family is highly conserved in eukaryotic cells. In humans, mutations in the gene encoding the family member VPS13A lead to the neurodegenerative disorder chorea-acanthocytosis. In the yeast Saccharomyces cerevisiae, there is just a single version of VPS13, thereby simplifying the task of unraveling its molecular function(s). While VPS13 was originally identified in yeast by its role in vacuolar sorting, recent studies have revealed a completely different function for VPS13 in sporulation, where VPS13 regulates phosphatidylinositol-4-phosphate (PtdIns(4) P) levels in the prospore membrane. This discovery raises the possibility that the disease phenotype associated with vps13A mutants in humans is due to misregulation of PtdIns(4) P in membranes. To determine whether VPS13A affects PtdIns(4) P in membranes from mammalian neuronal cells, phosphatidylinositol phosphate pools were compared in PC12 tissue culture cells in the absence or presence of VPS13A. Consistent with the yeast results, the localization of PtdIns(4) P is specifically altered in VPS13A knockdown cells while other phosphatidylinositol phosphates appear unaffected. In addition, VPS13A is necessary to prevent the premature degeneration of neurites that develop in response to Nerve Growth Factor. The regulation of PtdIns(4) P is therefore a conserved function of the Vps13 family and may play a role in the maintenance of neuronal processes in mammals.	[Park, Jae-Sook; Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Halegoua, Simon] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Kishida, Shosei] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Kagoshima University	Neiman, AM (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	aaron.neiman@stonybrook.edu		kishida, shosei/0000-0003-0405-851X; Neiman, Aaron/0000-0002-6600-6996	NIH [R01 GM072540]; Hartman Center for Parkinson's Research at SBU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartman Center for Parkinson's Research at SBU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grant R01 GM072540 to and a research grant from the Advocacy for Neuroacanthocytosis Patients www.naadvocacy.org to AMN and the Hartman Center for Parkinson's Research at SBU to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesutan I, 2013, CELL PHYSIOL BIOCHEM, V32, P728, DOI 10.1159/000354475; An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Foller M, 2012, FASEB J, V26, P1526, DOI 10.1096/fj.11-198317; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HARDIE RJ, 1991, BRAIN, V114, P13; Hayashi T, 2012, BIOCHEM BIOPH RES CO, V419, P511, DOI 10.1016/j.bbrc.2012.02.047; Henkel K, 2006, MOVEMENT DISORD, V21, P1728, DOI 10.1002/mds.21046; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Nakanishi H, 2007, J CELL SCI, V120, P908, DOI 10.1242/jcs.03405; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Park JS, 2012, J CELL SCI; Park JS, 2013, EUKARYOT CELL; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Schmidt EM, 2013, FASEB J, V27, P2799, DOI 10.1096/fj.13-229286; Shiokawa N, 2013, BIOCHEM BIOPH RES CO, V441, P96, DOI 10.1016/j.bbrc.2013.10.011; Sinnamon JR, 2012, RNA, V18, P704, DOI 10.1261/rna.030742.111; Tomemori Y, 2005, J NEUROCHEM, V92, P759, DOI 10.1111/j.1471-4159.2004.02924.x; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Walker RH, 2008, NEUROACANTHOCYTOSIS SYNDROMES II, P3, DOI 10.1007/978-3-540-71693-8_1; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	36	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124836	10.1371/journal.pone.0124836	http://dx.doi.org/10.1371/journal.pone.0124836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915401	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100071
J	Wu, CH; Li, KJ; Yu, CL; Tsai, CY; Hsieh, SC				Wu, Cheng-Han; Li, Ko-Jen; Yu, Chia-Li; Tsai, Chang-Youh; Hsieh, Song-Chou			Sjogren's Syndrome Antigen B Acts as an Endogenous Danger Molecule to Induce Interleukin-8 Gene Expression in Polymorphonuclear Neutrophils	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DENDRITIC CELLS; CYTOKINES; AUTOANTIGENS; ACTIVATION; DISEASE; LUPUS; DIFFERENTIATION; AUTOANTIBODIES; INFLAMMATION	Background Sjogren's syndrome antigen B is expressed in the nucleus and surface membrane of human polymorphonuclear neutrophils and is released after cell death. However, its biological role is not clear. This study is aimed to investigate the effect of Sjogren's syndrome antigen B on human polymorphonuclear neutrophils. Methods Human recombinant Sjogren's syndrome antigen B (rSSB) purified from E. coli was incubated with human polymorphonuclear neutrophils as well as retinoid acid-induced granulocytic differentiated HL-60 cells, HL-60 (RA). Interleukin (IL)-8 protein production and mRNA expressions were measured by enzyme-linked immunosorbent assay and quantitative-polymerase chain reaction, respectively. Uptake of fluorescein isothiocyanate (FITC)-rSSB was assessed by flow cytometry and fluorescence microscopy. Moreover, mitogen-activated protein kinase (MAPK) pathways and nuclear factor-kappaB activation were investigated. Results Human rSSB stimulated IL-8 production from normal human neutrophils and HL-60 (RA) cells in a time-and dose-dependent manner. This IL-8-stimulated activity was blocked by chloroquine and NH4Cl, indicating that endosomal acidification is important for this effect. We found rSSB activated both MAPK pathway and nuclear factor-kappaB signaling to transcribe the IL-8 gene expression of cells. Furthermore, tumor necrosis factor-a exerted an additive effect and rSSB-anti-SSB immune complex exhibited a synergistic effect on rSSB-induced IL-8 production. Conclusions Sjogren's syndrome antigen B might act as an endogenous danger molecule to enhance IL-8 gene expression in human polymorphonuclear neutrophils.	[Wu, Cheng-Han] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Li, Ko-Jen] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Cheng-Han; Li, Ko-Jen; Yu, Chia-Li; Hsieh, Song-Chou] Natl Taiwan Univ Hosp, Dept Internal Med, Div Immunol Rheumatol & Allergy, Taipei 100, Taiwan; [Wu, Cheng-Han; Li, Ko-Jen; Yu, Chia-Li; Hsieh, Song-Chou] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yu, Chia-Li] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Tsai, Chang-Youh] Taipei Vet Gen Hosp, Sect Allergy Immunol & Rheumatol, Taipei, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Veterans General Hospital	Hsieh, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Immunol Rheumatol & Allergy, Taipei 100, Taiwan.	hsiehsc@ntu.edu.tw	Tsai, Chang-Youh/G-1747-2013	Tsai, Chang-Youh/0000-0002-4154-4018; LI, KO-JEN/0000-0002-4544-4620	Ministry of Science and Technology, Taiwan [MOST 99-2314-B-002-079-MY2, MOST 101-2314-B-002-159-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Ministry of Science and Technology, Taiwan (http://www.most.gov.tw), Grant number: MOST 99-2314-B-002-079-MY2, MOST 101-2314-B-002-159- to CHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bethke K, 2002, J IMMUNOL, V169, P6141, DOI 10.4049/jimmunol.169.11.6141; Betteridge ZE, 2009, CURR OPIN RHEUMATOL, V21, P604, DOI 10.1097/BOR.0b013e328331638a; Bondanza A, 2004, ARTHRITIS RHEUM-US, V50, P1549, DOI 10.1002/art.20187; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brito-Zeron P, 2009, SEMIN ARTHRITIS RHEU, V38, P389, DOI 10.1016/j.semarthrit.2008.01.014; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Deshmukh US, 2008, ARTHRITIS RHEUM-US, V58, P1318, DOI 10.1002/art.23368; Elst EF, 2008, ARTHRITIS RHEUM-US, V58, P547, DOI 10.1002/art.23202; Ford LP, 2001, RNA, V7, P1068, DOI 10.1017/S1355838201010159; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Howard OMZ, 2006, CURR OPIN RHEUMATOL, V18, P642, DOI 10.1097/01.bor.0000245728.40630.27; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Hsieh SC, 2003, CLIN EXP IMMUNOL, V131, P506, DOI 10.1046/j.1365-2249.2003.02084.x; Kaplan MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4325; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Oppenheim JJ, 2005, J LEUKOCYTE BIOL, V77, P854, DOI 10.1189/jlb.1004623; Pittoni Valerio, 2002, Autoimmunity Reviews, V1, P154, DOI 10.1016/S1568-9972(02)00032-0; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Schnurr M, 2000, J IMMUNOL, V165, P4704, DOI 10.4049/jimmunol.165.8.4704; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Torsteinsdottir I, 1998, CLIN EXP RHEUMATOL, V16, P255; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; van Woerkom JM, 2004, CLIN EXP RHEUMATOL, V22, P285; VANVENROOIJ WJ, 1991, J IMMUNOL METHODS, V140, P181, DOI 10.1016/0022-1759(91)90369-Q; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Yoshida H, 2002, ARTHRITIS RHEUM, V46, P2235, DOI 10.1002/art.10441	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125501	10.1371/journal.pone.0125501	http://dx.doi.org/10.1371/journal.pone.0125501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915936	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100132
J	Anzalone, A; Gabriel, M; Estrada, LC; Gratton, E				Anzalone, Andrea; Gabriel, Manuela; Estrada, Laura C.; Gratton, Enrico			Spectral Properties of Single Gold Nanoparticles in Close Proximity to Biological Fluorophores Excited by 2-Photon Excitation	PLOS ONE			English	Article							DYNAMICS; ENHANCEMENT	Metallic nanoparticles (NPs) are able to modify the excitation and emission rates (plasmonic enhancement) of fluorescent molecules in their close proximity. In this work, we measured the emission spectra of 20 nm Gold Nanoparticles (AuNPs) fixed on a glass surface submerged in a solution of different fluorophores using a spectral camera and 2-photon excitation. While on the glass surface, we observed the presence in the emission at least 3 components: i) second harmonic signal (SHG), ii) a broad emission from AuNPS and iii) fluorescence arising from fluorophores nearby. When on the glass surface, we found that the 3 spectral components have different relative intensities when the incident direction of linear polarization was changed indicating different physical origins for these components. Then we measured by fluctuation correlation spectroscopy (FCS) the scattering and fluorescence signal of the particles alone and in a solution of 100 nM EGFP using the spectral camera or measuring the scattering and fluorescence from the particles. We observed occasional fluorescence bursts when in the suspension we added fluorescent proteins. The spectrum of these burst was devoid of the SHG and of the broad emission in contrast to the signal collected from the gold nanoparticles on the glass surface. Instead we found that the spectrum during the burst corresponded closely to the spectrum of the fluorescent protein. An additional control was obtained by measuring the cross-correlation between the reflection from the particles and the fluorescence arising from EGFP both excited at 488 nm. We found a very weak cross-correlation between the AuNPs and the fluorescence confirming that the burst originate from a few particles with a fluorescence signal.	[Anzalone, Andrea; Gabriel, Manuela; Estrada, Laura C.; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92697 USA; [Gratton, Enrico] Univ New England, Ctr Bioact Discovery Hlth & Ageing, Sch Sci & Technol, Armidale, NSW, Australia	University of California System; University of California Irvine; University of New England	Gratton, E (corresponding author), Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92697 USA.	egratton@uci.edu			National Institutes of Health NIH [P41 GM103540, P50-GM076516]; Universidad de Buenos Aires [20020130300045BA]; ANPCyT [PICT 2013-2340]; Laboratory for Fluorescence Dynamics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103540, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad de Buenos Aires(University of Buenos Aires); ANPCyT(ANPCyT); Laboratory for Fluorescence Dynamics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health NIH (P41 GM103540 and P50-GM076516 to EG, RD, LCE. MG was supported by grants from Universidad de Buenos Aires (20020130300045BA) and from ANPCyT (Prestamo BID PICT 2013-2340) and funds from the Laboratory for Fluorescence Dynamics. LCE is member of CONICET and MG a fellow from CIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzalone A, 2014, JOVE-J VIS EXP, DOI 10.3791/51794; Aslan K, 2005, CURR OPIN CHEM BIOL, V9, P538, DOI 10.1016/j.cbpa.2005.08.021; Biswas A, 2010, NANOSCALE, V2, P1560, DOI 10.1039/c0nr00133c; Estrada LC, 2012, CHEMPHYSCHEM, V13, P1087, DOI 10.1002/cphc.201100771; Estrada LC, 2012, J PHYS CHEM B, V116, P2306, DOI 10.1021/jp209467t; Estrada LC, 2011, NANO LETT, V11, P4656, DOI 10.1021/nl2022042; Estrada LC, 2008, OPT EXPRESS, V16, P20597, DOI 10.1364/OE.16.020597; Eustis S, 2006, CHEM SOC REV, V35, P209, DOI 10.1039/b514191e; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Kis-Petikova K, 2004, MICROSC RES TECHNIQ, V63, P34, DOI 10.1002/jemt.10417; Levi V, 2008, CHROMOSOME RES, V16, P439, DOI 10.1007/s10577-008-1240-8; Levi V, 2007, CELL BIOCHEM BIOPHYS, V48, P1, DOI 10.1007/s12013-007-0010-0; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Tam F, 2007, NANO LETT, V7, P496, DOI 10.1021/nl062901x; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518	16	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124975	10.1371/journal.pone.0124975	http://dx.doi.org/10.1371/journal.pone.0124975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909648	Green Published, gold			2022-12-26	WOS:000353376800119
J	Fan, FX; Du, PC; Kan, B; Yan, MY				Fan, Fenxia; Du, Pengcheng; Kan, Biao; Yan, Meiying			The Development and Evaluation of a Loop-Mediated Isothermal Amplification Method for the Rapid Detection of Salmonella enterica serovar Typhi	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIAGNOSTIC-TESTS; FEVER; BLOOD; PCR; POPULATION; PAKISTAN; INDIA	Typhoid fever remains a public health threat in many countries. A positive result in traditional culture is a gold-standard for typhoid diagnosis, but this method is time consuming and not sensitive enough for detection of samples containing a low copy number of the target organism. The availability of the loop-mediated isothermal amplification (LAMP) assay, which offers high speed and simplicity in detection of specific targets, has vastly improved the diagnosis of numerous infectious diseases. However, little research efforts have been made on utilizing this approach for diagnosis of Salmonella enterica serovar Typhi by targeting a single and specific gene. In this study, a LAMP assay for rapid detection of S. Typhi based on a novel marker gene, termed STY2879-LAMP, was established and evaluated with realtime PCR (RT-PCR). The specificity tests showed that STY2879 could be amplified in all S. Typhi strains isolated in different years and regions in China, whereas no amplification was observable in non-typhoidal strains covering 34 Salmonella serotypes and other pathogens causing febrile illness. The detection limit of STY2879-LAMP for S. Typhi was 15 copies/reaction in reference plasmids, 200 CFU/g with simple heat-treatment of DNA extracted from simulated stool samples and 20 CFU/ml with DNA extracted from simulated blood samples, which was 10 fold more sensitive than the parallel RT-PCR control experiment. Furthermore, the sensitivity of STY2879-LAMP and RT-PCR combining the traditional culture enrichment method for simulated stool and blood spiked with lower S. Typhi count during the 10 h enrichment time was also determined. In comparison with LAMP, the positive reaction time for RT-PCR required additional 2-3 h enrichment time for either simulated stool or blood specimens. Therefore, STY2879-LAMP is of practical value in the clinical settings and has a good potential for application in developing regions due to its easy-to-use protocol.	[Fan, Fenxia; Du, Pengcheng; Kan, Biao; Yan, Meiying] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Fan, Fenxia; Du, Pengcheng; Kan, Biao; Yan, Meiying] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Kan, B (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	kanbiao@icdc.cn; yanmeiying@icdc.cn			Ministry of Health, China [2012ZX10004215, 2008ZX10004-008]	Ministry of Health, China	This work was supported by the Priority Project on Infectious Disease Control and Prevention (2012ZX10004215 and 2008ZX10004-008) from the Ministry of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, EPIDEMIOL INFECT, V137, P102, DOI 10.1017/S0950268808000654; Ali K, 2006, SAUDI MED J, V27, P1134; Ambati SR, 2007, INDIAN J PEDIATR, V74, P909, DOI 10.1007/s12098-007-0167-y; Baker S, 2005, J CLIN MICROBIOL, V43, P4418, DOI 10.1128/JCM.43.9.4418-4425.2005; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dong B, 2007, EPIDEMIOL INFECT, V135, P1014, DOI 10.1017/S0950268806007801; Fan FenXia, 2012, Disease Surveillance, V27, P325; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; He PY, 2012, THESIS SUZHOU U; Jaffery G, 2004, ANN PATH C 2003 PAK; Kawano RL, 2007, J CLIN MICROBIOL, V45, P246, DOI 10.1128/JCM.01403-06; Kumar A, 2010, BIOTECHNOL LETT, V32, P707, DOI 10.1007/s10529-010-0211-2; Kumar R, 2006, TROP MED INT HEALTH, V11, P41, DOI 10.1111/j.1365-3156.2005.01538.x; Levy H, 2008, J CLIN MICROBIOL, V46, P1861, DOI 10.1128/JCM.00109-08; Mahbubur Rahman P-LL, 2005, 6 INT C TYPH FEV SAL; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Massi Muhammad Nasrum, 2003, Journal of Infection and Chemotherapy, V9, P233, DOI 10.1007/s10156-003-0256-4; Maurya P, 2010, SE ASIAN J TROP MED, V41, P913; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Naheed A, 2008, DIAGN MICR INFEC DIS, V61, P381, DOI 10.1016/j.diagmicrobio.2008.03.018; Nakhla I, 2011, DIAGN MICR INFEC DIS, V70, P435, DOI 10.1016/j.diagmicrobio.2011.03.020; Nie K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052486; Nizami SQ, 2006, SCAND J CLIN LAB INV, V66, P429, DOI 10.1080/00365510600791724; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; PETIT PLC, 1994, E AFR MED J, V71, P183; Sharma V, 1995, Indian J Med Sci, V49, P157; Singh A, 2014, APPL BIOCH BIOTECHNO; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; World Health Organization, 2003, COMM DIS SURV RESP V	33	26	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124507	10.1371/journal.pone.0124507	http://dx.doi.org/10.1371/journal.pone.0124507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910059	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800086
J	Philip, S; Isaakidis, P; Sagili, KD; Meharunnisa, A; Mrithyunjayan, S; Kumar, AMV				Philip, Sairu; Isaakidis, Petros; Sagili, Karuna D.; Meharunnisa, Asanarupillai; Mrithyunjayan, Sunilkumar; Kumar, Ajay M. V.			"They Know, They Agree, but They Don't Do"-The Paradox of Tuberculosis Case Notification by Private Practitioners in Alappuzha District, Kerala, India	PLOS ONE			English	Article							PUBLIC-HEALTH; PARTNERSHIP	Background Despite being a recognized standard of tuberculosis (TB) care internationally, mandatory TB case notification brings forth challenges from the private sector. Only three TB cases were notified in 2013 by private practitioners compared to 2000 TB cases notified yearly from the public sector in Alappuzha district. The study objective was to explore the knowledge, opinion and barriers regarding TB Notification among private practitioners offering TB services in Alappuzha, Kerala state, India. Methods & Findings This was a mixed-methods study with quantitative (survey) and qualitative components conducted between December 2013 and July 2014. The survey, using a structured questionnaire, among 169 private practitioners revealed that 88% were aware of mandatory notification. All patient-related details requested in the notification form (except government-issued identification number) were perceived to be important and easy to provide by more than 80% of practitioners. While more than 95% felt that notification should be mandatory, punitive action in case of failure to notify was considered unnecessary by almost two third. General practitioners (98%) were more likely to be aware of notification than specialists (84 %). (P<0.01). Qualitative purposive personal interviews (n=34) were carried out among private practitioners and public health providers. On thematic framework analysis of the responses, barriers to TB notification were grouped into three themes: 'private provider misconceptions about notification', 'patient confidentiality, and stigma and discrimination' and 'lack of cohesion and coordination between public and private sector'. Private practitioners did not consider it necessary to notify TB cases treated with daily regimen. Conclusion Communication strategies like training, timely dissemination of information of policy changes and one-to-one dialogue with private practitioners to dispel misconceptions may enhance TB notification. Trust building strategies like providing feedback about referred cases from private sector, health personnel visit or a liaison private doctor may ensure compliance to public health activities.	[Philip, Sairu; Meharunnisa, Asanarupillai] Govt TD Med Coll, Alappuzha, Kerala, India; [Isaakidis, Petros] Medecins Sans Frontieres, Operat Res Unit, Delhi, India; [Sagili, Karuna D.; Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [Mrithyunjayan, Sunilkumar] State TB Training & Demonstrat Ctr, Directorate Hlth Serv, State TB Cell, Thiruvananthapuram, Kerala, India		Philip, S (corresponding author), Govt TD Med Coll, Alappuzha, Kerala, India.	sairuphilip09@gmail.com		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Isaakidis, Petros/0000-0002-7881-1554	American People through the United States Agency for International Development (USAID); SORT IT programme; State Board of Medical Research (SBMR) Unit of Government T.D. Medical College, Alappuzha	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); SORT IT programme; State Board of Medical Research (SBMR) Unit of Government T.D. Medical College, Alappuzha	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). The contents of this paper do not necessarily reflect the views of USAID, the United States Government, or International Union Against Tuberculosis and Lung Disease (The Union). The training for research methodology was received in National Operations Research Course from the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres. The support for this publication is from a specific SORT IT programme which was jointly developed and implemented by: The Union South-East Asia Regional Office, New Delhi, India, and the Centre for Operational Research, The Union, Paris, France and Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Center, India. The funds required to conduct the study in Alappuzha was provided by the State Board of Medical Research (SBMR) Unit of Government T.D. Medical College, Alappuzha. SBMR funds are utilised to promote research activities among faculty of the institution. The funders had no role in study design, data collection, analysis and interpretation of data, decision to publish or preparation of the manuscript.	[Anonymous], 2012, GUIDANCE TB NOTIFICA; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Chughtai AA, 2009, EMHJ, V19, P213; Dandona R, 2004, NATL MED J INDIA, V17, P292; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Hollo V, 2011, EURO SURVEILL, V16; Karki DK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-84; Kumar MKA, 2005, INT J TUBERC LUNG D, V9, P870; Newell JN, 2004, B WORLD HEALTH ORGAN, V82, P92; Satyanarayana S, 2011, PLOS ONE, P9; Saw Saw, 2009, Health Res Policy Syst, V7, P19, DOI 10.1186/1478-4505-7-19; Tan HF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-11; TB INDIA, 2013, ANN STAT REP; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ullah AZ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001534; Universal Access to TB Care, PRACT GUID PROGR MAN; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Vyas RM, 2003, INT J TUBERC LUNG D, V7, P543; World Health Organization, GLOB TUB REP 2013	20	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123286	10.1371/journal.pone.0123286	http://dx.doi.org/10.1371/journal.pone.0123286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909330	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800032
J	Yang, MK; Wee, WR; Kwon, JW; Han, YK				Yang, Min Kyu; Wee, Won Ryang; Kwon, Ji-Won; Han, Young Keun			Anterior Chamber Depth and Refractive Change in Late Postoperative Capsular Bag Distension Syndrome: A Retrospective Analysis	PLOS ONE			English	Article							BLOCK SYNDROME; APRACLONIDINE; BRIMONIDINE	Purpose To assess the characteristic findings and effects of laser capsulotomy in patients with late postoperative capsular bag distension syndrome (CBDS). Methods Twenty patients diagnosed with late postoperative CBDS between July 2010 and August 2013 were retrospectively reviewed. Before and 1 week after capsulotomy, changes in the anterior chamber depth (ACD) were assessed using ultrasound biomicroscopy. Changes in the refractive status and uncorrected visual acuity (UCVA) were also measured 1 week and 1 month after capsulotomy. For patients who received bilateral cataract surgery, preoperative ACD and axial length measured by IOLMaster were compared between the two eyes. Results Twenty-two eyes from 20 patients who had undergone laser capsulotomy showed a mean UCVA improvement of 0.27 +/- 0.24 logMAR (range, 0.00-0.90). ACD was increased by an average of +0.04 mm (95% confidence interval, +0.01 to +0.06 mm, p = 0.034), equivalent to predicted refractive change of +0.10 D. The discrepancy between actual (+1.33 D) and predicted refractive change after capsulotomy suggests that refractive change may not be generated from IOL displacement in late postoperative CBDS. Preoperative ACD was deeper in the eye with late postoperative CBDS in all bilaterally pseudophakic patients (mean, 3.68 mm vs. 3.44 mm in the fellow eye, p = 0.068). Conclusions Late postoperative CBDS showed refractive changes that were resolved successfully after laser capsulotomy. The convex lens effects of opalescent material in the distended capsular bag may play a major role in myopic shift. A larger preoperative ACD is possibly associated with the development of late postoperative CBDS.	[Yang, Min Kyu; Han, Young Keun] Seoul Natl Univ, Seoul Metropolitan Government, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Yang, Min Kyu; Wee, Won Ryang] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Kwon, Ji-Won] Kwandong Univ, Myongji Hosp, Coll Med, Dept Ophthalmol, Goyang Si, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Catholic Kwandong University; Myongji Hospital	Han, YK (corresponding author), Seoul Natl Univ, Seoul Metropolitan Government, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea.	eye129@paran.com						Bao YZ, 2008, J CATARACT REFR SURG, V34, P1799, DOI 10.1016/j.jcrs.2008.04.057; Colakoglu A, 2007, J CATARACT REFR SURG, V33, P1344, DOI 10.1016/j.jcrs.2007.02.041; DAVISON JA, 1990, J CATARACT REFR SURG, V16, P99, DOI 10.1016/S0886-3350(13)80883-8; Durak I, 2001, J CATARACT REFR SURG, V27, P555, DOI 10.1016/S0886-3350(00)00689-1; Durig J, 1999, EUR J OPHTHALMOL, V9, P66, DOI 10.1177/112067219900900111; Eifrig DE, 1997, J CATARACT REFR SURG, V23, P450, DOI 10.1016/S0886-3350(97)80193-9; GABELT BT, 1994, EXP EYE RES, V59, P633, DOI 10.1006/exer.1994.1149; HOLTZ SJ, 1992, J CATARACT REFR SURG, V18, P310, DOI 10.1016/S0886-3350(13)80910-8; Kim HK, 2008, J CATARACT REFR SURG, V34, P357, DOI 10.1016/j.jcrs.2007.11.026; Landa G, 2006, CLIN EXP OPHTHALMOL, V34, P866, DOI 10.1111/j.1442-9071.2006.01338.x; Lo Presti L, 1998, ACTA OPHTHALMOL SCAN, V76, P32; Miyake K, 1998, J CATARACT REFR SURG, V24, P1230, DOI 10.1016/S0886-3350(98)80017-5; Omar O, 1996, J CATARACT REFR SURG, V22, P1365, DOI 10.1016/S0886-3350(96)80099-X; Patil S, 2007, EYE, V21, P113, DOI 10.1038/sj.eye.6702419; Pinarci EY, 2012, J CATARACT REFR SURG, V38, P672, DOI 10.1016/j.jcrs.2011.11.024; Qu JF, 2010, J CATARACT REFR SURG, V36, P1687, DOI 10.1016/j.jcrs.2010.02.026; Rozema JJ, 2014, AM J OPHTHALMOL, V158, P1111, DOI 10.1016/j.ajo.2014.08.014; Shah NA, 2006, J CATARACT REFR SURG, V32, P1974, DOI 10.1016/j.jcrs.2006.06.026; Sorenson AL, 2000, OPHTHALMOLOGY, V107, P902, DOI 10.1016/S0161-6420(00)00020-8	19	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125895	10.1371/journal.pone.0125895	http://dx.doi.org/10.1371/journal.pone.0125895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910003	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800145
J	Becker, AAMJ; Janssens, GPJ; Snauwaert, C; Hesta, M; Huys, G				Becker, Anne A. M. J.; Janssens, Geert P. J.; Snauwaert, Cindy; Hesta, Myriam; Huys, Geert			Integrated Community Profiling Indicates Long-Term Temporal Stability of the Predominant Faecal Microbiota in Captive Cheetahs	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; REAL-TIME PCR; GRADIENT GEL-ELECTROPHORESIS; VERTEBRATE GUT MICROBIOTA; CLOSTRIDIUM-PERFRINGENS; ACINONYX-JUBATUS; INTESTINAL MICROBIOTA; BACTERIAL-POPULATIONS; PROBIOTIC PRODUCTS; PANTHERA-TIGRIS	Understanding the symbiotic relationship between gut microbes and their animal host requires characterization of the core microbiota across populations and in time. Especially in captive populations of endangered wildlife species such as the cheetah (Acinonyx jubatus), this knowledge is a key element to enhance feeding strategies and reduce gastrointestinal disorders. In order to investigate the temporal stability of the intestinal microbiota in cheetahs under human care, we conducted a longitudinal study over a 3-year period with bimonthly faecal sampling of 5 cheetahs housed in two European zoos. For this purpose, an integrated 16S rRNA DGGE-clone library approach was used in combination with a series of real-time PCR assays. Our findings disclosed a stable faecal microbiota, beyond intestinal community variations that were detected between zoo sample sets or between animals. The core of this microbiota was dominated by members of Clostridium clusters I, XI and XIVa, with mean concentrations ranging from 7.5-9.2 log10 CFU/g faeces and with significant positive correlations between these clusters (P<0.05), and by Lactobacillaceae. Moving window analysis of DGGE profiles revealed 23.3-25.6% change between consecutive samples for four of the cheetahs. The fifth animal in the study suffered from intermediate episodes of vomiting and diarrhea during the monitoring period and exhibited remarkably more change (39.4%). This observation may reflect the temporary impact of perturbations such as the animal's compromised health, antibiotic administration or a combination thereof, which temporarily altered the relative proportions of Clostridium clusters I and XIVa. In conclusion, this first long-term monitoring study of the faecal microbiota in feline strict carnivores not only reveals a remarkable compositional stability of this ecosystem, but also shows a qualitative and quantitative similarity in a defined set of faecal bacterial lineages across the five animals under study that may typify the core phylogenetic microbiome of cheetahs.	[Becker, Anne A. M. J.; Huys, Geert] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium; [Snauwaert, Cindy; Huys, Geert] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, BCCM LMG Bacteria Collect, B-9000 Ghent, Belgium; [Becker, Anne A. M. J.; Janssens, Geert P. J.; Hesta, Myriam] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Anim Nutr Lab, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Becker, AAMJ (corresponding author), Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium.	Anne.Becker@UGent.be	Janssens, Geert/C-2264-2008; Huys, Geert R.B./V-8633-2019; Huys, Geert/M-6781-2019	Huys, Geert R.B./0000-0002-7092-4837; Hesta, Myriam/0000-0001-9423-9765	Special Research Fund of Ghent University (Belgium) [BOF/10/2JO/254, BOF11/24J/122]; Morris Animal Foundation (USA) [D12ZO-404]	Special Research Fund of Ghent University (Belgium)(Ghent University); Morris Animal Foundation (USA)	Our work was kindly supported by the Special Research Fund of Ghent University (Belgium), Grants BOF/10/2JO/254 and BOF11/24J/122 (http://www.ugent.be), and by the Morris Animal Foundation (USA), Grant D12ZO-404 (http://www.morrisanimalfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen ME, 2004, ZOO BIOL, V23, P475, DOI 10.1002/zoo.20029; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; [Anonymous], 1994, P ASS REPTILE AMPHIB, P301; Barc MC, 2004, ANTIMICROB AGENTS CH, V48, P1365, DOI 10.1128/AAC.48.4.1365-1368.2004; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Becker AAMJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-43; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500; Brinkman BM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.101; Buddington RK, 2011, J ANIM SCI, V89, P1506, DOI 10.2527/jas.2010-3705; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Dierenfeld E.S., 2002, NUTR COMPOSITION WHO; El Aidy S, 2013, BIOESSAYS, V35, P913, DOI 10.1002/bies.201300073; Endo A, 2010, ANAEROBE, V16, P590, DOI 10.1016/j.anaerobe.2010.10.005; Fahey GC, 2008, ANNU REV NUTR, V28, P425, DOI 10.1146/annurev.nutr.28.061807.155325; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Huys Geert, 2008, Interdiscip Perspect Infect Dis, V2008, P597603, DOI 10.1155/2008/597603; Jores J, 2008, J WILDLIFE DIS, V44, P155, DOI 10.7589/0090-3558-44.1.155; Kawata Ken, 2008, Zoologische Garten, V78, P17, DOI 10.1016/j.zoolgart.2008.09.004; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; Kotsch V, 2002, WIEN TIERARZTL MONAT, V89, P341; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Marker LL, 2014, INT CHEETAH STUDBOOK; Masco L, 2007, INT J FOOD MICROBIOL, V113, P351, DOI 10.1016/j.ijfoodmicro.2006.07.021; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Menke S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00526; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Pfaffl M.W., 2004, A Z QUANT PCR, P87; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Plantinga EA, 2011, BRIT J NUTR, V106, pS35, DOI 10.1017/S0007114511002285; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwab C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027905; Schwab C, 2011, CAN J MICROBIOL, V57, P177, DOI 10.1139/W10-113; Schwab C, 2009, CAN J MICROBIOL, V55, P1335, DOI 10.1139/W09-083; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Silva ROS, 2014, ANAEROBE, V28, P207, DOI 10.1016/j.anaerobe.2014.06.012; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Temmerman R, 2003, APPL ENVIRON MICROB, V69, P220, DOI 10.1128/AEM.69.1.220-226.2003; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Vester BM, 2008, P COMP NUTR SOC 2008, P243; Vester BM, 2010, ZOO BIOL, V29, P432, DOI 10.1002/zoo.20275; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Whitehouse-Tedd K., 2012, P 14 ANN BIAZA RES S, P9; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zeira O, 2012, J ZOO WILDLIFE MED, V43, P666, DOI 10.1638/2011-0265R.1; Zentek J, 2003, J ANIM PHYSIOL AN N, V87, P397, DOI 10.1046/j.0931-2439.2003.00451.x; Zhang YL, 2012, J ZOO WILDLIFE MED, V43, P394, DOI 10.1638/2010-0197.1	72	8	9	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123933	10.1371/journal.pone.0123933	http://dx.doi.org/10.1371/journal.pone.0123933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905625	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000050
J	Leite, JP; Duarte, M; Paiva, AM; Ferreira-da-Silva, F; Matias, PM; Nunes, OC; Gales, L				Leite, Jose P.; Duarte, Marcia; Paiva, Ana M.; Ferreira-da-Silva, Frederico; Matias, Pedro M.; Nunes, Olga C.; Gales, Luis			Structure-Guided Engineering of Molinate Hydrolase for the Degradation of Thiocarbamate Pesticides	PLoS One			English	Article							HERBICIDE MOLINATE; DIFFRACTION DATA; AMIDOHYDROLASE; MINERALIZATION; SUPERFAMILY; SOFTWARE; CRYSTALS	Molinate is a recalcitrant thiocarbamate used to control grass weeds in rice fields. The recently described molinate hydrolase, from Gulosibacter molinativorax ON4T, plays a key role in the only known molinate degradation pathway ending in the formation of innocuous compounds. Here we report the crystal structure of recombinant molinate hydrolase at 2.27 angstrom. The structure reveals a homotetramer with a single mononuclear metal-dependent active site per monomer. The active site architecture shows similarities with other amidohydrolases and enables us to propose a general acid-base catalysis mechanism for molinate hydrolysis. Molinate hydrolase is unable to degrade bulkier thiocarbamate pesticides such as thiobencarb which is used mostly in rice crops. Using a structural-based approach, we were able to generate a mutant (Arg187Ala) that efficiently degrades thiobencarb. The engineered enzyme is suitable for the development of a broader thiocarbamate bioremediation system.	[Leite, Jose P.; Ferreira-da-Silva, Frederico; Gales, Luis] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Leite, Jose P.; Duarte, Marcia; Ferreira-da-Silva, Frederico; Gales, Luis] Univ Porto, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Duarte, Marcia; Paiva, Ana M.; Nunes, Olga C.] Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, P-4100 Oporto, Portugal; [Matias, Pedro M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2781901 Oeiras, Portugal; [Matias, Pedro M.] IBET, P-2781901 Oeiras, Portugal; [Gales, Luis] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade Nova de Lisboa; Universidade do Porto	Gales, L (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lgales@ibmc.up.pt	Matias, Pedro M/B-7180-2008; Leite, José P./AAF-4209-2021; Silva, Frederico F/K-3820-2013; Gales, Luis/J-8716-2013	Matias, Pedro M/0000-0001-6170-451X; Silva, Frederico F/0000-0002-8890-4228; Gales, Luis/0000-0002-8352-6539; Leite, Jose P./0000-0001-5063-515X; Nunes, Olga/0000-0003-4742-2537	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [PEst-OE/EQB/LA0004/2011, FCOMP-01-0124-FEDER-027883 (PTDC/AAGTEC/3909/2012FCOMP)]	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia	This work was funded by FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia grants PEst-OE/EQB/LA0004/2011 (PMM) and FCOMP-01-0124-FEDER-027883 (PTDC/AAGTEC/3909/2012FCOMP).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barreiros L, 2003, ENVIRON MICROBIOL, V5, P944, DOI 10.1046/j.1462-2920.2003.00492.x; Barreiros L, 2008, MICROBIOL-SGM, V154, P1038, DOI 10.1099/mic.0.2007/015297-0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dao FX, 2009, BIOCHEMISTRY-US, V48, P4567, DOI [10.1021/bi900453u, DOI 10.1021/BI900453U]; Dao FX, 2009, BIOCHEMISTRY-US, V48, P3730, DOI [10.1021/bi900111q, DOI 10.1021/BI900111Q]; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Du XL, 2005, FEBS LETT, V579, P6140, DOI 10.1016/j.febslet.2005.09.086; Duarte M, 2011, J BACTERIOL, V193, P5810, DOI 10.1128/JB.05054-11; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khurana JL, 2009, BIOCHEM J, V418, P431, DOI 10.1042/BJ20081488; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGY I, 1995, J BACTERIOL, V177, P676, DOI 10.1128/jb.177.3.676-687.1995; Nunes OC, 2013, APPL MICROBIOL BIOT, V97, P10275, DOI 10.1007/s00253-013-5316-9; Schrodinger L., 2020, PYMOL; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659	26	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123430	10.1371/journal.pone.0123430	http://dx.doi.org/10.1371/journal.pone.0123430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905461	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000031
J	Li, YQ; Deng, XW; Huang, ZH; Xiang, WH; Yan, WD; Lei, PF; Zhou, XL; Peng, CH				Li, Yan-qiong; Deng, Xiang-wen; Huang, Zhi-hong; Xiang, Wen-hua; Yan, Wen-de; Lei, Pi-feng; Zhou, Xiao-lu; Peng, Chang-hui			Development and Evaluation of Models for the Relationship between Tree Height and Diameter at Breast Height for Chinese-Fir Plantations in Subtropical China	PLOS ONE			English	Article							PINE PLANTATIONS; BLACK SPRUCE; AGED STANDS; GROWTH; EQUATIONS; CURVE; BANKSIANA	Tree diameter at breast height (dbh) and height are the most important variables used in forest inventory and management as well as forest carbon-stock estimation. In order to identify the key stand variables that influence the tree height-dbh relationship and to develop and validate a suit of models for predicting tree height, data from 5961 tree samples aged from 6 years to 53 years and collected from 80 Chinese-fir plantation plots were used to fit 39 models, including 33 nonlinear models and 6 linear models, were developed and evaluated into two groups. The results showed that composite models performed better in height estimate than one-independent-variable models. Nonlinear composite Model 34 and linear composite Model 6 were recommended for predicting tree height in Chinese fir plantations with a dbh range between 4 cm and 40 cm when the dbh data for each tree and the quadratic mean dbh of the stand (Dq) and mean height of the stand (Hm) were available. Moreover, Hm could be estimated by using the formula Hm=11.707xln(Dq)-18.032. Clearly, Dq was the primary stand variable that influenced the height-dbh relationship. The parameters of the models varied according to stand age and site. The inappropriate application of provincial or regional height-dbh models for predicting small tree height at local scale may result in larger uncertainties. The method and the recommended models developed in this study were statistically reliable for applications in growth and yield estimation for even-aged Chinese- fir plantation in Huitong and Changsha. The models could be extended to other regions and to other tree species only after verification in subtropical China.	[Li, Yan-qiong; Deng, Xiang-wen; Huang, Zhi-hong; Xiang, Wen-hua; Yan, Wen-de; Lei, Pi-feng; Zhou, Xiao-lu; Peng, Chang-hui] Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha 410004, Hunan, Peoples R China; [Deng, Xiang-wen; Huang, Zhi-hong; Xiang, Wen-hua; Yan, Wen-de; Lei, Pi-feng] Natl Engn Lab Appl Technol Forestry & Ecol South, Changsha 410004, Hunan, Peoples R China; [Zhou, Xiao-lu; Peng, Chang-hui] Univ Quebec, Dept Biol Sci, Inst Environm Sci, Montreal, PQ H3C 3P8, Canada	Central South University of Forestry & Technology; University of Quebec; University of Quebec Montreal	Deng, XW (corresponding author), Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha 410004, Hunan, Peoples R China.	dxwfree@126.com	Lei, Pifeng/AAB-4847-2020	Li, Yanqiong/0000-0002-3362-7366; deng, xiang wen/0000-0002-9399-1231	state forestry special fund for non-profit industries of China [201404316]	state forestry special fund for non-profit industries of China	This work was supported by the state forestry special fund for non-profit industries of China [201404316] (http://www.hymof.net.cn/).	Arcangeli C, 2014, FORESTRY, V87, P177, DOI 10.1093/forestry/cpt041; BAILEY RL, 1980, CAN J FOREST RES, V10, P117, DOI 10.1139/x80-021; Ban DC, 1994, FOR RES, V7, P512; BATES DM, 1980, J ROY STAT SOC B MET, V42, P1; BUFORD MA, 1986, FOREST SCI, V32, P812; Burkhart HE, 1974, GROWTH MODELS TREE S, P128; Castedo-Dorado F, 2006, FOREST ECOL MANAG, V229, P202, DOI 10.1016/j.foreco.2006.04.028; Castedo-Doradoa F, 2005, ANN FOREST SCI, V62, P455, DOI 10.1051/forest:2005042; Colbert KC, 2002, NORTH J APPL FOR, V19, P171, DOI 10.1093/njaf/19.4.171; Cox F., 1994, MODELOS PARAMETRIZAD; CURTIS RO, 1967, FOREST SCI, V13, P365; CURTIS RO, 1970, FOREST SCI, V16, P403; CURTIS RO, 1981, PNW128 USDA FOR SERV; Cutini A., 2013, iForest, V6, P331; FARR WA, 1989, CAN J FOREST RES, V19, P1203, DOI 10.1139/x89-181; HAFLEY WL, 1977, CAN J FOREST RES, V7, P481, DOI 10.1139/x77-062; HARRISON W C, 1986, Southern Journal of Applied Forestry, V10, P99; Henriksen H. A., 1950, Dansk Skovforeningens Tidsskrift, V35, P193; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; Huang SM, 2000, FOREST ECOL MANAG, V129, P125, DOI 10.1016/S0378-1127(99)00151-6; Hui G, 1999, MODELLING FOREST DEV; Kearsley E, 2014, NATURE COMMUNICATION, V4, P226; Lang A. C., 2014, iForest, V7, P19, DOI 10.3832/ifor1033-007; Larsen DR, 1987, 49 OR STAT U FOR ER; LARSON BC, 1986, CAN J FOREST RES, V16, P367, DOI 10.1139/x86-063; Leduc D, 2009, SOUTH J APPL FOR, V33, P164, DOI 10.1093/sjaf/33.4.164; Lei XD, 2009, FOREST CHRON, V85, P43, DOI 10.5558/tfc85043-1; Lei YC, 2001, REMARKS HEIGHT DIAME; Lopez-Sancheza CA, 2003, ANN FOREST SCI, V60, P237, DOI 10.1051/forest:2003015; Mehtatalo L, 2004, CAN J FOREST RES, V34, P131, DOI 10.1139/X03-207; Mirkovic D, 1958, GLASNIK SUMARSKOG FA, V13; Moravie MA, 1999, FOREST ECOL MANAG, V117, P221, DOI 10.1016/S0378-1127(98)00480-0; Newton RF, 2007, FOREST ECOL MANAG, V247, P149, DOI 10.1016/j.foreco.2007.04.029; Pan WC, 1979, J CENTRAL S FORESTRY, V4, P1; Pascoa F, 1987, THESIS; Pearl R, 1920, P NATL ACAD SCI USA, V6, P275, DOI 10.1073/pnas.6.6.275; Peng CH, 2004, NORTH J APPL FOR, V21, P83, DOI 10.1093/njaf/21.2.83; Prodan M, 1968, FOREST BIOMETRICS, P341; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; RATKOWSKY DA, 1986, BIOMETRICS, V42, P575, DOI 10.2307/2531207; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rojo A, 2005, FORESTRY, V78, P385, DOI 10.1093/forestry/cpi030; SCHREUDER HT, 1979, FOREST SCI, V25, P25; Seber G., 1989, NONLINEAR REGRESSION; Sharma M, 2004, SCAND J FOREST RES, V19, P442, DOI 10.1080/02827580410030163; SIBBESEN E, 1981, J SOIL SCI, V32, P67, DOI 10.1111/j.1365-2389.1981.tb01686.x; SLOBODA B, 1993, ALLG FORST JAGDZTG, V164, P225; Stage A.R, 1975, INT164 USDA FOR SERV; STAGE ALBERT R., 1963, FOREST SCI, V9, P167; Stankova TV, 2013, ANN FOR RES, V56, P149; Stoffels A., 1953, Nederlandsch Boschbouwtijdschrift, V25, P190; Temesgen H, 2004, EUR J FOR RES, V123, P45, DOI 10.1007/s10342-004-0020-z; Vanclay JK, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009063; VANCLAY JK, 1995, FOREST SCI, V41, P7, DOI 10.1093/forestscience/41.1.7; Vargas-Larreta B, 2009, FORESTRY, V82, P445, DOI 10.1093/forestry/cpp016; Wang CH, 1988, 51 OR STAT U FOR RES; Watts SB, 1983, FORESTRY HDB BRIT CO; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wykoff W.R., 1982, INT122 USDA FOR SERV; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104012; YANG RC, 1978, CAN J FOREST RES, V8, P424, DOI 10.1139/x78-062; ZEIDE B, 1989, CAN J FOREST RES, V19, P1283, DOI 10.1139/x89-195; Zhang LJ, 2002, FOREST CHRON, V78, P530, DOI 10.5558/tfc78530-4; Zhao MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055376	64	32	35	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125118	10.1371/journal.pone.0125118	http://dx.doi.org/10.1371/journal.pone.0125118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905458	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000103
J	Lima, VD; Graf, I; Beckwith, CG; Springer, S; Altice, FL; Coombs, D; Kim, B; Messina, L; Montaner, JSG; Spaulding, A				Lima, Viviane D.; Graf, Isabell; Beckwith, Curt G.; Springer, Sandra; Altice, Frederick L.; Coombs, Daniel; Kim, Brian; Messina, Lauren; Montaner, Julio S. G.; Spaulding, Anne			The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PUBLIC-HEALTH; INFECTED PRISONERS; ANAL INTERCOURSE; UNDIAGNOSED HIV; HIGH PREVALENCE; HOMOSEXUAL-MEN; UNITED-STATES; RISK; TRANSMISSION	Background Annually, 10 million adults transition through prisons or jails in the United States (US) and the prevalence of HIV among entrants is three times higher than that for the country as a whole. We assessed the potential impact of increasing HIV Testing/Treatment/Retention (HIV-TTR) in the community and within the criminal justice system (CJS) facilities, coupled with sexual risk behavior change, focusing on black men-who-have-sex-with-men, 15-54 years, in Atlanta, USA. Methods We modeled the effect of a HIV-TTR strategy on the estimated cumulative number of new (acquired) infections and mortality, and on the HIV prevalence at the end of ten years. We additionally assessed the effect of increasing condom use in all settings. Results In the Status Quo scenario, at the end of 10 years, the cumulative number of new infections in the community, jail and prison was, respectively, 9246, 77 and 154 cases; HIV prevalence was 10815, 69 and 152 cases, respectively; and the cumulative number of deaths was 2585, 18 and 34 cases, respectively. By increasing HIV-TTR coverage, the cumulative number of new infections could decrease by 15% in the community, 19% in jail, and 8% in prison; HIV prevalence could decrease by 8%, 9% and 7%, respectively; mortality could decrease by 20%, 39% and 18%, respectively. Based on the model results, we have shown that limited use and access to condoms have contributed to the HIV incidence and prevalence in all settings. Conclusions Aggressive implementation of a CJS-focused HIV-TTR strategy has the potential to interrupt HIV transmission and reduce mortality, with benefit to the community at large. To maximize the impact of these interventions, retention in treatment, including during the period after jail and prison release, and increased condom use was vital for decreasing the burden of the HIV epidemic in all settings.	[Lima, Viviane D.; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane D.; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Div Aids, Dept Med, Vancouver, BC, Canada; [Graf, Isabell] Simon Fraser Univ, Dept Math, Burnaby, BC V5A 1S6, Canada; [Beckwith, Curt G.] Brown Univ, Miriam Hosp, Alpert Med Sch, Providence, RI USA; [Springer, Sandra; Altice, Frederick L.] Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT USA; [Altice, Frederick L.] Yale Univ, Div Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA; [Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Kim, Brian; Messina, Lauren; Spaulding, Anne] Emory Univ, Sch Med, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Simon Fraser University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Yale University; Yale University; University of British Columbia; Emory University; Rollins School Public Health	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca	Springer, Sandra/ABC-4569-2020	Coombs, Daniel/0000-0002-8038-6278; Altice, Frederick/0000-0002-7860-693X	National Institute of Drug Abuse; US National Institute on Drug Abuse [R03 DA033851, R01 DA025943, R01 DA029910, R01 DA033679, R01 DA030762, K24 DA017072]; Canadian Institutes of Health Research (CIHR) [MOP-125948]; Michael Institute for Health Research; British Columbia Ministry of Health; US National Institutes of Health [R01 DA036307]; National Institute of Allergy and Infectious Diseases through the Emory Center for AIDS Research [P30 AI050409];  [R01 DA021525];  [R01 DA27211];  [R01 DA030768]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033679, R01DA036307, K02DA032322, R01DA027211, R01DA025943, R01DA021525, K24DA017072, R01DA029910, R01DA030762, R03DA033851, R01DA030768] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Institute for Health Research; British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases through the Emory Center for AIDS Research; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	CB, SS, AS, FA, VDL and JM received grant supplements through the National Institute of Drug Abuse for the Criminal Justice Modeling Project. The parent grants for these supplements were R01 DA021525, R01 DA27211 and R01 DA030768. In addition, VDL is supported by a grant from the US National Institute on Drug Abuse (R03 DA033851), a grant from the Canadian Institutes of Health Research (CIHR; MOP-125948), by a Scholar Award from the Michael Institute for Health Research and a New Investigator award from CIHR. JM is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01 DA036307). FA is supported through different grants from the US National Institute of Drug Abuse (R01 DA025943, R01 DA029910, R01 DA033679, R01 DA030762 and K24 DA017072). AS is supported through a grant from the National Institute of Allergy and Infectious Diseases through the Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff AL, 2013, AIDS BEHAV, V17, P156, DOI 10.1007/s10461-012-0372-1; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P421; AVERT, 2014, PRIS HIV AIDS; Baggaley RF, 2010, AIDS, V24, P2418, DOI 10.1097/QAD.0b013e32833dbdfd; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Beck A., 2013, SEXUAL VICTIMIZATION; Beckwith C, 2014, AIDS PATIENT CARE ST, V28, P183, DOI 10.1089/apc.2013.0357; Beckwith CG, 2012, AM J PUBLIC HEALTH, V102, pS184, DOI 10.2105/AJPH.2011.300514; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Booker CA, 2013, AIDS BEHAV, V17, P128, DOI 10.1007/s10461-012-0354-3; Brewer RA, 2014, AM J PUBLIC HEALTH, V104, P448, DOI 10.2105/AJPH.2013.301786; Carson EA, 2013, 243920 NCJ US DEP JU; Carson EA, 2012, B NCJ; Centers for Disease Control and Prevention, 2013, HIV SURV S REP; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Chen Mi, 2012, MMWR Suppl, V61, P57; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; de Voux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037603; Department of Health and Human Services, 2014, GUIDELINES USE ANTIR; Draine J, 2011, AIDS CARE, V23, P366, DOI 10.1080/09540121.2010.507738; Flanigan TP, 2008, CLIN INFECT DIS, V47, P1366, DOI 10.1086/592754; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Fu JJ, 2013, AIDS BEHAV, V17, P145, DOI 10.1007/s10461-013-0590-1; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Georgia Department of Public Health, 2008, GEORG HIV AIDS SURV; Georgia Department of Public Health, 2012, 2012 HIV FACT SHEET; Georgia Department of Public Health, 2009, GEORG HIV AIDS SURV; Georgia Department of Public Health, 2010, 2010 HIV FACT SHEET; Georgia Department of Public Health, 2010, GEORG HIV AIDS SURV; Georgia Department of Public Health, 2011, 2011 HIV FACT SHEET; Georgia Department of Public Health, 2008, 2008 HIV FACT SHEET; Georgia Department of Public Health, 2009, 2009 HIV FACT SHEET; Ginder S, 2013, MORTALITY LOCAL JAIL; Guerino P, 2011, 236095 NCJ US DEP JU; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Khan MR, 2008, J URBAN HEALTH, V85, P100, DOI 10.1007/s11524-007-9237-8; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lima V, 2011, 18 C RETR OPP INF FE; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lyons T, 2014, J CORRECT HEALTH CAR, V20, P105, DOI 10.1177/1078345813518630; Mao LM, 2011, SEX TRANSM INFECT, V87, P489, DOI 10.1136/sextrans-2011-050041; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Maruschak LM, 2009, HIV PRISONS JAILS SE; Maruschak LM, 2012, HIV PRISONS JAILS SE; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Meyer JP, 2014, JAMA INTERN MED, V174, P721, DOI 10.1001/jamainternmed.2014.601; Meyer JP, 2014, LANCET HIV; Minton T. D., 2014, JAIL INMATES MIDYEAR; Montague BT, 2012, VIRULENCE, V3, P319, DOI 10.4161/viru.20432; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; National Centre for Primary Care, 2004, GEORG MIN HLTH HLTH; Nunn A, 2011, CLIN INFECT DIS, V53, P499, DOI 10.1093/cid/cir418; Office of Health Indicators for Planning (OHIP), 2013, ONL AN STAT INF SYST; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Rosenberg ES, 2013, JAIDS-J ACQ IMM DEF, V63, P514, DOI 10.1097/QAI.0b013e318294bcce; Rosenberg ES, 2012, SEX TRANSM DIS, V39, P741, DOI 10.1097/OLQ.0b013e31825ec09b; Siegler AJ, 2013, JAIDS-J ACQ IMM DEF, V64, P307, DOI 10.1097/QAI.0b013e3182a0e880; Smith D, 2013, 20 C RETR OPP INF MA; Spaulding AC, 2011, 1 INT TREATM PREV WO; Spaulding AC, 2014, INTRO CORRECTIONS HI; Spaulding AC, 2013, AIDS BEHAV, V17, P203, DOI 10.1007/s10461-012-0341-8; Spaulding AC, 2013, AIDS BEHAV, V17, P100, DOI 10.1007/s10461-012-0339-2; Spaulding AC, 2013, MMWR-MORBID MORTAL W, V62, P495; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2011, CLIN INFECT DIS, V53, P469, DOI 10.1093/cid/cir446; Stein MS, 2013, AIDS BEHAV, V17, P108, DOI 10.1007/s10461-012-0340-9; Sullivan PS, 2014, ARCH SEX BEHAV, V43, P173, DOI 10.1007/s10508-013-0214-x; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tieu HV, 2012, 19 INT AIDS C JUL 22; United States Census Bureau, 2013, POP EST 2013; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; West HC, 2010, 231675 NCJ US DEP JU; Westergaard RP, 2013, CURR OPIN INFECT DIS, V26, P10, DOI 10.1097/QCO.0b013e32835c1dd0; Westergaard RP, 2011, CLIN INFECT DIS, V53, P725, DOI 10.1093/cid/cir491; Western B, 2010, INCARCERATION SOCIAL; Williams BG, 2011, CURR HIV RES, V9, P367, DOI 10.2174/157016211798038533; Wohl DA, 2013, JAMA-J AM MED ASSOC, V310, P2198, DOI 10.1001/jama.2013.280740; Zelenev A, 2013, AIDS BEHAV, V17, P181, DOI 10.1007/s10461-013-0472-6; Zuckerman RA, 2004, J INFECT DIS, V190, P156, DOI 10.1086/421246	87	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123482	10.1371/journal.pone.0123482	http://dx.doi.org/10.1371/journal.pone.0123482			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905725	gold, Green Submitted, Green Published			2022-12-26	WOS:000353332000033
J	Tripette, J; Nguyen, C; Allard, L; Robillard, P; Soulez, G; Cloutier, G				Tripette, Julien; Linh-Chi Nguyen; Allard, Louise; Robillard, Pierre; Soulez, Gilles; Cloutier, Guy			In Vivo Venous Assessment of Red Blood Cell Aggregate Sizes in Diabetic Patients with a Quantitative Cellular Ultrasound Imaging Method: Proof of Concept	PLoS One			English	Article							ACUTE-PHASE PROTEINS; ERYTHROCYTE AGGREGATION; HEMORHEOLOGICAL DISORDERS; RBC AGGREGATION; SHEAR RATE; MELLITUS; DISEASE; DETERMINANT; FIBRINOGEN; ESTIMATOR	Background Diabetic patients present higher level of red blood cell (RBC) aggregation contributing to the development of vascular complications. While it has been suggested that this hematology/rheology parameter could bring additional prognostic information for the management of those patients, RBC aggregation screening is not included as a clinical practice. Most medical centers are not equipped to measure properly this parameter, although sedimentation tests can bring some indication. Here, we aimed at evaluating the feasibility of using ultrasound to assess in-vivohyper-aggregation in type 2 diabetic patients. Research design and methods Seventeen diabetic patients and 15 control subjects underwent ultrasound measurements of RBC aggregation in both cephalic and great saphenous veins. Non-invasive in-vivo ultrasound measurements were performed using a newly developed cellular imaging technique, the structure factor size and attenuation estimator (SFSAE). Comparisons with an ex-vivogold standard rheometry technique were done, along with measurements of pro-aggregating plasma molecule concentrations. Results In-vivo RBC aggregation was significantly higher in diabetic patients compared with controls for cephalic vein measurements, while a trend (p = 0.055) was noticed in the great saphenous vein. SFSAE measurements were correlated with gold standard in-vitromeasures, fibrinogen and C-reactive protein plasma concentrations. Conclusion RBC aggregation can be measured in-vivo in diabetic patients using ultrasound. Prospective studies are needed to determine whether the SFSAE method could help clinicians in the early management of vascular complications in this patient population.	[Tripette, Julien; Linh-Chi Nguyen; Allard, Louise; Cloutier, Guy] Univ Montreal Hosp CRCHUM, Res Ctr, Lab Biorheol & Med Ultrason, Quebec City, PQ, Canada; [Linh-Chi Nguyen; Soulez, Gilles; Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Quebec City, PQ, Canada; [Robillard, Pierre; Soulez, Gilles] Univ Montreal Hosp CHUM, Dept Radiol, Quebec City, PQ, Canada; [Robillard, Pierre; Soulez, Gilles; Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Cloutier, G (corresponding author), Univ Montreal Hosp CRCHUM, Res Ctr, Lab Biorheol & Med Ultrason, Quebec City, PQ, Canada.	guy.cloutier@umontreal.ca	tripette, julien/AAC-5414-2019; Soulez, Gilles/F-2834-2013	tripette, julien/0000-0002-5669-5337; 	Canadian Institutes of Health Research [MOP-84358]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding of this study was provided by the Canadian Institutes of Health Research (grant number MOP-84358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; Cloutier G, 1996, IEEE T BIO-MED ENG, V43, P441, DOI 10.1109/10.488792; Cloutier G, 2008, DIABETES CARE, V31, P1400, DOI 10.2337/dc07-1802; Foresto P, 2000, MEDICINA-BUENOS AIRE, V60, P570; Franceschini E, 2008, J ACOUST SOC AM, V123, pEL85, DOI 10.1121/1.2896115; Franceschini E, 2010, J ACOUST SOC AM, V127, P1104, DOI 10.1121/1.3277200; Gabbay IE, 2014, MED HYPOTHESES, V82, P57, DOI 10.1016/j.mehy.2013.11.005; Hardeman MR, 2007, BIOMED HEALTH RES, V69, P242; Khodabandehlou T, 2004, CLIN HEMORHEOL MICRO, V30, P219; Khodabandehlou T, 2003, Int J Low Extrem Wounds, V2, P13, DOI 10.1177/1534734603002001003; Khodabandehlou T, 1996, CLIN HEMORHEOL, V16, P303; Le Devehat C, 2004, CLIN HEMORHEOL MICRO, V30, P297; LEDEVEHAT C, 1990, INT ANGIOL, V9, P11; Maharshak N, 2009, INFLAMM BOWEL DIS, V15, P707, DOI 10.1002/ibd.20838; Mantskava M, 2006, CLIN HEMORHEOL MICRO, V35, P307; Mchedlishvili G, 2001, JPN J PHYSIOL, V51, P19, DOI 10.2170/jjphysiol.51.19; Meiselman HJ, 2006, CLIN HEMORHEOL MICRO, V35, P37; Momtselidze N, 2006, CLIN HEMORHEOL MICRO, V35, P261; Neu B, 2007, BIOMED HEALTH RES, V69, P114; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Saldanha C, 2013, CLIN HEMORHEOL MICRO, V53, P39, DOI 10.3233/CH-2012-1574; Schmid-Schonbein H., 1990, TIJDSCHR NVKC, V15, P88; Tripette J, 2013, CRIT CARE MED, V41, pE171, DOI 10.1097/CCM.0b013e31828a2354; Weng XD, 1996, AM J PHYSIOL-HEART C, V271, pH2346, DOI 10.1152/ajpheart.1996.271.6.H2346; Weng XD, 1998, THROMB HAEMOSTASIS, V80, P903, DOI 10.1055/s-0037-1615386; Yu FTH, 2011, J THROMB HAEMOST, V9, P481, DOI 10.1111/j.1538-7836.2010.04164.x; Yu FTH, 2007, J ACOUST SOC AM, V122, P645, DOI 10.1121/1.2735805; Yu FTH, 2009, BIORHEOLOGY, V46, P343, DOI 10.3233/BIR-2009-0546	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124712	10.1371/journal.pone.0124712	http://dx.doi.org/10.1371/journal.pone.0124712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906140	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000082
J	Wang, W; Fromm, M				Wang, Wei; Fromm, Michael			Sphingolipids Are Required for Efficient Triacylglycerol Loss in Conjugated Linoleic Acid Treated Adipocytes	PLOS ONE			English	Article							NF-KAPPA-B; WHITE ADIPOSE-TISSUE; ENDOTHELIAL-CELLS; SPHINGOSINE 1-PHOSPHATE; MEDIATED ACTIVATION; BODY-COMPOSITION; CERAMIDE; MICE; TRANS-10; APOPTOSIS	Conjugated linoleic acid (CLA) reduces adiposity in human and mouse adipocytes. This outcome is achieved through a variety of biological responses including increased energy expenditure and fatty acid oxidation, increased inflammation, repression of fatty acid biosynthesis, attenuated glucose transport, and apoptosis. In the current study, profiling of 261 metabolites was conducted to gain new insights into the biological pathways responding to CLA in 3T3-L1 adipocytes. Sphinganine and sphingosine levels were observed to be highly elevated in CLA treated adipocytes. Exogenous chemicals that increased endogenous ceramide levels decreased lipid levels in adipocytes, and activated AMP-activated protein kinase (AMPK) as well as NF-kappa B, both of which are typically activated in CLA treated adipocytes. Concurrent inhibition of ceramide de novo biosynthesis and recycling from existing sphingolipid pools attenuated the lipid lowering effect normally associated with responses to CLA, implicating ceramides as an important component of the lipid lowering response in CLA treated adipocytes.	[Wang, Wei] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA; [Fromm, Michael] Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Fromm, M (corresponding author), Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA.	mfromm2@unl.edu		wang, wei/0000-0002-6642-9358	Center for Biotechnology	Center for Biotechnology	This work was supported by the Center for Biotechnology (WW and MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Romero A, 2013, BIOCH BIOPHYS ACTA; Castro BM, 2014, PROG LIPID RES; Choi KM, 2011, BIOL PHARM BULL, V34, P912, DOI 10.1248/bpb.34.912; Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200; Gondai T, 2008, NUCLEIC ACIDS RES, V36, P5426, DOI 10.1093/nar/gkn547; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gupta V, 2010, J LIPID RES, V51, P866, DOI 10.1194/jlr.D002949; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hargrave-Barnes KM, 2008, OBESITY, V16, P2245, DOI 10.1038/oby.2008.338; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; House RL, 2005, OBES REV, V6, P247, DOI 10.1111/j.1467-789X.2005.00198.x; House RL, 2005, PHYSIOL GENOMICS, V21, P351, DOI 10.1152/physiolgenomics.00244.2004; Jiang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048874; Jiang S, 2011, J NUTR BIOCHEM, V22, P656, DOI 10.1016/j.jnutbio.2010.05.005; Jiang S, 2009, J NUTR, V139, P2244, DOI 10.3945/jn.109.112417; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Kennedy A, 2009, J LIPID RES, V50, P225, DOI 10.1194/jlr.M800258-JLR200; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kim HS, 2000, BIOCHEM BIOPH RES CO, V270, P76, DOI 10.1006/bbrc.2000.2373; Kogot-Levin A, 2013, BIOCHIMIE; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; LaRosa PC, 2007, PHYSIOL GENOMICS, V31, P544, DOI 10.1152/physiolgenomics.00156.2007; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Moon MH, 2012, EXP MOL MED, V44, P603, DOI 10.3858/emm.2012.44.10.069; O'Sullivan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095566; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Obsen T, 2012, J NUTR BIOCHEM, V23, P580, DOI 10.1016/j.jnutbio.2011.02.014; Oh E, 2014, ARCH DERMATOL RES, V306, P339, DOI 10.1007/s00403-013-1434-6; Papineau D, 2003, METABOLISM, V52, P987, DOI 10.1016/S0026-0495(03)00165-3; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Pyne NJ, 2013, CANCER CELL, V23, P5, DOI 10.1016/j.ccr.2012.12.005; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Viehaber G, 2001, GLYCOBIOLOGY, V11, P451; Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829; Xu F, 2010, APPL BIOCHEM BIOTECH, V160, P197, DOI 10.1007/s12010-008-8505-8; Yamashita-Sugahara Y, 2013, J BIOL CHEM, V288, P4522, DOI 10.1074/jbc.M112.440792; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0119005	10.1371/journal.pone.0119005	http://dx.doi.org/10.1371/journal.pone.0119005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906159	Green Published, gold			2022-12-26	WOS:000353332000001
J	Yan, H; Liang, CZ; Li, ZY; Liu, ZL; Miao, BL; He, CG; Sheng, LX				Yan, Hong; Liang, Cunzhu; Li, Zhiyong; Liu, Zhongling; Miao, Bailing; He, Chunguang; Sheng, Lianxi			Impact of Precipitation Patterns on Biomass and Species Richness of Annuals in a Dry Steppe	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; SEASONAL ENVIRONMENTAL VARIATION; CLIMATE-CHANGE; ABOVEGROUND PRODUCTIVITY; RAINFALL VARIABILITY; INNER-MONGOLIA; NORTH-AMERICAN; SEED DORMANCY; ANNUAL PLANTS; RESPONSES	Annuals are an important component part of plant communities in arid and semiarid grassland ecosystems. Although it is well known that precipitation has a significant impact on productivity and species richness of community or perennials, nevertheless, due to lack of measurements, especially long-term experiment data, there is little information on how quantity and patterns of precipitation affect similar attributes of annuals. This study addresses this knowledge gap by analyzing how quantity and temporal patterns of precipitation affect aboveground biomass, interannual variation aboveground biomass, relative aboveground biomass, and species richness of annuals using a 29-year dataset from a dry steppe site at the Inner Mongolia Grassland Ecosystem Research Station. Results showed that aboveground biomass and relative aboveground biomass of annuals increased with increasing precipitation. The coefficient of variation in aboveground biomass of annuals decreased significantly with increasing annual and growing-season precipitation. Species richness of annuals increased significantly with increasing annual precipitation and growing-season precipitation. Overall, this study highlights the importance of precipitation for aboveground biomass and species richness of annuals.	[Yan, Hong; He, Chunguang; Sheng, Lianxi] NE Normal Univ, State Environm Protect, Key Lab Wetland Ecol & Vegetat Restorat, Changchun, Peoples R China; [Liang, Cunzhu; Li, Zhiyong; Liu, Zhongling; Miao, Bailing] Inner Mongolia Univ, Sch Ecol & Environm Sci, Hohhot, Peoples R China; [Miao, Bailing] Meteorol Res Inst Inner Mongolia, Hohhot, Peoples R China	Northeast Normal University - China; Inner Mongolia University	Sheng, LX (corresponding author), NE Normal Univ, State Environm Protect, Key Lab Wetland Ecol & Vegetat Restorat, Changchun, Peoples R China.	shenglx@nenu.edu.cn			Special Funds of the State Environmental Protection Public Welfare Industry [2011467032]; Natural Science Foundation of China [31160476, 31160119]; National Key Basic Research Program of China [2010CB950602]; Enhancing Comprehensive Strength Project of Inner Mongolia University [14020202]	Special Funds of the State Environmental Protection Public Welfare Industry; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Enhancing Comprehensive Strength Project of Inner Mongolia University	Research was funded by the Special Funds of the State Environmental Protection Public Welfare Industry (Project NO. 2011467032), Natural Science Foundation of China (Project NO. 31160476 and 31160119), National Key Basic Research Program of China (Project NO. 2010CB950602), and the Enhancing Comprehensive Strength Project of Inner Mongolia University (Project NO. 14020202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt SK, 2006, PLANT SOIL, V285, P1, DOI 10.1007/s11104-006-9097-0; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; BASKIN CC, 1993, J ECOL, V81, P551, DOI 10.2307/2261533; Berg N, 2012, GEODERMA, V185, P6, DOI 10.1016/j.geoderma.2012.03.023; BERTILLER MB, 1991, J ARID ENVIRON, V21, P1; Brown G, 2003, PLANT ECOL, V165, P53, DOI 10.1023/A:1021425308451; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Dieleman JA, 1998, SCI HORTIC-AMSTERDAM, V76, P183, DOI 10.1016/S0304-4238(98)00131-9; Dreesen FE, 2012, ENVIRON EXP BOT, V79, P21, DOI 10.1016/j.envexpbot.2012.01.005; DUNCAN DA, 1975, J RANGE MANAGE, V28, P327, DOI 10.2307/3897788; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; FOX GA, 1990, AM J BOT, V77, P1508, DOI 10.2307/2444763; FREAS KE, 1983, J ECOL, V71, P211, DOI 10.2307/2259973; Fry EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057027; Gonzalez-Astorga J, 2000, PLANT ECOL, V151, P253, DOI 10.1023/A:1026570623406; Guo QF, 2002, J VEG SCI, V13, P575, DOI 10.1111/j.1654-1103.2002.tb02084.x; GUTIERREZ JR, 1987, ECOLOGY, V68, P2032, DOI 10.2307/1939894; Hou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070114; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jongen M, 2011, AGR FOREST METEOROL, V151, P595, DOI 10.1016/j.agrformet.2011.01.008; Kidron GJ, 2014, J HYDROL, V508, P128, DOI 10.1016/j.jhydrol.2013.10.045; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2006, OECOLOGIA, V149, P456, DOI 10.1007/s00442-006-0468-2; Lane DR, 1998, J VEG SCI, V9, P239, DOI 10.2307/3237123; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ma WH, 2010, J PLANT RES, V123, P509, DOI 10.1007/s10265-009-0302-0; Mathias A, 2013, THEOR POPUL BIOL, V84, P56, DOI 10.1016/j.tpb.2012.11.009; Miranda JD, 2011, J ARID ENVIRON, V75, P1302, DOI 10.1016/j.jaridenv.2011.04.022; Miranda JD, 2009, J VEG SCI, V20, P269, DOI 10.1111/j.1654-1103.2009.05680.x; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; MULROY TW, 1977, BIOSCIENCE, V27, P109, DOI 10.2307/1297607; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Quevedo-Robledo L, 2010, J ARID ENVIRON, V74, P167, DOI 10.1016/j.jaridenv.2009.08.002; Rivas-Arancibia SP, 2006, J ARID ENVIRON, V67, P416, DOI 10.1016/j.jaridenv.2006.03.005; Robertson TR, 2009, NEW PHYTOL, V181, P230, DOI 10.1111/j.1469-8137.2008.02643.x; Robinson TMP, 2013, OIKOS, V122, P727, DOI 10.1111/j.1600-0706.2012.20655.x; Salve R, 2011, J HYDROL, V410, P51, DOI 10.1016/j.jhydrol.2011.09.003; Solbreck C, 2012, BASIC APPL ECOL, V13, P414, DOI 10.1016/j.baae.2012.07.003; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005; Whitehead D, 2004, FOREST ECOL MANAG, V193, P113, DOI 10.1016/j.foreco.2004.01.026; Whitford WG, 1995, ENVIRON MONIT ASSESS, V37, P319, DOI 10.1007/BF00546898; Williams KJ, 1998, OIKOS, V81, P463, DOI 10.2307/3546768; Xia Y, 2010, J ARID ENVIRON, V74, P378, DOI 10.1016/j.jaridenv.2009.08.016; Xu ZZ, 2014, PLANTA, V239, P421, DOI 10.1007/s00425-013-1987-9; Xu ZZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-21; Yoneyama T, 2001, PLANT CELL ENVIRON, V24, P133, DOI 10.1046/j.1365-3040.2001.00663.x; Yuan Fei, 2008, Yingyong Shengtai Xuebao, V19, P2168; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; Zhang BC, 2013, CLIMATIC CHANGE, V118, P197, DOI 10.1007/s10584-012-0622-2; Zhao LJ, 2013, ECOL ENG, V60, P116, DOI 10.1016/j.ecoleng.2013.07.022; Zhu H, 2014, ECOL ENTOMOL, V39, P453, DOI 10.1111/een.12120	59	49	53	10	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125300	10.1371/journal.pone.0125300	http://dx.doi.org/10.1371/journal.pone.0125300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906187	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000109
J	Ali, A; Bhatti, MZ; Shah, AS; Duong, HQ; Alkreathy, HM; Mohammad, SF; Khan, RA; Ahmad, A				Ali, Amjad; Bhatti, Muhammad Zeeshan; Shah, Abdus Saboor; Hong-Quan Duong; Alkreathy, Huda Mohammad; Mohammad, Shah Faisal; Khan, Rahmat Ali; Ahmad, Ayaz			Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Metastasis; KLF17; tumor suppressor p53; lung cancer; chemotherapy	EPITHELIAL-MESENCHYMAL TRANSITIONS; KLF17 EXPRESSION; POOR-PROGNOSIS; MUTANT P53; GROWTH; GENE; PATHWAY; RESTORATION; ACETYLATION; ACTIVATION	Background: How Kruppel-like factor 17 (KLF17) controls metastasis and epithelial-mesenchymal transition (EMT) during cancer progression remains unknown. Results: Tumor-suppressive p53 signaling is critical for KLF17 to inhibit cancer metastasis in NSCLC. Conclusion: These results indicate novel insights into the anti-EMT effect of KLF17 via p53-dependent pathway. Significance: Targeting KLF17 for cancer therapy may be applicable to NSCLC tumors with TP53 status, which may improve the prognosis of NSCLC patients. Metastasis, which is controlled by concerted action of multiple genes, is a complex process and is an important cause of cancer death. Kruppel-like factor 17 (KLF17) is a negative regulator of metastasis and epithelial-mesenchymal transition (EMT) during cancer progression. However, the underlying molecular mechanism and biological relevance of KLF17 in cancer cells are poorly understood. Here, we show that tumor suppressor protein p53 plays an integral role to induce KLF17 expression in non-small cell lung cancer (NSCLC). p53 is recruited to the KLF17 promoter and results in the formation of p53-DNA complex. p53 enhances binding of p300 and favors histone acetylation on the KLF17 promoter. Mechanistically, p53 physically interacts with KLF17 and thereby enhances the anti-metastatic function of KLF17. p53 empowers KLF17-mediated EMT genes transcription via enhancing physical association of KLF17 with target gene promoters. Nutlin-3 recruits KLF17 to EMT target gene promoters and results in the formation of KLF17-DNA complex via a p53-dependent pathway. p53 depletion abrogates DNA binding affinity of KLF17 to EMT target gene promoters. KLF17 is critical for p53 cellular activities in NSCLC. Importantly, KLF17 enhances p53 transcription to generate a novel positive feedback loop. KLF17 depletion accelerates lung cancer cell growth in response to chemotherapy. Mechanistically, we found that KLF17 increases the expression of tumor suppressor genes p53, p21, and pRB. Functionally, KLF17 required p53 to suppress cancer cell invasion and migration in NSCLC. In conclusion, our study highlights a novel insight into the anti-EMT effect of KLF17 via a p53-dependent pathway in NSCLC, and KLF17 may be a new therapeutic target in NSCLC with p53 status.	[Ali, Amjad; Bhatti, Muhammad Zeeshan; Shah, Abdus Saboor] E China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Hong-Quan Duong] Duy Tan Univ, Inst Res & Dev, Danang 59000, Vietnam; [Alkreathy, Huda Mohammad] King Abdulaziz Univ, Fac Med, Dept Pharmacol, Jeddah 21413, Saudi Arabia; [Mohammad, Shah Faisal] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Lab Enzymol & Mol Evolut, Shanghai 200240, Peoples R China; [Mohammad, Shah Faisal; Khan, Rahmat Ali] Univ Sci & Technol Bannu, Fac Biol Sci, Dept Biotechnol, Khyber Pakhtunkhwa, Pakistan; [Ahmad, Ayaz] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Ali, Amjad; Bhatti, Muhammad Zeeshan; Ahmad, Ayaz] Abdul Wali Khan Univ, Dept Biotechnol, Mardan 23200, Pakistan	East China Normal University; Duy Tan University; King Abdulaziz University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Abdul Wali Khan University	Ali, A (corresponding author), E China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	amjad_486@yahoo.com; ahdayazb5@awkum.edu.pk	ALKREATHY, HUDA/AAF-1939-2019; Bhatti, Muhammad Zeeshan/ACS-5136-2022; Khan, Rahmat Ali/AAD-7790-2020; Ahmad, Ayaz/GVT-1025-2022	ALKREATHY, HUDA/0000-0002-7824-8802; Ahmad, Ayaz/0000-0003-3555-4735; Bhatti, Muhammad Zeeshan/0000-0003-0532-0532	Higher Education Commission; Ministry of Education of Pakistan	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Ministry of Education of Pakistan	This work was supported by the Higher Education Commission and the Ministry of Education of Pakistan.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ali A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.48; Ali A, 2014, CANCER LETT, V354, P87, DOI 10.1016/j.canlet.2014.07.045; Ali A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3667; Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Arva Nicoleta C, 2008, Ethn Dis, V18, pS2; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Cai XD, 2012, BIOCHEM BIOPH RES CO, V418, P67, DOI 10.1016/j.bbrc.2011.12.129; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dong PX, 2014, CARCINOGENESIS, V35, P760, DOI 10.1093/carcin/bgt369; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Iwanicki MP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-244; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kunkele A, 2012, NEURO-ONCOLOGY, V14, P859, DOI 10.1093/neuonc/nos115; Lazar V, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-53; Lee ER, 2007, STEM CELLS, V25, P2191, DOI 10.1634/stemcells.2007-0203; Lee JH, 2010, ONCOGENE, V29, P1431, DOI 10.1038/onc.2009.438; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu FY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0425-3; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Matsuoka M, 2003, ENVIRON HEALTH PERSP, V111, P509, DOI 10.1289/ehp.5945; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun Z, 2013, MOL ONCOL, V7, P884, DOI 10.1016/j.molonc.2013.04.007; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Tang HR, 2009, ACTA BIOCH BIOPH SIN, V41, P588, DOI 10.1093/abbs/gmp046; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yee KS, 2005, CARCINOGENESIS, V26, P1317, DOI 10.1093/carcin/bgi122	49	16	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21336	21351		10.1074/jbc.M114.635730	http://dx.doi.org/10.1074/jbc.M114.635730			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	25911104	Green Published, hybrid			2022-12-26	WOS:000360637600012
J	Bilotas, MA; Olivares, CN; Ricci, AG; Baston, JI; Bengochea, TS; Meresman, GF; Baranao, RI				Andrea Bilotas, Mariela; Noemi Olivares, Carla; Gabriela Ricci, Analia; Ignacio Baston, Juan; Soledad Bengochea, Tatiana; Fabiana Meresman, Gabriela; Ines Baranao, Rosa			Interplay between Endometriosis and Pregnancy in a Mouse Model	PLOS ONE			English	Article							SURGICALLY INDUCED ENDOMETRIOSIS; INFERTILE WOMEN; PERITONEAL ENDOMETRIOSIS; PERFORATION; FERTILITY; THERAPIES; DIENOGEST; TISSUE; CELLS; LACTATION	Objectives To evaluate the effect of endometriosis on fertility and the levels of the IL-2 and IFN-gamma in the peritoneal fluid in a mouse model; to evaluate the effect of pregnancy on endometriotic lesion growth, apoptosis and cell proliferation. Study Design Two month old C57BL/6 female mice underwent either a surgical procedure to induce endometriosis or a sham surgery. Four weeks after surgery mice were mated and sacrificed at day 18 of pregnancy. Number of implantation sites, fetuses and fetal weight were recorded. Endometriotic lesions were counted, measured, excised and fixed. Apoptosis and cell proliferation were evaluated in lesions by TUNEL and immunohistochemistry for PCNA respectively. Levels of IL-2 and IFN-gamma were assessed by ELISA in the peritoneal fluid. Results Pregnancy rate (i.e. pregnant mice/N) decreased in mice with endometriosis. However there were no significant differences in resorption rate, litter size and pup weight between groups. IFN-gamma augmented in endometriosis mice independently of pregnancy outcome. Additionally IFN-gamma increased in pregnant endometriosis mice compared to pregnant sham animals. While IFN-gamma increased in non pregnant versus pregnant mice in the sham group, IL-2 was increased in non pregnant mice in the endometriosis group. The size of endometriotic lesions increased in pregnant mice while apoptosis increased in the stroma and cell proliferation decreased in the epithelium of these lesions. Additionally, leukocyte infiltration, necrosis and decidualization were increased in the same lesions. Conclusions Pregnancy rate is reduced in this mouse model of endometriosis. Levels of IL-2 are increased in the peritoneal fluid of mice with endometriosis suggesting a role of this cytokine in infertility related to this disease. The size of endometriotic lesions is increased in pregnant mice; however pregnancy has a beneficial effect on lesions by decreasing cell proliferation and by increasing apoptosis, decidualization and necrosis.	[Andrea Bilotas, Mariela; Noemi Olivares, Carla; Gabriela Ricci, Analia; Ignacio Baston, Juan; Soledad Bengochea, Tatiana; Fabiana Meresman, Gabriela; Ines Baranao, Rosa] Consejo Nacl Invest Cient & Tecn, IBYME, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Bilotas, MA (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, RA-1033 Buenos Aires, DF, Argentina.	mabilotas@dna.uba.ar		Meresman, Gabriela Fabiana/0000-0002-5058-8450	Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (PRESTAMO BID PICT) [01632]; Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina [PIP 1223]	Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (PRESTAMO BID PICT); Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina (PRESTAMO BID PICT No 01632) http://www.agencia.mincyt.gob.ar/ - RIB GFM Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (PIP 1223) http://www.conicet.gob.ar/ - RIB GFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akande VA, 2004, HUM REPROD, V19, P96, DOI 10.1093/humrep/deh045; Balasch J, 1996, HUM REPROD, V11, P387, DOI 10.1093/HUMREP/11.2.387; Barbieri M, 2009, HUM REPROD, V24, P1818, DOI 10.1093/humrep/dep089; BARRAGAN JC, 1992, FERTIL STERIL, V58, P1215; Bilotas M, 2010, FERTIL STERIL, V93, P2513, DOI 10.1016/j.fertnstert.2009.08.058; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CHAOUAT G, 1990, J REPROD FERTIL, V89, P447; CHAOUAT G, 1995, J IMMUNOL, V154, P4261; Coccia ME, 2012, EUR J OBSTET GYN R B, V160, P35, DOI 10.1016/j.ejogrb.2011.10.004; Cummings AM, 1996, P SOC EXP BIOL MED, V212, P332; D'Hooghe TM, 1997, ARCH GYNECOL OBSTET, V261, P15, DOI 10.1007/s004040050191; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; DONNA A, 1967, Cancro, V20, P400; DUNSELMAN GAJ, 1991, FERTIL STERIL, V56, P340; Fu L, 2008, FERTIL STERIL, V89, P1344, DOI 10.1016/j.fertnstert.2007.03.042; Garrido N, 2000, HUM REPROD UPDATE, V6, P67, DOI 10.1093/humupd/6.1.67; GINI PC, 1981, BRIT J OBSTET GYNAEC, V88, P456, DOI 10.1111/j.1471-0528.1981.tb01014.x; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Ho HN, 1997, HUM REPROD, V12, P2528, DOI 10.1093/humrep/12.11.2528; Katorza E, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.030; Katsuki Y, 1998, EUR J ENDOCRINOL, V138, P216, DOI 10.1530/eje.0.1380216; KISTNER RW, 1958, AM J OBSTET GYNECOL, V75, P264, DOI 10.1016/0002-9378(58)90384-3; Kwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156; Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002; MAHMOOD TA, 1991, HUM REPROD, V6, P544, DOI 10.1093/oxfordjournals.humrep.a137377; McArthur J W, 1965, Obstet Gynecol Surv, V20, P709, DOI 10.1097/00006254-196510000-00001; Minami T, 2013, EUR J OBSTET GYN R B, V166, P76, DOI 10.1016/j.ejogrb.2012.08.023; Nishikawa A, 2013, EUR J OBSTET GYN R B, V170, P20, DOI 10.1016/j.ejogrb.2013.04.018; Okada H, 2001, MOL HUM REPROD, V7, P341, DOI 10.1093/molehr/7.4.341; Olivares CN, 2013, REPRODUCTION, V145, P119, DOI 10.1530/REP-12-0386; Oral E, 1996, FERTIL STERIL, V66, P787, DOI 10.1016/S0015-0282(16)58637-3; Pisanu A, 2010, WORLD J GASTROENTERO, V16, P648, DOI 10.3748/wjg.v16.i5.648; Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516; Podgaec S, 2010, REV ASSOC MED BRAS, V56, P92, DOI 10.1590/S0104-42302010000100022; Porpora MG, 2010, FERTIL STERIL, V93, P716, DOI 10.1016/j.fertnstert.2008.10.018; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Preciado Ruiz Raymundo, 2005, Ginecol Obstet Mex, V73, P471; Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532; RAJKUMAR K, 1990, FERTIL STERIL, V53, P921; Ricci AG, 2013, HUM REPROD, V28, P178, DOI 10.1093/humrep/des369; Rozen P, 2003, ENDOSCOPY, V35, P975; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; SCHENKEN RS, 1980, FERTIL STERIL, V34, P581; SCHENKEN RS, 1987, AM J OBSTET GYNECOL, V157, P1392, DOI 10.1016/S0002-9378(87)80230-2; Schweitzer KJ, 2006, INT J GYNECOL OBSTET, V93, P152, DOI 10.1016/j.ijgo.2006.01.022; Soares SR, 2012, FERTIL STERIL, V98, P529, DOI 10.1016/j.fertnstert.2012.07.1120; Stilley JAW, 2012, CELL TISSUE RES, V349, P849, DOI 10.1007/s00441-011-1309-0; Stilley JAW, 2009, BIOL REPROD, V80, P649, DOI 10.1095/biolreprod.108.073411; SURREY ES, 1992, FERTIL STERIL, V58, P273; Ueda Y, 2010, FERTIL STERIL, V94, P78, DOI 10.1016/j.fertnstert.2009.02.092; Vercellini P, 2009, DRUGS, V69, P649, DOI 10.2165/00003495-200969060-00002; VERNON MW, 1985, FERTIL STERIL, V44, P684; Yuan P, 2012, HUM REPROD, V27, P2089, DOI 10.1093/humrep/des142	54	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124900	10.1371/journal.pone.0124900	http://dx.doi.org/10.1371/journal.pone.0124900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915402	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100078
J	Saenz-de-Juano, MD; Vicente, JS; Hollung, K; Marco-Jimenez, F				Desemparats Saenz-de-Juano, Maria; Salvador Vicente, Jose; Hollung, Kristin; Marco-Jimenez, Francisco			Effect of Embryo Vitrification on Rabbit Foetal Placenta Proteome during Pregnancy	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; NEONATAL OUTCOMES; MOUSE EMBRYOS; LONG-TERM; CRYOPRESERVATION; EXPRESSION; GROWTH; CANCER; MICE	Very limited information on the post-implantatory effects of vitrification has been published till now. We observed in a previous study that the vitrification procedure for the cryopreservation of embryos introduced transcriptomic and proteomic modifications in the rabbit foetal placenta at the middle of gestation. Now, we have conducted a proteomic study to determine whether protein alterations in the foetal placenta induced by the vitrification procedure remain during pregnancy. In this study, we used 2D-DIGE and mass spectrometry (MALDI-TOF-TOF and LC-MS/MS analysis) to identify the protein changes during middle and late stages of gestation (Day 14 and Day 24, respectively) in rabbit foetal placenta. We identified 11 differentially expressed proteins at Day 14 and 13 proteins at Day 24. Data are available via ProteomeXchange with identifiers PXD001840 and PXD001836. In addition, we demonstrate the presence of three proteins, serum albumin, isocitrate dehydrogenase 1 [ NADP+], and phosphoglycerate mutase 1, which were altered during pregnancy. We demonstrate the existence of changes in foetal placental protein during pregnancy induced by the vitrification procedure, which brings into question whether vitrification effects observed during foetal development could lead to physiological and metabolic disorders in adulthood. This effect, taken together with other effects reported in the literature, suggests that embryo cryopreservation is not neutral.	[Desemparats Saenz-de-Juano, Maria; Salvador Vicente, Jose; Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain; [Hollung, Kristin] Nofima AS, As, Norway	Universitat Politecnica de Valencia; Nofima	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46022 Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012; Vicente, Jose/F-7738-2017	Jiménez, Francisco Marco/0000-0002-5226-4118; Vicente, Jose/0000-0003-0481-3802; Saenz-de-Juano, Mara D./0000-0002-2860-2252	Generalitat Valenciana research program [Prometeo 2014/036]; Spanish Research Projects [CICYT AGL2011-29831-C03-01]; Generalitat Valenciana (Programa VALI+d) [ACIF/2011/254]; Nofima AS	Generalitat Valenciana research program; Spanish Research Projects(Spanish Government); Generalitat Valenciana (Programa VALI+d)(Center for Forestry Research & Experimentation (CIEF)); Nofima AS(Nofima)	This work was supported by the Generalitat Valenciana research program (Prometeo 2014/036) and the Spanish Research Projects (CICYT AGL2011-29831-C03-01). M. D. Saenz-de-Juano was supported by a research grant from Generalitat Valenciana (Programa VALI+d, ACIF/2011/254). Nofima AS provided support in the form of salaries for author KH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Auroux M, 2004, REPROD TOXICOL, V18, P813, DOI 10.1016/j.reprotox.2004.04.010; BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; Boison D, 2013, PHARMACOL REV, V65, P906, DOI 10.1124/pr.112.006361; Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; Calle A, 2012, THERIOGENOLOGY, V77, P785, DOI 10.1016/j.theriogenology.2011.07.016; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Desai NN, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-41; Gharesi-Fard B, 2010, PLACENTA, V31, P121, DOI 10.1016/j.placenta.2009.11.004; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Jensen ON, 1998, PROTEINS, P74; Jia X, 2009, J ANIM SCI, V87, P2391, DOI 10.2527/jas.2009-1792; Landers KA, 2013, PLACENTA, V34, P513, DOI 10.1016/j.placenta.2013.04.013; Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029; Lavara R, 2014, THERIOGENOLOGY, V81, P988, DOI 10.1016/j.theriogenology.2014.01.030; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Liu SY, 2013, HUM REPROD, V28, P2093, DOI 10.1093/humrep/det104; Marco-Jimenez F, 2013, THERIOGENOLOGY, V79, P1124, DOI 10.1016/j.theriogenology.2013.02.008; McMillen IC, 2004, P NUTR SOC, V63, P405, DOI 10.1079/PNS2004370; Moce ML, 2010, THERIOGENOLOGY, V73, P704, DOI 10.1016/j.theriogenology.2009.11.010; Mushahary D, 2013, PLACENTA, V34, P193, DOI 10.1016/j.placenta.2012.11.015; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Saenz-de-Juano MD, 2014, REPRODUCTION, V147, P789, DOI 10.1530/REP-14-0019; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shi WH, 2012, FERTIL STERIL, V97, P1338, DOI 10.1016/j.fertnstert.2012.02.051; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Vicente JS, 2013, CRYOBIOLOGY, V67, P321, DOI 10.1016/j.cryobiol.2013.09.165; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang ZY, 2010, FERTIL STERIL, V93, P2729, DOI 10.1016/j.fertnstert.2010.03.025; Wikland M, 2010, HUM REPROD, V25, P1699, DOI 10.1093/humrep/deq117; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhao XM, 2012, MOL REPROD DEV, V79, P445, DOI 10.1002/mrd.22052	32	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125157	10.1371/journal.pone.0125157	http://dx.doi.org/10.1371/journal.pone.0125157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915775	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000353659100102
J	Fauchier, L; Greenlaw, N; Ferrari, R; Ford, I; Fox, KM; Tardif, JC; Tendera, M; Steg, PG				Fauchier, Laurent; Greenlaw, Nicola; Ferrari, Roberto; Ford, Ian; Fox, Kim M.; Tardif, Jean-Claude; Tendera, Michal; Steg, Ph. Gabriel		CLARIFY Investigators	Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry	PLOS ONE			English	Article							ADHERENT ANTITHROMBOTIC TREATMENT; EURO HEART SURVEY; STENT IMPLANTATION; ORAL ANTICOAGULATION; CONSENSUS DOCUMENT; WORKING GROUP; TASK-FORCE; HIGH-RISK; THERAPY; CLOPIDOGREL	Background Few data are available regarding the use of antithrombotic strategies in coronary artery disease patients with atrial fibrillation (AF) in everyday practice. We sought to describe the prevalence of AF and its antithrombotic management in a contemporary population of patients with stable coronary artery disease. Methods and Findings CLARIFY is an international, prospective, longitudinal registry of outpatients with stable coronary artery disease, defined as prior (>= 12 months) myocardial infarction, revascularization procedure, coronary stenosis >50%, or chest pain associated with evidence of myocardial ischemia. Overall, 33,428 patients were screened, of whom 32,954 had data available for analysis at baseline; of these 2,229 (6.7%) had a history of AF. Median (interquartile range) CHA2DS2-VASc score was 4 (3, 5). Oral anticoagulation alone was used in 25.7%, antiplatelet therapy alone in 52.8% (single 41.8%, dual 11.0%), and both in 21.5%. OAC use was independently associated with permanent AF (p<0.001), CHA2DS2-VASc score (p=0.006), pacemaker (p<0.001), stroke (p=0.04), absence of angina (p=0.004), decreased left ventricular ejection fraction (p<0.001), increased waist circumference (p=0.005), and longer history of coronary artery disease (p=0.008). History of percutaneous coronary intervention (p=0.004) and no/partial reimbursement for cardiovascular medication (p=0.01, p<0.001, respectively) were associated with reduced oral anticoagulant use. Conclusions In this contemporary cohort of patients with stable coronary artery disease and AF, most of whom are theoretical candidates for anticoagulation, oral anticoagulants were used in only 47.2%. Half of the patients received antiplatelet therapy alone and one-fifth received both antiplatelets and oral anticoagulants. Efforts are needed to improve adherence to guidelines in these patients.	[Fauchier, Laurent] CHU Trousseau, Serv Cardiol, Tours, France; [Fauchier, Laurent] Univ Tours, Tours, France; [Greenlaw, Nicola; Ford, Ian] Univ Glasgow, Robertson Ctr, Glasgow, Lanark, Scotland; [Ferrari, Roberto] Univ Hosp Ferrara, Dept Cardiol, Cotignola, Italy; [Ferrari, Roberto] ES Hlth Sci Fdn, Maria Cecilia Hosp, GVM Care&Res, Cotignola, Italy; [Fox, Kim M.; Steg, Ph. Gabriel] Royal Brompton Hosp, NHLI Imperial Coll, ICMS, London SW3 6LY, England; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Tendera, Michal] Med Univ Silesia, Katowice, Poland; [Steg, Ph. Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, Ph. Gabriel] INSERM U1148, Paris, France; [Steg, Ph. Gabriel] Dept Hosp Univ FIRE, Hop Bichat, AP HP, F-75877 Paris, France	CHU Tours; Universite de Tours; University of Glasgow; University of Ferrara; Arcispedale Sant'Anna; Maria Cecilia Hospital; Imperial College London; Royal Brompton Hospital; Universite de Montreal; Medical University Silesia; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Fauchier, L (corresponding author), CHU Trousseau, Serv Cardiol, Tours, France.	lfau@med.univ-tours.fr	Hairullina, Adelya/AAF-6013-2019; Díaz, José Luis JLDD Díaz/Q-2523-2015; fauchier, laurent/HDN-2353-2022; Lago, Noelia Faginas/E-8015-2011; Nkombua, Lushiku/N-7043-2019; Marchionni, Niccolò/ABE-3977-2020; Nguyen, Thach N./N-1711-2019; Dženkevičiūtė, Vilma/AAB-6975-2021; Nastari, Luciano/C-8528-2012; Chioncel, Ovidiu/R-7556-2017; Ford, Ian/ABE-6145-2020; Idoate, Miguel-Ángel/D-8502-2019; Ushakov, Alexei V/P-4465-2015; Bogdański, Paweł/ABB-2938-2020; Sosner, Philippe/I-6119-2019; Pes, Giovanni Mario/AAH-3340-2019; CESAR, LUIZ ANTONIO MACHADO/N-7296-2014; Christodorescu, Ruxandra Maria/AAB-4653-2021; Tendera, Michal/AAA-1875-2022; Fauchier, Laurent/AAE-6366-2021; Georgescu, Catalina Arsenescu/R-5709-2017; Climent, Vicente/D-6129-2019; Gowdak, Luis Henrique Wolff/C-4844-2012; Prunier, Fabrice/A-5210-2011; BUAKHAMSRI, ADISAI/ABD-3971-2020; Бородина, Наталья/ABC-9347-2021; Popova, Ludmila viktorovna/ABC-5841-2021; Makarenkova, Kseniia/AAB-5482-2019; STEG, Philippe Gabriel/Z-1567-2019; Lukina, Yulia/J-9925-2017; Gowdak, Luis Henrique Wolff/M-7153-2017; FERRARI, ROBERTO/ABD-5169-2020; chioncel, ovidiu/K-8425-2019; Colquhoun, David M/F-9078-2013; Gruchala, Marcin/S-8407-2018; Smith, Albert Vernon/K-5150-2015; Ferrieres, Jean/S-7993-2016; MORENO-ARRIBAS, JOSE/G-4047-2011; Serazhim, Anna/G-6857-2016; Hernandez Afonso, Julio/I-2223-2017	Hairullina, Adelya/0000-0002-7832-2267; Lago, Noelia Faginas/0000-0002-4056-3364; Nkombua, Lushiku/0000-0002-8992-0465; Marchionni, Niccolò/0000-0002-8101-4695; Nguyen, Thach N./0000-0002-1252-8174; Dženkevičiūtė, Vilma/0000-0003-1471-9131; Nastari, Luciano/0000-0002-7959-3827; Chioncel, Ovidiu/0000-0002-3197-3628; Idoate, Miguel-Ángel/0000-0002-1596-1192; Ushakov, Alexei V/0000-0002-7020-4442; Bogdański, Paweł/0000-0002-0563-1624; Sosner, Philippe/0000-0002-5771-8174; Pes, Giovanni Mario/0000-0003-3265-2823; CESAR, LUIZ ANTONIO MACHADO/0000-0003-4436-1791; Christodorescu, Ruxandra Maria/0000-0001-8267-5404; Fauchier, Laurent/0000-0002-9267-1658; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Climent, Vicente/0000-0001-7362-1922; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; BUAKHAMSRI, ADISAI/0000-0002-1026-1349; Бородина, Наталья/0000-0003-3265-006X; Popova, Ludmila viktorovna/0000-0002-3496-6466; Lukina, Yulia/0000-0001-8252-3099; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Baleeva, Larisa/0000-0002-7974-5894; Gruchala, Marcin/0000-0003-4901-2291; Aylward, Philip/0000-0002-5358-8552; Ferrari, Roberto/0000-0003-2046-9175; Pedretti, Roberto/0000-0003-1789-8657; STEG, Philippe Gabriel/0000-0001-6896-2941; GALINIER, Michel/0000-0003-1735-3390; LOPEZ-CABANILLAS, NESTOR HUGO/0000-0001-5653-1255; Aksutina, Natal'a/0000-0002-4856-2729; Gomez Doblas, Juan Jose/0000-0002-9020-639X; Boonyapisit, Warangkna/0000-0002-5278-0091; Alexanderson-Rosas, Erick/0000-0002-2408-8727; TAVAZZI, LUIGI/0000-0003-4448-5209; Bravo Baptista, Sergio/0000-0002-4546-5261; Walker, David/0000-0002-3541-8955; jourdain, patrick/0000-0002-5202-6902; Facila, Lorenzo/0000-0003-1402-4364; Playford, David/0000-0003-4492-1103; Jerjes - Sanchez, Carlos/0000-0003-3222-7405; Steeds, Richard/0000-0001-5687-2535; Pella, Daniel/0000-0001-9999-6271; Phrommintikul, Arintaya/0000-0003-3986-1951; Gomez-Barrado, Jose Javier/0000-0002-4623-9952; Smith, Albert Vernon/0000-0003-1942-5845; Florescu, Cristina/0000-0001-8597-3407; Ferrieres, Jean/0000-0001-6144-1297; Lang, Irene/0000-0003-0485-2692; Reid, Christopher/0000-0001-9173-3944; Morais, Joao/0000-0003-3406-2878; Bryl, Wieslaw/0000-0003-0135-409X; Oganov, Rafael/0000-0003-0875-0773; Monteiro, Pedro/0000-0002-6631-207X; MORENO-ARRIBAS, JOSE/0000-0002-4070-6476; Wongcharoen, Wanwarang/0000-0002-2418-329X; HEDDLE, WILLIAM/0000-0001-8167-2826; Aboyans, Victor/0000-0002-0322-9818; Serazhim, Anna/0000-0002-0090-4785; Escobedo, Jorge/0000-0003-1942-7402; Yusufali, Afzalhussein/0000-0003-3378-2646; Hernandez Afonso, Julio/0000-0002-0982-1759; Streb, Witold/0000-0003-4856-8511; Shin, Jinho/0000-0001-6706-6504; Oganov, Rafael G./0000-0001-8087-4231; Antonicelli, Roberto/0000-0002-5921-1828; Khripun, Alexey/0000-0001-6765-2837; Tendera, Michal/0000-0002-0812-6113; Erglis, Andrejs/0000-0002-3999-0182; Arias-Mendoza, Alexandra/0000-0002-5942-4102	Servier, France; National Institute for Health Research [NF-SI-0611-10149] Funding Source: researchfish	Servier, France(Servier); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was designed and conducted by the investigators and funded via research grants from Servier, France, including a grant to the academic statistical centre. The sponsor provided assistance for study set-up and management in each country, and funded editorial assistance in the preparation of the manuscript, tables, and figures. The sponsor was sent the manuscript before submission. Data collection was performed via an electronic case record form; all data analysis was conducted by an independent academic data statistics center. The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript.	Aguilar E, 2012, THROMB RES, V130, P390, DOI 10.1016/j.thromres.2012.05.016; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; De Caterina R, 2012, J AM COLL CARDIOL, V59, P1413, DOI 10.1016/j.jacc.2012.02.008; De Caterina R, 2010, EUR HEART J, V31, P2133, DOI 10.1093/eurheartj/ehq250; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Faxon DP, 2011, THROMB HAEMOSTASIS, V106, P572, DOI 10.1160/TH11-04-0262; Gao F, 2010, CIRC J, V74, P701, DOI 10.1253/circj.CJ-09-0880; Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436; Goto S, 2008, AM HEART J, V156, P855, DOI 10.1016/j.ahj.2008.06.029; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970; Huber K, 2011, THROMB HAEMOSTASIS, V106, P569, DOI 10.1160/TH11-08-0602; January CT, 2014, J AM COLL CARDIOL; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip GYH, 2010, THROMB HAEMOSTASIS, V103, P13, DOI 10.1160/TH09-08-0580; Lip GYH, 1996, HEART, V75, P200, DOI 10.1136/hrt.75.2.200; Man-Son-Hing M, 2003, ARCH INTERN MED, V163, P1580, DOI 10.1001/archinte.163.13.1580; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Nieuwlaat R, 2007, AM HEART J, V153, P1006, DOI 10.1016/j.ahj.2007.03.008; Patrono C, 2013, CIRCULATION, V128, P684, DOI 10.1161/CIRCULATIONAHA.113.004564; Peterson GM, 2002, INTERN MED J, V32, P15, DOI 10.1046/j.1445-5994.2002.00156.x; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rubboli A, 2011, CHEST, V139, P981, DOI 10.1378/chest.10-2719; Ruiz-Nodar JM, 2008, J AM COLL CARDIOL, V51, P818, DOI 10.1016/j.jacc.2007.11.035; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Steg PG, 2012, EUR HEART J, V33, P2831, DOI 10.1093/eurheartj/ehs289; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Waldo AL, 2005, J AM COLL CARDIOL, V46, P1729, DOI 10.1016/j.jacc.2005.06.077; Zhao HJ, 2011, CHEST, V139, P260, DOI 10.1378/chest.09-3083	29	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125164	10.1371/journal.pone.0125164	http://dx.doi.org/10.1371/journal.pone.0125164			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915904	Green Published, Green Accepted, gold			2022-12-26	WOS:000353659100103
J	Lu, NN; Jin, J; Wang, SL; Wang, WH; Song, YW; Liu, YP; Ren, H; Fang, H; Liu, XF; Yu, ZH; Li, YX				Lu, Ning-Ning; Jin, Jing; Wang, Shu-Lian; Wang, Wei-Hu; Song, Yong-Wen; Liu, Yue-Ping; Ren, Hua; Fang, Hui; Liu, Xin-Fan; Yu, Zi-Hao; Li, Ye-Xiong			Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; TOTAL MESORECTAL EXCISION; FLUOROURACIL PLUS LEUCOVORIN; SURGICAL ADJUVANT BREAST; PREOPERATIVE RADIOTHERAPY; PHASE-III; INTRAVENOUS FLUOROURACIL; RADIATION-THERAPY; ORAL CAPECITABINE; FINAL REPORT	Background The aim of this study was to evaluate the survival outcomes and toxicity of postoperative chemoradiotherapy with capecitabine and concurrent intensity-modulated radiotherapy (IMRT) or three-dimensional conformal radiotherapy (3D-CRT) in patients with stage II and III rectal cancer. Patients We recruited 184 patients with pathologically proven, stage II or III rectal cancer. Following total mesorectal excision (TME), the patients were treated with capecitabine and concurrent IMRT/3D-CRT. The treatment regimen consisted of two cycles of oral capecitabine (1600 mg/m(2)/day), administered twice daily from day 1-14 of radiotherapy, followed by a 7-day rest. The median pelvic dose was 50 Gy in 25 fractions. Oxaliplatin-based adjuvant chemotherapy was administered after the chemoradiotherapy. Results The 5-year overall survival, disease-free survival and locoregional control (LRC) rates were 85.1%, 80% and 95.4%, respectively. Grade 3 and 4 toxicities were observed in 28.3% of patients during treatment. Grade 3 or 4 late toxicity, including neurotoxicity or gastrointestinal toxicity, was only observed in nine patients (4.9%). Conclusions This study demonstrated that capecitabine chemotherapy with concurrent IMRT/3D-CRT following TME is safe, is well tolerated and achieves superior LRC and favorable survival rates, with acceptable toxicity.	[Jin, Jing] CAMS, Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol, Beijing 100021, Peoples R China; PUMC, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, J (corresponding author), CAMS, Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol, Beijing 100021, Peoples R China.	jingjin1025@163.com; yexiong12@163.com	li, ye/GWN-2672-2022		Ministry of Health of the People's Republic of China [07090010, WKJ2005-3-006(21)]; National Natural Science Foundation of China [81402524]; Beijing Hope Run Special Fund [LC2007A17]	Ministry of Health of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hope Run Special Fund	This study was funded from the Ministry of Health of the People's Republic of China Grant [07090010, WKJ2005-3-006(21)], and Dr. YXL received the funding; National Natural Science Foundation of China [81402524] which was received by Dr. NNL; and Beijing Hope Run Special Fund [LC2007A17] which was received by Dr. JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, NEW ENGL J MED, V312, P1465; Arbea L, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-17; Cassidy J, 2002, ANN ONCOL, V13, P566, DOI 10.1093/annonc/mdf089; Cheng L, 2011, AM J CLIN ONCOL-CANC, V34, P573, DOI DOI 10.1097/C0C.0B013E3181FE41ED; Das P, 2006, INT J RADIAT ONCOL, V66, P1378, DOI 10.1016/j.ijrobp.2006.07.1374; [邓垒 DENG Lei], 2008, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V17, P450; Diaz-Rubio E, 2007, J CLIN ONCOL, V25, P4224, DOI 10.1200/JCO.2006.09.8467; Dunst J, 2002, J CLIN ONCOL, V20, P3983, DOI 10.1200/JCO.2002.02.049; Duthoy W, 2004, INT J RADIAT ONCOL, V60, P794, DOI 10.1016/j.ijrobp.2004.04.016; FISHER B, 1988, JNCI-J NATL CANCER I, V80, P21, DOI 10.1093/jnci/80.1.21; Havenga K, 1999, EUR J SURG ONCOL, V25, P368, DOI 10.1053/ejso.1999.0659; Hoff PM, 2001, J CLIN ONCOL, V19, P2282, DOI 10.1200/JCO.2001.19.8.2282; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Jin J, 2006, INT J RADIAT ONCOL, V64, P725, DOI 10.1016/j.ijrobp.2005.08.017; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kim DY, 2007, INT J RADIAT ONCOL, V67, P378, DOI 10.1016/j.ijrobp.2006.08.063; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; OCONNELL M, 1994, NEW ENGL J MED, V331, P502, DOI 10.1056/NEJM199408253310803; Pacelli F, 2004, DIS COLON RECTUM, V47, P170, DOI 10.1007/s10350-003-0028-3; Parekh Arti, 2013, Gastrointest Cancer Res, V6, P137; Park JH, 2011, CANCER-AM CANCER SOC, V117, P3703, DOI 10.1002/cncr.25943; Porschen R, 2007, J CLIN ONCOL, V25, P4217, DOI 10.1200/JCO.2006.09.2684; Qian LT, 2003, CHIN J RAD ONCOL, V11, P101; Ridgway Paul F, 2003, Cancer Control, V10, P205; Roels S, 2006, INT J RADIAT ONCOL, V65, P1129, DOI 10.1016/j.ijrobp.2006.02.050; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Samuelian JM, 2012, INT J RADIAT ONCOL, V82, P1981, DOI 10.1016/j.ijrobp.2011.01.051; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Souglakos J, 2003, INT J RADIAT ONCOL, V56, P1284, DOI 10.1016/S0360-3016(03)00275-X; Tepper JE, 2002, J CLIN ONCOL, V20, P1744, DOI 10.1200/JCO.2002.07.132; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Urbano MTG, 2006, INT J RADIAT ONCOL, V65, P907, DOI 10.1016/j.ijrobp.2005.12.056; Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097, DOI 10.1200/JCO.2001.19.21.4097; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wolmark N, 2000, JNCI-J NATL CANCER I, V92, P388, DOI 10.1093/jnci/92.5.388	37	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124601	10.1371/journal.pone.0124601	http://dx.doi.org/10.1371/journal.pone.0124601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915948	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100055
J	Roy, C				Roy, Christian			Quantifying Geographic Variation in the Climatic Drivers of Midcontinent Wetlands with a Spatially Varying Coefficient Model	PLOS ONE			English	Article							PRAIRIE POTHOLE REGION; NORTH-DAKOTA; GREAT-PLAINS; WATER; AREA; AUTOCORRELATION; DISTRIBUTIONS; CONVERSION	The wetlands in the Prairie Pothole Region and in the Great Plains are notorious for their sensitivity to weather variability. These wetlands have been the focus of considerable attention because of their ecological importance and because of the expected impact of climate change. Few models in the literature, however, take into account spatial variation in the importance of wetland drivers. This is surprising given the importance spatial heterogeneity in geomorphology and climatic conditions have in the region. In this paper, I use spatially-varying coefficients to assess the variation in ecological drivers in a number of ponds observed over a 50-year period (1961-2012). I included the number of ponds observed the year before on a log scale, the log of total precipitation, and mean maximum temperature during the four previous seasons as explanatory variables. I also included a temporal component to capture change in the number of ponds due to anthropogenic disturbance. Overall, fall and spring precipitation were most important in pond abundance in the west, whereas winter and summer precipitation were the most important drivers in the east. The ponds in the east of the survey area were also more dependent on pond abundance during the previous year than those in the west. Spring temperature during the previous season influenced pond abundance; while the temperature during the other seasons had a limited effect. The ponds in the southwestern part of the survey area have been increasing independently of climatic conditions, whereas the ponds in the northeast have been steadily declining. My results underline the importance of accounting the spatial heterogeneity in environmental drivers, when working at large spatial scales. In light of my results, I also argue that assessing the impacts of climate change on wetland abundance in the spring, without more accurate climatic forecasting, will be difficult.	[Roy, Christian] Univ Laval, Fac Foresterie Geog & Geomat, Quebec City, PQ, Canada; [Roy, Christian] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada	Laval University; Laval University	Roy, C (corresponding author), Univ Laval, Fac Foresterie Geog & Geomat, Pavillon Abitibi Price, Quebec City, PQ, Canada.	christian.roy.79@gmail.com	Roy, Christian/AAB-4016-2019	Roy, Christian/0000-0002-5599-6234	BMP-Innovation Scholarship - Ducks Unlimited Canada; Natural Sciences and Engineering Research Council of Canada; Le Fonds quebecois de la recherche sur la nature et les technologies	BMP-Innovation Scholarship - Ducks Unlimited Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Le Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	This work was supported by a BMP-Innovation Scholarship funded by by Ducks Unlimited Canada, the Natural Sciences and Engineering Research Council of Canada, Le Fonds quebecois de la recherche sur la nature et les technologies during this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Adams, 1988, ECOLOGICAL LAND CLAS, V24, P155; Assuncao RM, 2003, ENVIRONMETRICS, V14, P453, DOI 10.1002/env.599; Banerjee S., 2004, HIERARCHICAL MODELIN; Batt B.D.J., 1989, P204; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; BETHKE RW, 1993, OECOLOGIA, V93, P242, DOI 10.1007/BF00317677; Congdon P, 2006, COMPUT STAT DATA AN, V50, P422, DOI 10.1016/j.csda.2004.08.008; Congdon P., 2003, J GEOGRAPHICAL SYSTE, V5, P161, DOI DOI 10.1007/S10109-003-0099-7.AC-CESSED; Covich AP, 1997, HYDROL PROCESS, V11, P993; Dahl T.E., 2006, STATUS TRENDS WETLAN; Dahl TE, 2011, STATUS TRENDS WETLAN; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Fang X, 2008, HYDROL PROCESS, V22, P2858, DOI 10.1002/hyp.7074; Finley AO, 2011, METHODS ECOL EVOL, V2, P143, DOI 10.1111/j.2041-210X.2010.00060.x; Foody GM, 2003, REMOTE SENS ENVIRON, V88, P283, DOI 10.1016/j.rse.2003.08.004; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Garbrecht JD, 2002, J HYDROL ENG, V7, P64, DOI 10.1061/(ASCE)1084-0699(2002)7:1(64); Gelfand AE, 2003, J AM STAT ASSOC, V98, P387, DOI 10.1198/016214503000170; Gleason RA, 2011, ECOL APPL, V21, pS65, DOI 10.1890/09-0216.1; Herfindal I, 2012, LANDSCAPE ECOL, V27, P1435, DOI 10.1007/s10980-012-9798-0; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; HOWERTER DW, 2014, WILDLIFE MONOGR JUL, P1, DOI DOI 10.1002/WM0N.1012.ACCESSED; JOHNSON DH, 1988, WILDLIFE MONOGR, P1; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Johnson WC, 2004, WETLANDS, V24, P385, DOI 10.1672/0277-5212(2004)024[0385:IOWEOT]2.0.CO;2; Johnston CA, 2013, WETLANDS, V33, P175, DOI 10.1007/s13157-012-0365-x; Kery M., 2010, INTRO WINBUGS ECOLOG; LARSON DL, 1995, CLIMATIC CHANGE, V30, P169, DOI 10.1007/BF01091840; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; Miller JA, 2012, PROG PHYS GEOG, V36, P681, DOI 10.1177/0309133312442522; Millett B, 2009, CLIMATIC CHANGE, V93, P243, DOI 10.1007/s10584-008-9543-5; Murkin HR, 1997, ECOL APPL, V7, P1144; Niemuth ND, 2003, WATERBIRDS, V26, P233, DOI 10.1675/1524-4695(2003)026[0233:ROWTNO]2.0.CO;2; Niemuth ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100034; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; O'Sullivan D, 2003, GEOGR ANAL, V35, P272, DOI 10.1353/geo.2003.0008; Obe R., 2011, POSTGIS IN ACTION; PICKETT STA, 1995, SCIENCE, V269, P331, DOI 10.1126/science.269.5222.331; Prairie Habitat Joint Venture, 2008, PRAIR HAB JOINT VENT; R Core Team, 2021, R LANGUAGE ENV STAT; Rashford BS, 2011, CONSERV BIOL, V25, P276, DOI 10.1111/j.1523-1739.2010.01618.x; Schindler DW, 2006, P NATL ACAD SCI USA, V103, P7210, DOI 10.1073/pnas.0601568103; Smith G. W., 1995, CRITICAL REV AERIAL; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorenson LG, 1998, CLIMATIC CHANGE, V40, P343, DOI 10.1023/A:1005441608819; Stan Development Team, 2013, STAN A C LIB PROB SA; Steen V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096747; Stephens SE, 2008, CONSERV BIOL, V22, P1320, DOI 10.1111/j.1523-1739.2008.01022.x; Unwin A, 1998, J ROY STAT SOC D-STA, V47, P415, DOI 10.1111/1467-9884.00143; Watmough M., 2007, ENV CANADAS PRAIRIE; Wheeler DC, 2007, J GEOGR SYST, V9, P145, DOI 10.1007/s10109-006-0040-y; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winiarski KJ, 2013, MAR ECOL PROG SER, V492, P273, DOI 10.3354/meps10492; WINTER TC, 1995, WETLANDS, V15, P193, DOI 10.1007/BF03160700; Withey P, 2011, ECOL ECON, V70, P798, DOI 10.1016/j.ecolecon.2010.11.019	62	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126961	10.1371/journal.pone.0126961	http://dx.doi.org/10.1371/journal.pone.0126961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915770	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100158
J	Shi, HB; Guo, XY; Zhang, Q; Wu, HM; Du, HM; Liu, L; Wang, CJ; Xia, Y; Liu, X; Li, CL; Sun, SM; Wang, X; Zhou, M; Jia, QY; Zhao, HL; Song, K; Wei, DJ; Niu, KJ				Shi, Hongbin; Guo, Xiaoyan; Zhang, Qing; Wu, Hongmei; Du, Huanmin; Liu, Li; Wang, Chongjin; Xia, Yang; Liu, Xing; Li, Chunlei; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Wei, Dianjun; Niu, Kaijun			Serum Immunoglobulin M Concentration Varies with Triglyceride Levels in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; METABOLIC SYNDROME; IGM ANTIBODIES; RISK-FACTORS; FATTY-ACIDS; OBESITY; PREVALENCE; CHILDREN; IMPACT; LINKS	Persistent low-grade inflammation is thought to underlie the pathogenesis of many chronic diseases, such as cardiovascular diseases and metabolic syndrome. Autoimmunity is correlated with increased levels of chronic low-grade inflammation, and immunoglobulin M (IgM) is reactive to autoantigens and believed to be important for autoimmunity. Triglyceride (TG) is fatty acid carrier and initiator of oxidative stress, and it has been hypothesized that TG stimulates B cells to secrete IgM. However, few studies have investigated the relationship between TG and IgM in human populations. We designed a cross-sectional and prospective cohort study to evaluate how serum TG levels are related to IgM concentration. Participants were recruited from Tianjin Medical University General Hospital-Health Management Centre. Both a baseline cross-sectional (n = 10,808) and a prospective assessment (n = 2,615) were performed. Analysis of covariance was used in the cross-sectional analysis. After multiple adjustments for confounding factors, serum IgM level in the highest quartile of TG in males was significantly higher than levels in lower quartiles (P < 0.05). There was no significant difference between the four quartiles in females (P = 0.91). In follow-up analysis, a multiple linear regression model showed a significant and positive correlation between changes in IgM levels and changes of TG concentration in males (P = 0.04, standard beta coefficient = 0.882). This cross-sectional and cohort study is the first to show that serum concentration of IgM varies with TG levels in adult male populations. Further research is needed to explore the mechanism by which TG leads to increased IgM concentration.	[Shi, Hongbin; Wei, Dianjun] Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China; [Shi, Hongbin; Zhang, Qing; Liu, Li; Wang, Chongjin; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Niu, Kaijun] Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China; [Guo, Xiaoyan; Wu, Hongmei; Du, Huanmin; Xia, Yang; Liu, Xing; Li, Chunlei; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Guo, Xiaoyan; Wu, Hongmei; Du, Huanmin; Xia, Yang; Liu, Xing; Li, Chunlei; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wei, DJ (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China.	nkj0809@gmail.com; nkj0809@163.com	Xia, Yang/AAW-9116-2021	Xia, Yang/0000-0001-8783-1592; Niu, Kaijun/0000-0002-8772-2481	key technologies R&D program of Tianjin [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; Technologies development program of Beichen District of Tianjin [bcws2013-21, bc2014-05]; technologies project of Tianjin Binhai New Area [2013-02-04, 2013-02-06]; Science Foundation of Tianjin Medical University [2010KY28]; technology fund of Tianjin Health Bureau, China [2013KZ099]	key technologies R&D program of Tianjin; Technologies development program of Beichen District of Tianjin; technologies project of Tianjin Binhai New Area; Science Foundation of Tianjin Medical University; technology fund of Tianjin Health Bureau, China	This study was supported by grants from the key technologies R&D program of Tianjin (Key Project: No. 11ZCGYSY05700, 12ZCZDSY20400, and 13ZCZDSY20200), the Technologies development program of Beichen District of Tianjin (No. bcws2013-21 and bc2014-05), the technologies project of Tianjin Binhai New Area (No. 2013-02-04 and 2013-02-06), the Science Foundation of Tianjin Medical University (No. 2010KY28) and the technology fund of Tianjin Health Bureau (No. 2013KZ099), China.	Agarwal C, 2013, INT J PEDIAT ENDOCRI, V2013, P18, DOI [10.1186/1687-9856-2013-18, DOI 10.1186/1687-9856-2013-18]; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brogan K, 2014, CHILD OBES, V10, P207, DOI 10.1089/chi.2013.0146; Alves MIB, 2010, J PHYSIOL BIOCHEM, V66, P221, DOI 10.1007/s13105-010-0028-4; Buscemi S, 2014, EAT WEIGHT DISORD-ST, V19, P225, DOI 10.1007/s40519-014-0117-4; Ciccone MM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-22; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Doria A, 2005, RHEUM DIS CLIN N AM, V31, P355, DOI 10.1016/j.rdc.2005.01.006; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Fernandez-Nebro A, 2014, LUPUS; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Marzullo P, 2014, ENDOCRINE, V45, P392, DOI 10.1007/s12020-013-0006-z; Montgomery IA, 2010, DIABETES OBES METAB, V12, P744, DOI 10.1111/j.1463-1326.2010.01228.x; MORROW JD, 1994, J BIOL CHEM, V269, P4317; dos Santos FDM, 2013, RHEUMATOL INT, V33, P681, DOI 10.1007/s00296-012-2402-8; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Odaka Y, 2010, OBESITY, V18, P1688, DOI 10.1038/oby.2009.513; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Quan W, 2013, DIABETES OBES METAB, V15, P141, DOI 10.1111/dom.12153; Rashidi H, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-53; Rosenbloom AL, 2003, DIABETES CARE, V26, P2954, DOI 10.2337/diacare.26.10.2954; Sakcak I, 2010, OBES SURG, V20, P610, DOI 10.1007/s11695-009-0061-y; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Song K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088701; Sun J, 2014, INT J ENV RES PUB HE, V11, P3956, DOI 10.3390/ijerph110403956; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Vollmers HP, 2006, ADV DRUG DELIVER REV, V58, P755, DOI 10.1016/j.addr.2005.08.007; Winer DA, 2013, CELL MOL LIFE SCI; Yang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047990; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	38	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124255	10.1371/journal.pone.0124255	http://dx.doi.org/10.1371/journal.pone.0124255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915947	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100041
J	Staege, MS				Staege, Martin S.			A Multi-Component Model of Hodgkin's Lymphoma	PLOS ONE			English	Article							REGULATORY T-CELLS; EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; DISEASE; ENHANCEMENT; EXPRESSION; THERAPY; IMPACT; LINES	Hodgkin's lymphoma is an example for a tumor with an extremely tight interaction of tumor cells with cells from the tumor micro-environment. These so-called bystander cells are not inert but interact actively with the tumor cells. Some of these cells support tumor growth by delivery of co-stimulating and anti-apoptotic signals ("helper cells"). Other cells ("killer cells") are involved in the anti-tumor immune response which is obviously not efficient enough for tumor elimination. The activity of both helper cells and killer cells is regulated by additional cells in the stroma ("regulatory cells"). The dynamic behavior of such multicomponent systems is difficult to predict. In the present paper we propose a model that can be used for simulation of essential features of this system. In this model, tumor growth depends on (i) presence of few cancer stem cells, (ii) co-stimulation of cancer cells by the tumor stroma, (iii) activity of regulatory cells that suppress killer cells without suppression of helper cells. The success of cytotoxic/cytostatic therapy in this model varies depending on the therapy-related toxicity for each of the cell populations. The model also allows the analysis of immunotherapeutic interventions. Under certain conditions, paradox enhancement of tumor growth can occur after therapeutic intervention. The model might be useful for the design of new treatment strategies for Hodgkin's lymphoma and other tumors with prominent tumor-stroma interaction.	Univ Halle Wittenberg, Dept Pediat, Halle, S, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Univ Halle Wittenberg, Dept Pediat, Halle, S, Germany.	martin.staege@medizin.uni-halle.de	Staege, Martin/AAX-8994-2021	Staege, Martin/0000-0003-3765-7068				Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Asano N, 2006, J CLIN ONCOL, V24, P4626, DOI 10.1200/JCO.2006.06.5342; Assis MCG, 2012, MED ONCOL, V29, P3614, DOI 10.1007/s12032-012-0299-4; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bollard CM, J EXP MED, V204, P1623; Chiarella P, 2008, CLIN MED INSIGHTS-ON, V2, P237; Cruse JM, 2002, EXP MOL PATHOL, V73, P112, DOI 10.1006/exmp.2002.2458; DREXLER HG, 1993, LEUKEMIA LYMPHOMA, V9, P1, DOI 10.3109/10428199309148499; Ikeda JI, 2010, AM J PATHOL, V177, P3081, DOI 10.2353/ajpath.2010.100089; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Karan D, 2007, INT J CANCER, V121, P1520, DOI 10.1002/ijc.22873; Kelley TW, 2007, AM J CLIN PATHOL, V128, P958, DOI 10.1309/NB3947K383DJ0LQ2; Koreishi AF, 2010, APPL IMMUNOHISTO M M, V18, P206, DOI 10.1097/PAI.0b013e3181c7138b; Lucas KG, 2004, CANCER, V100, P1892, DOI 10.1002/cncr.20188; Moreno-Ramirez D, 2014, CANCER IMMUNOL IMMUN, V63, P1229, DOI 10.1007/s00262-014-1583-2; Nakashima M, 2010, CANCER SCI, V101, P2490, DOI 10.1111/j.1349-7006.2010.01693.x; PREHN RT, 1994, CANCER RES, V54, P908; Schellong G, 2004, KLIN PADIATR, V216, P364, DOI 10.1055/s-2004-832340; Schreck S, 2009, HEMATOL ONCOL, V27, P31, DOI 10.1002/hon.878; Smolewski P, 2000, INT J ONCOL, V17, P603; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401	21	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124614	10.1371/journal.pone.0124614	http://dx.doi.org/10.1371/journal.pone.0124614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915037	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100056
J	Zhang, HJ; Kawase-Koga, Y; Sun, T				Zhang, Haijun; Kawase-Koga, Yoko; Sun, Tao			Protein Expression Profiles Characterize Distinct Features of Mouse Cerebral Cortices at Different Developmental Stages	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; PROGENITOR CELLS; BRAIN; NEURONS; MUTATIONS; GENES; KINASE; PHOSPHORYLATION; PROLIFERATION; BEHAVIOR	The proper development of the mammalian cerebral cortex requires precise protein synthesis and accurate regulation of protein expression levels. To reveal signatures of protein expression in developing mouse cortices, we here generate proteomic profiles of cortices at embryonic and postnatal stages using tandem mass spectrometry (MS/MS). We found that protein expression profiles are mostly consistent with biological features of the developing cortex. Gene Ontology (GO) and KEGG pathway analyses demonstrate conserved molecules that maintain cortical development such as proteins involved in metabolism. GO and KEGG pathway analyses further identify differentially expressed proteins that function at specific stages, for example proteins regulating the cell cycle in the embryonic cortex, and proteins controlling axon guidance in the postnatal cortex, suggesting that distinct protein expression profiles determine biological events in the developing cortex. Furthermore, the STRING network analysis has revealed that many proteins control a single biological event, such as the cell cycle regulation, through cohesive interactions, indicating a complex network regulation in the cortex. Our study has identified protein networks that control the cortical development and has provided a protein reference for further investigation of protein interactions in the cortex.	[Zhang, Haijun; Kawase-Koga, Yoko; Sun, Tao] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; [Zhang, Haijun] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10021 USA; [Kawase-Koga, Yoko] Tokyo Univ Hosp, Dept Oral & Maxillofacial Surg, Tokyo 113, Japan	Cornell University; Cornell University; University of Tokyo	Sun, T (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA.	haz2004@med.cornell.edu; tas2009@med.cornell.edu			Hirschl/Weill-Caulier Trust; NIH/NIMH [2R01MH083680-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083680] Funding Source: NIH RePORTER	Hirschl/Weill-Caulier Trust; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an award from the Hirschl/Weill-Caulier Trust (TS) and a 2R01MH083680-06 grant from the NIH/NIMH (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Carrette O, 2006, PROTEOMICS, V6, P4940, DOI 10.1002/pmic.200600084; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cushion TD, 2014, AM J HUM GENET, V94, P634, DOI 10.1016/j.ajhg.2014.03.009; Dai XQ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-107; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Dubravka D, 2000, CELL RES, V10, P1, DOI 10.1038/sj.cr.7290031; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishihara K, 2014, NEUROSCIENCE, V281, P1, DOI 10.1016/j.neuroscience.2014.09.039; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Lee AS, 2012, MOL PSYCHIATR, V17, P1054, DOI [10.1038/mp.2012.149, 10.1038/mp.2012.71]; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Liu C, 2011, PLACENTA, V32, P168, DOI 10.1016/j.placenta.2010.11.007; Lonic A, 2008, MOL CELL BIOL, V28, P3372, DOI 10.1128/MCB.01837-07; Manavalan A, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.76; Middleton FA, 2005, NEUROPSYCHOPHARMACOL, V30, P974, DOI 10.1038/sj.npp.1300674; Mignon-Ravix C, 2010, J MED GENET, V47, P132, DOI 10.1136/jmg.2009.069112; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; MORIMURA R, 2013, J PEDIATR ONCOL NURS, V30, P911, DOI DOI 10.1002/DNEU.22117; Nakajima J, 2014, CLIN GENET; Ngo L, 2014, HUM MOL GENET, V23, P5147, DOI 10.1093/hmg/ddu238; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ozeki Y, 2011, NEUROSCI RES, V69, P154, DOI 10.1016/j.neures.2010.10.003; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; Radhakrishnan VM, 2012, J BIOL CHEM, V287, P43300, DOI 10.1074/jbc.M112.397877; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Romaniello R, 2012, DEV MED CHILD NEUROL, V54, P765, DOI 10.1111/j.1469-8749.2012.04316.x; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Taraslia VK, 2013, CANCER GENOM PROTEOM, V10, P125; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wong AHC, 2003, MOL PSYCHIATR, V8, P156, DOI 10.1038/sj.mp.4001237; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yang YT, 2012, NAT NEUROSCI	54	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125608	10.1371/journal.pone.0125608	http://dx.doi.org/10.1371/journal.pone.0125608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915664	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100136
J	Li, XM; Li, J; Wu, YK				Li, Xinmiao; Li, Jing; Wu, Yukeng			A Global Optimization Approach to Multi-Polarity Sentiment Analysis	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; FEATURE-SELECTION; CLASSIFICATION; REDUCTION	Following the rapid development of social media, sentiment analysis has become an important social media mining technique. The performance of automatic sentiment analysis primarily depends on feature selection and sentiment classification. While information gain (IG) and support vector machines (SVM) are two important techniques, few studies have optimized both approaches in sentiment analysis. The effectiveness of applying a global optimization approach to sentiment analysis remains unclear. We propose a global optimization-based sentiment analysis (PSOGO-Senti) approach to improve sentiment analysis with IG for feature selection and SVM as the learning engine. The PSOGO-Senti approach utilizes a particle swarm optimization algorithm to obtain a global optimal combination of feature dimensions and parameters in the SVM. We evaluate the PSOGO-Senti model on two datasets from different fields. The experimental results showed that the PSOGO-Senti model can improve binary and multi-polarity Chinese sentiment analysis. We compared the optimal feature subset selected by PSOGO-Senti with the features in the sentiment dictionary. The results of this comparison indicated that PSOGO-Senti can effectively remove redundant and noisy features and can select a domain-specific feature subset with a higherexplanatory power for a particular sentiment analysis task. The experimental results showed that the PSOGO-Senti approach is effective and robust for sentiment analysis tasks in different domains. By comparing the improvements of two-polarity, three-polarity and five-polarity sentiment analysis results, we found that the five-polarity sentiment analysis delivered the largest improvement. The improvement of the two-polarity sentiment analysis was the smallest. We conclude that the PSOGO-Senti achieves higher improvement for a more complicated sentiment analysis task. We also compared the results of PSOGO-Senti with those of the genetic algorithm (GA) and grid search method. From the results of this comparison, we found that PSOGO-Senti is more suitable for improving a difficult multipolarity sentiment analysis problem.	[Li, Xinmiao; Li, Jing; Wu, Yukeng] Shanghai Univ Finance & Econ, Sch Informat Management & Engn, Shanghai, Peoples R China	Shanghai University of Finance & Economics	Li, XM (corresponding author), Shanghai Univ Finance & Econ, Sch Informat Management & Engn, Shanghai, Peoples R China.	xinmiaoli@shufe.edu.cn			National Natural Science Foundation of China [71001059]; Shanghai Municipal Natural Science Foundation of China [14ZR1413400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation of China	This work was supported by the National Natural Science Foundation of China (NO. 71001059). The URL is http://www.nsfc.gov.cn/. It was also supported by the Shanghai Municipal Natural Science Foundation of China (NO. 14ZR1413400). The URL is http://www.stcsm.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2010, MIS QUART, V34, P435; Abbasi A, 2008, ACM T INFORM SYST, V26, DOI [10.1145/1344411.1344413, 10.1145/1361684.1361685]; Agarwal Basant, 2013, Computational Linguistics and Intelligent Text Processing. 14th International Conference, CICLing 2013. Proceedings, P13, DOI 10.1007/978-3-642-37256-8_2; Akay MF, 2009, EXPERT SYST APPL, V36, P3240, DOI 10.1016/j.eswa.2008.01.009; Basari AH, 2013, PROCEDIA ENGINEER, V53, P453, DOI 10.1016/j.proeng.2013.02.059; Chen CC, 2011, DECIS SUPPORT SYST, V50, P755, DOI 10.1016/j.dss.2010.08.023; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coussement K, 2008, EXPERT SYST APPL, V34, P313, DOI 10.1016/j.eswa.2006.09.038; Desmet B, 2013, EXPERT SYST APPL, V40, P6351, DOI 10.1016/j.eswa.2013.05.050; Dyrba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064925; Frohlich H, 2003, PROC INT C TOOLS ART, P142, DOI 10.1109/TAI.2003.1250182; Gamon M., 2004, P 20 INT C COMP LING, P841, DOI [10.3115/1220355.1220476, DOI 10.3115/1220355.1220476]; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He Y, 2010, INFORM PROCESSING MA, V47, P606; Heisele B, 2003, PATTERN RECOGN, V36, P2007, DOI 10.1016/S0031-3203(03)00062-1; Huang CL, 2007, EXPERT SYST APPL, V33, P847, DOI 10.1016/j.eswa.2006.07.007; Huang CF, 2012, APPL SOFT COMPUT, V12, P807, DOI 10.1016/j.asoc.2011.10.009; Kim H, 2005, J MACH LEARN RES, V6, P37; Lane PCR, 2012, DECIS SUPPORT SYST, V53, P712, DOI 10.1016/j.dss.2012.05.028; Li JX, 2006, COMMUN ACM, V49, P76, DOI 10.1145/1121949.1121951; Li N, 2010, DECIS SUPPORT SYST, V48, P354, DOI 10.1016/j.dss.2009.09.003; Lin SW, 2009, EXPERT SYST APPL, V36, P11543, DOI 10.1016/j.eswa.2009.03.029; Liu B, 2010, IEEE INTELL SYST, V25, P76; Lu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056221; Manevitz LM, 2002, J MACH LEARN RES, V2, P139, DOI 10.1162/15324430260185574; Manimala K, 2011, APPL SOFT COMPUT, V11, P5485, DOI 10.1016/j.asoc.2011.05.010; Moraes R, 2013, EXPERT SYST APPL, V40, P621, DOI 10.1016/j.eswa.2012.07.059; O'Leary DE, 2011, DECIS SUPPORT SYST, V51, P821, DOI 10.1016/j.dss.2011.01.016; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Park Y, 2011, EXPERT SYST APPL, V38, P10638, DOI 10.1016/j.eswa.2011.02.125; Tan SB, 2011, EXPERT SYST APPL, V38, P12094, DOI 10.1016/j.eswa.2011.02.105; Uguz H, 2011, KNOWL-BASED SYST, V24, P1024, DOI 10.1016/j.knosys.2011.04.014; Waila P, 2012, IEEE INT C COMP INT; Wiebe J, 2004, COMPUT LINGUIST, V30, P277, DOI 10.1162/0891201041850885; Xia YQ, 2008, INT J COMPUTER PROCE, V21, P309; Yi J., 2003, P 2 INT C KNOWL CAPT, P70, DOI DOI 10.1145/945645.945658	37	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124672	10.1371/journal.pone.0124672	http://dx.doi.org/10.1371/journal.pone.0124672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909740	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800100
J	Fu, S; Liang, Y; Lin, YB; Wang, F; Huang, MY; Zhang, ZC; Wang, J; Cen, WJ; Shao, JY				Fu, Sha; Liang, Ying; Lin, Yong-Bin; Wang, Fang; Huang, Ma-Yan; Zhang, Zi-Chen; Wang, Jing; Cen, Wen-Jian; Shao, Jian-Yong			The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; EML4-ALK FUSION GENE; TARGETING ROS1; ALK; INHIBITOR; MUTATIONS; IDENTIFICATION; RESISTANCE; LANDSCAPE; SURVIVAL	To evaluate the frequency and clinicopathological features of ROS1 and RET rearrangements in N2 node positive stage IIIA (IIIA-N2) non-small cell lung cancer (NSCLC) patients, we retrospectively screened 204 cases with a tissue microarray (TMA) panel by fluorescent in situ hybridization (FISH), and confirmed by direct sequencing and immunohistochemistry (IHC). The relationship between ROS1 or RET rearrangements, clinicopathological features, and prognostic factors were analyzed in resected stage IIIA-N2 NSCLC. Of the 204 cases, 4 cases were confirmed with ROS1 rearrangement, but no RET rearrangement was detected. All 4 ROS1-rearranged cases were adenocarcinomas. The predominant pathological type was acinar pattern in ROS1-rearranged tumors, except for 1 case harboring a mixture acinar and mucous tumor cells. Variants of ROS1 rearrangement were SDC4ROS1 (E2:E32), SDC4-ROS1 (E4:E32) and SDC4-ROS1 (E4:E34). There was no significant association between ROS1 rearrangement and clinicopathological characteristics. In this cohort, multivariate analysis for overall survival (OS) indicated that squamous cell carcinoma and lobectomy were independent predictors of poor prognosis; R0 surgical resection and non-pleural invasion were independent predictors of good prognosis. In resected stage IIIA-N2 NSCLC patients, ROS1-rearranged cases tended to occur in younger patients with adenocarcinomas. The prognosis of resected stage IIIA-N2 is generally considered poor, but patients with ROS1 rearrangement will benefit from the targeted therapy.	[Fu, Sha; Wang, Fang; Zhang, Zi-Chen; Wang, Jing; Cen, Wen-Jian; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China; [Liang, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China; [Lin, Yong-Bin] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China; [Huang, Ma-Yan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Shao, JY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China,Collaborat Innova, Guangzhou 510060, Guangdong, Peoples R China.	shaojy@sysucc.org.cn	wang, fang/GYD-4295-2022		National High Technology Research and Development Program of China (863 Program) [2012AA02A502]; State Key Laboratory Grant at Sun Yat-sen University Cancer Center	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Laboratory Grant at Sun Yat-sen University Cancer Center	This work was supported in part by National High Technology Research and Development Program of China (863 Program) (2012AA02A502) for study design, data collection and analysis. A State Key Laboratory Grant at Sun Yat-sen University Cancer Center was used for study design hand data analysis. The funders had no role in the decision to publish or in the preparation of the manuscript.	Asai N, 2006, PATHOL INT, V56, P164, DOI 10.1111/j.1440-1827.2006.01942.x; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; Cai W, 2013, ANN ONCOL, V24, P1822, DOI 10.1093/annonc/mdt071; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Cha YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103333; Chin LP, 2012, J THORAC ONCOL, V7, P1625, DOI 10.1097/JTO.0b013e31826baf83; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Esfahani K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00174; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Gerber David E, 2014, Am Soc Clin Oncol Educ Book, pe353, DOI 10.14694/EdBook_AM.2014.34.e353; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Ichinose Y, 2001, LUNG CANCER-J IASLC, V34, P29, DOI 10.1016/S0169-5002(01)00207-0; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee HJ, 2013, ANN SURG ONCOL, V20, P200, DOI 10.1245/s10434-012-2553-6; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Ou SHI, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00058; Pan YJ, 2014, LUNG CANCER, V84, P121, DOI 10.1016/j.lungcan.2014.02.007; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shaw AT, 2012, J CLIN ONCOL, V23, P7508; Shen L, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stinchcombe TE, 2006, ONCOLOGIST, V11, P809, DOI 10.1634/theoncologist.11-7-809; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanaka F, 2000, EUR J CARDIO-THORAC, V18, P147, DOI 10.1016/S1010-7940(00)00490-5; Tuononen K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/757490; Veeramachaneni NK, 2012, ANN THORAC SURG, V94, P922, DOI 10.1016/j.athoracsur.2012.04.087; Wang XQ, 2013, BBA-PROTEINS PROTEOM, V1834, P2205, DOI 10.1016/j.bbapap.2012.10.008; Yoshida A, 2013, AM J SURG PATHOL, V37, P554, DOI 10.1097/PAS.0b013e3182758fe6; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064821; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	50	13	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124354	10.1371/journal.pone.0124354	http://dx.doi.org/10.1371/journal.pone.0124354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905642	gold, Green Submitted, Green Published			2022-12-26	WOS:000353332000068
J	Garner, MJ; Carson, C; Lingohr, EJ; Fazil, A; Edge, VL; Waddell, JT				Garner, Michael J.; Carson, Carolee; Lingohr, Erika J.; Fazil, Aamir; Edge, Victoria L.; Waddell, Jan Trumble			An Assessment of Antimicrobial Resistant Disease Threats in Canada	PLoS One			English	Article							SETTING PRIORITIES; CLOSTRIDIUM-DIFFICILE; DECISION-MAKING; RISK-FACTORS; INFECTION	Background Antimicrobial resistance (AMR) of infectious agents is a growing concern for public health organizations. Given the complexity of this issue and how widespread the problem has become, resources are often insufficient to address all concerns, thus prioritization of AMR pathogens is essential for the optimal allocation of risk management attention. Since the epidemiology of AMR pathogens differs between countries, country-specific assessments are important for the determination of national priorities. Objective To develop a systematic and transparent approach to AMR risk prioritization in Canada. Methods Relevant AMR pathogens in Canada were selected through a transparent multi-step consensus process (n=32). Each pathogen was assessed using ten criteria: incidence, mortality, case-fatality, communicability, treatability, clinical impact, public/political attention, ten-year projection of incidence, economic impact, and preventability. For each pathogen, each criterion was assigned a numerical score of 0, 1, or 2, and multiplied by criteria-specific weighting determined through researcher consensus of importance. The scores for each AMR pathogen were summed and ranked by total score, where a higher score indicated greater importance. A sensitivity analysis was conducted to determine the effects of changing the criteria-specific weights. Results The AMR pathogen with the highest total weighted score was extended spectrum B-lactamase-producing (ESBL) Enterobacteriaceae (score=77). When grouped by percentile, ESBL Enterobacteriaceae, Clostridium difficile, carbapenem-resistant Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus were in the 80-100(th) percentile. Conclusion This assessment provides useful information for prioritising public health strategies regarding AMR resistance at the national level in Canada. As the AMR environment and challenges change over time and space, this systematic and transparent approach can be adapted for use by other stakeholders domestically and internationally. Given the complexity of influences, resource availability and multiple stakeholders, regular consideration of AMR activities in the public health realm is essential for appropriate and responsible prioritisation of risk management that optimises the health and security of the population.	[Garner, Michael J.; Lingohr, Erika J.; Edge, Victoria L.; Waddell, Jan Trumble] Publ Hlth Agcy Canada, Populat Hlth Assessment & Scenarios Team, Ottawa, ON, Canada; [Carson, Carolee; Fazil, Aamir] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Garner, MJ (corresponding author), Publ Hlth Agcy Canada, Populat Hlth Assessment & Scenarios Team, Ottawa, ON, Canada.	michael.garner@phac-aspc.gc.ca		Edge, Victoria/0000-0002-2830-8395				Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Berra S, 2010, INT J TECHNOL ASSESS, V26, P217, DOI 10.1017/S0266462310000012; BRANS JP, 1985, MANAGE SCI, V31, P647, DOI 10.1287/mnsc.31.6.647; D-sight, 2010, D SIGHT DESKT VERS 4; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; Fazil A, 2008, J FOOD PROTECT, V71, P2323, DOI 10.4315/0362-028X-71.11.2323; Fleurence RL, 2004, HEALTH POLICY, V69, P1, DOI 10.1016/j.healthpol.2003.11.002; Garner MJ, 2014, 16 INT C INF DIS APR; Kleinkauf N., 2013, RISK ASSESSMENT IMPA; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Microsoft Corporation, 2022, MICR EXC COMP SOFTW; Ng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072172; Nuyens Y, 2007, B WORLD HEALTH ORGAN, V85, P319, DOI 10.2471/BLT.06.032375; Ruzante JM, 2010, RISK ANAL, V30, P724, DOI 10.1111/j.1539-6924.2009.01278.x; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; World Health Organization, 2014, ANT RES GLOB REP SUR; World Health Organization, 2003, WHO M BUCH ROM 21 23	18	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125155	10.1371/journal.pone.0125155	http://dx.doi.org/10.1371/journal.pone.0125155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905797	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000106
J	Stolz, E; Burkert, N; Grossschadl, F; Rasky, E; Stronegger, WJ; Freidl, W				Stolz, Erwin; Burkert, Nathalie; Grossschaedl, Franziska; Rasky, Eva; Stronegger, Willibald J.; Freidl, Wolfgang			Determinants of Public Attitudes towards Euthanasia in Adults and Physician-Assisted Death in Neonates in Austria: A National Survey	PLOS ONE			English	Article							EUROPEAN COUNTRIES; SUICIDE; ACCEPTANCE; TRENDS; END; AUTHORITARIANISM; INDIVIDUALISM; NETHERLANDS; CARE	Background Euthanasia remains a controversial topic in both public discourses and legislation. Although some determinants of acceptance of euthanasia and physician-assisted death have been identified in previous studies, there is still a shortage of information whether different forms of euthanasia are supported by the same or different sub-populations and whether authoritarian personality dispositions are linked to attitudes towards euthanasia. Methods A large, representative face-to-face survey was conducted in Austria in 2014 (n = 1,971). Respondents faced three scenarios of euthanasia and one of physician assisted death differing regarding the level of specificity, voluntariness and subject, requiring either approval or rejection: (1) abstract description of euthanasia, (2) abstract description of physician-assisted suicide, (3) the case of euthanasia of a terminally-ill 79-year old cancer patient, and (4) the case of non-voluntary, physician assisted death of a severely disabled or ill neonate. A number of potential determinants for rejection ordered in three categories (socio-demographic, personal experience, orientations) including authoritarianism were tested via multiple logistic regression analyses. Results Rejection was highest in the case of the neonate (69%) and lowest for the case of the older cancer patient (35%). A consistent negative impact of religiosity on the acceptance across all scenarios and differential effects for socio-economic status, area of residence, religious confession, liberalism, and authoritarianism were found. Individuals with a stronger authoritarian personality disposition were more likely to reject physician-assisted suicide for adults but at the same time also more likely to approve of physician-assisted death of a disabled neonate. Conclusion Euthanasia in adults was supported by a partially different sub-population than assisted death of disabled neonates.	[Stolz, Erwin; Burkert, Nathalie; Grossschaedl, Franziska; Rasky, Eva; Stronegger, Willibald J.; Freidl, Wolfgang] Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria	Medical University of Graz	Freidl, W (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria.	wolfgang.freidl@medunigraz.at	Stronegger, Willibald J./C-2425-2018	Stronegger, Willibald J./0000-0003-3496-1208; Stolz, Erwin/0000-0001-7393-1568; Grossschadl, Franziska/0000-0002-6726-0443				Adorno Theodor W., 1995, STUDIEN ZUM AUTORITA; Boehnke K, 2004, ENCY APPL PSYCHOL, V1, P251; Buiting HM, 2012, J MED ETHICS, V38, P267, DOI 10.1136/medethics-2011-100066; Burkhardt S, 2006, MED SCI LAW, V46, P287, DOI 10.1258/rsmmsl.46.4.287; Chambaere K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1055; Cohen J, 2006, EUR J PUBLIC HEALTH, V16, P663, DOI 10.1093/eurpub/ckl042; Cohen J, 2006, SOC SCI MED, V63, P743, DOI 10.1016/j.socscimed.2006.01.026; Cohen J, 2013, EUR J PUBLIC HEALTH, V23, P378, DOI 10.1093/eurpub/cks186; Czech Herwig, 2014, HUMAN SUBJECTS RES H, P109; Duncan OD, 2006, J MED ETHICS, V32, P266, DOI 10.1136/jme.2004.011072; Freidl W, 2000, LANCET, V356, P1994, DOI 10.1016/S0140-6736(05)72973-1; Freidl W, 2006, INT J MENT HEALTH, V35, P30, DOI 10.2753/IMH0020-7411350303; Frileux S, 2003, J MED ETHICS, V29, P330, DOI 10.1136/jme.29.6.330; Grassi L, 1999, J PAIN SYMPTOM MANAG, V17, P188, DOI 10.1016/S0885-3924(98)00155-9; Hagelin J, 2004, J MED ETHICS, V30, P521, DOI 10.1136/jme.2002.002543; Hudson L, 2009, J PAEDIATR CHILD H, V8, P508; Inghelbrecht E, 2009, INT J NURS STUD, V46, P1209, DOI 10.1016/j.ijnurstu.2009.02.009; Institut fur empirische Sozialforschung GmbH (IFES), 2014, STUD ZUM THEM LEB; Jaspers E, 2007, INT J PUBLIC OPIN R, V19, P451, DOI 10.1093/ijpor/edm029; Kemmelmeier M, 1999, J APPL SOC PSYCHOL, V29, P2613, DOI 10.1111/j.1559-1816.1999.tb00128.x; Kemmelmeier M, 2002, J APPL SOC PSYCHOL, V32, P60, DOI 10.1111/j.1559-1816.2002.tb01420.x; Lotto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031735; MacDonald WL, 1998, SOC SCI MED, V46, P73, DOI 10.1016/S0277-9536(97)00146-9; Moulton BW, 2004, J LAW MED ETHICS, V32, P2, DOI 10.1111/j.1748-720X.2004.tb00172.x; O'Neill C, 2003, SOC SCI MED, V57, P721, DOI 10.1016/S0277-9536(02)00421-5; Oesterreich D, 2005, POLIT PSYCHOL, V26, P275, DOI 10.1111/j.1467-9221.2005.00418.x; Peretti-Watel P, 2003, BRIT MED J, V327, P595, DOI 10.1136/bmj.327.7415.595; Rietjens JAC, 2005, SOC SCI MED, V61, P1723, DOI 10.1016/j.socscimed.2005.03.024; Ryynanen OP, 2002, PUBLIC HEALTH, V116, P322, DOI 10.1038/sj.ph.1900875; Seale C, 2009, PALLIATIVE MED, V23, P205, DOI 10.1177/0269216308102041; SINGER PA, 1995, SOC SCI MED, V41, P1517, DOI 10.1016/0277-9536(95)00057-E; Stack S, 1996, OMEGA-J DEATH DYING, V34, P71; Stack S, 2011, J SCI STUD RELIG, V50, P289, DOI 10.1111/j.1468-5906.2011.01568.x; Steck N, 2013, MED CARE, V51, P938, DOI 10.1097/MLR.0b013e3182a0f427; Stronegger WJ, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-26; SuarezAlmazor ME, 1997, J CLIN ONCOL, V15, P418, DOI 10.1200/JCO.1997.15.2.418; Teisseyre N, 2005, SOC SCI MED, V60, P357, DOI 10.1016/j.socscimed.2004.05.016; Teisseyre N, 2010, MONASH BIOETH REV, V14, P1; Televantos A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-878; Verbakel E, 2010, PUBLIC OPIN QUART, V74, P109, DOI 10.1093/poq/nfp074; Verhagen E, 2005, NEW ENGL J MED, V352, P959, DOI 10.1056/NEJMp058026; Watzka C, 2008, VEREIN SOZIALGESCHIC, P147; 2008, MOSBYS MED DICT	43	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124320	10.1371/journal.pone.0124320	http://dx.doi.org/10.1371/journal.pone.0124320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906265	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000065
J	Gao, F; Kight, AD; Henderson, R; Jayanthi, S; Patel, P; Murchison, M; Sharma, P; Goforth, RL; Kumar, TKS; Henry, RL; Heyes, CD				Gao, Feng; Kight, Alicia D.; Henderson, Rory; Jayanthi, Srinivas; Patel, Parth; Murchison, Marissa; Sharma, Priyanka; Goforth, Robyn L.; Kumar, Thallapuranam Krishnaswamy Suresh; Henry, Ralph L.; Heyes, Colin D.			Regulation of Structural Dynamics within a Signal Recognition Particle Promotes Binding of Protein Targeting Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; isothermal titration calorimetry (ITC); membrane transport; molecular dynamics; protein dynamic; protein targeting; signal recognition particle (SRP); single molecule biophysics	SINGLE-MOLECULE FLUORESCENCE; TRANSFER CONFOCAL MICROSCOPY; THYLAKOID MEMBRANE-PROTEIN; RESONANCE ENERGY-TRANSFER; CHLOROPLAST HOMOLOG; CPSRP43; SUBUNIT; CHROMODOMAINS; INTEGRATION; COMPONENTS	Background: Targeting of proteins requires a signal recognition particle (SRP) and multiple protein interactions. Results: We observed a decrease in the structural dynamics of cpSRP43 and an increase in substrate affinity upon its binding to cpSRP54. Conclusion: Changes in domain dynamics induced by cpSRP subunit interactions mediate substrate affinity. Significance: Relating structure and dynamics of SRP proteins allows for a better understanding of vectorial targeting within cells. Protein targeting is critical in all living organisms and involves a signal recognition particle (SRP), an SRP receptor, and a translocase. In co-translational targeting, interactions among these proteins are mediated by the ribosome. In chloroplasts, the light-harvesting chlorophyll-binding protein (LHCP) in the thylakoid membrane is targeted post-translationally without a ribosome. A multidomain chloroplast-specific subunit of the SRP, cpSRP43, is proposed to take on the role of coordinating the sequence of targeting events. Here, we demonstrate that cpSRP43 exhibits significant interdomain dynamics that are reduced upon binding its SRP binding partner, cpSRP54. We showed that the affinity of cpSRP43 for the binding motif of LHCP (L18) increases when cpSRP43 is complexed to the binding motif of cpSRP54 (cpSRP54(pep)). These results support the conclusion that substrate binding to the chloroplast SRP is modulated by protein structural dynamics in which a major role of cpSRP54 is to improve substrate binding efficiency to the cpSRP.	[Gao, Feng; Henderson, Rory; Jayanthi, Srinivas; Patel, Parth; Murchison, Marissa; Kumar, Thallapuranam Krishnaswamy Suresh; Heyes, Colin D.] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Kight, Alicia D.; Sharma, Priyanka; Goforth, Robyn L.; Henry, Ralph L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Kumar, TKS (corresponding author), Univ Arkansas, Dept Chem & Biochem, 345 N Campus Dr, Fayetteville, AR 72701 USA.	sthalla@uark.edu; rahenry@uark.edu; cheyes@uark.edu	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Suresh Thallapuranam/R-5606-2016; Jayanthi, Srinivas/AAD-2808-2019; Kumar, Dr Suresh/HHZ-2615-2022	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Suresh Thallapuranam/0000-0001-7262-1373; Kumar, Dr Suresh/0000-0002-2539-6553; Henderson, Rory/0000-0002-4301-6382; Jayanthi, Srinivas/0000-0001-7357-760X; Heyes, Colin/0000-0003-1124-9947	National Institutes of Health through the Centers of Biomedical Research Excellence program [P30 GM103450]; U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-FG02-01ER15161]; Arkansas Biosciences Institute; National Center for Research Resources, a component of the NIH [1P30RR031154]; National Science Foundation [MRI 0722625, MRI-R2 0959124, ARI 0963249, 0918970]; Arkansas Science and Technology Authority; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1263119] Funding Source: National Science Foundation	National Institutes of Health through the Centers of Biomedical Research Excellence program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Arkansas Biosciences Institute; National Center for Research Resources, a component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); Arkansas Science and Technology Authority; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by National Institutes of Health Grant P30 GM103450 through the Centers of Biomedical Research Excellence program. This work was also supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, under Award #DE-FG02-01ER15161 (to R. L. H. and T. K. S. K.: cloning and recombinant protein production, molecular dynamics simulations, and thylakoid insertion), and the Arkansas Biosciences Institute. We thank the Arkansas Statewide Mass Spectrometry Facility for analytical support and the mass spectral data (Grant Number 1P30RR031154 from the National Center for Research Resources, a component of the NIH). MD simulations were supported in part by National Science Foundation Grants MRI 0722625 (Star of Arkansas), MRI-R2 0959124 (Razor), and ARI 0963249 and 0918970 (Cyberinfrastructure for Transformational Scientific Discovery, CI-TRAIN) and a grant from the Arkansas Science and Technology Authority with resources managed by the Arkansas High Performance Computing Center.	Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Chen P, 2010, NAT PROD REP, V27, P757, DOI 10.1039/b906691h; Cline K., 2003, LIGHT HARVESTING ANT, P353; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Gao F, 2006, J AM CHEM SOC, V128, P4814, DOI 10.1021/ja058098a; Gao F, 2013, ANAL CHEM, V85, P4414, DOI 10.1021/ac3036926; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; GREEN BR, 1996, MOL GENETICS PHOTOSY, P75; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Henry R, 2007, ENZYMES, V25, P493, DOI 10.1016/S1874-6047(07)25019-X; Henry RL, 2010, NAT STRUCT MOL BIOL, V17, P676, DOI 10.1038/nsmb0610-676; Holdermann I, 2012, NAT STRUCT MOL BIOL, V19, P260, DOI 10.1038/nsmb.2196; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jia YW, 1999, CHEM PHYS, V247, P69, DOI 10.1016/S0301-0104(99)00127-5; Kathir KM, 2008, J MOL BIOL, V381, P49, DOI 10.1016/j.jmb.2008.05.065; Kuzmenkina EV, 2005, P NATL ACAD SCI USA, V102, P15471, DOI 10.1073/pnas.0507728102; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; Nishimura SY, 2006, J PHYS CHEM B, V110, P8151, DOI 10.1021/jp0574145; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Talaga DS, 2000, P NATL ACAD SCI USA, V97, P13021, DOI 10.1073/pnas.97.24.13021; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; YUAN JG, 1993, P NATL ACAD SCI USA, V90, P8552, DOI 10.1073/pnas.90.18.8552; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	51	15	15	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15462	15474		10.1074/jbc.M114.624346	http://dx.doi.org/10.1074/jbc.M114.624346			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25918165	Green Published, hybrid			2022-12-26	WOS:000356527400013
J	Aslanoglou, D; Alvarez-Curto, E; Marsango, S; Milligan, G				Aslanoglou, Despoina; Alvarez-Curto, Elisa; Marsango, Sara; Milligan, Graeme			Distinct Agonist Regulation of Muscarinic Acetylcholine M-2-M-3 Heteromers and Their Corresponding Homomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; FLUORESCENCE CORRELATION SPECTROSCOPY; SNAP-TAG TECHNOLOGY; CRYSTAL-STRUCTURE; DIMER; DIMERIZATION; COMPLEXES; SEROTONIN; DYNAMICS; MONOMERS	Each subtype of the muscarinic receptor family of G protein-coupled receptors is activated by similar concentrations of the neurotransmitter acetylcholine or closely related synthetic analogs such as carbachol. However, pharmacological selectivity can be generated by the introduction of a pair of mutations to produce Receptor Activated Solely by Synthetic Ligand (RASSL) forms of muscarinic receptors. These display loss of potency for acetylcholine/carbachol alongside a concurrent gain in potency for the ligand clozapine N-oxide. Co-expression of a form of wild type human M-2 and a RASSL variant of the human M-3 receptor resulted in concurrent detection of each of M-2-M-2 and M-3-M-3 homomers alongside M-2-M-3 heteromers at the surface of stably transfected Flp-In (TM) T-REx (TM) 293 cells. In this setting occupancy of the receptors with a muscarinic antagonist was without detectable effect on any of the muscarinic oligomers. However, selective agonist occupancy of the M2 receptor resulted in enhanced M-2-M-2 homomer interactions but decreased M-2-M-3 heteromer interactions. By contrast, selective activation of the M-3 RASSL receptor did not significantly alter either M-3-M-3 homomer or M-2-M-3 heteromer interactions. Selectively targeting closely related receptor oligomers may provide novel therapeutic opportunities.	[Aslanoglou, Despoina; Alvarez-Curto, Elisa; Marsango, Sara; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk		Aslanoglou, Despoina/0000-0002-8444-1385	Medical Research Council (UK) [MR/L023806/1, G0900050]; Medical Research Council (UK); Medical Research Council [G0900050, 1097074, MR/L023806/1] Funding Source: researchfish; MRC [G0900050, MR/L023806/1] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Medical Research Council (UK) Grants (MR/L023806/1 and G0900050).r Recipient of studentship support from the Medical Research Council (UK).	Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Borroto-Escuela DO, 2010, BBA-MOL CELL RES, V1803, P813, DOI 10.1016/j.bbamcr.2010.04.002; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gavalas A, 2013, MOL PHARMACOL, V84, P346, DOI 10.1124/mol.113.086868; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hamamura M, 2006, MOL CELL ENDOCRINOL, V247, P192, DOI 10.1016/j.mce.2006.01.004; Heinrich JN, 2009, EUR J PHARMACOL, V605, P53, DOI 10.1016/j.ejphar.2008.12.044; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Hussain AF, 2013, CURR PHARM DESIGN, V19, P5437, DOI 10.2174/1381612811319300014; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kolberg K, 2013, CURR PHARM DESIGN, V19, P5406, DOI 10.2174/13816128113199990514; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; Marquer C, 2010, BIOL CELL, V102, P409, DOI 10.1042/BC20090171; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Pou C, 2012, J BIOL CHEM, V287, P8864, DOI 10.1074/jbc.M111.326678; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	39	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14785	14796		10.1074/jbc.M115.649079	http://dx.doi.org/10.1074/jbc.M115.649079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25918156	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000355754600047
J	Lapkouski, M; Chuenchor, W; Kim, MS; Gellert, M; Yang, W				Lapkouski, Mikalai; Chuenchor, Watchalee; Kim, Min-Sung; Gellert, Martin; Yang, Wei			Assembly Pathway and Characterization of the RAG1/2-DNA Paired and Signal-end Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V(D)J RECOMBINATION; SYNAPTIC COMPLEX; SOMATIC RECOMBINATION; ACTIVE-SITE; CHAIN GENES; RAG1; CLEAVAGE; DNA; PROTEINS; SYNAPSIS	Mammalian immune receptor diversity is established via a unique restricted set of site-specific DNA rearrangements in lymphoid cells, known as V(D)J recombination. The lymphoid-specific RAG1-RAG2 protein complex (RAG1/2) initiates this process by binding to two types of recombination signal sequences (RSS), 12RSS and 23RSS, and cleaving at the boundaries of RSS and V, D, or J gene segments, which are to be assembled into immunoglobulins and T-cell receptors. Here we dissect the ordered assembly of the RAG1/2 heterotetramer with 12RSS and 23RSS DNAs. We find that RAG1/2 binds only a single 12RSS or 23RSS and reserves the second DNA-binding site specifically for the complementary RSS, to form a paired complex that reflects the known 12/23 rule of V(D)J recombination. The assembled RAG1/2 paired complex is active in the presence of Mg2+, the physiologically relevant metal ion, in nicking and double-strand cleavage of both RSS DNAs to produce a signal-end complex. We report here the purification and initial crystallization of the RAG1/2 signal-end complex for atomic-resolution structure elucidation. Strict pairing of the 12RSS and 23RSS at the binding step, together with information from the crystal structure of RAG1/2, leads to a molecular explanation of the 12/23 rule.	[Lapkouski, Mikalai; Chuenchor, Watchalee; Kim, Min-Sung; Gellert, Martin; Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Chuenchor, Watchalee/0000-0002-4366-9914	NIDDK, National Institutes of Health [DK036147, DK036167]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036167, Z01DK036147, ZIADK036167] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by the intramural research program of the NIDDK, National Institutes of Health (DK036147 and DK036167).	Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Jones JM, 2001, P NATL ACAD SCI USA, V98, P12926, DOI 10.1073/pnas.221471198; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li WH, 1997, MOL CELL BIOL, V17, P6932, DOI 10.1128/MCB.17.12.6932; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Shlyakhtenko LS, 2009, J BIOL CHEM, V284, P20956, DOI 10.1074/jbc.M109.028977; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593	34	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14618	14625		10.1074/jbc.M115.641787	http://dx.doi.org/10.1074/jbc.M115.641787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903130	Green Published, hybrid			2022-12-26	WOS:000355754600032
J	Zhou, QJ; Lavorgna, A; Bowman, M; Hiscott, J; Harhaj, EW				Zhou, Qinjie; Lavorgna, Alfonso; Bowman, Melissa; Hiscott, John; Harhaj, Edward W.			Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RIG-I; REGULATORY FACTOR-7; NEGATIVE REGULATION; UBIQUITIN LIGASE; MEDIATED DEGRADATION; TRANSCRIPTION FACTOR; AH RECEPTOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; SUBCELLULAR-LOCALIZATION	The transcription factor IRF7 (interferon regulatory factor 7) is a key regulator of type I interferon and plays essential roles in restricting virus infection and spread. IRF7 activation is tightly regulated to prevent excessive inflammation and autoimmunity; however, how IRF7 is suppressed by negative regulators remains poorly understood. Here, we have identified AIP (aryl hydrocarbon receptor interacting protein) as a new binding partner of IRF7. The interaction between AIP and IRF7 is enhanced upon virus infection, and AIP potently inhibits IRF7-induced type I IFN (IFN alpha/beta) production. Overexpression of AIP blocks virus-induced activation of IFN, whereas knockdown of AIP by siRNA potentiates virally activated IFN production. Consistently, AIP-deficient murine embryonic fibroblasts are highly resistant to virus infection because of increased production of IFN alpha/beta. AIP inhibits IRF7 function by antagonizing the nuclear localization of IRF7. Together, our study identifies AIP as a novel inhibitor of IRF7 and a negative regulator of innate antiviral signaling.	[Zhou, Qinjie] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Lavorgna, Alfonso; Bowman, Melissa; Harhaj, Edward W.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, 1650 Orleans St, Baltimore, MD 21287 USA; [Bowman, Melissa] Johns Hopkins Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Hiscott, John] Vaccine & Gene Therapy Inst Florida, Div Infect Dis, Port St Lucie, FL 34987 USA	University of Miami; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Vaccine & Gene Therapy Institute of Florida	Harhaj, EW (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, 1650 Orleans St, Baltimore, MD 21287 USA.	eharhaj1@jhmi.edu	Zhou, Qinjie/B-3300-2018; Regan, Clinton/E-6250-2012	Zhou, Qinjie/0000-0002-1321-7490; 	National Institutes of Health [PO1CA128115, RO1CA135362]; NATIONAL CANCER INSTITUTE [R01CA135362, P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1CA128115 and RO1CA135362 (to E. W. H.).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Burleson GR, 1996, FUND APPL TOXICOL, V29, P40, DOI 10.1006/faat.1996.0004; Carver LA, 1997, J BIOL CHEM, V272, P11452; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Charoenthongtrakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053717; Charoenthongtrakul S, 2011, J VIROL, V85, P6955, DOI 10.1128/JVI.00007-11; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hu Y, 2011, J IMMUNOL, V187, P6456, DOI 10.4049/jimmunol.1003691; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kashuba E, 2000, ONCOGENE, V19, P1801, DOI 10.1038/sj.onc.1203501; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Lavorgna A, 2012, J VIROL, V86, P3357, DOI 10.1128/JVI.06456-11; Lawrence BP, 2006, J IMMUNOL, V177, P5819, DOI 10.4049/jimmunol.177.9.5819; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sathish N, 2011, J BIOL CHEM, V286, P746, DOI 10.1074/jbc.M110.150920; Schimmack G, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0049-7; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Wang J, 2013, J IMMUNOL, V191, P3393, DOI 10.4049/jimmunol.1300740; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	73	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14729	14739		10.1074/jbc.M114.633065	http://dx.doi.org/10.1074/jbc.M114.633065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911105	Green Published, hybrid			2022-12-26	WOS:000355754600042
J	Ma, WJ; Ma, HQ; Mosher, DF				Ma, Wenjiang; Ma, Hanqing; Mosher, Deane F.			On-Off Kinetics of Engagement of FNI Modules of Soluble Fibronectin by beta-Strand Addition	PLOS ONE			English	Article							GELATIN-BINDING DOMAIN; BORRELIA-BURGDORFERI; STREPTOCOCCUS-PYOGENES; PROTEIN BBK32; COOPERATIVE BINDING; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURES; COLLAGEN-BINDING; EPITHELIAL-CELLS; LIGAND-BINDING	Intrinsically disordered sequences within bacterial adhesins bind to E-strands in the beta-sheets of multiple FNI modules of fibronectin (FN) by anti-parallel beta-strand addition, also called tandem beta-zipper formation. The FUD segment of SfbI of Streptococcus pyogenes and Bbk32 segment of BBK32 of Borrelia burgdorferi, despite being imbedded in different adhesins from different bacteria, target the same FNI modules, 2-5,8-9FNI, in the N-terminal 70-kDa region (FN70K) of FN. To facilitate further comparisons, FUD, Bbk32, two other polypeptides based on SfbI that target 1-5FNI (HADD) and 2-5FNI (FRD), and mutant Bbk32 (Delta Bbk32) were produced with fluorochromes placed just outside of the binding sequences. Unlabeled FUD competed similar to 1000-fold better for binding of labeled Bbk32 to FN than unlabeled Bbk32 competed for binding of labeled FUD to FN. Binding kinetics were determined by fluorescence polarization in a stopped-flow apparatus. On-rates for FUD, Bbk32, HADD, and FRD were similar, and all bound more rapidly to FN70K fragment than to full length FN. In stopped-flow displacement and size exclusion chromatographic assays, however, k(off) for FUD or HADD to FN70K or FN was considerably lower compared to k(off) of FRD or Bbk32. FUD and Bbk32 differ in the spacing between sequences that interact with (FNI)-F-3 and (FNI)-F-4 or with (FNI)-F-5 and (FNI)-F-8. Delta Bbk32, in which 2 residues were removed from Bbk32 to make the spacing more like FUD, had a k(off) intermediate between that of Bbk32 and FUD. These results indicate a "folding-after-binding" process after initial association of certain polypeptide sequences to FN that results in formation of a stable complex and is a function of number of FNI modules engaged by the polypeptide, spacing of engagement sites, and perhaps flexibility within the polypeptide-FN complex. We suggest that contributions of SfbI and BBK32 adhesins to bacterial pathogenicity may be determined in part by stability of adhesin-FN complexes.	[Ma, Wenjiang; Ma, Hanqing; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53718 USA	University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53718 USA.	dfmosher@wisc.edu			National Institute of Health [P01 HL088594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644, P01HL088594] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health P01 HL088594 to NJ, P.I. Reagents and ideas for these studies also were developed with National Institute of Health RO1 HL021644 to DFM, P.I.	Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Brissette CA, 2009, INFECT IMMUN, V77, P2802, DOI 10.1128/IAI.00227-09; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Harris G, 2014, J BIOL CHEM, V289, P22490, DOI 10.1074/jbc.M114.578419; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Ma WJ, 2015, J BIOL CHEM, V290, P4866, DOI 10.1074/jbc.M114.612259; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Moschioni M, 2010, MICROB BIOTECHNOL, V3, P370, DOI 10.1111/j.1751-7915.2009.00138.x; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Nyberg P, 2004, EMBO J, V23, P2166, DOI 10.1038/sj.emboj.7600214; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124941	10.1371/journal.pone.0124941	http://dx.doi.org/10.1371/journal.pone.0124941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919138	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659400067
J	Aleman, MM; Holle, LA; Stember, KG; Devette, CI; Monroe, DM; Wolberg, AS				Aleman, Maria M.; Holle, Lori A.; Stember, Katherine G.; Devette, Christa I.; Monroe, Dougald M.; Wolberg, Alisa S.			Cystamine Preparations Exhibit Anticoagulant Activity	PLOS ONE			English	Article							FACTOR-XIII; TISSUE TRANSGLUTAMINASE; THROMBIN GENERATION; HUNTINGTON-DISEASE; MODEL; INFLAMMATION; CONTRIBUTES; INHIBITION; MECHANISMS; STABILITY	Transglutaminases are a superfamily of isoenzymes found in cells and plasma. These enzymes catalyze the formation of epsilon-N-(gamma-glutamyl)-lysyl crosslinks between proteins. Cystamine blocks transglutaminase activity and is used in vitro in human samples and in vivo in mice and rats in studies of coagulation, immune dysfunction, and inflammatory disease. These studies have suggested cystamine blocks fibrin crosslinking and has antiinflammatory effects, implicating transglutaminase activity in the pathogenesis of several diseases. We measured the effects of cystamine on fibrin crosslinking, tissue factortriggered plasma clot formation and thrombin generation, and coagulation factor enzymatic activity. At concentrations that blocked fibrin crosslinking, cystamine also inhibited plasma clot formation and reduced thrombin generation. Cystamine inhibited the amidolytic activity of coagulation factor XI and thrombin towards chromogenic substrates. These findings demonstrate that cystamine exhibits anticoagulant activity during coagulation. Given the close relationship between coagulation and inflammation, these findings suggest prior studies that used cystamine to implicate transglutaminase activity in disease pathogenesis warrant re-examination.	[Aleman, Maria M.; Holle, Lori A.; Stember, Katherine G.; Devette, Christa I.; Wolberg, Alisa S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Aleman, Maria M.; Monroe, Dougald M.; Wolberg, Alisa S.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Monroe, Dougald M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wolberg, AS (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	alisa_wolberg@med.unc.edu		Monroe, Dougald/0000-0002-0493-2943; Aleman, Maria M./0000-0002-1714-0363; DeVette, Christa/0000-0001-9972-0646	National Institutes of Health [R01HL094740, R56HL094740]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [1UL1TR001111]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL094740, R01HL094740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funding from the National Institutes of Health (R01HL094740 and R56HL094740 to ASW) and by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number 1UL1TR001111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386; Bailey CDC, 2006, NEUROBIOL AGING, V27, P871, DOI 10.1016/j.neurobiolaging.2005.04.001; Bakker ENTP, 2005, CIRC RES, V96, P119, DOI 10.1161/01.RES.0000151333.56089.66; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; Borrell-Pages M, 2006, J CLIN INVEST, V116, P1410, DOI 10.1172/JCI27607; Bortvedt SF, 2010, NEUROBIOL DIS, V40, P130, DOI 10.1016/j.nbd.2010.04.007; Dardik R, 2006, J THROMB HAEMOST, V4, P19, DOI 10.1111/j.1538-7836.2005.01473.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Elli L, 2011, LAB INVEST, V91, P452, DOI 10.1038/labinvest.2010.186; Hsu TC, 2008, EUR J PHARMACOL, V591, P307, DOI 10.1016/j.ejphar.2008.06.078; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645; KORSGREN C, 1990, P NATL ACAD SCI USA, V87, P613, DOI 10.1073/pnas.87.2.613; Lerner A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-89; Levy JH, 2013, TRANSFUSION, V53, P1120, DOI 10.1111/j.1537-2995.2012.03865.x; Liu C, 2014, HYPERTENSION, V63, P353, DOI 10.1161/HYPERTENSIONAHA.113.02361; Machlus KR, 2009, THROMB HAEMOSTASIS, V102, P936, DOI 10.1160/TH09-03-0180; Marty I, 2001, J CLIN INVEST, V107, P631, DOI 10.1172/JCI11064; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Raghu H, 2015, BLOOD, V125, P427, DOI 10.1182/blood-2014-08-594754; Ribeiro M, 2013, TOXICOL SCI, V136, P487, DOI 10.1093/toxsci/kft199; Tang JJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/753483; Tzang BS, 2013, LIFE SCI, V92, P719, DOI 10.1016/j.lfs.2013.01.027; Van Raamsdonk JM, 2005, J NEUROCHEM, V95, P210, DOI 10.1111/j.1471-4159.2005.03357.x; Varisco PA, 2000, ANN RHEUM DIS, V59, P781, DOI 10.1136/ard.59.10.781; Villella VR, 2013, AUTOPHAGY, V9, P1431, DOI 10.4161/auto.25517; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Zucker M, 2014, J THROMB HAEMOST, V12, P1121, DOI 10.1111/jth.12600	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124448	10.1371/journal.pone.0124448	http://dx.doi.org/10.1371/journal.pone.0124448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915545	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100051
J	Jarvi, SI; Pitt, WC; Farias, ME; Shiels, L; Severino, MG; Howe, KM; Jacquier, SH; Shiels, AB; Amano, KK; Luiz, BC; Maher, DE; Allison, ML; Holtquist, ZC; Scheibelhut, NT				Jarvi, Susan I.; Pitt, William C.; Farias, Margaret E.; Shiels, Laura; Severino, Michael G.; Howe, Kathleen M.; Jacquier, Steven H.; Shiels, Aaron B.; Amano, Karis K.; Luiz, Blaine C.; Maher, Daisy E.; Allison, Maureen L.; Holtquist, Zachariah C.; Scheibelhut, Neil T.			Detection of Angiostrongylus cantonensis in the Blood and Peripheral Tissues of Wild Hawaiian Rats (Rattus rattus) by a Quantitative PCR (qPCR) Assay	PLOS ONE			English	Article							EOSINOPHILIC MENINGITIS; INFECTION; DIAGNOSIS; LUNGWORM	The nematode Angiostrongylus cantonensis is a rat lungworm, a zoonotic pathogen that causes human eosinophilic meningitis and ocular angiostrongyliasis characteristic of rat lungworm (RLW) disease. Definitive diagnosis is made by finding and identifying A. cantonensis larvae in the cerebral spinal fluid or by using a custom immunological or molecular test. This study was conducted to determine if genomic DNA from A. cantonensis is detectable by qPCR in the blood or tissues of experimentally infected rats. F1 offspring from wild rats were subjected to experimental infection with RLW larvae isolated from slugs, then blood or tissue samples were collected over multiple time points. Blood samples were collected from 21 rats throughout the course of two trials (15 rats in Trial I, and 6 rats in Trial II). In addition to a control group, each trial had two treatment groups: the rats in the low dose (LD) group were infected by approximately 10 larvae and the rats in the high dose (HD) group were infected with approximately 50 larvae. In Trial I, parasite DNA was detected in cardiac bleed samples from five of five LD rats and five of five HD rats at six weeks post-infection (PI), and three of five LD rats and five of five HD rats from tail tissue. In Trial II, parasite DNA was detected in peripheral blood samples from one of two HD rats at 53 minutes PI, one of two LD rats at 1.5 hours PI, one of two HD rats at 18 hours PI, one of two LD rats at five weeks PI and two of two at six weeks PI, and two of two HD rats at weeks five and six PI. These data demonstrate that parasite DNA can be detected in peripheral blood at various time points throughout RLW infection in rats.	[Jarvi, Susan I.; Farias, Margaret E.; Shiels, Laura; Severino, Michael G.; Howe, Kathleen M.; Jacquier, Steven H.; Amano, Karis K.; Luiz, Blaine C.; Maher, Daisy E.; Allison, Maureen L.; Holtquist, Zachariah C.; Scheibelhut, Neil T.] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Pitt, William C.; Shiels, Laura; Shiels, Aaron B.] Natl Wildlife Res Ctr, Hawaii Field Stn, USDA APHIS Wildlife Serv, Hilo, HI 96720 USA; [Pitt, William C.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA	University of Hawaii System; University Hawaii Hilo; United States Department of Agriculture (USDA); Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Jarvi, SI (corresponding author), Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA.	jarvi@hawaii.edu			UHH Daniel K. Inouye College of Pharmacy; University of Hawaii at Hilo; United States Department of Agriculture-APHIS National Wildlife Research Center's National Wildlife Disease Program; University of Hawaii at Hilo Research Council; National Institute of General Medical Sciences, National Institutes of Health [P20GM 103466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER	UHH Daniel K. Inouye College of Pharmacy; University of Hawaii at Hilo; United States Department of Agriculture-APHIS National Wildlife Research Center's National Wildlife Disease Program; University of Hawaii at Hilo Research Council; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the UHH Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, United States Department of Agriculture-APHIS National Wildlife Research Center's National Wildlife Disease Program, University of Hawaii at Hilo Research Council, and a grant from the National Institute of General Medical Sciences, National Institutes of Health, award number: P20GM 103466. The content is solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALICATA JE, 1991, PARASITOL TODAY, V7, P151, DOI 10.1016/0169-4758(91)90285-V; Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312; Chye SM, 2004, CLIN CHEM, V50, P51, DOI 10.1373/clinchem.2003.020867; CROSS JH, 1987, PARASITOL TODAY, V3, P367, DOI 10.1016/0169-4758(87)90242-0; Silva Ana Cristina Arámburu da, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P295, DOI 10.1590/S0036-46652003000500011; Eamsobhana P, 2013, MEM I OSWALDO CRUZ, V108, P116, DOI 10.1590/S0074-02762013000100020; Er-Hu J, 2008, CHINESE MED J-PEKING, V121, P67, DOI 10.1097/00029330-200801010-00013; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; Hollingsworth Robert G., 2006, P121; Hollingsworth Robert G, 2013, Hawaii J Med Public Health, V72, P75; JAROONVESAMA N, 1988, PARASITOL TODAY, V4, P262, DOI 10.1016/0169-4758(88)90146-9; JARRETT EEE, 1983, IMMUNOLOGY, V48, P49; Jarvi SI, 2012, MOL BIOCHEM PARASIT, V185, P174, DOI 10.1016/j.molbiopara.2012.08.002; Jeffries R, 2011, PARASITOL RES; Jin E, 2005, CLIN RADIOL, V60, P242, DOI 10.1016/j.crad.2004.05.012; Kanpittaya J, AJNR AM J NEURORADIO, P1090; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; Lindo JF, 2004, AM J TROP MED HYG, V70, P425, DOI 10.4269/ajtmh.2004.70.425; MACKERRAS M. JOSEPHINE, 1955, AUSTRALIAN JOUR ZOOL, V3, P1, DOI 10.1071/ZO9550001; Martin-Alonso A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027747; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Punyagupta S., 1979, Studies on angiostrongyliasis in Eastern Asia and Australia., P138; Qvarnstrom Y, 2010, APPL ENVIRON MICROB, V76, P5287, DOI 10.1128/AEM.00546-10; SHIH SL, 1992, PEDIATR INFECT DIS J, V11, P1064, DOI 10.1097/00006454-199211120-00018; Simoes RO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-100; Tsai HC, 2003, AM J TROP MED HYG, V68, P281, DOI 10.4269/ajtmh.2003.68.281; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Wang QP, 2011, EUR J CLIN MICROBIOL, DOI [10.1007/s10096-0111328-5, DOI 10.1007/S10096-0111328-5]; Wu G.H., 2006, NATURE BORNE DIS, P1182	30	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123064	10.1371/journal.pone.0123064	http://dx.doi.org/10.1371/journal.pone.0123064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910229	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800028
J	Killoran, RC; Fan, JS; Yang, DW; Shilton, BH; Choy, WY				Killoran, Ryan C.; Fan, Jingsong; Yang, Daiwen; Shilton, Brian H.; Choy, Wing-Yiu			Structural Analysis of the 14-3-3 zeta/Chibby Interaction Involved in Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							NUCLEAR-EXPORT SIGNALS; BETA-CATENIN; INTRINSIC DISORDER; CRYSTAL-STRUCTURE; 14-3-3 PROTEINS; BINDING; COMPLEX; CHIBBY; INSIGHTS; TARGET	The partially disordered Chibby (Cby) is a conserved nuclear protein that antagonizes the Wnt/beta-catenin signaling pathway. By competing with the Tcf/Lef family proteins for binding to beta-catenin, Cby abrogates the beta-catenin-mediated transcription of Wnt signaling genes. Additionally, upon phosphorylation on S20 by the kinase Akt, Cby forms a complex with 14-3-3 to facilitate the nuclear export of beta-catenin, which represents another crucial mechanism for the regulation of Wnt signaling. To obtain a mechanistic understanding of the 14-3-3/Cby interaction, we have extensively characterized the complex using X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and isothermal titration calorimetry (ITC). The crystal structure of the human 14-3-3 zeta/Cby protein-peptide complex reveals a canonical binding mode; however the residue at the + 2 position from the phosphorylated serine is shown to be uniquely oriented relative to other solved structures of 14-3-3 complexes. Our ITC results illustrate that although the phosphorylation of S20 is essential for Cby to recognize 14-3-3, residues flanking the phosphorylation site also contribute to the binding affinity. However, as is commonly observed in other 14-3-3/phosphopeptide crystal structures, residues of Cby flanking the 14-3-3 binding motif lack observable electron density. To obtain a more detailed binding interface, we have completed the backbone NMR resonance assignment of 14-3-3 zeta. NMR titration experiments reveal that residues outside of the 14-3-3 conserved binding cleft, namely a flexible loop consisting of residues 203-210, are also involved in binding Cby. By using a combined X-ray and NMR approach, we have dissected the molecular basis of the 14-3-3/Cby interaction.	[Killoran, Ryan C.; Shilton, Brian H.; Choy, Wing-Yiu] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Fan, Jingsong; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Western University (University of Western Ontario); National University of Singapore	Choy, WY (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	jchoy4@uwo.ca	Shilton, Brian H/A-6667-2011; Choy, Wing-Yiu/O-7608-2017; yang, daiwen/H-8408-2012	Choy, Wing-Yiu/0000-0002-2124-7278; yang, daiwen/0000-0002-6804-0071	Canadian Institutes of Health Research (CIHR) [MOP 74679]; Natural Sciences and Engineering Research (NSERC) [RGPIN 06372-2014]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (CIHR; MOP 74679; WYC) and Natural Sciences and Engineering Research (NSERC; RGPIN 06372-2014; WYC). We thank Kevin Leung for useful discussions on our Xray crystallography experiments. We thank the Biomolecular NMR Facility, Macromolecular Crystallography Facility and the Biomolecular Interaction and Conformation Facility at the University of Western Ontario for their assistance and use of the facilities. We also acknowledge and thank the support from the NMR facility at the National University of Singapore.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bonet R, 2013, J MOL BIOL, V425, P3060, DOI 10.1016/j.jmb.2013.05.024; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Das RK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003091; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Mofunanya A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-41; Mokhtarzada S, 2011, BIOCHEMISTRY-US, V50, P715, DOI 10.1021/bi101236z; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2012, FEBS J, V279, P563, DOI 10.1111/j.1742-4658.2011.08445.x; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Mori Mattia, 2013, Drug Discov Today Technol, V10, pe541, DOI 10.1016/j.ddtec.2012.10.001; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ottmann C, 2013, BIOORGAN MED CHEM, V21, P4058, DOI 10.1016/j.bmc.2012.11.028; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Schumacher B, 2010, ACTA CRYSTALLOGR F, V66, P978, DOI 10.1107/S1744309110025479; Skjevik AA, 2014, J MOL BIOL, V426, P150, DOI 10.1016/j.jmb.2013.09.012; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Uhart M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00010; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200	55	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123934	10.1371/journal.pone.0123934	http://dx.doi.org/10.1371/journal.pone.0123934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909186	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800051
J	Wade, LJ; Bartolome, V; Mauleon, R; Vasant, VD; Prabakar, SM; Chelliah, M; Kameoka, E; Nagendra, K; Reddy, KRK; Varma, CMK; Patil, KG; Shrestha, R; Al-Shugeairy, Z; Al-Ogaidi, F; Munasinghe, M; Gowda, V; Semon, M; Suralta, RR; Shenoy, V; Vadez, V; Serraj, R; Shashidhar, HE; Yamauchi, A; Babu, RC; Price, A; McNally, KL; Henry, A				Wade, Len J.; Bartolome, Violeta; Mauleon, Ramil; Vasant, Vivek Deshmuck; Prabakar, Sumeet Mankar; Chelliah, Muthukumar; Kameoka, Emi; Nagendra, K.; Reddy, K. R. Kamalnath; Varma, C. Mohan Kumar; Patil, Kalmeshwar Gouda; Shrestha, Roshi; Al-Shugeairy, Zaniab; Al-Ogaidi, Faez; Munasinghe, Mayuri; Gowda, Veeresh; Semon, Mande; Suralta, Roel R.; Shenoy, Vinay; Vadez, Vincent; Serraj, Rachid; Shashidhar, H. E.; Yamauchi, Akira; Babu, Ranganathan Chandra; Price, Adam; McNally, Kenneth L.; Henry, Amelia			Environmental Response and Genomic Regions Correlated with Rice Root Growth and Yield under Drought in the OryzaSNP Panel across Multiple Study Systems	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SOIL-FILLED CHAMBERS; SATIVA L.; WATER-DEFICIT; GRAIN-YIELD; MORPHOLOGICAL TRAITS; PENETRATION ABILITY; ALUMINUM TOLERANCE; RESISTANCE TRAITS; PLANT-PRODUCTION	The rapid progress in rice genotyping must be matched by advances in phenotyping. A better understanding of genetic variation in rice for drought response, root traits, and practical methods for studying them are needed. In this study, the OryzaSNP set (20 diverse genotypes that have been genotyped for SNP markers) was phenotyped in a range of field and container studies to study the diversity of rice root growth and response to drought. Of the root traits measured across more than 20 root experiments, root dry weight showed the most stable genotypic performance across studies. The environment (E) component had the strongest effect on yield and root traits. We identified genomic regions correlated with root dry weight, percent deep roots, maximum root depth, and grain yield based on a correlation analysis with the phenotypes and aus, indica, or japonica introgression regions using the SNP data. Two genomic regions were identified as hot spots in which root traits and grain yield were co-located; on chromosome 1 (39.7-40.7 Mb) and on chromosome 8 (20.3-21.9 Mb). Across experiments, the soil type/growth medium showed more correlations with plant growth than the container dimensions. Although the correlations among studies and genetic co-location of root traits from a range of study systems points to their potential utility to represent responses in field studies, the best correlations were observed when the two setups had some similar properties. Due to the co-location of the identified genomic regions (from introgression block analysis) with QTL for a number of previously reported root and drought traits, these regions are good candidates for detailed characterization to contribute to understanding rice improvement for response to drought. This study also highlights the utility of characterizing a small set of 20 genotypes for root growth, drought response, and related genomic regions.	[Wade, Len J.] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia; [Bartolome, Violeta; Mauleon, Ramil; Gowda, Veeresh; Serraj, Rachid; McNally, Kenneth L.; Henry, Amelia] Int Rice Res Inst, Manila 1301, Philippines; [Vasant, Vivek Deshmuck; Prabakar, Sumeet Mankar; Chelliah, Muthukumar; Babu, Ranganathan Chandra] Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Coimbatore 641003, Tamil Nadu, India; [Kameoka, Emi; Yamauchi, Akira] Nagoya Univ Chikusa, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nagendra, K.; Reddy, K. R. Kamalnath; Varma, C. Mohan Kumar; Patil, Kalmeshwar Gouda; Shenoy, Vinay] Barwale Fdn, Hyderabad 500029, Andhra Pradesh, India; [Shrestha, Roshi; Al-Shugeairy, Zaniab; Al-Ogaidi, Faez; Munasinghe, Mayuri; Price, Adam] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [Semon, Mande] Africa Rice Ctr, IITA, Ibadan, Nigeria; [Suralta, Roel R.] Philippine Rice Res Inst, Science City Of Munoz 3119, Nueva Ecija, Philippines; [Vadez, Vincent] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Telangana, India; [Shashidhar, H. E.] Univ Agr Sci Gandhi Krishi Vignana Kendra GKVK, Coll Agr, Bangalore 560065, Karnataka, India	Charles Sturt University; CGIAR; International Rice Research Institute (IRRI); Tamil Nadu Agricultural University; Nagoya University; University of Aberdeen; CGIAR; Africa Rice Center; International Institute of Tropical Agriculture (IITA); Philippine Rice Research Institute; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Agricultural Sciences Bangalore	Henry, A (corresponding author), Int Rice Res Inst, DAPO Box 7777, Manila 1301, Philippines.	a.henry@irri.org	Wade, Len J/A-8872-2008; McNally, Kenneth L./L-3970-2019; Mankar, Sumeet/AAT-6287-2020; Vadez, Vincent/GLU-8981-2022; Mauleon, Ramil/AAW-1697-2020; ALshugeairy, zainab Kareem/GXF-1895-2022; Vadez, Vincent/C-5310-2014	Wade, Len J/0000-0002-1321-4310; McNally, Kenneth L./0000-0002-9613-5537; Mankar, Sumeet/0000-0002-9603-121X; Mauleon, Ramil/0000-0001-8512-144X; ALshugeairy, zainab Kareem/0000-0002-0821-3110; Henry, Amelia/0000-0001-6255-5480	Generation Challenge Program (GCP) project, "Targeting Drought-Avoidance Root Traits to Enhance Rice Productivity under Water-Limited Environments" [G3008.06]	Generation Challenge Program (GCP) project, "Targeting Drought-Avoidance Root Traits to Enhance Rice Productivity under Water-Limited Environments"	This research was funded by the Generation Challenge Program (GCP) project G3008.06, "Targeting Drought-Avoidance Root Traits to Enhance Rice Productivity under Water-Limited Environments". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna TLB, 2008, FIELD CROP RES, V108, P117, DOI 10.1016/j.fcr.2008.04.003; Ali ML, 2000, THEOR APPL GENET, V101, P756, DOI 10.1007/s001220051541; Babu RC, 2001, PLANT BREEDING, V120, P233, DOI 10.1046/j.1439-0523.2001.00578.x; Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Cairns JE, 2009, FIELD CROP RES, V114, P108, DOI 10.1016/j.fcr.2009.07.009; Cooper M, 1999, FIELD CROP RES, V64, P131, DOI 10.1016/S0378-4290(99)00056-8; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Gomez MS., 2006, AM, V2, P161, DOI [10.3844/ajbbsp.2006.161.169, DOI 10.3844/AJBBSP.2006.161.169]; Gomez SM, 2010, ACTA PHYSIOL PLANT, V32, P355, DOI 10.1007/s11738-009-0413-1; Gowda VRP, 2012, FUNCT PLANT BIOL, V39, P402, DOI 10.1071/FP12015; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Hardy B., 2008, DROUGHT FRONTIERS RI, P3, DOI [10.3389/fphys.2012.00429, DOI 10.3389/FPHYS.2012.00429]; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; *IRRI, 2007, CROPSTAT WIND VERS 7; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Kamoshita A, 2008, FIELD CROP RES, V109, P1, DOI 10.1016/j.fcr.2008.06.010; Kano-Nakata M, 2013, FIELD CROP RES, V144, P288, DOI 10.1016/j.fcr.2013.01.024; Kano-Nakatal M, 2011, PLANT PROD SCI, V14, P307, DOI 10.1626/pps.14.307; Khowaja FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-276; Lafitte HR, 2001, FIELD CROP RES, V71, P57, DOI 10.1016/S0378-4290(01)00150-2; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Nguyen BD, 2003, THEOR APPL GENET, V106, P583, DOI 10.1007/s00122-002-1072-4; Nguyen HT, 1997, CROP SCI, V37, P1426, DOI 10.2135/cropsci1997.0011183X003700050002x; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pasuquin EM, 2013, PLANT PROD SCI, V16, P217, DOI 10.1626/pps.16.217; Price AH, 2000, THEOR APPL GENET, V100, P49, DOI 10.1007/s001220050007; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Price AH, 2002, FIELD CROP RES, V76, P11, DOI 10.1016/S0378-4290(02)00012-6; R Core Team, 2021, R LANGUAGE ENV STAT; Ray JD, 1996, THEOR APPL GENET, V92, P627, DOI 10.1007/BF00226082; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Samson BK, 2002, FIELD CROP RES, V76, P175, DOI 10.1016/S0378-4290(02)00038-2; SAS Institute Inc, 2012, SAS ONLINEDOC VERS 9; Serraj R, 2009, ADV AGRON, V103, P41, DOI 10.1016/S0065-2113(09)03002-8; Serraj R, 2011, PLANT PROD SCI, V14, P1, DOI 10.1626/pps.14.1; Shashidhar HE, 2013, PLANT BREEDING LAB F, P151; Shashidhar HE, 2012, METHODOLOGIES ROOT D; Shen L, 2001, THEOR APPL GENET, V103, P75, DOI 10.1007/s001220100538; Shrestha R, 2014, PLANT BIOLOGY, V16, P632, DOI 10.1111/plb.12096; Siopongco JDLC, 2005, PLANT PROD SCI, V8, P497, DOI 10.1626/pps.8.497; Srinivasan S, 2008, PLANT GROWTH REGUL, V56, P245, DOI 10.1007/s10725-008-9304-5; Suji KK, 2012, FIELD CROP RES, V137, P89, DOI 10.1016/j.fcr.2012.08.006; Venuprasad R, 2002, EUPHYTICA, V128, P293, DOI 10.1023/A:1021281428957; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wade Len J., 2000, Plant Production Science, V3, P173; Wade LJ, 1999, FIELD CROP RES, V64, P35, DOI 10.1016/S0378-4290(99)00049-0; Wu P, 2000, THEOR APPL GENET, V100, P1295, DOI 10.1007/s001220051438; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Zhang WP, 2001, THEOR APPL GENET, V103, P118, DOI 10.1007/s001220100561; Zheng HG, 2000, GENOME, V43, P53, DOI 10.1139/gen-43-1-53	55	19	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124127	10.1371/journal.pone.0124127	http://dx.doi.org/10.1371/journal.pone.0124127			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909711	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800060
J	Xu, K; Li, SS; Yang, W; Li, K; Bai, YW; Xu, YY; Jin, J; Wang, YY; Bartlam, M				Xu, Kun; Li, Shanshan; Yang, Wen; Li, Kan; Bai, Yuwei; Xu, Yueyang; Jin, Jin; Wang, Yingying; Bartlam, Mark			Structural and Biochemical Analysis of Tyrosine Phosphatase Related to Biofilm Formation A (TpbA) from the Opportunistic Pathogen Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							SUBSTRATE; EXPRESSION; RESISTANCE; MECHANISM; VHZ	Biofilms are important for cell communication and growth in most bacteria, and are responsible for a number of human clinical infections and diseases. TpbA (PA3885) is a dual specific tyrosine phosphatase (DUSP) that negatively regulates biofilm formation in the opportunistic pathogen Pseudomonas aeruginosa PAO1 by converting extracellular quorum sensing signals into internal gene cascade reactions that result in reduced biofilm formation. We have determined the three-dimensional crystal structure of wild-type TpbA from Pseudomonas aeruginosa PAO1 in the phosphate-bound state and a TpbA (C132S) mutant with phosphotyrosine. Comparison between the phosphate-bound structure and the previously reported ligand-free TpbA structure reveals the extent of conformational changes that occur upon substrate binding. The largest changes occur in the functional loops that define the substrate binding site, including the PTP, general acid and alpha 4-alpha 5 loops. We further show that TpbA efficiently catalyzes the hydrolysis of two phosphotyrosine peptides derived from the periplasmic domain of TpbB (YfiN, PA1120), with a strong preference for dephosphorylating Tyr48 over Tyr62. This work adds to the small repertoire of DUSP structures in both the ligand-free and ligand-bound states, and provides a starting point for further study of the role of TpbA in biofilm formation.	[Xu, Kun; Li, Shanshan; Bartlam, Mark] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Xu, Kun; Li, Shanshan; Yang, Wen; Li, Kan; Bai, Yuwei; Xu, Yueyang; Bartlam, Mark] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Jin, Jin] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Wang, Yingying] Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Wang, YY (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China.	wangyy@nankai.edu.cn; bartlam@nankai.edu.cn	YANG, WEN/A-1993-2014; wang, yingying/GRS-3058-2022; wang, yan/GSE-6489-2022	Xu, Yueyang/0000-0003-2375-9135; Bartlam, Mark/0000-0001-5173-5080	Ministry of Science & Technology 973 Project [2014CB560709]; Natural Science Foundation of China [31450110071]; Tianjin Municipal Science and Technology Commission [13JCYBJC20800, 12JCZDJC29700]	Ministry of Science & Technology 973 Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission	This work was supported by the Ministry of Science & Technology 973 Project (grant number 2014CB560709 to MB), the Natural Science Foundation of China (grant number 31450110071 to MB) and the Tianjin Municipal Science and Technology Commission (grant number 13JCYBJC20800 to MB and 12JCZDJC29700 to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Giardina G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081324; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Koveal D, 2013, J MOL BIOL, V425, P2219, DOI 10.1016/j.jmb.2013.03.023; Kuznetsov VI, 2012, BIOCHEMISTRY-US, V51, P9869, DOI 10.1021/bi300908y; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; OCHSNER UA, 1995, P NATL ACAD SCI USA, V92, P6424, DOI 10.1073/pnas.92.14.6424; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776; Pu MM, 2010, BIOCHEM BIOPH RES CO, V402, P351, DOI 10.1016/j.bbrc.2010.10.032; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Sakharkar MK, 2009, J MICROBIOL IMMUNOL, V42, P364; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Ueda A, 2010, ENV MICROBIOL REP, V2, P449, DOI 10.1111/j.1758-2229.2010.00171.x; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Wang Wen-min, 2010, Zhejiang Da Xue Xue Bao Yi Xue Ban, V39, P103; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yang W, 2010, ACTA CRYSTALLOGR F, V66, P1473, DOI 10.1107/S1744309110034317	39	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124330	10.1371/journal.pone.0124330	http://dx.doi.org/10.1371/journal.pone.0124330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909591	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800077
J	Zamiri, R; Ahangar, HA; Kaushal, A; Zakaria, A; Zamiri, G; Tobaldi, D; Ferreira, JMF				Zamiri, Reza; Ahangar, Hossein Abbastabar; Kaushal, Ajay; Zakaria, Azmi; Zamiri, Golnoosh; Tobaldi, David; Ferreira, J. M. F.			Dielectrical Properties of CeO2 Nanoparticles at Different Temperatures	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; PARTICLES; HYDROLYSIS; TRANSPORT	A template-free precipitation method was used as a simple and low cost method for preparation of CeO2 nanoparticles. The structure and morphology of the prepared nanoparticle samples were studied in detail using X-ray diffraction, Raman spectroscopy and Scanning Electron Microscopy (SEM) measurements. The whole powder pattern modelling (WPPM) method was applied on XRD data to accurately measure the crystalline domain size and their size distribution. The average crystalline domain diameter was found to be 5.2 nm, with a very narrow size distribution. UV-visible absorbance spectrum was used to calculate the optical energy band gap of the prepared CeO2 nanoparticles. The FT-IR spectrum of prepared CeO2 nanoparticles showed absorption bands at 400 cm(-1) to 450 cm(-1) regime, which correspond to CeO2 stretching vibration. The dielectric constant (er) and dielectric loss (tan delta) values of sintered CeO2 compact consolidated from prepared nanoparticles were measured at different temperatures in the range from 298 K (room temperature) to 623 K, and at different frequencies from 1 kHz to 1 MHz.	[Zamiri, Reza; Zakaria, Azmi; Zamiri, Golnoosh] Univ Putra Malaysia, Dept Phys, Fac Sci, Upm Serdang 43400, Selangor, Malaysia; [Zamiri, Reza; Kaushal, Ajay; Tobaldi, David; Ferreira, J. M. F.] Univ Aveiro, Dept Mat & Ceram Engn DEMaC, CICECO, P-3810193 Aveiro, Portugal; [Ahangar, Hossein Abbastabar] Islamic Azad Univ, Najafabad Branch, Dept Chem, Fac Sci, Esfahan, Iran	Universiti Putra Malaysia; Universidade de Aveiro; Islamic Azad University	Zamiri, R (corresponding author), Univ Putra Malaysia, Dept Phys, Fac Sci, Upm Serdang 43400, Selangor, Malaysia.	zamiri.r@gmail.com; azmizak@gmail.com	Zamiri, Golnoush/AAK-8009-2020; zamir, reza/D-4100-2016; Tobaldi, David Maria/H-9620-2019; Abbastabar, Hossein/AAE-4447-2021; Ahangar, Hossein Abbastabar/AAN-2224-2021	Zamiri, Golnoush/0000-0003-4223-5062; zamir, reza/0000-0002-1413-9797; Tobaldi, David Maria/0000-0002-0112-8570; Ahangar, Hossein Abbastabar/0000-0002-3716-2172; Ferreira, Jose/0000-0002-7520-2809	Foundation for Science and Technology of Portugal (FCT); Universiti Putra Malaysia Postdoctoral research fellow program [SFRH/BPD/76185/2011, NSR-8978]; Foundation for Science and Technology of Portugal (FCT) [SFRH/BPD/77598/2011]; ECO-SEE project (European Union's Seventh Framework Programme for research, technological development and demonstration) [609234]	Foundation for Science and Technology of Portugal (FCT)(Portuguese Foundation for Science and Technology); Universiti Putra Malaysia Postdoctoral research fellow program; Foundation for Science and Technology of Portugal (FCT)(Portuguese Foundation for Science and Technology); ECO-SEE project (European Union's Seventh Framework Programme for research, technological development and demonstration)	Reza Zamiri would like to thank the Foundation for Science and Technology of Portugal (FCT) and Universiti Putra Malaysia Postdoctoral research fellow program (Reza Zamiri) for the financial support under the grant references, SFRH/BPD/76185/2011 and NSR-8978 (G. P. D.). Ajay Kaushal thanks the financial support under the grant references SFRH/BPD/77598/2011 from the Foundation for Science and Technology of Portugal (FCT). David M. Tobaldi is grateful to the ECO-SEE project (funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 609234. Note: The views expressed are purely those of the authors and may not in any circumstances be regarded as stating an official position of the European Commission). The authors would also like to thank CICECO for the work at the University of Aveiro.	Abecassis-Wolfovich M, 2005, APPL CATAL B-ENVIRON, V59, P91, DOI 10.1016/j.apcatb.2005.01.001; Araujo VD, 2012, CRYSTENGCOMM, V14, P1150, DOI 10.1039/c1ce06188g; Aspinall HC, 2011, INORG CHEM, V50, P11644, DOI 10.1021/ic201593s; AYYUB P, 1995, PHYS REV B, V51, P6135, DOI 10.1103/PhysRevB.51.6135; Brandily-Anne ML, 2010, J NON-CRYST SOLIDS, V356, P2337, DOI 10.1016/j.jnoncrysol.2010.02.020; CAGLIOTI G, 1960, NUCL INSTRUM METHODS, V9, P195, DOI 10.1016/0029-554X(60)90101-4; Chen HI, 2005, CERAM INT, V31, P795, DOI 10.1016/j.ceramint.2004.09.006; CHU X, 1993, J AM CERAM SOC, V76, P2115, DOI 10.1111/j.1151-2916.1993.tb08344.x; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; Hirano M, 2000, J MATER CHEM, V10, P473, DOI 10.1039/a907510k; HSU WP, 1988, LANGMUIR, V4, P31, DOI 10.1021/la00079a005; Hu ZY, 2006, COMMUN SOIL SCI PLAN, V37, P1381, DOI 10.1080/00103620600628680; KIRK TJ, 1993, J ELECTROCHEM SOC, V140, P3494, DOI 10.1149/1.2221117; Klug H.P., 1974, XRAY DIFFRACTION PRO; Leoni M, 2006, Z KRISTALLOGR, P249; Lewis JA, 2000, J AM CERAM SOC, V83, P2341, DOI 10.1111/j.1151-2916.2000.tb01560.x; Lira-Cantu M, 2006, CHEM MATER, V18, P5684, DOI 10.1021/cm061429d; Masui T, 1997, CHEM MATER, V9, P2197, DOI 10.1021/cm970359v; Mokkelbost T, 2004, CHEM MATER, V16, P5489, DOI 10.1021/cm048583p; Niu JL, 2007, CARDIOVASC RES, V73, P549, DOI 10.1016/j.cardiores.2006.11.031; Pautrot-d'Alencon L, 2006, J SOL-GEL SCI TECHN, V39, P261, DOI 10.1007/s10971-006-7803-2; Phoka S, 2009, MATER CHEM PHYS, V115, P423, DOI 10.1016/j.matchemphys.2008.12.031; Phokha S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-425; Rani, 2012, ADV SCI LETT, V5, P1, DOI [10.1166/asl.2012.3312, DOI 10.1166/ASL.2012.3312]; Riccardi CS, 2009, SOLID STATE IONICS, V180, P288, DOI 10.1016/j.ssi.2008.11.016; Samuel MS, 2011, PHYSICA B, V406, P3023, DOI 10.1016/j.physb.2011.04.070; Samuel MS, 2011, CURR APPL PHYS, V11, P1094, DOI 10.1016/j.cap.2011.02.002; Santha NL, 2004, J AM CERAM SOC, V87, P1233, DOI 10.1111/j.1151-2916.2004.tb07717_33.x; Scardi P, 2005, ACTA MATER, V53, P5229, DOI 10.1016/j.actamat.2005.08.002; Scardi P, 2004, DIFFRACTION ANALYSIS OF THE MICROSTRUCTURE OF MATERIALS, P51; Scardi P, 2002, ACTA CRYSTALLOGR A, V58, P190, DOI 10.1107/S0108767301021298; Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129; Sehgal A, 2005, LANGMUIR, V21, P9359, DOI 10.1021/la0513757; Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f; VERDON E, 1995, MATER LETT, V25, P127, DOI 10.1016/0167-577X(95)00161-1; WEBER WH, 1993, PHYS REV B, V48, P178, DOI 10.1103/PhysRevB.48.178; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Wu NC, 2002, J AM CERAM SOC, V85, P2462, DOI 10.1111/j.1151-2916.2002.tb00481.x; Xu HR, 2002, J AM CERAM SOC, V85, P139; Zamiri R, 2014, CERAM INT, V40, P6031, DOI 10.1016/j.ceramint.2013.11.052; Zamiri R, 2014, CERAM INT, V40, P4471, DOI 10.1016/j.ceramint.2013.08.120; Zhang DS, 2007, INORG CHEM, V46, P2446, DOI 10.1021/ic061697d; ZHANG Y, 1995, APPL CATAL B-ENVIRON, V6, P325, DOI 10.1016/0926-3373(95)00041-0; ZHOU YC, 1995, J AM CERAM SOC, V78, P981, DOI 10.1111/j.1151-2916.1995.tb08425.x; Zong Y, 2010, MATER LETT, V64, P243, DOI 10.1016/j.matlet.2009.09.032	45	79	80	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122989	10.1371/journal.pone.0122989	http://dx.doi.org/10.1371/journal.pone.0122989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910071	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800026
J	Green, DJ; Whitehorne, IBJ; Middleton, HA; Morrissey, CA				Green, David J.; Whitehorne, Ivy B. J.; Middleton, Holly A.; Morrissey, Christy A.			Do American Dippers Obtain a Survival Benefit from Altitudinal Migration?	PLOS ONE			English	Article							LIFE-HISTORY; ERITHACUS-RUBECULA; PARTIAL MIGRANT; PREDATION RISK; CLIMATE-CHANGE; POPULATION; EVOLUTION; COSTS; CONSEQUENCES; TEMPERATE	Studies of partial migrants provide an opportunity to assess the cost and benefits of migration. Previous work has demonstrated that sedentary American dippers (residents) have higher annual productivity than altitudinal migrants that move to higher elevations to breed. Here we use a ten-year (30 period) mark-recapture dataset to evaluate whether migrants offset their lower productivity with higher survival during the migration-breeding period when they occupy different habitat, or early and late-winter periods when they coexist with residents. Mark-recapture models provide no evidence that apparent monthly survival of migrants is higher than that of residents at any time of the year. The best-supported model suggests that monthly survival is higher in the migration-breeding period than winter periods. Another well-supported model suggested that residency conferred a survival benefit, and annual apparent survival (calculated from model weighted monthly apparent survival estimates using the Delta method) of residents (0.511 +/- 0.038SE) was slightly higher than that of migrants (0.487 +/- 0.032). Winter survival of American dippers was influenced by environmental conditions; monthly apparent survival increased as maximum daily flow rates increased and declined as winter temperatures became colder. However, we found no evidence that environmental conditions altered differences in winter survival of residents and migrants. Since migratory American dippers have lower productivity and slightly lower survival than residents our data suggests that partial migration is likely an outcome of competition for limited nest sites at low elevations, with less competitive individuals being forced to migrate to higher elevations in order to breed.	[Green, David J.; Whitehorne, Ivy B. J.; Middleton, Holly A.; Morrissey, Christy A.] Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada; [Morrissey, Christy A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	Simon Fraser University; University of Saskatchewan	Green, DJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada.	djgreen@sfu.ca	Green, David J/B-5096-2012	Morrissey, Christy/0000-0001-8128-4209	NSERC [DJG-RGPIN-2014-05798]; NSERC PGS-M (IBJW); Environment Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-M (IBJW); Environment Canada(CGIAR)	Funding for this study was provided by an NSERC Discovery Grant (DJG-RGPIN-2014-05798), an NSERC PGS-M (IBJW), and Environment Canada under the Georgia Basin Ecosystem Initiative (http://www.sustainable.org/governance/policiesordinances-a-taxes/551-the-georgia-basinecosystem-initiative) (CAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAENSEN F, 1990, J ANIM ECOL, V59, P1077, DOI 10.2307/5033; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; BERGERUD AT, 1984, CAN J ZOOL, V62, P1566, DOI 10.1139/z84-229; Blem C.R., 1980, P175; Bloch AM, 2010, CAN J ZOOL, V88, P1113, DOI 10.1139/Z10-079; Boyle WA, 2008, OECOLOGIA, V155, P397, DOI 10.1007/s00442-007-0897-6; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061223; Chiu MC, 2008, FRESHWATER BIOL, V53, P1335, DOI 10.1111/j.1365-2427.2008.01968.x; Combreau O, 2001, ANIM CONSERV, V4, P133, DOI 10.1017/S1367943001001160; Cooch E, 2012, PROGRAM MARK GENTLE, V11th; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; COX GW, 1968, EVOLUTION, V22, P180, DOI 10.1111/j.1558-5646.1968.tb03461.x; Dingle H, 1996, ANIMAL MIGRATION BIO; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Environment Canada, 2010, NAT CLIM DAT INF ARC; Fretwell S., 1980, P517; Garwood JM, 2009, WILSON J ORNITHOL, V121, P600, DOI 10.1676/08-117.1; Gillis EA, 2008, ECOLOGY, V89, P1687, DOI 10.1890/07-1122.1; Gourlay-Larour ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096478; Grayson KL, 2009, J ZOOL, V279, P71, DOI 10.1111/j.1469-7998.2009.00591.x; Grayson KL, 2011, ECOLOGY, V92, P1236, DOI 10.1890/11-0133.1; Grayson KL, 2009, ECOLOGY, V90, P306, DOI 10.1890/08-0935.1; Green DJ, 2009, WILSON J ORNITHOL, V121, P141, DOI 10.1676/07-163.1; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hebblewhite M, 2011, OIKOS, V120, P1860, DOI 10.1111/j.1600-0706.2011.19436.x; Kingery HE, 1996, BIRDS N AM 229; Kinnison MT, 2001, EVOLUTION, V55, P1656, DOI 10.1111/j.0014-3820.2001.tb00685.x; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Larkin LA, 2007, CONDOR, V109, P949; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Leyrer J, 2013, J ORNITHOL, V154, P933, DOI 10.1007/s10336-013-0959-y; Loison A, 2002, J APPL STAT, V29, P289, DOI 10.1080/02664760120108665; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; Mackas RH, 2010, CAN J ZOOL, V88, P369, DOI 10.1139/Z10-013; Marzolin G, 2002, J WILDLIFE MANAGE, V66, P1023, DOI 10.2307/3802934; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Middleton HA, 2006, J AVIAN BIOL, V37, P169, DOI 10.1111/j.2006.0908-8857.03514.x; Middleton HA, 2008, CAN J ZOOL, V86, P875, DOI 10.1139/Z08-069; Morrissey CA, 2004, CONDOR, V106, P815, DOI 10.1650/7455; Morrissey CA, 2004, CAN J ZOOL, V82, P800, DOI 10.1139/Z04-042; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson ALK, 2006, GLOBAL CHANGE BIOL, V12, P2014, DOI 10.1111/j.1365-2486.2006.01237.x; Olsson IC, 2006, ECOL LETT, V9, P645, DOI 10.1111/j.1461-0248.2006.00909.x; ROFF DA, 1991, AM ZOOL, V31, P205; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Salgado-Ortiz J, 2008, AUK, V125, P402, DOI 10.1525/auk.2008.07012; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skov C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1178; Stearns S.C., 1992, pi; SWALES S, 1986, CAN J ZOOL, V64, P1506, DOI 10.1139/z86-225; Telleria JL, 2001, ARDEA, V89, P363; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Water Survey of Canada, 2010, HYDAT HIST DAT STAT; Whitehorne I, 2010, WATERBIRDS, V33, P461, DOI 10.1675/063.033.0405; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	58	15	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125734	10.1371/journal.pone.0125734	http://dx.doi.org/10.1371/journal.pone.0125734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905712	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000114
J	Guo, SS; Guo, YM; Ergun, A; Lu, L; Walker, WA; Ganguli, K				Guo, Shuangshuang; Guo, Yuming; Ergun, Ayla; Lu, Lei; Walker, W. Allan; Ganguli, Kriston			Secreted Metabolites of Bifidobacterium infantis and Lactobacillus acidophilus Protect Immature Human Enterocytes from IL-1 beta-Induced Inflammation: A Transcription Profiling Analysis	PLOS ONE			English	Article							NF-KAPPA-B; NECROTIZING ENTEROCOLITIS; PROBIOTICS REDUCE; TIGHT JUNCTIONS; MODULATION; INTESTINE; APOPTOSIS; RESPONSES; GG; ACTIVATION	Combination regimens of Bifidobacterium infantis and Lactobacillus acidophilus have been demonstrated to prevent necrotizing enterocolitis (NEC) in clinical trials. However, the molecular mechanisms responsible for this protective effect are not well understood. Additionally, conditioned media from individual cultures of these two probiotics show strain specific modulation of inflammation using in vitro human intestinal NEC models. Here we report a transcription profiling analysis of gene expression in immature human fetal intestinal epithelial cells (H4 cells) pretreated with conditioned media from B. infantis (BCM) or L. acidophilus (LCM) prior to IL-1 beta stimulation. Compared with control media, the two probiotic-conditioned media (PCM) treatments altered the expression of hundreds of genes involved in the immune response, apoptosis and cell survival, cell adhesion, the cell cycle, development and angiogenesis. In IL-1 beta-stimulated cells, PCM treatment decreased the upregulation of genes in the NF-kappa B activation pathway and downregulated genes associated with extracellular matrix (ECM) remodeling. Compared with LCM, BCM showed more significant modulatory effects on ECM remodeling, reflected by a lower p value. IL-6 and IL-8 production was significantly reduced in IL-1 beta-stimulated cells pretreated with PCM (p<0.05), which was consistent with their altered gene expression. Western blot analysis showed that compared with IL-1 beta stimulation alone, PCM treatment attenuated the decrease of cytoplasmic I kappa B alpha and NF-kappa B p65 levels as well as the increase of nuclear NF-kappa B p65 levels in the stimulated cells (p<0.05). In conclusion, PCM treatment exerted anti-inflammatory effects in immature human fetal enterocytes primarily by modulating genes in the NF-kappa B signaling and ECM remodeling pathways. Additionally, some components of these signaling pathways, particularly the ECM remodeling pathway, were more profoundly affected by BCM than LCM.	[Guo, Shuangshuang; Guo, Yuming] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Guo, Shuangshuang; Walker, W. Allan; Ganguli, Kriston] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Guo, Shuangshuang; Walker, W. Allan; Ganguli, Kriston] Harvard Univ, Sch Med, Charlestown, MA USA; [Ergun, Ayla] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lu, Lei] Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA	China Agricultural University; Harvard University; Harvard University; Massachusetts General Hospital; University of Chicago	Walker, WA (corresponding author), Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.	wwalker@partners.org; kganguli@partners.org			National Institutes of Health [R01-HD012437, R01-HD059126, P01-DK033506, P30-DK040561]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437, R01HD059126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P01DK033506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health R01-HD012437; R01-HD059126; P01-DK033506 and P30-DK040561. WAW received the funding. The URL of National Institutes of Health is http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audy J, 2012, BENEF MICROBES, V3, P273, DOI 10.3920/BM2012.0027; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Borriello SP, 2003, CLIN INFECT DIS, V36, P775, DOI 10.1086/368080; Borthakur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075664; Chan KYY, 2014, ANN SURG, V260, P1128, DOI 10.1097/SLA.0000000000000374; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Claud EC, 2007, AM J PHYSIOL-GASTR L, V292, pG1411, DOI 10.1152/ajpgi.00557.2006; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Ganguli K, 2011, J CLIN GASTROENTEROL, V45, pS133, DOI 10.1097/MCG.0b013e318228b799; Garrido-Mesa N, 2011, BIOCHEM PHARMACOL, V82, P1891, DOI 10.1016/j.bcp.2011.09.004; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Joint FAO/ WHO Working Group, 2002, GUID EV PROB FOOD; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kleessen B, 1995, ACTA PAEDIATR, V84, P1347, DOI 10.1111/j.1651-2227.1995.tb13567.x; Kumar A, 2014, GUT MICROBES, V5, P152, DOI 10.4161/gmic.27877; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacPherson C, 2014, APPL ENVIRON MICROB, V80, P1692, DOI 10.1128/AEM.03411-13; Montalto M, 2004, DIGESTION, V69, P225, DOI 10.1159/000079152; Moorthy G, 2007, NUTRITION, V23, P424, DOI 10.1016/j.nut.2007.03.003; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Parikh AA, 1997, J SURG RES, V69, P139, DOI 10.1006/jsre.1997.5061; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shiou SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065108; Stepanova VV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P109, DOI 10.1023/A:1013912500373; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; Yanagihara S, 2012, J MED FOOD, V15, P511, DOI 10.1089/jmf.2012.0040; Yang YJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-38; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009	55	31	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124549	10.1371/journal.pone.0124549	http://dx.doi.org/10.1371/journal.pone.0124549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906317	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000074
J	Monaco, A; Cattaneo, R; Mesin, L; Ortu, E; Giannoni, M; Pietropaoli, D				Monaco, Annalisa; Cattaneo, Ruggero; Mesin, Luca; Ortu, Eleonora; Giannoni, Mario; Pietropaoli, Davide			Dysregulation of the Descending Pain System in Temporomandibular Disorders Revealed by Low-Frequency Sensory Transcutaneous Electrical Nerve Stimulation: A Pupillometric Study	PLOS ONE			English	Article							BOVINE IRIS SPHINCTER; LOCUS-COERULEUS; FUNCTIONAL CONNECTIVITY; DYNAMIC PUPILLOMETRY; PERIAQUEDUCTAL GRAY; OPIOID RECEPTORS; EVOKED PAIN; ULF-TENS; MODULATION; MUSCLE	Using computerized pupillometry, our previous research established that the autonomic nervous system (ANS) is dysregulated in patients suffering from temporomandibular disorders (TMDs), suggesting a potential role for ANS dysfunction in pain modulation and the etiology of TMD. However, pain modulation hypotheses for TMD are still lacking. The periaqueductal gray (PAG) is involved in the descending modulation of defensive behavior and pain through mu, k and delta opioid receptors. Transcutaneous electrical nerve stimulation (TENS) has been extensively used for pain relief, as low-frequency stimulation can activate mu receptors. Our aim was to use pupillometry to evaluate the effect of low-frequency TENS stimulation of mu receptors on opioid descending pathways in TMD patients. In accordance with the Research Diagnostic Criteria for TMD, 18 females with myogenous TMD and 18 matched-controls were enrolled. All subjects underwent subsequent pupillometric evaluations under dark and light conditions before, soon after (end of stimulation) and long after (recovery period) sensorial TENS. The overall statistics derived from the darkness condition revealed no significant differences in pupil size between cases and controls; indeed, TENS stimulation significantly reduced pupil size in both groups. Controls, but not TMD patients, displayed significant differences in pupil size before compared with after TENS. Under light conditions, TMD patients presented a smaller pupil size compared with controls; the pupil size was reduced only in the controls. Pupil size differences were found before and during TENS and before and after TENS in the controls only. Pupillometry revealed that stimulating the descending opioid pathway with low-frequency sensory TENS of the fifth and seventh pairs of cranial nerves affects the peripheral target. The TMD patients exhibited a different pattern of response to TENS stimulation compared with the controls, suggesting that impaired modulation of the descending pain system may be involved in TMD.	[Monaco, Annalisa; Cattaneo, Ruggero; Ortu, Eleonora; Giannoni, Mario; Pietropaoli, Davide] Univ Aquila, Dept Life Hlth & Environm Sci, Dent Unit, St Salvatore Hosp, I-67100 Laquila, Italy; [Mesin, Luca] Politecn Torino, Dept Elect & Telecommun, Turin, Italy	University of L'Aquila; Polytechnic University of Turin	Pietropaoli, D (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Dent Unit, St Salvatore Hosp, Bldg Delta 6,Via Vetoio, I-67100 Laquila, Italy.	davide.pietropaoli@univaq.it	Pietropaoli, Davide/V-6668-2019; mesin, luca/B-7457-2013	Pietropaoli, Davide/0000-0001-9585-1809; mesin, luca/0000-0002-8239-2348; Ortu, Eleonora/0000-0002-9550-2155; Monaco, Annalisa/0000-0002-9567-4459; Giannoni, Mario/0000-0003-4305-970X				Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Aston-Jones G, 2005, SLEEP MED, V6, pS3, DOI 10.1016/S1389-9457(05)80002-4; Ayesh EE, 2007, EXP BRAIN RES, V179, P415, DOI 10.1007/s00221-006-0801-3; Bar KJ, 2009, J NEUROL SCI, V279, P9, DOI 10.1016/j.jns.2009.01.010; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Brightwell JJ, 2009, NEUROSCIENCE, V160, P174, DOI 10.1016/j.neuroscience.2009.02.023; Bruehl S, 2009, NEUROSCI BIOBEHAV R, V33, P475, DOI 10.1016/j.neubiorev.2008.12.003; Chen H, 2013, J PAIN, V14, P983, DOI 10.1016/j.jpain.2013.03.011; Chipaila N, 2014, CRANIO, V32, P118, DOI 10.1179/0886963413Z.00000000018; Cooper BC, 2008, CRANIO, V26, P104, DOI 10.1179/crn.2008.015; Cooper BC, 2011, CRANIO, V29, P237, DOI 10.1179/crn.2011.034; Curtis AL, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-13-j0001.2001; Desantana JM, 2009, NEUROSCIENCE, V163, P1233, DOI 10.1016/j.neuroscience.2009.06.056; DeSantana Josimari M, 2008, Curr Rheumatol Rep, V10, P492; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Eliav E, 2003, PAIN, V104, P481, DOI 10.1016/S0304-3959(03)00077-0; Eze-Nliam CM, 2011, J OROFAC PAIN, V25, P232; Fliegert F, 2005, EUR J CLIN PHARMACOL, V61, P257, DOI 10.1007/s00228-005-0920-y; Gabay S, 2011, ATTEN PERCEPT PSYCHO, V73, P123, DOI 10.3758/s13414-010-0015-4; Graeff FG, 2012, BRAZ J MED BIOL RES, V45, P366, DOI 10.1590/S0100-879X2012007500036; Gutstein HB, 2006, GOODMAN GILMANS PHAR, P547; Hayashi N, 2010, J PHYSIOL ANTHROPOL, V29, P119, DOI 10.2114/jpa2.29.119; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hou RH, 2005, PSYCHOPHARMACOLOGY, V181, P537, DOI 10.1007/s00213-005-0013-8; Ichesco E, 2012, HEADACHE, V52, P441, DOI 10.1111/j.1526-4610.2011.01998.x; ISHIGAKI H, 1991, Journal of Human Ergology, V20, P61; Ishimatsu M, 1996, J NEUROSCI, V16, P5196; Jain S, 2011, PARKINSONISM RELAT D, V17, P119, DOI 10.1016/j.parkreldis.2010.11.005; Jankelson B, 1969, Sci Educ Bull, V2, P29; Johnson M, 2007, PAIN, V130, P157, DOI 10.1016/j.pain.2007.02.007; Kalra A, 2001, J PHARMACOL EXP THER, V298, P257; Kamyszek G, 2001, CRANIO, V19, P162, DOI 10.1080/08869634.2001.11746165; Katch E M, 1986, Anesth Prog, V33, P156; Keay KA, 2001, NEUROSCI LETT, V313, P17, DOI 10.1016/S0304-3940(01)02226-1; Keivanidou A, 2010, CARDIOL J, V17, P65; Kobayashi S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00136; KONCHAK PA, 1988, ANGLE ORTHOD, V58, P343; Korszun A, 2002, J DENT RES, V81, P279, DOI 10.1177/154405910208100411; Larson MD, 2008, CLIN NEUROPHYSIOL, V119, P1358, DOI 10.1016/j.clinph.2008.01.106; Light KC, 2009, J PAIN, V10, P542, DOI 10.1016/j.jpain.2008.12.006; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Lumb BM, 2002, EXP PHYSIOL, V87, P281, DOI 10.1113/eph8702356; Maixner W, 1998, PAIN, V76, P71, DOI 10.1016/S0304-3959(98)00028-1; Maixner W, 1995, PAIN, V63, P341, DOI 10.1016/0304-3959(95)00068-2; Maixner W, 2011, J PAIN, V12, pT75, DOI 10.1016/j.jpain.2011.09.002; Matouskova O, 2011, J CLIN PHARM THER, V36, P513, DOI 10.1111/j.1365-2710.2010.01203.x; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; Monaco A, 2014, CRANIO, V32, P139, DOI 10.1179/0886963413Z.00000000022; Monaco A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-168; Monaco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045424; Monaco A, 2012, J ELECTROMYOGR KINES, V22, P463, DOI 10.1016/j.jelekin.2011.12.008; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Murillo R, 2004, METHOD FIND EXP CLIN, V26, P271; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Nebel MB, 2010, J PAIN, V11, P1083, DOI 10.1016/j.jpain.2010.02.021; Nikolaou A, 2008, PSYCHOPHARMACOLOGY, V196, P167, DOI 10.1007/s00213-007-0949-y; Nilsson AM, 2010, ACTA ODONTOL SCAND, V68, P284, DOI 10.3109/00016357.2010.494620; Ossipov MH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/561761; PATIL PN, 1991, J OCUL PHARMACOL, V7, P297, DOI 10.1089/jop.1991.7.297; Ploner M, 2011, CEREB CORTEX, V21, P719, DOI 10.1093/cercor/bhq146; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Radhakrishnan R, 2003, PAIN, V105, P205, DOI 10.1016/S0304-3959(03)00207-0; Rodrigues Delaine, 2004, Braz. oral res., V18, P290, DOI 10.1590/S1806-83242004000400003; Schmidt JE, 2009, J OROFAC PAIN, V23, P230; Sluka KA, 1999, J PHARMACOL EXP THER, V289, P840; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Staud R, 2012, EXPERT REV NEUROTHER, V12, P577, DOI [10.1586/ern.12.41, 10.1586/ERN.12.41]; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stone EA, 2011, BRAIN RES REV, V67, P193, DOI 10.1016/j.brainresrev.2011.02.002; Suvinen TI, 2005, EUR J PAIN, V9, P613, DOI 10.1016/j.ejpain.2005.01.012; Svensson P, 2001, PAIN, V92, P399, DOI 10.1016/S0304-3959(01)00284-6; Szabadi E, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00094; TACHADO SD, 1989, INVEST OPHTH VIS SCI, V30, P2232; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Topalkara A, 2006, EUR J PHARMACOL, V548, P144, DOI 10.1016/j.ejphar.2006.08.014; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Valentino RJ, 2001, PSYCHOPHARMACOLOGY, V158, P331, DOI 10.1007/s002130000673; Verster JC, 2006, CLIN J PAIN, V22, P499, DOI 10.1097/01.ajp.0000202981.28915.b2; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; Wilhelm B, 1998, SLEEP, V21, P258; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Yamamoto K, 2013, ENVIRON HEALTH PREV, V18, P361, DOI 10.1007/s12199-013-0331-0; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006	88	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122826	10.1371/journal.pone.0122826	http://dx.doi.org/10.1371/journal.pone.0122826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905862	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000017
J	Nagata, N; Sakamoto, K; Arai, T; Niikura, R; Shimbo, T; Shinozaki, M; Ihana, N; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Yanase, M; Akiyama, J; Uemura, N; Noda, M				Nagata, Naoyoshi; Sakamoto, Kayo; Arai, Tomohiro; Niikura, Ryota; Shimbo, Takuro; Shinozaki, Masafumi; Ihana, Noriko; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Uemura, Naomi; Noda, Mitsuhiko			Effect of Body Mass Index and Intra-Abdominal Fat Measured by Computed Tomography on the Risk of Bowel Symptoms	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT SYMPTOMS; OBESITY; PREVALENCE; ADULTS	Background This study aims to investigate the association between body mass index (BMI) or intra-abdominal fat measured by computed tomography (CT) and bowel symptoms. Method A cohort of 958 Japanese adults who underwent colonoscopy and CT and completed questionnaires after excluding colorectal diseases was analyzed. Six symptoms (constipation, diarrhea, loose stools, hard stools, fecal urgency, and incomplete evacuation) using a 7-point Likert scale were evaluated between baseline and second questionnaire for test-retest reliability. Associations between BMI, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and symptom score were analyzed by a rank-ordered logistic model, adjusting for age, sex, smoking, and alcohol consumption, hypertension, diabetes mellitus, and dyslipidemia. Results Some bowel symptom scores were significantly (p < 0.05) different between the age groups, sexes, smoking, and alcohol consumption. In multivariate analysis, constipation was associated with low BMI (p < 0.01), low VAT area (p = 0.01), and low SAT area (p < 0.01). Moreover, hard stools was associated with low BMI (p < 0.01) and low SAT area (p < 0.01). The remaining symptoms were not significantly associated with BMI or intra-abdominal fat. Test-retest reliability of bowel symptom scores with a mean duration of 7.5 months was good (mean kappa, 0.672). Conclusions Both low BMI and low abdominal fat accumulation appears to be useful indicators of increased risk for constipation and hard stools. The long-term test-retest reliability of symptom score suggests that bowel symptoms relevant to BMI or visceral fat remain consistent over several months.	[Nagata, Naoyoshi; Niikura, Ryota; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1628655, Japan; [Sakamoto, Kayo; Arai, Tomohiro; Shinozaki, Masafumi] Natl Ctr Global Hlth & Med, Dept Diagnost Radiol, Shinjuku Ku, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Res Inst, Dept Clin Res & Informat,Shinjuku Ku, Tokyo 1628655, Japan; [Ihana, Noriko; Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Ichikawa, Chiba 2728516, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Diabet Res, Shinjuku Ku, Tokyo 1628655, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp	Noda, Mitsuhiko/W-3905-2019	Noda, Mitsuhiko/0000-0003-0413-4631	Ministry of Health, Labour and Welfare of Japan [H25-016]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was funded by Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H25-016) from the Ministry of Health, Labour and Welfare of Japan. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EB, 2005, ALIMENT PHARM THER, V22, P935, DOI 10.1111/j.1365-2036.2005.02671.x; Aro P, 2005, GUT, V54, P1377, DOI 10.1136/gut.2004.057497; Burton C, 2011, PSYCHOL MED, V41, P555, DOI 10.1017/S0033291710001017; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Campbell AK, 2010, TOXICOLOGY, V278, P268, DOI 10.1016/j.tox.2010.09.001; Collins SM, 2014, NAT REV GASTRO HEPAT, V11, P497, DOI 10.1038/nrgastro.2014.40; CROWELL MD, 1994, AM J GASTROENTEROL, V89, P387; Delgado-Aros S, 2004, AM J GASTROENTEROL, V99, P1801, DOI 10.1111/j.1572-0241.2004.30887.x; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; El-Serag HB, 2014, GUT, V63, P220, DOI 10.1136/gutjnl-2012-304189; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Engsbro AL, 2013, AM J GASTROENTEROL, V108, P972, DOI 10.1038/ajg.2013.15; Eslick GD, 2012, OBES REV, V13, P469, DOI 10.1111/j.1467-789X.2011.00969.x; Farzaneh N, 2013, ANN MED HEALTH SCI R, V3, P391, DOI 10.4103/2141-9248.117958; Goebel-Stengel M, 2014, J NEUROGASTROENTEROL, V20, P228, DOI [10.5056/jnm.2014.20.2.228, 10.5056/jnm.20.2.228]; Goodpaster BH, 2002, CURR OPIN CLIN NUTR, V5, P481, DOI 10.1097/00075197-200209000-00005; Han SH, 2006, J GASTROEN HEPATOL, V21, P1687, DOI 10.1111/j.1440-1746.2006.04269.x; Heizer WD, 2009, J AM DIET ASSOC, V109, P1204, DOI 10.1016/j.jada.2009.04.012; Henningsen P, 2008, J PSYCHOSOM RES, V64, P625, DOI 10.1016/j.jpsychores.2008.02.015; Hoddinott P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005524; Koch CA, 2008, EUR J GASTROEN HEPAT, V20, P822, DOI 10.1097/MEG.0b013e3282f5f75e; Kubo M, 2011, NEUROGASTROENT MOTIL, V23, P249, DOI 10.1111/j.1365-2982.2010.01640.x; Lee SY, 2009, DIGESTION, V79, P196, DOI 10.1159/000211715; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Moayyedi P, 2008, DIGEST DIS SCI, V53, P2293, DOI 10.1007/s10620-008-0410-z; Nagata N, 2014, INT J CANC; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; Nam Su Youn, 2010, J Neurogastroenterol Motil, V16, P47, DOI 10.5056/jnm.2010.16.1.47; Reding KW, 2013, AM J GASTROENTEROL, V108, P270, DOI 10.1038/ajg.2012.414; Shiotani A, 2006, J GASTROENTEROL, V41, P562, DOI 10.1007/s00535-006-1805-2; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Talley NJ, 2004, AM J GASTROENTEROL, V99, P1807, DOI 10.1111/j.1572-0241.2004.30388.x; Talley NJ, 2004, NEUROGASTROENT MOTIL, V16, P413, DOI 10.1111/j.1365-2982.2004.00530.x; THAETE FL, 1995, INT J OBESITY, V19, P464; Wiklund IK, 2003, SCAND J GASTROENTERO, V38, P947, DOI 10.1080/00365520310004209; Zhao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043749	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123993	10.1371/journal.pone.0123993	http://dx.doi.org/10.1371/journal.pone.0123993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906052	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000054
J	van der Flier, A; Liu, Z; Tan, SY; Chen, K; Drager, D; Liu, TY; Patarroyo-White, S; Jiang, HY; Light, DR				van der Flier, Arjan; Liu, Zhan; Tan, Siyuan; Chen, Kai; Drager, Douglas; Liu, Tongyao; Patarroyo-White, Susannah; Jiang, Haiyan; Light, David R.			FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; PEGYLATED FACTOR-VIII; PROLONGED ACTIVITY; FACTOR-IX; ENDOTHELIAL-CELLS; IGG HOMEOSTASIS; PLASMA-LEVELS; HALF-LIFE; RECEPTOR	We recently developed a longer lasting recombinant factor VIII-Fc fusion protein, rFVIIIFc, to extend the half-life of replacement FVIII for the treatment of people with hemophilia A. In order to elucidate the biological mechanism for the elongated half-life of rFVIIIFc at a cellular level we delineated the roles of VWF and the tissue-specific expression of the neonatal Fc receptor (FcRn) in the biodistribution, clearance and cycling of rFVIIIFc. We find the tissue biodistribution is similar for rFVIIIFc and rFVIII and that liver is the major clearance organ for both molecules. VWF reduces the clearance and the initial liver uptake of rFVIIIFc. Pharma-cokinetic studies in FcRn chimeric mice show that FcRn expressed in somatic cells (hepatocytes or liver sinusoidal endothelial cells) mediates the decreased clearance of rFVIIIFc, but FcRn in hematopoietic cells (Kupffer cells) does not affect clearance. Immunohistochemical studies show that when rFVIII or rFVIIIFc is in dynamic equilibrium binding with VWF, they mostly co localize with VWF in Kupffer cells and macrophages, confirming a major role for liver macrophages in the internalization and clearance of the VWF-FVIII complex. In the absence of VWF a clear difference in cellular localization of VWF-free rFVIII and rFVIIIFc is observed and neither molecule is detected in Kupffer cells. Instead, rFVIII is observed in hepatocytes, indicating that free rFVIII is cleared by hepatocytes, while rFVIIIFc is observed as a diffuse liver sinusoidal staining, suggesting recycling of free-rFVIIIFc out of hepatocytes. These studies reveal two parallel linked clearance pathways, with a dominant pathway in which both rFVIIIFc and rFVIII complexed with VWF are cleared mainly by Kupffer cells without FcRn cycling. In contrast, the free fraction of rFVIII or rFVIIIFc unbound by VWF enters hepatocytes, where FcRn reduces the degradation and clearance of rFVIIIFc relative to rFVIII by cycling rFVIIIFc back to the liver sinusoid and into circulation, enabling the elongated half-life of rFVIIIFc.	[van der Flier, Arjan; Liu, Zhan; Tan, Siyuan; Chen, Kai; Drager, Douglas; Liu, Tongyao; Patarroyo-White, Susannah; Jiang, Haiyan; Light, David R.] Biogen, Hematol Res, Cambridge, MA 02142 USA	Biogen	Light, DR (corresponding author), Biogen, Hematol Res, Cambridge, MA 02142 USA.	david.light@biogen.com		van der Flier, Arjan/0000-0002-6911-9291				Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Antoni G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-102; Baker K, 2013, CELL MOL LIFE SCI, V70, P1319, DOI 10.1007/s00018-012-1100-8; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Butenas S, 2010, THROMB RES, V126, P119, DOI 10.1016/j.thromres.2010.04.004; Chang CH, 2008, IN VIVO, V22, P693; Christianson GJ, 2012, MABS-AUSTIN, V4, P208, DOI 10.4161/mabs.4.2.19397; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Denis CV, 2008, THROMB HAEMOSTASIS, V99, P271, DOI 10.1160/TH07-10-0629; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dumont JA, 2012, BLOOD, V119, P3024, DOI 10.1182/blood-2011-08-367813; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FAY PJ, 1991, J BIOL CHEM, V266, P2172; Federici AB, 2003, HAEMATOLOGICA, V88; Froh M, 2003, CURR PROTOC TOXICOL; Gadisseur A, 2009, ACTA HAEMATOL-BASEL, V121, P71, DOI 10.1159/000214846; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Gui T, 2002, BLOOD, V100, P153, DOI 10.1182/blood.V100.1.153; Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x; Kanaji S, 2012, J THROMB HAEMOST, V10, P1646, DOI 10.1111/j.1538-7836.2012.04797.x; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Kuo TT, 2010, J CLIN IMMUNOL, V30, P777, DOI 10.1007/s10875-010-9468-4; Lenting PJ, 2007, J THROMB HAEMOST, V5, P1353, DOI 10.1111/j.1538-7836.2007.02572.x; Lenting PJ, 2010, HAEMOPHILIA, V16, P194, DOI 10.1111/j.1365-2516.2010.02320.x; Lenting PJ, 2010, HAEMOPHILIA, V16, P6, DOI 10.1111/j.1365-2516.2008.01864.x; Lillicrap D, 2013, BLOOD, V122, P3735, DOI 10.1182/blood-2013-06-498303; Liu ZL, 2014, BLOOD, V124, P4223; Mahlangu J, 2014, BLOOD, V123, P317, DOI 10.1182/blood-2013-10-529974; Medesan C, 1997, J IMMUNOL, V158, P2211; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Mordenti J, 1996, TOXICOL APPL PHARM, V136, P75, DOI 10.1006/taap.1996.0008; Nakata K, 2010, BIOCHEM BIOPH RES CO, V395, P238, DOI 10.1016/j.bbrc.2010.03.170; National Research Council, 2011, GUIDE CARE USE LAB A; Navarrete A, 2009, J THROMB HAEMOST, V7, P1816, DOI 10.1111/j.1538-7836.2009.03571.x; Nonaka H, 2007, DEV DYNAM, V236, P2258, DOI 10.1002/dvdy.21227; Ogawara K, 1999, J CONTROL RELEASE, V59, P15, DOI 10.1016/S0168-3659(99)00015-2; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; Powell JS, 2012, BLOOD, V119, P3031, DOI 10.1182/blood-2011-09-382846; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Rastegarlari G, 2012, BLOOD, V119, P2126, DOI 10.1182/blood-2011-08-373605; Rath T., 2013, CRIT REV BIOTECHNOL, V1, P1; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rydz N, 2013, BLOOD, V121, P5228, DOI 10.1182/blood-2012-10-457507; Sarafanov AG, 2001, J BIOL CHEM, V276, P11970, DOI 10.1074/jbc.M008046200; Sarin Hemant, 2010, J Angiogenes Res, V2, P14, DOI 10.1186/2040-2384-2-14; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Shapiro AD, 2014, J THROMB HAEMOST, V12, P1788, DOI 10.1111/jth.12723; Shi Q, 2012, HAEMOPHILIA, V18, P639, DOI 10.1111/j.1365-2516.2011.02735.x; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; SODETZ JM, 1977, J BIOL CHEM, V252, P5538; Stennicke HR, 2013, BLOOD, V121, P2108, DOI 10.1182/blood-2012-01-407494; Tang L, 2013, HAEMOPHILIA, V19, P539, DOI 10.1111/hae.12116; Terraube V, 2010, HAEMOPHILIA, V16, P3, DOI 10.1111/j.1365-2516.2009.02005.x; van Schooten CJ, 2008, BLOOD, V112, P1704, DOI 10.1182/blood-2008-01-133181; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; Vlot AJ, 1996, BLOOD, V87, P1809; Wisse E, 2008, GENE THER, V15, P1193, DOI 10.1038/gt.2008.60	71	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124930	10.1371/journal.pone.0124930	http://dx.doi.org/10.1371/journal.pone.0124930			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905473	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000094
J	Wang, L; Velazquez, H; Chang, J; Safirstein, R; Desir, GV				Wang, Ling; Velazquez, Heino; Chang, John; Safirstein, Robert; Desir, Gary V.			Identification of a Receptor for Extracellular Renalase	PLOS ONE			English	Article							MEMBRANE CALCIUM-ATPASE; BLOOD-PRESSURE; HYPERTENSION; ASSOCIATION; SURVIVAL; OXIDASE; STROKE; GENE; AKI	Background An increased risk for developing essential hypertension, stroke and diabetes is associated with single nucleotide gene polymorphisms in renalase, a newly described secreted flavoprotein with oxidoreductase activity. Gene deletion causes hypertension, and aggravates acute ischemic kidney (AKI) and cardiac injury. Independent of its intrinsic enzymatic activities, extracellular renalase activates MAPK signaling and prevents acute kidney injury (AKI) in wild type (WT) mice. Therefore, we sought to identity the receptor for extracellular renalase. Methods and Results RP-220 is a previously identified, 20 amino acids long renalase peptide that is devoid of any intrinsic enzymatic activity, but it is equally effective as full-length recombinant renalase at protecting against toxic and ischemic injury. Using biotin transfer studies with RP-220 in the human proximal tubular cell line HK-2 and protein identification by mass spectrometry, we identified PMCA4b as a renalase binding protein. This previously characterized plasma membrane ATPase is involved in cell signaling and cardiac hypertrophy. Co-immunoprecipitation and co-immunolocalization confirmed protein-protein interaction between endogenous renalase and PMCA4b. Down-regulation of endogenous PMCA4b expression by siRNA transfection, or inhibition of its enzymatic activity by the specific peptide inhibitor caloxin 1b each abrogated RP-220 dependent MAPK signaling and cytoprotection. In control studies, these maneuvers had no effect on epidermal growth factor mediated signaling, confirming specificity of the interaction between PMCA4b and renalase. Conclusions PMCA4b functions as a renalase receptor, and a key mediator of renalase dependent MAPK signaling.	[Wang, Ling; Velazquez, Heino; Chang, John; Safirstein, Robert; Desir, Gary V.] Yale Univ, Dept Med, VACHS, New Haven, CT 06520 USA; [Wang, Ling] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200030, Peoples R China	Yale University; Shanghai Jiao Tong University	Desir, GV (corresponding author), Yale Univ, Dept Med, VACHS, New Haven, CT 06520 USA.	gary.desir@yale.edu			Bessor Pharma Company; VA Connecticut; National Institutes of Health [RC1DK086465, RC1DK086402, R01DK081037]; National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; Shanghai Health Bureau [ZXSNXD-CC-ZDYJ002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, RC1DK086465, RC1DK086402, R01DK081037] Funding Source: NIH RePORTER	Bessor Pharma Company; VA Connecticut; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China 973 Program(National Basic Research Program of China); Shanghai Health Bureau; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Research grants from Bessor Pharma Company, VA Connecticut (H.V, R.S. and G.V.D.), National Institutes of Health grant RC1DK086465, RC1DK086402 and R01DK081037 (G.V.D), National Basic Research Program of China 973 Program 2012CB517600 and 2012CB517602, and Shanghai Health Bureau ZXSNXD-CC-ZDYJ002 (W.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Buraczynska M, 2011, NEUROMOL MED, V13, P321, DOI 10.1007/s12017-011-8158-6; Cartwright EJ, 2007, ANN NY ACAD SCI, V1099, P247, DOI 10.1196/annals.1387.007; Desir GV, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002634; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013496; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Malyszko J, 2012, RENAL FAILURE, V34, P727, DOI 10.3109/0886022X.2012.681534; Milani M, 2011, J MOL BIOL, V411, P463, DOI 10.1016/j.jmb.2011.06.010; Mohamed TMA, 2013, J MOL CELL CARDIOL, V63, P57, DOI 10.1016/j.yjmcc.2013.07.007; Pande J, 2008, J CELL MOL MED, V12, P1049, DOI 10.1111/j.1582-4934.2008.00140.x; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693; Wu YL, 2011, KIDNEY INT, V79, P853, DOI 10.1038/ki.2010.488; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4	23	44	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122932	10.1371/journal.pone.0122932	http://dx.doi.org/10.1371/journal.pone.0122932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906147	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000019
J	Zhang, Y; Yang, HQ; Fang, F; Song, LL; Jiao, YY; Wang, H; Peng, XL; Zheng, YP; Wang, J; He, JS; Hung, T				Zhang, Ying; Yang, Hai-Qiang; Fang, Fang; Song, Lin-Lin; Jiao, Yue-Ying; Wang, He; Peng, Xiang-Lei; Zheng, Yan-Peng; Wang, Jun; He, Jin-Sheng; Hung, Tao			Single Chain Variable Fragment Against A beta Expressed in Baculovirus Inhibits Abeta Fibril Elongation and Promotes its Disaggregation	PLOS ONE			English	Article							MOUSE MODELS; FV; IMMUNOTHERAPY; IMMUNIZATION; OLIGOMERS; DISEASE	Alzheimer's disease (AD) is the most common form of age-related dementia, and the most urgent problem is that it is currently incurable. Amyloid-beta (A beta) peptide is believed to play a major role in the pathogenesis of AD. We previously reported that an A beta N-terminal amino acid targeting monoclonal antibody (MAb), A8, inhibits A beta fibril formation and has potential as an immunotherapy for AD based on a mouse model. To further study the underlying mechanisms, we tested our hypothesis that the single chain fragment variable (scFv) without the Fc fragment is capable of regulating either A beta aggregation or disaggregation in vitro. Here, a model of cell-free A beta "on-pathway" aggregation was established and identified using PCR, Western blot, ELISA, transmission electron microscopy (TEM) and thioflavin T (ThT) binding analyses. His-tagged A8 scFvs was cloned and solubly expressed in baculovirus. Our data demonstrated that the Ni-NTA agarose affinity-purified A8 scFv inhibited the forward reaction of "on-pathway" aggregation and A beta fibril maturation. The effect of A8 scFv on A beta fibrillogenesis was markedly more significant when administered at the start of the A beta folding reaction. Furthermore, the results also showed that pre-formed A beta fibrils could be disaggregated via incubation with purified A8 scFv, which suggested that A8 scFv is involved in the reverse reaction of A beta aggregation. Therefore, A8 scFv was capable of both inhibiting fibrillogenesis and disaggregating matured fibrils. Our present study provides valuable insight into the regulators of ultrastructural dynamics of cell-free "on-pathway" A beta aggregation and will assist in the development of therapeutic strategies for AD.	[Zhang, Ying; Yang, Hai-Qiang; Fang, Fang; Song, Lin-Lin; Jiao, Yue-Ying; Wang, He; Peng, Xiang-Lei; Zheng, Yan-Peng; Wang, Jun; He, Jin-Sheng; Hung, Tao] Beijing Jiaotong Univ, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Hung, Tao] China CDC, Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Beijing Jiaotong University; Chinese Center for Disease Control & Prevention	Zhang, Y (corresponding author), Beijing Jiaotong Univ, Coll Life Sci & Bioengn, Beijing, Peoples R China.	yingzhang@bjtu.edu.cn	HE, Jin-Sheng/G-4585-2011; yang, zheng/HGC-7753-2022	HE, Jin-Sheng/0000-0002-6592-0540; 	National Natural Science Foundation of China [81100809, 81271417]; Beijing Natural Science Foundation [7152090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (81100809 and 81271417) and the Beijing Natural Science Foundation (http://www.bjnsf.org/) (7152090) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDZYK WD, 1990, J BIOL CHEM, V265, P18615; Blennow K, 2014, NEUROPSYCHOPHARMACOL, V39, P189, DOI 10.1038/npp.2013.154; Cattepoel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018296; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; Donofrio G, 2005, J VIROL, V79, P8330, DOI 10.1128/JVI.79.13.8330-8338.2005; Drachman DA, 2014, ALZHEIMERS DEMENT; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Joseph-Mathurin N, 2013, NEUROBIOL AGING, V34, P2613, DOI 10.1016/j.neurobiolaging.2013.05.013; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Laske C, 2014, NEW ENGL J MED, V370, P1459, DOI 10.1056/NEJMc1402193; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Roychaudhuri R, 2013, J MOL BIOL; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Upadhaya AR, 2012, NEUROBIOL AGING, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Wang X, 2010, LETTERS BIOTECHNOLOG, V21, P192; Wang YJ, 2014, NAT REV NEUROL, V10, P188, DOI 10.1038/nrneurol.2014.44; Weatherill EE, 2012, PROTEIN ENG DES SEL, V25, P321, DOI 10.1093/protein/gzs021; WHITLOW M, 1994, PROTEIN ENG, V7, P1017, DOI 10.1093/protein/7.8.1017; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zhang Y, 2011, J ALZHEIMERS DIS, V23, P551, DOI 10.3233/JAD-2010-091195; Zhang Y, 2009, HYBRIDOMA, V28, P349, DOI 10.1089/hyb.2009.0015	30	4	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124736	10.1371/journal.pone.0124736	http://dx.doi.org/10.1371/journal.pone.0124736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919299	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400059
J	Guzman-Puyol, S; Benitez, JJ; Dominguez, E; Bayer, IS; Cingolani, R; Athanassiou, A; Heredia, A; Heredia-Guerrero, JA				Guzman-Puyol, Susana; Jesus Benitez, Jose; Dominguez, Eva; Bayer, Ilker Sefik; Cingolani, Roberto; Athanassiou, Athanassia; Heredia, Antonio; Heredia-Guerrero, Jose Alejandro			Pectin-Lipid Self-Assembly: Influence on the Formation of Polyhydroxy Fatty Acids Nanoparticles	PLOS ONE			English	Article							PYROLYTIC-GRAPHITE SURFACE; FRUIT CUTICLE; PLANT BIOPOLYESTER; VESICLES; CHAINS	Nanoparticles, named cutinsomes, have been prepared from aleuritic (9,10,16-trihidroxipalmitic) acid and tomato fruit cutin monomers (a mixture of mainly 9(10), 16-dihydroxypalmitic acid (85%, w/w) and 16-hydroxyhexadecanoic acid (7.5%, w/w)) with pectin in aqueous solution. The process of formation of the nanoparticles of aleuritic acid plus pectin has been monitored by UV-Vis spectrophotometry, while their chemical and morphological characterization was analyzed by ATR-FTIR, TEM, and non-contact AFM. The structure of these nanoparticles can be described as a lipid core with a pectin shell. Pectin facilitated the formation of nanoparticles, by inducing their aggregation in branched chains and favoring the condensation between lipid monomers. Also, pectin determined the self-assembly of cutinsomes on highly ordered pyrolytic graphite (HOPG) surfaces, causing their opening and forming interconnected structures. In the case of cutin monomers, the nanoparticles are fused, and the condensation of the hydroxy fatty acids is strongly affected by the presence of the polysaccharide. The interaction of pectin with polyhydroxylated fatty acids could be related to an initial step in the formation of the plant biopolyester cutin.	[Guzman-Puyol, Susana; Bayer, Ilker Sefik; Athanassiou, Athanassia; Heredia-Guerrero, Jose Alejandro] Fdn Ist Italiano Tecnol IIT, Nanophys, Smart Mat, I-16163 Genoa, Italy; [Jesus Benitez, Jose] Ctr Mixto CSIC Univ Sevilla, ICMS, E-41092 Seville, Spain; [Dominguez, Eva] Univ Malaga CSIC, IHSM Mayora, E-29750 Malaga, Spain; [Cingolani, Roberto] Fdn Ist Italiano Tecnol IIT, I-16163 Genoa, Italy; [Heredia, Antonio] Univ Malaga, UMA CSIC, IHSM La Mayora, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain	Istituto Italiano di Tecnologia - IIT; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Ciencia de Materiales de Sevilla (ICMS-CSIC); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Istituto Italiano di Tecnologia - IIT; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Heredia-Guerrero, JA (corresponding author), Fdn Ist Italiano Tecnol IIT, Nanophys, Smart Mat, Via Morego 30, I-16163 Genoa, Italy.	jose.guerrero@iit.it	Domínguez, Eva/D-6137-2014; Guzman-Puyol, Susana/W-4155-2017; Heredia-Guerrero, José Alejandro/H-8822-2012; ATHANASSIOU, ATHANASSIA/B-4197-2018; Heredia, Antonio/AAR-2209-2021; Heredia, Antonio/H-4366-2015; Benitez, Jose J/K-5662-2014; Puyol, Susana Guzman/AAG-8919-2019	Domínguez, Eva/0000-0003-4129-9849; Guzman-Puyol, Susana/0000-0001-5658-5181; Heredia-Guerrero, José Alejandro/0000-0002-8251-7577; ATHANASSIOU, ATHANASSIA/0000-0002-6533-3231; Heredia, Antonio/0000-0001-9051-6876; Benitez, Jose J/0000-0002-3222-0564; Puyol, Susana Guzman/0000-0001-5658-5181; Bayer, Ilker S./0000-0002-7951-8851	Marie Curie Intra-European Fellowship (BIOPROTO project); EU	Marie Curie Intra-European Fellowship (BIOPROTO project); EU(European Commission)	Jose A. Heredia-Guerrero is supported by a Marie Curie Intra-European Fellowship (BIOPROTO project), financed by the EU's Seventh Framework Programme for Research (FP7).	Apel CL, 2002, BBA-BIOMEMBRANES, V1559, P1, DOI 10.1016/S0005-2736(01)00400-X; Beniitez JJ, 2004, BBA-GEN SUBJECTS, V1674, P1, DOI 10.1016/j.bbagen.2004.06.012; Benitez JJ, 2014, J APPL POLY IN PRESS, DOI 10.1002./APP.41328; D'Angeli S, 2013, NEW PHYTOL, V197, P123, DOI 10.1111/j.1469-8137.2012.04372.x; Dominguez E, 2010, MOL BIOSYST, V6, P948, DOI 10.1039/b927186d; Frey-Wyssling A, 1965, ULTRASTRUCTURAL PLAN; Heredia A, 2003, BBA-GEN SUBJECTS, V1620, P1, DOI 10.1016/S0304-4165(02)00510-X; Heredia A, 2009, BIOINTERPHASES, V4, pP1, DOI 10.1116/1.3063816; Heredia-Guerrero JA, 2011, SOFT MATTER, V7, P4357, DOI 10.1039/c0sm01545h; Heredia-Guerrero JA, 2008, BIOESSAYS, V30, P273, DOI 10.1002/bies.20716; Heredia-Guerrero JA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00305; Heredia-Guerrero JA, 2010, CHEM PHYS LIPIDS, V163, P329, DOI 10.1016/j.chemphyslip.2010.01.006; Heredia-Guerrero JA, 2009, POLYMER, V50, P5633, DOI 10.1016/j.polymer.2009.10.018; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kwiatkowska M, 2014, PROTOPLASMA, V251, P1151, DOI 10.1007/s00709-014-0623-2; Lara I, 2014, POSTHARVEST BIOL TEC, V87, P103, DOI 10.1016/j.postharvbio.2013.08.012; LUQUE P, 1995, ARCH BIOCHEM BIOPHYS, V317, P417, DOI 10.1006/abbi.1995.1183; Martin LBB, 2014, J EXP BOT, V65, P4639, DOI 10.1093/jxb/eru301; Parsons EP, 2013, PHYSIOL PLANTARUM, V149, P160, DOI 10.1111/ppl.12035; PETRACEK PD, 1995, PLANT PHYSIOL, V109, P675, DOI 10.1104/pp.109.2.675; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Riederer M., 2006, BIOL PLANT CUTICLE; Tsubaki S, 2008, J AGR FOOD CHEM, V56, P11293, DOI 10.1021/jf802253s; Vilela C, 2014, POLYM CHEM-UK, V5, P3119, DOI 10.1039/c3py01213a; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Yeats TH, 2012, NAT CHEM BIOL, V8, P609, DOI [10.1038/NCHEMBIO.960, 10.1038/nchembio.960]; Yokota S, 2007, CARBOHYD RES, V342, P2593, DOI 10.1016/j.carres.2007.08.018; Yokota S, 2007, BIOMACROMOLECULES, V8, P3848, DOI 10.1021/bm700819f	28	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124639	10.1371/journal.pone.0124639	http://dx.doi.org/10.1371/journal.pone.0124639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915490	Green Published, gold			2022-12-26	WOS:000353659100058
J	Kim, H; Bakshi, A; Kim, J				Kim, Hana; Bakshi, Arundhati; Kim, Joomyeong			Retrotransposon-Derived Promoter of Mammalian Aebp2	PLOS ONE			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; EVOLUTION; POLYCOMB; PRIMATES; GENES	Variable DNA methylation in promoter regions has been implicated in altering transcriptional regulation. The current study analyzed the evolutionary origin and DNA methylation pattern of one of the promoters of Aebp2. According to the results, the first promoter of Aebp2 has been derived from retrotransposons independently in the primate and rodent lineages. DNA methylation analyses revealed that this promoter is unmethylated in sperm, methylated in mature oocytes, and partially methylated at embryonic day 10.5 (78.3%) and 14.5 (58.3%). This promoter also shows variable levels of DNA methylation among adult organs, ranging from the highest in spleen (similar to 80%) to the lowest in tail (similar to 50%). The results from the F1 hybrid of interspecific crossing further indicated that both alleles are equally methylated without any allele bias, also supported by its biallelic expression. Therefore, the partial methylation observed among somatic tissues is an outcome of the genome-wide resetting of DNA methylation during the implantation stage, but not of the inherited allelic methylation pattern preset during gametogenesis. Taken together, mammalian Aebp2 has adopted retrotransposons as its promoter, which displays partial DNA methylation pattern of allelic-or nonallelic origin during the different stages of development.	[Kim, Hana; Bakshi, Arundhati; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Bakshi, Arundhati/0000-0001-8483-1597	National Institute of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of Health (J.K. R01-GM066225 and R01-GM097074). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bunch PO, 1991, BIOL REPROD, V44, P672; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CATZEFLIS FM, 1993, MAMMAL PHYLOGENY : PLACENTALS, P159; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; EPPIG JJ, 1993, METHOD ENZYMOL, V225, P77; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hogan B, 1994, MANIPULATING MOUSE E, DOI [10.1007/978-1-60327-019-9_13, DOI 10.1007/978-1-60327-019-9_13]; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kim H, 2015, GENOMICS, V105, P108, DOI 10.1016/j.ygeno.2014.11.007; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025174; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kim J, 2012, ILAR J, V53, P232, DOI 10.1093/ilar.53.3-4.232; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schroeder DI, 2011, GENOME RES, V21, P1583, DOI 10.1101/gr.119131.110; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	30	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126966	10.1371/journal.pone.0126966	http://dx.doi.org/10.1371/journal.pone.0126966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915901	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100159
J	Abebe, SM; Berhane, Y; Worku, A; Getachew, A				Abebe, Solomon Mekonnen; Berhane, Yemane; Worku, Alemayehu; Getachew, Assefa			Prevalence and Associated Factors of Hypertension: A Crossectional Community Based Study in Northwest Ethiopia	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BLOOD-PRESSURE; FASTING GLUCOSE; RISK; AFRICA	Background Hypertension, being the root cause of many of the body sytem and organs failure, remains to be a major public health challenge globally. Though the problem is huge in both developed and developing countries, data are scarce in developing countries like Ethiopia. Therefore, this study was aimed to determine the magnitude and associated factors of hypertension in North West Ethiopia. Methods A cross-sectional survey was conducted on adults aged 35 years and above in the rural and urban communities of Dabat district and Gondar town in 2012. The data were collected using the WHO STEPwise strategy. Hypertension was defined as having a Systolic blood pressure of >= 140 mmHg and/or a Diastolic BP of >= 90mmHg or a reported use of anti-hypertensive medications for raised blood pressure. Prevalence was computed with a 95% confidence interval. Selected risk factors were assessed using a biviarete logistic regression. Results A total of 2200 participants were included in the study. The median age (+/- SD) was 47 (+/- 12.4) years. The overall prevalence of hypertension was found to be 27.9%[95% CI 26.0, 29.8], with the proportion in the urban and rural residents being 30.7% and 25.3% respectively. The prevalence of hypertension was 29.3% for women and 26.3% for men. Out of the 598 hypertensive patients 241 (40.3%) had blood pressure measurements, and 99 (16.6%) had known hypertension and were on treatment. The proportion of systolic and diastolic hypertension in this subgroup of adults was 133(6.2%). The multivariable logistic regression analysis showed older age (AOR = 1.06; 1.05, 1.07), raised fasting glucose (AOR = 1.01; 1.001, 1.01), alcohol consumption (AOR = 1.71; 1.24, 2.36), and raised BMI (AOR = 1.07; 1.04, 1.10) were significantly associated with hypertension. Conclusion The prevalence of hypertension was considerably higher in rural areas than previously reported. The health system needs to develop strategies to increase the reach of relevant screening and diagnostic services to both rural and urban populations.	[Abebe, Solomon Mekonnen] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Getachew, Assefa] Univ Gondar, Sch Med, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; Addis Continental Institute of Public Health; Addis Ababa University; University of Gondar	Abebe, SM (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	solomekonnen@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	World Health Organization; Addis Continental Institute of Public Health	World Health Organization(World Health Organization); Addis Continental Institute of Public Health	Partial funding for this study was received from the World Health Organization and the Addis Continental Institute of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-97; Abu Sayeed M, 2004, DIABETES CARE, V27, P1054, DOI 10.2337/diacare.27.5.1054; Admassu M., 2011, ETHIOPIAN J HLTH BIO, V4, P1; Agyemang C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-114; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Akhmedjonov A, 2013, DRUG ALCOHOL REV, V32, P248, DOI 10.1111/j.1465-3362.2012.00521.x; [Anonymous], 2012, LANCET, V379, P2213, DOI 10.1016/S0140-6736(12)60960-X; [Anonymous], 2007, SUMMARY STAT REPORT; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper Richard S, 2003, Ethn Dis, V13, pS48; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Fuster, 2010, PROMOTING CARDIOVASC; Gierach Marcin, 2014, ISRN Endocrinol, V2014, P514589, DOI 10.1155/2014/514589; Hillbom M, 2011, CURR HYPERTENS REP, V13, P208, DOI 10.1007/s11906-011-0194-y; Kim HK, 2013, DIABETES CARE, V36, P328, DOI 10.2337/dc12-0587; Longo-Mbenza B, 2008, EUR J CARDIOV PREV R, V15, P503, DOI 10.1097/HJR.0b013e3282f21640; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nshisso LD, 2012, DIABETES METAB SYND, V6, P36, DOI 10.1016/j.dsx.2012.05.005; Osei K, 2004, DIABETES CARE, V27, P1439, DOI 10.2337/diacare.27.6.1439; Peter Lloyd-Sherlock, 2014, INT J EPIDEMIOL, V1; Rguibi M, 2006, PUBLIC HEALTH NUTR, V9, P722, DOI 10.1079/PHN2005866; Sayeed M A, 2007, Bangladesh Med Res Counc Bull, V33, P1; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; Tran A., 2011, INT J HYPERTENSION; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yanai H, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-10	31	94	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125210	10.1371/journal.pone.0125210	http://dx.doi.org/10.1371/journal.pone.0125210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909382	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800133
J	Gong, WP; Wang, PC; Xiong, XL; Jiao, J; Yang, XM; Wen, BH				Gong, Wenping; Wang, Pengcheng; Xiong, Xiaolu; Jiao, Jun; Yang, Xiaomei; Wen, Bohai			Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice	PLOS ONE			English	Article							MOUNTAIN-SPOTTED-FEVER; PROTECTIVE IMMUNITY; ANTIVIRAL IMMUNITY; ENDOTHELIAL-CELLS; NITRIC-OXIDE; INFECTION; PHASE; VACCINE; ACTIVATION; ANTIBODIES	The obligate intracellular bacteria, Rickettsia rickettsii and Coxiella burnetii, are the potential agents of bio-warfare/bio-terrorism. Here C3H/HeN mice were immunized with a recombinant protein fragment rOmp-4 derived from outer membrane protein B, a major protective antigen of R. rickettsii, combined with chloroform-methanol residue (CMR) extracted from phase I C. burnetii organisms, a safer Q fever vaccine. These immunized mice had significantly higher levels of IgG1 and IgG2a to rOmpB-4 and interferon-gamma .(IFN-gamma.)and tumor necrosis factor-alpha (TNF-alpha), two crucial cytokines in resisting intracellular bacterial infection, as well as significantly lower rickettsial loads and slighter pathological lesions in organs after challenge with R. rickettsii, compared with mice immunized with rOmpB-4 or CMR alone. Additionally, after challenge with C. burnetii, the coxiella loads in the organs of these mice were significantly lower than those of mice immunized with rOmpB-4 alone. Our results prove that CMR could markedly potentiate enhance the rOmpB-4-specific immunoprotection by promoting specific and non-specific immunoresponses and the immunization with the protective antigen of R. rickettsii combined with CMR of C. burnetii could confer effective protection against infection of R. rickettsii or C. burnetii.	[Gong, Wenping; Wang, Pengcheng; Xiong, Xiaolu; Jiao, Jun; Yang, Xiaomei; Wen, Bohai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Pengcheng] PLA, Hosp 105, Dept Clin Lab, Hefei, Anhui, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Xiong, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiongxiaolu624@sohu.com; wenbohai@yahoo.com	Jiao, Jun/ABE-7519-2021; Gong, Wenping/B-8183-2018	Gong, Wenping/0000-0002-0333-890X	National Natural Science Foundation of China [31470894, 81371767, 31170161]; Natural Science and Technology Major Project of China [2013ZX10004803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science and Technology Major Project of China	This work was supported by the National Natural Science Foundation of China grants 31470894, 81371767 and 31170161, the Natural Science and Technology Major Project of China (grant 2013ZX10004803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; ACKLAND JR, 1994, MED J AUSTRALIA, V160, P704, DOI 10.5694/j.1326-5377.1994.tb125909.x; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; Balraj P, 2008, FEMS MICROBIOL LETT, V286, P257, DOI 10.1111/j.1574-6968.2008.01283.x; Benenson AS., 1959, Q FEVER VACCINE EFFI; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07; CLARK IA, 1979, INFECT IMMUN, V24, P319, DOI 10.1128/IAI.24.2.319-325.1979; DAMROW TA, 1985, INFECT IMMUN, V47, P149, DOI 10.1128/IAI.47.1.149-156.1985; de Cremoux R, 2012, FEMS IMMUNOL MED MIC, V64, P104, DOI 10.1111/j.1574-695X.2011.00892.x; Duan CS, 2011, AM J TROP MED HYG, V85, P504, DOI 10.4269/ajtmh.2011.10-0660; DUPONT HL, 1973, J INFECT DIS, V128, P340, DOI 10.1093/infdis/128.3.340; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FRIES LF, 1993, INFECT IMMUN, V61, P1251, DOI 10.1128/IAI.61.4.1251-1258.1993; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; HANSON BA, 1983, INFECT IMMUN, V42, P341, DOI 10.1128/IAI.42.1.341-349.1983; HARRELL GT, 1949, ARCH INTERN MED, V83, P331, DOI 10.1001/archinte.1949.00220320085007; HORNEY LF, 1988, SOUTHERN MED J, V81, P915, DOI 10.1097/00007611-198807000-00028; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Kampschreur LM, 2013, EMERG INFECT DIS, V19, P768, DOI 10.3201/eid1905.120353; KELLY MT, 1977, CELL IMMUNOL, V28, P198, DOI 10.1016/S0008-8749(77)80020-8; KELLY MT, 1976, CANCER IMMUNOL IMMUN, V1, P187, DOI 10.1007/BF00205464; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; Kokkini S, 2013, INT J INFECT DIS, V17, pE977, DOI 10.1016/j.ijid.2013.04.010; KOSTER FT, 1985, J IMMUNOL, V135, P1067; Kwak Wooseok, 2013, Osong Public Health Res Perspect, V4, P34, DOI 10.1016/j.phrp.2012.12.006; LEENEN PJM, 1994, J IMMUNOL, V153, P5141; Li QF, 2005, ANN NY ACAD SCI, V1063, P130, DOI 10.1196/annals.1355.021; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Niu Dong-sheng, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P526; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; PARKER R. R., 1941, AMER JOUR TROP MED, V21, P369; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Qi Y, 2013, VACCINE, V31, P5643, DOI 10.1016/j.vaccine.2013.09.064; Rolph MS, 2004, VIROLOGY, V326, P1, DOI 10.1016/j.virol.2004.04.049; Rothoeft T, 2003, IMMUNOLOGY, V110, P430, DOI 10.1111/j.1365-2567.2003.01758.x; SILVERMAN DJ, 1986, J INFECT DIS, V153, P694, DOI 10.1093/infdis/153.4.694; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Varghees S, 2002, INFECT IMMUN, V70, P6741, DOI 10.1128/IAI.70.12.6741-6750.2002; Waag DM, 2008, CLIN VACCINE IMMUNOL, V15, P1505, DOI 10.1128/CVI.00119-08; WAAG DM, 1990, ANN NY ACAD SCI, V590, P203, DOI 10.1111/j.1749-6632.1990.tb42221.x; Waag DM, 2002, VACCINE, V20, P2623, DOI 10.1016/S0264-410X(02)00176-7; WALKER DH, 1980, HUM PATHOL, V11, P263, DOI 10.1016/S0046-8177(80)80008-6; WEINBERG EH, 1969, J BACTERIOL, V98, P398, DOI 10.1128/JB.98.2.398-402.1969; Wilhelmsen CL, 2000, COMPARATIVE MED, V50, P374; WILLIAMS JC, 1982, INFECT IMMUN, V35, P1091, DOI 10.1128/IAI.35.3.1091-1102.1982; WILLIAMS JC, 1992, ANN NY ACAD SCI, V653, P88, DOI 10.1111/j.1749-6632.1992.tb19633.x; Woods ME, 2008, J CLIN IMMUNOL, V28, P174, DOI 10.1007/s10875-007-9140-9; Xiong XL, 2012, VACCINE, V30, P6809, DOI 10.1016/j.vaccine.2012.09.017; ZVILICH M, 1995, ANTIVIR RES, V27, P389, DOI 10.1016/0166-3542(95)00022-E	58	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124664	10.1371/journal.pone.0124664	http://dx.doi.org/10.1371/journal.pone.0124664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909586	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800097
J	Nghiem, N; Blakely, T; Cobiac, LJ; Pearson, AL; Wilson, N				Nghiem, Nhung; Blakely, Tony; Cobiac, Linda J.; Pearson, Amber L.; Wilson, Nick			Health and Economic Impacts of Eight Different Dietary Salt Reduction Interventions	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SODIUM-INTAKE; COST-EFFECTIVENESS; BLOOD-PRESSURE; GLOBAL BURDEN; NEW-ZEALAND; MORTALITY; INEQUALITIES; POLICY; TRADE	Background Given the high importance of dietary sodium (salt) as a global disease risk factor, our objective was to compare the impact of eight sodium reduction interventions, including feasible and more theoretical ones, to assist prioritisation. Methods Epidemiological modelling and cost-utility analysis were performed using a Markov macro-simulation model. The setting was New Zealand (NZ) (2.3 million citizens, aged 35+ years) which has detailed individual-level administrative cost data. Results Of the most feasible interventions, the largest health gains were from (in descending order): (i) mandatory 25% reduction in sodium levels in all processed foods; (ii) the package of interventions performed in the United Kingdom (UK); (iii) mandatory 25% reduction in sodium levels in bread, processed meats and sauces; (iv) media campaign (as per a previous UK one); (v) voluntary food labelling as currently used in NZ; (vi) dietary counselling as currently used in NZ. Even larger health gains came from the more theoretical options of a "sinking lid" on the amount of food salt released to the national market to achieve an average adult intake of 2300 mg sodium/day (211,000 QALYs gained, 95% uncertainty interval: 170,000 255,000), and from a salt tax. All the interventions produced net cost savings (except counselling -albeit still cost-effective). Cost savings were especially large with the sinking lid (NZ$ 1.1 billion, US$ 0.7 billion). Also the salt tax would raise revenue (up to NZ$ 452 million/year). Health gain per person was greater for Maori (indigenous population) men and women compared to non-Maori. Conclusions This study substantially expands on the range of previously modelled salt reduction interventions and suggests that some of these might achieve major health gains and major cost savings (particularly the regulatory interventions). They could also reduce ethnic inequalities in health.	[Nghiem, Nhung; Blakely, Tony; Cobiac, Linda J.; Pearson, Amber L.; Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand; [Cobiac, Linda J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Otago; University of Queensland	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand.	nick.wilson@otago.ac.nz		Nghiem, Nhung/0000-0003-0078-4549; Blakely, Tony/0000-0002-6995-4369	Health Research Council of New Zealand [10/248]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand (10/248). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; [Anonymous], 2012, CHOOS INT AR COST EF; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baltussen RM., 2003, MAKING CHOICES HLTH; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Basu S, 2014, AM J PUBLIC HEALTH, V104, P2432, DOI 10.2105/AJPH.2014.302170; Bayer R, 2012, HEALTH AFFAIR, V31, P2738, DOI 10.1377/hlthaff.2012.0554; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Blakely T, 2012, 3 U OT DEP PUBL HLTH; Blakely T, 2014, NZ MED J, V127, P1; Blakely T., 2015, BODE3 PROGRAMME; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Cobiac LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041842; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Collins M, 2014, VALUE HEALTH, V17, P517, DOI 10.1016/j.jval.2014.03.1722; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Eatwell, 2012, D2 3 EVALUATION COST; Forshee RA, 2008, NUTR REV, V66, P280, DOI 10.1111/j.1753-4887.2008.00033.x; Goodman Richard A, 2006, MMWR Suppl, V55, P29; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; He FJ, 2013, J HUM HYPERTENS; Hofman KJ, 2013, LANCET GLOB HEALTH, V1, pE66, DOI 10.1016/S2214-109X(13)70019-6; Institute of Medicine, 2013, SOD INT POP ASS EV; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Landsburg S, 2010, PRICE THEORY APPL EC; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis KH, 2011, NEW ENGL J MED, V365, P1561, DOI 10.1056/NEJMp1105128; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLean R, 2011, MUCH SALT ARE WE EAT; McLean RM, 2011, NEW ZEAL MED J, V124, P68; McLean RM, 2013, NZ MED J, V126, P1; McLeod M, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-15; Merino J, 2015, AM J CLIN NUTR, V101, P440, DOI 10.3945/ajcn.114.096750; Ministry of Health, 2013, WAYS MEANS REP METH; Moulton AD, 2009, AM J PUBLIC HEALTH, V99, P17, DOI 10.2105/AJPH.2007.130278; National Institute for Clinical Excellence (NICE), 2010, NICE PUBL HLTH GUID, P25; Neal B, 2013, CURR HYPERTENS REP, V15, P687, DOI 10.1007/s11906-013-0389-5; Nghiem N, 2014, VALIDATION ISSUES RE; O'Donnell M, 2014, NEW ENGL J MED, V371, P2137, DOI 10.1056/NEJMc1412113; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; OECD, 2013, NEW INT COMP GDP CON; OECD, 2014, DOES NZ COMP; Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P901, DOI 10.1017/S1368980010001072; Rees K., 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002128.PUB4; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; van Baal PHM, 2007, HEALTH POLICY, V82, P142, DOI 10.1016/j.healthpol.2006.09.004; van Baal PHM, 2011, HEALTH ECON, V20, P432, DOI 10.1002/hec.1599; WHO, 2012, GUID SOD INT AD CHIL; Wilson N, 2014, TECHNICAL REPORT; Wilson N, 2014, BACKGROUND REPORT BO; Wilson N, 2014, NEW ZEAL MED J, V127, P85; Wilson N, 2012, B WORLD HEALTH ORGAN, V90, P532, DOI 10.2471/BLT.11.097584	61	55	57	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123915	10.1371/journal.pone.0123915	http://dx.doi.org/10.1371/journal.pone.0123915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25910259	Green Published, gold			2022-12-26	WOS:000353376800050
J	Fossati, E; Narcross, L; Ekins, A; Falgueyret, JP; Martin, VJJ				Fossati, Elena; Narcross, Lauren; Ekins, Andrew; Falgueyret, Jean-Pierre; Martin, Vincent J. J.			Synthesis of Morphinan Alkaloids in Saccharomyces cerevisiae	PLOS ONE			English	Article							OPIUM POPPY; PAPAVER-SOMNIFERUM; DIOXYGENASES CATALYZE; MOLECULAR-CLONING; O-DEMETHYLATION; BIOSYNTHESIS; ENZYME; SYNTHASE; PATHWAY; METABOLISM	Morphinan alkaloids are the most powerful narcotic analgesics currently used to treat moderate to severe and chronic pain. The feasibility of morphinan synthesis in recombinant Saccharomyces cerevisiae starting from the precursor (R, S)-norlaudanosoline was investigated. Chiral analysis of the reticuline produced by the expression of opium poppy methyltransferases showed strict enantioselectivity for (S)-reticuline starting from (R, S)-norlaudanosoline. In addition, the P. somniferum enzymes salutaridine synthase (PsSAS), salutaridine reductase (PsSAR) and salutaridinol acetyltransferase (PsSAT) were functionally co-expressed in Saccharomyces cerevisiae and optimization of the pH conditions allowed for productive spontaneous rearrangement of salutaridinol-7-O-acetate and synthesis of thebaine from (R)-reticuline. Finally, we reconstituted a 7-gene pathway for the production of codeine and morphine from (R)-reticuline. Yeast cell feeding assays using (R)-reticuline, salutaridine or codeine as substrates showed that all enzymes were functionally co-expressed in yeast and that activity of salutaridine reductase and codeine-O-demethylase likely limit flux to morphine synthesis. The results of this study describe a significant advance for the synthesis of morphinans in Saccharomyces cerevisiae and pave the way for their complete synthesis in recombinant microbes.	[Fossati, Elena; Narcross, Lauren; Ekins, Andrew; Martin, Vincent J. J.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Fossati, Elena; Narcross, Lauren; Ekins, Andrew; Falgueyret, Jean-Pierre; Martin, Vincent J. J.] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Concordia University - Canada; Concordia University - Canada	Martin, VJJ (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	vincent.martin@concordia.ca			Genome Canada; Genome Quebec; Canada Research Chair	Genome Canada(Genome Canada); Genome Quebec; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was financially supported by Genome Canada (http://www.genomecanada.ca) and Genome Quebec (http://www.genomequebec.com). VJJM is supported by a Canada Research Chair (http://www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabo T, 2011, J R SOC INTERFACE, V8, P1635, DOI 10.1098/rsif.2011.0148; Beaudoin GAW, 2014, PLANTA, V240, P19, DOI 10.1007/s00425-014-2056-8; Biancofiore Giuseppe, 2006, Ther Clin Risk Manag, V2, P229, DOI 10.2147/tcrm.2006.2.3.229; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Farrow SC, 2013, J BIOL CHEM, V288, P28997, DOI 10.1074/jbc.M113.488585; Fisinger U, 2007, NAT PROD COMMUN, V2, P249; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; Ilari A, 2009, J BIOL CHEM, V284, P897, DOI 10.1074/jbc.M803738200; INCB Supply of opiate raw materials and demand for opiates for medical and scientific purposes, 2013, ESTIM WORLD REQUIR 2, V3, P92; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Kim EY, 2014, BIOTECHNOL J, V9, P348, DOI 10.1002/biot.201300391; KRAUS PFX, 1995, P NATL ACAD SCI USA, V92, P2071, DOI 10.1073/pnas.92.6.2071; Millgate AG, 2004, NATURE, V431, P413, DOI 10.1038/431413a; Nakagawa A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06695; Nakagawa A, 2012, BIOENGINEERED, V3, P49, DOI [10.4161/bbug.3.1.18446, 10.1038/ncomms1327]; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; Sabarna K., 2006, THESIS MARTIN LUTHER; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; THEUNS HG, 1984, PHYTOCHEMISTRY, V23, P1157, DOI 10.1016/S0031-9422(00)82630-8; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	36	65	77	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124459	10.1371/journal.pone.0124459	http://dx.doi.org/10.1371/journal.pone.0124459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905794	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000070
J	Jin, XL; Sun, Y; Yang, HY; Li, J; Yu, SN; Chang, XY; Lu, ZH; Chen, J				Jin, Xianglan; Sun, Yang; Yang, Haiyan; Li, Ji; Yu, Shuangni; Chang, Xiaoyan; Lu, Zhaohui; Chen, Jie			Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DUCTAL ADENOCARCINOMA; ACINAR-CELLS; RAS ACTIVITY; K-RAS; MICRORNA FUNCTIONS; ANIMAL DEVELOPMENT; EXOCRINE PANCREAS; TUMOR-SUPPRESSOR; ONCOGENIC KRAS	Modulation of KRAS activity by upstream signals has revealed a promising new approach for pancreatic cancer therapy; however, it is not clear whether microRNA-associated KRAS axis is involved in the carcinogenesis of pancreatic cancer. Here, we identified miR-193b as a tumor-suppressive miRNA in pancreatic ductal adenocarcinoma (PDAC). Expression analyses revealed that miR-193b was downregulated in (10/11) PDAC specimens and cell lines. Moreover, we found that miR-193b functioned as a cell-cycle brake in PDAC cells by inducing G1-phase arrest and reducing the fraction of cells in S phase, thereby leading to dampened cell proliferation. miR-193b also modulated the malignant transformation phenotype of PDAC cells by suppressing anchorage-independent growth. Mechanistically, KRAS was verified as a direct effector of miR-193b, through which the AKT and ERK pathways were modulated and cell growth of PDAC cells was suppressed. Taken together, our findings indicate that miR-193b-mediated deregulation of the KRAS axis is involved in pancreatic carcinogenesis, and suggest that miR-193b could be a potentially effective target for PDAC therapy.	[Chen, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; Tsinghua Univ, Peking Union Med Coll, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Chen, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China.	xhblk@163.com			National Natural Science Foundation of China [81172334, 30471970]; National Key Technology RD program [2006BAI02A14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD program(National Key Technology R&D Program)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81172334 and 30471970) (URL: http://www.nsfc.gov.cn/), and the National Key Technology R&D program (No. 2006BAI02A14) (URL: http://www.most.gov.cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; American Cancer Society, 2012, CANC FACTS FIG 2012, P19; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; BANSAL P, 1995, GASTROENTEROLOGY, V109, P247, DOI 10.1016/0016-5085(95)90291-0; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Collins MA, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00407; Collins MA, 2014, GASTROENTEROLOGY, V146, P822, DOI 10.1053/j.gastro.2013.11.052; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hu HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P424, DOI [10.1093/abbs/gms018, 10.1093/abbs/gms018.]; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kowalski J, 2007, CANCER GENET CYTOGEN, V178, P26, DOI 10.1016/j.cancergencyto.2007.06.004; Lanuti P, 2006, J IMMUNOL METHODS, V315, P37, DOI 10.1016/j.jim.2006.06.015; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mazzon E, 2012, PANCREAS, V41, P560, DOI 10.1097/MPA.0b013e31823acd56; PARSA I, 1985, CANCER RES, V45, P1285; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Satoh J, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-17; Seton-Rogers S, 2012, NAT REV CANCER, V12, P739, DOI 10.1038/nrc3383; Sohn D, 2011, CELL DEATH DIFFER, V18, P1664, DOI 10.1038/cdd.2011.34; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CP, 2014, HISTOPATHOLOGY, V64, P567, DOI 10.1111/his.12283; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	52	37	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125515	10.1371/journal.pone.0125515	http://dx.doi.org/10.1371/journal.pone.0125515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905463	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000112
J	Li, Y; Wang, H; Li, XB				Li, Ying; Wang, Hong; Li, Xiao Bing			Fractional Vegetation Cover Estimation Based on an Improved Selective Endmember Spectral Mixture Model	PLOS ONE			English	Article							REMOTE-SENSING ESTIMATION; REGION; BASIN	Vegetation is an important part of ecosystem and estimation of fractional vegetation cover is of significant meaning to monitoring of vegetation growth in a certain region. With Landsat TM images and HJ-1B images as data source, an improved selective endmember linear spectral mixture model (SELSMM) was put forward in this research to estimate the fractional vegetation cover in Huangfuchuan watershed in China. We compared the result with the vegetation coverage estimated with linear spectral mixture model (LSMM) and conducted accuracy test on the two results with field survey data to study the effectiveness of different models in estimation of vegetation coverage. Results indicated that: (1) the RMSE of the estimation result of SELSMM based on TM images is the lowest, which is 0.044. The RMSEs of the estimation results of LSMM based on TM images, SELSMM based on HJ-1B images and LSMM based on HJ-1B images are respectively 0.052, 0.077 and 0.082, which are all higher than that of SELSMM based on TM images; (2) the R-2 of SELSMM based on TM images, LSMM based on TM images, SELSMM based on HJ-1B images and LSMM based on HJ-1B images are respectively 0.668, 0.531, 0.342 and 0.336. Among these models, SELSMM based on TM images has the highest estimation accuracy and also the highest correlation with measured vegetation coverage. Of the two methods tested, SELSMM is superior to LSMM in estimation of vegetation coverage and it is also better at unmixing mixed pixels of TM images than pixels of HJ-1B images. So, the SELSMM based on TM images is comparatively accurate and reliable in the research of regional fractional vegetation cover estimation.	[Li, Ying; Wang, Hong; Li, Xiao Bing] Beijing Normal Univ, Coll Resources Sci & Technol, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Li, Ying] CERI Eco Technol Co Ltd, Beijing, Peoples R China	Beijing Normal University	Wang, H (corresponding author), Beijing Normal Univ, Coll Resources Sci & Technol, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	wanghong@bnu.edu.cn			National Natural Science Foundation of China [41471350]; National Key Basic Research Program of China [2014CB138803]; Funds for Creative Research Groups of China [41321001]; Sate Key Laboratory of Earth Surface processes and Resource Ecology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); Sate Key Laboratory of Earth Surface processes and Resource Ecology	This work was supported by the National Natural Science Foundation of China (No. 41471350), the National Key Basic Research Program of China (2014CB138803), the Funds for Creative Research Groups of China (41321001) and Sate Key Laboratory of Earth Surface processes and Resource Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buyantuyev A, 2007, INT J REMOTE SENS, V28, P269, DOI 10.1080/01431160600658149; [陈峰 Chen Feng], 2010, [遥感信息, Remote Sensing Information], P22; [丛浩 CONG Hao], 2006, [中国图象图形学报, Journal of image and graphics], V11, P1092; Dawelbait M, 2012, J ARID ENVIRON, V80, P45, DOI 10.1016/j.jaridenv.2011.12.011; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gong Jian-zhou, 2007, Yingyong Shengtai Xuebao, V18, P575; Hostert P, 2003, REMOTE SENS ENVIRON, V87, P183, DOI 10.1016/S0034-4257(03)00145-7; Li M.M., 2003, METHOD VEGETATION FR; Li X, 2008, QUANTITIVE RETRIEVAL; Li Xiao-song, 2010, Yingyong Shengtai Xuebao, V21, P152; Liu Jun-hui, 2008, Yingyong Shengtai Xuebao, V19, P2016; Oki K, 2011, COMPUT ELECTRON AGR, V79, P30, DOI 10.1016/j.compag.2011.08.001; Purevdorj T, 1998, INT J REMOTE SENS, V19, P3519, DOI 10.1080/014311698213795; Qi J, 2000, AGR FOREST METEOROL, V105, P55, DOI 10.1016/S0168-1923(00)00195-7; RIDD MK, 1995, INT J REMOTE SENS, V16, P2165, DOI 10.1080/01431169508954549; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Silvan-Cardenas JL, 2010, REMOTE SENS ENVIRON, V114, P1777, DOI 10.1016/j.rse.2010.04.003; Theau J, 2005, REMOTE SENS ENVIRON, V94, P232, DOI 10.1016/j.rse.2004.10.008; Wang G, 2002, INT J REMOTE SENS, V23, P3649, DOI 10.1080/01431160110114538; Wu Chang-guang, 2012, Yingyong Shengtai Xuebao, V23, P1728; Wu K, 2011, OPT ENG, V20, P114; [吴柯 WU Ke], 2007, [遥感学报, Journal of Remote Sensing], V11, P20; Xiao JF, 2005, REMOTE SENS ENVIRON, V98, P237, DOI 10.1016/j.rse.2005.07.011; [邢著荣 XING Zhu-rong], 2009, [遥感技术与应用, Remote Sensing Technology and Application], V24, P849; Yang Xiao-qiong, 2008, Yingyong Shengtai Xuebao, V19, P1860; Yang ZP, 2011, J GEOGR SCI, V21, P979, DOI 10.1007/s11442-011-0894-x; Zhang LP, 2010, IEEE T GEOSCI REMOTE, V48, P2633, DOI 10.1109/TGRS.2010.2040284; Zhang XueXia, 2008, Journal of Beijing Forestry University, V30, P164; Zhang Yan, 2002, Yingyong Shengtai Xuebao, V13, P1033; [张云霞 Zhang Yun Xia], 2003, [地球科学进展, Advance in Earth Sciences], V18, P85; Zhao CaiXia, 2005, Acta Phytoecologica Sinica, V29, P68; Zhu Jing-Fang, 2011, Chinese Journal of Plant Ecology, V35, P615, DOI 10.3724/SP.J.1258.2011.00615; Zhu WB, 2012, J GEOGR SCI, V22, P346, DOI 10.1007/s11442-012-0931-4	34	13	15	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124608	10.1371/journal.pone.0124608	http://dx.doi.org/10.1371/journal.pone.0124608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905772	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000079
J	Talhaoui, I; Shafirovich, V; Liu, Z; Saint-Pierre, C; Akishev, Z; Matkarimov, BT; Gasparutto, D; Geacintov, NE; Saparbaev, M				Talhaoui, Ibtissam; Shafirovich, Vladimir; Liu, Zhi; Saint-Pierre, Christine; Akishev, Zhiger; Matkarimov, Bakhyt T.; Gasparutto, Didier; Geacintov, Nicholas E.; Saparbaev, Murat			Oxidatively Generated Guanine(C8)-Thymine(N3) Intrastrand Cross-links in Double-stranded DNA Are Repaired by Base Excision Repair Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL-INDUCED FORMATION; ESCHERICHIA-COLI; HUMAN-CELLS; MAMMALIAN-CELLS; UVRABC NUCLEASE; IN-VIVO; LESIONS; GUANINE; DAMAGE; INCISION	Oxidatively generated guanine radical cations in DNA can undergo various nucleophilic reactions including the formation of C8-guanine cross-links with adjacent or nearby N3-thymines in DNA in the presence of O-2. The G*[C8-N3]T* lesions have been identified in the DNA of human cells exposed to oxidative stress, and are most likely genotoxic if not removed by cellular defense mechanisms. It has been shown that the G*[C8-N3]T* lesions are substrates of nucleotide excision repair in human cell extracts. Cleavage at the sites of the lesions was also observed but not further investigated (Ding et al. (2012) Nucleic Acids Res. 40, 2506-2517). Using a panel of eukaryotic and prokaryotic bifunctional DNA glycosylases/lyases (NEIL1, Nei, Fpg, Nth, and NTH1) and apurinic/apyrimidinic (AP) endonucleases (Apn1, APE1, and Nfo), the analysis of cleavage fragments by PAGE and MALDI-TOF/MS show that the G*[C8-N3]T* lesions in 17-mer duplexes are incised on either side of G*, that none of the recovered cleavage fragments contain G*, and that T* is converted to a normal T in the 3'-fragment cleavage products. The abilities of the DNA glycosylases to incise the DNA strand adjacent to G*, while this base is initially cross-linked with T*, is a surprising observation and an indication of the versatility of these base excision repair proteins.	[Talhaoui, Ibtissam; Saparbaev, Murat] Univ Paris 11, Grp Reparat ADN, CNRS UMR8200, Inst Cancerol Gustave Roussy, F-94805 Villejuif, France; [Saint-Pierre, Christine; Gasparutto, Didier] Univ Grenoble Alpes, CEA, INAC, SCIB,UMR E3,LAN, F-38000 Grenoble, France; [Akishev, Zhiger] Al Farabi Kazakh Natl Univ, Dept Mol Biol & Genet, Fac Biol, Alma Ata 530038, Kazakhstan; [Matkarimov, Bakhyt T.] Nazarbayev Univ Res & Innovat Syst, Astana 010000, Kazakhstan; [Shafirovich, Vladimir; Liu, Zhi; Geacintov, Nicholas E.] NYU, Dept Chem, 31 Washington Pl, New York, NY 10003 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Al-Farabi Kazakh National University; Nazarbayev University; New York University	Shafirovich, V (corresponding author), NYU, Dept Chem, 31 Washington Pl, New York, NY 10003 USA.	vs5@nyu.edu; ng1@nyu.edu; smurat@igr.fr	Matkarimov, Bakhyt T/J-6201-2012; Saparbaev, Murat/AAC-5478-2020; Akishev, Zhiger D/N-6206-2017; Saparbaev, Murat K/N-3225-2015	Matkarimov, Bakhyt T/0000-0003-0775-7324; Saparbaev, Murat/0000-0002-4630-1074; Akishev, Zhiger D/0000-0001-9943-1625; Saparbaev, Murat K/0000-0002-4630-1074; Shafirovich, Vladimir/0000-0001-8225-6509	Research Facilities Improvement Grant from the National Center for Research Resources, National Institutes of Health [C06 RR-16572]; National Science Foundation [CHE-0958457]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011589] Funding Source: NIH RePORTER	Research Facilities Improvement Grant from the National Center for Research Resources, National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Components of this work were conducted in the Shared Instrumentation Facility at NYU that was constructed with support from a Research Facilities Improvement Grant (C06 RR-16572) from the National Center for Research Resources, National Institutes of Health. The acquisition of the MALDI-TOF mass spectrometer at NYU was supported by the National Science Foundation (CHE-0958457).	Bourdat AG, 1999, NUCLEIC ACIDS RES, V27, P1015, DOI 10.1093/nar/27.4.1015; Box HC, 2001, FREE RADICAL BIO MED, V31, P856, DOI 10.1016/S0891-5849(01)00653-0; Box HC, 1996, RADIAT RES, V145, P641, DOI 10.2307/3579285; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Crean C, 2008, CHEMBIOCHEM, V9, P1985, DOI 10.1002/cbic.200800105; Crean C, 2008, NUCLEIC ACIDS RES, V36, P742, DOI 10.1093/nar/gkm1092; Darwanto A, 2009, ANAL BIOCHEM, V394, P13, DOI 10.1016/j.ab.2009.07.015; Ding S, 2012, NUCLEIC ACIDS RES, V40, P2506, DOI 10.1093/nar/gkr1087; DIRKSEN ML, 1988, INT J RADIAT BIOL, V54, P195, DOI 10.1080/09553008814551631; DIZDAROGLU M, 1986, BIOCHEM J, V238, P247, DOI 10.1042/bj2380247; Faure V, 2005, BIOCHEM BIOPH RES CO, V328, P1188, DOI 10.1016/j.bbrc.2005.01.082; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gu CN, 2006, BIOCHEMISTRY-US, V45, P10739, DOI 10.1021/bi060423z; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jasti VP, 2011, BIOCHEMISTRY-US, V50, P3862, DOI 10.1021/bi2004944; Jiang Y, 2007, BIOCHEMISTRY-US, V46, P12757, DOI 10.1021/bi7012195; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kropachev K, 2014, NUCLEIC ACIDS RES, V42, P5020, DOI 10.1093/nar/gku162; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Madugundu GS, 2013, CHEM RES TOXICOL, V26, P1031, DOI 10.1021/tx400158g; Mazouzi A, 2013, P NATL ACAD SCI USA, V110, pE3071, DOI 10.1073/pnas.1305281110; Pande P, 2012, DNA REPAIR, V11, P926, DOI 10.1016/j.dnarep.2012.09.002; Prorok P, 2013, P NATL ACAD SCI USA, V110, pE3695, DOI 10.1073/pnas.1305624110; Scott TL, 2014, ANTIOXID REDOX SIGN, V20, P708, DOI 10.1089/ars.2013.5529; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wang J, 2012, NUCLEIC ACIDS RES, V40, P7368, DOI 10.1093/nar/gks357; Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x; Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g; Wong D, 2003, J BIOL CHEM, V278, P36242, DOI 10.1074/jbc.M306065200; Yang ZG, 2005, CHEM RES TOXICOL, V18, P1339, DOI 10.1021/tx050147+; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Zhang QB, 2003, J AM CHEM SOC, V125, P12795, DOI 10.1021/ja034866r; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	45	15	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14610	14617		10.1074/jbc.M115.647487	http://dx.doi.org/10.1074/jbc.M115.647487			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903131	hybrid, Green Published			2022-12-26	WOS:000355754600031
J	Pinho, R; Garcia, V; Feldman, MW				Pinho, Ricardo; Garcia, Victor; Feldman, Marcus W.			Phenotype Accessibility and Noise in Random Threshold Gene Regulatory Networks	PLOS ONE			English	Article							EVO-DEVO; EVOLUTION; EXPRESSION; ROBUSTNESS; SYSTEMS; STOCHASTICITY; CONSEQUENCES; TOPOLOGY	Evolution requires phenotypic variation in a population of organisms for selection to function. Gene regulatory processes involved in organismal development affect the phenotypic diversity of organisms. Since only a fraction of all possible phenotypes are predicted to be accessed by the end of development, organisms may evolve strategies to use environmental cues and noise-like fluctuations to produce additional phenotypic diversity, and hence to enhance the speed of adaptation. We used a generic model of organismal development -gene regulatory networks-to investigate how different levels of noise on gene expression states (i.e. phenotypes) may affect access to new, unique phenotypes, thereby affecting phenotypic diversity. We studied additional strategies that organisms might adopt to attain larger phenotypic diversity: either by augmenting their genome or the number of gene expression states. This was done for different types of gene regulatory networks that allow for distinct levels of regulatory influence on gene expression or are more likely to give rise to stable phenotypes. We found that if gene expression is binary, increasing noise levels generally decreases phenotype accessibility for all network types studied. If more gene expression states are considered, noise can moderately enhance the speed of discovery if three or four gene expression states are allowed, and if there are enough distinct regulatory networks in the population. These results were independent of the network types analyzed, and were robust to different implementations of noise. Hence, for noise to increase the number of accessible phenotypes in gene regulatory networks, very specific conditions need to be satisfied. If the number of distinct regulatory networks involved in organismal development is large enough, and the acquisition of more genes or fine tuning of their expression states proves costly to the organism, noise can be useful in allowing access to more unique phenotypes.	[Pinho, Ricardo; Feldman, Marcus W.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Pinho, Ricardo] Inst Gulbenkian Ciencias, PhD Program Computat Biol, Oeiras, Portugal; [Garcia, Victor] ETH, Inst Integrat Biol, Zurich, Switzerland	Stanford University; Instituto Gulbenkian de Ciencia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pinho, R (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	pinho.ricardo@gmail.com	Garcia, Victor/H-4403-2019; Pinho, Ricardo/G-2643-2012; Pinho, Ricardo/GQH-3657-2022	Pinho, Ricardo/0000-0003-3116-4553; Pinho, Ricardo/0000-0003-3116-4553	Fundacao Calouste Gulbenkian; Siemens SA; Fundacao para a Ciencia e Tecnologia [SFRH/BD/33531/2008]; Stanford Center for Computational, Evolutionary and Human Genomics; National Institutes of Health [GM28016]; Swiss National Science Foundation [P1EZP3_148648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	Fundacao Calouste Gulbenkian(European Commission); Siemens SA; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Stanford Center for Computational, Evolutionary and Human Genomics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The Ph.D. Program in Computational Biology is sponsored by Fundacao Calouste Gulbenkian, Siemens SA, and Fundacao para a Ciencia e Tecnologia (fellowship SFRH/BD/33531/2008). This work was supported in part by The Stanford Center for Computational, Evolutionary and Human Genomics, and by National Institutes of Health grant no. GM28016. V.G. gratefully acknowledges the funding of the Swiss National Science Foundation, grant number P1EZP3_148648. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Borenstein E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000202; Bornholdt S, 2001, BIOL CHEM, V382, P1289, DOI 10.1515/BC.2001.161; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Brent R. P., 1980, BIT (Nordisk Tidskrift for Informationsbehandling), V20, P176, DOI 10.1007/BF01933190; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Crauel H., 1997, Journal of Dynamics and Differential Equations, V9, P307, DOI 10.1007/BF02219225; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; GILBERT SF, 1994, DEV BIOL; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Gray F., 1953, U. S. Patent, Patent No. [2,632,058, 2632058, 2 632 058]; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jaeger J, 2012, J EXP ZOOL PART B, V318B, P591, DOI 10.1002/jez.b.22468; Jenkins DJ, 2010, J MOL EVOL, V70, P215, DOI 10.1007/s00239-010-9323-5; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kim M, 2010, BIOINFORMATICS, V26, P486, DOI 10.1093/bioinformatics/btp685; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KURTEN KE, 1988, J PHYS A-MATH GEN, V21, pL615, DOI 10.1088/0305-4470/21/11/009; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Masel J, 2004, J EVOLUTION BIOL, V17, P1106, DOI 10.1111/j.1420-9101.2004.00739.x; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Pinho R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034285; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thomas P, 2014, P NATL ACAD SCI USA, V111, P6994, DOI 10.1073/pnas.1400049111; Viney M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1104; Waddington C H, 1957, STRATEGY GENES DISCU; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-20; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-6; Zhang ZH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.58	55	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0119972	10.1371/journal.pone.0119972	http://dx.doi.org/10.1371/journal.pone.0119972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919290	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400002
J	Wang, Y; Wang, Z; Chen, MP; Fan, N; Yang, J; Liu, L; Wang, Y; Liu, XY				Wang, Yun; Wang, Zhi; Chen, Mengping; Fan, Ning; Yang, Jie; Liu, Lu; Wang, Ying; Liu, Xuyang			Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism	PLOS ONE			English	Article							PINK-EYED DILUTION; TYROSINASE GENE; P-GENE; IDENTIFICATION; PHENOTYPE; DIAGNOSIS; SEQUENCE; TYPE-1; MAPS	Background Oculocutaneous albinism (OCA) is an autosomal recessive disorder. The most common type OCA1 and OCA2 are caused by homozygous or compound heterozygous mutations in the tyrosinase gene (TYR) and OCA2 gene, respectively. Objective The purpose of this study was to evaluate the molecular basis of oculocutaneous albinism in four Chinese families. Patients and Methods Four non-consanguineous OCA families were included in the study. The TYR and OCA2 genes of all individuals were amplified by polymerase chain reaction (PCR), sequenced and compared with a reference database. Results Four patients with a diagnosis of oculocutaneous albinism, presented with milky skin, white or light brown hair and nystagmus. Genetic analyses demonstrated that patient A was compound heterozygous for c.1037-7T. A, c.1037-10_11delTT and c.1114delG mutations in the TYR gene; patient B was heterozygous for c.593C>T and c.1426A>G mutations in the OCA2 gene, patients C and D were compound heterozygous mutations in the TYR gene (c.549_550delGT and c.896G>A, c.832C>T and c.985T>C, respectively). The heterozygous c.549_550delGT and c.1114delG alleles in the TYR gene were two novel mutations. Interestingly, heterozygous members in these pedigrees who carried c.1114delG mutations in the TYR gene or c.1426A>G mutations in the OCA2 gene presented with blond or brown hair and pale skin, but no ocular disorders when they were born; the skin of these patients accumulated pigment over time and with sun exposure. Conclusion This study expands the mutation spectrum of oculocutaneous albinism. It is the first time, to the best of our knowledge, to report that c.549_550delGT and c.1114delG mutations in the TYR gene were associated with OCA. The two mutations (c.1114delG in the TYR gene and c.1426A>G in the OCA2 gene) may be responsible for partial clinical manifestations of OCA.	[Wang, Yun; Fan, Ning; Liu, Lu; Wang, Ying; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Peoples R China; [Wang, Zhi; Yang, Jie] Nanchang Univ, Inst Translat Med, Nanchang, Peoples R China; [Chen, Mengping] Second Peoples Hosp Zhengzhou, Dept Ophthalmol, Zhengzhou, Peoples R China	Jinan University; Nanchang University	Liu, XY (corresponding author), Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Peoples R China.	xliu1213@126.com			National Natural Science Foundation of China (NSFC) [81170851, 81270995, 81200688, 81371009]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81170851, 81270995, 81200688 and 81371009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; BRILLIANT MH, 1994, PIGM CELL RES, V7, P398, DOI 10.1111/j.1600-0749.1994.tb00068.x; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; Gong Y, 1994, Yi Chuan Xue Bao, V21, P169; Goto M, 2004, J DERMATOL SCI, V35, P215, DOI 10.1016/j.jdermsci.2004.06.007; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Gronskov K, 2013, AM J HUM GENET, V92, P415, DOI 10.1016/j.ajhg.2013.01.006; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; Jeffery G, 1997, DEV BRAIN RES, V99, P95, DOI 10.1016/S0165-3806(96)00211-8; Kausar T, 2013, CLIN GENET, V84, P91, DOI 10.1111/cge.12019; KING RA, 1985, AM J MED GENET, V20, P49, DOI 10.1002/ajmg.1320200108; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; Lee ST, 1997, JPN J HUM GENET, V42, P499, DOI 10.1007/BF02767026; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; LERNER AB, 1950, J BIOL CHEM, V187, P793; Levin AV, 2011, J AAPOS, V15, P59, DOI 10.1016/j.jaapos.2010.10.012; Li HY, 2007, PRENATAL DIAG, V27, P502, DOI 10.1002/pd.1713; Matsunaga J, 1999, DERMATOLOGY, V199, P124, DOI 10.1159/000018218; Matsunaga J, 1998, DERMATOLOGY, V196, P189, DOI 10.1159/000017897; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; Park SK, 1997, MOL CELLS, V7, P187; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; Rundshagen U, 2004, HUM MUTAT, V23, P106, DOI 10.1002/humu.10311; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; Sundaresan P, 2004, MOL VIS, V10, P1005; Suzuki T, 2003, J INVEST DERMATOL, V120, P781, DOI 10.1046/j.1523-1747.2003.12127.x; TRIPATHI RK, 1992, AM J MED GENET, V43, P865, DOI 10.1002/ajmg.1320430523; TRIPATHI RK, 1993, AM J HUM GENET, V53, P1173; Wang Y, 2009, J DERMATOL SCI, V53, P80, DOI 10.1016/j.jdermsci.2008.07.002; Wei AH, 2013, J INVEST DERMATOL, V133, P1834, DOI 10.1038/jid.2013.49; Wei AH, 2013, CHINESE MED J-PEKING, V126, P226, DOI 10.3760/cma.j.issn.0366-6999.20121104; Wei AH, 2010, J INVEST DERMATOL, V130, P716, DOI 10.1038/jid.2009.339; Zahed L, 2005, J HUM GENET, V50, P317, DOI 10.1007/s10038-005-0257-5	36	4	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125651	10.1371/journal.pone.0125651	http://dx.doi.org/10.1371/journal.pone.0125651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919014	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400087
J	Chaplin, A; Parra, P; Serra, F; Palou, A				Chaplin, Alice; Parra, Pilar; Serra, Francisca; Palou, Andreu			Conjugated Linoleic Acid Supplementation under a High-Fat Diet Modulates Stomach Protein Expression and Intestinal Microbiota in Adult Mice	PLOS ONE			English	Article							REDUCES BODY-FAT; GROWTH-HORMONE SECRETAGOGUE; GUT MICROBIOTA; GASTRIC LEPTIN; WEIGHT-GAIN; FOOD-INTAKE; AKKERMANSIA-MUCINIPHILA; GHRELIN SECRETION; GLUCAGON RECEPTOR; ENERGY-METABOLISM	The gastrointestinal tract constitutes a physiological interface integrating nutrient and microbiota-host metabolism. Conjugated linoleic acids (CLA) have been reported to contribute to decreased body weight and fat accretion. The modulation by dietary CLA of stomach proteins related to energy homeostasis or microbiota may be involved, although this has not been previously analysed. This is examined in the present study, which aims to underline the potential mechanisms of CLA which contribute to body weight regulation. Adult mice were fed either a normal fat (NF, 12% kJ content as fat) or a high-fat (HF, 43% kJ content as fat) diet. In the latter case, half of the animals received daily oral supplementation of CLA. Expression and content of stomach proteins and specific bacterial populations from caecum were analysed. CLA supplementation was associated with an increase in stomach protein expression, and exerted a prebiotic action on both Bacteroidetes/Prevotella and Akkermansia muciniphila. However, CLA supplementation was not able to override the negative effects of HF diet on Bifidobacterium spp., which was decreased in both HF and HF+CLA groups. Our data show that CLA are able to modulate stomach protein expression and exert a prebiotic effect on specific gut bacterial species.	[Serra, Francisca] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol, Palma De Mallorca, Spain; CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma De Mallorca, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Serra, F (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol, Palma De Mallorca, Spain.	francisca.serra@uib.es	Chaplin, Alice/R-5067-2019; Palou, Andreu/K-9881-2014; Serra, Francisca/B-8641-2008	Palou, Andreu/0000-0002-0295-4452; Serra, Francisca/0000-0002-8307-9732; Chaplin, Alice/0000-0003-0685-4237	EU [BIOCLAIMS FP7-244995]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn; "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB); FEDER funds (EU); Conselleria d'Educacio, Cultura i Universitats, Govern de les Illes Balears; European Social Fund;  [AGL2012-33692]	EU(European Commission); Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn; "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB); FEDER funds (EU)(European Commission); Conselleria d'Educacio, Cultura i Universitats, Govern de les Illes Balears; European Social Fund(European Social Fund (ESF)); 	This work was supported by the grant AGL2012-33692 and the EU-funded project (BIOCLAIMS FP7-244995). The authors' group receives financial support from Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBERobn. Authors belong to the Nutrigenomics-group, awarded as "Group of Excellence" of CAIB and supported by "Direccio General d'Universitats, Recerca i Transferencia del Coneixement" of Regional Government (CAIB) and FEDER funds (EU). AC is supported by a PhD fellowship by Conselleria d'Educacio, Cultura i Universitats, Govern de les Illes Balears, a project which is cofinanced by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownawell AM, 2012, J NUTR, V142, P962, DOI 10.3945/jn.112.158147; Cammisotto P, 2012, ANAT CELL BIOL, V45, P1, DOI 10.5115/acb.2012.45.1.1; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cinti S, 2001, GUT, V49, P155, DOI 10.1136/gut.49.1.155; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; dos Santos VM, 2010, CURR OPIN BIOTECH, V21, P539, DOI 10.1016/j.copbio.2010.08.003; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Erdmann J, 2003, REGUL PEPTIDES, V116, P101, DOI 10.1016/S0167-0115(03)00195-2; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330; Gaullier JM, 2007, BRIT J NUTR, V97, P550, DOI 10.1017/S0007114507381324; Greenman Y, 2004, CLIN ENDOCRINOL, V60, P382, DOI 10.1111/j.1365-2265.2004.01993.x; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Hernandez E, 2013, GUT MICROBES, V4, P306, DOI 10.4161/gmic.25321; Kanaya N, 2010, NUTR RES, V30, P714, DOI 10.1016/j.nutres.2010.09.001; Katayama T, 2007, BIOCHEM BIOPH RES CO, V357, P865, DOI 10.1016/j.bbrc.2007.04.001; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kumar U, 2010, RESULTS PROBL CELL D, V50, P137, DOI 10.1007/400_2009_29; Laraichi S, 2013, LIPIDS, V48, P817, DOI 10.1007/s11745-013-3798-y; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; McKee KK, 1997, GENOMICS, V46, P426, DOI 10.1006/geno.1997.5069; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; Neary MT, 2009, PHARMACOL THERAPEUT, V124, P44, DOI 10.1016/j.pharmthera.2009.06.005; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nogueiras R, 2003, FEBS LETT, V548, P21, DOI 10.1016/S0014-5793(03)00708-7; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Oliver P, 2002, DEV DYNAM, V223, P148, DOI 10.1002/dvdy.1233; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Park Y, 2007, J FOOD SCI, V72, pS612, DOI 10.1111/j.1750-3841.2007.00477.x; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Parra Pilar, 2010, Nutr Metab (Lond), V7, P5, DOI 10.1186/1743-7075-7-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Sanchez J, 2007, GENES NUTR, V2, P135, DOI 10.1007/s12263-007-0033-6; Sanchez J, 2004, ENDOCRINOLOGY, V145, P5049, DOI 10.1210/en.2004-0493; Sanchez J, 2004, PFLUG ARCH EUR J PHY, V448, P500, DOI 10.1007/s00424-004-1283-4; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonoyama K, 2010, BRIT J NUTR, V103, P218, DOI 10.1017/S0007114509991589; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Takahashi Y, 2002, COMP BIOCHEM PHYS B, V133, P395, DOI 10.1016/S1096-4959(02)00164-1; Thom E, 2001, J INT MED RES, V29, P392, DOI 10.1177/147323000102900503; Trigueros L, 2013, CRIT REV FOOD SCI, V53, P929, DOI 10.1080/10408398.2011.574215; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wadden D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045748; West DB, 1998, AM J PHYSIOL-REG I, V275, pR667; West DB, 2000, J NUTR, V130, P2471, DOI 10.1093/jn/130.10.2471; Zabala A, 2006, NUTRITION, V22, P528, DOI 10.1016/j.nut.2005.10.005; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhao Z, 2008, J ENDOCRINOL, V196, P529, DOI 10.1677/JOE-07-0300	71	44	46	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125091	10.1371/journal.pone.0125091	http://dx.doi.org/10.1371/journal.pone.0125091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915857	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100096
J	Fontenete, S; Leite, M; Guimaraes, N; Madureira, P; Ferreira, RM; Figueiredo, C; Wengel, J; Azevedo, NF				Fontenete, Silvia; Leite, Marina; Guimaraes, Nuno; Madureira, Pedro; Ferreira, Rui Manuel; Figueiredo, Ceu; Wengel, Jesper; Azevedo, Nuno Filipe			Towards Fluorescence In Vivo Hybridization (FIVH) Detection of H. pylori in Gastric Mucosa Using Advanced LNA Probes	PLOS ONE			English	Article							ANTISENSE PHOSPHOROTHIOATE OLIGONUCLEOTIDES; CONFOCAL LASER ENDOMICROSCOPY; NUCLEIC-ACID PROBE; HELICOBACTER-PYLORI; SITU HYBRIDIZATION; RIBOSOMAL-RNA; CHEMICAL-MODIFICATION; CLARITHROMYCIN RESISTANCE; ESCHERICHIA-COLI; EPITHELIAL-CELLS	In recent years, there have been several attempts to improve the diagnosis of infection caused by Helicobacter pylori. Fluorescence in situ hybridization (FISH) is a commonly used technique to detect H. pylori infection but it requires biopsies from the stomach. Thus, the development of an in vivo FISH-based method (FIVH) that directly detects and allows the visualization of the bacterium within the human body would significantly reduce the time of analysis, allowing the diagnosis to be performed during endoscopy. In a previous study we designed and synthesized a phosphorothioate locked nucleic acid (LNA)/2' O-methyl RNA (2'OMe) probe using standard phosphoramidite chemistry and FISH hybridization was then successfully performed both on adhered and suspended bacteria at 37 degrees C. In this work we simplified, shortened and adapted FISH to work at gastric pH values, meaning that the hybridization step now takes only 30 minutes and, in addition to the buffer, uses only urea and probe at non-toxic concentrations. Importantly, the sensitivity and specificity of the FISH method was maintained in the range of conditions tested, even at low stringency conditions (e.g., low pH). In conclusion, this methodology is a promising approach that might be used in vivo in the future in combination with a confocal laser endomicroscope for H. pylori visualization.	[Fontenete, Silvia; Guimaraes, Nuno; Azevedo, Nuno Filipe] Univ Porto, Fac Engn, Lab Proc Engn Environm Biotechnol & Energy, LEPABE, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Guimaraes, Nuno; Madureira, Pedro; Ferreira, Rui Manuel; Figueiredo, Ceu] Univ Porto, Inst Invest Inovacao Saude, P-4100 Oporto, Portugal; [Fontenete, Silvia; Leite, Marina; Guimaraes, Nuno; Ferreira, Rui Manuel; Figueiredo, Ceu; Wengel, Jesper] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4100 Oporto, Portugal; [Fontenete, Silvia; Guimaraes, Nuno] Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense M, Denmark; [Fontenete, Silvia; Madureira, Pedro] Univ Porto, Inst Biomed Sci Abel Salazar, ICBAS, P-4100 Oporto, Portugal; [Madureira, Pedro] Inst Mol Biol & Cell Biol, IBMC, Oporto, Portugal; [Figueiredo, Ceu] Univ Porto, Fac Med, FMUP, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Southern Denmark; Universidade do Porto; Universidade do Porto; Universidade do Porto	Fontenete, S (corresponding author), Univ Porto, Fac Engn, Lab Proc Engn Environm Biotechnol & Energy, LEPABE, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sfontenete@fe.up.pt	Ferreira, Rui M./J-6915-2013; Figueiredo, Ceu/B-8776-2008; Madureira, Pedro/D-2174-2013; Leite, Carla Marina Gonçalves/J-5976-2013; Guimaraes, Nuno/H-3270-2019; Fontenete, Sílvia/Q-1936-2018	Ferreira, Rui M./0000-0003-0961-2356; Figueiredo, Ceu/0000-0001-5247-840X; Madureira, Pedro/0000-0003-4078-800X; Leite, Carla Marina Gonçalves/0000-0003-4286-0247; Guimaraes, Nuno/0000-0002-7623-3877; Fontenete, Sílvia/0000-0003-1972-6349; Azevedo, Nuno/0000-0001-5864-3250; Wengel, Jesper/0000-0001-9835-1009	Fundacao de Ciencia e Tecnologia [PIC/IC/82815/2007]; Ministerio da Ciencia, Tecnologia e Ensino Superior [SFRH/BD/72999/2010, SFRH/BPD/33420/2008, SFRH/BPD/78846/2011]; Nucleic Acid Center, University of Southern Denmark; FEDER (Operational Programme for Competitiveness Factors - COMPETE, ON.2 - O Novo Norte - North Portugal Regional Operational Programme) [NORTE-07-0124-FEDER- 000022]	Fundacao de Ciencia e Tecnologia; Ministerio da Ciencia, Tecnologia e Ensino Superior; Nucleic Acid Center, University of Southern Denmark; FEDER (Operational Programme for Competitiveness Factors - COMPETE, ON.2 - O Novo Norte - North Portugal Regional Operational Programme)	This work was supported by Fundacao de Ciencia e Tecnologia [DNA mimics Research Project PIC/IC/82815/2007], Ministerio da Ciencia, Tecnologia e Ensino Superior, PhD grant [SFRH/BD/72999/2010 to SF], Post-Doctoral fellowship [SFRH/BPD/33420/2008 to ML and grant SFRH/BPD/78846/2011 to NG], Nucleic Acid Center, University of Southern Denmark and FEDER (Operational Programme for Competitiveness Factors - COMPETE, ON.2 - O Novo Norte - North Portugal Regional Operational Programme, reference NORTE-07-0124-FEDER- 000022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida C, 2010, APPL ENVIRON MICROB, V76, P4476, DOI 10.1128/AEM.01678-09; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Anjum MF, 1997, EUR J OPER RES, V101, P65, DOI 10.1016/S0377-2217(96)00232-9; Backert S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-28; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bergman JJGHM, 2005, GUT, V54, pI38, DOI 10.1136/gut.2004.041590; Bouvier T, 2003, FEMS MICROBIOL ECOL, V44, P3, DOI 10.1016/S0168-6496(02)00461-0; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bucker R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00994; Burdick AD, 2014, NUCLEIC ACIDS RES, V42, P4882, DOI 10.1093/nar/gku142; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Cerqueira L, 2013, J CLIN MICROBIOL, V51, P1887, DOI 10.1128/JCM.00302-13; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Chung HJ, 2011, ACS NANO, V5, P8834, DOI 10.1021/nn2029692; Crinelli R, 2002, NUCLEIC ACIDS RES, V30, P2435, DOI 10.1093/nar/30.11.2435; Crinelli R, 2004, CURR DRUG TARGETS, V5, P745, DOI 10.2174/1389450043345083; de Groot A, 2010, CONTACT DERMATITIS, V63, P117, DOI 10.1111/j.1600-0536.2010.01714.x; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Ezzat K, 2012, J CONTROL RELEASE, V162, P1, DOI 10.1016/j.jconrel.2012.06.006; Ferreira RM, 2012, J CLIN MICROBIOL, V50, P3983, DOI 10.1128/JCM.02087-12; FIMMEL CJ, 1985, GASTROENTEROLOGY, V88, P1842, DOI 10.1016/0016-5085(85)90009-5; Finotto S, 2001, J ALLERGY CLIN IMMUN, V107, P279, DOI 10.1067/mai.2001.113049; Fontenete S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081230; FORMAN D, 1995, ALIMENT PHARM THER, V9, P71; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Gozzetti A, 2000, SEMIN HEMATOL, V37, P320, DOI 10.1016/S0037-1963(00)90013-1; Guga P, 2011, CHEM BIODIVERS, V8, P1642, DOI 10.1002/cbdv.201100130; Guimaraes N, 2007, J CLIN MICROBIOL, V45, P3089, DOI 10.1128/JCM.00858-07; Hagedorn PH, 2013, NUCLEIC ACID THER, V23, P302, DOI 10.1089/nat.2013.0436; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hildebrandt-Eriksen ES, 2012, NUCLEIC ACID THER, V22, P152, DOI 10.1089/nat.2011.0332; Hildner KM, 2007, J IMMUNOL, V178, P3427, DOI 10.4049/jimmunol.178.6.3427; Karstensen JG, 2014, WORLD J GASTROENTERO, V20, P7794, DOI 10.3748/wjg.v20.i24.7794; Kenzaka T, 1998, MICROBIOL-UK, V144, P2085, DOI 10.1099/00221287-144-8-2085; Khan AA, 2012, BBA-REV CANCER, V1826, P331, DOI 10.1016/j.bbcan.2012.05.005; Kiesslich Ralf, 2005, Clin Gastroenterol Hepatol, V3, pS58, DOI 10.1016/S1542-3565(05)00252-1; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lawson TS, 2012, LETT APPL MICROBIOL, V54, P263, DOI 10.1111/j.1472-765X.2011.03197.x; Lennox KA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.46; Levin AA, 1999, BBA-GENE STRUCT EXPR, V1489, P69, DOI 10.1016/S0167-4781(99)00140-2; Lian SQ, 2013, LUMINESCENCE, V28, P967, DOI 10.1002/bio.2469; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; Markey FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093488; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Matthiesen Steen H, 2012, PLoS One, V7, pe40675, DOI 10.1371/journal.pone.0040675; McNulty CAM, 2011, HELICOBACTER, V16, P10, DOI 10.1111/j.1523-5378.2011.00875.x; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; Moralli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004483; Myers RH., 2016, RESPONSE SURFACE MET; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; NOACH LA, 1994, J CLIN PATHOL, V47, P699, DOI 10.1136/jcp.47.8.699; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; Olfat FO, 2002, J INFECT DIS, V186, P423, DOI 10.1086/341459; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Rickard A., 2003, BIOFILM COMMUNITIES, P105; Santos RS, 2014, J BIOTECHNOL, V187, P16, DOI 10.1016/j.jbiotec.2014.06.023; Schreiber S, 2005, INFECT IMMUN, V73, P1584, DOI 10.1128/IAI.73.3.1584-1589.2005; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Seidel CAM, 1996, J PHYS CHEM-US, V100, P5541, DOI 10.1021/jp951507c; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Shukla R, 2011, WORLD J GASTRO ENDOS, V3, P183, DOI 10.4253/wjge.v3.i10.183; Soe MJ, 2011, J HISTOCHEM CYTOCHEM, V59, P661, DOI 10.1369/0022155411409411; Stanton R, 2012, NUCLEIC ACID THER, V22, P344, DOI 10.1089/nat.2012.0366; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun Z, 2011, BIOCHEM BIOPH RES CO, V409, P430, DOI 10.1016/j.bbrc.2011.05.016; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Tang YZ, 2005, APPL ENVIRON MICROB, V71, P8157, DOI 10.1128/AEM.71.12.8157-8164.2005; Vinette KMB, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-5; Wadstrom T, 1997, J PHYSIOL PHARMACOL, V48, P325; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; WESSENDORF MW, 1992, HISTOCHEMISTRY, V98, P81, DOI 10.1007/BF00716998; WETMUR JG, 1976, ANNU REV BIOPHYS BIO, V5, P337, DOI 10.1146/annurev.bb.05.060176.002005; Wong Kee Song Louis-Michel, 2005, Best Pract Res Clin Gastroenterol, V19, P833, DOI 10.1016/j.bpg.2005.04.006; Yilmaz O, 2007, WORLD J GASTROENTERO, V13, P671, DOI 10.3748/wjg.v13.i5.671; You Y, 2011, BIOPOLYMERS, V95, P472, DOI 10.1002/bip.21615; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]	78	28	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125494	10.1371/journal.pone.0125494	http://dx.doi.org/10.1371/journal.pone.0125494			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915865	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100131
J	Ganjali, M; Baghfalaki, T; Berridge, D				Ganjali, Mojtaba; Baghfalaki, Taban; Berridge, Damon			Robust Modeling of Differential Gene Expression Data Using Normal/Independent Distributions: A Bayesian Approach	PLOS ONE			English	Article							INFERENCE; IDENTIFICATION; MICROARRAYS	In this paper, the problem of identifying differentially expressed genes under different conditions using gene expression microarray data, in the presence of outliers, is discussed. For this purpose, the robust modeling of gene expression data using some powerful distributions known as normal/independent distributions is considered. These distributions include the Student's t and normal distributions which have been used previously, but also include extensions such as the slash, the contaminated normal and the Laplace distributions. The purpose of this paper is to identify differentially expressed genes by considering these distributional assumptions instead of the normal distribution. A Bayesian approach using the Markov Chain Monte Carlo method is adopted for parameter estimation. Two publicly available gene expression data sets are analyzed using the proposed approach. The use of the robust models for detecting differentially expressed genes is investigated. This investigation shows that the choice of model for differentiating gene expression data is very important. This is due to the small number of replicates for each gene and the existence of outlying data. Comparison of the performance of these models is made using different statistical criteria and the ROC curve. The method is illustrated using some simulation studies. We demonstrate the flexibility of these robust models in identifying differentially expressed genes.	[Ganjali, Mojtaba; Baghfalaki, Taban] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran; [Ganjali, Mojtaba] Shahid Beheshti Univ, Fac Math Sci, Dept Stat, Tehran, Iran; [Baghfalaki, Taban] Tarbiat Modares Univ, Fac Math Sci, Dept Stat, Tehran, Iran; [Berridge, Damon] Swansea Univ, Coll Med, Farr Inst CIPHER, Swansea, W Glam, Wales	Shahid Beheshti University; Tarbiat Modares University; Swansea University	Ganjali, M (corresponding author), Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran.	m-ganjali@sbu.ac.ir	Baghfalaki, Taban/R-7017-2019	Berridge, Damon/0000-0002-5442-6686	Computer Science department of Institute for Research in Fundamental Sciences (IPM); Iranian National Science Foundation [INSF BS1392201]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Computer Science department of Institute for Research in Fundamental Sciences (IPM); Iranian National Science Foundation(Iran National Science Foundation (INSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research presented in this study was carried out on the High Performance Computing Cluster supported by the Computer Science department of Institute for Research in Fundamental Sciences (IPM). The authors would like to thank the Iranian National Science Foundation (INSF BS1392201) for their support.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bhowmick D, 2006, BIOSTATISTICS, V7, P630, DOI 10.1093/biostatistics/kxj032; Casella G., 2002, STAT INFERENCE, V2nd; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Chu G, 2002, SAM SIGNIFICANT ANAL; Dudoit S, 2002, STAT SINICA, V12, P111; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gottardo R, 2006, BIOMETRICS, V62, P10, DOI 10.1111/j.1541-0420.2005.00397.x; Gottardo R, 2003, 438 U WASH STAT DEP; Gottardo R, 2008, BIOMETRICS, V64, P468, DOI 10.1111/j.1541-0420.2007.00899.x; Haye Alexandre, 2012, BMC Res Notes, V5, P46, DOI 10.1186/1756-0500-5-46; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Ibrahim JG, 2002, J AM STAT ASSOC, V97, P88, DOI 10.1198/016214502753479257; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Lachos VH, 2010, STAT SINICA, V20, P303; Lange K., 1993, J COMPUT GRAPH STAT, V2, P175, DOI DOI 10.2307/1390698; Mallick BK, 2009, BAYESIAN ANAL GENE E; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Posekany A, 2011, BIOINFORMATICS, V27, P807, DOI 10.1093/bioinformatics/btr018; Subramaniam S, 2012, NAT IMMUNOL, V13, P199, DOI 10.1038/ni.2244; Tadesse MG, 2003, BIOMETRICS, V59, P542, DOI 10.1111/1541-0420.00064; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123791	10.1371/journal.pone.0123791	http://dx.doi.org/10.1371/journal.pone.0123791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910040	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800046
J	Kirrane, MJ; de Guzman, LI; Holloway, B; Frake, AM; Rinderer, TE; Whelan, PM				Kirrane, Maria J.; de Guzman, Lilia I.; Holloway, Beth; Frake, Amanda M.; Rinderer, Thomas E.; Whelan, Padraig M.			Phenotypic and Genetic Analyses of the Varroa Sensitive Hygienic Trait in Russian Honey Bee (Hymenoptera: Apidae) Colonies	PLOS ONE			English	Article							DESTRUCTOR MESOSTIGMATA VARROIDAE; APIS-CERANA FABR; MITE REPRODUCTION; INFESTATION RATE; JACOBSONI OUD; BEHAVIOR; RESISTANCE; MELLIFERA; BROOD; RESPONSES	Varroa destructorcontinues to threaten colonies of European honey bees. General hygiene, and more specific Varroa Sensitive Hygiene (VSH), provide resistance towards the Varroa mite in a number of stocks. In this study, 32 Russian (RHB) and 14 Italian honey bee colonies were assessed for the VSH trait using two different assays. Firstly, colonies were assessed using the standard VSH behavioural assay of the change in infestation of a highly infested donor comb after a one-week exposure. Secondly, the same colonies were assessed using an "actual brood removal assay" that measured the removal of brood in a section created within the donor combs as a potential alternative measure of hygiene towards Varroa-infested brood. All colonies were then analysed for the recently discovered VSH quantitative trait locus (QTL) to determine whether the genetic mechanisms were similar across different stocks. Based on the two assays, RHB colonies were consistently more hygienic toward Varroa-infested brood than Italian honey bee colonies. The actual number of brood cells removed in the defined section was negatively correlated with the Varroa infestations of the colonies (r(2) = 0.25). Only two (percentages of brood removed and reproductive foundress Varroa) out of nine phenotypic parameters showed significant associations with genotype distributions. However, the allele associated with each parameter was the opposite of that determined by VSH mapping. In this study, RHB colonies showed high levels of hygienic behaviour towards Varroa - infested brood. The genetic mechanisms are similar to those of the VSH stock, though the opposite allele associates in RHB, indicating a stable recombination event before the selection of the VSH stock. The measurement of brood removal is a simple, reliable alternative method of measuring hygienic behaviour towards Varroa mites, at least in RHB stock.	[Kirrane, Maria J.; Whelan, Padraig M.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci BEES, Cork, Ireland; [Kirrane, Maria J.; Whelan, Padraig M.] Natl Univ Ireland Univ Coll Cork, ERI, Cork, Ireland; [de Guzman, Lilia I.; Holloway, Beth; Frake, Amanda M.; Rinderer, Thomas E.] USDA ARS, Honey Bee Breeding Genet & Physiol Lab, Baton Rouge, LA 70820 USA	University College Cork; University College Cork; United States Department of Agriculture (USDA)	Kirrane, MJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci BEES, Cork, Ireland.	s105692474@student.ucc.ie			Irish Research Council, Government of Ireland	Irish Research Council, Government of Ireland	MJK is funded by the Irish Research Council, Government of Ireland Postgraduate Scholarship Scheme (www.research.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeier P, 2001, APIDOLOGIE, V32, P253, DOI 10.1051/apido:2001127; BOECKING O, 1991, APIDOLOGIE, V22, P237, DOI 10.1051/apido:19910308; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Danka JR, 2009, J APICULT RES, V48, P156; Danka RG, 2012, J APICULT RES, V52, P69; Danka RG, 2011, J ECON ENTOMOL, V104, P745, DOI 10.1603/EC10401; de Guzman LI, 2008, J APICULT RES, V47, P216, DOI 10.1080/00218839.2008.11101462; de Guzman LI, 2008, EXP APPL ACAROL, V44, P227, DOI 10.1007/s10493-008-9142-1; De Guzman LI, 2007, ANN ENTOMOL SOC AM, V100, P187, DOI 10.1603/0013-8746(2007)100[187:GOVDAV]2.0.CO;2; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Donze G, 1996, ECOL ENTOMOL, V21, P17, DOI 10.1111/j.1365-2311.1996.tb00261.x; Frey E, 2013, J INVERTEBR PATHOL, V113, P56, DOI 10.1016/j.jip.2013.01.007; Gramacho KP, 2003, BEHAV ECOL SOCIOBIOL, V54, P472, DOI 10.1007/s00265-003-0643-y; Harbo JR, 2009, J APICULT RES, V48, P156, DOI 10.3896/IBRA.1.48.3.02; Harbo JR, 1999, J ECON ENTOMOL, V92, P261, DOI 10.1093/jee/92.2.261; Harbo JR, 2005, J APICULT RES, V44, P21, DOI 10.1080/00218839.2005.11101141; Harbo JR, 2001, J ECON ENTOMOL, V94, P1319, DOI 10.1603/0022-0493-94.6.1319; Harris JW, 2007, J APICULT RES, V46, P134, DOI 10.1080/00218839.2007.11101383; Harris JW, 2012, ANN ENTOMOL SOC AM, V105, P512, DOI 10.1603/AN11188; Holloway B, 2013, J APICULT RES, V52, P134, DOI 10.3896/IBRA.1.52.3.04; Ibrahim A, 2006, APIDOLOGIE, V37, P31, DOI 10.1051/apido:2005052; Ibrahim A, 2007, APIDOLOGIE, V38, P67, DOI 10.1051/apido:2006065; Kavinseksan B, 2004, AM BEE J, V144, P870; Kirrane MJ, 2011, J ECON ENTOMOL, V104, P1146, DOI 10.1603/EC11035; Lapidge KL, 2002, NATURWISSENSCHAFTEN, V89, P565, DOI 10.1007/s00114-002-0371-6; Le Conte Y, 2011, INSECT MOL BIOL, V20, P399, DOI 10.1111/j.1365-2583.2011.01074.x; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Masterman R, 2001, J COMP PHYSIOL A, V187, P441, DOI 10.1007/s003590100216; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; RATH W, 1990, APIDOLOGIE, V21, P311, DOI 10.1051/apido:19900406; Rinderer TE, 2001, APIDOLOGIE, V32, P381, DOI 10.1051/apido:2001138; Rinderer TE, 2000, AM BEE J, V140, P305; ROTHENBUHLER WC, 1964, AM ZOOL, V4, P111; Schoning C, 2012, J EXP BIOL, V215, P264, DOI 10.1242/jeb.062562; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; Spivak M, 2001, J ECON ENTOMOL, V94, P326, DOI 10.1603/0022-0493-94.2.326; STEINER J, 1994, INVERTEBR REPROD DEV, V25, P175, DOI 10.1080/07924259.1994.9672384; Tarpy DR, 2007, J ECON ENTOMOL, V100, P258, DOI 10.1603/0022-0493(2007)100[258:COPMIR]2.0.CO;2; Tsuruda JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048276; Vandame R, 2002, APIDOLOGIE, V33, P433, DOI 10.1051/apido:2002025; Villa JD, 2009, J APICULT RES, V48, P162, DOI 10.3896/IBRA.1.48.3.03; Villegas AJ, 2006, J APICULT RES, V45, P203, DOI 10.1080/00218839.2006.11101348; Ward K, 2008, J ECON ENTOMOL, V101, P654, DOI 10.1603/0022-0493(2008)101[654:CPOTMS]2.0.CO;2	45	18	18	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0116672	10.1371/journal.pone.0116672	http://dx.doi.org/10.1371/journal.pone.0116672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909856	Green Published, gold			2022-12-26	WOS:000353376800002
J	Laube, M; Bossmann, M; Thome, UH				Laube, Mandy; Bossmann, Miriam; Thome, Ulrich H.			Glucocorticoids Distinctively Modulate the CFTR Channel with Possible Implications in Lung Development and Transition into Extrauterine Life	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; CONDUCTANCE REGULATOR CFTR; EPITHELIAL FLUID CLEARANCE; CYSTIC-FIBROSIS GENE; HUMAN FETAL TISSUES; BICARBONATE SECRETION; CELL-PROLIFERATION; SODIUM-TRANSPORT; NA+ CHANNEL; KINASE SGK1	During fetal development, the lung is filled with fluid that is secreted by an active Cl-transport promoting lung growth. The basolateral Na+, K+, 2Cl(-) cotransporter (NKCC1) participates in Cl-secretion. The apical Cl-channels responsible for secretion are unknown but studies suggest an involvement of the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is developmentally regulated with a high expression in early fetal development and a decline in late gestation. Perinatal lung transition is triggered by hormones that stimulate alveolar Na+ channels resulting in fluid absorption. Little is known on how hormones affect pulmonary Cl-channels. Since the rise of fetal cortisol levels correlates with the decrease in fetal CFTR expression, a causal relation may be assumed. The aim of this study was to analyze the influence of glucocorticoids on pulmonary Cl-channels. Alveolar cells from fetal and adult rats, A549 cells, bronchial Calu-3 and 16HBE14o-cells, and primary rat airway cells were studied with real-time quantitative PCR and Ussing chambers. In fetal and adult alveolar cells, glucocorticoids strongly reduced Cftr expression and channel activity, which was prevented by mifepristone. In bronchial and primary airway cells CFTR mRNA expression was also reduced, whereas channel activity was increased which was prevented by LY-294002 in Calu-3 cells. Therefore, glucocorticoids strongly reduce CFTR expression while their effect on CFTR activity depends on the physiological function of the cells. Another apical Cl-channel, anoctamin 1 showed a glucocorticoid-induced reduction of mRNA expression in alveolar cells and an increase in bronchial cells. Furthermore, voltage- gated chloride channel 5 and anoctamine 6 mRNA expression were increased in alveolar cells. NKCCl expression was reduced by glucocorticoids in alveolar and bronchial cells alike. The results demonstrate that glucocorticoids differentially modulate pulmonary Clchannels and are likely causing the decline of CFTR during late gestation in preparation for perinatal lung transition.	[Laube, Mandy; Bossmann, Miriam; Thome, Ulrich H.] Univ Leipzig, Ctr Pediat Res Leipzig, Hosp Children & Adolescents, Div Neonatol, D-04109 Leipzig, Germany	Leipzig University	Laube, M (corresponding author), Univ Leipzig, Ctr Pediat Res Leipzig, Hosp Children & Adolescents, Div Neonatol, D-04109 Leipzig, Germany.	Mandy.Laube@medizin.uni-leipzig.de		Laube, Mandy/0000-0002-7180-2858	medical faculty of Leipzig University; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	medical faculty of Leipzig University; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	The study was supported by a research grant of the medical faculty of Leipzig University to ML. The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN D, 1977, J ANAT, V123, P649; BARKER PM, 1995, AM J PHYSIOL-LUNG C, V268, pL270, DOI 10.1152/ajplung.1995.268.2.L270; Blackburn S.T., 2012, MATERNAL FETAL NEONA, V4; Bland RD, 2001, AM J PHYSIOL-LUNG C, V280, pL602, DOI 10.1152/ajplung.2001.280.4.L602; Bomberger JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089599; Bourbon JR, 2006, AM J PHYSIOL-LUNG C, V291, pL1, DOI 10.1152/ajplung.00091.2006; Broackes-Carter FC, 2002, HUM MOL GENET, V11, P125, DOI 10.1093/hmg/11.2.125; Cadepond F, 1997, ANNU REV MED, V48, P129; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CASSIN S, 1986, P SOC EXP BIOL MED, V181, P427; CLARKE LL, 1992, AM J PHYSIOL, V263, pL519, DOI 10.1152/ajplung.1992.263.5.L519; Cohen JC, 2006, DEV DYNAM, V235, P2736, DOI 10.1002/dvdy.20912; Cohen JC, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-2; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Farrell PM, 2003, PEDIATR PULM, V36, P230, DOI 10.1002/ppul.10336; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Finley N, 1998, J CLIN INVEST, V101, P972, DOI 10.1172/JCI1478; Folkesson HG, 2000, J APPL PHYSIOL, V88, P416, DOI 10.1152/jappl.2000.88.2.416; Gappa M, 2001, PEDIATR PULM, V32, P228, DOI 10.1002/ppul.1113; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; GEORGE DK, 1987, AM REV RESPIR DIS, V136, P947, DOI 10.1164/ajrccm/136.4.947; Harding R, 1996, J APPL PHYSIOL, V81, P209, DOI 10.1152/jappl.1996.81.1.209; Hudak JJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-34; Hug MJ, 2003, NEWS PHYSIOL SCI, V18, P38, DOI 10.1152/nips.01412.2002; JASSAL D, 1991, IN VITRO CELL DEV B, V27, P625; KINDLER PM, 1993, ACTA ENDOCRINOL-COP, V129, P169, DOI 10.1530/acta.0.1290169; KITTERMAN JA, 1979, J APPL PHYSIOL, V47, P985, DOI 10.1152/jappl.1979.47.5.985; KOTAS RV, 1971, J APPL PHYSIOL, V30, P358, DOI 10.1152/jappl.1971.30.3.358; Kunzelmann K, 2012, INT J BIOCHEM CELL B, V44, P1897, DOI 10.1016/j.biocel.2012.06.011; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Larson JE, 2006, AM J PHYSIOL-LUNG C, V291, pL4, DOI 10.1152/ajplung.00372.2005; Larson JE, 2000, AM J PHYSIOL-LUNG C, V279, pL333, DOI 10.1152/ajplung.2000.279.2.L333; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Miklavc P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010982; Mustafa SB, 2004, AM J PHYSIOL-LUNG C, V286, pL73, DOI 10.1152/ajplung.00342.2002; OLVER RE, 1974, J PHYSIOL-LONDON, V241, P327, DOI 10.1113/jphysiol.1974.sp010659; ORNOY A, 1987, AM J MED GENET, V28, P935, DOI 10.1002/ajmg.1320280420; Oshika E, 1998, PEDIATR RES, V43, P305, DOI 10.1203/00006450-199803000-00001; Prota LFM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047405; Reddy MM, 2003, NATURE, V423, P756, DOI 10.1038/nature01694; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; Sakamoto H, 1996, J BIOL CHEM, V271, P10210, DOI 10.1074/jbc.271.17.10210; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Schmidt C, 2014, LUNG, V192, P935, DOI 10.1007/s00408-014-9640-3; Sharp JK, 2002, CLIN REV ALLERG IMMU, V23, P59, DOI 10.1385/CRIAI:23:1:059; Shcheynikov N, 2004, J BIOL CHEM, V279, P21857, DOI 10.1074/jbc.M313323200; SMITH BT, 1974, J CLIN INVEST, V53, P1518, DOI 10.1172/JCI107702; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tang L, 2009, J CYST FIBROS, V8, P115, DOI 10.1016/j.jcf.2008.10.004; TEBBUTT SJ, 1995, P NATL ACAD SCI USA, V92, P2293, DOI 10.1073/pnas.92.6.2293; Thome UH, 2003, AM J PHYSIOL-LUNG C, V284, pL376, DOI 10.1152/ajplung.00218.2002; TIZZANO EF, 1993, HUM MOL GENET, V2, P219, DOI 10.1093/hmg/2.3.219; TREZISE AEO, 1993, HUM MOL GENET, V2, P213, DOI 10.1093/hmg/2.3.213; Tuo BG, 2009, AM J PHYSIOL-CELL PH, V297, pC503, DOI 10.1152/ajpcell.00460.2008; von Wangenheim KH, 1998, J THEOR BIOL, V193, P663, DOI 10.1006/jtbi.1998.0731; Wagner CA, 2001, CELL PHYSIOL BIOCHEM, V11, P209, DOI 10.1159/000051935; Yigit E, 2013, NUCLEIC ACIDS RES, V41, P2857, DOI 10.1093/nar/gks1462	63	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124833	10.1371/journal.pone.0124833	http://dx.doi.org/10.1371/journal.pone.0124833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910246	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000353376800109
J	Zhang, SD; Ling, LZ; Zhang, QF; Xu, JD; Cheng, L				Zhang, Shu-Dong; Ling, Li-Zhen; Zhang, Quan-Fang; Xu, Jian-Di; Cheng, Le			Evolutionary Comparison of Two Combinatorial Regulators of SBP-Box Genes, MiR156 and MiR529, in Plants	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM; MOLECULAR EVOLUTION; GENOME DUPLICATION; SMALL RNAS; MICRORNAS; ARABIDOPSIS; FASTER; DROSHA; RATES	A complete picture of the evolution of miRNA combinatorial regulation requires the synthesis of information on all miRNAs and their targets. MiR156 and miR529 are two combinatorial regulators of squamosa promoter binding protein-like (SBP-box) genes. Previous studies have clarified the evolutionary dynamics of their targets; however, there have been no reports on the evolutionary patterns of two miRNA regulators themselves to date. In this study, we investigated the evolutionary differences between these two miRNA families in extant land plants. Our work found that miR529 precursor, especially of its mature miRNA sequence, has a higher evolutionary rate. Such accelerating evolution of miR529 has significantly effects on its structural stability, and sequence conservation against existence of itself. By contrast, miR156 evolves more rapidly in loop region of the stable secondary structure, which may contribute to its functional diversity. Moreover, miR156 and miR529 genes have distinct rates of loss after identical duplication events. MiR529 genes have a higher average loss rate and asymmetric loss rate in duplicated gene pairs, indicating preferred miR529 gene losses become another predominant mode of inactivation, that are implicated in the contraction of this family. On the contrary, duplicated miR156 genes have a low loss rate, and could serve as another new source for functional diversity. Taken together, these results provide better insight into understanding the evolutionary divergence of miR156 and miR529 family in miRNA combinational regulation network.	[Zhang, Shu-Dong] Germplasm Bank Wild Species, Kunming 650201, Peoples R China; [Ling, Li-Zhen; Cheng, Le] BGI Shenzhen, BGI Yunnan, Kunming 650106, Peoples R China; [Zhang, Quan-Fang] Shandong Acad Agr Sci, Biotech Res Ctr, Jinan 250100, Peoples R China; [Xu, Jian-Di] Shandong Acad Agr Sci, Shandong Rice Res Inst, Jinan 250100, Peoples R China	Beijing Genomics Institute (BGI); Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Ling, LZ (corresponding author), BGI Shenzhen, BGI Yunnan, Kunming 650106, Peoples R China.	linglizhen@genomics.cn; chengle@genomics.cn			National Natural Science Foundation of China [31200172]; Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province [BS2013SW003]; Special Fund for BGI-Yunnan's High Throughput Sequencing Platform (P. R. China, Yunnan Provincial Science and Technology Department) [2013 DA008]; Research of High Throughput Sequencing Technology in the Application of Prevention and Control of the Mediterranean Anemia High-Risk Groups (P.R. China, Yunnan Province) [2014FC003]; Cultivation of Backup Young and Middle-Aged Academic Technology Leaders in Yunnan Province (P.R. China, Yunnan Province) [2014HB053]; Application of Genomics Technology in Notoginseng Breeding (P.R. China, Yunnan Province) [2014BC005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province; Special Fund for BGI-Yunnan's High Throughput Sequencing Platform (P. R. China, Yunnan Provincial Science and Technology Department); Research of High Throughput Sequencing Technology in the Application of Prevention and Control of the Mediterranean Anemia High-Risk Groups (P.R. China, Yunnan Province); Cultivation of Backup Young and Middle-Aged Academic Technology Leaders in Yunnan Province (P.R. China, Yunnan Province); Application of Genomics Technology in Notoginseng Breeding (P.R. China, Yunnan Province)	This work was supported by the National Natural Science Foundation of China (grant no. 31200172), Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province (BS2013SW003), Special Fund for BGI-Yunnan's High Throughput Sequencing Platform (P. R. China, Yunnan Provincial Science and Technology Department, 2013 DA008), The Research of High Throughput Sequencing Technology in the Application of Prevention and Control of the Mediterranean Anemia High-Risk Groups (P.R. China, Yunnan Province, 2014FC003), The Cultivation of Backup Young and Middle-Aged Academic Technology Leaders in Yunnan Province (P.R. China, Yunnan Province, 2014HB053), and The Application of Genomics Technology in Notoginseng Breeding (P.R. China, Yunnan Province, 2014BC005). BGI provided support in the form of salaries for authors L-ZL and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Barakat A, 2007, PLANT J, V51, P991, DOI 10.1111/j.1365-313X.2007.03197.x; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Cai B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-79; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Jeong DH, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r145; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Ling LZ, 2012, GENETICA, V140, P317, DOI 10.1007/s10709-012-9684-3; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Mohammed J, 2013, RNA, V19, P1295, DOI 10.1261/rna.039248.113; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Preston JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00080; Shen Y, 2011, P NATL ACAD SCI USA, V108, P15942, DOI 10.1073/pnas.1110098108; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang CM, 2013, INT J BIOL SCI, V9, P578, DOI 10.7150/ijbs.6357; Wang S, 2007, FEBS LETT, V581, P4789, DOI 10.1016/j.febslet.2007.09.002; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Yampolsky LY, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-2; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1155/2012/360358, 10.1093/nar/gkr1092]; Zhu Y, 2012, BMC GENOMICS, V13	39	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124621	10.1371/journal.pone.0124621	http://dx.doi.org/10.1371/journal.pone.0124621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909360	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800093
J	Donnelier, J; Braun, ST; Dolzhanskaya, N; Ahrendt, E; Braun, AP; Velinov, M; Braun, JEA				Donnelier, Julien; Braun, Samuel T.; Dolzhanskaya, Natalia; Ahrendt, Eva; Braun, Andrew P.; Velinov, Milen; Braun, Janice E. A.			Increased Expression of the Large Conductance, Calcium-Activated K+ (BK) Channel in Adult-Onset Neuronal Ceroid Lipofuscinosis	PLoS One			English	Article							CYSTEINE-STRING-PROTEIN; CSP-ALPHA; AUTOSOMAL-DOMINANT; MODULATION; EXOCYTOSIS; NEURODEGENERATION; PHOSPHORYLATION; DEGENERATION; AGGREGATION; DROSOPHILA	Cysteine string protein (CSP alpha) is a presynaptic J protein co-chaperone that opposes neurodegeneration. Mutations in CSP alpha (i.e., Leu115 to Arg substitution or deletion (Delta) of Leu116) cause adult neuronal ceroid lipofuscinosis (ANCL), a dominantly inherited neurodegenerative disease. We have previously demonstrated that CSP alpha limits the expression of large conductance, calcium-activated K+ (BK) channels in neurons, which may impact synaptic excitability and neurotransmission. Here we show by western blot analysis that expression of the pore-forming BK alpha subunit is elevated similar to 2.5 fold in the post-mortem cortex of a 36-year-old patient with the Leu116. CSP alpha mutation. Moreover, we find that the increase in BK alpha subunit level is selective for ANCL and not a general feature of neurodegenerative conditions. While reduced levels of CSP alpha are found in some postmortem cortex specimens from Alzheimer's disease patients, we find no concomitant increase in BK alpha subunit expression in Alzheimer's specimens. Both CSP alpha monomer and oligomer expression are reduced in synaptosomes prepared from ANCL cortex compared with control. In a cultured neuronal cell model, CSP alpha oligomers are short lived. The results of this study indicate that the Leu116 Delta mutation leads to elevated BK alpha subunit levels in human cortex and extend our initial work in rodent models demonstrating the modulation of BK alpha subunit levels by the same CSP alpha mutation. While the precise sequence of pathogenic events still remains to be elucidated, our findings suggest that dysregulation of BK channels may contribute to neurodegeneration in ANCL.	[Donnelier, Julien; Braun, Samuel T.; Ahrendt, Eva; Braun, Janice E. A.] Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Dolzhanskaya, Natalia; Braun, Andrew P.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Velinov, Milen] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Velinov, Milen] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA	University of Calgary; University of Calgary; Yeshiva University; Albert Einstein College of Medicine; Institute for Basic Research in Developmental Disabilities	Braun, JEA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada.	braunj@ucalgary.ca			New York State Office of People with Developmental Disabilities (OPWDD); NSERC; APRI/ASANT	New York State Office of People with Developmental Disabilities (OPWDD); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); APRI/ASANT	The authors have received funding from the New York State Office of People with Developmental Disabilities (OPWDD), as well as NSERC and APRI/ASANT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086586; Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; Boal F, 2011, FASEB J, V25, P132, DOI 10.1096/fj.09-152033; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Donnelier J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00116; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Greaves J, 2012, J BIOL CHEM, V287, P37330, DOI 10.1074/jbc.M112.389098; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Kakkar V, 2012, CURR TOP MED CHEM, V12, P2479; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kashyap SS, 2014, HUM MOL GENET, V23, P5916, DOI 10.1093/hmg/ddu316; Koutras C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00191; Kyle BD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00316; Kyle BD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02447; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Miller LC, 2003, J CELL SCI, V116, P2967, DOI 10.1242/jcs.00595; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Sharma M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004028; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sims KB, 2011, NEW ENGL J MED, V364, P1062, DOI 10.1056/NEJMcpc1013927; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Swayne LA, 2005, MOL CELL NEUROSCI, V30, P339, DOI 10.1016/j.mcn.2005.07.016; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Zhang YQ, 2014, BBA-MOL BASIS DIS, V1842, P2136, DOI 10.1016/j.bbadis.2014.07.009; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125205	10.1371/journal.pone.0125205	http://dx.doi.org/10.1371/journal.pone.0125205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905915	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000107
J	Sadi, G; Baloglu, MC; Pektas, MB				Sadi, Gokhan; Baloglu, Mehmet Cengiz; Pektas, Mehmet Bilgehan			Differential Gene Expression in Liver Tissues of Streptozotocin-Induced Diabetic Rats in Response to Resveratrol Treatment	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; OXIDATIVE STRESS; KIDNEY; ANTIOXIDANT; ACID; SUPPLEMENTATION	This study was conducted to elucidate the genome-wide gene expression profile in streptozotocin induced diabetic rat liver tissues in response to resveratrol treatment and to establish differentially expressed transcription regulation networks with microarray technology. In addition to measure the expression levels of several antioxidant and detoxification genes, real-time quantitative polymerase chain reaction (qRT-PCR) was also used to verify the microarray results. Moreover, gene and protein expressions as well as enzymatic activities of main antioxidant enzymes; superoxide dismutase (SOD-1 and SOD-2) and glutathione Stransferase (GST-Mu) were analyzed. Diabetes altered 273 genes significantly and 90 of which were categorized functionally which suggested that genes in cellular catalytic activities, oxidation-reduction reactions, co-enzyme binding and terpenoid biosynthesis were dominated by up-regulated expression in diabetes. Whereas; genes responsible from cellular carbohydrate metabolism, regulation of transcription, cell signal transduction, calcium independent cell-to-cell adhesion and lipid catabolism were down-regulated. Resveratrol increased the expression of 186 and decreased the expression of 494 genes in control groups. While cellular and extracellular components, positive regulation of biological processes, biological response to stress and biotic stimulants, and immune response genes were up-regulated, genes responsible from proteins present in nucleus and nucleolus were mainly down-regulated. The enzyme assays showed a significant decrease in diabetic SOD-1 and GST-Mu activities. The qRT-PCR and Western-blot results demonstrated that decrease in activity is regulated at gene expression level as both mRNA and protein expressions were also suppressed. Resveratrol treatment normalized the GST activities towards the control values reflecting a post-translational effect. As a conclusion, global gene expression in the liver tissues is affected by streptozotocin induced diabetes in several specific pathways. The present data suggest the presence of several processes which contribute and possibly interact to impair liver functions in type 1 diabetes, several of which are potentially amenable to therapeutic interventions with resveratrol.	[Sadi, Gokhan] Karamanoglu Mehmetbey Univ, Kamil Ozdag Sci Fac, Dept Biol, Karaman, Turkey; [Baloglu, Mehmet Cengiz] Kastamonu Univ, Fac Engn, Dept Genet & Bioengn, Kastamonu, Turkey; [Pektas, Mehmet Bilgehan] Afyon Kocatepe Univ, Fac Med, Dept Med Pharm, Afyon, Turkey	Karamanoglu Mehmetbey University; Kastamonu University; Afyon Kocatepe University	Sadi, G (corresponding author), Karamanoglu Mehmetbey Univ, Kamil Ozdag Sci Fac, Dept Biol, Karaman, Turkey.	sadi@kmu.edu.tr	Sadi, Gökhan/AAK-5468-2021; PEKTAŞ, MEHMET BİLGEHAN/L-9912-2014; PEKTAŞ, MEHMET BİLGEHAN/V-7886-2017; Baloglu, Mehmet Cengiz/P-7411-2016; Baloglu, Mehmet Cengiz/P-2803-2019	PEKTAŞ, MEHMET BİLGEHAN/0000-0001-9790-8397; Baloglu, Mehmet Cengiz/0000-0003-2976-7224; Baloglu, Mehmet Cengiz/0000-0003-2976-7224; Sadi, Gokhan/0000-0002-6422-1203	Scientific and Technological Research Council of Turkey [112T159]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Funding was provided by Scientific and Technological Research Council of Turkey (TUBITAK-http://www.tubitak.gov.tr/en) with grant number of 112T159. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Arinc E, 2007, FOOD CHEM TOXICOL, V45, P107, DOI 10.1016/j.fct.2006.07.026; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Bree AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE194, DOI 10.1152/ajpendo.91041.2008; Chin YT, 2014, ONCOTARGET, V5, P12891, DOI 10.18632/oncotarget.2632; Dominguez B, 2013, INT IMMUNOPHARMACOL, V15, P588, DOI 10.1016/j.intimp.2013.01.024; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harati K, 2015, ANTICANCER RES, V35, P767; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Konings E, 2014, INT J OBESITY, V38, P470, DOI 10.1038/ijo.2013.155; Kume E, 2005, EXP TOXICOL PATHOL, V56, P235, DOI 10.1016/j.etp.2004.09.002; Leon-Galicia I, 2013, EUR J CANCER PREV, V22, P11, DOI 10.1097/CEJ.0b013e328353edcb; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Sadi G, 2008, MOL CELL BIOCHEM, V309, P109, DOI 10.1007/s11010-007-9648-6; Sadi G, 2013, TURK J BIOCHEM, V38, P92, DOI 10.5505/tjb.2013.96720; Sadi G, 2012, DIABETES-METAB RES, V28, P228, DOI 10.1002/dmrr.1302; Schmatz R, 2012, BIOCHIMIE, V94, P374, DOI 10.1016/j.biochi.2011.08.005; Seven A, 2004, YONSEI MED J, V45, P703, DOI 10.3349/ymj.2004.45.4.703; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Towbin H, 1992, Biotechnology, V24, P145; van Lunteren E, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-5; van Lunteren E, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-43; Venturini CD, 2010, OXID MED CELL LONGEV, V3, P434, DOI 10.4161/oxim.3.6.14741; Vlachogianni IC, 2015, FOOD CHEM, V177, P165, DOI 10.1016/j.foodchem.2014.12.092; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057766; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	41	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124968	10.1371/journal.pone.0124968	http://dx.doi.org/10.1371/journal.pone.0124968			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905778	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000097
J	Meguenani, M; Miljkovic-Licina, M; Fagiani, E; Ropraz, P; Hammel, P; Aurrand-Lions, M; Adams, RH; Christofori, G; Imhof, BA; Garrido-Urbani, S				Meguenani, Mehdi; Miljkovic-Licina, Marijana; Fagiani, Ernesta; Ropraz, Patricia; Hammel, Philippe; Aurrand-Lions, Michel; Adams, Ralf H.; Christofori, Gerhard; Imhof, Beat A.; Garrido-Urbani, Sarah			Junctional adhesion molecule B interferes with angiogenic VEGF/VEGFR2 signaling	FASEB JOURNAL			English	Article						tumor angiogenesis; aortic ring; endothelial cells	TUMOR ANGIOGENESIS; BLOOD-VESSELS; INTEGRIN ALPHA-V-BETA-3; ANTIANGIOGENIC THERAPY; PERICYTE INTERACTIONS; ENDOTHELIAL-CELLS; CANCER; GROWTH; METASTASIS; ANTIBODY	De novo formation of blood vessels is a pivotal mechanism during cancer development. During the past few years, antiangiogenic drugs have been developed to target tumor vasculature. However, because of limitations and adverse effects observed with current therapies, there is a strong need for alternative antiangiogenic strategies. Using specific anti-junctional adhesion molecule (JAM)-B antibodies and Jam-b-deficient mice, we studied the role in antiangiogenesis of JAM-B. We found that antibodies against murine JAM-B, an endothelium-specific adhesion molecule, inhibited microvessel outgrowth from ex vivo aortic rings and in vitro endothelial network formation. In addition, anti-JAM-B antibodies blocked VEGF signaling, an essential pathway for angiogenesis. Moreover, increased aortic ring branching was observed in aortas isolated from Jam-b-deficient animals, suggesting that JAM-B negatively regulates proangiogenic pathways. In mice, JAM-B expression was detected in de novo-formed blood vessels of tumors, but anti-JAM-B antibodies unexpectedly did not reduce tumor growth. Accordingly, JAM-B deficiency in vivo had no impact on blood vessel formation, suggesting that targeting JAM-B in vivo may be offset by other proangiogenic mechanisms. In conclusion, despite the promising effects observed in vitro, targeting JAM-B during tumor progression seems to be inefficient as a stand-alone antiangiogenesis therapy.	[Meguenani, Mehdi; Imhof, Beat A.; Garrido-Urbani, Sarah] Univ Geneva, Univ Med Ctr, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Fagiani, Ernesta; Christofori, Gerhard] Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland; [Aurrand-Lions, Michel] Ctr Rech Cancerol Marseille, INSERM, Unite Mixte Rech 1068, Marseille, France; [Aurrand-Lions, Michel] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Aurrand-Lions, Michel] Marseille Univ, Marseille, France; [Aurrand-Lions, Michel] CNRS, Unite Mixte Rech 7258, Marseille, France; [Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	University of Geneva; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Max Planck Society; University of Munster	Imhof, BA (corresponding author), Univ Med Ctr, Dept Pathol & Immunol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	beat.imhof@unige.ch; sarah.garrido-urbani@unige.ch	Aurrand-Lions, Michel/O-9953-2016; Adams, Ralf H/AAE-9274-2019	Aurrand-Lions, Michel/0000-0002-8361-3034; Garrido-Urbani, Sarah/0000-0002-7309-0137; Miljkovic-Licina, Marijana/0000-0001-9023-2208; Hammel, Pascal/0000-0002-4630-4996; Fagiani, Ernesta/0000-0003-1415-3510	Swiss National Foundation for Research [31003AB_135701, 310030_53456]; Oncosuisse [KFS-2914-02-2012]	Swiss National Foundation for Research(Swiss National Science Foundation (SNSF)); Oncosuisse	The authors thank Stephane Jemelin (University of Geneva, Geneva, Switzerland) and Boris P. Lee (University of Toronto, Toronto, ON, Canada) for their technical help; Paul Bradfield (University of Geneva, Geneva, Switzerland) for editing the manuscript; and Olivier Brun, Francois Prodon, and Sergei Stratchik (The Bioimaging Core Facility University of Geneva, Switzerland) for their help in microscopy and Metamorph and Imaris analyses. This work was funded by Grants 31003AB_135701 and 310030_53456 from the Swiss National Foundation for Research and Grant KFS-2914-02-2012 from Oncosuisse. The authors declare no conflicts of interest.	Arcangeli ML, 2012, FEBS LETT, V586, P4046, DOI 10.1016/j.febslet.2012.10.005; Arcangeli ML, 2011, BLOOD, V118, P4609, DOI 10.1182/blood-2010-12-323972; Aurrand-Lions M, 2004, J PATHOL, V203, P700, DOI 10.1002/path.1571; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bonner MY, 2014, FUTURE MED CHEM, V6, P1413, DOI [10.4155/FMC.14.86, 10.4155/fmc.14.86]; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; Donate C, 2013, CANCER RES, V73, P640, DOI 10.1158/0008-5472.CAN-12-1756; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fagiani E, 2011, CANCER RES, V71, P5717, DOI 10.1158/0008-5472.CAN-10-4635; Fisher KE, 2009, J CELL SCI, V122, P4558, DOI 10.1242/jcs.050724; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ibrahim N, 2012, ONCOL REP, V27, P1303, DOI 10.3892/or.2012.1675; Joko T, 2013, EXP EYE RES, V108, P23, DOI 10.1016/j.exer.2012.11.018; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Kodack DP, 2012, P NATL ACAD SCI USA, V109, pE3119, DOI 10.1073/pnas.1216078109; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Kusaba H, 2013, CANCER CHEMOTH PHARM, V71, P29, DOI 10.1007/s00280-012-2023-7; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Lamagna C, 2005, CANCER RES, V65, P5703, DOI 10.1158/0008-5472.CAN-04-4012; Legler DF, 2001, J CELL SCI, V114, P1545; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Ludwig RJ, 2009, IMMUNOLOGY, V128, P196, DOI 10.1111/j.1365-2567.2009.03100.x; Ludwig RJ, 2005, J INVEST DERMATOL, V125, P969, DOI 10.1111/j.0022-202X.2005.23912.x; MacMillan CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089770; Miljkovic-Licina M, 2012, MOL CANCER THER, V11, P2588, DOI 10.1158/1535-7163.MCT-12-0245; Mochin MT, 2015, MICROVASC RES, V97, P55, DOI 10.1016/j.mvr.2014.09.008; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Naik MU, 2014, BLOOD, V123, P1393, DOI 10.1182/blood-2013-04-496232; Naik MU, 2003, ARTERIOSCL THROM VAS, V23, P2165, DOI 10.1161/01.ATV.0000093982.84451.87; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Reynolds LE, 2010, NATURE, V465, P813, DOI 10.1038/nature09106; Ribatti D, 2012, DEV BIOL, V372, P157, DOI 10.1016/j.ydbio.2012.09.018; Rubenstein M, 2011, IN VIVO, V25, P725; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Seano G, 2014, NAT CELL BIOL, V16, P931, DOI 10.1038/ncb3036; Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824; Siekmann AF, 2013, EXP CELL RES, V319, P1255, DOI 10.1016/j.yexcr.2013.01.019; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Sweeney P, 2002, CLIN CANCER RES, V8, P2714; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tokuoka H, 2011, J BIOL CHEM, V286, P43549, DOI 10.1074/jbc.M111.284729; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Wong CWY, 2000, MOL BIOL CELL, V11, P3109, DOI 10.1091/mbc.11.9.3109; Xu CS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-148	64	9	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3411	3425		10.1096/fj.15-270223	http://dx.doi.org/10.1096/fj.15-270223			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911611				2022-12-26	WOS:000358796900028
J	Cheng, YH; Ho, MS; Huang, WT; Chou, YT; King, K				Cheng, Yu-Hong; Ho, Mei-Shang; Huang, Wei-Ting; Chou, Ying-Ting; King, Klim			Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; CENTRAL-NERVOUS-SYSTEM; INSULIN-SECRETION; PARKINSONS-DISEASE; ENERGY-METABOLISM; RAT INSULINOMA; BRAIN-STEM; CELL-LINES; HORMONE; EXENATIDE	Glucagon-like peptide-1 (GLP-1) analogs are approved for treatment of type 2 diabetes and are in clinical trials for disorders including neurodegenerative diseases. GLP-1 receptor (GLP-1R) is expressed in many peripheral and neuronal tissues and is activated by circulating GLP-1. Other than food intake, little is known about factors regulating GLP-1 secretion. Given a normally basal circulating level of GLP-1, knowledge of mechanisms regulating GLP-1R signaling, which has diverse functions in extrapancreatic tissues, remains elusive. In this study, we found that the potency of GLP-1, not exendin 4, is specifically enhanced by the endocannabinoid-like lipids oleoylethanolamide (OEA) and 2-oleoylglycerol but not by stearoylethanolamide (SEA) or palmitoylethanolamide. 9.2 mu M OEA enhances the potency of GLP-1 in stimulating cAMP production by 10-fold but does not affect its receptor binding affinity. OEAand 2-oleoylglycerol, but not SEA, bind to GLP-1 in a dose-dependent and saturable manner. OEA but not SEA promoted GLP1( 7-36) amide to trypsin inactivation in a dose-dependent and saturable manner. Susceptibility of GLP-1(7-36) amide to trypsin inactivation is increased 40-fold upon binding to OEA but not to SEA. Our findings indicate that OEA binds to GLP-1(7-36) amide and enhances the potency that may result from a conformational change of the peptide. In conclusion, modulating potency of GLP-1 by physiologically regulated endocannabinoid- like lipids allows GLP-1R signaling to be regulated spatiotemporally at a constant basal GLP-1 level.	[Cheng, Yu-Hong; Huang, Wei-Ting; King, Klim] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Ho, Mei-Shang; Chou, Ying-Ting] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan	King, K (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.	bmkxk@ibms.sinica.edu.tw			Academia Sinica, Taiwan	Academia Sinica, Taiwan(Academia Sinica - Taiwan)	We thank Dr. Ming-Jing Hwang, Dr. Lee-Young Chau, and Dr. Chi-Huy Wong for constructive discussions and Ching-Shu Suen for technical support. The study was supported by Academia Sinica, Taiwan.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Ezzili C, 2010, BIOORG MED CHEM LETT, V20, P5959, DOI 10.1016/j.bmcl.2010.08.048; GALLWITZ B, 1993, J MOL ENDOCRINOL, V10, P259, DOI 10.1677/jme.0.0100259; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164, DOI 10.1210/endo-126-4-2164; Gu GB, 2013, J COMP NEUROL, V521, P2235, DOI 10.1002/cne.23282; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Hsu YY, 2009, BIOTECHNOL BIOENG, V104, P1142, DOI 10.1002/bit.22495; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kerr BD, 2011, BIOCHEM BIOPH RES CO, V404, P870, DOI 10.1016/j.bbrc.2010.12.077; Kleberg K, 2014, BIOFACTORS, V40, P363, DOI 10.1002/biof.1158; KORMAN LY, 1985, DIABETES, V34, P717, DOI 10.2337/diabetes.34.8.717; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Llewellyn-Smith IJ, 2013, NEUROSCIENCE, V229, P130, DOI 10.1016/j.neuroscience.2012.09.071; Llewellyn-Smith IJ, 2011, NEUROSCIENCE, V180, P111, DOI 10.1016/j.neuroscience.2011.02.023; Lockie SH, 2013, J NEUROENDOCRINOL, V25, P597, DOI 10.1111/jne.12039; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lonborg J, 2012, CIRC-CARDIOVASC INTE, V5, P288, DOI 10.1161/CIRCINTERVENTIONS.112.968388; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Ning Y, 2008, BRIT J PHARMACOL, V155, P1056, DOI 10.1038/bjp.2008.337; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; ORSKOV C, 1992, DIABETOLOGIA, V35, P701; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PHILIPPE J, 1987, J CLIN INVEST, V79, P351, DOI 10.1172/JCI112819; Richardson D, 2007, ANAL BIOCHEM, V360, P216, DOI 10.1016/j.ab.2006.10.039; Roberts CJ, 2012, NEUROSCIENCE, V204, P74, DOI 10.1016/j.neuroscience.2011.11.065; ROBINSON RM, 1982, BIOPOLYMERS, V21, P1217, DOI 10.1002/bip.360210615; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Trapp S, 2013, CURR OPIN PHARMACOL, V13, P964, DOI 10.1016/j.coph.2013.09.006; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; Vaughn LK, 2010, BRIT J PHARMACOL, V160, P530, DOI 10.1111/j.1476-5381.2010.00790.x; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; WIEDENKELLER DE, 1983, ENDOCRINOLOGY, V113, P2311, DOI 10.1210/endo-113-6-2311; Yang Y, 2013, J ALZHEIMERS DIS, V37, P637, DOI 10.3233/JAD-130491	49	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14302	14313		10.1074/jbc.M115.655662	http://dx.doi.org/10.1074/jbc.M115.655662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903129	Green Published, hybrid			2022-12-26	WOS:000355754600004
J	Tong, D; Ortega, J; Kim, C; Huang, J; Gu, LY; Li, GM				Tong, Dan; Ortega, Janice; Kim, Christine; Huang, Jian; Gu, Liya; Li, Guo-Min			Arsenic Inhibits DNA Mismatch Repair by Promoting EGFR Expression and PCNA Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; DRINKING-WATER; DAMAGE; MORTALITY; EXPOSURE; ALPHA; CHILE; POLYMERASE; MUTATIONS; ARGENTINA	Both genotoxic and non-genotoxic chemicals can act as carcinogens. However, while genotoxic compounds lead directly to mutations that promote unregulated cell growth, the mechanism by which non-genotoxic carcinogens lead to cellular transformation is poorly understood. Using a model non-genotoxic carcinogen, arsenic, we show here that exposure to arsenic inhibits mismatch repair (MMR) in human cells, possibly through its ability to stimulate epidermal growth factor receptor (EGFR)-dependent tyrosine phosphorylation of proliferating cellular nuclear antigen (PCNA). HeLa cells exposed to exogenous arsenic demonstrate a dose-and time-dependent increase in the levels of EGFR and tyrosine 211-phosphorylated PCNA. Cell extracts derived from arsenic-treated HeLa cells are defective in MMR, and unphosphorylated recombinant PCNA restores normal MMR activity to these extracts. These results suggest a model in which arsenic induces expression of EGFR, which in turn phosphorylates PCNA, and phosphorylated PCNA then inhibits MMR, leading to increased susceptibility to carcinogenesis. This study suggests a putative novel mechanism of action for arsenic and other non-genotoxic carcinogens.	[Tong, Dan; Huang, Jian; Li, Guo-Min] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Tong, Dan; Ortega, Janice; Kim, Christine; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Markey Canc Ctr, Lexington, KY 40536 USA; [Tong, Dan; Li, Guo-Min] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Wuhan University; University of Kentucky; Tsinghua University	Li, GM (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, 789 South Limestone St, Lexington, KY 40536 USA.	gmli@uky.edu		Kim, Christine/0000-0001-5027-7591; Li, Guo-Min/0000-0002-9842-4578	National Cancer Institute [CA167181, T32 CA165990]; National Institutes of Health, of the United States; National Natural Science Foundation of China [31370766, 31461143005, 30740420548]; Kentucky Lung Cancer Research program; NATIONAL CANCER INSTITUTE [T32CA165990, R01CA167181] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kentucky Lung Cancer Research program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute (CA167181), National Institutes of Health, of the United States, the National Natural Science Foundation of China (31370766, 31461143005, and 30740420548), and Kentucky Lung Cancer Research program.r Supported by a National Cancer Institute training grant (T32 CA165990).	Andrew AS, 2006, ENVIRON HEALTH PERSP, V114, P1193, DOI 10.1289/ehp.9008; Andrew AS, 2009, TOXICOL SCI, V109, P350, DOI 10.1093/toxsci/kfp015; Bates MN, 2004, AM J EPIDEMIOL, V159, P381, DOI 10.1093/aje/kwh054; Briggs S, 2013, J PATHOL, V230, P148, DOI 10.1002/path.4185; Chen XQ, 1996, NAT MED, V2, P1033; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; COHN SE, 1992, EPIDEMIOLOGY, V3, P471, DOI 10.1097/00001648-199209000-00016; FANG WH, 1993, J BIOL CHEM, V268, P11838; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Heck JE, 2009, ENVIRON HEALTH PERSP, V117, P1718, DOI 10.1289/ehp.0900566; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Knobeloch LM, 2006, J HEALTH POPUL NUTR, V24, P206; Li D, 2001, Environ Health Prev Med, V6, P27, DOI 10.1007/BF02897306; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liaw J, 2008, CANCER EPIDEM BIOMAR, V17, P1982, DOI 10.1158/1055-9965.EPI-07-2816; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; Martinez VD, 2012, AM J RESP CRIT CARE, V185, P1131, DOI 10.1164/ajrccm.185.10.1131; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; MERLO A, 1994, CANCER RES, V54, P2098; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; OKAJIMA T, 1993, ANAL BIOCHEM, V211, P293, DOI 10.1006/abio.1993.1272; Ortega J, 2015, P NATL ACAD SCI USA, V112, P5667, DOI 10.1073/pnas.1417711112; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pifarre A, 1997, BRIT J CANCER, V75, P184, DOI 10.1038/bjc.1997.31; Putila JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025886; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Qin XJ, 2008, CHEM RES TOXICOL, V21, P1806, DOI 10.1021/tx8001548; Aballay LR, 2012, INT J ENVIRON HEAL R, V22, P220, DOI 10.1080/09603123.2011.628792; Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Smith KR, 2001, AM J PHYSIOL-LUNG C, V280, pL442, DOI 10.1152/ajplung.2001.280.3.L442; Soto-Reyes E, 2005, BIOMETALS, V18, P493, DOI 10.1007/s10534-005-0858-7; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Tran HP, 2002, TOXICOL LETT, V133, P59, DOI 10.1016/S0378-4274(02)00088-7; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Yuan Y, 2010, EPIDEMIOLOGY, V21, P103, DOI 10.1097/EDE.0b013e3181c21e46; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhou X, 2000, CLIN CANCER RES, V6, P559	50	23	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14536	14541		10.1074/jbc.M115.641399	http://dx.doi.org/10.1074/jbc.M115.641399			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25907674	hybrid, Green Published			2022-12-26	WOS:000355754600025
J	Bashir, T; Patgaonkar, M; Kumar, CS; Pasi, A; Reddy, KVR				Bashir, Tahir; Patgaonkar, Mandar; Kumar, Selvaa C.; Pasi, Achhelal; Reddy, Kudumula Venkata Rami			HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIMICROBIAL PEPTIDES; HUMAN DEFENSINS; FUSION INHIBITOR; PROTEIN; HEMOGLOBIN; ENFUVIRTIDE; GLYCOPROTEIN; INFLAMMATION; REPLICATION	Human Immunodeficiency Virus (HIV-1) poses a serious threat to the developing world and sexual transmission continues to be the major source of new infections. Therefore, the development of molecules, which prevent new HIV-1 infections, is highly warranted. In the present study, a panel of human hemoglobin (Hb)-alpha subunit derived peptides and their analogues, with an ability to bind gp120, were designed in-silico and their anti-HIV-1 activity was evaluated. Of these peptides, HbAHP-25, an analogue of Hb-alpha derived peptide, demonstrated significant anti-HIV-1 activity. HbAHP-25 was found to be active against CCR5-tropic HIV-1 strains (ADA5 and BaL) and CXCR4-tropic HIV-1 strains (IIIB and NL4-3). Surface plasmon resonance (SPR) and ELISA revealed direct interaction between HbAHP-25 and HIV-1 envelope protein, gp120. The peptide prevented binding of CD4 to gp120 and blocked subsequent steps leading to entry and/or fusion or both. Anti-HIV activity of HbAHP-25 appeared to be specific as it failed to inhibit the entry of HIV-1 pseudotyped virus (HIV-1 VSV). Further, HbAHP-25 was found to be non-cytotoxic to TZM-bl cells, VK2/E6E7 cells, CEM-GFP cells and PBMCs, even at higher concentrations. Moreover, HbAHP-25 retained its anti-HIV activity in presence of seminal plasma and vaginal fluid. In brief, the study identified HbAHP-25, a novel anti-HIV peptide, which directly interacts with gp120 and thus has a potential to inhibit early stages of HIV-1 infection.	[Bashir, Tahir; Pasi, Achhelal; Reddy, Kudumula Venkata Rami] Indian Council Med Res, Natl Inst Res Reprod Hlth, Div Mol Immunol & Microbiol, Bombay, Maharashtra, India; [Patgaonkar, Mandar] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Kumar, Selvaa C.] DY Patil Univ, Sch Biotechnol & Bioinformat, Dept Bioinformat, Navi Mumbai, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Tata Institute of Fundamental Research (TIFR)	Reddy, KVR (corresponding author), Indian Council Med Res, Natl Inst Res Reprod Hlth, Div Mol Immunol & Microbiol, Bombay, Maharashtra, India.	reddyk@nirrh.res.in	Dar, Tahir/AAR-8854-2021	Dar, Tahir/0000-0001-5191-8346				Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Akari H, 1999, J GEN VIROL, V80, P2945, DOI 10.1099/0022-1317-80-11-2945; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Cai LF, 2011, CURR TOP MED CHEM, V11, P2959, DOI 10.2174/156802611798808497; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034947; Cole AM, 2005, PROTEIN PEPTIDE LETT, V12, P41, DOI 10.2174/0929866053406101; Cornelia L, 2003, J CHROMATOGR B, V791, P345; Dassen H, 2008, HUM REPROD, V23, P635, DOI 10.1093/humrep/dem430; Deng LX, 2009, HUM REPROD, V24, P211, DOI 10.1093/humrep/den318; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Du RJ, 2010, EMBO J, V29, P632, DOI 10.1038/emboj.2009.380; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hugo AA, 2012, J APPL MICROBIOL, V113, P1491, DOI 10.1111/j.1365-2672.2012.05433.x; Klibanov OM, 2010, CURR OPIN INVEST DR, V11, P940; Kong L, 2015, PROTEINS, V83, P590, DOI 10.1002/prot.24747; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lu WY, 2013, BIOCHEM BIOPH RES CO, V436, P557, DOI 10.1016/j.bbrc.2013.06.015; Mak P, 2004, PEPTIDES, V25, P1839, DOI 10.1016/j.peptides.2004.06.015; Mak P, 2008, FRONT BIOSCI-LANDMRK, V13, P6859, DOI 10.2741/3194; Mak P, 2007, AM J REPROD IMMUNOL, V57, P81, DOI 10.1111/j.1600-0897.2006.00456.x; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patgaonkar M, 2011, VET IMMUNOL IMMUNOP, V139, P176, DOI 10.1016/j.vetimm.2010.10.012; Patgaonkar MS, 2011, CLIN VACCINE IMMUNOL, V18, P1632, DOI 10.1128/CVI.00411-10; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Sundaresan Sigamani, 2008, Protein Pept Lett, V15, P318; UNAIDS, 2013, REP GLOB AIDS EP; VanCompernolle SE, 2005, J VIROL, V79, P11598, DOI 10.1128/JVI.79.18.11598-11606.2005; Wachinger M, 1998, J GEN VIROL, V79, P731, DOI 10.1099/0022-1317-79-4-731; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wicherek L, 2007, EUR J OBSTET GYN R B, V131, P97, DOI 10.1016/j.ejogrb.2006.03.012; Yang QE, 2005, J VIROL, V79, P6122, DOI 10.1128/JVI.79.10.6122-6133.2005	52	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124839	10.1371/journal.pone.0124839	http://dx.doi.org/10.1371/journal.pone.0124839			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915507	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100072
J	Cesca, F; Bregant, E; Peterlin, B; Zadel, M; de Wittenau, GD; Siciliano, G; Ceravolo, R; Petrozzi, L; Pauletto, G; Verriello, L; Bergonzi, P; Damante, G; Barillari, G; Lucci, B; Curcio, F; Lonigro, IR				Cesca, Federica; Bregant, Elisa; Peterlin, Borut; Zadel, Maja; de Wittenau, Giorgia Dubsky; Siciliano, Gabriele; Ceravolo, Roberto; Petrozzi, Lucia; Pauletto, Giada; Verriello, Lorenzo; Bergonzi, Paolo; Damante, Giuseppe; Barillari, Giovanni; Lucci, Bruno; Curcio, Francesco; Lonigro, Incoronata Renata			Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR-MEDIATED EXCITOTOXICITY; GENE-EXPRESSION PROFILE; TRANSGENIC MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; IN-VITRO; CALCIUM; BLOOD; TRANSPORT	Abnormalities of intracellular Ca2+ homeostasis and signalling as well as the down-regulation of neurotrophic factors in several areas of the central nervous system and in peripheral tissues are hallmarks of Huntington's disease (HD). As there is no therapy for this hereditary, neurodegenerative fatal disease, further effort should be made to slow the progression of neurodegeneration in patients through the definition of early therapeutic interventions. For this purpose, molecular biomarker(s) for monitoring disease onset and/or progression and response to treatment need to be identified. In the attempt to contribute to the research of peripheral candidate biomarkers in HD, we adopted a multiplex real-time PCR approach to analyse the mRNA level of targeted genes involved in the control of cellular calcium homeostasis and in neuroprotection. For this purpose we recruited a total of 110 subjects possessing the HD mutation at different clinical stages of the disease and 54 sex-and age-matched controls. This study provides evidence of reduced transcript levels of sarco-endoplasmic reticulum-associated ATP2A2 calcium pump (SERCA2) and vascular endothelial growth factor (VEGF) in peripheral blood mononuclear cells (PBMCs) of manifest and pre-manifest HD subjects. Our results provide a potentially new candidate molecular biomarker for monitoring the progression of this disease and contribute to understanding some early events that might have a role in triggering cellular dysfunctions in HD.	[Cesca, Federica; de Wittenau, Giorgia Dubsky; Curcio, Francesco; Lonigro, Incoronata Renata] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Bregant, Elisa; Damante, Giuseppe] Univ Udine, Azienda Osped, SOC Ist Genet, I-33100 Udine, Italy; [Peterlin, Borut; Zadel, Maja] Univ Med Ctr, Clin Inst Med Genet, Ljubljana, Slovenia; [Zadel, Maja] Community Hlth Ctr Ljubljana, Ljubljana, Slovenia; [Siciliano, Gabriele; Ceravolo, Roberto; Petrozzi, Lucia] Univ Pisa, Dipartimento Med Clin & Sperimentale, Pisa, Italy; [Pauletto, Giada; Verriello, Lorenzo; Bergonzi, Paolo] Univ Udine, Clin Neurol Azienda Osped, I-33100 Udine, Italy; [Barillari, Giovanni] Univ Udine, Azienda Osped, Med Trasfus, I-33100 Udine, Italy; [Lucci, Bruno] Azienda Osped, Neurol, Pordenone, Italy; [Curcio, Francesco; Lonigro, Incoronata Renata] Univ Udine, Azienda Osped, SOC Ist Patol Clin, I-33100 Udine, Italy	University of Udine; University of Udine; University Medical Centre Ljubljana; University of Pisa; University of Udine; University of Udine; University of Udine	Lonigro, IR (corresponding author), Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy.	renata.lonigro@uniud.it	Damante, Giuseppe/AAC-5200-2022; ceravolo, roberto/AAB-1293-2019; Peterlin, Borut/C-6086-2011; Curcio, Francesco/K-4669-2014; Lonigro, Incoronata/AAE-5996-2020; ceravolo, roberto/K-6831-2016; Siciliano, Gabriele/K-7259-2016	ceravolo, roberto/0000-0003-1412-9406; Peterlin, Borut/0000-0001-7824-4978; ceravolo, roberto/0000-0003-1412-9406; CURCIO, Francesco/0000-0002-9070-4807; Damante, Giuseppe/0000-0003-2312-4009; Siciliano, Gabriele/0000-0002-6142-2384; Barillari, Giovanni/0000-0002-0706-8839	SNO (Societa dei Neurologi, Neurochirurghi e Neuroradiologi degli Ospedali Italiani) on legacy "Gobessi"	SNO (Societa dei Neurologi, Neurochirurghi e Neuroradiologi degli Ospedali Italiani) on legacy "Gobessi"	This work was funded by SNO (Societa dei Neurologi, Neurochirurghi e Neuroradiologi degli Ospedali Italiani) on legacy "Gobessi". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; BESSE S, 1993, AM J PHYSIOL, V265, pH183, DOI 10.1152/ajpheart.1993.265.1.H183; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Boyle PJ, 1995, NEW ENGL J MED, V333, P1726, DOI 10.1056/NEJM199512283332602; Chang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046492; Choi KC, 2011, J PHYSIOL PHARMACOL, V62, P499; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Czeredys M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00042; Dantz D, 2002, J CLIN ENDOCR METAB, V87, P835, DOI 10.1210/jc.87.2.835; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Diamanti D, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-28; Ellison SM, 2013, MOL THER, V21, P1862, DOI 10.1038/mt.2013.132; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Guo KK, 2006, AGING CELL, V5, P259, DOI 10.1111/j.1474-9726.2006.00215.x; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Heng MY, 2009, J NEUROSCI, V29, P3200, DOI 10.1523/JNEUROSCI.5599-08.2009; Issa R, 1999, LAB INVEST, V79, P417; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Krzyszton-Russjan J, 2013, J BIOENERG BIOMEMBR, V45, P71, DOI 10.1007/s10863-012-9479-3; KUMAGAI AK, 1995, DIABETES, V44, P1399, DOI 10.2337/diabetes.44.12.1399; Lakatta Edward G, 2002, Heart Lung Circ, V11, P76, DOI 10.1046/j.1444-2892.2002.00126.x; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losekoot M, 2013, EUR J HUM GENET, V21, P480, DOI 10.1038/ejhg.2012.200; Lovrecic L, 2009, MOVEMENT DISORD, V24, P2277, DOI 10.1002/mds.22477; MacDonald Marcy E, 2003, Sci STKE, V2003, ppe48; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Marian MJ, 2007, CELL CALCIUM, V41, P87, DOI 10.1016/j.ceca.2006.05.003; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; PEKALA P, 1990, J BIOL CHEM, V265, P18051; Prasad V, 2007, ANN NY ACAD SCI, V1099, P276, DOI 10.1196/annals.1387.029; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Roze E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00055; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Sanchez-Lopez F, 2012, NEUROL RES, V34, P721, DOI 10.1179/1743132812Y.0000000073; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Sone H, 2000, INVEST OPHTH VIS SCI, V41, P1876; Song C, 2003, J BIOL CHEM, V278, P33364, DOI 10.1074/jbc.M304240200; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Volm M, 1999, ANTICANCER RES, V19, P1669; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	62	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125259	10.1371/journal.pone.0125259	http://dx.doi.org/10.1371/journal.pone.0125259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915065	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100112
J	Louis, J; Schaal, K; Bieuzen, F; Le Meur, Y; Filliard, JR; Volondat, M; Brisswalter, J; Hausswirth, C				Louis, Julien; Schaal, Karine; Bieuzen, Francois; Le Meur, Yann; Filliard, Jean-Robert; Volondat, Marielle; Brisswalter, Jeanick; Hausswirth, Christophe			Head Exposure to Cold during Whole-Body Cryostimulation: Influence on Thermal Response and Autonomic Modulation	PLOS ONE			English	Article							WATER FACE IMMERSION; RATE-VARIABILITY; DORSAL HEAD; EXERCISE; PERFORMANCE; REFLEX; STIMULATION; PREDICTOR; PRESSURE; DESIGN	Recent research on whole-body cryotherapy has hypothesized a major responsibility of head cooling in the physiological changes classically reported after a cryostimulation session. The aim of this experiment was to verify this hypothesis by studying the influence of exposing the head to cold during whole-body cryostimulation sessions, on the thermal response and the autonomic nervous system (ANS). Over five consecutive days, two groups of 10 participants performed one whole-body cryostimulation session daily, in one of two different systems; one exposing the whole-body to cold (whole-body cryostimulation, WBC), and the other exposing the whole-body except the head (partial-body cryostimulation, PBC). 10 participants constituted a control group (CON) not receiving any cryostimulation. In order to isolate the head-cooling effect on recorded variables, it was ensured that the WBC and PBC systems induced the same decrease in skin temperature for all body regions (mean decrease over the 5 exposures: -8.6 degrees C +/- 1.3 degrees C and -8.3 +/- 0.7 degrees C for WBC and PBC, respectively), which persisted up to 20-min after the sessions (P20). The WBC sessions caused an almost certain decrease in tympanic temperature from Pre to P20 (-0.28 +/- 0.11 degrees C), while it only decreased at P20 (-0.14 +/- 0.05 degrees C) after PBC sessions. Heart rate almost certainly decreased after PBC (-8.6%) and WBC (-12.3%) sessions. Resting vagal-related heart rate variability indices (the root-mean square difference of successive normal RR intervals, RMSSD, and high frequency band, HF) were very likely to almost certainly increased after PBC (RMSSD:+49.1%, HF:+123.3%) and WBC (RMSSD:+38.8%, HF:+70.3%). Plasma norepinephrine concentration was likely increased in similar proportions after PBC and WBC, but only after the first session. Both cryostimulation techniques stimulated the ANS with a predominance of parasympathetic tone activation from the first to the fifth session and in slightly greater proportion with WBC than PBC. The main result of this study indicates that the head exposure to cold during whole-body cryostimulation may not be the main factor responsible for the effects of cryostimulation on the ANS.	[Louis, Julien; Schaal, Karine; Bieuzen, Francois; Le Meur, Yann; Hausswirth, Christophe] French Natl Inst Sport Expertise & Performance IN, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France; [Schaal, Karine] Univ Calif Davis, Sports Med Program, Sports Performance Lab, Sacramento, CA 95817 USA; [Filliard, Jean-Robert; Volondat, Marielle] French Natl Inst Sport Expertise & Performance IN, Dept Med, Paris, France; [Brisswalter, Jeanick] Univ Nice Sophia Antipolis, Lab Human Motr Educ Sport & Hlth, F-06189 Nice, France	University of California System; University of California Davis; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Universite Cote d'Azur	Louis, J (corresponding author), French Natl Inst Sport Expertise & Performance IN, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France.	julien.louis@insep.fr	Louis, Julien/AAI-4392-2021; Bieuzen, Francois/F-8162-2013	Louis, Julien/0000-0002-9109-0958; Schaal, Karine/0000-0001-9215-9665; Bieuzen, Francois/0000-0002-9690-9168				Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Al Haddad H, 2010, EUR J APPL PHYSIOL, V108, P599, DOI 10.1007/s00421-009-1253-9; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Buch AN, 2002, EXP PHYSIOL, V87, P423, DOI 10.1111/j.1469-445X.2002.tb00055.x; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Camm AJ, 1996, CIRCULATION, V93, P1043; Cholewka A, 2012, SKIN RES TECHNOL, V18, P180, DOI 10.1111/j.1600-0846.2011.00550.x; Chudecka M, 2014, AVIAT SPACE ENVIR MD, V85, P1170, DOI 10.3357/ASEM.3678.2014; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Costello JT, 2013, COCHRANE LIB; ECKBERG DL, 1984, J PHYSIOL-LONDON, V347, P75, DOI 10.1113/jphysiol.1984.sp015054; Giesbrecht GG, 2005, J APPL PHYSIOL, V99, P1958, DOI 10.1152/japplphysiol.00052.2005; Hausswirth C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072658; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; HAYWARD JS, 1984, RESUSCITATION, V11, P21, DOI 10.1016/0300-9572(84)90031-5; HEISTAD DD, 1968, J APPL PHYSIOL, V25, P542, DOI 10.1152/jappl.1968.25.5.542; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 1999, MED SCI SPORT EXER, V31, P472, DOI 10.1097/00005768-199903000-00018; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HURWITZ BE, 1986, PHYSIOL BEHAV, V36, P287, DOI 10.1016/0031-9384(86)90018-1; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; KAWAKAMI Y, 1967, J APPL PHYSIOL, V23, P964, DOI 10.1152/jappl.1967.23.6.964; Khurana RK, 2006, CLIN AUTON RES, V16, P202, DOI 10.1007/s10286-006-0332-9; Khurana RK, 1997, HEADACHE, V37, P522, DOI 10.1046/j.1526-4610.1997.3708522.x; Kinoshita T, 2006, CIRC J, V70, P773, DOI 10.1253/circj.70.773; Larsen PD, 2010, RESP PHYSIOL NEUROBI, V174, P111, DOI 10.1016/j.resp.2010.04.021; Lockhart TL, 2005, AVIAT SPACE ENVIR MD, V76, P954; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Pretorius T, 2006, J APPL PHYSIOL, V101, P669, DOI 10.1152/japplphysiol.01241.2005; Pump B, 2001, AM J PHYSIOL-HEART C, V280, pH2607, DOI 10.1152/ajpheart.2001.280.6.H2607; Ring EFJ, 2015, INFRARED IMAGING: A CASEBOOK IN CLINICAL MEDICINE, DOI 10.1088/978-0-7503-1143-4ch1; Schaal K, 2013, APPL PHYSIOL NUTR ME, V38, P126, DOI 10.1139/apnm-2012-0155; SCHUITEMA K, 1988, ACTA PHYSIOL SCAND, V132, P119, DOI 10.1111/j.1748-1716.1988.tb08306.x; Shibahara N, 1996, J AUTONOM NERV SYST, V61, P109, DOI 10.1016/S0165-1838(96)00065-3; Stanley J, 2013, EUR J APPL PHYSIOL, V113, P371, DOI 10.1007/s00421-012-2445-2; Stanley J, 2012, EUR J APPL PHYSIOL, V112, P951, DOI 10.1007/s00421-011-2052-7; Udo T, 2013, J STUD ALCOHOL DRUGS, V74, P787, DOI 10.15288/jsad.2013.74.787; Utter AC, 2010, MED SCI SPORT EXER, V42, P361, DOI 10.1249/MSS.0b013e3181b2e8b4; Vaile J, 2011, BRIT J SPORT MED, V45, P825, DOI 10.1136/bjsm.2009.067272; Westerlund T, 2006, J THERM BIOL, V31, P342, DOI 10.1016/j.jtherbio.2006.01.004	46	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124776	10.1371/journal.pone.0124776	http://dx.doi.org/10.1371/journal.pone.0124776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915642	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100066
J	Tachi, T; Teramachi, H; Tanaka, K; Asano, S; Osawa, T; Kawashima, A; Yasuda, M; Mizui, T; Nakada, T; Noguchi, Y; Tsuchiya, T; Goto, C				Tachi, Tomoya; Teramachi, Hitomi; Tanaka, Kazuhide; Asano, Shoko; Osawa, Tomohiro; Kawashima, Azusa; Yasuda, Masahiro; Mizui, Takashi; Nakada, Takumi; Noguchi, Yoshihiro; Tsuchiya, Teruo; Goto, Chitoshi			The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; DIAGNOSIS; EQ-5D; WOMEN	The objective of our study was to clarify the impact of adverse events associated with the initial course of outpatient chemotherapy on the quality of life of breast cancer patients. We conducted a survey to assess the quality of life in 48 breast cancer patients before and after receiving their first course of outpatient chemotherapy at Gifu Municipal Hospital. Patients completed the European Quality of Life 5 Dimensions and Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs before and after 1 course of outpatient chemotherapy. European Quality of Life 5 Dimensions utility value and Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs total score decreased significantly after chemotherapy (p<0.001 and p = 0.018, respectively). The mean scores for the activity, physical condition, and psychological condition subscales of the Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs decreased significantly after chemotherapy (p = 0.003, p<0.001, and p = 0.032, respectively), whereas the social relationships score increased significantly (p<0.001). Furthermore, in the evaluation of quality of life according to individual adverse events, the decrease in quality of life after chemotherapy in terms of the European Quality of Life 5 Dimensions utility value and the Quality of Life Questionnaire for Cancer Patients Treated with Anticancer Drugs total score was greater in anorexic patients than in non-anorexic patients (p = 0.009 and p<0.001, respectively). This suggests that anorexia greatly reduces quality of life. Our findings reveal that anticancer drug-related adverse events, particularly anorexia, reduce overall quality of life following the first course of outpatient chemotherapy in current breast cancer patients. These findings are extremely useful and important in understanding the impact of anticancer drug-related adverse events on quality of life.	[Tachi, Tomoya; Teramachi, Hitomi; Asano, Shoko; Noguchi, Yoshihiro] Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu, Japan; [Tachi, Tomoya; Tanaka, Kazuhide; Osawa, Tomohiro; Kawashima, Azusa; Yasuda, Masahiro; Mizui, Takashi; Goto, Chitoshi] Gifu Municipal Hosp, Dept Pharm, Gifu, Japan; [Nakada, Takumi] Gifu Municipal Hosp, Dept Breast Surg, Gifu, Japan; [Tsuchiya, Teruo] Community Hlth Support & Res Ctr, Gifu, Japan	Gifu Pharmaceutical University; Gifu Municipal Hospital; Gifu Municipal Hospital	Teramachi, H (corresponding author), Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu, Japan.	teramachih@gifu-pu.ac.jp	Tachi, Tomoya/AAM-8441-2020; Noguchi, Yoshihiro/ABI-5618-2020	Tachi, Tomoya/0000-0002-5380-0218; Noguchi, Yoshihiro/0000-0002-9110-9604; Osawa, Tomohiro/0000-0003-3984-6911; Yasuda, Masahiro/0000-0003-4119-0149				Ando N, 2009, SUPPORT CARE CANCER, V17, P1361, DOI 10.1007/s00520-009-0593-7; Arndt V, 2006, CANCER-AM CANCER SOC, V107, P2496, DOI 10.1002/cncr.22274; AYRES A, 1994, J PSYCHOSOM RES, V38, P393, DOI 10.1016/0022-3999(94)90100-7; Dorval M, 1998, CANCER, V83, P2130, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2130::AID-CNCR11>3.0.CO;2-8; Fallowfield LJ, 2006, J CLIN ONCOL, V24, P910, DOI 10.1200/JCO.2005.03.3654; Fernandez-Ortega P, 2012, SUPPORT CARE CANCER, V20, P3141, DOI 10.1007/s00520-012-1448-1; Fujii T, 2006, JPN J PHARM HLTH CAR, V32, P946, DOI DOI 10.5649/JJPHCS.32.946; Group EQ, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Hashizume K, 2013, PALLIATIVE CARE RES, V8, P232; Hjerl K, 2003, PSYCHOSOMATICS, V44, P24, DOI 10.1176/appi.psy.44.1.24; Institute NC, 2010, COMM TERM CRIT ADV E, P1; Ishiura Yoshihisa, 2009, Gan To Kagaku Ryoho, V36, P2565; Iwamitsu Y, 2005, PSYCHOSOMATICS, V46, P19, DOI 10.1176/appi.psy.46.1.19; Janni W, 2001, ANN SURG ONCOL, V8, P542, DOI 10.1007/s10434-001-0542-2; Khanna R, 2013, VALUE HEALTH, V16, P778, DOI 10.1016/j.jval.2013.04.007; Kim DH, 2010, J KOREAN MED SCI, V25, P1140, DOI 10.3346/jkms.2010.25.8.1140; Kitada N, 2006, JPN J PHARM HLTH CAR, V32, P835, DOI DOI 10.5649/jjphcs.32.835; Kuroda Y, 2010, JPN J GEN HOSP PSYCH, V22, P27; Miyake T., 2008, JPN J PHARM HEALTH C, V34, P268, DOI [10.5649/jjphcs.34.268, DOI 10.5649/JJPHCS.34.268]; Okamoto T., 2004, JPN J REHABIL MED, V41, P678, DOI [10.2490/jjrm1963.41.678, DOI 10.2490/JJRM1963.41.678]; Park BW, 2011, J BREAST CANCER, V14, P112, DOI 10.4048/jbc.2011.14.2.112; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Shimozuma, 1994, Breast Cancer, V1, P123, DOI 10.1007/BF02967042; Shimozuma, 1995, Breast Cancer, V2, P35, DOI 10.1007/BF02966894; Shimozuma K, 2000, SURG TODAY, V30, P255, DOI 10.1007/s005950050055; SHIMOZUMA K, 1995, SURG TODAY, V25, P874, DOI 10.1007/BF00311752; Taira N, 2014, BREAST CANCER RES TR, V145, P155, DOI 10.1007/s10549-014-2935-5; Toume M, 2007, NURS J KAGAWA U, V11, P37	28	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124169	10.1371/journal.pone.0124169	http://dx.doi.org/10.1371/journal.pone.0124169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915539	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100037
J	Vilos, C; Velasquez, LA; Rodas, PI; Zepeda, K; Bong, SJ; Herrera, N; Cantin, M; Simon, F; Constandil, L				Vilos, Cristian; Velasquez, Luis A.; Rodas, Paula I.; Zepeda, Katherine; Bong, Soung-Jae; Herrera, Natalia; Cantin, Mario; Simon, Felipe; Constandil, Luis			Preclinical Development and In Vivo Efficacy of Ceftiofur-PLGA Microparticles	PLOS ONE			English	Article							INJECTABLE MICROENCAPSULATED VITAMIN-B-12; VITRO; MICROSPHERES; NANOPARTICLES; DESFUROYLCEFTIOFUR; ENCAPSULATION; METABOLITES; PLASMA; MICRO; SERUM	Drug delivery systems based on polymeric microparticles represent an interesting field of development for the treatment of several infectious diseases for humans and animals. In this work, we developed PLGA microparticles loaded with ceftiofur (PLGA-cef), a third-generation cephalosporin that is used exclusively used in animals. PLGA-cef was prepared by the double emulsion w/o/w method, and exhibited a diameter in the range of 1.5-2.2 mu m, and a negative zeta potential in the range of -35 to -55 mV. The loading yield of PLGA-cef was similar to 7% and encapsulation efficiency was approximately 40%. The pharmacokinetic study demonstrated a sustained release profile of ceftiofur for 20 days. PLGA-cef administrated in a single dose was more effective than ceftiofur non-encapsulated in rats challenged with S. Typhimurium. The in vivo toxicological evaluation showed that PLGA-cef did not affect the blood biochemical, hematological and hemostasis parameters. Overall, the PLGA-cef showed slow in vivo release profile, high antibacterial efficacy, and low toxicity. The results obtained supports the safe application of PLGA-cef as sustained release platform in the veterinary industry.	[Vilos, Cristian; Velasquez, Luis A.; Rodas, Paula I.; Zepeda, Katherine; Bong, Soung-Jae; Herrera, Natalia] Univ Andres Bello, Ctr Integrat Med & Innovat Sci, Fac Med, Santiago, Chile; [Vilos, Cristian; Velasquez, Luis A.; Constandil, Luis] Univ Santiago Chile, Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile; [Constandil, Luis] Univ Santiago Chile, Neurobiol Lab, Dept Biol, Fac Quim & Biol, Santiago, Chile; [Cantin, Mario] Univ La Frontera, Dept Integral Dent, CIMA, Fac Dent, Temuco, Chile; [Cantin, Mario] Univ Autonoma Chile, Biomed Sci Res Ctr, Temuco, Chile; [Simon, Felipe] Univ Andres Bello, Lab Fisiopatol Integrat, Dept Ciencias Biol, Fac Ciencias Biol, Santiago, Chile; [Simon, Felipe] Univ Andres Bello, Fac Med, Santiago, Chile	Universidad Andres Bello; Universidad de Santiago de Chile; Universidad de Santiago de Chile; Universidad de La Frontera; Universidad Autonoma de Chile; Universidad Andres Bello; Universidad Andres Bello	Constandil, L (corresponding author), Univ Santiago Chile, Ctr Desarrollo Nanociencia & Nanotecnol CEDENNA, Santiago, Chile.	luis.constandil@usach.cl	Ortiz, Cristian Vilos/F-9162-2014; Rodas, Paula I./I-3631-2013; Cantin, Mario/L-9054-2013	Ortiz, Cristian Vilos/0000-0001-5619-3348; Rodas, Paula I./0000-0002-8071-1229; Cantin, Mario/0000-0002-1749-8672; Velasquez, Luis/0000-0002-9479-1792; Simon, Felipe/0000-0002-2653-9798	CONICYT under BASAL Grant [FB0807]; FONDECYT [1120952]; Becas-Chile fellowship CONICYT-Chile; Vicerrectoria de Investigacion, Desarrollo e Innovacion, from Universidad de Santiago de Chile [021540CC_APOYOQ1];  [TPI06]	CONICYT under BASAL Grant; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Becas-Chile fellowship CONICYT-Chile; Vicerrectoria de Investigacion, Desarrollo e Innovacion, from Universidad de Santiago de Chile; 	The authors acknowledge the financial support of CONICYT under BASAL Grant FB0807 and FONDECYT 1120952. CV acknowledges the support of the Grant TPI06 and Becas-Chile fellowship CONICYT-Chile. http://cedenna.cl/en http://www.conicyt.cl http://www.fondecyt.cl. L.C. acknowledges the support of Vicerrectoria de Investigacion, Desarrollo e Innovacion, from Universidad de Santiago de Chile, Code Number 021540CC_APOYOQ1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna L, 2011, INT J MORPHOL, V29, P403, DOI 10.4067/S0717-95022011000200016; Arnold MM, 2007, J CONTROL RELEASE, V121, P100, DOI 10.1016/j.jconrel.2007.05.039; Bronstad A, 2011, LAB ANIMAL, V40, P22, DOI 10.1038/laban0111-22; Coimbra PA, 2008, J MICROENCAPSUL, V25, P170, DOI [10.1080/02652040701814140, 10.1080/02652040701814140 ]; DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2; Grace ND, 2000, NEW ZEAL VET J, V48, P70, DOI 10.1080/00480169.2000.36162; Grace ND, 1999, NEW ZEAL VET J, V47, P3, DOI 10.1080/00480169.1999.36099; Hejazi R, 2002, INT J PHARM, V235, P87, DOI 10.1016/S0378-5173(01)00985-1; Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; JAGLAN PS, 1989, J AGR FOOD CHEM, V37, P1112, DOI 10.1021/jf00088a066; JAGLAN PS, 1994, J VET PHARMACOL THER, V17, P24, DOI 10.1111/j.1365-2885.1994.tb00517.x; JAGLAN PS, 1990, J ASSOC OFF ANA CHEM, V73, P26; Jovanovic I, 2008, MICROSC RES TECHNIQ, V71, P86, DOI 10.1002/jemt.20529; Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110; Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k; Lee JH, 2000, INT J PHARM, V196, P75, DOI 10.1016/S0378-5173(99)00440-8; Luzardo-Alvarez A, 2005, J CONTROL RELEASE, V109, P62, DOI 10.1016/j.jconrel.2005.09.015; Miller JA, 1999, J ECON ENTOMOL, V92, P1142, DOI 10.1093/jee/92.5.1142; Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014; Patel J, 2012, J MICROENCAPSUL, V29, P398, DOI 10.3109/02652048.2012.655329; Prior S, 2000, INT J PHARM, V196, P115, DOI 10.1016/S0378-5173(99)00448-2; Ribeiro-Costa RM, 2004, J MICROENCAPSUL, V21, P371, DOI 10.1080/02652040410001673919; Roy P, 2010, INT J NANOMED, V5, P1113, DOI 10.2147/IJN.S14787; Salmon SA, 1996, J VET DIAGN INVEST, V8, P332, DOI 10.1177/104063879600800309; Shi X, 2014, COLLOIDS SURF B; Tang S, 2010, J VET PHARMACOL THER, V33, P238, DOI 10.1111/j.1365-2885.2009.01126.x; Vilos C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/672760; Vilos C, 2012, ELECTRON J BIOTECHN, V15, P13; Vilos C, 2014, DRUG DES DEV THER, V8, P651, DOI 10.2147/DDDT.S60444; Weidmann A, 2008, OPEN OPHTHALMOL J, V2, P112, DOI 10.2174/1874364100802010112	33	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123335	10.1371/journal.pone.0123335	http://dx.doi.org/10.1371/journal.pone.0123335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915043	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100021
J	Zhou, YY; Zhang, LY; Pan, H; Wang, BS; Yan, F; Fang, XD; Munnee, K; Tang, ZG				Zhou, Yueying; Zhang, Leiyi; Pan, Hao; Wang, Baisheng; Yan, Fei; Fang, Xiaodan; Munnee, Krishna; Tang, Zhangui			Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; EXPRESSION; BREAST; PROLIFERATION; METASTASIS; STATISTICS; INHIBITOR; EZRIN	Oral tongue squamous cell carcinoma (OTSCC) is one of the most common head and neck cancers. Innate or acquired resistance to cisplatin, a standard chemotherapy agent for OTSCC, is common in patients with OTSCC. Understanding the molecular basis for cisplatin chemoresistance in OTSCC cells may serve as a basis for identification of novel therapeutic targets. Podocalyxin (PODXL) has been found critical for malignant progression in a variety of cancers. Bmi1 has recently been found to induce cell apoptosis and cisplatin chemosensitivity in OTSCC cells. In this study, we explored the interaction between PODXL and Bmi1 in OTSCC cells, and assessed its impact on OTSCC cell chemoresistance to cisplatin. PODXL and/or Bmi1 were stably overexpressed or knocked down in SCC-4 and Tca8113 human OTSCC cells. Overexpression of PODXL in both cell lines markedly elevated the expression level of Bmi1 and the half maximal inhibitory concentration (IC50) of cisplain and reduced cisplatin-induced cell apoptosis, which was abolished by knockdown of Bmi1 or a selective focal adhesion kinase (FAK) inhibitor. On the other hand, knockdown of PODXL significantly decreased the Bmi1 expression level and cisplatin IC50 and increased cisplatin-induced cell apoptosis, which was completely reversed by overexpression of Bmi1. While overexpression and knockdown of PODXL respectively increased and decreased the FAK activity, Bmi1 showed no significant effect on the FAK activity in OTSCC cells. In addition, overexpression of PODXL markedly elevated the stability of Bmi1 mRNA, which was abolished by a selective FAK inhibitor. In conclusion, this study provides the first evidence that PODXL up-regulates the expression level of Bmi1 in OTSCC cells by increasing the stability of Bmi1 mRNA through a FAK-dependent mechanism; this effect leads to enhanced cisplatin chemoresistance in OTSCC cells. This study adds new insights into the molecular mechanisms underlying OTSCC chemoresistance.	[Zhou, Yueying; Wang, Baisheng; Munnee, Krishna] Cent S Univ, Xiangya Hosp, Dept Stomatol, Changsha, Hunan, Peoples R China; [Zhang, Leiyi] Cent S Univ, Xiangya Hosp 2, Dept Minimal Invas Surg, Changsha, Hunan, Peoples R China; [Pan, Hao; Fang, Xiaodan; Tang, Zhangui] Cent S Univ, Xiangya Stomatol Hosp, Dept Maxillofacial Surg, Changsha, Hunan, Peoples R China; [Yan, Fei] Cent S Univ, Xiangya Stomatol Hosp, Dept Prosthodont, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Tang, ZG (corresponding author), Cent S Univ, Xiangya Stomatol Hosp, Dept Maxillofacial Surg, Changsha, Hunan, Peoples R China.	tangzhangui@aliyun.com			Nature Sciences Foundation of Qinghai Province [2013-z-908]; Science and Technology Bureau of Hunan Province [2013-FJ-4078]	Nature Sciences Foundation of Qinghai Province; Science and Technology Bureau of Hunan Province	This work was supported by The Nature Sciences Foundation of Qinghai Province (grant no. 2013-z-908) and The Science and Technology Bureau of Hunan Province (grant no. 2013-FJ-4078).	Byun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037917; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Choi K., 2009, JOURNAL OF PHYSICS, V42, P1; Ding XQ, 2011, ONCOL RES, V19, P303, DOI 10.3727/096504011X13079697132790; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; He QT, 2015, INT J BIOL SCI, V11, P1, DOI 10.7150/ijbs.10405; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kelley TW, 2005, AM J CLIN PATHOL, V124, P134, DOI 10.1309/7BHLAHHU0N4MHT7Q; Kurio N, 2012, ORAL ONCOL, V48, P1159, DOI 10.1016/j.oraloncology.2012.05.019; Li ZW, 2014, LAB INVEST, V94, P1431, DOI 10.1038/labinvest.2014.123; Lin CW, 2014, CARCINOGENESIS, V35, P2425, DOI 10.1093/carcin/bgu139; Lin CW, 2014, INT J ONCOL, V45, P710, DOI 10.3892/ijo.2014.2427; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Price KAR, 2012, CURR TREAT OPTION ON, V13, P35, DOI 10.1007/s11864-011-0176-y; Riccioni R, 2006, BLOOD CELL MOL DIS, V37, P218, DOI 10.1016/j.bcmd.2006.09.001; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Smith LL, 2011, CELL STEM CELL, V8, P649, DOI 10.1016/j.stem.2011.05.004; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Su Hsing-Hao, 2006, J Chin Med Assoc, V69, P478; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402; Wu H, 2013, EXP THER MED, V5, P1025, DOI 10.3892/etm.2013.957; Xia J, 2009, J ORAL PATHOL MED, V38, P524, DOI 10.1111/j.1600-0714.2008.00728.x; Xing Y, 2013, EXP CELL RES, V319, P2058, DOI 10.1016/j.yexcr.2013.05.014; Yasuoka H, 2008, J CLIN PATHOL, V61, P1228, DOI 10.1136/jcp.2008.059956; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002	30	12	13	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123208	10.1371/journal.pone.0123208	http://dx.doi.org/10.1371/journal.pone.0123208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915207	gold, Green Submitted, Green Published			2022-12-26	WOS:000353659100015
J	Clifton, MC; Dranow, DM; Leed, A; Fulroth, B; Fairman, JW; Abendroth, J; Atkins, KA; Wallace, E; Fan, DZ; Xu, GP; Ni, ZJ; Daniels, D; Van Drie, J; Wei, G; Burgin, AB; Golub, TR; Hubbard, BK; Serrano-Wu, MH				Clifton, Matthew C.; Dranow, David M.; Leed, Alison; Fulroth, Ben; Fairman, James W.; Abendroth, Jan; Atkins, Kateri A.; Wallace, Ellen; Fan, Dazhong; Xu, Guoping; Ni, Z. J.; Daniels, Doug; Van Drie, John; Wei, Guo; Burgin, Alex B.; Golub, Todd R.; Hubbard, Brian K.; Serrano-Wu, Michael H.			A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1	PLOS ONE			English	Article							INHIBITORS; CANCER; POTENT; ACTIVATION; DISCOVERY; APOPTOSIS; SURVIVAL	Crystallization of a maltose-binding protein MCL1 fusion has yielded a robust crystallography platform that generated the first apo MCL1 crystal structure, as well as five ligandbound structures. The ability to obtain fragment-bound structures advances structurebased drug design efforts that, despite considerable effort, had previously been intractable by crystallography. In the ligand-independent crystal form we identify inhibitor binding modes not observed in earlier crystallographic systems. This MBP-MCL1 construct dramatically improves the structural understanding of well-validated MCL1 ligands, and will likely catalyze the structure-based optimization of high affinity MCL1 inhibitors.	[Leed, Alison; Fulroth, Ben; Daniels, Doug; Wei, Guo; Burgin, Alex B.; Golub, Todd R.; Hubbard, Brian K.; Serrano-Wu, Michael H.] Broad Inst, Cambridge, MA USA; [Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Clifton, Matthew C.; Dranow, David M.; Fairman, James W.; Abendroth, Jan; Atkins, Kateri A.; Wallace, Ellen] Beryllium, Bedford, MA 01730 USA; [Fan, Dazhong; Xu, Guoping; Ni, Z. J.] Acme Biosci, Palo Alto, CA USA; [Van Drie, John] Van Drie Res, N Andover, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Clifton, MC (corresponding author), Beryllium, Bedford, MA 01730 USA.	mclifton@be4.com; swu@broadinstitute.org		Daniels, Douglas/0000-0003-0238-9403	Carlos Slim Health Institute; Robertson Foundation; Van Drie Research	Carlos Slim Health Institute; Robertson Foundation; Van Drie Research	This study was funded by the Broad Institute with generous support from the Carlos Slim Health Institute and the Robertson Foundation. AL, BF, D. Daniels, GW, AB, TRG, BKH, and MSW are employees of the Broad Institute and received funding for this study in the form of a salary. MCC, D. Dranow, JWF, JA, KAA, and EW are employees of Beryllium and received funding for this study in the form of a salary. DF, ZN, and GX are employees of Acme Bioscience and received funding for this study in the form of a salary. JVD is the sole proprietor of Van Drie Research and received funding for this study in the form of a salary. The Broad Institute, Beryllium, Acme, and Van Drie Research played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Abulwerdi F, 2014, MOL CANCER THER, V13, P565, DOI 10.1158/1535-7163.MCT-12-0767; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kelly GL, 2011, ADV CANCER RES, V111, P39, DOI 10.1016/B978-0-12-385524-4.00002-7; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Liu GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096521; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Petros AM, 2014, BIOORG MED CHEM LETT, V24, P1484, DOI 10.1016/j.bmcl.2014.02.010; Richard DJ, 2013, BIOORGAN MED CHEM, V21, P6642, DOI 10.1016/j.bmc.2013.08.017; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885	32	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125010	10.1371/journal.pone.0125010	http://dx.doi.org/10.1371/journal.pone.0125010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909780	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800121
J	Dalgaard, LS; Norgaard, M; Jespersen, B; Jensen-Fangel, S; Ostergaard, LJ; Schonheyder, HC; Sogaard, OS				Dalgaard, Lars Skov; Norgaard, Mette; Jespersen, Bente; Jensen-Fangel, Soren; Ostergaard, Lars Jorgen; Schonheyder, Henrik Carl; Sogaard, Ole Schmeltz			Risk and Prognosis of Bloodstream Infections among Patients on Chronic Hemodialysis: A Population-Based Cohort Study	PLOS ONE			English	Article							AUREUS NASAL CARRIAGE; DIALYSIS PATIENTS; CLINICAL-SIGNIFICANCE; BACTEREMIA; SEPTICEMIA; CULTURES; QUALITY; SURVEILLANCE; PROPHYLAXIS; FUNGEMIA	Background and Objectives Infections are common complications among patients on chronic hemodialysis. This population-based cohort study aims to estimate risk and case fatality of bloodstream infection among chronic hemodialysis patients. Methods In this population-based cohort study we identified residents with end-stage renal disease in Central and North Jutland, Denmark who had hemodialysis as first renal replacement therapy (hemodialysis patients) during 1995-2010. For each hemodialysis patient, we sampled 19 persons from the general population matched on age, gender, and municipality. Information on positive blood cultures was obtained from regional microbiology databases. All persons were observed from cohort entry until first episode of bloodstream infection, emigration, death, or end of hemodialysis treatment, whichever came first. Incidence-rates and incidence-rate ratios were computed and risk factors for bloodstream infection assessed by Poisson regression. Case fatality was compared by Cox regression. Results Among 1792 hemodialysis patients and 33 618 matched population controls, we identified 461 and 1126 first episodes of bloodstream infection, respectively. Incidence rates of first episode of bloodstream infection were 13.7 (95% confidence interval (CI), 12.5-15.0) per 100 person-years among hemodialysis patients and 0.53 (95% CI, 0.50-0.56) per 100 person-years among population controls. In hemodialysis patients, the most common causative microorganisms were Staphylococcus aureus (43.8%) and Escherichia coli (12.6%). The 30-day case fatality was similar among hemodialysis patients and population controls 16% (95% CI, 13%-20%) vs. 18% (95% CI, 15%-20%). Conclusions Hemodialysis patients have extraordinary high risk of bloodstream infection while short-term case fatality following is similar to that of population controls.	[Dalgaard, Lars Skov; Jensen-Fangel, Soren; Ostergaard, Lars Jorgen; Sogaard, Ole Schmeltz] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Norgaard, Mette] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Jespersen, Bente] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Schonheyder, Henrik Carl] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Schonheyder, Henrik Carl] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Aalborg University	Dalgaard, LS (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark.	lars.dalgaard@clin.au.dk	Søgaard, Ole Schmeltz/AEP-7968-2022; Søgaard, Ole S/P-6058-2016; Ostergaard, Lars/AAA-3020-2020	Søgaard, Ole Schmeltz/0000-0001-9107-2023; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X; Jespersen, Bente/0000-0001-7196-2870; Skov Dalgaard, Lars/0000-0002-4398-6821	Faculty of Health Science, University of Aarhus, Denmark	Faculty of Health Science, University of Aarhus, Denmark	LD is supported by a PhD grant from the Faculty of Health Science, University of Aarhus, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2001, CLIN NEPHROL, V56, P124; Allon M, 2003, J AM SOC NEPHROL, V14, P1863, DOI 10.1097/01.ASN.0000074237.78764.D1; BOELAERT JR, 1993, NEPHROL DIAL TRANSPL, V8, P235; CHOW JW, 1989, ARCH INTERN MED, V149, P1258, DOI 10.1001/archinte.149.6.1258; CHURCHILL DN, 1992, AM J KIDNEY DIS, V19, P214, DOI 10.1016/S0272-6386(13)80002-9; Foley RN, 2004, J AM SOC NEPHROL, V15, P1038, DOI 10.1097/01.ASN.0000119144.95922.C4; Foley RN, 2007, INFECT DIS CLIN N AM, V21, P659, DOI 10.1016/j.idc.2007.06.005; Gradel KO, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-139; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Ishani A, 2005, KIDNEY INT, V68, P311, DOI 10.1111/j.1523-1755.2005.00414.x; Johnson DW, 2002, NEPHROL DIAL TRANSPL, V17, P1802, DOI 10.1093/ndt/17.10.1802; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen KM, 1998, INFECT CONT HOSP EP, V19, P175; Nephrology DSo, 2010, DAN NEPHR REG ANN RE; Nephrology DSo, 2012, DAN NEPHR REG ANN RE; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; Prevention CfDCa, BLOODSTR INF EV CENT; Rosenblum A, 2014, AM J KIDNEY DIS, V63, P259, DOI 10.1053/j.ajkd.2013.08.019; Sesso R, 1998, J AM SOC NEPHROL, V9, P1085; Tacconelli E, 2003, CLIN INFECT DIS, V37, P1629, DOI 10.1086/379715; Taylor G, 2004, AM J INFECT CONTROL, V32, P155, DOI 10.1016/j.ajic.2003.05.007; Thomson PC, 2007, QJM-INT J MED, V100, P415, DOI 10.1093/qjmed/hcm040; Tokars JI, 2004, CLIN INFECT DIS, V39, P333, DOI 10.1086/421941; U.S. Renal Data System, 2013, USRDS 2013 ANN DAT R; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204	30	31	33	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124547	10.1371/journal.pone.0124547	http://dx.doi.org/10.1371/journal.pone.0124547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910221	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800088
J	Dong, Y; Gao, GR; Fan, HY; Li, SX; Li, XH; Liu, W				Dong, Ying; Gao, Guirong; Fan, Hongyan; Li, Shengxian; Li, Xuhang; Liu, Wei			Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; FREE FATTY-ACIDS; CELL DYSFUNCTION; SKELETAL-MUSCLE; IN-VITRO; BETA; LXR; LIPOGENESIS; INHIBITION; EXPRESSION	Activation of Liver X receptors (LXRs), key transcriptional regulators of glucose metabolism, normalizes glycemia and improves insulin sensitivity in rodent models with insulin resistance. However, the molecular mechanism is unclear. This study is aimed to elucidate the mechanism of LXRs-mediated liver glucose metabolic regulation in vitro and in vivo. Db/db mice were used as an in vivo model of diabetes; palmitate (PA)-stimulated HepG2 cells were used as an in vitro cell model with impairment of insulin signaling. TO901317 (TO) was chosen as the LXRs agonist. We demonstrated that TO treatment for 14 days potently improved the hepatic glucose metabolism in db/db mice, including fasting blood glucose, fasting insulin level, and HOMA-IR. TO had no effect on the glucose metabolism in normal WT mice. TO-mediated activation of hepatic LXRs led to strong inhibition of ROS production accompanied by inactivation of JNK pathway and re-activation of Akt pathway. TO also suppressed the expression of gluconeogenic genes such as PEPCK and G-6-pase in db/db mice, but not in WT mice. In HepG2 cells, TO almost completely restored PA-induced Akt inactivation, and suppressed PA-stimulated ROS production and JNK activation. Interestingly, basal level of ROS was also inhibited by TO in HepG2 cells. TO significantly inhibited PA-stimulated expressions of gluconeogenic genes. Finally, we found that anti-oxidative genes, such as Nrf2, were up-regulated after LXRs activation by TO. These results strongly support the notion that activation of LXRs is critical in suppression of liver gluconeogenesis and improvement of insulin sensitivity in diabetic individuals. At molecular levels, the mode of action appears to be as fellows: under diabetic condition, ROS production is increased, JNK is activated, and Akt activity is inhibited; TO-mediated LXR activation potently inhibits ROS production, increases anti-oxidative gene expressions, suppresses JNK activation, and restores Akt activity. Our data provide new evidence to support LXRs as promising therapeutic targets for anti-diabetic drug development.	[Dong, Ying; Gao, Guirong; Fan, Hongyan; Li, Shengxian; Liu, Wei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Endocrinol, Shanghai 200030, Peoples R China; [Dong, Ying; Li, Xuhang] Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA	Shanghai Jiao Tong University; Johns Hopkins University	Li, XH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GI Div, Baltimore, MD 21205 USA.	sue_liuwei@163.com; xuhang@jhmi.edu	Li, Shengxian/AFT-2979-2022		Foundation of Science and Technology Commission of Shanghai Grand [124119a5700]; National Institute of Health [PO1 DK72084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	Foundation of Science and Technology Commission of Shanghai Grand; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was support by Foundation of Science and Technology Commission of Shanghai Grand 124119a5700 and National Institute of Health Grant PO1 DK72084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer A, 2014, AM J PHYSIOL-ENDOC M, V306, pE494, DOI 10.1152/ajpendo.00410.2013; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Diaz-Flores M, 2013, CAN J PHYSIOL PHARM, V91, P855, DOI 10.1139/cjpp-2012-0341; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Faulds MH, 2010, CURR OPIN PHARMACOL, V10, P692, DOI 10.1016/j.coph.2010.07.003; Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3; Gong HBA, 2009, J BIOL CHEM, V284, P30113, DOI 10.1074/jbc.M109.047753; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Grefhorst A, 2005, AM J PHYSIOL-GASTR L, V289, pG592, DOI 10.1152/ajpgi.00063.2005; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hassing HC, 2012, HEPATOLOGY, V55, P1746, DOI 10.1002/hep.25580; He Q, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0149-0; He Q, 2014, CIRC-HEART FAIL, V7, P1032, DOI 10.1161/CIRCHEARTFAILURE.114.001260; Hessvik NP, 2010, AM J PHYSIOL-ENDOC M, V298, pE602, DOI 10.1152/ajpendo.00553.2009; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hokayem M, 2013, DIABETES CARE, V36, P1454, DOI 10.2337/dc12-1652; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jiang SN, 2011, AM J PHYSIOL-GASTR L, V301, pG454, DOI 10.1152/ajpgi.00148.2011; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539; Li XX, 2012, MICROCIRCULATION, V19, P547, DOI 10.1111/j.1549-8719.2012.00186.x; Liu S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06894; Liu YJ, 2006, ENDOCRINOLOGY, V147, P5061, DOI 10.1210/en.2006-0243; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Muurling M, 2004, J LIPID RES, V45, P9, DOI 10.1194/jlr.M300240-JLR200; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nielsen F, 1997, CLIN CHEM, V43, P1209; Pereira S, 2014, AM J PHYSIOL-ENDOC M, V307, pE34, DOI 10.1152/ajpendo.00436.2013; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shi DM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-173; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Steffensen KR, 2013, EXPERT OPIN THER TAR, V17, P977, DOI 10.1517/14728222.2013.806490; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V310, P589, DOI 10.1016/j.bbrc.2003.08.139; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Venteclef N, 2014, BIOCHEM J, V459, pE1, DOI 10.1042/BJ20140211; Wang ZB, 2012, J PHARM PHARMACOL, V64, P293, DOI 10.1111/j.2042-7158.2011.01402.x; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Yamashita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097419; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8	54	17	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124778	10.1371/journal.pone.0124778	http://dx.doi.org/10.1371/journal.pone.0124778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909991	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800105
J	Gao, XJ; Tian, F; Wang, XY; Zhao, J; Wan, X; Zhang, L; Wu, C; Li, N; Li, JS				Gao, Xuejin; Tian, Feng; Wang, Xinying; Zhao, Jie; Wan, Xiao; Zhang, Li; Wu, Chao; Li, Ning; Li, Jieshou			Leucine Supplementation Improves Acquired Growth Hormone Resistance in Rats with Protein-Energy Malnutrition	PLOS ONE			English	Article							I IGF-I; BINDING PROTEIN; SOMATOMEDIN-C; RESTRICTED RATS; LIVER; AXIS; REDUCTION; CHILDREN; CELLS; ACID	Background Protein-energy malnutrition (PEM) can lead to growth hormone (GH) resistance. Leucine supplementation diets have been shown to increase protein synthesis in muscles. Our study aimed at investigating if long-term leucine supplementation could modulate GH-insulin-like growth factor (IGF)-1 system function and mammalian target of rapamycin (mTOR)related signal transduction in skeletal muscles in a rat model of severe malnutrition. Methodology/Principal Findings Male Sprague-Dawley rats (n = 50; weight, 302 +/- 5 g) were divided into 5 treatment groups, including 2 control groups (a normal control group that was fed chow and ad libitum water [CON, n = 10] and a malnourished control group [MC, n = 10] that was fed a 50% chow diet). After undergoing a weight loss stage for 4 weeks, rats received either the chow diet (MC-CON, n = 10), the chow diet supplemented with low-dose leucine (MC-L, n = 10), or the chow diet supplemented with high-dose leucine (MC-H, n = 10) for 2 weeks. The muscle masses of the gastrocnemius, soleus, and extensor digitorum longus were significantly reduced in the MC group. Re-feeding increased muscle mass, especially in the MC-L and MC-H groups. In the MC group, serum IGF-1, IGF-binding protein (IGFBP)-3, and hepatic growth hormone receptor (GHR) levels were significantly decreased and phosphorylation of the downstream anabolic signaling effectors protein kinase B (Akt), mTOR, and ribosomal protein S6 kinase 1 (S6K1) were significantly lower than in other groups. However, serum IGF-1 and IGF binding protein (IGFBP)-3 concentrations and hepatic growth hormone receptor (GHR) levels were significantly higher in the MC-L and MC-H groups than in the MC-CON group, and serum IGFBP-1 levels was significantly reduced in the MC-L and MC-H groups. These changes were consistent with those observed for hepatic mRNA expression levels. Phosphorylation of the downstream anabolic signaling effectors Akt, mTOR, and S6K1 were also significantly higher in the MC-L and MC-H groups than in the MC-CON group. Conclusion/Significance Our data are the first to demonstrate that long-term supplementation with leucine improved acquired growth hormone resistance in rats with protein-energy malnutrition. Leucine might promote skeletal muscle protein synthesis by regulating downstream anabolic signaling transduction.	[Gao, Xuejin; Wang, Xinying] Southern Med Univ, Res Inst Gen Surg, Jinling Hosp, Guangzhou, Guangdong, Peoples R China; [Tian, Feng; Wang, Xinying; Wan, Xiao; Zhang, Li; Wu, Chao; Li, Ning; Li, Jieshou] Nanjing Univ, Sch Med, Res Inst Gen Surg, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Jie] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China	Southern Medical University - China; Nanjing University; Nanjing University	Wang, XY (corresponding author), Southern Med Univ, Res Inst Gen Surg, Jinling Hosp, Guangzhou, Guangdong, Peoples R China.	wxinying@263.net	Li, jie/GXG-4583-2022; Wu, Chao/H-3195-2019		National Natural Science Foundation in China [81470797]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC))	The authors' research project is sponsored by the National Natural Science Foundation in China (81470797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argente J, 1997, HORM RES, V48, P16, DOI 10.1159/000191306; Balage M, 2010, CURR OPIN CLIN NUTR, V13, P265, DOI 10.1097/MCO.0b013e328336f6b8; Banks MD, 2010, CLIN NUTR, V29, P180, DOI 10.1016/j.clnu.2009.08.006; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Borelli P, 2009, BRAZ J MED BIOL RES, V42, P523, DOI 10.1590/S0100-879X2009000600008; Caregaro L, 2001, CLIN NUTR, V20, P251, DOI 10.1054/clnu.2001.0397; Casperson SL, 2012, CLIN NUTR, V31, P512, DOI 10.1016/j.clnu.2012.01.005; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; CLEMMONS DR, 1981, J CLIN ENDOCR METAB, V53, P1247, DOI 10.1210/jcem-53-6-1247; Favaro A, 2000, PSYCHOSOM MED, V62, P535, DOI 10.1097/00006842-200007000-00012; HOCHBERG Z, 1992, METABOLISM, V41, P106, DOI 10.1016/0026-0495(92)90198-J; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Iizaka S, 2010, CLIN NUTR, V29, P47, DOI 10.1016/j.clnu.2009.05.018; ISLEY WL, 1984, JPEN-PARENTER ENTER, V8, P407, DOI 10.1177/0148607184008004407; Kagansky N, 2005, AM J CLIN NUTR, V82, P784, DOI 10.1093/ajcn/82.4.784; KETELSLEGERS JM, 1995, METABOLISM, V44, P50, DOI 10.1016/0026-0495(95)90221-X; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LEMOZY S, 1994, ENDOCRINOLOGY, V135, P617, DOI 10.1210/en.135.2.617; Magne H, 2013, NUTR METABOLISM C S1, V1, pS51; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; OSTER MH, 1995, J CLIN INVEST, V95, P2258, DOI 10.1172/JCI117916; Pedrosa RG, 2013, APPL PHYSIOL NUTR ME, V38, P694, DOI 10.1139/apnm-2012-0440; Pedrosa RG, 2010, APPL PHYSIOL NUTR ME, V35, P180, DOI 10.1139/H09-132; Sanchez FF, 2011, BRAZ J MED BIOL RES, V44, P453, DOI 10.1590/S0100-879X2011007500024; Shuto Y, 1999, J CLIN ENDOCR METAB, V84, P2320, DOI 10.1210/jc.84.7.2320; Skipworth RJE, 2006, SURG-J R COLL SURG E, V4, P273, DOI 10.1016/S1479-666X(06)80004-1; SMITH WJ, 1995, J CLIN ENDOCR METAB, V80, P443, DOI 10.1210/jc.80.2.443; STRAUS DS, 1990, MOL ENDOCRINOL, V4, P91, DOI 10.1210/mend-4-1-91; STRAUS DS, 1993, ENDOCRINOLOGY, V132, P1090, DOI 10.1210/en.132.3.1090; UNTERMAN TG, 1985, AM J MED, V78, P228, DOI 10.1016/0002-9343(85)90431-0; World Health Organization. WHO, 2002, PROM PROP FEED INF Y; Xia XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077823	33	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125023	10.1371/journal.pone.0125023	http://dx.doi.org/10.1371/journal.pone.0125023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909895	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800123
J	Rizal, G; Karki, S; Garcia, R; Larazo, N; Alcasid, M; Quick, WP				Rizal, Govinda; Karki, Shanta; Garcia, Richard; Larazo, Nikki; Alcasid, Michael; Quick, William Paul			The Use of Maleic Hydrazide for Effective Hybridization of Setaria viridis	PLOS ONE			English	Article							FOXTAIL MILLET; VICIA-FABA; MODEL; EMASCULATION; GERMINATION; INDUCTION; ITALICA; SYSTEMS; GROWTH	An efficient method for crossing green foxtail (Setaria viridis) is currently lacking. S. viridis is considered to be the new model plant for the study of C4 system in monocots and so an effective crossing protocol is urgently needed. S. viridis is a small grass with C4-NADP (ME) type of photosynthesis and has the advantage of having small genome of about 515 Mb, small plant stature, short life cycle, multiple tillers, and profuse seed set, and hence is an ideal model species for research. The objectives of this project were to develop efficient methods of emasculation and pollination, and to speed up generation advancement. We assessed the response of S. viridis flowers to hot water treatment (48 degrees C) and to different concentrations of gibberellic acid, abscisic acid, maleic hydrazide (MH), and kinetin. We found that 500 mu M of MH was effective in the emasculation of S. viridis, whilst still retaining the receptivity of the stigma to pollination. We also report effective ways to accelerate the breeding cycle of S. viridis for research through the germination of mature as well as immature seeds in optimized culture media. We believe these findings will be of great interest to researchers using Setaria.	[Rizal, Govinda; Karki, Shanta; Garcia, Richard; Larazo, Nikki; Alcasid, Michael; Quick, William Paul] C4 Rice Ctr, Int Rice Res Inst, Los Banos, Laguna, Philippines; [Quick, William Paul] Univ Sheffield, Sheffield, S Yorkshire, England	CGIAR; International Rice Research Institute (IRRI); University of Sheffield	Quick, WP (corresponding author), C4 Rice Ctr, Int Rice Res Inst, Los Banos, Laguna, Philippines.	w.p.quick@irri.org	Karki, Shanta/AAO-2373-2021	Garcia, Richard/0000-0002-8311-0365; Rizal, Govinda/0000-0002-6245-1996	Bill & Melinda Gates Foundation; UK AID; C4 Rice Consortium; International Rice Research Institute	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK AID(CGIAR); C4 Rice Consortium; International Rice Research Institute(CGIAR)	This work was supported by the Bill & Melinda Gates Foundation, the UK AID, the C4 Rice Consortium; and the International Rice Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. N, 1968, GERMINATION ESTABLIS; BASSIRI A, 1972, CAN J PLANT SCI, V52, P846, DOI 10.4141/cjps72-141; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Chahal G.S., 2002, PRINCIPLES PROCEDURE; Coffman W. R., 1979, International Rice Research Newsletter, V4, P2; Coffman W. R., 1980, HYBRIDIZATION CROP P, P511; DEMARCO A, 1992, MUTAT RES, V279, P9, DOI 10.1016/0165-1218(92)90260-7; EVANS HJ, 1964, GENETICS, V49, P17; Faehnrich B, 2012, J APPL BOT FOOD QUAL, V85, P73; GRANT WF, 1994, MUTAT RES-FUND MOL M, V310, P187, DOI 10.1016/0027-5107(94)90113-9; Herrera R., 1974, P 5 SCI M, P12; House LR, 1985, GUIDE SORGHUM BREEDI; Jiang H, 2013, JOVE-J VIS EXP, DOI 10.3791/50527; Kalidasu G, 2009, J HORT FOREST, V1, P126; KIHLMAN BA, 1975, MUTAT RES, V31, P401, DOI 10.1016/0165-1161(75)90050-3; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; LI H. W., 1935, JOUR AMER SOC AGRON, V27, P963; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Lyakhovkin A. G., 1976, Byul. nauch.-tekhn. inform. VNII risa, P9; Mackill D.J., 1996, RAINFED LOWLAND RICE; MANTHEY DR, 1987, WEED TECHNOL, V1, P302, DOI 10.1017/S0890037X0002978X; Ponnampalam R, 1983, Regul Toxicol Pharmacol, V3, P38, DOI 10.1016/0273-2300(83)90048-X; Ribas G, 1996, MUTAGENESIS, V11, P221, DOI 10.1093/mutage/11.3.221; Rizal G, 2013, J BOT; SAVAGE D. A., 1935, Journal of the American Society of Agronomy, V27, P774; Sebastian J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095109; SWIETLINSKA Z, 1978, MUTAT RES, V55, P15, DOI 10.1016/0165-1110(78)90010-6; Tong L, 2008, PLANT PROD SCI, V11, P132, DOI 10.1626/pps.11.132; TYSDAL H. M., 1940, JOUR AMER SOC AGRON, V32, P405; VANDENBORN WH, 1971, CAN J PLANT SCI, V51, P53; Vollmann J, 2009, SERIES HDB PLANT BRE, V4; Wang T, 2010, WEED RES, V50, P228, DOI 10.1111/j.1365-3180.2010.00774.x; Wang YJ, 2007, ADVANCES IN BUCKWHEAT RESEARCH, P100; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Zhao G, 2014, CLIN MICROBIOL INFEC, V20, pO776, DOI 10.1111/1469-0691.12571	36	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125092	10.1371/journal.pone.0125092	http://dx.doi.org/10.1371/journal.pone.0125092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910193	Green Accepted, gold, Green Published			2022-12-26	WOS:000353376800128
J	Shao, P; Ou, JJ; Peng, M; Zhao, JP; Chen, JD; Wu, RR				Shao, Ping; Ou, Jianjun; Peng, Mei; Zhao, Jingping; Chen, Jindong; Wu, Renrong			Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis	PLOS ONE			English	Article							PREGNANCY; SCHIZOPHRENIA; RELAPSE; THERAPY; DRUGS; WOMEN; COST	Objective To investigate the developmental effects of clozapine and other atypical antipsychotics on infants who were exposed to as fetus. Method The developmental progress of 33 infants who were exposed to clozapine as fetus was compared to 30 infants who were exposed to risperidone, olanzapine or quetiapine as fetus by assessing Apgar scoring, birth weight at birth, body weight, height, and the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III) at months 2, 6 and 12 of age. Five subscale scores of BSID-III including cognitive, language, motor, social-emotional, and adaptive behavior were also compared. Student's t test and Chi-square analysis were used as appropriate. Repeated measurements were evaluated by analysis of covariance. Results Of the 63 infants, 58 (92.1%) completed a 12-month study period. At the age of 2 and 6 months, mean adaptive behavior scores of BSID-III were significantly lower in clozapine-exposed infants than infants who exposed to other atypical antipsychotic at 2 and 6 months of age. More clozapine-exposed infants had delayed development (defined as the subscale score of <85) for adaptive behavior at 2 and 6 months of age. There was no difference between the two groups for cognitive, language, motor, social and emotional at 2, 6 and 12 months of age. More infants who were exposed to clozapine as fetus (25 of 33, 75.8%) had disturbed sleep and a labile state than those who were exposed to other atypical antipsychotics (8 of 30, 26.7%) during 2 months of age (P<0.001). Conclusion These results suggest that clozapine has more adaptive behavior effects on infants who were exposed to as a fetus than other atypical antipsychotics at 2 and 6 months of age.	[Shao, Ping; Ou, Jianjun; Zhao, Jingping; Chen, Jindong; Wu, Renrong] Cent South Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha 410011, Hunan, Peoples R China; [Shao, Ping] Brains Hosp Hunan Prov, Changsha 410007, Hunan, Peoples R China; [Peng, Mei] Cent South Univ, Xiangya Hosp 2, Dept Obstet, Changsha 410011, Hunan, Peoples R China	Central South University; Central South University	Wu, RR (corresponding author), Cent South Univ, Xiangya Hosp 2, Inst Mental Hlth, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	chenjd269@163.com; wurenrong2013@163.com	zhao, jing/B-3868-2019		National Natural Science Foundation of China [81371481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81371481 to RRW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson GD, 2005, CLIN PHARMACOKINET, V44, P989, DOI 10.2165/00003088-200544100-00001; Bayley N., 2005, BAYLEY SCALES INFANT; Duran A, 2008, J PSYCHOPHARMACOL, V22, P111, DOI 10.1177/0269881107079171; First M. B., 1997, STRUCTURED CLIN INTE; Gentile S, 2008, J CLIN PSYCHIAT, V69, P666, DOI 10.4088/JCP.v69n0421; Gilad O, 2011, BREASTFEED MED, V6, P55, DOI 10.1089/bfm.2010.0027; Gupta N, 2004, CAN J PSYCHIAT, V49, P865, DOI 10.1177/070674370404901213; Hong JY, 2009, PROG NEURO-PSYCHOPH, V33, P835, DOI 10.1016/j.pnpbp.2009.03.034; Lin HC, 2010, SCHIZOPHR RES, V116, P55, DOI 10.1016/j.schres.2009.10.011; Lindenmayer JP, 2009, J CLIN PSYCHIAT, V70, P990, DOI 10.4088/JCP.08m04221; McKenna K, 2005, J CLIN PSYCHIAT, V66, P444, DOI 10.4088/JCP.v66n0406; Mendhekar DN, 2007, J NEUROPSYCH CLIN N, V19, P196, DOI 10.1176/appi.neuropsych.19.2.196; Msall ME, 2010, ARCH PEDIAT ADOL MED, V164, P391, DOI 10.1001/archpediatrics.2010.25; MUCKLOW JC, 1986, CLIN OBSTET GYNAECOL, V13, P161; Newport DJ, 2007, AM J PSYCHIAT, V164, P1214, DOI 10.1176/appi.ajp.2007.06111886; Nguyen HN, 2003, ENCEPHALE, V29, P119; Peng M, 2013, PSYCHOPHARMACOLOGY, V228, P577, DOI 10.1007/s00213-013-3060-6; Robertson CMT, 2010, ARCH PEDIAT ADOL MED, V164, P1072, DOI 10.1001/archpediatrics.2010.199; WEIDEN PJ, 1995, SCHIZOPHRENIA BULL, V21, P419, DOI 10.1093/schbul/21.3.419; Wunderink L, 2007, J CLIN PSYCHIAT, V68, P654, DOI 10.4088/JCP.v68n0502	21	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123373	10.1371/journal.pone.0123373	http://dx.doi.org/10.1371/journal.pone.0123373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909513	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800036
J	Siebers, N; Martius, C; Eckhardt, KU; Garcia, MVB; Leinweber, P; Amelung, W				Siebers, Nina; Martius, Christopher; Eckhardt, Kai-Uwe; Garcia, Marcos V. B.; Leinweber, Peter; Amelung, Wulf			Origin and Alteration of Organic Matter in Termite Mounds from Different Feeding Guilds of the Amazon Rainforests	PLOS ONE			English	Article							DENSITY FRACTIONS; PHOSPHORUS FORMS; TROPICAL FORESTS; MURAMIC ACID; AMINO-SUGARS; BEECH LITTER; SOIL; LIGNIN; CARBON; NITROGEN	The impact of termites on nutrient cycling and tropical soil formation depends on their feeding habits and related material transformation. The identification of food sources, however, is difficult, because they are variable and changed by termite activity and nest construction. Here, we related the sources and alteration of organic matter in nests from seven different termite genera and feeding habits in the Terra Firme rainforests to the properties of potential food sources soil, wood, and microepiphytes. Chemical analyses comprised isotopic composition of C and N, cellulosic (CPS), non-cellulosic (NCPS), and N-containing saccharides, and molecular composition screening using pyrolysis-field ionization mass spectrometry (Py-FIMS). The isotopic analysis revealed higher soil delta C-13 (-27.4%) and delta N-15 (6.6%) values in nests of wood feeding Nasutitermes and Cornitermes than in wood samples (delta C-13 = -29.1 parts per thousand, delta N-15 = 3.4 parts per thousand), reflecting stable-isotope enrichment with organic matter alterations during or after nest construction. This result was confirmed by elevated NCPS: CPS ratios, indicating a preferential cellulose decomposition in the nests. High portions of muramic acid (MurAc) pointed to the participation of bacteria in the transformation processes. Non-metric multidimensional scaling (MDS) revealed increasing geophagy in the sequence Termes < Embiratermes < Anoplotermes and increasing xylophagy for Cornitermes < Nasutitermes., and that the nest material of Constrictotermes was similar to the microepiphytes sample, confirming the report that Constrictotermes belongs to the microepiphyte-feeders. We therewith document that nest chemistry of rainforest termites shows variations and evidence of modification by microbial processes, but nevertheless it primarily reflects the trophic niches of the constructors.	[Siebers, Nina; Amelung, Wulf] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, D-53115 Bonn, Germany; [Martius, Christopher; Garcia, Marcos V. B.] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany; [Eckhardt, Kai-Uwe; Leinweber, Peter] Univ Rostock, Soil Sci, D-18051 Rostock, Germany; [Garcia, Marcos V. B.] Embrapa Amazonia Ocidental, BR-69010970 Manaus, Amazonas, Brazil	University of Bonn; University of Bonn; University of Rostock; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Siebers, N (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, Nussallee 13, D-53115 Bonn, Germany.	n.siebers@fz-juelich.de	Amelung, Wulf/H-2136-2013	Amelung, Wulf/0000-0002-4920-4667; Martius, Christopher/0000-0002-6884-0298; Siebers, Nina/0000-0002-6431-0046	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The work had been funded by the German Research Foundation.	Amelung W, 1997, SOIL SCI SOC AM J, V61, P115, DOI 10.2136/sssaj1997.03615995006100010018x; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; Amelung W, 2002, SOIL BIOL BIOCHEM, V34, P367, DOI 10.1016/S0038-0717(01)00192-4; Amelung W, 1999, SOIL SCI SOC AM J, V63, P86, DOI 10.2136/sssaj1999.03615995006300010014x; Amelung W., 2001, ASSESSMENT METHODS S, P233, DOI [10.1201/9781482278644-27, DOI 10.1201/9781482278644-27]; Araujo R. L., 1970, P527; Bandowe BAM, 2009, SOIL BIOL BIOCHEM, V41, P630, DOI 10.1016/j.soilbio.2008.12.029; BENZINGPURDIE L, 1984, SOIL SCI SOC AM J, V48, P219, DOI 10.2136/sssaj1984.03615995004800010040x; Bezerra-Gusmao MA, 2011, APPL SOIL ECOL, V47, P1, DOI 10.1016/j.apsoil.2010.11.003; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bourguignon T, 2009, SOIL BIOL BIOCHEM, V41, P2038, DOI 10.1016/j.soilbio.2009.07.005; BOUTTON TW, 1983, OECOLOGIA, V59, P1, DOI 10.1007/BF00388065; Brauman A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P233; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; BURNEY C M, 1977, Marine Chemistry, V5, P15, DOI 10.1016/0304-4203(77)90012-3; CHESHIRE MV, 1966, J SOIL SCI, V17, P372, DOI 10.1111/j.1365-2389.1966.tb01480.x; COCHRAN TW, 1978, CARBOHYD RES, V61, P529, DOI 10.1016/S0008-6215(00)84511-5; DELIGNE J, 1966, CR ACAD SCI D NAT, V263, P1323; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Ding XL, 2010, J SOIL SEDIMENT, V10, P758, DOI 10.1007/s11368-009-0132-7; EISNER T, 1976, BEHAV ECOL SOCIOBIOL, V1, P83, DOI 10.1007/BF00299954; Fabritius H, 2011, TOP GEOBIOL, V34, P35, DOI 10.1007/978-90-481-9684-5_2; Fall S, 2004, MICROB ECOL, V48, P191, DOI 10.1007/s00248-003-1047-2; Glaser B, 2004, SOIL BIOL BIOCHEM, V36, P399, DOI 10.1016/j.soilbio.2003.10.013; Griffiths BS, 2013, SOIL BIOL BIOCHEM, V57, P957, DOI 10.1016/j.soilbio.2012.08.012; GUGGENBERGER G, 1994, EUR J SOIL SCI, V45, P449, DOI 10.1111/j.1365-2389.1994.tb00530.x; HEDGES JI, 1982, ANAL CHEM, V54, P174, DOI 10.1021/ac00239a007; Kiersch K, 2012, THERMOCHIM ACTA, V537, P36, DOI 10.1016/j.tca.2012.02.034; KOGEL I, 1986, SOIL BIOL BIOCHEM, V18, P589, DOI 10.1016/0038-0717(86)90080-5; KOGEL I, 1985, SOIL BIOL BIOCHEM, V17, P637, DOI 10.1016/0038-0717(85)90040-9; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lee K. E., 1971, TERMITES AND SOILS; Leinweber P., 2009, BIOPHYSICOCHEMICAL P, P539, DOI DOI 10.1002/9780470494950.CH14; Leinweber P, 2013, ADV AGRON, V119; Martius C, 2000, SOCIOBIOLOGY, V35, P379; MARTIUS C, 1994, PEDOBIOLOGIA, V38, P407; Miltner A, 1998, SOIL BIOL BIOCHEM, V30, P1, DOI 10.1016/S0038-0717(97)00092-8; Nadelhoffer K., 1994, STABLE ISOTOPES ECOL, P22; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Parsons J. W., 1981, Soil biochemistry. Volume 5, P197; R Core Team, 2021, R LANGUAGE ENV STAT; Rodionov A, 2001, GEODERMA, V102, P299, DOI 10.1016/S0016-7061(01)00038-6; Roth PJ, 2011, GLOBAL CHANGE BIOL, V17, P3405, DOI 10.1111/j.1365-2486.2011.02500.x; Ruckamp D, 2012, GEODERMA, V170, P239, DOI 10.1016/j.geoderma.2011.10.004; Ruckamp D, 2010, GEODERMA, V155, P269, DOI 10.1016/j.geoderma.2009.12.010; SCHNITZER M, 1992, SOIL SCI SOC AM J, V56, P1811, DOI 10.2136/sssaj1992.03615995005600060027x; Schulten HR, 1999, EUR J SOIL SCI, V50, P237, DOI 10.1046/j.1365-2389.1999.00241.x; Schulten HR, 1998, IUPAC S ANAL PHYS CH, V4, P281; Sleaford F, 1996, ECOL ENTOMOL, V21, P279, DOI 10.1111/j.1365-2311.1996.tb01245.x; Sleutel S, 2008, BIOGEOCHEMISTRY, V89, P253, DOI 10.1007/s10533-008-9217-4; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Solomon D, 2002, SOIL SCI SOC AM J, V66, P68, DOI 10.2136/sssaj2002.0068; SOWDEN FJ, 1977, CAN J SOIL SCI, V57, P445, DOI 10.4141/cjss77-050; Spain AV, 1996, SOIL BIOL BIOCHEM, V28, P1585, DOI 10.1016/S0038-0717(96)00260-X; SPSS: IBM Corp, 2012, IBM SPSS STAT WIND V; Sradnick A, 2014, GEODERMA, V226, P79, DOI 10.1016/j.geoderma.2014.03.005; Stevenson F.J., 1982, NITROGEN AGR SOILS, P101; Tayasu I, 2002, SOIL BIOL BIOCHEM, V34, P297, DOI 10.1016/S0038-0717(01)00181-X; Tayasu I, 1998, FUNCT ECOL, V12, P536, DOI 10.1046/j.1365-2435.1998.00220.x; Tayasu I, 1997, ECOL ENTOMOL, V22, P343, DOI 10.1046/j.1365-2311.1997.00070.x; UZAKI M, 1983, J CHROMATOGR, V260, P487, DOI 10.1016/0021-9673(83)80058-2; VARMA A, 1994, FEMS MICROBIOL REV, V15, P9, DOI 10.1111/j.1574-6976.1994.tb00120.x; Wilcke W, 2003, ORG GEOCHEM, V34, P1405, DOI 10.1016/S0146-6380(03)00137-2; Wood T.G., 1978, International Biological Programme, P245; Yamada A, 2005, ECOL RES, V20, P453, DOI 10.1007/s11284-005-0062-9; Zhang XD, 1996, SOIL BIOL BIOCHEM, V28, P1201, DOI 10.1016/0038-0717(96)00117-4; ZIEGLER F, 1991, Z PFLANZ BODENKUNDE, V154, P377, DOI 10.1002/jpln.19911540511	68	7	7	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123790	10.1371/journal.pone.0123790	http://dx.doi.org/10.1371/journal.pone.0123790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909987	Green Published, gold			2022-12-26	WOS:000353376800045
J	van der Hoeven, R; Cruz, MR; Chavez, V; Garsin, DA				van der Hoeven, Ransome; Cruz, Melissa R.; Chavez, Violeta; Garsin, Danielle A.			Localization of the Dual Oxidase BLI-3 and Characterization of Its NADPH Oxidase Domain during Infection of Caenorhabditis elegans	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; PHAGOCYTE OXIDASE; NOX/DUOX FAMILY; CROSS-LINKING; REVEALS; HOST; DUOX; EPITHELIUM; VIRULENCE; FAECALIS	Dual oxidases (DUOX) are enzymes that contain an NADPH oxidase domain that produces hydrogen peroxide (H2O2) and a peroxidase domain that can utilize H2O2 to carry out a variety of reactions. The model organism Caenorhabditis elegans produces the DUOX, BLI-3, which has roles in both cuticle development and in protection against infection. In previous work, we demonstrated that while certain peroxidases were protective against the human bacterial pathogen Enterococcus faecalis, the peroxidase domain of BLI-3 was not, leading to the postulate that the NADPH oxidase domain is the basis for BLI-3's protective effects. In this work, we show that a strain carrying a mutation in the NADPH oxidase domain of BLI-3, bli-3(im10), is more susceptible to E. faecalis and the human fungal pathogen Candida albicans. Additionally, less H2O2 is produced in response to pathogen using both an established Amplex Red assay and a strain of C. albicans, WT-OXYellow, which acts as a biosensor of reactive oxygen species (ROS). Finally, a C. elegans line containing a BLI-3:: mCherry transgene was generated. Previous work suggested that BLI-3 is produced in the hypodermis and the intestine. Expression of the transgene was observed in both these tissues, and additionally in the pharynx. The amount and pattern of localization of BLI-3 did not change in response to pathogen exposure.	[van der Hoeven, Ransome; Cruz, Melissa R.; Chavez, Violeta; Garsin, Danielle A.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Garsin, DA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Danielle.A.Garsin@uth.tmc.edu		van der Hoeven, Ransome/0000-0001-9686-832X; Cruz, Melissa/0000-0003-2399-3343	National Institutes of Health [R01AI076406]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076406, R01AI110432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01AI076406 to D.A.G and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerssens J, 2008, CLIN GASTROENTEROL H, V6, P194, DOI 10.1016/j.cgh.2007.11.012; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; Brothers KM, 2011, EUKARYOT CELL, V10, P932, DOI 10.1128/EC.05005-11; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Cruz MR, 2013, INFECT IMMUN, V81, P189, DOI 10.1128/IAI.00914-12; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Flores MV, 2010, BIOCHEM BIOPH RES CO, V400, P164, DOI 10.1016/j.bbrc.2010.08.037; FONZI WA, 1993, GENETICS, V134, P717; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hope IA., 1999, C ELEGANS PRACTICAL; Jain C, 2009, EUKARYOT CELL, V8, P1218, DOI 10.1128/EC.00367-08; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Mango Susan E, 2007, WormBook, P1; Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957; Nagai K, 2008, ANTIOXID REDOX SIGN, V10, P705, DOI 10.1089/ars.2007.1941; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Tiller GR, 2014, GENETICS, V197, P515, DOI 10.1534/genetics.113.160606; Tiller GR, 2014, SKPO 1 PEROXIDASE FU; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194	34	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124091	10.1371/journal.pone.0124091	http://dx.doi.org/10.1371/journal.pone.0124091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909649	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800059
J	Zanni, R; Galvez-Llompart, M; Morell, C; Rodriguez-Henche, N; Diaz-Laviada, I; Recio-Iglesias, MC; Garcia-Domenech, R; Galvez, J				Zanni, Riccardo; Galvez-Llompart, Maria; Morell, Cecilia; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines; Carmen Recio-Iglesias, Maria; Garcia-Domenech, Ramon; Galvez, Jorge			Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors	PLOS ONE			English	Article							NF-KAPPA-B; MELANOMA CELL-GROWTH; WNT/BETA-CATENIN; SIGNALING PATHWAY; HUMAN COLON; DOWN-REGULATION; PROTEIN-KINASE; UP-REGULATION; HUMAN PROSTATE; IN-VITRO	Background and Purpose Colorectal and prostate cancers are two of the most common types and cause of a high rate of deaths worldwide. Therefore, any strategy to stop or at least slacken the development and progression of malignant cells is an important therapeutic choice. The aim of the present work is the identification of novel cancer chemotherapy agents. Nowadays, many different drug discovery approaches are available, but this paper focuses on Molecular Topology, which has already demonstrated its extraordinary efficacy in this field, particularly in the identification of new hit and lead compounds against cancer. This methodology uses the graph theoretical formalism to numerically characterize molecular structures through the so called topological indices. Once obtained a specific framework, it allows the construction of complex mathematical models that can be used to predict physical, chemical or biological properties of compounds. In addition, Molecular Topology is highly efficient in selecting and designing new hit and lead drugs. According to the aforementioned, Molecular Topology has been applied here for the construction of specific Akt/mTOR and beta-catenin inhibition mathematical models in order to identify and select novel antitumor agents. Experimental Approach Based on the results obtained by the selected mathematical models, six novel potential inhibitors of the Akt/mTOR and beta-catenin pathways were identified. These compounds were then tested in vitro to confirm their biological activity. Conclusion and Implications Five of the selected compounds, CAS no 256378-54-8 (Inhibitor no 1), 663203-38-1 (Inhibitor no 2), 247079-73-8 (Inhibitor no 3), 689769-86-6 (Inhibitor no 4) and 431925-096 (Inhibitor no 6) gave positive responses and resulted to be active for Akt/mTOR and/or beta-catenin inhibition. This study confirms once again the Molecular Topology's reliability and efficacy to find out novel drugs in the field of cancer.	[Zanni, Riccardo; Galvez-Llompart, Maria; Garcia-Domenech, Ramon; Galvez, Jorge] Univ Valencia, Sch Pharm, Dept Phys Chem, Valencia, Spain; [Morell, Cecilia; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines] Univ Alcala, Sch Med, Biochem & Mol Biol Unit, Dept Syst Biol, Alcala De Henares, Spain; [Zanni, Riccardo; Galvez-Llompart, Maria; Carmen Recio-Iglesias, Maria] Univ Valencia, Sch Pharm, Dept Pharmacol, Valencia, Spain	University of Valencia; Universidad de Alcala; University of Valencia	Galvez, J (corresponding author), Univ Valencia, Sch Pharm, Dept Phys Chem, Valencia, Spain.	jorge.galvez@uv.es	Diaz-Laviada, Ines/I-2838-2015; Galvez-Llompart, Maria/ABH-4751-2020; Galvez, Jorge/P-6466-2014; Rodriguez-Henche, Nieves/K-6828-2017; Garcia-Domenech, Ramon/R-5909-2018	Diaz-Laviada, Ines/0000-0001-9704-4373; Galvez-Llompart, Maria/0000-0002-0718-4143; Galvez, Jorge/0000-0003-0928-8437; Rodriguez-Henche, Nieves/0000-0001-9798-359X; Morell Pucci, Maria Cecilia/0000-0002-9759-855X; Garcia-Domenech, Ramon/0000-0003-1137-0587; Zanni, Riccardo/0000-0002-3388-3730; MCarmen, Recio/0000-0002-0933-2306	Spanish Minneco [BFU2012-31444]; Comunidad de Madrid [S2010/BMD-2308]; Junta de Castilla-La Mancha [POII-2014-011-P]; Fundacion Tatiana Perez de Guzman [2013-001]; Valencia University (Especials Accions Grant) [UV-INV-AE13-139455]; University of Valencia (Atraction of Talent Grant) [UV-INV-PDOC11-39853]	Spanish Minneco; Comunidad de Madrid(Comunidad de Madrid); Junta de Castilla-La Mancha; Fundacion Tatiana Perez de Guzman; Valencia University (Especials Accions Grant); University of Valencia (Atraction of Talent Grant)	IDL is supported by grants from Spanish Minneco (grant BFU2012-31444), Comunidad de Madrid (grant S2010/BMD-2308) Junta de Castilla-La Mancha (grant POII-2014-011-P), Fundacion Tatiana Perez de Guzman (grant 2013-001). MCR is supported by Valencia University (Especials Accions Grant UV-INV-AE13-139455). MGL is supported by University of Valencia (Atraction of Talent Grant UV-INV-PDOC11-39853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha P, 2013, EUR J NUTR, V52, P75, DOI 10.1007/s00394-011-0288-y; [Anonymous], 2009, CHEMDRAW ULTR VERS 1; [Anonymous], SPECS DAT; Antony L, 2014, PROSTATE, V74, P1118, DOI 10.1002/pros.22828; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Bajer MM, 2014, BIOCHEM PHARMACOL, V88, P313, DOI 10.1016/j.bcp.2014.01.034; Bao-ying H, 2012, CHINESE J INTEGRATED, V32, P965; Baskar AA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-24; Behari J, 2007, J HEPATOL, V46, P849, DOI 10.1016/j.jhep.2006.11.017; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Blum CA, 2001, CARCINOGENESIS, V22, P315, DOI 10.1093/carcin/22.2.315; Bokmann S, 2003, EUR J CANCER PREV, V12, P469, DOI [10.1097/01.cej.0000102800.33147.d9, 10.1097/00008469-200312000-00005]; Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038; Buitrago CG, 2012, J CELL BIOCHEM, V113, P1170, DOI 10.1002/jcb.23444; Caboni L, 2014, J CHEM INF MODEL, V54, P2953, DOI 10.1021/ci500324f; Canter RJ, 2005, ANN SURG ONCOL, V12, P733, DOI 10.1245/ASO.2005.10.005; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Chen WY, 2014, INT IMMUNOPHARMACOL, V22, P409, DOI 10.1016/j.intimp.2014.07.026; Cheng B, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/797968; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Choi H, 2010, BIOCHEM BIOPH RES CO, V391, P915, DOI 10.1016/j.bbrc.2009.11.164; Choi J, 2014, J MED FOOD, V17, P842, DOI 10.1089/jmf.2013.0159; Choo EJ, 2011, BIOL PHARM BULL, V34, P41, DOI 10.1248/bpb.34.41; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Cui L, 2014, J PHARM PHARMACOL, V66, P1615, DOI 10.1111/jphp.12283; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Deeb D, 2014, INT J ONCOL, V44, P1707, DOI 10.3892/ijo.2014.2325; Dehnhardt CM, 2010, J MED CHEM, V53, P897, DOI 10.1021/jm901370m; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dihlmann S, 2003, MOL CANCER THER, V2, P509; Duart MJ, 2002, INT J PHARMACEUT, V246, P111, DOI 10.1016/S0378-5173(02)00352-6; Eagle D, 2012, ONCOLOGY-NY, V26, P918; Edlind MP, 2014, ASIAN J ANDROL, V16, P378, DOI 10.4103/1008-682X.122876; Esmaeili MA, 2014, S AFR J BOT, V93, P37, DOI 10.1016/j.sajb.2014.03.010; Fila C, 2008, J BIOL CHEM, V283, P21714, DOI 10.1074/jbc.M710264200; Fu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102535; FURNIVAL GM, 1971, TECHNOMETRICS, V13, P403, DOI 10.2307/1266801; Galvez J, 1996, BIOORG MED CHEM LETT, V6, P2301, DOI 10.1016/0960-894X(96)00418-0; Galvez J, 2000, J MOL STRUC-THEOCHEM, V504, P241, DOI 10.1016/S0166-1280(00)00365-1; Galvez J, 1996, J MOL GRAPH MODEL, V14, P272, DOI 10.1016/S0263-7855(96)00081-1; Galvez J, 2010, QSPR QSAR STUDIES DE, P63; Galvez J, 2004, US patent, Patent No. [US20040266732, 20040266732]; Galvez Jorge, 2013, Drug Discov Today Technol, V10, pe475, DOI 10.1016/j.ddtec.2013.05.001; Galvez J, 2012, CURR COMPUT-AID DRUG, V8, P196, DOI 10.2174/157340912801619094; Galvez J, 2012, EXPERT OPIN DRUG DIS, V7, P133, DOI 10.1517/17460441.2012.652083; Galvez J, 2011, COMB CHEM HIGH T SCR, V14, P279, DOI 1386-2073/11 $58.00+.00; Galvez J, 2010, CURR COMPUT-AID DRUG, V6, P252; Galvez-Llompart M, 2013, MOL DIVERS, V17, P573, DOI 10.1007/s11030-013-9458-6; Galvez-Llompart M, 2013, MED CHEM RES, V22, P3466, DOI 10.1007/s00044-012-0361-y; Galvez-Llompart M, 2011, MOL DIVERS, V15, P917, DOI 10.1007/s11030-011-9323-4; Galvez-Llompart M, 2010, LETT DRUG DES DISCOV, V7, P438, DOI 10.2174/157018010791306597; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Garcia-Domenech R, 2008, CHEM REV, V108, P1127, DOI 10.1021/cr0780006; Garcia-Domenech R, 2013, EXPERT OPIN DRUG DIS, V8, P933, DOI 10.1517/17460441.2013.800043; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Gardner SH, 2004, BRIT J CANCER, V91, P153, DOI 10.1038/sj.bjc.6601901; Greenspan EJ, 2011, CANCER PREV RES, V4, P161, DOI 10.1158/1940-6207.CAPR-10-0021; Haegele L, 2003, MOL CELL NEUROSCI, V24, P696, DOI 10.1016/S1044-7431(03)00232-X; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Han AJ, 2008, EUR J PHARMACOL, V583, P26, DOI 10.1016/j.ejphar.2007.12.034; Hara A, 2005, ONCOL REP, V14, P345; Haug U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088407; [侯丽颖 Hou Liying], 2013, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V25, P343; Hu C, 2008, BIOORGAN MED CHEM, V16, P7888, DOI 10.1016/j.bmc.2008.07.076; Huang MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092161; Hwang TL, 2010, BIOCHEM PHARMACOL, V80, P1190, DOI 10.1016/j.bcp.2010.06.028; Jasinski P, 2008, INVEST NEW DRUG, V26, P223, DOI 10.1007/s10637-007-9096-x; Jasinski P, 2011, INVEST NEW DRUG, V29, P846, DOI 10.1007/s10637-010-9432-4; Jayasooriya RGPT, 2014, TOXICOL IN VITRO, V28, P751, DOI 10.1016/j.tiv.2014.02.015; Jeon SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-17; Jia D, 2015, CELL DEATH DIFFER, V22, P298, DOI 10.1038/cdd.2014.145; Jiang S, 2012, ZHONGHUA SHENJINGKE, V45, P500; Jin KS, 2014, FOOD CHEM TOXICOL, V68, P38, DOI 10.1016/j.fct.2014.03.001; Jin X, 2004, BRIT J CANCER, V91, P1808, DOI 10.1038/sj.bjc.6602214; Johnson SM, 2010, J AM COLL SURGEONS, V210, P767, DOI 10.1016/j.jamcollsurg.2009.12.008; Joo YN, 2014, INT J ONCOL, V44, P187, DOI 10.3892/ijo.2013.2178; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kaur J, 2010, AM J BIOMED SCI, V2, P63; Kawabata K, 2006, FEBS LETT, V580, P5288, DOI 10.1016/j.febslet.2006.08.072; Kaza N, 2014, THESIS; Kim JH, 2014, FOOD CHEM TOXICOL, V67, P87, DOI 10.1016/j.fct.2014.02.019; Kim MB, 2014, BIOCHEM BIOPH RES CO, V445, P433, DOI 10.1016/j.bbrc.2014.02.017; KLECKA WR, 1980, SAGE U PAPER SERIES; Krech T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-287; Kwak DH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/413906; Lambert JR, 2007, BIOCHEM BIOPH RES CO, V361, P189, DOI 10.1016/j.bbrc.2007.07.012; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Lee H, 2011, LIFE SCI, V88, P294, DOI 10.1016/j.lfs.2010.12.004; Lee IA, 2014, WORLD J GASTROENTERO, V20, P1127, DOI 10.3748/wjg.v20.i5.1127; Lee MA, 2013, BIOORG MED CHEM LETT, V23, P5511, DOI 10.1016/j.bmcl.2013.08.065; Lee SY, 2013, CANCER PREV RES, V6, P1356, DOI 10.1158/1940-6207.CAPR-13-0241; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Leow PC, 2010, INVEST NEW DRUG, V28, P766, DOI 10.1007/s10637-009-9311-z; Li HZ, 2013, TOXICOL LETT, V220, P219, DOI 10.1016/j.toxlet.2013.05.006; Li J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-241; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Li L, 2011, ASIAN PAC J CANCER P, V12, P3293; Li QH, 2012, ARCH GERONTOL GERIAT, V55, P749, DOI 10.1016/j.archger.2012.06.013; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Liagre B, 2007, INT J MOL MED, V20, P451; [林碧华 Lin Bihua], 2014, [中国药学杂志, Chinese Pharmaceutical Journal], V49, P837; Liu J, 2014, MOL MED REP, V9, P1289, DOI 10.3892/mmr.2014.1928; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036237; Liu Y, 2014, CN patent, Patent No. [CN104055779, 104055779]; Liu YL, 2013, ONCOL REP, V30, P1723, DOI 10.3892/or.2013.2658; Llacer MT, 2006, INTERNET ELECT J MOL, V5, P306; Llompart J, 2006, US patent, Patent No. [US20060014770, 20060014770]; Llompart J, 2004, US patent, Patent No. [US20040059000, 20040059000]; Lopez ME, 2013, IJCCE, V3, P64; Lu DS, 2005, P NATL ACAD SCI USA, V102, P18567, DOI 10.1073/pnas.0509316102; Lu WY, 2012, CELL SIGNAL, V24, P2291, DOI 10.1016/j.cellsig.2012.07.009; Lu WZ, 2012, LIFE SCI, V91, P279, DOI 10.1016/j.lfs.2012.07.032; Ma L, 2013, FEBS J, V280, P2027, DOI 10.1111/febs.12226; Maier TJ, 2005, FASEB J, V19, P1353, DOI 10.1096/fj.04-3274fje; Makhov PB, 2012, MOL CANCER THER, V11, P1510, DOI 10.1158/1535-7163.MCT-11-0907; Mao JM, 2013, DIABETES, V62, P3736, DOI 10.2337/db13-0035; Mao YJ, 2014, J HETEROCYCLIC CHEM, V51, P594, DOI 10.1002/jhet.1111; Matsuzaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076808; McGuire TF, 2001, J BIOL CHEM, V276, P26365, DOI 10.1074/jbc.M010101200; Merhi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025963; Merla R, 2007, AM J PHYSIOL-HEART C, V293, pH1918, DOI 10.1152/ajpheart.00416.2007; Meropol NJ, 2009, J CLIN ONCOL, V27, P3868, DOI 10.1200/JCO.2009.23.1183; Meuillet EJ, 2010, MOL CANCER THER, V9, P706, DOI 10.1158/1535-7163.MCT-09-0985; Do MT, 2013, FOOD CHEM, V141, P2591, DOI 10.1016/j.foodchem.2013.04.125; Mojsin M, 2014, FOOD FUNCT, V5, P2564, DOI [10.1039/c4fo00484a, 10.1039/C4FO00484A]; Mologni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051449; Morikawa K, 2008, J AGR FOOD CHEM, V56, P11030, DOI 10.1021/jf801965n; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muche S, 2014, ANTICANCER RES, V34, P4677; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; Oh JH, 2009, INT IMMUNOPHARMACOL, V9, P614, DOI 10.1016/j.intimp.2009.02.002; Olivier-Van Stichelen Stephanie, 2012, Am J Physiol Endocrinol Metab, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Ou X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095393, 10.1371/journal.pone.0101587]; Pandey MK, 2014, EXP HEMATOL, V42, P883, DOI 10.1016/j.exphem.2014.07.261; Pang XF, 2011, MOL CANCER THER, V10, P795, DOI 10.1158/1535-7163.MCT-10-0936; Panno ML, 2010, FEBS LETT, V584, P2321, DOI 10.1016/j.febslet.2010.04.001; Park HS, 2012, FOOD CHEM TOXICOL, V50, P2407, DOI 10.1016/j.fct.2012.04.034; Park S, 2013, BIOL PHARM BULL, V36, P1040, DOI 10.1248/bpb.b13-00158; Piazza GA, 2010, PHARMACEUTICALS, V3, P1652, DOI 10.3390/ph3051652; Pradhan A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119016; Prinz H, 2011, J MED CHEM, V54, P4247, DOI 10.1021/jm200436t; Raina K, 2013, AUTOPHAGY, V9, P697, DOI 10.4161/auto.23960; Raju J, 2007, CANCER LETT, V255, P194, DOI 10.1016/j.canlet.2007.04.011; Roy HK, 2005, CANCER LETT, V217, P161, DOI 10.1016/j.canlet.2004.07.042; Saifo MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-310; Saini MK, 2014, BIOMED PHARMACOTHER, V68, P537, DOI 10.1016/j.biopha.2014.03.007; Saiprasad G, 2014, EUR J CANCER, V50, P2489, DOI 10.1016/j.ejca.2014.06.013; Scalo JF, 2014, EXPERT REV PHARM OUT, V14, P35, DOI 10.1586/14737167.2014.864561; Scartabelli T, 2008, NEUROPHARMACOLOGY, V55, P509, DOI 10.1016/j.neuropharm.2008.06.019; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Shanmugam MK, 2012, CANCER LETT, V320, P158, DOI 10.1016/j.canlet.2012.02.037; Singh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060749; Song NR, 2014, FOOD CHEM, V142, P66, DOI 10.1016/j.foodchem.2013.07.002; StatSoft I, STAT DAT AN SOFTW SY; Stein U, 2012, BRIT J CANCER, V106, P1395, DOI 10.1038/bjc.2012.81; Su TR, 2013, INT J MOL SCI, V14, P20443, DOI 10.3390/ijms141020443; Su Y, 2009, CARCINOGENESIS, V30, P331, DOI 10.1093/carcin/bgn279; Suh N, 2011, CANCER PREV RES, V4, P1895, DOI 10.1158/1940-6207.CAPR-11-0222; Sundram V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035368; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Suzuki M, 2006, PHARM BIOL, V44, P178, DOI 10.1080/13880200600686491; Syed DN, 2014, BIOCHEM PHARMACOL, V89, P349, DOI 10.1016/j.bcp.2014.03.007; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Tabernero J, 2011, ANN ONCOL, V2011, P22; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Tinsley Heather N, 2013, Recent Results Cancer Res, V191, P105, DOI 10.1007/978-3-642-30331-9_6; Dung TTM, 2014, INT IMMUNOPHARMACOL, V20, P37, DOI 10.1016/j.intimp.2014.02.019; Todeschini R., 2006, DRAGON WINDOWS SOFTW; Todeschini R, 2008, HDB MOL DESCRIPTORS, DOI [10.1002/9783527613106.oth2, DOI 10.1002/9783527613106.OTH2]; Toulany M, 2013, CANC BIOL THERAPY, V15, P0; Vanella L, 2013, ONCOL REP, V30, P2804, DOI 10.3892/or.2013.2757; Vara D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.141; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Villagra S, 2000, MOLECULES, V5, P330, DOI 10.3390/50300330; Wang C, 2015, EXP CELL RES, V331, P115, DOI 10.1016/j.yexcr.2014.10.023; Wang D, 2011, ASIAN PAC J CANCER P, V12, P2581; Wang G, 2012, SHIYONG YIXUE ZAZHI, V28, P1756; Wang HY, 2014, INT J MED SCI, V11, P841, DOI 10.7150/ijms.8128; Wang J, 2011, CELL MOL BIOL NOISY, V57; Wang N, 2014, CARCINOGENESIS, V35, P2544, DOI 10.1093/carcin/bgu187; Wang S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-81; Wang Y, 2013, ZHONGGUO SHIYAN FANG, V19, P167; Wang Y, 2011, CAN J PHYSIOL PHARM, V89, P345, DOI [10.1139/Y11-024, 10.1139/y11-024]; Watson SA, 2001, LANCET, V357, P572, DOI 10.1016/S0140-6736(00)04074-5; Way TD, 2014, EUR J CANCER, V50, P366, DOI 10.1016/j.ejca.2013.09.025; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Wolle D, 2014, CANCER MED-US, V3, P1146, DOI 10.1002/cam4.314; Woo KJ, 2004, BIOCHEM BIOPH RES CO, V325, P1215, DOI 10.1016/j.bbrc.2004.09.225; Xia JJ, 2010, J INT MED RES, V38, P1294, DOI 10.1177/147323001003800411; Xiao D, 2006, NUTR CANCER, V55, P94, DOI 10.1207/s15327914nc5501_12; Xiaonan W, 2011, J CANC THER, P2011; Xie Rong-Hui, 2014, Zhong Yao Cai, V37, P465; Xiong NA, 2010, BIOL BLOOD MARROW TR, V16, P1519, DOI 10.1016/j.bbmt.2010.06.004; Xu H, 2013, INFLAMMATION, V36, P216, DOI 10.1007/s10753-012-9537-3; Yabroff K. Robin, 2013, Journal of the National Cancer Institute Monographs, P62, DOI 10.1093/jncimonographs/lgt001; Yadav VR, 2012, BRIT J PHARMACOL, V165, P741, DOI 10.1111/j.1476-5381.2011.01603.x; Yang Y, 2014, FOOD CHEM TOXICOL, V74, P14, DOI 10.1016/j.fct.2014.08.013; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321; Yoshimitsu T, 2009, ORG LETT, V11, P3402, DOI 10.1021/ol9012684; YuJun H, 2009, CHINESE J DIGESTIVE, V8, P294; Zeller J, 2013, BIOORG MED CHEM LETT, V23, P5814, DOI 10.1016/j.bmcl.2013.08.111; Zhang XD, 2004, MOL CANCER THER, V3, P187; ZHAO S, 2010, B ACAD MILITARY MED, V5	207	12	12	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124244	10.1371/journal.pone.0124244	http://dx.doi.org/10.1371/journal.pone.0124244			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910265	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800070
J	Dhanaraj, B; Papanna, MK; Adinarayanan, S; Vedachalam, C; Sundaram, V; Shanmugam, S; Sekar, G; Menon, PA; Wares, F; Swaminathan, S				Dhanaraj, Baskaran; Papanna, Mohan Kumar; Adinarayanan, Srividya; Vedachalam, Chandrasekaran; Sundaram, Vijayaraj; Shanmugam, Shivakumar; Sekar, Gomathi; Menon, Pradeep Aravindan; Wares, Fraser; Swaminathan, Soumya			Prevalence and Risk Factors for Adult Pulmonary Tuberculosis in a Metropolitan City of South India	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DOTS PROGRAM; COMMUNITY	Background The present study measured the community prevalence and risk factors of adult pulmonary tuberculosis (PTB) in Chennai city, and also studied geographical distribution and the presence of different M. tuberculosis strains in the survey area. Methods A community-based cross sectional survey was carried out from July 2010 to October 2012 in Chennai city. Prevalence of bacteriologically positive PTB was estimated by direct standardization method. Univariate and multivariate analyses were carried out to identify significant risk factors. Drug susceptibility testing and spoligotyping was performed on isolated M. tuberculosis strains. Mapping of PTB cases was done using geographic positioning systems. Results Of 59,957 eligible people, 55,617 were screened by X-ray and/or TB symptoms and the prevalence of smear, culture, and bacteriologically positive PTB was estimated to be 228 (95% CI 189-265), 259 (95% CI 217-299) and 349 (95% CI 330-428) per 100,000 population, respectively. Prevalence of smear, culture, and bacteriologically positive PTB was highest amongst men aged 55-64 years. Multivariate analysis showed that occurrence of both culture and bacteriologically positive PTB disease was significantly associated with: age >35 years, past history of TB treatment, BMI <18.5 Kgs/m(2), solid cooking fuel, and being a male currently consuming alcohol. The most frequent spoligotype family was East African Indian. Spatial distribution showed that a high proportion of patients were clustered in the densely populated north eastern part of the city. Conclusion Our findings demonstrate that TB is a major public health problem in this urban area of south India, and support the use of intensified case finding in high risk groups. Undernutrition, slum dwelling, indoor air pollution and alcohol intake are modifiable risk factors for TB disease.	[Dhanaraj, Baskaran; Adinarayanan, Srividya; Vedachalam, Chandrasekaran; Sundaram, Vijayaraj; Shanmugam, Shivakumar; Sekar, Gomathi; Menon, Pradeep Aravindan; Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Papanna, Mohan Kumar] Natl Ctr Dis Control, India EIS Programme, New Delhi, India; [Wares, Fraser] World Hlth Org, Global TB Programme, Geneva, Switzerland	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Centre for Disease Control (NCDC); World Health Organization	Swaminathan, S (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	doctorsoumya@yahoo.com			United States Agency for International Development (USAID) under Model DOTS Project [MDP TSA-2010/103409]; Indian Council of Medical Research	United States Agency for International Development (USAID) under Model DOTS Project(United States Agency for International Development (USAID)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The analysis and presentation of the data was supported in part by the World Health Organization, with financial assistance provided by the United States Agency for International Development (USAID), under the Model DOTS Project (Grant no: MDP TSA-2010/103409). Additional funding was provided by the Indian Council of Medical Research.	ADELSTEIN A. M., 1967, Tubercle, V48, P219, DOI 10.1016/S0041-3879(67)80026-6; Azhar GS, 2012, LUNG INDIA, V29, P147, DOI 10.4103/0970-2113.95320; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Central TB Division Ministry of Health & Family Welfare, 2013, GOVT IND REV TB CONT; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Chandramouli C, 2003, 3 INT C ENV HLTH CHE; Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Government of India, 2013, PRIM CENS ABSTR SLUM; Gupta K.A., 2010, J GEOGRAPHY REGIONAL, V3, P365; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; ICMR, TUB IND SAMPL SURV 1, P1; Jacobson JM, 1992, ALCOHOL HEALTH RES W, V16, P39; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kan XH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-498; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; Kolappan C, 2013, Indian J Tuberc, V60, P168; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Rajapaksa US, 2008, T ROY SOC TROP MED H, V102, P997, DOI 10.1016/j.trstmh.2008.04.025; Rao VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043225; Shanmugam S, 2011, INFECT GENET EVOL, V11, P980, DOI 10.1016/j.meegid.2011.03.011; Shetty N, 2006, INT J TUBERC LUNG D, V10, P80; Shprykov A S, 1994, Probl Tuberk, P26; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Sopori ML, 1998, ADV EXP MED BIOL, V437, P279; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; World Health Organization, 2011, TUB PREV SURV HDB LI; YU GP, 1988, TUBERCLE, V69, P105, DOI 10.1016/0041-3879(88)90072-4	34	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124260	10.1371/journal.pone.0124260	http://dx.doi.org/10.1371/journal.pone.0124260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905900	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000062
J	Lin, JC; Wang, CC; Jiang, RS; Wang, WY; Liu, SA				Lin, Jin-Ching; Wang, Chen-Chi; Jiang, Rong-San; Wang, Wen-Yi; Liu, Shih-An			Impact of Somatic Mutations in the D-Loop of Mitochondrial DNA on the Survival of Oral Squamous Cell Carcinoma Patients	PLoS One			English	Article							CANCER; BETEL; NECK; HEAD; POLYMORPHISMS; TUMORS	Objectives The aim of this study was to investigate somatic mutations in the D-loop of mitochondrial DNA (mtDNA) and their impact on survival in oral squamous cell carcinoma patients. Materials and Methods Surgical specimen confirmed by pathological examination and corresponding non-cancerous tissues were collected from 120 oral squamous cell carcinoma patients. The sequence in the D-loop of mtDNA from non-cancerous tissues was compared with that from paired cancer samples and any sequence differences were recognized as somatic mutations. Results Somatic mutations in the D-loop of mtDNA were identified in 75 (62.5%) oral squamous cell carcinoma patients and most of them occurred in the poly-C tract. Although there were no significant differences in demographic and tumor-related features between participants with and without somatic mutation, the mutation group had a better survival rate (5 year disease-specific survival rate: 64.0% vs. 43.0%, P = 0.0266). Conclusion Somatic mutation in D-loop of mtDNA was associated with a better survival in oral squamous cell carcinoma patients.	[Lin, Jin-Ching] Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Wang, Chen-Chi; Jiang, Rong-San; Liu, Shih-An] Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan; [Lin, Jin-Ching; Wang, Chen-Chi; Liu, Shih-An] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Wang, Wen-Yi] Hung Kuang Univ, Dept Nursing, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Hungkuang University	Liu, SA (corresponding author), Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan.	an1654@seed.net.tw			National Science Council [NSC 98-2314-B-075A-005-MY3]; Ministry of Health and Welfare, Taiwan, Republic of China [MOHW103-TD-B-111-10]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare, Taiwan, Republic of China	This study was supported by grants from the National Science Council, (NSC 98-2314-B-075A-005-MY3) and the Ministry of Health and Welfare, (MOHW103-TD-B-111-10), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Challen C, 2011, BRIT J CANCER, V104, P1319, DOI 10.1038/bjc.2011.96; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Ha PK, 2002, CLIN CANCER RES, V8, P2260; Hsu SH, 2013, HEAD NECK-J SCI SPEC, V35, P1801, DOI 10.1002/hed.23242; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065578; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lee HC, 2001, MUTAT RES-GEN TOX EN, V493, P67, DOI 10.1016/S1383-5718(01)00160-7; Lievre A, 2006, BRIT J CANCER, V94, P692, DOI 10.1038/sj.bjc.6602993; Liu SA, 2012, EUR ARCH OTO-RHINO-L, V269, P1665, DOI 10.1007/s00405-011-1806-5; Mambo E, 2003, P NATL ACAD SCI USA, V100, P1838, DOI 10.1073/pnas.0437910100; Mondal R, 2013, ORAL ONCOL, V49, P345, DOI 10.1016/j.oraloncology.2012.11.003; Pai CY, 2006, FORENSIC SCI INT, V156, P124, DOI 10.1016/j.forsciint.2004.12.021; Pande P, 2002, ORAL ONCOL, V38, P491, DOI 10.1016/S1368-8375(01)00090-2; Prior SL, 2006, CARCINOGENESIS, V27, P945, DOI 10.1093/carcin/bgi326; Tan DJ, 2004, ANN NY ACAD SCI, V1011, P310, DOI 10.1196/annals.1293.030; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Uzawa K, 2012, ONCOTARGET, V3, P670; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yin PH, 2010, MITOCHONDRION, V10, P174, DOI 10.1016/j.mito.2009.12.147; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-155; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124322	10.1371/journal.pone.0124322	http://dx.doi.org/10.1371/journal.pone.0124322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906372	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000066
J	Talukder, AK; Ravishankar, S; Sasmal, K; Gandham, S; Prabhukumar, J; Achutharao, PH; Barh, D; Blasi, F				Talukder, Asoke K.; Ravishankar, Shashidhar; Sasmal, Krittika; Gandham, Santhosh; Prabhukumar, Jyothsna; Achutharao, Prahalad H.; Barh, Debmalya; Blasi, Francesco			XomAnnotate: Analysis of Heterogeneous and Complex Exome-A Step towards Translational Medicine	PLOS ONE			English	Article							COPY-NUMBER VARIATION; BREAST-CANCER; GENE-EXPRESSION; CELL-ADHESION; PATHWAYS; GENOME; ENRICHMENT; DISCOVERY; FRAMEWORK; SURVIVAL	In translational cancer medicine, implicated pathways and the relevant master genes are of focus. Exome's specificity, processing-time, and cost advantage makes it a compelling tool for this purpose. However, analysis of exome lacks reliable combinatory analysis tools and techniques. In this paper we present XomAnnotate -a meta-and functional-analysis software for exome. We compared UnifiedGenotyper, Freebayes, Delly, and Lumpy algorithms that were designed for whole-genome and combined their strengths in XomAnnotate for exome data through meta-analysis to identify comprehensive mutation profile (SNPs/SNVs, short inserts/deletes, and SVs) of patients. The mutation profile is annotated followed by functional analysis through pathway enrichment and network analysis to identify most critical genes and pathways implicated in the disease genesis. The efficacy of the software is verified through MDS and clustering and tested with available 11 familial nonBRCA1/ BRCA2 breast cancer exome data. The results showed that the most significantly affected pathways across all samples are cell communication and antigen processing and presentation. ESCO1, HYAL1, RAF1 and PRKCA emerged as the key genes. Network analysis further showed the purine and propanotate metabolism pathways along with RAF1 and PRKCA genes to be master regulators in these patients. Therefore, XomAnnotate is able to use exome data to identify entire mutation landscape, pathways, and the master genes accurately with wide concordance from earlier microarray and wholegenome studies -making it a suitable biomedical software for using exome in nextgeneration translational medicine.	[Talukder, Asoke K.; Ravishankar, Shashidhar; Sasmal, Krittika; Gandham, Santhosh; Prabhukumar, Jyothsna; Achutharao, Prahalad H.; Barh, Debmalya] InterpretOmics India Pvt Ltd, Bangalore 560008, Karnataka, India; [Barh, Debmalya] Inst Integrat Om & Appl Biotechnol, Ctr Genom & Appl Gene Technol, Purba Medinipur 721172, W Bengal, India; [Blasi, Francesco] IFOM Fdn Ist FIRC Oncol Mol, Lab Transcript Regulat Dev & Canc, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology	Talukder, AK (corresponding author), InterpretOmics India Pvt Ltd, 329,7th Main,HAL 2nd Stage, Bangalore 560008, Karnataka, India.	asoke.talukder@interpretomics.co	Barh, Debmalya/O-4246-2015; Ravishankar, Shashidhar/AAL-2036-2021	Barh, Debmalya/0000-0002-2557-7768; Blasi, Francesco/0000-0001-9406-1784	InterpretOmics, Pvt. Ltd.	InterpretOmics, Pvt. Ltd.	The project was funded by InterpretOmics, Pvt. Ltd. The funder provided support in the form of salaries for authors AKT, SR, KS, SG, JP, PHA, DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Backenroth D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku345; Cartegni L, 2009, NAT REV GENET, V220, P538; Chen Yidong, 2005, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0711s10; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; D'Antonio M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S11; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Emery LA, 2009, AM J PATHOL, V175, P1292, DOI 10.2353/ajpath.2009.090115; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; FISHER JC, 1951, CANCER, V4, P916, DOI 10.1002/1097-0142(195109)4:5<916::AID-CNCR2820040504>3.0.CO;2-7; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Garrison E., 2012, PREPRINT; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Gonzalez-Angulo AM, 2012, CLIN CANCER RES, V18, P1109, DOI 10.1158/1078-0432.CCR-11-2762; Gu ZG, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-56; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Hou JP, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0056-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Gracia-Aznarez FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055681; Jones ME, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3206; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latapy M, 2008, SOC NETWORKS, V30, P31, DOI 10.1016/j.socnet.2007.04.006; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Leontovich AA, 2012, INT J ONCOL, V40, P1858, DOI 10.3892/ijo.2012.1407; Li JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095217; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu Y, 2012, CANCER IMMUNOL IMMUN, V61, P789, DOI 10.1007/s00262-011-1137-9; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Luedeke M, 2009, CANCER EPIDEM BIOMAR, V18, P3030, DOI 10.1158/1055-9965.EPI-09-0772; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; Mardinoglu A, 2012, J INTERN MED, V271, P142, DOI 10.1111/j.1365-2796.2011.02493.x; McCormick F, 2004, NATURE, V428, P267, DOI 10.1038/428267a; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Newman MEJ, 2000, CONDMAT0011144 ARXIV; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Price JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063313; R Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUR0IMAGE.2011.01.013]; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Robins G., 2004, Computational & Mathematical Organization Theory, V10, P69, DOI 10.1023/B:CMOT.0000032580.12184.c0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Schramm G, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-39; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Sindi SS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r22; Singh-Blom UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058977; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; TABIBZADEH SS, 1990, J CLIN ENDOCR METAB, V71, P740, DOI 10.1210/jcem-71-3-740; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tan JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022836; Viola T, 2011, CELL MOL LIFE SCI, V68, P1131, DOI 10.1007/s00018-010-0600-7; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Yan Q, 2013, TRANSL MED, V3, pe120, DOI [10.4172/2161-1025.1000e120, DOI 10.4172/2161-1025.1000E120]	68	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123569	10.1371/journal.pone.0123569	http://dx.doi.org/10.1371/journal.pone.0123569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905921	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000035
J	Lee, J; Taylor, SEB; Smeriglio, P; Lai, J; Maloney, WJ; Yang, F; Bhutani, N				Lee, Jieun; Taylor, Sarah E. B.; Smeriglio, Piera; Lai, Janice; Maloney, William J.; Yang, Fan; Bhutani, Nidhi			Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells	FASEB JOURNAL			English	Article						hiPSC-derived chondrocytes; prechondrogenic population; cartilage regeneration	CARTILAGE; FIBROBLASTS; SOX9; DIFFERENTIATION; EXPRESSION; SPECIFICATION; BONE	Regeneration of human cartilage is inherently inefficient; an abundant autologous source, such as human induced pluripotent stem cells (hiPSCs), is therefore attractive for engineering cartilage. We report a growth factor-based protocol for differentiating hiPSCs into articular-like chondrocytes (hiChondrocytes) within 2weeks, with an overall efficiency >90%. The hiChondrocytes are stable and comparable to adult articular chondrocytes in global gene expression, extracellular matrix production, and ability to generate cartilage tissue in vitro and in immune-deficient mice. Molecular characterization identified an early SRY (sex-determining region Y) box (Sox)9(low) cluster of differentiation (CD)44(low)CD140(low) prechondrogenic population during hiPSC differentiation. In addition, 2 distinct Sox9-regulated gene networks were identified in the Sox9(low) and Sox9(high) populations providing novel molecular insights into chondrogenic fate commitment and differentiation. Our findings present a favorable method for generating hiPSC-derived articular-like chondrocytes. The hiChondrocytes are an attractive cell source for cartilage engineering because of their abundance, autologous nature, and potential to generate articular-like cartilage rather than fibrocartilage. In addition, hiChondrocytes can be excellent tools for modeling human musculoskeletal diseases in a dish and for rapid drug screening.	[Lee, Jieun; Taylor, Sarah E. B.; Smeriglio, Piera; Lai, Janice; Maloney, William J.; Yang, Fan; Bhutani, Nidhi] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA USA; [Lai, Janice] Stanford Univ, Sch Med, Dept Mech Engn, Stanford, CA USA; [Yang, Fan] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Bhutani, N (corresponding author), 300 Pasteur Dr,Edwards Bldg,R164, Stanford, CA 94305 USA.	nbhutani@stanford.edu	Yang, Fan/GYU-4249-2022; Smeriglio, Piera/AAK-9870-2021	Smeriglio, Piera/0000-0002-3430-6839	U.S. National Institutes of Health S10 Shared Instrument Grant [S10RR027431-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027431] Funding Source: NIH RePORTER	U.S. National Institutes of Health S10 Shared Instrument Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank Prof. John P. Cooke (Methodist Hospital Research Institute), Profs. Renee Reijo Pera (Montana State University), and Drs. Vittorio Sebastiano (Stanford University) and Arwen Hunter (Stem Cell Technologies) for help with hiPSC generation and Natalia Kosovilka (Stanford University School of Medicine Protein and Nucleic Acid Facility) for running the microarrays. FACS data were performed on an instrument in the shared FACS facility obtained using U.S. National Institutes of Health S10 Shared Instrument Grant S10RR027431-01. No financial support or other benefits have been obtained from any commercial sources for this study. The authors declare no conflicts of interest.	Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Lai JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep03553; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lohmander LS, 2007, LANCET, V370, P2082, DOI 10.1016/S0140-6736(07)61879-0; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Pelttari K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009688; Smeriglio P, 2015, TISSUE ENG PT A, V21, P147, DOI [10.1089/ten.tea.2014.0070, 10.1089/ten.TEA.2014.0070]; Stoddart MJ, 2009, REGEN MED, V4, P81, DOI 10.2217/17460751.4.1.81; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor SEB, 2014, ARTHRITIS RHEUMATOL, V66, P90, DOI 10.1002/art.38200; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200	36	32	34	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3399	3410		10.1096/fj.14-269720	http://dx.doi.org/10.1096/fj.14-269720			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25911615	Green Published			2022-12-26	WOS:000358796900027
J	van den Biggelaar, M; Madsen, JJ; Faber, JH; Zuurveld, MG; van der Zwaan, C; Olsen, OH; Stennicke, HR; Mertens, K; Meijer, AB				van den Biggelaar, Maartje; Madsen, Jesper J.; Faber, Johan H.; Zuurveld, Marleen G.; van der Zwaan, Carmen; Olsen, Ole H.; Stennicke, Henning R.; Mertens, Koen; Meijer, Alexander B.			Factor VIII Interacts with the Endocytic Receptor Low-density Lipoprotein Receptor-related Protein 1 via an Extended Surface Comprising "Hot-Spot" Lysine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; PLASMINOGEN-ACTIVATOR INHIBITOR-1; VON-WILLEBRAND-FACTOR; CARBOXYL-TERMINAL DOMAIN; ALPHA-2-MACROGLOBULIN RECEPTOR; BINDING-SITE; C1 DOMAIN; PROTEIN/ALPHA(2)-MACROGLOBULIN RECEPTOR; LIGAND RECOGNITION; MASS-SPECTROMETRY	Lysine residues are implicated in driving the ligand binding to the LDL receptor family. However, it has remained unclear how specificity is regulated. Using coagulation factor VIII as a model ligand, we now study the contribution of individual lysine residues in the interaction with the largest member of the LDL receptor family, low-density lipoprotein receptor-related protein (LRP1). Using hydrogen-deuterium exchange mass spectrometry (HDX-MS) and SPR interaction analysis on a library of lysine replacement variants as two independent approaches, we demonstrate that the interaction between factor VIII (FVIII) and LRP1 occurs over an extended surface containing multiple lysine residues. None of the individual lysine residues account completely for LRP1 binding, suggesting an additive binding model. Together with structural docking studies, our data suggest that FVIII interacts with LRP1 via an extended surface of multiple lysine residues that starts at the bottom of the C1 domain and winds around the FVIII molecule.	[van den Biggelaar, Maartje; Zuurveld, Marleen G.; van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.] Sanquin Blood Supply Fdn, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Madsen, Jesper J.; Faber, Johan H.; Olsen, Ole H.; Stennicke, Henning R.] Novo Nordisk AS, Global Res, DK-2760 Malov, Denmark; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TC Utrecht, Netherlands	Novo Nordisk; Utrecht University	van den Biggelaar, M (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	m.vandenbiggelaar@sanquin.nl	Madsen, Jesper Jonasson/AAU-5858-2020; Madsen, Jesper J/E-7233-2015	Madsen, Jesper Jonasson/0000-0003-1411-9080; Madsen, Jesper J/0000-0003-1411-9080				Andersen MD, 2011, INT J MASS SPECTROM, V302, P139, DOI 10.1016/j.ijms.2010.09.010; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Bloem E, 2013, J BIOL CHEM, V288, P29670, DOI 10.1074/jbc.M113.473116; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Ebina T, 2009, BIOPOLYMERS, V92, P1, DOI 10.1002/bip.21105; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fribourg C, 2006, BIOCHEMISTRY-US, V45, P10777, DOI 10.1021/bi060451h; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Gilbert GE, 2012, BLOOD, V120, P1923, DOI 10.1182/blood-2012-01-408245; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; LEYTE A, 1989, BIOCHEM J, V263, P187, DOI 10.1042/bj2630187; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; Svensson LA, 2013, BIOL CHEM, V394, P761, DOI 10.1515/hsz-2012-0298; Thim L, 2010, HAEMOPHILIA, V16, P349, DOI 10.1111/j.1365-2516.2009.02135.x; Van den Biggelaar M, 2007, J THROMB HAEMOST, V5, P2235, DOI 10.1111/j.1538-7836.2007.02737.x; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van Helden PMW, 2008, BRIT J HAEMATOL, V142, P644, DOI 10.1111/j.1365-2141.2008.07232.x; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Zaiou M, 2000, J LIPID RES, V41, P1087	52	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16463	16476		10.1074/jbc.M115.650911	http://dx.doi.org/10.1074/jbc.M115.650911			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25903134	Green Published, hybrid			2022-12-26	WOS:000357572800001
J	Liu, FG; Geng, JF; Gumpper, RH; Barman, A; Davis, I; Ozarowski, A; Hamelberg, D; Liu, AM				Liu, Fange; Geng, Jiafeng; Gumpper, Ryan H.; Barman, Arghya; Davis, Ian; Ozarowski, Andrew; Hamelberg, Donald; Liu, Aimin			An Iron Reservoir to the Catalytic Metal: THE RUBREDOXIN IRON IN AN EXTRADIOL DIOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computation; dioxygenase; iron-sulfur protein; metabolism; tryptophan; iron reservoir; kynurenine	DESULFOVIBRIO-VULGARIS; SACCHAROMYCES-CEREVISIAE; DECARBOXYLASE ACMSD; CRYSTAL-STRUCTURES; ELECTRON-TRANSFER; STRUCTURAL BASIS; PROTEIN; 3-HYDROXYANTHRANILATE; ACID; PURIFICATION	Background: An accessory [Fe(Cys)(4)] center of unknown function is present in 3-hydroxyanthranilate 3,4-dioxygenase. Results: An intermolecular iron shuttling from the [Fe(Cys)(4)] site to the catalytic site is observed. Conclusion: The rubredoxin-like domain is an iron reservoir for the catalytic site when the catalytic metal becomes stripped during metabolic events. Significance: An iron shuttling mechanism is proposed for the iron-sulfur center. The rubredoxin motif is present in over 74,000 protein sequences and 2,000 structures, but few have known functions. A secondary, non-catalytic, rubredoxin-like iron site is conserved in 3-hydroxyanthranilate 3,4-dioxygenase (HAO), from single cellular sources but not multicellular sources. Through the population of the two metal binding sites with various metals in bacterial HAO, the structural and functional relationship of the rubredoxin-like site was investigated using kinetic, spectroscopic, crystallographic, and computational approaches. It is shown that the first metal presented preferentially binds to the catalytic site rather than the rubredoxin-like site, which selectively binds iron when the catalytic site is occupied. Furthermore, an iron ion bound to the rubredoxin-like site is readily delivered to an empty catalytic site of metal-free HAO via an intermolecular transfer mechanism. Through the use of metal analysis and catalytic activity measurements, we show that a downstream metabolic intermediate can selectively remove the catalytic iron. As the prokaryotic HAO is often crucial for cell survival, there is a need for ensuring its activity. These results suggest that the rubredoxin-like site is a possible auxiliary iron source to the catalytic center when it is lost during catalysis in a pathway with metabolic intermediates of metal-chelating properties. A spare tire concept is proposed based on this biochemical study, and this concept opens up a potentially new functional paradigm for iron-sulfur centers in iron-dependent enzymes as transient iron binding and shuttling sites to ensure full metal loading of the catalytic site.	[Liu, Fange; Geng, Jiafeng; Gumpper, Ryan H.; Barman, Arghya; Davis, Ian; Hamelberg, Donald; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Liu, Fange; Hamelberg, Donald; Liu, Aimin] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Geng, Jiafeng; Davis, Ian; Hamelberg, Donald; Liu, Aimin] Georgia State Univ, Mol Basis Dis Program, Atlanta, GA 30303 USA; [Ozarowski, Andrew] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; State University System of Florida; Florida State University	Liu, AM (corresponding author), Georgia State Univ, 50 Decatur St SE, Atlanta, GA 30303 USA.	Feradical@gsu.edu	Liu, Aimin/C-1572-2017; Geng, Jiafeng/G-4948-2015	Liu, Aimin/0000-0002-4182-8176; Geng, Jiafeng/0000-0001-9488-0974; Davis, Ian/0000-0002-1566-4972; Liu, Fange/0000-0002-3235-9996	NSF [DMR-1157490]; State of Florida; DOE; User Collaboration Grants Program Award [5064 (2007)]; DOE, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Direct For Biological Sciences [0953061] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); State of Florida; DOE(United States Department of Energy (DOE)); User Collaboration Grants Program Award; DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mossbauer spectroscopy data were collected at the National High Magnetic Field Laboratory, which is funded by the NSF through the Cooperative Agreement No. DMR-1157490, the State of Florida, and the DOE. The Mossbauer spectrometer was funded by the User Collaboration Grants Program Award 5064 (2007) (to A. O.). X-ray diffraction data were collected at the South-east Regional Collaborative Access Team (SER-CAT) 22-ID beamline with the Advanced Photon Source at the Argonne National Laboratory. The use of the Advanced Photon Source was supported by DOE, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; ARCHER M, 1995, J MOL BIOL, V251, P690, DOI 10.1006/jmbi.1995.0465; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cerutti DS, 2009, J CHEM THEORY COMPUT, V5, P2322, DOI 10.1021/ct9001015; Chakraborty S, 2008, BIOSCI BIOTECH BIOCH, V72, P735, DOI 10.1271/bbb.70606; Coelho AV, 1997, J BIOL INORG CHEM, V2, P680, DOI 10.1007/s007750050184; Colabroy KL, 2005, BIOCHEMISTRY-US, V44, P7623, DOI 10.1021/bi0473455; Coulter ED, 2001, ARCH BIOCHEM BIOPHYS, V394, P76, DOI 10.1006/abbi.2001.2531; Dilovic I, 2009, BIOPOLYMERS, V91, P1189, DOI 10.1002/bip.21167; Dong M, 2014, J AM CHEM SOC, V136, P1754, DOI 10.1021/ja4118957; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G. W, 1982, LIFE CHEM REPORTS, V1, P57; Farnaud S, 2008, BIOCHEM J, V413, P553, DOI 10.1042/BJ20080406; Franco R., 1999, IRON METABOLISM INOR, P341; Gil M, 2013, FREE RADICAL BIO MED, V65, P150, DOI 10.1016/j.freeradbiomed.2013.06.021; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huo L, 2015, PROTEINS, V83, P178, DOI 10.1002/prot.24722; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; ICHIYAMA A, 1965, J BIOL CHEM, V240, P740; Iyer RB, 2005, J BIOL INORG CHEM, V10, P407, DOI 10.1007/s00775-005-0650-8; Jin S, 2002, J AM CHEM SOC, V124, P9845, DOI 10.1021/ja026587u; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; Kawasaki S, 2007, FEBS LETT, V581, P2460, DOI 10.1016/j.febslet.2007.04.050; Kim C, 2001, J BACTERIOL, V183, P4866, DOI 10.1128/JB.183.16.4866-4875.2001; KOONTZ WA, 1976, J BIOL CHEM, V251, P368; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lambert AR, 2008, STRUCTURE, V16, P558, DOI 10.1016/j.str.2008.01.017; Larini L, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2464095; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; LESUISSE E, 1992, J GEN MICROBIOL, V138, P85, DOI 10.1099/00221287-138-1-85; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Li X, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-4; Logan DT, 2003, P NATL ACAD SCI USA, V100, P3826, DOI 10.1073/pnas.0736456100; LOVENBERG W, 1965, P NATL ACAD SCI USA, V54, P193, DOI 10.1073/pnas.54.1.193; Luke I, 2008, ARCH MICROBIOL, V190, P685, DOI 10.1007/s00203-008-0420-4; MIKOGAMI T, 1995, BIOCHEM J, V308, P391, DOI 10.1042/bj3080391; Minakata K, 2011, J CLIN BIOCHEM NUTR, V49, P207, DOI 10.3164/jcbn.11-16; MOURA I, 1990, J BIOL CHEM, V265, P21596; Mukhopadhyay A, 2011, J BIOL INORG CHEM, V16, P51, DOI 10.1007/s00775-010-0700-8; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; Nicolaes V, 2014, J BACTERIOL, V196, P300, DOI 10.1128/JB.00921-13; OGASAWARA N, 1966, J BIOL CHEM, V241, P613; ORMEJOHN.WH, 1973, ANNU REV BIOCHEM, V42, P159, DOI 10.1146/annurev.bi.42.070173.001111; Ozarowski A, 2003, J AM CHEM SOC, V125, P12606, DOI 10.1021/ja030221f; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Sheldon RA, 1998, ACCOUNTS CHEM RES, V31, P485, DOI 10.1021/ar9700163; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; Sun JP, 2005, BIOCHEMISTRY-US, V44, P8801, DOI 10.1021/bi0504714; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thakur A, 2012, J BIOL CHEM, V287, P13194, DOI 10.1074/jbc.M112.339655; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; WATENPAUGH KD, 1980, J MOL BIOL, V138, P615, DOI 10.1016/S0022-2836(80)80020-9; Zhang Y, 2005, BIOCHEMISTRY-US, V44, P7632, DOI 10.1021/bi047353l	67	8	8	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15621	15634		10.1074/jbc.M115.650259	http://dx.doi.org/10.1074/jbc.M115.650259			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25918158	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000356527400026
J	Barrera-Moreno, OA; Ciros-Perez, J; Ortega-Mayagoitia, E; Alcantara-Rodriguez, JA; Piedra-Ibarra, E				Alfredo Barrera-Moreno, Omar; Ciros-Perez, Jorge; Ortega-Mayagoitia, Elizabeth; Arturo Alcantara-Rodriguez, Jose; Piedra-Ibarra, Elias			From Local Adaptation to Ecological Speciation in Copepod Populations from Neighboring Lakes	PLOS ONE			English	Article							FRESH-WATER; REPRODUCTIVE ISOLATION; SALINITY TOLERANCE; GENETIC-STRUCTURE; CRATER LAKES; WALKER LAKE; EVOLUTION; DIVERGENCE; DNA; SYSTEMATICS	Continental copepods have been derived from several independent invasive events from the sea, but the subsequent evolutionary processes that account for the current diversity in lacustrine environments are virtually unknown. Salinity is highly variable among lakes and constitutes a source of divergent selection driving potential reproductive isolation. We studied four populations of the calanoid copepod Leptodiaptomus cf. sicilis inhabiting four neighboring lakes with a common history (since the Late Pleistocene) located in the Oriental Basin, Mexico; one lake is shallow and varies in salinity periodically (1.4-10 g L-1), while three are deep and permanent, with constant salinity (0.5, 1.1 and 6.5 g L-1, respectively). We hypothesized that (1) these populations belong to a different species than L. sicilis sensu stricto and (2) are experiencing ecologically based divergence due to salinity differences. We assessed morphological and molecular (mtDNA) COI variation, as well as fitness differences and tests of reproductive isolation. Although relationships of the Mexican populations with L. sicilis s.s. could not be elucidated, we identified a clear pattern of divergent selection driven by salinity conditions. The four populations can still be considered a single biological species (sexual recognition and hybridization are still possible in laboratory conditions), but they have diverged into at least three different phenotypes: two locally adapted, specialized in the lakes of constant salinity (saline vs. freshwater), and an intermediate generalist phenotype inhabiting the temporary lake with fluctuating salinity. The specialized phenotypes are poorly suited as migrants, so prezygotic isolation due to immigrant inviability is highly probable. This implication was supported by molecular evidence that showed restricted gene flow, persistence of founder events, and a pattern of allopatric fragmentation. This study showed how ecologically based divergent selection may explain diversification patterns in lacustrine copepods.	[Alfredo Barrera-Moreno, Omar] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Programa Doctorado Ciencias Mar & Limnol, Tlalnepantla, Estado De Mexic, Mexico; [Ciros-Perez, Jorge; Ortega-Mayagoitia, Elizabeth] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Proyecto Invest Limnol Trop, Tlalnepantla, Estado De Mexic, Mexico; [Arturo Alcantara-Rodriguez, Jose] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Programa Doctorado Ciencias Biol, Tlalnepantla, Estado De Mexic, Mexico; [Piedra-Ibarra, Elias] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, UBIPRO, Lab Fisiol Vegetal, Tlalnepantla, Estado De Mexic, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ciros-Perez, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Proyecto Invest Limnol Trop, Tlalnepantla, Estado De Mexic, Mexico.	jorge.ciros@gmail.com	Ciros, Jorge/G-5958-2018; Ortega-Mayagoitia, Elizabeth/AAF-8441-2020; Alcántara, Arturo/AAZ-6228-2020	Ciros, Jorge/0000-0002-4292-7539; Ortega-Mayagoitia, Elizabeth/0000-0002-8892-1888; Alcantara-Rodriguez, Jose Arturo/0000-0002-2536-4615	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [PAPIIT IN-222709, IN-217513]; Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion - FES Iztacala, UNAM (PAPCA); Consejo Nacional de Ciencia y Tecnologia (CONACYT)	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico; Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion - FES Iztacala, UNAM (PAPCA)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (PAPIIT IN-222709 and IN-217513; http://dgapa.unam.mx/html/papiit/papit.html) to JCP and EOM, Programa de Apoyo a los Profesores de Carrera para la Formacion de Grupos de Investigacion - FES Iztacala, UNAM (PAPCA 2007-2008; http://www.iztacala.unam.mx/spcc/spcc_papca.php) to EOM and JCP. OABM thanks the scholarship granted by Consejo Nacional de Ciencia y Tecnologia (CONACYT; http://www.conacyt.mx/) to support his PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2007, BIOL J LINN SOC, V90, P279, DOI 10.1111/j.1095-8312.2007.00723.x; Alcocer J., 1999, Aquatic Ecosystem Health & Management, V1, P291, DOI 10.1080/14634989808656925; Alcocer J, 2014, J LIMNOL, V73, P223, DOI 10.4081/jlimnol.2014.783; Aliberti M. A., 2013, IMAGE BASED KEY ZOOP; Andersen R. A., 2005, ALGAL CULTURING TECH; Gutierrez-Aguirre MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085019; Armienta MA, 2008, J VOLCANOL GEOTH RES, V178, P249, DOI 10.1016/j.jvolgeores.2008.06.019; Alcantara-Rodriguez JA, 2012, FRESHWATER BIOL, V57, P728, DOI 10.1111/j.1365-2427.2012.02738.x; Balcer M. D., 1984, ZOOPLANKTON GREAT LA; Berdan EL, 2012, J ZOOL, V287, P283, DOI 10.1111/j.1469-7998.2012.00914.x; Beutel MW, 2001, HYDROBIOLOGIA, V466, P91, DOI 10.1023/A:1014569521381; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Bloom DD, 2009, COPEIA, P408, DOI 10.1643/CI-07-151; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Boxshall GA, 2000, ADV ECOL RES, V31, P61, DOI 10.1016/S0065-2504(00)31007-8; Boxshall GA, 2008, HYDROBIOLOGIA, V595, P195, DOI 10.1007/s10750-007-9014-4; BYRON ER, 1982, ECOLOGY, V63, P1871, DOI 10.2307/1940127; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Carrasco-Nunez G, 2007, J VOLCANOL GEOTH RES, V159, P179, DOI 10.1016/j.jvolgeores.2006.07.001; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohuo-Duran S, 2014, REV BIOL TROP, V62, P15, DOI 10.15517/rbt.v62i1.11796; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conner J. K., 2004, PRIMER ECOLOGICAL GE; COOPER JJ, 1984, HYDROBIOLOGIA, V118, P275, DOI 10.1007/BF00046625; De los Rios-Escalanta Patricio, 2011, International Journal of Aquatic Science, V2, P80; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DeClerck S, 2001, FRESHWATER BIOL, V46, P187, DOI 10.1046/j.1365-2427.2001.00632.x; Derry AM, 2003, LIMNOL OCEANOGR, V48, P675, DOI 10.4319/lo.2003.48.2.0675; DEXTER DM, 1993, HYDROBIOLOGIA, V267, P203, DOI 10.1007/BF00018802; Dobzhansky T., 1935, PHILOS SCI, V2, P344, DOI DOI 10.1086/286379; Dussart BH, 2001, INTRO COPEPODA; Dytham C., 2011, CHOOSING USING STAT; Elias-Gutierrez M, 1999, J PLANKTON RES, V21, P603, DOI 10.1093/plankt/21.4.603; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Escobar-Briones E, 2002, HYDROBIOLOGIA, V477, P93, DOI 10.1023/A:1021013132626; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fuller RC, 2007, J EVOLUTION BIOL, V20, P1962, DOI 10.1111/j.1420-9101.2007.01368.x; GALAT DL, 1981, HYDROBIOLOGIA, V81-2, P281, DOI 10.1007/BF00048722; Haag CR, 2006, HEREDITY, V96, P150, DOI 10.1038/sj.hdy.6800774; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Herrick CL, 1884, FINAL REPORT CRUSTAC; HERZIG A, 1980, HOLARCTIC ECOL, V3, P50; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karanovic T, 2012, INVERTEBR SYST, V26, P115, DOI 10.1071/IS11027; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingsolver JG, 2002, TRENDS ECOL EVOL, V17, P540, DOI 10.1016/S0169-5347(02)02641-1; Kiorboe T, 2011, J PLANKTON RES, V33, P677, DOI 10.1093/plankt/fbq159; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Lampert W, 2007, LIMNOECOLOGY, V2ed; Lee CE, 2012, J EVOLUTION BIOL, V25, P625, DOI 10.1111/j.1420-9101.2012.02459.x; Lee CE, 2011, EVOLUTION, V65, P2229, DOI 10.1111/j.1558-5646.2011.01308.x; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lee CE, 2002, PHYSIOL BIOCHEM ZOOL, V75, P335, DOI 10.1086/343138; Lee MSY, 2003, J EVOLUTION BIOL, V16, P179, DOI 10.1046/j.1420-9101.2003.00520.x; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lesko LT, 2003, CALANOID COPEPODS LA; Lowe CD, 2005, MAR BIOL, V146, P923, DOI 10.1007/s00227-004-1501-9; Macek M, 2002, LAGOS PRESAS MEXICO, P199; Marrone F, 2013, MOL PHYLOGENET EVOL, V66, P190, DOI 10.1016/j.ympev.2012.09.016; Marsh C.D., 1907, T WIS ACAD SCI ARTS, V15, P381; Matute DR, 2013, J EVOLUTION BIOL, V26, P2299, DOI 10.1111/jeb.12246; Mayr E, 1942, SYSTEMATICS ORIGIN S; McCullagh P, 1989, GEN LINEAR MODELS; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montiel-Martinez A, 2008, J PLANKTON RES, V30, P1079, DOI 10.1093/plankt/fbn067; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Oliva MG, 2006, DIATOM RES, V21, P81; Oliva MG, 2001, HYDROBIOLOGIA, V466, P299, DOI 10.1023/A:1014578024049; Ortega-Mayagoitia E, 2011, J PLANKTON RES, V33, P1574, DOI 10.1093/plankt/fbr045; Panchal M, 2007, BIOINFORMATICS, V23, P509, DOI 10.1093/bioinformatics/btl614; Peralta L, 2002, HYDROBIOLOGIA, V467, P109, DOI 10.1023/A:1014913503577; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 1999, GEODIS INFERENCE KEY; Purcell KM, 2012, J EVOLUTION BIOL, V25, P2623, DOI 10.1111/jeb.12016; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; ROBERTSON A, 1981, Journal of Great Lakes Research, V7, P382; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Runge J.A., 2000, P401, DOI 10.1016/B978-012327645-2/50010-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTER B, 1994, J PLANKTON RES, V16, P171, DOI 10.1093/plankt/16.2.171; Schacht FW, 1897, B ILLINOIS STATE LAB, V5, P97; Seidel RA, 2010, J N AM BENTHOL SOC, V29, P1161, DOI 10.1899/09-098.1; Sereda SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090010; Sokal RR., 2011, BIOMETRY; Suarez-Morales E, 2005, INT REV HYDROBIOL, V90, P71, DOI 10.1002/iroh.200410742; Suarez-Morales E, 2000, J LIMNOL, V59, P5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; TEMPLETON AR, 1987, GENETICS, V117, P343; Ting JH, 2000, MAR BIOL, V137, P31, DOI 10.1007/s002270000320; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Torke B, 2001, HYDROBIOLOGIA, V453, P351, DOI 10.1023/A:1013185916287; USEPA United States Environmental Protection Agency USEPA, 2002, METH MEAS AC TOX EFF; Vaillant JJ, 2013, ECOL EVOL, V3, P3083, DOI 10.1002/ece3.697; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Williams WD, 1998, HYDROBIOLOGIA, V381, P191, DOI 10.1023/A:1003287826503; Williamson Craig E., 2001, P915, DOI 10.1016/B978-012690647-9/50023-5; Wilson M.S., 1959, WARDS WHIPPLES FRESH, P735; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; [No title captured]; [No title captured]; [No title captured]; [No title captured]	116	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125524	10.1371/journal.pone.0125524	http://dx.doi.org/10.1371/journal.pone.0125524			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915059	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100133
J	Chen, HG; Zhou, X; Zhao, Y; Gong, XJ; He, Y; Ma, FW; Zhou, M; Zhao, C; Niu, Y; Deng, J				Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao; Niu, Yi; Deng, Jie			HPLC-DAD-ELSD Combined Pharmacodynamics and Serum Medicinal Chemistry for Quality Assessment of Huangqi Granule	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIX-ASTRAGALI; PHOTODIODE-ARRAY; IN-VIVO; IV; ISOFLAVONOIDS; RATS; SAPONINS; EXTRACTION; EXPRESSION	Objective To more scientifically and reasonably control the quality of Huangqi Granules, preliminary studies on the pharmacodynamics and serum pharmacochemistry of this medicine were performed. DPPH and MTT experiments showed that water extracts of Huangqi Granules had good antioxidant activity and increased immunity. Timed blood samples collected 5 min, 15 min, and 30 min after oral administration of a set amount of Huangqi Granules were collected and tested using UPLC-ESI-MS/MS. As a result, calycosin-7-O-beta-D-glucoside, ononin, calycosin, astragaloside IV, and formononetin were found to exist in rat blood after dosing, indicating that the five chemical compounds might have pharmacological activity, and based on this result, they were designated biomarkers for quality control of Huangqi Granules. Consequently, a simple, rapid and efficient method was developed in the present study for the simultaneous determination of the five characteristic compounds in Huangqi Granules using HPLC-DAD-ELSD. Materials and Methods The separation was performed using an Agilent Hypersil ODS column (4.6 x 250 mm, 5 mu m) at 30 degrees C. The mobile phase was composed of water (solvent A) and acetonitrile (solvent B) with a flow rate of 1 mL/min. The drift tube temperature of the ELSD system was set to 85 degrees C, and the nitrogen pressure was 3.5 bar. Results All five characteristic compounds had good linear behavior with r2 values greater than 0.9972. The recoveries varied from 96.31% to 101.22%. Subsequently, the developed method was applied to evaluate the quality of Huangqi Granules from different batches, and hierarchical clustering analysis (HCA) was used to analyze the classification of the samples based on the values of the five compounds. Conclusion The established HPLC method combined with HCA proved to be effective to evaluate the quality of Huangqi Granules.	[Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao] Guizhou Engn Lab Qual Control & Evaluat Technol M, Guiyang, Guizhou, Peoples R China; [Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao] Guizhou Normal Univ, Res Ctr Qual Control Nat Med, Guiyang, Guizhou, Peoples R China; [Chen, Huaguo; Zhou, Xin; Zhao, Yang; Gong, Xiao-Jian; He, Yan; Ma, Feng-Wei; Zhou, Mei; Zhao, Chao] Guizhou Normal Univ, Key Lab Informat Syst Mountainous Areas & Protect, Guiyang, Guizhou, Peoples R China; [Niu, Yi; Deng, Jie] Han Fang Pharmaceut Co Ltd Guizhou Prov, Guiyang, Guizhou, Peoples R China	Guizhou Normal University; Guizhou Normal University	Zhou, X (corresponding author), Guizhou Engn Lab Qual Control & Evaluat Technol M, Guiyang, Guizhou, Peoples R China.	642452984@qq.com			Natural Science Research Project from the Department of Education of the Guizhou Province [2011 026]; Science and Technology Plan Projects of Guiyang [2011 204-24]; Guizhou Provincial Special Program on Research and Development of Science and Technology Industry on Modernization of TCMs [ZY 2011 3013, KY 2012 005, 2011040]	Natural Science Research Project from the Department of Education of the Guizhou Province; Science and Technology Plan Projects of Guiyang; Guizhou Provincial Special Program on Research and Development of Science and Technology Industry on Modernization of TCMs	Natural Science Research Project from the Department of Education of the Guizhou Province (No. 2011 026), Science and Technology Plan Projects of Guiyang (No. 2011 204-24), Guizhou Provincial Special Program on Research and Development of Science and Technology Industry on Modernization of TCMs (No. ZY 2011 3013) were used to fund study design and manuscript preparation, project (No. KY 2012 005) was used for data collection and project (No. 2011040) provided funds for sample analysis.	Bahorun T, 2004, J SCI FOOD AGR, V84, P1553, DOI 10.1002/jsfa.1820; Committee NP, 2010, PHARMACOPOEIA PEOPLE; Deschamps FS, 2002, ANALYST, V127, P35, DOI 10.1039/b108810f; Gui SY, 2006, J ETHNOPHARMACOL, V103, P154, DOI 10.1016/j.jep.2005.07.025; GUIOCHON G, 1988, J LIQ CHROMATOGR, V11, P2547, DOI 10.1080/01483918808076746; Huang XL, 2009, TALANTA, V78, P1129, DOI 10.1016/j.talanta.2009.01.029; Juan YC, 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1155/2011/349807; Li ZP, 2002, ACTA PHARMACOL SIN, V23, P898; Liang XR, 2013, PHARMACOGN MAG, V9, P238, DOI 10.4103/0973-1296.113277; Lin YW, 2008, PROCESS BIOCHEM, V43, P244, DOI 10.1016/j.procbio.2007.11.020; Liu RR, 2006, PLANT CELL REP, V25, P705, DOI 10.1007/s00299-005-0072-7; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Ouyang Z, 2012, PHARMACOGN MAG, V8, P256, DOI 10.4103/0973-1296.103648; Qi LW, 2006, J CHROMATOGR A, V1134, P162, DOI 10.1016/j.chroma.2006.08.085; Sinclair S, 1998, Altern Med Rev, V3, P338; Song JZ, 2008, J PHARMACEUT BIOMED, V47, P399, DOI 10.1016/j.jpba.2007.12.036; Song JZ, 2007, J SEP SCI, V30, P819, DOI 10.1002/jssc.200600340; Wang D, 2006, J SEP SCI, V29, P2012, DOI 10.1002/jssc.200500486; Wang SG, 2009, BIOL PHARM BULL, V32, P132, DOI 10.1248/bpb.32.132; Wu T, 2005, FITOTERAPIA, V76, P157, DOI 10.1016/j.fitote.2004.11.006; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Yong-Chun J., 2012, PHARMACOGN MAG, V8, P42; Yu JX, 2006, CAN J PHYSIOL PHARM, V84, P579, DOI 10.1139/Y06-015; Yu QT, 2007, J SEP SCI, V30, P1292, DOI 10.1002/jssc.200600422; Zhang WD, 2006, PLANTA MED, V72, P4, DOI 10.1055/s-2005-873126; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136	26	41	46	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123176	10.1371/journal.pone.0123176	http://dx.doi.org/10.1371/journal.pone.0123176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915040	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100014
J	Fan, PH; Li, XJ; Su, WH; Kong, W; Kong, XG; Wang, ZX; Wang, YC; Jiang, CL; Gao, F				Fan, Peihu; Li, Xiaojun; Su, Weiheng; Kong, Wei; Kong, Xianggui; Wang, Zhenxin; Wang, Youchun; Jiang, Chunlai; Gao, Feng			Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ULTRASENSITIVE ENZYME-IMMUNOASSAY; IMMUNOSORBENT-ASSAY; INFECTION; ELISA; NANOPARTICLE; DIAGNOSIS; ANTIBODY; VIREMIA; PROTEINS	The relatively high detection limit of the Enzyme-linked immunosorbent assay (ELISA) prevents its application for detection of low concentrations of antigens. To increase the sensitivity for detection of HIV-1 p24 antigen, we developed a highly sensitive nuclease-linked fluorescence oligonucleotide assay (NLFOA). Two major improvements were incorporated in NLFOA to amplify antibody-antigen interaction signals and reduce the signal/noise ratio; a large number of nuclease molecules coupled to the gold nanoparticle/streptavidin complex and fluorescent signals generated from fluorescent-labeled oligonucleotides by the nuclease. The detection limit of p24 by NLFOA was 1 pg/mL, which was 10-fold more sensitive than the conventional ELISA (10 pg/mL). The specificity was 100% and the coefficient of variation (CV) was 7.8% at low p24 concentration (1.5 pg/mL) with various concentrations of spiked p24 in HIV-1 negative sera. Thus, NLFOA is highly sensitive, specific, reproducible and user-friendly. The more sensitive detection of low p24 concentrations in HIV-1-infected individuals by NLFOA could allow detection of HIV-1 infections that are missed by the conventional ELISA at the window period during acute infection to further reduce the risk for HIV-1 infection due to the undetected HIV-1 in the blood products. Moreover, NLFOA can be easily applied to more sensitive detection of other antigens.	[Fan, Peihu; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai; Gao, Feng] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China; [Fan, Peihu; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai; Gao, Feng] Jilin Univ, Natl Engn Lab Acquired Immune Deficiency Syndrome, Changchun 130023, Jilin, Peoples R China; [Kong, Wei; Jiang, Chunlai] Jilin Univ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China; [Kong, Xianggui] Chinese Acad Sci, Changchun Inst Opt Fine Mech & Phys, State Key Lab Luminescence & Applicat, Changchun, Jilin, Peoples R China; [Wang, Zhenxin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Youchun] Natl Inst Food & Drug Control, Div Human Immunodeficiency Virus Acquired Immune, Beijing, Peoples R China	Jilin University; Jilin University; Jilin University; Chinese Academy of Sciences; Changchun Institute of Optics, Fine Mechanics & Physics, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; National Institute of Food & Drug Control - China	Jiang, CL (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China.	jiangcl@jlu.edu.cn; feng0215@gmail.com		wang, zhen xin/0000-0002-1908-9848	National Science and Technology Major Project [2012ZX10001009]	National Science and Technology Major Project	This work was supported by the National Science and Technology Major Project (2012ZX10001009) to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasti SS, 2010, ADV DRUG DELIVER REV, V62, P316, DOI 10.1016/j.addr.2009.11.004; ALLAIN JP, 1986, LANCET, V2, P1233; Ambrosi A, 2007, ANAL CHEM, V79, P5232, DOI 10.1021/ac070357m; Ambrosi A, 2010, ANAL CHEM, V82, P1151, DOI 10.1021/ac902492c; CAO Y, 1987, BLOOD, V70, P575; CARTHEW P, 1981, LAB ANIM, V15, P69, DOI 10.1258/002367781780958504; CHARGELEGUE D, 1992, J VIROL METHODS, V38, P323, DOI 10.1016/0166-0934(92)90077-Q; Chirra HD, 2011, ACTA BIOMATER, V7, P2865, DOI 10.1016/j.actbio.2011.01.003; CLARK SJ, 1991, NEW ENGL J MED, V324, P954, DOI 10.1056/NEJM199104043241404; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Crowther J., 2008, MOL BIOMETHODS HDB, P657; CROWTHER JR, 1990, BIOLOGICALS, V18, P331, DOI 10.1016/1045-1056(90)90038-2; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; de la Rica R, 2012, NAT NANOTECHNOL, V7, P821, DOI [10.1038/nnano.2012.186, 10.1038/NNANO.2012.186]; Dong HH, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-180; DOWBENKO DJ, 1985, P NATL ACAD SCI USA, V82, P7748, DOI 10.1073/pnas.82.22.7748; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Fransen K, 1997, J MED VIROL, V53, P31, DOI 10.1002/(SICI)1096-9071(199709)53:1&lt;31::AID-JMV6&gt;3.0.CO;2-R; Gan SD, 2013, J INVEST DERMATOL, V133, pE10, DOI 10.1038/jid.2013.287; Hashida S, 1995, Biotechnol Annu Rev, V1, P403; HASHIDA S, 1995, J CLIN MICROBIOL, V33, P298, DOI 10.1128/JCM.33.2.298-303.1995; Hashida S, 1996, J CLIN LAB ANAL, V10, P302, DOI 10.1002/(SICI)1098-2825(1996)10:5<302::AID-JCLA11>3.0.CO;2-0; HORSBURGH CR, 1989, LANCET, V2, P637; Hutchinson AB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000342; ISHIKAWA E, 1990, CLIN CHIM ACTA, V194, P51, DOI 10.1016/0009-8981(90)90303-A; Ke RQ, 2010, ANAL BIOCHEM, V406, P8, DOI 10.1016/j.ab.2010.06.039; Laperche S, 2012, J INFECT DIS, V206, P1946, DOI 10.1093/infdis/jis616; Lequin RM, 2005, CLIN CHEM, V51, P2415, DOI 10.1373/clinchem.2005.051532; Li YY, 2007, CLIN CHEM, V53, P1061, DOI 10.1373/clinchem.2006.082271; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; Liu MY, 2010, ANALYST, V135, P327, DOI 10.1039/b916629g; Long EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027625; Maritz J, 2011, J CLIN MICROBIOL, V49, P1704, DOI 10.1128/JCM.02497-10; Meng Y, 2005, ANAL BIOCHEM, V345, P227, DOI 10.1016/j.ab.2005.07.026; Nadal D, 1999, J INFECT DIS, V180, P1089, DOI 10.1086/315012; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; SCHARPE SL, 1976, CLIN CHEM, V22, P733; Schupbach J, 2003, JAIDS-J ACQ IMM DEF, V33, P292, DOI 10.1097/00126334-200307010-00002; SHEKARCHI IC, 1985, J CLIN MICROBIOL, V21, P92, DOI 10.1128/JCM.21.1.92-96.1985; Sutthent R, 2003, J CLIN MICROBIOL, V41, P1016, DOI 10.1128/JCM.41.3.1016-1022.2003; Tang SX, 2010, CLIN VACCINE IMMUNOL, V17, P1244, DOI 10.1128/CVI.00066-10; Tang SX, 2010, J INFECT DIS, V201, pS59, DOI 10.1086/650386; YOLKEN RH, 1979, J CLIN MICROBIOL, V10, P317, DOI 10.1128/JCM.10.3.317-321.1979; YOLKEN RH, 1982, J CLIN MICROBIOL, V15, P757, DOI 10.1128/JCM.15.5.757-760.1982; ZAAIJER HL, 1992, LANCET, V340, P770, DOI 10.1016/0140-6736(92)92303-W; Zhou F, 2012, ANALYST, V137, P1779, DOI 10.1039/c2an16257a; Zhou F, 2011, LANGMUIR, V27, P2155, DOI 10.1021/la1049937	51	10	10	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125701	10.1371/journal.pone.0125701	http://dx.doi.org/10.1371/journal.pone.0125701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915630	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100143
J	IJzerman, H; Janssen, JA; Coan, JA				IJzerman, Hans; Janssen, Janneke A.; Coan, James A.			Maintaining Warm, Trusting Relationships with Brands: Increased Temperature Perceptions after Thinking of Communal Brands	PLOS ONE			English	Article							EXPERIENCING PHYSICAL WARMTH; UNIVERSAL DIMENSIONS; SOCIAL PROXIMITY; ATTACHMENT; REPLICATION; COMPETENCE; EMOTION; ECONOMY; AGENCY; MOTOR	Classical theories on interpersonal relations have long suggested that social interactions are influenced by sensation, such as the experience of warmth. Past empirical work now confirms that perceived differences in temperature impact how people form thoughts about relationships. The present work first integrates our knowledge database on brand research with this idea of "grounded social cognition". It then leverages a large sample (total N = 2,552) toward elucidating links between estimates of temperature and positive versus negative evaluations of communal brands. In five studies, the authors have found that thinking about positively (vs. negatively) perceived communal brands leads to heightened temperature estimates. A meta-analysis of the five studies shows a small but consistent effect in this noisy environment, r = .11, 95% CI,.05,.18. Exploratory analyses in Studies 1a and b further suggest that temperature perceptions mediate the (significant) relationship between perceived communality and willingness to purchase from the brand. The authors discuss implications for theory and practice and consider the effects from a Social Baseline Perspective.	[IJzerman, Hans] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Janssen, Janneke A.] Tilburg Univ, Dept Social Psychol, Sch Social & Behav Sci, NL-5000 LE Tilburg, Netherlands; [Coan, James A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	Vrije Universiteit Amsterdam; Tilburg University; University of Virginia	IJzerman, H (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	h.ijzerman@gmail.com		IJzerman, Hans/0000-0002-0990-2276	Netherlands Organization for Scientific Research (NWO) [016.145.049]; National Institute of Mental Health [NIMH R01MH080725, NIMH R01-MH066902]; National Science Foundation [NSF DMS-1209118, NSF BCS-1261499]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080725, R01MH066902] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The paper was partially supported by a Veni grant of the Netherlands Organization for Scientific Research (NWO; www.nwo.nl) (016.145.049) awarded to HIJ. JAC received funding from the National Institute of Mental Health (NIMH R01MH080725, NIMH R01-MH066902) and the National Science Foundation (NSF DMS-1209118, NSF BCS-1261499). The research was embedded in HIJ and JAC research program, whose salaries are paid for by their institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaker J, J CONSUM RES, V3, P1; Aaker JL, 1997, J MARKETING RES, V34, P347, DOI 10.2307/3151897; Abele AE, 2014, ACCEPTED IN ADV EXP; Abele AE, 2007, J PERS SOC PSYCHOL, V93, P751, DOI 10.1037/0022-3514.93.5.751; Ahuvia AC, 2001, THESIS; Bakan D., 1966, THE DUALITY OF HUMAN; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Beckes L, 2014, TOWARD A RADICALLY E; Beckes L, 2011, SOC PERSONAL PSYCHOL, V5, P976, DOI 10.1111/j.1751-9004.2011.00400.x; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Blanken I, 2014, SOC PSYCHOL-GERMANY, V45, P232, DOI 10.1027/1864-9335/a000189; Bowlby J., 1969, ATTACHMENT AND LOSS; Brandt MJ, 2014, J EXP SOC PSYCHOL, V50, P217, DOI 10.1016/j.jesp.2013.10.005; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fay AJ, 2012, J EXP SOC PSYCHOL, V48, P1369, DOI 10.1016/j.jesp.2012.05.017; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Foroni F, 2009, PSYCHOL SCI, V20, P974, DOI 10.1111/j.1467-9280.2009.02400.x; Fournier S, 1998, J CONSUM RES, V24, P343, DOI 10.1086/209515; Hafner M, 2011, PERS SOC PSYCHOL B, V37, P1551, DOI 10.1177/0146167211415629; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; IJzerman H, 2014, ACTA PSYCHOL, V148, P136, DOI 10.1016/j.actpsy.2014.01.013; Ijzerman H, 2013, EUR J PERSONALITY, V27, P128; IJzerman H, 2013, SOC PSYCHOL-GERMANY, V44, P160, DOI 10.1027/1864-9335/a000142; Ijzerman H, 2012, ACTA PSYCHOL, V140, P283, DOI 10.1016/j.actpsy.2012.05.002; Ijzerman H, 2011, EUR J SOC PSYCHOL, V41, P456, DOI 10.1002/ejsp.806; IJzerman H, 2011, PSYCHOL BULL, V137, P355, DOI 10.1037/a0022373; Ijzerman H, 2010, J EXP SOC PSYCHOL, V46, P867, DOI 10.1016/j.jesp.2010.07.015; IJzerman H, 2009, PSYCHOL SCI, V20, P1214, DOI 10.1111/j.1467-9280.2009.02434.x; Judd CM, 2005, J PERS SOC PSYCHOL, V89, P899, DOI 10.1037/0022-3514.89.6.899; LeBel EP, 2013, PSYCHOL SCI, V24, P2128, DOI 10.1177/0956797613486983; Lynott D, 2014, SOC PSYCHOL-GERMANY, V45, P216, DOI 10.1027/1864-9335/a000187; OSF, 2014, RELATIONSHIPS WITH B; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Proffitt DR, 2001, PSYCHOL SCI, V12, P418, DOI 10.1111/1467-9280.00377; Richins ML, 1997, J CONSUM RES, V24, P127, DOI 10.1086/209499; Schilder JD, 2014, PHYSICAL WARMTH AND; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; SEARLE JR, 1980, BEHAV BRAIN SCI, V3, P417, DOI 10.1017/S0140525X00006038; Shimp T.A., 1988, ADV CONSUM RES, V15, P163; Simmons JP, 2015, LIFE AFTER P HACKING; Simmons JP, 2013, A 21 WORD SOLUTION; Slater JS, 2001, ADV CONSUM RES, V28, P362; STERNBERG RJ, 1986, PSYCHOL REV, V93, P119, DOI 10.1037/0033-295X.93.2.119; Sung YJ, 2010, PSYCHOL MARKET, V27, P639, DOI 10.1002/mar.20349; Szymkow A, 2012, SOC PSYCHOL, V44, P168; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wojciszke B, 2008, EUR J SOC PSYCHOL, V38, P1139, DOI 10.1002/ejsp.549; Yoon C, 2006, J CONSUM RES, V33, P31, DOI 10.1086/504132; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x	57	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125194	10.1371/journal.pone.0125194	http://dx.doi.org/10.1371/journal.pone.0125194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915686	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100108
J	Orosz, A; Csajbok, E; Czekus, C; Gavaller, H; Magony, S; Valkusz, Z; Varkonyi, TT; Nemes, A; Baczko, I; Forster, T; Wittmann, T; Papp, JG; Varro, A; Lengyel, C				Orosz, Andrea; Csajbok, Eva; Czekus, Csilla; Gavaller, Henriette; Magony, Sandor; Valkusz, Zsuzsanna; Varkonyi, Tamas T.; Nemes, Attila; Baczko, Istvan; Forster, Tamas; Wittmann, Tibor; Papp, Julius Gy.; Varro, Andras; Lengyel, Csaba			Increased Short-Term Beat-To-Beat Variability of QT Interval in Patients with Acromegaly	PLOS ONE			English	Article							COMPLETE ATRIOVENTRICULAR-BLOCK; HEART-RATE-VARIABILITY; SUDDEN CARDIAC DEATH; DOWN-REGULATION; VENTRICULAR-ARRHYTHMIAS; LATE POTENTIALS; FAILING CANINE; BLOOD-PRESSURE; RISK-FACTORS; DE-POINTES	Cardiovascular diseases, including ventricular arrhythmias are responsible for increased mortality in patients with acromegaly. Acromegaly may cause repolarization abnormalities such as QT prolongation and impairment of repolarization reserve enhancing liability to arrhythmia. The aim of this study was to determine the short-term beat-to-beat QT variability in patients with acromegaly. Thirty acromegalic patients (23 women and 7 men, mean age +/- SD: 55.7 +/- 10.4 years) were compared with age-and sex-matched volunteers (mean age 51.3 +/- 7.6 years). Cardiac repolarization parameters including frequency corrected QT interval, PQ and QRS intervals, duration of terminal part of T waves (T-peak-T-end) and short-term variability of QT interval were evaluated. All acromegalic patients and controls underwent transthoracic echocardiographic examination. Autonomic function was assessed by means of five standard cardiovascular reflex tests. Comparison of the two groups revealed no significant differences in the conventional ECG parameters of repolarization (QT: 401.1 +/- 30.6 ms vs 389.3 +/- 16.5 ms, corrected QT interval: 430.1 +/- 18.6 ms vs 425.6 +/- 17.3 ms, QT dispersion: 38.2 +/- 13.2 ms vs 36.6 +/- 10.2 ms; acromegaly vs control, respectively). However, short-term beat-to-beat QT variability was significantly increased in acromegalic patients (4.23 +/- 1.03 ms vs 3.02 +/- 0.80, P<0.0001). There were significant differences between the two groups in the echocardiographic dimensions (left ventricular end diastolic diameter: 52.6 +/- 5.4 mm vs 48.0 +/- 3.9 mm, left ventricular end systolic diameter: 32.3 +/- 5.2 mm vs 29.1 +/- 4.4 mm, interventricular septum: 11.1 +/- 2.2 mm vs 8.8 +/- 0.7 mm, posterior wall of left ventricle: 10.8 +/- 1.4 mm vs 8.9 +/- 0.7 mm, P<0.05, respectively). Short-term beat-to-beat QT variability was elevated in patients with acromegaly in spite of unchanged conventional parameters of ventricular repolarization. This enhanced temporal QT variability may be an early indicator of increased liability to arrhythmia.	[Orosz, Andrea; Baczko, Istvan; Papp, Julius Gy.; Varro, Andras; Lengyel, Csaba] Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Csajbok, Eva; Czekus, Csilla; Magony, Sandor; Valkusz, Zsuzsanna; Varkonyi, Tamas T.; Wittmann, Tibor; Lengyel, Csaba] Univ Szeged, Fac Med, Dept Internal Med 1, Szeged, Hungary; [Gavaller, Henriette; Nemes, Attila; Forster, Tamas] Univ Szeged, Fac Med, Dept Internal Med 2, Szeged, Hungary; [Gavaller, Henriette; Nemes, Attila; Forster, Tamas] Univ Szeged, Fac Med, Ctr Cardiol, Szeged, Hungary; [Papp, Julius Gy.; Varro, Andras] Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Szeged University; Hungarian Academy of Sciences	Lengyel, C (corresponding author), Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary.	lecs.in1st@gmail.com	Varro, Andras/M-2647-2016; Forster, Tamas/AAV-9037-2020; Dagdelen, Selcuk/A-9432-2017; Baczko, István/I-7752-2019	Dagdelen, Selcuk/0000-0002-0513-1750; Baczko, István/0000-0002-9588-0797; Nemes, Attila/0000-0002-7570-6214; Orosz, Andrea/0000-0002-0750-4741; Csajbok, Eva/0000-0002-7089-5431	Hungarian Research Fund [OTKA NK-104331, CNK-77855]; National Development Agency; European Social Fund [TAMOP-4.2.2A-11/1/KONV-2012-0073, TAMOP-4.2.2./B-10/1-2010-0012, GOP-1.1.1-11-2011-00812-0035]; National Research, Development and Innovation Office [PIAC_13-1-2013-0201]; Hungarian National Office for Research and Technology [TECH_08_A1_CARDIO 08]; Hungarian Academy of Sciences; HU-RO Cross-Border Cooperation Programmes [HURO/0901/137-HU-RO_TRANSMED]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; European Social Fund(European Social Fund (ESF)); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian National Office for Research and Technology(National Office for Research and Technology); Hungarian Academy of Sciences(Hungarian Academy of Sciences); HU-RO Cross-Border Cooperation Programmes	This work was supported by grants from the Hungarian Research Fund [OTKA NK-104331, CNK-77855], the National Development Agency and co-financed by the European Social Fund [TAMOP-4.2.2A-11/1/KONV-2012-0073, TAMOP-4.2.2./B-10/1-2010-0012; GOP-1.1.1-11-2011-00812-0035], the National Research, Development and Innovation Office [PIAC_13-1-2013-0201], Hungarian National Office for Research and Technology (TECH_08_A1_CARDIO 08), the Hungarian Academy of Sciences (Janos Bolyai Research Scholarship to AN, IB, CsL), and by the HU-RO Cross-Border Cooperation Programmes (HURO/0901/137-HU-RO_TRANSMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriemma RS, 2013, EUR J ENDOCRINOL, V168, P15, DOI 10.1530/EJE-12-0596; Baykan M, 2008, ECHOCARDIOGR-J CARD, V25, P374, DOI 10.1111/j.1540-8175.2007.00615.x; Berg C, 2010, J CLIN ENDOCR METAB, V95, P3648, DOI 10.1210/jc.2009-2570; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Bihan H, 2004, J CLIN ENDOCR METAB, V89, P5308, DOI 10.1210/jc.2004-0821; Bogazzi F, 2007, J CLIN ENDOCR METAB, V92, P4271, DOI 10.1210/jc.2007-1213; Bohlooly-Y M, 2001, ENDOCRINOLOGY, V142, P3317, DOI 10.1210/en.142.8.3317; Bollano E, 2000, ENDOCRINOLOGY, V141, P2229, DOI 10.1210/en.141.6.2229; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Cabo C, 2003, AM J PHYSIOL-HEART C, V284, pH372, DOI 10.1152/ajpheart.00512.2002; Chemla D, 2014, J CLIN ENDOCR METAB, V99, P2925, DOI 10.1210/jc.2013-4288; Ciulla M, 1999, J HYPERTENS, V17, P1965, DOI 10.1097/00004872-199917121-00028; Clayton RN, 2003, ENDOCR REV, V24, P272, DOI 10.1210/er.2003-0009; Colao A, 2004, EUR J ENDOCRINOL, V151, pS93, DOI 10.1530/eje.0.151S093; Comunello A, 2015, PITUITARY, V18, P525, DOI 10.1007/s11102-014-0605-6; Dassie F, 2012, EUR J ENDOCRINOL, V166, P199, DOI 10.1530/EJE-11-0835; Dural M, 2014, PITUITARY, V17, P163, DOI 10.1007/s11102-013-0482-4; Fatti LM, 2006, CLIN ENDOCRINOL, V65, P626, DOI 10.1111/j.1365-2265.2006.02639.x; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; Hanton G., 2008, Journal of Pharmacological and Toxicological Methods, V57, P194, DOI 10.1016/j.vascn.2008.03.001; Herrmann BL, 2001, CLIN ENDOCRINOL, V55, P201, DOI 10.1046/j.1365-2265.2001.01319.x; Hinterseer M, 2008, EUR HEART J, V29, P185, DOI 10.1093/eurheartj/ehm586; Hinterseer M, 2010, AM J CARDIOL, V106, P216, DOI 10.1016/j.amjcard.2010.02.033; Hinterseer M, 2009, AM J CARDIOL, V103, P1244, DOI 10.1016/j.amjcard.2009.01.011; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; KAHALY G, 1992, EUR HEART J, V13, P51, DOI 10.1093/oxfordjournals.eurheartj.a060047; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Lengyel C, 2007, BRIT J PHARMACOL, V151, P941, DOI 10.1038/sj.bjp.0707297; Lengyel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018751; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; LIE JT, 1980, AM HEART J, V100, P41, DOI 10.1016/0002-8703(80)90277-X; LUE WM, 1992, CIRCULATION, V85, P1175, DOI 10.1161/01.CIR.85.3.1175; Maffei P, 2005, INT J CARDIOL, V104, P197, DOI 10.1016/j.ijcard.2004.12.010; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Mohamed A L, 1999, Med J Malaysia, V54, P338; Murabayashi T, 2002, J ELECTROCARDIOL, V35, P19, DOI 10.1054/jelc.2002.30250; Nabauer M, 1998, CARDIOVASC RES, V37, P324, DOI 10.1016/S0008-6363(97)00274-5; Nemes A, 2008, INT J CARDIOL, V124, P121, DOI 10.1016/j.ijcard.2006.11.196; Oosterhoff P, 2011, HEART RHYTHM, V8, P1584, DOI 10.1016/j.hrthm.2011.04.033; Pinto JMB, 1998, J CARDIOVASC ELECTR, V9, P299, DOI 10.1111/j.1540-8167.1998.tb00915.x; Resmini E, 2006, J CLIN ENDOCR METAB, V91, P115, DOI 10.1210/jc.2005-1506; Rhee SS, 2011, REV ESP CARDIOL, V64, P220, DOI 10.1016/j.recesp.2010.10.015; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; RODRIGUES EA, 1989, BRIT HEART J, V62, P185; ROSSI L, 1977, CHEST, V72, P495, DOI 10.1378/chest.72.4.495; Seegers J, 2012, EUROPACE, V14, P416, DOI 10.1093/europace/eur352; Seravalle G, 2012, CLIN ENDOCRINOL, V77, P262, DOI 10.1111/j.1365-2265.2012.04335.x; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Spinelli L, 2003, J CLIN ENDOCR METAB, V88, P4105, DOI 10.1210/jc.2003-030462; Stengl M, 2006, CARDIOVASC RES, V72, P90, DOI 10.1016/j.cardiores.2006.07.015; Suyama K, 2000, ENDOCR J, V47, pS73, DOI 10.1507/endocrj.47.SupplMarch_S73; Thomsen MB, 2007, BRIT J PHARMACOL, V151, P909, DOI 10.1038/sj.bjp.0707299; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Thomsen MB, 2005, BASIC RES CARDIOL, V100, P279, DOI 10.1007/s00395-005-0519-6; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; van Eck HJR, 2009, COMPUT CARDIOL, V36, P585; Varkevisser R, 2012, HEART RHYTHM, V9, P1718, DOI 10.1016/j.hrthm.2012.05.016; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Varro A, 2011, BRIT J PHARMACOL, V164, P14, DOI 10.1111/j.1476-5381.2011.01367.x; Varro A, 2010, PFLUG ARCH EUR J PHY, V460, P31, DOI 10.1007/s00424-010-0798-0; Volders PGA, 1998, CIRCULATION, V98, P1136, DOI 10.1161/01.CIR.98.11.1136; Volders PGA, 1999, CIRCULATION, V100, P2455, DOI 10.1161/01.CIR.100.24.2455; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	66	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125639	10.1371/journal.pone.0125639	http://dx.doi.org/10.1371/journal.pone.0125639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915951	Green Accepted, Green Published, gold			2022-12-26	WOS:000353659100139
J	Rajah, T; Chow, SC				Rajah, Tanuja; Chow, Sek Chuen			Suppression of Human T Cell Proliferation Mediated by the Cathepsin B Inhibitor, z-FA-FMK Is Due to Oxidative Stress	PLOS ONE			English	Article							Z-VAD-FMK; GLUTATHIONE DEPLETION; INTRACELLULAR GLUTATHIONE; LYMPHOCYTE-ACTIVATION; CASPASE ACTIVATION; HOMOCYSTEINE SULFOXIMINE; BUTHIONINE SULFOXIMINE; FLUOROMETHYL KETONES; INDUCED APOPTOSIS; JOINT DISEASES	The cathepsin B inhibitor, benzyloxycarbonyl-phenylalanine-alanine-fluoromethyl ketone (z-FA-FMK) readily inhibits anti-CD3-induced human T cell proliferation, whereas the analogue benzyloxycarbonyl-phenylalanine-alanine-diazomethyl ketone (z-FA-DMK) had no effect. In contrast, benzyloxycarbonyl-phenylalanine-alanine-chloromethyl ketone (z-FA-CMK) was toxic. The inhibition of T cell proliferation mediated by z-FA-FMK requires not only the FMK moiety, but also the benzyloxycarbonyl group at the N-terminal, suggesting some degree of specificity in z-FA-FMK-induced inhibition of primary T cell proliferation. We showed that z-FA-FMK treatment leads to a decrease in intracellular glutathione (GSH) with a concomitant increase in reactive oxygen species (ROS) levels in activated T cells. The inhibition of anti-CD3-induced T cell proliferation mediated by z-FA-FMK was abolished by the presence of low molecular weight thiols such as GSH, N-acetylcysteine (NAC) and L-cysteine, whereas D-cysteine which cannot be metabolised to GSH has no effect. The inhibition of anti-CD3-induced up-regulation of CD25 and CD69 expression mediated by z-FA-FMK was also attenuated in the presence of exogenous GSH. Similar to cell proliferation, GSH, NAC and L-cysteine but not D-cysteine, completely restored the processing of caspase-8 and caspase-3 to their respective subunits in z-FA-FMK-treated activated T cells. Our collective results demonstrated that the inhibition of T cell activation and proliferation mediated by z-FA-FMK is due to oxidative stress via the depletion of GSH.	[Rajah, Tanuja; Chow, Sek Chuen] Monash Univ, Sch Sci, Bandar Sunway 46150, Selangor Darul, Malaysia	Monash University; Monash University Sunway	Chow, SC (corresponding author), Monash Univ, Sch Sci, Sunway Campus, Bandar Sunway 46150, Selangor Darul, Malaysia.	chow.sek.chuen@monash.edu			Monash University Malaysia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	Monash University Malaysia(Monash University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded by Monash University Malaysia student grant.	AHMED NK, 1992, BIOCHEM PHARMACOL, V44, P1201, DOI 10.1016/0006-2952(92)90385-V; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; ANGLIKER H, 1987, BIOCHEM J, V241, P871, DOI 10.1042/bj2410871; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392, DOI 10.1152/ajplung.2001.281.6.L1392; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Bidere N, 2002, J BIOL CHEM, V277, P32339, DOI 10.1074/jbc.M205153200; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Cai Hua, 2007, V139, P293; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; CHAPLIN DD, 1978, CELL IMMUNOL, V36, P303, DOI 10.1016/0008-8749(78)90274-5; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; D'Agostino DP, 2007, J NEUROPHYSIOL, V98, P1030, DOI 10.1152/jn.01003.2006; Deas O, 1998, J IMMUNOL, V161, P3375; ESSER RE, 1994, ARTHRITIS RHEUM, V37, P236, DOI 10.1002/art.1780370213; FIDELUS RK, 1987, EXP CELL RES, V170, P269, DOI 10.1016/0014-4827(87)90305-3; GABRIJELCIC D, 1990, J CLIN CHEM CLIN BIO, V28, P149; GMUNDER H, 1990, CELL IMMUNOL, V129, P32, DOI 10.1016/0008-8749(90)90184-S; GMUNDER H, 1991, CELL IMMUNOL, V138, P229, DOI 10.1016/0008-8749(91)90147-4; GRIFFITH OW, 1979, J BIOL CHEM, V254, P1205; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HIDAKA T, 1990, ARCH TOXICOL, V64, P103, DOI 10.1007/BF01974394; Hung LF, 2010, MECH AGEING DEV, V131, P682, DOI 10.1016/j.mad.2010.09.005; KETTNER C, 1981, METHOD ENZYMOL, V80, P826; Koenig A, 2008, CELL DEATH DIFFER, V15, P1701, DOI 10.1038/cdd.2008.100; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lawrence CP, 2012, TOXICOL APPL PHARM, V265, P103, DOI 10.1016/j.taap.2012.09.002; Lawrence CP, 2006, J IMMUNOL, V177, P3827, DOI 10.4049/jimmunol.177.6.3827; LENARCIC B, 1988, BIOL CHEM H-S, V369, P257; Liow KY, 2013, TOXICOL APPL PHARM, V272, P559, DOI 10.1016/j.taap.2013.07.022; McColl KS, 1998, MOL CELL ENDOCRINOL, V139, P229, DOI 10.1016/S0303-7207(98)00051-3; MESSINA JP, 1989, J IMMUNOL, V143, P1974; Osseni RA, 1999, TOXICOL IN VITRO, V13, P683, DOI 10.1016/S0887-2333(99)00050-8; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Paulsen M, 2008, EUR J IMMUNOL, V38, P1979, DOI 10.1002/eji.200838211; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; POWERS JC, 1977, CHEM BIOCH AMINO ACI, V4, P65; Rajah T, 2014, TOXICOL APPL PHARM, V278, P100, DOI 10.1016/j.taap.2014.04.014; RASNICK D, 1985, ANAL BIOCHEM, V149, P461, DOI 10.1016/0003-2697(85)90598-6; RAUBER P, 1986, BIOCHEM J, V239, P633, DOI 10.1042/bj2390633; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; RONZIO RA, 1969, BIOCHEMISTRY-US, V8, P1066, DOI 10.1021/bi00831a038; Roozendaal R, 2002, IMMUNOLOGY, V107, P334, DOI 10.1046/j.1365-2567.2002.01502.x; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sarin A, 1996, J EXP MED, V184, P2445, DOI 10.1084/jem.184.6.2445; Schotte P, 2001, J BIOL CHEM, V276, P21153, DOI 10.1074/jbc.M102239200; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Sun HL, 2009, CLIN CANCER RES, V15, P4904, DOI 10.1158/1078-0432.CCR-09-0269; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; VANNOORDEN CJF, 1988, J RHEUMATOL, V15, P1525; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; WALSH AC, 1995, TOXICOL APPL PHARM, V133, P249, DOI 10.1006/taap.1995.1149; WEBER CA, 1990, AM J PHYSIOL, V258, pL308, DOI 10.1152/ajplung.1990.258.6.L308; YIM CY, 1994, J IMMUNOL, V152, P5796; Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916	54	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123711	10.1371/journal.pone.0123711	http://dx.doi.org/10.1371/journal.pone.0123711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915766	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100025
J	Wu, SC; Chen, WTL; Muo, CH; Sung, FC				Wu, Shih-Chi; Chen, William Tzu-Liang; Muo, Chih-Hsin; Sung, Fung-Chang			Appendicitis as an Early Manifestation of Subsequent Malignancy: An Asian Population Study	PLOS ONE			English	Article							CANCER-RISK; LARGE-BOWEL; APPENDECTOMY; LEUKEMIA; BIOFILMS; INVASION; COLON; RATS; DMH	Background & Aims Cancer risk after appendectomy in patients with appendicitis remains unclear. This study examined the role of appendicitis as an early manifestation harbingering the distant malignancy. Methods From the insurance claims data of Taiwan, we identified a cohort of 130,374 patients newly received appendectomy from 2000-2009, without cancer diagnosis. A comparison cohort of 260,746 persons without appendectomy and cancer was selected from the same database, frequency matched by age, sex, comorbidity and index year. We monitored subsequent cancers with a 12-month follow-up. Results Over all, 1406 and 616 cancer cases were identified in the appendectomy cohort and comparisons, respectively, with all cancers incidence rate 4.64-fold higher in the appendectomy cohort (9.06 vs. 1.96 per 1000 person-months). Digestive and female genital organs harbored 80.9% of cancer cases in the appendectomy cohort. The Cox model measured site-specific hazard ratio (HR) was the highest for female genital cancers (23.3), followed by cancers of colorectum (14.7), small intestine (10.1), pancreas (7.40), lymphoma (5.89) and urinary system (4.50), all significant at 0.001 level. The HR of all cancers decreased from 13.7 within 3 months after appendectomy to 1.37 in 7-12 months after the surgery. In general, relative to the comparison cohort, younger appendectomy patients tended to have a higher HR than older patients. Conclusions The high incident cancers identified soon after appendectomy suggest the acute appendicitis is the early sign of distant metastatic malignancy. The risk of colorectal cancer, female genital cancer and haemopoietic malignancy deserve attention.	[Wu, Shih-Chi] China Med Univ Hosp, Trauma & Emergency Ctr, Taichung 404, Taiwan; [Wu, Shih-Chi; Chen, William Tzu-Liang; Muo, Chih-Hsin] China Med Univ, Coll Med, Taichung 404, Taiwan; [Chen, William Tzu-Liang] China Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung 404, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ & Hosp, Management Off Hlth Data, Taichung 404, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Inst Clin Med Sci, Taichung 404, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ, Inst Clin Med Sci, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	fcsung1008@yahoo.com	Chen, William Tzu-Liang/ABA-5673-2021		Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; National Sciences Council, Executive Yuan	The study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM104010092), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, Katsuzo and Kiyo Aoshima Memorial Funds, Japan and the National Sciences Council, Executive Yuan (NSC 100-2621-M-039-001). The funding agencies had no role in study design, data management and analyses, and results interpretation and publication of this study.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Azzali G, 2003, IMMUNOL REV, V195, P178, DOI 10.1034/j.1600-065X.2003.00072.x; BIERMAN HR, 1968, CANCER, V21, P109, DOI 10.1002/1097-0142(196801)21:1<109::AID-CNCR2820210117>3.0.CO;2-#; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Bollinger RR, 2007, GUT, V56, P1481; Cope JU, 2003, PEDIATRICS, V111, P1343, DOI 10.1542/peds.111.6.1343; Gross L, 1996, CANCER, V19, P849; Hueman MT, 2009, ANN SURG ONCOL, V16, P2101, DOI 10.1245/s10434-009-0538-x; HYAMS L, 1968, J CHRON DIS, V21, P391, DOI 10.1016/0021-9681(68)90003-9; Karachiwala H, 2012, J CANCER RES THER, V8, P132, DOI 10.4103/0973-1482.95194; Lai HW, 2006, J GASTROEN HEPATOL, V21, P1693, DOI 10.1111/j.1440-1746.2006.04426.x; Laurin M, 2011, ANAT REC, V294, P567, DOI 10.1002/ar.21357; Lin CY, 2005, INT J CLIN PRACT, V59, P89, DOI 10.1111/j.1368-504X.2005.00360.x; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; McIntosh GH, 1999, NUTR CANCER, V35, P153, DOI 10.1207/S15327914NC352_9; Mellemkjaer L, 1998, CANCER CAUSE CONTROL, V9, P183, DOI 10.1023/A:1008834311514; Muller G, 1997, J CANCER RES CLIN, V123, P560, DOI 10.1007/s004320050105; Poruk KE, 2013, ANN SURG, V257, P17, DOI 10.1097/SLA.0b013e31825ffbfb; Rappaport H, 1967, ATLAS TUMOR PATHOL, P241; Ratanarapee Samrerng, 2010, Journal of the Medical Association of Thailand, V93, P1327; Rauenzahn S, 2013, CASE REP HEMATOL, V2013, DOI 10.1155/2013/815365; ROBINSON E, 1968, BRIT J CANCER, V22, P250, DOI 10.1038/bjc.1968.32; Rowland IR, 1996, NUTR CANCER, V26, P37, DOI 10.1080/01635589609514461; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Swidsinski A, 2012, SAUDI J GASTROENTERO, V18, P55, DOI 10.4103/1319-3767.91734; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Toubai T, 2003, ACTA HAEMATOL-BASEL, V109, P199, DOI 10.1159/000070971; Tsimberidou AM, 2006, CANCER-AM CANCER SOC, V107, P1294, DOI 10.1002/cncr.22121; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011	31	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122725	10.1371/journal.pone.0122725	http://dx.doi.org/10.1371/journal.pone.0122725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915658	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100010
J	Decaris, ML; Emson, CL; Li, K; Gatmaitan, M; Luo, F; Cattin, J; Nakamura, C; Holmes, WE; Angel, TE; Peters, MG; Turner, SM; Hellerstein, MK				Decaris, Martin L.; Emson, Claire L.; Li, Kelvin; Gatmaitan, Michelle; Luo, Flora; Cattin, Jerome; Nakamura, Corelle; Holmes, William E.; Angel, Thomas E.; Peters, Marion G.; Turner, Scott M.; Hellerstein, Marc K.			Turnover Rates of Hepatic Collagen and Circulating Collagen-Associated Proteins in Humans with Chronic Liver Disease	PLOS ONE			English	Article							ISOTOPOMER DISTRIBUTION ANALYSIS; EXTRACELLULAR-MATRIX; MASS-SPECTROMETRY; PROTEOMIC ANALYSIS; NATURAL-HISTORY; IN-VIVO; FIBROSIS; PROGRESSION; FIBROGENESIS; BIOPSIES	Accumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in vivo metabolic labeling to measure the turnover rate of hepatic collagen and collagen-associated proteins in plasma for the first time in human subjects. Eight subjects with chronic liver disease were labeled with daily oral doses of (H2O)-H-2 for up to 8 weeks prior to diagnostic liver biopsy and plasma collection. Tandem mass spectrometry was used to measure the abundance and fractional synthesis rate (FSR) of proteins in liver and blood. Relative protein abundance and FSR data in liver revealed marked differences among subjects. FSRs of hepatic type I and III collagen ranged from 0.2-0.6% per day (half-lives of 4 months to a year) and correlated significantly with worsening histologic fibrosis. Analysis of plasma protein turnover revealed two collagen-associated proteins, lumican and transforming growth factor beta-induced-protein (TGFBI), exhibiting FSRs that correlated significantly with FSRs of hepatic collagen. In summary, this is the first direct measurement of liver collagen turnover in vivo in humans and suggests a high rate of collagen remodeling in advanced fibrosis. In addition, the FSRs of collagen-associated proteins in plasma are measurable and may provide a novel strategy for monitoring hepatic fibrogenesis rates.	[Decaris, Martin L.; Emson, Claire L.; Li, Kelvin; Gatmaitan, Michelle; Luo, Flora; Cattin, Jerome; Nakamura, Corelle; Holmes, William E.; Angel, Thomas E.; Turner, Scott M.; Hellerstein, Marc K.] KineMed Inc, Dept Fibrosis, Emeryville, CA 94608 USA; [Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Peters, Marion G.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Decaris, ML (corresponding author), KineMed Inc, Dept Fibrosis, Emeryville, CA 94608 USA.	mdecaris@kinemed.com; sturner@kinemed.com		Cattin, Jerome/0000-0002-8988-4265	KineMed, Inc.; UCSF Liver Center [P30 DK026743]; National Cancer Institute at the NIH [SBIR 1 R43 CA110965-01]; NATIONAL CANCER INSTITUTE [R43CA110965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	KineMed, Inc.; UCSF Liver Center; National Cancer Institute at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Experimental studies were funded by KineMed, Inc. (www.kinemed.com), the UCSF Liver Center (P30 DK026743; http://livercenter.ucsf.edu), and the National Cancer Institute at the NIH (SBIR 1 R43 CA110965-01; http://www.cancer.gov). Study design, data collection and analysis, decision to publish, or preparation of the manuscript were carried out by KineMed, Inc.	Angel TE, 2012, CHEM SOC REV, V41, P3912, DOI 10.1039/c2cs15331a; Baker ES, 2014, MOL CELL PROTEOMICS, V13, P1119, DOI 10.1074/mcp.M113.034595; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Decaris ML, 2014, MOL CELL PROTEOMICS, V13, P1741, DOI 10.1074/mcp.M113.037267; Diamond DL, 2007, HEPATOLOGY, V46, P649, DOI 10.1002/hep.21751; Fassio E, 2004, HEPATOLOGY, V40, P820, DOI 10.1002/hep.20410; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gonzalez-Casas R, 2009, WORLD J GASTROENTERO, V15, P4653, DOI 10.3748/wjg.15.4653; Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146; Hellerstein MK, 2004, CURR OPIN MOL THER, V6, P249; Hoefs JC, 2011, GASTROENTEROLOGY, V141, P900, DOI 10.1053/j.gastro.2011.06.007; Kasumov T, 2011, ANAL BIOCHEM, V412, P47, DOI 10.1016/j.ab.2011.01.021; Kim MY, 2014, WORLD J GASTROENTERO, V20, P4300, DOI 10.3748/wjg.v20.i15.4300; Krishnan A, 2012, LAB INVEST, V92, P1712, DOI 10.1038/labinvest.2012.121; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lee YA, 2014, ANTIVIR RES, V107, P23, DOI 10.1016/j.antiviral.2014.03.012; Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332; Neuschwander-Tetri BA, 2014, LANCET, DOI [10.1016/S0140-6736(08)61345-8, DOI 10.1016/S0140-6736(08)61345-8]; Papageorgopoulos C, 1999, ANAL BIOCHEM, V267, P1, DOI 10.1006/abio.1998.2958; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; Price JC, 2012, ANAL BIOCHEM, V420, P73, DOI 10.1016/j.ab.2011.09.007; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; Stephen S, 2012, EXPERT REV GASTROENT, V6, P163, DOI [10.1586/EGH.11.97, 10.1586/egh.11.97]	29	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123311	10.1371/journal.pone.0123311	http://dx.doi.org/10.1371/journal.pone.0123311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909381	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800033
J	Jung, K; Cho, JY; Soh, YJ; Lee, J; Shin, SW; Jang, S; Jung, E; Kim, MH; Lee, J				Jung, Kwangseon; Cho, Jae Youl; Soh, Young-Jin; Lee, Jienny; Shin, Seoung Woo; Jang, Sunghee; Jung, Eunsun; Kim, Min Hee; Lee, Jongsung			Antagonizing Effects of Aspartic Acid against Ultraviolet A-Induced Downregulation of the Stemness of Human Adipose Tissue-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							ACTIVATION; RADIATION; HYPOXIA	Ultraviolet A (UVA) irradiation is responsible for a variety of changes in cell biology. The purpose of this study was to investigate effects of aspartic acid on UVA irradiation-induced damages in the stemness properties of human adipose tissue-derived mesenchymal stem cells (hAMSCs). Furthermore, we elucidated the UVA-antagonizing mechanisms of aspartic acid. The results of this study showed that aspartic acid attenuated the UVA-induced reduction of the proliferative potential and stemness of hAMSCs, as evidenced by increased proliferative activity in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and upregulation of stemness-related genes OCT4, NANOG, and SOX2 in response to the aspartic acid treatment. UVA-induced reduction in the mRNA level of hypoxiainducible factor (HIF)-1 alpha was also significantly recovered by aspartic acid. In addition, the antagonizing effects of aspartic acid against the UVA effects were found to be mediated by reduced production of PGE2 through the inhibition of JNK and p42/44 MAPK. Taken together, these findings show that aspartic acid improves reduced stemness of hAMSCs induced by UVA and its effects are mediated by upregulation of HIF-1 alpha via the inhibition of PGE2-cAMP signaling. In addition, aspartic acid may be used as an antagonizing agent to mitigate the effects of UVA.	[Jung, Kwangseon; Lee, Jongsung] Eulji Univ, Dept Convergence Biomed Sci & Engn, Songnam, Gyunggi Do, South Korea; [Jung, Kwangseon] Skincure Life Sci Inst, Songnam, Gyunggi Do, South Korea; [Cho, Jae Youl] Sungkyunkwan Univ, Dept Genet Engn, Suwon, Gyeonggi Do, South Korea; [Lee, Jienny] Anim & Plant Quarantine Agcy, Div Viral Dis, Anyang Si, Gyeonggi Do, South Korea; [Shin, Seoung Woo; Jung, Eunsun] Biospectr Life Sci Inst, Songnam, Gyunggi Do, South Korea; [Jang, Sunghee; Lee, Jongsung] Eulji Univ, Grad Sch, Dept Senior Healthcare, Plus Program BK21, Songnam, Gyunggi Do, South Korea; [Kim, Min Hee] Eulji Univ, Dept Phys Therapy, Coll Hlth Sci, Songnam, Gyunggi Do, South Korea; [Soh, Young-Jin] Eulji Univ, Coll Hlth Sci, Dept Dermatol Hlth Management, Songnam, Gyunggi Do, South Korea	Eulji University; Sungkyunkwan University (SKKU); Animal & Plant Quarantine Agency; Eulji University; Eulji University; Eulji University	Lee, J (corresponding author), Eulji Univ, Dept Convergence Biomed Sci & Engn, Songnam, Gyunggi Do, South Korea.	jslee@eulji.ac.kr		Shin, Seoungwoo/0000-0001-5354-7286	Korean Health Technology R & D Project, Ministry of Health and Welfare, Republic of Korea [HN13C0072]; Skincure Life Science Institute	Korean Health Technology R & D Project, Ministry of Health and Welfare, Republic of Korea; Skincure Life Science Institute	This study was supported by a grant from the Korean Health Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (Grant Number: HN13C0072). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Kwangseon Jung is employed by Skincure Life Science Institute. Skincure Life Science Institute provided support in the form of salary for author KJ, but did not have any additional role in the study	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Halliday GM, 2008, PHOTOCHEM PHOTOBIOL, V84, P35, DOI 10.1111/j.1751-1097.2007.00212.x; HORN TD, 1994, J AM ACAD DERMATOL, V31, P735, DOI 10.1016/S0190-9622(94)70234-9; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; Lee J, 2012, J CELL BIOCHEM, V113, P3681, DOI 10.1002/jcb.24241; Lee J, 2010, J BIOL CHEM, V285, P32647, DOI 10.1074/jbc.M110.135830; Mitani H, 1999, PHOTOCHEM PHOTOBIOL, V69, P41, DOI 10.1562/0031-8655(1999)069<0041:AOHMSE>2.3.CO;2; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Nadler JV, 2011, NEUROCHEM RES, V36, P668, DOI 10.1007/s11064-010-0291-3; Rycerz K, 2013, FOLIA NEUROPATHOL, V51, P10, DOI 10.5114/fn.2013.34191; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Situm M, 2010, COLLEGIUM ANTROPOL, V34, P9; Sunderkotter C, 2006, RHEUMATOLOGY, V45, P52, DOI 10.1093/rheumatology/kel293; Torii S, 2009, J BIOCHEM, V146, P839, DOI 10.1093/jb/mvp129	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124417	10.1371/journal.pone.0124417	http://dx.doi.org/10.1371/journal.pone.0124417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909857	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800082
J	Lim, YW; Meyer, NP; Shah, AS; Budde, MD; Stemper, BD; Olsen, CM				Lim, Yi Wei; Meyer, Nathan P.; Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.			Voluntary Alcohol Intake following Blast Exposure in a Rat Model of Mild Traumatic Brain Injury	PLOS ONE			English	Article							SUBSTANCE-ABUSE; ETHANOL-CONSUMPTION; PREFRONTAL CORTEX; ANIMAL-MODELS; DRINKING; OVERPRESSURE; PREFERENCE; RESISTANT; ADDICTION; BEHAVIOR	Alcoholism is a frequent comorbidity following mild traumatic brain injury (mTBI), even in patients without a previous history of alcohol dependence. Despite this correlational relationship, the extent to which the neurological effects of mTBI contribute to the development of alcoholism is unknown. In this study, we used a rodent blast exposure model to investigate the relationship between mTBI and voluntary alcohol drinking in alcohol naive rats. We have previously demonstrated in Sprague Dawley rats that blast exposure leads to microstructural abnormalities in the medial prefrontal cortex (mPFC) and other brain regions that progress from four to thirty days. The mPFC is a brain region implicated in alcoholism and drug addiction, although the impact of mTBI on drug reward and addiction using controlled models remains largely unexplored. Alcohol naive Sprague Dawley rats were subjected to a blast model of mTBI (or sham conditions) and then tested in several common measures of voluntary alcohol intake. In a seven-week intermittent two-bottle choice alcohol drinking test, sham and blast exposed rats had comparable levels of alcohol intake. In a short access test session at the conclusion of the two-bottle test, blast rats fell into a bimodal distribution, and among high intake rats, blast treated animals had significantly elevated intake compared to shams. We found no effect of blast when rats were tested for an alcohol deprivation effect or compulsive drinking in a quinine adulteration test. Throughout the experiment, alcohol drinking was modest in both groups, consistent with other studies using Sprague Dawley rats. In conclusion, blast exposure had a minimal impact on overall alcohol intake in Sprague Dawley rats, although intake was increased in a subpopulation of blast animals in a short access session following intermittent access exposure.	[Lim, Yi Wei; Meyer, Nathan P.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Lim, Yi Wei; Meyer, Nathan P.; Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Olsen, CM (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA.	colsen@mcw.edu	Stemper, Brian/AAX-7611-2020; Olsen, Christopher/G-9595-2013	Olsen, Christopher/0000-0003-2700-0310	Neuroscience Research Center at the Medical College of Wisconsin; Research and Education Initiative Fund , a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; United States (U.S.) Department of Veterans Affairs [I01 RX000380]; Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA039276] Funding Source: NIH RePORTER	Neuroscience Research Center at the Medical College of Wisconsin; Research and Education Initiative Fund , a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; United States (U.S.) Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Neuroscience Research Center at the Medical College of Wisconsin (CMO), the Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin (CMO), Merit Review Award I01 RX000380 from the United States (U.S.) Department of Veterans Affairs (MDB), Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research (BDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; AMIT Z, 1970, PSYCHOPHARMACOLOGIA, V17, P367, DOI 10.1007/BF00403808; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Beck A, 2012, ARCH GEN PSYCHIAT, V69, P842, DOI 10.1001/archgenpsychiatry.2011.2026; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Bito-Onon JJ, 2011, ADDICT BIOL, V16, P440, DOI 10.1111/j.1369-1600.2010.00309.x; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Control NcfIPa, 2003, REP C MILD TRAUM BRA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Edwards S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.70; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fein G, 2002, ALCOHOL CLIN EXP RES, V26, P558, DOI 10.1111/j.1530-0277.2002.tb02574.x; Fetzner MG, 2011, DEPRESS ANXIETY, V28, P632, DOI 10.1002/da.20852; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; KHANNA JM, 1990, ALCOHOL, V7, P429, DOI 10.1016/0741-8329(90)90027-A; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Li J, 2011, BRAIN RES BULL, V86, P428, DOI 10.1016/j.brainresbull.2011.08.013; LINSEMAN MA, 1987, PSYCHOPHARMACOLOGY, V92, P254; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lowing JL, 2014, J NEUROTRAUMA; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; Moorman DE, 2009, ALCOHOL, V43, P379, DOI 10.1016/j.alcohol.2009.07.002; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Samson HH, 2003, INT REV NEUROBIOL, V54, P109; Seif T, 2013, NAT NEUROSCI, V16, P1094, DOI 10.1038/nn.3445; Shah Ms Alok S, 2012, Biomed Sci Instrum, V48, P393; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; SINCLAIR JD, 1968, Q J STUD ALCOHOL, V29, P863; Stemper B.D., 2014, ANN BIOMED ENG; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teng SX, 2014, BRAIN BEHAV IMMUN; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vengeliene V, 2014, ALCOHOL, V48, P313, DOI 10.1016/j.alcohol.2014.03.002; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	66	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125130	10.1371/journal.pone.0125130	http://dx.doi.org/10.1371/journal.pone.0125130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910266	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800130
J	Bian, Z; Shixia, C; Duan, T				Bian, Zheng; Shixia, Chenzi; Duan, Tao			First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; PLACENTA GROWTH-FACTOR; GESTATIONAL HYPERTENSION; ANGIOGENIC FACTORS; NULLIPAROUS WOMEN; EARLY-PREGNANCY; CLINICAL RISK; 2ND-TRIMESTER; DISORDERS	Background Placental growth factor (PGF), soluble fms-like tyrosine kinase 1 (sFLT1) and asymmetric dimethylarginine (ADMA) are involved in the pathogenesis of preeclampsia. Abnormal maternal sFLT1, PGF and ADMA levels are detectable weeks before the onset of preeclampsia. Objective To investigate sFLT1, PGF and ADMA in the first trimester of pregnancy as predictors of preeclampsia. Methods In this prospective nested case-control study, 740 pregnant women enrolled at 12-16 weeks of gestation and followed up until 6 weeks after delivery at the Shanghai First Maternity and Infant Health Hospital of Tongji University between January 2010 and December 2012. Forty-four women developed preeclampsia. Urinary proteins were measured using 24-hour collection or dipsticks. sFLT1, PGF and ADMA were measured by ELISA in the first trimester. Pulsatility index (PI) was measured by Doppler ultrasound in the second trimester. Results First-trimester serum sFLT1 and ADMA levels of women who developed preeclampsia were significantly higher compared with women with normal pregnancies (sFLT1: 0.321 +/- 0.023 vs. 0.308 +/- 0.019 ng/ml, P = 0.001; ADMA: 0.86 +/- 0.16 vs. 0.68 +/- 0.20 mu M, P<0.001). First-trimester serum PGF levels of women who developed preeclampsia were significantly lower than in women with normal pregnancies (115.72 +/- 32.55 vs. 217.30 +/- 74.48 pg/ml, P<0.001). Multiple logistic regression and receiver-operating characteristic curves identified first-trimester PGF and ADMA to be sensitive and selective predictors of preeclampsia (area under the curve [AUC]: 0.902), as well as second-trimester uterine artery pulse index (AUC: 0.836). Conclusion In the first trimester, maternal serum sFLT1, PGF and ADMA levels, as well as second-trimester uterine artery PI, could predict preeclampsia.	[Bian, Zheng; Shixia, Chenzi; Duan, Tao] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China	Tongji University	Duan, T (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China.	tduan@yahoo.com			Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai [PWZxq2014-02]	Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai	The study was supported by Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai (Grant No.: PWZxq2014-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell S, 2000, ACTA OBSTET GYN SCAN, V79, P631, DOI 10.1034/j.1600-0412.2000.079008631.x; CAMPBELL S, 1983, LANCET, V1, P675; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; D'Anna R, 2005, OBSTET GYNECOL, V106, P340, DOI 10.1097/01.AOG.0000168441.79050.03; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Gallos ID, 2013, BJOG-INT J OBSTET GY, V120, P1321, DOI 10.1111/1471-0528.12375; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Holmes VA, 2011, DIABETES CARE, V34, P1683, DOI 10.2337/dc11-0244; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Lapaire O, 2010, EUR J OBSTET GYN R B, V151, P122, DOI 10.1016/j.ejogrb.2010.04.009; Leeman L, 2008, AM FAM PHYSICIAN, V78, P93; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lim JH, 2008, OBSTET GYNECOL, V111, P1403, DOI 10.1097/AOG.0b013e3181719b7a; Lindheimer MD, 2009, J CLIN HYPERTENS, V11, P214, DOI 10.1111/j.1751-7176.2009.00085.x; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McKeeman GC, 2004, AM J OBSTET GYNECOL, V191, P1240, DOI 10.1016/j.ajog.2004.03.004; Metz TD, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.027; Nilsen RM, 2012, OBSTET GYNECOL, V119, P1243, DOI 10.1097/AOG.0b013e318255004e; Noorbakhsh Marjan, 2013, ISRN Obstet Gynecol, V2013, P104213, DOI 10.1155/2013/104213; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2007, AM J OBSTET GYNECOL, V197, P1, DOI 10.1016/j.ajog.2007.04.021; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876; Su YN, 2001, OBSTET GYNECOL, V97, P898, DOI 10.1016/S0029-7844(01)01341-2; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Vainio M, 2005, ACTA OBSTET GYN SCAN, V84, P1062, DOI 10.1111/j.0001-6349.2005.00889.x; Widmer M, 2007, OBSTET GYNECOL, V109, P168, DOI 10.1097/01.AOG.0000249609.04831.7c	37	45	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124684	10.1371/journal.pone.0124684	http://dx.doi.org/10.1371/journal.pone.0124684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906026	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000081
J	Chan, R; Wong, VWS; Chu, WCW; Wong, GLH; Li, LS; Leung, J; Chim, AML; Yeung, DKW; Sea, MMM; Woo, J; Chan, FKL; Chan, HLY				Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Leung, Jason; Chim, Angel Mei-Ling; Yeung, David Ka-Wai; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen			Higher Estimated Net Endogenous Acid Production May Be Associated with Increased Prevalence of Nonalcoholic Fatty Liver Disease in Chinese Adults in Hong Kong	PLoS One			English	Article							ASIA-PACIFIC REGION; GROWTH-FACTOR-I; METABOLIC-ACIDOSIS; ENERGY-INTAKE; HIGH-PROTEIN; DIET; HORMONE; POPULATION; CIRRHOSIS; RATS	Nonalcoholic fatty liver disease (NAFLD) has been associated with reduced growth hormone levels and signaling. Such hormonal changes also occur in metabolic acidosis. Since mild metabolic acidosis can be diet induced, diet-induced acid load may constitute a nutritional factor with possible influence on NAFLD development. This study explored whether a higher diet-induced acid load is associated with an increased likelihood of NAFLD. Apparently healthy Chinese adults (330 male, 463 female) aged 19-72 years were recruited through population screening between 2008 and 2010 in a cross-sectional population-based study in Hong Kong. Estimated net endogenous acid production (NEAP) was calculated using Frassetto's method and potential renal acid load (PRAL) was calculated using Remer's method based on dietary data from a food frequency questionnaire. NAFLD was defined as intrahepatic triglyceride content at >5% by proton-magnetic resonance spectroscopy. Possible advanced fibrosis was defined as liver stiffness at >7.9 kPa by transient elastography. Multivariate logistic regression models were used to examine the association between each measure of dietary acid load and prevalent NAFLD or possible advanced fibrosis with adjustment for potential anthropometric and lifestyle factors. 220 subjects (27.7%) were diagnosed with NAFLD. Estimated NEAP was positively associated with the likelihood of having NAFLD after adjustment for age, sex, body mass index, current drinker status and the presence of metabolic syndrome [OR (95% CI) = 1.25 (1.02-1.52), p = 0.022]. The association was slightly attenuated but remained significant when the model was further adjusted for other dietary variables. No association between PRAL and NAFLD prevalence was observed. Both estimated NEAP and PRAL were not associated with the presence of possible advance fibrosis. Our findings suggest that there may be a modest association between diet-induced acid load and NAFLD. More studies are needed to ascertain the link between diet-induced acid load and NAFLD and to investigate the underlying mechanisms.	[Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Chim, Angel Mei-Ling; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Ruth; Sea, Mandy Man-Mei; Woo, Jean] Chinese Univ Hong Kong, Ctr Nutr Studies, Hong Kong, Hong Kong, Peoples R China; [Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung; Chim, Angel Mei-Ling; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Chu, Winnie Chiu-Wing] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China; [Yeung, David Ka-Wai] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	ruthchansm@cuhk.edu.hk	Chan, Ruth/K-4995-2014; Chan, Francis K. L./F-4851-2010; Chu, Winnie CW/F-8449-2014; Chan, Henry Lik-Yuen/B-9636-2008; Woo, Jean/K-2625-2014; Wong, Grace LH/L-8586-2014; Wong, Vincent WS/K-3864-2014	Chan, Francis K. L./0000-0001-7388-2436; Chu, Winnie CW/0000-0003-4962-4132; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Woo, Jean/0000-0001-7593-3081; Wong, Grace LH/0000-0002-2863-9389; Wong, Vincent WS/0000-0003-2215-9410; Chan, Ruth/0000-0002-5725-4066	Health and Health Services Research Fund; Government of Hong Kong SAR [07080081]; Centre for Nutritional Studies; Chinese University of Hong Kong	Health and Health Services Research Fund; Government of Hong Kong SAR; Centre for Nutritional Studies; Chinese University of Hong Kong(Chinese University of Hong Kong)	The study was supported by funding from the Health and Health Services Research Fund sponsored by the Government of Hong Kong SAR (Reference number 07080081) and the Centre for Nutritional Studies, under the auspices of The Chinese University of Hong Kong. The Centre for Nutritional Studies did have a role in the data collection and analysis.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Centre for Food Safety, 2006, NUTR INF INQ; CHALLA A, 1993, AM J PHYSIOL, V265, pE547, DOI 10.1152/ajpendo.1993.265.4.E547; Chan RSM, 2009, EUR J CLIN NUTR, V63, P505, DOI 10.1038/ejcn.2008.3; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Frassetto LA, 1998, AM J CLIN NUTR, V68, P576, DOI 10.1093/ajcn/68.3.576; Frassetto LA, 2007, J NUTR, V137, P1491, DOI 10.1093/jn/137.6.1491; Frassetto LA, 2006, J NEPHROL, V19, pS33; Gannon MC, 2011, METABOLISM, V60, P1300, DOI 10.1016/j.metabol.2011.01.016; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4; Kargulewicz A, 2014, PRZ GASTROENTEROL, V9, P18, DOI 10.5114/pg.2014.40845; Krupp D, 2012, J NUTR, V142, P313, DOI 10.3945/jn.111.150540; McCarthy EM, 2012, J ACAD NUTR DIET, V112, P401, DOI 10.1016/j.jada.2011.10.007; Mitch WE, 2006, J NEPHROL, V19, pS70; Mouzaki M, 2012, J CLIN GASTROENTEROL, V46, P457, DOI 10.1097/MCG.0b013e31824cf51e; Pichon L, 2006, J NUTR, V136, P1256, DOI 10.1093/jn/136.5.1256; Pizzorno J, 2010, BRIT J NUTR, V103, P1185, DOI 10.1017/S0007114509993047; Remer T, 2000, SEMIN DIALYSIS, V13, P221, DOI 10.1046/j.1525-139x.2000.00062.x; Remer T, 2003, AM J CLIN NUTR, V77, P1255, DOI 10.1093/ajcn/77.5.1255; Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322; Wiederkehr MR, 2004, NEPHROL DIAL TRANSPL, V19, P1190, DOI 10.1093/ndt/gfh096; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wong VWS, 2006, CLIN GASTROENTEROL H, V4, P1154, DOI 10.1016/j.cgh.2006.06.011; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wong VWS, 2011, GUT, V60, P1721, DOI 10.1136/gut.2011.242016; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044136; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yang YX, 2004, CHINA FOOD COMPOSITI	39	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122406	10.1371/journal.pone.0122406	http://dx.doi.org/10.1371/journal.pone.0122406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905490	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000013
J	Mougin, B; Tian, RBD; Drancourt, M				Mougin, Benjamin; Tian, Roger B. D.; Drancourt, Michel			Tropical Plant Extracts Modulating the Growth of Mycobacterium ulcerans	PLOS ONE			English	Article							BURULI ULCER; ENVIRONMENT; DISEASE; FLUORESCENCE; TUBERCULOSIS; MYCOLACTONE; INFECTION; EVOLUTION; CAMEROON; CULTURE	Mycobacterium ulcerans, the etiologic agent of Buruli ulcer, has been detected on aquatic plants in endemic tropical regions. Here, we tested the effect of several tropical plant extracts on the growth of M. ulcerans and the closely related Mycobacterium marinum. M. ulcerans and M. marinum were inoculated on Middlebrook 7H11 medium with and without extracts from tropical aquatic plants, including Ammannia gracilis, Crinum calamistratum, Echinodorus africanus, Vallisneria nana and Vallisneria torta. Delay of detection of the first colony and the number of colonies at day 7 (M. marinum) or day 16 (M. ulcerans) were used as endpoints. The first M. ulcerans colonies were detected at 8 +/- 0 days on control Middlebrook 7H11 medium, 6.34 +/- 0.75 days on A. gracilis-enriched medium (p<0.01), 6 +/- 1 days on E. africanus- and V. torta-enriched media (p<0.01), 6 +/- 0 days on V. nana-enriched medium (p<0.01) and 5.67 +/- 0.47 days on C. calamistratum-enriched medium (p<0.01). Furthermore, the number of detected colonies was significantly increased in C. calamistratum-and E. africanus-enriched media at each time point compared to Middlebrook 7H11 (p<0.05). V. nana- and V. torta-enriched media significantly increased the number of detected colonies starting from day 6 and day 10, respectively (p<0.001). At the opposite, A. gracilis-enriched medium significantly decreased the number of detected colonies starting from day 8 PI (p<0.05). In conclusion, some aquatic plant extracts, could be added as adjuvants to the Middlebrook 7H11 medium for the culturing of M. marinum and M. ulcerans.	[Mougin, Benjamin; Tian, Roger B. D.; Drancourt, Michel] Aix Marseille Univ, Inserm 1095, IRD 198, URMITE,UMR CNRS 7278, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, Inserm 1095, IRD 198, URMITE,UMR CNRS 7278, Marseille, France.	michel.drancourt@univ-amu.fr						Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; Bouricha M, 2014, INT J INFECT DIS, V21, P17, DOI 10.1016/j.ijid.2013.11.020; Bratschi MW, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002756; CLARK HF, 1963, J BACTERIOL, V86, P1057, DOI 10.1128/JB.86.5.1057-1069.1963; Dailloux M, 1999, WATER RES, V33, P2219, DOI 10.1016/S0043-1354(98)00466-7; El Khechine A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024720; FRICKER MD, 1992, J MICROSC-OXFORD, V166, P29, DOI 10.1111/j.1365-2818.1992.tb01505.x; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Ghodbane R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04236; Kaser M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-177; Kenu E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003279; LANG M, 1991, RADIAT ENVIRON BIOPH, V30, P333, DOI 10.1007/BF01210517; Marion E, 2011, EMERG INFECT DIS, V17, P551, DOI 10.3201/eid1703.091859; Marsollier L, 2004, APPL ENVIRON MICROB, V70, P1097, DOI 10.1128/AEM.70.2.1097-1103.2004; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P3829, DOI 10.1128/JCM.00783-11; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; Patino S, 2008, J CLIN MICROBIOL, V46, P3296, DOI [10.1128/JCM.02183-08, 10.1128/JCM.02183-07]; Petrini B, 2006, Eur J Clin Microbiol Infect Dis, V25, P609, DOI 10.1007/s10096-006-0201-4; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Qi WH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000580; Williamson HR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001506; World Health Organization, 2013, BUR ULC; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9; Yip MJ, 2007, J BACTERIOL, V189, P2021, DOI 10.1128/JB.01442-06	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124626	10.1371/journal.pone.0124626	http://dx.doi.org/10.1371/journal.pone.0124626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905816	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000080
J	Wu, DW; Chen, CY; Chu, CL; Lee, H				Wu, D-W; Chen, C-Y; Chu, C-L; Lee, H.			Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability	ONCOGENE			English	Article							PHOSPHORYLATION; EXPRESSION; SURVIVAL; MUTATION; CELLS; DEGRADATION; PROMOTES; PATHWAY	Tyrosine kinase inhibitors (TKIs) have been documented to have substantial clinical benefits to non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutation. TKI resistance occurs in nearly all patients who receive TKI-targeting therapy, resulting in a modest overall survival benefit. Therefore, establishing a biomarker for early prediction and exploring the mechanism of primary TKI resistance is essential for improving the therapeutic efficacy in non-small cell lung cancer patients. In this study, we provide evidence indicating that paxillin (PXN) overexpression may confer TKI resistance in EGFR-mutant lung cancer cells. Mechanistically, PXN-mediated extracellular signal-regulated kinases (ERK) activation is responsible for TKI resistance via decreased Bcl2-interacting mediator of cell death (BIM) and increased Mcl-1 expression due to modulating their protein stabilities by phosphorylation of BIM at serine 69 and Mcl-1 at threonine 163. The mechanistic action in the cell model was further confirmed by the observation of xenograft tumors in nude mice, revealing that the PXN-mediated TKI resistance was conquered by ERK inhibitor (AZD6244) and Bcl-2 family inhibitor (obatoclax), but the TKI resistance overcome by AZD6244 is more effective than that of obatoclax. Therefore, we suggest that PXN expression may be useful in predicting primary TKI resistance, and combining TKI with ERK inhibitors may clinically benefit EGFR-mutant non-small cell lung cancer patients whose tumors exhibit high PXN expression.	[Wu, D-W; Lee, H.] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chen, C-Y; Chu, C-L] China Med Univ Hosp, Ctr Canc, Taichung, Taiwan; [Chen, C-Y] Chung Shan Med Univ Hosp, Dept Surg, Taichung 40201, Taiwan	Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Lee, H (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Room 5,12F,3 Pk St, Taipei 115, Taiwan.	hl@tmu.edu.tw			National Health Research Institute [NHRI-EX103-10328BI]; National Science Council of Taiwan, ROC [NSC100-2314-B-038-043-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was jointly supported by grants from the National Health Research Institute (NHRI-EX103-10328BI) and the National Science Council (NSC100-2314-B-038-043-MY3) of Taiwan, ROC.	Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Costa DB, 2007, LUNG CANCER, V58, P95, DOI 10.1016/j.lungcan.2007.05.017; de Bruin EC, 2014, CANCER DISCOV, V4, P606, DOI 10.1158/2159-8290.CD-13-0741; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Huang MH, 2013, MOL ONCOL, V7, P112, DOI 10.1016/j.molonc.2012.09.002; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Kim HR, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-50; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Liao MM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-44; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Ochi N, 2014, EXP CELL RES, V322, P168, DOI 10.1016/j.yexcr.2014.01.007; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song JY, 2013, INVEST NEW DRUG, V31, P1458, DOI 10.1007/s10637-013-0030-0; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Wu DW, 2014, ONCOGENE, V33, P4385, DOI 10.1038/onc.2013.389; Wu DW, 2012, AM J PATHOL, V181, P1796, DOI 10.1016/j.ajpath.2012.07.032; Zhao JF, 2009, MOL CANCER RES, V7, P1954, DOI 10.1158/1541-7786.MCR-09-0304	28	28	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					621	630		10.1038/onc.2015.120	http://dx.doi.org/10.1038/onc.2015.120			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25915848				2022-12-26	WOS:000369548800009
J	Esaki, K; Sayano, T; Sonoda, C; Akagi, T; Suzuki, T; Ogawa, T; Okamoto, M; Yoshikawa, T; Hirabayashi, Y; Furuya, S				Esaki, Kayoko; Sayano, Tomoko; Sonoda, Chiaki; Akagi, Takumi; Suzuki, Takeshi; Ogawa, Takuya; Okamoto, Masahiro; Yoshikawa, Takeo; Hirabayashi, Yoshio; Furuya, Shigeki			L-Serine Deficiency Elicits Intracellular Accumulation of Cytotoxic Deoxysphingolipids and Lipid Body Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOGLYCERATE DEHYDROGENASE-DEFICIENCY; SPHINGOLIPID METABOLISM; QUANTITATIVE-ANALYSIS; CERAMIDE SYNTHASES; DIABETES-MELLITUS; PYRUVATE-KINASE; AMINO ACIDS; PALMITOYLTRANSFERASE; PLASMA; BIOSYNTHESIS	L-Serine is required to synthesize membrane lipids such as phosphatidylserine and sphingolipids. Nevertheless, it remains largely unknown how a diminished capacity to synthesize L-serine affects lipid homeostasis in cells and tissues. Here, we show that deprivation of external L-serine leads to the generation of 1-deoxysphingolipids (doxSLs), including 1-deoxysphinganine, in mouse embryonicfibroblasts(KO-MEFs)lackingD-3-phosphoglyceratede-hydrogenase (Phgdh), which catalyzes the first step in the de novo synthesis of L-serine. A novel mass spectrometry-based lipidomic approach demonstrated that 1-deoxydihydroceramide was the most abundant species of doxSLs accumulated in L-serine-deprived KO-MEFs. Among normal sphingolipid species in KO-MEFs, levels of sphinganine, dihydroceramide, ceramide, and hexosylceramide were significantly reduced after deprivation of external L-serine, whereas those of sphingomyelin, sphingosine, and sphingosine 1-phosphate were retained. The synthesis of doxSLs was suppressed by supplementing the culture medium with L-serine but was potentiated by increasing the ratio of L-alanine to L-serine in the medium. Unlike with L-serine, depriving cells of external L-leucine did not promote the occurrence of doxSLs. Consistent with results obtained from KO-MEFs, brain-specific deletion of Phgdh in mice also resulted in accumulation of doxSLs in the brain. Furthermore, L-serine-deprived KO-MEFs exhibited increased formation of cytosolic lipid bodies containing doxSLs and other sphingolipids. These in vitro and in vivo studies indicate that doxSLs are generated in the presence of a high ratio of L-alanine to L-serine in cells and tissues lacking Phgdh, and de novo synthesis of L-serine is necessary to maintain normal sphingolipid homeostasis when the external supply of this amino acid is limited.	[Esaki, Kayoko; Sayano, Tomoko; Sonoda, Chiaki; Furuya, Shigeki] Kyushu Univ, Lab Funct Genom & Metab, Grad Sch Bioresource & Bioenvironm Sci, Div Syst Bioengn, Fukuoka 8128581, Japan; [Suzuki, Takeshi; Okamoto, Masahiro] Kyushu Univ, Lab Synthet Biol, Grad Sch Bioresource & Bioenvironm Sci, Div Syst Bioengn, Fukuoka 8128581, Japan; [Okamoto, Masahiro; Furuya, Shigeki] Kyushu Univ, Bioarchitecture Ctr, Fukuoka 8128581, Japan; [Esaki, Kayoko; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan; [Esaki, Kayoko; Sayano, Tomoko; Hirabayashi, Yoshio] RIKEN Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan; [Akagi, Takumi] RIKEN Brain Sci Inst, Support Unit Neuromorphol Anal, Wako, Saitama 3510198, Japan; [Ogawa, Takuya] Int Univ Hlth & Welf, Dept Pharmaceut Sci, Otawara, Tochigi 3248501, Japan	Kyushu University; Kyushu University; Kyushu University; RIKEN; RIKEN; RIKEN; International University of Health & Welfare	Furuya, S (corresponding author), Kyushu Univ, Div Syst Bioengn, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan.	shigekifur@brs.kyushu-u.ac.jp	Ogawa, Takuya/ABC-9628-2020; Yoshikawa, Takeo/F-9599-2019	Ogawa, Takuya/0000-0001-9194-3079; Hirabayashi, Yoshio/0000-0002-5774-7354; Furuya, Shigeki/0000-0001-9020-3597	Tojuro Iijima Foundation for Food and Technology; Japan Society for the Promotion of Science KAKENHI [14J05809]; Junior Research Associate of RIKEN; Grants-in-Aid for Scientific Research [24614007] Funding Source: KAKEN	Tojuro Iijima Foundation for Food and Technology; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Junior Research Associate of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from The Tojuro Iijima Foundation for Food and Technology (to S. F.) and Japan Society for the Promotion of Science KAKENHI Grant 14J05809 (to K. E.).r Supported by the fellowship of Junior Research Associate of RIKEN.	Baird RD, 2009, MOL CANCER THER, V8, P1430, DOI 10.1158/1535-7163.MCT-08-1167; Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Causeret C, 2000, LIPIDS, V35, P1117, DOI 10.1007/s11745-000-0627-6; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cuadros R, 2000, CANCER LETT, V152, P23, DOI 10.1016/S0304-3835(99)00428-0; de Koning TJ, 1998, ANN NEUROL, V44, P261, DOI 10.1002/ana.410440219; De Luca G, 2001, METABOLISM, V50, P739, DOI 10.1053/meta.2001.24193; Ding YF, 2013, NAT PROTOC, V8, P43, DOI 10.1038/nprot.2012.142; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Hanada K, 2000, FEBS LETT, V474, P63, DOI 10.1016/S0014-5793(00)01579-9; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; ICHIHARA A, 1955, P NATL ACAD SCI USA, V41, P605, DOI 10.1073/pnas.41.9.605; Kamaura M, 2010, CIRC J, V74, P2434, DOI 10.1253/circj.CJ-10-0150; Kawakami Y, 2009, NEUROSCI RES, V63, P184, DOI 10.1016/j.neures.2008.12.002; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Marshall Lee L., 2014, Journal of Chemical Biology, V7, P67, DOI 10.1007/s12154-014-0108-y; Massard C, 2012, INVEST NEW DRUG, V30, P2318, DOI 10.1007/s10637-011-9772-8; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mitoma J, 2004, GENE, V334, P15, DOI 10.1016/j.gene.2004.03.015; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Ogawa T, 2006, J BONE MINER METAB, V24, P373, DOI 10.1007/s00774-006-0705-0; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Othman A, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000073; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Salcedo M, 2007, APOPTOSIS, V12, P395, DOI 10.1007/s10495-006-0573-z; Sayano T, 2013, FEBS J, V280, P1502, DOI 10.1111/febs.12146; SCHARFF R, 1966, BIOCHEM J, V99, P173, DOI 10.1042/bj0990173; Schoffski P, 2011, CANCER CHEMOTH PHARM, V68, P1397, DOI 10.1007/s00280-011-1612-1; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yang JH, 2010, J BIOL CHEM, V285, P41380, DOI 10.1074/jbc.M110.187443; Yoshida K, 2004, J BIOL CHEM, V279, P3573, DOI 10.1074/jbc.C300507200; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	49	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14595	14609		10.1074/jbc.M114.603860	http://dx.doi.org/10.1074/jbc.M114.603860			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903138	Green Published, hybrid			2022-12-26	WOS:000355754600030
J	Deng, QL; Odhiambo, JF; Farooq, U; Lam, T; Dunn, SM; Ametaj, BN				Deng, Qilan; Odhiambo, John F.; Farooq, Umar; Lam, Tran; Dunn, Suzanna M.; Ametaj, Burim N.			Intravaginal Lactic Acid Bacteria Modulated Local and Systemic Immune Responses and Lowered the Incidence of Uterine Infections in Periparturient Dairy Cows	PLOS ONE			English	Article							LACTOBACILLUS-RHAMNOSUS GR-1; LIPOPOLYSACCHARIDE-BINDING; REPRODUCTIVE-PERFORMANCE; FERMENTUM RC-14; VAGINAL FLORA; POSTPARTUM; PROTEIN; ABSORPTION; PROBIOTICS; MASTITIS	The objective of this investigation was to evaluate whether intravaginal infusion of a lactic acid bacteria (LAB) cocktail around parturition could influence the immune response, incidence rate of uterine infections, and the overall health status of periparturient dairy cows. One hundred pregnant Holstein dairy cows were assigned to 1 of the 3 experimental groups as follows: 1) one dose of LAB on wk -2 and -1, and one dose of carrier (sterile skim milk) on wk +1 relative to the expected day of parturition (TRT1); 2) one dose of LAB on wk -2, -1, and +1 (TRT2), and 3) one dose of carrier on wk -2, -1, and +1 (CTR). The LAB were a lyophilized culture mixture composed of Lactobacillus sakei FUA3089, Pediococcus acidilactici FUA3138, and Pediococcus acidilactici FUA3140 with a cell count of 108-109 cfu/dose. Blood samples and vaginal mucus were collected once a week from wk -2 to +3 and analyzed for content of serum total immunoglobulin G (IgG), lipopolysaccharide-binding protein (LBP), serum amyloid A (SAA), haptoglobin (Hp), tumor necrosis factor (TNF), interleukin (IL)-1, IL-6, and vaginal mucus secretory IgA (sIgA). Clinical observations including rectal temperature, vaginal discharges, retained placenta, displaced abomasum, and laminitis were monitored from wk -2 to +8 relative to calving. Results showed that intravaginal LAB lowered the incidence of metritis and total uterine infections. Intravaginal LAB also were associated with lower concentrations of systemic LBP, an overall tendency for lower SAA, and greater vaginal mucus sIgA. No differences were observed for serum concentrations of Hp, TNF, IL-1, IL-6 and total IgG among the treatment groups. Administration with LAB had no effect on the incidence rates of other transition cow diseases. Overall intravaginal LAB lowered uterine infections and improved local and systemic immune responses in the treated transition dairy cows.	[Deng, Qilan; Odhiambo, John F.; Farooq, Umar; Lam, Tran; Dunn, Suzanna M.; Ametaj, Burim N.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada	University of Alberta	Ametaj, BN (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.	burim.ametaj@ualberta.ca	odhiambo, john/AAC-2444-2020	odhiambo, john/0000-0002-1005-3486; Ametaj, Burim/0000-0003-0957-9373	Alberta Livestock and Meat Agency Ltd. (ALMA); Alberta Milk; Natural Sciences and Engineering Research Council of Canada (NSERC)	Alberta Livestock and Meat Agency Ltd. (ALMA); Alberta Milk; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge the financial support of the funding agencies including Alberta Livestock and Meat Agency Ltd. (ALMA), Alberta Milk, and Natural Sciences and Engineering Research Council of Canada (NSERC) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametaj BN, 2014, RES VET SCI, V96, P365, DOI 10.1016/j.rvsc.2014.02.007; Ametaj BN, 2011, ACUTE PHASE PROTEINS AS EARLY NON-SPECIFIC BIOMARKERS OF HUMAN AND VETERINARY DISEASES, P299; Azawi OI, 2008, ANIM REPROD SCI, V105, P187, DOI 10.1016/j.anireprosci.2008.01.010; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Burton JL, 2001, ACTA VET SCAND, V42, P407; BURTON NR, 1995, VET REC, V136, P90, DOI 10.1136/vr.136.4.90; Chan JPW, 2010, VET CLIN PATH, V39, P72, DOI 10.1111/j.1939-165X.2009.00182.x; Cross ML, 2002, FEMS IMMUNOL MED MIC, V34, P245, DOI 10.1111/j.1574-695X.2002.tb00632.x; Falagas ME, 2006, DRUGS, V66, P1253, DOI 10.2165/00003495-200666090-00007; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; Gardiner GE, 2002, CLIN DIAGN LAB IMMUN, V9, P92, DOI 10.1128/CDLI.9.1.92-96.2002; Government of Canada, 2013, CULL REPL RAT DAIR H; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Herr M, 2011, THERIOGENOLOGY, V75, P377, DOI 10.1016/j.theriogenology.2010.09.009; HILTON E, 1995, J CLIN MICROBIOL, V33, P1433, DOI 10.1128/JCM.33.5.1433-1433.1995; HUSSAIN AM, 1989, J VET MED B, V36, P641, DOI 10.1111/j.1439-0450.1989.tb00657.x; KAILA M, 1992, PEDIATR RES, V32, P141, DOI 10.1203/00006450-199208000-00002; Kasimanickam RK, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-103; Kim IH, 2005, J REPROD DEVELOP, V51, P757, DOI 10.1262/jrd.17036; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Kucharski J, 2008, POL J VET SCI, V11, P9; Kutteh WH, 1996, CLIN EXP IMMUNOL, V104, P538, DOI 10.1046/j.1365-2249.1996.36742.x; Laugerette F, 2011, BIOCHIMIE, V93, P39, DOI 10.1016/j.biochi.2010.04.016; Lewis GS, 1997, J DAIRY SCI, V80, P984, DOI 10.3168/jds.S0022-0302(97)76024-7; Madsen K, 2006, J CLIN GASTROENTEROL, V40, P232, DOI 10.1097/00004836-200603000-00014; MAITRA SK, 1981, HEPATOLOGY, V1, P401, DOI 10.1002/hep.1840010506; Mateus L, 2002, REPROD DOMEST ANIM, V37, P31, DOI 10.1046/j.1439-0531.2002.00317.x; MATHISON J, 1993, J CLIN INVEST, V92, P2053, DOI 10.1172/JCI116801; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161; Olsson J, 1996, BRIT J OBSTET GYNAEC, V103, P558, DOI 10.1111/j.1471-0528.1996.tb09806.x; Reid G, 2003, FEMS IMMUNOL MED MIC, V35, P131, DOI 10.1016/S0928-8244(02)00465-0; Reid G, 2003, POSTGRAD MED J, V79, P428, DOI 10.1136/pmj.79.934.428; Reid G, 2001, FEMS IMMUNOL MED MIC, V32, P37, DOI 10.1111/j.1574-695X.2001.tb00531.x; REID G, 1994, LANCET, V344, P1229, DOI 10.1016/S0140-6736(94)90543-6; RIGHTER HF, 1975, CAN VET J, V16, P10; RUSSELL MW, 1999, MUCOSAL IMMUNOLOGY, P225; Schukken YH, 2003, VET RES, V34, P579, DOI 10.1051/vetres:2003028; Shao BM, 2012, INNATE IMMUN-LONDON, V18, P825, DOI 10.1177/1753425912442431; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P429, DOI 10.5713/ajas.2011.10233; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Wang Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-19; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Zeng R, 2009, J DAIRY SCI, V92, P980, DOI 10.3168/jds.2008-1636; Zerbe H, 1996, THERIOGENOLOGY, V46, P1339, DOI 10.1016/S0093-691X(96)00314-7	48	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124167	10.1371/journal.pone.0124167	http://dx.doi.org/10.1371/journal.pone.0124167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919010	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400043
J	Kale, MS; Federman, AD; Krauskopf, K; Wolf, M; O'Conor, R; Martynenko, M; Leventhal, H; Wisnivesky, JP				Kale, Minal S.; Federman, Alex D.; Krauskopf, Katherine; Wolf, Michael; O'Conor, Rachel; Martynenko, Melissa; Leventhal, Howard; Wisnivesky, Juan P.			The Association of Health Literacy with Illness and Medication Beliefs among Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SELF-MANAGEMENT; ADHERENCE; ASTHMA; COPD; NONADHERENCE; PERCEPTIONS; VALIDATION; MORTALITY; PATTERNS; OUTCOMES	Background Low health literacy is associated with low adherence to self-management in many chronic diseases. Additionally, health beliefs are thought to be determinants of self-management behaviors. In this study we sought to determine the association, if any, of health literacy and health beliefs among elderly individuals with COPD. Methods We enrolled a cohort of patients with COPD from two academic urban settings in New York, NY and Chicago, IL. Health literacy was measured using the Short Test of Functional Health Literacy in Adults. Using the framework of the Self-Regulation Model, illness and medication beliefs were measured with the Brief Illness Perception Questionnaire (B-IPQ) and Beliefs about Medications Questionnaire (BMQ). Unadjusted analyses, with corresponding Cohen's d effect sizes, and multiple logistic regression were used to assess the relationships between HL and illness and medication beliefs. Results We enrolled 235 participants, 29% of whom had low health literacy. Patients with low health literacy were more likely to belong to a racial minority group (p<0.001), not be married (p = 0.006), and to have lower income (p<0.001) or education (p<0.001). In unadjusted analyses, patients with low health literacy were less likely to believe they will always have COPD (p = 0.003, Cohen's d = 0.42), and were more likely to be concerned about their illness ((p = 0.04, Cohen's d = 0.17). In analyses adjusted for sociodemographic factors and other health beliefs, patients with low health literacy were less likely to believe that they will always have COPD (odds ratio [OR]: 0.78, 95% confidence interval [CI]: 0.65-0.94). In addition, the association of low health literacy with expressed concern about medications remained significant (OR: 1.20, 95% CI: 1.05-1.37) though the association of low health literacy with belief in the necessity of medications was no longer significant (OR: 0.92, 95% CI: 0.82-1.04). Conclusions In this cohort of urban individuals with COPD, low health literacy was prevalent, and associated with illness beliefs that predict decreased adherence. Our results suggest that targeted strategies to address low health literacy and related illness and medications beliefs might improve COPD medication adherence and other self-management behaviors.	[Kale, Minal S.; Federman, Alex D.; Krauskopf, Katherine; Martynenko, Melissa; Wisnivesky, Juan P.] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA; [Wolf, Michael; O'Conor, Rachel] Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med, Chicago, IL 60611 USA; [Leventhal, Howard] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA; [Wisnivesky, Juan P.] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Northwestern University; Feinberg School of Medicine; Rutgers State University New Brunswick; Icahn School of Medicine at Mount Sinai	Kale, MS (corresponding author), Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA.	minal.kale@mountsinai.org	Wolf, Michael/V-3351-2018	Wolf, Michael/0000-0002-4342-6517	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL105385]; National Cancer Institute of the National Institutes of Health [K07CA187071]; NATIONAL CANCER INSTITUTE [K07CA187071] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105385] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R01HL105385. Minal Kale was supported by a grant from the National Cancer Institute of the National Institutes of Health under Award Number K07CA187071 during the writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P., 1996, VITAL HLTH STAT, V10, P1; [Anonymous], GLOBAL STRATEGY FOR; Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Cameron H., 2003, SELF REGULATION HLTH; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Cho YI, 2008, SOC SCI MED, V66, P1809, DOI 10.1016/j.socscimed.2008.01.003; Cohen J, 1988, STAT POWER ANAL BEHA, Vxxi; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; DOLCE JJ, 1991, CHEST, V99, P837, DOI 10.1378/chest.99.4.837; DOMPELING E, 1992, FAM PRACT, V9, P161, DOI 10.1093/fampra/9.2.161; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Eisner MD, 2005, CHEST, V127, P1890, DOI 10.1378/chest.127.6.1890; Federman AD, 2013, PATIENT EDUC COUNS, V92, P273, DOI 10.1016/j.pec.2013.02.013; Federman AD, 2010, J ASTHMA, V47, P620, DOI 10.3109/02770901003702816; George J, 2005, CHEST, V128, P3198, DOI 10.1378/chest.128.5.3198; Halm EA, 2006, CHEST, V129, P573, DOI 10.1378/chest.129.3.573; Halpin David M G, 2006, Proc Am Thorac Soc, V3, P619, DOI 10.1513/pats.200603-093SS; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Institute of Medicine, 2004, HLTH LITERACY PRESCR; JAMES PNE, 1985, POSTGRAD MED J, V61, P7, DOI 10.1136/pgmj.61.711.7; Kaptein AA, 2008, J ASTHMA, V45, P625, DOI 10.1080/02770900802127048; Kaptein AA, 2010, CURR OPIN ALLERGY CL, V10, P194, DOI 10.1097/ACI.0b013e32833950c1; Khdour MR, 2012, EUR J CLIN PHARMACOL, V68, P1365, DOI 10.1007/s00228-012-1279-5; Mann DM, 2009, J BEHAV MED, V32, P278, DOI 10.1007/s10865-009-9202-y; Menckeberg TT, 2008, J PSYCHOSOM RES, V64, P47, DOI 10.1016/j.jpsychores.2007.07.016; Mooss A, 2013, HEALTH EDUC J, V72, P292, DOI 10.1177/0017896912442952; Nurss JR, 2003, TEST FUNCTIONAL HLTH; Omachi TA, 2013, J GEN INTERN MED, V28, P74, DOI 10.1007/s11606-012-2177-3; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Tordera MP, 2009, ARCH BRONCONEUMOL, V45, P218, DOI 10.1016/j.arbres.2008.06.006; Rand CS, 2005, EUR RESPIR REV, V14, P97, DOI 10.1183/09059180.05.00009604; Shoemaker SJ, 2014, PATIENT EDUC COUNS, V96, P395, DOI 10.1016/j.pec.2014.05.027; Sofianou A, 2013, J GEN INTERN MED, V28, P67, DOI 10.1007/s11606-012-2160-z; TAYLOR DR, 1984, BRIT J CLIN PHARMACO, V17, P15, DOI 10.1111/j.1365-2125.1984.tb04992.x; THOMPSON J, 1994, CHEST, V105, P715, DOI 10.1378/chest.105.3.715; White S, 2008, AM J HEALTH BEHAV, V32, P227; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946	42	68	71	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123937	10.1371/journal.pone.0123937	http://dx.doi.org/10.1371/journal.pone.0123937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915420	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100029
J	Kim, JK; Kim, JM; Song, BH; Yun, SI; Yun, GN; Byun, SJ; Lee, YM				Kim, Jin-Kyoung; Kim, Jeong-Min; Song, Byung-Hak; Yun, Sang-Im; Yun, Gil-Nam; Byun, Sung-June; Lee, Young-Min			Profiling of Viral Proteins Expressed from the Genomic RNA of Japanese Encephalitis Virus Using a Panel of 15 Region-Specific Polyclonal Rabbit Antisera: Implications for Viral Gene Expression	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; DENGUE VIRUS; CORE PROTEIN; NONSTRUCTURAL PROTEIN; NUCLEAR-LOCALIZATION; FLAVIVIRUS KUNJIN; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; FUNCTIONAL IMPORTANCE	Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, is closely related to West Nile (WN), yellow fever (YF), and dengue (DEN) viruses. Its plus-strand genomic RNA carries a single open reading frame encoding a polyprotein that is cleaved into three structural (C, prM/M, and E) and at least seven nonstructural (NS1/NS1', NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins, based on previous work with WNV, YFV, and DENV. Here, we aimed to profile experimentally all the viral proteins found in JEV-infected cells. We generated a collection of 15 JEV-specific polyclonal antisera covering all parts of the viral proteincoding regions, by immunizing rabbits with 14 bacterially expressed glutathione-Stransferase fusion proteins (for all nine viral proteins except NS2B) or with a chemically synthesized oligopeptide (for NS2B). In total lysates of JEV-infected BHK-21 cells, immunoblotting with these antisera revealed: (i) three mature structural proteins (similar to 12-kDa C, similar to 8-kDa M, and similar to 53-kDa E), a precursor of M (similar to 24-kDa prM) and three other M-related proteins (similar to 10-14 kDa); (ii) the predicted similar to 45-kDa NS1 and its frameshift product, similar to 58-kDa NS1', with no evidence of the predicted similar to 25-kDa NS2A; (iii) the predicted but hardly detectable similar to 14-kDa NS2B and an unexpected but predominant similar to 12-kDa NS2B-related protein; (iv) the predicted similar to 69-kDa NS3 plus two major cleavage products (similar to 34-kDa NS3(N-term) and similar to 35-kDa NS3(C-term)), together with at least nine minor proteins of similar to 016-52 kDa; (v) the predicted similar to 14kDa NS4A; (vi) two NS4B-related proteins (similar to 27-kDa NS4B and similar to 25-kDa NS4B'); and (vii) the predicted similar to 103-kDa NS5 plus at least three other NS5-related proteins (similar to 15 kDa, similar to 27 kDa, and similar to 90 kDa). Combining these data with confocal microscopic imaging of the proteins' intracellular localization, our study is the first to provide a solid foundation for the study of JEV gene expression, which is crucial for elucidating the regulatory mechanisms of JEV genome replication and pathobiology.	[Kim, Jin-Kyoung; Song, Byung-Hak; Yun, Sang-Im; Lee, Young-Min] Utah State Univ, Coll Agr & Appl Sci, Dept Anim Dairy & Vet Sci, Utah Sci Technol & Res, Logan, UT 84322 USA; [Kim, Jeong-Min; Yun, Gil-Nam] Chungbuk Natl Univ, Coll Med, Dept Microbiol, Cheongju, South Korea; [Byun, Sung-June] Korea Natl Inst Anim Sci, Anim Biotechnol Div, Suwon, South Korea	Utah System of Higher Education; Utah State University; Chungbuk National University; National Institute of Animal Science, Republic of Korea	Lee, YM (corresponding author), Utah State Univ, Coll Agr & Appl Sci, Dept Anim Dairy & Vet Sci, Utah Sci Technol & Res, Logan, UT 84322 USA.	youngmin.lee@usu.edu			Utah Science Technology and Research [A25454]; Utah Agricultural Experiment Station [UTA01102]; Basic Science Research Program of the National Research Foundation - Ministry of Education, Science, and Technology of Korea [2009-0069679]; Chungbuk National University	Utah Science Technology and Research; Utah Agricultural Experiment Station; Basic Science Research Program of the National Research Foundation - Ministry of Education, Science, and Technology of Korea; Chungbuk National University	This work was supported by funding from the Utah Science Technology and Research (A25454), the Utah Agricultural Experiment Station (UTA01102), and the Basic Science Research Program (2009-0069679) of the National Research Foundation by the Ministry of Education, Science, and Technology of Korea. This research was approved as journal paper number UAES #8752. YML was supported in part by a grant from Chungbuk National University in 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P331; ARIAS CF, 1993, VIROLOGY, V193, P888, DOI 10.1006/viro.1993.1198; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Beasley DWC, 2008, EXPERT OPIN BIOL TH, V8, P95, DOI 10.1517/14712598.8.1.95; Bhattachan A, 2009, EMERG INFECT DIS, V15, P1691, DOI 10.3201/eid1510.081641; Blitvich BJ, 1999, VIRUS RES, V60, P67, DOI 10.1016/S0168-1702(99)00003-9; Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Burke DS, 1988, ARBOVIRUSES EPIDEMIO, V3, P63; Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; CASTLE E, 1986, VIROLOGY, V149, P10, DOI 10.1016/0042-6822(86)90082-6; CASTLE E, 1985, VIROLOGY, V145, P227, DOI 10.1016/0042-6822(85)90156-4; CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991; CHAMBERS TJ, 1989, VIROLOGY, V169, P100, DOI 10.1016/0042-6822(89)90045-7; CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1; Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/ERV.11.7, 10.1586/erv.11.7]; Hanna JN, 1999, MED J AUSTRALIA, V170, P533, DOI 10.5694/j.1326-5377.1999.tb127878.x; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HORI H, 1990, J VIROL, V64, P4573, DOI 10.1128/JVI.64.9.4573-4577.1990; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005; Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kumar R, 2006, CLIN INFECT DIS, V43, P123, DOI 10.1086/505121; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Kuwayama M, 2005, EMERG INFECT DIS, V11, P471; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003; LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; Lowry PW, 1998, AM J TROP MED HYG, V58, P324, DOI 10.4269/ajtmh.1998.58.324; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Mackenzie JS, 2007, PERSP MED V, V16, P201, DOI 10.1016/S0168-7069(06)16010-3; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P1; Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P49; MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X; MASON PW, 1987, VIROLOGY, V158, P361, DOI 10.1016/0042-6822(87)90208-X; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200; Monath TP, 2002, CURR TOP MICROBIOL, V267, P105; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; NESTOROWICZ A, 1994, VIROLOGY, V199, P114, DOI 10.1006/viro.1994.1103; Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; PAUL WS, 1993, J INFECT DIS, V167, P1053, DOI 10.1093/infdis/167.5.1053; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Pijlman GP, 2006, J VIROL, V80, P11255, DOI 10.1128/JVI.01559-06; PREUGSCHAT F, 1991, VIROLOGY, V185, P689, DOI 10.1016/0042-6822(91)90540-R; PUGACHEV KV, 1992, FEBS LETT, V297, P67, DOI 10.1016/0014-5793(92)80329-F; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Rayamajhi A, 2006, ANN TROP PAEDIATR, V26, P293, DOI 10.1179/146532806X152818; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Robertson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066168; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; SCHIMENTI KJ, 1992, CYTOMETRY, V13, P48, DOI 10.1002/cyto.990130109; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Solomon T, 2004, ARCH VIROL, P161; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Song BH, 2008, RNA, V14, P1791, DOI 10.1261/rna.993608; Song BH, 2012, J MICROBIOL, V50, P698, DOI 10.1007/s12275-012-2336-6; SPEIGHT G, 1988, J GEN VIROL, V69, P23, DOI 10.1099/0022-1317-69-1-23; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4; Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Teo KF, 1997, J GEN VIROL, V78, P337, DOI 10.1099/0022-1317-78-2-337; Thiel H-J, 2005, VIRUS TAXONOMY, P981; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P491, DOI 10.4161/hv.18925; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; Watt G, 2003, AM J TROP MED HYG, V68, P704, DOI 10.4269/ajtmh.2003.68.704; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; WENGLER G, 1985, VIROLOGY, V147, P264, DOI 10.1016/0042-6822(85)90129-1; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323; Wilder-Smith A, 2010, CURR OPIN INFECT DIS, V23, P426, DOI 10.1097/QCO.0b013e32833c1d01; Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12; Xu YH, 1996, PEDIATR INFECT DIS J, V15, P1018, DOI 10.1097/00006454-199611000-00017; YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994; Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Yun S. I., 2006, MOL BIOL FLAVIVIRUS, P225; Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902; Yun SI, 2009, J VIROL, V83, P7909, DOI 10.1128/JVI.02541-08; Yun SI, 2003, VIRUS RES, V96, P129, DOI 10.1016/S0168-1702(03)00181-3; Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	150	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124318	10.1371/journal.pone.0124318	http://dx.doi.org/10.1371/journal.pone.0124318			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915765	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100046
J	Li, YL; Yu, GP; Li, QX; Wang, WL; Shen, XQ; Liu, H; Liu, RJ				Li, Yunlong; Yu, Guopeng; Li, Qiaoxing; Wang, Weilu; Shen, Xiangqian; Liu, Hua; Liu, Ruijiang			Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3)	PLOS ONE			English	Article							CANCER	To establish a BALB/c-nu mouse model of invasive bladder carcinoma and to investigate the feasibility, efficacy, and side effects of treating the mouse xenografts with internal iliac arterial infusion of albumin-bound arsenic trioxide (As2O3). Bladder tumors were established by intravesicular injection. Color Doppler were used to monitor tumor growth. Albumin-bound As2O3 and bovine serum albumin (BSA) nanoparticles were synthesized by cross-linking. BALB/c-nu mice were randomly divided into four treatment groups: 1) normal saline, 2) BSA nanoparticles, 3) As2O3 injections, and 4) albumin-bound As2O3. In an attempt to replicate the treatment of bladder cancer in humans using internal iliac arterial infusion, the drugs were injected into the mouse abdominal aorta. Tumor xenografts were established successfully. Mice treated with As2O3 injections and with albumin-bound As2O3 had significantly smaller bladders (36.59% and 37.82% smaller, respectively) than mice given normal saline injections (P < 0.01). Mice receiving As2O3 injections had lower white blood cell (WBC) and platelet counts compared with mice receiving normal saline injections only (P < 0.05). However, mice treated with albumin-bound As2O3 did not experience a significant decrease in WBC or platelet counts compared with control mice. A model of intra-arterial bladder cancer treatment was successfully established in BALB/c-nu mice. In this model, albumin-bound As2O3 appeared to be an effective method for treating bladder tumors, with less severe hematologic side effects compared with As2O3 alone. The infusion of albumin-bound As2O3 through the internal iliac artery is a promising method of bladder cancer therapy.	[Li, Yunlong; Li, Qiaoxing; Wang, Weilu; Liu, Hua] Jiangsu Univ, Affiliated Kunshan Hosp, Dept Urol, Suzhou 215300, Peoples R China; [Yu, Guopeng] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200040, Peoples R China; [Yu, Guopeng] Fudan Univ, Fudan Inst Urol, Shanghai 200040, Peoples R China; [Liu, Hua] Jiangsu Univ, Affiliated Kunshan Hosp, Dept Neurosurg, Suzhou 215300, Peoples R China; [Shen, Xiangqian; Liu, Ruijiang] Jiangsu Univ, Sch Mat Sci & Engn, Zhenjiang 212013, Peoples R China	Jiangsu University; Fudan University; Fudan University; Jiangsu University; Jiangsu University	Liu, H (corresponding author), Jiangsu Univ, Affiliated Kunshan Hosp, Dept Urol, Suzhou 215300, Peoples R China.	urologymed@sina.com; luckystar_lrj@ujs.edu.cn	Liu, Ruijiang/F-5213-2019	Liu, Ruijiang/0000-0002-0716-832X	Jiangsu province clinical medicine science and technology special funds [BL2014056]; Kunshan social development science and technology plan projects [KS1335];  [30700836]	Jiangsu province clinical medicine science and technology special funds; Kunshan social development science and technology plan projects; 	This research was partially supported by Grants-in-Aid for Chinese National Natural Science (30700836). This research was partially supported by Jiangsu province clinical medicine science and technology special funds (BL2014056) and Kunshan social development science and technology plan projects (KS1335).	Ahn RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058491; Ai ZL, 2006, CLIN MED J CHINA, V13, P429; Chen GC, 2002, ANTICANCER RES, V22, P633; Chen G, 2012, INT J ONCOL, V40, P139, DOI 10.3892/ijo.2011.1210; Du CW, 2002, CHINESE J CANC PREVE, V9, P350; Feng Chun-qiong, 2002, Ai Zheng, V21, P1386; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang PC, 2000, FOREIGN MED SCI UROL, V20, P226; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji XY, 2006, CHINESE J CLIN MED, V13, P949; Kchour G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-91; Leu L, 2009, AM J HEALTH-SYST PH, V66, P1913, DOI 10.2146/ajhp080342; [李凌 Li Ling], 2002, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V19, P78; Li Y, 2014, LEUKEMIA LYMPHOMA, V55, P1366, DOI 10.3109/10428194.2013.829573; Liu HB, 2000, CHINA PHARM, V11, P155; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Orntoft TF, 2011, LANCET ONCOL, V12, P111, DOI 10.1016/S1470-2045(11)70001-8; Qu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032215; Rink M, 2012, EUR UROL, V62, P1204, DOI 10.1016/j.eururo.2012.08.057; Shah JB, 2004, CURR OPIN UROL, V14, P287, DOI 10.1097/00042307-200409000-00007; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; [孙昊 Sun Hao], 2010, [介入放射学杂志, Journal of Interventional Radiology], V19, P454; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Tong QS, 2000, J CLIN UROLOGY, V15, P72; Ulbrich K, 2011, INT J PHARMACEUT, V406, P128, DOI 10.1016/j.ijpharm.2010.12.023; Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3; Weizer AZ, 2011, WORLD J UROL, V29, P59, DOI 10.1007/s00345-010-0617-4; Yang Shen-Min, 2007, Ai Zheng, V26, P341; Zhang XH, 2013, LEUKEMIA RES, V37, P1719, DOI 10.1016/j.leukres.2013.09.019; Zhang Y, 2011, CHINA MODERN MEIDCIN, V18, P59; [周洁 Zhou Ji], 2005, [中国新药杂志, Chinese Journal New Drugs], V14, P54; Zhu J, 2004, J CLIN UROLOGY, V19, P83	32	1	1	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124959	10.1371/journal.pone.0124959	http://dx.doi.org/10.1371/journal.pone.0124959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915411	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100085
J	Pan, HP; Yang, XW; Siegfried, BD; Zhou, XG				Pan, Huipeng; Yang, Xiaowei; Siegfried, Blair D.; Zhou, Xuguo			A Comprehensive Selection of Reference Genes for RT-qPCR Analysis in a Predatory Lady Beetle, Hippodamia convergens (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; TRANSGENIC CROPS; NORMALIZATION; GUIDELINES	Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) is a reliable, rapid, and reproducible technique for measuring and evaluating changes in gene expression. To facilitate gene expression studies and obtain more accurate RT-qPCR data, normalization relative to stable reference genes is required. In this study, expression profiles of seven candidate reference genes, including beta-actin (Actin), elongation factor 1 a (EF1A), glyceralde hyde-3-phosphate dehydro-genase (GAPDH), cyclophilins A (CypA), vacuolartype H+-ATPase (ATPase), 28S ribosomal RNA (28S), and 18S ribosomal RNA (18S) from Hippodamia convergens were investigated. H. convergens is an abundant predatory species in the New World, and has been widely used as a biological control agent against sapsucking insect pests, primarily aphids. A total of four analytical methods, geNorm, Normfinder, BestKeeper, and the Delta Ct method, were employed to evaluate the performance of these seven genes as endogenous controls under diverse experimental conditions. Additionally, RefFinder, a comprehensive evaluation platform integrating the four above mentioned algorithms, ranked the overall stability of these candidate genes. A suite of reference genes were specifically recommended for each experimental condition. Among them, 28S, EF1A, and CypA were the best reference genes across different development stages; GAPDH, 28S, and CypA were most stable in different tissues. GAPDH and CypA were most stable in female and male adults and photoperiod conditions, 28S and EF1A were most stable under a range of temperatures, Actin and CypA were most stable under dietary RNAi condition. This work establishes a standardized RT-qPCR analysis in H. convergens. Additionally, this study lays a foundation for functional genomics research in H. convergens and sheds light on the ecological risk assessment of RNAi-based biopesticides on this non-target biological control agent.	[Pan, Huipeng; Yang, Xiaowei; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Yang, Xiaowei] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Siegfried, Blair D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA	University of Kentucky; Cornell University; University of Nebraska System; University of Nebraska Lincoln	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu			University of Kentucky; USDA BRAG [3048108827]	University of Kentucky; USDA BRAG	This research was supported by a start-up fund from the University of Kentucky to XGZ, a grant from USDA BRAG grant (Award Agreement No.: 3048108827) to XGZ and BDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dreistadt SH, 1996, ENVIRON ENTOMOL, V25, P688, DOI 10.1093/ee/25.3.688; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Haug G. W., 1938, Annals of the Entomological Society of America, V31, P240, DOI 10.1093/aesa/31.2.240; Hodek I, 2012, ECOLOGY BEHAV LADYBI, DOI DOI 10.1002/9781118223208; Kupferschmidt K, 2013, SCIENCE, V341, P732, DOI 10.1126/science.341.6147.732; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Lin JT, 2012, DEV GENES EVOL, V222, P369, DOI 10.1007/s00427-012-0420-x; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Lundgren JG, 2013, BIOSCIENCE, V63, P657, DOI 10.1525/bio.2013.63.8.8; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Obrycki JJ, 1998, ANNU REV ENTOMOL, V43, P295, DOI 10.1146/annurev.ento.43.1.295; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Raupp Michael J., 1994, Journal of Arboriculture, V20, P241; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	34	68	72	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125868	10.1371/journal.pone.0125868	http://dx.doi.org/10.1371/journal.pone.0125868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915640	Green Published, gold			2022-12-26	WOS:000353659100150
J	Zhong, QY; Gelaye, B; Zaslavsky, AM; Fann, JR; Rondon, MB; Sanchez, SE; Williams, MA				Zhong, Qiu-Yue; Gelaye, Bizu; Zaslavsky, Alan M.; Fann, Jesse R.; Rondon, Marta B.; Sanchez, Sixto E.; Williams, Michelle A.			Diagnostic Validity of the Generalized Anxiety Disorder-7 (GAD-7) among Pregnant Women	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; WORLD-HEALTH-ORGANIZATION; PARTIAL CREDIT MODEL; PRIMARY-CARE; SPANISH VERSION; INTERVIEW CIDI; DEPRESSION; RISK; PREVALENCE; VALIDATION	Objective Generalized anxiety disorder (GAD) during pregnancy is associated with several adverse maternal and perinatal outcomes. A reliable and valid screening tool for GAD should lead to earlier detection and treatment. Among pregnant Peruvian women, a brief screening tool, the GAD-7, has not been validated. This study aims to evaluate the reliability and validity of the GAD-7. Methods Of 2,978 women who attended their first perinatal care visit and had the GAD-7 screening, 946 had a Composite International Diagnostic Interview (CIDI). The Cronbach's alpha was calculated to examine the reliability. We assessed the criterion validity by calculating operating characteristics. The construct validity was evaluated using factor analysis and association with health status on the CIDI. The cross-cultural validity was explored using the Rasch Rating Scale Model (RSM). Results The reliability of the GAD-7 was good (Cronbach's alpha = 0.89). A cutoff score of 7 or higher, maximizing the Youden Index, yielded a sensitivity of 73.3% and a specificity of 67.3%. One-factor structure of the GAD-7 was confirmed by exploratory and confirmatory factor analysis. Concurrent validity was supported by the evidence that higher GAD-7 scores were associated with poor self-rated physical and mental health. The Rasch RSM further confirmed the cross-cultural validity of the GAD-7. Conclusion The results suggest that the Spanish-language version of the GAD-7 may be used as a screening tool for pregnant Peruvian women. The GAD-7 has good reliability, factorial validity, and concurrent validity. The optimal cutoff score obtained by maximizing the Youden Index should be considered cautiously; women who screened positive may require further investigation to confirm GAD diagnosis.	[Zhong, Qiu-Yue; Gelaye, Bizu; Williams, Michelle A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rondon, Marta B.] Cayetano Heredia Peruvian Univ, Dept Med, Lima, Peru; [Sanchez, Sixto E.] Univ Peruana Ciencias Aplicadas, Lima, Peru; [Sanchez, Sixto E.] Asociac Civil PROESA, Lima, Peru	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Universidad Peruana Cayetano Heredia; Universidad Peruana de Ciencias Aplicadas (UPC)	Zhong, QY (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	qyzhong@mail.harvard.edu		Sanchez, Sixto/0000-0003-0354-0523; Rondon, Marta/0000-0001-8459-6785; Gelaye, Bizu/0000-0001-7934-548X	Eunice Kennedy Shriver Institute of Child Health and Human Development at the National Institutes of Health (NIH) [R01-HD-059835]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059835] Funding Source: NIH RePORTER	Eunice Kennedy Shriver Institute of Child Health and Human Development at the National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by an award from the Eunice Kennedy Shriver Institute of Child Health and Human Development (R01-HD-059835) at the National Institutes of Health (NIH). The NIH had no further role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abbey CK, 2013, MED DECIS MAKING, V33, P510, DOI 10.1177/0272989X12470756; ACOG Committee on Practice Bulletins--Obstetrics, 2008, Obstet Gynecol, V111, P1001, DOI 10.1097/AOG.0b013e31816fd910; Adams RJ, 2012, EDUC PSYCHOL MEAS, V72, P547, DOI 10.1177/0013164411432166; Adewuya AO, 2006, ARCH WOMEN MENT HLTH, V9, P325, DOI 10.1007/s00737-006-0157-5; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Andrich D, 2005, RASCH MODEL EXPLAINE; Andrich D., 1978, APPL PSYCH MEAS, V2, P581, DOI [DOI 10.1177/014662167800200413, 10.1177/014662167800200413]; Austin M-P, 2004, Arch Womens Ment Health, V7, P1, DOI 10.1007/s00737-003-0034-4; Baker F., 2001, BASICS ITEM RESPONSE; Bar-Shai M, PSYCHOSOMATICS; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Bond TG, 2013, APPL RASCH MODEL FUN, DOI [10.1186/1471-2377-13-78, DOI 10.1186/1471-2377-13-78]; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; BURSTEIN I, 1974, AM J OBSTET GYNECOL, V118, P195, DOI 10.1016/0002-9378(74)90549-3; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; Delgadillo J, 2012, DRUG ALCOHOL DEPEN, V125, P37, DOI 10.1016/j.drugalcdep.2012.03.011; Ding XX, 2014, J AFFECT DISORDERS, V159, P103, DOI 10.1016/j.jad.2014.02.027; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forkmann T, 2013, J AFFECT DISORD; Garcia-Campayo Javier, 2012, Health Qual Life Outcomes, V10, P114, DOI 10.1186/1477-7525-10-114; Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gelaye B, 2013, INT J PSYCHIAT MED, V46, P387, DOI 10.2190/PM.46.4.e; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kertz S, 2013, CLIN PSYCHOL PSYCHOT, V20, P456, DOI 10.1002/cpp.1802; Kessler R. C., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P511; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2005, PSYCHOL MED, V35, P1073, DOI 10.1017/S0033291705004538; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; KRAEMER HC, 1992, EVALUATING MED TESTS; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lamoureux EL, 2009, OPTOMETRY VISION SCI, V86, P139, DOI 10.1097/OPX.0b013e318194eb47; Li YL, 2012, STAT MED, V31, P2010, DOI 10.1002/sim.4475; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; MURAKI E, 1992, APPL PSYCH MEAS, V16, P159, DOI 10.1177/014662169201600206; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Orr ST, 2007, PSYCHOSOM MED, V69, P566, DOI 10.1097/PSY.0b013e3180cac25d; Pepe M. S., 2003, STAT EVALUATION MED; Perales MT, 2009, VIOLENCE AGAINST WOM, V15, P224, DOI 10.1177/1077801208329387; Pompili M, 2012, SUICIDE GLOBAL PERSP; Portman ME, 2011, PSYCHIAT ANN, V41, P79, DOI 10.3928/00485713-20110203-06; Qiu CF, 2009, AM J HYPERTENS, V22, P397, DOI 10.1038/ajh.2008.366; Rasch G., 1960, PROBABILISTIC MODELS; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Roy-Byrne P, 2010, JAMA-J AM MED ASSOC, V303, P1921, DOI 10.1001/jama.2010.608; Rubertsson C, 2014, ARCH WOMEN MENT HLTH, P1; Ruiz MA, 2011, J AFFECT DISORDERS, V128, P277, DOI 10.1016/j.jad.2010.07.010; Shear MK, 1995, PSYCHOPHARMACOL BULL, V31, P693; Sidik SM, 2012, J PRIM HEALTH CARE, V4, P5; Simpson W, 2014, CAN J PSYCHIAT, V59, P434, DOI 10.1177/070674371405900806; Smits N, 2007, INT J METH PSYCH RES, V16, P219, DOI 10.1002/mpr.230; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sutter-Dallay AL, 2004, EUR PSYCHIAT, V19, P459, DOI 10.1016/j.eurpsy.2004.09.025; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tijdink J, 2014, QUAL LIFE RES, P1, DOI [10.1007/s11136-014-0769-6, DOI 10.1007/S11136-014-0769-6]; Van den Bergh B, 1990, J PRENAT PERINAT PSY, V5; Vythilingum Bavanisha, 2008, Curr Psychiatry Rep, V10, P331, DOI 10.1007/s11920-008-0053-y; Wetzel E, 2014, REVERSED THRESHOLDS; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhong QY, 2014, J AFFECT DISORDERS, V158, P148, DOI 10.1016/j.jad.2014.02.012	72	115	124	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125096	10.1371/journal.pone.0125096	http://dx.doi.org/10.1371/journal.pone.0125096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915929	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100097
J	Albano, G; Moor, M; Dolder, S; Siegrist, M; Wagner, CA; Biber, J; Hernando, N; Hofstetter, W; Bonny, O; Fuster, DG				Albano, Giuseppe; Moor, Matthias; Dolder, Silvia; Siegrist, Mark; Wagner, Carsten A.; Biber, Juerg; Hernando, Nati; Hofstetter, Willy; Bonny, Olivier; Fuster, Daniel G.			Sodium-Dependent Phosphate Transporters in Osteoclast Differentiation and Function	PLOS ONE			English	Article							BASAL GANGLIA CALCIFICATION; BONE-RESORBING OSTEOCLASTS; INORGANIC-PHOSPHATE; IN-VITRO; MICE; CALCIUM; CELLS; RESORPTION; HOMEOSTASIS; METABOLISM	Osteoclasts are multinucleated bone degrading cells. Phosphate is an important constituent of mineralized bone and released in significant quantities during bone resorption. Molecular contributors to phosphate transport during the resorptive activity of osteoclasts have been controversially discussed. This study aimed at deciphering the role of sodium-dependent phosphate transporters during osteoclast differentiation and bone resorption. Our studies reveal RANKL-induced differential expression of sodium-dependent phosphate transport protein IIa (NaPi-IIa) transcript and protein during osteoclast development, but no expression of the closely related NaPi-IIb and NaPi-IIc SLC34 family isoforms. In vitro studies employing NaPi-IIa-deficient osteoclast precursors and mature osteoclasts reveal that NaPi-IIa is dispensable for bone resorption and osteoclast differentiation. These results are supported by the analysis of structural bone parameters by high-resolution microcomputed tomography that yielded no differences between adult NaPi-IIa WT and KO mice. By contrast, both type III sodium-dependent phosphate transporters Pit-1 and Pit-2 were abundantly expressed throughout osteoclast differentiation, indicating that they are the relevant sodium-dependent phosphate transporters in osteoclasts and osteoclast precursors. We conclude that phosphate transporters of the SLC34 family have no role in osteoclast differentiation and function and propose that Pit-dependent phosphate transport could be pivotal for bone resorption and should be addressed in further studies.	[Albano, Giuseppe; Fuster, Daniel G.] Univ Hosp Bern, Div Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland; [Albano, Giuseppe; Fuster, Daniel G.] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Albano, Giuseppe; Dolder, Silvia; Siegrist, Mark; Hofstetter, Willy; Fuster, Daniel G.] Univ Bern, NCCR Transcure, Bern, Switzerland; [Moor, Matthias; Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Dolder, Silvia; Siegrist, Mark; Hofstetter, Willy] Univ Bern, Dept Clin Res, Grp Bone Biol & Orthopaed Res, Bern, Switzerland; [Wagner, Carsten A.; Biber, Juerg; Hernando, Nati] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Albano, Giuseppe; Moor, Matthias; Dolder, Silvia; Siegrist, Mark; Wagner, Carsten A.; Biber, Juerg; Hernando, Nati; Hofstetter, Willy; Bonny, Olivier; Fuster, Daniel G.] Univ Zurich, NCCR Kidney CH, Zurich, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Lausanne; University of Bern; University of Zurich; University of Zurich	Fuster, DG (corresponding author), Univ Hosp Bern, Div Nephrol Hypertens & Clin Pharmacol, CH-3010 Bern, Switzerland.	Daniel.Fuster@ibmm.unibe.ch	Fuster, Daniel G/AAA-7079-2021; Moor, Matthias/W-1627-2019	Fuster, Daniel G/0000-0001-7220-1803; Hofstetter, Wilhelm/0000-0003-0126-8423; bonny, olivier/0000-0003-4123-4279; Moor, Matthias/0000-0002-7717-651X	Swiss National Science Foundation [3100A0_135503, 3100A0_152829, PP00P3-133648]; Swiss National Science Foundation NCCR Trancure; Swiss National Science Foundation NCCR Kidney	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation NCCR Trancure; Swiss National Science Foundation NCCR Kidney	Swiss National Science Foundation NCCR Trancure to DF, WH. Swiss National Science Foundation NCCR Kidney. CH to DF, JB, CW, NH, OB. Swiss National Science Foundation grants # 3100A0_135503 and 3100A0_152829 to DF. Prof. Max Cloetta Foundation grant to DF. Swiss National Science Foundation grant # PP00P3-133648 to OB.	Balga R, 2006, BONE, V39, P325, DOI 10.1016/j.bone.2006.02.056; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Berger CEM, 2001, J BONE MINER RES, V16, P2092, DOI 10.1359/jbmr.2001.16.11.2092; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bourgeois S, 2013, PFLUG ARCH EUR J PHY, V465, P1557, DOI 10.1007/s00424-013-1298-9; Bourgine A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065979; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chavkin NW, 2015, EXP CELL RES; Choy J, 2014, BONE, V69, P80, DOI 10.1016/j.bone.2014.09.013; Crouthamel MH, 2013, ARTERIOSCL THROM VAS, V33, P2625, DOI 10.1161/ATVBAHA.113.302249; Datta HK, 2003, J ENDOCRINOL, V176, P1, DOI 10.1677/joe.0.1760001; Dolder S, 2006, J BONE MINER RES, V21, P647, DOI 10.1359/JBMR.060111; Egermann M, 2009, J ORTHOP RES; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; Gupta A, 1997, J CLIN INVEST, V100, P538, DOI 10.1172/JCI119563; Gupta A, 1996, KIDNEY INT, V49, P968, DOI 10.1038/ki.1996.137; Gupta A, 2001, BONE, V29, P467, DOI 10.1016/S8756-3282(01)00601-9; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Ito M, 2005, AM J PHYSIOL-CELL PH, V288, pC921, DOI 10.1152/ajpcell.00412.2004; Ito M, 2007, AM J PHYSIOL-CELL PH, V292, pC526, DOI 10.1152/ajpcell.00357.2006; Jensen N, 2013, J MOL NEUROSCI, V51, P994, DOI 10.1007/s12031-013-0085-6; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Miyazaki T, 2010, DENT MATER J, V29, P403, DOI 10.4012/dmj.2009-132; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Myakala K, 2014, AM J PHYSIOL-RENAL, V306, pF833, DOI 10.1152/ajprenal.00133.2013; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Nowik M, 2008, PFLUG ARCH EUR J PHY, V457, P539, DOI 10.1007/s00424-008-0530-5; Onishi T, 2007, J DENT RES, V86, P158, DOI 10.1177/154405910708600210; Picard N, 2010, PFLUG ARCH EUR J PHY, V460, P677, DOI 10.1007/s00424-010-0841-1; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Segawa H, 2009, J AM SOC NEPHROL, V20, P104, DOI 10.1681/ASN.2008020177; Sharma P, 2010, BIOCHEM BIOPH RES CO, V399, P129, DOI 10.1016/j.bbrc.2010.07.022; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077	40	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125104	10.1371/journal.pone.0125104	http://dx.doi.org/10.1371/journal.pone.0125104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910236	Green Published, gold, Green Accepted			2022-12-26	WOS:000353376800129
J	Chung, WW; Chua, SS; Lai, PSM; Morisky, DE				Chung, Wen Wei; Chua, Siew Siang; Lai, Pauline Siew Mei; Morisky, Donald E.			The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia	PLOS ONE			English	Article							PREDICTIVE-VALIDITY; NONADHERENCE; HOSPITALIZATION; INDIVIDUALS; SENSITIVITY; POPULATION; MELLITUS; THERAPY; RATES; KEY	Medication non-adherence is a prevalent problem worldwide but up to today, no gold standard is available to assess such behavior. This study was to evaluate the psychometric properties, particularly the concurrent validity of the English version of the Malaysian Medication Adherence Scale (MALMAS) among people with type 2 diabetes in Malaysia. Individuals with type 2 diabetes, aged 21 years and above, using at least one anti-diabetes agent and could communicate in English were recruited. The MALMAS was compared with the 8-item Morisky Medication Adherence Scale (MMAS-8) to assess its convergent validity while concurrent validity was evaluated based on the levels of glycated hemoglobin (HbA1C). Participants answered the MALMAS twice: at baseline and 4 weeks later. The study involved 136 participants. The MALMAS achieved acceptable internal consistency (Cronbach's alpha=0.565) and stable reliability as the test-retest scores showed fair correlation (Spearman's rho=0.412). The MALMAS has good correlation with the MMAS-8 (Spearman's rho=0.715). Participants who were adherent to their anti-diabetes medications had significantly lower median HbA1C values than those who were non-adherence (7.90 versus 8.55%, p=0.032). The odds of participants who were adherent to their medications achieving good glycemic control was 3.36 times (95% confidence interval: 1.09-10.37) of those who were non-adherence. This confirms the concurrent validity of the MALMAS. The sensitivity of the MALMAS was 88.9% while its specificity was 29.6%. The findings of this study further substantiates the reliability and validity of the MALMAS, in particular its concurrent validity and sensitivity for assessing medication adherence of people with type 2 diabetes in Malaysia.	[Chung, Wen Wei; Chua, Siew Siang] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Chung, Wen Wei] Univ Malaya, Med Ctr, Dept Pharm, Kuala Lumpur, Malaysia; [Lai, Pauline Siew Mei] Univ Malaya, Fac Med, Primary Care Res Grp UMPCRG, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Morisky, Donald E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of California System; University of California Los Angeles	Chua, SS (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	chuass@um.edu.my	Chua, Siew Siang/B-9778-2010; Morisky, Donald/AAU-4679-2021; Chua, Siew Siang/AAH-9218-2021; Lai, Pauline Siew Mei/B-1031-2012	Lai, Pauline Siew Mei/0000-0002-9940-9644	University of Malaya Research Grant [RG 457/12HTM]	University of Malaya Research Grant	This study was supported by the University of Malaya Research Grant (RG 457/12HTM) which was awarded to SSC. (URL: http://umresearch.um.edu.my/mainpage.php?module=Maklumat&kategori=86&id=62&papar=1) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; Balkrishnan R, 2003, CLIN THER, V25, P2958, DOI 10.1016/S0149-2918(03)80347-8; Bowling A, 2009, RES METHODS HLTH INV, DOI [10.7748/ns.29.14.32.s36, DOI 10.7748/NS.29.14.32.S36]; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chua SS., 2013, J PHARM PHARM SCI, V5, P790; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen JS, 2001, ARCH INTERN MED, V161, P880, DOI 10.1001/archinte.161.6.880; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; DeVellis R., 1991, SCALE DEV THEORY APP; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Goff SL, 2008, J GEN INTERN MED, V23, P236, DOI 10.1007/s11606-007-0470-3; Grant RW, 2003, DIABETES CARE, V26, P1408, DOI 10.2337/diacare.26.5.1408; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Kane S, 2008, DIGEST DIS SCI, V53, P1020, DOI 10.1007/s10620-007-9968-0; Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612; Krousel-Wood M, 2004, CURR OPIN CARDIOL, V19, P357, DOI 10.1097/01.hco.0000126978.03828.9e; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Laditka SB, 2001, ARCH INTERN MED, V161, P1301, DOI 10.1001/archinte.161.10.1301; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lau DT, 2004, DIABETES CARE, V27, P2149, DOI 10.2337/diacare.27.9.2149; Lerman I, 2005, ARCH MED RES, V36, P300, DOI 10.1016/j.arcmed.2004.12.001; Li WW, 2012, J CLIN NURS, V21, P1816, DOI 10.1111/j.1365-2702.2012.04088.x; Lingam R, 2002, ACTA PSYCHIAT SCAND, V105, P164, DOI 10.1034/j.1600-0447.2002.1r084.x; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Manias E, 2007, ANN PHARMACOTHER, V41, P764, DOI 10.1345/aph.1H623; Marcum ZA, 2013, RES SOC ADMIN PHARM, V9, P817, DOI 10.1016/j.sapharm.2012.12.002; Marcum ZA, 2013, JAMA-J AM MED ASSOC, V310, P1506, DOI 10.1001/jama.2013.277311; Marcum ZA, 2013, JAMA-J AM MED ASSOC, V309, P2105, DOI 10.1001/jama.2013.4638; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; MORISKY DE, 1990, HEALTH EDUC QUART, V17, P253, DOI 10.1177/109019819001700303; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; Odegard PS, 2007, DIABETES EDUCATOR, V33, P1014, DOI 10.1177/0145721707308407; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Schectman JM, 2002, DIABETES CARE, V25, P1015, DOI 10.2337/diacare.25.6.1015; Schlenk Elizabeth A, 2004, J Gerontol Nurs, V30, P33; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Sodergard B, 2006, J CLIN PHARM THER, V31, P605, DOI 10.1111/j.1365-2710.2006.00782.x; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Streiner DL, 1995, HLTH MEASUREMENT SCA, DOI [10.1097/DBP.0b013e31819670fa, DOI 10.1097/DBP.0B013E31819670FA]; Sushil S., 2010, EUR J SCI RES, V46, P172; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wood B, 2012, US PHARM, V37, P3; World Health Organization, 2003, NONC DIS MENT HLTH A	49	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124275	10.1371/journal.pone.0124275	http://dx.doi.org/10.1371/journal.pone.0124275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909363	Green Published, gold			2022-12-26	WOS:000353376800073
J	Ruiz-Lafuente, N; Alcaraz-Garcia, MJ; Sebastian-Ruiz, S; Garcia-Serna, AM; Gomez-Espuch, J; Moraleda, JM; Minguela, A; Garcia-Alonso, AM; Parrado, A				Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Garcia-Serna, Azahara-Maria; Gomez-Espuch, Joaquin; Moraleda, Jose-Maria; Minguela, Alfredo; Garcia-Alonso, Ana-Maria; Parrado, Antonio			IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							KAPPA-B ACTIVITY; CLL PATIENTS; MICRORNA EXPRESSION; CELL-PROLIFERATION; ACTIVATION; APOPTOSIS; RESISTANCE; CANCER; DELETION; SUBSETS	Interleukin 4 (IL-4) induces B-cell differentiation and survival of chronic lymphocytic leukemia (CLL) cells. MicroRNAs (miRNAs) regulate mRNA and protein expression, and several miRNAs, deregulated in CLL, might play roles as oncogenes or tumor suppressors. We have studied the miRNA profile of CLL, and its response to IL-4, by oligonucleotide microarrays, resulting in the detection of a set of 129 mature miRNAs consistently expressed in CLL, which included 41 differentially expressed compared to normal B cells (NBC), and 6 significantly underexpressed in ZAP-70 positive patients. IL-4 stimulation brought about upregulation of the 5p and 3p mature variants of the miR-21 gene, which maps immediately downstream to the VMP1 gene, and of the mature forms generated from the miR-362 (3p and 5p), miR-500a (3p), miR-502 (3p), and miR-532 (3p and 5p) genes, which map within the third intron of the CLCN5 gene. Both genes are in turn regulated by IL-4, suggesting that these miRNAs were regulated by IL-4 as passengers from their carrier genes. Their levels of up-regulation by IL-4 significantly correlated with cytoprotection. MiR-21 has been reported to be leukemogenic, associated to bad prognosis in CLL, and the miRNA more frequently overexpressed in human cancer. Up-regulation by IL-4 of miR-21 and the miRNAs hosted in the CLCN5 locus may contribute to evasion of apoptosis of CLL cells. These findings indicate that the IL-4 pathway and the miRNAs induced by IL-4 are promising targets for the development of novel therapies in CLL.	[Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Garcia-Serna, Azahara-Maria; Minguela, Alfredo; Garcia-Alonso, Ana-Maria; Parrado, Antonio] Univ Virgen Arrixaca, Hosp Clin, Serv Inmunol, Murcia, Spain; [Gomez-Espuch, Joaquin; Moraleda, Jose-Maria] Univ Virgen Arrixaca, Hosp Clin, Serv Hematol & Hemoterapia, Murcia, Spain; [Garcia-Serna, Azahara-Maria; Moraleda, Jose-Maria] Univ Murcia, Murcia, Spain; [Minguela, Alfredo; Garcia-Alonso, Ana-Maria] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Murcia, Spain; [Ruiz-Lafuente, Natalia; Alcaraz-Garcia, Maria-Jose; Sebastian-Ruiz, Silvia; Garcia-Serna, Azahara-Maria; Gomez-Espuch, Joaquin; Moraleda, Jose-Maria; Minguela, Alfredo; Garcia-Alonso, Ana-Maria; Parrado, Antonio] Inst Murciano Invest Biosanitaria Virgen Arrixaca, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca	Parrado, A (corresponding author), Univ Virgen Arrixaca, Hosp Clin, Serv Inmunol, Murcia, Spain.	antonio.parrado@carm.es	García, Maria Jose Alcaraz/ABH-2338-2020; Ruiz-Lafuente, Natalia/R-5449-2019; Moraleda, José María/AAB-4119-2020; Minguela, Alfredo/Q-9783-2019; Parrado, Antonio/K-9591-2014	Ruiz-Lafuente, Natalia/0000-0003-4628-7038; Minguela, Alfredo/0000-0003-2472-5893; Parrado, Antonio/0000-0002-7660-018X; Alcaraz/0000-0002-1057-0299; Garcia-Serna, Azahara M/0000-0001-7828-3213	Plan Nacional de I+D+I, Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo [PI07/0135]; Plan Nacional de I+D+I, Accion Estrategica en Salud [PI10/01226]; European Regional Development Funds; II PCTRM, Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia [08721/PI/08]; ISCIII Spanish Cell Therapy Network (Tercel) [RD06/0010/0023]; CIBERehd scientific program	Plan Nacional de I+D+I, Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo; Plan Nacional de I+D+I, Accion Estrategica en Salud; European Regional Development Funds(European Commission); II PCTRM, Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia; ISCIII Spanish Cell Therapy Network (Tercel); CIBERehd scientific program	This work was supported by grants from Plan Nacional de I+D+I 2004-2007, Programa de Promocion de la Investigacion Biomedica y en Ciencias de la Salud del Ministerio de Sanidad y Consumo (PI07/0135 to AP) and Plan Nacional de I +D+I 2008-2011, Accion Estrategica en Salud (PI10/01226 to AP) (Instituto de Salud Carlos III (ISCIII) co-financed with European Regional Development Funds, "Una manera de hacer Europa"), II PCTRM 2007-2010, Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia (08721/PI/08 to AP), ISCIII Spanish Cell Therapy Network (Tercel; RD06/0010/0023 to JMM), and the CIBERehd scientific program to AM and AMGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer C, 2012, CANCER RES, V72, P3775, DOI 10.1158/0008-5472.CAN-12-0803; Bhattacharya N, 2015, INT J CANCER, V136, P65, DOI 10.1002/ijc.28974; Bomben R, 2012, LEUKEMIA, V26, P1584, DOI 10.1038/leu.2012.44; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chiorazzi N, 2012, HEMATOL-AM SOC HEMAT, P76, DOI 10.1182/asheducation-2012.1.76; Christensen LL, 2013, INT J CANCER, V133, P67, DOI 10.1002/ijc.28010; Coscia M, 2011, LEUKEMIA, V25, P828, DOI 10.1038/leu.2011.12; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Dijkstra MK, 2009, LEUKEMIA, V23, P625, DOI 10.1038/leu.2008.264; Douglas RS, 1997, BLOOD, V89, P941, DOI 10.1182/blood.V89.3.941; Rodriguez AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048485; Ferracin M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-123; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Lawrie CH, 2009, BRIT J HAEMATOL, V147, P398, DOI 10.1111/j.1365-2141.2009.07857.x; LI S, 2011, PLOS GENET, V7, P16956, DOI DOI 10.1371/JOURNAL.PONE.0016956; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; Negrini M, 2014, CLIN CANCER RES, V20, P4141, DOI 10.1158/1078-0432.CCR-13-2497; Okada H, 2003, CYTOKINE HDB, VI, P227; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Papakonstantinou N, 2013, MOL MED, V19, P115, DOI 10.2119/molmed.2013.00005; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Ribas J, 2012, NUCLEIC ACIDS RES, V40, P6821, DOI 10.1093/nar/gks308; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889; Ruiz-Lafuente N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109533; Sandhu SK, 2013, P NATL ACAD SCI USA, V110, P18208, DOI 10.1073/pnas.1315365110; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Smonskey MT, 2012, AM J CLIN PATHOL, V137, P641, DOI 10.1309/AJCPP31FSSRQTTAQ; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Stamatopoulos B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012780; Steele AJ, 2010, BLOOD, V116, P4569, DOI 10.1182/blood-2009-09-245811; Thapa DR, 2012, AIDS, V26, P1177, DOI 10.1097/QAD.0b013e3283543e0e; Thieu VT, 2007, J LEUKOCYTE BIOL, V82, P370, DOI 10.1189/jlb.1106707; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Wang WJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-819; Xia JT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-33; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Zamorano J, 2001, INT IMMUNOL, V13, P1479, DOI 10.1093/intimm/13.12.1479; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254; Zhai H, 2013, ONCOGENE, V32, P1570, DOI 10.1038/onc.2012.167; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179	49	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124936	10.1371/journal.pone.0124936	http://dx.doi.org/10.1371/journal.pone.0124936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909590	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800117
J	Cao, Z; McGow, DP; Shepherd, C; Lindsay, JG				Cao, Zhenbo; McGow, Donna P.; Shepherd, Colin; Lindsay, J. Gordon			Improved Catenated Structures of Bovine Peroxiredoxin III F190L Reveal Details of Ring-Ring Interactions and a Novel Conformational State	PLoS One			English	Article							MOLECULAR CHAPERONE FUNCTION; CYSTEINE-SULFINIC ACID; MYCOBACTERIUM-TUBERCULOSIS; ANTIOXIDANT DEFENSE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; SITE CYSTEINE; MITOCHONDRIAL; INTERMEDIATE	Mitochondrial 2-cys peroxiredoxin III (PrxIII) is a key player in antioxidant defence reducing locally-generated H2O2 to H2O. A Phe to Leu (F190L) mutation in the C-terminal alpha-helix of PrxIII, mimicking that found in some bacteria and parasites, increases its resistance to hyperoxidation but has no obvious influence on peroxidase activity. Here we report on the oxidized and reduced crystal structures of bovine PrxIII F190L at 2.4 angstrom and 2.2 angstrom, respectively. Both structures exist as two-ring catenanes with their dodecameric rings inclined at 55o to each other, similar to that previously reported for PrxIII C168S. The new higher-resolution structures reveal details of the complex network of H-bonds stabilising the inter-toroid contacts. In addition, Arg123, the key conserved residue, that normally interacts with the catalytic cys (Cp, cys 47) is found in a distinct conformation extending away from the Cp while the characteristic Arg-Glu-Arg network, underpinning the active-site geometry also displays a distinctive arrangement, not observed previously. This novel active-site organisation may provide new insights into the dynamics of the large-scale conformational changes occurring between oxidized and reduced states.	[Cao, Zhenbo; McGow, Donna P.; Shepherd, Colin; Lindsay, J. Gordon] Univ Glasgow, CMVLS, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Glasgow	Lindsay, JG (corresponding author), Univ Glasgow, CMVLS, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	Gordon.Lindsay@glasgow.ac.uk	Shepherd, Colin/AAF-8927-2019	Shepherd, Colin/0000-0003-3334-3379	BBSRC [BB/F001851/1]; Biotechnology and Biological Sciences Research Council [BB/F001851/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was fully supported by a grant from the BBSRC (BB/F001851/1).	Ardini M, 2014, NANOSCALE, V6, P8052, DOI 10.1039/c4nr01526f; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Cao ZB, 2005, STRUCTURE, V13, P1661, DOI 10.1016/j.str.2005.07.021; Cao Zhenbo, 2007, V44, P295; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gourlay LJ, 2003, J BIOL CHEM, V278, P32631, DOI 10.1074/jbc.M303862200; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Li S, 2005, J MOL BIOL, V346, P1035, DOI 10.1016/j.jmb.2004.12.046; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; van Eldijk MB, 2013, CHEM COMMUN, V49, P7770, DOI 10.1039/c3cc43219j; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	31	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123303	10.1371/journal.pone.0123303	http://dx.doi.org/10.1371/journal.pone.0123303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906064	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000353332000027
J	Manohar, CM; Prabhawathi, V; Sivakumar, PM; Doble, M				Manohar, Cynthya Maria; Prabhawathi, Veluchamy; Sivakumar, Ponnurengam Malliappan; Doble, Mukesh			Design of a Papain Immobilized Antimicrobial Food Package with Curcumin as a Crosslinker	PLOS ONE			English	Article							GLUCOSE-OXIDASE; ESSENTIAL OIL; CHITOSAN; FILMS; RESAZURIN; DIFFUSION; BIOFILMS; PEPTIDE; GROWTH	Contamination of food products by spoilage and pathogenic microorganisms during post process handling is one of the major causes for food spoilage and food borne illnesses. The present green sustainable approach describes the covalent immobilization of papain to LDPE (low density polyethylene), HDPE (high density polyethylene), LLDPE (linear low density polyethylene) and PCL (polycaprolactam) with curcumin as the photocrosslinker. About 50% of curcumin and 82-92% of papain were successfully immobilized on these polymers. After 30 days, the free enzyme retained 87% of its original activity, while the immobilized enzyme retained more than 90% of its activity on these polymers. Papain crosslinked to LLDPE exhibited the best antibiofilm properties against Acinetobacter sp. KC119137.1 and Staphylococcus aureus NCIM 5021 when compared to the other three polymers, because of the highest amount of enzyme immobilized on this surface. Papain acts by damaging the cell membrane. The enzyme is able to reduce the amount of carbohydrate and protein contents in the biofilms formed by these organisms. Meat wrapped with the modified LDPE and stored at 4 degrees C showed 9 log reduction of these organisms at the end of the seventh day when compared to samples wrapped with the bare polymer. This method of cross-linking can be used on polymers with or without functional groups and can be adopted to bind any type of antimicrobial agent.	[Manohar, Cynthya Maria; Prabhawathi, Veluchamy; Sivakumar, Ponnurengam Malliappan; Doble, Mukesh] Indian Inst Technol, Bhupat & Jyoti Mehta Sch BioSci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Doble, M (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch BioSci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	mukeshd@iitm.ac.in		Sivakumar, Ponnurengam Malliappan/0000-0002-5880-9596; Veluchamy, Prabhawathi/0000-0002-9703-5714; Doble, Mukeshd/0000-0002-4335-0698				Amri Ezekiel, 2012, American Journal of Biochemistry and Biotechnology, V8, P99, DOI 10.3844/ajbbsp.2012.99.104; Arkatkar A, 2010, INT BIODETER BIODEGR, V64, P530, DOI 10.1016/j.ibiod.2010.06.002; Beeley JA, 2000, BRIT DENT J, V188, P427, DOI 10.1038/sj.bdj.4800501a; Beevers C., 2011, BOT TARGETS THER, V1, P5, DOI [10.2147/btat.s17244, DOI 10.2147/BTAT.S17244]; Besse NG, 2004, INT J FOOD MICROBIOL, V91, P119, DOI 10.1016/S0168-1605(03)00375-1; Brase S, 2005, ANGEW CHEM INT EDIT, V44, P5188, DOI 10.1002/anie.200400657; Bueno C, 2002, PHOTOCHEM PHOTOBIOL, V76, P385; Calzolai L, 2012, FOOD ADDIT CONTAM A, V29, P1183, DOI 10.1080/19440049.2012.689777; Candan F, 2003, J ETHNOPHARMACOL, V87, P215, DOI 10.1016/S0378-8741(03)00149-1; Cerqueira MA, 2012, FOOD HYDROCOLLOID, V27, P175, DOI 10.1016/j.foodhyd.2011.07.007; Chau CF, 2007, TRENDS FOOD SCI TECH, V18, P269, DOI 10.1016/j.tifs.2007.01.007; Choi JH, 2005, LWT-FOOD SCI TECHNOL, V38, P417, DOI 10.1016/j.lwt.2004.07.004; Dankbar DM, 2006, ANAL BIOANAL CHEM, V386, P1967, DOI 10.1007/s00216-006-0871-x; Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2; Ercolini D, 2010, FOOD MICROBIOL, V27, P137, DOI 10.1016/j.fm.2009.09.006; Erdogan B, 2004, J AM CHEM SOC, V126, P3678, DOI 10.1021/ja0320020; Eshamah H, 2014, MEAT SCI, V96, P1494, DOI 10.1016/j.meatsci.2013.12.010; Fajardo P, 2010, J FOOD ENG, V101, P349, DOI 10.1016/j.jfoodeng.2010.06.029; Fu GL, 2012, TALANTA, V97, P438, DOI 10.1016/j.talanta.2012.04.059; Fucinos C, 2012, J FOOD SCI, V77, pN21, DOI 10.1111/j.1750-3841.2012.02781.x; Gamage GR, 2009, FOOD RES INT, V42, P832, DOI 10.1016/j.foodres.2009.03.012; Gemili S, 2009, J FOOD ENG, V90, P453, DOI 10.1016/j.jfoodeng.2008.07.014; Han C, 2013, MEAT SCI, V157, P239; Hanusova K, 2013, CENT EUR J CHEM, V11, P1066, DOI 10.2478/s11532-013-0241-4; Hauser C, 2011, PROC FOOD SCI, V1, P197, DOI 10.1016/j.profoo.2011.09.031; Iseppi R, 2008, INT J FOOD MICROBIOL, V123, P281, DOI 10.1016/j.ijfoodmicro.2007.12.015; Kondyurin AV, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/126170; Lapidot A, 2006, INT J FOOD MICROBIOL, V109, P229, DOI 10.1016/j.ijfoodmicro.2006.01.012; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Li B, 2013, MAR DRUGS, V11, P1534, DOI 10.3390/md11051534; Liggieri C, 2009, ACTA BIOCH BIOPH SIN, V41, P154, DOI 10.1093/abbs/gmn018; Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p; Limjaroen P, 2003, J PLAST FILM SHEET, V19, P95, DOI 10.1177/8756087903039409; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manso S, 2013, FOOD CONTROL, V30, P370, DOI 10.1016/j.foodcont.2012.07.018; Mateo C, 2002, BIOTECHNOL PROGR, V18, P629, DOI 10.1021/bp010171n; Mohan PRK, 2012, VIB SPECTROSC, V62, P77, DOI 10.1016/j.vibspec.2012.05.002; Morvay A. A., 2011, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Veterinary Medicine, V68, P245; Muriel-Galet V, 2012, INT J FOOD MICROBIOL, V157, P239, DOI 10.1016/j.ijfoodmicro.2012.05.009; Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8; Nwinyi OC, 2010, AFR J AGR RES, V5, P1531; Orgaz B, 2011, INT J MOL SCI, V12, P817, DOI 10.3390/ijms12010817; Ouattara B, 2000, J FOOD SCI, V65, P768, DOI 10.1111/j.1365-2621.2000.tb13584.x; Prabhu V., 2014, P JOINT M PME 38 PME, V5, P1; Quintavalla S, 2002, MEAT SCI, V62, P373, DOI 10.1016/S0309-1740(02)00121-3; Rajandas H, 2012, POLYM TEST, V31, P1094, DOI 10.1016/j.polymertesting.2012.07.015; Ramos M, 2012, J FOOD ENG, V109, P513, DOI 10.1016/j.jfoodeng.2011.10.031; Robertson GL, 2012, FOOD PACKAGING PRINC, V3; Rooney M. L., 1995, ACTIVE FOOD PACKAGIN; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sharma K., 2012, INT J DRUG DEV RES, V4, P375; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Siracusa V, 2008, TRENDS FOOD SCI TECH, V19, P634, DOI 10.1016/j.tifs.2008.07.003; Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037; STEVENSON DE, 1991, BIOTECHNOL BIOENG, V37, P519, DOI 10.1002/bit.260370605; Sung SY, 2014, FOOD CONTROL, V39, P214, DOI 10.1016/j.foodcont.2013.11.020; Suppakul P, 2011, LWT-FOOD SCI TECHNOL, V44, P1888, DOI 10.1016/j.lwt.2011.03.024; Tang WT, 2013, EUR FOOD RES TECHNOL, V237, P591, DOI 10.1007/s00217-013-2034-6; TIWARI NP, 1972, J FOOD SCI, V37, P901, DOI 10.1111/j.1365-2621.1972.tb03698.x; Tripathi S, 2009, INT J BIOL MACROMOL, V45, P372, DOI 10.1016/j.ijbiomac.2009.07.006; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Veluchamy P, 2011, J AGR FOOD CHEM, V59, P10869, DOI 10.1021/jf201124v; Wu Y, 2007, FOOD MICROBIOLOGY SA, V72, P369	63	27	28	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0121665	10.1371/journal.pone.0121665	http://dx.doi.org/10.1371/journal.pone.0121665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906061	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000009
J	Wang, YF; Lavender, P; Watson, J; Arno, M; Lehner, T				Wang, Yufei; Lavender, Paul; Watson, Julie; Arno, Matthew; Lehner, Thomas			Stress-activated Dendritic Cells (DC) Induce Dual Interleukin (IL)-15-and IL1-mediated Pathways, Which May Elicit CD4(+) Memory T Cells and Interferon (IFN)-stimulated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; inflammasome; stress; T helper cells; transcription factor	I INTERFERON; IMMUNE-RESPONSES; INFECTION; INFLAMMASOME; EXPRESSION; PHENOTYPE; DIFFERENTIATION; PROLIFERATION; STIMULATION; HOMEOSTASIS	Background: Immunological memory is maintained by antigen-independent tonic stimulation. Results: Stress-treated dendritic cells stimulate IL-15- and IL-1-mediated pathways, required for optimum memory T cell induction. Conclusion: Stress agents may be responsible for the persistence of immunological memory, involving an epigenetic mechanism. Significance: Repetitive stress may account for tonic stimulation, which maintains immunological memory. The prevailing evidence suggests that immunological memory does not require antigenic re-stimulation but is maintained by low level tonic stimulation. We examined the hypothesis that stress agents contribute to tonic cellular activation and maintain immunological memory. Stimulation of monocyte-derived dendritic cells (DC) with stress agents elicits reactive oxygen species and HSP70. NFB is activated, which up-regulates membrane-associated (ma) IL-15, caspase-1 and IL-1. Co-culture of stress-treated DC with mononuclear cells activates IL-15 and IL-1 receptors on CD4(+) T cells, eliciting CD40L, proliferation, and up-regulation of CD45RO(+) memory T cells. The transcription factors Tbet(high) and RORt are up-regulated, whereas FoxP3 is down-regulated, resulting in enhanced Th1 and Th17 expression and the corresponding cytokines. The interaction between maIL-15 expressed by DC and IL-15R on CD4(+) T cells results in one pathway and the corresponding cells expressing IL-1 and IL1R as a second pathway. Importantly, inhibition studies with IL-15 antibodies and IL-1R inhibitor suggest that both pathways may be required for optimum CD4(+) CD45RO(+) memory T cell expression. Type 1 IFN expression in splenic CD11c DC of stress-treated mice demonstrated a significant increase of IFN- in CD11c CD317(+) and CD8(+) DC. Analysis of RNA in human CD4(+) memory T cells showed up-regulation of type 1 IFN-stimulated genes and inhibition with histone methyltransferase inhibitor. We suggest the paradigm that stress-induced tonic stimulation might be responsible for the robust persistence of the immune response in vaccination and that epigenetic changes are involved in maintaining CD4(+) T cell memory.	[Wang, Yufei; Lehner, Thomas] Kings Coll London, Mucosal Immunol Unit, London SE1 1UL, England; [Lavender, Paul; Watson, Julie] Kings Coll London, MRC, London SE1 1UL, England; [Lavender, Paul; Watson, Julie] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, London SE1 1UL, England; [Arno, Matthew] Kings Coll London, Genom Ctr, London SE1 1UL, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Lehner, T (corresponding author), Guys Hosp, Mucosal Immunol Unit, Room 2-64S,2nd Floor,Hodgkin Bldg, London SE1 1UL, England.	Thomas.lehner@kcl.ac.uk		Lavender, Paul/0000-0001-8710-0263	European Union Network of excellence, Europrise Grant [LSHP-CT-2006-037611C]; Advanced Immunization Technology Grant [280873]; King's Health Partner's Research and Challenge Fund; Department of Health, National Institute for Health Research (NIHR) Biomedical Research Centre; Medical Research Council [G1000758] Funding Source: researchfish	European Union Network of excellence, Europrise Grant; Advanced Immunization Technology Grant; King's Health Partner's Research and Challenge Fund; Department of Health, National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Union Network of excellence, Europrise Grant LSHP-CT-2006-037611C), Advanced Immunization Technology Grant 280873, and King's Health Partner's Research and Challenge Fund.; Supported by the Department of Health, National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Abt MC, 2009, CURR OPIN GASTROEN, V25, P496, DOI 10.1097/MOG.0b013e328331b6b4; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Andris F, 2011, J IMMUNOL, V186, P2245, DOI 10.4049/jimmunol.1002333; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Corcoran BM, 2008, CURR PHARM DESIGN, V14, P1382, DOI 10.2174/138161208784480225; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Flahaut S, 1996, FEMS MICROBIOL LETT, V138, P49, DOI 10.1016/0378-1097(96)00080-8; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Intlekofer AM, 2006, IMMUNOL REV, V211, P203, DOI 10.1111/j.0105-2896.2006.00396.x; Jordan-Williams KL, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-16; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; LOS M, 1995, EMBO J, V14, P3731, DOI 10.1002/j.1460-2075.1995.tb00043.x; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Manlapat AK, 2007, EUR J IMMUNOL, V37, P1064, DOI 10.1002/eji.200636690; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Srivastava S, 2014, J EXP MED, V211, P961, DOI 10.1084/jem.20131556; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Wang YF, 2012, J BIOL CHEM, V287, P17152, DOI 10.1074/jbc.M112.347179; Wang YF, 2010, EUR J IMMUNOL, V40, P1628, DOI 10.1002/eji.200940251; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Youngblood B, 2013, IMMUNOLOGY, V139, P277, DOI 10.1111/imm.12074; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	58	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15595	15609		10.1074/jbc.M115.645754	http://dx.doi.org/10.1074/jbc.M115.645754			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25907558	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000356527400024
J	Chang, SS; Hu, HY				Chang, Shen-Shong; Hu, Hsiao-Yun			Long-Term Use of Steroids Protects from the Development of Symptomatic Diverticulitis Requiring Hospitalization in the Asian Population	PLOS ONE			English	Article							COMPLICATED DIVERTICULITIS; DISEASE; COLON; EPIDEMIOLOGY; HEALTH; IMPACT	Objective The pathophysiology of diverticulitis is poorly understood. Factors such as physical inactivity, constipation, obesity, smoking, and the use of nonsteroidal antiinflammatory drugs (NSAIDs) have been associated with an increased risk of diverticular disease. To evaluate whether patients exhibiting long-term steroid use are at increased risk of colonic diverticulitis. Method We conducted a population-based, nested case-control study. Data were retrospectively collected from the National Health Insurance Research Database. The study cohort comprised patients diagnosed with diverticulitis, identified using inpatient discharge records using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes (562.11 and 562.13), and those who were administered one or more prescriptions for corticosteroids for systemic use. Control patients were matched to cases by age, sex, NSAID use, laxative drug use, and index date. We enrolled 690 patients with colonic diverticulitis and 2760 in the control group. The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression. Results Compared with steroid nonusers, the adjusted ORs were 0.60 (95% CI = 0.35-1.06) and 0.80 (95% CI = 0.64-1.008) in current steroid users and previous steroid users, respectively. In addition, the adjusted ORs were 0.55 (95% CI = 0.31-0.98), 0.57 (95% CI = 0.31-0.98), and 0.44 (95% CI = 0.22-0.86) for steroid use duration more than half time by an exposure period of 90 days, 180 days, and 365 days before the claim date of colonic diverticulitis, respectively. Conclusions The results indicated that long-term steroid use within one year is associated with lower risk of colonic diverticulitis.	[Chang, Shen-Shong] Taipei City Hosp, Yang Ming Branch, Div Gastroenterol, Taipei, Taiwan; [Chang, Shen-Shong] Taipei City Hosp, Yang Ming Branch, Dept Internal Med, Taipei, Taiwan; [Chang, Shen-Shong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Hsiao-Yun] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hu, Hsiao-Yun] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Hu, HY (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	hyhu@ym.edu.tw						ALMY TP, 1980, NEW ENGL J MED, V302, P324, DOI 10.1056/NEJM198002073020605; [Anonymous], [No title captured]; Bose KP, 2013, J CLIN GASTROENTEROL, V47, P160, DOI 10.1097/MCG.0b013e318259e71c; Chapman J, 2005, ANN SURG, V242, P576, DOI 10.1097/01.sla.0000184843.89836.35; Cheng SH, 1997, JAMA-J AM MED ASSOC, V278, P89, DOI 10.1001/jama.278.2.89; Delvaux M, 2003, ALIMENT PHARM THERAP, V18, P71, DOI 10.1046/j.0953-0673.2003.01720.x; Humes DJ, 2011, GUT, V60, P219, DOI 10.1136/gut.2010.217281; Jacobs DO, 2007, NEW ENGL J MED, V357, P2057, DOI 10.1056/NEJMcp073228; Laine L, 2008, GASTROENTEROLOGY, V135, P1517, DOI 10.1053/j.gastro.2008.07.067; Lanas A, 2006, DIGESTION, V73, P136, DOI 10.1159/000089789; Lanas A, 2009, GASTROENTEROL CLIN N, V38, P333, DOI 10.1016/j.gtc.2009.03.007; Morris CR, 2002, POSTGRAD MED J, V78, P654, DOI 10.1136/pmj.78.925.654; PARKS TG, 1968, POSTGRAD MED J, V44, P680, DOI 10.1136/pgmj.44.515.680; SLACK WW, 1962, BRIT J SURG, V50, P185, DOI 10.1002/bjs.18005022012; Stollman NH, 1999, J CLIN GASTROENTEROL, V29, P241, DOI 10.1097/00004836-199910000-00004; Strate LL, 2012, AM J GASTROENTEROL, V107, P1486, DOI 10.1038/ajg.2012.194; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; von Rahden BHA, 2012, COLORECTAL DIS, V14, P1276, DOI 10.1111/j.1463-1318.2012.02967.x	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124598	10.1371/journal.pone.0124598	http://dx.doi.org/10.1371/journal.pone.0124598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919040	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400056
J	Fukuzaki, Y; Shin, H; Kawai, HD; Yamanoha, B; Kogure, S				Fukuzaki, Yumi; Shin, Hyeryun; Kawai, Hideki D.; Yamanoha, Banri; Kogure, Shinichi			532 nm Low-Power Laser Irradiation Facilitates the Migration of GABAergic Neural Stem/Progenitor Cells in Mouse Neocortex	PLOS ONE			English	Article							STEM-CELLS; PROLIFERATION; THERAPY; PATHWAY; DIFFERENTIATION; NEURONS; PHOTOBIOMODULATION; PRECURSORS; EXPRESSION; INDUCTION	Background and Objective Accumulating evidence has shown that low-power laser irradiation (LLI) affects cell proliferation and survival, but little is known about LLI effects on neural stem/progenitor cells (NSPCs). Here we investigate whether transcranial 532 nm LLI affects NSPCs in adult murine neocortex and in neurospheres from embryonic mice. Study Design/Materials and Methods We applied 532 nm LLI (Nd:YVO4, CW, 60 mW) on neocortical surface via cranium in adult mice and on cultured cells from embryonic mouse brains in vitro to investigate the proliferation and migration of NSPCs and Akt expression using immunohistochemical assays and Western blotting techniques. Results In vivo experiments demonstrated that 532 nm LLI significantly facilitated the migration of GABAergic NSPCs that were induced to proliferate in layer 1 by mild ischemia. In vitro experiments using GABAergic NSPCs derived from embryonic day 14 ganglionic eminence demonstrated that 532 nm LLI for 60 min promoted the migration of GAD67-immunopositive NSPCs with a significant increase of Akt expression. Meanwhile, the LLI induced proliferation, but not migration, of NSPCs that give rise to excitatory neurons. Conclusion It is concluded that 532 nm LLI promoted the migration of GABAergic NSPCs into deeper layers of the neocortex in vivo by elevating Akt expression.	[Fukuzaki, Yumi; Shin, Hyeryun; Kawai, Hideki D.; Kogure, Shinichi] Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan; [Yamanoha, Banri] Soka Univ, Fac Engn, Dept Environm Engn Symbiosis, Hachioji, Tokyo, Japan	Soka University; Soka University	Kogure, S (corresponding author), Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan.	kogure@soka.ac.jp		Kawai, Hideki/0000-0003-2113-6866	Soka University; JSPS KAKENHI [26.8139]	Soka University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: The authors have received Faculty Research Fees (total: 1,600,000 Yen) from Soka University in 2013 and 2014 and Grant-in-Aid for JSPS Fellows (total: 1,000,000 Yen) from JSPS KAKENHI Grant Number 26.8139 in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang FY, 2012, LASER MED SCI, V27, P935, DOI 10.1007/s10103-011-1009-8; Anwer AG, 2012, LASER SURG MED, V44, P769, DOI 10.1002/lsm.22083; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Brosseau L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002049.pub2; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; da Silva JP, 2010, PHOTOMED LASER SURG, V28, P17, DOI 10.1089/pho.2008.2372; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Fukuzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070737; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Gresner P, 2005, J PHOTOCH PHOTOBIO B, V79, P43, DOI 10.1016/j.jphotobiol.2004.11.018; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Huang D, 2008, CHINESE GERMAN J CLI, V7, P227, DOI [10.1007/s10330-007-0185-2, DOI 10.1007/S10330-007-0185-2]; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; Karu T, 2003, BIOMEDICAL PHOTONICS, V48; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Kassak P, 2005, GEN PHYSIOL BIOPHYS, V24, P209; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; MESTER E, 1968, ACTA CHIR HUNG, V9, P349; Moore P, 2005, LASER SURG MED, V36, P8, DOI 10.1002/lsm.20117; Murayama H, 2012, LASER MED SCI, V27, P87, DOI 10.1007/s10103-011-0924-z; Novoselova EG, 2006, PHOTODERMATOL PHOTO, V22, P33, DOI 10.1111/j.1600-0781.2006.00191.x; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Reddy GK, 2001, WOUND REPAIR REGEN, V9, P248, DOI 10.1046/j.1524-475x.2001.00248.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Souza BR, 2011, J NEUROSCI, V31, P5512, DOI 10.1523/JNEUROSCI.5548-10.2011; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Te Alexis E, 2006, Rev Urol, V8 Suppl 3, pS24; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van den Ameele J, 2014, TRENDS NEUROSCI, V37, P334, DOI 10.1016/j.tins.2014.03.005; Vinck EM, 2003, LASER MED SCI, V18, P95, DOI 10.1007/s10103-003-0262-x; Webb C, 1998, LASER SURG MED, V22, P294, DOI 10.1002/(SICI)1096-9101(1998)22:5<294::AID-LSM6>3.3.CO;2-J; Yip KK, 2011, NEUROSCIENCE, V190, P301, DOI 10.1016/j.neuroscience.2011.06.022; Zhang LL, 2009, J CELL PHYSIOL, V219, P553, DOI 10.1002/jcp.21697; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123833	10.1371/journal.pone.0123833	http://dx.doi.org/10.1371/journal.pone.0123833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919297	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400036
J	Ogasawara, S; Chiba, T; Ooka, Y; Kanogawa, N; Motoyama, T; Suzuki, E; Tawada, A; Azemoto, R; Shinozaki, M; Yoshikawa, M; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Motoyama, Tenyu; Suzuki, Eiichiro; Tawada, Akinobu; Azemoto, Ryosaku; Shinozaki, Masami; Yoshikawa, Masaharu; Yokosuka, Osamu			A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization	PLOS ONE			English	Article							SUBCLASSIFICATION; MANAGEMENT; SURVIVAL	Background Intermediate-stage hepatocellular carcinoma (HCC), defined according to the Barcelona Clinic Liver Cancer (BCLC) staging system, is a heterogeneous condition with variable clinical benefits from transarterial chemoembolization (TACE). This study aimed to develop a simple validated prognostic score based on the predictive factors for survival in patients with intermediate-stage HCC treated with TACE. Methods Three-hundred and fifty patients with intermediate-stage HCC undergoing initial TACE at Chiba University Hospital (training cohort; n = 187) and two affiliated hospitals (validation cohort; n = 163) were included. Following variables were entered into univariate and multivariate Cox regression models to develop a points-based clinical scoring system: gender, age, etiology, pretreatment, Child-Pugh score, aspartate aminotransferase, creatinine, Creactive protein, alfa-fetoprotein, size of the largest lesion, and number and location of lesions. Results The number of lesions and the Child-Pugh score were identified as independent prognostic factors in the training cohort. The development of a 0-7-point prognostic score, named the Chiba HCC in intermediate-stage prognostic (CHIP) score, was based on the sum of three subscale scores (Child-Pugh score = 0, 1, 2, or 3, respectively, number of lesions = 0, 2, or 3, respectively, HCV-RNA positivity = 0 or 1, respectively). The generated scores were then differentiated into five groups (0-2 points, 3 points, 4 points, 5 points, and 6-7 points) by the median survival time (65.2, 29.2, 24.3, 13.1, and 8.4 months, respectively; p < 0.0001). These results were confirmed in the external validation cohort (p < 0.0001). Conclusions The CHIP score is easy-to-use and may assist in finding an appropriate treatment strategy for intermediate-stage HCC.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Motoyama, Tenyu; Suzuki, Eiichiro; Tawada, Akinobu; Yoshikawa, Masaharu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Azemoto, Ryosaku] Kimitsu Chuo Hosp, Dept Gastroenterol, Chiba, Japan; [Shinozaki, Masami] Numazu City Hosp, Dept Gastroenterol, Shizuoka, Japan	Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064	Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan); Nippon Kayaku Co, Ltd (Tokyo, Japan)	Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan); Nippon Kayaku Co, Ltd (Tokyo, Japan)	Prof. Osamu Yokosuka received grant support (scholarship contribution) from Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan) and Nippon Kayaku Co, Ltd (Tokyo, Japan). The remaining authors disclose no conflicts. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Dumortier J, 2006, DIGEST LIVER DIS, V38, P125, DOI 10.1016/j.did.2005.10.025; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao HJ, 2014, LIVER INT, V34, P612, DOI 10.1111/liv.12307; Golfieri R, 2011, HEPATOLOGY, V53, P1580, DOI 10.1002/hep.24246; Ha Y, 2014, J GASTROEN HEPATOL, V29, P787, DOI 10.1111/jgh.12452; Kadalayil L, 2013, ANN ONCOL, V24, P2565, DOI 10.1093/annonc/mdt247; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Poon RTP, 2003, ANN SURG, V237, P376, DOI 10.1097/00000658-200303000-00012; Sieghart W, 2013, HEPATOLOGY, V57, P2261, DOI 10.1002/hep.26256; Takayasu K, 2012, J HEPATOL, V56, P886, DOI 10.1016/j.jhep.2011.10.021; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Wang JH, 2015, J GASTROEN HEPATOL, V30, P358, DOI 10.1111/jgh.12686; Xiao J, 2014, INT J CLIN EXP PATHO, V7, P1114; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9	21	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125244	10.1371/journal.pone.0125244	http://dx.doi.org/10.1371/journal.pone.0125244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919025	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659400077
J	Song, ZY; Yamasaki, R; Kawano, Y; Sato, S; Masaki, K; Yoshimura, S; Matsuse, D; Murai, H; Matsushita, T; Kira, J				Song, Zi-Ye; Yamasaki, Ryo; Kawano, Yuji; Sato, Shinya; Masaki, Katsuhisa; Yoshimura, Satoshi; Matsuse, Dai; Murai, Hiroyuki; Matsushita, Takuya; Kira, Jun-ichi			Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod	PLOS ONE			English	Article							1-PHOSPHATE RECEPTOR MODULATOR; JAPANESE PATIENTS; CONTROLLED-TRIAL; FTY720 THERAPY; CENTRAL MEMORY; SUBSETS; LESIONS; PROFILES; TH17	Background Fingolimod efficiently reduces multiple sclerosis (MS) relapse by inhibiting lymphocyte egress from lymph nodes through down-modulation of sphingosine 1-phosphate (S1P) receptors. We aimed to clarify the alterations in peripheral blood T cell subsets associated with MS relapse on fingolimod. Methods/Principal Findings Blood samples successively collected from 23 relapsing-remitting MS patients before and during fingolimod therapy (0.5 mg/day) for 12 months and 18 healthy controls (HCs) were analysed for T cell subsets by flow cytometry. In MS patients, the percentages of central memory T (CCR7(+)CD45RO(+)) cells (TCM) and naive T (CCR7(+)CD45RO(-)) cells decreased significantly, while those of effector memory T (CCR7-CD45RA-) and suppressor precursor T (CD28-) cells increased in both CD4(+)T and CD8(+)T cells from 2 weeks to 12 months during fingolimod therapy. The percentages of regulatory T (CD4(+)CD25(high)CD127(low)) cells in CD4(+)T cells and CCR7(-)CD45RA(+)T cells in CD8(+)T cells also increased significantly. Eight relapsed patients demonstrated greater percentages of CD4(+)TCM than 15 non-relapsed patients at 3 and 6 months (p=0.0051 and p=0.0088, respectively). The IL17-, IL9-, and IL4-producing CD4(+)T cell percentages were significantly higher at pre-treatment in MS patients compared with HCs (p<0.01 for all), while the IL17-producing CD4(+)T cell percentages tended to show a transient increase at 2 weeks of fingolimod therapy (p(corr)=0.0834). Conclusions The CD4(+)TCM percentages at 2 weeks to 12 months during fingolimod therapy are related to relapse.	[Song, Zi-Ye; Kawano, Yuji; Sato, Shinya; Masaki, Katsuhisa; Yoshimura, Satoshi; Matsuse, Dai; Murai, Hiroyuki; Matsushita, Takuya; Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Yamasaki, Ryo] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol Therapeut, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kira, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan.	kira@neuro.med.kyushu-u.ac.jp			Health and Labour Sciences Research Grants on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan [H24-Nanchitou (Nan)-Ippan-055, H23-Nanchi-Ippan-017]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25293204, 25670423, 25117012]; Bayer Schering Pharma; Biogen Idec; Novartis Pharma; Mitsubishi Tanabe Pharma; Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Kaibara Morikazu Medical Science Promotion Foundation, Japan; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Pfizer Japan; Japan Blood Products Organization; Grants-in-Aid for Scientific Research [25670423] Funding Source: KAKEN	Health and Labour Sciences Research Grants on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Novartis Pharma; Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kaibara Morikazu Medical Science Promotion Foundation, Japan(Kaibara Morikazu Medical Science Promotion Foundation); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer Japan(Pfizer); Japan Blood Products Organization; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Health and Labour Sciences Research Grants on Intractable Diseases (H24-Nanchitou (Nan)-Ippan-055 and H23-Nanchi-Ippan-017) from the Ministry of Health, Labour and Welfare, Japan, and by a Grant-in-Aid for Scientific Research B (No. 25293204), a Grant-in-Aid for Exploratory Research (No. 25670423), and a Grant-in-Aid for Scientific Research on Innovative Areas (No. 25117012) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Ryo Yamasaki has received research support from Bayer Schering Pharma, Biogen Idec, Novartis Pharma, and Mitsubishi Tanabe Pharma. Takuya Matsushita has received speaker honoraria from Bayer Schering Pharma, Biogen Idec, and Pfizer and receives research support from Bayer Schering Pharma, Biogen Idec, Novartis Pharma, Mitsubishi Tanabe Pharma, the Ministry of Health, Labour and Welfare of Japan, the Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Kaibara Morikazu Medical Science Promotion Foundation, Japan. Junichi Kira has received honoraria from Biogen Idec Japan, Novartis Pharma Japan, and Mitsubishi Tanabe Pharma Corporation. He is funded by a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare, Japan, and grants from the Japan Science and Technology Agency, the Ministry of Education, Culture, Sports, Science and Technology, Japan, Pfizer Japan, and the Japan Blood Products Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiba K, 2011, INT IMMUNOPHARMACOL, V11, P366, DOI 10.1016/j.intimp.2010.10.005; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; CRUCIAN B, 1995, CLIN DIAGN LAB IMMUN, V2, P249, DOI 10.1128/CDLI.2.2.249-252.1995; CUI YW, 2014, CLIN EXP NEUROIMMUNO, V5, P92; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jander S, 2012, MULT SCLER J, V18, P1650, DOI 10.1177/1352458512463768; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Killestein J, 2001, MULT SCLER, V7, P145, DOI 10.1191/135245801678438357; Kira J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-21; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Matsushita T, 2009, MULT SCLER J, V15, P834, DOI 10.1177/1352458509104595; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Ochi H, 2001, J NEUROIMMUNOL, V119, P297, DOI 10.1016/S0165-5728(01)00393-9; Ochi HF, 2004, J NEUROL SCI, V222, P65, DOI 10.1016/j.jns.2004.04.012; PANITCH HS, 1987, LANCET, V1, P893; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER S, 1981, J NEUROL, V225, P219, DOI 10.1007/BF00313751; Putheti P, 2003, J NEUROIMMUNOL, V144, P125, DOI 10.1016/j.jneuroim.2003.08.001; Saida T, 2012, MULT SCLER J, V18, P1269, DOI 10.1177/1352458511435984; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Sato DK, 2014, J NEUROIMMUNOL, V268, P95, DOI 10.1016/j.jneuroim.2014.01.008; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Tanaka M, 2008, NEUROLOGY, V71, P974, DOI 10.1212/01.wnl.0000326589.57128.c3; Visser F, 2012, NEUROLOGY, V79, P2000, DOI 10.1212/WNL.0b013e3182735cb3; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Yoshimura S, 2013, J NEUROL NEUROSUR PS, V84, P29, DOI 10.1136/jnnp-2012-302925	36	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124923	10.1371/journal.pone.0124923	http://dx.doi.org/10.1371/journal.pone.0124923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919001	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400065
J	Amemiya, T; Nakamura, T; Yamamoto, T; Kinoshita, S; Kanamura, N				Amemiya, Takeshi; Nakamura, Takahiro; Yamamoto, Toshiro; Kinoshita, Shigeru; Kanamura, Narisato			Autologous Transplantation of Oral Mucosal Epithelial Cell Sheets Cultured on an Amniotic Membrane Substrate for Intraoral Mucosal Defects	PLOS ONE			English	Article							SURFACE RECONSTRUCTION; BASEMENT-MEMBRANE; KERATIN PROTEINS; LOCALIZATION; EQUIVALENT; CORNEAL; SERUM; IV	The human amniotic membrane (AM) is a thin intrauterine placental membrane that is highly biocompatible and possesses anti-inflammatory and anti-scarring properties. Using AM, we developed a novel method for cultivating oral mucosal epithelial cell sheets. We investigated the autologous transplantation of oral mucosal epithelial cells cultured on AM in patients undergoing oral surgeries. We obtained specimens of AM from women undergoing cesarean sections. This study included five patients without any history of a medical disorder who underwent autologous cultured oral epithelial transplantation following oral surgical procedures. Using oral mucosal biopsy specimens obtained from these patients, we cultured oral epithelial cells on an AM carrier. We transplanted the resultant cell sheets onto the oral mucosal defects. Patients were followed-up for at least 12 months after transplantation. After 2-3 weeks of being cultured on AM, epithelial cells were well differentiated and had stratified into five to seven layers. Immunohistochemistry revealed that the cultured cells expressed highly specific mucosal epithelial cell markers and basement membrane proteins. After the surgical procedures, no infection, bleeding, rejection, or sheet detachment occurred at the reconstructed sites, at which new oral mucous membranes were evident. No recurrence was observed in the long-term follow-up, and the postoperative course was excellent. Our results suggest that AM-cultured oral mucosal epithelial cell sheets represent a useful biomaterial and feasible method for oral mucosal reconstruction. However, our primary clinical study only evaluated their effects on a limited number of small oral mucosal defects.	[Amemiya, Takeshi; Yamamoto, Toshiro; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan; [Nakamura, Takahiro; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Ophthalmol, Kyoto, Japan; [Nakamura, Takahiro] Doshisha Univ, Fac Life & Med Sci, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Doshisha University	Amemiya, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kyoto, Japan.	amemiya@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science [21592535]; Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research [15K11261, 25861966] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto Prefectural University of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work supported by a Grant-in-Aid for Scientific Research (No. 21592535) from the Japan Society for the Promotion of Science (NK), and a Grant for Advanced Medical Treatment in Kyoto Prefectural University of Medicine (NK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2014, ORAL DIS, V20, P582, DOI 10.1111/odi.12176; Amemiya T, 2004, J ORAL TISSUE ENG, V1, P89; Amemiya T, 2010, JPN J CONSERV DENT, V53, P214; Amemiya T, 2003, J JPN ASS REGENERATI, V1, P25; Amemiya T, 2010, BIO-MED MATER ENG, V20, P37, DOI 10.3233/BME-2010-0613; Amemyia T., 2010, INFLAMM REGEN, V30, P176, DOI [10.2492/inflammregen.30.176, DOI 10.2492/INFLAMMREGEN.30.176]; Black AF, 2005, TISSUE ENG, V11, P723, DOI 10.1089/ten.2005.11.723; CLAUSEN H, 1986, J ORAL PATHOL MED, V15, P36, DOI 10.1111/j.1600-0714.1986.tb00561.x; COLOCHO G, 1974, ARCH SURG-CHICAGO, V109, P370; COOPER D, 1986, J BIOL CHEM, V261, P4646; Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29; Feghali-Assaly M, 1997, EUR J ORAL SCI, V105, P599, DOI 10.1111/j.1600-0722.1997.tb00224.x; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018; Izumi K, 2003, INT J ORAL MAX SURG, V32, P188, DOI 10.1054/ijom.2002.0365; JUHL M, 1989, SCAND J DENT RES, V97, P159; Kanamura, 2008, J ORAL TISSUE ENG, V6, P106; Kesting MR, 2014, ORAL MAXILLOFAC SURG, V18, P153, DOI 10.1007/s10006-012-0382-1; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; Maragou P, 1999, ORAL DIS, V5, P20; Modesti A, 1989, Prog Clin Biol Res, V296, P459; Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203; Nakamura T, 2006, INVEST OPHTH VIS SCI, V47, P909, DOI 10.1167/iovs.05-1188; Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nakamura T, 2011, BRIT J OPHTHALMOL, V95, P942, DOI 10.1136/bjo.2010.188714; NANAEV AK, 1991, PLACENTA, V12, P573, DOI 10.1016/0143-4004(91)90493-Y; Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0; ROSDY M, 1990, J INVEST DERMATOL, V95, P409, DOI 10.1111/1523-1747.ep12555510; ROSDY M, 1993, BRIT J DERMATOL, V129, P227, DOI 10.1111/j.1365-2133.1993.tb11839.x; Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031; SHABANA AHM, 1991, ARCH ORAL BIOL, V36, P747, DOI 10.1016/0003-9969(91)90041-R; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D; TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8; Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431; Yamamoto T, 2007, J ORAL TISSUE ENG, V5, P54	37	13	15	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125391	10.1371/journal.pone.0125391	http://dx.doi.org/10.1371/journal.pone.0125391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915046	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100126
J	Gessler, F; Dutzmann, S; Quick, J; Tizi, K; Voigt, MA; Mutlak, H; Vatter, H; Seifert, V; Senft, C				Gessler, Florian; Duetzmann, Stephan; Quick, Johanna; Tizi, Karima; Voigt, Melanie Alexandra; Mutlak, Haitham; Vatter, Hartmut; Seifert, Volker; Senft, Christian			Is Postoperative Imaging Mandatory after Meningioma Removal? Results of a Prospective Study	PLOS ONE			English	Article							RECURRENCE; SURGERY; TUMORS	Background Routine postoperative imaging (PI) following surgery for intracranial meningiomas is common practice in most neurosurgical departments. The purpose of this study was to determine the role of routine PI and its impact on clinical decision making after resection of meningioma. Methods Patient and tumor characteristics, details of radiographic scans, symptoms and alteration of treatment courses were prospectively collected for patients undergoing removal of a supratentorial meningioma of the convexity, falx, tentorium, or lateral sphenoid wing at the authors' institution between January 1st, 2010 and March 31st, 2012. Patients with infratentorial manifestations or meningiomas of the skull base known to be surgically difficult (e.g. olfactory groove, petroclival, medial sphenoid wing) were not included. Maximum tumor diameter was divided into groups of < 3cm (small), 3 to 6 cm (medium), and > 6 cm (large). Results 206 patients with meningiomas were operated between January 2010 and March 2012. Of these, 113 patients met the inclusion criteria and were analyzed in this study. 83 patients (73.5%) did not present new neurological deficits, whereas 30 patients (26.5%) became clinically symptomatic. Symptomatic patients had a change in treatment after PI in 21 cases (70%), while PI was without consequence in 9 patients (30%). PI did not result in a change of treatment in all asymptomatic patients (p<0.001) irrespective of tumor size (p<0.001) or localization (p<0.001). Conclusions PI is mandatory for clinically symptomatic patients but it is safe to waive it in clinically asymptomatic patients, even if the meningioma was large in size.	[Gessler, Florian; Duetzmann, Stephan; Quick, Johanna; Tizi, Karima; Mutlak, Haitham; Vatter, Hartmut; Seifert, Volker; Senft, Christian] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany; [Voigt, Melanie Alexandra] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Neuroradiol, D-60528 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Gessler, F (corresponding author), Univ Cambridge, Dept Clin Neurosci, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England.	f.gessler@med.uni-frankfurt.de	Senft, Christian/F-4252-2010	Senft, Christian/0000-0003-1288-6913				ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Binning M, 2007, J NEUROSURG, V107, P43, DOI 10.3171/PED-07/07/043; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dutzmann S, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12219; HODGSON TJ, 1995, J NEUROL NEUROSUR PS, V59, P545, DOI 10.1136/jnnp.59.5.545; Hoover Jason M, 2011, Surg Neurol Int, V2, P142, DOI 10.4103/2152-7806.85983; Hussain SA, 2001, BRIT J NEUROSURG, V15, P116; Ildan F, 2007, SKULL BASE-INTERD AP, V17, P157, DOI 10.1055/s-2007-970554; Jiang ZY, 2013, OTOLARYNG HEAD NECK, V149, P786, DOI 10.1177/0194599813502311; Jung JM, 2012, CHILD NERV SYST, V28, P673, DOI 10.1007/s00381-012-1716-x; Kim EH, 2011, ACTA NEUROCHIR, V153, P1487, DOI 10.1007/s00701-011-1046-x; LONGSTRETH WT, 1993, CANCER, V72, P639, DOI 10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Schulder M, 2003, ACTA NEUROCHIR SUPPL, V85, P79; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Solheim O, 2009, ACTA NEUROCHIR, V151, P1143, DOI 10.1007/s00701-009-0395-1; Sughrue ME, 2013, J NEUROSURG, V119, P86, DOI 10.3171/2012.12.JNS11539; Terlecki RP, 2011, UROLOGY, V78, P450, DOI 10.1016/j.urology.2011.01.071; Tomasello F, 2012, WORLD NEUROSURG, V77, P631, DOI 10.1016/j.wneu.2011.11.012; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; van den Bergh B, 2011, INT J ORAL MAX SURG, V40, P1373, DOI 10.1016/j.ijom.2011.08.008; Vassilyadi M, 2010, J NEUROSURG-PEDIATR, V6, P468, DOI 10.3171/2010.8.PEDS09557	23	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124534	10.1371/journal.pone.0124534	http://dx.doi.org/10.1371/journal.pone.0124534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915782	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100053
J	Liang, JG; Liu, L; Cheung, M; Lee, MP; Wang, HB; Li, CH; Chan, CC; Nishiura, K; Tang, X; Tan, ZW; Peng, J; Cheung, KW; Yam, WC; Chen, ZW				Liang, Jianguo; Liu, Li; Cheung, Mandy; Lee, Man-Po; Wang, Haibo; Li, Chun-ho; Chan, Chun-Chung; Nishiura, Kenji; Tang, Xian; Tan, Zhiwu; Peng, Jie; Cheung, Ka-Wai; Yam, Wing-Cheong; Chen, Zhiwei			Community-Based HIV-1 Early Diagnosis and Risk Behavior Analysis of Men Having Sex with Men in Hong Kong	PLOS ONE			English	Article							REAL-TIME PCR; DRIED BLOOD SPOTS; PROVIRAL DNA; INFECTION; QUANTIFICATION; PREVENTION; CHINA; CELLS; TRANSMISSION; PREVALENCE	The increasing prevalence of HIV-1 among men having sex with men (MSM) calls for an investigation of HIV-1 prevalence and incidence in MSM by early diagnosis to assist with early preventive interventions in Hong Kong. The participants were recruited randomly from MSM communities within a one-year period. Rapid HIV Test (RHT) and real-time dried blood spot (DBS)-based quantitative polymerase chain reaction (DBS-qPCR) were used for the early diagnosis of 474 participants. Risk behavior analysis was performed by studying information obtained from the participants during the study period. The HIV-1 prevalence and incident rates in the studied MSM population were 4.01%(19/474) and 1.47% (7/474), respectively. Three infected participants were found at the acute phase of infection by DBS-qPCR. Only 46.4%(220/474) MSM were using condoms regularly for anal sex. HIV infection significantly correlated with unprotected receptive anal sex and syphilis infection. An increased number of infections was found among foreign MSM in Hong Kong. This study is the first to use DBS-qPCR to identify acutely infected individuals in a community setting and to provide both the prevalence and incident rates of HIV-1 infection among MSM in Hong Kong. The risk analysis provided evidence that behavior intervention strengthening is necessary to fight against the increasing HIV-1 epidemic among MSM in Hong Kong and surrounding regions in Asia.	[Liang, Jianguo; Liu, Li; Wang, Haibo; Nishiura, Kenji; Tang, Xian; Tan, Zhiwu; Peng, Jie; Cheung, Ka-Wai; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, Pokfulam, Hong Kong, Peoples R China; [Liang, Jianguo; Liu, Li; Wang, Haibo; Nishiura, Kenji; Tang, Xian; Tan, Zhiwu; Peng, Jie; Cheung, Ka-Wai; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Cheung, Mandy; Li, Chun-ho; Chan, Chun-Chung] AIDS Concern, Chaiwan, Hong Kong, Peoples R China; [Lee, Man-Po] Queen Elizabeth Hosp Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Yam, Wing-Cheong] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Liu, L (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	liuli71@hkucc.hku.hk; zchenai@hku.hk	Liu, Li/ABA-8315-2020; Chen, Zhiwei/B-7793-2019	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888; Nishiura, Kenji/0000-0002-9573-6808	Hong Kong AIDS Trust [MSS166R, MSS 183R]; University Development Fund (HKU UDF); Li Ka Shing Faculty of Medicine Matching Fund (LKSFM); National Science and Technology Major Project [2012ZX10001-009]; AIDS Trust Fund [MSS 227R]	Hong Kong AIDS Trust; University Development Fund (HKU UDF); Li Ka Shing Faculty of Medicine Matching Fund (LKSFM); National Science and Technology Major Project; AIDS Trust Fund	The authors thank Hong Kong AIDS Trust Fund for financial support MSS166R (to LL) and MSS 183R (to ZC). This work was partially supported by University Development Fund (HKU UDF) and Li Ka Shing Faculty of Medicine Matching Fund (LKSFM) matching fund to AIDS Institute and by the National Science and Technology Major Project 2012ZX10001-009. The authors thank K.H. Wong for providing patient PBMC samples. The authors thank D.D. Ho and K.Y. Yuen for scientific advice. AIDS Trust Fund, MSS 227R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, HIV TEST BAS CONS; Chen J.J., 2011, MODEL SIMUL ENG, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0025286; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chiminqgi M, 2007, CLIN CHEM LAB MED, V45, P993, DOI 10.1515/CCLM.2007.191; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; De Crignis E, 2010, J VIROL METHODS, V165, P51, DOI 10.1016/j.jviromet.2009.12.017; Defoort JP, 2000, J CLIN MICROBIOL, V38, P1066, DOI 10.1128/JCM.38.3.1066-1071.2000; Desire N, 2001, J CLIN MICROBIOL, V39, P1303, DOI 10.1128/JCM.39.4.1303-1310.2001; DH, 2012, HIV PREV RISK BEH SU; Gibellini D, 2004, J CLIN VIROL, V29, P282, DOI 10.1016/S1386-6532(03)00169-0; HAENDLER B, 1990, EUR J BIOCHEM, V190, P477, DOI 10.1111/j.1432-1033.1990.tb15598.x; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; HORSBURGH CR, 1989, LANCET, V2, P637; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kabamba-Mukadi B, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-15; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lau JTF, 2004, SEX TRANSM INFECT, V80, P459, DOI 10.1136/sti.2003.008854; Lau JTF, 2004, SEX TRANSM DIS, V31, P568, DOI 10.1097/01.olq.0000137905.94154.0a; Lau JTF, 2002, ARCH SEX BEHAV, V31, P367, DOI 10.1023/A:1016280411280; Lee EM SS, REPORT ASSESSMENT RE; Lee SS, 2009, AIDS, V23, P1753, DOI 10.1097/QAD.0b013e32832dc025; Leung TWC, 2008, AIDS RES HUM RETROV, V24, P903, DOI 10.1089/aid.2007.0272; Ling AE, 2000, JAMA-J AM MED ASSOC, V284, P210, DOI 10.1001/jama.284.2.210; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Luo MQ, 2009, JAIDS-J ACQ IMM DEF, V50, P1, DOI 10.1097/QAI.0b013e31818ffcdc; McKirnan DJ, 2010, J CONSULT CLIN PSYCH, V78, P952, DOI 10.1037/a0020759; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005819; Ngo-Giang-Huong N, 2008, JAIDS-J ACQ IMM DEF, V49, P465, DOI 10.1097/QAI.0b013e31818e2531; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Rienzo M, 2013, CLIN TRANSL ONCOL, V15, P211, DOI 10.1007/s12094-012-0904-1; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125715	10.1371/journal.pone.0125715	http://dx.doi.org/10.1371/journal.pone.0125715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915755	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100144
J	Silva-Sanchez, A; Meza-Perez, S; Flores-Langarica, A; Donis-Maturano, L; Estrada-Garcia, I; Calderon-Amador, J; Hernandez-Pando, R; Idoyaga, J; Steinman, RM; Flores-Romo, L				Silva-Sanchez, Aaron; Meza-Perez, Selene; Flores-Langarica, Adriana; Donis-Maturano, Luis; Estrada-Garcia, Iris; Calderon-Amador, Juana; Hernandez-Pando, Rogelio; Idoyaga, Juliana; Steinman, Ralph M.; Flores-Romo, Leopoldo			ESAT-6 Targeting to DEC205+Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VIVO; ANTIGEN PRESENTATION; LYMPH-NODES; PHAGOSOME MATURATION; IMMUNE-RESPONSES; RECEPTOR DEC-205; CUTTING EDGE; BOVIS BCG; MICE	Airways infection with Mycobacterium tuberculosis (Mtb) is contained mostly by T cell responses, however, Mtb has developed evasion mechanisms which affect antigen presenting cell (APC) maturation/recruitment delaying the onset of Ag-specific T cell responses. Hypothetically, bypassing the natural infection routes by delivering antigens directly to APCs may overcome the pathogen's naturally evolved evasion mechanisms, thus facilitating the induction of protective immune responses. We generated a murine monoclonal fusion antibody (alpha-DEC-ESAT) to deliver Early Secretory Antigen Target (ESAT)-6 directly to DEC205(+) APCs and to assess its in vivo effects on protection associated responses (IFN-gamma production, in vivo CTL killing, and pulmonary mycobacterial load). Treatment with alpha-DEC-ESAT alone induced ESAT-6-specific IFN-gamma producing CD4(+) T cells and prime-boost immunization prior to Mtb infection resulted in early influx (d14 post-infection) and increased IFN-gamma(+) production by specific T cells in the lungs, compared to scarce IFN-gamma production in control mice. In vivo CTL killing was quantified in relevant tissues upon transferring target cells loaded with mycobacterial antigens. During infection, alpha-DEC-ESAT-treated mice showed increased target cell killing in the lungs, where histology revealed cellular infiltrate and considerably reduced bacterial burden. Targeting the mycobacterial antigen ESAT-6 to DEC205(+) APCs before infection expands specific T cell clones responsible for early T cell responses (IFN-gamma production and CTL activity) and substantially reduces lung bacterial burden. Delivering mycobacterial antigens directly to APCs provides a unique approach to study in vivo the role of APCs and specific T cell responses to assess their potential anti-mycobacterial functions.	[Silva-Sanchez, Aaron; Meza-Perez, Selene; Donis-Maturano, Luis; Calderon-Amador, Juana; Flores-Romo, Leopoldo] CINVESTAV, IPN, Dept Cell Biol, Mexico City 14000, DF, Mexico; [Silva-Sanchez, Aaron; Meza-Perez, Selene; Estrada-Garcia, Iris] ENCB IPN, Dept Immunol, Mexico City, DF, Mexico; [Flores-Langarica, Adriana; Idoyaga, Juliana; Steinman, Ralph M.] Rockefeller Univ, Physiol & Cell Biol, New York, NY 10021 USA; [Hernandez-Pando, Rogelio] Dept Pathol INNSZ, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Rockefeller University	Flores-Romo, L (corresponding author), CINVESTAV, IPN, Dept Cell Biol, Mexico City 14000, DF, Mexico.	leflores@cinvestav.mx	Meza-Perez, Selene/AAX-2300-2021; Silva-Sanchez, Aaron/AAI-8572-2021	Meza-Perez, Selene/0000-0001-7881-6964; Silva-Sanchez, Aaron/0000-0002-1882-2534; Donis Maturano, Luis/0000-0001-8430-5669; Flores-Langarica, Adriana/0000-0003-2183-4437; Hernandez-Pando, Rogelio/0000-0003-1292-3833	National Council for Science and Technology of Mexico, CONACyT; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI13013]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [5K99AR062595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI013013, R01AI013013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR062595] Funding Source: NIH RePORTER	National Council for Science and Technology of Mexico, CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was in part funded by the National Council for Science and Technology of Mexico, CONACyT (LFR, RHP and IEG). RMS was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant AI13013. JI is supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) grant 5K99AR062595.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Anand PK, 2005, FEMS MICROBIOL LETT, V250, P137, DOI 10.1016/j.femsle.2005.06.056; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brusasca PN, 2003, COMPARATIVE MED, V53, P165; Brusasca PN, 2001, SCAND J IMMUNOL, V54, P448, DOI 10.1046/j.1365-3083.2001.00975.x; Cardona DP-J, 2012, UNDERSTANDING TUBERC; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Cohn L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00255; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Derrick SC, 2013, VACCINE, V31, P4641, DOI 10.1016/j.vaccine.2013.07.032; Djelouadji Z, 2011, LANCET INFECT DIS, V11, P641, DOI 10.1016/S1473-3099(11)70093-7; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Einarsdottir T, 2009, INFECT IMMUN, V77, P4621, DOI 10.1128/IAI.00415-09; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Garcia-Romo GS, 2013, IMMUNOBIOLOGY, V218, P393, DOI 10.1016/j.imbio.2012.05.022; Garcia-Romo GS, 2004, IMMUNOLOGY, V112, P661, DOI 10.1046/j.1365-2567.2004.01904.x; Gueirard P, 2003, INFECT IMMUN, V71, P4137, DOI 10.1128/IAI.71.7.4137-4143.2003; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; HernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Jung YJ, 2008, IMMUNOLOGY, V124, P514, DOI 10.1111/j.1365-2567.2007.02803.x; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kastenmuller W, 2014, NAT REV IMMUNOL, V14, P705, DOI 10.1038/nri3727; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; NORTH RJ, 1995, J INFECT DIS, V172, P1550, DOI 10.1093/infdis/172.6.1550; Pedroza-Gonzalez A, 2004, INT J EXP PATHOL, V85, P135, DOI 10.1111/j.0959-9673.2004.00381.x; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Quintero-Macias L, 2010, SCAND J IMMUNOL, V71, P20, DOI 10.1111/j.1365-3083.2009.02335.x; Quintero-Macias L, 2012, IMMUNOL INVEST, V41, P51, DOI 10.3109/08820139.2011.580408; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Sendide K, 2004, INFECT IMMUN, V72, P4200, DOI 10.1128/IAI.72.7.4200-4209.2004; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Stylianou E, 2011, VACCINE, V29, P2279, DOI 10.1016/j.vaccine.2011.01.030; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; von GC, 2009, SWISSMEDWKLY, V139, P186; Wang H, 2000, P NATL ACAD SCI USA, V97, P847, DOI 10.1073/pnas.97.2.847; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Yang EZ, 2014, MICROB PATHOGENESIS, V69-70, P53, DOI 10.1016/j.micpath.2014.03.011	63	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124828	10.1371/journal.pone.0124828	http://dx.doi.org/10.1371/journal.pone.0124828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915045	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100070
J	Soulas, C; Autissier, PJ; Burdo, TH; Piatak, M; Lifson, JD; Williams, KC				Soulas, Caroline; Autissier, Patrick J.; Burdo, Tricia H.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Williams, Kenneth C.			Distinct Phenotype, Longitudinal Changes of Numbers and Cell-Associated Virus in Blood Dendritic Cells in SIV-Infected CD8-Lymphocyte Depleted Macaques	PLOS ONE			English	Article							PREFERENTIALLY HARBORS HIV-1; CD16(+) MONOCYTE SUBSET; PERIPHERAL-BLOOD; RHESUS MACAQUES; LYMPH-NODES; T-CELLS; IN-VIVO; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; FLOW-CYTOMETRY	Loss of circulating CD123+ plasmacytoid dendritic cells (pDCs) during HIV infection is well established. However, changes of myeloid DCs (mDCs) are ambiguous since they are studied as a homogeneous CD11c+ population despite phenotypic and functional heterogeneity. Heterogeneity of CD11c+ mDCs in primates is poorly described in HIV and SIV infection. Using multiparametric flow cytometry, we monitored longitudinally cell number and cell-associated virus of CD123+ pDCs and non-overlapping subsets of CD1c+ and CD16+ mDCs in SIV-infected CD8-depleted rhesus macaques. The numbers of all three DC subsets were significantly decreased by 8 days post-infection. Whereas CD123+ pDCs were persistently depleted, numbers of CD1c+ and CD16+ mDCs rebounded. Numbers of CD1c+ mDCs significantly increased by 3 weeks post-infection while numbers of CD16+ mDCs remained closer to pre-infection levels. We found similar changes in the numbers of all three DC subsets in CD8 depleted animals as we found in animals that were SIV infected animals that were not CD8 lymphocyte depleted. CD16+ mDCs and CD123+ pDCs but not CD1c+ mDCs were significantly decreased terminally with AIDS. All DC subsets harbored SIV RNA as early as 8 days and then throughout infection. However, SIV DNA was only detected in CD123+ pDCs and only at 40 days post-infection consistent with SIV RNA, at least in mDCs, being surface-bound. Altogether our data demonstrate that SIV infection differently affects CD1c+ and CD16+ mDCs where CD16+ but not CD1c+ mDCs are depleted and might be differentially regulated in terminal AIDS. Finally, our data underline the importance of studying CD1c+ and CD16+ mDCs as discrete populations, and not as total CD11c+ mDCs.	[Soulas, Caroline; Autissier, Patrick J.; Burdo, Tricia H.; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD 21702 USA	Boston College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Williams, KC (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	williauy@bc.edu			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIH [R01NS40237, R01NS37654, U19MH081835, R01NS06897]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101, U24AI126683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH081835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082116, R01NS040237, R01NS037654] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This work was also supported by NIH grants R01NS40237, R01NS37654, U19MH081835, and R01NS06897 to K.C.W. Nonhuman Primate Reagent Resource (RR016001, AI040101) provided the in vivo CD8 T lymphocyte depletion antibodies used in these studies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barratt-Boyes SM, 2010, J MED PRIMATOL, V39, P235, DOI 10.1111/j.1600-0684.2010.00428.x; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; CAMERON PU, 1992, CLIN EXP IMMUNOL, V88, P226, DOI 10.1111/j.1365-2249.1992.tb03066.x; Centlivre M, 2011, J LEUKOCYTE BIOL, V89, P785, DOI 10.1189/jlb.0410231; Cline AN, 2005, J MED PRIMATOL, V34, P303; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Fitzgerald-Bocarsly P, 2010, J LEUKOCYTE BIOL, V87, P609, DOI 10.1189/jlb.0909635; Izquierdo-Useros N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004146; Jaworowski A, 2007, J INFECT DIS, V196, P38, DOI 10.1086/518443; Jones GJ, 2001, AIDS, V15, P1657, DOI 10.1097/00002030-200109070-00008; Koopman G, 2004, HUM IMMUNOL, V65, P303, DOI 10.1016/j.humimm.2004.01.013; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; MACATONIA SE, 1990, IMMUNOLOGY, V71, P38; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Otero M, 2003, AIDS RES HUM RETROV, V19, P1097, DOI 10.1089/088922203771881194; Patterson S, 1998, J GEN VIROL, V79, P247, DOI 10.1099/0022-1317-79-2-247; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Pichyangkul S, 2001, J IMMUNOL METHODS, V252, P15, DOI 10.1016/S0022-1759(01)00327-1; Schmidt B, 2006, J CLIN IMMUNOL, V26, P55, DOI 10.1007/s10875-006-8401-3; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; WEISSMAN D, 1995, P NATL ACAD SCI USA, V92, P826, DOI 10.1073/pnas.92.3.826; Wijewardana V, 2014, IMMUNOLOGY, V143, P146, DOI 10.1111/imm.12295; Wijewardana V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001235; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Wonderlich ER, 2013, J IMMUNOL, V190, P2188, DOI 10.4049/jimmunol.1201645	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0119764	10.1371/journal.pone.0119764	http://dx.doi.org/10.1371/journal.pone.0119764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915601	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100003
J	Al-Subari, K; Al-Baddai, S; Tome, AM; Volberg, G; Hammwohner, R; Lang, EW				Al-Subari, Karema; Al-Baddai, Saad; Tome, Ana Maria; Volberg, Gregor; Hammwoehner, Rainer; Lang, Elmar W.			Ensemble Empirical Mode Decomposition Analysis of EEG Data Collected during a Contour Integration Task	PLOS ONE			English	Article							COMMUNICATION; DYNAMICS; CLOSURE; BAND	We discuss a data-driven analysis of EEG data recorded during a combined EEG/fMRI study of visual processing during a contour integration task. The analysis is based on an ensemble empirical mode decomposition (EEMD) and discusses characteristic features of event related modes (ERMs) resulting from the decomposition. We identify clear differences in certain ERMs in response to contour vs noncontour Gabor stimuli mainly for response amplitudes peaking around 100 [ms] (called P100) and 200 [ms] (called N200) after stimulus onset, respectively. We observe early P100 and N200 responses at electrodes located in the occipital area of the brain, while late P100 and N200 responses appear at electrodes located in frontal brain areas. Signals at electrodes in central brain areas show bimodal early/late response signatures in certain ERMs. Head topographies clearly localize statistically significant response differences to both stimulus conditions. Our findings provide an independent proof of recent models which suggest that contour integration depends on distributed network activity within the brain.	[Al-Subari, Karema; Al-Baddai, Saad; Lang, Elmar W.] Univ Regensburg, Inst Biophys, Dept Biol, D-93053 Regensburg, Germany; [Al-Subari, Karema; Al-Baddai, Saad; Hammwoehner, Rainer] Univ Regensburg, Inst Informat Sci, Dept Linguist Literature & Culture, D-93053 Regensburg, Germany; [Tome, Ana Maria] Univ Aveiro, Inst Elect Engn & Elect, Dept Elect Engn Telecommun & Informat, P-3800 Aveiro, Portugal; [Volberg, Gregor] Univ Regensburg, Inst Expt Psychol, Dept Psychol Pedag & Sport, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; Universidade de Aveiro; University of Regensburg	Lang, EW (corresponding author), Univ Regensburg, Inst Biophys, Dept Biol, D-93053 Regensburg, Germany.	elmar.lang@ur.de		Volberg, Gregor/0000-0002-4427-2409; Tome, Ana Maria/0000-0002-1210-0266	DAAD	DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	DAAD (Acciones Conjuntas (Integradas) Hispano-Alemanas). DAAD (Accoes Integradas Luso-Alemas and FCT Cooperacao Transnacional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas LI, 2001, NEUROSCI LETT, V303, P115, DOI 10.1016/S0304-3940(01)01703-7; Al-Baddai S, 2014, BIOMED SIGNAL PROCES, V13, P218, DOI 10.1016/j.bspc.2014.04.011; Aru J, 2012, NEUROSCI BIOBEHAV R, V36, P737, DOI 10.1016/j.neubiorev.2011.12.003; Attoh-Okine N, 2008, EURASIP J ADV SIGNAL; Claessens PME, 2008, J VISION, V8, DOI 10.1167/8.7.33; Claessens PM, 2005, PERCEPT PSYCHOPHYS, V67, P1446, DOI 10.3758/BF03193649; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eriksson J, 2008, J COGNITIVE NEUROSCI, V20, P1777, DOI 10.1162/jocn.2008.20064; Faltermeier R, 2011, ADV DATA SCI ADAPT, V3, P509, DOI 10.1142/S1793536911000891; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gilad A, 2013, NEURON, V78, P389, DOI 10.1016/j.neuron.2013.02.013; Hanslmayr S, 2013, CURR BIOL, V23, P2273, DOI 10.1016/j.cub.2013.09.020; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Imamoglu F, 2014, NEUROIMAGE, V102, P688, DOI 10.1016/j.neuroimage.2014.08.045; Keil A, 1999, J NEUROSCI, V19, P7152, DOI 10.1523/JNEUROSCI.19-16-07152.1999; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lang EW, 2011, EXPLORATORY MATRIX F, P26, DOI DOI 10.2174/97816080521891110101; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LEHMANN D, 1984, PROG NEUROBIOL, V23, P227, DOI 10.1016/0301-0082(84)90003-0; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Luck SJ, 2012, OXFORD HDB EVENT REL; Machilsen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025151; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Mathes B, 2006, BRAIN RES, V1114, P98, DOI 10.1016/j.brainres.2006.07.068; May KA, 2007, J VISION, V7, DOI 10.1167/7.13.9; Mijovic B, 2014, NEUROIMAGE, V88, P10, DOI 10.1016/j.neuroimage.2013.11.032; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Novitskiy N, 2011, NEUROIMAGE, V54, P824, DOI 10.1016/j.neuroimage.2010.09.041; Pettet MW, 1998, VISION RES, V38, P865, DOI 10.1016/S0042-6989(97)00238-1; Shpaner M, 2013, NEUROIMAGE, V69, P146, DOI 10.1016/j.neuroimage.2012.11.023; Tarokh L, 2009, BEHAV BRAIN RES, V196, P55, DOI 10.1016/j.bbr.2008.07.026; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Volberg G, 2014, EXP PSYCHOL, V61, P331, DOI 10.1027/1618-3169/a000252; Volberg G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00264; Volberg G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054085; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P339, DOI 10.1142/S1793536909000187; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Zeiler A, 2013, NEURAL PROCESS LETT, V37, P21, DOI 10.1007/s11063-012-9270-9	45	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0119489	10.1371/journal.pone.0119489	http://dx.doi.org/10.1371/journal.pone.0119489			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910061	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800006
J	Dunkley, BT; Sedge, PA; Doesburg, SM; Grodecki, RJ; Jetly, R; Shek, PN; Taylor, MJ; Pang, EW				Dunkley, Benjamin T.; Sedge, Paul A.; Doesburg, Sam M.; Grodecki, Richard J.; Jetly, Rakesh; Shek, Pang N.; Taylor, Margot J.; Pang, Elizabeth W.			Theta, Mental Flexibility, and Post-Traumatic Stress Disorder: Connecting in the Parietal Cortex	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; VIETNAM VETERANS; FUNCTIONAL CONNECTIVITY; CORTICAL MECHANISMS; NEURAL ACTIVITY; ATTENTION; MEMORY; OSCILLATIONS; SYNCHRONIZATION	Post-traumatic stress disorder (PTSD) is a mental health injury characterised by re-experiencing, avoidance, numbing and hyperarousal. Whilst the aetiology of the disorder is relatively well understood, there is debate about the prevalence of cognitive sequelae that manifest in PTSD. In particular, there are conflicting reports about deficits in executive function and mental flexibility. Even less is known about the neural changes that underlie such deficits. Here, we used magnetoencephalography to study differences in functional connectivity during a mental flexibility task in combat-related PTSD (all males, mean age = 37.4, n = 18) versus a military control (all males, mean age = 33.05, n = 19) group. We observed large-scale increases in theta connectivity in the PTSD group compared to controls. The PTSD group performance was compromised in the more attentionally-demanding task and this was characterised by 'late-stage' theta hyperconnectivity, concentrated in network connections involving right parietal cortex. Furthermore, we observed significant correlations with the connectivity strength in this region with a number of cognitive-behavioural outcomes, including measures of attention, depression and anxiety. These findings suggest atypical coordination of neural synchronisation in large scale networks contributes to deficits in mental flexibility for PTSD populations in timed, attentionally-demanding tasks, and this propensity toward network hyperconnectivity may play a more general role in the cognitive sequelae evident in this disorder.	[Dunkley, Benjamin T.; Doesburg, Sam M.; Taylor, Margot J.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Dunkley, Benjamin T.; Doesburg, Sam M.; Taylor, Margot J.; Pang, Elizabeth W.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Sedge, Paul A.; Jetly, Rakesh] Canadian Forces Hlth Serv, Directorate Mental Hlth, Ottawa, ON, Canada; [Doesburg, Sam M.; Taylor, Margot J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Doesburg, Sam M.; Taylor, Margot J.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Grodecki, Richard J.] Canadian Forces Environm Med Estab, Toronto, ON, Canada; [Shek, Pang N.] Def Res & Dev Canada, Toronto, ON, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Defence Research & Development Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Dunkley, BT (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ben.dunkley@sickkids.ca		Dunkley, Benjamin Thomas/0000-0001-6173-1171	Defence Research and Development Canada (DRDC) [W7719-135182/001/TOR]; Canadian Forces Health Services	Defence Research and Development Canada (DRDC); Canadian Forces Health Services	This work was supported by funding from Defence Research and Development Canada (DRDC) (Contract #: W7719-135182/001/TOR; http://www.drdc-rddc.gc.ca/en/index.page) and the Canadian Forces Health Services (http://www.forces.gc.ca/en/caf-community-health-services/index.page) to MJTand EWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Boulos D, 2013, CAN MED ASSOC J, V185, pE545, DOI 10.1503/cmaj.122120; Caplan JB, 2003, J NEUROSCI, V23, P4726; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; Dunkley BT, 2014, NEUROIMAGE-CLIN, V5, P377, DOI 10.1016/j.nicl.2014.07.017; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Fox MT, 2003, J NEUROSCI, V23, P676, DOI 10.1523/JNEUROSCI.23-02-00676.2003; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Garber BG, 2012, CAN J PSYCHIAT, V57, P736, DOI 10.1177/070674371205701205; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Gold AL, 2011, PSYCHOL MED, V41, P2563, DOI 10.1017/S0033291711000730; James LM, 2013, JAMA PSYCHIAT, V70, P410, DOI 10.1001/jamapsychiatry.2013.878; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kimble MO, 2010, J ANXIETY DISORD, V24, P293, DOI 10.1016/j.janxdis.2009.12.006; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Kolassa IT, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-56; Konishi S, 2002, P NATL ACAD SCI USA, V99, P7803, DOI 10.1073/pnas.122644899; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; LaGarde G, 2010, PSYCHIAT RES, V177, P144, DOI 10.1016/j.psychres.2009.02.002; Leber AB, 2008, P NATL ACAD SCI USA, V105, P13592, DOI 10.1073/pnas.0805423105; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Lindauer RJL, 2006, BIOL PSYCHIAT, V59, P171, DOI 10.1016/j.biopsych.2005.06.033; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Marmar CR, 2006, ANN NY ACAD SCI, V1071, P1, DOI 10.1196/annals.1364.001; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Muthukumaraswamy SD, 2013, NEUROPSYCHOPHARMACOL, V1, P1, DOI DOI 10.3389/FNHUM; Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Sauseng P, 2006, EXP BRAIN RES, V170, P295, DOI 10.1007/s00221-005-0211-y; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Shomstein S, 2003, SOC NEUR ABSTR, V29, P873; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Tewarie P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069318; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wu J, 2010, NEUROSCI LETT; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	69	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123541	10.1371/journal.pone.0123541	http://dx.doi.org/10.1371/journal.pone.0123541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909654	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800039
J	Khairoun, M; van den Heuvel, M; van den Berg, BM; Sorop, O; de Boer, R; van Ditzhuijzen, NS; Bajema, IM; Baelde, HJ; Zandbergen, M; Duncker, DJ; Rabelink, TJ; Reinders, MEJ; van der Giessen, WJ; Rotmans, JI				Khairoun, Meriem; van den Heuvel, Mieke; van den Berg, Bernard M.; Sorop, Oana; de Boer, Rients; van Ditzhuijzen, Nienke S.; Bajema, Ingeborg M.; Baelde, Hans J.; Zandbergen, Malu; Duncker, Dirk J.; Rabelink, Ton J.; Reinders, Marlies E. J.; van der Giessen, Wim J.; Rotmans, Joris I.			Early Systemic Microvascular Damage in Pigs with Atherogenic Diabetes Mellitus Coincides with Renal Angiopoietin Dysbalance	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; KIDNEY-TRANSPLANTATION; EARLY ATHEROSCLEROSIS; IN-VIVO; EXPRESSION; NEPHROPATHY; RETINOPATHY; GROWTH; VEGF; DYSFUNCTION	Background Diabetes mellitus (DM) is associated with a range of microvascular complications including diabetic nephropathy (DN). Microvascular abnormalities in the kidneys are common histopathologic findings in DN, which represent one manifestation of ongoing systemic microvascular damage. Recently, sidestream dark-field (SDF) imaging has emerged as a noninvasive tool that enables one to visualize the microcirculation. In this study, we investigated whether changes in the systemic microvasculature induced by DM and an atherogenic diet correlated spatiotemporally with renal damage. Methods Atherosclerotic lesion development was triggered in streptozotocin-induced DM pigs (140 mg/kg body weight) by administering an atherogenic diet for approximately 11 months. Fifteen months following induction of DM, microvascular morphology was visualized in control pigs (n = 7), non-diabetic pigs fed an atherogenic diet (ATH, n = 5), and DM pigs fed an atherogenic diet (DM+ATH, n = 5) using SDF imaging of oral mucosal tissue. Subsequently, kidneys were harvested from anethesized pigs and the expression levels of well-established markers for microvascular integrity, such as Angiopoietin-1 (Angpt1) and Angiopoietin-2 (Angpt2) were determined immunohistochemically, while endothelial cell (EC) abundance was determined by immunostaining for von Willebrand factor (vWF). Results Our study revealed an increase in the capillary tortuosity index in DM+ATH pigs (2.31 +/- 0.17) as compared to the control groups (Controls 0.89 +/- 0.08 and ATH 1.55 +/- 0.11; p<0.05). Kidney biopsies showed marked glomerular lesions consisting of mesangial expansion and podocyte lesions. Furthermore, we observed a disturbed Angpt2/Angpt1balance in the cortex of the kidney, as evidenced by increased expression of Angpt2 in DM+ATH pigs as compared to Control pigs (p<0.05). Conclusion In the setting of DM, atherogenesis leads to the augmentation of mucosal capillary tortuosity, indicative of systemic microvascular damage. Concomitantly, a dysbalance in renal angiopoietins was correlated with the development of diabetic nephropathy. As such, our studies strongly suggest that defects in the systemic microvasculature mirror the accumulation of microvascular damage in the kidney.	[Khairoun, Meriem; van den Berg, Bernard M.; de Boer, Rients; Rabelink, Ton J.; Reinders, Marlies E. J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [van den Berg, Bernard M.; Rabelink, Ton J.; Reinders, Marlies E. J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Res, Leiden, Netherlands; [Bajema, Ingeborg M.; Baelde, Hans J.; Zandbergen, Malu] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [van den Heuvel, Mieke; Sorop, Oana; van Ditzhuijzen, Nienke S.; Duncker, Dirk J.; van der Giessen, Wim J.] Erasmus MC, Dept Cardiol, Div Expt Cardiol, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Rotmans, JI (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	j.i.rotmans@lumc.nl	Reinders, Marlies/AAF-2710-2019; van den berg, bernard m/D-8444-2014; Rotmans, Joris I./G-8866-2014; Rabelink, Ton J./A-5316-2008	Rotmans, Joris I./0000-0001-9682-6234; Rabelink, Ton J./0000-0001-6780-5186; Reinders, Marlies/0000-0001-9543-567X; van den Berg, Bernard/0000-0002-5726-5777; baelde, Hans/0000-0002-1214-500X	Netherlands CardioVascular Research Initiative [CVON2014-11: RECONNECT]; European Commission [MEDIA-261409]	Netherlands CardioVascular Research Initiative; European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was in part supported by grants from the Netherlands CardioVascular Research Initiative (CVON2014-11: RECONNECT) and from the European Commission (FP7-Health-2010; MEDIA-261409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; BARNES JL, 1995, J HISTOCHEM CYTOCHEM, V43, P895, DOI 10.1177/43.9.7642963; Bonnet F, 2000, DIABETES METAB, V26, P254; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Cumbie BC, 2007, VASC HEALTH RISK MAN, V3, P823; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Djaberi R, 2012, DIAB VASC DIS RES; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Feng DL, 2000, DIABETES CARE, V23, P1694, DOI 10.2337/diacare.23.11.1694; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Ishidoya S, 2002, J UROLOGY, V167, P1503, DOI 10.1016/S0022-5347(05)65353-0; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kalani M, 2008, VASC HEALTH RISK MAN, V4, P1061, DOI 10.2147/VHRM.S3920; Khairoun M, 2013, AM J TRANSPLANT, V13, P1272, DOI 10.1111/ajt.12182; Khairoun M, 2013, AM J PHYSIOL-RENAL, V305, pF901, DOI 10.1152/ajprenal.00542.2012; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kim KL, 2006, CARDIOVASC RES, V72, P394, DOI 10.1016/j.cardiores.2006.08.002; Koopmans SJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-64; Koopmans SJ, 2006, METABOLISM, V55, P960, DOI 10.1016/j.metabol.2006.03.004; Kuryliszyn-Moskal A, 2011, FOLIA HISTOCHEM CYTO, V49, P104, DOI 10.5603/FHC.2011.0015; Lassila M, 2007, DIABETOLOGIA, V50, P1315, DOI 10.1007/s00125-007-0652-x; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Nadar SK, 2005, J INTERN MED, V258, P336, DOI 10.1111/j.1365-2796.2005.01550.x; Nakamura S, 2000, KIDNEY INT, V58, P251, DOI 10.1046/j.1523-1755.2000.00160.x; Patel JI, 2005, BRIT J OPHTHALMOL, V89, P480, DOI 10.1136/bjo.2004.049940; Paueksakon P, 2002, KIDNEY INT, V61, P2142, DOI 10.1046/j.1523-1755.2002.00384.x; Rizkalla B, 2005, J HYPERTENS, V23, P153, DOI 10.1097/00004872-200501000-00026; Sasongko MB, 2011, DIABETOLOGIA, V54, P2409, DOI 10.1007/s00125-011-2200-y; Sasongko MB, 2012, AM J OPHTHALMOL, V153, P176, DOI 10.1016/j.ajo.2011.06.005; Stefansson S, 2003, CURR PHARM DESIGN, V9, P1545, DOI 10.2174/1381612033454621; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; Sugaru E, 2005, AM J PHYSIOL-RENAL, V289, pF998, DOI 10.1152/ajprenal.00065.2005; Sugaru E, 2006, AM J PHYSIOL-RENAL, V290, pF813, DOI 10.1152/ajprenal.00357.2005; Taneja D, 2010, J LIPID RES, V51, P1464, DOI 10.1194/jlr.M002972; Targher G, 2005, DIABETIC MED, V22, P999, DOI 10.1111/j.1464-5491.2005.01562.x; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Thompson J, 2011, AM J PATHOL, V179, P1179, DOI 10.1016/j.ajpath.2011.05.016; Tooke JE, 1996, CARDIOVASC RES, V32, P764, DOI 10.1016/S0008-6363(96)00091-0; Trouw LA, 2004, J CLIN INVEST, V114, P679, DOI 10.1172/JCI200421075; van den Heuvel M, 2012, AM J PHYSIOL-HEART C, V302, pH85, DOI 10.1152/ajpheart.00311.2011; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; van Ditzhuijzen NS, 2011, NETH HEART J, V19, P442, DOI 10.1007/s12471-011-0187-0	50	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121555	10.1371/journal.pone.0121555	http://dx.doi.org/10.1371/journal.pone.0121555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909188	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800011
J	Lai, KMV; Gong, GC; Atanasio, A; Rojas, J; Quispe, J; Posca, J; White, D; Huang, M; Fedorova, D; Grant, C; Miloscio, L; Droguett, G; Poueymirou, WT; Auerbach, W; Yancopoulos, GD; Frendewey, D; Rinn, J; Valenzuela, DM				Lai, Ka-Man Venus; Gong, Guochun; Atanasio, Amanda; Rojas, Jose; Quispe, Joseph; Posca, Julita; White, Derek; Huang, Mei; Fedorova, Daria; Grant, Craig; Miloscio, Lawrence; Droguett, Gustavo; Poueymirou, William T.; Auerbach, Wojtek; Yancopoulos, George D.; Frendewey, David; Rinn, John; Valenzuela, David M.			Diverse Phenotypes and Specific Transcription Patterns in Twenty Mouse Lines with Ablated LincRNAs	PLOS ONE			English	Article							LONG NONCODING RNA; HUMAN-CELLS; ES CELLS; MICE; GENE; EXPRESSION; DISRUPTION; DELETION; GENOME; LANDSCAPE	In a survey of 20 knockout mouse lines designed to examine the biological functions of large intergenic non-coding RNAs (lincRNAs), we have found a variety of phenotypes, ranging from perinatal lethality to defects associated with premature aging and morphological and functional abnormalities in the lungs, skeleton, and muscle. Each mutant allele carried a lacZ reporter whose expression profile highlighted a wide spectrum of spatiotemporal and tissue-specific transcription patterns in embryos and adults that informed our phenotypic analyses and will serve as a guide for future investigations of these genes. Our study shows that lincRNAs are a new class of encoded molecules that, like proteins, serve essential and important functional roles in embryonic development, physiology, and homeostasis of a broad array of tissues and organs in mammals.	[Lai, Ka-Man Venus; Gong, Guochun; Atanasio, Amanda; Rojas, Jose; Quispe, Joseph; Posca, Julita; White, Derek; Huang, Mei; Fedorova, Daria; Grant, Craig; Miloscio, Lawrence; Droguett, Gustavo; Poueymirou, William T.; Auerbach, Wojtek; Yancopoulos, George D.; Frendewey, David; Valenzuela, David M.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rinn, John] Regeneron Pharmaceut Inc, VelociGene, Tarrytown, NY 10591 USA; [Rinn, John] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Regeneron; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Frendewey, D (corresponding author), Regeneron Pharmaceut Inc, VelociGene, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	david.valenzuela@regeneron.com; john_rinn@harvard.edu		Rinn, John/0000-0002-7231-7539	Regeneron Pharmaceuticals, Inc.	Regeneron Pharmaceuticals, Inc.(Regeneron)	Regeneron Pharmaceuticals, Inc., provided support in the form of salaries for the authors; Ka-Man Venus Lai, Guochun Gong, Amanda Atanasio, Jose Rojas, Joseph Quispe, Julita Posca, Derek White, Mei Huang, Daria Fedorova, Craig Grant, Lawrence Miloscio, Gustavo Droguett, William T. Poueymirou, Wojtek Auerbach, George D. Yancopoulos, David Frendewey and David M. Valenzuela, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Bishop NB, 2011, AM J RESP CRIT CARE, V184, P172, DOI 10.1164/rccm.201010-1697CI; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; DeChiara TM, 2010, METHOD ENZYMOL, V476, P285, DOI 10.1016/S0076-6879(10)76016-X; DeChiara Thomas M., 2009, V530, P311, DOI 10.1007/978-1-59745-471-1_16; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Evans MJ, 2001, NAT MED, V7, P1081, DOI 10.1038/nm1001-1081; Frendewey D, 2010, METHOD ENZYMOL, V476, P295, DOI 10.1016/S0076-6879(10)76017-1; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hostikka SL, 1998, MECH DEVELOP, V70, P133, DOI 10.1016/S0925-4773(97)00182-2; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Lu PF, 2008, DEVELOPMENT, V135, P1395, DOI 10.1242/dev.018945; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Marin-Bejar O, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r104; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mohammad F, 2010, DEVELOPMENT, V137, P2493, DOI 10.1242/dev.048181; Nagy A., 2003, MANIPULATING MOUSE E; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Sado T, 2001, DEVELOPMENT, V128, P1275; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smithies O, 2001, NAT MED, V7, P1083, DOI 10.1038/nm1001-1083; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003	42	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125522	10.1371/journal.pone.0125522	http://dx.doi.org/10.1371/journal.pone.0125522			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909911	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800143
J	Pfannmuller, A; Wagner, D; Sieber, C; Schonig, B; Boeckstaens, M; Marini, AM; Tudzynski, B				Pfannmueller, Andreas; Wagner, Dominik; Sieber, Christian; Schoenig, Birgit; Boeckstaens, Melanie; Marini, Anna Maria; Tudzynski, Bettina			The General Amino Acid Permease FfGap1 of Fusarium fujikuroi Is Sorted to the Vacuole in a Nitrogen-Dependent, but Npr1 Kinase-Independent Manner	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GIBBERELLA-FUJIKUROI; UPTAKE SYSTEMS; TRANSCRIPTION FACTORS; PSEUDOHYPHAL GROWTH; YEAST AMMONIUM; GAP1 PERMEASE; HIGH-AFFINITY; PROTEIN; EXPRESSION	The rice pathogenic fungus Fusarium fujikuroiis well known for the production of a broad spectrum of secondary metabolites (SMs) such as gibberellic acids (GAs), mycotoxins and pigments. The biosynthesis of most of these SMs strictly depends on nitrogen availability and of the activity of permeases of nitrogen sources, e.g. the ammonium and amino acid permeases. One of the three ammonium permeases, MepB, was recently shown to act not only as a transporter but also as a nitrogen sensor affecting the production of nitrogen-repressed SMs. Here we describe the identification of a general amino acid permease, FfGap1, among the 99 putative amino acid permeases (AAPs) in the genome of F. fujikuroi. FfGap1 is able to fully restore growth of the yeast gap1 Delta mutant on several amino acids including citrulline and tryptophane. In S. cerevisiae, Gap1 activity is regulated by shuttling between the plasma membrane (nitrogen limiting conditions) and the vacuole (nitrogen sufficiency), which we also show for FfGap1. In yeast, the Npr1 serine/threonine kinase stabilizes the Gap1 position at the plasma membrane. Here, we identified and characterized three NPR1-homologous genes, encoding the putative protein kinases FfNpr1-1, FfNpr1-2 and FfNpr1-3 with significant similarity to yeast Npr1. Complementation of the yeast npr1 Delta mutant with each of the three F. fujikuroi NPR1homologues, resulted in partial restoration of ammonium, arginine and proline uptake by FfNPR1-1 while none of the three kinases affect growth on different nitrogen sources and nitrogen-dependent sorting of FfGap1 in F. fujikuroi. However, exchange of the putative ubiquitin-target lysine 9 (K9A) and 15 (K15A) residues of FfGap1 resulted in extended localization to the plasma membrane and increased protein stability independently of nitrogen availability. These data suggest a similar regulation of FfGap1 by nitrogen-dependent ubiquitination, but differences regarding the role of FusariumNpr1 homologues compared to yeast.	[Pfannmueller, Andreas; Wagner, Dominik; Schoenig, Birgit; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Boeckstaens, Melanie; Marini, Anna Maria] Univ Libre Bruxelles, Inst Biol & Med Mol, Lab Biol Transport Membranaire, Gosselies, Belgium; [Sieber, Christian] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany	University of Munster; Universite Libre de Bruxelles; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Tudzynski, B (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany.	tudzynsb@uni-muenster.de		Boeckstaens, Melanie/0000-0003-1629-7403; Sieber, Christian/0000-0002-9560-0281	DFG Deutsche Forschungsgemeinschaft (DFG) [TU101-7, TU101-12]; F.R.S.M. [3.4633.09]; Mandat d'Impulsion Scientifique (M.I.S.) from the Belgian Fund for Scientific Research (F.R.S.-FNRS) [F.4.521.10.F]; ARC convention [AUWB-2012-12/17]; Jean Brachet Foundation; Alice et David Van Buuren Foundation	DFG Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); F.R.S.M.(Fonds de la Recherche Scientifique - FNRS); Mandat d'Impulsion Scientifique (M.I.S.) from the Belgian Fund for Scientific Research (F.R.S.-FNRS); ARC convention(Australian Research Council); Jean Brachet Foundation; Alice et David Van Buuren Foundation	This study was funded by DFG Deutsche Forschungsgemeinschaft (DFG), TU101-7, TU101-12, by F.R.S.M. (3.4633.09) and Mandat d'Impulsion Scientifique (M.I.S.) (F.4.521.10.F) from the Belgian Fund for Scientific Research (F.R.S.-FNRS), an ARC convention (AUWB-2012-12/17), and the Jean Brachet and the Alice et David Van Buuren Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Bluhm BH, 2008, MOL PLANT PATHOL, V9, P203, DOI 10.1111/J.1364-3703.2007.00458.X; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Boeckstaens M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4101; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Feller A, 2006, J BIOL CHEM, V281, P28546, DOI 10.1074/jbc.M605551200; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; GRENSON M, 1982, EUR J BIOCHEM, V121, P643, DOI 10.1111/j.1432-1033.1982.tb05834.x; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Margelis S, 2001, J BACTERIOL, V183, P5826, DOI 10.1128/JB.183.20.5826-5833.2001; Margolis-Clark E, 2001, FUNGAL GENET BIOL, V33, P127, DOI 10.1006/fgbi.2001.1273; Marini AM, 2000, MOL MICROBIOL, V38, P552, DOI 10.1046/j.1365-2958.2000.02151.x; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Michielse CB, 2014, MOL MICROBIOL, V91, P472, DOI 10.1111/mmi.12472; Mihlan M, 2003, MOL MICROBIOL, V47, P975, DOI 10.1046/j.1365-2958.2003.03326.x; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Neuhauser B, 2011, EUKARYOT CELL, V10, P332, DOI 10.1128/EC.00293-10; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; Niehaus EM, 2013, CHEM BIOL, V20, P1055, DOI 10.1016/j.chembiol.2013.07.004; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Regenberg B, 1998, CURR GENET, V33, P171, DOI 10.1007/s002940050324; Regenberg B, 2000, YEAST, V16, P1111, DOI 10.1002/1097-0061(20000915)16:12<1111::AID-YEA611>3.0.CO;2-3; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Risinger AL, 2006, MOL BIOL CELL, V17, P4411, DOI 10.1091/mbc.E06-06-0506; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schonig B, 2008, EUKARYOT CELL, V7, P1831, DOI 10.1128/EC.00130-08; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Sherman F, 1986, LAB COURSE MANUAL ME; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Siegmund U, 2015, MOL MICROBIOL, V95, P988, DOI 10.1111/mmi.12869; Soetens O, 2001, J BIOL CHEM, V276, P43939; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Springael JY, 1999, J CELL SCI, V112, P1375; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Stanbrough M, 1996, J BACTERIOL, V178, P2465, DOI 10.1128/jb.178.8.2465-2468.1996; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Teichert S, 2008, EUKARYOT CELL, V7, P187, DOI 10.1128/EC.00351-07; Thevelein JM, 2005, BIOCHEM SOC T, V33, P253, DOI 10.1042/BST0330253; Trip H, 2004, APPL ENVIRON MICROB, V70, P4775, DOI 10.1128/AEM.70.8.4775-4783.2004; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Van Zeebroeck G, 2014, MOL MICROBIOL, V93, P213, DOI 10.1111/mmi.12654; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845; VANDENBOL M, 1987, EUR J BIOCHEM, V164, P607, DOI 10.1111/j.1432-1033.1987.tb11170.x; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wagner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080740; Wiemann P, 2013, FUSARIUM: GENOMICS, MOLECULAR AND CELLULAR BIOLOGY, P111; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	88	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125487	10.1371/journal.pone.0125487	http://dx.doi.org/10.1371/journal.pone.0125487			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909858	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800142
J	Burnett, RD; Roberts, LJ				Burnett, Ryan D.; Roberts, L. Jay			A Quantitative Evaluation of the Conservation Umbrella of Spotted Owl Management Areas in the Sierra Nevada	PLOS ONE			English	Article							MIXED-CONIFER FOREST; LAKE TAHOE BASIN; BIRD COMMUNITIES; NATIONAL-PARK; CALIFORNIA; FIRE; LANDSCAPE; DYNAMICS; OCCUPANCY; FLAGSHIPS	Whether by design or default, single species management often serves as an umbrella for species with similar habitat requirements. In recent decades the focus of National Forest management in the Sierra Nevada of California has shifted towards increasing closed canopy mature forest conditions through the protection of areas occupied by the California Spotted Owl (Strix occidentalis occidentalis). To evaluate the implications of these habitat changes and the potential umbrella resulting from a system of owl reserves on the broader avian community, we estimated occupancy of birds inside and outside of Spotted Owl Home Range Core Areas in northeastern California. We used point count data in a multi-species hierarchical Bayesian model incorporating the detection history of 81 species over a two-year time period (2005-2006). A small set of vegetation cover and topography covariates were included in the model to account for broad differences in habitat conditions, as well as a term identifying whether or not a site was within a Core Area. Seventeen species had a negative Core Area effect, seven had a positive effect, and the rest were not significant. Estimated species richness was significantly different with 23.1 species per 100 m radius circle outside Core Areas and 21.7 inside Core Areas. The majority of the species negatively associated with Core Areas are tied to early successional and other disturbance-dependent habitats. Conservation and climate vulnerability rankings were mixed. On average we found higher scores (greater risk) for the species positively associated with Core Areas, but a larger number of species with the highest scores were negatively associated with Core Areas. We discuss the implications for managing the Sierra Nevada ecosystem and illustrate the role of monitoring broader suites of species in guiding management of large complex ecosystems.	[Burnett, Ryan D.; Roberts, L. Jay] Point Blue Conservat Sci, Petaluma, CA 94954 USA		Burnett, RD (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	rburnett@pointblue.org			United States Department of Agriculture Forest Service Pacific Southwest Region Resources Legacy Fund [2012-0334]; United States Forest Service	United States Department of Agriculture Forest Service Pacific Southwest Region Resources Legacy Fund; United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This study was supported by the United States Department of Agriculture Forest Service Pacific Southwest Region Resources Legacy Fund Grant #2012-0334. Part of the funding for data collection was provided by the United States Forest Service whose land management this study evaluates. The authors adhered to the Point Blue policy on scientific ethics and do not believe the source of funding influenced this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman B, 2007, RAINFOREST BIRDS LAN, P2006; Altman B, 2000, BIRDS N AM ONLINE; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2006, ARCGIS 9 2; [Anonymous], 2000, ARCVIEW GIS 3 2A; Barbour M, 2002, J VEG SCI, V13, P461, DOI 10.1111/j.1654-1103.2002.tb02073.x; Beardsley D, 1999, 516 PNW PAC NW RES S; Beaty RM, 2008, FOREST ECOL MANAG, V255, P707, DOI 10.1016/j.foreco.2007.09.044; BEEDY EC, 1981, CONDOR, V83, P97, DOI 10.2307/1367415; Berigan WJ, 2012, J FOREST, V110, P299, DOI 10.5849/jof.11-018; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Blakesley JA, 2010, WILDLIFE MONOGR, P1; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Bond Monica L., 2013, Western Birds, V44, P114; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Burnett RD, 2012, PRBO CONSERVATION SC, V1912; Burnett RD, 2007, PRBO CONSERVATION SC, V1869; California Partners in Flight, 2002, CON FOR BIRD CONS PL; CALWATER, 1999, CAL WAT VERS 2 2; Chase Mary K., 2005, U S Forest Service General Technical Report PSW, V191, P130; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fleishman E, 2000, ECOL APPL, V10, P569, DOI 10.1890/1051-0761(2000)010[0569:ANMFSO]2.0.CO;2; Franklin J.F., 1996, SIERRA NEVADA ECOSYS, VVolume 37, P627, DOI DOI 10.3996/012012-JFWM-002.S9);; FRANKLIN JF, 1994, ECOL APPL, V4, P208; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Gelman A., 2007, DATA ANAL USING REGR; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Hutto RL, 1998, AVIAN CONSERVATION: RESEARCH AND MANAGEMENT, P75; Innes RJ, 2007, J MAMMAL, V88, P1523, DOI 10.1644/07-MAMM-A-002R.1; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jones BE, 2005, RESTOR ECOL, V13, P373, DOI 10.1111/j.1526-100X.2005.00046.x; Keating KA, 2007, J WILDLIFE MANAGE, V71, P1344, DOI 10.2193/2006-359; Kery M, 2008, J APPL ECOL, V45, P589, DOI 10.1111/j.1365-2664.2007.01441.x; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Lee DE, 2012, CONDOR, V114, P792, DOI 10.1525/cond.2012.110147; Mallek C, 2013, ECOSPHERE, V4, DOI [10.1890/ES13-00217, 10.1890/ES13-00217.1]; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; McDonald P.M, 1976, USDA PAC SW; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Miller C, 1999, ECOSYSTEMS, V2, P76, DOI 10.1007/s100219900060; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; MINNICH RA, 1995, CONSERV BIOL, V9, P902, DOI 10.1046/j.1523-1739.1995.09040902.x; Nagel TA, 2005, J TORREY BOT SOC, V132, P442, DOI 10.3159/1095-5674(2005)132[442:FAPOMC]2.0.CO;2; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Panjabi A.O., 2005, PARTNERS FLIGHT TECH; PARSONS DJ, 1979, FOREST ECOL MANAG, V2, P21, DOI 10.1016/0378-1127(79)90034-3; Plummer M., 2013, PACKAGE RJAGS COMPRE; R Core Team, 2021, R LANGUAGE ENV STAT; Ralph C. John, 1995, U S Forest Service General Technical Report PSW, V149, P161; Ralph CJ, 1993, 144 PSWGTR USDA FOR; RAPHAEL MG, 1987, CONDOR, V89, P614, DOI 10.2307/1368651; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Rogers PC, 2007, NAT AREA J, V27, P183, DOI 10.3375/0885-8608(2007)27[183:AITSNR]2.0.CO;2; Sauer JD, N AM BREEDING BIRD S; SCHIECK J, 1995, CONSERV BIOL, V9, P1072, DOI [10.1046/j.1523-1739.1995.9051072.x, 10.1046/j.1523-1739.1995.9051059.x-i1]; Shuford W.D, 2008, STUDIES W BIRDS, V1, P254; Siegel RB, 2003, WILSON BULL, V115, P155, DOI 10.1676/02-103; Sierra Nevada Ecosystem Project, 1999, SIERR NEV REG DIG EL; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Skinner CN, 1996, SIERRA NEVADA ECOSYS, V2, P1041; Smith JR, 2009, THESIS U CALIFORNIA; Stephens SL, 2007, FOREST ECOL MANAG, V251, P205, DOI 10.1016/j.foreco.2007.06.005; Stine P, 2002, FIRE FUELS MANAGEMEN; Su Y.-S, 2011, R2JAGS PACKAGE RUNNI; Swanson ME, 2014, FOREST ECOL MANAG, V324, P160, DOI 10.1016/j.foreco.2014.03.046; Taylor AH, 2000, J BIOGEOGR, V27, P87, DOI 10.1046/j.1365-2699.2000.00353.x; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; USDA, 2004, SIERR NEV FOR PLAN A; USDA, 2007, SIERR NEV FOR MAN IN; [USDA] US DEPARTMENT OF AGRICULTURE, 2001, SIERR NEV FOR PLAN A; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; VANKAT JL, 1978, J BIOGEOGR, V5, P377, DOI 10.2307/3038030; VERNER J, 1989, AUK, V106, P447; White AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063088; Wiens JA, 2008, BIOSCIENCE, V58, P241, DOI 10.1641/B580310; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	78	14	15	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123778	10.1371/journal.pone.0123778	http://dx.doi.org/10.1371/journal.pone.0123778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905920	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000044
J	Lee, HS; Kwon, HS; Park, DE; Woo, YD; Kim, HY; Kim, HR; Cho, SH; Min, KU; Kang, HR; Chang, YS				Lee, Hyun Seung; Kwon, Hyouk-Soo; Park, Da-Eun; Woo, Yeon Duk; Kim, Hye Young; Kim, Hang-Rae; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun; Chang, Yoon-Seok			Thalidomide Inhibits Alternative Activation of Macrophages In Vivo and In Vitro: A Potential Mechanism of Anti-Asthmatic Effect of Thalidomide	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EOSINOPHILIC AIRWAY INFLAMMATION; MULTIPLE-MYELOMA; EPITHELIAL-CELLS; SEVERE ASTHMA; EXPRESSION; LUNG; HYPERRESPONSIVENESS; PHARMACOKINETICS; CHITINASE	Background Thalidomide is known to have anti-inflammatory and immunomodulatory actions. However, the effect and the anti-asthmatic mechanism of thalidomide in the pathogenesis of asthmatic airways are not fully understood. Objective This study is designed to determine the effect and the potential mechanism of thalidomide in the pathogenesis of asthmatic airways using animal model of allergic asthma. Methods Six-week-old female BALB/C mice were sensitized with alum plus ovalbumin (OVA) and were exposed to OVA via intranasal route for 3 days for challenge. Thalidomide 200 mg/kg was given via gavage twice a day from a day before the challenge and airway hyperresponsivenss (AHR), airway inflammatory cells, and cytokines in bronchoalveolar lavage fluids (BALF) were evaluated. The expression levels of pro-inflammatory cytokines and other mediators were evaluated using ELISA, real time (RT)-qPCR, and flow cytometry. CRL-2456, alveolar macrophage cell line, was used to test the direct effect of thalidomide on the activation of macrophages in vitro. Results The mice with thalidomide treatment showed significantly reduced levels of allergen-induced BALF and lung inflammation, AHR, and the expression of a number of pro-inflammatory cytokines and mediators including Th2 related, IL-17 cytokines, and altered levels of allergen-specific IgG1/IgG2a. Of interesting note, thalidomide treatment significantly reduced expression levels of allergen-or Th2 cytokine-stimulated alternative activation of macrophages in vivo and in vitro. Conclusion These studies highlight a potential use of thalidomide in the treatment of allergic diseases including asthma. This study further identified a novel inhibitory effect of thalidomide on alternative activation of macrophages as a potential mechanism of anti-asthmatic effect of thalidomide.	[Lee, Hyun Seung; Kwon, Hyouk-Soo; Park, Da-Eun; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Kwon, Hyouk-Soo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Woo, Yeon Duk; Kim, Hye Young] Seoul Natl Univ, Coll Med, Dept Med Sci, Seoul 151, South Korea; [Kim, Hang-Rae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 151, South Korea; [Chang, Yoon-Seok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea.	helenmed@snu.ac.kr; addchang@snu.ac.kr	Kim, Hye Young/AAF-7609-2020; Chang, Yoon-Seok/J-5628-2012; Kim, Hang-Rae/J-5448-2012	Kim, Hye Young/0000-0001-5978-512X; Chang, Yoon-Seok/0000-0003-3157-0447; Kim, Hang-Rae/0000-0002-3983-6193	Korea Research Foundation - Korean Government (MOEHRD) [KRF-2006-E00149]; Seoul National University Hospital [04-2011-1170]	Korea Research Foundation - Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaNational Research Foundation of KoreaKorean Government); Seoul National University Hospital	This work was supported financially by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2006-E00149) and by a grant from Seoul National University Hospital (04-2011-1170).	Asano T, 2010, BIOL PHARM BULL, V33, P1028, DOI 10.1248/bpb.33.1028; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; Calabrese L, 2000, AM J MED, V108, P487, DOI 10.1016/S0002-9343(99)00408-8; CHEN TL, 1989, DRUG METAB DISPOS, V17, P402; Chung F, 2004, CLIN CANCER RES, V10, P5949, DOI 10.1158/1078-0432.CCR-04-0421; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cohn L, 1998, J IMMUNOL, V161, P3813; CORRIGAN CJ, 1988, LANCET, V1, P1129; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hashimoto Y, 2008, ARCH PHARM, V341, P536, DOI 10.1002/ardp.200700217; Homer RJ, 2006, AM J PHYSIOL-LUNG C, V291, pL502, DOI 10.1152/ajplung.00364.2005; Kamikawa R, 2006, BIOL PHARM BULL, V29, P2331, DOI 10.1248/bpb.29.2331; Kay AB, 2006, CHEM IMMUNOL ALLERGY, V91, P59; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kwon HS, THESIS U SEOUL NATL; La Flamme AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046989; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Moller DR, 1997, J IMMUNOL, V159, P5157; Moon KA, 2007, INT IMMUNOL, V19, P1371, DOI 10.1093/intimm/dxm108; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Sun Y, 2008, LUNG, V186, P375, DOI 10.1007/s00408-008-9099-1; Tavares JL, 1997, RESP MED, V91, P31, DOI 10.1016/S0954-6111(97)90134-7; Tsai YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064105; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V284, pL260, DOI 10.1152/ajplung.00226.2002; Vercelli D, 2003, J CLIN INVEST, V111, P1815, DOI 10.1172/JCI200318908; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; Winkler C, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-12; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	42	17	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123094	10.1371/journal.pone.0123094	http://dx.doi.org/10.1371/journal.pone.0123094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905462	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000022
J	Moravcova, L; Pysek, P; Jarosik, V; Pergl, J				Moravcova, Lenka; Pysek, Petr; Jarosik, Vojtech; Pergl, Jan			Getting the Right Traits: Reproductive and Dispersal Characteristics Predict the Invasiveness of Herbaceous Plant Species	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; INVASION SUCCESS; ALIEN PLANTS; PROPAGULE PRESSURE; BIOLOGICAL INVASIONS; RESIDENCE TIME; PHENOTYPIC PLASTICITY; NATURALIZED PLANTS; INTRODUCED PLANTS; SEEDLING GROWTH	To better understand the effect of species traits on plant invasion, we collected comparative data on 20 reproductive and dispersal traits of 93 herbaceous alien species in the Czech Republic, central Europe, introduced after 1500 A. D. We explain plant invasion success, expressed by two measures: invasiveness, i.e. whether the species is naturalized but noninvasive, or invasive; and dominance in plant communities expressed as the mean cover in vegetation plots. We also tested how important reproductive and dispersal traits are in models including other characteristics generally known to predict invasion outcome, such as plant height, life history and residence time. By using regression/ classification trees we show that the biological traits affect invasion success at all life stages, from reproduction (seed production) to dispersal (propagule properties), and the ability to compete with resident species (height). By including species traits information not usually available in multispecies analyses, we provide evidence that traits do play important role in determining the outcome of invasion and can be used to distinguish between alien species that reach the final stage of the invasion process and dominate the local communities from those that do not. No effect of taxonomy ascertained in regression and classification trees indicates that the role of traits in invasiveness should be assessed primarily at the species level.	[Moravcova, Lenka; Pysek, Petr; Jarosik, Vojtech; Pergl, Jan] Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic; [Pysek, Petr; Jarosik, Vojtech] Charles Univ Prague, Fac Sci, Dept Ecol, CR-11636 Prague 1, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Moravcova, L (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic.	lenka.moravcova@ibot.cas.cz	Pysek, Petr/B-1957-2012; Pergl, Jan/H-1071-2011	Pergl, Jan/0000-0002-0045-1974	Czech Science Foundation (Centre of Excellence PLADIAS) [206/05/0323, 14-36079G]; Academy of Sciences of the Czech Republic [RVO 67985939]; Ministry of Education, Youth, and Sports of the Czech Republic	Czech Science Foundation (Centre of Excellence PLADIAS); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was funded by the Czech Science Foundation (grant no. 206/05/0323 and project no. 14-36079G, Centre of Excellence PLADIAS), long-term research development project RVO 67985939 (Academy of Sciences of the Czech Republic), institutional resources of the Ministry of Education, Youth, and Sports of the Czech Republic, and PP acknowledges the support of a Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew AP, 1997, FUNCT ECOL, V11, P121, DOI 10.1046/j.1365-2435.1997.00049.x; Baker H. G., 1965, The genetics of colonizing species., P147; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2009, ECOGRAPHY, V32, P83, DOI 10.1111/j.1600-0587.2008.05661.x; Breiman L., 2017, CLASSIFICATION REGRE; Bucharova A, 2009, J ECOL, V97, P230, DOI 10.1111/j.1365-2745.2008.01469.x; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Cadotte MW, 2006, ECOSCIENCE, V13, P388, DOI 10.2980/i1195-6860-13-3-388.1; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Cassey P, 2004, J BIOGEOGR, V31, P277, DOI 10.1046/j.0305-0270.2003.00979.x; Castro SA, 2005, DIVERS DISTRIB, V11, P183, DOI 10.1111/j.1366-9516.2005.00145.x; Castro-Diez P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100254; Chytry M, 2003, PRESLIA, V75, P1; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Colautti RI, 2004, DIVERS DISTRIB, V10, P135, DOI 10.1111/j.1366-9516.2004.00061.x; Colautti RI, 2005, CAN J FISH AQUAT SCI, V62, P950, DOI 10.1139/F05-002; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Couvreur M, 2004, SEED SCI RES, V14, P147, DOI 10.1079/SSR2004164; Crawley M. J, 2002, STAT COMPUTING INTRO; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DAEHLER CC, 2000, BIOL INVASIONS, V2, P93, DOI DOI 10.1023/A:1010002005024; Daehler CC, 2006, PRESLIA, V78, P389; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Egler FE, 1983, CE PHILLIPS HERBARIU, V6; Ellenberg H., 1988, Vegetation ecology of Central Europe.; FENNER M, 1983, NEW PHYTOL, V95, P697, DOI 10.1111/j.1469-8137.1983.tb03533.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Godoy O, 2014, ECOLOGY, V95, P726, DOI 10.1890/13-1157.1; Gordon Doria R., 2010, Plant Protection Quarterly, V25, P56; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Grime JP., 2014, COMP PLANT ECOLOGY F; Grotkopp E, 2010, J APPL ECOL, V47, P1320, DOI 10.1111/j.1365-2664.2010.01878.x; Grotkopp Eva, 1998, American Journal of Botany, V85, P34; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; Hochachka WM, 2007, J WILDLIFE MANAGE, V71, P2427, DOI 10.2193/2006-503; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2011, TRENDS ECOL EVOL, V26, P318, DOI 10.1016/j.tree.2011.03.018; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Jarosik V, 2011, ENCY BIOL INVASIONS, P104; Jeschke JM, 2008, ECOGRAPHY, V31, P124, DOI 10.1111/j.2007.0906-7590.05343.x; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kubesova M, 2010, PRESLIA, V82, P81; Kueffer C, 2013, NEW PHYTOL, V200, P615, DOI 10.1111/nph.12415; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moravcova L, 2010, PRESLIA, V82, P365; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Muth NZ, 2006, AM J BOT, V93, P188, DOI 10.3732/ajb.93.2.188; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Phillips ML, 2010, PRESLIA, V82, P465; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek Petr, 2007, V193, P97; Pysek P, 2012, PRESLIA, V84, P575; Pysek P, 2012, PRESLIA, V84, P155; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Pysek Petr, 2002, Preslia (Prague), V74, P97; Pysek P, 2009, ECOLOGY, V90, P2734, DOI 10.1890/08-0857.1; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Ross LC, 2008, PERSPECT PLANT ECOL, V10, P251, DOI 10.1016/j.ppees.2008.06.001; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Roy J., 1990, BIOL INVASIONS EUROP, P335; Ruprecht E, 2014, BIOL INVASIONS, V16, P1359, DOI 10.1007/s10530-013-0574-0; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Schaminee JHJ, 2009, PRESLIA, V81, P173; Schmidt JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017391; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Skalova H, 2012, ANN BOT-LONDON, V110, P1429, DOI 10.1093/aob/mcr316; Sokal R.R., 2012, BIOMETRY; Steinberg G, 1997, CLASSIFICATION REGRE; STEINBERG G, 1995, CART TREE STRUCTURED; Steinberg G, 2006, CART 6 0 USERS MANUA; Stevens P.F., ANGIOSPERM PHYLOGENY; Swanborough P, 1996, FUNCT ECOL, V10, P176, DOI 10.2307/2389841; Thiele J, 2010, J VEG SCI, V21, P213, DOI 10.1111/j.1654-1103.2009.01139.x; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; van Kleunen M, 2011, TRENDS ECOL EVOL, V26, P317, DOI 10.1016/j.tree.2011.03.019; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; WILLIAMSON M, 1993, EXPERIENTIA, V49, P219, DOI 10.1007/BF01923529; Williamson M, 2009, DIVERS DISTRIB, V15, P158, DOI 10.1111/j.1472-4642.2008.00528.x; Williamson M, 2006, BIOL INVASIONS, V8, P1561, DOI 10.1007/s10530-005-5849-7; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Wu SH, 2005, TAXON, V54, P133, DOI 10.2307/25065311	116	65	69	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123634	10.1371/journal.pone.0123634	http://dx.doi.org/10.1371/journal.pone.0123634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906399	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000039
J	Ortiz, MS; Myers, HF; Schetter, CD; Rodriguez, CJ; Seeman, TE				Ortiz, Manuel S.; Myers, Hector F.; Schetter, Christine Dunkel; Rodriguez, Carlos J.; Seeman, Teresa E.			Psychosocial Predictors of Metabolic Syndrome among Latino Groups in the Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							MEXICAN-AMERICAN WOMEN; STRESSFUL LIFE EVENTS; DEPRESSIVE SYMPTOMS; CARDIOVASCULAR-DISEASE; PSYCHIATRIC-DISORDERS; SOCIAL SUPPORT; RISK-FACTORS; PREVALENCE; HEALTH; ACCULTURATION	Objective We sought to determine the contribution of psychological variables to risk for metabolic syndrome (MetS) among Latinos enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA), and to investigate whether social support moderates these associations, and whether inflammatory markers mediate the association between psychological variables and MetS. Research design and methods Cross-sectional analyses at study baseline were conducted with a national Latino cohort (n = 1,388) that included Mexican Americans, Dominican Americans, Puerto Rican Americans and Central/South Americans. Hierarchical logistic regression analyses were conducted to test the effects of psychosocial variables (chronic stress, depressive symptoms, and social support) on MetS. In addition, separate subgroup-specific models, controlling for nationality, age, gender, socioeconomic position, language spoken at home, exercise, smoking and drinking status, and testing for the effects of chronic stress, depressive symptoms and inflammation (IL-6, CRP, fibrinogen) in predicting risk for MetS were conducted. Results In the overall sample, high chronic stress independently predicted risk for MetS, however this association was found to be significant only in Mexican Americans and Puerto Rican Americans. Social support did not moderate the associations between chronic stress and MetS for any group. Chronic stress was not associated with inflammatory markers in either the overall sample or in each group. Conclusions Our results suggest a differential contribution of chronic stress to the prevalence of MetS by national groups.	[Ortiz, Manuel S.] Univ La Frontera, Dept Psychol, Temuco, Chile; [Myers, Hector F.] Vanderbilt Univ, Ctr Med Hlth & Soc & Psychol, Nashville, TN 37235 USA; [Schetter, Christine Dunkel] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Rodriguez, Carlos J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Div Publ Hlth Sci, Winston Salem, NC 27103 USA; [Seeman, Teresa E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Universidad de La Frontera; Vanderbilt University; University of California System; University of California Los Angeles; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ortiz, MS (corresponding author), Univ La Frontera, Dept Psychol, Temuco, Chile.	manuel.ortiz@ufrontera.cl	Ortiz, Manuel/G-1044-2019	Ortiz, Manuel/0000-0002-7749-0699	National Heart, Lung, and Blood Institute [N01 HC95159, N01 HC-95160, N1HC95161, UL1-RR-024156, N01 HC-95162, UL1-RR-025005, N01 HC-95163, N01 HC-95164, N01 HC95165, N01HC95166]; NCRR [UL1-RR-024156, UL1-RR-025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095166, N01HC095162, N01HC095165, N01HC095161, N01HC095163, N01HC095160, N01HC095164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL095166, R43HL095161] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by contracts N01 HC95159; N01 HC-95160; N1HC95161; UL1-RR- 024156; N01 HC-95162; UL1-RR-025005; N01 HC-95163; N01 HC-95164; N01 HC95165; N01HC95166 from the National Heart, Lung, and Blood Institute and by grants UL1-RR-024156 and UL1-RR-025005 from NCRR. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria M, 2007, SOC SCI MED, V65, P214, DOI 10.1016/j.socscimed.2007.03.026; Alegria M, 2007, AM J PUBLIC HEALTH, V97, P68, DOI 10.2105/AJPH.2006.087205; Allison MA, 2008, AM J EPIDEMIOL, V167, P962, DOI 10.1093/aje/kwm402; Araujo BY, 2006, HISPANIC J BEHAV SCI, V28, P245, DOI 10.1177/0739986305285825; Ayala GX, 2005, J AM DIET ASSOC, V105, P38, DOI 10.1016/j.jada.2004.10.023; Berkman LF, 2000, AM HEART J, V139, P1; Berlin I, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-9; Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bird HR, 2001, J ABNORM CHILD PSYCH, V29, P465, DOI 10.1023/A:1012279707372; Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Bromberger JT, 1996, PSYCHOL AGING, V11, P207, DOI 10.1037/0882-7974.11.2.207; CDC, 2006, MMWR-MORBID MORTAL W, V55, P177; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P941; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Cohen BE, 2010, PSYCHIAT RES, V175, P133, DOI 10.1016/j.psychres.2009.02.004; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Delaney JAC, 2010, HYPERTENSION, V55, P408, DOI 10.1161/HYPERTENSIONAHA.109.139824; Dixon LB, 2000, AM J EPIDEMIOL, V152, P548, DOI 10.1093/aje/152.6.548; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Gallo LC, 2009, PSYCHOSOM MED, V71, P756, DOI 10.1097/PSY.0b013e3181b0d2b4; Gregory-Mercado KY, 2006, ETHNIC DIS, V16, P89; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Iversen LB, 2012, EUR J EPIDEMIOL, V27, P119, DOI 10.1007/s10654-012-9659-9; Jiang W, 2005, AM HEART J, V150, P871, DOI 10.1016/j.ahj.2005.01.041; Luppino FS, 2011, PSYCHOSOM MED, V73, P257, DOI 10.1097/PSY.0b013e31820a59c0; Mulvaney-Day NE, 2007, SOC SCI MED, V64, P477, DOI 10.1016/j.socscimed.2006.08.030; Page RL, 2004, JOGNN-J OBST GYN NEO, V33, P783, DOI 10.1177/0884217504270595; Pakalska-Korcala A, 2008, KARDIOL POL, V66, P500; Pyykkonen AJ, 2010, DIABETES CARE, V33, P378, DOI 10.2337/dc09-1027; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schneiderman N, 2014, DIABETES CARE, V37, P2233, DOI 10.2337/dc13-2939; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Tamashiro KLK, 2011, ANN NY ACAD SCI, V1231, P46, DOI 10.1111/j.1749-6632.2011.06134.x; Tsurugano S, 2012, TOHOKU J EXP MED, V226, P101, DOI 10.1620/tjem.226.101; Van Wieren AJ, 2011, J IMMIGR MINOR HEALT, V13, P975, DOI 10.1007/s10903-011-9483-4; Whisman MA, 2010, HEALTH PSYCHOL, V29, P550, DOI 10.1037/a0020760; Zsembik BA, 2005, SOC SCI MED, V61, P53, DOI 10.1016/j.socscimed.2004.11.040	44	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124517	10.1371/journal.pone.0124517	http://dx.doi.org/10.1371/journal.pone.0124517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5KZ	25906072	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000072
J	Ribeiro, R; Wilson, AJ; Nunes, T; Ramilo, DW; Amador, R; Madeira, S; Baptista, FM; Harrup, LE; Lucientes, J; Boinas, F				Ribeiro, Rita; Wilson, Anthony J.; Nunes, Telmo; Ramilo, David W.; Amador, Rita; Madeira, Sara; Baptista, Filipa M.; Harrup, Lara E.; Lucientes, Javier; Boinas, Fernando			Spatial and Temporal Distribution of Culicoides Species in Mainland Portugal (2005-2010). Results of the Portuguese Entomological Surveillance Programme	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BLUETONGUE-VIRUS; DIPTERA-CERATOPOGONIDAE; BITING MIDGES; IMICOLA; CLIMATE; VECTOR; EUROPE; IDENTIFICATION; TRANSMISSION	Bluetongue virus (BTV) is transmitted by Culicoides biting midges and causes an infectious, non-contagious disease of ruminants. It has been rapidly emerging in southern Europe since 1998. In mainland Portugal, strains of BTV belonging to three serotypes have been detected: BTV-10 (1956-1960), BTV-4 (2004-2006 and 2013) and BTV-1 (2007-2012). This paper describes the design, implementation and results of the Entomological Surveillance Programme covering mainland Portugal, between 2005 and 2010, including 5,650 caches. Culicoides imicola Kieffer was mostly found in central and southern regions of Portugal, although it was sporadically detected in northern latitudes. Its peak activity occurred in the autumn and it was active during the winter months in limited areas of the country. Obsoletus group was present at the highest densities in the north although they were found throughout the country in substantial numbers. Culicoides activity occurred all year round but peaked in the spring. A generalized linear mixed model was developed for the analysis of the environmental factors associated with activity of the species of Culicoides suspected vectors of BTV in the country. For C. imicola Kieffer, the most important variables were month, diurnal temperature range (DTR), the number of frost days (FRS) and median monthly temperature (TMP). For the Obsoletus group, the most important factors were month, diurnal temperature range (DTR), and linear and quadratic terms for median monthly temperature (TMP). The results reported can improve our understanding of climatic factors in Culicoides activity influencing their distribution and seasonal pattern.	[Ribeiro, Rita; Nunes, Telmo; Ramilo, David W.; Madeira, Sara; Baptista, Filipa M.; Boinas, Fernando] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal; [Wilson, Anthony J.] Pirbright Inst, Integrat Entomol Grp, Woking, Surrey, England; [Amador, Rita] Food & Vet Cent Serv, Direcao Geral Alimentacao & Vet, Lisbon, Portugal; [Harrup, Lara E.] Pirbright Inst, Vector Borne Viral Dis Programme, Entomol Grp, Woking, Surrey, England; [Lucientes, Javier] Univ Zaragoza, Fac Vet, Dept Anim Pathol Anim Hlth, Parasitol & Parasit Dis, Zaragoza, Spain	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Zaragoza	Boinas, F (corresponding author), Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, P-1699 Lisbon, Portugal.	fboinas@fmv.ulisboa.pt	Boinas, Fernando/AAD-9779-2022	Boinas, Fernando/0000-0001-6259-4404; Ramilo, David/0000-0003-4096-2581; Nunes, Telmo/0000-0003-4388-5366; Harrup, Lara/0000-0001-8828-7349; Ribeiro, Rita/0000-0002-9976-3731; Wilson, Anthony/0000-0002-2000-2914; Madeira, Sara/0000-0001-5804-9745	Project National entomological surveillance programme of Culicoides midges, vectors of Bluetongue virus - Direcao Geral de Veterinaria [NINGA 7185573]; CIISA-Faculdade de Medicina Veterinaria; BBSRC [BBS/E/I/00001409]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001409] Funding Source: researchfish	Project National entomological surveillance programme of Culicoides midges, vectors of Bluetongue virus - Direcao Geral de Veterinaria; CIISA-Faculdade de Medicina Veterinaria; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Project National entomological surveillance programme of Culicoides midges, vectors of Bluetongue virus, reference: NINGA 7185573 Funded by Direcao Geral de Veterinaria. Author who received the funding: FB (coordinator of the programme at CIISA-Faculdade de Medicina Veterinaria). AJW and LH were funded by the BBSRC [BBS/E/I/00001409]. Funders at Direcao Geral de Veterinaria had a role in the data collection and study design, but had no role in the analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Ayllon T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-34; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Barros SC, 2007, VET MICROBIOL, V124, P25, DOI 10.1016/j.vetmic.2007.04.014; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2006, VET REC, V158, P130, DOI 10.1136/vr.158.4.130; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte Annamaria, 2007, Vet Ital, V43, P571; Dal Pozzo F, 2009, VET MICROBIOL, V136, P352, DOI 10.1016/j.vetmic.2008.11.012; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; Delecolle JC, 1985, NOUVELLE CONTRIBUITI, DOI [10.1016/j.crvi.2014.04.006, DOI 10.1016/J.CRVI.2014.04.006]; Direccao Geral de Alimentacao e Veterinaria (DGAV), 2012, PROGR ERR CONTR VIG; Direccao Geral de Alimentacao e Veterinaria (DGAV), 2014, BLUET SIT PORT; EFSA Panel on Animal Health and Welfare (AHAW), 2011, EFSA J; European Commission (EC), 2012, AN DIS NOT SYST; European Food Safety Authority (EFSA), 2008, EFSA J, V735, P1, DOI DOI 10.2903/J.EFSA.2008.735; Ferreira AMPJ, 2000, THESIS U AVEIRO AVEI; FFMS, 2014, PORD TEMP MED AR MED; Garcia-Lastra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034421; Garros C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-223; Goffredo M, 2004, VETER ITAL SER, V40, P260; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Meiswinkel R, 1997, ONDERSTEPOORT J VET, V64, P81; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; Monteys VSI, 2005, VET REC, V156, P415, DOI 10.1136/vr.156.13.415; Patakakis MJ, 2009, J VECTOR ECOL, V34, P243, DOI [10.3376/038.034.0211, 10.1111/j.1948-7134.2009.00033.x]; Pena I, 2003, CONTRIBUICAO ESTUDO; Portas M, 1999, EPIDEMIOL INFECT, V123, P337, DOI 10.1017/S0950268899002897; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Ramilo DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034896; Rawlings Peter, 1996, Graellsia, V52, P57; Scolamacchia F, 2014, MED VET ENTOMOL, V28, P143, DOI 10.1111/mve.12028; Sellers R. F., 1980, Bulletin de l'Office International des Epizooties, V92, P587; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; VANARK H, 1992, ONDERSTEPOORT J VET, V59, P183; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470	47	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124019	10.1371/journal.pone.0124019	http://dx.doi.org/10.1371/journal.pone.0124019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906151	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000055
J	Yuan, Z; Guo, WH; Yang, J; Li, L; Wang, ML; Lei, Y; Wan, Y; Zhao, XY; Luo, N; Cheng, P; Liu, XY; Nie, CL; Peng, Y; Tong, AP; Wei, YQ				Yuan, Zhu; Guo, Wenhao; Yang, Jun; Li, Lei; Wang, Meiliang; Lei, Yi; Wan, Yang; Zhao, Xinyu; Luo, Na; Cheng, Ping; Liu, Xinyu; Nie, Chunlai; Peng, Yong; Tong, Aiping; Wei, Yuquan			PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; THERAPEUTIC-EFFICACY; CYCLE ARREST; HUMAN CDC25A; CHK1; INHIBITOR; EXPRESSION; CLEAVAGE; ATM; DEGRADATION	PNAS-4, a novel pro-apoptotic gene, was activated during the early response to DNA damage. Our previous study has shown that PNAS-4 induces S phase arrest and apoptosis when overexpressed in A549 lung cancer cells. However, the underlying action mechanism remains far from clear. In this work, we found that PNAS-4 expression in lung tumor tissues is significantly lower than that in adjacent lung tissues; its expression is significantly increased in A549 cells after exposure to cisplatin, methyl methane sulfonate, and mitomycin; and its overexpression induces S phase arrest and apoptosis in A549 (p53 WT), NCI-H460 (p53 WT), H526 (p53 mutation), and Calu-1 (p53(-/-)) lung cancer cells, leading to proliferation inhibition irrespective of their p53 status. The S phase arrest is associated with up-regulation of p21Waf1/Cip1 and inhibition of the Cdc25A-CDK2-cyclin E/A pathway. Up-regulation of p21Waf1/Cip1 is p53-independent and correlates with activation of ERK. We further showed that the intra-S phase checkpoint, which occurs via DNA-dependent protein kinase-mediated activation of Chk1 and Chk2, is involved in the S phase arrest and apoptosis. Gene silencing of Chk1/2 rescues, whereas that of ATM or ATR does not affect, S phase arrest and apoptosis. Furthermore, human PNAS-4 induces DNA breaks in comet assays and gamma-H2AX staining. Intriguingly, caspase-dependent cleavage of Chk1 has an additional role in enhancing apoptosis. Taken together, our findings suggest a novel mechanism by which elevated PNAS-4 first causes DNA-dependent protein kinase-mediated Chk1/2 activation and then results in inhibition of the Cdc25A-CDK2-cyclin E/A pathway, ultimately causing S phase arrest and apoptosis in lung cancer cells.	[Yuan, Zhu; Yang, Jun; Li, Lei; Wang, Meiliang; Lei, Yi; Wan, Yang; Zhao, Xinyu; Cheng, Ping; Liu, Xinyu; Nie, Chunlai; Peng, Yong; Tong, Aiping; Wei, Yuquan] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Yuan, Zhu; Yang, Jun; Li, Lei; Wang, Meiliang; Lei, Yi; Wan, Yang; Zhao, Xinyu; Cheng, Ping; Liu, Xinyu; Nie, Chunlai; Peng, Yong; Tong, Aiping; Wei, Yuquan] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Ctr Canc, Chengdu 610041, Peoples R China; [Guo, Wenhao] Sichuan Univ, West China Med Sch, Dept Abdominal Oncol, Ctr Canc, Chengdu 610041, Sichuan Provinc, Peoples R China; [Guo, Wenhao] Sichuan Univ, West China Med Sch, State Key Lab Biotherapy, Chengdu 610041, Sichuan Provinc, Peoples R China; [Luo, Na] Nankai Univ, Sch Med, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Nankai University	Yuan, Z (corresponding author), Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Peoples R China.	yuanzhu@scu.edu.cn; aipingtong@scu.edu.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022		National Natural Science Foundation of China [30900744, 81272524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30900744 and 81272524.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ashton AW, 1999, J BIOL CHEM, V274, P20805, DOI 10.1074/jbc.274.30.20805; Baluchamy S, 2010, J BIOL CHEM, V285, P24769, DOI 10.1074/jbc.M110.138099; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Cai PL, 2012, MOL BIOL REP, V39, P621, DOI 10.1007/s11033-011-0779-1; Choy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078077; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clarke CAL, 2005, J BIOL CHEM, V280, P35337, DOI 10.1074/jbc.M506460200; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Filippov V, 2007, CANCER RES, V67, P7621, DOI 10.1158/0008-5472.CAN-07-0145; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Foster SS, 2012, P NATL ACAD SCI USA, V109, P9953, DOI 10.1073/pnas.1120476109; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gehen SC, 2008, ONCOGENE, V27, P4065, DOI 10.1038/onc.2008.48; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Gewandter JS, 2011, CELL CYCLE, V10, P2561, DOI 10.4161/cc.10.15.16347; Han SW, 2010, CURR CANCER DRUG TAR, V10, P566, DOI 10.2174/156800910791859461; HARPER JW, 1993, CELL, V75, P805; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hou SY, 2009, CELL BIOL INT, V33, P276, DOI 10.1016/j.cellbi.2008.11.014; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kang K, 2011, NEOPLASIA, V13, P1043, DOI 10.1593/neo.11972; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Lee AYL, 2012, J BIOL CHEM, V287, P2531, DOI 10.1074/jbc.M111.291104; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Li L, 2013, APOPTOSIS, V18, P467, DOI 10.1007/s10495-012-0797-z; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Okita N, 2013, BBA-GEN SUBJECTS, V1830, P2204, DOI 10.1016/j.bbagen.2012.10.009; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Park KS, 2002, BRIT J PHARMACOL, V137, P597, DOI 10.1038/sj.bjp.0704909; Ray D, 2007, CELL CYCLE, V6, P3039, DOI 10.4161/cc.6.24.5104; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Shin EJ, 2012, EMBO REP, V13, P339, DOI 10.1038/embor.2012.3; Sinkkonen ST, 2011, SCI REP-UK, V1, DOI 10.1038/srep00026; Solier S, 2014, CELL MOL LIFE SCI, V71, P2289, DOI 10.1007/s00018-013-1555-2; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; WEI YQ, 1994, CANCER RES, V54, P4952; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yan F, 2009, BIOCHIMIE, V91, P502, DOI 10.1016/j.biochi.2008.12.002; Yang D, 2013, CELL DEATH DIFFER, V20, P235, DOI 10.1038/cdd.2012.113; Yeo EJ, 2006, CANCER RES, V66, P6345, DOI 10.1158/0008-5472.CAN-05-4460; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yuan Z, 2009, CANCER CHEMOTH PHARM, V65, P13, DOI 10.1007/s00280-009-0998-5; Yuan Z, 2009, CANCER SCI, V100, P1757, DOI 10.1111/j.1349-7006.2009.01242.x; Zeng H, 2012, INT J RADIAT ONCOL, V84, pE533, DOI 10.1016/j.ijrobp.2012.06.028; Zhang N, 2012, HUM GENE THER, V23, P837, DOI 10.1089/hum.2011.136; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou B, 2012, MOL BIOL REP, V39, P243, DOI 10.1007/s11033-011-0732-3	64	25	25	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14927	14944		10.1074/jbc.M115.658419	http://dx.doi.org/10.1074/jbc.M115.658419			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25918161	Green Published, hybrid			2022-12-26	WOS:000356177300012
J	Bhat, SV; Booth, SC; McGrath, SGK; Dahms, TES				Bhat, Supriya V.; Booth, Sean C.; McGrath, Seamus G. K.; Dahms, Tanya E. S.			Rhizobium leguminosarum bv. viciae 3841 Adapts to 2,4-Dichlorophenoxyacetic Acid with "Auxin-Like" Morphological Changes, Cell Envelope Remodeling and Upregulation of Central Metabolic Pathways	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ROOT-NODULE DEVELOPMENT; ESCHERICHIA-COLI; OXIDATIVE STRESS; AZOSPIRILLUM-BRASILENSE; NITROGEN-FIXATION; PROTEOME ANALYSIS; PHOSPHOTRANSFERASE SYSTEM; CHLOROPHENOXY HERBICIDES; LYSINE ACETYLATION	There is a growing need to characterize the effects of environmental stressors at the molecular level on model organisms with the ever increasing number and variety of anthropogenic chemical pollutants. The herbicide 2,4-dichlorophenoxyacetic acid (2,4-D), as one of the most widely applied pesticides in the world, is one such example. This herbicide is known to have non-targeted undesirable effects on humans, animals and soil microbes, but specific molecular targets at sublethal levels are unknown. In this study, we have used Rhizobium leguminosarum bv. viciae 3841 (Rlv) as a nitrogen fixing, beneficial model soil organism to characterize the effects of 2,4-D. Using metabolomics and advanced microscopy we determined specific target pathways in the Rlv metabolic network and consequent changes to its phenotype, surface ultrastructure, and physical properties during sublethal 2,4-D exposure. Auxin and 2,4-D, its structural analogue, showed common morphological changes in vitro-which were similar to bacteroids isolated from plant nodules, implying that these changes are related to bacteroid differentiation required for nitrogen fixation. Rlv showed remarkable adaptation capabilities in response to the herbicide, with changes to integral pathways of cellular metabolism and the potential to assimilate 2,4-D with consequent changes to its physical and structural properties. This study identifies biomarkers of 2,4-D in Rlv and offers valuable insights into the mode-of-action of 2,4-D in soil bacteria.	[Bhat, Supriya V.; McGrath, Seamus G. K.; Dahms, Tanya E. S.] Univ Regina, Dept Chem & Biochem, Regina, SK S4S 0A2, Canada; [Booth, Sean C.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Regina; University of Calgary	Dahms, TES (corresponding author), Univ Regina, Dept Chem & Biochem, 3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada.	tanya.dahms@uregina.ca	Booth, Sean Cameron/H-6480-2019	Booth, Sean Cameron/0000-0003-2552-5324	National Science and Engineering Research Council of Canada [228206-2012]; Canada Foundation for Innovation Leaders Opportunity Fund [29962]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation)	Funding: This work was supported by the National Science and Engineering Research Council of Canada Discovery Grant (228206-2012) to TESD, and the Canada Foundation for Innovation Leaders Opportunity Fund (29962) to TESD.	AKAO S, 1991, PLANT SOIL, V138, P207, DOI 10.1007/BF00012247; Pereira SIA, 2006, APPL SOIL ECOL, V33, P286, DOI 10.1016/j.apsoil.2005.10.002; ARIAS RN, 1993, TOXICOL LETT, V68, P267, DOI 10.1016/0378-4274(93)90017-R; Balague C, 2001, ENVIRON TOXICOL, V16, P43, DOI 10.1002/1522-7278(2001)16:1<43::AID-TOX50>3.0.CO;2-R; Balague CE, 2002, TOXICOLOGY, V177, P143, DOI 10.1016/S0300-483X(02)00161-0; BALAJEE S, 1990, XENOBIOTICA, V20, P607, DOI 10.3109/00498259009046876; Benndorf D, 2002, MICROBIOL-SGM, V148, P2883, DOI 10.1099/00221287-148-9-2883; Benndorf D, 2001, FEMS MICROBIOL LETT, V200, P247, DOI 10.1111/j.1574-6968.2001.tb10723.x; Benndorf D, 2006, PROTEOMICS, V6, P3319, DOI 10.1002/pmic.200500781; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bernal V, 2014, NEW BIOTECHNOL, V31, P586, DOI 10.1016/j.nbt.2014.03.002; Bhat S., 2012, VISCOELASTICITY THEO, P123; Bhat VS, 2015, CHEMOSPHERE IN PRESS; Boivin A, 2005, ENVIRON POLLUT, V138, P92, DOI 10.1016/j.envpol.2005.02.016; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Bukowska B, 2006, POL J ENVIRON STUD, V15, P365; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Camerini S, 2008, ARCH MICROBIOL, V190, P67, DOI 10.1007/s00203-008-0365-7; Castro S, 1996, TOXICOL LETT, V84, P33, DOI 10.1016/0378-4274(95)03462-5; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Chavez FP, 2004, APPL ENVIRON MICROB, V70, P3064, DOI 10.1128/AEM.70.5.3064-3072.2004; Cherepenko Y, 2005, CELL BIOL INT, V29, P3, DOI 10.1016/j.cellbi.2004.11.006; Chinalia A.F., 2007, TERR AQUAT ENV TOXIC, V1, P24; Cho YS, 2000, CURR MICROBIOL, V41, P33, DOI 10.1007/s002840010087; Corticeiro SC, 2006, ENZYME MICROB TECH, V40, P132, DOI 10.1016/j.enzmictec.2005.10.053; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; DEPERETTI AF, 1992, ARCH ENVIRON CON TOX, V23, P301, DOI 10.1007/BF00216237; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dong J, 2011, MICROBIOL-SGM, V157, P3049, DOI 10.1099/mic.0.051045-0; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; EBERBACH PL, 1989, PLANT SOIL, V119, P15, DOI 10.1007/BF02370265; Elanchezhian R, 1997, J AGRON CROP SCI, V178, P129, DOI 10.1111/j.1439-037X.1997.tb00480.x; FABRA A, 1993, TOXICOLOGY, V83, P19, DOI 10.1016/0300-483X(93)90088-A; Fabra A, 1997, B ENVIRON CONTAM TOX, V59, P645, DOI 10.1007/s001289900528; Fanous A, 2007, CHEMOSPHERE, V69, P25, DOI 10.1016/j.chemosphere.2007.04.075; Fox JE, 2007, P NATL ACAD SCI USA, V104, P10282, DOI 10.1073/pnas.0611710104; Gabor E, 2011, EUR J CELL BIOL, V90, P711, DOI 10.1016/j.ejcb.2011.04.002; GAGE DJ, 1993, J BACTERIOL, V175, P7105, DOI 10.1128/jb.175.21.7105-7108.1993; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Gupta VK, 2012, BIOPHYS J, V103, P137, DOI 10.1016/j.bpj.2012.05.044; Hausinger RP, 1995, ENVIRON HEALTH PERSP, V103, P37, DOI 10.2307/3432476; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Houot L, 2008, J BACTERIOL, V190, P311, DOI 10.1128/JB.01410-07; Hrydziuszko O, 2012, METABOLOMICS, V8, pS161, DOI 10.1007/s11306-011-0366-4; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; Jofre E, 1996, TOXICOLOGY, V107, P9, DOI 10.1016/0300-483X(95)03196-M; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; KATUPITIYA S, 1995, SOIL BIOL BIOCHEM, V27, P447, DOI 10.1016/0038-0717(95)98617-W; Kelley KB, 2006, WEED SCI, V54, P220; Keum YS, 2008, APPL MICROBIOL BIOT, V80, P863, DOI 10.1007/s00253-008-1581-4; Kitagawa W, NOVEL 2 4 DICHLOROPH, P0131; Kurland NE, 2012, MICRON, V43, P116, DOI 10.1016/j.micron.2011.07.017; Lambert LA, 1997, J BACTERIOL, V179, P7595, DOI 10.1128/jb.179.23.7595-7599.1997; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P904, DOI 10.1115/1.2800826; Loffhagen N, 2003, ARCH ENVIRON CON TOX, V45, P317, DOI 10.1007/s00244-003-2142-6; LUPI CG, 1995, APPL ENVIRON MICROB, V61, P2863, DOI 10.1128/AEM.61.8.2863-2872.1995; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Mazzoli R, 2011, MOL BIOSYST, V7, P598, DOI 10.1039/c0mb00112k; Moore MN, 2004, MUTAT RES-FUND MOL M, V552, P247, DOI 10.1016/j.mrfmmm.2004.06.028; Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008; MYLONA P, 1995, PLANT CELL, V7, P869, DOI 10.1105/tpc.7.7.869; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Pacios-Bras C, 2003, PLANT MOL BIOL, V52, P1169, DOI 10.1023/B:PLAN.0000004308.78057.f5; Palanisami S, 2009, PESTIC BIOCHEM PHYS, V94, P68, DOI 10.1016/j.pestbp.2009.03.003; Paul BC, 2011, EUKARYOT CELL, V10, P646, DOI 10.1128/EC.00304-10; Pazmino DM, 2012, PLANT SIGNAL BEHAV, V7, P425, DOI 10.4161/psb.19124; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; Ramirez-Trujillo JA, 2007, J BACTERIOL, V189, P5875, DOI 10.1128/JB.00385-07; Remans R, 2008, PLANT SOIL, V312, P25, DOI 10.1007/s11104-008-9606-4; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; RIVAROLA V, 1992, TOXICOLOGY, V73, P71, DOI 10.1016/0300-483X(92)90171-A; Roberts Mary F., 2006, V39, P103; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Schneider BL, 2013, MOL MICROBIOL, V88, P537, DOI 10.1111/mmi.12207; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Seo JS, 2013, BIODEGRADATION, V24, P795, DOI 10.1007/s10532-013-9629-2; Simoes T, 2003, APPL ENVIRON MICROB, V69, P4019, DOI 10.1128/AEM.69.7.4019-4028.2003; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Suwa Y, 1996, APPL ENVIRON MICROB, V62, P2464, DOI 10.1128/AEM.62.7.2464-2469.1996; Teixeira MC, 2005, PROTEOMICS, V5, P1889, DOI 10.1002/pmic.200401085; Teixeira MC, 2004, BIOCHEM BIOPH RES CO, V324, P1101, DOI 10.1016/j.bbrc.2004.09.158; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Viegas CA, 2005, BIOCHEM BIOPH RES CO, V330, P271, DOI 10.1016/j.bbrc.2005.02.158; Wang JX, 2013, J PROTEOME RES, V12, P5302, DOI 10.1021/pr400640u; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wishart DS, 2009, BIOANALYSIS, V1, P1579, DOI 10.4155/BIO.09.138; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zabaloy MC, 2010, APPL SOIL ECOL, V46, P240, DOI 10.1016/j.apsoil.2010.08.006; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0	98	8	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0123813	10.1371/journal.pone.0123813	http://dx.doi.org/10.1371/journal.pone.0123813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919284	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659400035
J	Han, SW; Alonso, JM; Rojas-Pierce, M				Han, Sang Won; Alonso, Jose M.; Rojas-Pierce, Marcela			REGULATOR OF BULB BIOGENESIS1 (RBB1) Is Involved in Vacuole Bulb Formation in Arabidopsis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ROOT HAIR-CELLS; TRANSVACUOLAR STRAND; PLANT VILLIN; MEMBRANE; DYNAMICS; TONOPLAST; SNARE; BROWSER; COMPLEX	Vacuoles are dynamic compartments with constant fluctuations and transient structures such as trans-vacuolar strands and bulbs. Bulbs are highly dynamic spherical structures inside vacuoles that are formed by multiple layers of membranes and are continuous with the main tonoplast. We recently carried out a screen for mutants with abnormal trafficking to the vacuole or aberrant vacuole morphology. We characterized regulator of bulb biogenesis1-1 (rbb1-1), a mutant in Arabidopsis that contains increased numbers of bulbs when compared to the parental control. rbb1-1 mutants also contain fewer transvacuolar strands than the parental control, and we propose the hypothesis that the formation of transvacuolar strands and bulbs is functionally related. We propose that the bulbs may function transiently to accommodate membranes and proteins when transvacuolar strands fail to elongate. We show that RBB1 corresponds to a very large protein of unknown function that is specific to plants, is present in the cytosol, and may associate with cellular membranes. RBB1 is involved in the regulation of vacuole morphology and may be involved in the establishment or stability of trans-vacuolar strands and bulbs.	[Han, Sang Won; Alonso, Jose M.; Rojas-Pierce, Marcela] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Rojas-Pierce, M (corresponding author), N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	mrojasp@ncsu.edu	Alonso, Jose M/K-6826-2014	Alonso, Jose M/0000-0001-7087-1571	National Science Foundation [MCB-1244354]; North Carolina State University; Div Of Molecular and Cellular Bioscience [1244354] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); North Carolina State University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grant MCB-1244354 (http://www.nsf.gov) to M.R.P. and North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bassham Diane C, 2008, Arabidopsis Book, V6, pe0116, DOI 10.1199/tab.0116; Beebo A, 2009, PLANT MOL BIOL, V70, P193, DOI 10.1007/s11103-009-9465-2; Bottanelli F, 2011, PLANT CELL, V23, P3007, DOI 10.1105/tpc.111.085480; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Escobara NM, 2003, PLANT CELL, V15, P1507, DOI 10.1105/tpc.013284; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Gulledge AA, 2012, AM J BOT, V99, P219, DOI 10.3732/ajb.1100355; Hicks GR, 2004, PLANT PHYSIOL, V134, P1227, DOI 10.1104/pp.103.037382; Higaki T, 2006, PLANT CELL PHYSIOL, V47, P839, DOI 10.1093/pcp/pcj056; Hoffmann A, 2004, PROTOPLASMA, V224, P201, DOI 10.1007/s00709-004-0068-0; Hunter PR, 2007, PLANT PHYSIOL, V145, P1371, DOI 10.1104/pp.107.103945; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; Kutsuna N, 2002, PLANT CELL PHYSIOL, V43, P965, DOI 10.1093/pcp/pcf138; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Maitrejean M, 2011, PLANT SIGNAL BEHAV, V6, P1809, DOI 10.4161/psb.6.11.17867; Maitrejean M, 2011, PLANT PHYSIOL, V156, P1783, DOI 10.1104/pp.111.177816; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Muntz K, 2007, J EXP BOT, V58, P2391, DOI 10.1093/jxb/erm089; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Novakova P, 2014, P NATL ACAD SCI USA, V111, P2818, DOI 10.1073/pnas.1324264111; Pagny S, 2000, PLANT CELL, V12, P739, DOI 10.1105/tpc.12.5.739; Rivera-Serrano EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044735; Ruthardt N, 2005, PROTOPLASMA, V225, P205, DOI 10.1007/s00709-005-0093-7; Saito C, 2002, PLANT J, V29, P245, DOI 10.1046/j.0960-7412.2001.01189.x; Saito C, 2011, PLANT J, V68, P64, DOI 10.1111/j.1365-313X.2011.04665.x; Sanderfoot AA, 2001, MOL BIOL CELL, V12, P3733, DOI 10.1091/mbc.12.12.3733; Segami S, 2014, PLANT CELL, V26, P3416, DOI 10.1105/tpc.114.127571; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; STAIGER CJ, 1994, CURR BIOL, V4, P215, DOI 10.1016/S0960-9822(00)00050-6; Szymanski DB, 2009, CURR BIOL, V19, pR800, DOI 10.1016/j.cub.2009.07.056; Tominaga M, 2000, PLANTA, V210, P836, DOI 10.1007/s004250050687; Tominaga M, 1998, PLANT CELL PHYSIOL, V39, P1342, DOI 10.1093/oxfordjournals.pcp.a029340; Uemura T, 2002, GENES CELLS, V7, P743, DOI 10.1046/j.1365-2443.2002.00550.x; van der Honing HS, 2010, NEW PHYTOL, V185, P90, DOI 10.1111/j.1469-8137.2009.03017.x; Vermeer JEM, 2006, PLANT J, V47, P687, DOI 10.1111/j.1365-313X.2006.02830.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xiang L, 2013, FEBS J, V280, P979, DOI 10.1111/febs.12092; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zheng JM, 2014, MOL PLANT, V7, P1026, DOI 10.1093/mp/ssu019; Zhou RR, 2011, PLANT J, V66, P712, DOI 10.1111/j.1365-313X.2011.04524.x; Zouhar J, 2009, CURR OPIN PLANT BIOL, V12, P677, DOI 10.1016/j.pbi.2009.08.004	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125621	10.1371/journal.pone.0125621	http://dx.doi.org/10.1371/journal.pone.0125621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915922	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100138
J	Srijaruskul, K; Charoenlap, N; Namchaiw, P; Chattrakarn, S; Giengkam, S; Mongkolsuk, S; Vattanaviboon, P				Srijaruskul, Kriangsuk; Charoenlap, Nisanart; Namchaiw, Poommaree; Chattrakarn, Sorayut; Giengkam, Suparat; Mongkolsuk, Skorn; Vattanaviboon, Paiboon			Regulation by SoxR of mfsA, Which Encodes a Major Facilitator Protein Involved in Paraquat Resistance in Stenotrophomonas maltophilia	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; AGROBACTERIUM-TUMEFACIENS; ACINETOBACTER-BAUMANNII; EFFLUX PUMP; DISINFECTANT RESISTANCE; STREPTOMYCES-COELICOLOR; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; GENE-REGULATION; SUPERFAMILY	Stenotrophomonas maltophilia MfsA (Smlt1083) is an efflux pump in the major facilitator superfamily (MFS). Deletion of mfsA renders the strain more susceptible to paraquat, but no alteration in the susceptibility levels of other oxidants is observed. The expression of mfsA is inducible upon challenge with redox cycling/superoxide-generating drug (paraquat, menadione and plumbagin) treatments and is directly regulated by SoxR, which is a transcription regulator and sensor of superoxide-generating agents. Analysis of mfsA expression patterns in wild-type and a soxR mutant suggests that oxidized SoxR functions as a transcription activator of the gene. soxR (smlt1084) is located in a head-to-head fashion with mfsA, and these genes share the -10 motif of their promoter sequences. Purified SoxR specifically binds to the putative mfsA promoter motifs that contain a region that is highly homologous to the consensus SoxR binding site, and mutation of the SoxR binding site abolishes binding of purified SoxR protein. The SoxR box is located between the putative -35 and -10 promoter motifs of mfsA; and this position is typical for a promoter in which SoxR acts as a transcriptional activator. At the soxR promoter, the SoxR binding site covers the transcription start site of the soxR transcript; thus, binding of SoxR auto-represses its own transcription. Taken together, our results reveal for the first time that mfsA is a novel member of the SoxR regulon and that SoxR binds and directly regulates its expression.	[Srijaruskul, Kriangsuk; Charoenlap, Nisanart; Namchaiw, Poommaree; Mongkolsuk, Skorn; Vattanaviboon, Paiboon] Chulabhorn Res Inst, Biotechnol Lab, Bangkok 10210, Thailand; [Srijaruskul, Kriangsuk; Chattrakarn, Sorayut; Giengkam, Suparat; Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok 10210, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Ctr Emerging Bacterial Infect, Fac Sci, Bangkok 10400, Thailand; [Mongkolsuk, Skorn] Ctr Excellence Environm Hlth & Toxicol, Bangkok, Thailand	Chulabhorn Research Institute; Chulabhorn Graduate Institute; Mahidol University; Mahidol University	Vattanaviboon, P (corresponding author), Chulabhorn Res Inst, Biotechnol Lab, Lak Si, Bangkok 10210, Thailand.	paiboon@cri.or.th	Namchaiw, Poommaree/ABC-5389-2020; Vattanaviboon, Paiboon/V-1380-2019; Namchaiw, Poommaree/AAO-3663-2020	Namchaiw, Poommaree/0000-0003-0275-6234; Scheu nee Giengkam, Suparat/0000-0003-0747-4316	Chulabhorn Research Institute; Mahidol University; Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand [EHT-R-1/2556-1]; Chulabhorn Graduate Institute	Chulabhorn Research Institute; Mahidol University; Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand; Chulabhorn Graduate Institute	This work was supported by grants from the Chulabhorn Research Institute, Mahidol University, and the Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Education, Thailand (EHT-R-1/2556-1). Authors KS, SC, and SG were supported by scholarships from the Chulabhorn Graduate Institute.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Dela Cruz R, 2010, J BACTERIOL, V192, P6428, DOI 10.1128/JB.00916-10; Eiamphungporn W, 2006, J BACTERIOL, V188, P8669, DOI 10.1128/JB.00856-06; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI 10.2217/FMB.09.84; Godreuil S, 2003, ANTIMICROB AGENTS CH, V47, P704, DOI 10.1128/AAC.47.2.704-708.2003; Ha UW, 1999, INFECT IMMUN, V67, P5324, DOI 10.1128/IAI.67.10.5324-5331.1999; HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x; Hidalgo E, 1998, EMBO J, V17, P2629, DOI 10.1093/emboj/17.9.2629; Hidalgo E, 1997, EMBO J, V16, P1056, DOI 10.1093/emboj/16.5.1056; Hidalgo E, 1997, TRENDS BIOCHEM SCI, V22, P207, DOI 10.1016/S0968-0004(97)01068-2; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jittawuttipoka T, 2010, ARCH MICROBIOL, V192, P331, DOI 10.1007/s00203-010-0558-8; Jittawuttipoka T, 2009, FEMS MICROBIOL LETT, V298, P111, DOI 10.1111/j.1574-6968.2009.01707.x; Josephy P.D., 2006, MOL TOXICOLOGY, V2nd ed., P333; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; LEVY SB, 1992, ANTIMICROB AGENTS CH, V36, P695, DOI 10.1128/AAC.36.4.695; Ma YQ, 2000, MICROBIOL-UK, V146, P345, DOI 10.1099/00221287-146-2-345; Mahavihakanont A, 2012, J BACTERIOL, V194, P209, DOI 10.1128/JB.05603-11; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Prapagdee B, 2004, FEMS MICROBIOL LETT, V232, P217, DOI 10.1016/S0378-1097(04)00075-8; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Saenkham P, 2007, J BACTERIOL, V189, P8807, DOI 10.1128/JB.00960-07; Saidijam M, 2006, CURR DRUG TARGETS, V7, P793, DOI 10.2174/138945006777709575; Sambrook J., 2001, MOL CLONING LAB MANU; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Sheplock R, 2013, MOL MICROBIOL, V87, P368, DOI 10.1111/mmi.12101; Shin JH, 2011, J BACTERIOL, V193, P75, DOI 10.1128/JB.00965-10; Singh AK, 2013, MOL MICROBIOL, V90, P983, DOI 10.1111/mmi.12410; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; TENNENT JM, 1989, J GEN MICROBIOL, V135, P1; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Ward A, 2001, J MOL MICROB BIOTECH, V3, P193; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Wu Ping-Sheng, 2006, Journal of Microbiology Immunology and Infection, V39, P144	43	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123699	10.1371/journal.pone.0123699	http://dx.doi.org/10.1371/journal.pone.0123699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915643	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100024
J	Wang, HT; Zhou, YM; Chen, Y; Wang, QX; Jiang, LF; Luo, YQ				Wang, Huatian; Zhou, Yumei; Chen, Yang; Wang, Quanxi; Jiang, Lifen; Luo, Yiqi			Allelopathic Potential of Invasive Plantago virginica on Four Lawn Species	PLOS ONE			English	Article							LONICERA-MAACKII; ACTIVATED CARBON; PHRAGMITES-AUSTRALIS; RESTORATION TOOL; ECONOMIC COSTS; IMPACTS; ASIATICA; WEAPONS; GROWTH; SOIL	Plantago virginica L. has invaded many lawn ecosystems in the Eastern part of China. The invasion has incurred an economic cost to remove them. In order to prevent the invasion, it is critical to understand the invasive mechanisms of this species. However, few studies have been conducted on the allelopathic mechanisms of its invasion. In this study, we examined allelopathic effects of P. virginica on germination of seeds and growth of seedlings of four widely used lawn species. We found extensive allelopathic potential of P. virginica on other lawn species, which varied with species and developmental stage. While most effects of the extracts of P. virginica were inhibitory, some variables in some species were promoted by the addition of the extracts. The extracts of P. virginica significantly inhibited seed germination of Agrostis matsumurae. While the overall differences in seed germination rate of Poa annua were significant among treatments, difference between control and any of the treatments was not significant. The height of seedlings of A. matsumurae and Cynodon dactylon was significantly lower under the treatments of adding extracts of P. virginica. In contrast, growth of seedlings of Festuca elata and P. annua did not show significant differences among treatments. The root length of A. matsumurae, C. dactylon and P. annua was suppressed by the extracts of P. virginica whereas root length of F. elata was not affected. Aboveground biomass of A. matsumurae and F. elata was significantly higher than control, except for F. elata at the concentration of 50mg/mL, whereas aboveground biomass of C. dactylon and P. annua was reduced at higher concentrations of the extracts. Except for A. matsumurae, root biomass of the other three lawn species declined under the treatments with the extracts of P. virginica. Our results revealed that P. virginica had allelopathic potential on four lawn species and supported the theory of "novel weapons hypothesis". Invasion by P. virginica in lawn can be moderated by selecting those species that are not affected or promotionally affected by it.	[Wang, Huatian; Wang, Quanxi] Shanghai Normal Univ, Shanghai, Peoples R China; [Wang, Huatian; Zhou, Yumei; Chen, Yang] Shanghai Inst Technol, Shanghai, Peoples R China; [Jiang, Lifen; Luo, Yiqi] Univ Oklahoma, Norman, OK 73019 USA	Shanghai Normal University; Shanghai Institute of Technology; University of Oklahoma System; University of Oklahoma - Norman	Wang, QX (corresponding author), Shanghai Normal Univ, Shanghai, Peoples R China.	wangqx@shnu.edu.cn	Zhou, Yu/HHN-3071-2022		Shanghai Municipal Education Commission	Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This research was funded by the grants Visiting Scholarship for Young Teachers of Shanghai Universities from Shanghai Municipal Education Commission. HW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnum Kimberly, 2013, International Journal of Plant Biology, V4, P8, DOI 10.4081/pb.2013.e2; Bauer JT, 2012, PLANT ECOL, V213, P1907, DOI 10.1007/s11258-012-0036-2; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Chen Xiang, 2011, Bulletin of Botanical Research, V31, P680; Chen Xiang, 2011, Guangxi Zhiwu / Guihaia, V31, P495; Cipollini D, 2008, J CHEM ECOL, V34, P144, DOI 10.1007/s10886-008-9426-2; Cipollini KA, 2008, AM MIDL NAT, V160, P117, DOI 10.1674/0003-0031(2008)160[117:SAABEO]2.0.CO;2; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Czarnota MA, 2003, J CHEM ECOL, V29, P2073, DOI 10.1023/A:1025634402071; Daehler CC, 2001, BIOTIC HOMOGENIZATION, P81; Duponnois R, 2011, SOIL BIOL BIOCHEM, V43, P2160, DOI 10.1016/j.soilbio.2011.06.020; Editorial Committee of flora of Chinese, 2002, FLOR CHIN; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Guo S., 1996, ACTA ECOLOGICA SINIC, V16, P302; Guo ShuiLiang, 2004, Acta Phytoecologica Sinica, V28, P787; [郭水良 Guo Shuiliang], 2003, [植物研究, Bulletin of Botanical Research], V23, P464; Guo SL, 2002, J ZHEJIANG NORMAL U, V25, P49; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Hu JL, 2013, FOOD CHEM, V138, P2338, DOI 10.1016/j.foodchem.2012.12.016; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2003, CRIT REV PLANT SCI, V22, P221, DOI 10.1080/713610857; Kettunen M., 2009, TECHNICAL SUPPORT EU; Kulmatiski A, 2006, RESTOR ECOL, V14, P251, DOI 10.1111/j.1526-100X.2006.00127.x; Kulmatiski A, 2011, RESTOR ECOL, V19, P102, DOI 10.1111/j.1526-100X.2009.00632.x; Lau JA, 2008, NEW PHYTOL, V178, P412, DOI 10.1111/j.1469-8137.2007.02360.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Li Yun, 2008, Shengtaixue Zazhi, V27, P514; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Liu Y, 2011, WEED BIOL MANAG, V11, P160, DOI 10.1111/j.1445-6664.2011.00416.x; Lorenzo P, 2013, SOIL BIOL BIOCHEM, V57, P156, DOI 10.1016/j.soilbio.2012.08.018; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Lu X, 2011, J NANYANG NORMAL U, V10, P58; Murai Y, 2009, BIOCHEM SYST ECOL, V37, P378, DOI 10.1016/j.bse.2009.07.005; National Pharmacopoeia Committee, 2005, PHARM PEOPL REP CH 2; NISHIBE S, 1995, PHYTOCHEMISTRY, V38, P741, DOI 10.1016/0031-9422(94)00299-9; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pisula NL, 2010, J TORREY BOT SOC, V137, P81, DOI 10.3159/09-RA-040.1; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Ren MX, 2009, WEED RES, V49, P449, DOI 10.1111/j.1365-3180.2009.00723.x; Rice EL, 1984, ALLELOPATHY; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Shuiliang Guo, 1995, WEED SCI, V2, P4; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Silva FML, 2014, J CHEM ECOL, V40, P276, DOI 10.1007/s10886-014-0390-8; Simmons ME, 2012, RESTOR ECOL, V20, P369, DOI 10.1111/j.1526-100X.2011.00778.x; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; Uddin MN, 2014, AM J BOT, V101, P479, DOI 10.3732/ajb.1400021; Vidotto F, 2013, CROP PROT, V54, P161, DOI 10.1016/j.cropro.2013.08.009; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Wang Y, 2012, J ECOL, V100, P894, DOI 10.1111/j.1365-2745.2012.01980.x; Wang Y, 2011, ECOL APPL, V21, P729, DOI 10.1890/09-2406.1; Weiher E, 2007, RESTOR ECOL, V15, P340, DOI 10.1111/j.1526-100X.2007.00221.x; Weisshuhn K, 2009, BASIC APPL ECOL, V10, P500, DOI 10.1016/j.baae.2008.10.009; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Xu HG, 2006, BIOL INVASIONS, V8, P1495, DOI 10.1007/s10530-005-5841-2; [杨少华 YANG Shaohua], 2008, [草业科学, Pratacultural Science], V25, P103; Ye CL, 2011, CARBOHYD POLYM, V84, P495, DOI 10.1016/j.carbpol.2010.12.014; Yin JY, 2012, CARBOHYD POLYM, V88, P1395, DOI 10.1016/j.carbpol.2012.02.025; Yin JY, 2012, CARBOHYD POLYM, V87, P2416, DOI 10.1016/j.carbpol.2011.11.009; Yuan YG, 2013, J PLANT ECOL, V6, P253, DOI 10.1093/jpe/rts033; Zhang Wan-ling, 2013, Shengtaixue Zazhi, V32, P2959	73	4	5	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125433	10.1371/journal.pone.0125433	http://dx.doi.org/10.1371/journal.pone.0125433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915515	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100128
J	Robalino, J; Sandoval, C; Barton, DN; Chacon, A; Pfaff, A				Robalino, Juan; Sandoval, Catalina; Barton, David N.; Chacon, Adriana; Pfaff, Alexander			Evaluating Interactions of Forest Conservation Policies on Avoided Deforestation	PLOS ONE			English	Article							PROTECTED AREAS; ENVIRONMENTAL SERVICES; PROPENSITY SCORE; PAYMENTS; LOCATION; BIODIVERSITY; GOVERNANCE; EFFICIENCY; IMPACT	We estimate the effects on deforestation that have resulted from policy interactions between parks and payments and between park buffers and payments in Costa Rica between 2000 and 2005. We show that the characteristics of the areas where protected and unprotected lands are located differ significantly. Additionally, we find that land characteristics of each of the policies and of the places where they interact also differ significantly. To adequately estimate the effects of the policies and their interactions, we use matching methods. Matching is implemented not only to define adequate control groups, as in previous research, but also to define those groups of locations under the influence of policies that are comparable to each other. We find that it is more effective to locate parks and payments away from each other, rather than in the same location or near each other. The high levels of enforcement inside both parks and lands with payments, and the presence of conservation spillovers that reduce deforestation near parks, significantly reduce the potential impact of combining these two policies.	[Robalino, Juan; Sandoval, Catalina; Chacon, Adriana] Ctr Agron Trop Inves & Ensenanza, Turrialba, Costa Rica; [Robalino, Juan] Univ Costa Rica, San Pedro, Costa Rica; [Barton, David N.] Norwegian Inst Nat & Res, Oslo, Norway; [Pfaff, Alexander] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA	Universidad Costa Rica; Norwegian Institute Nature Research; Duke University	Robalino, J (corresponding author), Ctr Agron Trop Inves & Ensenanza, Turrialba, Costa Rica.	robalino@catie.ac.cr	Chacón-Cascante, Adriana/AAH-2140-2019	Chacon-Cascante, Adriana/0000-0002-9326-4659; Robalino, Juan/0000-0003-1450-7382	POLICYMIX project; European Union [244065]; Inter-American Institute for Global Change Research; Swedish International Development Cooperation Agency through the Environment for Development Initiative; Tinker Foundation; Research Council of Norway [204058]; ICER [1128040] Funding Source: National Science Foundation	POLICYMIX project; European Union(European Commission); Inter-American Institute for Global Change Research; Swedish International Development Cooperation Agency through the Environment for Development Initiative; Tinker Foundation; Research Council of Norway(Research Council of Norway); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by POLICYMIX project (http://policymix.nina.no/) and the funding from the European Union's Seventh Programme for research, technological development, and demonstration under grant agreement No. 244065, The Inter-American Institute for Global Change Research (http://www.iai.int/) through the project Tropi-dry II CRN3, The Swedish International Development Cooperation Agency through the Environment for Development Initiative (http://www.efdinitiative.org/), Tinker Foundation, The Research Council of Norway through the PESILA-REDD Project under the grant agreement no. 204058 to the Norwegian Institute for Nature Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Duflo E., 2005, EVALUATING DEV EFFEC, V7, P205; Duflo Esther, 2007, 6059 CTR EC POL RES; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gimenez T, 2012, MASTER ENV MANAGEMEN; Glennerster Rachel, 2013, RUNNING RANDOMIZED E; Glewwe P, 2003, 9671 NBER; Haruna A, 2010, MASTER ENV MANAGEMEN; Joppa L, 2010, ANN NEW YORK ACAD SC, V1185; Joppa LN, 2010, P ROYAL SOC B; Lecuyer O, 2011, FONDAZIONE ENI E MAT; Mas JF, 2005, ENVIRON MONIT ASSESS, V105, P69, DOI 10.1007/s10661-005-3156-5; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pattanayak S. K., 2010, REV ENV EC POLICY; Pfaff A, 2015, PROTECTED AREAS IMPA; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Ring I., 2015, HDB ECOLOGICAL EC; Ring I, 2011, TECHNICAL BRIEF REC, V5; Robalino J, 2008, RESOURCE FUTURE EFD; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Robalino JA, 2007, ENVIRON DEV ECON, V12, P521, DOI 10.1017/S1355770X07003671; Robalino JA, 2012, J DEV ECON, V97, P427, DOI 10.1016/j.jdeveco.2011.06.003; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Samii C, 2014, CAMPBELL SYSTEMATIC, V10; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sierra R, 2006, ECOL ECON, V59, P131, DOI 10.1016/j.ecolecon.2005.10.010; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Sims KRE, 2015, ITS COMPLICATED DIRE; Vuohelainen AJ, 2012, ENVIRON MANAGE, V50, P645, DOI 10.1007/s00267-012-9901-y; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	38	40	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124910	10.1371/journal.pone.0124910	http://dx.doi.org/10.1371/journal.pone.0124910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG6AH	25909323	gold, Green Published			2022-12-26	WOS:000353376800112
J	Ye, JH; Pao, LH				Ye, Jia-Hung; Pao, Li-Heng			Using Visualized Matrix Effects to Develop and Improve LC-MS/MS Bioanalytical Methods, Taking TRAM-34 as an Example	PLOS ONE			English	Article							KCA3.1 POTASSIUM CHANNELS; HUMAN-PLASMA; MASS-SPECTROMETRY; ION SUPPRESSION; MONITORING PHOSPHOLIPIDS; LC/MS/MS ANALYSES; RENAL FIBROSIS; ESI; EXTRACTION; SECRETION	Matrix effects (MEs) continue to be an obstacle in the development of the LC-MS/MS method, with phospholipids being the major cause of MEs. Changing the mobile phase has been a common strategy to reduce MEs; however, the underlying mechanism is unclear. "Insource multiple-reaction monitoring" (IS-MRM) for glycerophosphocholines (PCs) has been commonly applied in many bioanalytical methods. "Visualized MEs" is a suitable term to describe the application of IS-MRM to visualize the elution pattern of phospholipids. We selected a real case to discuss the relationship of MEs and phospholipids in different mobile phases by quantitative, qualitative, and visualized MEs in LC-MS/MS bioanalysis. The application of visualized MEs not only predicts the ion-suppression zone but also helps in selecting an appropriate (1) mobile phase, (2) column, (3) needle wash solvent for the residue of analyte and phospholipids, and (4) evaluates the clean-up efficiency of sample preparation. The TRAM-34 LC-MS/MS method, improved by using visualized MEs, was shown to be a precise and accurate analytical method. All data indicated that the use of visualized MEs indeed provided useful information about the LC-MS/MS method development and improvement. In this study, an integrative approach for the qualitative, quantitative, and visualized MEs was used to decipher the complexity of MEs.	[Ye, Jia-Hung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Pao, Li-Heng] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Pao, Li-Heng] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Pao, Li-Heng] Chang Gung Univ Sci & Technol, Grad Inst Hlth Ind Technol, Taoyuan, Taiwan	National Defense Medical Center; National Defense Medical Center; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Pao, LH (corresponding author), Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.	paolhaa@gmail.com			Chang Gung Memorial Hospital [CMRPF1D0111]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Funding for this work came from the Chang Gung Memorial Hospital CMRPF1D0111, (Chang-Gung Medical Research Project, CMRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.3.CO;2-S; Chambers E, 2007, J CHROMATOGR B, V852, P22, DOI 10.1016/j.jchromb.2006.12.030; Ghosh C, 2012, J CHROMATOGR B, V893, P193, DOI 10.1016/j.jchromb.2012.03.012; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Ismaiel OA, 2007, J CHROMATOGR B, V859, P84, DOI 10.1016/j.jchromb.2007.09.007; Ismaiel OA, 2010, J CHROMATOGR B, V878, P3303, DOI 10.1016/j.jchromb.2010.10.012; Ismaiel OA, 2008, J CHROMATOGR B, V875, P333, DOI 10.1016/j.jchromb.2008.08.032; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jiang H, 2012, J CHROMATOGR B, V891, P71, DOI 10.1016/j.jchromb.2012.02.031; Little JL, 2006, J CHROMATOGR B, V833, P219, DOI 10.1016/j.jchromb.2006.02.011; Matuszewski BK, 1998, ANAL CHEM, V70, P882, DOI 10.1021/ac971078+; Mene P, 2010, NEPHROL DIAL TRANSPL, V25, P353, DOI 10.1093/ndt/gfp634; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; Peters FT, 2012, ANAL BIOANAL CHEM, V403, P2155, DOI 10.1007/s00216-012-6035-2; Pucci V, 2009, J PHARMACEUT BIOMED, V50, P867, DOI 10.1016/j.jpba.2009.05.037; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Shen JX, 2005, J PHARMACEUT BIOMED, V37, P359, DOI 10.1016/j.jpba.2004.10.035; Trufelli H, 2011, MASS SPECTROM REV, V30, P491, DOI 10.1002/mas.20298; Xia YQ, 2009, RAPID COMMUN MASS SP, V23, P2125, DOI 10.1002/rcm.4121; Ye JH, 2014, CHROMATOGRAPHIA, V77, P695, DOI 10.1007/s10337-014-2674-0	23	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0118818	10.1371/journal.pone.0118818	http://dx.doi.org/10.1371/journal.pone.0118818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909956	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800004
J	Lasecka, L; Bin-Tarif, A; Bridgen, A; Juleff, N; Waters, RA; Baron, MD				Lasecka, Lidia; Bin-Tarif, Abdelghani; Bridgen, Anne; Juleff, Nicholas; Waters, Ryan A.; Baron, Michael D.			Antibodies to the Core Proteins of Nairobi Sheep Disease Virus/Ganjam Virus Reveal Details of the Distribution of the Proteins in Infected Cells and Tissues	PLOS ONE			English	Article							CONGO-HEMORRHAGIC-FEVER; DUGBE VIRUS; UUKUNIEMI-VIRUS; GANJAM VIRUS; RNA SEGMENT; NUCLEOCAPSID PROTEIN; CYSTEINE PROTEASES; NAIROVIRUS GENUS; CYTOPLASMIC TAIL; PAPAIN-LIKE	Nairobi sheep disease virus (NSDV; also called Ganjam virus in India) is a bunyavirus of the genus Nairovirus. It causes a haemorrhagic gastroenteritis in sheep and goats with mortality up to 90%. The virus is closely related to the human pathogen Crimean-Congo haemorrhagic fever virus (CCHFV). Little is currently known about the biology of NSDV. We have generated specific antibodies against the virus nucleocapsid protein (N) and polymerase (L) and used these to characterise NSDV in infected cells and to study its distribution during infection in a natural host. Due to its large size and the presence of a papain-like protease (the OTU-like domain) it has been suggested that the L protein of nairoviruses undergoes an autoproteolytic cleavage into polymerase and one or more accessory proteins. Specific antibodies which recognise either the N-terminus or the C-terminus of the NSDV L protein showed no evidence of L protein cleavage in NSDV-infected cells. Using the specific anti-N and anti-L antibodies, it was found that these viral proteins do not fully colocalise in infected cells; the N protein accumulated near the Golgi at early stages of infection while the L protein was distributed throughout the cytoplasm, further supporting the multifunctional nature of the L protein. These antibodies also allowed us to gain information about the organs and cell types targeted by the virus in vivo. We could detect NSDV in cryosections prepared from various tissues collected post-mortem from experimentally inoculated animals; the virus was found in the mucosal lining of the small and large intestine, in the lungs, and in mesenteric lymph nodes (MLN), where NSDV appeared to target monocytes and/or macrophages.	[Lasecka, Lidia; Bin-Tarif, Abdelghani; Juleff, Nicholas; Waters, Ryan A.; Baron, Michael D.] Pirbright Inst, Woking GU24 0NF, Surrey, England; [Bridgen, Anne] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Ulster University	Lasecka, L (corresponding author), Pirbright Inst, Ash Rd, Woking GU24 0NF, Surrey, England.	lidia.lasecka@pirbright.ac.uk	Dykes, Lidia/HHM-9104-2022	Lasecka-Dykes, Lidia/0000-0003-3188-4198	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00740X/1, BB/F006764/1]; BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute; BBSRC PhD studentship; Biotechnology and Biological Sciences Research Council [BB/F00740X/1, BB/F006764/1, BBS/E/I/00001718] Funding Source: researchfish; BBSRC [BB/F006764/1, BB/F00740X/1, BBS/E/I/00001718] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants BB/F00740X/1 and BB/F006764/1 from the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) and the BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute. LL was the recipient of a BBSRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Bakshi S, 2013, J GEN VIROL, V94, P298, DOI 10.1099/vir.0.048322-0; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Beier D, 2004, J VIROL METHODS, V121, P239, DOI 10.1016/j.jviromet.2004.06.017; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; bin Tarif A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-71; Bjerrum O., 1986, BUFFER SYSTEMS TRANS; BOOTH TF, 1991, VIRUS RES, V21, P199, DOI 10.1016/0168-1702(91)90033-R; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; BOSHELL J, 1970, INDIAN J MED RES, V58, P561; Brennan B, 2011, J GEN VIROL, V92, P2906, DOI 10.1099/vir.0.036749-0; Bridgen A, 2002, VIROLOGY, V294, P364, DOI 10.1006/viro.2001.1324; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; Burt FJ, 1997, ARCH PATHOL LAB MED, V121, P839; Burt FJ, 1996, EPIDEMIOL INFECT, V116, P353, DOI 10.1017/S0950268800052687; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Carr JM, 2003, J MED VIROL, V69, P521, DOI 10.1002/jmv.10340; CASALS J, 1980, INTERVIROLOGY, V14, P144, DOI 10.1159/000149175; CASH P, 1985, J GEN VIROL, V66, P141, DOI 10.1099/0022-1317-66-1-141; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Choi J, 2003, BIOCHEM BIOPH RES CO, V305, P1049, DOI 10.1016/S0006-291X(03)00881-7; CLERX JPM, 1981, J GEN VIROL, V55, P165, DOI 10.1099/0022-1317-55-1-165; Connolly-Andersen AM, 2009, VIROLOGY, V390, P157, DOI 10.1016/j.virol.2009.06.010; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P799; DAVIDWES.TS, 1974, J GEN VIROL, V23, P297, DOI 10.1099/0022-1317-23-3-297; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P259, DOI 10.1017/S0022172400025092; DAVIES FG, 1978, J COMP PATHOL, V88, P519, DOI 10.1016/0021-9975(78)90005-1; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P251, DOI 10.1017/S0022172400025080; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Drosten C, 2002, J CLIN MICROBIOL, V40, P1122, DOI 10.1128/JCM.40.3.1122-1123.2002; Dunster L, 2002, EMERG INFECT DIS, V8, P1005, DOI 10.3201/eid0809.010510; ElAzazy OME, 1997, T ROY SOC TROP MED H, V91, P275, DOI 10.1016/S0035-9203(97)90072-9; ELLIS DS, 1981, ARCH VIROL, V70, P189, DOI 10.1007/BF01315125; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Estrada DF, 2011, J BIOL CHEM, V286, P21678, DOI 10.1074/jbc.M110.216515; Estrada DF, 2009, J BIOL CHEM, V284, P8645, DOI 10.1074/jbc.M808081200; Flick R, 2001, J VIROL, V75, P1643, DOI 10.1128/JVI.75.4.1643-1655.2001; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Groseth A, 2009, VIRUS RES, V140, P8, DOI 10.1016/j.virusres.2008.10.017; HEWLETT MJ, 1977, J VIROL, V21, P1085, DOI 10.1128/JVI.21.3.1085-1093.1977; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Honig JE, 2004, VIROLOGY, V321, P29, DOI 10.1016/j.virol.2003.09.042; HOWARTH JA, 1965, J COMP PATHOL THERAP, V75, P437, DOI 10.1016/0021-9975(65)90024-1; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Joshi MV, 2005, J MED ENTOMOL, V42, P204, DOI 10.1603/0022-2585(2005)042[0204:IOGVFT]2.0.CO;2; Katz A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-187; Kinsella E, 2004, VIROLOGY, V321, P23, DOI 10.1016/j.virol.2003.09.046; Lasecka L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094656; LAWRENCE DM, 1995, VIROLOGY, V207, P127, DOI 10.1006/viro.1995.1058; LOPEZ N, 1995, J VIROL, V69, P3972, DOI 10.1128/JVI.69.7.3972-3979.1995; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; Marriott A. C., 1996, The Bunyaviridae., P91; MARRIOTT AC, 1992, VIROLOGY, V190, P606, DOI 10.1016/0042-6822(92)90898-Y; Marriott AC, 1996, J GEN VIROL, V77, P1775, DOI 10.1099/0022-1317-77-8-1775; Mettam RWM, 1931, REPORT VET PATHOLOGI; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Montgomery RE, 1917, J COMP PATHOL, V30; Nabeth P, 2004, EMERG INFECT DIS, V10, P1881, DOI 10.3201/eid1010.040586; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; Papa A, 2004, EMERG INFECT DIS, V10, P1465, DOI 10.3201/eid1008.040162; Papa A, 2010, CLIN MICROBIOL INFEC, V16, P843, DOI 10.1111/j.1469-0691.2009.02996.x; Papa A, 2002, EMERG INFECT DIS, V8, P50, DOI 10.3201/eid0801.010087; Papa A, 2006, J CLIN VIROL, V36, P272, DOI 10.1016/j.jcv.2006.04.007; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Peyrefitte CN, 2010, J GEN VIROL, V91, P189, DOI 10.1099/vir.0.015701-0; Putlitz JZ, 1999, J VIROL, V73, P4188, DOI 10.1128/JVI.73.5.4188-4196.1999; Rwambo PM, 1996, ARCH VIROL, V141, P1479, DOI 10.1007/BF01718249; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Shi XH, 2009, J GEN VIROL, V90, P297, DOI 10.1099/vir.0.007567-0; Simon M, 2009, VIROLOGY, V385, P313, DOI 10.1016/j.virol.2008.11.020; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; SNIJDER EJ, 1995, J BIOL CHEM, V270, P16671, DOI 10.1074/jbc.270.28.16671; Sudeep AB, 2009, INDIAN J MED RES, V130, P514; Sweetman DA, 2001, VIROLOGY, V281, P193, DOI 10.1006/viro.2000.0805; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Terasaki K, 2011, P NATL ACAD SCI USA, V108, P804, DOI 10.1073/pnas.1013155108; Trunschke M, 2013, VIROLOGY, V441, P135, DOI 10.1016/j.virol.2013.03.013; Uilenberg G., 1997, Parassitologia (Rome), V39, P161; Wang H, 2010, VIRUS RES, V151, P205, DOI 10.1016/j.virusres.2010.05.008; WATRET GE, 1985, J GEN VIROL, V66, P2513, DOI 10.1099/0022-1317-66-11-2513; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; WEINBREN M. P., 1958, JOUR COMP PATHOL AND THERAP, V68, P174, DOI 10.1016/S0368-1742(58)80018-1; White WR, 2008, FOREIGN ANIMAL DIS, P335; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Williams RJ, 2000, TROP MED INT HEALTH, V5, P99, DOI 10.1046/j.1365-3156.2000.00524.x; ZELLER HG, 1989, ARCH VIROL, V108, P211, DOI 10.1007/BF01310935	104	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124966	10.1371/journal.pone.0124966	http://dx.doi.org/10.1371/journal.pone.0124966			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905707	gold, Green Submitted, Green Published			2022-12-26	WOS:000353332000096
J	Lukesova, T; Kohout, P; Vetrovsky, T; Vohnik, M				Lukesova, Tereza; Kohout, Petr; Vetrovsky, Tomas; Vohnk, Martin			The Potential of Dark Septate Endophytes to Form Root Symbioses with Ectomycorrhizal and Ericoid Mycorrhizal Middle European Forest Plants	PLOS ONE			English	Article							PHIALOCEPHALA-FORTINII S.L.; DIRECT DNA EXTRACTION; ACEPHALA-APPLANATA; HAIR ROOTS; MOLECULAR CHARACTERIZATION; HETEROCONIUM-CHAETOSPIRA; COMMUNITY STRUCTURE; FUNGAL COMMUNITIES; CO-COLONIZATION; VACCINIUM ROOTS	The unresolved ecophysiological significance of Dark Septate Endophytes (DSE) may be in part due to existence of morphologically indistinguishable cryptic species in the most common Phialocephala fortinii s. l.-Acephala applanata species complex (PAC). We inoculated three middle European forest plants (European blueberry, Norway spruce and silver birch) with 16 strains of eight PAC cryptic species and other DSE and ectomycorrhizal/ericoid mycorrhizal fungi and focused on intraradical structures possibly representing interfaces for plant-fungus nutrient transfer and on host growth response. The PAC species Acephala applanata simultaneously formed structures resembling ericoid mycorrhiza (ErM) and DSE microsclerotia in blueberry. A. macrosclerotiorum, a close relative to PAC, formed ectomycorrhizae with spruce but not with birch, and structures resembling ErM in blueberry. Phialocephala glacialis, another close relative to PAC, formed structures resembling ErM in blueberry. In blueberry, six PAC strains significantly decreased dry shoot biomass compared to ErM control. In birch, one A. macrosclerotiorum strain increased root biomass and the other shoot biomass in comparison with non-inoculated control. The dual mycorrhizal ability of A. macrosclerotiorum suggested that it may form mycorrhizal links between Ericaceae and Pinaceae. However, we were unable to detect this species in Ericaceae roots growing in a forest with presence of A. macrosclerotiorum ectomycorrhizae. Nevertheless, the diversity of Ericaceae mycobionts was high (380 OTUs) with individual sites often dominated by hitherto unreported helotialean and chaetothyrialean/verrucarialean species; in contrast, typical ErM fungi were either absent or low in abundance. Some DSE apparently have a potential to form mycorrhizae with typical middle European forest plants. However, except A. applanata, the tested representatives of all hitherto described PAC cryptic species formed typical DSE colonization without specific structures necessary for mycorrhizal nutrient transport. A. macrosclerotiorum forms ectomycorrhiza with conifers but not with broadleaves and probably does not form common mycorrhizal networks between conifers with Ericaceae.	[Lukesova, Tereza; Kohout, Petr; Vohnk, Martin] Charles Univ Prague, Fac Sci, Dept Plant Expt Biol, Prague, Czech Republic; [Lukesova, Tereza; Kohout, Petr; Vohnk, Martin] Inst Bot ASCR, Dept Mycorrhizal Symbioses, Pruhonice, Czech Republic; [Kohout, Petr] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Vetrovsky, Tomas] Inst Microbiol ASCR, Lab Environm Microbiol, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Vohnik, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Plant Expt Biol, Prague, Czech Republic.	vohnik@ibot.cas.cz	Kohout, Petr/B-4975-2011; Vohnik, Martin/I-1736-2017; Vohník, Martin/H-1636-2014; Knoblochová, Tereza/J-3493-2017; Vetrovsky, Tomas/R-5817-2017	Kohout, Petr/0000-0002-3985-2310; Vohnik, Martin/0000-0002-8655-2708; Vohník, Martin/0000-0002-8655-2708; Knoblochová, Tereza/0000-0002-3862-9184; 	Grant Agency of Charles University [GAUK 320311]; Department of Experimental Plant Biology, Faculty of Science, Charles University in Prague [MSMT LO1417]; Institute of Botany ASCR [RVO 67985939]	Grant Agency of Charles University; Department of Experimental Plant Biology, Faculty of Science, Charles University in Prague; Institute of Botany ASCR(Czech Academy of Sciences)	This study was financed by the Grant Agency of Charles University (GAUK 320311) and constitutes a part of the long-term research projects of the Department of Experimental Plant Biology, Faculty of Science, Charles University in Prague (MSMT LO1417) and the Institute of Botany ASCR (RVO 67985939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy HD, 2000, MYCOL RES, V104, P1213, DOI 10.1017/S0953756200002896; Ahlich K, 1996, NEW PHYTOL, V132, P259, DOI 10.1111/j.1469-8137.1996.tb01845.x; Allen TR, 2003, NEW PHYTOL, V160, P255, DOI 10.1046/j.1469-8137.2003.00885.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beiler KJ, 2010, NEW PHYTOL, V185, P543, DOI 10.1111/j.1469-8137.2009.03069.x; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Berch SM, 2002, PLANT SOIL, V244, P55, DOI 10.1023/A:1020291516884; Bougoure DS, 2007, MOL ECOL, V16, P4624, DOI 10.1111/j.1365-294X.2007.03540.x; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P1743, DOI 10.1111/j.1462-2920.2005.00919.x; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P819, DOI 10.1111/j.1462-2920.2005.00755.x; Brundrett M, 2006, MICROBIAL ROOT ENDOP, P179; Bruzone MC, 2015, MYCORRHIZA, V25, P25, DOI 10.1007/s00572-014-0586-3; Duo A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-166; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gorzelak MA, 2012, FUNGAL ECOL, V5, P36, DOI 10.1016/j.funeco.2011.08.008; Grelet GA, 2010, NEW PHYTOL, V188, P210, DOI 10.1111/j.1469-8137.2010.03353.x; Grelet GA, 2009, NEW PHYTOL, V182, P359, DOI 10.1111/j.1469-8137.2009.02813.x; Grunig CR, 2006, FUNGAL GENET BIOL, V43, P410, DOI 10.1016/j.fgb.2006.01.007; Grunig CR, 2009, MYCOL RES, V113, P207, DOI 10.1016/j.mycres.2008.10.005; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hashimoto Y, 2001, ECOL RES, V16, P117, DOI 10.1046/j.1440-1703.2001.00377.x; Hazard C, 2014, FEMS MICROBIOL ECOL, V87, P586, DOI 10.1111/1574-6941.12247; Ishida TA, 2010, SOIL BIOL BIOCHEM, V42, P234, DOI 10.1016/j.soilbio.2009.10.021; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Kaldorf M, 2004, MYCORRHIZA, V14, P295, DOI 10.1007/s00572-003-0266-1; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kjoller R, 2010, FUNGAL ECOL, V3, P205, DOI 10.1016/j.funeco.2009.10.005; Klymiuk AA, 2013, MYCOLOGIA, V105, P1100, DOI 10.3852/13-025; Kohout P, 2013, FUNGAL ECOL, V6, P50, DOI 10.1016/j.funeco.2012.08.005; Kohout P, 2012, FEMS MICROBIOL ECOL, V80, P216, DOI 10.1111/j.1574-6941.2011.01291.x; Kohout P, 2011, MYCORRHIZA, V21, P403, DOI 10.1007/s00572-010-0350-2; Mayerhofer MS, 2013, MYCORRHIZA, V23, P119, DOI 10.1007/s00572-012-0456-9; Melin E, 1921, J ECOL, V9, P254; Menkis A, 2004, MYCOL RES, V108, P965, DOI 10.1017/S0953756204000668; Merrild MP, 2013, NEW PHYTOL, V200, P229, DOI 10.1111/nph.12351; Molina R., 1982, Methods and principles of mycorrhizal research., P115; Munzenberger B, 2009, MYCORRHIZA, V19, P481, DOI 10.1007/s00572-009-0239-0; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Newsham KK, 1999, NEW PHYTOL, V144, P517, DOI 10.1046/j.1469-8137.1999.00537.x; Obase K, 2014, MYCORRHIZA, V24, P635, DOI 10.1007/s00572-014-0584-5; ODELL TE, 1993, NEW PHYTOL, V124, P93, DOI 10.1111/j.1469-8137.1993.tb03800.x; PEARSON V, 1973, NEW PHYTOL, V72, P371, DOI 10.1111/j.1469-8137.1973.tb02044.x; Peterson RL, 2008, BOTANY, V86, P445, DOI 10.1139/B08-016; Reininger V, 2013, ENV MICROBIOL REP, V5, P892, DOI 10.1111/1758-2229.12091; Reininger V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042865; Reininger V, 2012, ENVIRON MICROBIOL, V14, P1064, DOI 10.1111/j.1462-2920.2011.02686.x; RICHARD C, 1971, Canadian Journal of Forest Research, V1, P246, DOI 10.1139/x71-034; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Selosse MA, 2008, NEW PHYTOL, V178, P3, DOI 10.1111/j.1469-8137.2008.02390.x; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; STOYKE G, 1993, ARCTIC ALPINE RES, V25, P189, DOI 10.2307/1551812; STOYKE G, 1991, CAN J BOT, V69, P347, DOI 10.1139/b91-047; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tellenbach C, 2012, FEMS MICROBIOL ECOL, V82, P157, DOI 10.1111/j.1574-6941.2012.01415.x; Tellenbach C, 2011, ENVIRON MICROBIOL, V13, P2508, DOI 10.1111/j.1462-2920.2011.02523.x; Usuki F, 2005, MYCORRHIZA, V15, P61, DOI 10.1007/s00572-004-0333-2; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Villarreal-Ruiz L, 2012, SYMBIOSIS, V56, P67, DOI 10.1007/s13199-012-0161-7; Vohnik M, 2007, FOLIA MICROBIOL, V52, P407, DOI 10.1007/BF02932096; Vohnik M, 2005, SYMBIOSIS, V40, P87; Vohnik M, 2003, FOLIA GEOBOT, V38, P191, DOI 10.1007/BF02803151; Vohnik M, 2013, FUNGAL ECOL, V6, P281, DOI 10.1016/j.funeco.2013.03.006; Vohnik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039524; Vohnik M, 2012, PLANT SOIL, V355, P341, DOI 10.1007/s11104-011-1106-2; Vohnik M, 2011, FOLIA GEOBOT, V46, P373, DOI 10.1007/s12224-011-9098-5; Vralstad T, 2004, NEW PHYTOL, V164, P7, DOI 10.1111/j.1469-8137.2004.01180.x; Walker JF, 2011, NEW PHYTOL, V191, P515, DOI 10.1111/j.1469-8137.2011.03703.x; WANG CJK, 1985, MYCOLOGIA, V77, P951, DOI 10.2307/3793308; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; WILCOX HE, 1987, CAN J FOREST RES, V17, P884, DOI 10.1139/x87-140; Wu LQ, 2010, MYCORRHIZA, V20, P127, DOI 10.1007/s00572-009-0268-8; Zhang C, 2009, MYCORRHIZA, V19, P417, DOI 10.1007/s00572-009-0246-1; Zimmerman E, 2007, SYMBIOSIS, V43, P45	82	58	59	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124752	10.1371/journal.pone.0124752	http://dx.doi.org/10.1371/journal.pone.0124752			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905493	Green Submitted, Green Published, gold			2022-12-26	WOS:000353332000085
J	Sezgin, E; Gutmann, T; Buhl, T; Dirkx, R; Grzybek, M; Coskun, U; Solimena, M; Simons, K; Levental, I; Schwille, P				Sezgin, Erdinc; Gutmann, Theresia; Buhl, Tomasz; Dirkx, Ron; Grzybek, Michal; Coskun, Uenal; Solimena, Michele; Simons, Kai; Levental, Ilya; Schwille, Petra			Adaptive Lipid Packing and Bioactivity in Membrane Domains	PLOS ONE			English	Article							GENERALIZED POLARIZATION; FLUORESCENT-PROBE; CELL-MEMBRANES; RAFTS; MODEL; PHASES; MICROSCOPY; PROTEIN; FLUCTUATIONS; RESISTANCE	Lateral compositional and physicochemical heterogeneity is a ubiquitous feature of cellular membranes on various length scales, from molecular assemblies to micrometric domains. Segregated lipid domains of increased local order, referred to as rafts, are believed to be prominent features in eukaryotic plasma membranes; however, their exact nature (i.e. size, lifetime, composition, homogeneity) in live cells remains difficult to define. Here we present evidence that both synthetic and natural plasma membranes assume a wide range of lipid packing states with varying levels of molecular order. These states may be adapted and specifically tuned by cells during active cellular processes, as we show for stimulated insulin secretion. Most importantly, these states regulate both the partitioning of molecules between coexisting domains and the bioactivity of their constituent molecules, which we demonstrate for the ligand binding activity of the glycosphingolipid receptor GM1. These results confirm the complexity and flexibility of lipid-mediated membrane organization and reveal mechanisms by which this flexibility could be functionalized by cells.	[Sezgin, Erdinc] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Sezgin, Erdinc; Buhl, Tomasz; Solimena, Michele; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Gutmann, Theresia; Dirkx, Ron; Grzybek, Michal; Coskun, Uenal; Solimena, Michele] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Dresden, Germany; [Gutmann, Theresia; Dirkx, Ron; Grzybek, Michal; Coskun, Uenal; Solimena, Michele] German Ctr Diabet Res DZD, Neuherberg, Germany; [Levental, Ilya] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Schwille, Petra] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Oxford; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Texas System; University of Texas Health Science Center Houston; Max Planck Society	Levental, I (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	ilya.levental@uth.tmc.edu; schwille@biochem.mpg.de	Schwille, Petra/A-4983-2010; Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011; Levental, Ilya/F-4707-2011; Coskun, Ünal/F-4683-2011; Sezgin, Erdinc/R-1980-2018; Gutmann, Theresia/R-6408-2018; Grzybek, Michal/D-3802-2017	Levental, Ilya/0000-0002-1206-9545; Coskun, Ünal/0000-0003-4375-3144; Sezgin, Erdinc/0000-0002-4915-388X; Gutmann, Theresia/0000-0003-0562-2880; Simons, Kai/0000-0002-9231-9996; Grzybek, Michal/0000-0003-2083-0506	Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research (BMBF) [SO818/1-1, SCHW716/7-1, "Transregio 83" TRR83 TP18]; Max Planck Society; CPRIT Scholar for Cancer Research [R1215]	Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research (BMBF); Max Planck Society(Max Planck Society); CPRIT Scholar for Cancer Research	This work was supported by grants SO818/1-1, SCHW716/7-1 and "Transregio 83" TRR83 TP18 from Deutsche Forschungsgemeinschaft (DFG), German Federal Ministry of Education and Research (BMBF) grant to the German Center for Diabetes Research (DZD e.V.) and Max Planck Society. IL is a CPRIT Scholar for Cancer Research (grant R1215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatolli LA, 1997, BBA-BIOMEMBRANES, V1325, P80, DOI 10.1016/S0005-2736(96)00246-5; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Delaunay JL, 2008, BBA-BIOMEMBRANES, V1778, P105, DOI 10.1016/j.bbamem.2007.09.017; Eisenberg S, 2011, MOL CELL BIOL, V31, P3938, DOI 10.1128/MCB.05570-11; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Gray E, 2013, BIOPHYS J, V105, P2751, DOI 10.1016/j.bpj.2013.11.005; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Juhasz J, 2010, BIOCHEM J, V430, P415, DOI [10.1042/Bj20100516, 10.1042/BJ20100516]; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Klotzsch E, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0033; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Levental I, 2010, PNAS; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ozhan G, 2013, DEV CELL, V26, P331, DOI 10.1016/j.devcel.2013.07.020; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sanchez SA, 2012, P NATL ACAD SCI USA, V109, P7314, DOI 10.1073/pnas.1118288109; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Sezgin E, 2011, COLD SPRING HARBOR P, V3, DOI [10.1101/cshperspect.a005017, DOI 10.1101/CSHPERSPECT.A005017]; Sezgin E, 2013, CHEMBIOCHEM, V14, P695, DOI 10.1002/cbic.201300038; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shi DW, 2013, J BIOL CHEM, V288, P12605, DOI 10.1074/jbc.M112.399477; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Thaa B, 2011, BIOCHEM J, V437, P389, DOI 10.1042/BJ20110706; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2003, BIOPHYS J, V84, P725, DOI 10.1016/S0006-3495(03)74891-7; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Waugh MG, 2011, J LIPID RES, V52, P582, DOI 10.1194/jlr.D012807; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zidar J, 2009, J PHYS CHEM B, V113, P15795, DOI 10.1021/jp907138h	43	69	69	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123930	10.1371/journal.pone.0123930	http://dx.doi.org/10.1371/journal.pone.0123930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905447	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000049
J	Shvab, A; Haase, G; Ben-Shmuel, A; Gavert, N; Brabletz, T; Dedhar, S; Ben-Ze'ev, A				Shvab, A.; Haase, G.; Ben-Shmuel, A.; Gavert, N.; Brabletz, T.; Dedhar, S.; Ben-Ze'ev, A.			Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression	ONCOGENE			English	Article							INTEGRIN-LINKED KINASE; COLORECTAL-CANCER; EXPRESSION; METASTASIS; DISEASE; TARGET; L1; OVEREXPRESSION; TUMORIGENESIS; PROTEINS	Overactivation of Wnt-beta-catenin signaling, including beta-catenin-TCF target gene expression, is a hallmark of colorectal cancer (CRC) development. We identified the immunoglobulin family of cell-adhesion receptors member L1 as a beta-catenin-TCF target gene preferentially expressed at the invasive edge of human CRC tissue. L1 can confer enhanced motility and liver metastasis when expressed in CRC cells. This ability of L1-mediated metastasis is exerted by a mechanism involving ezrin and the activation of NF-kappa B target genes. In this study, we identified the secreted modular calcium-binding matricellular protein-2 (SMOC-2) as a gene activated by L1-ezrin-NF-kappa B signaling. SMOC-2 is also known as an intestinal stem cell signature gene in mice expressing Lgr5 in cells at the bottom of intestinal crypts. The induction of SMOC-2 expression in L1-expressing CRC cells was necessary for the increase in cell motility, proliferation under stress and liver metastasis conferred by L1. SMOC-2 expression induced a more mesenchymal like phenotype in CRC cells, a decrease in E-cadherin and an increase in Snail by signaling that involves integrin-linked kinase (ILK). SMOC-2 was localized at the bottom of normal human colonic crypts and at increased levels in CRC tissue with preferential expression in invasive areas of the tumor. We found an increase in Lgr5 levels in CRC cells overexpressing L1, p65 or SMOC-2, suggesting that L1-mediated CRC progression involves the acquisition of a stem cell-like phenotype, and that SMOC-2 elevation is necessary for L1-mediated induction of more aggressive/invasive CRC properties.	[Shvab, A.; Haase, G.; Ben-Shmuel, A.; Gavert, N.; Ben-Ze'ev, A.] Weizmann Inst Sci, Dept Mol & Cell Biol, 234 Hertzl St, IL-76100 Rehovot, Israel; [Brabletz, T.] Univ Erlangen Nuernberg, Dept Expt Med 1, Erlangen, Germany; [Dedhar, S.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada	Weizmann Institute of Science; University of Erlangen Nuremberg; British Columbia Cancer Agency	Ben-Ze'ev, A (corresponding author), Weizmann Inst Sci, Dept Mol & Cell Biol, 234 Hertzl St, IL-76100 Rehovot, Israel.	avri.ben-zeev@weizmann.ac.il		Gavert, Nancy/0000-0003-1639-4684; Dedhar, Shoukat/0000-0003-4355-1657; ben-ze'ev, avri/0000-0001-6113-3921	Israel Cancer Research Fund (ICRF); Israel Science Foundation (ISF)	Israel Cancer Research Fund (ICRF); Israel Science Foundation (ISF)(Israel Science Foundation)	We thank Drs C Vaziri, U Hartmann, B Lenarcic, S Milano, R Cerione and P McDonald for reagents. This study was supported by grants from the Israel Cancer Research Fund (ICRF) and from the Israel Science Foundation (ISF).	Ben-Shmuel A, 2013, ONCOGENE, V32, P3220, DOI 10.1038/onc.2012.340; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Gavert N, 2013, CANCER RES, V73, P5754, DOI 10.1158/0008-5472.CAN-13-0576; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Liu P, 2009, GENE, V433, P72, DOI 10.1016/j.gene.2008.12.010; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Milano SK, 2012, J BIOL CHEM, V287, P24955, DOI 10.1074/jbc.M111.306514; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Novinec M, 2008, PROTEIN EXPRES PURIF, V62, P75, DOI 10.1016/j.pep.2008.07.009; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Simons BD, 2011, EXP CELL RES, V317, P2719, DOI 10.1016/j.yexcr.2011.07.010; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Yan ZP, 2014, ACTA HISTOCHEM, V116, P527, DOI 10.1016/j.acthis.2013.11.001	30	38	39	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					549	557		10.1038/onc.2015.127	http://dx.doi.org/10.1038/onc.2015.127			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25915847				2022-12-26	WOS:000369548800002
J	Lim, PX; Patel, DR; Poisson, KE; Basuita, M; Tsai, C; Lyndaker, AM; Hwang, BJ; Lu, AL; Weiss, RS				Lim, Pei Xin; Patel, Darshil R.; Poisson, Kelsey E.; Basuita, Manpreet; Tsai, Charlton; Lyndaker, Amy M.; Hwang, Bor-Jang; Lu, A-Lien; Weiss, Robert S.			Genome Protection by the 9-1-1 Complex Subunit HUS1 Requires Clamp Formation, DNA Contacts, and ATR Signaling-independent Effector Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHECKPOINT SENSOR; CELL NUCLEAR ANTIGEN; DAMAGE RESPONSE; STRUCTURAL BASIS; SLIDING CLAMP; FISSION YEAST; MUTY HOMOLOG; PCNA; RAD9-HUS1-RAD1; RECRUITMENT	The RAD9A-HUS1-RAD1 (9-1-1) complex is a heterotrimeric clamp that promotes checkpoint signaling and repair at DNA damage sites. In this study, we elucidated HUS1 functional residues that drive clamp assembly, DNA interactions, and downstream effector functions. First, we mapped a HUS1-RAD9A interface residue that was critical for 9-1-1 assembly and DNA loading. Next, we identified multiple positively charged residues in the inner ring of HUS1 that were crucial for genotoxin-induced 9-1-1 chromatin localization and ATR signaling. Finally, we found two hydrophobic pockets on the HUS1 outer surface that were important for cell survival after DNA damage. Interestingly, these pockets were not required for 9-1-1 chromatin localization or ATR-mediated CHK1 activation but were necessary for interactions between HUS1 and its binding partner MYH, suggesting that they serve as interaction domains for the recruitment and coordination of downstream effectors at damage sites. Together, these results indicate that, once properly loaded onto damaged DNA, the 9-1-1 complex executes multiple, separable functions that promote genome maintenance.	[Lim, Pei Xin; Patel, Darshil R.; Poisson, Kelsey E.; Basuita, Manpreet; Tsai, Charlton; Lyndaker, Amy M.; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Hwang, Bor-Jang; Lu, A-Lien] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA	Cornell University; University System of Maryland; University of Maryland Baltimore	Weiss, RS (corresponding author), Cornell Univ, Dept Biomed Sci, Tower Rd, Ithaca, NY 14853 USA.	rsw26@cornell.edu	Regan, Clinton/E-6250-2012	Tsai, Charlton/0000-0003-0502-7467; Lim, Pei Xin/0000-0001-5742-3539	National Institutes of Health [R01 CA108773, R01 CA78391]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078391, R01CA108773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA108773 (to R. S. W.) and R01 CA78391 (to A. L.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Alver RC, 2014, NUCLEIC ACIDS RES, V42, P8389, DOI 10.1093/nar/gku479; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bai HB, 2010, DNA REPAIR, V9, P478, DOI 10.1016/j.dnarep.2010.01.011; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; Chang DY, 2005, J BIOL CHEM, V280, P408, DOI 10.1074/jbc.M406800200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Eichinger CS, 2011, TRENDS BIOCHEM SCI, V36, P563, DOI 10.1016/j.tibs.2011.08.002; Eichinger CS, 2010, P NATL ACAD SCI USA, V107, P11370, DOI 10.1073/pnas.1004248107; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gu YS, 2001, NUCLEIC ACIDS RES, V29, P2666, DOI 10.1093/nar/29.12.2666; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Han L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-67; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kaur R, 2001, MOL BIOL CELL, V12, P3744, DOI 10.1091/mbc.12.12.3744; Lyndaker AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003320; Madabushi A., 2011, ADV MED BIOL, P41; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; McNally R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-3; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Park MJ, 2009, DNA REPAIR, V8, P1190, DOI 10.1016/j.dnarep.2009.06.004; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vasileva A, 2013, J CELL SCI, V126, P3927, DOI 10.1242/jcs.126763; Weiss RS, 2000, GENE DEV, V14, P1886; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Xing GX, 2009, MOL MICROBIOL, V71, P678, DOI 10.1111/j.1365-2958.2008.06553.x; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu XJ, 2013, NUCLEIC ACIDS RES, V41, P10020, DOI 10.1093/nar/gkt810; Yazinski SA, 2009, P NATL ACAD SCI USA, V106, P21282, DOI 10.1073/pnas.0904965106	52	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14826	14840		10.1074/jbc.M114.630640	http://dx.doi.org/10.1074/jbc.M114.630640			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25911100	hybrid, Green Published			2022-12-26	WOS:000356177300003
J	Akacem, LD; Simpkin, CT; Carskadon, MA; Wright, KP; Jenni, OG; Achermann, P; LeBourgeois, MK				Akacem, Lameese D.; Simpkin, Charles T.; Carskadon, Mary A.; Wright, Kenneth P., Jr.; Jenni, Oskar G.; Achermann, Peter; LeBourgeois, Monique K.			The Timing of the Circadian Clock and Sleep Differ between Napping and Non-Napping Toddlers	PLOS ONE			English	Article							NOCTURNAL SLEEP; PHASE-SHIFT; LIGHT; MELATONIN; PATTERNS; CHILDREN; RHYTHM; NAPS; KINDERGARTEN; PHYSIOLOGY	The timing of the internal circadian clock shows large inter-individual variability across the lifespan. Although the sleep-wakefulness pattern of most toddlers includes an afternoon nap, the association between napping and circadian phase in early childhood remains unexplored. This study examined differences in circadian phase and sleep between napping and non-napping toddlers. Data were collected on 20 toddlers (34.2 +/- 2.0 months; 12 females; 15 nappers). Children followed their habitual napping and non-napping sleep schedules (monitored with actigraphy) for 5 days before an in-home salivary dim light melatonin onset (DLMO) assessment. On average, napping children fell asleep during their nap opportunities on 3.6 +/- 1.2 of the 5 days before the DLMO assessment. For these napping children, melatonin onset time was 38 min later (p = 0.044; d = 0.93), actigraphically-estimated bedtime was 43 min later (p = 0.014; d = 1.24), sleep onset time was 59 min later (p = 0.006; d = 1.46), and sleep onset latency was 16 min longer (p = 0.030; d = 1.03) than those not napping. Midsleep and wake time did not differ by napping status. No difference was observed in the bedtime, sleep onset, or midsleep phase relationships with DLMO; however, the wake time phase difference was 47 min smaller for napping toddlers (p = 0.029; d = 1.23). On average, nappers had 69 min shorter nighttime sleep durations (p = 0.006; d = 1.47) and spent 49 min less time in bed (p = 0.019; d = 1.16) than non-nappers. Number of days napping was correlated with melatonin onset time (r = 0.49;p = 0.014). Our findings indicate that napping influences individual variability in melatonin onset time in early childhood. The delayed bedtimes of napping toddlers likely permits light exposure later in the evening, thereby delaying the timing of the clock and sleep. Whether the early developmental trajectory of circadian phase involves an advance associated with the decline in napping is a question necessitating longitudinal data as children transition from a biphasic to monophasic sleep-wakefulness pattern.	[Akacem, Lameese D.; Simpkin, Charles T.; LeBourgeois, Monique K.] Univ Colorado, Dept Integrat Physiol, Sleep & Dev Lab, Boulder, CO 80309 USA; [Simpkin, Charles T.] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA; [Carskadon, Mary A.] Brown Univ, Warren Alpert Med Sch, Sleep & Chronobiol Lab, EP Bradley Hosp,Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Carskadon, Mary A.] Univ S Australia, Sch Psychol Social Work & Social Policy, Ctr Sleep Res, Adelaide, SA 5001, Australia; [Wright, Kenneth P., Jr.] Univ Colorado, Dept Integrat Physiol, Sleep & Chronobiol Lab, Boulder, CO 80309 USA; [Jenni, Oskar G.] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Sect Chronobiol & Sleep Res, Zurich, Switzerland	University of Colorado System; University of Colorado Boulder; Brown University; University of South Australia; University of Colorado System; University of Colorado Boulder; University Children's Hospital Zurich; University of Zurich	LeBourgeois, MK (corresponding author), Univ Colorado, Dept Integrat Physiol, Sleep & Dev Lab, Boulder, CO 80309 USA.	monique.lebourgeois@colorado.edu	Jenni, Oskar/AAG-4391-2019; Achermann, Peter/N-1215-2014	Jenni, Oskar/0000-0002-4561-6277; Achermann, Peter/0000-0002-0208-3511	National Institutes of Health [K01-MH074643, R01-MH08566]; Howard Hughes Medical Institute through the Biological Sciences Initiative at the University of Colorado Boulder; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH074643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute through the Biological Sciences Initiative at the University of Colorado Boulder; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	K01-MH074643 and R01-MH08566 were awarded to MKL from the National Institutes of Health (http://www.nih.gov/). LDA and CTS received grants from the Howard Hughes Medical Institute through the Biological Sciences Initiative at the University of Colorado Boulder (http://bsi.colotado.edu/)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo C, 2005, SLEEP, V28, P1568, DOI 10.1093/sleep/28.12.1568; Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; BELTRAMINI AU, 1983, PEDIATRICS, V71, P153; Berger RH, 2012, J SLEEP RES, V21, P235, DOI 10.1111/j.1365-2869.2011.00962.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Bruni O, 2000, CLIN NEUROPHYSIOLO S, V53, P358; Burgess Helen J, 2003, Behav Sleep Med, V1, P102, DOI 10.1207/S15402010BSM0102_3; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Burgess HJ, 2004, NEUROSCI LETT, V356, P115, DOI 10.1016/j.neulet.2003.11.032; Buxton OM, 2000, AM J PHYSIOL-REG I, V278, pR373, DOI 10.1152/ajpregu.2000.278.2.R373; Cairns A, 2013, BEHAV SLEEP MED, V12, P1, DOI [10.1080/15402002.2012.720315, DOI 10.1080/15402002.2012.720315]; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Chang A, 2012, SLEEP, V35, pA205; Cohen J.E., 1988, STAT POWER ANAL BEHA; Common Sense Media, 2013, ZER 8 CHILDR MED US; Craven HJ, 2012, SLEEP, V35, pA127; Crosby B, 2005, PEDIATRICS, V115, P225, DOI 10.1542/peds.2004-0815D; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Crowley SJ, 2006, SLEEP, V29, P1632, DOI 10.1093/sleep/29.12.1632; Crowley SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112199; CZEISLER CA, 1995, CIBA F SYMP, V183, P254; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Dales RJ, 1941, PEDAGOG SEMIN J GEN, V58, P161; Daniel LC, 2005, SLEEP, V28, pA102; Gooneratne NS, 2003, J PINEAL RES, V34, P88, DOI 10.1034/j.1600-079X.2003.02945.x; Hartman VA, 2011, SLEEP, V34, pA272; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Jenni OG, 2006, CURR OPIN PSYCHIATR, V19, P282, DOI 10.1097/01.yco.0000218599.32969.03; Jenni OG, 2005, PEDIATRICS S, V115, P204; Kawinska A, 2005, J BIOL RHYTHM, V20, P451, DOI 10.1177/0748730405280248; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; KOCH P, 1984, ACTA PAEDIATR SCAND, V73, P667, DOI 10.1111/j.1651-2227.1984.tb09993.x; Komada Y, 2012, SLEEP MED, V13, P107, DOI 10.1016/j.sleep.2011.10.017; Kurdziel L, 2013, P NATL ACAD SCI USA, V110, P17267, DOI 10.1073/pnas.1306418110; Lassonde J, 2013, SLEEP, V36, pA342; LeBourgeois MK, 2013, MIND BRAIN EDUC, V7, P234, DOI 10.1111/mbe.12032; LeBourgeois MK, 2013, J BIOL RHYTHM, V28, P322, DOI 10.1177/0748730413506543; LOZOFF B, 1985, PEDIATRICS, V75, P477; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Mason TBA, 2005, J PEDIATR-US, V147, P388, DOI 10.1016/j.jpeds.2005.06.042; Miller AL, 2014, J SLEEP RES; Pierpoint LA, 2014, SLEEP, V37, pA10; Sakashita Y, 1995, JAPANESE J MED PSYCH, V4, P27; Simpkin CT, 2014, J SLEEP RES, V23, P397, DOI 10.1111/jsr.12142; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Tikotzky L, 2001, J CLIN CHILD PSYCHOL, V30, P581, DOI 10.1207/S15374424JCCP3004_13; U.S. Department of Health and Human Services Website, 2008, WORK MOTH CHILD CAR; van der Lely S, 2015, J ADOLESCENT HEALTH, V56, P113, DOI 10.1016/j.jadohealth.2014.08.002; Ward TM, 2008, J PEDIATR PSYCHOL, V33, P666, DOI 10.1093/jpepsy/jsm102; WEISSBLUTH M, 1995, SLEEP, V18, P82, DOI 10.1093/sleep/18.2.82; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; Wood B, 2013, APPL ERGON, V44, P237, DOI 10.1016/j.apergo.2012.07.008; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039	55	30	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125181	10.1371/journal.pone.0125181	http://dx.doi.org/10.1371/journal.pone.0125181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915066	Green Published, gold, Green Accepted			2022-12-26	WOS:000353659100105
J	Li, N; Peng, W; Shi, JQ; Wang, XF; Liu, GH; Wang, HZ				Li, Na; Peng, Wei; Shi, Jiaqin; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong			The Natural Variation of Seed Weight Is Mainly Controlled by Maternal Genotype in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENETIC-STRUCTURE; CELL ELONGATION; SIZE; ASSOCIATION; LINKAGE; TRAITS; MARKER; GROWTH; YIELD	Seed weight is a very important and complex trait in rapeseed (Brassica napus L.). The seed weight of rapeseed shows great variation in its natural germplasm resources; however, the morphological, cytological and genetic causes of this variation have remained unclear. In the present study, nine highly pure inbred rapeseed lines with large seed weight variation and different genetic backgrounds were selected for morphological, cytological and genetic studies on seed weight. The results showed the following: (1) Seed weight showed an extremely significant correlation and coordinated variation with seed size (including seed diameter, seed surface area and seed volume), but it showed no significant correlation with bulk density, which suggests that seed weight is determined by size rather than bulk density. (2) Seed weight showed a higher correlation with the cell numbers of seed coats and cotyledons than the cell sizes of seed coats and cotyledons, which suggests that cell number is more tightly correlated with final seed weight. (3) Seed weight was mainly controlled by the maternal genotype, with little or no xenia and cytoplasmic effects. This is the first report on the morphological and cytological causes of seed weight natural variation in rapeseed. We concluded that the natural variation of seed weight is mainly controlled by maternal genotype. This finding lays a foundation for genetic and breeding studies of seed weight in rapeseed and opens a new field of research on the regulation of seed traits in plants.	[Li, Na; Peng, Wei; Shi, Jiaqin; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Hubei Province, Peoples R China; [Peng, Wei] Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei Province, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Hubei University	Shi, JQ (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Hubei Province, Peoples R China.	shijiaqin@caas.cn		Li, Na/0000-0001-5311-2418	National High Technology Research and Development Program of China [2012AA101107, 2011AA10A104]; National Science Foundation of China [31101181]; Rapeseed Industry Technology System [CARS-13]; Hubei Agricultural Science and Technology Innovation Center of China; Core Research Budget of the Non-profit Governmental Research Institution [1610172014001]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Rapeseed Industry Technology System; Hubei Agricultural Science and Technology Innovation Center of China; Core Research Budget of the Non-profit Governmental Research Institution	This work was supported by the National High Technology Research and Development Program (2012AA101107 and 2011AA10A104) of China, GHL; the National Science Foundation (31101181) of China, JQS; the Rapeseed Industry Technology System (CARS-13), HZW; the Hubei Agricultural Science and Technology Innovation Center of China, JQS; Core Research Budget of the Non-profit Governmental Research Institution (1610172014001), XFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski NM, 2009, P NATL ACAD SCI USA, V106, P20115, DOI 10.1073/pnas.0907024106; Ali N, 2003, PAK J BOT, V35, P167; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; BODNARYK RP, 1991, CAN J PLANT SCI, V71, P397, DOI 10.4141/cjps91-055; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cong Z, 1996, THESIS CHINA AGR U; Culcuoglu E, 2002, ENERG SOURCE, V24, P329, DOI 10.1080/00908310252888709; Fang WJ, 2012, PLANT J, V70, P929, DOI 10.1111/j.1365-313X.2012.04907.x; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; GROCHOWSKI L, 1995, ACTA SOC BOT POL, V64, P175, DOI 10.5586/asbp.1995.025; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Hu ZY, 2009, PLANT CELL REP, V28, P541, DOI 10.1007/s00299-008-0654-2; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Lemontey C, 2000, J EXP BOT, V51, P167, DOI 10.1093/jexbot/51.343.167; Li HT, 2013, THEOR APPL GENET, V126, P937, DOI 10.1007/s00122-012-2027-z; Li N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-114; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; MILLET E, 1984, J CEREAL SCI, V2, P31, DOI 10.1016/S0733-5210(84)80005-3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Ohto MA, 2009, SEX PLANT REPROD, V22, P277, DOI 10.1007/s00497-009-0116-1; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; SAS Institute Inc, 2000, C SAS STAT US GUID V; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; STANLEY DW, 1976, CAN I FOOD SC TECH J, V9, P54, DOI 10.1016/S0315-5463(76)73612-5; Sundaresan V, 2005, P NATL ACAD SCI USA, V102, P17887, DOI 10.1073/pnas.0509021102; Tsuge T, 1996, DEVELOPMENT, V122, P1589; TSUKAYA H, 1993, DEVELOPMENT, V118, P751; Wang XF, 2010, EUPHYTICA, V173, P17, DOI 10.1007/s10681-009-0062-x; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu J, 2001, CHINESE J RICE SCI, V16, P6; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZHU J, 1994, THEOR APPL GENET, V89, P153, DOI 10.1007/BF00225135; Zhu Jun, 1996, Acta Genetica Sinica, V23, P56	42	15	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125360	10.1371/journal.pone.0125360	http://dx.doi.org/10.1371/journal.pone.0125360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915862	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100124
J	Naclerio, F; Larumbe-Zabala, E; Cooper, R; Allgrove, J; Earnest, CP				Naclerio, Fernando; Larumbe-Zabala, Eneko; Cooper, Robert; Allgrove, Judith; Earnest, Conrad P.			A Multi-Ingredient Containing Carbohydrate, Proteins L-Glutamine and L-Carnitine Attenuates Fatigue Perception with No Effect on Performance, Muscle Damage or Immunity in Soccer Players	PLOS ONE			English	Article							INTERMITTENT SPRINT PERFORMANCE; EXERCISE; RECOVERY; MATCH; SUPPLEMENTATION; COINGESTION; INGESTION; RESPONSES; MARKERS; STRESS	We investigated the effects of ingesting a multi-ingredient (53g carbohydrate, 14.5g whey protein, 5g glutamine, 1.5g L-carnitine-L-tartrate) supplement, carbohydrate only, or placebo on intermittent performance, perception of fatigue, immunity, and functional and metabolic markers of recovery. Sixteen amateur soccer players ingested their respective treatments before, during and after performing a 90-min intermittent repeated sprint test. Primary outcomes included time for a 90-min intermittent repeated sprint test (IRS) followed by eleven 15 m sprints. Measurements included creatine kinase, myoglobin, interleukine-6, Neutrophil; Lymphocytes and Monocyte before (pre), immediately after (post), 1h and 24h after exercise testing period. Overall, time for the IRS and 15 m sprints was not different between treatments. However, the perception of fatigue was attenuated (P<0.001) for the multi-ingredient (15.9 +/- 1.4) vs. placebo (17.8 +/- 1.4) but not for the carbohydrate (17.0 +/- 1.9) condition. Several changes in immune/inflammatory indices were noted as creatine kinase peaked at 24h while Interleukin-6 and myoglobin increased both immediately after and at 1h compared with baseline (P<0.05) for all three conditions. However, Myoglobin (P<0.05) was lower 1h post-exercise for the multi-ingredient (241.8 +/- 142.6 ng.ml(-1)) and CHO (265.4 +/- 187.8 ng.ml(-1)) vs. placebo (518.6 +/- 255.2 ng.ml(-1)). Carbohydrate also elicited lower neutrophil concentrations vs. multi-ingredient (3.9 +/- 1.5 10(9)/L vs. 4.9 +/- 1.8 10(9)/L, P = 0.016) and a reduced (P<0.05) monocytes count (0.36 +/- 0.09 10(9)/L) compared to both multi-ingredient (0.42 +/- 0.09 10(9)/L) and placebo (0.42 +/- 0.12 10(9)/L). In conclusion, multi-ingredient and carbohydrate supplements did not improve intermittent performance, inflammatory or immune function. However, both treatments did attenuate serum myoglobin, while only carbohydrate blunted post-exercise leukocytosis.	[Naclerio, Fernando; Cooper, Robert] Univ Greenwich, Ctr Sport Sci & Human Performance, Medway, England; [Larumbe-Zabala, Eneko] Texas Tech Univ, Hlth Sci Ctr, Clin Res Inst, Lubbock, TX 79430 USA; [Allgrove, Judith] Univ Kingston, Fac Sci Engn & Comp, London, England; [Earnest, Conrad P.] Woodbolt Int, Res, College Stn, TX USA; [Earnest, Conrad P.] Texas A&M Univ, College Stn, TX USA	University of Greenwich; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Kingston University; Texas A&M University System; Texas A&M University College Station	Naclerio, F (corresponding author), Univ Greenwich, Ctr Sport Sci & Human Performance, Medway, England.	f.j.naclerio@gre.ac.uk	Larumbe-Zabala, Eneko/I-1648-2013; Naclerio, Fernando/G-4407-2013; Earnest, Conrad P./M-6849-2017; Larumbe-Zabala, Eneko/I-7519-2019	Larumbe-Zabala, Eneko/0000-0002-8949-0602; Naclerio, Fernando/0000-0001-7405-4894; Earnest, Conrad P./0000-0002-6546-1268; Larumbe-Zabala, Eneko/0000-0002-8949-0602	Maxinutrition GlaxoSmithKline	Maxinutrition GlaxoSmithKline(GlaxoSmithKline)	Maxinutrition GlaxoSmithKline provided joint funding for the development of the project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghannam AF, 2011, APPL PHYSIOL NUTR ME, V36, P748, DOI [10.1139/h11-097, 10.1139/H11-097]; Ascensao A, 2008, CLIN BIOCHEM, V41, P841, DOI 10.1016/j.clinbiochem.2008.04.008; Bassini-Cameron A, 2008, BRIT J SPORT MED, V42, P260, DOI 10.1136/bjsm.2007.040378; Betts J, 2007, J SPORT SCI, V25, P1449, DOI 10.1080/02640410701213459; Bianco A, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-25; Bishop DJ, 2012, CLIN EXP PHARMACOL P, V39, P836, DOI 10.1111/j.1440-1681.2012.05735.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Castell LM, 1996, EUR J APPL PHYSIOL O, V73, P488, DOI 10.1007/BF00334429; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper R, 2014, EUR J SPORT SCI, V14, P353, DOI 10.1080/17461391.2013.813972; Darvishi L, 2013, INT J PREVENTIVE MED, V4, pS68; Edwards AM, 2009, SPORTS MED, V39, P1, DOI 10.2165/00007256-200939010-00001; Erdman KA, 2007, CLIN J SPORT MED, V17, P458, DOI 10.1097/JSM.0b013e31815aed33; Gleeson M, 2006, ADV SPORT EXERCISE S, P115; Highton J, 2013, J SPORT SCI, V31, P361, DOI 10.1080/02640414.2012.735370; Howatson G, 2008, SPORTS MED, V38, P483, DOI 10.2165/00007256-200838060-00004; Ivy JL, 2002, J APPL PHYSIOL, V93, P1337, DOI 10.1152/japplphysiol.00394.2002; Kirksey B, 1999, J STRENGTH COND RES, V13, P148; Kreider RB, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-7; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1165, DOI 10.1249/01.mss.0000222845.89262.cd; Lancaster GI, 2006, ADV SPORT EXERCISE S, P205; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Magalhaes J, 2010, EUR J APPL PHYSIOL, V108, P39, DOI 10.1007/s00421-009-1161-z; Maughan RJ, 2011, J SPORT SCI, V29, pS57, DOI 10.1080/02640414.2011.587446; McLellan TM, 2014, SPORTS MED, V44, P535, DOI 10.1007/s40279-013-0133-y; Moreira A, 2007, EUR J CLIN NUTR, V61, P443, DOI 10.1038/sj.ejcn.1602549; Naclerio F, 2014, APPL PHYSIOL NUTR ME, V39, P1151, DOI 10.1139/apnm-2013-0556; Nedelec M, 2013, SPORTS MED, V43, P9, DOI 10.1007/s40279-012-0002-0; Nedelec M, 2012, SPORTS MED, V42, P997, DOI 10.2165/11635270-000000000-00000; Nicholas CW, 2000, J SPORT SCI, V18, P97, DOI 10.1080/026404100365162; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Nieman DC, 2006, J SPORT SCI, V24, P763, DOI 10.1080/02640410500482982; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2011, J EXP BIOL, V214, P337, DOI 10.1242/jeb.048074; Rebouche CJ, 2004, ANN NY ACAD SCI, P1033; Sasaki E, 2013, LUMINESCENCE, V28, P442, DOI 10.1002/bio.2474; Saunders MJ, 2007, INT J SPORT NUTR EXE, V17, pS87, DOI 10.1123/ijsnem.17.s1.s87; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Spiering BA, 2007, J STRENGTH COND RES, V21, P259, DOI 10.1519/00124278-200702000-00046; Thiago Gomes H, 2012, SKELETAL MUSCLE MYOG, P105; Tipton KD, 2004, J SPORT SCI, V22, P65, DOI 10.1080/0264041031000140554; Volek JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE474, DOI 10.1152/ajpendo.00277.2001; Wall BT, 2011, J PHYSIOL-LONDON, V589, P963, DOI 10.1113/jphysiol.2010.201343; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Williams C, 2006, J SPORT SCI, V24, P687, DOI 10.1080/02640410500482628	46	20	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125188	10.1371/journal.pone.0125188	http://dx.doi.org/10.1371/journal.pone.0125188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915424	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100106
J	Wadewitz, P; Hammerschmidt, K; Battaglia, D; Witt, A; Wolf, F; Fischer, J				Wadewitz, Philip; Hammerschmidt, Kurt; Battaglia, Demian; Witt, Annette; Wolf, Fred; Fischer, Julia			Characterizing Vocal Repertoires-Hard vs. Soft Classification Approaches	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; ACOUSTIC STRUCTURE; BABOONS; CALLS; COMMUNICATION; FEATURES; MONKEYS; URSINUS; VOCALIZATIONS; RESPONSES	To understand the proximate and ultimate causes that shape acoustic communication in animals, objective characterizations of the vocal repertoire of a given species are critical, as they provide the foundation for comparative analyses among individuals, populations and taxa. Progress in this field has been hampered by a lack of standard in methodology, however. One problem is that researchers may settle on different variables to characterize the calls, which may impact on the classification of calls. More important, there is no agreement how to best characterize the overall structure of the repertoire in terms of the amount of gradation within and between call types. Here, we address these challenges by examining 912 calls recorded from wild chacma baboons (Papio ursinus). We extracted 118 acoustic variables from spectrograms, from which we constructed different sets of acoustic features, containing 9, 38, and 118 variables; as well 19 factors derived from principal component analysis. We compared and validated the resulting classifications of k-means and hierarchical clustering. Datasets with a higher number of acoustic features lead to better clustering results than datasets with only a few features. The use of factors in the cluster analysis resulted in an extremely poor resolution of emerging call types. Another important finding is that none of the applied clustering methods gave strong support to a specific cluster solution. Instead, the cluster analysis revealed that within distinct call types, subtypes may exist. Because hard clustering methods are not well suited to capture such gradation within call types, we applied a fuzzy clustering algorithm. We found that this algorithm provides a detailed and quantitative description of the gradation within and between chacma baboon call types. In conclusion, we suggest that fuzzy clustering should be used in future studies to analyze the graded structure of vocal repertoires. Moreover, the use of factor analyses to reduce the number of acoustic variables should be discouraged.	[Wadewitz, Philip; Hammerschmidt, Kurt; Fischer, Julia] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Wadewitz, Philip; Battaglia, Demian; Witt, Annette; Wolf, Fred] Max Planck Inst Dynam & Self Org, Theoret Neurophys, Gottingen, Germany; [Wadewitz, Philip; Battaglia, Demian; Witt, Annette; Wolf, Fred; Fischer, Julia] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Battaglia, Demian] Inst Syst Neurosci, Theoret Neurosci Grp, Marseille, France	Deutsches Primatenzentrum (DPZ); Max Planck Society	Wadewitz, P (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	pwadewitz@dpz.eu	Battaglia, Demian/C-1281-2017; Fischer, Julia/B-6674-2008	Battaglia, Demian/0000-0003-2021-7920; Fischer, Julia/0000-0002-5807-0074; Wolf, Fred/0000-0002-7068-3762	German Federal Ministry of Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen [01GQ1005C]	German Federal Ministry of Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen(Federal Ministry of Education & Research (BMBF))	The authors acknowledge financial support by the German Federal Ministry of Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen under Grant No. 01GQ1005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, ANIM BEHAV, V72, P643, DOI 10.1016/j.anbehav.2005.11.017; Battaglia D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00013; BEZDEK JC, 1974, J MATH BIOL, V1, P57, DOI 10.1007/BF02339490; Boersma P., 2001, GLOT INT, V5, P341; Bouchet H, 2012, J COMP PSYCHOL, V126, P45, DOI 10.1037/a0025018; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; EQUIHUA M, 1990, J ECOL, V78, P519, DOI 10.2307/2261127; Fischer J, 2000, P ROY SOC B-BIOL SCI, V267, P2317, DOI 10.1098/rspb.2000.1285; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ANIM BEHAV, V61, P925, DOI 10.1006/anbe.2000.1687; FISCHER J, 1995, ETHOLOGY, V101, P51, DOI 10.1111/j.1439-0310.1995.tb00345.x; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; FORREST TG, 1994, AM ZOOL, V34, P644; Fuller JL, 2014, AM J PRIMATOL, V76, P203, DOI 10.1002/ajp.22223; Green S, 1975, PRIMATE BEHAV, P1, DOI DOI 10.1016/B978-0-12-534004-5.50006-3; Gros-Louis JJ, 2008, INT J PRIMATOL, V29, P641, DOI 10.1007/s10764-008-9263-8; Gustison ML, 2012, PHILOS T R SOC B, V367, P1847, DOI 10.1098/rstb.2011.0218; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hammerschmidt K, 1998, ETHOLOGY, V104, P203; Hammerschmidt K, 1995, INDIVIDUAL DIFFERENC; Keenan S, 2013, ANIM BEHAV, V85, P109, DOI 10.1016/j.anbehav.2012.10.014; Kershenbaum A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077671; Kitchen DM, 2005, ANIM COGN, V8, P1, DOI 10.1007/s10071-004-0222-2; Laiolo P, 2000, J ORNITHOL; Maciej P, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-58; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MARLER P, 1970, FOLIA PRIMATOL, V13, P81, DOI 10.1159/000155312; Marler P., 1976, GROWING POINTS ETHOL, P239; Marler P., 1975, ROLE SPEECH LANG, V11; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; MCKUSICK VA, 1969, PERSPECT BIOL MED, V12, P298; Mizutani E, 1997, NEURO FUZZY SOFT COM, DOI DOI 10.1109/TAC.1997.633847; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Papworth S, 2008, BIOL LETTERS, V4, P472, DOI 10.1098/rsbl.2008.0299; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; ROWELL T. E., 1962, PROC ZOOL SOC LONDON, V138, P279; Shulezhko TS, 2008, RUSS J MAR BIOL+, V34, P118, DOI 10.1134/S1063074008020053; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tomasello M, 2002, COGNITIVE ANIMAL, P293; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; WINTER P, 1966, EXP BRAIN RES, V1, P359; Xu D., 2008, APPL FUZZY LOGIC BIO; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zadeh LA, 2008, INFORM SCIENCES, V178, P2751, DOI 10.1016/j.ins.2008.02.012	51	41	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125785	10.1371/journal.pone.0125785	http://dx.doi.org/10.1371/journal.pone.0125785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915039	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100147
J	Najyb, O; Brissette, L; Rassart, E				Najyb, Ouafa; Brissette, Louise; Rassart, Eric			Apolipoprotein D Internalization Is a Basigin-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein D (apoD); basigin; internalization; cyclophilin A; human neuroblastoma	MATRIX-METALLOPROTEINASE INDUCER; LIPOCALIN PROTEIN FAMILY; ARACHIDONIC-ACID; MESSENGER-RNA; GROWTH-FACTOR; IMMUNOGLOBULIN SUPERFAMILY; MOLECULAR CHARACTERIZATION; EXPRESSION PATTERN; CYCLOPHILIN-A; MICE LACKING	Background: ApoD appears to be a protein with multiple functions that could influence inflammatory and oxidative pathways to prevent neurotoxicity. Results: The internalization of apoD is mediated by a specific cell surface receptor. Conclusion: Basigin, a transmembrane glycoprotein, is implicated in the internalization process of apoD. Significance: This is the first evidence that a specific receptor is involved in apoD internalization. Apolipoprotein D (apoD), a member of the lipocalin family, is a 29-kDa secreted glycoprotein that binds and transports small lipophilic molecules. Expressed in several tissues, apoD is up-regulated under different stress stimuli and in a variety of pathologies. Numerous studies have revealed that overexpression of apoD led to neuroprotection in various mouse models of acute stress and neurodegeneration. This multifunctional protein is internalized in several cells types, but the specific internalization mechanism remains unknown. In this study, we demonstrate that the internalization of apoD involves a specific cell surface receptor in 293T cells, identified as the transmembrane glycoprotein basigin (BSG, CD147); more particularly, its low glycosylated form. Our results show that internalized apoD colocalizes with BSG into vesicular compartments. Down-regulation of BSG disrupted the internalization of apoD in cells. In contrast, overexpression of basigin in SH-5YSY cells, which poorly express BSG, restored the uptake of apoD. Cyclophilin A, a known ligand of BSG, competitively reduced apoD internalization, confirming that BSG is a key player in the apoD internalization process. In summary, our results demonstrate that basigin is very likely the apoD receptor and provide additional clues on the mechanisms involved in apoD-mediated functions, including neuroprotection.	[Najyb, Ouafa; Rassart, Eric] Univ Quebec, Ctr Biomed, Dept Sci Biol, Lab Biol Mol, Montreal, PQ H3C 398, Canada; [Brissette, Louise] Univ Quebec, Ctr Biomed, Dept Sci Biol, Lab Metab Lipoprot, Montreal, PQ H3C 398, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Rassart, E (corresponding author), Univ Quebec, Ctr Biomed, Dept Sci Biol, Lab Biol Mol, Succursale Ctr Ville, Montreal, PQ H3C 398, Canada.	rassart.eric@uqam.ca			Canadian Institutes of Health Research [MOP-15677]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-15677.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; AYRAULTJARRIER M, 1963, B SOC CHIM BIOL, V45, P703; Bajo-Graneras R, 2011, GLIA, V59, P1551, DOI 10.1002/glia.21200; BAJZER Z, 1989, J BIOL CHEM, V264, P13623; Beesley AH, 2008, BRIT J HAEMATOL, V142, P1000, DOI 10.1111/j.1365-2141.2008.07296.x; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; BISWAS C, 1995, CANCER RES, V55, P434; BLAIS Y, 1994, INT J CANCER, V59, P400, DOI 10.1002/ijc.2910590319; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Brodeur MR, 2008, J BONE MINER RES, V23, P326, DOI 10.1359/JBMR.071022; CABRAL JHM, 1995, FEBS LETT, V366, P53, DOI 10.1016/0014-5793(95)00484-Q; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Caudroy S, 2002, CLIN EXP METASTAS, V19, P697, DOI 10.1023/A:1021350718226; Chen HM, 2010, CLIN EXP METASTAS, V27, P557, DOI 10.1007/s10585-010-9345-9; Choi EY, 2002, EXP MOL MED, V34, P391, DOI 10.1038/emm.2002.56; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; DRAYNA D, 1986, J BIOL CHEM, V261, P6535; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Fan QW, 1998, NEUROSCI RES, V30, P53, DOI 10.1016/S0168-0102(97)00119-3; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fukamachi K, 2002, J BIOL CHEM, V277, P43549, DOI 10.1074/jbc.C200502200; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Gioiosa L, 2008, BEHAV BRAIN RES, V188, P255, DOI 10.1016/j.bbr.2007.11.002; Guo HM, 1997, J BIOL CHEM, V272, P24; Heo S, 2012, NEUROCHEM INT, V61, P702, DOI 10.1016/j.neuint.2012.07.006; Hino M, 2003, SURG TODAY, V33, P486, DOI 10.1007/s10595-002-2538-4; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Huang W, 2013, BIOCHEM J, V449, P437, DOI 10.1042/BJ20120343; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Jia L, 2006, IUBMB LIFE, V58, P209, DOI 10.1080/15216540600719580; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kosugi T, 2015, NEPHROL DIAL TRANSPL, V30, P1097, DOI 10.1093/ndt/gfu302; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Leung WCY, 2004, CIRC RES, V95, P179, DOI 10.1161/01.RES.0000135482.74178.14; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nahalkova J, 2010, NEUROCHEM INT, V56, P67, DOI 10.1016/j.neuint.2009.09.003; Naruhashi K, 1997, BIOCHEM BIOPH RES CO, V236, P733, DOI 10.1006/bbrc.1997.6993; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Oakley AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034057; Perdomo G, 2009, AGING-US, V1, P17; PETERS K, 1977, ANNU REV BIOCHEM, V46, P523, DOI 10.1146/annurev.bi.46.070177.002515; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; PROVOST PR, 1991, J LIPID RES, V32, P1959; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Rickhag M, 2008, J CEREBR BLOOD F MET, V28, P551, DOI 10.1038/sj.jcbfm.9600552; Ruiz M, 2013, FEBS J, V280, P3928, DOI 10.1111/febs.12394; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; Sasaki Y, 2009, J BIOL CHEM, V284, P872, DOI 10.1074/jbc.M807185200; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Silva JP, 2010, ADV EXP MED BIOL, V706, P59; Siwik DA, 2008, J MOL CELL CARDIOL, V44, P210, DOI 10.1016/j.yjmcc.2007.07.054; SMITH KM, 1990, J LIPID RES, V31, P995; Soiland H, 2007, CELL ONCOL, V29, P195; Sun JX, 2001, CANCER RES, V61, P2276; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Thomas EA, 2003, PROSTAG LEUKOTR ESS, V69, P421, DOI 10.1016/j.plefa.2003.08.014; Thomas EA, 2003, CURR MOL MED, V3, P408, DOI 10.2174/1566524033479681; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Tribouillard-Tanvier D, 2012, J BIOL CHEM, V287, P4628, DOI 10.1074/jbc.M111.269480; Tsukamoto K, 2013, P NATL ACAD SCI USA, V110, P17023, DOI 10.1073/pnas.1315986110; VIEIRA AV, 1995, MOL REPROD DEV, V42, P443, DOI 10.1002/mrd.1080420411; Vogt M, 2001, J MOL RECOGNIT, V14, P79, DOI 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.0.CO;2-4; Waldow T, 2009, J SURG RES, V152, P198, DOI 10.1016/j.jss.2008.03.014; XU Q, 1992, J BIOL CHEM, V267, P11968; Yoon YW, 2005, ATHEROSCLEROSIS, V180, P37, DOI 10.1016/j.atherosclerosis.2004.11.021; Yuasa J, 2001, ANDROLOGIA, V33, P293, DOI 10.1046/j.1439-0272.2001.00448.x; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	85	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16077	16087		10.1074/jbc.M115.644302	http://dx.doi.org/10.1074/jbc.M115.644302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25918162	hybrid, Green Published			2022-12-26	WOS:000356930100014
J	Christensen, MG; Fagerberg, SK; de Bruijn, PI; Bjaelde, RG; Jakobsen, H; Leipziger, J; Skals, M; Praetorius, HA				Christensen, Mette G.; Fagerberg, Steen K.; de Bruijn, Pauline I.; Bjaelde, Randi G.; Jakobsen, Helle; Leipziger, Jens; Skals, Marianne; Praetorius, Helle A.			[Ca2+](i) Oscillations and IL-6 Release Induced by alpha-Hemolysin from Escherichia coli Require P2 Receptor Activation in Renal Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION INTEGRITY; EXTRACELLULAR ATP; TRANSPORT; P2Y(2); PORE; AMPLIFICATION; ERYTHROCYTES; INHIBITION; EXPRESSION; INFECTION	Urinary tract infections are commonly caused by alpha-hemolysin (HlyA)-producing Escherichia coli. In erythrocytes, the cytotoxic effect of HlyA is strongly amplified by P2X receptors, which are activated by extracellular ATP released from the cytosol of the erythrocytes. In renal epithelia, HlyA causes reversible [Ca2+](i) oscillations, which trigger interleukin-6 (IL-6) and IL-8 release. We speculate that this effect is caused by HlyA-induced ATP release from the epithelial cells and successive P2 receptor activation. Here, we demonstrate that HlyA-induced [Ca2+](i) oscillations in renal epithelia were completely prevented by scavenging extracellular ATP. In accordance, HlyA was unable to inflict any [Ca2+](i) oscillations in 132-1N1 cells, which lack P2R completely. After transfecting these cells with the hP2Y(2) receptor, HlyA readily triggered [Ca2+](i) oscillations, which were abolished by P2 receptor antagonists. Moreover, HlyA-induced [Ca2+](i) oscillations were markedly reduced in medullary thick ascending limbs isolated from P2Y(2) receptor-deficient mice compared with wild type. Interestingly, the following HlyA-induced IL-6 release was absent in P2Y(2) receptor-deficient mice. This suggests that HlyA induces ATP release from renal epithelia, which via P2Y(2) receptors is the main mediator of HlyA-induced [Ca2+](i) oscillations and IL-6 release. This supports the notion that ATP signaling occurs early during bacterial infection and is a key player in the further inflammatory response.	[Christensen, Mette G.; Fagerberg, Steen K.; de Bruijn, Pauline I.; Bjaelde, Randi G.; Jakobsen, Helle; Leipziger, Jens; Skals, Marianne; Praetorius, Helle A.] Aarhus Univ, Dept Biomed, Physiol, DK-8000 Aarhus C, Denmark	Aarhus University	Praetorius, HA (corresponding author), Aarhus Univ, Ole Worms Alle 3,Build 1170, DK-8000 Aarhus C, Denmark.	hp@biomed.au.dk		Leipziger, Jens/0000-0002-6719-7034; Praetorius, Helle/0000-0002-0970-5061; Christensen, Mette G./0000-0001-9249-2070; Fagerberg, Steen/0000-0001-5846-0155	Danish Council for Independent Research, Medical Sciences [DFF-1331-00203A, 12-125828]; Novo Nordisk Fonden [0505892]; Lundbeck Foundation [R100-A9482]	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden)	The work was supported by The Danish Council for Independent Research, Medical Sciences Grants DFF-1331-00203A and 12-125828, Novo Nordisk Fonden Grant 0505892, and Lundbeck Foundation Grant R100-A9482.	Bailey MA, 2000, KIDNEY INT, V58, P1893, DOI 10.1111/j.1523-1755.2000.00361.x; Baqi Y, 2011, J MED CHEM, V54, P817, DOI 10.1021/jm1012193; Becker MD, 2000, INVEST OPHTH VIS SCI, V41, P1812; Benson M, 1996, J INFECT DIS, V174, P1080, DOI 10.1093/infdis/174.5.1080; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BHAKDI S, 1988, EUR J EPIDEMIOL, V4, P135, DOI 10.1007/BF00144740; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Bjaelde RG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00238; Bucker R, 2011, J INFECT DIS, V204, P1283, DOI 10.1093/infdis/jir504; BULLEN JJ, 1972, BMJ-BRIT MED J, V1, P69, DOI 10.1136/bmj.1.5792.69; CAVALIERI SJ, 1984, MICROBIOL REV, V48, P326, DOI 10.1128/MMBR.48.4.326-343.1984; Chauffier K, 2012, JOINT BONE SPINE, V79, P604, DOI 10.1016/j.jbspin.2011.12.013; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hejl JL, 2013, PFLUG ARCH EUR J PHY, V465, P529, DOI 10.1007/s00424-012-1174-z; Ihara H, 2005, BIOCHEM BIOPH RES CO, V326, P329, DOI 10.1016/j.bbrc.2004.11.037; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Khalil A, 2000, CLIN EXP IMMUNOL, V122, P200, DOI 10.1046/j.1365-2249.2000.01377.x; Kishore BK, 1995, AM J PHYSIOL-RENAL, V269, pF863, DOI 10.1152/ajprenal.1995.269.6.F863; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; Kruse R, 2012, J UROLOGY, V188, P2419, DOI 10.1016/j.juro.2012.07.095; Larsen CK, 2011, J MEMBRANE BIOL, V244, P131, DOI 10.1007/s00232-011-9406-2; LEE J, 1995, J IMMUNOL, V155, P2158; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Marques RD, 2012, AM J PHYSIOL-RENAL, V302, pF487, DOI 10.1152/ajprenal.00570.2011; Masin J, 2013, INFECT IMMUN, V81, P4571, DOI 10.1128/IAI.00711-13; Munksgaard PS, 2012, CELL MICROBIOL, V14, P1904, DOI 10.1111/cmi.12021; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; ROPELE M, 1989, BIOCHIM BIOPHYS ACTA, V985, P9, DOI 10.1016/0005-2736(89)90096-5; Save S, 2010, INFECT IMMUN, V78, P3609, DOI 10.1128/IAI.00074-10; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Skals M, 2013, ACTA PHYSIOL, V209, P95, DOI 10.1111/apha.12156; Skals M, 2014, J BIOL CHEM, V289, P19098, DOI 10.1074/jbc.M114.571414; Skals M, 2011, PFLUG ARCH EUR J PHY, V462, P669, DOI 10.1007/s00424-011-1010-x; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Wood MW, 2012, J COMP PATHOL, V147, P11, DOI 10.1016/j.jcpa.2011.09.005; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14776	14784		10.1074/jbc.M115.639526	http://dx.doi.org/10.1074/jbc.M115.639526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25911098	Green Published, hybrid			2022-12-26	WOS:000355754600046
J	Ma, DC; Yoon, AJ; Faull, KF; Desharnais, R; Zemanick, ET; Porter, E				Ma, Daniel C.; Yoon, Alexander J.; Faull, Kym F.; Desharnais, Robert; Zemanick, Edith T.; Porter, Edith			Cholesteryl Esters Are Elevated in the Lipid Fraction of Bronchoalveolar Lavage Fluid Collected from Pediatric Cystic Fibrosis Patients	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; FATTY-ACID DEFICIENCY; PSEUDOMONAS-AERUGINOSA; LIPOPROTEIN ABNORMALITIES; CHRONIC RHINOSINUSITIS; PULMONARY-FUNCTION; PEPTIDE LL-37; INFLAMMATION; SPUTUM; LUNG	Background Host-derived lipids including cholesteryl esters (CEs) such as cholesteryl linoleate have emerged as important antibacterial effectors of innate immunity in the airways and cholesteryl linoleate has been found elevated in the context of inflammation. Cystic fibrosis (CF) patients suffer from chronic infection and severe inflammation in the airways. Here, we identified and quantified CEs in bronchoalveolar lavage fluid (BALF) from CF patients and non-CF disease controls, and tested whether CE concentrations are linked to the disease. Materials and Methods CEs in BALF from 6 pediatric subjects with CF and 7 pediatric subjects with non-CF chronic lung disease were quantified by mass spectral analysis using liquid chromatography coupled with tandem mass spectrometry and multiple reaction monitoring. BALFs were also examined for total lipid, total protein, albumin, and, as a marker for inflammation, human neutrophil peptide (HNP) 1-3 concentrations. Statistical analysis was conducted after log 10 transformation of the data. Results Total lipid/protein ratio was reduced in CF BALF (p = 0.018) but the concentrations of CEs, including cholesteryl linoleate, were elevated in the total lipid fraction in CF BALF compared to non-CF disease controls (p < 0.050). In addition, the concentrations of CEs and HNP1-3 correlated with one another (p < 0.050). Conclusions The data suggests that the lipid composition of BALF is altered in CF with less total lipid relative to protein but with increased CE concentrations in the lipid fraction, likely contributed by inflammation. Future longitudinal studies may reveal the suitability of CEs as a novel biomarker for CF disease activity which may provide new information on the lipid mediated pathophysiology of the disease.	[Ma, Daniel C.; Desharnais, Robert; Porter, Edith] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA; [Yoon, Alexander J.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Zemanick, Edith T.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Colorado System; University of Colorado Anschutz Medical Campus	Porter, E (corresponding author), Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA.	eporter@calstatela.edu	Zemanick, Edith/D-5260-2017; Ma, Daniel/AAG-1890-2021; Zemanick, Edith T/ABF-9455-2020	Zemanick, Edith/0000-0002-7507-9337; Ma, Daniel/0000-0002-2957-4687; Zemanick, Edith T/0000-0002-7507-9337; Desharnais, Robert/0000-0003-2874-6835	Cystic Fibrosis Foundation [PORTER12I0, ZEMANI11A0]; NIH [1SC1GM096916, K23HL114883]; NSF/DMS [1225529]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL114883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM096916] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1225529] Funding Source: National Science Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF/DMS(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study has been supported by the Cystic Fibrosis Foundation (http://www.cff.org; PORTER12I0, ZEMANI11A0), NIH (http://www.nih. gov; 1SC1GM096916 to EP, K23HL114883 to EZ), and NSF/DMS (http://www.nsf.gov; 1225529 to RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2014, J CYST FIBROS, V13, P139, DOI 10.1016/j.jcf.2013.09.007; Asmis R, 1997, J CHROMATOGR B, V691, P59, DOI 10.1016/S0378-4347(96)00436-7; Beisswenger Christoph, 2005, V86, P55, DOI 10.1159/000086651; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Booton R, 2014, CHEST, V146, P193, DOI 10.1378/chest.13-2736; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Chen CH, 2011, J MICROBIOL BIOTECHN, V21, P391, DOI 10.4014/jmb.1011.11014; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Colombo C, 2011, INT J IMMUNOPATH PH, V24, P423, DOI 10.1177/039463201102400215; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Fischer BM, 2013, AM J PHYSIOL-LUNG C, V304, pL394, DOI 10.1152/ajplung.00091.2012; Gifford AM, 2014, CURR OPIN HEMATOL, V21, P16, DOI 10.1097/MOH.0000000000000009; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kimura K, 2004, J MICROBIOL METH, V56, P331, DOI 10.1016/j.mimet.2003.10.018; Konstan Michael W, 2009, J Cyst Fibros, V8 Suppl 1, pS15, DOI 10.1016/S1569-1993(09)60006-0; Lee JT, 2014, INT FORUM ALLERGY RH, V4, P893, DOI 10.1002/alr.21404; Lee JT, 2010, AM J RHINOL ALLERGY, V24, P99, DOI 10.2500/ajra.2010.24.3444; LEVY E, 1993, AM J CLIN NUTR, V57, P573, DOI 10.1093/ajcn/57.4.573; LEVY E, 1989, J LIPID RES, V30, P1197; Martinez JG, 2009, BIOCHEM J, V419, P193, DOI 10.1042/BJ20081505; May GL, 1997, J LIPID RES, V38, P1562; Mayer-Hamblett Nicole, 2007, Proc Am Thorac Soc, V4, P370, DOI 10.1513/pats.200703-040BR; Megiorni F, 2013, J CYST FIBROS, V12, P797, DOI 10.1016/j.jcf.2013.03.007; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; Ollero M, 2011, J LIPID RES, V52, P1011, DOI 10.1194/jlr.P013722; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sagel SD, 2009, PEDIATR PULM, V44, P402, DOI 10.1002/ppul.21028; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; SLOMIANY A, 1982, BIOCHIM BIOPHYS ACTA, V710, P106, DOI 10.1016/0005-2760(82)90196-5; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Solomon GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072398; Sousa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047708; Suzuki T, 2008, INT J BIOCHEM CELL B, V40, P1348, DOI 10.1016/j.biocel.2008.01.003; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Tollin M, 2005, CELL MOL LIFE SCI, V62, P2390, DOI 10.1007/s00018-005-5260-7; Uda S, 2013, J LIPID RES, V54, P3158, DOI 10.1194/jlr.M042663; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125326	10.1371/journal.pone.0125326	http://dx.doi.org/10.1371/journal.pone.0125326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919295	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659400080
J	Sugie, K; Sugie, M; Taoka, T; Tonomura, Y; Kumazawa, A; Izumi, T; Kichikawa, K; Ueno, S				Sugie, Kazuma; Sugie, Miho; Taoka, Toshio; Tonomura, Yasuyo; Kumazawa, Aya; Izumi, Tesseki; Kichikawa, Kimihiko; Ueno, Satoshi			Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1	PLOS ONE			English	Article							SKELETAL-MUSCLE; DEGENERATION	The objective of our study was to evaluate the relation between muscle MRI findings and upper limb weakness with grip myotonia in patients with myotonic dystrophy type 1 (DM1). Seventeen patients with DM1 were evaluated by manual muscle strength testing and muscle MRI of the upper limbs. Many DM1 patients presenting with decreased grasping power frequently showed high intensity signals in the flexor digitorum profundus (FDP) muscles on T1-weighted imaging. Patients presenting with upper limb weakness frequently also showed high intensity signals in the flexor pollicis longus, abductor pollicis longus, and extensor pollicis muscles. Disturbances of the distal muscles of the upper limbs were predominant in all DM1 patients. Some DM1 patients with a prolonged disease duration showed involvement of not only distal muscles but also proximal muscles in the upper limbs. Muscle involvement of the upper limbs on MRI strongly correlated positively with the disease duration or the numbers of CTG repeats. To our knowledge, this is the first study to provide a detailed description of the distribution and severity of affected muscles of the upper limbs on MRI in patients with DM1. We conclude that muscle MRI findings are very useful for identifying affected muscles and predicting the risk of muscle weakness in the upper limbs of DM1 patients.	[Sugie, Kazuma; Sugie, Miho; Tonomura, Yasuyo; Kumazawa, Aya; Izumi, Tesseki; Ueno, Satoshi] Nara Med Univ, Sch Med, Dept Neurol, Nara, Japan; [Sugie, Miho] Nara Prefectural Rehabil Ctr, Dept Neurol, Nara, Japan; [Taoka, Toshio; Kichikawa, Kimihiko] Nara Med Univ, Sch Med, Dept Radiol, Nara, Japan	Nara Medical University; Nara Medical University	Sugie, K (corresponding author), Nara Med Univ, Sch Med, Dept Neurol, Nara, Japan.	ksugie@naramed-u.ac.jp	Taoka, Toshiaki/A-1637-2016	Taoka, Toshiaki/0000-0001-9227-0240				Andersen G, 2013, MUSCLE NERVE, V47, P409, DOI 10.1002/mus.23535; [Anonymous], [No title captured]; Bachmann G, 1996, NEURORADIOLOGY, V38, P629, DOI 10.1007/s002340050322; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; Cote C, 2011, CAN J NEUROL SCI, V38, P112, DOI 10.1017/S0317167100011148; EDWARDS RHT, 1980, BRIT MED BULL, V36, P159, DOI 10.1093/oxfordjournals.bmb.a071632; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; FUJINO H, 1991, MUSCLE NERVE, V14, P716, DOI 10.1002/mus.880140805; Hamano T, 2010, EUR NEUROL, V63, P144, DOI 10.1159/000280763; Hiba B, 2012, J MAGN RESON IMAGING, V35, P678, DOI 10.1002/jmri.22849; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kornblum C, 2006, J NEUROL, V253, P753, DOI 10.1007/s00415-006-0111-5; Kornblum C, 2010, ACTA NEUROL SCAND, V121, P131, DOI 10.1111/j.1600-0404.2009.01228.x; SCHREIBER A, 1987, PEDIATR RADIOL, V17, P495, DOI 10.1007/BF02388288; Sekul EA, 1997, NEUROLOGY, V48, P863, DOI 10.1212/WNL.48.4.863; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261	17	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0125051	10.1371/journal.pone.0125051	http://dx.doi.org/10.1371/journal.pone.0125051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25919300	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400069
J	Antony, C; Mehto, S; Tiwari, BK; Singh, Y; Natarajan, K				Antony, Cecil; Mehto, Subhash; Tiwari, Brijendra K.; Singh, Yogendra; Natarajan, Krishnamurthy			Regulation of L-type Voltage Gated Calcium Channel CACNA1S in Macrophages upon Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; PROTECTIVE IMMUNITY; ACTIVATION; PROTEIN; RESPONSES; APOPTOSIS; SURVIVAL; DIFFERENTIATION; MODULATION	We demonstrated earlier the inhibitory role played by Voltage Gated Calcium Channels (VGCCs) in regulating Mycobacterium tuberculosis (M. tb) survival and pathogenesis. In this report, we investigated mechanisms and key players that regulate the surface expression of VGCC-CACNA1S by Rv2463 and Mycobacterium tuberculosis infection in macrophages. Our earlier work identified Rv2463 to be expressed at early times post infection in macrophages that induced suppressor responses to dendritic cells and macrophages. Our results in this study demonstrate a role of MyD88 independent TLR pathway in mediating CACNA1S expression. Dissecting the role for second messengers, we show that calcium homeostasis plays a key role in CACNA1S expression during Mycobacterium tuberculosis infection. Using siRNAs against molecular sensors of calcium regulation, we show an involvement of ER associated Stromal Interaction Molecules 1 and 2 (STIM1 and STIM2), and transcription factor pCREB, towards CACNA1S expression that also involved the MyD88 independent pathway. Interestingly, reactive oxygen species played a negative role in Mycobacterium tuberculosis mediated CACNA1S expression. Further, a cross-regulation of ROS and pCREB was noted that governed CACNA1S expression. Characterizing the mechanisms governing CACNA1S expression would improve our understanding of the regulation of VGCC expression and its role in Mycobacterium tuberculosis pathogenesis during Mycobacterium tuberculosis infection.	[Antony, Cecil; Mehto, Subhash; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol, Delhi 110007, India; [Tiwari, Brijendra K.; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Antony, C (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol, Delhi 110007, India.	cecilantony.f@gmail.com; knatarajan@acbr.du.ac.in	Tiwari, Brijesh Kumar/K-6227-2013; Antony, Cecil/AFE-5951-2022; Antony, Cecil/O-7733-2017	Tiwari, Brijesh Kumar/0000-0002-4834-6831; Mehto, Subhash/0000-0002-5351-7850; Antony, Cecil/0000-0001-7622-4586	Department of Biotechnology, Ministry of Science and Technology, Government of India; ICMR Senior Research Fellowship	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); ICMR Senior Research Fellowship	This work was supported by grants to KN and YS from the Department of Biotechnology, Ministry of Science and Technology, Government of India, and CA is a recipient of the ICMR Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Azenabor AA, 2003, MED MICROBIOL IMMUN, V192, P99, DOI 10.1007/s00430-002-0164-8; Badou A, 1997, J BIOL CHEM, V272, P32411, DOI 10.1074/jbc.272.51.32411; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Balkhi MY, 2004, J LEUKOCYTE BIOL, V75, P874, DOI 10.1189/jlb.1003476; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Carmona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067277; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DOUGHERTY RW, 1986, J BIOL CHEM, V261, P4097; Faries MB, 2001, BLOOD, V98, P2489, DOI 10.1182/blood.V98.8.2489; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Grafton G, 2003, BIOCHEM PHARMACOL, V66, P2001, DOI 10.1016/j.bcp.2003.07.005; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Harris TH, 2007, INFECT IMMUN, V75, P2366, DOI 10.1128/IAI.01649-06; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liu WL, 2011, CURR OPIN INFECT DIS, V24, P254, DOI 10.1097/QCO.0b013e3283463e5b; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; MORRIS SA, 1988, MOL BIOCHEM PARASIT, V29, P213, DOI 10.1016/0166-6851(88)90076-X; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; Nejatbakhsh N, 2011, ACTA PHARMACOL SIN, V32, P741, DOI 10.1038/aps.2011.64; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; PETERSEN OH, 1994, ANNU REV PHYSIOL, V56, P297, DOI 10.1146/annurev.ph.56.030194.001501; Podinovskaia M, 2013, CELL MICROBIOL, V15, P843, DOI 10.1111/cmi.12092; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; ROSALES C, 1992, J BIOL CHEM, V267, P1443; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; Selvakumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096427; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Singhal J, 2012, J BIOL CHEM, V287, P11108, DOI 10.1074/jbc.M111.300319; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wieland H, 2006, FEMS IMMUNOL MED MIC, V47, P296, DOI 10.1111/j.1574-695X.2006.00092.x; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zheng ZL, 2002, J PHYSIOL-LONDON, V540, P397, DOI 10.1113/jphysiol.2001.013464; Zocchi MR, 1998, J IMMUNOL, V161, P2938	64	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124263	10.1371/journal.pone.0124263	http://dx.doi.org/10.1371/journal.pone.0124263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915405	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100043
J	Arntzen, MO; Karlskas, IL; Skaugen, M; Eijsink, VGH; Mathiesen, G				Arntzen, Magnus Overlie; Karlskas, Ingrid Lea; Skaugen, Morten; Eijsink, Vincent G. H.; Mathiesen, Geir			Proteomic Investigation of the Response of Enterococcus faecalis V583 when Cultivated in Urine	PLOS ONE			English	Article							VIRULENCE-RELATED GENES; STREPTOCOCCUS-SANGUIS; NUCLEOTIDE-SEQUENCE; SURFACE-PROTEINS; SIGNAL PEPTIDES; STRESS-RESPONSE; IDENTIFICATION; EXPRESSION; BINDING; VANCOMYCIN	Enterococcus faecalis is a robust bacterium, which is able to survive in and adapt to hostile environments such as the urinary tract and bladder. In this label-free quantitative proteomic study based on MaxQuant LFQ algorithms, we identified 127 proteins present in the secretome of the clinical vancomycin-resistant isolate E. faecalis V583 and we compared proteins secreted in the initial phase of cultivation in urine with the secretome during cultivation in standard laboratory medium, 2xYT. Of the 54 identified proteins predicted to be secreted, six were exclusively found after cultivation in urine including the virulence factor EfaA ("endocarditis specific antigen") and its homologue EF0577 ("adhesion lipoprotein"). These two proteins are both involved in manganese transport, known to be an important determinant of colonization and infection, and may additionally function as adhesins. Other detected urine-specific proteins are involved in peptide transport (EF0063 and EF3106) and protease inhibition (EF3054). In addition, we found an uncharacterized protein (EF0764), which had not previously been linked to the adaptation of V583 to a urine environment, and which is unique to E. faecalis. Proteins found in both environments included a histone-like protein, EF1550, that was up-regulated during cultivation in urine and that has a homologue in streptococci (HlpA) known to be involved in bacterial adhesion to host cells. Up-regulated secreted proteins included autolysins. These results from secretome analyses are largely compatible with previously published data from transcriptomics studies. All in all, the present data indicate that transport, in particular metal transport, adhesion, cell wall remodelling and the unknown function carried out by the unique EF0764 are important for enterococcal adaptation to the urine environment. These results provide a basis for a more targeted exploration of novel proteins involved in the adaptability and pathogenicity of E. faecalis.	[Arntzen, Magnus Overlie; Karlskas, Ingrid Lea; Skaugen, Morten; Eijsink, Vincent G. H.; Mathiesen, Geir] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Norwegian University of Life Sciences	Arntzen, MO (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	magnus.arntzen@nmbu.no	Arntzen, Magnus Ø/N-6983-2016	Arntzen, Magnus Ø/0000-0002-1803-727X	FUGE programme of the Norwegian Research Council [183627, 183637]	FUGE programme of the Norwegian Research Council	This work was funded by the FUGE programme of the Norwegian Research Council, grant numbers 183627 & 183637. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Abranches J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064875; Abrantes MC, 2013, INFECT IMMUN, V81, P935, DOI 10.1128/IAI.06377-11; Abrantes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026519; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Benachour A, 2009, CAN J MICROBIOL, V55, P967, DOI [10.1139/W09-052, 10.1139/w09-052]; Bohle LA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-135; Bohle LA, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-37; Boleij A, 2009, INFECT IMMUN, V77, P5519, DOI 10.1128/IAI.00384-09; Bravetti AL, 2009, ANTIMICROB AGENTS CH, V53, P1667, DOI 10.1128/AAC.00692-08; Carlos AR, 2010, J APPL MICROBIOL, V108, P1563, DOI 10.1111/j.1365-2672.2009.04551.x; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deb Roy S, 2014, ENTEROCOCCI COMMENSA; Dundar H, 2015, J BACTERIOL, V197, P2112, DOI 10.1128/JB.02513-14; Eirich J, 2011, J AM CHEM SOC, V133, P12144, DOI 10.1021/ja2039979; FACHONKALWEIT S, 1985, INFECT IMMUN, V48, P617, DOI 10.1128/IAI.48.3.617-624.1985; FENNO JC, 1989, INFECT IMMUN, V57, P3527, DOI 10.1128/IAI.57.11.3527-3533.1989; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; GANESHKUMAR N, 1991, INFECT IMMUN, V59, P1093, DOI 10.1128/IAI.59.3.1093-1099.1991; GANESHKUMAR N, 1988, INFECT IMMUN, V56, P1150, DOI 10.1128/IAI.56.5.1150-1157.1988; Giard JC, 2001, ELECTROPHORESIS, V22, P2947, DOI 10.1002/1522-2683(200108)22:14&lt;2947::AID-ELPS2947&gt;3.0.CO;2-K; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; GUZMAN CA, 1989, INFECT IMMUN, V57, P1834; Hanin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011879; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Horsley H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083637; Huang CJ, 2011, APPL MICROBIOL BIOT, V90, P235, DOI 10.1007/s00253-011-3118-5; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Komeil D, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-35; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Lindenstrauss AG, 2013, ARCH MICROBIOL, V195, P121, DOI 10.1007/s00203-012-0857-3; Low YL, 2003, J MED MICROBIOL, V52, P113, DOI 10.1099/jmm.0.05039-0; LOWE AM, 1995, INFECT IMMUN, V63, P703, DOI 10.1128/IAI.63.2.703-706.1995; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Maddalo G, 2011, PROTEOMICS, V11, P3935, DOI 10.1002/pmic.201100103; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Murray BE, 1998, EMERG INFECT DIS, V4, P37, DOI 10.3201/eid0401.980106; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pakotiprapha D, 2012, NAT STRUCT MOL BIOL, V19, P291, DOI 10.1038/nsmb.2240; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peppoloni S, 2011, MICROBIOL-SGM, V157, P1816, DOI 10.1099/mic.0.047381-0; Pessione A, 2012, PROTEOMICS, V12, P431, DOI 10.1002/pmic.201100468; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Reffuveille F, 2011, MICROBIOL-SGM, V157, P3001, DOI 10.1099/mic.0.053314-0; RUHFEL RE, 1993, J BACTERIOL, V175, P5253, DOI 10.1128/JB.175.16.5253-5259.1993; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shankar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033450; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Solheim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094571; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Stinson MW, 1998, INFECT IMMUN, V66, P259, DOI 10.1128/IAI.66.1.259-265.1998; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang XS, 2010, J PROTEOME RES, V9, P1772, DOI 10.1021/pr901216e; Wisniewski JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.44; Yeats C, 2004, TRENDS BIOCHEM SCI, V29, P169, DOI 10.1016/j.tibs.2004.02.004; Zhang LP, 1999, INFECT IMMUN, V67, P6473	68	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126694	10.1371/journal.pone.0126694	http://dx.doi.org/10.1371/journal.pone.0126694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915650	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000353659100157
J	Grbesa, I; Pajares, MJ; Martinez-Terroba, E; Agorreta, J; Mikecin, AM; Larrayoz, M; Idoate, MA; Gall-Troselj, K; Pio, R; Montuenga, LM				Grbesa, Ivana; Pajares, Maria J.; Martinez-Terroba, Elena; Agorreta, Jackeline; Mikecin, Ana-Matea; Larrayoz, Marta; Idoate, Miguel A.; Gall-Troselj, Koraljka; Pio, Ruben; Montuenga, Luis M.			Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							REGULATES SIRT1; P53; DEACETYLASE; SENESCENCE; CARCINOMA; GROWTH; ADENOCARCINOMA; INHIBITION; KNOCKDOWN; APOPTOSIS	Background Sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2) are NAD+-dependent protein deacetylases involved in the regulation of key cancer-associated genes. In this study we evaluated the relevance of these deacetylases in lung cancer biology. Material and Methods Protein levels of SIRT1 and SIRT2 were determined in non-small cell lung cancer (NSCLC) cell lines and primary tumors from 105 patients. Changes in proliferation were assessed after SIRT1 and SIRT2 downregulation in lung cancer cell lines using siRNA-mediated technology or tenovin-1, a SIRT1 and SIRT2 inhibitor. Results High SIRT1 and SIRT2 protein levels were found in NSCLC cell lines compared with nontumor lung epithelial cells. The expression of SIRT1 and SIRT2 proteins was also significantly higher in lung primary tumors than in normal tissue (P<0.001 for both sirtuins). Stronger nuclear SIRT1 staining was observed in adenocarcinomas than in squamous cell carcinomas (P=0.033). Interestingly, in NSCLC patients, high SIRT1 and SIRT2 expression levels were associated with shorter recurrence-free survival (P=0.04 and P=0.007, respectively). Moreover, the combination of high SIRT1 and SIRT2 expression was an independent prognostic factor for shorter recurrence-free survival (P=0.002) and overall survival (P=0.022). In vitro studies showed that SIRT1 and/or SIRT2 downregulation significantly decreased proliferation of NSCLC. Conclusions Our results support the hypothesis that SIRT1 and SIRT2 have a protumorigenic role in lung cancer, promoting cell proliferation. Moreover, the expression of these proteins is associated with poor prognosis in NSCLC patients and may help to identify those NSCLC patients with high risk of recurrence that could benefit from adjuvant therapy after resection.	[Grbesa, Ivana; Pajares, Maria J.; Martinez-Terroba, Elena; Agorreta, Jackeline; Larrayoz, Marta; Pio, Ruben; Montuenga, Luis M.] Univ Navarra, Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Biomarkers Lab, Pamplona 31008, Spain; [Grbesa, Ivana] Rudjer Boskovic Inst, Div Mol Med, Grp Translat Med, Zagreb 10000, Croatia; [Pajares, Maria J.; Martinez-Terroba, Elena; Agorreta, Jackeline; Montuenga, Luis M.] Univ Navarra, Sch Med, Dept Histol & Pathol, Pamplona 31008, Spain; [Pajares, Maria J.; Agorreta, Jackeline; Idoate, Miguel A.; Pio, Ruben; Montuenga, Luis M.] Navarras Hlth Res Inst IDISNA, Pamplona, Spain; [Mikecin, Ana-Matea] Rudjer Boskovic Inst, Div Mol Med, Lab Expt Therapy, Zagreb 10000, Croatia; [Idoate, Miguel A.] Univ Hosp, Dept Pathol, Pamplona 31008, Spain; [Idoate, Miguel A.] Univ Navarra, Fac Med, Pamplona 31008, Spain; [Gall-Troselj, Koraljka] Rudjer Boskovic Inst, Div Mol Med, Lab Epigen, Zagreb 10000, Croatia; [Pio, Ruben] Univ Navarra, Sch Sci, Dept Biochem & Genet, Pamplona 31008, Spain	University of Navarra; Rudjer Boskovic Institute; University of Navarra; University of Navarra; Rudjer Boskovic Institute; University of Navarra	Pajares, MJ (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Biomarkers Lab, Pamplona 31008, Spain.	mpajares@unav.es	Larrayoz, Marta/F-9456-2016; Pio, Ruben/F-5353-2017; Idoate, Miguel-Ángel/D-8502-2019; Grbesa, Ivana/AAT-4455-2020; Agorreta, Jackeline/N-2393-2018; Montuenga, Luis M/AAF-7783-2020; Gall Troselj, Koraljka/B-5866-2017	Larrayoz, Marta/0000-0001-6097-8244; Pio, Ruben/0000-0002-6831-6111; Idoate, Miguel-Ángel/0000-0002-1596-1192; Agorreta, Jackeline/0000-0003-4503-9884; Montuenga, Luis M/0000-0002-8739-1387; Gall Troselj, Koraljka/0000-0001-7501-7614; Grbesa, Ivana/0000-0002-4579-9149	CIMA; Spanish Ministries of Health/Economy and Competitivity; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional(FEDER) [ISCIII: RTICC RD12/0036/0040, FIS-PI 10/00166 PI 11/00618, PI13/00806, PI14/01686]; AECC Scientific Foundation [GCB14-2170]; Seventh Framework Programme project [CURELUNG HEALTH-F2-2010-258677]; Croatian Science Foundation [O-190-2011]; Croatian Ministry of Science, Education and Sport [098-0982464-2511]	CIMA(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Spanish Ministries of Health/Economy and Competitivity; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional(FEDER); AECC Scientific Foundation; Seventh Framework Programme project; Croatian Science Foundation; Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported by CIMA, the Spanish Ministries of Health/Economy and Competitivity and *Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional(FEDER)* (ISCIII: RTICC RD12/0036/0040, FIS-PI 10/00166 PI 11/00618,PI13/00806 and PI14/01686), and AECC Scientific Foundation (GCB14-2170) and a Seventh Framework Programme project (CURELUNG HEALTH-F2-2010-258677). IG was financed by Croatian Science Foundation (Brain Gain-Postdoc program, O-190-2011) and Croatian Ministry of Science, Education and Sport (098-0982464-2511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen J, 2013, HEPATOLOGY, V57, P2287, DOI 10.1002/hep.26278; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Fong Y, 2014, SCI WORLD J, DOI 10.1155/2014/937051; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Herranz D, 2013, ONCOGENE, V32, P4052, DOI 10.1038/onc.2012.407; Hirai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102831; Hoffmann G, 2014, J BIOL CHEM, V289, P5208, DOI 10.1074/jbc.M113.487736; Holloway KR, 2013, MOL ENDOCRINOL, V27, P480, DOI 10.1210/me.2012-1347; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045119; Jung-Hynes B, 2009, CELL CYCLE, V8, P1478, DOI 10.4161/cc.8.10.8408; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lejeune A, 2001, CHEM BIOL, V8, P831, DOI 10.1016/S1074-5521(01)00053-9; Li LT, 2012, J ADV CERAM, V1, P1, DOI 10.1007/s40145-012-0001-5; Li ZM, 2013, LUNG CANCER, V82, P9, DOI 10.1016/j.lungcan.2013.05.013; Lima RT, 2013, ANTI-CANCER AGENT ME, V13, P414; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nguewa PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-103; Noh SJ, 2013, PATHOL RES PRACT, V209, P365, DOI 10.1016/j.prp.2013.03.011; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Pajares MJ, 2012, J CLIN ONCOL, V30, P1129, DOI 10.1200/JCO.2011.37.4231; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shin DH, 2014, CANCER RES, V74, P298, DOI 10.1158/0008-5472.CAN-13-2620; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simmons GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098861; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Sun YN, 2007, LUNG CANCER, V58, P21, DOI 10.1016/j.lungcan.2007.05.013; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Travis W, 2004, WHO CLASSIFICATION T; Tseng RC, 2009, NEOPLASIA, V11, P763, DOI 10.1593/neo.09470; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang T, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-351; Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81	50	54	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124670	10.1371/journal.pone.0124670	http://dx.doi.org/10.1371/journal.pone.0124670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915617	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100059
J	Kalota, A; Selak, MA; Garcia-Cid, LA; Carroll, M				Kalota, Anna; Selak, Mary A.; Garcia-Cid, Laura A.; Carroll, Martin			Eltrombopag Modulates Reactive Oxygen Species and Decreases Acute Myeloid Leukemia Cell Survival	PLOS ONE			English	Article							THROMBOPOIETIN RECEPTOR AGONIST; CHRONIC IMMUNE THROMBOCYTOPENIA; DAMAGE; EXPRESSION	Previous studies have demonstrated that the small molecule thrombopoietin (TPO) mimetic, eltrombopag (E), induces apoptosis in acute myeloid leukemia (AML) cells. Here, we sought to define the mechanism of the anti-leukemic effect of eltrombopag. Our studies demonstrate that, at a concentration of 5 mu M E in 2% serum, E induces apoptosis in leukemia cells by triggering PARP cleavage and activation of caspase cascades within 2-6 hours. The induction of apoptotic enzymes is critically dependent on drug concentration and the concentration of serum. This effect is not associated with an alteration in mitochondrial potential but is associated with a rapid decrease in a reactive oxygen species (ROS) in particular hydrogen peroxide (H2O2). Interestingly, E also decreases mitochondrial maximal and spare respiratory capacities suggesting an induced mitochondrial dysfunction that may not be readily apparent under basal conditions but becomes manifest only under stress. Co-treatment of MOLM14 AML cells with E plus Tempol or H2O2 provides a partial rescue of cell toxicity. Ferric ammonioum citrate (FAC) also antagonized the E induced toxicity, by inducing notable increase in ROS level. Overall, we propose that E dramatically decreases ROS levels leading to a disruption of AML intracellular metabolism and rapid cell death.	[Kalota, Anna; Garcia-Cid, Laura A.; Carroll, Martin] Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Selak, Mary A.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Carroll, M (corresponding author), Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA.	carroll2@mail.med.upenn.edu			Veterans Affairs Administration [1I01BX000918-01]; National Institute of Health [1R01CA149566-01A1]; National Institutes of Health [1-R21-CA-153018-01]; GlaxoSmithKline, Collegeville, PA; NATIONAL CANCER INSTITUTE [R21CA153018, R01CA149566] Funding Source: NIH RePORTER	Veterans Affairs Administration(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline, Collegeville, PA(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Veterans Affairs Administration (1I01BX000918-01), National Institute of Health (1R01CA149566-01A1) and National Institutes of Health (1-R21-CA-153018-01), and in part with research funds provided by GlaxoSmithKline, Collegeville, PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Cardamone D, 2013, ARCH PATHOL LAB MED, V137, P1175, DOI 10.5858/arpa.2012-0716-LE; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Deng YL, 2011, DRUG METAB DISPOS, V39, P1734, DOI 10.1124/dmd.111.040170; DIZDAROGLU M, 1991, ARCH BIOCHEM BIOPHYS, V285, P317, DOI 10.1016/0003-9861(91)90366-Q; Erickson-Miller CL, 2009, STEM CELLS, V27, P424, DOI 10.1634/stemcells.2008-0366; Fathi AT, 2012, LEUKEMIA RES, V36, P224, DOI 10.1016/j.leukres.2011.07.011; Frey Noelle V., 2012, ASH M; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Kalota A, 2006, NUCLEIC ACIDS RES, V34, P451, DOI 10.1093/nar/gkj455; Kalota A, 2010, BLOOD, V115, P89, DOI 10.1182/blood-2009-06-227751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maraldi T, 2009, FREE RADICAL RES, V43, P1111, DOI 10.1080/10715760903186132; Molineux G, 2010, BRIT J HAEMATOL, V150, P9, DOI 10.1111/j.1365-2141.2010.08140.x; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; NIo H., 2013, ELTROMBOPAG ELDERLY; Roth M, 2012, BLOOD, V120, P386, DOI 10.1182/blood-2011-12-399667; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Sugita M, 2013, LEUKEMIA, V27, P1207, DOI 10.1038/leu.2012.310; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Will B, 2009, BLOOD, V114, P3899, DOI 10.1182/blood-2009-04-219493; Zhou FL, 2010, J BIOL CHEM, V285, P15010, DOI 10.1074/jbc.M110.103713	26	31	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0126691	10.1371/journal.pone.0126691	http://dx.doi.org/10.1371/journal.pone.0126691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915523	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100156
J	Kuehl, MN; Rodriguez, H; Burkhardt, BR; Alman, AC				Kuehl, Melanie N.; Rodriguez, Henry; Burkhardt, Brant R.; Alman, Amy C.			Tumor Necrosis Factor-alpha, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects	PLOS ONE			English	Article							PERIODONTAL TREATMENT; GLYCEMIC CONTROL; COTININE LEVELS; PEPTIDOME; MELLITUS; HOST; BIOMARKERS; DISEASE	Background Type 1 diabetes (T1D) is an autoimmune disease resulting in the targeted destruction of pancreatic beta-cells and permanent loss of insulin production. Proper glucose management results in better clinical outcomes for T1D and provides a strong rationale to identify non-invasive biomarkers indicative or predictive of glycemic control. Therefore, we investigated the association of salivary inflammation with HbA(1c) in a T1D cohort. Methods Unstimulated saliva was collected from 144 subjects with T1D at the USF Diabetes Center. BMI, duration of diabetes, and HbA(1c) were recorded during clinical visit. Levels of interleukin (IL)-1 beta, -6, -8, -10, IFN-gamma, TNF-alpha, MMP-3, -8, and -9 were measured using multiplexing immunoassay analysis. To account for smoking status, salivary cotinine levels were also determined. Results Multiple linear (HbA(1c)) and logistic (self-reported gingival condition) regression analyses were performed to examine the relationships between the Principal Component Analysis (PCA) components and HbA(1c) and gingival condition (adjusted for age, duration of diabetes, BMI, and sex; model for HbA(1c) also adjusted for gingival condition and model for gingival condition also adjusted for HbA(1c)). PCA components 1 (MMP-8 and MMP-9) and 3 (TNF-alpha) were significantly associated with HbA(1c) (beta = 0.28 +/- 0.14, p = 0.045; beta = 0.31 +/- 0.14, p = 0.029), while PCA component 2 (IL-6, IL-1 beta, and IL-8) was significantly associated with gingival condition (OR 1.60 95% CI 1.09-2.34, p = 0.016). In general, increased salivary inflammatory burden is associated with decreased glycemic control and self-reported gingival condition. Conclusions The saliva may represent a useful reservoir of novel noninvasive inflammatory biomarkers predictive of the progression and control of T1D.	[Kuehl, Melanie N.; Burkhardt, Brant R.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Rodriguez, Henry; Burkhardt, Brant R.] Univ S Florida, Coll Med, Ctr Diabet, Tampa, FL USA; [Alman, Amy C.] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Burkhardt, BR (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	bburkhardt@usf.edu			USF College of Public Health	USF College of Public Health	This study was supported by the USF College of Public Health, New Investigator Award (to ACA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajita M, 2013, DIABETES METAB SYND, V7, P61, DOI 10.1016/j.dsx.2013.03.001; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bencharit S, 2013, MOL BIOSYST, V9, P2785, DOI 10.1039/c3mb70196d; Binnie V, 2004, ORAL DIS, V10, P287, DOI 10.1111/j.1601-0825.2004.01018.x; Cabras T, 2010, MOL CELL PROTEOMICS, V9, P2099, DOI 10.1074/mcp.M110.001057; Caseiro A, 2013, J PROTEOME RES, V12, P1700, DOI 10.1021/pr3010343; Caseiro A, 2012, BIOMED CHROMATOGR, V26, P571, DOI 10.1002/bmc.1677; Dakovic D, 2013, J CLIN PEDIATR DENT, V37, P377, DOI 10.17796/jcpd.37.4.l135531h4542gj66; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Engebretson SP, 2004, J PERIODONTOL, V75, P1203, DOI 10.1902/jop.2004.75.9.1203; Engebretson S, 2013, J PERIODONTOL, V84, pS153, DOI [10.1902/jop.2013.1340017, 10.1111/jcpe.12084]; Engebretson SP, 2006, J CLIN PERIODONTOL, V33, P784, DOI 10.1111/j.1600-051X.2006.00984.x; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Etter JF, 2000, AM J EPIDEMIOL, V151, P251; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Gilbert GH, 2007, J PERIODONTOL, V78, P1429, DOI 10.1902/jop.2007.060199; Gursoy UK, 2013, J CLIN PERIODONTOL, V40, P18, DOI 10.1111/jcpe.12020; Gursoy UK, 2011, DIS MARKERS, V30, P299, DOI [10.3233/DMA-2011-0788, 10.1155/2011/621484]; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Mealey BL, 2006, J AM DENT ASSOC, V137, p26S, DOI 10.14219/jada.archive.2006.0404; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rathnayake N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061356; Sgolastra F, 2013, J PERIODONTOL, V84, P958, DOI 10.1902/jop.2012.120377; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Wang X., 2014, PLOS ONE, V9; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x	31	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125320	10.1371/journal.pone.0125320	http://dx.doi.org/10.1371/journal.pone.0125320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915398	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659100120
J	Marini, E; Buffa, R; Contreras, M; Magris, M; Hidalgo, G; Sanchez, W; Ortiz, V; Urbaez, M; Cabras, S; Blaser, MJ; Dominguez-Bello, MG				Marini, Elisabetta; Buffa, Roberto; Contreras, Monica; Magris, Magda; Hidalgo, Glida; Sanchez, Wilmer; Ortiz, Vanessa; Urbaez, Maryluz; Cabras, Stefano; Blaser, Martin J.; Dominguez-Bello, Maria G.			Effect of Influenza-Induced Fever on Human Bioimpedance Values	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; NUTRITIONAL-STATUS; VECTOR	Background and Aims Bioelectrical impedance analysis (BIA) is a widely used technique to assess body composition and nutritional status. While bioelectrical values are affected by diverse variables, there has been little research on validation of BIA in acute illness, especially to understand prognostic significance. Here we report the use of BIA in acute febrile states induced by influenza. Methods Bioimpedance studies were conducted during an H1N1 influenza A outbreak in Venezuelan Amerindian villages from the Amazonas. Measurements were performed on 52 subjects between 1 and 40 years of age, and 7 children were re-examined after starting Oseltamivir treatment. Bioelectrical Impedance Vector Analysis (BIVA) and permutation tests were applied. Results For the entire sample, febrile individuals showed a tendency toward greater reactance (p=0.058) and phase angle (p=0.037) than afebrile individuals, while resistance and impedance were similar in the two groups. Individuals with repeated measurements showed significant differences in bioimpedance values associated with fever, including increased reactance (p<0.001) and phase angle (p=0.007), and decreased resistance (p=0.007) and impedance (p<0.001). Conclusions There are bioelectrical variations induced by influenza that can be related to dehydration, with lower extracellular to intracellular water ratio in febrile individuals, or a direct thermal effect. Caution is recommended when interpreting bioimpedance results in febrile states.	[Marini, Elisabetta; Buffa, Roberto; Cabras, Stefano] Univ Cagliari, Cagliari, Italy; [Contreras, Monica; Urbaez, Maryluz] Venezuelan Inst Sci Res IVIC, Caracas, Venezuela; [Magris, Magda; Hidalgo, Glida] Amazon Ctr Res & Control Trop Dis CAICET, Puerto Ayacucho, Amazonas, Venezuela; [Hidalgo, Glida; Sanchez, Wilmer] Fdn Ctr Studies Growth & Dev Venezuelan Populat, Caracas, Venezuela; [Ortiz, Vanessa] Popular Minist Hlth, Caracas, Venezuela; [Cabras, Stefano] Univ Carlos III Madrid, Madrid, Spain; [Blaser, Martin J.; Dominguez-Bello, Maria G.] NYU, Sch Med, New York, NY 10012 USA; [Dominguez-Bello, Maria G.] Univ Puerto Rico, San Juan, PR 00936 USA	University of Cagliari; Venezuelan Institute Science Research; Universidad Carlos III de Madrid; New York University; University of Puerto Rico	Dominguez-Bello, MG (corresponding author), NYU, Sch Med, New York, NY 10012 USA.	maria.dominguez-bello@nyumc.org	Cabras, Stefano/AAA-2477-2019	Cabras, Stefano/0000-0001-6690-8378; BUFFA, Roberto/0000-0001-7082-859X; Marini, Elisabetta/0000-0001-8779-8745; Contreras Valero, Monica/0000-0003-4729-9559	University of Cagliari; Diane Belfer Program for Human Microbial Ecology	University of Cagliari; Diane Belfer Program for Human Microbial Ecology	The study was partially supported by the C&D and Emch Research Funds and visiting Professor program of University of Cagliari (to MGDB) and by the Diane Belfer Program for Human Microbial Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffa R, 2009, J TROP PEDIATRICS, V55, P406, DOI 10.1093/tropej/fmp032; CHERTOW GM, 1995, J AM SOC NEPHROL, V6, P75; De Palo T, 2000, NUTRITION, V16, P417, DOI 10.1016/S0899-9007(00)00269-0; Hidalgo G, 2014, AM J HUM BIOL, V26, P710, DOI 10.1002/ajhb.22567; Jacobs JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042328; Klassen P, 2000, ANN NY ACAD SCI, V904, P163, DOI 10.1111/j.1749-6632.2000.tb06442.x; Kushner RF, 1996, AM J CLIN NUTR, V64, P423, DOI 10.1093/ajcn/64.3.423S; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Marini E, 2007, AM J TROP MED HYG, V76, P534, DOI 10.4269/ajtmh.2007.76.534; NIH, 1996, AM J CLIN NUTR, V64, pS524; PICCOLI A, 1995, AM J CLIN NUTR, V61, P269, DOI 10.1093/ajcn/61.2.269; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; World Health Organization, 2010, EV PAND H1NI 2009	13	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125301	10.1371/journal.pone.0125301	http://dx.doi.org/10.1371/journal.pone.0125301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915945	gold, Green Published			2022-12-26	WOS:000353659100118
J	Panenka, WJ; Lange, RT; Bouix, S; Shewchuk, JR; Heran, MKS; Brubacher, JR; Eckbo, R; Shenton, ME; Iverson, GL				Panenka, William J.; Lange, Rael T.; Bouix, Sylvain; Shewchuk, Jason R.; Heran, Manraj K. S.; Brubacher, Jeffrey R.; Eckbo, Ryan; Shenton, Martha E.; Iverson, Grant L.			Neuropsychological Outcome and Diffusion Tensor Imaging in Complicated versus Uncomplicated Mild Traumatic Brain Injury	PLOS ONE			English	Article							POST-CONCUSSION SYNDROME; COMPUTED-TOMOGRAPHY; HEAD-INJURY; AXONAL INJURY; MODERATE; CT; PREDICTION; ASSOCIATION; SYMPTOMS; CHILDREN	This study examined whether intracranial neuroimaging abnormalities in those with mild traumatic brain injury (MTBI) (i.e., "complicated" MTBIs) are associated with worse subacute outcomes as measured by cognitive testing, symptom ratings, and/or diffusion tensor imaging (DTI). We hypothesized that (i) as a group, participants with complicated MTBIs would report greater symptoms and have worse neurocognitive outcomes than those with uncomplicated MTBI, and (ii) as a group, participants with complicated MTBIs would show more Diffusion Tensor Imaging (DTI) abnormalities. Participants were 62 adults with MTBIs (31 complicated and 31 uncomplicated) who completed neurocognitive testing, symptom ratings, and DTI on a 3T MRI scanner approximately 6-8 weeks post injury. There were no statistically significant differences between groups on symptom ratings or on a broad range of neuropsychological tests. When comparing the groups using tract-based spatial statistics for DTI, no significant difference was found for axial diffusivity or mean diffusivity. However, several brain regions demonstrated increased radial diffusivity (purported to measure myelin integrity), and decreased fractional anisotropy in the complicated group compared with the uncomplicated group. Finally, when we extended the DTI analysis, using a multivariate atlas based approach, to 32 orthopedic trauma controls (TC), the findings did not reveal significantly more areas of abnormal DTI signal in the complicated vs. uncomplicated groups, although both MTBI groups had a greater number of areas with increased radial diffusivity compared with the trauma controls. This study illustrates that macrostructural neuroimaging changes following MTBI are associated with measurable changes in DTI signal. Of note, however, the division of MTBI into complicated and uncomplicated subtypes did not predict worse clinical outcome at 6-8 weeks post injury.	[Panenka, William J.; Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Bouix, Sylvain; Eckbo, Ryan; Shenton, Martha E.] Harvard Univ, Sch Med, Brigham Womens Hosp, Psychiat Neuroimaging Lab, Boston, MA USA; [Shewchuk, Jason R.; Heran, Manraj K. S.] Univ British Columbia, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Brubacher, Jeffrey R.] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton, MA USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA	University of British Columbia; Walter Reed National Military Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of British Columbia; University of British Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Massachusetts General Hospital	Panenka, WJ (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada.	wpanenka@mail.ubc.ca	Shenton, Martha/V-8780-2019	Bouix, Sylvain/0000-0003-1326-6054; Brubacher, Jeffrey/0000-0002-4866-4231; Panenka, William/0000-0001-7143-6512; Iverson, Grant/0000-0001-7348-9570	Canadian Institute of Health Research [200903MOP-200377-BSB-CAAA-161276]; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program	Primary funding for this study was provided by the Canadian Institute of Health Research (200903MOP-200377-BSB-CAAA-161276); provided to RTL as PI). MES and GLI note that this work was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00010]; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beck A., 1993, BECK ANXIETY INVENTO; Beck AT., 1996, MANUAL BECK DEPRESSI; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mori A, 2005, MRI ATLAS HUMAN WHIT; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stern R. A., 2003, NEUROPSYCHOLOGICAL A; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Waljas M, 2013, J NEUROTRAUMA; White T, 2003, NAB DEMOGRAPHICALLY; WHO, 2018, INT STAT CLASS DIS R; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	85	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0122746	10.1371/journal.pone.0122746	http://dx.doi.org/10.1371/journal.pone.0122746			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915776	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100011
J	Pelisch, N; Dan, T; Ichimura, A; Sekiguchi, H; Vaughan, DE; de Strihou, CV; Miyata, T				Pelisch, Nicolas; Dan, Takashi; Ichimura, Atsuhiko; Sekiguchi, Hiroki; Vaughan, Douglas E.; de Strihou, Charles van Ypersele; Miyata, Toshio			Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NEUROTROPHIC FACTOR; RECEPTOR MODULATOR; POTENTIAL ROLE; FINGOLIMOD; NEURODEGENERATION; FIBRINOLYSIS; INFLAMMATION	Multiple sclerosis (MS) is characterized by inflammatory demyelination and deposition of fibrinogen in the central nervous system (CNS). Elevated levels of a critical inhibitor of the mammalian fibrinolitic system, plasminogen activator inhibitor 1 (PAI-1) have been demonstrated in human and animal models of MS. In experimental studies that resemble neuroinflammatory disease, PAI-1 deficient mice display preserved neurological structure and function compared to wild type mice, suggesting a link between the fibrinolytic pathway and MS. We previously identified a series of PAI-1 inhibitors on the basis of the 3-dimensional structure of PAI-1 and on virtual screening. These compounds have been reported to provide a number of in vitro and in vivo benefits but none was tested in CNS disease models because of their limited capacity to penetrate the blood-brain barrier (BBB). The existing candidates were therefore optimized to obtain CNS-penetrant compounds. We performed an in vitro screening using a model of BBB and were able to identify a novel, low molecular PAI-1 inhibitor, TM5484, with the highest penetration ratio among all other candidates. Next, we tested the effects on inflammation and demyelination in an experimental allergic encephalomyelitis mice model. Results were compared to either fingolimod or 6a-methylprednisolone. Oral administration of TM5484 from the onset of signs, ameliorates paralysis, attenuated demyelination, and axonal degeneration in the spinal cord of mice. Furthermore, it modulated the expression of brain-derived neurotrophic factor, which plays a protective role in neurons against various pathological insults, and choline acetyltransferase, a marker of neuronal density. Taken together, these results demonstrate the potential benefits of a novel PAI-1 inhibitor, TM5484, in the treatment of MS.	[Pelisch, Nicolas; Dan, Takashi; Ichimura, Atsuhiko; Sekiguchi, Hiroki; Miyata, Toshio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Mol Med & Therapy, Sendai, Miyagi 980, Japan; [Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [de Strihou, Charles van Ypersele] Clin Univ St Luc, Serv Nephrol, B-1200 Brussels, Belgium	Tohoku University; Northwestern University; Feinberg School of Medicine; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Pelisch, N (corresponding author), Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Mol Med & Therapy, Sendai, Miyagi 980, Japan.	n.pelisch@med.tohoku.ac.jp	Miyata, Toshio/A-4872-2010	Ichimura, Atsuhiko/0000-0003-0366-5211	Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; National Institute of Biomedical Innovation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	The authors' work is supported in part by grants from the Ministry of Health, Labour and Welfare of Japan (Initiative to facilitate development of innovative drug, medical devices, and cellular and tissue-based products), from the Japan Science and Technology Agency (Adaptable & Seamless Technology Transfer Program through Target-driven Research and Development) and from the National Institute of Biomedical Innovation (Advanced Research for Medical Products Mining Progamme).	Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Akenami FOT, 1997, J CLIN PATHOL, V50, P157, DOI 10.1136/jcp.50.2.157; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Chan J, 2008, AUTOIMMUNITY, V41, P405, DOI 10.1080/08916930802011258; Chiba K, 2011, INT IMMUNOPHARMACOL, V11, P366, DOI 10.1016/j.intimp.2010.10.005; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; East E, 2008, NEUROPATH APPL NEURO, V34, P216, DOI 10.1111/j.1365-2990.2007.00889.x; East E, 2005, AM J PATHOL, V167, P545, DOI 10.1016/S0002-9440(10)62996-3; Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249; Gur-Wahnon D, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-124; Gveric D, 2003, BRAIN, V126, P1590, DOI 10.1093/brain/awg167; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Loskutoff DJ, 1999, APMIS, V107, P54, DOI 10.1111/j.1699-0463.1999.tb01526.x; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luhder F, 2013, ARCH IMMUNOL THER EX, V61, P95, DOI 10.1007/s00005-012-0211-0; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Norinder U, 2002, ADV DRUG DELIVER REV, V54, P291, DOI 10.1016/S0169-409X(02)00005-4; Oh J, 2013, CNS DRUGS, V27, P591, DOI 10.1007/s40263-013-0080-z; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Rossi S, 2014, MULT SCLER J, V20, P304, DOI 10.1177/1352458513498128; Shin T, 2012, ANAT CELL BIOL, V45, P141, DOI 10.5115/acb.2012.45.3.141; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Thone J, 2012, AM J PATHOL, V180, P267, DOI 10.1016/j.ajpath.2011.09.037; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; van Horssen J, 2005, J NEUROPATH EXP NEUR, V64, P722, DOI 10.1097/01.jnen.0000173894.09553.13; van Horssen J, 2006, NEUROBIOL DIS, V24, P484, DOI 10.1016/j.nbd.2006.08.005; Wager TT, 2010, ACS CHEM NEUROSCI, V1, P420, DOI 10.1021/cn100007x; Wiendl H, 2009, NEUROLOGY, V72, P1008, DOI 10.1212/01.wnl.0000344417.42972.54	37	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124510	10.1371/journal.pone.0124510	http://dx.doi.org/10.1371/journal.pone.0124510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915660	Green Submitted, Green Published, gold			2022-12-26	WOS:000353659100052
J	Dingwell, JB; Cusumano, JP				Dingwell, Jonathan B.; Cusumano, Joseph P.			Identifying Stride-To-Stride Control Strategies in Human Treadmill Walking	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; LONG-RANGE CORRELATIONS; CAPTURABILITY-BASED ANALYSIS; CENTRAL PATTERN GENERATORS; OPTIMAL FEEDBACK-CONTROL; FOOT PLACEMENT; LEGGED LOCOMOTION; KINEMATIC VARIABILITY; VISUAL GUIDANCE; OPTIC FLOW	Variability is ubiquitous in human movement, arising from internal and external noise, inherent biological redundancy, and from the neurophysiological control actions that help regulate movement fluctuations. Increased walking variability can lead to increased energetic cost and/or increased fall risk. Conversely, biological noise may be beneficial, even necessary, to enhance motor performance. Indeed, encouraging more variability actually facilitates greater improvements in some forms of locomotor rehabilitation. Thus, it is critical to identify the fundamental principles humans use to regulate stride-to-stride fluctuations in walking. This study sought to determine how humans regulate stride-to-stride fluctuations in stepping movements during treadmill walking. We developed computational models based on pre-defined goal functions to compare if subjects, from each stride to the next, tried to maintain the same speed as the treadmill, or instead stay in the same position on the treadmill. Both strategies predicted average behaviors empirically indistinguishable from each other and from that of humans. These strategies, however, predicted very different strideto- stride fluctuation dynamics. Comparisons to experimental data showed that human stepping movements were generally well-predicted by the speed-control model, but not by the position-control model. Human subjects also exhibited no indications they corrected deviations in absolute position only intermittently: i.e., closer to the boundaries of the treadmill. Thus, humans clearly do not adopt a control strategy whose primary goal is to maintain some constant absolute position on the treadmill. Instead, humans appear to regulate their stepping movements in a way most consistent with a strategy whose primary goal is to try to maintain the same speed as the treadmill at each consecutive stride. These findings have important implications both for understanding how biological systems regulate walking in general and for being able to harness these mechanisms to develop more effective rehabilitation interventions to improve locomotor performance.	[Dingwell, Jonathan B.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Cusumano, Joseph P.] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA	University of Texas System; University of Texas Austin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dingwell, JB (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.	jdingwell@austin.utexas.edu		Dingwell, Jonathan/0000-0001-6990-4153	Whitaker Biomedical Engineering Foundation grant [RG-02-0354]; National Institutes of Health [R01-HD059844]; National Science Foundation [0625764]; Congressionally Directed Medical Research Programs [W81XWH-11-2-0222]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059844] Funding Source: NIH RePORTER	Whitaker Biomedical Engineering Foundation grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Congressionally Directed Medical Research Programs(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided in part by the Whitaker Biomedical Engineering Foundation grant # RG-02-0354 (to JBD), the National Institutes of Health (http://www.nih.gov/) grant # R01-HD059844 (to JBD), the National Science Foundation (http://www.nsf.gov) grant # 0625764 (to JPC), and the Congressionally Directed Medical Research Programs (https://cdmrp.org/) contract #W81XWH-11-2-0222 (to JBD and JPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; ARSENAULT AB, 1986, ERGONOMICS, V29, P665, DOI 10.1080/00140138608968301; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bollens B, 2010, GAIT POSTURE, V32, P369, DOI 10.1016/j.gaitpost.2010.06.011; Bruggeman H, 2007, CURR BIOL, V17, P2035, DOI 10.1016/j.cub.2007.10.059; Byl K, 2009, INT J ROBOT RES, V28, P1040, DOI 10.1177/0278364909340446; Collins SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073597; Crenshaw JR, 2012, J BIOMECH, V45, P129, DOI 10.1016/j.jbiomech.2011.09.022; Cusumano JP, 2013, HUM MOVEMENT SCI, V32, P899, DOI 10.1016/j.humov.2013.07.019; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; Marc-Andre C, 2007, J BIOMECH, V40, P2857, DOI 10.1016/j.jbiomech.2007.03.012; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2010, DATA DO HUMANS OPTIM; Dingwell JB, 2013, J NEUROPHYSIOL, V109, P225, DOI 10.1152/jn.00951.2011; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Duschau-Wicke A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-43; Engelbrecht SE, 2001, J MATH PSYCHOL, V45, P497, DOI 10.1006/jmps.2000.1295; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Forner Cordero A, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00160-1; Franchak JM, 2010, VISION RES, V50, P2766, DOI 10.1016/j.visres.2010.09.024; Full RJ, 1999, J EXP BIOL, V202, P3325; Gates DH, 2012, GAIT POSTURE, V35, P36, DOI 10.1016/j.gaitpost.2011.08.001; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GUBINA F, 1974, IEEE T BIO-MED ENG, VBM21, P102, DOI 10.1109/TBME.1974.324294; Guckenheimer J, 2013, APPL MATH SCI, V42; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Koolen T, 2012, INT J ROBOT RES, V31, P1094, DOI 10.1177/0278364912452673; Krishnan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077370; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Lewek MD, 2009, PHYS THER, V89, P829, DOI 10.2522/ptj.20080180; Luenberg D.G., 2008, LINEAR NONLINEAR PRO; Lyon I, 2005, EXP BRAIN RES, V161, P193, DOI 10.1007/s00221-004-2058-z; Lyon IN, 1997, EXP BRAIN RES, V115, P345, DOI 10.1007/PL00005703; Manoonpong P, 2007, PLOS COMPUT BIOL, V3, P1305, DOI 10.1371/journal.pcbi.0030134; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P495, DOI 10.5194/npg-11-495-2004; Marigold DS, 2007, NEUROSCIENCE, V144, P302, DOI 10.1016/j.neuroscience.2006.09.006; Marigold DS, 2008, EXERC SPORT SCI REV, V36, P145, DOI 10.1097/JES.0b013e31817bff72; Matthis JS, 2014, J EXP PSYCHOL HUMAN, V40, P106, DOI 10.1037/a0033101; Matthis JS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0700; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Moraes R, 2007, J NEUROPHYSIOL, V98, P1928, DOI 10.1152/jn.00044.2006; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; PAILHOUS J, 1992, BEHAV BRAIN RES, V47, P181, DOI 10.1016/S0166-4328(05)80124-X; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Potocanac Z, 2014, EXP BRAIN RES, V232, P3579, DOI 10.1007/s00221-014-4038-2; Pratt J, 2012, INT J ROBOT RES, V31, P1117, DOI 10.1177/0278364912452762; Racz K, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00155; REDFERN MS, 1994, J BIOMECH, V27, P1339, DOI 10.1016/0021-9290(94)90043-4; Reynolds RF, 2005, J PHYSIOL-LONDON, V569, P677, DOI 10.1113/jphysiol.2005.095869; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Rosenblatt NJ, 2010, GAIT POSTURE, V31, P380, DOI 10.1016/j.gaitpost.2010.01.002; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Sethna JP, 2006, STAT MECH ENTROPY OR; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Su JLS, 2007, J BIOMECH ENG-T ASME, V129, P802, DOI 10.1115/1.2800760; Terrier P, 2005, HUM MOVEMENT SCI, V24, P97, DOI 10.1016/j.humov.2005.03.002; Terrier P, 2012, HUM MOVEMENT SCI, V31, P1585, DOI 10.1016/j.humov.2012.05.004; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; TOWNSEND MA, 1985, J BIOMECH, V18, P21, DOI 10.1016/0021-9290(85)90042-9; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; van Beers RJ, 2013, J NEUROPHYSIOL, V109, P969, DOI 10.1152/jn.00706.2012; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; VANINGENSCHENAU GJ, 1980, MED SCI SPORT EXER, V12, P257; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Wang Y, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0405; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011; Wisse M, 2005, IEEE T ROBOT, V21, P393, DOI 10.1109/TRO.2004.838030; Ziegler MD, 2010, J NEUROSCI, V30, P10720, DOI 10.1523/JNEUROSCI.1938-10.2010	91	46	46	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124879	10.1371/journal.pone.0124879	http://dx.doi.org/10.1371/journal.pone.0124879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910253	Green Submitted, Green Published, gold			2022-12-26	WOS:000353376800110
J	Drewnowska, JM; Zambrzycka, M; Kalska-Szostko, B; Fiedoruk, K; Swiecicka, I				Drewnowska, Justyna M.; Zambrzycka, Monika; Kalska-Szostko, Beata; Fiedoruk, Krzysztof; Swiecicka, Izabela			Melanin-Like Pigment Synthesis by Soil Bacillus weihenstephanensis Isolates from Northeastern Poland	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; VIBRIO-CHOLERAE; THURINGIENSIS; DIVERSITY; CEREUS; SUSCEPTIBILITY; PURIFICATION; LACCASE; STRAIN; GENE	Although melanin is known for protecting living organisms from harmful physical and chemical factors, its synthesis is rarely observed among endospore-forming Bacillus cereus sensu lato. Here, for the first time, we reported that psychrotolerant Bacillus weihenstephanensis from Northeastern Poland can produce melanin-like pigment. We assessed physicochemical properties of the pigment and the mechanism of its synthesis in relation to Bacillus weihenstephanensis genotypic and phenotypic characteristics. Electron paramagnetic resonance (EPR) spectroscopy displayed a stable free radical signal of the pigment from environmental isolates which are consistent with the commercial melanin. Fourier transform infrared spectroscopy (FT-IR) and physicochemical tests indicated the phenolic character of the pigment. Several biochemical tests showed that melanin-like pigment synthesis by Bacillus weihenstephanensis was associated with laccase activity. The presence of the gene encoding laccase was confirmed by the next generation whole genome sequencing of one Bacillus weihenstephanensis strain. Biochemical (API 20E and 50CHB tests) and genetic (Multi-locus Sequence Typing, 16S rRNA sequencing, and Pulsed-Field Gel Electrophoresis) characterization of the isolates revealed their close relation to the psychrotrophic Bacillus weihenstephanensis DSMZ 11821 reference strain. The ability to synthesize melanin-like pigment by soil Bacillus weihenstephanensis isolates and their psychrotrophic character seemed to be a local adaptation to a specific niche. Detailed genetic and biochemical analyses of melanin-positive environmental Bacillus weihenstephanensis strains shed some light on the evolution and ecological adaptation of these bacteria. Moreover, our study raised new biotechnological possibilities for the use of water-soluble melanin-like pigment naturally produced by Bacillus weihenstephanensis as an alternative to commercial non-soluble pigment.	[Drewnowska, Justyna M.; Zambrzycka, Monika; Swiecicka, Izabela] Univ Bialystok, Inst Biol, Dept Microbiol, Bialystok, Poland; [Kalska-Szostko, Beata] Univ Bialystok, Inst Chem, Dept Physicochem Anal, Bialystok, Poland; [Fiedoruk, Krzysztof] Med Univ Bialystok, Dept Microbiol, Bialystok, Poland; [Swiecicka, Izabela] Univ Bialystok, Appl Microbiol Lab, Bialystok, Poland	University of Bialystok; University of Bialystok; Medical University of Bialystok; University of Bialystok	Swiecicka, I (corresponding author), Univ Bialystok, Inst Biol, Dept Microbiol, Bialystok, Poland.	izabelas@uwb.edu.pl	Drewnowska, Justyna M/K-2076-2016; Fiedoruk, Krzysztof/R-5460-2018	Drewnowska, Justyna M/0000-0002-2004-8824; Fiedoruk, Krzysztof/0000-0001-7343-8837; Kalska-Szostko, Beata/0000-0002-6353-243X; Swiecicka, Izabela/0000-0002-2750-9451	National Science Centre of Poland grant [UMO-2013/09/N/NZ8/03209]; European Union, Operational Program Development of Eastern Poland [POPW.01.03.00-20-034/09-00]	National Science Centre of Poland grant(National Science Centre, Poland); European Union, Operational Program Development of Eastern Poland	This work was supported by the National Science Centre of Poland (https://www.ncn.gov.pl/?language=en) grant UMO-2013/09/N/NZ8/03209 to JMD. FT-IR was performed in the Center of Synthesis and Analysis BioNanoTechno of University of Bialystok funded by the European Union as a part of the Operational Program Development of Eastern Poland 2007-2013 (project POPW.01.03.00-20-034/09-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2011, FEMS MICROBIOL REV, V35, P201, DOI 10.1111/j.1574-6976.2010.00244.x; Aghajanyan AE, 2005, PIGM CELL RES, V18, P130, DOI 10.1111/j.1600-0749.2005.00211.x; Amal AM, 2011, RES J CHEM SCI, V1, P22, DOI DOI 10.1017/CB09781107415324.004; Banerjee D, 2014, LETT APPL MICROBIOL, V58, P25, DOI 10.1111/lam.12151; Bargabus RL, 2002, PHYSIOL MOL PLANT P, V61, P289, DOI 10.1006/pmpp.2003.0443; Bartoszewicz M, 2009, J APPL MICROBIOL, V106, P1967, DOI 10.1111/j.1365-2672.2009.04166.x; Belotte D, 2003, EVOLUTION, V57, P27, DOI 10.1111/j.0014-3820.2003.tb00213.x; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; Chen YH, 2004, J GEN APPL MICROBIOL, V50, P183, DOI 10.2323/jgam.50.183; Coates J., 2000, ENCY ANAL CHEM, P10815, DOI DOI 10.1002/9780470027318.A5606; Crickmore N, 2006, J APPL MICROBIOL, V101, P616, DOI 10.1111/j.1365-2672.2006.02936.x; Cunha MML, 2005, MICROSC RES TECHNIQ, V68, P377, DOI 10.1002/jemt.20260; Drewnowska JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080175; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; FAVA F, 1993, CHEMOSPHERE, V27, P825, DOI 10.1016/0045-6535(93)90014-V; Funa N, 2005, J BACTERIOL, V187, P8149, DOI 10.1128/JB.187.23.8149-8155.2005; Garcia-Rivera J, 2001, MED MYCOL, V39, P353, DOI 10.1080/mmy.39.4.353.357; Geng J, 2008, J EUR ACAD DERMATOL, V22, P852, DOI 10.1111/j.1468-3083.2007.02574.x; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; HOTI SL, 1993, J GEN MICROBIOL, V139, P2365, DOI 10.1099/00221287-139-10-2365; Ibarra JE, 2003, APPL ENVIRON MICROB, V69, P5269, DOI 10.1128/AEM.69.9.5269-5274.2003; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jimenez G, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01080-13; Kannan P., 2009, J SCI RES, V1, P655, DOI DOI 10.3329/jsr.v1i3.2005; Kolczynski-Szafraniec U, 1992, CURR TOP BIOPHYS, V16, P77; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; Kumar CG, 2013, LETT APPL MICROBIOL, V57, P295, DOI 10.1111/lam.12111; Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373; Liang TW, 2013, CARBOHYD POLYM, V92, P2141, DOI 10.1016/j.carbpol.2012.11.097; Liu FX, 2013, ANN MICROBIOL, V63, P1131, DOI 10.1007/s13213-012-0570-0; Liu N, 2004, LETT APPL MICROBIOL, V39, P407, DOI 10.1111/j.1472-765X.2004.01599.x; Logan NA, 2012, J APPL MICROBIOL, V112, P417, DOI 10.1111/j.1365-2672.2011.05204.x; Magarelli M., 2010, Revista CES Medicina Veterinaria y Zootecnia, V5, P18; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Minussi RC, 2007, AFR J BIOTECHNOL, V6, P1248; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Moeller R, 2005, FEMS MICROBIOL ECOL, V51, P231, DOI 10.1016/j.femsec.2004.08.008; NAIR S, 1992, WATER RES, V26, P431, DOI 10.1016/0043-1354(92)90042-3; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Pinero S, 2007, J MOL MICROB BIOTECH, V13, P35, DOI 10.1159/000103595; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Raymond B, 2012, SCIENCE, V337, P85, DOI 10.1126/science.1218196; Rivera AMG, 2003, FEMS MICROBIOL LETT, V223, P61, DOI 10.1016/S0378-1097(03)00347-1; Rosas AL, 1997, FEMS MICROBIOL LETT, V153, P265, DOI 10.1016/S0378-1097(97)00239-5; Ruan L, 2002, LETT APPL MICROBIOL, V34, P244, DOI 10.1046/j.1472-765x.2002.01049.x; Sajjan S, 2010, J MICROBIOL BIOTECHN, V20, P1513, DOI 10.4014/jmb.1002.02006; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Singh S, 2013, BIOINFORMATION, V9, P94, DOI 10.6026/97320630009094; Solano F, 2001, FEMS MICROBIOL LETT, V204, P175, DOI 10.1111/j.1574-6968.2001.tb10882.x; Swiecicka I, 2006, FEMS MICROBIOL ECOL, V56, P132, DOI 10.1111/j.1574-6941.2006.00063.x; Swiecicka I, 2003, J APPL MICROBIOL, V94, P60, DOI 10.1046/j.1365-2672.2003.01790.x; Swiecicka I, 2008, BIOCONTROL SCI TECHN, V18, P221, DOI 10.1080/09583150801942334; Swiecicka I, 2013, FEMS MICROBIOL ECOL, V85, P262, DOI 10.1111/1574-6941.12116; Tada M, 2010, J CLIN BIOCHEM NUTR, V46, P224, DOI 10.3164/jcbn.09-84; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang RB, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-109; Youngchim S, 2011, MICROBIOL-SGM, V157, P2348, DOI 10.1099/mic.0.047928-0; Zdybel M, 2015, J APPL BIOMED, V13, P131, DOI 10.1016/j.jab.2015.01.002; Zdybel M, 2013, NUKLEONIKA, V58, P407	61	39	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125428	10.1371/journal.pone.0125428	http://dx.doi.org/10.1371/journal.pone.0125428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909751	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800140
J	Harpenslager, SF; Smolders, AJP; Kieskamp, AAM; Roelofs, JGM; Lamers, LPM				Harpenslager, Sarah F.; Smolders, Alfons J. P.; Kieskamp, Ariet A. M.; Roelofs, Jan G. M.; Lamers, Leon P. M.			To Float or Not to Float: How Interactions between Light and Dissolved Inorganic Carbon Species Determine the Buoyancy of Stratiotes aloides	PLOS ONE			English	Article							DIFFERENTIAL ABILITY; AQUATIC PLANTS; WATER; MACROPHYTE; NETHERLANDS; HYDROCHARITACEAE; ASSIMILATION; BICARBONATE; LIMITATION; DYNAMICS	Structural diversity formed by dense, floating Stratiotes aloides stands, generates hotspots of biodiversity of flora and fauna in wetlands. However, only part of the populations become emergent and provide this important facilitation. Since it has been hypothesised that its buoyancy depends on the rates of underwater photosynthesis, we investigated the role of dissolved CO2 availability and PAR on photosynthesis, biomass production and buoyancy in a controlled greenhouse experiment. Photosynthesis and growth were strongly influenced by both PAR and CO2 availability. At low PAR, plants formed less biomass and produced no emergent leaves, even when CO2 was abundant. At low CO2 levels, S. aloides switched to HCO3- use, resulting in a lower photosynthetic O-2 production, decreased emergent leaf formation and increased CaCO3 precipitation on its leaves, all of which impaired buoyancy. At high PAR, low CO2 availability resulted in slower colonisation of the water layer, whereas CO2 availability did not influence PAR-limited plants. Our study shows that site conditions, rather than the sole abundance of potentially facilitating species, may strongly determine whether or not they form the structure necessary to act as a facilitator for biodiversity in aquatic environments.	[Harpenslager, Sarah F.; Smolders, Alfons J. P.; Kieskamp, Ariet A. M.; Roelofs, Jan G. M.; Lamers, Leon P. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands; [Smolders, Alfons J. P.] B Ware Res Ctr, Nijmegen, Netherlands	Radboud University Nijmegen	Harpenslager, SF (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands.	S.Harpenslager@science.ru.nl	Harpenslager, Sarah Faye/Q-7274-2017; Smolders, Alfons J.P./H-2583-2012; Roelofs, Jan GM/C-1243-2011; Lamers, Leon P.M./A-8718-2012	Harpenslager, Sarah Faye/0000-0002-0338-3372; Lamers, Leon P.M./0000-0003-3769-2154	PeatCap: Natural capping in the polluted Volgermeer Polder (the Netherlands) provides new chances for peat growth counteracting land subsidence [11264]; Technology Foundation STW	PeatCap: Natural capping in the polluted Volgermeer Polder (the Netherlands) provides new chances for peat growth counteracting land subsidence; Technology Foundation STW(Technologiestichting STW)	Research performed as part of Project: 11264; PeatCap: Natural capping in the polluted Volgermeer Polder (the Netherlands) provides new chances for peat growth counteracting land subsidence. Subsidised by Technology Foundation STW, giving grants to applied research.	ALLEN ED, 1981, NEW PHYTOL, V87, P269, DOI 10.1111/j.1469-8137.1981.tb03198.x; Bloemendaal FHJL, 1988, WATERPLANTEN WATERKW; BOROWITZKA MA, 1984, PLANT CELL ENVIRON, V7, P457, DOI 10.1111/j.1365-3040.1984.tb01436.x; COOK CDK, 1983, AQUAT BOT, V16, P213, DOI 10.1016/0304-3770(83)90035-9; Efremov Andrey N., 2012, Botanica Serbica, V36, P59; ERIXON G, 1979, HYDROBIOLOGIA, V67, P215, DOI 10.1007/BF00023178; GRASSHOFF K, 1972, J CONSEIL, V34, P516; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Higler L. W. G., 1977, MACROFAUNA CENOSES S; KAMPHAKE LJ, 1967, WATER RES, V1, P205, DOI 10.1016/0043-1354(67)90011-5; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Lichtenthaler HK, 1983, BIOCHEM SOC T, V11, P519; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; MADSEN TV, 1991, FRESHWATER BIOL, V26, P175, DOI 10.1111/j.1365-2427.1991.tb01727.x; MADSEN TV, 1991, AQUAT BOT, V41, P5, DOI 10.1016/0304-3770(91)90037-6; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Milla R, 2007, P ROY SOC B-BIOL SCI, V274, P2109, DOI 10.1098/rspb.2007.0417; MNR, 2013, ONT INV AQ PLANT LIS; Montesantos N, 1913, FLORA, V105, P1; Mulderij G, 2006, FRESHWATER BIOL, V51, P554, DOI 10.1111/j.1365-2427.2006.01510.x; Nielsen LT, 2008, AQUAT BOT, V89, P379, DOI 10.1016/j.aquabot.2008.04.008; NRCS, 2014, STAT NOX WEED LISTS; NRM-SA, 2011, STAT AL WEED STR AL; PRINS HBA, 1986, AQUAT BOT, V26, P225, DOI 10.1016/0304-3770(86)90023-9; PRINS HBA, 1982, PLANT CELL ENVIRON, V5, P207, DOI 10.1111/1365-3040.ep11571916; Rantala MJ, 2004, AQUAT ECOL, V38, P77; RENMAN G, 1989, HYDROBIOLOGIA, V185, P211, DOI 10.1007/BF00036609; ROELOFS JGM, 1991, AQUAT BOT, V39, P267, DOI 10.1016/0304-3770(91)90004-O; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; SMOLDERS A, 1993, AQUAT BOT, V46, P247, DOI 10.1016/0304-3770(93)90005-H; Smolders AJP, 2003, HYDROBIOLOGIA, V506, P603, DOI 10.1023/B:HYDR.0000008551.56661.8e; Smolders AJP, 1996, NEW PHYTOL, V133, P253, DOI 10.1111/j.1469-8137.1996.tb01892.x; Strzalek M, 2009, AQUAT BOT, V90, P1, DOI 10.1016/j.aquabot.2008.04.010; Stumm W, 1996, CURRENT CONTENTS AGR, P157, DOI [10.7717/peerj.328PMID:24749007, DOI 10.7717/PEERJ.328PMID:24749007]; Sugier P, 2010, HYDROBIOLOGIA, V656, P43, DOI 10.1007/s10750-010-0433-2; Suhonen J, 2013, J INSECT CONSERV, V17, P393, DOI 10.1007/s10841-012-9521-0; Toma C., 2006, BIODIVERSITY RES CON, V3-4, P251; Van der Winden J, 2004, ARDEA, V92, P53; Verhoeven JTA, 2001, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 2, P65	39	3	3	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124026	10.1371/journal.pone.0124026	http://dx.doi.org/10.1371/journal.pone.0124026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909504	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800056
J	Jansen, FM; Prins, RG; Etman, A; van der Ploeg, HP; de Vries, SI; van Lenthe, FJ; Pierik, FH				Jansen, F. Marijke; Prins, Rick G.; Etman, Astrid; van der Ploeg, Hidde P.; de Vries, Sanne I.; van Lenthe, Frank J.; Pierik, Frank H.			Physical Activity in Non-Frail and Frail Older Adults	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; EXERCISE; DECLINE; HEALTH	Introduction Physical activity (PA) is important for healthy ageing. Better insight into objectively measured PA levels in older adults is needed, since most previous studies employed self-report measures for PA assessment, which are associated with overestimation of PA. Aim This study aimed to provide insight in objectively measured indoor and outdoor PA of older adults, and in PA differences by frailty levels. Methods Data were collected among non-frail (N = 74) and frail (N = 10) subjects, aged 65 to 89 years. PA, measured for seven days with accelerometers and GPS-devices, was categorized into three levels of intensity (sedentary, light, and moderate-to-vigorous PA). Results Older adults spent most time in sedentary and light PA. Subjects spent 84.7%, 15.1% and 0.2% per day in sedentary, light and moderate-to-vigorous PA respectively. On average, older adults spent 9.8 (SD 23.7) minutes per week in moderate-to-vigorous activity, and 747.0 (SD 389.6) minutes per week in light activity. None of the subjects met the WHO recommendations of 150 weekly minutes of moderate-to-vigorous PA. Age-, sex- and health status-adjusted results revealed no differences in PA between non-frail and frail older adults. Subjects spent significantly more sedentary time at home, than not at home. Non-frail subjects spent significantly more time not at home during moderate-to-vigorous activities, than at home. Conclusions Objective assessment of PA in older adults revealed that most PA was of light intensity, and time spent in moderate-to-vigorous PA was very low. None of the older adults met the World Health Organization recommendations for PA. These levels of MVPA are much lower than generally reported based on self-reported PA. Future studies should employ objective methods, and age specific thresholds for healthy PA levels in older adults are needed. These results emphasize the need for effective strategies for healthy PA levels for the growing proportion of older adults.	[Jansen, F. Marijke; Pierik, Frank H.] TNO, Dept Urban Environm & Safety, Utrecht, Netherlands; [Prins, Rick G.; Etman, Astrid; van Lenthe, Frank J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van der Ploeg, Hidde P.] VU Univ Med Ctr Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [de Vries, Sanne I.] TNO, Dept Hlth Living, Leiden, Netherlands; [de Vries, Sanne I.] Hague Univ Appl Sci, Hlth Lifestyle Supporting Environm, The Hague, Netherlands; [Jansen, F. Marijke] Univ Utrecht, Human Geog & Planning, Utrecht, Netherlands	Netherlands Organization Applied Science Research; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Organization Applied Science Research; Utrecht University	Pierik, FH (corresponding author), TNO, Dept Urban Environm & Safety, Utrecht, Netherlands.	frank.pierik@tno.nl	de Vries, Sanne/ABH-4704-2020; van der Ploeg, Hidde P/B-2599-2013; van der Ploeg, Hidde/ABD-6402-2021	van der Ploeg, Hidde P/0000-0002-3719-5249; De Vries, Sanne/0000-0002-9032-883X	Netherlands Organisation for Health Research and Development [60-61900-98-451]; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1, MC_UU_12015/6] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/6, MR/K023187/1] Funding Source: researchfish	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by The Netherlands Organisation for Health Research and Development (funding number: 60-61900-98-451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acree LS, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-37; Aoyagi Y, 2013, ARCH GERONTOL GERIAT, V56, P327, DOI 10.1016/j.archger.2012.11.006; Asmus-Szepesi KJE, 2013, AGE AGEING, V42, P803, DOI 10.1093/ageing/aft126; Barreto PD, 2013, J PHYS ACT HEALTH, V10, P359, DOI 10.1123/jpah.10.3.359; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Catellier DJ, 2005, MED SCI SPORT EXER, V37, pS555, DOI 10.1249/01.mss.0000185651.59486.4e; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; de Vos AJBM, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-7; Etman A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-7; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fruianu M., 2009, CYCLING NETHERLANDS; Fuzeki E, 2013, PUBLIC HLTH FORUM, V21, DOI DOI 10.1016/J.PHF.2013.03.002; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Hoogerduijn JG, 2012, AGE AGEING, V41, P381, DOI 10.1093/ageing/afs015; Kerr J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-89; Lally F, 2007, POSTGRAD MED J, V83, P16, DOI 10.1136/pgmj.2006.048587; Maas J, 2013, NEIGHBOURHOOD STRUCT, P153; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Ministry of Transport Public Works and Water Management, 2010, MOB NED 2009; Park Soyoung, 2012, J Prev Med Public Health, V45, P21, DOI 10.3961/jpmph.2012.45.1.21; Prins RG, 2014, HEALTH PLACE, V27, P127, DOI 10.1016/j.healthplace.2014.01.012; Santos DA, 2012, EXP GERONTOL, V47, P908, DOI 10.1016/j.exger.2012.07.011; Sterkenburg RP, 2012, TNO060UT201201287; Strath SJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-40; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Suzuki T, 2010, TELEMED J E-HEALTH, V16, P686, DOI 10.1089/tmj.2009.0175; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Watkinson C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-68; Wendel-Vos, 2013, HOEVEEL MENSEN ZIJN; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2011, WHO PUBL	38	33	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123168	10.1371/journal.pone.0123168	http://dx.doi.org/10.1371/journal.pone.0123168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910249	Green Published, gold, Green Submitted			2022-12-26	WOS:000353376800029
J	Lei, W; Ni, H; Herington, J; Reese, J; Paria, BC				Lei, Wei; Ni, Hua; Herington, Jennifer; Reese, Jeff; Paria, Bibhash C.			Alkaline Phosphatase Protects Lipopolysaccharide-Induced Early Pregnancy Defects in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UTERINE EPITHELIAL-CELLS; MONOPHOSPHORYL-LIPID-A; ACUTE KIDNEY INJURY; PRETERM LABOR; MOUSE UTERUS; BACTERIAL-ENDOTOXIN; VACCINE ADJUVANT; INNATE IMMUNITY; IN-VIVO	Excessive cytokine inflammatory response due to chronic or superphysiological level of microbial infection during pregnancy leads to pregnancy complications such as early pregnancy defects/loss and preterm birth. Bacterial toxin lipopolysaccharide (LPS), long recognized as a potent proinflammatory mediator, has been identified as a risk factor for pregnancy complications. Alkaline phosphatase (AP) isozymes have been shown to detoxify LPS by dephosphorylation. In this study, we examined the role of alkaline phosphatase (AP) in mitigating LPS-induced early pregnancy complications in mice. We found that 1) the uterus prior to implantation and implantation sites following embryo implantation produce LPS recognition and dephosphorylation molecules TLR4 and tissue non-specific AP (TNAP) isozyme, respectively; 2) uterine TNAP isozyme dephosphorylates LPS at its sites of production; 3) while LPS administration following embryo implantation elicits proinflammatory cytokine mRNA levels at the embryo implantation sites (EISs) and causes early pregnancy loss, dephosphorylated LPS neither triggers proinflammatory cytokine mRNA levels at the EISs nor induces pregnancy complications; 4) AP isozyme supplementation to accelerate LPS detoxification attenuates LPS-induced pregnancy complications following embryo implantation. These findings suggest that a LPS dephosphorylation strategy using AP isozyme may have a unique therapeutic potential to mitigate LPS- or Gram-negative bacteria-induced pregnancy complications in at-risk women.	[Lei, Wei; Herington, Jennifer; Reese, Jeff; Paria, Bibhash C.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; [Ni, Hua] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China	Vanderbilt University; Northeast Agricultural University - China	Paria, BC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA.	bc.paria@vanderbilt.edu	Lei, Wei/N-7611-2013	Lei, Wei/0000-0002-8342-8859; Reese, Jeff/0000-0001-8751-6146	National Institutes of Health [HD044741]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044741, R01HD081121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health grant HD044741.	Aisemberg J, 2010, NEUROIMMUNOMODULAT, V17, P150, DOI 10.1159/000258710; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Austin KJ, 2003, ENDOCRINOLOGY, V144, P3107, DOI 10.1210/en.2002-0031; Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Bucci M, 1995, CELL BIOL INT, V19, P921, DOI 10.1006/cbir.1995.1030; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; CHAN JRA, 1986, J BIOL CHEM, V261, P7635; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; Clark DA, 2004, AM J REPROD IMMUNOL, V52, P370, DOI 10.1111/j.1600-0897.2004.00237.x; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Deb K, 2004, REPRODUCTION, V128, P87, DOI 10.1530/rep.1.00110; Deb Kaushik, 2005, Infect Dis Obstet Gynecol, V13, P125, DOI 10.1080/10647440500147885; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hajishafiha M, 2011, INT J WOMENS HEALTH, V3, P329, DOI 10.2147/IJWH.S24424; HALL CL, 1983, P NATL ACAD SCI-BIOL, V80, P6671, DOI 10.1073/pnas.80.21.6671; HASE S, 1977, EUR J BIOCHEM, V75, P23, DOI 10.1111/j.1432-1033.1977.tb11500.x; Haziot A, 1995, Prog Clin Biol Res, V392, P349; Hirsch E, 2005, J SOC GYNECOL INVEST, V12, P145, DOI 10.1016/j.jsgi.2005.01.007; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huck O, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/164654; Ie S, 2002, OBSTET GYNECOL SURV, V57, P39, DOI 10.1097/00006254-200201000-00022; Jaiswal MK, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108068; Jaiswal YK, 2009, FERTIL STERIL, V91, P2095, DOI 10.1016/j.fertnstert.2008.04.050; JOHANSSON S, 1994, ANAT EMBRYOL, V190, P287; JONES DJ, 1974, LIFE SCI, V14, P1577, DOI 10.1016/0024-3205(74)90168-4; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kozlenkov A, 2004, J BONE MINER RES, V19, P1862, DOI 10.1359/JBMR.040608; Krikun G, 2007, HISTOL HISTOPATHOL, V22, P847, DOI 10.14670/HH-22.847; Kurien BT, 1997, ANAL BIOCHEM, V245, P123, DOI 10.1006/abio.1996.9971; Lei W, 2013, REPRODUCTION, V146, P419, DOI 10.1530/REP-13-0153; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin JH, 1997, PHARMACOL REV, V49, P403; Liska D J, 1998, Altern Med Rev, V3, P187; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; MURDOCH RN, 1978, J REPROD FERTIL, V54, P293, DOI 10.1530/jrf.0.0540293; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NARISAWA S, 1992, DEVELOPMENT, V116, P159; Narisawa S, 2007, AM J PHYSIOL-GASTR L, V293, pG1068, DOI 10.1152/ajpgi.00073.2007; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Ojogun N, 2009, J INFECT DIS, V200, P1685, DOI 10.1086/646616; Pan HY, 2006, ENDOCRINOLOGY, V147, P4904, DOI 10.1210/en.2006-0140; Pararas MV, 2006, EUR J CLIN MICROBIOL, V25, P562, DOI 10.1007/s10096-006-0190-3; Paria BC, 1999, DEV BIOL, V208, P488, DOI 10.1006/dbio.1999.9206; Peters E, 2014, AM J KIDNEY DIS, V63, P1038, DOI 10.1053/j.ajkd.2013.11.027; Peters E, 2013, J PHARMACOL EXP THER, V344, P2, DOI 10.1124/jpet.112.198226; Poelstra K, 1997, LAB INVEST, V76, P319; Poelstra K, 1997, AM J PATHOL, V151, P1163; POLLARD JW, 1990, J REPROD FERTIL, V89, P735; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012906; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Soboll G, 2006, BIOL REPROD, V75, P131, DOI 10.1095/biolreprod.106.050690; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Veen SQ, 2005, INFECT IMMUN, V73, P4309, DOI 10.1128/IAI.73.7.4309-4314.2005; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wang XH, 2004, J CELL SCI, V117, P53, DOI 10.1242/jcs.00826; Wang XH, 2002, DEVELOPMENT, V129, P4125; Whitehouse JS, 2010, J SURG RES, V163, P79, DOI 10.1016/j.jss.2010.04.048; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	71	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0123243	10.1371/journal.pone.0123243	http://dx.doi.org/10.1371/journal.pone.0123243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910276	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800030
J	Xu, XX; Li, JY; Zhang, W; Huang, HQ; Shi, PJ; Luo, HY; Liu, B; Zhang, YH; Zhang, ZF; Fan, YL; Yao, B				Xu, Xinxin; Li, Jinyang; Zhang, Wei; Huang, Huoqing; Shi, Pengjun; Luo, Huiying; Liu, Bo; Zhang, Yuhong; Zhang, Zhifang; Fan, Yunliu; Yao, Bin			A Neutral Thermostable beta-1,4-Glucanase from Humicola insolens Y1 with Potential for Applications in Various Industries	PLOS ONE			English	Article							PHIALOPHORA SP G5; ENZYMATIC-PROPERTIES; CELLULASES; ENDOGLUCANASE; CELLULOSE; DEGRADATION; PURIFICATION; SYNERGY; CLONING; MODE	We cloned a new glycoside hydrolase family 6 gene, Hicel6C, from the thermophilic fungus Humicola insolens Y1 and expressed it in Pichia pastoris. Using barley beta-glucan as a substrate, recombinant HiCel6C protein exhibited neutral pH (6.5) and high temperature (70 degrees C) optima. Distinct from most reported acidic fungal endo-beta-1,4-glucanases, HiCel6C was alkali- tolerant, retaining greater than 98.0, 61.2, and 27.6% of peak activity at pH 8.0, 9.0, and 10.0, respectively, and exhibited good stability over a wide pH range (pH 5.0-11.0) and at temperatures up to 60 degrees C. The Km and V-max values of HiCel6C for barley beta-glucan were 1.29 mg/mL and 752 mu mol/min.mg, respectively. HiCel6C was strictly specific for the beta-1,4-glucoside linkage exhibiting activity toward barley beta-glucan, lichenan, and carboxy methylcellulose sodium salt (CMC-Na), but not toward laminarin (1,3-beta-glucan). HiCel6C cleaved the internal glycosidic linkages of cellooligosaccharides randomly and thus represents an endo-cleaving enzyme. The predominant product of polysaccharide hydrolysis by HiCel6C was cellobiose, suggesting that it functions by an endo-processive mechanism. The favorable properties of HiCel6C make it a good candidate for basic research and for applications in the textile and brewing industries.	[Xu, Xinxin; Li, Jinyang; Zhang, Wei; Liu, Bo; Zhang, Yuhong; Zhang, Zhifang; Fan, Yunliu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China; [Huang, Huoqing; Shi, Pengjun; Luo, Huiying; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, W (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China.	zhangwei02@caas.cn; binyao@caas.cn			National High Technology Research and Development Program of China [2012AA022105, 2012AA022207]; National Science Foundation for Distinguished Young Scholars of China [31225026]; China Modern Agriculture Research System [CARS-42]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Modern Agriculture Research System	This research was supported by the National High Technology Research and Development Program of China (2012AA022105, 2012AA022207) and the National Science Foundation for Distinguished Young Scholars of China (31225026) and the China Modern Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anish R, 2007, BIOTECHNOL BIOENG, V96, P48, DOI 10.1002/bit.21175; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Busk PK, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-47; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cavaco-Paulo A, 1998, TEXT RES J, V68, P398, DOI 10.1177/004051759806800602; Conde R, 2004, J BIOL CHEM, V279, P43789, DOI 10.1074/jbc.M406678200; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Du YL, 2013, BIORESOURCE TECHNOL, V130, P161, DOI 10.1016/j.biortech.2012.12.067; Ghatge SS, 2014, APPL MICROBIOL BIOT, V98, P4421, DOI 10.1007/s00253-013-5446-0; Jeya M, 2010, APPL MICROBIOL BIOT, V85, P1005, DOI 10.1007/s00253-009-2070-0; Karlsson J, 2002, BIOPOLYMERS, V63, P32, DOI 10.1002/bip.1060; Li D.C., 2011, ENZYME RES, V2011; Luo HY, 2012, J IND MICROBIOL BIOT, V39, P547, DOI 10.1007/s10295-011-1067-8; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Miettinen-Oinonen A, 2004, ENZYME MICROB TECH, V34, P332, DOI 10.1016/j.enzmictec.2003.11.011; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Souza FHM, 2013, J MOL CATAL B-ENZYM, V94, P119, DOI 10.1016/j.molcatb.2013.05.012; Oliveira GS, 2013, WORLD J MICROB BIOT, V29, P19, DOI 10.1007/s11274-012-1153-8; Pham TH, 2011, J MICROBIOL BIOTECHN, V21, P1012, DOI 10.4014/jmb.1104.04030; Samanta S, 2012, J MICROBIOL, V50, P518, DOI 10.1007/s12275-012-1207-5; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; Sorensen HR, 2006, APPL MICROBIOL BIOT, V73, P850, DOI 10.1007/s00253-006-0543-y; Takashima S, 1999, J BIOTECHNOL, V67, P85, DOI 10.1016/S0168-1656(98)00168-0; Tiwari P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/203735; Wang K, 2014, APPL MICROBIOL BIOTE; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Yang XZ, 2014, FOOD CHEM, V148, P381, DOI 10.1016/j.foodchem.2013.10.062; Zhao JQ, 2012, J BIOSCI BIOENG, V114, P379, DOI 10.1016/j.jbiosc.2012.04.021; Zhao JQ, 2012, BIORESOURCE TECHNOL, V121, P404, DOI 10.1016/j.biortech.2012.07.027; Zheng F, 2013, APPL ENVIRON MICROB, V79, P989, DOI 10.1128/AEM.02725-12	34	69	74	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124925	10.1371/journal.pone.0124925	http://dx.doi.org/10.1371/journal.pone.0124925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909505	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800116
J	Auldridge, ME; Cao, HN; Sen, S; Franz, LP; Bingman, CA; Yennamalli, RM; Phillips, GN; Mead, D; Steinmetz, EJ				Auldridge, Michele E.; Cao, Hongnan; Sen, Saurabh; Franz, Laura P.; Bingman, Craig A.; Yennamalli, Ragothaman M.; Phillips, George N., Jr.; Mead, David; Steinmetz, Eric J.			LucY: A Versatile New Fluorescent Reporter Protein	PLOS ONE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE MURB; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; VIBRIO-FISCHERI; DYNAMICS; COMPLEMENTATION; PURIFICATION; FEMTOSECOND; ALIGNMENT	We report on the discovery, isolation, and use of a novel yellow fluorescent protein. Lucigen Yellow (LucY) binds one FAD molecule within its core, thus shielding it from water and maintaining its structure so that fluorescence is 10-fold higher than freely soluble FAD. LucY displays excitation and emission spectra characteristic of FAD, with 3 excitation peaks at 276nm, 377nm, and 460nm and a single emission peak at 530nm. These excitation and emission maxima provide the large Stokes shift beneficial to fluorescence experimentation. LucY belongs to the MurB family of UDP-N-acetylenolpyruvylglucosamine reductases. The high resolution crystal structure shows that in contrast to other structurally resolved MurB enzymes, LucY does not contain a potentially quenching aromatic residue near the FAD isoalloxazine ring, which may explain its increased fluorescence over related proteins. Using E. coli as a system in which to develop LucY as a reporter, we show that it is amenable to circular permutation and use as a reporter of protein-protein interaction. Fragmentation between its distinct domains renders LucY non-fluorescent, but fluorescence can be partially restored by fusion of the fragments to interacting protein domains. Thus, LucY may find application in Protein-fragment Complementation Assays for evaluating proteinprotein interactions.	[Auldridge, Michele E.; Sen, Saurabh; Franz, Laura P.; Mead, David; Steinmetz, Eric J.] Lucigen Corp, Middleton, WI 53562 USA; [Cao, Hongnan; Yennamalli, Ragothaman M.; Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Rice University; University of Wisconsin System; University of Wisconsin Madison	Steinmetz, EJ (corresponding author), Lucigen Corp, Middleton, WI 53562 USA.	esteinmetz@lucigen.com	Yennamalli, Ragothaman/M-7870-2017	Yennamalli, Ragothaman/0000-0002-3327-1582; Cao, Hongnan/0000-0003-2496-1298; MEAD, David/0000-0003-1982-9356	U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]	U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor	Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], PYM MOL GRAPH SYST V; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; Axley MJ, 1997, BIOCHEMISTRY-US, V36, P812, DOI 10.1021/bi962260s; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BENSON TE, 1995, NAT STRUCT BIOL, V2, P644, DOI 10.1038/nsb0895-644; Benson TE, 1996, STRUCTURE, V4, P47, DOI 10.1016/S0969-2126(96)00008-1; BENSON TE, 1993, BIOCHEMISTRY-US, V32, P2024, DOI 10.1021/bi00059a019; Benson TE, 2001, BIOCHEMISTRY-US, V40, P2340, DOI 10.1021/bi002162d; Benson TE, 1997, BIOCHEMISTRY-US, V36, P796, DOI 10.1021/bi962220o; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; DAUBNER SC, 1987, P NATL ACAD SCI USA, V84, P8912, DOI 10.1073/pnas.84.24.8912; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filippova E, XRAY CRYSTAL S UNPUB; Filonov GS, 2013, CHEM BIOL, V20, P1078, DOI 10.1016/j.chembiol.2013.06.009; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Hof M, 2005, FLUORECENCE SPECTROS; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kim MK, 2007, PROTEINS, V66, P751, DOI 10.1002/prot.21174; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lugsanangarm K, 2012, PROTEIN STRUCTURE; Lukacs A, 2012, J PHYS CHEM B, V116, P5810, DOI 10.1021/jp2116559; MACHEROUX P, 1987, BIOCHEM BIOPH RES CO, V146, P101, DOI 10.1016/0006-291X(87)90696-6; Mataga N, 2002, J PHYS CHEM B, V106, P8917, DOI 10.1021/jp0205741; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Mukherjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064753; Mukherjee A, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-20; Munro AW, 1999, METH MOL B, V131, P25; Nakabayashi T, 2010, J PHYS CHEM B, V114, P15254, DOI 10.1021/jp1063066; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Sarver RW, 2002, J BIOMOL SCREEN, V7, P21, DOI 10.1177/108705710200700104; Sen S, 2012, NAT METHODS, V9, pIII, DOI 10.1038/nmeth.f.356; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Steinmetz E, 2010, GENETIC ENG BIOTECHN; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanaka F, 2007, J PHYS CHEM B, V111, P5694, DOI 10.1021/jp066450g; Tchekanda E, 2014, NAT METHODS, V11, P641, DOI [10.1038/nmeth.2934, 10.1038/NMETH.2934]; Theorell H, 1955, NOBLE PRIZE LECT; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van den Berg PAW, 1998, BIOPHYS J, V74, P2046, DOI 10.1016/S0006-3495(98)77911-1; WILLIAMS ATR, 1983, ANALYST, V108, P1067, DOI 10.1039/an9830801067; Yang YJ, 2006, ANTIMICROB AGENTS CH, V50, P556, DOI 10.1128/AAC.50.2.556-564.2006; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zhang R, XRAY CRYSTAL S UNPUB	63	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124272	10.1371/journal.pone.0124272	http://dx.doi.org/10.1371/journal.pone.0124272			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906065	gold, Green Submitted, Green Published			2022-12-26	WOS:000353332000063
J	Keith, MCL; Tang, XL; Tokita, Y; Li, QH; Ghafghazi, S; Moore, J; Hong, KU; Elmore, B; Amraotkar, A; Ganzel, BL; Grubb, KJ; Flaherty, MP; Hunt, G; Vajravelu, B; Wysoczynski, M; Bolli, R				Keith, Matthew C. L.; Tang, Xian-Liang; Tokita, Yukichi; Li, Qian-hong; Ghafghazi, Shahab; Moore, Joseph; Hong, Kyung U.; Elmore, Brandon; Amraotkar, Alok; Ganzel, Brian L.; Grubb, Kendra J.; Flaherty, Michael P.; Hunt, Gregory; Vajravelu, Bathri; Wysoczynski, Marcin; Bolli, Roberto			Safety of Intracoronary Infusion of 20 Million C-Kit Positive Human Cardiac Stem Cells in Pigs	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; ACUTE MYOCARDIAL-INFARCTION; PROGENITOR CELLS; PORCINE MODEL; DELIVERY; TRANSPLANTATION; REGENERATION; INJECTION; EFFICACY	Background There is mounting interest in using c-kit positive human cardiac stem cells (c-kit(pos) hCSCs) to repair infarcted myocardium in patients with ischemic cardiomyopathy. A recent phase I clinical trial (SCIPIO) has shown that intracoronary infusion of 1 million hCSCs is safe. Higher doses of CSCs may provide superior reparative ability; however, it is unknown if doses >1 million cells are safe. To address this issue, we examined the effects of 20 million hCSCs in pigs. Methods Right atrial appendage samples were obtained from patients undergoing cardiac surgery. The tissue was processed by an established protocol with eventual immunomagnetic sorting to obtain in vitro expanded hCSCs. A cumulative dose of 20 million cells was given intracoronarily to pigs without stop flow. Safety was assessed by measurement of serial biomarkers (cardiac: troponin I and CK-MB, renal: creatinine and BUN, and hepatic: AST, ALT, and alkaline phosphatase) and echocardiography pre- and post-infusion. hCSC retention 30 days after infusion was quantified by PCR for human genomic DNA. All personnel were blinded as to group assignment. Results Compared with vehicle-treated controls (n=5), pigs that received 20 million hCSCs (n=9) showed no significant change in cardiac function or end organ damage (assessed by organ specific biomarkers) that could be attributed to hCSCs (P>0.05 in all cases). No hCSCs could be detected in left ventricular samples 30 days after infusion. Conclusions Intracoronary infusion of 20 million c-kit positive hCSCs in pigs (equivalent to similar to 40 million hCSCs in humans) does not cause acute cardiac injury, impairment of cardiac function, or liver and renal injury. These results have immediate translational value and lay the groundwork for using doses of CSCs >1 million in future clinical trials. Further studies are needed to ascertain whether administration of >1 million hCSCs is associated with greater efficacy in patients with ischemic cardiomyopathy.	[Keith, Matthew C. L.; Tang, Xian-Liang; Tokita, Yukichi; Li, Qian-hong; Ghafghazi, Shahab; Moore, Joseph; Hong, Kyung U.; Elmore, Brandon; Amraotkar, Alok; Flaherty, Michael P.; Hunt, Gregory; Vajravelu, Bathri; Wysoczynski, Marcin; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [Ganzel, Brian L.; Grubb, Kendra J.] Univ Louisville, Dept Cardiothorac Surg, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Bolli, R (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	Roberto.Bolli@louisville.edu	Moore, Joseph B/I-4161-2013; Wysoczynski, Marcin/I-4334-2013; Vajravelu, Bathri/K-5504-2019; Hong, Kyung Uk/G-7145-2011; Li, Qianhong/AAJ-7643-2020; Amraotkar, Alok/B-6429-2016	Hong, Kyung Uk/0000-0001-6700-9470; Amraotkar, Alok/0000-0001-7506-8673; Grubb, Kendra/0000-0002-1369-5521; Ghafghazi, Shahab/0000-0001-5061-6119	NIH [P01-HL78825, 1 UM1 HL-113530]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL113530, P01HL078825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by NIH grants P01-HL78825 and 1 UM1 HL-113530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen Shaoliang, 2006, J Invasive Cardiol, V18, P552; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; ENGLISH J, 1987, TRANSPLANTATION, V44, P135, DOI 10.1097/00007890-198707000-00027; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Gao LR, 2013, INT J CARDIOL, V168, P3191, DOI 10.1016/j.ijcard.2013.04.112; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673, DOI 10.2214/ajr.183.6.01831673; Grieve SM, 2010, CIRC-HEART FAIL, V3, pE5, DOI 10.1161/CIRCHEARTFAILURE.109.931360; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; KASSAB GS, 1994, AM J PHYSIOL, V267, pH319, DOI 10.1152/ajpheart.1994.267.1.H319; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Keith MC, 2014, CIRCULATION, V130; Lakota J, 2014, INT J CARDIOL, V176, P547, DOI 10.1016/j.ijcard.2014.07.024; Lee JW, 2014, J KOREAN MED SCI, V29, P23, DOI 10.3346/jkms.2014.29.1.23; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Meluzin J, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.004; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Suzuki G, 2011, CIRC RES, V109, P1044, DOI 10.1161/CIRCRESAHA.111.245969; Taghavi S, 2013, AM J TRANSL RES, V5, P404; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670; Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X; Weibrecht K, 2010, J MED TOXICOL, V6, P294, DOI 10.1007/s13181-010-0075-9	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124227	10.1371/journal.pone.0124227	http://dx.doi.org/10.1371/journal.pone.0124227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905721	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000060
J	Lopez-Campos, JL; Hartl, S; Pozo-Rodriguez, F; Roberts, M				Luis Lopez-Campos, Jose; Hartl, Sylvia; Pozo-Rodriguez, Francisco; Roberts, Michael		European COPD Audit Team	Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; PROCALCITONIN; MOXIFLOXACIN; MANAGEMENT; OUTCOMES; SPUTUM; SEX	Objective Appropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved. Methods The European COPD audit was a study of clinical care in 384 hospitals from 13 European countries between 2010 and 2011 enrolling 16018 patients. Those admitted to hospital due to a clinician-made diagnosis of exacerbation of COPD at the time of discharge were audited. We defined antibiotic prescribing compliance as consistent with the GOLD 2010 recommendations. Two different multivariate models were used to evaluate factors associated with the prescription of antibiotics and the guideline-compliant prescriptions. Results Overall 86% of admissions were given antibiotics but only 61.4% cases met the GOLD recommendations. Antibiotics were more likely to be given in hospital and at discharge if received prior to admission. Antibiotic prescription was more likely in patients who met the GOLD recommendations and in those with radiological consolidation but there was also a significant use of antibiotics in patients who did not meet either criterion. Patients cared for on a Respiratory Ward were more likely to receive GOLD compliant antibiotic management. Conclusions The present study describes the audited in-hospital antibiotic prescription for COPD exacerbation across different European countries. In general, there is an apparent overuse of antibiotics likely to be associated with both patient and practice-related variables.	[Luis Lopez-Campos, Jose] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Luis Lopez-Campos, Jose; Pozo-Rodriguez, Francisco] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Hartl, Sylvia] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Inst Invest I 12, E-28041 Madrid, Spain; [Roberts, Michael] Univ London, Barts & London Sch Med & Dent, London WC1E 7HU, England	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Ludwig Boltzmann Institute; Hospital Universitario 12 de Octubre; University of London; Queen Mary University London	Lopez-Campos, JL (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	lcampos@separ.es	López-Quílez, Antonio/H-5945-2011; Özgür, Eylem Sercan/I-1921-2015; Bodineau, José Luis López-Campos/AAG-5203-2019; Arghir, Oana C/F-8515-2015; Guardia, Sergi Pascual/L-7652-2014	López-Quílez, Antonio/0000-0002-7022-9260; Özgür, Eylem Sercan/0000-0003-4459-232X; Bodineau, José Luis López-Campos/0000-0003-1703-1367; Arghir, Oana C/0000-0001-9844-8521; Guardia, Sergi Pascual/0000-0002-6567-0916; CORBACHO, DOLORES/0000-0003-1239-5276; roberts, christopher/0000-0001-8212-1460	Almirall; Takeda; Bohringer; Novartis; GlaxoSmithKline; Torrex Chiesi; AstraZeneca; MeckSharpDome	Almirall(Almirall); Takeda(Takeda Pharmaceutical Company Ltd); Bohringer; Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Torrex Chiesi(Chiesi Pharmaceuticals Inc); AstraZeneca(AstraZeneca); MeckSharpDome	Almirall, Takeda, Bohringer, Novartis, GlaxoSmithKline, Torrex Chiesi, AstraZeneca, and MeckSharpDome provided support in the form of salaries for authors SH and CMR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aryal S, 2014, INT J CHRONIC OBSTR, V9, P1145, DOI 10.2147/COPD.S54476; Brusse-Keizer M, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000052; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Daniels JMA, 2010, CHEST, V138, P1108, DOI 10.1378/chest.09-2927; DiSantostefano RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097149; Huerta A, 2013, CHEST, V144, P1134, DOI 10.1378/chest.13-0488; Liu KX, 2014, J THORAC DIS, V6, P221, DOI 10.3978/j.issn.2072-1439.2013.11.12; Llor C, 2013, THER ADV RESPIR DIS, V7, P131, DOI 10.1177/1753465812472387; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; Myint PK, 2011, RESPIRATION, V82, P320, DOI 10.1159/000327203; Papaioannou AI, 2014, INT J CHRONIC OBSTR, V9, P203, DOI 10.2147/COPD.S52500; Pozo-Rodriguez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042156; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Roche N, 2007, RESPIRATION, V74, P19, DOI 10.1159/000093158; Roche N, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-20; Schwarzmann S W, 2000, Postgrad Med, V108, P25, DOI 10.3810/pgm.12.2000.suppl10.53; Stefan MS, 2013, CHEST, V143, P82, DOI 10.1378/chest.12-0649; Stockley RA, 2000, CHEST, V117, P1638, DOI 10.1378/chest.117.6.1638; Stolz D, 2009, CURR OPIN PULM MED, V15, P126, DOI 10.1097/MCP.0b013e328324e6d7; Vollenweider Daniela J, 2012, Cochrane Database Syst Rev, V12, pCD010257, DOI 10.1002/14651858.CD010257; Weis N, 2006, EUR J INTERN MED, V17, P88, DOI 10.1016/j.ejim.2005.09.020; Wilson R, 2012, EUR RESPIR J, V40, P17, DOI 10.1183/09031936.00090311; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705	24	32	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124374	10.1371/journal.pone.0124374	http://dx.doi.org/10.1371/journal.pone.0124374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905726	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000069
J	Carvalho, S; Lindzen, M; Lauriola, M; Shirazi, N; Sinha, S; Abdul-Hai, A; Levanon, K; Korach, J; Barshack, I; Cohen, Y; Onn, A; Mills, G; Yarden, Y				Carvalho, S.; Lindzen, M.; Lauriola, M.; Shirazi, N.; Sinha, S.; Abdul-Hai, A.; Levanon, K.; Korach, J.; Barshack, I.; Cohen, Y.; Onn, A.; Mills, G.; Yarden, Y.			An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors	ONCOGENE			English	Article							FACTOR RECEPTOR; ERBB RECEPTORS; EGFR LIGANDS; CANCER; AUTOCRINE; EXPRESSION; COMBINATIONS; GEFITINIB; CARCINOMA; PARACRINE	Growth factors of the epidermal growth factor (EGF)/neuregulin family are involved in tumor progression and, accordingly, antibodies that intercept a cognate receptor, epidermal growth factor receptor ( EGFR)/ERBB1, or a co-receptor, HER2, have been approved for cancer therapy. Although they might improve safety and delay onset of chemoresistance, no anti-ligand antibodies have been clinically approved. To identify suitable ligands, we surveyed fluids from ovarian and lung cancer patients and found that amphiregulin (AREG) is the most abundant and generalized ligand secreted by advanced tumors. AREG is a low affinity EGFR ligand, which is upregulated following treatment with chemotherapeutic drugs. Because AREG depletion retarded growth of xenografted ovarian tumors in mice, we generated a neutralizing monoclonal anti-AREG antibody. The antibody inhibited growth of ovarian cancer xenografts and strongly enhanced chemotherapy efficacy. Taken together, these results raise the possibility that AREG and other low-or high-affinity binders of EGFR might serve as potential targets for cancer therapy.	[Carvalho, S.; Lindzen, M.; Lauriola, M.; Shirazi, N.; Sinha, S.; Yarden, Y.] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Abdul-Hai, A.] Kaplan Med Ctr, Rehovot, Israel; [Levanon, K.] Chaim Sheba Med Ctr, Dr Pinchas Borenstein Talpiot Med Leadership Prog, Ramat Gan, Israel; [Levanon, K.] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel; [Korach, J.] Chaim Sheba Med Ctr, Dept Gynecol Oncol, Ramat Gan, Israel; [Barshack, I.] Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Cohen, Y.] Sheba Med Ctr, Inst Tissue Banks, Ramat Gan, Israel; [Onn, A.] Chaim Sheba Med Ctr, Inst Pulm Oncol, Ramat Gan, Israel; [Mills, G.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lauriola, M.] Univ Bologna, Dept Expt Diagnost & Specialty Med, Unit Histol Embryol & Appl Biol, I-40126 Bologna, Italy	Weizmann Institute of Science; Hebrew University of Jerusalem; Kaplan Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of Bologna	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	lauriola, mattia/N-6435-2014	Levanon, Keren/0000-0002-5122-064X; lauriola, mattia/0000-0002-7966-0065	Merck KGaA; Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; MD Moross Institute for Cancer Research; Flight Attendants Medical Research Institute (FAMRI); NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	Merck KGaA(Merck & Company); Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; MD Moross Institute for Cancer Research; Flight Attendants Medical Research Institute (FAMRI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Julian Downward for lung cell lines. This work was performed at the Marvin Tanner Laboratory for Cancer Research and it was supported, in part, by Merck KGaA. The research in our laboratory is supported by the Israel Cancer Research Fund and the Dr Miriam and Sheldon G Adelson Medical Research Foundation and by the MD Moross Institute for Cancer Research. YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair. The Sheba Institutional Tissue Banks have received financial support from the Flight Attendants Medical Research Institute (FAMRI).	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Brustmann H, 2008, INT J GYNECOL PATHOL, V27, P380, DOI 10.1097/PGP.0b013e31815d060d; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; DeWitt A, 2002, DEV BIOL, V250, P305, DOI 10.1006/dbio.2002.0807; EBNER R, 1991, CELL REGUL, V2, P599, DOI 10.1091/mbc.2.8.599; Eckstein N, 2008, J BIOL CHEM, V283, P739, DOI 10.1074/jbc.M706287200; Esposito CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024071; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Gui T, 2012, CANCER EPIDEMIOL, V36, P490, DOI 10.1016/j.canep.2012.06.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Lassus H, 2006, J MOL MED-JMM, V84, P671, DOI 10.1007/s00109-006-0054-4; Lazzara MJ, 2009, EXP CELL RES, V315, P717, DOI 10.1016/j.yexcr.2008.10.033; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lindzen M, 2012, ONCOGENE, V31, P3505, DOI 10.1038/onc.2011.518; Lindzen M, 2010, P NATL ACAD SCI USA, V107, P12559, DOI 10.1073/pnas.1006218107; Lopez J, 2013, ANN ONCOL, V24, P69, DOI 10.1093/annonc/mdt475; Murphy M, 2011, DRUG RESIST UPDATE, V14, P177, DOI 10.1016/j.drup.2011.02.004; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Panupinthu N, 2014, ONCOGENE, V33, P2846, DOI 10.1038/onc.2013.259; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Reddy CC, 1996, NAT BIOTECHNOL, V14, P1696, DOI 10.1038/nbt1296-1696; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sato S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051964; Sauer L, 2010, ONCOGENE, V29, P2628, DOI 10.1038/onc.2010.24; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Siwak DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/568938; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948; Van Zoelen E J, 2000, Vitam Horm, V59, P99, DOI 10.1016/S0083-6729(00)59005-0; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Zwang Yaara, 2009, Traffic, V10, P349, DOI 10.1111/j.1600-0854.2008.00870.x	52	23	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 28	2016	35	4					438	447		10.1038/onc.2015.93	http://dx.doi.org/10.1038/onc.2015.93			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC2OT	25915843				2022-12-26	WOS:000369056700004
J	Boucher, D; Vu, T; Bain, AL; Tagliaro-Jahns, M; Shi, W; Lane, SW; Khanna, KK				Boucher, Didier; Vu, Therese; Bain, Amanda L.; Tagliaro-Jahns, Marina; Shi, Wei; Lane, Steven W.; Khanna, Kum Kum			Ssb2/Nabp1 is dispensable for thymic maturation, male fertility, and DNA repair in mice	FASEB JOURNAL			English	Article						knockout mouse model; thymopoiesis; testis development; DNA damage response	STRAND BREAK REPAIR; BINDING-PROTEINS; DAMAGE; HSSB1; PHOSPHORYLATION; PARTICIPATE; RECRUITMENT; MAINTENANCE; COMPLEXES	SSB1 and SSB2 are newly identified singlestranded (ss) DNAbinding proteins that play a crucial role in genome maintenance in humans. We recently generated a knockout mouse model of Ssb1 and revealed its essential role for neonatal survival. Notably, we found compensatory up-regulation of Ssb2 protein levels in multiple tissues of conditional Ssb1(-/-) mice, suggesting functional compensation between these 2 proteins. We report here the first description of Ssb2(-/-) knockout mice. Surprisingly, unlike Ssb1 knockout mice, Ssb2(-/-) mice are viable and fertile and do not exhibit marked phenotypic changes when compared with their Ssb2(+/+) and Ssb2(+/-) littermates. Notably, we did not detect any pathologic changes in the thymus, spleen, or testes, tissues with the most abundant expression of Ssb2. Moreover, Ssb2(-/-) mouse embryonic fibroblasts (MEFs) did not show any sensitivity to DNA-damaging agents, or defects in DNA repair capacity. However, we observed modest up-regulation of Ssb1 levels in Ssb2(-/-) MEFs as well as in Ssb2(-/-) thymus and spleen, suggesting that Ssb1 is likely able to compensate for the loss of Ssb2 in mice. Altogether, our results show that Ssb2 is dispensable for embryogenesis and adult tissue homeostasis, including thymopoiesis, splenic development, male fertility, and DNA repair in mice.	[Boucher, Didier; Bain, Amanda L.; Tagliaro-Jahns, Marina; Shi, Wei; Khanna, Kum Kum] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Herston, Qld 4006, Australia; [Vu, Therese; Lane, Steven W.] QIMR Berghofer Med Res Inst, Translat Leukaemia Res, Herston, Qld 4006, Australia; [Vu, Therese] Univ Queensland, Brisbane, Qld, Australia; [Tagliaro-Jahns, Marina] Ctr Natl Rech Sci 3559, Inst Natl Rech Agron, Inst Jean Pierre Bourgin, Equipes Rech Labellisees,Saclay Plant Sci,UMR 131, Versailles, France	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Khanna, KK (corresponding author), QIMR Berghofer Med Res Inst, Signal Transduct Lab, 300 Herston Rd, Herston, Qld 4006, Australia.	kumkum.khanna@qimrberghofer.edu.au	Shi, Wei/AAX-6450-2021	Shi, Wei/0000-0002-0378-8361; Vu, Therese/0000-0003-2831-2957; Khanna, Kum Kum/0000-0001-8650-5381; Boucher, Didier/0000-0002-7964-0881	Australian Research Council [DP109661]; National Health and Medical Research Council (NHMRC) [1031327]; Leukaemia Foundation; Cure Cancer Australia Foundation	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation; Cure Cancer Australia Foundation	The authors thank Stephen Miles and the QIMR Berghofer Animal Facility for technical assistance, and Dr. John Finnie for assistance with histopathological analysis. This work is supported by an Australian Research Council discovery grant (DP109661) and National Health and Medical Research Council (NHMRC) project grant (1031327) awarded to K.K.K. K.K.K. is supported by an NHMRC Senior Principle Research Fellowship. S.W.L. gratefully acknowledges funding from the NHMRC, Leukaemia Foundation, and Cure Cancer Australia Foundation.	Ashton NW, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-9; Bain AL, 2013, CELL RES, V23, P744, DOI 10.1038/cr.2013.63; Bee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069061; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Feldhahn N, 2012, EMBO J, V31, P4045, DOI 10.1038/emboj.2012.247; Gibb B, 2014, NAT STRUCT MOL BIOL, V21, P893, DOI 10.1038/nsmb.2886; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Gu P, 2013, CELL RES, V23, P705, DOI 10.1038/cr.2013.31; Hadjantonakis Anna-Katerina, 2008, V461, P111, DOI 10.1007/978-1-60327-483-8_8; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/573936; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janbandhu VC, 2014, CELL CYCLE, V13, P462, DOI 10.4161/cc.27271; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Kang HS, 2006, BIOCHEM J, V397, P89, DOI 10.1042/BJ20051781; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Lemaitre C, 2014, DNA REPAIR, V19, P163, DOI 10.1016/j.dnarep.2014.03.015; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Ochi T, 2014, DNA REPAIR, V17, P98, DOI 10.1016/j.dnarep.2014.02.010; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P3643, DOI 10.1093/nar/gkq1340; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P1692, DOI 10.1093/nar/gkq1098; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Shi W, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003298; Sinha M, 2008, MOL CELL, V30, P803, DOI 10.1016/j.molcel.2008.04.015; Skaar JR, 2009, J CELL BIOL, V187, P25, DOI 10.1083/jcb.200907026; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zhang F, 2013, J CELL SCI, V126, P4850, DOI 10.1242/jcs.132514; Zhang F, 2009, J BIOL CHEM, V284, P30408, DOI 10.1074/jbc.M109.039404	36	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3326	3334		10.1096/fj.14-269944	http://dx.doi.org/10.1096/fj.14-269944			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25917330				2022-12-26	WOS:000358796900020
J	Hisano, Y; Inoue, A; Okudaira, M; Taimatsu, K; Matsumoto, H; Kotani, H; Ohga, R; Aoki, J; Kawahara, A				Hisano, Yu; Inoue, Asuka; Okudaira, Michiyo; Taimatsu, Kiyohito; Matsumoto, Hirotaka; Kotani, Hirohito; Ohga, Rie; Aoki, Junken; Kawahara, Atsuo			Maternal and Zygotic Sphingosine Kinase 2 Are Indispensable for Cardiac Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL SAMPLES; 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE; MIGRATION; TALEN; FTY720; SPHINGOLIPIDS; METABOLISM; PRECURSORS; RECEPTORS	Sphingosine 1-phosphate (S1P) is synthesized from sphingosine by sphingosine kinases (SPHK1 and SPHK2) in invertebrates and vertebrates, whereas specific receptors for S1P (S1PRs) selectively appear in vertebrates, suggesting that S1P acquires novel functions invertebrates. Because the developmental functions of SPHK1 and SPHK2 remain obscure in vertebrates, we generated sphk1 or sphk2 gene-disrupted zebrafish by introducing premature stop codons in their coding regions using transcription activator-like effector nucleases. Both zygotic sphk1 and sphk2 zebrafish mutants exhibited no obvious developmental defects and grewtoadults. The maternal-zygotic sphk2 mutant(MZsphk2), but not the maternal-zygotic sphk1 mutant and maternal sphk2 mutant, had a defect in the cardiac progenitor migration and a concomitant decrease in S1P level, leading to a two-heart phenotype (cardia bifida). Cardia bifida in MZsphk2, which was rescued by injecting sphk2 mRNA, was a phenotype identical to that of zygotic mutants of the S1P transporter spns2 and S1P receptor s1pr2, indicating that the Sphk2-Spns2-S1pr2 axis regulates the cardiac progenitor migration in zebrafish. The contribution of maternally supplied lipid mediators during vertebrate organogenesis presents as a requirement for maternal-zygotic Sphk2.	[Hisano, Yu] RIKEN, Lab Dev Gene Regulat, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Inoue, Asuka; Okudaira, Michiyo; Matsumoto, Hirotaka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Univ Yamanashi, Grad Sch Med Sci, PRESTO, Chuo 4093898, Japan; [Aoki, Junken] Univ Yamanashi, Grad Sch Med Sci, Japan Sci & Technol Agcy, CREST, Chuo 4093898, Japan; [Taimatsu, Kiyohito; Kotani, Hirohito; Ohga, Rie; Kawahara, Atsuo] Univ Yamanashi, Grad Sch Med Sci, Ctr Med Educ & Sci, Dev Biol Lab, Chuo 4093898, Japan	RIKEN; Tohoku University; Japan Science & Technology Agency (JST); University of Yamanashi; Japan Science & Technology Agency (JST); University of Yamanashi; University of Yamanashi	Hisano, Y (corresponding author), RIKEN, Lab Dev Gene Regulat, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	y.hisano@riken.jp; akawahara@yamanashi.ac.jp	Okudaira, Michiyo/AGR-2053-2022	Aoki, Junken/0000-0001-9435-1896	Japan Society for the Promotion of Science; Program for Next Generation World-Leading Researchers (NEXT Program); Takeda Science Foundation; Special Postdoctoral Researcher Program from RIKEN; PRESTO (Precursory Research for Embryonic Science and Technology); CREST from Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Next Generation World-Leading Researchers (NEXT Program); Takeda Science Foundation(Takeda Science Foundation (TSF)); Special Postdoctoral Researcher Program from RIKEN; PRESTO (Precursory Research for Embryonic Science and Technology); CREST from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Japan Society for the Promotion of Science and the Program for Next Generation World-Leading Researchers (NEXT Program) and by Takeda Science Foundation. This work was also supported by the Special Postdoctoral Researcher Program (to Y. H.) from RIKEN and by PRESTO (Precursory Research for Embryonic Science and Technology; to A. I.) and CREST (to J. A.), from Japan Science and Technology Agency (JST).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Balczerski B, 2012, DEV BIOL, V362, P230, DOI 10.1016/j.ydbio.2011.12.010; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hanaoka R, 2006, GENES CELLS, V11, P293, DOI 10.1111/j.1365-2443.2006.00939.x; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hisano Y, 2013, BIOL OPEN, V2, P789, DOI 10.1242/bio.20134994; Hisano Y, 2013, BIOL OPEN, V2, P363, DOI 10.1242/bio.20133871; Hisano Y, 2012, J BIOCHEM, V152, P305, DOI 10.1093/jb/mvs090; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Mendelson K, 2013, J BIOL CHEM, V288, P2143, DOI 10.1074/jbc.M112.427344; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Orr Gandy K. A., 2013, BIOCHIM BIOPHYS ACTA, V1831, P157; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Saigusa D, 2012, ANAL BIOANAL CHEM, V403, P1897, DOI 10.1007/s00216-012-6004-9; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Ye D, 2013, DEVELOPMENT, V140, P789, DOI 10.1242/dev.085340; Yokota S, 2004, FEBS LETT, V578, P106, DOI 10.1016/j.febslet.2004.10.081; Zhang L, 2013, BLOOD, V122, P791, DOI 10.1182/blood-2012-12-473884	43	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14841	14851		10.1074/jbc.M114.634717	http://dx.doi.org/10.1074/jbc.M114.634717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25907554	Green Published, hybrid			2022-12-26	WOS:000356177300004
J	Allsopp, RC; Evans, RJ				Allsopp, Rebecca C.; Evans, Richard J.			Contribution of the Juxtatransmembrane Intracellular Regions to the Time Course and Permeation of ATP-gated P2X7 Receptor Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(2) RECEPTOR; XENOPUS OOCYTES; C-TERMINUS; DESENSITIZATION; PORE; ACTIVATION; EXPRESSION; MOTIF; LYMPHOCYTES; SENSITIVITY	P2X7 receptors are ATP-gated ion channels that contribute to inflammation and cell death. They have the novel property of showing marked facilitation to repeated applications of agonist, and the intrinsic channel pore dilates to allow the passage of fluorescent dyes. A 60-s application of ATP to hP2X7 receptors expressed in Xenopus oocytes gave rise to a current that had a biphasic time course with initial and secondary slowly developing components. A second application of ATP evoked a response with a more rapid time to peak. This facilitation was reversed to initial levels following a 10-min agonist-free interval. A chimeric approach showed that replacement of the pre-TM1 amino-terminal region with the corresponding P2X2 receptor section (P2X7-2N beta) gave responses that quickly reached a steady state and did not show facilitation. Subsequent point mutations of variant residues identified Asn-16 and Ser-23 as important contributors to the time course/facilitation. The P2X7 receptor is unique in having an intracellular carboxylterminal cysteine-rich region (Ccys). Deletion of this region removed the secondary slowly developing current, and, when expressed in HEK293 cells, ethidium bromide uptake was only similar to 5% that ofWTlevels, indicating reduced large pore formation. Dye uptake was also reduced for the P2X7-2N beta chimera. Surprisingly, combination of the chimera and the Ccys deletion (P2X7-2N beta delCcys) restored the current rise time and ethidium uptake toWTlevels. These findings suggest that there is a coevolved interaction between the juxtatransmembrane amino and carboxyl termini in the regulation of P2X7 receptor gating.	[Allsopp, Rebecca C.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk			Wellcome Trust [080487/Z/06/Z]; Medical Research Council [MR/K027018/1]; MRC [MR/K027018/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust Grant 080487/Z/06/Z and Medical Research Council Grant MR/K027018/1.	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, BIOCHEM BIOPH RES CO, V291, P611, DOI 10.1006/bbrc.2002.6488; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Fryatt AG, 2014, MOL PHARMACOL, V86, P707, DOI 10.1124/mol.114.095307; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Jiang LH, 2009, EUR BIOPHYS J BIOPHY, V38, P339, DOI 10.1007/s00249-008-0315-y; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang YQ, 2013, CHINESE SCI BULL, V58, P2812, DOI 10.1007/s11434-013-5870-7; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khadra A, 2013, BIOPHYS J, V104, P2612, DOI 10.1016/j.bpj.2013.05.006; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Klapperstuck M, 2000, BBA-BIOMEMBRANES, V1467, P444, DOI 10.1016/S0005-2736(00)00245-5; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Petrou S, 1997, FEBS LETT, V411, P339, DOI 10.1016/S0014-5793(97)00700-X; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Robinson LE, 2014, J BIOL CHEM, V289, P31983, DOI 10.1074/jbc.M114.574699; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2010, J BIOL CHEM, V285, P17514, DOI 10.1074/jbc.M109.053082; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Simon J, 1997, MOL PHARMACOL, V52, P237, DOI 10.1124/mol.52.2.237; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; WILEY JS, 1992, ARCH BIOCHEM BIOPHYS, V292, P411, DOI 10.1016/0003-9861(92)90010-T; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059	46	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14556	14566		10.1074/jbc.M115.642033	http://dx.doi.org/10.1074/jbc.M115.642033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25903136	Green Published, hybrid			2022-12-26	WOS:000355754600027
J	Mahadevan, C; Jaleel, A; Deb, L; Thomas, G; Sakuntala, M				Mahadevan, Chidambareswaren; Jaleel, Abdul; Deb, Lokesh; Thomas, George; Sakuntala, Manjula			Development of an Efficient Virus Induced Gene Silencing Strategy in the Non-Model Wild Ginger-Zingiber zerumbet and Investigation of Associated Proteome Changes	PLOS ONE			English	Article							STRIPE-MOSAIC-VIRUS; CHLOROPLAST PHOSPHOGLYCERATE KINASE; NICOTIANA-BENTHAMIANA; INFECTION; PROTEINS; PLANTS; BIOSYNTHESIS; RESISTANCE; SEPARATION; SYSTEM	Zingiber zerumbet (Zingiberaceae) is a wild, tropical medicinal herb that shows a high degree of resistance to diseases affecting cultivated ginger. Barley stripe mosaic virus (BSMV) silencing vectors containing an endogenous phytoene desaturase (PDS) gene fragment were agroinfiltrated into young leaves of Z. zerumbet under controlled growth conditions to effect virus-induced gene silencing (VIGS). Infiltrated leaves as well as newly emerged leaves and tillers showed visual signs of PDS silencing after 30 days. Replication and systemic movement of the viral vectors in silenced plants were confirmed by RT-PCR. Real-time quantitative PCR analysis verified significant down-regulation of PDS transcripts in the silenced tissues. Label-free proteomic analysis was conducted in leaves with established PDS transcript down regulation and buffer-infiltrated (mock) leaves. A total of 474 proteins were obtained, which were up-regulated, down-regulated or modulated de novo during VIGS. Most of these proteins were localized to the chloroplast, as revealed by UniprotKB analysis, and among the up-regulated proteins there were abiotic stress responsive, photosynthetic, metabolic and membrane proteins. Moreover, the demonstration of viral proteins together with host proteins proved successful viral infection. We report for the first time the establishment of a high-throughput gene functional analysis platform using BSMV-mediated VIGS in Z. zerumbet, as well as proteomic changes associated with VIGS.	[Mahadevan, Chidambareswaren; Thomas, George; Sakuntala, Manjula] Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram 695014, Kerala, India; [Jaleel, Abdul] Rajiv Gandhi Ctr Biotechnol, Prote Core Facil, Thiruvananthapuram 695014, Kerala, India; [Deb, Lokesh] Inst Bioresources & Sustainable Dev, Imphal 795001, Manipur, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD)	Thomas, G (corresponding author), Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram 695014, Kerala, India.	gthomas@rgcb.res.in; smanjula@rgcb.res.in	Mahadevan, Chidambareswaren/AAT-3947-2020; Deb, Lokesh/N-6226-2019	Mahadevan, Chidambareswaren/0000-0001-8410-8286; , ABDUL JALEEL/0000-0003-2536-9093	Department of Biotechnology, Government of India;  [BT/PR11168/NDB/51/185/2008]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); 	This study was funded by The Department of Biotechnology, Government of India, URL http://dbtindia.nic.in. Funds received by CM, LD, GT and MS, grant number BT/PR11168/NDB/51/185/2008.	Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Benedito Vagner A, 2004, Genet Mol Res, V3, P323; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Cakir C, 2010, CROP SCI, V50, pS77, DOI 10.2135/cropsci2009.10.0567; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Cheng SF, 2013, PLANT PHYSIOL, V163, P1598, DOI 10.1104/pp.113.229666; Cruz SS, 1999, TRENDS MICROBIOL, V7, P237, DOI 10.1016/S0966-842X(99)01508-5; Dai JR, 1997, NAT PROD LETT, V10, P115, DOI 10.1080/10575639708043725; Eichelmann H, 2004, PLANT BIOLOGY, V6, P307, DOI 10.1055/s-2004-820874; Fantini E, 2013, PLANT PHYSIOL, V163, P986, DOI 10.1104/pp.113.224733; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Glaser E, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P385, DOI 10.1007/978-1-4020-3166-3_14; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kavitha PG, 2008, J BIOSCIENCES, V33, P81, DOI 10.1007/s12038-008-0002-2; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Lee WS, 2012, PLANT PHYSIOL, V160, P582, DOI 10.1104/pp.112.203489; Levin Y, 2011, PROTEOMICS, V11, P3273, DOI 10.1002/pmic.201000661; Lin JW, 2007, NUCLEIC ACIDS RES, V35, P424, DOI 10.1093/nar/gkl1061; LIN NS, 1984, J GEN VIROL, V65, P2217, DOI 10.1099/0022-1317-65-12-2217; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06; McGregor CE, 2009, J AM SOC HORTIC SCI, V134, P658, DOI 10.21273/JASHS.134.6.658; MCMORROW EM, 1990, PLANT PHYSIOL, V93, P374, DOI 10.1104/pp.93.2.374; Mininno M, 2012, J BIOL CHEM, V287, P21034, DOI 10.1074/jbc.M112.359976; Nair RA, 2013, GENE, V516, P58, DOI 10.1016/j.gene.2012.12.011; Niehl A, 2013, J PROTEOME RES, V12, P2491, DOI 10.1021/pr3010698; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Renner T, 2009, MOL PLANT, V2, P1084, DOI 10.1093/mp/ssp033; Romero I, 2011, J PLANT PHYSIOL, V168, P1129, DOI 10.1016/j.jplph.2010.12.020; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Shin M, 2004, PHOTOSYNTH RES, V80, P307, DOI 10.1023/B:PRES.0000030456.96329.f9; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350; Spetea C, 2012, FEBS LETT, V586, P2946, DOI 10.1016/j.febslet.2012.07.005; Torrance L, 2006, J GEN VIROL, V87, P2403, DOI 10.1099/vir.0.81975-0; Tournier B, 2006, PLANT J, V47, P383, DOI 10.1111/j.1365-313X.2006.02796.x; Weigel Detlef, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4666; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468	48	10	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2015	10	4							e0124518	10.1371/journal.pone.0124518	http://dx.doi.org/10.1371/journal.pone.0124518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SE	25918840	Green Published, Green Submitted, gold			2022-12-26	WOS:000353659400053
J	Abud, MJ; Hall, B; Helmers, C				Abud, Maria Jose; Hall, Bronwyn; Helmers, Christian			An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile	PLOS ONE			English	Article							PROTECTION	We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between "primary" (active ingredient) and "secondary" patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). There is prior evidence that secondary patents are used by pharmaceutical originator companies in the U.S. and Europe to extend patent protection on drugs in length and breadth. Using a novel dataset that comprises all drugs registered in Chile between 1991 and 2010 as well as the corresponding patents and trademarks, we find evidence that foreign originator companies pursue similar strategies in Chile. We find a primary to secondary patents ratio of 1:4 at the drug-level, which is comparable to the available evidence for Europe; most secondary patents are filed over several years following the original primary patent and after the protected active ingredient has obtained market approval in Chile. This points toward effective patent term extensions through secondary patents. Secondary patents dominate "older" therapeutic classes like anti-ulcer and anti-depressants. In contrast, newer areas like anti-virals and anti-neoplastics (anti-cancer) have a much larger share of primary patents.	[Abud, Maria Jose] Columbia Univ, Sch Int & Publ Affairs, New York, NY USA; [Hall, Bronwyn] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA; [Hall, Bronwyn] Maastricht Univ, UNU MERIT, NL-6200 MD Maastricht, Netherlands; [Helmers, Christian] Santa Clara Univ, Dept Econ, Santa Clara, CA 95053 USA	Columbia University; University of California System; University of California Berkeley; Maastricht University; Santa Clara University	Helmers, C (corresponding author), Santa Clara Univ, Dept Econ, Santa Clara, CA 95053 USA.	chelmers@scu.edu		Hall, Bronwyn/0000-0002-3802-5567	World Intellectual Property Organization; United Nations University-MERIT; Santa Clara University	World Intellectual Property Organization; United Nations University-MERIT; Santa Clara University	This study was supported by the World Intellectual Property Organization to MA, BH, and CH (WIPO, http://www.wipo.int); United Nations University-MERIT to BH; and Santa Clara University to CH. WIPO's chief economist, Carsten Fink, provided advice in the study design and data collection, and manuscript.	Abud M.J., 2013, 11 WIPO; Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; Arora A, 2011, LOCATION BIOPHARMACE; Burdon M, 2003, INT J MED MARKETING, V3; Chaudhuri S, 2006, AM ECON REV, V96, P1477, DOI 10.1257/aer.96.5.1477; European Commission, 2009, PHARM SECT INQ FIN R; Goldberg PK, 2010, J EUR ECON ASSOC, V8, P326, DOI 10.1111/j.1542-4774.2010.tb00506.x; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hutchins M, 2003, J GENERIC MED, V1, P57, DOI DOI 10.1057/PALGRAVE.JGM.4940018; Hutchins M, 2003, J MED MARKETING DEVI, V3, P212; Kapczynski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049470; Sternitzke C, 2013, RES POLICY, V42, P542, DOI 10.1016/j.respol.2012.11.003	12	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124257	10.1371/journal.pone.0124257	http://dx.doi.org/10.1371/journal.pone.0124257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG9SB	25915050	Green Published, gold			2022-12-26	WOS:000353659100042
J	Jiang, LG; Zhang, QY; Ren, H; Ma, S; Lu, CJ; Liu, B; Liu, J; Liang, J; Li, MY; Zhu, RZ				Jiang, Lianggui; Zhang, Qingyu; Ren, Hao; Ma, Sheng; Lu, CaiJie; Liu, Bin; Liu, Jie; Liang, Jian; Li, Mingyi; Zhu, Runzhi			Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/BcI-2 Pathway in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							CANCER CELLS; CISPLATIN; PACLITAXEL; CHEMOTHERAPY; INHIBITION; ACTIVATION	Chemotherapy is an effective weapon in the battle against cancer. Nedaplatin (NDP) is an improved platinum-containing drug with lower cytotoxicity than other similar drugs. However, the repeated use of NDP results in substantial hepatocyte damage as well as drug resistance in hepatocellular carcinoma (HCC) cases. Therefore, the development of effective chemotherapy strategies that enhance tumor sensitivity to chemotherapeutics and reduce the secondary damage to liver cells is urgently needed. Dihydromyricetin (DHM), a natural flavonoid compound, has been shown to have antitumor activity with no obvious toxicity to normal cells in vitro and in vivo. In this study, DHM and NDP were combined to treat liver cancer cells; we found that DHM functions as a protector of normal cells compared with the use of NDP alone. In addition, the synergy of DHM with NDP enhanced the effect of NDP on the induction of HCC cell apoptosis. We found that the combination caused clear changes in the level of reactive oxygen species (ROS). Furthermore, we demonstrated that the combination of DHM and NDP activated the p53/BcI-2 signaling pathway, which resulted in mitochondrial dysfunction and induced cell death and growth inhibition in HCC cells.	[Jiang, Lianggui; Zhang, Qingyu; Ren, Hao; Ma, Sheng; Lu, CaiJie; Liu, Bin; Liu, Jie; Li, Mingyi; Zhu, Runzhi] Guangdong Med Coll, Affiliated Hosp, Zhanjiang Key Lab Hepatobiliary Dis, Lab Hepatobiliary Surg, Zhanjiang, Peoples R China; [Liang, Jian] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Peoples R China	Guangdong Medical University; Guangdong Medical University	Li, MY (corresponding author), Guangdong Med Coll, Affiliated Hosp, Zhanjiang Key Lab Hepatobiliary Dis, Lab Hepatobiliary Surg, Zhanjiang, Peoples R China.	limingyi63@163.com; hepatolab@163.com			Guangdong Medical College Youth Fund [Q2012017]; Outstanding master's thesis cultivation project of Guangdong Medical College [2014-12#]; Key Laboratory of Zhanjiang project [2013A402-4]; competitive projects of Zhanjiang [2013-17#, 2013-10#]; National Natural Science Funds [81041099]; Guangdong Province Natural Science Funds [S2011010003750]	Guangdong Medical College Youth Fund; Outstanding master's thesis cultivation project of Guangdong Medical College; Key Laboratory of Zhanjiang project; competitive projects of Zhanjiang; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Funds	This study was supported by The Guangdong Medical College Youth Fund (Q2012017, QYZ received this funding); Outstanding master's thesis cultivation project of Guangdong Medical College (2014-12#, LGJ received this funding); Key Laboratory of Zhanjiang project (2013A402-4, MYL received this funding); competitive projects of Zhanjiang, secondary financial support project (2013-17# and -10#, RZZ and JL (RZZ and Jian Liang received this funding); The National Natural Science Funds 81041099 and Guangdong Province Natural Science Funds S2011010003750 (MYL received these fundings). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunner TB, 2011, RADIAT ONCOL, V6, pe88; Chu DJ, 2014, GENET MOL RES, V13, P2796, DOI 10.4238/2014.April.14.8; Deng LT, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-71; Fukui Tadahisa, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P813; Gamarra-Luques CD, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-45; Gamarra-Luques CD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-200; Hirata K, 2014, JPN J CLIN ONCOL, V44, P556, DOI 10.1093/jjco/hyu048; Huang H, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461913; Kubala M, 2014, BIOMED PAP, V158, P194, DOI 10.5507/bp.2014.018; Li CH, 2014, ASIAN PAC J CANCER P, V15, P731, DOI 10.7314/APJCP.2014.15.2.731; Nedaplatin Ota K., 1996, CANC CHEMOTH, V23, P379; Nishioka K, 2014, JPN J CLIN ONCOL, V44, P28, DOI 10.1093/jjco/hyt182; Sato D, 2013, CHEMOTHERAPY, V59, P314, DOI 10.1159/000357469; Shaili Evyenia, 2014, Science Progress, V97, P20, DOI 10.3184/003685014X13904811808460; Shen Y, 2012, J NEUROSCI, V32, P390, DOI 10.1523/JNEUROSCI.4639-11.2012; Sims JT, 2009, BIOCHEM PHARMACOL, V78, P249, DOI 10.1016/j.bcp.2009.04.007; Srinivasan KN, 2014, CASE REP ONCOL MED, V2014, DOI 10.1155/2014/940591; Takamoto Daiji, 2014, Hinyokika Kiyo, V60, P95; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Xia J, 2014, FOOD CHEM TOXICOL, V66, P7, DOI 10.1016/j.fct.2014.01.014; Zaidi Y, 2014, METALLOMICS, V6, P1469, DOI 10.1039/c4mt00035h; Zhang QY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04628	22	34	39	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124994	10.1371/journal.pone.0124994	http://dx.doi.org/10.1371/journal.pone.0124994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915649	Green Published, gold, Green Submitted			2022-12-26	WOS:000353659100087
J	Lin, M; Yang, LY; Xie, DD; Chen, JT; Nguba, SMM; Ehapo, CS; Zhan, XF; Eyi, JUM; Matesa, RA; Obono, MMO; Yang, H; Yang, HT; Cheng, JD				Lin, Min; Yang, Li Ye; Xie, Dong De; Chen, Jiang Tao; Nguba, Santiago-m Monte; Ehapo, Carlos Sala; Zhan, Xiao Fen; Eyi, Juan Urbano Monsuy; Matesa, Rocio Apicante; Obono, Maximo Miko Ondo; Yang, Hui; Yang, Hui Tian; Cheng, Ji Dong			G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; NIGERIAN POPULATION; WEST-AFRICA; DEHYDROGENASE; HAEMOGLOBIN; DISORDERS; REGION	Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency and hemoglobinopathies were the inherited conditions found mostly in African. However, few epidemiological data of these disorders was reported in Equatorial Guinea (EQG). This study aimed to assess the prevalence and healthy effects of G6PD deficiency and hemoglobinopathies among the people on malaria endemic Bioko Island, EQG. Materials and Methods Blood samples from 4,144 unrelated subjects were analyzed for G6PD deficieny by fluorescence spot test (FST), high-resolution melting assay and PCR-DNA sequencing. In addition, 1,186 samples were randomly selected from the 4,144 subjects for detection of hemoglobin S (HbS), HbC, and alpha-thalassemia deletion by complete blood count, PCR-DNA sequencing and reverse dot blot (RDB). Results The prevalence of malaria and anemia was 12.6%(522/4,144) and 32.8% (389/1,186), respectively. Overall, 8.7% subjects (359/4,144) were G6PD-deficient by FST, including 9.0% (249/2,758) males and 7.9%(110/1,386) females. Among the 359 G6PD-deficient individuals molecularly studied, the G6PD A(-)(G202A/A376G) were detected in 356 cases (99.2%), G6PD Betica (T968C/A376G) in 3 cases. Among the 1,186 subjects, 201 cases were HbS heterozygotes, 35 cases were HbC heterozygotes, and 2 cases were HbCS double heterozygotes; 452 cases showed heterozygous alpha-thalassemia 3.7 kb deletion (-alpha(3.7) kb deletion) and 85 homozygous -alpha(3.7) kb deletion. The overall allele frequencies were HbS 17.1% ( 203/1186); HbC, 3.1%( 37/1186); and -alpha(3.7) kb deletion 52.4% (622/1186), respectively. Conclusions High G6PD deficiency in this population indicate that diagnosis and management of G6PD deficiency is necessary on Bioko Island. Obligatory newborn screening, prenatal screening and counseling for these genetic disorders, especially HbS, are needed on the island.	[Lin, Min; Cheng, Ji Dong] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China; [Lin, Min; Yang, Li Ye; Zhan, Xiao Fen; Yang, Hui; Yang, Hui Tian] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Xie, Dong De; Chen, Jiang Tao] Chinese Med Aid Team Republ Equatorial Guinea, Guangzhou, Guangdong, Peoples R China; [Nguba, Santiago-m Monte] Malabo Reg Hosp, Med Lab, Malabo, Equat Guinea; [Ehapo, Carlos Sala; Eyi, Juan Urbano Monsuy; Matesa, Rocio Apicante; Obono, Maximo Miko Ondo] Malabo Reg Hosp, Cent Blood Transfus Serv, Malabo, Equat Guinea	Shantou University; Southern Medical University - China	Cheng, JD (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China.	Jidongcheng36@hotmail.com			China Postdoctoral Science Foundation [2013M542195]; Medical Science Fund of Guangdong Province [A2013780]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical Science Fund of Guangdong Province	This work was partially supported by China Postdoctoral Science Foundation (contract/grant number 2013M542195 to Min Lin) and Medical Science Fund of Guangdong Province (contract/grant number A2013780 to Jiang-Tao Chen). The funders had no role in study design and data analysis, decision to publish, or reparation of the manuscript.	Ademowo O G, 2002, East Afr Med J, V79, P42; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; Aygun B, 2012, PEDIATR BLOOD CANCER, V59, P386, DOI 10.1002/pbc.24175; Bouanga JC, 1998, HUM HERED, V48, P192, DOI 10.1159/000022801; Burchard GD, 2001, ACTA TROP, V80, P103, DOI 10.1016/S0001-706X(01)00157-7; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Charle P, 2013, AM J TROP MED HYG, V88, P1087, DOI 10.4269/ajtmh.12-0290; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; DUFLO B, 1979, B SOC PATHOL EXOT, V72, P258; Ewusie JE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-626; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Jiang J, 2014, GENET MOL RES, V13, P4272, DOI 10.4238/2014.June.9.13; Kaplan M, 2011, SEMIN PERINATOL, V35, P155, DOI 10.1053/j.semperi.2011.02.010; Kashmoola MA, 2015, INDIAN J HEMATOL BLO, V31, P133, DOI 10.1007/s12288-014-0368-2; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Lin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101505; Lin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055024; LUZZATTO L, 1968, NATURE, V219, P1041, DOI 10.1038/2191041a0; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; Maiga B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-270; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Meissner PE, 2005, BRIT J HAEMATOL, V131, P395, DOI 10.1111/j.1365-2141.2005.05778.x; Millimono TS, 2012, HEMOGLOBIN, V36, P25, DOI 10.3109/03630269.2011.600491; MODICA RE, 1970, T ROY SOC TROP MED H, V64, P730, DOI 10.1016/0035-9203(70)90014-3; Overgaard HJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-253; Pan MC, 2013, MOL BIOL REP, V40, P3073, DOI 10.1007/s11033-012-2381-6; Rehman AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-154; Rohner F, 2013, FOOD NUTR BULL, V34, pS17, DOI 10.1177/15648265130342S104; Smith-Whitley K, 2014, BLOOD, V124, P3538, DOI 10.1182/blood-2014-07-577619; Spolarics Z, 2001, CRIT CARE MED, V29, P728, DOI 10.1097/00003246-200104000-00005; Taylor SM, 2014, CURR OPIN HEMATOL, V21, P193, DOI 10.1097/MOH.0000000000000039; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; Tsang BL, 2014, AM J TROP MED HYG, V90, P955, DOI 10.4269/ajtmh.13-0496; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Williams O, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068800, 10.1371/journal.pone.0080616, 10.1371/journal.pone.0081098, 10.1371/journal.pone.0079344]; Yang H, 2015, INT J LAB HEMATOL, V37, P410, DOI 10.1111/ijlh.12303; Yue L, 2014, MOL MED REP, V9, P2479, DOI 10.3892/mmr.2014.2130	39	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0123991	10.1371/journal.pone.0123991	http://dx.doi.org/10.1371/journal.pone.0123991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915902	Green Submitted, gold, Green Published			2022-12-26	WOS:000353659100033
J	Zuo, JJ; Wu, F; Liu, YH; Xiao, J; Xu, M; Yu, QP; Xia, MH; He, XJ; Zou, SG; Tan, HZ; Feng, DY				Zuo, Jianjun; Wu, Fan; Liu, Yihua; Xiao, Juan; Xu, Mei; Yu, Qinping; Xia, Minhao; He, Xiaojun; Zou, Shigeng; Tan, Huize; Feng, Dingyuan			MicroRNA Transcriptome Profile Analysis in Porcine Muscle and the Effect of miR-143 on the MYH7 Gene and Protein	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; FIBER-TYPE; MEAT QUALITY; LARGE WHITE; EXPRESSION; REGULATOR; GROWTH; ALPHA; MEF2; BIOGENESIS	Porcine skeletal muscle fibres are classified based on their different physiological and biochemical properties. Muscle fibre phenotype is regulated by several independent signalling pathways, including the mitogen-activated protein kinase (MAPK), nuclear factor of activated T cells (NFAT), myocyte enhancer factor 2 (MEF2) and peroxisome proliferator-activated receptor (PPAR) signalling pathways. MicroRNAs are non-coding small RNAs that regulate many biological processes. However, their function in muscle fibre type regulation remains unclear. The aim of our study was to identify miRNAs that regulate muscle fibre type during porcine growth to help understand the miRNA regulation mechanism of fibre differentiation. We performed Solexa/Illumina deep sequencing for the microRNAome during 3 muscle growth stages (63, 98 and 161 d). In this study, 271 mature miRNAs and 243 pre-miRNAs were identified. We detected 472 novel miRNAs in the muscle samples. Among the mature miRNAs, there are 23 highest expression miRNAs (over 10000 RPM), account for 85.3% of the total counts of mature miRNAs., including 10 (43.5%) muscle-related miRNAs (ssc-miR133a-3p, ssc-miR-486, ssc-miR-1, ssc-miR-143-3p, ssc-miR-30a-5p, ssc-miR-181a, ssc-miR-148a-3p, ssc-miR-92a, ssc-miR-21, ssc-miR-126-5p). Particularly, both ssc-miR-1 and ssc-miR-133 belong to the MyomiRs, which control muscle myosin content, myofibre identity and muscle performance. The involvement of these miRNAs in muscle fibre phenotype provides new insight into the mechanism of muscle fibre regulation underlying muscle development. Furthermore, we performed cell transfection experiment. Overexpression/inhibition of ssc-miR-143-3p in porcine skeletal muscle satellite cell induced an/a increase/reduction of the slow muscle fibre gene and protein (MYH7), indicating that miR-143 activity regulated muscle fibre differentiate in skeletal muscle. And it regulate MYH7 through the HDAC4-MEF2 pathway.	[Zuo, Jianjun; Wu, Fan; Liu, Yihua; Xiao, Juan; Xu, Mei; Yu, Qinping; Xia, Minhao; He, Xiaojun; Feng, Dingyuan] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China; [Zou, Shigeng; Tan, Huize] WENs Grp, Prod Technol Dept, Xinxing 527400, Peoples R China	South China Agricultural University	Zuo, JJ (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China.	zuojianjun2000@163.com; puramber@163.com; fengdingyuan2000@163.com			National Basic Research Program of China (973 project) [2012CB12470]; WENs Group	National Basic Research Program of China (973 project)(National Basic Research Program of China); WENs Group	This work was supported by the National Basic Research Program of China (973 project; project number 2012CB12470). (http://www.973.gov.cn/English/Index.aspx) Co-authors Shigeng Zou and Huizhe Tan are employed by WENs Group. WENs Group provided support in the form of salaries for authors SZ and HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; ASHMORE CR, 1972, J ANIM SCI, V34, P37; BEATTY CH, 1963, AM J PHYSIOL, V204, P939, DOI 10.1152/ajplegacy.1963.204.5.939; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen L, 2014, CURR MOL MED, V14, P370, DOI 10.2174/1566524014666140228100250; Chen ZM, 2012, DEVELOPMENT, V139, P3543, DOI 10.1242/dev.082719; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; Ehlers ML, 2014, CELL REP, V8, P1639, DOI 10.1016/j.celrep.2014.08.035; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fazius F, 2012, MOL MICROBIOL, V86, P1508, DOI 10.1111/mmi.12076; Gea J, 2000, AM J RESP CRIT CARE, V161, P1274, DOI 10.1164/ajrccm.161.4.99040103; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; HANDEL SE, 1987, J ANAT, V152, P107; Jiang HB, 2004, DEV DYNAM, V231, P292, DOI 10.1002/dvdy.20137; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Joo ST, 2013, MEAT SCI, V95, P828, DOI 10.1016/j.meatsci.2013.04.044; Jordan T, 2005, J CELL SCI, V118, P2295, DOI 10.1242/jcs.02341; Klont RE, 1998, MEAT SCI, V49, pS219; Krawczynski K, 2012, REPROD DOMEST ANIM, V47, P545; Larzul C, 1997, J ANIM SCI, V75, P3126; Lebrasseur NK, 2003, AM J PHYSIOL-CELL PH, V284, pC1149, DOI 10.1152/ajpcell.00487.2002; Lefaucheur L, 2004, J ANIM SCI, V82, P1931; Lefaucheur L, 2002, J HISTOCHEM CYTOCHEM, V50, P719, DOI 10.1177/002215540205000513; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Qin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072418; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Valdez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093140; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang L, 2012, ACTA PHYSIOL, V204, P525, DOI 10.1111/j.1748-1716.2011.02354.x; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wegner J, 2000, J ANIM SCI, V78, P1485; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wimmers K, 2008, J ANIM SCI, V86, P795, DOI 10.2527/jas.2006-521; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	51	18	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0124873	10.1371/journal.pone.0124873	http://dx.doi.org/10.1371/journal.pone.0124873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25915937	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100076
J	Habib, SM; Abrahams, AC; Korte, MR; Zietse, R; de Vogel, LL; Boer, WH; Dendooven, A; Clahsen-van Groningen, MC; Betjes, MGH				Habib, Sayed M.; Abrahams, Alferso C.; Korte, Mario R.; Zietse, Robert; de Vogel, Lisette L.; Boer, Walther H.; Dendooven, Amelie; Clahsen-van Groningen, Marian C.; Betjes, Michiel G. H.			CD4-Positive T Cells and M2 Macrophages Dominate the Peritoneal Infiltrate of Patients with Encapsulating Peritoneal Sclerosis	PLOS ONE			English	Article							CAPD TREATMENT; DUTCH EPS; INFLAMMATION; DIALYSIS; FIBROSIS; DIAGNOSIS; PARADIGM; MODELS	Background Encapsulating peritoneal sclerosis (EPS) is a severe complication of peritoneal dialysis (PD). Previously, it has been shown that infiltrating CD4-positive T cells and M2 macrophages are associated with several fibrotic conditions. Therefore, the characteristics of the peritoneal cell infiltrate in EPS may be of interest to understand EPS pathogenesis. In this study, we aim to elucidate the composition of the peritoneal cell infiltrate in EPS patients and relate the findings to clinical outcome. Study Design, Setting, and Participants We studied peritoneal membrane biopsies of 23 EPS patients and compared them to biopsies of 15 PD patients without EPS. The cellular infiltrate was characterized by immunohistochemistry to detect T cells(CD3-positive), CD4-positive (CD4+) and CD8-positive T cell subsets, B cells(CD20-positive), granulocytes(CD15-positive), macrophages(CD68-positive), M1(CD80-positive), and M2(CD163-positive) macrophages. Tissues were analysed using digital image analysis. Kaplan-Meier survival analysis was performed to investigate the survival in the different staining groups. Results The cellular infiltrate in EPS biopsies was dominated by mononuclear cells. For both CD3 and CD68, the median percentage of area stained was higher in biopsies of EPS as opposed to non-EPS patients (p<0.001). EPS biopsies showed a higher percentage of area stained for CD4 (1.29%(0.61-3.20)) compared to CD8 (0.71%(0.46-1.01), p = 0.04), while in the non-EPS group these cells were almost equally represented (respectively 0.28% (0.05-0.83) versus 0.22%(0.17-0.43), p = 0.97). The percentage of area stained for both CD80 and CD163 was higher in EPS than in non-EPS biopsies (p<0.001), with CD163+ cells being the most abundant phenotype. Virtually no CD20-positive and CD15-positive cells were present in biopsies of a subgroup of EPS patients. No relation was found between the composition of the mononuclear cell infiltrate and clinical outcome. Conclusions A characteristic mononuclear cell infiltrate consisting of CD4+ and CD163+ cells dominates the peritoneum of EPS patients. These findings suggest a role for both CD4+ T cells and M2 macrophages in the pathogenesis of EPS.	[Habib, Sayed M.; Zietse, Robert; Betjes, Michiel G. H.] Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands; [Abrahams, Alferso C.; Boer, Walther H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Korte, Mario R.] Albert Schweitzer Hosp, Dept Internal Med, Div Nephrol, Dordrecht, Netherlands; [Clahsen-van Groningen, Marian C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Dendooven, Amelie] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Albert Schweitzer Ziekenhuis; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Habib, SM (corresponding author), Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands.	s.m.habib@erasmusmc.nl	Dendooven, Amélie/AAC-1192-2021; Groningen, Marian Clahsen-van/J-8250-2015	Groningen, Marian Clahsen-van/0000-0003-0565-9560; boer, walther/0000-0001-5048-2755; Dendooven, Amelie/0000-0002-9900-7952; Betjes, Michiel/0000-0001-9435-6208				Ahmad S, 2010, EUR J CLIN INVEST, V40, P1067, DOI 10.1111/j.1365-2362.2010.02353.x; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; BETJES MGH, 1993, KIDNEY INT, V43, P641, DOI 10.1038/ki.1993.93; Chung DR, 2002, J EXP MED, V195, P1471, DOI 10.1084/jem.20020028; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Groningen MCRV, 2006, J AM SOC NEPHROL, V17, P881, DOI 10.1681/ASN.2005080891; Grzegorzewska A E, 2001, Adv Perit Dial, V17, P10; Grzegorzewska AE, 2000, PERITON DIALYSIS INT, V20, P577; Habib SM, 2011, NETH J MED, V69, P500; Habib SM, 2013, AM J NEPHROL, V37, P223, DOI 10.1159/000348267; Habib SM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-203; Hoff CM, 2005, PERITON DIALYSIS INT, V25, pS57; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Honda Kazuho, 2003, Adv Perit Dial, V19, P169; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Korte MR, 2009, NETH J MED, V67, P359; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Korte MR, 2011, PERITON DIALYSIS INT, V31, P269, DOI 10.3747/pdi.2010.00167; Latus J, 2013, PERITON DIALYSIS INT, V33, P495, DOI 10.3747/pdi.2012.00019; Levine S, 1996, PERITON DIALYSIS INT, V16, P613; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; O'Reilly S, 2012, RHEUMATOLOGY, V51, P1540, DOI 10.1093/rheumatology/kes090; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Sampimon DE, 2010, PERITON DIALYSIS INT, V30, P163, DOI 10.3747/pdi.2009.00022; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940	34	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0120174	10.1371/journal.pone.0120174	http://dx.doi.org/10.1371/journal.pone.0120174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910222	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800008
J	Kovacs, M; Kiss, A; Gonczi, M; Miskolczi, G; Seprenyi, G; Kaszaki, J; Kohr, MJ; Murphy, E; Vegh, A				Kovacs, Maria; Kiss, Attila; Gonczi, Mrton; Miskolczi, Gottfried; Seprenyi, Gyorgy; Kaszaki, Jozsef; Kohr, Mark J.; Murphy, Elizabeth; Vegh, Agnes			Effect of Sodium Nitrite on Ischaemia and Reperfusion-Induced Arrhythmias in Anaesthetized Dogs: Is Protein S-Nitrosylation Involved?	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; INORGANIC NITRATE; CARDIOVASCULAR HEALTH; RYANODINE RECEPTOR; GAP-JUNCTIONS; EMERGING ROLE; L-ARGININE; IN-VIVO; OXIDE; PROTECTION	Background and Purpose To provide evidence for the protective role of inorganic nitrite against acute ischaemia and reperfusion-induced ventricular arrhythmias in a large animal model. Experimental Approach Dogs, anaesthetized with chloralose and urethane, were administered intravenously with sodium nitrite (0.2 mu molkg(-1)min(-1)) in two protocols. In protocol 1 nitrite was infused 10 min prior to and during a 25 min occlusion of the left anterior descending (LAD) coronary artery (NaNO2-PO; n = 14), whereas in protocol 2 the infusion was started 10 min prior to reperfusion of the occluded vessel (NaNO2-PR; n = 12). Control dogs (n = 15) were infused with saline and subjected to the same period of ischaemia and reperfusion. Severities of ischaemia and ventricular arrhythmias, as well as changes in plasma nitrate/nitrite (NOx) levels in the coronary sinus blood, were assessed throughout the experiment. Myocardial superoxide and nitrotyrosine (NT) levels were determined during reperfusion. Changes in protein S-nitrosylation (SNO) and S-glutathionylation were also examined. Key Results Compared with controls, sodium nitrite administered either pre-occlusion or pre-reperfusion markedly suppressed the number and severity of ventricular arrhythmias during occlusion and increased survival (0% vs. 50 and 92%) upon reperfusion. There were also significant decreases in superoxide and NT levels in the nitrite treated dogs. Compared with controls, increased SNO was found only in NaNO2-PR dogs, whereas S-glutathionylation occurred primarily in NaNO2-PO dogs. Conclusions Intravenous infusion of nitrite profoundly reduced the severity of ventricular arrhythmias resulting from acute ischaemia and reperfusion in anaesthetized dogs. This effect, among several others, may result from an NO-mediated reduction in oxidative stress, perhaps through protein SNO and/or S-glutathionylation.	[Kovacs, Maria; Kiss, Attila; Gonczi, Mrton; Miskolczi, Gottfried; Vegh, Agnes] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary; [Seprenyi, Gyorgy] Univ Szeged, Dept Med Biol, Fac Med, Szeged, Hungary; [Kaszaki, Jozsef] Univ Szeged, Inst Surg Res, Albert Szent Gyorgyi Med Ctr, Szeged, Hungary; [Kohr, Mark J.; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Szeged University; Szeged University; Szeged University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vegh, A (corresponding author), Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary.	vegh.agnes@med.u-szeged.hu	Kiss, Attila/ABF-3583-2021	Kiss, Attila/0000-0003-4652-1998; Dr. Seprenyi, Gyorgy/0000-0002-1318-860X	Hungarian Scientific Research Foundation (OTKA) [K75281, K105252]; MTA Postdoctoral Research Programme; National Institutes of Health Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL114721, ZIAHL006059, F32HL096142] Funding Source: NIH RePORTER	Hungarian Scientific Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA Postdoctoral Research Programme; National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Hungarian Scientific Research Foundation (OTKA; Project number K75281 and K105252) and the MTA Postdoctoral Research Programme. This work was also supported, in part, by the National Institutes of Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2011, PHARMACOL THERAPEUT, V131, P287, DOI 10.1016/j.pharmthera.2011.04.005; Babai L, 2002, CLIN SCI, V102, P435, DOI 10.1042/CS20010296; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Bryan NS, 2006, FREE RADICAL BIO MED, V41, P691, DOI 10.1016/j.freeradbiomed.2006.05.019; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Burwell LS, 2008, ANTIOXID REDOX SIGN, V10, P579, DOI 10.1089/ars.2007.1845; BUSSMANN WD, 1984, AM HEART J, V107, P940, DOI 10.1016/0002-8703(84)90832-9; Calvert JW, 2011, CARDIOVASC RES, V89, P499, DOI 10.1093/cvr/cvq307; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Dejam A, 2004, BLOOD CELL MOL DIS, V32, P423, DOI 10.1016/j.bcmd.2004.02.002; Dezfulian C, 2007, CARDIOVASC RES, V75, P327, DOI 10.1016/j.cardiores.2007.05.001; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Foster DB, 2009, J BIOENERG BIOMEMBR, V41, P159, DOI 10.1007/s10863-009-9217-7; Gilchrist M, 2011, CARDIOVASC RES, V89, P492, DOI 10.1093/cvr/cvq309; Gonczi M, 2012, CLIN SCI, V123, P39, DOI 10.1042/CS20110501; Gonczi M, 2009, BRIT J PHARMACOL, V156, P786, DOI 10.1111/j.1476-5381.2008.00089.x; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2009, J CARDIOVASC PHARM, V54, P188, DOI 10.1097/FJC.0b013e3181b72c9f; Gonzalez FM, 2008, CIRCULATION, V117, P2986, DOI 10.1161/CIRCULATIONAHA.107.748814; Gyorgy K, 2000, CARDIOVASC DRUG THER, V14, P481, DOI 10.1023/A:1007832921391; HOELZER M, 1981, J CARDIOVASC PHARM, V3, P917, DOI 10.1097/00005344-198109000-00001; Inserte J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005975; Iwase H, 2007, FREE RADICAL BIO MED, V43, P590, DOI 10.1016/j.freeradbiomed.2007.05.017; Kevil CG, 2011, FREE RADICAL BIO MED, V51, P576, DOI 10.1016/j.freeradbiomed.2011.04.042; Kevil CG, 2011, CARDIOVASC RES, V89, P489, DOI 10.1093/cvr/cvq409; Kis A, 1999, J MOL CELL CARDIOL, V31, P1229, DOI 10.1006/jmcc.1999.0955; Kis A, 1999, BRIT J PHARMACOL, V127, P1545, DOI 10.1038/sj.bjp.0702695; Kiss A, 2011, MEETING ON APPROACHI; Kiss A, 2010, J MOL CELL CARDIOL, V48, pS162; Kiss A, 2010, BRIT J PHARMACOL, V160, P1263, DOI 10.1111/j.1476-5381.2010.00774.x; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Lefer DJ, 2009, ARCH PHARM RES, V32, P1127, DOI 10.1007/s12272-009-1804-y; Lefer DJ, 2006, AM J PHYSIOL-RENAL, V290, pF777, DOI 10.1152/ajprenal.00470.2005; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; LOHMANN SM, 1991, BASIC RES CARDIOL, V86, P503, DOI 10.1007/BF02190700; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Lundberg JO, 2011, CARDIOVASC RES, V89, P525, DOI 10.1093/cvr/cvq325; Miller MR, 2007, BRIT J PHARMACOL, V151, P305, DOI 10.1038/sj.bjp.0707224; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Parratt Jr, 1997, ENDOTHEL CELL RES S, V2, P237; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Raat NJH, 2009, ADV DRUG DELIVER REV, V61, P339, DOI 10.1016/j.addr.2009.02.002; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Tamargo J, 2010, CARDIOVASC RES, V87, P593, DOI 10.1093/cvr/cvq214; Tripathi P, 2009, INDIAN J BIOCHEM BIO, V46, P498; VEGH A, 1992, CARDIOVASC RES, V26, P487, DOI 10.1093/cvr/26.5.487; VEGH A, 1994, BRIT J PHARMACOL, V113, P1081, DOI 10.1111/j.1476-5381.1994.tb17104.x; VEGH A, 1992, BRIT J PHARMACOL, V107, P648, DOI 10.1111/j.1476-5381.1992.tb14501.x; Vegh A, 1996, EUR J PHARMACOL, V305, P163, DOI 10.1016/0014-2999(96)00166-5; VEGH A, 1992, BRIT J PHARMACOL, V107, P910, DOI 10.1111/j.1476-5381.1992.tb13384.x; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122243	10.1371/journal.pone.0122243	http://dx.doi.org/10.1371/journal.pone.0122243			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909651	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000353376800019
J	Liu, X; Lai, CC; Wang, KY; Xing, L; Yang, PH; Duan, Q; Wang, XL				Liu, Xin; Lai, Chengcai; Wang, Keyu; Xing, Li; Yang, Penghui; Duan, Qing; Wang, Xiliang			A Functional Role of Fibroblast Growth Factor Receptor 1 (FGFR1) in the Suppression of Influenza A Virus Replication	PLOS ONE			English	Article							CELL ENTRY; H1N1 VIRUS; ANGIOGENESIS; MECHANISM; INFECTION; PROTEIN	Influenza A virus causes annual epidemics and occasional pandemics in humans. Here, we investigated four members of the fibroblast growth factor receptor (FGFR) family; FGFR1 to 4, and examined their expression patterns in human lung epithelial cells A549 with influenza A virus infection. We identified a functional role of FGFR1 in influenza A/Puerto Rico/8/1934 (PR8) and A/Anhui/01/2005 (H5N1) virus replication. Our results showed that FGFR1 silencing by siRNA interference promoted influenza A/PR8 and H5N1 virus replication in A549 cells, while lentivirus-mediated exogenous FGFR1 expression significantly suppressed influenza A virus replication; however, FGFR4 did not have the same effects. Moreover, FGFR1 phosphorylation levels were downregulated in A549 cells by influenza A virus infection, while the repression of FGFR1 kinase using PD173074, a potent and selective FGFR1 inhibitor, could enhance virus replication. Furthermore, we found that FGFR1 inhibits influenza virus internalization, but not binding, during viral entry. These results suggested that FGFR1 specifically antagonizes influenza A virus replication, probably by blocking viral entry.	[Liu, Xin; Lai, Chengcai; Wang, Keyu; Xing, Li; Yang, Penghui; Duan, Qing; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Yang, Penghui] 302 Mil Hosp, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Fifth Medical Center of Chinese PLA General Hospital	Wang, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiliangw@126.com		Wang, Keyu/0000-0002-1973-9927	Ministry of Science and Technology of China; National Basic Research Program [2012CB518905]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Program(National Basic Research Program of China)	This work is supported by the Ministry of Science and Technology of China, the National Basic Research Program (973, 2012CB518905, http://www.most.gov.cn/eng/). XW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; BYERS S, 1992, DEV BIOL, V152, P411, DOI 10.1016/0012-1606(92)90149-B; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Liu X, 2014, VIRUS RES, V185, P64, DOI 10.1016/j.virusres.2014.03.010; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MIMA T, 1995, P NATL ACAD SCI USA, V92, P467, DOI 10.1073/pnas.92.2.467; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; PATTERSON S, 1979, J GEN VIROL, V43, P223, DOI 10.1099/0022-1317-43-1-223; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roy AMM, 2000, VIROLOGY, V267, P17, DOI 10.1006/viro.1999.0109; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Yang N, 2012, J BIOL CHEM, V287, P8457, DOI 10.1074/jbc.M111.312561; Yang N, 2011, J MOL CELL BIOL, V3, P221, DOI 10.1093/jmcb/mjr017; YOSHIMURA A, 1982, J VIROL, V43, P284, DOI 10.1128/JVI.43.1.284-293.1982; Zhu LQ, 2014, J VIROL, V88, P417, DOI 10.1128/JVI.02591-13	29	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124651	10.1371/journal.pone.0124651	http://dx.doi.org/10.1371/journal.pone.0124651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909503	gold, Green Submitted, Green Published			2022-12-26	WOS:000353376800096
J	Minkwitz, S; Fassbender, M; Kronbach, Z; Wildemann, B				Minkwitz, Susann; Fassbender, Mirja; Kronbach, Zienab; Wildemann, Britt			Longitudinal Analysis of Osteogenic and Angiogenic Signaling Factors in Healing Models Mimicking Atrophic and Hypertrophic Non-Unions in Rats	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; GROWTH-FACTOR; RELEASE KINETICS; NONUNION; CLASSIFICATION; EXPRESSION; FUMAGILLIN; VASCULARITY; INHIBITION; GENTAMICIN	Impaired bone healing can have devastating consequences for the patient. Clinically relevant animal models are necessary to understand the pathology of impaired bone healing. In this study, two impaired healing models, a hypertrophic and an atrophic non-union, were compared to physiological bone healing in rats. The aim was to provide detailed information about differences in gene expression, vascularization and histology during the healing process. The change from a closed fracture (healing control group) to an open osteotomy (hypertrophy group) led to prolonged healing with reduced mineralized bridging after 42 days. RT-PCR data revealed higher gene expression of most tested osteogenic and angiogenic factors in the hypertrophy group at day 14. After 42 days a significant reduction of gene expression was seen for Bmp4 and Bambi in this group. The inhibition of angiogenesis by Fumagillin (atrophy group) decreased the formation of new blood vessels and led to a non-healing situation with diminished chondrogenesis. RT-PCR results showed an attempt towards overcoming the early perturbance by significant up regulation of the angiogenic regulators Vegfa, Angiopoietin 2 and Fgf1 at day 7 and a further continuous increase of Fgf1, -2 and Angiopoietin 2 over time. However mu CT angiograms showed incomplete recovery after 42 days. Furthermore, lower expression values were detected for the Bmps at day 14 and 21. The Bmp antagonists Dan and Twsg1 tended to be higher expressed in the atrophy group at day 42. In conclusion, the investigated animal models are suitable models to mimic human fracture healing complications and can be used for longitudinal studies. Analyzing osteogenic and angiogenic signaling patterns, clear changes in expression were identified between these three healing models, revealing the importance of a coordinated interplay of different factors to allow successful bone healing.	[Minkwitz, Susann; Fassbender, Mirja; Kronbach, Zienab; Wildemann, Britt] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wildemann, B (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Julius Wolff Inst, Augustenburger Pl 1, D-13353 Berlin, Germany.	Britt.Wildemann@charite.de	Minkwitz, Susann/G-6183-2017; Wildemann, Britt/G-7732-2012	Minkwitz, Susann/0000-0003-4331-1450; Wildemann, Britt/0000-0002-8365-1188	Oskar-Helene-Heim foundation (Oskar-Helene Medizinpreis); Elsa-Neumann foundation; Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 1315848A]; Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	Oskar-Helene-Heim foundation (Oskar-Helene Medizinpreis); Elsa-Neumann foundation; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	This study was supported by the Oskar-Helene-Heim foundation (Oskar-Helene Medizinpreis 2011) and the Elsa-Neumann foundation, and partially by the Bundesministerium fur Bildung und Forschung (BMBF, FKZ 1315848A) and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Beamer B., 2010, HSS J, V6, P85, DOI [10. 1007/s11420-009- 9129-4, DOI 10.1007/S11420-009-9129-4, 10.1007/s11420-009-9129-4]; Brownlow HC, 2002, INJURY, V33, P145, DOI 10.1016/S0020-1383(01)00153-X; Calori GM, 2008, INJURY, V39, pS59, DOI 10.1016/S0020-1383(08)70016-0; Cruess RL, 1985, TXB SMALL ANIMAL ORT; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; DICKSON K, 1994, CLIN ORTHOP RELAT R, P189; Fajardo M, 2009, CLIN ORTHOP RELAT R, V467, P3071, DOI 10.1007/s11999-009-0981-9; Fassbender M, 2011, EUR CELLS MATER, V22, P1; Frolke JPM, 2007, INJURY, V38, pS19, DOI 10.1016/S0020-1383(07)80005-2; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Guimaraes JM, 2013, J ORTHOP RES, V31, P1971, DOI 10.1002/jor.22455; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Heckman J D, 1997, Bull Hosp Jt Dis, V56, P63; Heinke J, 2013, J CELL SCI, V126, P3082, DOI 10.1242/jcs.122333; Holstein JH, 2008, BRIT J PHARMACOL, V154, P1055, DOI 10.1038/bjp.2008.167; Horner A, 2001, BONE, V28, P65, DOI 10.1016/S8756-3282(00)00422-1; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kaya M, 2001, Sarcoma, V5, P197, DOI 10.1080/13577140120099182; Kloen P, 2003, BONE, V33, P362, DOI 10.1016/S8756-3282(03)00191-1; Kloen P, 2012, BONE, V51, P59, DOI 10.1016/j.bone.2012.03.032; Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052; Kratzel C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-135; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; Ma L, 2010, J BONE MINER RES, V25, P1305, DOI 10.1002/jbmr.19; Malik MHA, 2004, J BONE JOINT SURG BR, V86B, P556, DOI 10.1302/0301-620X.86B4.14097; Marsell R, 2009, INJURY, V40, P4; Marsh DR, 1999, BRIT MED BULL, V55, P856, DOI 10.1258/0007142991902673; Mehta M, 2012, EUR CELLS MATER, V24, P358, DOI 10.22203/eCM.v024a26; Montjovent MO, 2013, BONE, V53, P79, DOI 10.1016/j.bone.2012.11.027; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Pountos I, 2013, INJURY, V44, P1725, DOI 10.1016/j.injury.2013.09.009; Reed AAC, 2003, J BONE JOINT SURG BR, V85B, P604, DOI 10.1302/0301-620X.85B4.12944; Reed AAC, 2002, J ORTHOP RES, V20, P593, DOI 10.1016/S0736-0266(01)00142-5; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Schmidmaier G, 2004, EUR J TRAUMA, V30, P35; Schwabe P, 2014, INT ORTHOP, V38, P2623, DOI 10.1007/s00264-014-2496-6; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; SKINNER SA, 1990, CANCER RES, V50, P2411; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Strobel C, 2011, J CONTROL RELEASE, V156, P37, DOI 10.1016/j.jconrel.2011.07.006; Strobel C, 2011, INT J ARTIF ORGANS, V34, P304, DOI 10.5301/IJAO.2011.6470; Tomlinson RE, 2013, BONE, V52, P212, DOI 10.1016/j.bone.2012.09.035; Tzioupis C, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(07)80003-9; Uhrig BA, 2013, BONE, V55, P410, DOI 10.1016/j.bone.2013.04.027; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wang JY, 2000, J CELL BIOCHEM, V77, P465, DOI 10.1002/(SICI)1097-4644(20000601)77:3<465::AID-JCB11>3.3.CO;2-D; WEBER BG, 1982, Z ORTHOP GRENZGEB, V120, P528; Zelle BA, 2006, J ORTHOP TRAUMA, V20, P76, DOI 10.1097/01.bot.0000202997.45274.a1	53	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124217	10.1371/journal.pone.0124217	http://dx.doi.org/10.1371/journal.pone.0124217			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25910190	Green Submitted, gold, Green Published			2022-12-26	WOS:000353376800068
J	Semaan, M; Ivanusic, D; Denner, J				Semaan, Marwan; Ivanusic, Daniel; Denner, Joachim			Cytotoxic Effects during Knock Out of Multiple Porcine Endogenous Retrovirus (PERV) Sequences in the Pig Genome by Zinc Finger Nucleases (ZFN)	PLOS ONE			English	Article							HUMAN-CELLS; TRANSGENIC PIGS; BIALLELIC KNOCKOUT; NEUTRALIZING ANTIBODIES; RESTRICTION ENZYMES; PROXIMITY LIGATION; RNA INTERFERENCE; IN-SITU; XENOTRANSPLANTATION; PROTEINS	Xenotransplantation has been proposed as a solution to the shortage of suitable human donors for transplantation and pigs are currently favoured as donor animals. However, xenotransplantation may be associated with the transmission of zoonotic microorganisms. Whereas most porcine microorganisms representing a risk for the human recipient may be eliminated by designated pathogen free breeding, multiple copies of porcine endogenous retroviruses (PERVs) are integrated in the genome of all pigs and cannot be eliminated this way. PERVs are released as infectious particles and infect human cells. The zinc finger nuclease (ZFN) technology allows knocking out specifically cellular genes, however it was not yet used to eliminate multiple integrated proviral sequences with a strong conservation in the target sequence. To reduce the risk of horizontal PERV transmission and to knock out as many as possible proviruses, for the first time the powerful tool of the ZFN technology was used. ZFN were designed to bind specifically to sequences conserved in all known replication-competent proviruses. Expression and transport of the ZFN into the nucleus was shown by Western blot analysis, co-localisation analysis, PLA and FRET. Survival of transfected cells was analysed using fluorescent ZFN and cell counting. After transfection a strong expression of the ZFN proteins and a co-localisation of the expressed ZFN proteins were shown. However, expression of the ZFN was found to be extremely toxic for the transfected cells. The induced cytotoxicity was likely due to the specific cutting of the high copy number of the PERV proviruses, which is also commonly observed when ZFN with low specificity cleave numerous off-target sites in a genome. This is the first attempt to knock out multiple, nearly identical, genes in a cellular genome using ZFN. The attempt failed, and other strategies should be used to prevent PERV transmission.	[Semaan, Marwan; Ivanusic, Daniel; Denner, Joachim] Robert Koch Inst, Berlin, Germany; [Ivanusic, Daniel] Free Univ Berlin, Berlin, Germany	Robert Koch Institute; Free University of Berlin	Denner, J (corresponding author), Robert Koch Inst, Nordufer 20, Berlin, Germany.	DennerJ@rki.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 127]; Peter and Traudl Engelhorn Foundation; Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Peter and Traudl Engelhorn Foundation; Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany	Funding was provided by Deutsche Forschungsgemeinschaft (DFG) (TR SFB 127), the Peter and Traudl Engelhorn Foundation and the Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Bao L, 2014, SCI CHINA LIFE SCI, V57, P263, DOI 10.1007/s11427-013-4601-2; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Denner J, 2008, ARCH VIROL, V153, P1421, DOI 10.1007/s00705-008-0141-7; Denner J, 2012, CLIN MICROBIOL REV, V25, P318, DOI 10.1128/CMR.05011-11; Denner J, 2009, XENOTRANSPLANTATION, V16, P239, DOI 10.1111/j.1399-3089.2009.00544.x; Dieckhoff B, 2008, XENOTRANSPLANTATION, V15, P36, DOI 10.1111/j.1399-3089.2008.00442.x; Fiebig U, 2003, VIROLOGY, V307, P406, DOI 10.1016/S0042-6822(02)00140-X; Fishman JA, 1998, ANN NY ACAD SCI, V862, P52, DOI 10.1111/j.1749-6632.1998.tb09117.x; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hauschild-Quintern J, 2013, TRANSGENIC RES, V22, P1, DOI 10.1007/s11248-012-9647-6; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Karlas A, 2004, VIROLOGY, V325, P18, DOI 10.1016/j.virol.2004.04.022; Kaulitz D, 2011, VIROLOGY, V411, P78, DOI 10.1016/j.virol.2010.12.032; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Li P, 2013, J SURG RES, V181, pE39, DOI 10.1016/j.jss.2012.06.035; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Lutz AJ, 2013, XENOTRANSPLANTATION, V20, P27, DOI 10.1111/xen.12019; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Ramsoondar J, 2009, XENOTRANSPLANTATION, V16, P164, DOI 10.1111/j.1399-3089.2009.00525.x; Sachs DH, 2001, ADV IMMUNOL, V79, P129, DOI 10.1016/S0065-2776(01)79004-9; Semaan M, 2012, XENOTRANSPLANTATION, V19, P112, DOI 10.1111/j.1399-3089.2012.00683.x; Shaikh Shamim, 2006, J Biomol Tech, V17, P283; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; Waechter A, 2014, IMMUNOL RES, V58, P9, DOI 10.1007/s12026-013-8430-y; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Whyte JJ, 2012, J ANIM SCI, V90, P1111, DOI 10.2527/jas.2011-4546; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70	46	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0122059	10.1371/journal.pone.0122059	http://dx.doi.org/10.1371/journal.pone.0122059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909512	gold, Green Published, Green Submitted			2022-12-26	WOS:000353376800016
J	Veerappa, AM; Vishweswaraiah, S; Lingaiah, K; Murthy, M; Suresh, RV; Manjegowda, DS; Ramachandra, NB				Veerappa, Avinash M.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Murthy, Megha; Suresh, Raviraj V.; Manjegowda, Dinesh S.; Ramachandra, Nallur B.			Global Spectrum of Copy Number Variations Reveals Genome Organizational Plasticity and Proposes New Migration Routes	PLOS ONE			English	Article							SUSCEPTIBILITY; INSIGHTS; MUTATION; HUMANS; MOUSE	Global spectrum of CNVs is required to catalog variations to provide a high-resolution on the dynamics of genome-organization and human migration. In this study, we performed genome-wide genotyping using high-resolution arrays and identified 44,109 CNVs from 1,715 genomes across 12 populations. The study unraveled the force of independent evolutionary dynamics on genome-organizational plasticity across populations. We demonstrated the use of CNV tool to study human migration and identified a second major settlement establishing new migration routes in addition to existing ones.	[Veerappa, Avinash M.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Murthy, Megha; Suresh, Raviraj V.; Ramachandra, Nallur B.] Univ Mysore, Dept Studies Zool, Genet & Genom Lab, Mysore 06, Karnataka, India; [Manjegowda, Dinesh S.] Nitte Univ, KS Hegde Med Acad, NUCSER, Mangalore 18, Karnataka, India	University of Mysore; NITTE (Deemed to be University); K.S. Hegde Medical Academy; Nitte University Center for Science Education & Research (NUCSER)	Ramachandra, NB (corresponding author), Univ Mysore, Dept Studies Zool, Genet & Genom Lab, Mysore 06, Karnataka, India.	nallurbr@gmail.com		Vishweswaraiah, Sangeetha/0000-0001-5681-5143	Department of Science and Technology-Health Science [SR/SO/HS-103/2007]	Department of Science and Technology-Health Science	The work was supported by Department of Science and Technology-Health Science, grant number SR/SO/HS-103/2007, funding website http://www.dst.gov.in/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adams SM, 2006, FORENSIC SCI INT, V159, P14, DOI 10.1016/j.forsciint.2005.06.003; Affymetrix Inc, 2008, US MAN GEN CONS SOFT; Affymetrix Inc, 2005, TECHN NOT GUID PROB; Affymetrix Inc, 2009, DAT SHEET GEN WID HU; Affymetrix Inc, 2007, WHIT PAP BRLMM P GEN; [Anonymous], 2008, ANN ICRP, V38, P1; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bozeman MT, SNP VAR SUIT VERS 7; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chen W, 2011, PLOS ONE, V6; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gautam P, 2012, HUM GENET, V131, P131, DOI 10.1007/s00439-011-1050-5; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haraksingh RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027859; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kanduri C, 2013, EUR J HUM GENET, V21, P1411, DOI 10.1038/ejhg.2013.60; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lacaria M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002713; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lin CH, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-92; Liu X, 2013, AEROSP MANUF TECHNOL, V1, P1, DOI DOI 10.1109/TNNLS.2013.2287275; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2008, HUM HERED, V66, P1, DOI 10.1159/000114160; Veerappa AM, 2014, GENET RES, V96, DOI 10.1017/S0016672314000202; Veerappa AM, 2013, AM J MED GENET B, V162, P889, DOI 10.1002/ajmg.b.32199; Veerappa AM, 2013, J HUM GENET, V58, P539, DOI 10.1038/jhg.2013.47; Wang J, 2009, OPEN BIOL J, V2, P54; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang Y., 2012, PLOS ONE, V7; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304	53	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0121846	10.1371/journal.pone.0121846	http://dx.doi.org/10.1371/journal.pone.0121846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909454	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000353376800014
J	Zhang, FJ; Dong, W; Huang, LL; Song, AP; Wang, HB; Fang, WM; Chen, FD; Teng, NJ				Zhang, Fengjiao; Dong, Wen; Huang, Lulu; Song, Aiping; Wang, Haibin; Fang, Weimin; Chen, Fadi; Teng, Nianjun			Identification of MicroRNAs and their Targets Associated with Embryo Abortion during Chrysanthemum Cross Breeding via High-Throughput Sequencing	PLOS ONE			English	Article							SMALL RNAS; FLORAL DEVELOPMENT; PISTIL DEVELOPMENT; ARABIDOPSIS; EXPRESSION; EMBRYOGENESIS; REPRESSION; MATURATION; BODENLOS; PATTERNS	Background MicroRNAs (miRNAs) are important regulators in plant development. They post-transcriptionally regulate gene expression during various biological and metabolic processes by binding to the 3'-untranslated region of target mRNAs to facilitate mRNA degradation or inhibit translation. Chrysanthemum (Chrysanthemum morifolium) is one of the most important ornamental flowers with increasing demand each year. However, embryo abortion is the main reason for chrysanthemum cross breeding failure. To date, there have been no experiments examining the expression of miRNAs associated with chrysanthemum embryo development. Therefore, we sequenced three small RNA libraries to identify miRNAs and their functions. Our results will provide molecular insights into chrysanthemum embryo abortion. Results Three small RNA libraries were built from normal chrysanthemum ovules at 12 days after pollination (DAP), and normal and abnormal chrysanthemum ovules at 18 DAP. We validated 228 miRNAs with significant changes in expression frequency during embryonic development. Comparative profiling revealed that 69 miRNAs exhibited significant differential expression between normal and abnormal embryos at 18 DAP. In addition, a total of 1037 miRNA target genes were predicted, and their annotations were defined by transcriptome data. Target genes associated with metabolic pathways were most highly represented according to the annotation. Moreover, 52 predicted target genes were identified to be associated with embryonic development, including 31 transcription factors and 21 additional genes. Gene ontology (GO) annotation also revealed that high-ranking miRNA target genes related to cellular processes and metabolic processes were involved in transcription regulation and the embryo developmental process. Conclusions The present study generated three miRNA libraries and gained information on miRNAs and their targets in the chrysanthemum embryo. These results enrich the growing database of new miRNAs and lay the foundation for the further understanding of miRNA biological function in the regulation of chrysanthemum embryo abortion.	[Zhang, Fengjiao; Huang, Lulu; Song, Aiping; Wang, Haibin; Fang, Weimin; Chen, Fadi; Teng, Nianjun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Zhang, Fengjiao; Teng, Nianjun] Jiangsu Prov Engn Lab Modern Facil Agr Technol &, Nanjing, Jiangsu, Peoples R China; [Dong, Wen] China Rural Technol Dev Ctr, Beijing, Peoples R China	Nanjing Agricultural University	Teng, NJ (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	nianjunteng@163.com			National Natural Science Foundation of China [31171983, 31471901]; Programs for New Century Excellent Talents in Universities, Ministry of Education of China [NCET-11-0669]; Fundamental Research Funds for the Central Universities [KYZ201308]; fourth phase of Jiangsu ''333'' project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programs for New Century Excellent Talents in Universities, Ministry of Education of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); fourth phase of Jiangsu ''333'' project	This study was supported by the National Natural Science Foundation of China (31171983, 31471901), the Programs for New Century Excellent Talents in Universities, Ministry of Education of China (NCET-11-0669), the Fundamental Research Funds for the Central Universities (KYZ201308), and the fourth phase of Jiangsu ''333'' project to NJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Agyi A, 2013, J PLANT BIOL, V56, P336, DOI 10.1007/s12374-013-0097-3; Anderson N.O., 2006, CHRYSANTHEMUM FLOWER, P389; Arathi HS, 1996, INT J PLANT SCI, V157, P49, DOI 10.1086/297319; Baroux C, 2002, ADV GENET, V46, P165; Baud Sebastien, 2008, Arabidopsis Book, V6, pe0113, DOI 10.1199/tab.0113; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Buxdorf K, 2010, PLANTA, V232, P1009, DOI 10.1007/s00425-010-1231-9; Chen J., 2001, CLASSIFICATION SYSTE; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; De Smet I, 2013, J EXP BOT, V64, P3009, DOI 10.1093/jxb/ert137; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Duarte GT, 2013, J EXP BOT, V64, P4301, DOI 10.1093/jxb/ert239; FRANZ RE, 1991, CROP SCI, V31, P1651, DOI 10.2135/cropsci1991.0011183X003100060054x; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Grunewald W, 2013, EMBO REP, V14, P1136, DOI 10.1038/embor.2013.169; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Johri BM, 2001, REPROD BIOL PLANTS, P237; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Liang G, 2014, PLANT PHYSIOL, V164, P249, DOI 10.1104/pp.113.225144; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2008, CURR OPIN PLANT BIOL, V11, P560, DOI 10.1016/j.pbi.2008.06.008; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mallory AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000646; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Ndoutoumou PN, 2007, PLANT CELL TISS ORG, V88, P329, DOI 10.1007/s11240-006-9198-8; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seefried WF, 2014, PLANT PHYSIOL, V165, P670, DOI 10.1104/pp.114.240846; Song A, 2012, PLANT BIOLOGY, V14, P706, DOI 10.1111/j.1438-8677.2011.00560.x; Song AP, 2014, INT J MOL SCI, V15, P14442, DOI 10.3390/ijms150814442; Song AP, 2014, PLANT PHYSIOL BIOCH, V80, P114, DOI 10.1016/j.plaphy.2014.03.030; Sun CQ, 2010, EUPHYTICA, V174, P51, DOI 10.1007/s10681-009-0117-z; Sun CQ, 2010, EUPHYTICA, V171, P181, DOI 10.1007/s10681-009-0005-6; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Vashisht D, 2014, BIOCHEM SOC T, V42, P352, DOI 10.1042/BST20130252; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang XC, 2009, CELL RES, V19, P224, DOI 10.1038/cr.2008.276; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie ZX, 2010, SEMIN CELL DEV BIOL, V21, P790, DOI 10.1016/j.semcdb.2010.03.012; Yamaguchi A, 2012, J PLANT RES, V125, P693, DOI 10.1007/s10265-012-0513-7; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Zhai L, 2014, PLANT MOL BIOL REP, P1; Zhang FJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06536; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	70	41	46	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0124371	10.1371/journal.pone.0124371	http://dx.doi.org/10.1371/journal.pone.0124371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	25909659	Green Published, Green Submitted, gold			2022-12-26	WOS:000353376800079
J	Devay, RM; Yamamoto, L; Shelton, DL; Liang, H				Devay, Rachel M.; Yamamoto, Lynn; Shelton, David L.; Liang, Hong			Common Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Epitopes Mediate Multiple Routes for Internalization and Function	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTORS; SECRETED PCSK9; LDL RECEPTORS; ANTIBODY; CHOLESTEROL; DOMAIN; TRAFFICKING; DEGRADATION; PLASMA; BINDS	Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs membrane-bound receptors to lysosomes for degradation. In the most studied example of this, PCSK9 binding leads to the degradation of low density lipoprotein receptor (LDLR), significantly affecting circulating LDL-C levels. The mechanism mediating this degradation, however, is not completely understood. We show here that LDLR facilitates PCSK9 interactions with amyloid precursor like protein 2 (APLP2) at neutral pH leading to PCSK9 internalization, although direct binding between PCSK9 and LDLR is not required. Moreover, binding to APLP2 or LDLR is independently sufficient for PCSK9 endocytosis in hepatocytes, while LDL can compete with APLP2 for PCSK9 binding to indirectly mediate PCSK9 endocytosis. Finally, we show that APLP2 and LDLR are also required for the degradation of another PCSK9 target, APOER2, necessitating a general role for LDLR and APLP2 in PCSK9 function. Together, these findings provide evidence that PCSK9 has at least two endocytic epitopes that are utilized by a variety of internalization mechanisms and clarifies how PCSK9 may direct proteins to lysosomes.	[Devay, Rachel M.; Yamamoto, Lynn; Shelton, David L.; Liang, Hong] Rinat Pfizer Inc, San Francisco, CA 94080 USA	Pfizer	Liang, H (corresponding author), Rinat Pfizer Inc, San Francisco, CA 94080 USA.	hong.liang@pfizer.com			Pfizer	Pfizer(Pfizer)	This study was sponsored by Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Canuel M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064145, DOI 10.1371/J0URNAL.P0NE.0064145]; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Liang H, 2012, J PHARM EXPT THERAPE; Luna Saavedra YG, 2012, J BIOL CHEM; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Strom TB, 2011, BIOCHEM BIOPH RES CO, V408, P642, DOI 10.1016/j.bbrc.2011.04.077; Surdo PL, 2011, EMBO REPORTS; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0125127	10.1371/journal.pone.0125127	http://dx.doi.org/10.1371/journal.pone.0125127			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905719	gold, Green Published, Green Submitted			2022-12-26	WOS:000353332000105
J	Kozak, A; Goldyn, R; Dondajewska, R				Kozak, Anna; Goldyn, Ryszard; Dondajewska, Renata			Phytoplankton Composition and Abundance in Restored Maltanski Reservoir under the Influence of Physico-Chemical Variables and Zooplankton Grazing Pressure	PLOS ONE			English	Article							FRESH-WATER; RESTORATION MEASURES; RECREATIONAL LAKES; HYPERTROPHIC LAKE; FILTERING RATE; SHALLOW LAKE; PHOSPHORUS; CYANOBACTERIA; DAPHNIA; POZNAN	In this paper we present the effects of environmental factors and zooplankton food pressure on phytoplankton in the restored man-made Maltanski Reservoir (MR). Two methods of restoration: biomanipulation and phosphorus inactivation have been applied in the reservoir. Nine taxonomical groups of phytoplankton represented in total by 183 taxa were stated there. The richest groups in respect of taxa number were green algae, cyanobacteria and diatoms. The diatoms, cryptophytes, chrysophytes, cyanobacteria, green algae and euglenophytes dominated in terms of abundance and/or biomass. There were significant changes among environmental parameters resulting from restoration measures which influenced the phytoplankton populations in the reservoir. These measures led to a decrease of phosphorus concentration due to its chemical inactivation and enhanced zooplankton grazing as a result of planktivorous fish stocking. The aim of the study is to analyse the reaction of phytoplankton to the restoration measures and, most importantly, to determine the extent to which the qualitative and quantitative composition of phytoplankton depends on variables changing under the influence of restoration in comparison with other environmental variables. We stated that application of restoration methods did cause significant changes in phytoplankton community structure. The abundance of most phytoplankton taxa was negatively correlated with large zooplankton filter feeders, and positively with zooplankton predators and concentrations of ammonium nitrogen and partly of phosphates. However, restoration was insufficient in the case of decreasing phytoplankton abundance. The effects of restoration treatments were of less importance for the abundance of phytoplankton than parameters that were independent of the restoration. This was due to the continuous inflow of large loads of nutrients from the area of the river catchment.	[Kozak, Anna; Goldyn, Ryszard; Dondajewska, Renata] Adam Mickiewicz Univ, Fac Biol, Dept Water Protect, Poznan, Poland	Adam Mickiewicz University	Kozak, A (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Water Protect, Poznan, Poland.	akozak@amu.edu.pl	Gołdyn, Ryszard Jan/J-1093-2018	Gołdyn, Ryszard Jan/0000-0001-8325-5161; Dondajewska-Pielka, Renata/0000-0002-6761-0669; Kozak, Anna/0000-0001-7448-0498	Ministry of Science and Higher Education (Poland) [NN305 372838]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	This research was financed by the grant No NN305 372838 from the Ministry of Science and Higher Education (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballot A, 2010, TOXICON, V56, P964, DOI 10.1016/j.toxicon.2010.06.021; Bednarska A, 2007, LIMNOL OCEANOGR, V52, P2358, DOI 10.4319/lo.2007.52.6.2358; BENNDORF J, 1990, HYDROBIOLOGIA, V200, P187, DOI 10.1007/BF02530339; Bishop WM, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2018-6; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Budzynska A, 2010, THESIS A MICKIEWICZ; Chen FZ, 2013, HYDROBIOLOGIA, V718, P59, DOI 10.1007/s10750-013-1603-9; Cooke GD, 2003, RESTORATION MANAGEME, P1; CRONBERG G, 1982, HYDROBIOLOGIA, V86, P185, DOI 10.1007/BF00005809; Ejsmont-Karabin Jolanta, 1998, Polskie Archiwum Hydrobiologii, V45, P513; Elbanowska H., 1999, PHYSICOCHEMICAL WATE; Elliott JA, 2012, WATER RES, V46, P1364, DOI 10.1016/j.watres.2011.12.018; FORSYTH DJ, 1990, ARCH HYDROBIOL, V117, P385; Gawroska H., 2007, LIMNOL REV, V7, P27; Goldyn R, 1997, HYDROBIOLOGIA, V342, P327, DOI 10.1023/A:1017036717550; Goldyn R, 2008, J PLANKTON RES, V30, P33, DOI 10.1093/plankt/fbm086; Goldyn Ryszard, 2014, Ecohydrology & Hydrobiology, V14, P68, DOI 10.1016/j.ecohyd.2013.12.001; Goldyn R, 2013, CARPATH J EARTH ENV, V8, P43; Goldyn R, 2010, OCEANOL HYDROBIOL ST, V39, P65, DOI 10.2478/v10009-010-0040-6; Grochowska JK, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013056; Hammer A, 2002, AQUAT MICROB ECOL, V29, P287, DOI 10.3354/ame029287; HAWKINS P, 1989, LIMNOL OCEANOGR, V34, P1084; Hodoki Y, 2012, HARMFUL ALGAE, V16, P49, DOI 10.1016/j.hal.2012.01.003; Jaworska Bozena, 2014, Archives of Polish Fisheries, V22, P7; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2007, HYDROBIOLOGIA, V584, P239, DOI 10.1007/s10750-007-0596-7; Kangro K, 2005, HYDROBIOLOGIA, V547, P91, DOI 10.1007/s10750-005-4151-0; KNOECHEL R, 1986, LIMNOL OCEANOGR, V31, P195, DOI 10.4319/lo.1986.31.1.0195; Kobos J, 2013, OCEANOL HYDROBIOL ST, V42, P358, DOI 10.2478/s13545-013-0093-8; Kokocinski M, 2013, ENVIRON SCI POLLUT R, V20, P5243, DOI 10.1007/s11356-012-1426-7; Kopp R, 2009, AQUAC RES, V40, P1683, DOI 10.1111/j.1365-2109.2009.02285.x; Kowalczewska-Madura K, 2010, OCEANOL HYDROBIOL ST, V39, P135, DOI 10.2478/v10009-010-0046-0; Kowalczewska-Madura K, 2010, OCEANOL HYDROBIOL ST, V39, P21, DOI 10.2478/v10009-010-0041-5; Kozak A, 2005, POL J ENVIRON STUD, V14, P451; Kozak A, 2004, J PLANKTON RES, V26, P37, DOI 10.1093/plankt/fbh006; Kozak A, 2007, TEKA KOM OCHR KSZT S, V4, P7; Kozak A, 2014, POL J ENVIRON STUD, V23, P1201; Kozak Anna, 2014, Archives of Polish Fisheries, V22, P17; Kozak Anna, 2013, Polish Journal of Natural Sciences, V28, P217; Kurmayer R, 2001, HYDROBIOLOGIA, V442, P279, DOI 10.1023/A:1017598518952; LAMPERT W, 1988, Limnologica, V19, P11; Lopata M, 2013, WATER SCI TECHNOL, V68, P2127, DOI 10.2166/wst.2013.461; Lopata M, 2008, OCEANOL HYDROBIOL ST, V37, P99, DOI 10.2478/v10009-007-0046-x; Lurling M, 2013, WATER RES, V47, P6527, DOI 10.1016/j.watres.2013.08.019; Lurling M, 2013, FRESHWATER BIOL, V58, P552, DOI 10.1111/j.1365-2427.2012.02866.x; Mehnert G, 2010, J PLANKTON RES, V32, P1009, DOI 10.1093/plankt/fbq033; Mischke U, 2003, ACTA OECOL, V24, pS11, DOI 10.1016/S1146-609X(03)00003-1; Moos MT, 2014, J ENVIRON MANAGE, V141, P77, DOI 10.1016/j.jenvman.2014.02.038; Padisak J, 1998, HYDROBIOLOGIA, V384, P41, DOI 10.1023/A:1003255529403; Pawlik-Skowronska B, 2011, OCEANOL HYDROBIOL ST, V40, P30, DOI 10.2478/s13545-011-0038-z; Pelechata Aleksandra, 2006, Oceanological and Hydrobiological Studies, V35, P3; Radwan S, 2004, FAUNA SLODKOWODNA PO; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; ROJO C, 1994, HYDROBIOLOGIA, V275, P165, DOI 10.1007/BF00026708; Sarnelle O, 2007, LIMNOL OCEANOGR, V52, P2120, DOI 10.4319/lo.2007.52.5.2120; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Shapiro J, 1991, P S WAT QUAL MAN BIO, P85; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; STEFANIAK K, 2005, OCEANOL HYDROBIOL ST, V34, P137; STEFKO B, 1976, Poznanskie Towarzystwo Przyjaciol Nauk Wydzial Matematyczno-Przyrodniczy Prace Komisji Biologicznej, V42, P55; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Walsby AE, 2006, NEW PHYTOL, V169, P109, DOI 10.1111/j.1469-8137.2005.01567.x; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Wilk-Wozniak E, 2003, BIOLOGIA, V58, P17; Wilk-Wozniak E, 2013, BIOLOGIA, V68, P838, DOI 10.2478/s11756-013-0221-3; Zagajewski P, 2009, OCEANOL HYDROBIOL ST, V38, P113; Zagajewski Pawel, 2007, Oceanological and Hydrobiological Studies, V36, P181; Zamparas M, 2014, SCI TOTAL ENVIRON, V496, P551, DOI 10.1016/j.scitotenv.2014.07.076	68	28	32	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124738	10.1371/journal.pone.0124738	http://dx.doi.org/10.1371/journal.pone.0124738			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906352	Green Submitted, gold, Green Published			2022-12-26	WOS:000353332000084
J	Lowther, AD; Lydersen, C; Fedak, MA; Lovell, P; Kovacs, KM				Lowther, Andrew D.; Lydersen, Christian; Fedak, Mike A.; Lovell, Phil; Kovacs, Kit M.			The Argos-CLS Kalman Filter: Error Structures and State-Space Modelling Relative to Fastloc GPS Data	PLOS ONE			English	Article							ANIMAL MOVEMENT; LOCATION ACCURACY; SATELLITE; TIME; TACTICS; WHALES; SEALS	Understanding how an animal utilises its surroundings requires its movements through space to be described accurately. Satellite telemetry is the only means of acquiring movement data for many species however data are prone to varying amounts of spatial error; the recent application of state-space models (SSMs) to the location estimation problem have provided a means to incorporate spatial errors when characterising animal movements. The predominant platform for collecting satellite telemetry data on free-ranging animals, Service Argos, recently provided an alternative Doppler location estimation algorithm that is purported to be more accurate and generate a greater number of locations that its predecessor. We provide a comprehensive assessment of this new estimation process performance on data from free-ranging animals relative to concurrently collected Fastloc GPS data. Additionally, we test the efficacy of three readily-available SSM in predicting the movement of two focal animals. Raw Argos location estimates generated by the new algorithm were greatly improved compared to the old system. Approximately twice as many Argos locations were derived compared to GPS on the devices used. Root Mean Square Errors (RMSE) for each optimal SSM were less than 4.25km with some producing RMSE of less than 2.50km. Differences in the biological plausibility of the tracks between the two focal animals used to investigate the utility of SSM highlights the importance of considering animal behaviour in movement studies. The ability to reprocess Argos data collected since 2008 with the new algorithm should permit questions of animal movement to be revisited at a finer resolution.	[Lowther, Andrew D.; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Fedak, Mike A.; Lovell, Phil] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 9AJ, Fife, Scotland	Norwegian Polar Institute; University of St Andrews	Lowther, AD (corresponding author), Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway.	andrew.lowther@npolar.no	Lowther, Andrew/T-2511-2019; Fedak, Michael A/B-3987-2009; Patterson, Ruth/A-7540-2018	Lowther, Andrew/0000-0003-4294-3157; Fedak, Michael A/0000-0002-9569-1128; 	Norwegian Polar Institute centre for Ice, Climate and Ecosystems (ICE); Natural Environment Research Council [smru10001] Funding Source: researchfish	Norwegian Polar Institute centre for Ice, Climate and Ecosystems (ICE); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Norwegian Polar Institute centre for Ice, Climate and Ecosystems (ICE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Argos, 1989, US MAN ARGOS SYST; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Bryant E, 2007, TR01 WILDTR TEL SYST; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; DIACONIS P, 1985, ANN STAT, V13, P845, DOI 10.1214/aos/1176349634; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Filzmoser P, 2005, COMPUT GEOSCI-UK, V31, P579, DOI 10.1016/j.cageo.2004.11.013; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Freitas C, 2008, OECOLOGIA, V155, P193, DOI 10.1007/s00442-007-0894-9; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hindell MA, 2011, KERGUELEN PLATEAU MA, P203, DOI DOI 10.1007/S003960050133; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Jakobsson M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052219; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kennedy AS, 2014, ENDANGER SPECIES RES, V23, P187, DOI 10.3354/esr00570; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; LEVANON N, 1985, IEEE T AERO ELEC SYS, V21, P783, DOI 10.1109/TAES.1985.310663; Lopez R, 2014, IEEE T GEOSCI REMOTE, V52, P4744, DOI 10.1109/TGRS.2013.2284293; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; R Core Team, 2021, R LANGUAGE ENV STAT; Silva MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092277; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022	42	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0124754	10.1371/journal.pone.0124754	http://dx.doi.org/10.1371/journal.pone.0124754			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905640	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000086
J	Sandoval, C; Ortega, A; Sanchez, SA; Morales, J; Gunther, G				Sandoval, Catalina; Ortega, Anakenna; Sanchez, Susana A.; Morales, Javier; Gunther, German			Structuration in the Interface of Direct and Reversed Micelles of Sucrose Esters, Studied by Fluorescent Techniques	PLOS ONE			English	Article							BETA-D-THIOGLUCOSIDE; MIXED MICELLES; EXCITED-STATE; SOLVATION DYNAMICS; SURFACTANT; SOLVENT; PYRANINE; SOLUBILIZATION; PROBE; DEACTIVATION	Background Reactors found in nature can be described as micro-heterogeneous systems, where media involved in each micro-environment can behave in a markedly different way compared with the properties of the bulk solution. The presence of water molecules in micro-organized assemblies is of paramount importance for many chemical processes, ranging from biology to environmental science. Self-organized molecular assembled systems are frequently used to study dynamics of water molecules because are the simplest models mimicking biological membranes. The hydrogen bonds between sucrose and water molecules are described to be stronger (or more extensive) than the ones between water molecules themselves. In this work, we studied the capability of sucrose moiety, attached to alkyl chains of different length, as a surface blocking agent at the water-interface and we compared its properties with those of polyethylenglycol, a well-known agent used for this purposes. Published studies in this topic mainly refer to the micellization process and the stability of mixed surfactant systems using glycosides. We are interested in the effect induced by the presence of sucrose monoesters at the interface (direct and reverse micelles) and at the palisade (mixtures with Triton X-100). We believe that the different functional group (ester), the position of alkyl chain (6-O) and the huge capability of sucrose to interact with water will dramatically change the water structuration at the interface and at the palisade, generating new possibilities for technological applications of these systems. Results Our time resolved and steady state fluorescence experiments in pure SEs micelles show that sucrose moieties are able to interact with a high number of water molecules promoting water structuration and increased viscosity. These results also indicate that the barrier formed by sucrose moieties on the surface of pure micelles is more effective than the polyoxyethylene palisade of Triton X-100. The fluorescence quenching experiments of SEs at the palisade of Triton X-100 micelles indicate a blocking effect dependent on the number of methylene units present in the hydrophobic tail of the surfactant. A remarkable blocking effect is observed when there is a match in size between the hydrophobic regions forming the apolar core (lauryl SE/Triton X-100). This blocking effect disappears when a mismatch in size between hydrophobic tails, exists due to the disturbing effect on the micelle core.	[Sandoval, Catalina; Ortega, Anakenna; Gunther, German] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fisicoquim, Santiago, Chile; [Sanchez, Susana A.] Univ Concepcion, Fac Quim, Dept Polimeros, Concepcion, Chile; [Morales, Javier] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencias Tecnol & Farmaceut, Santiago, Chile	Universidad de Chile; Universidad de Concepcion; Universidad de Chile	Gunther, G (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fisicoquim, Santiago, Chile.	ggunther@ciq.uchile.cl	Sánchez, Susana/HII-3113-2022; Gunther, German/I-1028-2013	Gunther, German/0000-0002-4733-8426; Morales Valenzuela, Javier Eduardo/0000-0002-9880-2567; Sandoval-Altamirano, Catalina/0000-0002-8550-3218	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1120196, 1140454]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funding was received from the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1120196, http://www.conicyt.cl/fondecyt/, GG; and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1140454, http://www.conicyt.cl/fondecyt/, SAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMGREN M, 1992, ADV COLLOID INTERFAC, V41, P9, DOI 10.1016/0001-8686(92)80004-H; Avnir Y, 2005, ANAL BIOCHEM, V347, P34, DOI 10.1016/j.ab.2005.09.026; Bales BL, 2000, J PHYS CHEM B, V104, P264, DOI 10.1021/jp993290i; Barnadas-Rodriguez R, 2008, J PHOTOCH PHOTOBIO A, V198, P262, DOI 10.1016/j.jphotochem.2008.04.003; Becerra N, 2008, COLLOID SURFACE A, V327, P134, DOI 10.1016/j.colsurfa.2008.06.012; Becerra N, 2006, COLLOID SURFACE A, V272, P2, DOI 10.1016/j.colsurfa.2005.04.024; Berrios E, 2008, J CHIL CHEM SOC, V53, P1728, DOI 10.4067/S0717-97072008000400021; Borsarelli CD, 1997, J PHYS CHEM B, V101, P6036, DOI 10.1021/jp971184f; Ruiz CC, 2012, PHOTOCH PHOTOBIO SCI, V11, P1331, DOI 10.1039/c2pp25049g; Ruiz CC, 2011, J COLLOID INTERF SCI, V361, P178, DOI 10.1016/j.jcis.2011.05.019; Chaudhuri A, 2009, BIOCHEM BIOPH RES CO, V390, P728, DOI 10.1016/j.bbrc.2009.10.037; DONG DC, 1984, CAN J CHEM, V62, P2560, DOI 10.1139/v84-437; DRUMMOND CJ, 1985, J PHYS CHEM-US, V89, P2103, DOI 10.1021/j100256a060; Garcia MT, 1997, CHEMOSPHERE, V35, P545; Garofalakis G, 2000, J COLLOID INTERF SCI, V229, P391, DOI 10.1006/jcis.2000.7035; GEHLEN MH, 1993, CHEM REV, V93, P199, DOI 10.1021/cr00017a010; Granizo N, 2004, J COLLOID INTERF SCI, V273, P638, DOI 10.1016/j.jcis.2004.02.004; Grasjo J, 2009, J PHYS CHEM B, V113, P8201, DOI 10.1021/jp902058w; Hara K, 2001, J PHYS CHEM A, V105, P7174, DOI 10.1021/jp0109776; Hierrezuelo JM, 2006, J COLLOID INTERF SCI, V294, P449, DOI 10.1016/j.jcis.2005.07.024; JENNY TA, 1982, TETRAHEDRON LETT, V23, P2923, DOI 10.1016/S0040-4039(00)87495-X; Jimenez-Banzo A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1003, DOI 10.1039/b804333g; KONDO H, 1982, J PHYS CHEM-US, V86, P4826, DOI 10.1021/j100221a035; Kumbhakar M, 2004, J CHEM PHYS, V121, P6026, DOI 10.1063/1.1784774; Mondal SK, 2005, CHEM PHYS LETT, V412, P228, DOI 10.1016/j.cplett.2005.07.001; Montenegro MA, 2002, PHOTOCHEM PHOTOBIOL, V75, P353, DOI 10.1562/0031-8655(2002)075<0353:SMOQAO>2.0.CO;2; Nonell S, 2000, METHOD ENZYMOL, V319, P37; Noritomi H, 2006, COLLOID POLYM SCI, V284, P677, DOI 10.1007/s00396-005-1419-x; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Rameez S, 2011, LANGMUIR, V27, P8829, DOI 10.1021/la201246m; Regev O, 1999, J COLLOID INTERF SCI, V210, P8, DOI 10.1006/jcis.1998.5776; Rodriguez HB, 2012, PHOTOCHEM PHOTOBIOL, V88, P831, DOI 10.1111/j.1751-1097.2012.01152.x; Ruiz CC, 2003, COLLOID POLYM SCI, V281, P531, DOI 10.1007/s00396-002-0801-1; Ruiz CC, 2000, LANGMUIR, V16, P7946, DOI 10.1021/la000154s; Salokhiddinov K. I., 1981, Journal of Applied Spectroscopy, V34, P561, DOI 10.1007/BF00613067; Sanchez SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029278; SCHMIDT R, 1987, J AM CHEM SOC, V109, P6976, DOI 10.1021/ja00257a012; Sierra ML, 1999, LANGMUIR, V15, P2301, DOI 10.1021/la9804177; Szuts A, 2012, INT J PHARMACEUT, V433, P1, DOI 10.1016/j.ijpharm.2012.04.076; Thevenet S, 1999, CARBOHYD RES, V318, P52, DOI 10.1016/S0008-6215(99)00079-8; Tong S, 2011, NANO LETT, V11, P3720, DOI 10.1021/nl201978c; Toro C, 2009, CHEM PHYS LIPIDS, V157, P104, DOI 10.1016/j.chemphyslip.2008.11.004; Ullrich S, 2008, EUR J PHARM BIOPHARM, V70, P550, DOI 10.1016/j.ejpb.2008.05.014; Valdes K, 2014, COLLOID SURFACE B, V117, P1, DOI 10.1016/j.colsurfb.2014.01.029; Verma PK, 2009, PHYS CHEM CHEM PHYS, V11, P8467, DOI 10.1039/b905573h; Vlahov IR, 1997, J CARBOHYD CHEM, V16, P1, DOI 10.1080/07328309708006506; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Wolszczak M, 2002, J PHOTOCH PHOTOBIO A, V147, P45, DOI 10.1016/S1010-6030(01)00611-6; Youan BBC, 2003, AAPS PHARMSCI, V5; Zhao SN, 2014, LANGMUIR, V30, P6920, DOI 10.1021/la501141m; ZULAUF M, 1979, J PHYS CHEM-US, V83, P480, DOI 10.1021/j100467a011	52	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0123669	10.1371/journal.pone.0123669	http://dx.doi.org/10.1371/journal.pone.0123669			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25905632	Green Published, gold, Green Submitted			2022-12-26	WOS:000353332000041
J	Yi, JZ; Mao, X; Chen, LJ; Xue, YL; Rovetta, A; Caleanu, CD				Yi, Jizheng; Mao, Xia; Chen, Lijiang; Xue, Yuli; Rovetta, Alberto; Caleanu, Catalin-Daniel			Illumination Normalization of Face Image Based on Illuminant Direction Estimation and Improved Retinex	PLOS ONE			English	Article							HISTOGRAM EQUALIZATION; RECOGNITION; COMPENSATION	Illumination normalization of face image for face recognition and facial expression recognition is one of the most frequent and difficult problems in image processing. In order to obtain a face image with normal illumination, our method firstly divides the input face image into sixteen local regions and calculates the edge level percentage in each of them. Secondly, three local regions, which meet the requirements of lower complexity and larger average gray value, are selected to calculate the final illuminant direction according to the error function between the measured intensity and the calculated intensity, and the constraint function for an infinite light source model. After knowing the final illuminant direction of the input face image, the Retinex algorithm is improved from two aspects: (1) we optimize the surround function; (2) we intercept the values in both ends of histogram of face image, determine the range of gray levels, and stretch the range of gray levels into the dynamic range of display device. Finally, we achieve illumination normalization and get the final face image. Unlike previous illumination normalization approaches, the method proposed in this paper does not require any training step or any knowledge of 3D face and reflective surface model. The experimental results using extended Yale face database B and CMU-PIE show that our method achieves better normalization effect comparing with the existing techniques.	[Yi, Jizheng; Mao, Xia; Chen, Lijiang; Xue, Yuli] Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China; [Rovetta, Alberto] Polytech Univ Milan, Dept Mech, I-20156 Milan, Italy; [Caleanu, Catalin-Daniel] Univ POLITEHN Timisoara, Dept Appl Elect, Timisoara 300223, Romania	Beihang University; Polytechnic University of Milan; Polytechnic University of Timisoara	Chen, LJ (corresponding author), Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China.	clj@ee.buaa.edu.cn	Caleanu, Catalin Daniel/AAE-2995-2019	Caleanu, Catalin Daniel/0000-0002-0252-7047	Specialized Research Fund for the Doctoral Program of Higher Education [20121102130001]; China Postdoctoral Science Foundation [2013M540837]; Innovation Foundation of BUAA for PhD Graduates; National Natural Science Foundation of China [61103097]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovation Foundation of BUAA for PhD Graduates; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20121102130001), the China Postdoctoral Science Foundation (Grant No. 2013M540837), the Innovation Foundation of BUAA for PhD Graduates, and the National Natural Science Foundation of China (Grant No. 61103097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini Y, 1997, IEEE T PATTERN ANAL, V19, P721, DOI 10.1109/34.598229; Bayu BSD, 2013, P 2013 IEEE WORKSH A, P131; Chacon M, P 10 IEEE INT C FUZZ, P675; Chacon M, P IEEE ANN M N AM FU, P241; Chen WL, 2006, IEEE T SYST MAN CY B, V36, P458, DOI 10.1109/TSMCB.2005.857353; Cheng Y, 2012, P 4 INT C INT HUM MA, V1, P94; Diaz-Ramirez VH, 2009, APPL OPTICS, V48, P1408, DOI 10.1364/AO.48.001408; Emadi M, 2012, PROCEDIA ENGINEER, V41, P854, DOI 10.1016/j.proeng.2012.07.254; Filippi AM, 2013, OPT LETT, V38, P1676, DOI 10.1364/OL.38.001676; Ge Wei, 2010, Optics and Precision Engineering, V18, P1011; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Jobson DJ, 1997, IEEE T IMAGE PROCESS, V6, P965, DOI 10.1109/83.597272; Jobson DJ, 1997, IEEE T IMAGE PROCESS, V6, P451, DOI 10.1109/83.557356; Jung C, 2013, NEUROCOMPUTING, V113, P130, DOI 10.1016/j.neucom.2013.01.038; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Lee PH, 2012, IEEE T IMAGE PROCESS, V21, P4280, DOI 10.1109/TIP.2012.2202670; Luo Y., 2013, INT J ADV MANUF TECH, P1; Mian A, 2011, OPT EXPRESS, V19, P7491, DOI 10.1364/OE.19.007491; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Park S, P 19 INT C PATT REC, P1; Patil NK, 2013, P 2013 INT S EL SYST, P148; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Qin J, 2013, APPL OPTICS, V52, P6512, DOI 10.1364/AO.52.006512; Rahman ZU, 2004, J ELECTRON IMAGING, V13, P100, DOI 10.1117/1.1636183; Rahman ZU, 2002, PROC SPIE, V4662, P390, DOI 10.1117/12.469537; Restrepo R, 2012, OPT COMMUN, V285, P546, DOI 10.1016/j.optcom.2011.10.077; Ruiz-Del-Solar J, 2008, PATTERN RECOGN LETT, V29, P1966, DOI 10.1016/j.patrec.2008.06.015; Shashua A, 2001, IEEE T PATTERN ANAL, V23, P129, DOI 10.1109/34.908964; Sim T, 2003, IEEE T PATTERN ANAL, V25, P1615, DOI 10.1109/TPAMI.2003.1251154; Vishwakarma Virendra P., 2009, International Journal of Recent Trends in Engineering, V1, P318; Wang HT, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P819; Wang HT, 2004, PROC CVPR IEEE, P498; Wang YH, 2008, INFORM SCIENCES, V178, P2705, DOI 10.1016/j.ins.2007.12.017; Xie XD, 2006, PATTERN RECOGN LETT, V27, P609, DOI 10.1016/j.patrec.2005.09.026; Xie XD, 2005, IEEE INT SYMP CIRC S, P3841; Xie XD, 2005, PATTERN RECOGN, V38, P221, DOI 10.1016/j.patcog.2004.07.002; Yang Jie, 2013, Journal of Multimedia, V8, P541, DOI 10.4304/jmm.8.5.541-547; Yang Jie, 2002, Journal of Shanghai Jiaotong University, V36, P894; Yi JZ, 2014, APPL OPTICS, V53, P226, DOI 10.1364/AO.53.000226; Zhao XX, 2011, THESIS CHINA U MININ; Zhou Y, 2013, OPT EXPRESS, V21, P11294, DOI 10.1364/OE.21.011294	42	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2015	10	4							e0122200	10.1371/journal.pone.0122200	http://dx.doi.org/10.1371/journal.pone.0122200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5KZ	25906370	Green Published, Green Submitted, gold			2022-12-26	WOS:000353332000012
J	Kim, H; Suzuki, T; Kim, M; Kojima, N; Ota, N; Shimotoyodome, A; Hase, T; Hosoi, E; Yoshida, H				Kim, Hunkyung; Suzuki, Takao; Kim, Miji; Kojima, Narumi; Ota, Noriyasu; Shimotoyodome, Akira; Hase, Tadashi; Hosoi, Erika; Yoshida, Hideyo			Effects of Exercise and Milk Fat Globule Membrane (MFGM) Supplementation on Body Composition, Physical Function, and Hematological Parameters in Community-Dwelling Frail Japanese Women: A Randomized Double Blind, Placebo-Controlled, Follow-Up Trial	PLOS ONE			English	Article							GROWTH-FACTOR; RESISTANCE EXERCISE; OLDER-PEOPLE; WEIGHT-LOSS; BDNF; SARCOPENIA; MYOSTATIN; STRENGTH; MOBILITY; ADULTS	Objective To investigate the combined and separate effects of exercise and milk fat globule membrane (MFGM) supplementation on frailty, physical function, physical activity level, and hematological parameters in community-dwelling elderly Japanese women. Methods A total of 131 frail, elderly women over 75 years were randomly assigned to one of four groups: exercise and MFGM supplementation (Ex+MFGM), exercise and placebo (Ex+Plac), MFGM supplementation, or the placebo group. The exercise group attended a 60-minute training program twice a week for three months, and the MFGM group ingested 1g of the MFGM supplement in pill form, daily for 3 months. The primary outcome measure was change in frailty status based on Fried's frailty phenotype. Secondary outcome measures included body composition, physical function and hematological parameters, and interview survey components assessing lifestyle factors. Participants were followed for 4 months post-intervention. Results Significant groupxtime interactions were observed for usual walking speed (P = 0.005), timed up & go (P < 0.001), and insulin-like growth factor-binding protein 3/insulin-like growth factor 1 ratio (P = 0.013). The frailty components revealed that weight loss, exhaustion, low physical activity, and slow walking speed were reversed, but low muscle strength did not significantly changed. Frailty reversal rate was significantly higher in the Ex+MFGM (57.6%) than in the MFGM (28.1%) or placebo (30.3%) groups at post-intervention (chi(2) = 8.827, P = 0.032), and at the follow-up was also significantly greater in the Ex+MFGM (45.5%) and Ex+Plac (39.4%) groups compared with the placebo (15.2%) group (chi(2) = 8.607, P = 0.035). The exercise+MFGM group had the highest odds ratio (OR) for frailty reversal at post-intervention and follow-up (OR = 3.12, 95% confidence interval (CI) = 1.13-8.60; and OR = 4.67, 95% CI = 1.45-15.08, respectively). Conclusion This study suggests that interventions including exercise and nutrition can improve frailty status. Statistically significant additive effects of MFGM with exercise could not be confirmed in this population, and further investigation in larger samples is necessary.	[Kim, Hunkyung; Kim, Miji; Kojima, Narumi; Hosoi, Erika; Yoshida, Hideyo] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Suzuki, Takao] Natl Inst Longev Sci, Obu, Aichi, Japan; [Ota, Noriyasu; Shimotoyodome, Akira; Hase, Tadashi] Kao Corp, Biol Sci Labs, Hlth Sci, Ichikai, Tochigi, Japan	Tokyo Metropolitan Institute of Gerontology; KAO Corporation	Kim, H (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan.	kimhk@tmig.or.jp	Kim, Heejin/HII-8568-2022; Lee, Sei Won/AAG-9977-2019	shimotoyodome, akira/0000-0001-7567-8316	Ministry of Health and Welfare of Japan; Japan Society for the Promotion of Science [22300243]	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a research grant of the Ministry of Health and Welfare of Japan and a Grant-in-Aid for Scientific Research B of the Japan Society for the Promotion of Science (22300243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Noriyasu Ota, Akira Shimotoyodome and Tadashi Hase are employed by Kao Corporation. Kao Corporation provided support in the form of salaries for authors NO, AS and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bermon S, 1999, ACTA PHYSIOL SCAND, V165, P51; Borst SE, 2002, J AM GERIATR SOC, V50, P884, DOI 10.1046/j.1532-5415.2002.50215.x; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Cameron ID, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-65; Chan DCD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-58; Clegg A, 2014, AGE AGEING; Coelho FM, 2012, ARCH GERONTOL GERIAT, V54, P415, DOI 10.1016/j.archger.2011.05.014; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; El-Loly Mohamed Mansour, 2011, Polish Journal of Food and Nutrition Sciences, V61, P7; Elliot TA, 2006, MED SCI SPORT EXER, V38, P667, DOI 10.1249/01.mss.0000210190.64458.25; Fallah N, 2011, J AM GERIATR SOC, V59, P524, DOI 10.1111/j.1532-5415.2011.03300.x; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gezen-Ak D, 2013, J ALZHEIMERS DIS, V37, P185, DOI 10.3233/JAD-130497; Hand BD, 2007, J APPL PHYSIOL, V103, P1678, DOI 10.1152/japplphysiol.00420.2007; Haramizu S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-339; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Josse AR, 2010, MED SCI SPORT EXER, V42, P1122, DOI 10.1249/MSS.0b013e3181c854f6; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Li CM, 2010, ARCH GERONTOL GERIAT, V50, pS39, DOI 10.1016/S0167-4943(10)70011-X; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Parkhouse WS, 2000, MECH AGEING DEV, V113, P75, DOI 10.1016/S0047-6374(99)00103-7; Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121; Rothman MD, 2008, J AM GERIATR SOC, V56, P2211, DOI 10.1111/j.1532-5415.2008.02008.x; Ryan AS, 2013, OBESITY, V21, P1350, DOI 10.1002/oby.20216; Shimada H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00069; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Theou Olga, 2011, J Aging Res, V2011, P569194, DOI 10.4061/2011/569194; Tylavsky F, 2003, J APPL PHYSIOL, V94, P959, DOI 10.1152/japplphysiol.00732.2002; van Kan GA, 2010, CLIN GERIATR MED, V26, P275, DOI 10.1016/j.cger.2010.02.002; Vaughan S, 2014, AGE AGEING; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028520	39	128	145	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116256	10.1371/journal.pone.0116256	http://dx.doi.org/10.1371/journal.pone.0116256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25659147	Green Submitted, gold, Green Published			2022-12-26	WOS:000349444900033
J	Kim, HJ; Baek, S; Kim, HJ; Lee, JS; Oh, YM; Lee, SD; Lee, SW				Kim, Hyun Jung; Baek, Seunghee; Kim, Hee Jin; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won			The Impact of Smoking on Airflow Limitation in Subjects with History of Asthma and Inactive Tuberculosis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKING; GLOBAL BURDEN; LUNG-DISEASE; RISK; HYPERRESPONSIVENESS; INFLAMMATION; PREVALENCE; HEALTH; KOREA	Background Although smoking is the most important and modifiable cause of chronic obstructive pulmonary disease (COPD), other risk factors including asthma and tuberculosis (TB) are also associated. It is common for COPD patients to have more than one of these risk factors. The aims of this study were to determine the prevalence of airflow limitation (FEV1/FVC<0.7) according to the risk factors and to investigate their impact and interaction in airflow limitation. Methods From the Korean National Health and Nutrition Examination Survey between 2008 and 2012, we analyzed participants over 40 years of age by spirometry, chest radiograph and questionnaire about asthma and smoking history. Results Of 12,631 participants, 1,548 (12.3%) had airflow limitation. The prevalence of airflow limitation in smokers (>= 10 pack-year), asthmatics, and those with inactive TB was 23.9%, 32.1%, and 33.6%. The prevalence increased with the number of risk factors: 86.1% had airflow limitation if they had all three risk factors. Impacts of inactive TB and asthma on airflow limitation were equivalent to 47 and 69 pack-years of smoking, respectively. Airflow limitation resulted from lower levels of smoking in those with inactive TB and asthma. A potential interaction between smoking and inactive tuberculosis in the development of airflow limitation was identified (p = 0.054). Conclusions Asthma and inactive TB lesions increase susceptibility to smoking in the development of airflow limitation. People with these risk factors should be seen as a major target population for anti-smoking campaigns to prevent COPD.	[Kim, Hyun Jung; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Kim, Hyun Jung; Lee, Jae Seung; Oh, Yeon-Mok; Lee, Sang-Do; Lee, Sei Won] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Res Ctr Chron Obstruct Airway Dis, Seoul, South Korea; [Kim, Hyun Jung] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Baek, Seunghee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Kim, Hee Jin] Korean Inst TB, Osong, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Kyungpook National University; University of Ulsan; Asan Medical Center	Lee, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea.	iseiwon@gmail.com	Kim, Heejin/HII-8568-2022; Lee, Sei Won/AAG-9977-2019	shimotoyodome, akira/0000-0001-7567-8316	National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea [HI10C2020]	National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea	This study was supported by a grant of the National Strategic Coordinating Center for Clinical Research, Ministry for Health & Welfare Affairs, Republic of Korea (HI10C2020) to SWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ANDERSON DO, 1962, NEW ENGL J MED, V267, P787, DOI 10.1056/NEJM196210182671601; [Anonymous], 2009, LANCET, V374, P663, DOI 10.1016/S0140-6736(09)61535-X; Boulet LP, 2000, AM J RESP CRIT CARE, V162, P1308, DOI 10.1164/ajrccm.162.4.9910051; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; COX DR, 1984, INT STAT REV, V52, P1, DOI 10.2307/1403235; DAVIS RM, 1989, AM REV RESPIR DIS, V140, pS82, DOI 10.1164/ajrccm/140.3_Pt_2.S82; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Global Institute for Chronic Obstructive Lung Disease, 2013, GLOB STRAT DIAGN MAN; Hagstad S, 2014, CHEST, V145, P1298, DOI 10.1378/chest.13-1349; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; Kim DS, 2005, AM J RESP CRIT CARE, V172, P842, DOI 10.1164/rccm.200502-259OC; Kim S, 2013, ALLERGY, V68, P1435, DOI 10.1111/all.12256; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; National Herat Lung and Blood Institue, 2004, MORB MORT CHARTB CAR; OSWALD NC, 1955, LANCET, V2, P843; Perret JL, 2013, AM J RESP CRIT CARE, V187, P42, DOI 10.1164/rccm.201205-0788OC; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Straus SE, 2000, JAMA-J AM MED ASSOC, V283, P1853, DOI 10.1001/jama.283.14.1853; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; The United States of America Department of State DoHcHS Centers for Disease Control and Preventionn, INSTR PAN PHYS COMPL; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Yoo KH, 2011, RESPIROLOGY, V16, P659, DOI 10.1111/j.1440-1843.2011.01951.x	42	128	145	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2015	10	4							e0125020	10.1371/journal.pone.0125020	http://dx.doi.org/10.1371/journal.pone.0125020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG9SB	25659147	gold, Green Published, Green Submitted			2022-12-26	WOS:000353659100090
